Citrus Sinensis ID: 041491
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 467 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.937 | 0.433 | 0.365 | 2e-77 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.916 | 0.415 | 0.371 | 2e-73 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.940 | 0.447 | 0.358 | 1e-68 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.948 | 0.432 | 0.376 | 9e-66 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.877 | 0.349 | 0.348 | 2e-59 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.918 | 0.342 | 0.333 | 2e-57 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.922 | 0.345 | 0.334 | 1e-56 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.918 | 0.355 | 0.350 | 6e-56 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.927 | 0.358 | 0.349 | 1e-55 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.897 | 0.351 | 0.312 | 4e-55 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 290 bits (741), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 191/522 (36%), Positives = 279/522 (53%), Gaps = 84/522 (16%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L +N ++P++ N + +L N LNG++PL+I ++ ++ +++S N L G +
Sbjct: 438 LDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSL 497
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESL----------------------- 98
P IG L NL LSL +N+L G +P++ G ++ESL
Sbjct: 498 PQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEV 557
Query: 99 DLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRS--------------------P 138
DLS N+LSG IP L+ LNLSFN L+G +P +
Sbjct: 558 DLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIM 617
Query: 139 HLQVPLCKSSS------HRKSSKNVIL---LGVVLPLSVFIIAVLLALGIGLITRYRKGN 189
Q+ C S + H K V++ +G+ L L +F+ +V L + R RK N
Sbjct: 618 GFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTL-----IWLRKRKKN 672
Query: 190 TELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGME-VAIK 248
E +N + + + + SY +L AT+ FS +++G GSFGTVYK L + VA+K
Sbjct: 673 KETNN-PTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVK 731
Query: 249 VFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN----GN-FEALVLEYMANGSLEK 303
V ++Q GA+KSF AECE LK +RHRNLVK++++CS+ GN F AL+ E+M NGSL+
Sbjct: 732 VLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDM 791
Query: 304 CLYSS--------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM 355
L+ + L + +RL+I IDVA L+YLH P+ HCD+KPSNVLLDDD+
Sbjct: 792 WLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDL 851
Query: 356 VAHLSDFGIAKLL--NGKESMRTQ----------TLATIEYGREGQVSPKSDVYGYGITL 403
AH+SDFG+A+LL +ES Q A EYG GQ S DVY +GI L
Sbjct: 852 TAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILL 911
Query: 404 IETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLR 445
+E FT K+PT E+F L ++ LP ++++VD S+L
Sbjct: 912 LEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILH 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 180/484 (37%), Positives = 263/484 (54%), Gaps = 56/484 (11%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L + +N L+ IP + S+ D S+N L G P ++ ++++V + S N L+G
Sbjct: 469 DLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+P IGG +++ L ++ N G IP+ L SL+++D S NNLSG IP L L L+
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587
Query: 121 DLNLSFNRLKGDIPT----------------------RSPHLQVPLCKSSSHRK---SSK 155
+LNLS N+ +G +PT R L+ + ++S ++ S +
Sbjct: 588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647
Query: 156 NVILLGVVLPLSVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYQELLL 215
++ G+ + ++ ++ +++A + R +K N N + + + SY+EL
Sbjct: 648 KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHS 707
Query: 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGME---VAIKVFHLQFDGALKSFDAECEVLKSVR 272
AT FS +LIG G+FG V+KG L G E VA+KV +L GA KSF AECE K +R
Sbjct: 708 ATSRFSSTNLIGSGNFGNVFKG--LLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIR 765
Query: 273 HRNLVKIISSCSN----GN-FEALVLEYMANGSLEKCLY--------SSNGILDIFQRLS 319
HRNLVK+I+ CS+ GN F ALV E+M GSL+ L + L ++L+
Sbjct: 766 HRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLN 825
Query: 320 IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL--NGKESMRTQ 377
I IDVA ALEYLH +PV HCDIKPSN+LLDDD+ AH+SDFG+A+LL +ES Q
Sbjct: 826 IAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQ 885
Query: 378 ----------TLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV 427
A EYG GQ S + DVY +GI L+E F+ KKPT E F + NL ++
Sbjct: 886 FSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYT 945
Query: 428 NDFL 431
L
Sbjct: 946 KSIL 949
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 260 bits (665), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 176/491 (35%), Positives = 259/491 (52%), Gaps = 52/491 (10%)
Query: 2 LSLGSNELSSVIP----STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYL 57
L L N L+ IP S NL L + SSN L+G +PL++ M +V+ ++LS N L
Sbjct: 422 LDLSHNNLTGTIPVEVVSNLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNEL 479
Query: 58 TGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
+G IPP +G L+ L+L N +P S G+L L+ LD+S N L+G IP S ++
Sbjct: 480 SGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSS 539
Query: 118 YLKDLNLSFNRLKGDIPTRSPHLQVP---------LCKSSSHRKSSK---NVILLGVVLP 165
LK LN SFN L G++ + ++ LC S ++ K + + +
Sbjct: 540 TLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVL 599
Query: 166 LSVFIIAVLLALGIGLITRYRKGNT-------ELSNIEVNMSPQAMWRRFSYQELLLATD 218
LS+ VL G L+ R R G E+ + E + R SYQ+L+ AT
Sbjct: 600 LSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATG 659
Query: 219 HFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFH----LQFDGALKSFDAECEVLKSVRHR 274
F+ SLIG G FG VYKG + +VA+KV L+F G SF EC++LK RHR
Sbjct: 660 GFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSG---SFKRECQILKRTRHR 716
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYL 331
NL++II++CS F ALVL M NGSLE+ LY S+ LD+ Q ++I DVA + YL
Sbjct: 717 NLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYL 776
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG-KESMRTQTLATI-------- 382
H VVHCD+KPSN+LLDD+M A ++DFGI++L+ G +E++ T +
Sbjct: 777 HHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLC 836
Query: 383 --------EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPIS 434
EYG + S DVY +G+ L+E + ++PT + E +L ++ P S
Sbjct: 837 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDS 896
Query: 435 VMNVVDTSLLR 445
+ +++ +L R
Sbjct: 897 LEGIIEQALSR 907
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 9e-66, Method: Compositional matrix adjust.
Identities = 187/497 (37%), Positives = 267/497 (53%), Gaps = 54/497 (10%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L+LG+N+L+ IP L S++ + S N L G L DI +K ++ +++S N L+G
Sbjct: 477 DLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQ 536
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP T+ +L+ L L+ N GPIP+ G LT L LDLS NNLSG IP + L+
Sbjct: 537 IPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQ 595
Query: 121 DLNLSFNRLKGDIPTRS--------------------PHLQVPLCKSS-SHRKSSKNVIL 159
+LNLS N G +PT P LQ+ C R SS I+
Sbjct: 596 NLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKII 655
Query: 160 LGVVLPLSVFIIAVLLALGIGLITRYRKGNTELSNIEVN--MSP-QAMWRRFSYQELLLA 216
V + ++ + L + + R + +N E + SP ++ + + SY EL
Sbjct: 656 TICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKT 715
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLDGME--VAIKVFHLQFDGALKSFDAECEVLKSVRHR 274
T FS +LIG G+FG V+KG FL VAIKV +L GA KSF AECE L +RHR
Sbjct: 716 TGGFSSSNLIGSGNFGAVFKG-FLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHR 774
Query: 275 NLVKIISSCSNGNFE-----ALVLEYMANGSLEKCLY--------SSNGILDIFQRLSIM 321
NLVK+++ CS+ +FE ALV E+M NG+L+ L+ + + L +F RL+I
Sbjct: 775 NLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIA 834
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL--NGKESMRTQ-- 377
IDVA AL YLH NP+ HCDIKPSN+LLD D+ AH+SDFG+A+LL +++ Q
Sbjct: 835 IDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFS 894
Query: 378 --------TLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND 429
A EYG G S DVY +GI L+E FT K+PT ++F + + L ++
Sbjct: 895 SAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKS 954
Query: 430 FLPI-SVMNVVDTSLLR 445
L +++ D ++LR
Sbjct: 955 ALQKRQALDITDETILR 971
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (585), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 157/450 (34%), Positives = 244/450 (54%), Gaps = 40/450 (8%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L+ +N L+ IP L + D S+N +GS+P ++ K V ++ S+N L+G I
Sbjct: 630 LNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHI 689
Query: 62 PPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
P + G+ + L+L N G IP+SFG +T L SLDLS NNL+G IP SL L LK
Sbjct: 690 PDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLK 749
Query: 121 DLNLSFNRLKGDIP---------------------TRSPHLQVPLCKSSSHRKSSKNVIL 159
L L+ N LKG +P ++ P + + SSH VIL
Sbjct: 750 HLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVIL 809
Query: 160 --LGVVLPLSVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLAT 217
LG L + ++ VL+ + + ++E S +++ + + +RF +EL AT
Sbjct: 810 IILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALK--LKRFEPKELEQAT 867
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRN 275
D F+ ++IG S TVYKG+ DG +A+KV +L+ A K F E + L ++HRN
Sbjct: 868 DSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRN 927
Query: 276 LVKIIS-SCSNGNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHF 333
LVKI+ + +G +ALVL +M NG+LE ++ S I + +++ + + +A ++YLH
Sbjct: 928 LVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHS 987
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP- 392
GY P+VHCD+KP+N+LLD D VAH+SDFG A++L +E T + G G ++P
Sbjct: 988 GYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPE 1047
Query: 393 ---------KSDVYGYGITLIETFTKKKPT 413
K+DV+ +GI ++E TK++PT
Sbjct: 1048 FAYMRKVTTKADVFSFGIIMMELMTKQRPT 1077
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 224 bits (570), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 167/501 (33%), Positives = 252/501 (50%), Gaps = 72/501 (14%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L SN+ +P+ ++L +IL+ NSLNGS+P +I N++ + +NL N L+G +
Sbjct: 677 LKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPL 736
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLES-LDLSVNNLSGVIPISLEKLVYLK 120
P TIG L+ L L L N L G IP G+L L+S LDLS NN +G IP ++ L L+
Sbjct: 737 PSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLE 796
Query: 121 DLNLSFNRLKGDIPTRSPHLQ-------------------------------VPLCKSS- 148
L+LS N+L G++P + ++ LC S
Sbjct: 797 SLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPL 856
Query: 149 SH--RKSSKN--------VILLGVV-----LPLSVFIIAVLLALGIGLITRYRKGNTELS 193
SH R SKN V+++ + + L V +I + L + R GN+ S
Sbjct: 857 SHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFS 916
Query: 194 NIEVN-----MSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIK 248
+ + S + +++ AT + +E+ +IG G G VYK +G +A+K
Sbjct: 917 SNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVK 976
Query: 249 VFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFEALVLEYMANGSLEKCL 305
+ D + KSF+ E + L ++RHR+LVK++ CS+ L+ EYMANGS+ L
Sbjct: 977 KILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWL 1036
Query: 306 YSSNG-----ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLS 360
+++ +L RL I + +A +EYLH+ P+VH DIK SNVLLD ++ AHL
Sbjct: 1037 HANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLG 1096
Query: 361 DFGIAKLLNGKESMRTQTLATIEYGREGQVSP----------KSDVYGYGITLIETFTKK 410
DFG+AK+L G T++ T+ G G ++P KSDVY GI L+E T K
Sbjct: 1097 DFGLAKILTGNYDTNTES-NTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGK 1155
Query: 411 KPTCEIFCEEMNLKNWVNDFL 431
PT +F EE ++ WV L
Sbjct: 1156 MPTEAMFDEETDMVRWVETVL 1176
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 163/487 (33%), Positives = 242/487 (49%), Gaps = 56/487 (11%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
LSL N L+ IP NL ++ + N +GSLP + + + E+ LSRN LTG+I
Sbjct: 700 LSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEI 759
Query: 62 PPTIGGLTNLQ-LLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
P IG L +LQ L L N G IP + G L+ LE+LDLS N L+G +P S+ + L
Sbjct: 760 PVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLG 819
Query: 121 DLNLSFNRLKGDI-------PTRSPHLQVPLCKSSSHRK------------SSKNVILLG 161
LN+SFN L G + P S LC S R S+++V+++
Sbjct: 820 YLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIIS 879
Query: 162 VVLPLS-----VFIIAVLLALGIGLITRYRKGNTELSNIEV--NMSPQAMWRR------F 208
+ L+ + +IA+ + G+T ++ + + ++R
Sbjct: 880 AISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDI 939
Query: 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEV 267
+++++ AT + SE+ +IG G G VYK +G VA+K + D + KSF E +
Sbjct: 940 RWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKT 999
Query: 268 LKSVRHRNLVKIISSCSNGN--FEALVLEYMANGSLEKCLYSSNGIL-------DIFQRL 318
L +RHR+LVK++ CS+ + L+ EYM NGS+ L+ +L D RL
Sbjct: 1000 LGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARL 1059
Query: 319 SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT 378
I + +A +EYLH P+VH DIK SNVLLD +M AHL DFG+AK+L E+ T T
Sbjct: 1060 RIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL--TENCDTNT 1117
Query: 379 LATI-----------EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV 427
+ EY + + KSDVY GI L+E T K PT +F EM++ WV
Sbjct: 1118 DSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWV 1177
Query: 428 NDFLPIS 434
L ++
Sbjct: 1178 ETHLEVA 1184
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (556), Expect = 6e-56, Method: Compositional matrix adjust.
Identities = 165/471 (35%), Positives = 229/471 (48%), Gaps = 42/471 (8%)
Query: 16 TFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLS 75
TF + S++ D S N L GS+P ++ M + +NL N L+G IP +GGL N+ +L
Sbjct: 658 TFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILD 717
Query: 76 LENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135
L NR G IP S LT L +DLS NNLSG+IP S D + N L G P
Sbjct: 718 LSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPES-APFDTFPDYRFANNSLCG-YPL 775
Query: 136 RSPHLQVPLCKSSSHRKSS-KNVILLGVV---LPLSVFIIAVLLALGIGLITRYRKGNTE 191
P P ++ H+KS + L G V L S+F I L+ + I R RK
Sbjct: 776 PIPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAA 835
Query: 192 LSNIEVNMSPQAM----W--------------------RRFSYQELLLATDHFSEKSLIG 227
L S A W R+ ++ +LL AT+ F SL+G
Sbjct: 836 LEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVG 895
Query: 228 IGSFGTVYKGRFLDGMEVAI-KVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG 286
G FG VYK + DG VAI K+ H+ G + F AE E + ++HRNLV ++ C G
Sbjct: 896 SGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD-REFTAEMETIGKIKHRNLVPLLGYCKVG 954
Query: 287 NFEALVLEYMANGSLEKCLYSSNGI---LDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
LV EYM GSLE L+ I L+ R I I A L +LH ++H D
Sbjct: 955 EERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRD 1014
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKES-MRTQTLATI------EYGREGQVSPKSDV 396
+K SNVLLD+++ A +SDFG+A+L++ ++ + TLA EY + + S K DV
Sbjct: 1015 MKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDV 1074
Query: 397 YGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRRE 447
Y YG+ L+E T K+PT + NL WV + +V D LL+ +
Sbjct: 1075 YSYGVVLLELLTGKQPTDSADFGDNNLVGWVKLHAKGKITDVFDRELLKED 1125
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 166/475 (34%), Positives = 231/475 (48%), Gaps = 42/475 (8%)
Query: 12 VIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNL 71
+ TF + S++ D S N L GS+P ++ M + +NL N L+G IP +GGL N+
Sbjct: 654 ITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNV 713
Query: 72 QLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131
+L L NR G IP S LT L +DLS NNLSG+IP S D + N L G
Sbjct: 714 AILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPES-APFDTFPDYRFANNSLCG 772
Query: 132 DIPTRSPHLQVPLCKSSSHRKSS-KNVILLGVV---LPLSVFIIAVLLALGIGLITRYRK 187
P P P ++ H+KS + L G V L S+F I L+ + I R RK
Sbjct: 773 -YPLPLPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRK 831
Query: 188 GNTELSNIEVNMSPQAM----W--------------------RRFSYQELLLATDHFSEK 223
L S A W R+ ++ +LL AT+ F
Sbjct: 832 KEAALEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHND 891
Query: 224 SLIGIGSFGTVYKGRFLDGMEVAI-KVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISS 282
SL+G G FG VYK + DG VAI K+ H+ G + F AE E + ++HRNLV ++
Sbjct: 892 SLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD-REFTAEMETIGKIKHRNLVPLLGY 950
Query: 283 CSNGNFEALVLEYMANGSLEKCLYS--SNGI-LDIFQRLSIMIDVALALEYLHFGYSNPV 339
C G LV EYM GSLE L+ GI L+ R I I A L +LH +
Sbjct: 951 CKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHI 1010
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-MRTQTLATI------EYGREGQVSP 392
+H D+K SNVLLD+++ A +SDFG+A+L++ ++ + TLA EY + + S
Sbjct: 1011 IHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCST 1070
Query: 393 KSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRRE 447
K DVY YG+ L+E T K+PT + NL WV + +V D LL+ +
Sbjct: 1071 KGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVKLHAKGKITDVFDRELLKED 1125
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 4e-55, Method: Compositional matrix adjust.
Identities = 152/486 (31%), Positives = 236/486 (48%), Gaps = 67/486 (13%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L+L +N+L+ IP +F L S++ + + N L+G +P + N+K + ++LS N L+G++
Sbjct: 657 LNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGEL 716
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ + L L +E N+ G IP G LT LE LD+S N LSG IP + L L+
Sbjct: 717 SSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEF 776
Query: 122 LNLSFNRLKGDIPTRSPHLQVPLCKSSSHRKSSKNVILLGVV------------------ 163
LNL+ N L+G++P+ +C+ S S N L G V
Sbjct: 777 LNLAKNNLRGEVPSDG------VCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGI 830
Query: 164 ----LPLSVFIIAVLLALGIGLITRYRKGNTELSNIE----------------------- 196
L ++ + + +L +T+ K + +E
Sbjct: 831 AGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREP 890
Query: 197 ----VNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHL 252
+ M Q + + +++ ATDHFS+K++IG G FGTVYK VA+K
Sbjct: 891 LSINIAMFEQPLLK-VRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSE 949
Query: 253 QFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGIL 312
+ F AE E L V+H NLV ++ CS + LV EYM NGSL+ L + G+L
Sbjct: 950 AKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGML 1009
Query: 313 DIF---QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369
++ +RL I + A L +LH G+ ++H DIK SN+LLD D ++DFG+A+L++
Sbjct: 1010 EVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLIS 1069
Query: 370 GKESMRTQTLATI------EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIF--CEEM 421
ES + +A EYG+ + + K DVY +G+ L+E T K+PT F E
Sbjct: 1070 ACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGG 1129
Query: 422 NLKNWV 427
NL W
Sbjct: 1130 NLVGWA 1135
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 467 | ||||||
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.991 | 0.425 | 0.541 | 1e-133 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.982 | 0.432 | 0.538 | 1e-133 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.383 | 0.535 | 1e-129 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.987 | 0.324 | 0.529 | 1e-128 | |
| 359485449 | 1583 | PREDICTED: LRR receptor-like serine/thre | 0.982 | 0.289 | 0.527 | 1e-125 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.987 | 0.452 | 0.517 | 1e-125 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.991 | 0.425 | 0.515 | 1e-125 | |
| 359497186 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.970 | 0.397 | 0.510 | 1e-123 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.970 | 0.433 | 0.512 | 1e-123 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.970 | 0.368 | 0.508 | 1e-123 |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1239), Expect = e-133, Method: Compositional matrix adjust.
Identities = 268/495 (54%), Positives = 340/495 (68%), Gaps = 32/495 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L LGSN+L+S IPST W+L ILS D SSN L G LP D+ N+KV+V+I+LSRN L+G+
Sbjct: 569 HLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGE 628
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP IGGL +L LSL +NR +GPI SF L SLE +DLS N L G IP SLE LVYLK
Sbjct: 629 IPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLK 688
Query: 121 DLNLSFNRLKGDIPTR-------------------SPHLQVPLCKSSSHRKSSKNVILLG 161
L++SFN L G+IP SP L++P C++ + ++ + +LL
Sbjct: 689 YLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTISWLLLK 748
Query: 162 VVLPLSVFIIAVLLALGIGLI-TRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHF 220
+LP I++ LL L + + TR RK N L ++ A WRR SYQE+ AT+ F
Sbjct: 749 YILPA---ILSTLLFLALIFVWTRCRKRNAVLPTQSESLL-TATWRRISYQEIFQATNGF 804
Query: 221 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKII 280
S +L+G GS G+VY+G DG AIKVF+LQ + A KSFDAECEV+ +RHRNL+KI+
Sbjct: 805 SAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIV 864
Query: 281 SSCSNG--NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
SSCSN +F+ALVLEY+ NGSLE+ LYS N LDI QRL+IMIDVALA+EYLH G S P
Sbjct: 865 SSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTP 924
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR-TQTLATI-----EYGREGQVSP 392
VVHCD+KPSN+LLD+D H+ DFGIAKLL +ES+R TQTLATI +Y G V+
Sbjct: 925 VVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTT 984
Query: 393 KSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFA 452
DVY YGI L+ETFT+++PT EIF EEM++KNWV D+L S+ VVD +LLR ED+ F
Sbjct: 985 SGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFM 1044
Query: 453 AKKQCVSSALSLAMN 467
AKKQC+S L LAM+
Sbjct: 1045 AKKQCISLILGLAMD 1059
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1239), Expect = e-133, Method: Compositional matrix adjust.
Identities = 265/492 (53%), Positives = 341/492 (69%), Gaps = 33/492 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L LGSN +S IP+TFW+L +L + S NSL G+LPL+I N+KVV I+ S N L+GDI
Sbjct: 537 LYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDI 595
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P +I L NL SL +NR+QGPIP SFG+L SLE LDLS N+LSG IP SLEKLV+LK
Sbjct: 596 PTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKT 655
Query: 122 LNLSFNRLKGDIPTRSP-------------------HLQVPLCKS-SSHRKSSK-NVILL 160
N+SFNRL+G+I P +QVP CKS S+HR+S + ++
Sbjct: 656 FNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVI 715
Query: 161 GVVLPLSVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHF 220
++P FII L L + +I R +LS E + P A WR+ SY EL AT+ F
Sbjct: 716 RYIVPAIAFII---LVLALAVIIFRRSHKRKLSTQEDPLPP-ATWRKISYHELYRATEGF 771
Query: 221 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKII 280
+E +L+G GS G+VYKG DG+ +A+KVFHLQ +G L FD+ECEVL+ +RHRNLVKII
Sbjct: 772 NETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKII 831
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
SSC N +F+AL+LE++ +GSLEK LYS N LDI QRL+IMIDVA ALEYLH G + PVV
Sbjct: 832 SSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVV 891
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLN-GKESMRTQTLATI-----EYGREGQVSPKS 394
HCD+KPSNVL+++DMVAH+SDFGI++LL G +T TLATI EYG EG VS K
Sbjct: 892 HCDLKPSNVLINEDMVAHVSDFGISRLLGEGDAVTQTLTLATIGYMAPEYGLEGIVSVKG 951
Query: 395 DVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAAK 454
DVY YGI L+ETFT+KKPT ++F EM+LKNWV LP ++ V+D +LL E+++F AK
Sbjct: 952 DVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLL-IEEEHFVAK 1010
Query: 455 KQCVSSALSLAM 466
K C++S L+LA+
Sbjct: 1011 KDCITSILNLAL 1022
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 466 bits (1200), Expect = e-129, Method: Compositional matrix adjust.
Identities = 264/493 (53%), Positives = 340/493 (68%), Gaps = 32/493 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
N+ L SN L+S IPS+ NL +L + SSN LN LPL + NMK +V ++LS+N +G+
Sbjct: 684 NVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGN 743
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP TI L NL L L +N+LQG IP +FG+L SLESLDLS NNLSG IP SLE L YL+
Sbjct: 744 IPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLE 803
Query: 121 DLNLSFNRLKGDIPTR-------------------SPHLQVPLCKSSSHRKSSKNVILLG 161
LN+SFN+L+G+IP +P QV C+ S RK++K+ +LL
Sbjct: 804 YLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACEKDS-RKNTKS-LLLK 861
Query: 162 VVLPLSVFIIAVLLALGIGLITRYRKGNTELSN-IEVNMSPQAMWRRFSYQELLLATDHF 220
++PLSV + ++L + L ++++ T+ I+V++S M R +QELL AT++F
Sbjct: 862 CIVPLSVSLSTIILVV---LFVQWKRRQTKSETPIQVDLSLPRMHRMIPHQELLYATNYF 918
Query: 221 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKII 280
E +LIG GS G VYKG DG+ VA+KVF+L+ GA KSF+ ECEV++++RHRNL KII
Sbjct: 919 GEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKII 978
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
SSCSN +F+ALVLEYM NGSLEK LYS N LD QRL IMIDVA LEYLH YSNPVV
Sbjct: 979 SSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVV 1038
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATI-----EYGREGQVSPKS 394
HCD+KPSNVLLDDDMVAH+SDFGIAKLL G E M RT+TL T+ EYG EG VS K
Sbjct: 1039 HCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMKRTKTLGTVGYMAPEYGSEGIVSTKG 1098
Query: 395 DVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAAK 454
D+Y YGI L+ETF +KKPT E+F EE+ LK+WV ++M V+D +LL ED+ FA K
Sbjct: 1099 DIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFALK 1157
Query: 455 KQCVSSALSLAMN 467
+ C SS ++LA++
Sbjct: 1158 RACFSSIMTLALD 1170
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1193), Expect = e-128, Method: Compositional matrix adjust.
Identities = 261/493 (52%), Positives = 334/493 (67%), Gaps = 32/493 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
N+SL SN L+S IPS+ W L +L + SSN LN LPL++ NMK ++ ++LS+N +G+
Sbjct: 685 NISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGN 744
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP TI L NL L L +N+LQG +P +FG L SLE LDLS NN SG IP SLE L YLK
Sbjct: 745 IPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLK 804
Query: 121 DLNLSFNRLKGDIPTR-------------------SPHLQVPLCKSSSHRKSSKNVILLG 161
LN+SFN+L+G+IP R +P QV C+ + R + +LL
Sbjct: 805 YLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACEKDARRNTKS--LLLK 862
Query: 162 VVLPLSVFIIAVLLALGIGLITRYRKGNTEL-SNIEVNMSPQAMWRRFSYQELLLATDHF 220
++PLSV + ++L + L T +++ TE S ++V++ M R S+QELL AT +F
Sbjct: 863 CIVPLSVSLSTMILVV---LFTLWKRRQTESESPVQVDLLLPRMHRLISHQELLYATSYF 919
Query: 221 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKII 280
E++LIG GS G VYKG DG+ VA+KVF+L+ GA KSF+ ECEV++++RHRNL KII
Sbjct: 920 GEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKII 979
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
SSCSN +F+ALVLEYM N SLEK LYS N LD QRL IMIDVA LEYLH YSNPVV
Sbjct: 980 SSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVV 1039
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATI-----EYGREGQVSPKS 394
HCD+KPSNVLLDDDMVAH+SDFGIAKLL G E M RT+TL TI EYG EG VS K
Sbjct: 1040 HCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMKRTKTLGTIGYMAPEYGSEGIVSTKC 1099
Query: 395 DVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAAK 454
D Y YGI L+E F +KKPT E+F EE+ LK+WV ++M V+D +LL ED+ FA K
Sbjct: 1100 DTYSYGIILMEIFVRKKPTDEMFVEELTLKSWVESSAN-NIMEVIDANLLTEEDESFALK 1158
Query: 455 KQCVSSALSLAMN 467
+ C SS ++LA++
Sbjct: 1159 QACFSSIMTLALD 1171
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485449|ref|XP_002276919.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1173), Expect = e-125, Method: Compositional matrix adjust.
Identities = 259/491 (52%), Positives = 333/491 (67%), Gaps = 32/491 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L SN L+S I S+ W+L IL + SSN LNG+LPL+I NMK +++++LS+N +G I
Sbjct: 1070 LFLDSNALASQITSSLWSLGGILYLNLSSNFLNGNLPLEIGNMKTIIKLDLSKNQFSGYI 1129
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P ++G L NL LSL N LQGPIP FG++ SLESLDLS NNLSG IP SLE L+YLK
Sbjct: 1130 PSSVGQLQNLVELSLSKNNLQGPIPLKFGDVVSLESLDLSWNNLSGTIPQSLEALIYLKH 1189
Query: 122 LNLSFNRLKGDIPTR-------------------SPHLQVPLCKSSSHRKSSK-NVILLG 161
LN+SFN+ +G+I +P QV CK + RKS+K +LL
Sbjct: 1190 LNVSFNKRQGEIRNGGPFVNFTAKSFISNEALCGAPRFQVMACKKVTTRKSTKAKSLLLK 1249
Query: 162 VVLPLSVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFS 221
VLP IA + + +I R+ I+V+ S +R+ S+QELL AT++FS
Sbjct: 1250 CVLP----TIASTIIILALIILLIRRQKRLDIPIQVDSSLPTTYRKISHQELLHATNYFS 1305
Query: 222 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
E +LIG GS GTVYKG DG+ AIKVF+L+F G+ K F+AECEV++++RHRNL+KIIS
Sbjct: 1306 EGNLIGKGSMGTVYKGVLFDGLTAAIKVFNLEFLGSFKGFEAECEVMRNIRHRNLIKIIS 1365
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
SCSN F+ALVLE+M N SLE+ LYS N LD+ QRL+IMIDVA ALEYLH YSNPVVH
Sbjct: 1366 SCSNLGFKALVLEFMPNRSLERWLYSHNYCLDLIQRLNIMIDVASALEYLHHDYSNPVVH 1425
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-MRTQTLATI-----EYGREGQVSPKSD 395
CD+KP+NVLLD+D VAH+ DFGIAKLL G ES +T+TL I EYG EG VS SD
Sbjct: 1426 CDLKPNNVLLDEDRVAHVGDFGIAKLLPGSESRQQTKTLGPIGYMAPEYGSEGIVS-TSD 1484
Query: 396 VYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAAKK 455
VY GI L+E F +KKPT E+F + LK+WV + L +VM VDT+LL +ED++FA K+
Sbjct: 1485 VYSNGIMLLEVFARKKPTDEMFVGDPTLKSWV-ESLASTVMEFVDTNLLDKEDEHFAIKE 1543
Query: 456 QCVSSALSLAM 466
CV ++LA+
Sbjct: 1544 NCVLCIMALAL 1554
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1172), Expect = e-125, Method: Compositional matrix adjust.
Identities = 255/493 (51%), Positives = 320/493 (64%), Gaps = 32/493 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
NL L N LSS IP W+L +L + SN L GSLP + M+ + I LS N L+G+
Sbjct: 496 NLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGN 555
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP TIG L NL SL N QG IPE+FG L SLE LDLS NNLSG IP SLE L YL+
Sbjct: 556 IPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLE 615
Query: 121 DLNLSFNRLKGDIPTRSP-------------------HLQVPLCKSSSHRKSSKNVILLG 161
++SFN L+G+IP P LQVP C S + S LL
Sbjct: 616 FFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLR 675
Query: 162 VVLPL--SVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDH 219
LP S+ ++ + L +G RYRK I + A+ RR SY ELL AT+
Sbjct: 676 FSLPTVASILLVVAFIFLVMGCRRRYRK-----DPIPEALPVTAIQRRISYLELLHATNE 730
Query: 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 279
F E +L+GIGSFG+VY+GR DG+ VA+K+F+LQ A +SFD ECE+++++RHRNLVKI
Sbjct: 731 FHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKI 790
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
I SCSN +F+ALVLEYM GSLEK LYS N LDI QR++IMIDVA ALEYLH GY +PV
Sbjct: 791 ICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPV 850
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATI-----EYGREGQVSPK 393
VHCD+KPSNVLLD+DMVAH+ DFGIAKLL ES +T+TLATI EYG +G VS K
Sbjct: 851 VHCDLKPSNVLLDEDMVAHVCDFGIAKLLGENESFAQTRTLATIGYMAPEYGLDGLVSTK 910
Query: 394 SDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAA 453
DVY +GI L+E T+K+PT E+F EM+LK V + LP SV+++VD+++L R D Y
Sbjct: 911 IDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVK 970
Query: 454 KKQCVSSALSLAM 466
K+ CV+S + LA+
Sbjct: 971 KEHCVTSIMELAL 983
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 455 bits (1170), Expect = e-125, Method: Compositional matrix adjust.
Identities = 254/493 (51%), Positives = 329/493 (66%), Gaps = 30/493 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
NL L SN S I ST W L IL + +SN L GSLP +IEN++ V IN+S+N L+G+
Sbjct: 565 NLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGE 624
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP +IGGL +L L L N+LQGPIP+S G++ SLE LDLS NNLSG+IP SL+ L+YLK
Sbjct: 625 IPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLK 684
Query: 121 DLNLSFNRLKGDIP-------------------TRSPHLQVPLCKSSSHR--KSSKNVIL 159
N+SFN L+G+IP S LQV CK + R ++ + I+
Sbjct: 685 YFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIV 744
Query: 160 LGVVLPLSVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDH 219
L VLP VF + VL + ++ RY + + S IE + RR SY EL LAT+
Sbjct: 745 LRYVLPAIVFAVFVLAF--VIMLKRYCERKAKFS-IEDDFLALTTIRRISYHELQLATNG 801
Query: 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 279
F E + +G+GSFG+VYKG DG +A KVF+LQ + A KSFD ECEVL+++RHRNLVKI
Sbjct: 802 FQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKI 861
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
I+SCS NF+ALVLE+M N SLEK LYS + L+ QRL+IM+DVA LEYLH GY+ P+
Sbjct: 862 ITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPM 921
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-MRTQTLATI-----EYGREGQVSPK 393
HCDIKPSNVLL++DMVA L+DFGI+KLL + S M+T TLATI EYG EG VS +
Sbjct: 922 AHCDIKPSNVLLNEDMVAFLADFGISKLLGEEGSVMQTMTLATIGYMAPEYGSEGIVSVR 981
Query: 394 SDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAA 453
DVY YG+ L+ETFT+KKPT ++F E+++LK+WV L V V+D +LL E+ + AA
Sbjct: 982 GDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAA 1041
Query: 454 KKQCVSSALSLAM 466
KK C+ S L LA+
Sbjct: 1042 KKDCIVSILKLAL 1054
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1154), Expect = e-123, Method: Compositional matrix adjust.
Identities = 254/498 (51%), Positives = 335/498 (67%), Gaps = 45/498 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L SN L+ IP++ W+L +L+ + SSN L G+LP ++ NMK + ++LS+N ++G I
Sbjct: 626 LFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYI 685
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P +G L +L LSL NRLQGPIP FG+L SLESLDLS NNLSG IP SLE L+YLK
Sbjct: 686 PSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKY 745
Query: 122 LNLSFNRLKGDIPTR-------------------SPHLQVPLCKSSSHRKS--SKNVILL 160
LN+S N+L+G+IP +PH QV C ++ +S +K+ IL
Sbjct: 746 LNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILK 805
Query: 161 GVVLPL-SVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMW-----RRFSYQELL 214
++LP+ S+ + V + L I R+ N E+ +P W + S+Q+LL
Sbjct: 806 YILLPVGSIVTLVVFIVLWI-----RRRDNMEIP------TPIDSWLPGTHEKISHQQLL 854
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR 274
AT+ F E +LIG GS G VYKG +G+ VAIKVF+L+F GAL+SFD+ECEV++ +RHR
Sbjct: 855 YATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHR 914
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
NLV+II+ CSN +F+ALVLEYM NGSLEK LYS N LD+ QRL+IMIDVA ALEYLH
Sbjct: 915 NLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHD 974
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATI-----EYGREG 388
S+ VVHCD+KP+NVLLDDDMVAH++DFGI KLL ESM +T+TL TI E+G +G
Sbjct: 975 CSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGYMAPEHGSDG 1034
Query: 389 QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRRED 448
VS KSDVY YGI L+E F++KKP E+F + LK WV + L SV+ VVD +LLRRED
Sbjct: 1035 IVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVVDANLLRRED 1093
Query: 449 KYFAAKKQCVSSALSLAM 466
+ A K C+SS ++LA+
Sbjct: 1094 EDLATKLSCLSSIMALAL 1111
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1154), Expect = e-123, Method: Compositional matrix adjust.
Identities = 255/498 (51%), Positives = 335/498 (67%), Gaps = 45/498 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
LSL SN L+ IP +FW+L +L + SSN L G+LP ++ NMK + ++LS+N ++G I
Sbjct: 532 LSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYI 591
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P +G L NL LSL N+LQGPIP FG+L SLESLDLS NNLSG IP +LE L+YLK
Sbjct: 592 PSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKY 651
Query: 122 LNLSFNRLKGDIPTR-------------------SPHLQVPLCKSSSHRKS--SKNVILL 160
LN+SFN+L+G+IP +PH QV C ++ +S +K+ IL
Sbjct: 652 LNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILK 711
Query: 161 GVVLPL-SVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMW-----RRFSYQELL 214
++LP+ S + V + L I R+ N E+ +P W + S+Q+LL
Sbjct: 712 YILLPVGSTVTLVVFIVLWI-----RRRDNMEIP------TPIDSWLPGTHEKISHQQLL 760
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR 274
AT+ F E +LIG GS G VYKG +G+ VAIKVF+L+F GAL+SF++ECEV++ +RHR
Sbjct: 761 YATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHR 820
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
NLV+II+ CSN +F+ALVL+YM NGSLEK LYS LD+ QRL+IMIDVA ALEYLH
Sbjct: 821 NLVRIITCCSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHD 880
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATI-----EYGREG 388
S+ VVHCD+KPSNVLLDDDMVAH++DFGIAKLL ESM +T+TL+TI E+G G
Sbjct: 881 CSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLSTIGYMAPEHGSAG 940
Query: 389 QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRRED 448
VS KSDVY YGI L+E F +KKP E+F ++ LK WV + L SV+ VVD +LLRRED
Sbjct: 941 IVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRRED 999
Query: 449 KYFAAKKQCVSSALSLAM 466
+ A K C+SS ++LA+
Sbjct: 1000 EDLATKLSCLSSIMALAL 1017
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1152), Expect = e-123, Method: Compositional matrix adjust.
Identities = 253/498 (50%), Positives = 334/498 (67%), Gaps = 45/498 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L SN L+ IP++ W+L +L + SSN L G+LP ++ NMK + ++LS+N ++G I
Sbjct: 715 LFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGHI 774
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P +G NL LSL N+LQGPIP FG+L SLESLDLS NNLSG IP SLE L+YLK
Sbjct: 775 PRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKY 834
Query: 122 LNLSFNRLKGDIPTR-------------------SPHLQVPLCKSSSHRKS--SKNVILL 160
LN+S N+L+G+IP +PH QV C ++ +S +K+ IL
Sbjct: 835 LNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILK 894
Query: 161 GVVLPL-SVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMW-----RRFSYQELL 214
++LP+ S+ + V + L I R+ N E+ +P W + S+Q+LL
Sbjct: 895 YILLPVGSIVTLVVFIVLWI-----RRRDNMEIP------TPIDSWLPGTHEKISHQQLL 943
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR 274
AT+ F E +LIG GS G VYKG +G+ VAIKVF+L+F GAL+SFD+ECEV++ +RHR
Sbjct: 944 YATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHR 1003
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
NLV+II+ CSN +F+ALVLEYM NGSLEK LYS N LD+ QRL+IMIDVA ALEYLH
Sbjct: 1004 NLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHD 1063
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATI-----EYGREG 388
S+ VVHCD+KP+NVLLDDDMVAH++DFGI KLL ESM +T+TL TI E+G +G
Sbjct: 1064 CSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGYMAPEHGSDG 1123
Query: 389 QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRRED 448
VS KSDVY YGI L+E F++KKP E+F ++ LK WV + L SV+ VVD +LLRRED
Sbjct: 1124 IVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANLLRRED 1182
Query: 449 KYFAAKKQCVSSALSLAM 466
+ A K C+SS ++LA+
Sbjct: 1183 EDLATKLSCLSSIMALAL 1200
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 467 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.927 | 0.428 | 0.383 | 2.1e-67 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.845 | 0.385 | 0.396 | 7.2e-66 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.978 | 0.452 | 0.352 | 8.1e-66 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.980 | 0.453 | 0.352 | 1e-63 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.828 | 0.394 | 0.374 | 1.2e-60 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.498 | 0.195 | 0.375 | 5.5e-60 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.871 | 0.346 | 0.347 | 3.9e-59 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.940 | 0.428 | 0.357 | 7.8e-59 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.841 | 0.313 | 0.318 | 3.8e-44 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.464 | 0.167 | 0.372 | 6.4e-56 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 2.1e-67, P = 2.1e-67
Identities = 183/477 (38%), Positives = 257/477 (53%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L + N L +P L ++ + N L+G LP + N + + L N GDI
Sbjct: 486 LDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDI 545
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + GL ++ + L NN L G IPE F + LE L+LS NNL G +P+ K ++
Sbjct: 546 PD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPV---KGIFENA 601
Query: 122 LNLSF---NRLKGDIP--TRSPHL-QVP--LCKSSSHRKSSKNVILLGVVLPLSVFXXXX 173
+S N L G I P L Q P + K SS K + +G+ L L +F
Sbjct: 602 TTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASV 661
Query: 174 XXXXXXXXXTRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGT 233
R RK N E +N + + + + SY +L AT+ FS +++G GSFGT
Sbjct: 662 TLIWL-----RKRKKNKETNN-PTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGT 715
Query: 234 VYKGRFLDGMEV-AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN----GN- 287
VYK L +V A+KV ++Q GA+KSF AECE LK +RHRNLVK++++CS+ GN
Sbjct: 716 VYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNE 775
Query: 288 FEALVLEYMANGSLEKCLYSS--------NGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
F AL+ E+M NGSL+ L+ + L + +RL+I IDVA L+YLH P+
Sbjct: 776 FRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPI 835
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLN--GKESMRTQ--------TL--ATIEYGRE 387
HCD+KPSNVLLDDD+ AH+SDFG+A+LL +ES Q T+ A EYG
Sbjct: 836 AHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVG 895
Query: 388 GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLL 444
GQ S DVY +GI L+E FT K+PT E+F L ++ LP ++++VD S+L
Sbjct: 896 GQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL 952
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 7.2e-66, P = 7.2e-66
Identities = 170/429 (39%), Positives = 245/429 (57%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSI-LSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG 59
+L L +N LS IPS +N+ ++ + + S N+L GS+P +I ++K +VE + N L+G
Sbjct: 476 SLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSG 535
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
IP T+G L+ L L+NN L G IP + G+L LE+LDLS NNLSG IP SL + L
Sbjct: 536 KIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITML 595
Query: 120 KDLNLSFNRLKGDIPTRSPH-------LQ--VPLCKSSSHRKSSKNVILLG-----VVLP 165
LNLSFN G++PT +Q LC + LL VLP
Sbjct: 596 HSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLP 655
Query: 166 LSV-FXXXXXXXXXXXXXTRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKS 224
+SV + K + + +M + SY +L+ ATD F+ +
Sbjct: 656 ISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPL---VSYSQLVKATDGFAPTN 712
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
L+G GSFG+VYKG+ VA+KV L+ ALKSF AECE L+++RHRNLVKI++ CS
Sbjct: 713 LLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICS 772
Query: 285 N----GN-FEALVLEYMANGSLEKCLYSSNGI------LDIFQRLSIMIDVALALEYLHF 333
+ GN F+A+V ++M NGSLE ++ L++ +R++I++DVA AL+YLH
Sbjct: 773 SIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHR 832
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY-GREGQVSP 392
PVVHCDIK SNVLLD DMVAH+ DFG+A++L S+ Q+ +++ + G G +P
Sbjct: 833 HGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAP 892
Query: 393 KSDVYGYGI 401
+ YG G+
Sbjct: 893 E---YGVGL 898
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 674 (242.3 bits), Expect = 8.1e-66, P = 8.1e-66
Identities = 176/499 (35%), Positives = 267/499 (53%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
NLS+ N LS +P+ +L +++ +N +G LP + N + ++ L N G
Sbjct: 486 NLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGA 545
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP----ISLEKL 116
IP I GL ++ + L NN L G IPE F + LE L+LS+NN +G +P +
Sbjct: 546 IP-NIRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTI 604
Query: 117 VYL-KDLNLSFNRLKGDIPTRSPHLQVPLC--KSSSHRKSSKNVILLGVVLPLSVFXXXX 173
V++ + NL +K D+ + Q P K SSH K ++ +G+ L L +
Sbjct: 605 VFVFGNKNLC-GGIK-DLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASM 662
Query: 174 XXXXXXXXXTRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGT 233
R R+ N + +N+ V + + SY +L AT+ FS +++G GSFGT
Sbjct: 663 VLCWF-----RKRRKNQQTNNL-VPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGT 716
Query: 234 VYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN----GN- 287
V+K + VA+KV ++Q GA+KSF AECE LK RHRNLVK++++C++ GN
Sbjct: 717 VFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNE 776
Query: 288 FEALVLEYMANGSLEKCLYSSN--------GILDIFQRLSIMIDVALALEYLHFGYSNPV 339
F AL+ EY+ NGS++ L+ L + +RL+I+IDVA L+YLH P+
Sbjct: 777 FRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPI 836
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLN--GKESMRTQ--------TL--ATIEYGRE 387
HCD+KPSNVLL+DD+ AH+SDFG+A+LL KES Q T+ A EYG
Sbjct: 837 AHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMG 896
Query: 388 GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRRE 447
GQ S DVY +G+ L+E FT K+PT E+F + L ++ LP V + D ++L
Sbjct: 897 GQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIG 956
Query: 448 DKYFAAKKQCVSSALSLAM 466
+ +C++ L + +
Sbjct: 957 LRVGFRTAECLTLVLEVGL 975
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 1.0e-63, P = 1.0e-63
Identities = 175/496 (35%), Positives = 265/496 (53%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L++ SN LS +P+ L +++ +N+L+G LP + + I L N+ G
Sbjct: 486 HLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGT 545
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP I GL ++ + L NN L G I E F + LE L+LS NN G +P E +
Sbjct: 546 IPD-IKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPT--EGIFQNA 602
Query: 121 DLNLSF-NR-LKGDIPTRSPHLQVPLCKSSSHRKSSKNVILLG-VVLPLSV-FXXXXXXX 176
L F N+ L G I L++ C + + +++ LL V + +SV
Sbjct: 603 TLVSVFGNKNLCGSIK----ELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLF 658
Query: 177 XXXXXXTRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYK 236
+ RK N +++N + + + SY +L ATD FS +++G GSFGTV+K
Sbjct: 659 IVSLSWFKKRKNNQKINN-SAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFK 717
Query: 237 GRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN----GN-FEA 290
+ VA+KV ++Q GA+KSF AECE LK +RHRNLVK++++C++ GN F A
Sbjct: 718 ALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRA 777
Query: 291 LVLEYMANGSLEKCLYSS--------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
L+ E+M NGSL+K L+ + L + +RL+I IDVA L+YLH P+ HC
Sbjct: 778 LIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHC 837
Query: 343 DIKPSNVLLDDDMVAHLSDFGIAKLLN--GKESMRTQ--------TL--ATIEYGREGQV 390
D+KPSN+LLDDD+ AH+SDFG+A+LL +ES Q T+ A EYG GQ
Sbjct: 838 DLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQP 897
Query: 391 SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKY 450
S DVY +G+ ++E FT K+PT E+F L ++ LP V+++ D S+L +
Sbjct: 898 SIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRV 957
Query: 451 FAAKKQCVSSALSLAM 466
+C+ L + +
Sbjct: 958 GFPVLECLKGILDVGL 973
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 1.2e-60, Sum P(2) = 1.2e-60
Identities = 155/414 (37%), Positives = 218/414 (52%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L+L SN LS IP ++ +LS D SSN L+G +P + + + +NLSRN + +
Sbjct: 448 LNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTL 507
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P ++G L L+ L + NRL G IP SF + ++L+ L+ S N LSG + +K + K
Sbjct: 508 PSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVS---DKGSFSK- 563
Query: 122 LNLSFNRLKGDIPTRSPHLQVPLCKSSSHRKSSKNVILLGVVL-P-LSVFXX-XXXXXXX 178
L+ GD + CK S +LL ++ P L VF
Sbjct: 564 --LTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRF 621
Query: 179 XXXXTRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGR 238
T Y K E + P+ + R SYQ+L+ AT F+ SLIG G FG VYKG
Sbjct: 622 GKNLTVYAKEEVEDEEKQNQNDPK--YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGV 679
Query: 239 FLDGMEVAIKVFH----LQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294
+ +VA+KV L+F G SF EC++LK RHRNL++II++CS F ALVL
Sbjct: 680 LRNNTKVAVKVLDPKTALEFSG---SFKRECQILKRTRHRNLIRIITTCSKPGFNALVLP 736
Query: 295 YMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL 351
M NGSLE+ LY S+ LD+ Q ++I DVA + YLH VVHCD+KPSN+LL
Sbjct: 737 LMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILL 796
Query: 352 DDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGRE-----GQVSPKSDVYGYG 400
DD+M A ++DFGI++L+ G E T ++ +G G V + YG G
Sbjct: 797 DDEMTALVTDFGISRLVQGVEET-VSTDDSVSFGSTDGLLCGSVGYIAPEYGMG 849
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 386 (140.9 bits), Expect = 5.5e-60, Sum P(2) = 5.5e-60
Identities = 92/245 (37%), Positives = 136/245 (55%)
Query: 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV 271
+++ ATDHFS+K++IG G FGTVYK VA+K + F AE E L V
Sbjct: 909 DIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKV 968
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF---QRLSIMIDVALAL 328
+H NLV ++ CS + LV EYM NGSL+ L + G+L++ +RL I + A L
Sbjct: 969 KHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGL 1028
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-TI----- 382
+LH G+ ++H DIK SN+LLD D ++DFG+A+L++ ES + +A T
Sbjct: 1029 AFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPP 1088
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNW-VNDFLPISVMNVV 439
EYG+ + + K DVY +G+ L+E T K+PT F E NL W + ++V+
Sbjct: 1089 EYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVI 1148
Query: 440 DTSLL 444
D L+
Sbjct: 1149 DPLLV 1153
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 3.9e-59, P = 3.9e-59
Identities = 149/429 (34%), Positives = 243/429 (56%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
+ L +N S IP + ++ + DFS N+L+G +P ++ + M +++ +NLSRN +G+
Sbjct: 654 IDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGE 713
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP + G +T+L L L +N L G IPES L++L+ L L+ NNL G +P E V+ K
Sbjct: 714 IPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVP---ESGVF-K 769
Query: 121 DLNLSFNRLKGDI-PTRSPHLQVPLCKSSSHRKSSKNVILLGVVLPLSVFXXXXXXXXXX 179
++N S D+ ++ P + + SSH VIL+ + ++
Sbjct: 770 NINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILT 829
Query: 180 XXXTRYRK-GNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGR 238
+ +K N+ S++ ++ +RF +EL ATD F+ ++IG S TVYKG+
Sbjct: 830 CCKKKEKKIENSSESSLP-DLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQ 888
Query: 239 FLDGMEVAIKVFHL-QFDGAL-KSFDAECEVLKSVRHRNLVKIIS-SCSNGNFEALVLEY 295
DG +A+KV +L +F K F E + L ++HRNLVKI+ + +G +ALVL +
Sbjct: 889 LEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPF 948
Query: 296 MANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354
M NG+LE ++ S I + +++ + + +A ++YLH GY P+VHCD+KP+N+LLD D
Sbjct: 949 MENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSD 1008
Query: 355 MVAHLSDFGIAKLLNGKE--SMRTQTLA---TI-----EYGREGQVSPKSDVYGYGITLI 404
VAH+SDFG A++L +E S T A TI E+ +V+ K+DV+ +GI ++
Sbjct: 1009 RVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMM 1068
Query: 405 ETFTKKKPT 413
E TK++PT
Sbjct: 1069 ELMTKQRPT 1077
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 7.8e-59, P = 7.8e-59
Identities = 170/475 (35%), Positives = 246/475 (51%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L++ N L + L +L+ D S N L+G +P + N + + L N G I
Sbjct: 502 LNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPI 561
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPIS-LEKLVYLK 120
P I GLT L+ L L N L G IPE + L++L+LS+NN G +P + +
Sbjct: 562 PD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAM 620
Query: 121 DLNLSFNRLKGDIPTRSPHLQVPLCKSSSHRKSSKNVILLGV-VLPLSVFXXXXXXXXXX 179
+ + N L G IP S LQ + S + +I + V + ++
Sbjct: 621 SVFGNIN-LCGGIP--SLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLC 677
Query: 180 XXXTRYRKGNTELSNIEVNMSP-QAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGR 238
R + + + + SP ++ + + SY EL T FS +LIG G+FG V+KG
Sbjct: 678 WYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKG- 736
Query: 239 FLDGME--VAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE-----AL 291
FL VAIKV +L GA KSF AECE L +RHRNLVK+++ CS+ +FE AL
Sbjct: 737 FLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRAL 796
Query: 292 VLEYMANGSLEKCLY----SSNG----ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
V E+M NG+L+ L+ G L +F RL+I IDVA AL YLH NP+ HCD
Sbjct: 797 VYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCD 856
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLN--GKESMRTQ--------TL--ATIEYGREGQVS 391
IKPSN+LLD D+ AH+SDFG+A+LL +++ Q T+ A EYG G S
Sbjct: 857 IKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPS 916
Query: 392 PKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPI-SVMNVVDTSLLR 445
DVY +GI L+E FT K+PT ++F + + L ++ L +++ D ++LR
Sbjct: 917 IMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILR 971
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 3.8e-44, P = 3.8e-44
Identities = 135/424 (31%), Positives = 213/424 (50%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVE-INLSRNYLTGD 60
L+L N+LS +PST L+ + S N+L G +P++I ++ + ++LS N TG
Sbjct: 725 LNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGR 784
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP TI L L+ L L +N+L G +P G++ SL L+LS NNL G + + +
Sbjct: 785 IPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSR--WQA 842
Query: 121 DLNLSFNRLKGDIPTRSPHLQVPLCKSSSHRK-SSKNVILLGVV-----LPLSVFXXXXX 174
D + L G SP S + R S K V+++ + + L V
Sbjct: 843 DAFVGNAGLCG-----SPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILF 897
Query: 175 XXXXXXXXTRYRKGNTELS-NIEVNMSPQ----AMWRRFSYQELLLATDHFSEKSLIGIG 229
+ R GN+ S N + +P + +++ AT + +E+ +IG G
Sbjct: 898 FKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSG 957
Query: 230 SFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSN--G 286
G VYK +G +A+K + D + KSF+ E + L ++RHR+LVK++ CS+
Sbjct: 958 GSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKAD 1017
Query: 287 NFEALVLEYMANGSLEKCLYSSNG-----ILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
L+ EYMANGS+ L+++ +L RL I + +A +EYLH+ P+VH
Sbjct: 1018 GLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVH 1077
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPKSDVYGYGI 401
DIK SNVLLD ++ AHL DFG+AK+L G T++ T+ G G ++P+ Y Y +
Sbjct: 1078 RDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTES-NTMFAGSYGYIAPE---YAYSL 1133
Query: 402 TLIE 405
E
Sbjct: 1134 KATE 1137
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 355 (130.0 bits), Expect = 6.4e-56, Sum P(2) = 6.4e-56
Identities = 88/236 (37%), Positives = 131/236 (55%)
Query: 207 RFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFH--LQFDGALKSFDAE 264
R + ++L AT++FS+ +IG G FGTVYK +G VAIK H QF G + F AE
Sbjct: 989 RVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGD-REFLAE 1047
Query: 265 CEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF---QRLSIM 321
E + V+H NLV ++ C G+ L+ EYM NGSLE L + L+ RL I
Sbjct: 1048 METIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLKIC 1107
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-MRTQTLA 380
+ A L +LH G+ ++H D+K SN+LLD++ +SDFG+A++++ E+ + T
Sbjct: 1108 LGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAG 1167
Query: 381 TI-----EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----NLKNWV 427
T EYG + + K DVY +G+ ++E T + PT + EE+ NL WV
Sbjct: 1168 TFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQ---EEVQGGGNLVGWV 1220
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 467 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.004 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-45
Identities = 69/189 (36%), Positives = 101/189 (53%), Gaps = 12/189 (6%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSC 283
+G G FGTVY R G +VAIK+ + L+ E E+LK + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+ N LV+EY GSL+ L + G L + L I++ + LEYLH SN ++H D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 344 IKPSNVLLD-DDMVAHLSDFGIAKLLNGKESMRTQTLATIEY------GREGQVSPKSDV 396
+KP N+LLD D+ L+DFG++KLL +S+ + T Y +G S KSD+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 397 YGYGITLIE 405
+ G+ L E
Sbjct: 178 WSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-44
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNL 276
+ +G GSFGTVYK + G VA+K+ + ++ E +L+ + H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
V++I + + + LV+EY G L S G L + I + + LEYLH S
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY-------GREGQ 389
N ++H D+KP N+LLD++ V ++DFG+AK L S T + T Y G G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
PK DV+ G+ L E T K P
Sbjct: 177 -GPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 64/200 (32%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLV 277
+ +G GSFG VY R G VAIKV + + E ++LK ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
++ + + LV+EY G L L G L + + + ALEYLH S
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SK 116
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY-----GREGQVSP 392
+VH D+KP N+LLD+D L+DFG+A+ L+ E + T + T EY
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF-VGTPEYMAPEVLLGKGYGK 175
Query: 393 KSDVYGYGITLIETFTKKKP 412
D++ G+ L E T K P
Sbjct: 176 AVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 21/198 (10%)
Query: 226 IGIGSFGTVYKGRFLD-----GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKI 279
+G G+FG VYKG+ +EVA+K + ++ F E +++ + H N+VK+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
+ C+ +V+EYM G L L + L + LS + +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT-------LA--TIEYGREGQV 390
+H D+ N L+ +++V +SDFG+++ L + R + +A +++ G+
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK---F 180
Query: 391 SPKSDVYGYGITLIETFT 408
+ KSDV+ +G+ L E FT
Sbjct: 181 TSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-37
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 219 HFSEKSLIGIGSFGTVYKGR-----FLDGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVR 272
+K +G G+FG VYKG +VA+K + F E ++K +
Sbjct: 2 ELGKK--LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS 59
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
H N+V+++ C+ G +V EYM G L L L + L + + +A +EYL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-------EYG 385
S VH D+ N L+ +++V +SDFG+++ + + R + + E
Sbjct: 120 ---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 386 REGQVSPKSDVYGYGITLIETFT 408
++G+ + KSDV+ +G+ L E FT
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 226 IGIGSFGTVYKGRFLDG-----MEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKI 279
+G G+FG VYKG +EVA+K + ++ F E +++ + H N+VK+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCL-YSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ C+ +V+EYM G L L + L + LS + +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT-------LA--TIEYGREGQ 389
+H D+ N L+ +++V +SDFG+++ L + + + +A +++ G+
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK--- 180
Query: 390 VSPKSDVYGYGITLIETFT 408
+ KSDV+ +G+ L E FT
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKII 280
+G G+FG VYKG+ EVA+K K F E V+K + H N+V+++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 281 SSCSNGNFEALVLEYMANGSLEKCL--------YSSNGILDIFQRLSIMIDVALALEYLH 332
C+ LVLEYM G L L L + LS I +A +EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-------EYG 385
S VH D+ N L+ +D+V +SDFG+++ + + R +T + E
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 386 REGQVSPKSDVYGYGITLIETFTK-KKPTCEIFCEEM 421
++G + KSDV+ +G+ L E FT P + EE+
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 117/452 (25%), Positives = 201/452 (44%), Gaps = 44/452 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
LSL N+ +P +F + + + D S N +G++P + ++ ++++ LS N L+G+I
Sbjct: 457 LSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + L L L +N+L G IP SF E+ L LDLS N LSG IP +L + L
Sbjct: 516 PDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ 575
Query: 122 LNLSFNRLKGDIPTRSPHLQV---------PLCKSSSH------RKSSKNVILLGVVLPL 166
+N+S N L G +P+ L + LC + ++ K +
Sbjct: 576 VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCT 635
Query: 167 SVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQAMW----------RRFSYQELLLA 216
+ + L G + + N EL +E + W + + ++L +
Sbjct: 636 LGAFLVLALV-AFGFVFIRGRNNLELKRVE---NEDGTWELQFFDSKVSKSITINDILSS 691
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
E+++I G G YKG+ + +GM+ +K + + S A+ + ++H N
Sbjct: 692 L---KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPN 744
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+VK+I C + L+ EY+ +L + L + L +R I I +A AL +LH
Sbjct: 745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRC 800
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQ-VSPKS 394
S VV ++ P +++D HL + LL + RE + ++ KS
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKS 859
Query: 395 DVYGYGITLIETFTKKKPTCEIFCEEMNLKNW 426
D+YG+G+ LIE T K P F ++ W
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRNLVKIIS 281
L+G GSFG+VY D G +A+K L D L++ + E +L S++H N+V+
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 282 SCSN--GNFEALVLEYMANGSLEKCLYSSNGILD--IFQRLSIMIDVALALEYLHFGYSN 337
S + N + LEY++ GSL L G L + ++ + I L YLH SN
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQI--LEGLAYLH---SN 120
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLA-TIEYG-----REGQV 390
+VH DIK +N+L+D D V L+DFG AK L E+ T ++ T + R +
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 391 SPKSDVYGYGITLIETFTKKKP 412
+D++ G T+IE T K P
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 71/195 (36%), Positives = 105/195 (53%), Gaps = 20/195 (10%)
Query: 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIIS 281
+ IG G FG V G + G +VA+K L+ D A ++F AE V+ ++RH NLV+++
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKC--LKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
GN +V EYMA GSL L S ++ + Q+L +DV +EYL V
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPK 393
H D+ NVL+ +D+VA +SDFG+A KE+ + Q + E RE + S K
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLA-----KEASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 394 SDVYGYGITLIETFT 408
SDV+ +GI L E ++
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 70/204 (34%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 219 HFSEKSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRN 275
++ LIG G+FG VYKG G VAIK L+ ALKS E ++LK+++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSI--MIDVALALEYLHF 333
+VK I S + ++LEY NGSL + + G + L + V L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQ-IIKKFGPFP--ESLVAVYVYQVLQGLAYLH- 116
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-----EYGREG 388
V+H DIK +N+L D V L+DFG+A LN + T E
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 389 QVSPKSDVYGYGITLIETFTKKKP 412
S SD++ G T+IE T P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 68/200 (34%), Positives = 95/200 (47%), Gaps = 10/200 (5%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
F IG G FG VYK R G EVAIKV L+ + E ++LK +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
K S + +V+E+ + GSL+ L S+N L Q + ++ LEYLH SN
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SN 117
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-----EYGREGQVSP 392
++H DIK +N+LL D L DFG++ L+ R + T E
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 393 KSDVYGYGITLIETFTKKKP 412
K+D++ GIT IE K P
Sbjct: 177 KADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 64/210 (30%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRN 275
+ IG GSFG VY R DG +K L + DA E ++LK + H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF---QRLSIMIDVALALEYLH 332
++K S +V+EY G L + + F Q L + + LAL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP 392
S ++H DIKP N+ L + + L DFGI+K+L+ + + T Y +SP
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY-----LSP 172
Query: 393 ----------KSDVYGYGITLIETFTKKKP 412
KSD++ G L E T K P
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 13/191 (6%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285
+G G FG V++G + + + VAIK+ + F E + LK +RH++L+ + + CS
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 286 GNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
G ++ E M GSL L S G +L + + + VA + YL +H D+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY-------GREGQVSPKSDVY 397
N+L+ +D+V ++DFG+A+L+ KE + + I Y G S KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 398 GYGITLIETFT 408
+GI L E FT
Sbjct: 189 SFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 70/210 (33%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH-RNLVKI 279
+G GSFG VY R D VA+KV + ++ F E ++L S+ H N+VK+
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 280 ISSCSNGNFEALVLEYMANGSLEK--CLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+ LV+EY+ GSLE G L + L I+ + ALEYLH S
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120
Query: 338 PVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKESMRTQTLAT--------------I 382
++H DIKP N+LLD D V L DFG+AKLL S + +
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
S SD++ GITL E T P
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 8e-24
Identities = 64/193 (33%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALK-SFDAECEVLKSVRHRNLVKIISSC 283
IG G+FG VYKG EVA+K LK F E E+LK H N+VK+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+V+E + GSL L L + + L + +D A +EYL S +H D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPKSDV 396
+ N L+ ++ V +SDFG+++ G + L I E G+ + +SDV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 397 YGYGITLIETFTK 409
+ YGI L ETF+
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+ + IG G+ G VYK G EVAIK L+ + E ++K +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPN 76
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+V S G+ +V+EYM GSL + + ++ Q + +V LEYLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--- 133
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT--------I---EY 384
S V+H DIK N+LL D L+DFG A L ++S R + T I +Y
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 385 GREGQVSPKSDVYGYGITLIE 405
G PK D++ GI IE
Sbjct: 194 G------PKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRN 275
++G GS G VYK R G A+K H+ D K E + L+S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 276 LVKIISSCSNGNFE----ALVLEYMANGSLEKCLYSSNGILDIFQRLSIM-IDVALALEY 330
+VK C ++ ++VLEYM GSL L I + L+ + + L+Y
Sbjct: 61 VVK----CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV--LAYIARQILKGLDY 114
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV 390
LH ++H DIKPSN+L++ ++DFGI+K+L + T+ Y +
Sbjct: 115 LH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY-----M 167
Query: 391 SP----------KSDVYGYGITLIETFTKKKP 412
SP +D++ G+TL+E K P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-22
Identities = 70/193 (36%), Positives = 99/193 (51%), Gaps = 22/193 (11%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC-- 283
IG G FG V G + G +VA+K ++ D ++F AE V+ +RH NLV+++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 284 SNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
G +V EYMA GSL L S +L L +DV A+EYL +N VH
Sbjct: 71 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126
Query: 343 DIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPKSD 395
D+ NVL+ +D VA +SDFG+ KE+ TQ + E RE + S KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 396 VYGYGITLIETFT 408
V+ +GI L E ++
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-22
Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH 273
LL + +IG G FG V +G + G +VA+K ++ D ++F E V+ + H
Sbjct: 2 LLNLQKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHH 58
Query: 274 RNLVKIISSC-SNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYL 331
+NLV+++ NG + +V+E M+ G+L L + ++ + Q L +DVA +EYL
Sbjct: 59 KNLVRLLGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL----ATIEYGRE 387
S +VH D+ N+L+ +D VA +SDFG+A++ G + L E +
Sbjct: 117 E---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEALKH 171
Query: 388 GQVSPKSDVYGYGITLIETFT 408
+ S KSDV+ YG+ L E F+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 226 IGIGSFGTVYKGR--FLD---GMEVAIKVF-HLQFDGALKSFDAECEVLKSVRHRNLVKI 279
+G G FG V R L G +VA+K H + F+ E E+L+++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 280 ISSC--SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
C G L++EY+ +GSL L +++ + L + ++YL S
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQ 128
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-GKESMRTQTLATI-------EYGREGQ 389
+H D+ N+L++ + + +SDFG+AK+L K+ + E R +
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 390 VSPKSDVYGYGITLIETFTKKKPTCE 415
S SDV+ +G+TL E FT P+
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 21/196 (10%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALK--SFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V+ G + +VA+K G + +F E +++K +RH LV++ + C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
S +V EYM+ GSL L S G L + Q + + +A + YL S +H
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127
Query: 343 DIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ---------TLATIEYGREGQVSPK 393
D+ N+L+ +++V ++DFG+A+L+ E + YGR + K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR---FTIK 184
Query: 394 SDVYGYGITLIETFTK 409
SDV+ +GI L E T
Sbjct: 185 SDVWSFGILLTEIVTY 200
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 8e-22
Identities = 60/197 (30%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 218 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
+ + IG G++G VYK R G VAIKV L+ + E +LK RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
V S + +V+EY GSL+ + G L Q + + L YLH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---E 119
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT--------IEYGREG 388
+H DIK +N+LL +D L+DFG++ L + R + T R+G
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 389 QVSPKSDVYGYGITLIE 405
K D++ GIT IE
Sbjct: 180 GYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-21
Identities = 63/140 (45%), Positives = 79/140 (56%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L LG N L IP++ NL S+ +SN L G +P ++ MK + I L N L+G+I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P IGGLT+L L L N L GPIP S G L +L+ L L N LSG IP S+ L L
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 122 LNLSFNRLKGDIPTRSPHLQ 141
L+LS N L G+IP LQ
Sbjct: 289 LDLSDNSLSGEIPELVIQLQ 308
|
Length = 968 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 28/203 (13%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DG----ALKSFDAECEVLKSVRHRNLVK 278
IG G++G VYK R G VA+K ++ +G A++ E ++L+ +RH N+V+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 279 ---IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
I++S G+ +V EYM + L L S Q M + L+YLH
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--- 117
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR-TQTLATIEYGR-------E 387
SN ++H DIK SN+L+++D V L+DFG+A+ + S T + T+ Y R
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY-RPPELLLGA 176
Query: 388 GQVSPKSDVYGYGITLIETFTKK 410
+ P+ D++ G L E F K
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 14/194 (7%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V+ G++ ++VAIK+ +GA+ F E +V+ + H NLV++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+ +V EYMANG L L G L L + DV A+EYL SN +H D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ------TLATIEYGREGQVSPKSDVY 397
+ N L+ +D V +SDFG+A+ + + +Q A E + S KSDV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 398 GYGITLIETFTKKK 411
+G+ + E F++ K
Sbjct: 186 SFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
F +G GS+G+VYK + G VAIKV + + L+ E +LK +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
S +V+EY GS+ + +N L + +I+ LEYLH SN
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP------ 392
+H DIK N+LL+++ A L+DFG++ L + R + T + ++P
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW-----MAPEVIQEI 174
Query: 393 ----KSDVYGYGITLIETFTKKKPTCEI 416
K+D++ GIT IE K P +I
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 60/144 (41%), Positives = 80/144 (55%), Gaps = 3/144 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L+L SN+L IP + S+ N+L+G +P +I + + ++L N LTG I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P ++G L NLQ L L N+L GPIP S L L SLDLS N+LSG IP + +L L+
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 122 LNLSFNRLKGDIP---TRSPHLQV 142
L+L N G IP T P LQV
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQV 336
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 49/134 (36%), Positives = 78/134 (58%), Gaps = 2/134 (1%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L+L +N + IP + ++ + D S+N L+G +P DI + + ++L N L G I
Sbjct: 123 LNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P ++ LT+L+ L+L +N+L G IP G++ SL+ + L NNLSG IP + L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 122 LNLSFNRLKGDIPT 135
L+L +N L G IP+
Sbjct: 241 LDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 53/131 (40%), Positives = 72/131 (54%)
Query: 4 LGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP 63
LG N LS IP L S+ D N+L G +P + N+K + + L +N L+G IPP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 64 TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLN 123
+I L L L L +N L G IPE +L +LE L L NN +G IP++L L L+ L
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338
Query: 124 LSFNRLKGDIP 134
L N+ G+IP
Sbjct: 339 LWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 65/208 (31%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFH----LQFDGALKSFDAECEVLKSVRHRNLVKII 280
+G GSFG V R D G A+KV ++ + E +L + H +VK+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ LVLEY G L L S G + ++ LALEYLH S ++
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLALEYLH---SLGII 115
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-TIEY-----GREGQVSPKS 394
+ D+KP N+LLD D L+DFG+AK E RT T T EY
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 395 DVYGYGITLIETFTKKKP-----TCEIF 417
D + G+ L E T K P EI+
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 7/192 (3%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRNLVKIISSC 283
+G G+ G V K G +A+K L+ + A+ K E ++L +V +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
N ++ +EYM GSL+K L G + I + V L YLH + ++H D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 344 IKPSNVLLDDDMVAHLSDFGIA-KLLN--GKESMRTQTLATIEYGREGQVSPKSDVYGYG 400
+KPSN+L++ L DFG++ +L+N K + T + E + S KSD++ G
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLG 186
Query: 401 ITLIETFTKKKP 412
++LIE T + P
Sbjct: 187 LSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 52/133 (39%), Positives = 77/133 (57%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L N+LS IP + ++L ++S D S NSL+G +P + ++ + ++L N TG I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + L LQ+L L +N+ G IP++ G+ +L LDLS NNL+G IP L L
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
Query: 122 LNLSFNRLKGDIP 134
L L N L+G+IP
Sbjct: 385 LILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLDG-MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
D E+ ++G G++G VY R L + +AIK + ++ E + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILD------IFQRLSIMIDVALALE 329
+V+ + S S F + +E + GSL L S G L IF I+ L+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLSDFGIAKLLNGKESMRTQTLATIEY---- 384
YLH N +VH DIK NVL++ V +SDFG +K L G T++Y
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179
Query: 385 ----GREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416
G G +P +D++ G T++E T K P E+
Sbjct: 180 VIDKGPRGYGAP-ADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-19
Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 14/194 (7%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
IG G FG V+ G +L+ +VAIK +GA+ + F E +V+ + H LV++ C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+ + LV E+M +G L L + G L + +DV + YL S+ V+H D
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKL-LNGKESMRTQT-----LATIEYGREGQVSPKSDVY 397
+ N L+ ++ V +SDFG+ + L+ + + T T ++ E + S KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 398 GYGITLIETFTKKK 411
+G+ + E F++ K
Sbjct: 186 SFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 226 IGIGSFGTVYKGRFL------DGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRNLVK 278
+G G+FG V+ G D VA+K + A K F+ E E+L + +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSN-------------GILDIFQRLSIMIDVA 325
C+ G+ +V EYM +G L K L S G L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 326 LALEYL---HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-------GKESM- 374
+ YL HF VH D+ N L+ D+V + DFG+++ + G +M
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 375 --RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKP 412
R +I Y + + +SDV+ +G+ L E FT K+P
Sbjct: 187 PIRWMPPESIMYRK---FTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 30/202 (14%)
Query: 226 IGIGSFGTVYKGRFL--DG--MEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLVKII 280
+G G+FG+V KG +L G +EVA+K + A K F E V+ + H +V++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL---HFGYSN 337
C LV+E G L K L + + + VA+ + YL HF
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHF---- 116
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-GKESMRTQTLA----------TIEYGR 386
VH D+ NVLL + A +SDFG+++ L G + R T I YG+
Sbjct: 117 --VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 387 EGQVSPKSDVYGYGITLIETFT 408
S KSDV+ YG+TL E F+
Sbjct: 175 ---FSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 53/133 (39%), Positives = 72/133 (54%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L +N LS IP+ + +S+ D N L G +P + N+ + + L+ N L G I
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P +G + +L+ + L N L G IP G LTSL LDL NNL+G IP SL L L+
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY 264
Query: 122 LNLSFNRLKGDIP 134
L L N+L G IP
Sbjct: 265 LFLYQNKLSGPIP 277
|
Length = 968 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFD-----AECEVLKSVR 272
+ IG GSFGTV K R DG + K G + + +E +L+ ++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELK 57
Query: 273 HRNLVKIISSCSNGNFEAL--VLEYMANGSL----EKCLYSSNGILDIFQRLSIMIDVAL 326
H N+V+ + + + L V+EY G L +KC ++ I+ + L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC-KKERKYIEEEFIWRILTQLLL 116
Query: 327 ALEYLHFGY--SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
AL H N V+H D+KP+N+ LD + L DFG+AK+L +S +T Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYVGTPY 175
Query: 385 G------REGQVSPKSDVYGYGITLIETFTKKKP 412
KSD++ G + E P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 6e-18
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHL--QFDG----ALKSFDAECEVLKSVR 272
+ + +G G++G VYK R G VA+K L + +G AL+ E +LK ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
H N+VK++ LV EY L+K L G L SIM + L Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
S+ ++H D+KP N+L++ D V L+DFG+A+
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 226 IGIGSFGTVYKGRFL----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280
IG G FG V +GR ++VAIK D F E ++ H N++++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL-HFGYSNPV 339
+ ++ EYM NGSL+K L ++G + Q + ++ +A ++YL Y
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY---- 127
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLN----------GKESMRTQTLATIEYGREGQ 389
VH D+ N+L++ ++V +SDFG+++ L GK +R I Y +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--- 184
Query: 390 VSPKSDVYGYGITLIETFT 408
+ SDV+ +GI + E +
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 16/185 (8%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVK 278
IG G++G VYK R L G VAIK L+F+ AL+ E ++LK + H N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
++ + LV E+M + L K + L S + + L + H S+
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPKSDVYG 398
++H D+KP N+L++ + V L+DFG+A+ T + T Y R ++ Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWY-RAPELLLGDKGYS 177
Query: 399 YGITL 403
+ +
Sbjct: 178 TPVDI 182
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 39/89 (43%), Positives = 53/89 (59%)
Query: 46 VVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
+ + L L G IP I L +LQ ++L N ++G IP S G +TSLE LDLS N+
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 106 SGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
+G IP SL +L L+ LNL+ N L G +P
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLV 277
F+ IG GSFG VYK VAIKV L + + ++ E + L R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
K S G+ +++EY GS L G LD I+ +V L LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLH---EE 117
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----IEYGREGQVSP 392
+H DIK +N+LL ++ L+DFG++ L S R + T E ++
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 393 KSDVYGYGITLIETFTKKKPTCEI 416
K+D++ GIT IE + P ++
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 9e-18
Identities = 62/212 (29%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 220 FSEKSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNL 276
F + IG GSFG V+K R D A+K L + +A E VL + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS------IMIDVALALEY 330
++ S + +V+EY NG L K L G + L I + L L +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAH 116
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV 390
LH S ++H DIK N+ LD + D G+AKLL+ + + T Y +
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYY-----L 168
Query: 391 SP----------KSDVYGYGITLIETFTKKKP 412
SP KSDV+ G+ L E T K P
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 9e-18
Identities = 71/259 (27%), Positives = 110/259 (42%), Gaps = 42/259 (16%)
Query: 225 LIGIGSFGTVYKGRFL-DGMEVAIKVF---HLQFDGALKSFDAECEVL-KSVRHRNLVKI 279
+IG GSF TV + E AIK+ L + +K E EVL + H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
+ + VLEY NG L + + G LD ++ LALEYLH S +
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH---SKGI 123
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES------MRTQTLATIEYGR------- 386
+H D+KP N+LLD DM ++DFG AK+L+ S T + IE R
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 387 ------------EGQVSPKSDVYGYGITLIETFTKKKPTC-----EIFCEEMNLK-NWVN 428
E SD++ G + + T K P F + + L+ ++
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP 243
Query: 429 DFLPISVMNVVDTSLLRRE 447
+F P ++++ LL +
Sbjct: 244 NFPPD-AKDLIE-KLLVLD 260
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 226 IGIGSFGTVYKGRFL-DG----MEVAIKVFHLQFDGALKSFDA---ECEVLKSVRHRNLV 277
+G G+FGTVYKG ++ +G + VAIKV L+ + + K+ E V+ SV H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+++ C + L+ + M G L + + + L+ + +A + YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES--------MRTQTLATIEYGREGQ 389
+VH D+ NVL+ ++DFG+AKLL+ E + + +A +E
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA-LESILHRI 187
Query: 390 VSPKSDVYGYGITLIE--TFTKK----KPTCEI 416
+ KSDV+ YG+T+ E TF K P EI
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 226 IGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDA---ECEVLKSVRHRNLVKIIS 281
IG G+FG VY LD E+ A+K +Q D K+ E +VL+ ++H NLVK
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQ-DNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILD--IFQRLSIMIDVALALEYLHFGYSNPV 339
+ + +EY + G+LE+ L ILD + + ++ + LA YLH S+ +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLA--YLH---SHGI 120
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQ---TLATIEY----------- 384
VH DIKP+N+ LD + V L DFG A L N +M + T Y
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 385 -GREGQVSPKSDVYGYGITLIETFTKKKP 412
G D++ G ++E T K+P
Sbjct: 181 KGHGRAA----DIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 220 FSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVRH 273
+ LIG G++G VY+G+ G VA+K+ +L D E +L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58
Query: 274 ---RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEY 330
N+ K S G +++EY GS+ + L + I + + + I+ +V +AL+Y
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKY 116
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----IEYG 385
+H V+H DIK +N+L+ + L DFG+A LLN S R+ + T E
Sbjct: 117 IH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 386 REGQV-SPKSDVYGYGITLIETFTKKKPTCE 415
EG+ K+D++ GIT+ E T P +
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKIISSC 283
IG+G+ VY L +VAIK L + ++ E + + H N+VK +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSN--GILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
G+ LV+ Y++ GSL + SS G LD +++ +V LEYLH SN +H
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP--------- 392
DIK N+LL +D ++DFG++ L + T G ++P
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCWMAPEVMEQVHGY 184
Query: 393 --KSDVYGYGITLIETFTKKKP 412
K+D++ +GIT IE T P
Sbjct: 185 DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 38/81 (46%), Positives = 56/81 (69%)
Query: 33 LNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGEL 92
L G +P DI ++ + INLS N + G+IPP++G +T+L++L L N G IPES G+L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 93 TSLESLDLSVNNLSGVIPISL 113
TSL L+L+ N+LSG +P +L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 63/193 (32%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 226 IGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG G+ GTVY G EVAIK +LQ + E V++ +H N+V + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
G+ +V+EY+A GSL + + +D Q ++ + ALE+LH SN V+H DI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----IEYGREGQVSPKSDVYGY 399
K N+LL D L+DFG + ++S R+ + T E PK D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 400 GITLIETFTKKKP 412
GI IE + P
Sbjct: 202 GIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALK-SFDAECEVLKSVRHRNLVKIISSC 283
L+G G+FG V+KG D VA+K LK F +E +LK H N+VK+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+ +V+E + G L L Q + +D A + YL S +H D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNG---------KESMRTQTLATIEYGREGQVSPKS 394
+ N L+ ++ V +SDFG+++ + + ++ + YGR S +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR---YSSES 175
Query: 395 DVYGYGITLIETFT 408
DV+ YGI L ETF+
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 50/134 (37%), Positives = 75/134 (55%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L L N L+ IPS+ NL ++ N L+G +P I +++ ++ ++LS N L+G+
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP + L NL++L L +N G IP + L L+ L L N SG IP +L K L
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359
Query: 121 DLNLSFNRLKGDIP 134
L+LS N L G+IP
Sbjct: 360 VLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 7/151 (4%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISS 282
IG G+ G V+K + + G VA+K L+ G E + L++ +H +VK++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 283 CSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
+G+ LV+EYM L + L L Q S M + + Y+H +N ++H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 343 DIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373
D+KP+N+L+ D V ++DFG+A+L + +E
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEP 154
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 224 SLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKS------FDA--ECEVLKSVRHR 274
+G G++ VYK R G VAIK L G K F A E ++L+ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKL---GERKEAKDGINFTALREIKLLQELKHP 62
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
N++ ++ + + LV E+M LEK + + +L S M+ LEYLH
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH-- 119
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
SN ++H D+KP+N+L+ D V L+DFG+A+
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-----ALKSFDAECEVLKSVRHRNLVK 278
L+G GSFG+VY+G LD G A+K L DG A+K + E +L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ + + + LE + GSL K L G + L LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAK---LLNGKESMRTQT--LATIEYGREGQVSPK 393
VH DIK +N+L+D + V L+DFG+AK + +S + +A ++G
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182
Query: 394 SDVYGYGITLIETFTKKKP 412
+D++ G T++E T K P
Sbjct: 183 ADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 8e-17
Identities = 54/134 (40%), Positives = 71/134 (52%), Gaps = 3/134 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVE-INLSRNYLTGD 60
+ L +S I S + L I + + S+N L+G +P DI + +NLS N TG
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP G + NL+ L L NN L G IP G +SL+ LDL N L G IP SL L L+
Sbjct: 134 IPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLE 191
Query: 121 DLNLSFNRLKGDIP 134
L L+ N+L G IP
Sbjct: 192 FLTLASNQLVGQIP 205
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 18/196 (9%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V+ G + VAIK G + ++F E +V+K +RH LV++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLH-FGYSNPVVH 341
S +V EYM+ GSL L G L + Q + + +A + Y+ Y VH
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VH 125
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ------TLATIEYGREGQVSPKSD 395
D++ +N+L+ +++V ++DFG+A+L+ E Q E G+ + KSD
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 396 VYGYGITLIETFTKKK 411
V+ +GI L E TK +
Sbjct: 186 VWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 56/182 (30%), Positives = 84/182 (46%), Gaps = 9/182 (4%)
Query: 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKII 280
++G G++G V K R G VAIK F D K+ E +VL+ +RH N+V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ LV EY+ LE S G L S + + A+ Y H S+ ++
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCH---SHNII 122
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR-TQTLATIEYGREGQVSPKSDVYGY 399
H DIKP N+L+ + V L DFG A+ L + + T +AT Y R ++ YG
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWY-RAPELLVGDTNYGK 181
Query: 400 GI 401
+
Sbjct: 182 PV 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 224 SLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGA---------LKSFDAECEVLKSVRH 273
+LIG GSFG+VY G G +A+K L A L + E +LK ++H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
N+V+ + S + + + LEY+ GS+ L + + R + + + L YLH
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH- 123
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK-----LLNGKESMRTQTLATIEYGREG 388
+ ++H DIK +N+L+D+ +SDFGI+K L+ K + +L +
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 389 QV------SPKSDVYGYGITLIETFTKKKP 412
+V + K+D++ G ++E T K P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 225 LIGIGSFGTVYKGRF-LDG---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 279
+IG G FG V GR L G + VAIK + + + F +E ++ H N++ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-FGYSNP 338
+ +V EYM NGSL+ L +G + Q + ++ +A ++YL GY
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-----------GKESMRTQTLATIEYGRE 387
VH D+ N+L++ ++V +SDFG++++L GK +R I Y +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK- 185
Query: 388 GQVSPKSDVYGYGITLIETFT 408
+ SDV+ YGI + E +
Sbjct: 186 --FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 219 HFSEKSLIGIGSFGTVYKGRF-LDGME---VAIKVFHLQF-DGALKSFDAECEVLKSVRH 273
H +++ +IG G FG V++G + G + VAIK + + + F +E ++ H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL-H 332
N++++ + ++ EYM NG+L+K L +G +Q + ++ +A ++YL
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-----------GKESMRTQTLAT 381
Y VH D+ N+L++ ++ +SDFG++++L GK +R
Sbjct: 126 MNY----VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 382 IEYGREGQVSPKSDVYGYGITLIETFT 408
I Y + + SDV+ +GI + E +
Sbjct: 182 IAYRK---FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 40/229 (17%)
Query: 212 ELLLATDHFSEKSLIGIGSFGTVYKGRF--LDGME----VAIKVFHLQFDGALKS-FDAE 264
E+ L+ F E+ +G G+FG VYKG + VAIK + ++ F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 265 CEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSN--------------- 309
E++ ++H N+V ++ C+ ++ EY+A+G L + L ++
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 310 GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369
LD L I I +A +EYL S+ VH D+ N L+ + + +SDFG+++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 370 GKESMRTQTLA----------TIEYGREGQVSPKSDVYGYGITLIETFT 408
+ R Q+ + I YG+ + +SD++ +G+ L E F+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGK---FTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKS--FDAECEVLKSVRHRNLVKIISSC 283
+G G FG V G++ +VAIK+ +G++ F E +V+ + H LV++ C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+ +V EYM+NG L L Q L + DV + YL S +H D
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKL---------LNGKESMRTQTLATIEYGREGQVSPKS 394
+ N L+DD +SDFG+++ + K +R + Y + S KS
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK---FSSKS 182
Query: 395 DVYGYGITLIETFTKKKPTCEIF 417
DV+ +G+ + E ++ K E F
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RH 273
T F +IG G++G VYK R G VAIK+ + D + E +L+ H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNH 62
Query: 274 RNLVK-----IISSCSNGNFEA-LVLEYMANGSLEKCLYSSNGILDIFQRLS------IM 321
N+ I + + + LV+E GS+ + G+ +RL I+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYIL 119
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT 381
+ L YLH N V+H DIK N+LL + L DFG++ L+ R + T
Sbjct: 120 RETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGT 176
Query: 382 ----------IEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416
+ + +SDV+ GIT IE K P C++
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 15/192 (7%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V++G + + VA+K G + K F AE +++K +RH L+++ + C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
+ +V E M GSL + L G L + Q + + VA + YL + +H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127
Query: 343 DIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-SMRTQTLATI-----EYGREGQVSPKSDV 396
D+ NVL+ ++ + ++DFG+A+++ R I E + S KSDV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 397 YGYGITLIETFT 408
+ +GI L E T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
+G G+FG VYK + + G+ A K+ ++ + L+ F E ++L +H N+V + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
N +++E+ G+L+ + L Q + + AL +LH S+ V+H D+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV--------SP---K 393
K N+LL D L+DFG++ N + T Y +V +P K
Sbjct: 130 KAGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK 188
Query: 394 SDVYGYGITLIETFTKKKP 412
+D++ GITLIE + P
Sbjct: 189 ADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIIS 281
L+G GS+G V K + + G VAIK F D + K E +LK +RH NLV +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
LV E++ + L+ NG LD + + + +E+ H S+ ++H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH---SHNIIH 123
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT------------IEYGREGQ 389
DIKP N+L+ V L DFG A+ L + T +AT +YGR
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR--- 180
Query: 390 VSPKSDVYGYGITLIETFT 408
D++ G + E T
Sbjct: 181 ---AVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 1e-15
Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG G+ GTVY G EVAI+ +LQ + E V++ ++ N+V + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
G+ +V+EY+A GSL + + +D Q ++ + ALE+LH SN V+H DI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVS-----PKSDVYGY 399
K N+LL D L+DFG + ++S R+ + T + V+ PK D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 400 GITLIETFTKKKP 412
GI IE + P
Sbjct: 203 GIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 226 IGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 279
+G G+FG V+ D M VA+K + A + F E E+L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSN--------------GILDIFQRLSIMIDVA 325
C+ G +V EYM +G L + L S G L + Q L+I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 326 LALEY---LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT--QTLA 380
+ Y LHF VH D+ N L+ +V + DFG+++ + + R +T+
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 381 TIEYGREGQV-----SPKSDVYGYGITLIETFTKKK 411
I + + + +SD++ +G+ L E FT K
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V+ G + +VA+K G + +SF E +++K +RH LV++ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLH-FGYSNPVVH 341
S +V EYM+ GSL L G L + + + VA + Y+ Y +H
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY----IH 125
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ------TLATIEYGREGQVSPKSD 395
D++ +N+L+ D +V ++DFG+A+L+ E Q E G+ + KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 396 VYGYGITLIETFTKKK 411
V+ +GI L E TK +
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL------KSFDAECEVLKSVRHRNLVK 278
++G G++GTVY G G +A+K L L + E ++LKS++H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDI-FQRLSIMIDVALALEYLHFGYSN 337
+ +C + N ++ +E++ GS+ L + + F + + I +A YLH +N
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YLH---NN 121
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-----NGKESMRTQTLATIEYG------R 386
VVH DIK +NV+L + + L DFG A+ L +G S +++ Y
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 387 EGQVSPKSDVYGYGITLIETFTKKKP 412
E KSD++ G T+ E T K P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 223 KSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
K +G G+FG V+ D M VA+K A K F E E+L +++H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYS---------------SNGILDIFQRLSIM 321
VK C +G+ +V EYM +G L K L + + G L + Q L I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT--QTL 379
+A + YL S VH D+ N L+ +++ + DFG+++ + + R T+
Sbjct: 130 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 380 ATIEYGREGQV-----SPKSDVYGYGITLIETFTKKK 411
I + + + +SDV+ +G+ L E FT K
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLVKIISSC 283
IG G+FG V+ GR D VA+K LK+ F E +LK H N+V++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+ +V+E + G L + L + + + ++ + A +EYL S +H D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 344 IKPSNVLLDDDMVAHLSDFGIAK-----LLNGKESMRTQTLA-----TIEYGREGQVSPK 393
+ N L+ + V +SDFG+++ + M+ + + YGR S +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR---YSSE 176
Query: 394 SDVYGYGITLIETFT 408
SDV+ +GI L E F+
Sbjct: 177 SDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 14/231 (6%)
Query: 220 FSEKSLIGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNL 276
F +G GS+G+VYK R D A+K L + DA E +L SV H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQR---LSIMIDVALALEYLHF 333
+ + +GN +V+EY G L K + + I I + L+ LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH- 120
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT----LATIEYGREGQ 389
++H D+K +N+LL + + + D GI+K+L K +TQ E +
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRP 177
Query: 390 VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVD 440
S KSD++ G L E T P +++ K + PI + D
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQD 228
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 62/193 (32%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG G+ GTV+ + G EVAIK +LQ + E V+K +++ N+V + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
G+ +V+EY+A GSL + + +D Q ++ + ALE+LH +N V+H DI
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVS-----PKSDVYGY 399
K NVLL D L+DFG + ++S R+ + T + V+ PK D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 400 GITLIETFTKKKP 412
GI IE + P
Sbjct: 202 GIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 226 IGIGSFGTVYKG---RFLDG---MEVAIK-VFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
+G GSFG VY+G + G VAIK V F E V+K ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 279 IISSCSNGNFEALVLEYMANGSL------------EKCLYSSNGILDIFQRLSIMIDVAL 326
++ S G +V+E MA G L + Q + ++A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ---MAAEIAD 130
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN--------GKESMRTQT 378
+ YL + VH D+ N ++ +D+ + DFG+ + + GK + +
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 379 LATIEYGREGQVSPKSDVYGYGITLIETFT 408
+A E ++G + KSDV+ +G+ L E T
Sbjct: 188 MAP-ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 226 IGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG G+ GTVY G EVAIK +LQ + E V++ ++ N+V + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
G+ +V+EY+A GSL + + +D Q ++ + AL++LH SN V+H DI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVS-----PKSDVYGY 399
K N+LL D L+DFG + ++S R+ + T + V+ PK D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 400 GITLIETFTKKKP 412
GI IE + P
Sbjct: 202 GIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 220 FSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGA-----LKSFDAECEVLKSVRH 273
F++ IG GSFG VY R VAIK + + G + E L+ +RH
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 274 RNLVKIISSCSNGNFEA-LVLEYMANGSLEKCLYSSNGILDI----FQRLSIMIDVALAL 328
N ++ C A LV+EY CL S++ IL++ Q + I AL
Sbjct: 75 PNTIEY-KGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGAL 125
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLAT 381
+ L + +S+ +H DIK N+LL + L+DFG A L++ S M + +
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILA 185
Query: 382 IEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
++ EGQ K DV+ GIT IE +K P
Sbjct: 186 MD---EGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDGALKSFDAECEVLKSVRH 273
HF +IG G+FG V + D M+ K ++ G++++ E +L+ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNH 59
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
LV + S + LV++ + G L L S Q + ++ LALEYLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY------GRE 387
S ++H DIKP N+LLD+ H++DF IA + +++ T T T Y R+
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 388 GQVSPKSDVYGYGITLIETFTKKKP 412
G D + G+T E K+P
Sbjct: 175 GYSVA-VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 18/196 (9%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V+ G + +VAIK G + ++F E +++K +RH LV + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLH-FGYSNPVVH 341
S +V E+M GSL L +G L + Q + + +A + Y+ Y +H
Sbjct: 71 SEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY----IH 125
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ------TLATIEYGREGQVSPKSD 395
D++ +N+L+ D++V ++DFG+A+L+ E Q E G+ + KSD
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 396 VYGYGITLIETFTKKK 411
V+ +GI L E TK +
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 53/195 (27%), Positives = 97/195 (49%), Gaps = 22/195 (11%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V+ G + +VAIK G++ ++F AE ++K ++H LV++ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
+ ++ EYM NGSL L + GI L I + + + +A + ++ +H
Sbjct: 71 TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126
Query: 343 DIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---------SMRTQTLATIEYGREGQVSPK 393
D++ +N+L+ + + ++DFG+A+L+ E ++ I Y G + K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY---GTFTIK 183
Query: 394 SDVYGYGITLIETFT 408
SDV+ +GI L E T
Sbjct: 184 SDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLDGME---VAIKVFHLQ-FDGALKSFDAECEVLKSVRHRN 275
F++ IG GSFG V+KG +D VAIK+ L+ + ++ E VL
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+ K S G +++EY+ GS L + G D FQ +++ ++ L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH--- 118
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----IEYGREGQV 390
S +H DIK +NVLL + L+DFG+A L + R + T E ++
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 391 SPKSDVYGYGITLIETFTKKKPTCEI 416
K+D++ GIT IE + P ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 226 IGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLVKI 279
+G G FG V + G VA+K + S + E +LK++ H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 280 ISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
CS + L++EY+ GSL L L++ Q L + + YLH S
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTLA-------TIEYGREGQ 389
+H D+ NVLLD+D + + DFG+AK + G E R + +E +E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
S SDV+ +G+TL E T
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 225 LIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRNLVK 278
++G G FG+V +G+ DG ++ + V ++ D ++ F +E +K H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 279 IISSC----SNGNFEA--LVLEYMANGSLEK-CLYSSNGILDIF---QRL-SIMIDVALA 327
+I C S ++L +M +G L LYS G L Q L M+D+AL
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA------- 380
+EYL + +H D+ N +L +DM ++DFG++K + + R +A
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 381 TIEYGREGQVSPKSDVYGYGITLIETFTK 409
IE + + KSDV+ +G+T+ E T+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 214 LLATDHFSEKSLIGIGSFGTVYKGRFL-DG----MEVAIKVFHLQFDGALKSFDAECE-- 266
+L + L+G G FGTV+KG ++ +G + VAIK +Q ++F +
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHM 60
Query: 267 -VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVA 325
+ S+ H +V+++ C + + LV + GSL + LD + L+ + +A
Sbjct: 61 LAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 326 LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL----------NGKESMR 375
+ YL + +VH ++ N+LL D + ++DFG+A LL K ++
Sbjct: 120 KGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 376 TQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
L +I +GR + +SDV+ YG+T+ E +
Sbjct: 177 WMALESILFGR---YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V+ G++ ++VAIK + +GA+ + F E +V+ + H LV++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+ +V E+M NG L L G L LS+ DV +EYL N +H D
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRD 125
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ------TLATIEYGREGQVSPKSDVY 397
+ N L+ V +SDFG+ + + E + + E + S KSDV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 398 GYGITLIETFTKKK 411
+G+ + E FT+ K
Sbjct: 186 SFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 223 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKII 280
K +G G +G VY+G + + VA+K L+ D ++ F E V+K ++H NLV+++
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPV 339
C+ ++ E+M G+L L N ++ L + ++ A+EYL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG---------KESMRTQTLATIEYGREGQV 390
+H D+ N L+ ++ + ++DFG+++L+ G K ++ ++ Y +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK---F 182
Query: 391 SPKSDVYGYGITLIETFT 408
S KSDV+ +G+ L E T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 44/211 (20%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALK-SFDAECEVLKSVRHRNLVKIISSC 283
IG G+ GTVYK G A+KV + + ++ E E+L+ V H N+VK C
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----C 137
Query: 284 -----SNGNFEALVLEYMANGSLEKCLYSSNGIL-DI-FQRLSIMIDVALALEYLHFGYS 336
NG + L LE+M GSLE + L D+ Q LS + YLH
Sbjct: 138 HDMFDHNGEIQVL-LEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLH---R 186
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPK--- 393
+VH DIKPSN+L++ ++DFG++++L ++ TI Y +SP+
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAY-----MSPERIN 241
Query: 394 ------------SDVYGYGITLIETFTKKKP 412
D++ G++++E + + P
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA-----LKSFDAECEVLKSVRHRNLVK 278
L+G G+FG VY +D G E+A+K D + + + E ++LK+++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ ++ +EYM GS++ L + + + R + +EYLH SN
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-------GKES-------MRTQTLATIEY 384
+VH DIK +N+L D L DFG +K L G +S M + ++ Y
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184
Query: 385 GREGQVSPKSDVYGYGITLIETFTKKKP 412
GR K+DV+ G T++E T+K P
Sbjct: 185 GR------KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 19/170 (11%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVR 272
+ IG G++G V G +VAIK FD DA E ++L+ +R
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLR 57
Query: 273 HRNLVK---IISSCSNGNFEAL--VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
H N++ I+ S +F + V E M L K + S + D + + +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRG 115
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
L+YLH S V+H D+KPSN+L++ + + DFG+A+ ++ E +
Sbjct: 116 LKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 61/178 (34%), Positives = 82/178 (46%), Gaps = 25/178 (14%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFD---AECEVLKSVRH 273
D F +G GSFG V R + A+K+ LK + E +L+S+RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI------DVALA 327
LV + S + + LV+EY+ G L L S R + V LA
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLA 113
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY 384
LEYLH S +V+ D+KP N+LLD D ++DFG AK + G RT TL T EY
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----RTYTLCGTPEY 164
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 73/223 (32%), Positives = 104/223 (46%), Gaps = 44/223 (19%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA----ECEVLKSVR 272
D F IG G++G VYK R D G VA+K L D + F E ++L+ +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAIREIKILRQLN 64
Query: 273 HRNLVKIISSCSN-----------GNFEALVLEYMAN---GSLEKCL--YSSNGILDIFQ 316
HRN+V + ++ G F LV EYM + G LE L +S + I +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAF-YLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 317 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR- 375
+L LE L++ + +H DIK SN+LL++ L+DFG+A+L N E R
Sbjct: 124 QL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEESRP 173
Query: 376 -TQTLATIEY-------GREGQVSPKSDVYGYGITLIETFTKK 410
T + T+ Y G E + P DV+ G L E FTKK
Sbjct: 174 YTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 37/255 (14%)
Query: 225 LIGIGSFGTVYKGRFL-DGMEVAIKVF--HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
++G G+FG V+ R D V IK + EC+VLK + H N+++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +V+EY G+L + + N +LD L + + LAL ++H + ++
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123
Query: 341 HCDIKPSNVLLDD-DMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP------- 392
H D+K N+LLD MV + DFGI+K+L+ K T + T Y +SP
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCY-----ISPELCEGKP 177
Query: 393 ---KSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDK 449
KSD++ G L E + K+ E N LP V+ ++ + D+
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAF-----EAAN--------LPALVLKIMSGTFAPISDR 224
Query: 450 YFAAKKQCVSSALSL 464
Y +Q + S L+L
Sbjct: 225 YSPDLRQLILSMLNL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 225 LIGIGSFGTVYKGRF-LDGME---VAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 279
+IG G FG V +GR L G VAIK + + + F +E ++ H N++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL-HFGYSNP 338
+ ++ E+M NG+L+ L ++G + Q + ++ +A ++YL Y
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY--- 127
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-------------GKESMRTQTLATIEYG 385
VH D+ N+L++ ++V +SDFG+++ L GK +R I Y
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 386 REGQVSPKSDVYGYGITLIETFT 408
+ + SDV+ YGI + E +
Sbjct: 187 K---FTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 9e-14
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRHRNL 276
L+G G+FG VY +D G E+A K +QFD + + + E ++LK+++H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAK--QVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 277 VKIISSCSNGNFEALV--LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
V+ + + L +EYM GS++ L + + + R + + YLH
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH-- 123
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-------GKES-------MRTQTLA 380
SN +VH DIK +N+L D L DFG +K L G S M + ++
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 381 TIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415
YGR K+DV+ G T++E T+K P E
Sbjct: 183 GEGYGR------KADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 52/174 (29%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKS 270
+ + + S IG GS+G V+K R + G VAIK F D AL+ E +LK
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQ 56
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEY 330
++H NLV +I LV EY + L + + G + I+ A+ +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNF 115
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
H + +H D+KP N+L+ L DFG A++L G T +AT Y
Sbjct: 116 CH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWY 166
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 70/228 (30%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 219 HFSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSV 271
H +G G+FG+V R+ G VA+K LQ A L+ F+ E E+LKS+
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSL 62
Query: 272 RHRNLVKIISSC-SNGNFE-ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALE 329
+H N+VK C S G LV+EY+ GSL L LD + L + +E
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME 122
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTLATIEYGR-- 386
YL S VH D+ N+L++ + + DFG+ K+L KE + + E G
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR-----EPGESP 174
Query: 387 ----------EGQVSPKSDVYGYGITLIETFTKKKPTC---EIFCEEM 421
E + S SDV+ +G+ L E FT +C F M
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
I G++G V+ + G AIKV + + E ++L + +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
S LV+EY+ G L L + G LD + ++ LALEYLH SN ++H
Sbjct: 61 SFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIH 116
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKL-LNGKESMR 375
D+KP N+L+D + L+DFG++K+ L ++
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 49/144 (34%), Positives = 73/144 (50%), Gaps = 3/144 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L SN + IP +L + SN +G +P ++ + ++LS N LTG+I
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + NL L L +N L+G IP+S G SL + L N+ SG +P KL +
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 122 LNLSFNRLKGDIPTRS---PHLQV 142
L++S N L+G I +R P LQ+
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQM 456
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 45/159 (28%), Positives = 66/159 (41%), Gaps = 29/159 (18%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L +N L+ IP + ++ SNSL G +P + + + + L N +G++
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 62 PPTIGGLTNLQL---LSLENNRLQGPIPESFGELTSLESLDLSVNN-------------- 104
P T L L L + NN LQG I ++ SL+ L L+ N
Sbjct: 421 P---SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRL 477
Query: 105 ---------LSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
SG +P L L L L LS N+L G+IP
Sbjct: 478 ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
|
Length = 968 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 226 IGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALK-SFDAECEVLKSVRHRNLVKIIS 281
+G G+FG V KG + ++VAIKV + + +++ E E++ + + +V++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
C LV+E + G L K L + + + +M V++ ++YL VH
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-----------TIEYGREGQV 390
D+ NVLL + A +SDFG++K L +S A I + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK---F 175
Query: 391 SPKSDVYGYGITLIETFT-KKKP 412
S +SDV+ YGIT+ E F+ +KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 51/193 (26%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285
+G G FG V+ G + + +VA+K ++++F E ++K+++H LV++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRL-SIMIDVALALEYLHFGYSNPVVHCDI 344
++ EYMA GSL L S G + +L +A + Y+ +H D+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKE-SMRTQTLATIEYGRE-----GQVSPKSDVYG 398
+ +NVL+ + ++ ++DFG+A+++ E + R I++ G + KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 399 YGITLIETFTKKK 411
+GI L E T K
Sbjct: 190 FGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 29/183 (15%)
Query: 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIK--VFHLQFDGALKSFDAECEVLKSVR---H 273
+ E + IG G++GTVYK R L G VA+K L +G S E +LK + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 274 RNLVKIISSCSNGNFE-----ALVLEYMA---NGSLEKCL---YSSNGILDI-FQRLSIM 321
N+V+++ C + LV E++ L KC I D+ Q L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR-- 118
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT 381
+++LH S+ +VH D+KP N+L+ D ++DFG+A++ E T + T
Sbjct: 119 -----GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVVT 169
Query: 382 IEY 384
+ Y
Sbjct: 170 LWY 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 223 KSLIGIGSFGTVYKGRFL-DG--MEVAIKVF-HLQFDGALKSFDAECEVL-KSVRHRNLV 277
+ +IG G+FG V + DG M AIK+ + + F E EVL K H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMI 322
++ +C N + + +EY G+L L S L Q L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-- 380
DVA ++YL +H D+ NVL+ +++ + ++DFG+++ G+E +T+
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 381 -----TIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEM 421
IE + KSDV+ +G+ L E + P C + C E+
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLDGME---VAIKVFHLQ-FDGALKSFDAECEVLKSVRHRN 275
F++ IG GSFG V+KG +D VAIK+ L+ + ++ E VL
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+ K S +++EY+ GS L G LD Q +I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH--- 118
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----IEYGREGQV 390
S +H DIK +NVLL + L+DFG+A L + R + T E ++
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 391 SPKSDVYGYGITLIETFTKKKPTCEI 416
K+D++ GIT IE + P E+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 25/189 (13%)
Query: 242 GMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKIISS--CSNGNFEALVLEYM 296
G EVAIK+ + + F E + + H N+V ++ S G A V EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61
Query: 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DD 353
+L + L +++G L + +M+ V AL H + +VH D+KP N+++
Sbjct: 62 PGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117
Query: 354 DMVAHLSDFGIAKLLNG-KESMRTQTLATIEY-G----------REGQVSPKSDVYGYGI 401
A + DFGI LL G +++ T E G R V+P SD+Y +G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 402 TLIETFTKK 410
+E T +
Sbjct: 178 IFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 22/196 (11%)
Query: 225 LIGIGSFGTVYKGRF-LDG---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 279
++G G FG + +G L + VAI D + F AE L H N+V++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL-HFGYSNP 338
+ GN +V EYM+NG+L+ L G L Q + ++ +A ++YL GY
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFG---------IAKLLNGKESMRTQTLATIEYGREGQ 389
VH + VL++ D+V +S F I ++GK + I+Y
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--- 184
Query: 390 VSPKSDVYGYGITLIE 405
S SDV+ +GI + E
Sbjct: 185 FSSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 48/144 (33%), Positives = 77/144 (53%), Gaps = 7/144 (4%)
Query: 226 IGIGSFGTVYKGRFLDGME-VAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISS 282
IG G++GTV+K + + E VA+K L D G S E +LK ++H+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 283 CSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
+ LV EY + L+K S NG +D S M + L + H S+ V+H
Sbjct: 68 LHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 343 DIKPSNVLLDDDMVAHLSDFGIAK 366
D+KP N+L++ + L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 226 IGIGSFGTVY--KGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIIS 281
IG GSFG +Y K + D IK L + ++ EV L ++H N+V +
Sbjct: 8 IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGIL-DIFQRLSIMIDVALALEYLHFGYSNPVV 340
S +V+EY G L K + G+L Q LS + ++L L+++H ++
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKIL 123
Query: 341 HCDIKPSNVLLDDD-MVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP------- 392
H DIK N+ L + MVA L DFGIA+ LN + + T Y +SP
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY-----LSPEICQNRP 178
Query: 393 ---KSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPIS 434
K+D++ G L E T K P ++ LK F PIS
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 226 IGIGSFGTVYKGRFLDGMEVA-IKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG G++G VYK R ++ E+A IKV L+ E ++K +H N+V S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
+ + +E+ GSL+ +Y G L Q + + L YLH S +H DI
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY--------GREGQVSPKSDV 396
K +N+LL D+ L+DFG++ + + R + T + R+G + D+
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192
Query: 397 YGYGITLIETFTKKKP 412
+ GIT IE + P
Sbjct: 193 WAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 223 KSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
K +G G+FG V+ D + VA+K D A K F E E+L +++H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCL--YSSNGI----------LDIFQRLSIMIDV 324
VK C G+ +V EYM +G L K L + + + L Q L I +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT--QTLATI 382
A + YL S VH D+ N L+ ++++ + DFG+++ + + R T+ I
Sbjct: 130 AAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 383 EYGREGQV-----SPKSDVYGYGITLIETFTKKK 411
+ + + +SDV+ G+ L E FT K
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 40/217 (18%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRHRNL 276
L+G G+FG VY D G E+A+K +QFD + + + E ++LK++ H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVK--QVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 277 VKIISSCSNGNFE---ALVLEYMANGSLEKCLYSSNGILD-IFQRLSIMIDVALALEYLH 332
V+ C E ++ +E+M GS++ L S + + + ++ + I LE +
Sbjct: 67 VQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVS 120
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-------GKES-------MRTQT 378
+ +SN +VH DIK +N+L D L DFG +K L G +S M +
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 379 LATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415
++ YGR K+D++ G T++E T+K P E
Sbjct: 181 ISGEGYGR------KADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 48/223 (21%)
Query: 226 IGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGAL---KSFDAECEVLKSVRHRNL 276
IG G+FG V++ R VA+K+ L+ + + F E ++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 277 VKIISSCSNGNFEALVLEYMANGSL-------------------EKCLYSSNGILDI--F 315
VK++ C+ G L+ EYMA G L L +
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 316 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK--------L 367
++L I VA + YL VH D+ N L+ ++MV ++DFG+++
Sbjct: 131 EQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 368 LNGKESM--RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
+ +++ R +I Y R + +SDV+ YG+ L E F+
Sbjct: 188 ASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 46/117 (39%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 19 NLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLT-NLQLLSLE 77
N + ++S D S +++G + I + + INLS N L+G IP I + +L+ L+L
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 78 NNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
NN G IP G + +LE+LDLS N LSG IP + LK L+L N L G IP
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
|
Length = 968 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHL---QFDGALKSFDAECEVLKSVRHRN 275
FS+ IG GSFG VY R + EV AIK Q + + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL----ALEYL 331
++ + LV+EY CL S++ +L++ ++ +++A AL+ L
Sbjct: 77 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEY 384
+ +S+ ++H D+K N+LL + + L DFG A ++ M + + ++
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMD- 187
Query: 385 GREGQVSPKSDVYGYGITLIETFTKKKP 412
EGQ K DV+ GIT IE +K P
Sbjct: 188 --EGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 212 ELLLATDHFSEKSLIGIGSFGTVYKGR-FLDGME----VAIKVFHLQFDGALK--SFDAE 264
EL L+ F E+ +G +FG +YKG +L GM+ VAIK + + F E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQE 57
Query: 265 CEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEK------------CLYSSNGI- 311
++ + H N+V ++ + ++ EY+ G L + C +G
Sbjct: 58 ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV 117
Query: 312 ---LDIFQRLSIMIDVALALEYL--HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
LD L I I +A +EYL HF VH D+ N+L+ + + +SD G+++
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 367 LLNGKESMRTQ--TLATIEYGRE-----GQVSPKSDVYGYGITLIETFT 408
+ + R Q +L I + G+ S SD++ +G+ L E F+
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 223 KSLIGIGSFGTVYKGRFL-DG--MEVAIKV---FHLQFDGALKSFDAECEVL-KSVRHRN 275
+ +IG G+FG V K R DG M+ AIK + + D + F E EVL K H N
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPN 69
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCL---------------YSSNGILDIFQRLSI 320
++ ++ +C + + L +EY +G+L L S+ L Q L
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 321 MIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA 380
DVA ++YL +H D+ N+L+ ++ VA ++DFG+++ G+E +T+
Sbjct: 130 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 183
Query: 381 -------TIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEM 421
IE + SDV+ YG+ L E + P C + C E+
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLV 277
F++ IG GSFG VYKG EV AIK+ L+ + ++ E VL +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+ S G +++EY+ GS L G L+ +I+ ++ L+YLH S
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH---SE 120
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----IEYGREGQVSP 392
+H DIK +NVLL + L+DFG+A L + R + T E ++
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 393 KSDVYGYGITLIETFTKKKPTCEI 416
K+D++ GIT IE + P ++
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 219 HFSEKSLIGIGSFGTVYKGRF-LDGMEVAIK---VFHLQFDGALKSFDAECEVLKSVRHR 274
+F + IG G F VY+ LDG+ VA+K +F L A E ++LK + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSI---MIDVALALEYL 331
N++K +S N +VLE G L + + + ++ + + ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG-----R 386
H S V+H DIKP+NV + V L D G+ + + K + + T Y
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 387 EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL 423
E + KSD++ G L E + P + ++MNL
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVA---IKVFHLQFDGALKSFDAECEVLKSVR 272
+F + IG G F VYK LDG VA +++F + A + E ++LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSI---MIDVALALE 329
H N++K ++S N +VLE G L + + + +I + + ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQ 389
++H S ++H DIKP+NV + V L D G+ + + K + + T Y
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY----- 172
Query: 390 VSP----------KSDVYGYGITLIETFTKKKPTCEIFCEEMNL 423
+SP KSD++ G L E + P + ++MNL
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 219 HFSEKSLIGIGSFGTVY----KGRFLDGME--VAIKVF-HLQFDGALKSFDAECEVLKSV 271
+ E + +G G FG V+ KG +G E V +K + + F E ++ + +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI--------LDIFQRLSIMID 323
H+N+V+++ C ++LEY G L++ L ++ L Q++++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR-TQTLATI 382
+AL +++L + VH D+ N L+ +S ++K + E + L +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 383 -----EYGREGQVSPKSDVYGYGITLIETFT 408
E +E S KSDV+ +G+ + E FT
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 226 IGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDGALKS---FDAECEVLKSVRHRNLVK 278
+G G+FG VY+G + D +E+ + V L + + F E ++ H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLY---------SSNGILDIFQRLSIMIDVALALE 329
+I ++LE MA G L+ L SS + D+ L DVA +
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFCARDVAKGCK 130
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIAKLLNGKESMRTQTLATI---- 382
YL N +H DI N LL VA ++DFG+A+ + R A +
Sbjct: 131 YLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 383 ---EYGREGQVSPKSDVYGYGITLIETFT 408
E +G + K+DV+ +G+ L E F+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 5e-12
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHL---QFDGALKSFDAECEVLKSVRHRN 275
F++ IG GSFG VY R + EV AIK Q + + E + L+ ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL----ALEYL 331
++ + LV+EY CL S++ +L++ ++ +++A AL+ L
Sbjct: 87 SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEY 384
+ +S+ ++H DIK N+LL + L+DFG A + + S M + + ++
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMD- 197
Query: 385 GREGQVSPKSDVYGYGITLIETFTKKKP 412
EGQ K DV+ GIT IE +K P
Sbjct: 198 --EGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 226 IGIGSFGTVYKGRFLDGMEVA-IKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
+G G++G VYK R L E+A +K+ L+ E ++K +H N+V S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
+ + +EY GSL+ +Y G L Q + + L YLH S +H DI
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY--------GREGQVSPKSDV 396
K +N+LL D+ L+DFG+A + + R + T + + G + D+
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192
Query: 397 YGYGITLIETFTKKKP 412
+ GIT IE + P
Sbjct: 193 WAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
+G G+FG VYK + + G A KV + + L+ + E E+L + H +VK++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
+++E+ G+++ + + L I + LE L + +S ++H D+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 345 KPSNVLLDDDMVAHLSDFGIA----KLLNGKESM------RTQTLATIEYGREGQVSPKS 394
K NVLL D L+DFG++ K L ++S + E ++ K+
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 196
Query: 395 DVYGYGITLIETFTKKKPTCEI 416
D++ GITLIE + P E+
Sbjct: 197 DIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 29/89 (32%), Positives = 50/89 (56%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L + L IP+ L + S + S NS+ G++P + ++ + ++LS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFG 90
P ++G LT+L++L+L N L G +P + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 70/233 (30%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 226 IGIGSFGT--VYKGRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKIIS 281
IG GSFG + K + DG + IK ++ + ++ E VL +++H N+V+
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 282 SCS-NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIM---IDVALALEYLHFGYSN 337
S NGN +V++Y G L K + + G+L F I+ + + LAL+++H
Sbjct: 67 SFEENGNL-YIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVH---DR 120
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP----- 392
++H DIK N+ L D L DFGIA++LN T LA G +SP
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEICEN 175
Query: 393 -----KSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-----NDFLPISV 435
KSD++ G L E T K E N+KN V + P+S
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAF-----EAGNMKNLVLKIIRGSYPPVSS 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 219 HFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQ------FDGALKSFDAECEVLKSV 271
+ + +G G+F + Y+ R G +A+K + +++ E ++ +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 272 RHRNLVKII-SSCSNGNFEALVLEYMANGSLEKCLYS----SNGILDIFQRLSIMIDVAL 326
H ++++++ ++C + +F L +E+MA GS+ L ++ + +
Sbjct: 61 NHPHIIRMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVIINYTE-----QLLR 114
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAKLLN----GKESMRTQTLAT 381
L YLH N ++H D+K +N+L+D ++DFG A L G + Q L T
Sbjct: 115 GLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 382 I-----EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
I E R Q DV+ G +IE T K P
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 219 HFSEKSLIGIGSFG--TVYKGRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHR 274
H+ ++G G+FG T+Y+ R D V K +L + DA E +L ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSL-EKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
N++ + + N + +EY G+L +K + + + L + + A+ Y+H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH- 118
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP- 392
++H DIK N+ L + L DFGI+K+L + SM + T Y +SP
Sbjct: 119 --KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYY-----MSPE 171
Query: 393 ---------KSDVYGYGITLIETFTKKK 411
KSD++ G L E T K+
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 56/175 (32%), Positives = 82/175 (46%), Gaps = 19/175 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSVRH 273
D +G G+FG V+ R + A+KV + LK E VLK V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEY 330
++++ + + F +++EY+ G L L +S + +F I+ ALEY
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC----ALEY 116
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY 384
LH S +V+ D+KP N+LLD + L+DFG AK K RT TL T EY
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEY 164
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
+G G+FG VYK + + G+ A KV + + L+ + E ++L S H N+VK++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
N +++E+ A G+++ + L Q + AL YLH N ++H D+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 345 KPSNVLLDDDMVAHLSDFGIA----KLLNGKESM------RTQTLATIEYGREGQVSPKS 394
K N+L D L+DFG++ + + ++S + E ++ K+
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 395 DVYGYGITLIETFTKKKPTCEI 416
DV+ GITLIE + P E+
Sbjct: 190 DVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGME-----VAIKVFHLQFDG--ALKSFDAECE 266
+L ++G G+FGTVYKG ++ E VAIK+ + + G A F E
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 61
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
++ S+ H +LV+++ C + + LV + M +G L ++ + L+ + +A
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES----------MRT 376
+ YL +VH D+ NVL+ ++DFG+A+LL G E ++
Sbjct: 121 GMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
L I Y + + +SDV+ YG+T+ E T
Sbjct: 178 MALECIHYRK---FTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRHRNL 276
L+G G+FG VY D G E+A+K + FD + + + E ++LK++RH +
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVK--QVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 277 VKIISSCSNGNFEALVL--EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
V+ + + L + EYM GS++ L + + + R + + YLH
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH-- 123
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-------GKES-------MRTQTLA 380
SN +VH DIK +N+L D L DFG +K + G +S M + ++
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 381 TIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415
YGR K+DV+ T++E T+K P E
Sbjct: 183 GEGYGR------KADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 225 LIGIGSFGTVYKGRFLDGMEV-AIKVFHL----------QFDGALKSFDAECEVLKSVRH 273
LIG G++G VY + E+ A+K L + +K+ +E E LK + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
N+V+ + + + ++ LEY+ GS+ C + G + V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSC-LRTYGRFEEQLVRFFTEQVLEGLAYLH- 125
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK----LLNGKESMRTQ------TLATIE 383
S ++H D+K N+L+D D + +SDFGI+K + + ++M Q I
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 384 YGREGQVSPKSDVYGYGITLIETFTKKKP 412
+G S K D++ G ++E F ++P
Sbjct: 184 SYSQG-YSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 283
+G G++ TVYKGR G VA+K HL + G + E ++K ++H N+V++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 284 SNGNFEALVLEYMANGSLEKCL--YSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
N LV EYM + L+K + + G LD S + L+ + F + N V+H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAK 366
D+KP N+L++ L+DFG+A+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 18/198 (9%)
Query: 225 LIGIGSFGTVYKGRFL----DGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRNLVKI 279
+G GSFG V +G + + VA+K + + F E ++ S+ H NL+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLY-SSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+V E GSL L + G I + +A + YL S
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAK-LLNGKESMRTQTLATI-------EYGREGQV 390
+H D+ N+LL D + DFG+ + L ++ + + E R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 391 SPKSDVYGYGITLIETFT 408
S SDV+ +G+TL E FT
Sbjct: 178 SHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 42/241 (17%)
Query: 226 IGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
+G+G FG V + A+K H+ G + +E E+L+ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
+ + + +++EY G L L G+ D + + V LA EYLH + +++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLH---NRGIIY 116
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEYGREGQVSPK------- 393
D+KP N+LLD + L DFG AK L + +T T T EY V+P+
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEY-----VAPEIILNKGY 169
Query: 394 ---SDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKY 450
D + GI L E T + P F E+ D P+ + N + L+ K
Sbjct: 170 DFSVDYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDI----LKGNGKL 213
Query: 451 F 451
Sbjct: 214 E 214
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 40/161 (24%)
Query: 226 IGIGSFGTVYKGRFLDGME-VAIKVFHLQFDGALKSFDAEC----EVLKSVR----HRNL 276
+G G+FG+VY R + E VAIK + S++ EC EV KS+R H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREV-KSLRKLNEHPNI 60
Query: 277 VKIISSCSNGNFEA--------LVLEYMANGSLEKCLYSS--NGILDIFQRLSIMIDVAL 326
VK+ E V EYM G+L + L SI+ +
Sbjct: 61 VKL--------KEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQ 110
Query: 327 ALEYLH-FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
L ++H G+ H D+KP N+L+ V ++DFG+A+
Sbjct: 111 GLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 226 IGIGSFGTVYKGRFLDG---MEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKII 280
+G G FG+V +G+ ++VA+K + ++ F +E +K H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 281 SSC----SNGNFEA--LVLEYMANGSLEK-CLYSSNGILDIF---QRL-SIMIDVALALE 329
C + + + ++L +M +G L LYS G + Q L M D+A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-------TI 382
YL S +H D+ N +L+++M ++DFG++K + + R +A I
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTK 409
E + + KSDV+ +G+T+ E T+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 225 LIGIGSFGTVYKGRFLDG----MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKI 279
+IG G FG VY G +D + A+K + D ++ F E ++K H N++ +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 280 ISSC-SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ C + +VL YM +G L + S + + + VA +EYL S
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKK 118
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--SMRTQTLA-------TIEYGREGQ 389
VH D+ N +LD+ ++DFG+A+ + KE S+ T A +E + +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
+ KSDV+ +G+ L E T+ P
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 6e-11
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 225 LIGIGSFGTVYKGRFL-DG--MEVAIKVF-HLQFDGALKSFDAECEVL-KSVRHRNLVKI 279
+IG G+FG V K R DG M+ AIK + F E EVL K H N++ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDV 324
+ +C + + L +EY +G+L L S L Q L DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA---- 380
A ++YL +H D+ N+L+ ++ VA ++DFG+++ G+E +T+
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175
Query: 381 ---TIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEM 421
IE + SDV+ YG+ L E + P C + C E+
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIK---VFHLQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
IG G F VY+ LD VA+K +F + A + E ++LK + H N++K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSI---MIDVALALEYLHFGYSNP 338
S N +VLE G L + + + ++ + + A+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG-----REGQVSPK 393
V+H DIKP+NV + V L D G+ + + K + + T Y E + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 394 SDVYGYGITLIETFTKKKPTCEIFCEEMNL 423
SD++ G L E + P + ++MNL
Sbjct: 187 SDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 225 LIGIGSFGTVYKGRFLDGME--VAIK---VFHLQFDGALKSFD-------AECEVLK-SV 271
+G G+FG VYK R + + +A+K V + F + D +E ++K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF--QRL-SIMIDVALAL 328
RH N+V+ + + +V++ + L + S F +R+ +I + + LAL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG--- 385
YLH +VH D+ P+N++L +D ++DFG+AK ES T + TI Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCPE 183
Query: 386 --REGQVSPKSDVYGYGITLIETFTKKKP 412
+ K+DV+ +G L + T + P
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDA----ECEVLKSVRHRNLVKII 280
IG G+FG V+K R VA+K + + + F E ++L+ ++H N+V +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 281 SSCSN-----GNFEA---LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
C ++ LV E+ + L L + N + + +M + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL----NGKESMRTQTLATIEYGR-- 386
N ++H D+K +N+L+ D + L+DFG+A+ N K + T + T+ Y R
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY-RPP 192
Query: 387 -----EGQVSPKSDVYGYGITLIETFTK 409
E P D++G G + E +T+
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 225 LIGIGSFGTVYKGRFLD------GMEVAIKVFHLQ-FDGALKSFDAECEVLKSV-RHRNL 276
+G G+FG V K + VA+K+ + L +E E++K + +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCL---------YSSNGILDIFQRL------SIM 321
+ ++ C+ +V+EY A+G+L L S + + L S
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT--- 378
VA +E+L S +H D+ NVL+ +D V ++DFG+A+ ++ + R T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 379 ----LATIEYGREGQVSPKSDVYGYGITLIETFT 408
E + + +SDV+ +G+ L E FT
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 20/157 (12%)
Query: 220 FSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL--QFDGALKSFDAECEVLKSVRHRNL 276
F + IG G++G VYK R L G VA+K L + +G + E +LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH---- 332
VK++ N LV E++ + L+K + +S I + L YL
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLS---------GIPLPLIKSYLFQLLQ 111
Query: 333 ---FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
F +S+ V+H D+KP N+L++ + L+DFG+A+
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 226 IGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFDGA-LKSFDAECEVLKSVRHRNLVKI 279
+G G FG V R+ G +VA+K + G + E E+L+++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 280 ISSCSN--GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
C+ GN L++E++ +GSL++ L + +++ Q+L + + ++YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT----QTLATIEYGREGQVSPK 393
VH D+ NVL++ + + DFG+ K + + T Y E + K
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 394 ----SDVYGYGITLIETFTKKKPTCEIFCEEMNL 423
SDV+ +G+TL E T C+ M L
Sbjct: 189 FYIASDVWSFGVTLYELLT----YCDSESSPMTL 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLV 277
F L+G G++G VYKGR + G AIKV + D + E +LK HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 278 KIISSCSNGNFEA------LVLEYMANGSLEKCLYSSNGILDIFQRLS-IMIDVALALEY 330
+ N LV+E+ GS+ + ++ G + ++ I ++ L +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT--------- 381
LH + V+H DIK NVLL ++ L DFG++ L+ R + T
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 382 -IEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416
+ + KSD++ GIT IE P C++
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 38/216 (17%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVR---HRNLVKI 279
IG+G++GTVYK R G VA+K +Q DG S E +LK + H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 280 ISSCSNGNFE-----ALVLEYMAN---GSLEKCL---YSSNGILDIFQRLSIMIDVALAL 328
+ C+ + LV E++ L+K + I D+ ++ L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF------LRGL 121
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREG 388
++LH +N +VH D+KP N+L+ L+DFG+A++ + + ++ T + T+ Y R
Sbjct: 122 DFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-TPVVVTLWY-RAP 176
Query: 389 QVSPKS------DVYGYGITLIETFTKKKPTCEIFC 418
+V +S D++ G E F ++KP +FC
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFC 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFDGALKS-FDAECEVLK 269
+ + + IG G FG VY+G ++ + VA+K +++ F E +++
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 270 SVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALE 329
H ++VK+I + N +V+E G L L + LD+ + ++ AL
Sbjct: 63 QFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN---------GKESMRTQTLA 380
YL S VH DI NVL+ L DFG+++ L GK ++
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 381 TIEYGREGQVSPKSDVYGYGITLIETFTK-KKP 412
+I + R + SDV+ +G+ + E KP
Sbjct: 179 SINFRR---FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 214 LLATDHFSEKSLIGIGSFGTVYKGRFL-DG----MEVAIKVF-HLQFDGALKSFDAECEV 267
+L F + ++G G+FGTVYKG ++ +G + VAIK A K E V
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 268 LKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
+ SV + ++ +++ C + L+ + M G L + + L+ + +A
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGRE 387
+ YL +VH D+ NVL+ ++DFG+AKLL E EY E
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK---------EYHAE 169
Query: 388 GQVSP----------------KSDVYGYGITLIETFT 408
G P +SDV+ YG+T+ E T
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIK--VFHLQFDGALKSFDAECEVLKSVRHRN 275
K +G G+FG VYK R + G VA+K + H + DG + E ++LK ++H N
Sbjct: 11 EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 276 LVKII---------SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
+V +I S G+ +V YM + L L + + L Q M+ +
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSV-YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL--NGKESMRTQTLATIEY 384
+ YLH N ++H DIK +N+L+D+ + ++DFG+A+ T +Y
Sbjct: 127 GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 385 GR---------------EGQVSPKSDVYGYGITLIETFTKK 410
E + + D++G G E FT++
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 220 FSEKSLIGIGSFGTV----YKGRFLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSVR 272
F +G GSFG V +KG G AIK + +K E +L +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSS----NGILDIFQRLSIMIDVALAL 328
H +V ++ S + N +LE++ G L L + N + + ++ LA
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAF 131
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY 384
EYLH S +++ D+KP N+LLD+ ++DFG AK K RT TL T EY
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEY 181
|
Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 226 IGIGSFGTVYKGRFLDGME-VAIKVFHL---QFDGALKSFDAECEVLKSVRHRNLVKIIS 281
IG GSFG VY E VA+K Q + + E + L+ ++H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL----ALEYLHFGYSN 337
+ LV+EY CL S++ +L++ ++ +++A AL+ L + +S+
Sbjct: 89 CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQV 390
++H DIK N+LL + L+DFG A + S M + + ++ EGQ
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMD---EGQY 197
Query: 391 SPKSDVYGYGITLIETFTKKKP 412
K DV+ GIT IE +K P
Sbjct: 198 DGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLV 277
F ++G G++G VYKGR + G AIKV + D + E +LK HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 278 K----IISSCSNGNFEAL--VLEYMANGSLEKCLYSSNGILDIFQR---LSIMIDVALAL 328
I G+ + L V+E+ GS+ + ++ G + + I ++ L
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGL 134
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT------- 381
+LH ++ V+H DIK NVLL ++ L DFG++ L+ R + T
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191
Query: 382 ---IEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416
+ + +SD++ GIT IE P C++
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 9/164 (5%)
Query: 226 IGIGSFGTVYKGRFLDGME-VAIKVFHL--QFDGALKSFDAECEVLKSVRHRNLVKIISS 282
IG G++G VY+ R E VA+K + + DG S E +L ++RH N+V++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 283 CSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ ++ LV+EY L L + Q +M+ + L+YLH N ++
Sbjct: 75 VVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFII 130
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
H D+K SN+LL D ++DFG+A+ T + T+ Y
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 53/193 (27%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285
+G G FG V+ + +VA+K ++++F AE V+K+++H LVK+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL-EYLHFGYSNPVVHCDI 344
++ E+MA GSL L S G Q L +ID + + E + F +H D+
Sbjct: 73 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKE---------SMRTQTLATIEYGREGQVSPKSD 395
+ +N+L+ +V ++DFG+A+++ E ++ I + G + KSD
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF---GSFTIKSD 185
Query: 396 VYGYGITLIETFT 408
V+ +GI L+E T
Sbjct: 186 VWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 27/202 (13%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISS 282
IG G++G VYKGR G VA+K L+ +G + E +LK ++H N+V +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 283 CSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-------FGY 335
+ L+ E+++ L+K L S +D L YL+ F +
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPK--------GQYMDAELVKSYLYQILQGILFCH 118
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV----- 390
S V+H D+KP N+L+D+ V L+DFG+A+ + T + T+ Y R +V
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWY-RAPEVLLGSP 177
Query: 391 --SPKSDVYGYGITLIETFTKK 410
S D++ G E TKK
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 13/187 (6%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG GS G V G +VA+K L+ + E +++ +H N+V++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
G+ +V+E++ G+L + + ++ Q ++ + V AL +LH + V+H DI
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV------SPKSDVYG 398
K ++LL D LSDFG ++ KE R ++L Y +V + D++
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWS 200
Query: 399 YGITLIE 405
GI +IE
Sbjct: 201 LGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 208 FSYQELLLATDHFSEKS-------LIGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGALK 259
F Y +L + + + IG G++G VYK DG A+K+ D +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDE 63
Query: 260 SFDAECEVLKSV-RHRNLVKII------SSCSNGNFEALVLEYMANGSLEKCLYSSNGIL 312
+AE +L+S+ H N+VK G LVLE GS+ + + G+L
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELV---KGLL 119
Query: 313 DIFQRLS------IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
QRL I+ L L++LH +N ++H D+K +N+LL + L DFG++
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 367 LLNGKESMRTQTLAT----------IEYGREGQVSPKSDVYGYGITLIE 405
L R ++ T E + + DV+ GIT IE
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRN 275
D + + +G GS+ TVYKG+ ++G VA+KV LQ + G + E +LK ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKC------LYSSNGILDIFQRLSIMIDVALALE 329
+V + LV EY+ + L+ N L +FQ L L
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLS 117
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGR--- 386
Y+H Y ++H D+KP N+L+ D L+DFG+A+ + + + T+ Y
Sbjct: 118 YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174
Query: 387 ---EGQVSPKSDVYGYGITLIE 405
+ S D++G G +E
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 46/241 (19%)
Query: 208 FSYQELLLATDHFSEKSLIGIGSFGTVYK------GRFL-------DGMEVAIKVFHLQF 254
F Q+L L K +G G FG V+ FL DG V + V L+
Sbjct: 2 FPRQQLRL-------KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRA 54
Query: 255 D---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL-----Y 306
D A F E +++ +++ N+++++ C + + ++ EYM NG L + L
Sbjct: 55 DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIE 114
Query: 307 S----SNGI--LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLS 360
S +N I + I L + + +A ++YL S VH D+ N L+ + ++
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIA 171
Query: 361 DFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPKSDVYGYGITLIETFT--KKK 411
DFG+++ L + R Q A + E G+ + SDV+ +G+TL E FT K++
Sbjct: 172 DFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231
Query: 412 P 412
P
Sbjct: 232 P 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 215 LATDHFSEKSLIGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGALKS-FDAECEVLKSVR 272
L D F + S +G G+ G V+K G+ +A K+ HL+ A+++ E +VL
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILD-IFQRLSIMIDVALALEYL 331
+V + + ++ +E+M GSL++ L + I + I ++SI V L YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYL 119
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV- 390
+ ++H D+KPSN+L++ L DFG++ L +SM + T Y ++
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQ 175
Query: 391 ----SPKSDVYGYGITLIETFTKKKP 412
S +SD++ G++L+E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRN 275
+ E S +G G+ G+V K R + GM A+K + L K E E+ KS +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 276 LVKIISSC---SNGNFEALVLEYMANGSLE---KCLYSSNGILDIFQRLSIMIDVALALE 329
+VK + S+ + + +EY GSL+ K + G + I V L
Sbjct: 61 IVKYYGAFLDESSSSI-GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA-KLLNGKESMRTQT---LATIEYG 385
YLH S ++H DIKPSN+LL L DFG++ +L+N T T +A E
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP-ERI 175
Query: 386 REGQVSPKSDVYGYGITLIE 405
+ S SDV+ G+TL+E
Sbjct: 176 QGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 16/196 (8%)
Query: 226 IGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRNLVKIISSC 283
+G G+ G+V K G +A KV H+ ++ K E +++ R +V +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA----LEYLHFGYSNPV 339
N N + +E+M GSL++ +Y G + + I+ +A+A L YL+ + +
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPI----PVEILGKIAVAVVEGLTYLY--NVHRI 125
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIA-KLLN--GKESMRTQTLATIEYGREGQVSPKSDV 396
+H DIKPSN+L++ L DFG++ +L+N + T T + E + G+ + KSDV
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 397 YGYGITLIETFTKKKP 412
+ GI++IE K P
Sbjct: 186 WSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 36/162 (22%)
Query: 226 IGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDA------------ECEVLKS 270
+G G++G V+K +D VA+K K FDA E L+
Sbjct: 15 LGKGAYGIVWKA--IDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQE 62
Query: 271 VR-HRNLVKIIS--SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
+ H N+VK+++ N LV EYM L + + IL+ + IM + A
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA--NILEDVHKRYIMYQLLKA 119
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369
L+Y+H S V+H D+KPSN+LL+ D L+DFG+A+ L+
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 51/223 (22%)
Query: 226 IGIGSFGTVY--------KGRFLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSV-RH 273
+G G FG V K + + VA+K+ L+ D K +E E++K + +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCL---------YS------SNGILDIFQRL 318
+N++ ++ +C+ +++EY + G+L + L YS L +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 319 SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA----------KLL 368
S VA +EYL S +H D+ NVL+ +D V ++DFG+A K
Sbjct: 138 SCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 369 NGK---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
NG+ + M + L Y + +SDV+ +G+ L E FT
Sbjct: 195 NGRLPVKWMAPEALFDRVY------THQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRH-R 274
+ + IG G+FGTV K G +A+K D K + +V+
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL----ALEY 330
+VK + + +E M + SL+K +L I+ +A+ AL Y
Sbjct: 64 YIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA-KLLNG---------KESMRTQTLA 380
L ++H D+KPSN+LLD + L DFGI+ +L++ + M + +
Sbjct: 123 LKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180
Query: 381 TIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
R+G +SDV+ GITL E T K P
Sbjct: 181 P--SARDG-YDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFH------------LQFDGALKSFDAECEVLKS 270
IG G+ G VYK RF G +A+K + D LKS D C
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD--CP---- 74
Query: 271 VRHRNLVKIISSCSNGNFEALV-LEYMANGSLEKCLYSSNGIL--DIFQRLSIMIDVALA 327
+VK + + + +E M+ L+K L G + DI ++++ I A
Sbjct: 75 ----YIVKCY-GYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAI--VKA 126
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATIEYGR 386
L YL + V+H D+KPSN+LLD L DFGI+ L +S +T++ Y
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMA 182
Query: 387 EGQVSPK---------SDVYGYGITLIETFTKKKP 412
++ P +DV+ GI+L+E T + P
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 225 LIGIGSFGTVYKGRFLD-------GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNL 276
+G G+FG VY+G D + VA+K D K F E ++ + H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSN------GILDIFQRLSIMIDVALALEY 330
VK++ C + +++E M G L L + +L + + L I +DVA Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 331 L---HFGYSNPVVHCDIKPSNVLL-----DDDMVAHLSDFGIAKLLNGKESMRTQTLATI 382
L HF +H D+ N L+ D D V + DFG+A+ + + R + +
Sbjct: 122 LEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 383 -------EYGREGQVSPKSDVYGYGITLIETFT 408
E +G+ + +SDV+ +G+ + E T
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKS-FDAECEVLKSVR 272
L D F S +G G+ G V K + G+ +A K+ HL+ A+++ E +VL
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYL 331
+V + + ++ +E+M GSL++ L + I +I ++SI + LA YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YL 119
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV- 390
+ ++H D+KPSN+L++ L DFG++ L +SM + T Y ++
Sbjct: 120 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQ 175
Query: 391 ----SPKSDVYGYGITLIETFTKKKP 412
S +SD++ G++L+E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 225 LIGIGSFGTVYKGRFL-DG----MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVK 278
++G G+FGTVYKG ++ DG + VAIKV A K E V+ V + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
++ C + LV + M G L + + + L+ + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN----------GKESMRTQTLATIEYGREG 388
+VH D+ NVL+ ++DFG+A+LL+ GK ++ L +I + R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR-- 187
Query: 389 QVSPKSDVYGYGITLIETFT 408
+ +SDV+ YG+T+ E T
Sbjct: 188 -FTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 60/247 (24%), Positives = 110/247 (44%), Gaps = 47/247 (19%)
Query: 196 EVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVY--------KGRFLDGMEVAI 247
E + W FS +L L +G G FG V K + + + VA+
Sbjct: 1 EYELPEDPRWE-FSRDKLTLGKP-------LGEGCFGQVVMAEALGIDKDKPKEAVTVAV 52
Query: 248 KVFHLQFDGALKSFD---AECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMANGSLEK 303
K+ L+ D K +E E++K + +H+N++ ++ +C+ +++EY + G+L +
Sbjct: 53 KM--LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110
Query: 304 CL-----------YSSNGILD---IFQRL-SIMIDVALALEYLHFGYSNPVVHCDIKPSN 348
L Y + D F+ L S VA +EYL S +H D+ N
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARN 167
Query: 349 VLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPKSDVYGYGI 401
VL+ ++ V ++DFG+A+ +N + + T + E + + +SDV+ +G+
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 227
Query: 402 TLIETFT 408
+ E FT
Sbjct: 228 LMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 22/236 (9%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
D+F + IG GS G V G VA+K L+ + E +++ +H N+
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
V++ +S G+ +V+E++ G+L + + ++ Q ++ + V AL LH +
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---A 134
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV------ 390
V+H DIK ++LL D LSDFG ++ KE R ++L Y ++
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPY 193
Query: 391 SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK--NWVNDFLPISVMNVVDTSLL 444
P+ D++ GI +IE + P + E LK + D LP + N+ S
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPKLKNLHKVSPS 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 41/236 (17%)
Query: 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKS-FDAE 264
E+ L+T F E+ +G FG VYKG VAIK + +G L+ F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 265 CEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL-----YSSNG--------- 310
+ ++H N+V ++ + +++ Y ++ L + L +S G
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 311 -ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI----- 364
L+ + I+ +A +E+L S+ VVH D+ NVL+ D + +SD G+
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 365 ----AKLL-NGKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKK-KPTC 414
KL+ N +R + I YG+ S SD++ YG+ L E F+ +P C
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQPYC 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISS 282
+G GS+G V R DG + IK +L+ K+ + E ++L ++H N+V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 283 CSNGN-FEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +V+ + G L L G +L Q + + +A+AL+YLH ++
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP-------- 392
H D+K NV L + + D GIA++L + M + + T Y +SP
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYY-----MSPELFSNKPY 179
Query: 393 --KSDVYGYGITLIETFTKK 410
KSDV+ G + E T K
Sbjct: 180 NYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 38/156 (24%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIK-VFHLQFDGALKSFDA-------------ECEVLKS 270
+G G++G V K L G VAIK V ++ + E +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEY 330
++H N++ ++ G+F LV++ MA L+K + L Q I++ + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKK-VVDRKIRLTESQVKCILLQILNGLNV 134
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
LH Y +H D+ P+N+ ++ + ++DFG+A+
Sbjct: 135 LHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 47/215 (21%)
Query: 225 LIGIGSFGTVYKGRFLDGMEV----AIKVFHLQFDGALKSFD-----AECEVLKSVRHRN 275
++G GSFG V+ R + G + A+KV LK D E ++L V H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK---KATLKVRDRVRTKMERDILAEVNHPF 59
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS--IMI----------D 323
+VK+ + L+L+++ G D+F RLS +M +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAE 106
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIE 383
+ALAL++LH S +++ D+KP N+LLD++ L+DFG++K E T+E
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 384 Y------GREGQVSPKSDVYGYGITLIETFTKKKP 412
Y R G + +D + +G+ + E T P
Sbjct: 164 YMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 216 ATDHFSEKSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVR 272
AT + + + L G GS+ TVYKG ++G VA+KV ++ + + F A E +LK ++
Sbjct: 4 ATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLK 61
Query: 273 HRNLV---KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALE 329
H N+V II + F V EYM + L + + G L + M + L
Sbjct: 62 HANIVLLHDIIHTKETLTF---VFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT----LATIEYG 385
Y+H ++H D+KP N+L+ L+DFG+A+ +S+ +QT + T+ Y
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR----AKSIPSQTYSSEVVTLWY- 169
Query: 386 REGQV-------SPKSDVYGYGITLIETF 407
R V S D++G G IE
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG GS G V R G +VA+K+ L+ + E +++ +H+N+V++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
G +++E++ G+L + S L+ Q ++ V AL YLH S V+H DI
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPKS------DVYG 398
K ++LL D LSDFG ++ K+ + ++L Y +V ++ D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 399 YGITLIETFTKKKP 412
GI +IE + P
Sbjct: 203 LGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 10/149 (6%)
Query: 222 EKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVK 278
EK IG G++G VYK R L G VA+K L+ + G + E +LK + H N+V+
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYSN 337
++ + N LV E++ + L+K + SS LD S + + + Y H S+
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SH 118
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
V+H D+KP N+L+D + L+DFG+A+
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 226 IGIGSFGTVYKG--RFLDGME-VAIKVFHLQF-DGALK-SFDAECEVLKSVRHRNLVKII 280
+G G+FGTV KG + + VA+K+ D ALK E V++ + + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI-DVALALEYLHFGYSNPV 339
C ++ LV+E G L K L + + + + ++ ++ V++ ++YL
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTE--KNITELVHQVSMGMKYLE---ETNF 116
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLL-----------NGKESMRTQTLATIEYGREG 388
VH D+ NVLL A +SDFG++K L +GK ++ + Y +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-- 174
Query: 389 QVSPKSDVYGYGITLIETFT-KKKP 412
S KSDV+ +G+ + E F+ +KP
Sbjct: 175 -FSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 283
+G G++ TV+KGR L VA+K L+ + GA + E +LK+++H N+V +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
LV EY+ + L++ L + ++ + M + L Y H ++H D
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRD 128
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV-------SPKSDV 396
+KP N+L+++ L+DFG+A+ + + + T+ Y R V S D+
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWY-RPPDVLLGSTEYSTPIDM 187
Query: 397 YGYGITLIETFTKK 410
+G G L E T +
Sbjct: 188 WGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 52/148 (35%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFD-----AECEVL-KSVRHRNLVK 278
IG GSFG V + DG A+KV LQ LK + AE VL K+V+H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ S + VL+Y+ G L L + R ++A AL YLH S
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+++ D+KP N+LLD L+DFG+ K
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV--AIKV---FHLQFDGALKSFDAECEVLKSVR 272
HF + L+G G G V+ R L G A+KV + +K E E+L ++
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVR-LKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI------DVAL 326
H L + +S + LV++Y G L + L G + LS + +V L
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG-----KCLSEEVARFYAAEVLL 114
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGR 386
ALEYLH +V+ D+KP N+LL + LSDF ++K + + ++ L
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 387 EGQVSPK 393
P
Sbjct: 172 SVNSIPS 178
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 36/184 (19%)
Query: 255 DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLY-------- 306
D A + F E ++L + N+ +++ C+ +++EYM NG L + L
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 307 SSNGILDI-FQRLSIMI-DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364
+ + F L M +A + YL S VH D+ N L+ + ++DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 365 AKLLNGKESMRTQTLATIEYGRE--------------GQVSPKSDVYGYGITLIETFT-- 408
++ L + R Q GR G+ + KSDV+ +G+TL E T
Sbjct: 177 SRNLYSSDYYRVQ-------GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229
Query: 409 KKKP 412
+++P
Sbjct: 230 REQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 9e-09
Identities = 26/60 (43%), Positives = 35/60 (58%)
Query: 70 NLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 129
NL+ L L NNRL +F L +L+ LDLS NNL+ + P + L L+ L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 225 LIGIGSFGTVYKGRFLDG--------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN- 275
++G G++G V+ R + G M+V K +Q ++ E VL+ VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI---DVALALEYLH 332
LV + + L+L+Y++ G + LY D F + ++ LALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH 122
Query: 333 -FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEYGREGQV 390
G +V+ DIK N+LLD + L+DFG++K +E RT + TIEY +
Sbjct: 123 KLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 391 SPKS------DVYGYGITLIETFTKKKP 412
K D + GI + E T P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 224 SLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKS-----FDAECEVLKSVRHRNLV 277
+IG G+FG V+ R D +V A+KV L+ +K AE ++L +V
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKV--LRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-FGYS 336
K+ S + LV+EYM G L L + + R I ++ LAL+ +H G+
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF- 122
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+H DIKP N+L+D D L+DFG+ K
Sbjct: 123 ---IHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 26/216 (12%)
Query: 226 IGIGSFGTVYKGRFLDGME-VAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
+G G +G V+ + D E VA+K L ++ E ++L + + LVK++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-FGYSNPVV 340
+ + + L +EY+ G + L ++ G+L M ++ A++ LH GY +
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAK--------LLNGKESMRTQTLATIEYGREGQVSP 392
H D+KP N L+D L+DFG++K ++ + M + L Y
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFT----- 178
Query: 393 KSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNW 426
D + G L E P E NLK W
Sbjct: 179 -VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 53/224 (23%)
Query: 226 IGIGSFGTVYKGRFLDGME---------VAIKVFHLQFDGALKSFD---AECEVLKSV-R 272
+G G FG V + G++ VA+K+ L+ D K +E E++K + +
Sbjct: 26 LGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGK 82
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCL---------YSSNGILDIFQRLSI--- 320
H+N++ ++ +C+ +++EY + G+L + L Y N ++LS
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 321 ---MIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA----------KL 367
VA +EYL S +H D+ NVL+ +D V ++DFG+A K
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 368 LNGK---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
NG+ + M + L Y + +SDV+ +G+ L E FT
Sbjct: 200 TNGRLPVKWMAPEALFDRIY------THQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 226 IGIGSFGTV-YKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG GS G V G +VA+K L+ + E +++ H N+V + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
G+ +V+E++ G+L + + ++ Q ++ + V AL YLH + V+H DI
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 345 KPSNVLLDDDMVAHLSDFG----IAKLLNGKES-------MRTQTLATIEYGREGQVSPK 393
K ++LL D LSDFG ++K + ++S M + ++ + YG E
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE------ 198
Query: 394 SDVYGYGITLIETFTKKKP 412
D++ GI +IE + P
Sbjct: 199 VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 42/132 (31%), Positives = 67/132 (50%), Gaps = 4/132 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L +N ++ + P +++ D S N + SLP + N+ + ++LS N L+ D+
Sbjct: 121 LDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DL 178
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + L+NL L L N++ +P L++LE LDLS NN + SL L L
Sbjct: 179 PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLSG 236
Query: 122 LNLSFNRLKGDI 133
L LS N+L+
Sbjct: 237 LELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 220 FSEKSLIGIGSFGTVY----KG--RFLDG-----------MEVAIKVFHLQFD-GALKSF 261
F EK +G G FG V+ +G +F+D + VA+K+ + A F
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 262 DAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL---------YSSNGIL 312
E +++ ++ N++++++ C + ++ EYM NG L + L ++ +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 313 DIFQRLSIM-IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371
+ L M +A ++YL S VH D+ N L+ + ++DFG+++ L
Sbjct: 127 ISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 372 ESMRTQTLATI-------EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE 420
+ R Q A + E G+ + SDV+ +G+TL E T C+E
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT--------LCKE 231
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 51/151 (33%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDA--ECEVLKSVRHRNLVKIIS 281
+G GS+ TVYKGR L G VA+K L+ + GA F A E +LK ++H N+V +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHD 70
Query: 282 SCSNGNFEALVLEYMANG---SLEKC---LYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
LV EY+ ++ C L N L +FQ L L Y H
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH--- 120
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
V+H D+KP N+L+ + L+DFG+A+
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 220 FSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRH 273
F+ ++G G FG+V + + +VA+K+ + ++ F E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 274 RNLVKIIS----SCSNGNFE--ALVLEYMANGSLEKCLYSS----NGILDIFQRL-SIMI 322
N++K+I S + G ++L +M +G L L S Q L MI
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-- 380
D+A +EYL S +H D+ N +L+++M ++DFG++K + + R +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 381 -----TIEYGREGQVSPKSDVYGYGITLIETFTK 409
+E + + SDV+ +G+T+ E T+
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 51/236 (21%), Positives = 94/236 (39%), Gaps = 26/236 (11%)
Query: 234 VYKGRFLDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKI----ISSCSNG 286
+YKG F + EV I+ F H + + E + L+ + N++KI I +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKP 346
+L+LEY G L + L L +L + ID L L+ + P + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 347 SNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV----SPKSDVYGYGIT 402
+ L+ ++ + G+ K+L+ + Y + + K D+Y G+
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211
Query: 403 LIETFTKKKP-----TCEIFCEEMNLKNWVNDFLPIS----VMNVVDTSLLRREDK 449
L E FT K P T EI+ ++ + + LP+ + +V+ K
Sbjct: 212 LWEIFTGKIPFENLTTKEIY--DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265
|
Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 48/188 (25%), Positives = 87/188 (46%), Gaps = 12/188 (6%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 283
+G G++ TV+KGR L VA+K L+ + GA + E +LK ++H N+V +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
LV EY+ + L++ + I+ + + + L Y H V+H D
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRD 129
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGR------EGQVSPKSDVY 397
+KP N+L+++ L+DFG+A+ + + + T+ Y + S + D++
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMW 189
Query: 398 GYGITLIE 405
G G E
Sbjct: 190 GVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 37/145 (25%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 229 GSFGTVYKGRFLDGME-VAIKVFHLQFDGALKSFDA----ECEVLKSVRHRNLVKI--IS 281
G++G VY+ R E VA+K L+ + + F E +L ++H N+V + +
Sbjct: 16 GTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV 73
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
SN + +V+EY+ + L+ + + + +M+ + + +LH N ++H
Sbjct: 74 VGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILH 129
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAK 366
D+K SN+LL++ + + DFG+A+
Sbjct: 130 RDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 226 IGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKII--- 280
IG G++G V+K +G + A+K+ D + +AE +LK++ H N+VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 281 --SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS------IMIDVALALEYLH 332
NG+ LVLE GS+ + G L +R+ I+ + + L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT----------I 382
N +H D+K +N+LL + L DFG++ L R ++ T
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416
E + + DV+ GIT IE P ++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 42/143 (29%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 283
+G G++ TVYKGR L VA+K L+ + GA + E +LK ++H N+V +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
LV EY+ + L++ L +++ + + L Y H V+H D
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRD 129
Query: 344 IKPSNVLLDDDMVAHLSDFGIAK 366
+KP N+L+++ L+DFG+A+
Sbjct: 130 LKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 69/253 (27%), Positives = 108/253 (42%), Gaps = 29/253 (11%)
Query: 223 KSLIGIGSFGTV-YKGRFLDGMEVAIKVFHLQ--FDGALKSFDAE------CEVLKSVR- 272
++G G+ GTV R DG A+KV ++ + AE C+ V+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 273 HRNLVKI-ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS---IMIDVALAL 328
H + K + N ALVL+Y G L + + S F+ + I V LA+
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-------GKESMRTQTLAT 381
++H S ++H DIK +N+LL + + L DFG +K+ G+ T
Sbjct: 157 HHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 382 IEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDF--LPISV---M 436
E R S K+D++ G+ L E T K+P EE+ K + LP S+ M
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEM 273
Query: 437 NVVDTSLLRREDK 449
+ T+LL + K
Sbjct: 274 QEIVTALLSSDPK 286
|
Length = 496 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 57/181 (31%), Positives = 84/181 (46%), Gaps = 34/181 (18%)
Query: 223 KSLIGIGSFGTVYKGRFLDGME----VAIKVFHL------QFDGALKSFDAECEVLKSVR 272
++G G +G V++ R + G + A+KV Q D A AE +L++V+
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVK 58
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVA------- 325
H +V +I + G L+LEY++ G L L GI M D A
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIF--------MEDTACFYLSEI 109
Query: 326 -LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIE 383
LALE+LH +++ D+KP N+LLD L+DFG+ K + E T T TIE
Sbjct: 110 SLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIE 165
Query: 384 Y 384
Y
Sbjct: 166 Y 166
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 14/103 (13%)
Query: 320 IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQT 378
I + + ALEYLH S V+H D+KPSNVL++ + L DFGI+ L +S+ +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163
Query: 379 LATIEYGREGQVSP---------KSDVYGYGITLIETFTKKKP 412
Y +++P KSDV+ GIT+IE T + P
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHR-NLVKII 280
I G+FG+VY + G AIKV + + + AE ++ + K+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
S + ++ LV+EY+ G + + G+ + + + I +V L +E LH ++
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLH---QRGII 119
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR 375
H DIKP N+L+D L+DFG+++ NG E+ +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR--NGLENKK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 226 IGIGSFGTVYKGRFLDG--------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-L 276
+G G++G V+ R + G M+V K +Q + E +VL++VR L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
V + + L+L+Y+ G L LY + R+ I ++ LAL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY-------GREG 388
+++ DIK N+LLD + L+DFG++K +E R + TIEY G G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 389 QVSPKSDVYGYGITLIETFTKKKP 412
D + G+ E T P
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 8/171 (4%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGME-VAIKVFH--LQFDGALKSFDAECEVLKSVRHR 274
+ F ++G G++G V K R + E VAIK F + + ++ E ++L++++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
N+V++ + LV EY+ LE NG+ R I ++ +H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWC 116
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK-LLNGKESMRTQTLATIEY 384
+ N +VH DIKP N+L+ + V L DFG A+ L G + T+ +AT Y
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 49/222 (22%)
Query: 226 IGIGSFGTVYKGRFLDGME---------VAIKVFHLQ-FDGALKSFDAECEVLKSV-RHR 274
+G G FG V + G++ VA+K+ D L +E E++K + +H+
Sbjct: 20 LGEGCFGQVVRAEAY-GIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLY---------------SSNGILDIFQRLS 319
N++ ++ C+ +++EY A G+L + L L +S
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 320 IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA----------KLLN 369
VA +EYL S +H D+ NVL+ +D V ++DFG+A K N
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 370 GK---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
G+ + M + L Y + +SDV+ +GI + E FT
Sbjct: 196 GRLPVKWMAPEALFDRVY------THQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 226 IGIGSFGTVYK------GRFLDGMEVAIKVF----HLQFDGALKSFDAECEVLKSV-RHR 274
+G G+FG V + + M+VA+K+ H AL S E +++ + H
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---ELKIMSHLGNHE 99
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHF 333
N+V ++ +C+ G ++ EY G L L L + LS VA + +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA- 158
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK--------LLNGKESMRTQTLATIEYG 385
S +H D+ NVLL + + DFG+A+ ++ G + + +A E
Sbjct: 159 --SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP-ESI 215
Query: 386 REGQVSPKSDVYGYGITLIETFT 408
+ +SDV+ YGI L E F+
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 21/68 (30%), Positives = 38/68 (55%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+++L N + IP + ++ S+ D S NS NGS+P + + + +NL+ N L+G
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 61 IPPTIGGL 68
+P +GG
Sbjct: 506 VPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 226 IGIGSFGTVYKGRFL---DGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKI 279
IG G++G VYK + DG E AIK F Q+ G +S E +L+ ++H N+V +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 280 ISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRL---SIMIDVALALEYLHFG 334
+ ++ L+ +Y + + + S++ + + YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-- 125
Query: 335 YSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLN 369
SN V+H D+KP+N+L+ + V + D G+A+L N
Sbjct: 126 -SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 8/122 (6%)
Query: 245 VAIKVFHL--QFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLE 302
VA+K +L LK E + ++H N++ ++S + +V MA GS E
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 303 KCL--YSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLS 360
L + G+ ++ I+ DV AL+Y+H S +H +K S++LL D LS
Sbjct: 88 DLLKTHFPEGLPELAIAF-ILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLS 143
Query: 361 DF 362
Sbjct: 144 GL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/167 (34%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 225 LIGIGSFGTVY-KGRFLDGMEVAIKVFHLQFDGALKSFD-----AECEVL-KSVRHRNLV 277
+IG GSFG V R DG A+KV LQ LK + AE VL K+++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+ S VL+Y+ G L L L+ R +VA A+ YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
+++ D+KP N+LLD L+DFG+ K E + T EY
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEY 162
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGME-VAIKVFHL-QFDGALKSFDA-ECEVLKSVRHR 274
D + + IG G++G VYK R E +A+K L Q D + S E +LK ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL--ALEYLH 332
N+V++ + LV EY+ + L+K + SS F + +I L L +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIA 116
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVA-HLSDFGIAK 366
+ +S+ V+H D+KP N+L+D A L+DFG+A+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 30/182 (16%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHR 274
D + S +G G++G V G +VAIK F A+ K E +LK + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 275 NLVKIIS----SCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLS------IMI 322
N++ ++ + S +F+ LV M N I+ Q+LS ++
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGA--------DLNNIVK-CQKLSDDHIQFLVY 125
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI 382
+ L+Y+H S ++H D+KPSN+ +++D + DFG+A+ + + M T +AT
Sbjct: 126 QILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD--DEM-TGYVATR 179
Query: 383 EY 384
Y
Sbjct: 180 WY 181
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 226 IGIGSFGTVY----KGRFLDGMEVAIKVFHLQFDGALKS---FDAECEVLKSVRHRNLVK 278
+G GSFG VY KG D E + + + +++ F E V+K ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYS-----SNGILDIFQRLSIMI----DVALALE 329
++ S G +++E M G L+ L S N + L MI ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-------NGKESMRTQTLATI 382
YL+ +N VH D+ N ++ +D + DFG+ + + G + + +
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 383 EYGREGQVSPKSDVYGYGITLIETFT 408
E ++G + SDV+ +G+ L E T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
I G+FG VY GR + A+KV + + AE + L + +V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
S + N LV+EY+ G + K L G D + + +VALAL+YLH + ++H
Sbjct: 72 SLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIH 127
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKL 367
D+KP N+L+ ++ L+DFG++K+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 223 KSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRNLVKII 280
+ ++G G+ GTVYK L +A+KV L L K +E E+L ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL------SIMIDVALALEYLHFG 334
+ N ++ E+M GSL D+++++ I + V L YL
Sbjct: 66 GAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL--- 111
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA-KLLN--GKESMRTQTLATIEYGREGQVS 391
+S ++H D+KPSN+L++ L DFG++ +L+N K + T E Q
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 392 PKSDVYGYGITLIETFTKKKPTCEIF 417
SDV+ GI+ +E + P +I
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQ 197
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRH 273
T+ + + +G+G+FG V R L G VAIK F + K E ++LK +RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 274 RNLVKI----ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALE 329
N++ + IS + F V E + L + L +S + F + + + L+
Sbjct: 69 ENIISLSDIFISPLEDIYF---VTELLGT-DLHRLL-TSRPLEKQFIQY-FLYQILRGLK 122
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367
Y+H S VVH D+KPSN+L++++ + DFG+A++
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 40/212 (18%)
Query: 192 LSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDG--MEVAIKV 249
L N++++ + + ++ + + F+ +G GSFG V + + VAIK
Sbjct: 4 LKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR 63
Query: 250 FHLQFDGALKSFD---AECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEK--- 303
F K D +E ++L + H V + S + ++ LVLE++ G
Sbjct: 64 FEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR 123
Query: 304 ----------CLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD 353
C Y++ + L EYL S +V+ D+KP N+LLD
Sbjct: 124 RNKRFPNDVGCFYAAQ--------------IVLIFEYLQ---SLNIVYRDLKPENLLLDK 166
Query: 354 DMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY 384
D ++DFG AK+++ RT TL T EY
Sbjct: 167 DGFIKMTDFGFAKVVD----TRTYTLCGTPEY 194
|
Length = 340 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 31/176 (17%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVRHRNLVK- 278
IG G++G V + + +VAIK FD + DA E ++L+ + H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI---DAKRTLREIKLLRHLDHENVIAI 69
Query: 279 --IISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILD------IFQRLSIMIDVALAL 328
I+ F +V E M + L + + SS + D ++Q L L
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GL 121
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
+Y+H S V+H D+KPSN+LL+ + + DFG+A+ + K T+ + T Y
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 226 IGIGSFGTVYKGRFLD----GMEVAIKVFHLQFDGALKS---FDAECEVLKSVRHRNLVK 278
+G GSFG VY+G D E + V + +L+ F E V+K ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYS-----SNGILDIFQRLSIMI----DVALALE 329
++ S G +V+E MA+G L+ L S N L MI ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL--------NGKESMRTQTLAT 381
YL+ + VH D+ N ++ D + DFG+ + + GK + + +A
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 382 IEYGREGQVSPKSDVYGYGITLIETFT 408
E ++G + SD++ +G+ L E +
Sbjct: 191 -ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 15/150 (10%)
Query: 226 IGIGSFGTVYKGRFLDGMEVA-IKVFHLQFDGALK---SFDAECEVLKSVRHRNLVKIIS 281
IG G FG V G GM A + V L+ F E + + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGIL------DIFQRLSIMIDVALALEYLHFGY 335
C LVLE+ G L+ L S+ G++ D+ QR++ +VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMA--CEVASGLLWLH--- 117
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
+H D+ N L D+ + D+G+A
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFLDG--------MEVAIKVFHLQFDGALKSFDAECEVLKS 270
+F ++G G++G V+ R + G M+V K +Q + E +VL+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 271 VRHRN-LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI-DVALAL 328
+R LV + + L+L+Y+ G L L + Q + I ++ LAL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLAL 118
Query: 329 EYLH-FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY-- 384
E+LH G +++ DIK N+LLD + L+DFG++K + E R + TIEY
Sbjct: 119 EHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 385 -----GREGQVSPKSDVYGYGITLIETFTKKKP 412
G +G D + G+ + E T P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 55/165 (33%), Positives = 74/165 (44%), Gaps = 9/165 (5%)
Query: 225 LIGIGSFGTVY-KGRFLDGMEVAIKVFHLQF---DGALKSFDAECEVL-KSVRHRNLVKI 279
+IG GSFG V R LDG A+KV + K AE VL K+V+H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
S VL+++ G L L + R ++A AL YLH S +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
V+ D+KP N+LLD L+DFG+ K + T T EY
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEY 162
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 30/206 (14%)
Query: 225 LIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAECEVLK------SVRHRNLV 277
++G GSFG V EV AIKV L+ D L+ D +C + + + +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+ + V+EY+ G L + S + R +V LAL +LH +
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAK--LLNGK---------ESMRTQTLATIEYGR 386
V++ D+K N+LLD + L+DFG+ K +LNG + + + L +EYG
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG- 174
Query: 387 EGQVSPKSDVYGYGITLIETFTKKKP 412
P D + G+ + E + P
Sbjct: 175 -----PSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 29/200 (14%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFD-----AECEVLKSVR-HRNLVK 278
IG G+F V K + G AIK F KS + E + L+ + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSPHPNILR 62
Query: 279 ---IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
++ G ALV E M + +L + + L + S M + +L+++H
Sbjct: 63 LIEVLFDRKTGRL-ALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGR-------EG 388
N + H DIKP N+L+ DD++ L+DFG + + K T+ ++T Y R +G
Sbjct: 118 RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPY-TEYISTRWY-RAPECLLTDG 174
Query: 389 QVSPKSDVYGYGITLIETFT 408
PK D++ G E +
Sbjct: 175 YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFLDGMEV-AIK------VFHLQFDGALKSFDAECEVLKSV 271
F + IGIG+FG V R +D + A+K V +K AE ++L
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEA 58
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQ----RLSIMIDVALA 327
+ +VK+ S + + V++Y+ G + L L IF+ R I ++ A
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCA 113
Query: 328 LEYLH-FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364
+E +H G+ +H DIKP N+L+D D L+DFG+
Sbjct: 114 IESVHKMGF----IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 43/224 (19%)
Query: 229 GSFGTVYKGRFLDGM-----EVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRNLVKI 279
G+FG ++ G +D EV +K D A + E +L + H+N++ I
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 280 ISSCSNGNFEALVLE-YMANGSL----EKCLYSSNGI---LDIFQRLSIMIDVALALEYL 331
+ C VL YM G+L ++C L Q + + I +A + YL
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK--------LLNGKES-----MRTQT 378
H V+H DI N ++D+++ ++D +++ L E+ M ++
Sbjct: 134 H---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALES 190
Query: 379 LATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEM 421
L EY S SDV+ +G+ L E T + P EI EM
Sbjct: 191 LVNKEY------SSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 226 IGIGSFGTVYKG---RFLDG-----MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
+G G+F ++KG D EV +KV +SF ++ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
C G+ +V EY+ GSL+ L + +++I +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 338 PVVHCDIKPSNVLL---DDDMVAH-----LSDFGIAKLLNGKESM--RTQTLATIEYGRE 387
+ H ++ NVLL +D + LSD GI+ + KE + R +
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 388 GQVSPKSDVYGYGITLIETFT 408
+S +D + +G TL E F+
Sbjct: 180 QNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 52/164 (31%), Positives = 73/164 (44%), Gaps = 10/164 (6%)
Query: 226 IGIGSFGTVYKGRFLDGMEV----AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
IG GSFG V + R D + I+ H+ + AE VL V +V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
S + LVL ++ G L L G D+ + ++ ALE LH V++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-QREGRFDLSRARFYTAELLCALENLH---KFNVIY 116
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY 384
D+KP N+LLD L DFG+ K LN K+ +T T T EY
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEY 159
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 226 IGIGSFGTVYKGRFLDGMEVA-IKVFHLQFDGALKS---FDAECEVLKSVRHRNLVKIIS 281
IG G FG V G G A + V L+ +++ F E + +S++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGI------LDIFQRLSIMIDVALALEYLHFGY 335
C+ LV+E+ G L+ L S QR++ ++AL L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLH--- 117
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367
N +H D+ N LL D+ + D+G++
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 35/209 (16%)
Query: 226 IGIGSFGTVYKGRFLD--GMEVAIKVFHLQF--DGALKSFDAECEVLK---SVRHRNLVK 278
IG G++G V+K R L G VA+K +Q +G S E VL+ + H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 279 IISSCSNGNFE-----ALVLEYMANG---SLEKCL---YSSNGILDIFQRLSIMIDVALA 327
+ C+ + LV E++ L+K + I D +M +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD------MMFQLLRG 122
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGRE 387
L++LH S+ VVH D+KP N+L+ L+DFG+A++ + + T + T+ Y R
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWY-RA 177
Query: 388 GQVSPKS------DVYGYGITLIETFTKK 410
+V +S D++ G E F +K
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 37/184 (20%)
Query: 226 IGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI--- 279
+G GS G V+ +D VA+K L ++K E ++++ + H N+VK+
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 280 -----------ISSCSNGNFEALVLEYMANG---SLEKCLYSSNGI-LDIFQRLSIMIDV 324
+ S + N +V EYM LE+ S L ++Q L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR----- 125
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKESMR---TQTLA 380
L+Y+H S V+H D+KP+NV ++ +D+V + DFG+A++++ S + ++ L
Sbjct: 126 --GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 381 TIEY 384
T Y
Sbjct: 181 TKWY 184
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 41/167 (24%), Positives = 70/167 (41%), Gaps = 15/167 (8%)
Query: 254 FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS---SNG 310
++GA+ E +L V R +V + + LV+ M G L +Y+ N
Sbjct: 37 YEGAM----VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP 92
Query: 311 ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA-KLLN 369
+ + LE+LH +++ D+KP NVLLD+D +SD G+A +L +
Sbjct: 93 GFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149
Query: 370 GKESMR----TQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
G+ + T E + + D + G+TL E + P
Sbjct: 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 52/149 (34%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 225 LIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFD-----AECEVL-KSVRHRNLV 277
+IG GSFG V R + A+KV LQ LK + +E VL K+V+H LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+ S + VL+Y+ G L L L+ R ++A AL YLH S
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+V+ D+KP N+LLD L+DFG+ K
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRN 275
D F + +G G+ G V K G+ +A K+ HL+ A+++ E +VL
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFG 334
+V + + ++ +E+M GSL++ L + I +I ++SI V L YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREK 118
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPK- 393
+ ++H D+KPSN+L++ L DFG++ L +SM + T Y +SP+
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSY-----MSPER 169
Query: 394 ---------SDVYGYGITLIETFTKKKP 412
SD++ G++L+E + P
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKS----FDAECE 266
++L + + + +IG G+FG V R +V +F+ +S F E +
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
++ +V++ + + + +V+EYM G L L S+ + + + R +V L
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVL 153
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT-LATIEY- 384
AL+ +H S +H D+KP N+LLD L+DFG +N + +R T + T +Y
Sbjct: 154 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 385 --------GREGQVSPKSDVYGYGITLIETFTKKKP 412
G +G + D + G+ L E P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDGALKSFDAECEVLKSVR 272
+ F +IG G+FG V + D M+ +K + D L AE +VL
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD-QLAHVKAERDVLAESD 59
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
+V + S + + L++E++ G L L + + R M + LA+E +H
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH 118
Query: 333 -FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
G+ +H DIKP N+L+D LSDFG++
Sbjct: 119 KLGF----IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 30/177 (16%)
Query: 226 IGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDG---ALKSFDAECEVLKSVRHRNLVKI-- 279
IG G++G V G +VAIK FD A ++ E ++L+ +H N++ I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIAIRD 71
Query: 280 ISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLS------IMIDVALALEYL 331
I +F+ +V++ M + L ++S Q L+ + + L+Y+
Sbjct: 72 ILRPPGADFKDVYVVMDLMES-DLHHIIHSD-------QPLTEEHIRYFLYQLLRGLKYI 123
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK----ESMRTQTLATIEY 384
H S V+H D+KPSN+L+++D + DFG+A+ L+ + T+ +AT Y
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 52/226 (23%)
Query: 226 IGIGSFGTVYKGRF--LDGM----EVAIKVFHLQFDGA-LKSFDAECEVLKSVRHRNLVK 278
+G G FG V K L G VA+K+ + L+ +E +LK V H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGI-----------------------LDIF 315
+ +CS L++EY GSL L S + L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 316 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-- 373
+S ++ ++YL +VH D+ NVL+ + +SDFG+++ + ++S
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 374 -----------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
M ++L Y + +SDV+ +G+ L E T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIY------TTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 37/153 (24%), Positives = 68/153 (44%), Gaps = 20/153 (13%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMID 323
E +L++V H +++++ + +G +VL + + L L + L I Q L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK----------LLNGKES 373
+ L YLH + ++H D+K N+ ++D + D G A+ L E+
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIET 406
+ LA +Y + K+D++ GI L E
Sbjct: 223 NAPEVLARDKY------NSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 49/173 (28%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 226 IGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
IG G+FG VY+ R D + A+KV + K A+ EV ++ RN++ + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNIL-VRTLLD 53
Query: 285 NGNFEA-------------LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL 331
F LV +YM+ G L L + + I ++ LALE+L
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
H +V+ D+KP N+LLD L DFG++K T EY
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEY 162
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 5e-06
Identities = 29/58 (50%), Positives = 34/58 (58%), Gaps = 2/58 (3%)
Query: 49 EINLSRNYLTGDIPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
++LS N LT IP GL NL++L L N L PE+F L SL SLDLS NNL
Sbjct: 4 SLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSVRHRNLVKII 280
L+G G+FG V R G A+K+ + A E VL++ RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ + V+EY G L L + R ++ ALEYLH S VV
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKL-LNGKESMRT----------QTLATIEYGREGQ 389
+ DIK N++LD D ++DFG+ K ++ +M+T + L +YGR
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR--- 174
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
D +G G+ + E + P
Sbjct: 175 ---AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 25/163 (15%)
Query: 218 DHFSEKSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHR 274
+ S IG G++G V G++VAIK F+ E ++L+ +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHE 63
Query: 275 NLVKIISSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGILD-----IFQRLSIMIDV 324
N++ I+ +FE+ +V E M L K + + + D ++Q L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR----- 117
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367
L+Y+H S V+H D+KPSN+LL+ + + DFG+A++
Sbjct: 118 --GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 63/252 (25%), Positives = 110/252 (43%), Gaps = 60/252 (23%)
Query: 220 FSEKSLIGIGSFGTVY--------------------KGRFLDGMEVAIKVFHLQFDG--- 256
F EK +G G FG V+ KGR L VA+K+ L+ D
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL---LVAVKI--LRPDANKN 61
Query: 257 ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS-------SN 309
A F E ++L ++ N+++++ C + + ++ EYM NG L + L S N
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 310 GILDIFQR-----------LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358
G + L + + +A ++YL S VH D+ N L+ +++
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIK 178
Query: 359 LSDFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPKSDVYGYGITLIETFT--K 409
++DFG+++ L + R Q A + E G+ + SDV+ +G+TL E K
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238
Query: 410 KKPTCEIFCEEM 421
++P E+ E++
Sbjct: 239 EQPYGELTDEQV 250
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKS----FDAECE 266
+L + + F +IG G+FG V R +V A+K+ +F+ +S F E +
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERD 95
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
++ +V++ + + + +V+EYM G L L S+ I + + R +V L
Sbjct: 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVL 153
Query: 327 ALEYLH-FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT-LATIEY 384
AL+ +H G+ +H D+KP N+LLD L+DFG ++ +R T + T +Y
Sbjct: 154 ALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 385 ---------GREGQVSPKSDVYGYGITLIETFTKKKP 412
G +G + D + G+ L E P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 32/112 (28%), Positives = 58/112 (51%), Gaps = 26/112 (23%)
Query: 301 LEKCLYSSNGILDIFQRL---------SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL 351
LEK + ++ +IF+R+ +IM D+ LEY+H + + H DIKP N+++
Sbjct: 106 LEKLVENTK---EIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159
Query: 352 DDDMVAHLSDFGIAK--LLNGKESMRTQTLATIEYGREGQVSPKSDVYGYGI 401
D + ++ D+GIA +++GK IEY +E + + +Y G+
Sbjct: 160 DGNNRGYIIDYGIASHFIIHGKH---------IEYSKEQKDLHRGTLYYAGL 202
|
Length = 294 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 46/178 (25%)
Query: 259 KSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL-----------EYMANGSLEKCLYS 307
K+ E ++LK++ HR ++ +I + + +V+ + LE+ +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 308 SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367
+L+ AL YLH ++H D+K N+ LD+ A L DFG A
Sbjct: 191 QRRLLE-------------ALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA-- 232
Query: 368 LNGKESMRTQTLATIEYGREGQV---SP----------KSDVYGYGITLIETFTKKKP 412
K T YG G + SP K+D++ G+ L E K
Sbjct: 233 --CKLDAHPDTPQC--YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 29/205 (14%)
Query: 225 LIGIGSFGTVY------KGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
L+G G+FG V G++ M++ K + D + E VLK+ RH L
Sbjct: 2 LLGKGTFGKVILVREKASGKYY-AMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTS 59
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ S + V+EY+ G L L + R ++ AL+YLH S
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGK 115
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKL-LNGKESMRT----------QTLATIEYGRE 387
+V+ D+K N++LD D ++DFG+ K + +M+T + L +YGR
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR- 174
Query: 388 GQVSPKSDVYGYGITLIETFTKKKP 412
D +G G+ + E + P
Sbjct: 175 -----AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 23/162 (14%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIM-- 321
E +L ++H N+V S +V+EY G L + + G L F +I+
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL--FPEDTILQW 105
Query: 322 -IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA 380
+ + L ++++H V+H DIK N+ L + L DFG A+LL + +
Sbjct: 106 FVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 381 TIEYGREGQVSP----------KSDVYGYGITLIETFTKKKP 412
T Y V P KSD++ G L E T K P
Sbjct: 163 TPYY-----VPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 42/114 (36%), Positives = 64/114 (56%), Gaps = 5/114 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
NL L N++S +P L+++ D S+NS+ L + N+K + + LS N L D
Sbjct: 190 NLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-D 246
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE 114
+P +IG L+NL+ L L NN++ S G LT+L LDLS N+LS +P+
Sbjct: 247 LPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 24/203 (11%)
Query: 225 LIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSV-RHRNLV 277
++G GSFG V E+ A+KV L+ D L+ D EC VL +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
++ S + V+EY+ G L + S G D + ++ L L++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ER 115
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAK--LLNGKESMRTQTL-ATIEYG-----REGQ 389
+++ D+K NVLLD + ++DFG+ K +L G T T T +Y
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCGTPDYIAPEILSYQP 172
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
P D + G+ L E + P
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 48/194 (24%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 226 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGA-LKSFDAECEVLKSVRHRNLVKIISSC 283
+G G++G+VYK G+ +A+K L+ D + E ++L +V +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 284 SNGNFEALVLEYMANGSLEKCLY---SSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +EYM GSL+K LY + + I V L++L ++ ++
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 341 HCDIKPSNVLLDDDMVAHLSDFG--------IAKLLNGKES-MRTQTLATIEYGREGQVS 391
H D+KP+NVL++ + L DFG +AK G +S M + + + + +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYT 185
Query: 392 PKSDVYGYGITLIE 405
+SDV+ G++++E
Sbjct: 186 VQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 16/169 (9%)
Query: 226 IGIGSFGTVYK---GRFLDGMEVAIKVFHLQFDG--ALKSFDAECEVLKSVRHRN---LV 277
IG G+FG V+ R DG VA+K F + K E ++L +H N +
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 278 KIISSCSNGNFEAL-VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
I+ FE + V+ + L K + S + ++ + + L+YLH S
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH---S 121
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR-TQTLATIEY 384
++H DIKP N+L++ + V + DFG+A++ ES TQ + T Y
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMI 322
E ++L+ V + +V + + + LVL M G L+ +Y+ N + + L
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI 382
++ LE LH V+ D+KP N+LLDD +SD G+A + ES+R + + T+
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-VGTV 165
Query: 383 EY-------GREGQVSPKSDVYGYGITLIETFTKKKP 412
Y + +SP D +G G + E + P
Sbjct: 166 GYMAPEVLNNQRYTLSP--DYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKS----FDAECE 266
++L + + + +IG G+FG V R +V +F+ +S F E +
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
++ +V++ + + + +V+EYM G L L S+ + + + + +V L
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVL 153
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT-LATIEY- 384
AL+ +H S ++H D+KP N+LLD L+DFG ++ +R T + T +Y
Sbjct: 154 ALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI 210
Query: 385 --------GREGQVSPKSDVYGYGITLIETFTKKKP 412
G +G + D + G+ L E P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRN 275
F + +GIG+FG V +D A+K + + AE ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-FG 334
+VK+ S + + V++Y+ G + L ++ R I ++ LA+E +H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG 121
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364
+ +H DIKP N+L+D D L+DFG+
Sbjct: 122 F----IHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 46/157 (29%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFH---LQFDGALKSFDAECEVLKSVRH 273
F KSL+G G FG V R ++ A+KV L + F+ E ++L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH- 332
+ ++ + + + LV+EY G L L D + ++ LA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369
GY VH DIKP NVL+D L+DFG A L
Sbjct: 121 MGY----VHRDIKPENVLIDRTGHIKLADFGSAARLT 153
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 263 AECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF---QRLS 319
AE ++L + +VK+ S + N+ L++EY+ G + L D F +
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRF 105
Query: 320 IMIDVALALEYLH-FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+ + LA++ +H GY +H DIKP N+LLD LSDFG+
Sbjct: 106 YIAETILAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 28/205 (13%)
Query: 225 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLK------SVRHRNLV 277
++G GSFG V+ AIK L+ D L D EC +++ + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+ + V+EY+ G L + S + D+ + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLH---SK 115
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPK---- 393
+V+ D+K N+LLD D ++DFG+ KE+M G ++P+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMC-----KENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 394 ------SDVYGYGITLIETFTKKKP 412
D + +G+ L E + P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 33/254 (12%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFH---LQFDGALKSFDAECEVLKSVRH 273
D F +IG G+FG V + + +V A+K+ + + F E +VL +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLH 332
R + + + + N LV++Y G L L + + + R + ++ LA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVH 119
Query: 333 -FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT------------QTL 379
GY VH DIKP NVLLD + L+DFG L ++++ + L
Sbjct: 120 QLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 380 ATIEYGREGQVSPKSDVYGYGITLIETFTKKKP-----TCEIFCEEMNLKNWVNDFLPIS 434
+E G+ G+ P+ D + G+ + E + P E + + MN K P
Sbjct: 176 QAMEDGK-GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ--FPPD 232
Query: 435 VMNVVDTS--LLRR 446
V +V + + L+RR
Sbjct: 233 VTDVSEEAKDLIRR 246
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 18/200 (9%)
Query: 225 LIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAECEVLK------SVRHRNLV 277
++G GSFG V E AIK L+ D L+ D EC +++ + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+ + V+EY+ G L + SS G D + ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLH---KK 115
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGR----EGQVSPK 393
+++ D+K NVLLD D ++DFG+ K E + T +Y +GQ +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 394 S-DVYGYGITLIETFTKKKP 412
S D + +G+ L E + P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 12/196 (6%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
+G G FG V + G A K L+ + E ++L+ V R +V +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ + LV+ M G L+ +Y+ + + + LE+LH +V
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR----TQTLATIEYGREGQVSPKSDV 396
+ D+KP NVLLDD +SD G+A L G + ++ T E + D
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 397 YGYGITLIETFTKKKP 412
+ G TL E + P
Sbjct: 178 FALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 50/172 (29%), Positives = 71/172 (41%), Gaps = 33/172 (19%)
Query: 224 SLIGIGSFGTV----YKGRFLDGMEVAIKVFHLQFDGA------LKSFDAECEVLKSVRH 273
+++G G FG V YK G AIK A L E S RH
Sbjct: 5 AVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI---DVALALEY 330
LV + + + V+EY A G L +++ D+F + V L L+Y
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQY 116
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM----RTQT 378
LH N +V+ D+K N+LLD + ++DFG+ KE M RT T
Sbjct: 117 LH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC-----KEGMGFGDRTST 160
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 28/157 (17%)
Query: 225 LIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKI 279
+G G++G+V +D G +VAIK F + + A E +LK ++H N++ +
Sbjct: 22 QVGSGAYGSVCSA--IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 280 I----SSCSNGNFEA--LVLEYMANGSLEKCL---YSSNGI-LDIFQRLSIMIDVALALE 329
+ S+ S F+ LV+ YM L+K + S + + ++Q L L+
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLC-------GLK 131
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
Y+H S ++H D+KP N+ +++D + DFG+A+
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 15/151 (9%)
Query: 226 IGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVR-HRNLVKI 279
+G G++G V R + VAIK F + + A E ++L+ R H+N+ +
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 280 ISS--CSNGNFEALVL-EYMANGSLEKCLYSSNGILDI-FQRLSIMIDVALALEYLHFGY 335
GNF L L E + L + + S + D FQ S + + L+Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQ--SFIYQILCGLKYIH--- 122
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
S V+H D+KP N+L++ D + DFG+A+
Sbjct: 123 SANVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 29/165 (17%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDA--ECEVLKSVR 272
D + + +G G++GTV LD G +VAIK + F L + A E +LK ++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSA--LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 273 HRNLVKII------SSCSNGNFEALVLEYMAN--GSLEKCLYSSNGILDIFQRLS---IM 321
H N++ ++ S + LV+ +M G L K ++LS I
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----------HEKLSEDRIQ 121
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
V L+ L + ++ ++H D+KP N+ +++D + DFG+A+
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 20/184 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDGALKSFDAECEVLKSVR 272
D F +IG G+FG V + D M++ K L+ + + AE ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEAD 59
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
+VK+ S + L++E++ G + L + + + + I + LA++ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH 118
Query: 333 -FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVS 391
G+ +H DIKP N+LLD LSDFG+ L K++ RT E+ R +
Sbjct: 119 QLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGL--KKAHRT------EFYRNLTHN 166
Query: 392 PKSD 395
P SD
Sbjct: 167 PPSD 170
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 224 SLIGIGSFGTVYKGRFLDGME-VAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI--- 279
++IG GSFG VY+ +D E VAIK LQ D K + E ++K++ H N++ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV-LQ-DPQYK--NRELLIMKNLNHINIIFLKDY 127
Query: 280 -ISSCSNGN----FEALVLEYMANGSLEKCLYSS--NGILDIFQRLSIMIDVALALEYLH 332
+ C N F +V+E++ + + + N L +F + AL Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 333 FGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAK-LLNGKESM 374
S + H D+KP N+L+D + L DFG AK LL G+ S+
Sbjct: 188 ---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
|
Length = 440 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 32/201 (15%)
Query: 226 IGIGSFGTVY-----KGRFLDGMEV--AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
+G GSFGTVY K + ++V I V L + +++ + E ++L + H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 279 IISS-CSNGNFEALVLEYMANGSLEKCL--YSSNG-ILDIFQRLSIMIDVALALEYLHFG 334
+S F ++ EY L+ L G L Q I + L + Y+H
Sbjct: 67 FHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP-- 392
++H D+K N+ L ++++ + DFG+++LL M + LAT G +SP
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-----MGSCDLATTFTGTPYYMSPEA 176
Query: 393 --------KSDVYGYGITLIE 405
KSD++ G L E
Sbjct: 177 LKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 25/158 (15%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVL-EYMANGSLEKCLYSSNGILDIFQRLSIMI 322
E +L+++ H +++++ + + F L+L Y + C ++ + I L+I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD---LYCYLAAKRNIAICDILAIER 189
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA---------KLLNGKES 373
V A++YLH N ++H DIK N+ ++ L DFG A K +
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 374 MRTQT---LATIEYGREGQVSPKSDVYGYGITLIETFT 408
+ T LA YG P D++ GI L E T
Sbjct: 247 IATNAPELLARDPYG------PAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRN 275
F + +GIG+FG V R +D A+K + + AE ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-FG 334
+V++ S + + V++Y+ G + L + R I ++ A+E +H G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG 121
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364
+ +H DIKP N+L+D D L+DFG+
Sbjct: 122 F----IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 49/238 (20%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEAL--VLEYMANGSL----EKCLYSSNGILDIFQR 317
E V++ ++H+N+V+ I N + L ++E+ G L +KC Y G ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC-YKMFGKIEEHAI 120
Query: 318 LSIMIDVALALEYLHFGYSNP----VVHCDIKPSNVLLDDDM-----------------V 356
+ I + AL Y H P V+H D+KP N+ L + +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 357 AHLSDFGIAKLLNGKESMRTQTLATIEY-------GREGQVSPKSDVYGYGITLIETFTK 409
A + DFG++K + G ESM + T Y KSD++ G + E +
Sbjct: 181 AKIGDFGLSKNI-GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 410 KKPTCEIFCEEMNLKNWVNDF-----LPI----SVMNVVDTSLLRREDKYFAAKKQCV 458
K P F + N +++ LPI +N++ +LL K + QC+
Sbjct: 240 KTP----FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 37/163 (22%)
Query: 224 SLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVRHRNLV 277
+IG GS+G V G +VAIK + F+ DA E ++L+ +RH ++V
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS---DATRILREIKLLRLLRHPDIV 62
Query: 278 K---IISSCSNGNFEAL--VLEYM---------ANGSLEKCLYSSNGILDIFQRLSIMID 323
+ I+ S F+ + V E M AN L + ++Q L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQ----FFLYQLLR---- 114
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
AL+Y+H + V H D+KP N+L + D + DFG+A+
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 38/142 (26%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMI 322
E E+L+ V +V + + + LV+ M G L+ +Y+ L++ + +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI 382
+ + +LH S +V+ D+KP NVLLDD LSD G+A L +++ T
Sbjct: 103 QITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI------TQ 153
Query: 383 EYGREGQVSP---KSDVYGYGI 401
G G ++P K + Y Y +
Sbjct: 154 RAGTNGYMAPEILKEEPYSYPV 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLK-----SVRHRNLVKI 279
+IG G FG VY R D ++ A+K D + +K ++ R ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMY----------AMKCLDKKRIKMKQGETLALNERIMLSL 50
Query: 280 ISS-------CSNGNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
+S+ C F +L+ M G L L S +G+ + ++ L
Sbjct: 51 VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILG 109
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
LE++H + VV+ D+KP+N+LLD+ +SD G+A
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 26/204 (12%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLK------SVRHRNLVK 278
++G GSFG V L G V L+ D L D EC +++ + + L
Sbjct: 2 VLGKGSFGKVLLAE-LKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ + V+E++ G L + G D+++ ++ L++LH S
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHI-QDKGRFDLYRATFYAAEIVCGLQFLH---SKG 116
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPK----- 393
+++ D+K NV+LD D ++DFG+ KE++ A+ G ++P+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMC-----KENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 394 -----SDVYGYGITLIETFTKKKP 412
D + +G+ L E + P
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 32/150 (21%), Positives = 65/150 (43%), Gaps = 15/150 (10%)
Query: 221 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV--K 278
S L+ G VY D + +K+ + GA + E +L+ + + L K
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDE-DYVLKINPSREKGAD--REREVAILQLLARKGLPVPK 57
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+++S + + L++E++ +L++ + ++ I +A L LH
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLL 108
Query: 339 VV-HCDIKPSNVLLDDDMVAHLSDFGIAKL 367
V+ H D+ P N+L+DD + + D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 13/141 (9%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMI 322
E ++L+ V R +V + + + LVL M G L+ +Y+ N D + +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI 382
++ LE LH +V+ D+KP N+LLDD +SD G+A + E++R +
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---- 162
Query: 383 EYGREGQVSP---KSDVYGYG 400
G G ++P K++ Y +
Sbjct: 163 --GTVGYMAPEVVKNERYTFS 181
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLK-----SVRHRNLVKI 279
+IG G FG VY R D ++ A+K D + +K ++ R ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMY----------AMKCLDKKRIKMKQGETLALNERIMLSL 50
Query: 280 ISS-------CSNGNFE-----ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
+S+ C + F + +L+ M G L L S +G+ + ++ L
Sbjct: 51 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILG 109
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
LE++H + VV+ D+KP+N+LLD+ +SD G+A
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 222 EKSLIGIGSFGTVYKGRFLDGM---EVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNL 276
E +G G++G VYK + DG E A+K Q +G S A E +L+ ++H N+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNV 60
Query: 277 V---KIISSCSNGNFEALVLEYMANG--SLEKCLYSSNGILDIFQRLSIMIDVAL--ALE 329
+ K+ S S+ L+ +Y + + K +S Q M+ L L+
Sbjct: 61 IALQKVFLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 330 YLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLN 369
+H+ ++N V+H D+KP+N+L+ + ++D G A+L N
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 30/173 (17%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
+ F LI G++G VY R K +F A+K + + +L++ + V
Sbjct: 1 EDFETIKLISNGAYGAVYLVRH--------KETRQRF--AMKKINKQNLILRNQIQQVFV 50
Query: 278 K--IISSCSN-------GNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMID 323
+ I++ N +FE +V+EY+ G L + G L + +
Sbjct: 51 ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFAE 109
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT 376
LALEYLH + +VH D+KP N+L+ L+DFG++K+ G S+ T
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI--GLMSLTT 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 27/156 (17%)
Query: 226 IGIGSFGTV---YKGRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKII 280
+G G++G+V Y R +VA+K F + + E +LK ++H N++ ++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 281 S----SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS------IMIDVALALEY 330
+ S NF + L G+ N I+ Q+LS ++ + L+Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQFLIYQLLRGLKY 133
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+H S ++H D+KPSNV +++D + DFG+A+
Sbjct: 134 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH---LQFDGALKSFDAECEVLKSVRH 273
+ F +IG G+FG V + D G A+K+ + + AE ++L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH- 332
+VK+ S + L++E++ G + L + + + + I + LA++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQ 119
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
G+ +H DIKP N+LLD LSDFG+ L K++ RT+
Sbjct: 120 LGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGL--KKAHRTE 158
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 4/103 (3%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMID 323
E VL++ RH L + S + V+EY G L L S + + +
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAE 103
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+ AL YLH S VV+ D+K N++LD D ++DFG+ K
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 4/103 (3%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMI 322
E ++L+ V R +V + + + LVL M G L+ +Y + + +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
++ LE LH +V+ D+KP N+LLDD +SD G+A
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 23/162 (14%)
Query: 218 DHFSEKSLIGIGSFGTV---YKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVR 272
+ + S +G G++G+V + + G+ VA+K F + K E +LK ++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 74
Query: 273 HRNLVKII------SSCSNGNFEALVLEYMAN--GSLEKCLYSSNGILDIFQRLSIMIDV 324
H N++ ++ S N LV M ++ KC ++ D Q L + +
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQI 129
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
L+Y+H S ++H D+KPSN+ +++D + DFG+A+
Sbjct: 130 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 55/250 (22%), Positives = 101/250 (40%), Gaps = 46/250 (18%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHR 274
D + + IG G++G VYK R + G VA+K L+ D G + E +L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 275 N-LVKIIS--SCSNGNFEA---LVLEYMANGSLEKCLYSSNG----ILDIFQRLSIMIDV 324
+V+++ N + LV EY+ + L+K + S+ L S M +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAKLLNGKESMRTQTLATIE 383
+ + H + V+H D+KP N+L+D + ++D G+ + + T + T+
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176
Query: 384 YGREGQV-------SPKSDVYGYGITLIETFTKK--------------------KPTCEI 416
Y R +V S D++ G E K+ PT ++
Sbjct: 177 Y-RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 417 FCEEMNLKNW 426
+ L++W
Sbjct: 236 WPGVSKLRDW 245
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 22/153 (14%)
Query: 226 IGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKII 280
IG G+ G V D G+ VA+K F + A E +LK V H+N++ ++
Sbjct: 29 IGSGAQGIVCAA--FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 281 SSCS-NGNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMI-DVALALEYLHF 333
+ + + E LV+E M + +L + ++ LD +R+S ++ + +++LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LD-HERMSYLLYQMLCGIKHLH- 140
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
S ++H D+KPSN+++ D + DFG+A+
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 55/200 (27%), Positives = 84/200 (42%), Gaps = 18/200 (9%)
Query: 225 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAEC-----EVLKSVR-HRNLV 277
++G GSFG V R G A+KV L+ D L+ D EC +L R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
++ + V+E++ G L + S + R ++ AL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAK--LLNGKESMR---TQTLATIEYGREGQVSP 392
+++ D+K NVLLD + L+DFG+ K + NGK + T E +E P
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 393 KSDVYGYGITLIETFTKKKP 412
D + G+ L E P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 13/181 (7%)
Query: 19 NLNSILSFDFSSNSLN--GSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLT-NLQLLS 75
NL ++L +LN S ++ + + ++L N +T DIPP IG L NL+ L
Sbjct: 88 NLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELD 146
Query: 76 LENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135
L +N+++ +P L +L++LDLS N+LS +P L L L +L+LS N++ D+P
Sbjct: 147 LSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 136 RSPHLQVPLCKSSSHRKSSKNVILLGVVLPLSVFIIAVLLALGIGLITRYRKGNTELSNI 195
L S+ N ++ ++ LS L L + + LSN+
Sbjct: 204 EIELL------SALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNL 257
Query: 196 E 196
E
Sbjct: 258 E 258
|
Length = 394 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.001
Identities = 12/34 (35%), Positives = 16/34 (47%), Gaps = 1/34 (2%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFH 251
F E+ I S V++ DG EVA+KV
Sbjct: 12 AEFDEEP-IAAASIAQVHRAVLKDGEEVAVKVQR 44
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 40/216 (18%)
Query: 226 IGIGSFGTVYKGRF-----LDG------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHR 274
+G G+F +YKG LD + V +KV +L +F ++ + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 275 NLVKIISSC-SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
+LVK+ C + N +V EY+ G L+ L+ + + +L + +A AL YL
Sbjct: 62 HLVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE- 118
Query: 334 GYSNPVVHCDIKPSNVLL---DDDM----VAHLSDFGIAKLLNGKES--MRTQTLATIEY 384
+VH ++ N+L+ + LSD GI + +E R +A E
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIA-PEC 175
Query: 385 GREGQVSPKS--DVYGYGITLIETFTKKKPTCEIFC 418
R GQ S D + +G TL EI
Sbjct: 176 IRNGQASLTIAADKWSFGTTL----------LEICS 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 227 GIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSC 283
G + +VY R G V +++ L+ + LK+ E + RH N++ +
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68
Query: 284 SNGNFEALVLEYMANGSLEKCL--YSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
+ G++ ++ +MA GS L Y G+ + +I+ L YLH N +H
Sbjct: 69 TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLH---QNGYIH 124
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLL----NGKESMRTQTLATIEYGREGQVSP----- 392
+IK S++L+ D + LS G++ L NG+++ +SP
Sbjct: 125 RNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ 182
Query: 393 -------KSDVYGYGITLIETFTKKKPTCEIFCEEMNLK 424
KSD+Y GIT E T + P ++ +M L+
Sbjct: 183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMI 322
E +L+ V R +V + + + LVL M G L+ +Y+ N D + +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI 382
++ LE L +V+ D+KP N+LLDD +SD G+A + E++R + + T+
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-VGTV 165
Query: 383 EYGREGQVSPKS-----DVYGYGITLIETFTKKKP 412
Y ++ + D +G G + E + P
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 28/205 (13%)
Query: 225 LIGIGSFGTVY------KGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
L+G G+FG V GR+ M++ K + D + E VL++ RH L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFLTA 59
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ S + V+EY G L L S + + ++ AL+YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLH--SEKN 116
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAK-----------LLNGKESMRTQTLATIEYGRE 387
VV+ D+K N++LD D ++DFG+ K E + + L +YGR
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR- 175
Query: 388 GQVSPKSDVYGYGITLIETFTKKKP 412
D +G G+ + E + P
Sbjct: 176 -----AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 33/170 (19%)
Query: 263 AECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS--- 319
+E L + H +VK + + L++EY + G L K I QRL
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHL 164
Query: 320 ---------IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370
+ + LAL+ +H S ++H D+K +N+ L + L DFG +K +
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
Query: 371 KESMRTQT--------LATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
S+ + LA + R+ + S K+D++ G+ L E T +P
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 14/173 (8%)
Query: 243 MEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301
+ V +KV D AL F+ ++ V H +L + C G+ +V E++ +G L
Sbjct: 45 LRVVLKVLDPSHRDIALAFFET-ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--- 358
+ CL G + + ++++ +A AL YL +VH ++ N+LL +A
Sbjct: 104 DVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTS 160
Query: 359 ----LSDFGIA-KLLNGKESM-RTQTLATIEYGREGQVSPKSDVYGYGITLIE 405
LSD G++ L+ +E + R +A +S +D + +G TL+E
Sbjct: 161 PFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 15/57 (26%), Positives = 26/57 (45%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYL 57
+L L +N L+ + F L ++ D S N+L P + + ++LS N L
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 57/251 (22%), Positives = 106/251 (42%), Gaps = 27/251 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFH---LQFDGALKSFDAECEVLKSVRH 273
+ F +IG G+FG V + + +V A+K+ + + F E +VL + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
+ + + + + N LV++Y G L L L + ++ +A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFG-IAKLLNGKESMRTQTLATIEY-------- 384
+ VH DIKP N+L+D + L+DFG KL+ + + T +Y
Sbjct: 121 LH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 385 --GREGQVSPKSDVYGYGITLIETFTKKKP-----TCEIFCEEMNLKNWVNDFLPISVMN 437
+G+ P+ D + G+ + E + P E + + MN K P V +
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--FPAQVTD 235
Query: 438 VVDTS--LLRR 446
V + + L+RR
Sbjct: 236 VSEDAKDLIRR 246
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 312 LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK----- 366
LD+ L VA +++L S +H D+ NVLL D VA + DFG+A+
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 367 ---LLNGKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
++ G + + +A E + + +SDV+ YGI L E F+
Sbjct: 266 SNYVVKGNARLPVKWMAP-ESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 22/65 (33%), Positives = 32/65 (49%), Gaps = 1/65 (1%)
Query: 74 LSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY-LKDLNLSFNRLKGD 132
+ L + G I + L +++++LS N LSG IP + L+ LNLS N G
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 133 IPTRS 137
IP S
Sbjct: 134 IPRGS 138
|
Length = 968 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 224 SLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKII 280
IG G+ G V + G VAIK F + A E ++K V H+N++ ++
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 281 SSCS-NGNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL-ALEYLHF 333
+ + + E LV+E M + +L + + LD +R+S ++ L +++LH
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELM-DANLCQVI---QMDLD-HERMSYLLYQMLCGIKHLH- 135
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM 374
S ++H D+KPSN+++ D + DFG+A+ M
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 20/211 (9%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFH---LQFDGALKSFDAECEVLKSVRH 273
D F +IG G+FG V + + A+K+ + + F E VL +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
+ + + + + N+ LV++Y G L L L + ++ LA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH- 119
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT------------QTLAT 381
VH DIKP NVLLD + L+DFG +N ++++ + L
Sbjct: 120 --QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 382 IEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+E G G+ P+ D + G+ + E + P
Sbjct: 178 MEDGM-GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 467 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.56 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.47 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.45 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.44 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.43 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.38 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.31 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.25 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.2 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.18 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.17 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.13 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.04 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.03 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.02 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.98 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.96 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.9 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.84 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.78 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.76 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.51 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.39 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.37 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.36 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-57 Score=497.34 Aligned_cols=447 Identities=27% Similarity=0.445 Sum_probs=320.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|++.+.+|..+. .++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|..+..+++|+.|+|++|.+
T Consensus 457 L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 535 (968)
T PLN00113 457 LSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535 (968)
T ss_pred EECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence 45555555555555443 46777778888888888888888899999999999999989999999999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCCCCCc--------c-cCCCCCCC---
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHL--------Q-VPLCKSSS--- 149 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~--------~-~~~c~~~~--- 149 (467)
++.+|..|..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.|.+|...... . ...|....
T Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~ 615 (968)
T PLN00113 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG 615 (968)
T ss_pred cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC
Confidence 99999999999999999999999999999999999999999999999998887542110 0 01232110
Q ss_pred ---CCCC-CCceeEeeeehhhHHHHHHHHHHHHhheeeeeecCCcccccccccC-------CCccccccccHHHHHHHhc
Q 041491 150 ---HRKS-SKNVILLGVVLPLSVFIIAVLLALGIGLITRYRKGNTELSNIEVNM-------SPQAMWRRFSYQELLLATD 218 (467)
Q Consensus 150 ---~~~~-~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 218 (467)
.... ....+.+.++++++++++++++++++. +.+++++ .+.+..+... ........++++++ ..
T Consensus 616 ~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 690 (968)
T PLN00113 616 LPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFV-FIRGRNN-LELKRVENEDGTWELQFFDSKVSKSITINDI---LS 690 (968)
T ss_pred CCCCccccccceeeeehhHHHHHHHHHHHHHHHHH-HHHhhhc-ccccccccccccccccccccccchhhhHHHH---Hh
Confidence 0000 111122222222222222222222221 2222211 1111111000 00011112233333 34
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
.|+..+.||+|+||.||+|++. ++..||+|.++.... ....|++++++++||||+++++++.+.+..++||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 6788899999999999999874 689999998864322 22356889999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC-CCcccc
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG-KESMRT 376 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~ 376 (467)
+|+|.++++ .++|.++..++.|+++|++|||..++++|+||||||+||+++.++.+++. ||.+..... ....++
T Consensus 767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t 841 (968)
T PLN00113 767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841 (968)
T ss_pred CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCcccc
Confidence 999999984 37899999999999999999996667799999999999999999888875 665543322 223456
Q ss_pred ccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhcc-----------------------c
Q 041491 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLP-----------------------I 433 (467)
Q Consensus 377 ~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-----------------------~ 433 (467)
..|.|||+..+..++.++|||||||++|||+||+.||+..........+|++.... .
T Consensus 842 ~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (968)
T PLN00113 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV 921 (968)
T ss_pred ccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence 78999999999999999999999999999999999997654444455555432211 0
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
++.+++.+|+..+|++|+ ++.|+++++.++
T Consensus 922 ~~~~l~~~Cl~~~P~~RP-t~~evl~~L~~~ 951 (968)
T PLN00113 922 EVMNLALHCTATDPTARP-CANDVLKTLESA 951 (968)
T ss_pred HHHHHHHhhCcCCchhCc-CHHHHHHHHHHh
Confidence 245677789999999997 677777777654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=363.19 Aligned_cols=242 Identities=27% Similarity=0.384 Sum_probs=204.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecc--cccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
..+|...+.||+|+||+||+|+++. +..||||.+.+. .....+.+..|+++|+.++|||||+++++++.++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4689999999999999999999874 899999999766 4456677899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC------CcEEEecccccee
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD------MVAHLSDFGIAKL 367 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~------~~~kl~Dfg~a~~ 367 (467)
|||.||||.+|++.. +.+++.+++.++.|++.||++|| +++||||||||+|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999654 57999999999999999999999 9999999999999999764 4689999999999
Q ss_pred cCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH--------HHHHhhhccccc
Q 041491 368 LNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL--------KNWVNDFLPISV 435 (467)
Q Consensus 368 ~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~ 435 (467)
+.+.. .++++.|+|||++..++|+.|+|+||+|+|+|+|++|+.||+.....+.-. .......++...
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 98654 357889999999999999999999999999999999999998654333211 111222233446
Q ss_pred ccccccccccchhHHHHHHHHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.+++-+.+.+++.+|..-.+.+...++
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l 271 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFL 271 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhc
Confidence 688888889988888665555555544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=369.60 Aligned_cols=241 Identities=44% Similarity=0.655 Sum_probs=214.7
Q ss_pred ccccccHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEe
Q 041491 204 MWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC 283 (467)
Q Consensus 204 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 283 (467)
..+.|++.++..+|++|.....||+|+||.||+|...+|+.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999988999999987655332146699999999999999999999999
Q ss_pred ecCC-eeeEEEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEec
Q 041491 284 SNGN-FEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 284 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 361 (467)
.+.+ ..+||+||+++|+|.++++.... .++|.++.+|+.++|+||+|||..+...||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 59999999999999999988776 899999999999999999999987777899999999999999999999999
Q ss_pred cccceecCC-CCc-----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccc-cccccHHHHHhhhccc-
Q 041491 362 FGIAKLLNG-KES-----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIF-CEEMNLKNWVNDFLPI- 433 (467)
Q Consensus 362 fg~a~~~~~-~~~-----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~~- 433 (467)
||+|+.... ... .++..|.+|||...+..+.|+|||||||++.|++||+.|.+... ..+..+.+|+...+..
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 999976654 322 56778999999999999999999999999999999999988643 4455689998877776
Q ss_pred ccccccccccc
Q 041491 434 SVMNVVDTSLL 444 (467)
Q Consensus 434 ~~~~~i~~~l~ 444 (467)
.+.+++|+.|.
T Consensus 301 ~~~eiiD~~l~ 311 (361)
T KOG1187|consen 301 KLREIVDPRLK 311 (361)
T ss_pred chhheeCCCcc
Confidence 48888888876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=348.76 Aligned_cols=234 Identities=26% Similarity=0.315 Sum_probs=199.5
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCC-eeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGN-FEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 294 (467)
.+.+..+.||+|..|+||+++++. ++.+|+|++....+ ...+++.+|+++++..+||+||++||.|...+ ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 345556899999999999999974 88899999965543 35678999999999999999999999999998 5999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
||++|+|++++... +++++....+++.++++||.|||. +++||||||||+|||++..|++||||||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIAN 235 (364)
T ss_pred hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcc
Confidence 99999999988544 679999999999999999999993 399999999999999999999999999999987654
Q ss_pred CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---cHHHHHhh---------hccccccccc
Q 041491 372 ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---NLKNWVND---------FLPISVMNVV 439 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---~~~~~~~~---------~~~~~~~~~i 439 (467)
...+|..|++||-+.++.|+.++||||||+.++|+++|+.||........ .+..++-. .++++++++|
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 35688999999999999999999999999999999999999976422111 22333211 2445699999
Q ss_pred ccccccchhHHHHHH
Q 041491 440 DTSLLRREDKYFAAK 454 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~ 454 (467)
+.||++||.+|++..
T Consensus 316 ~~CL~Kdp~~R~s~~ 330 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAK 330 (364)
T ss_pred HHHhcCCcccCCCHH
Confidence 999999999997543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=350.49 Aligned_cols=244 Identities=24% Similarity=0.328 Sum_probs=204.8
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc-------chHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG-------ALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||+++++... ......+|+++|++++|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5577899999999999999999875 5999999999765311 2234579999999999999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC---CcEEEecccc
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD---MVAHLSDFGI 364 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~ 364 (467)
..|+||||++||+|.+.+-. .+.+.+...+.+++|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999998854 346788888999999999999999 9999999999999999765 7899999999
Q ss_pred ceecCCCC----ccccccccccccccCCCC---CCcccchhhHHHHHHHhcCCCCCCcccccc----------ccHHHHH
Q 041491 365 AKLLNGKE----SMRTQTLATIEYGREGQV---SPKSDVYGYGITLIETFTKKKPTCEIFCEE----------MNLKNWV 427 (467)
Q Consensus 365 a~~~~~~~----~~~~~~~~~pe~~~~~~~---~~~~Dv~slGvil~el~tg~~Pf~~~~~~~----------~~~~~~~ 427 (467)
|+..+... .++|+.|.|||++..+.+ ..++|+||+|||+|-+++|.+||.+...+. ..+....
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 99987543 467889999999876543 348899999999999999999998764443 1222235
Q ss_pred hhhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 428 NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 428 ~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
|..++++..++|+.+|..||++|+++.+.+-..|++
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 666777899999999999999999877665555544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=343.98 Aligned_cols=232 Identities=28% Similarity=0.364 Sum_probs=200.8
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
...++|++.+.||+|+||+||.++.++ ++.+|+|++++.. ....+...+|..+|.+++||+||+++-.|++.+..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 446789999999999999999998875 8999999997653 235677889999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+|+||+.||.|...+. +.+.+++..+.-++.+|+.||.||| ++|||||||||+|||+|.+|+++|+|||+|+..-.
T Consensus 102 lVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999984 4568999999999999999999999 99999999999999999999999999999985432
Q ss_pred C-----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhcccccccc
Q 041491 371 K-----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNV 438 (467)
Q Consensus 371 ~-----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~ 438 (467)
. ..++|..|+|||++....|+..+|+||+|+++|||++|.+||.......+ ...... ..++.+.+++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-~~~I~~~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-YDKILKGKLPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-HHHHhcCcCCCCCccCCHHHHHH
Confidence 2 23678889999999999999999999999999999999999987533221 111222 2245568999
Q ss_pred cccccccchhHHH
Q 041491 439 VDTSLLRREDKYF 451 (467)
Q Consensus 439 i~~~l~~~~~~r~ 451 (467)
+.+.|.+||++|.
T Consensus 257 l~~LL~rdp~~RL 269 (357)
T KOG0598|consen 257 LKKLLKRDPRQRL 269 (357)
T ss_pred HHHHhccCHHHhc
Confidence 9999999999996
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=359.70 Aligned_cols=232 Identities=22% Similarity=0.283 Sum_probs=203.3
Q ss_pred ccCccCCccCcccceeEEEEEe-cCCCeEEEEEeecc---cccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.+|...+.||+|+|+.||.+++ ..|+.||+|++.+. .....+.+.+||++.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999999 56999999999763 3456678999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+|+.++|..+++ .+..+++.+++.+++||+.||.||| +++|+|||||..|+|++++.++||+|||+|..+..++
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999886 6678999999999999999999999 9999999999999999999999999999999987543
Q ss_pred ----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc-cHHHH----Hhhhccccccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-NLKNW----VNDFLPISVMNVVDTSL 443 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-~~~~~----~~~~~~~~~~~~i~~~l 443 (467)
.++|+.|-|||++.....+..+||||+|||||-|++|++||+...-.+. +-... +...++.++.++|.++|
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLL 253 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHh
Confidence 3578888889988888889999999999999999999999987532221 11111 22345557999999999
Q ss_pred ccchhHHHHH
Q 041491 444 LRREDKYFAA 453 (467)
Q Consensus 444 ~~~~~~r~~~ 453 (467)
..+|.+|++.
T Consensus 254 ~~~P~~Rpsl 263 (592)
T KOG0575|consen 254 RPNPSERPSL 263 (592)
T ss_pred cCCcccCCCH
Confidence 9999999753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=351.24 Aligned_cols=245 Identities=29% Similarity=0.390 Sum_probs=201.5
Q ss_pred HHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccc--hHHHHHHHHHHHcCCCCCceeEEEEeecCC-eee
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRNLVKIISSCSNGN-FEA 290 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 290 (467)
.+...+....+.+|+|+||+||+|.+.....||+|++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ..+
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 33344455567799999999999999654459999997653222 568999999999999999999999999887 789
Q ss_pred EEEecccCCCHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCeeecCCC-cEEEecccccee
Q 041491 291 LVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHFGYSNP-VVHCDIKPSNVLLDDDM-VAHLSDFGIAKL 367 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~ 367 (467)
+||||+++|+|.++++. ....+++..+..++.||++||.||| +.+ ||||||||+|||++.++ ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999999999987 4678999999999999999999999 888 99999999999999998 999999999987
Q ss_pred cCCC-----Ccccccccccccccc--CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------hhhccc
Q 041491 368 LNGK-----ESMRTQTLATIEYGR--EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-------NDFLPI 433 (467)
Q Consensus 368 ~~~~-----~~~~~~~~~~pe~~~--~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~ 433 (467)
.... ...+|..|+|||.+. ...|+.|+|||||||++|||+||+.||.+.........-.. ....++
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 6532 135677899999999 56999999999999999999999999988654221111111 112344
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.+.+++.+|+..||.+|+ +..+++..+.
T Consensus 274 ~l~~l~~~CW~~dp~~RP-~f~ei~~~l~ 301 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRP-SFLEIVSRLE 301 (362)
T ss_pred HHHHHHHHhCCCCCCcCC-CHHHHHHHHH
Confidence 589999999999999995 4555555443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=333.55 Aligned_cols=232 Identities=25% Similarity=0.315 Sum_probs=193.9
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecc--cccchHHHHHHHHHHHcCCCCCceeEEE-EeecCCe-eeEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIIS-SCSNGNF-EALV 292 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 292 (467)
.+|++.++||+|+||+||++++. +|..+|.|.++-. +....+....|+.+|++++|||||++++ .+.+++. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 46888899999999999999875 6999999988733 2345577889999999999999999998 4444444 8999
Q ss_pred EecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeecCCCcEEEecccccee
Q 041491 293 LEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
||||++|||.+.++. ....+++.++|+++.|++.||.++|..+ .. |+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999988754 3457999999999999999999999322 44 89999999999999999999999999999
Q ss_pred cCCCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-Hh--------hhccc
Q 041491 368 LNGKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-VN--------DFLPI 433 (467)
Q Consensus 368 ~~~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-~~--------~~~~~ 433 (467)
+.... ..+|+.|++||.+.+..|+.||||||+||++|||+.-++||.+.. -..+... .. ..++.
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~KI~qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCKKIEQGDYPPLPDEHYST 255 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHHHHHcCCCCCCcHHHhhh
Confidence 87654 357888999999999999999999999999999999999998741 1111111 11 23445
Q ss_pred ccccccccccccchhHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~ 452 (467)
++.++|..|+..|+++|+.
T Consensus 256 ~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPD 274 (375)
T ss_pred HHHHHHHHHccCCcccCCC
Confidence 6899999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=344.71 Aligned_cols=235 Identities=27% Similarity=0.384 Sum_probs=202.3
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 288 (467)
....++|...+.||.|+|++|++|+.++ +++||||++.+.. +...+.+..|-.+|.+| .||.|++++..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4456789999999999999999998865 9999999987542 33445677899999999 79999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
+|+|+||+++|+|.++++.. +.+++..++.++.||+.||+||| ++|||||||||+|||+|+++++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999999654 78999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCC------------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----
Q 041491 369 NGKE------------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---- 426 (467)
Q Consensus 369 ~~~~------------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---- 426 (467)
.+.. ..+|..|.+||++.....++.+|+|+||||+|+|+.|++||.+..+- ..+.+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqkI~~l~ 303 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQKIQALD 303 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHHHHHhc
Confidence 5321 23566788999999999999999999999999999999999864221 112222
Q ss_pred --HhhhcccccccccccccccchhHHHHH
Q 041491 427 --VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 --~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..+.+|+.+.++|++.|..||.+|.+.
T Consensus 304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~ 332 (604)
T KOG0592|consen 304 YEFPEGFPEDARDLIKKLLVRDPSDRLTS 332 (604)
T ss_pred ccCCCCCCHHHHHHHHHHHccCccccccH
Confidence 334566679999999999999999764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=320.73 Aligned_cols=233 Identities=24% Similarity=0.269 Sum_probs=192.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+.|+...++|+|+||.||+|++++ |+.||||.+....+ ...+-..+||++|++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 568889999999999999999986 99999999865432 234557899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
||+.. +.+-+......++...+..+++|++.|+.|+| ++++|||||||+|||++.+|.+||||||+|+.+..+.
T Consensus 82 ~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 82 YCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred ecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 99884 44446566667899999999999999999999 9999999999999999999999999999999988543
Q ss_pred ---ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccH----------H--------------
Q 041491 373 ---SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL----------K-------------- 424 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~----------~-------------- 424 (467)
...|.+|.|||.+-+ -+|++.+||||+||++.||++|.+.|.+.+.-+.-+ .
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 346778899998877 789999999999999999999999887643222100 0
Q ss_pred ---------HHHhhhcc---cccccccccccccchhHHHHHH
Q 041491 425 ---------NWVNDFLP---ISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 425 ---------~~~~~~~~---~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
+-....+| .-+.+++.+||..||++|++..
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ 279 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE 279 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH
Confidence 00111122 2367889999999999997643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=313.85 Aligned_cols=232 Identities=25% Similarity=0.317 Sum_probs=202.0
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
-++|+..+.||.|+||.|.+++.+. |..+|+|+++++. ....+...+|..+|+.+.||+++++++.+.+.+..|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4578899999999999999999875 8899999998663 23456678899999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||++||.|..++++ .++++++.++.++.||+.|++||| +.+|++|||||+|||+|.+|.+||+|||+|+...+..
T Consensus 123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence 999999999999954 457999999999999999999999 9999999999999999999999999999999987653
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLL 444 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~ 444 (467)
.++++.|.|||.+....+..++|.|||||++|||+.|.+||.+... ...+.+.+ .+.+++.+++++++.|+
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVKFPSYFSSDAKDLLKKLLQ 277 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcccCCcccCHHHHHHHHHHHh
Confidence 3578888888888889999999999999999999999999987543 22233332 34455679999999999
Q ss_pred cchhHHHHH
Q 041491 445 RREDKYFAA 453 (467)
Q Consensus 445 ~~~~~r~~~ 453 (467)
+|-.+|+-.
T Consensus 278 vD~t~R~gn 286 (355)
T KOG0616|consen 278 VDLTKRFGN 286 (355)
T ss_pred hhhHhhhcC
Confidence 999999643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=331.11 Aligned_cols=235 Identities=30% Similarity=0.401 Sum_probs=194.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC--eeeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--FEALVL 293 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 293 (467)
..+|...+.||+|+||.||++.+.+ |..+|||.+........+.+.+|+.+|++++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778999999999999998865 8999999987664333677899999999999999999999754444 689999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEEEeccccceecCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLSDFGIAKLLNG-- 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~-- 370 (467)
||+++|+|.+++....+.+++..+..+++|+++||+||| ++||+||||||+|||++. ++.+||+|||.++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999877668999999999999999999999 999999999999999999 79999999999987762
Q ss_pred ------CCccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCcc-ccccccHHHH-------Hhhhccccc
Q 041491 371 ------KESMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEI-FCEEMNLKNW-------VNDFLPISV 435 (467)
Q Consensus 371 ------~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~-~~~~~~~~~~-------~~~~~~~~~ 435 (467)
....+++.|++||+..++ ....++||||+||++.||+||++||.+. ......+... ....++++.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 224577889999998854 3345999999999999999999999863 1111111111 222344569
Q ss_pred ccccccccccchhHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~ 454 (467)
++++.+|+.++|.+|+++.
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~ 271 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAE 271 (313)
T ss_pred HHHHHHHhhcCcccCcCHH
Confidence 9999999999999998543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=331.25 Aligned_cols=236 Identities=28% Similarity=0.335 Sum_probs=196.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC--CeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 291 (467)
.+.|+.+++||+|.||.||+|++. +|+.||+|.+.... .+...-..+||.||++++||||+++.+...+. +.+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 456888899999999999999886 59999999998664 45567778999999999999999999988766 78999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|+|||+. ||.-++....-.+++.++..+++|++.||+|+| .+||+|||||.+|||||.+|.+||+|||+|+.+...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 999988776678999999999999999999999 999999999999999999999999999999988765
Q ss_pred Cc------cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccc-----------ccHHHHH------
Q 041491 372 ES------MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE-----------MNLKNWV------ 427 (467)
Q Consensus 372 ~~------~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~-----------~~~~~~~------ 427 (467)
.. ..|.+|.+||.+.+ ..|+.++|+||.|||+.||++|++.|.+...-+ ..-..|.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 42 34677899998876 479999999999999999999999987532111 0111121
Q ss_pred -----------------hhhcccccccccccccccchhHHHHHHHH
Q 041491 428 -----------------NDFLPISVMNVVDTSLLRREDKYFAAKKQ 456 (467)
Q Consensus 428 -----------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~ 456 (467)
...++....++++.+|..||++|.++...
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a 397 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA 397 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence 12234457788999999999999765543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=333.86 Aligned_cols=238 Identities=24% Similarity=0.335 Sum_probs=202.1
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
.....+..++|++++.||+|+||.||+|+-++ |..+|+|++++.. ....+.+..|-.+|...++|.||+++-.|.+
T Consensus 133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 33445678899999999999999999998775 9999999998653 3456778899999999999999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
.+++||||||++|||+..++. ..+.+++..+..++.+++-|+..+| +.|+|||||||+|+|||..|++||+|||+|
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred CCeeEEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccccc
Confidence 999999999999999999985 4468999999999999999999999 999999999999999999999999999998
Q ss_pred eecCC-------------------------C---------------------------CccccccccccccccCCCCCCc
Q 041491 366 KLLNG-------------------------K---------------------------ESMRTQTLATIEYGREGQVSPK 393 (467)
Q Consensus 366 ~~~~~-------------------------~---------------------------~~~~~~~~~~pe~~~~~~~~~~ 393 (467)
.-+.. . ...+++.|.|||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 53210 0 0124566778888888889999
Q ss_pred ccchhhHHHHHHHhcCCCCCCccccccc--cHHHHHhh-------hcccccccccccccccchhHHHH
Q 041491 394 SDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWVND-------FLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 394 ~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~~~-------~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
+|+||+|||+|||+.|.+||......+. .+..|... .+++++.++|.++|. ||++|.-
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999999987654442 45666422 234468999999999 9999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=338.90 Aligned_cols=237 Identities=27% Similarity=0.435 Sum_probs=203.0
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.+.+.+..+.+...+.||+|-||+||.|.++...+||+|.++.. ....+.|.+|+++|++++|++||+++++|..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 34445555566677999999999999999988889999999865 34457889999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 290 ALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
||||||++.|+|.+++.. .+..+...+.+.++.|||+||+||+ ++++|||||.+.||||+++..+||+|||+|+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999986 4558899999999999999999999 999999999999999999999999999999966
Q ss_pred CCCCc------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHH--------Hhhhccc
Q 041491 369 NGKES------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNW--------VNDFLPI 433 (467)
Q Consensus 369 ~~~~~------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~ 433 (467)
.+... ..+..|.|||.+..+.++.|||||||||+||||+| |+.|+.+....+ ..+. .....|+
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--v~~~le~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--VLELLERGYRLPRPEGCPD 431 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--HHHHHhccCcCCCCCCCCH
Confidence 54433 23445789999999999999999999999999999 888887654332 2222 2334567
Q ss_pred ccccccccccccchhHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~ 452 (467)
.+.++...|+..+|++|++
T Consensus 432 ~vY~lM~~CW~~~P~~RPt 450 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPT 450 (468)
T ss_pred HHHHHHHHHhhCCcccCCC
Confidence 7999999999999999953
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=337.70 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=202.9
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecc----cc-cchHHHHHHHHHHHcCC-CCCceeEEEEeecCC
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ----FD-GALKSFDAECEVLKSVR-HRNLVKIISSCSNGN 287 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 287 (467)
...++|.+.+.||+|+||.|+.|.+. ++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44678999999999999999999875 5899999987654 12 23456778999999999 999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-CcEEEeccccce
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAK 366 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~ 366 (467)
..++||||+.||+|.+++.. .+++.+..+..+++|++.|++|+| ++||+||||||+||++|.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999977 778999999999999999999999 9999999999999999999 999999999999
Q ss_pred ecC-C----CCccccccccccccccCCC-CC-CcccchhhHHHHHHHhcCCCCCCccccccccHHHH------Hhhhc-c
Q 041491 367 LLN-G----KESMRTQTLATIEYGREGQ-VS-PKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------VNDFL-P 432 (467)
Q Consensus 367 ~~~-~----~~~~~~~~~~~pe~~~~~~-~~-~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~~~-~ 432 (467)
... . ....+++.|.|||++.+.. |+ .++||||+||++|.|++|+.||++...... +... +...+ +
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~~ki~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-YRKIRKGEFKIPSYLLS 248 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-HHHHhcCCccCCCCcCC
Confidence 883 2 2356889999999998877 75 789999999999999999999987322211 1111 12223 5
Q ss_pred cccccccccccccchhHHHHHHHHHHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
+++..++.++|..+|.+|.+..+=+...|+
T Consensus 249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 249 PEARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 667999999999999999754433333343
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=335.16 Aligned_cols=228 Identities=30% Similarity=0.415 Sum_probs=197.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.. +...+.+.+|++|++.++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999876 48899999997653 3356778999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
|+.| +|..++. .++.++++.+..++.+++.||.||| +.+|.|||+||.||+++..|.+|+||||+|+.+.....
T Consensus 82 ~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9977 9999984 5678999999999999999999999 99999999999999999999999999999998876543
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-hh------hcccccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-ND------FLPISVMNVVDTS 442 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-~~------~~~~~~~~~i~~~ 442 (467)
.+++.|+|||...++.|+..+|+||+|||+||+++|++||....-. .+.+.+ .+ ..+..+.++++..
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~--~Lv~~I~~d~v~~p~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT--QLVKSILKDPVKPPSTASSSFVNFLQGL 234 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH--HHHHHHhcCCCCCcccccHHHHHHHHHH
Confidence 5788899999999999999999999999999999999999753222 111111 11 2223488999999
Q ss_pred cccchhHHHH
Q 041491 443 LLRREDKYFA 452 (467)
Q Consensus 443 l~~~~~~r~~ 452 (467)
|.+||.+|.+
T Consensus 235 L~kdP~~Rlt 244 (808)
T KOG0597|consen 235 LIKDPAQRLT 244 (808)
T ss_pred hhcChhhccc
Confidence 9999999954
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=327.85 Aligned_cols=239 Identities=22% Similarity=0.324 Sum_probs=199.8
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchH-HHHHHHHHHHcCC-CCCceeEEEEeecCC-eee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALK-SFDAECEVLKSVR-HRNLVKIISSCSNGN-FEA 290 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~ 290 (467)
...++|...++||.|.||.||+|+... |..||||.++.......+ .-.+|++.|++++ ||||+++.+++.+.+ ..|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346789999999999999999998764 899999999877554333 3468999999998 999999999998888 999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+|||||+. +|.++++.++..+++..+..|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+|+.+..
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999965 999999888889999999999999999999999 99999999999999999888999999999998876
Q ss_pred CC----ccccccccccccc-cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc-----------cHHHH--------
Q 041491 371 KE----SMRTQTLATIEYG-REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-----------NLKNW-------- 426 (467)
Q Consensus 371 ~~----~~~~~~~~~pe~~-~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-----------~~~~~-------- 426 (467)
.. ...|.+|.|||++ +.+.|+.+.||||+|||++|+.+-++.|.+..+-+. ....|
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 43 4578889999975 578899999999999999999999999976422111 00111
Q ss_pred ----------------HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 427 ----------------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 427 ----------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+-...+.+..+++.+|+.-||++|+++ .|++
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA-~~al 289 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA-SQAL 289 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH-HHHh
Confidence 111134468889999999999999754 4444
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=332.85 Aligned_cols=230 Identities=23% Similarity=0.281 Sum_probs=200.0
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.-|+..+.||.|+.|.|-.|++. +|+.+|||++.+.. +.....+.+||-+|+-+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 35778899999999999999885 59999999997652 334567899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||++||.|.+++.. ++++++.++.++++||+.|+.|+| ..+|+|||+||+|+|+|..+++||+|||+|..-.++
T Consensus 92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999954 567899999999999999999999 999999999999999999999999999999876543
Q ss_pred --CccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHH------Hhhhcccccccccccc
Q 041491 372 --ESMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------VNDFLPISVMNVVDTS 442 (467)
Q Consensus 372 --~~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~ 442 (467)
..++.+.|.+||...+..| +.++||||.|||+|.|+||+.||++..-... +.+. +...++.+..+++.+|
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L-LlKV~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL-LLKVQRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH-HHHHHcCcccCCCcCCHHHHHHHHHH
Confidence 3578899999999999988 5789999999999999999999986322211 1111 3356777899999999
Q ss_pred cccchhHHHH
Q 041491 443 LLRREDKYFA 452 (467)
Q Consensus 443 l~~~~~~r~~ 452 (467)
|..||.+|.+
T Consensus 247 l~VDp~~RiT 256 (786)
T KOG0588|consen 247 LDVDPSTRIT 256 (786)
T ss_pred hccCcccccc
Confidence 9999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=296.71 Aligned_cols=233 Identities=25% Similarity=0.348 Sum_probs=195.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|...+++|+|.||.||+|++. +|+.||+|.++... ++......+||+.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57888999999999999999886 49999999998653 3344567899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
|++. +|+..++.....++..++..++.++++|++||| ++.|+||||||.|+|++++|.+||+|||+|+.+..+..
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 999999888889999999999999999999999 99999999999999999999999999999999886543
Q ss_pred ----cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccc--------------------ccHHHHHh
Q 041491 374 ----MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--------------------MNLKNWVN 428 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--------------------~~~~~~~~ 428 (467)
..+..|.|||.+.+ ..|+..+||||.|||+.||+-|.+-|.+...-+ ..+.+++.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 34677899998765 579999999999999999999987665431111 12222221
Q ss_pred hh-c------------ccccccccccccccchhHHHHHH
Q 041491 429 DF-L------------PISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 429 ~~-~------------~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
-. . +....+++.+++.-+|.+|.++-
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 11 1 12367889999999999997543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=328.72 Aligned_cols=230 Identities=26% Similarity=0.350 Sum_probs=200.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
...|...++||+|+.|.||.|+.. +++.||+|++........+-+.+|+.+|+..+|+|||.+++.|...+..|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 346888899999999999999775 4899999999887767777889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
++||+|.+.+... .+++.++..+++++++||+||| .+||+|||||.+|||++.+|.+||+|||+|..+....
T Consensus 352 m~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred cCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 9999999988544 4899999999999999999999 9999999999999999999999999999999887554
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-----------Hhhhccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-----------VNDFLPISVMNVV 439 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-----------~~~~~~~~~~~~i 439 (467)
..+++.|+|||......|++|+||||||++++||+-|++||-.. .....-| .+..+++.+++++
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE---~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC---ChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 34678888999998999999999999999999999999999641 1111111 2344566799999
Q ss_pred ccccccchhHHHHHH
Q 041491 440 DTSLLRREDKYFAAK 454 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~ 454 (467)
++||..|+++|.++.
T Consensus 504 ~~cL~~dv~~RasA~ 518 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAK 518 (550)
T ss_pred HHHhhcchhcCCCHH
Confidence 999999999996543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=331.38 Aligned_cols=241 Identities=22% Similarity=0.270 Sum_probs=200.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999986 48999999997542 22346688999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999988643 56889999999999999999999 9999999999999999999999999999998775433
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLL 444 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~ 444 (467)
..++..|.+||+..+..++.++|||||||++|||+||+.||.+....+ ....... ..++..+.+++.+||.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 251 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKILAGRLKFPNWFDGRARDLVKGLLQ 251 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCCcCCCCCCCHHHHHHHHHHhh
Confidence 245677899999998889999999999999999999999997532211 1111111 1234458899999999
Q ss_pred cchhHHHHHHHHHHHHHH
Q 041491 445 RREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 445 ~~~~~r~~~~~~~~~~l~ 462 (467)
.||.+|++++.+.+.+++
T Consensus 252 ~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 252 TDHTKRLGTLKGGVADVK 269 (329)
T ss_pred cCHHHcCCCCCCCHHHHh
Confidence 999999876444444443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=326.42 Aligned_cols=240 Identities=24% Similarity=0.293 Sum_probs=199.5
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999986 48999999987542 123456889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence 999999999998643 46899999999999999999999 9999999999999999999999999999998765432
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLLR 445 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~~ 445 (467)
..++..|.+||.+.+..++.++|||||||++|||++|+.||......+ ....... ...++.+.+++.+||..
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCcCCCccCCHHHHHHHHHHcCC
Confidence 235677899999988889999999999999999999999997643221 1111111 12344589999999999
Q ss_pred chhHHHHHHHHHHHHHH
Q 041491 446 REDKYFAAKKQCVSSAL 462 (467)
Q Consensus 446 ~~~~r~~~~~~~~~~l~ 462 (467)
||.+|++++.+.+.+++
T Consensus 236 dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 236 DRTRRLGNMKNGADDVK 252 (291)
T ss_pred CHHHccCCccCCHHHHh
Confidence 99999975444444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=330.92 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=207.9
Q ss_pred cccHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEee
Q 041491 207 RFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCS 284 (467)
Q Consensus 207 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 284 (467)
..+.++|.+..+...+.+.||+|.||+||+|+|. ..||||++.... +...+.|++|+..+++-+|.||+-+.|+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 3455788888899999999999999999999984 579999997653 346688999999999999999999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
.++. .||+.+|+|.+|+.+++..+..++..+.+.|++|+++|+.||| .++|||||||..||++.+++.|||+|||+
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence 9988 9999999999999999988889999999999999999999999 99999999999999999999999999999
Q ss_pred ceecCC-------CCccccccccccccccC---CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc--------H--H
Q 041491 365 AKLLNG-------KESMRTQTLATIEYGRE---GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--------L--K 424 (467)
Q Consensus 365 a~~~~~-------~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--------~--~ 424 (467)
+..-.. ....+...|+|||+++. .+|++.+||||||+|+|||+||..||.....+.+. . .
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 875432 12234566899998763 47899999999999999999999999843322211 1 1
Q ss_pred HHHhhhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 425 NWVNDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 425 ~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
-......|.+++++++.|+..++++|+ ...+.+..|.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP-~F~~il~~l~ 651 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERP-LFPQLLSKLE 651 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCc-cHHHHHHHHH
Confidence 123444556799999999999999995 3444444443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=294.58 Aligned_cols=232 Identities=23% Similarity=0.271 Sum_probs=201.7
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|.||.||.|+.+. +-.||+|++.+.. ....+++.+|++|-+.++||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4678899999999999999998764 7889999986542 34567899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 293 LEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
+||...|++...+..... .+++.....+++|++.|+.|+| .++++||||||+|+|++..+..||+|||.+......
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 999999999999875443 6899999999999999999999 999999999999999999999999999999876532
Q ss_pred C---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH------Hhhhcccccccccccc
Q 041491 372 E---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------VNDFLPISVMNVVDTS 442 (467)
Q Consensus 372 ~---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~ 442 (467)
. -+++..|-+||+..+..++..+|+|++|+..||++.|.+||.....++ .+.+. ....++.++.++|.++
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI~k~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRIRKVDLKFPSTISGGAADLISRL 256 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHHHHccccCCcccChhHHHHHHHH
Confidence 2 357778899999999999999999999999999999999998765332 33333 2244556799999999
Q ss_pred cccchhHHHH
Q 041491 443 LLRREDKYFA 452 (467)
Q Consensus 443 l~~~~~~r~~ 452 (467)
+.++|.+|.+
T Consensus 257 l~~~p~~r~~ 266 (281)
T KOG0580|consen 257 LVKNPIERLA 266 (281)
T ss_pred hccCcccccc
Confidence 9999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.65 Aligned_cols=246 Identities=19% Similarity=0.283 Sum_probs=196.5
Q ss_pred HHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEeec
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCSN 285 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 285 (467)
.++.++|++.+.||+|+||.||+|.+. +++.||+|+++.... ...+.+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 455688999999999999999999752 256899999875432 2346788999999999 89999999998876
Q ss_pred C-CeeeEEEecccCCCHHHhhhcCC-------------------------------------------------------
Q 041491 286 G-NFEALVLEYMANGSLEKCLYSSN------------------------------------------------------- 309 (467)
Q Consensus 286 ~-~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 309 (467)
. +..++||||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 46789999999999999886431
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-------cccc
Q 041491 310 ------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRT 376 (467)
Q Consensus 310 ------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~ 376 (467)
..+++.++..++.|+++||+||| ++||+||||||+||+++.++.+||+|||+++...... ...+
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 23677888999999999999999 9999999999999999999999999999998653321 1223
Q ss_pred ccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-------hhhcccccccccccccccchh
Q 041491 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-------NDFLPISVMNVVDTSLLRRED 448 (467)
Q Consensus 377 ~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~~~ 448 (467)
..|.+||++.+..++.++|||||||++|||++ |..||.+....+....... ....++.+.+++.+|+..||+
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 56899999998999999999999999999997 9999976432221111111 112344588999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 041491 449 KYFAAKKQCVSSALS 463 (467)
Q Consensus 449 ~r~~~~~~~~~~l~~ 463 (467)
+|+ ++.++++.|-+
T Consensus 320 ~RP-s~~el~~~l~~ 333 (338)
T cd05102 320 ERP-TFSALVEILGD 333 (338)
T ss_pred hCc-CHHHHHHHHHH
Confidence 996 56677766644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=328.10 Aligned_cols=233 Identities=23% Similarity=0.267 Sum_probs=195.8
Q ss_pred HhccCccCCccCcccceeEEEEEecC--CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD--GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..++|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999998654 3689999986542 233466889999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++|+|.+++... ..+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+|||+++....
T Consensus 108 lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999998543 46899999999999999999999 99999999999999999999999999999987654
Q ss_pred CC--ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccc
Q 041491 371 KE--SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTS 442 (467)
Q Consensus 371 ~~--~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~ 442 (467)
.. ..++..|.|||+..+..++.++||||+||++|||++|+.||....... ....... ..+++.+.+++.+|
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~~ 262 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILEGIIYFPKFLDNNCKHLMKKL 262 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 32 346677999999988889999999999999999999999997643221 1111111 22344588999999
Q ss_pred cccchhHHHHH
Q 041491 443 LLRREDKYFAA 453 (467)
Q Consensus 443 l~~~~~~r~~~ 453 (467)
|..+|.+|++.
T Consensus 263 l~~dp~~R~~~ 273 (340)
T PTZ00426 263 LSHDLTKRYGN 273 (340)
T ss_pred cccCHHHcCCC
Confidence 99999999853
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=312.18 Aligned_cols=236 Identities=22% Similarity=0.319 Sum_probs=200.7
Q ss_pred hccCccCCccCcccceeEEEEEe-cCCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
..+|++.+.||+|.||.|-+|+. ..|+.||||.+++.. ....-.+.+||+||+.++||||+.++.+|++.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46899999999999999999976 469999999997653 23345678999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||..+|.|++|+. ..+.+++.++.++++||..|+.|+| .++++|||||.+|||+|.++++||+|||++..+....
T Consensus 132 MEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 99999999999995 4567999999999999999999999 9999999999999999999999999999999887654
Q ss_pred ----ccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCcccccc----ccHHHHHhhhccccccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEE----MNLKNWVNDFLPISVMNVVDTSL 443 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l 443 (467)
.++++.|.+||...+.+| ++.+|-||+||++|.++.|..||++..... +.-..|..+.-|....-+|.-||
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWML 287 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHH
Confidence 357788899999988887 689999999999999999999998742221 11112222333445889999999
Q ss_pred ccchhHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQC 457 (467)
Q Consensus 444 ~~~~~~r~~~~~~~ 457 (467)
..+|++| +++++.
T Consensus 288 mVNP~RR-ATieDi 300 (668)
T KOG0611|consen 288 MVNPERR-ATIEDI 300 (668)
T ss_pred hcCcccc-hhHHHH
Confidence 9999988 455444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=323.69 Aligned_cols=224 Identities=23% Similarity=0.270 Sum_probs=188.2
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.||+|+||.||+|++. +|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999876 58999999997542 223456778999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Ccc
Q 041491 300 SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ESM 374 (467)
Q Consensus 300 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~ 374 (467)
+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence 99998854 457899999999999999999999 999999999999999999999999999998754221 123
Q ss_pred ccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccccccchh
Q 041491 375 RTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLLRRED 448 (467)
Q Consensus 375 ~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~~~ 448 (467)
++..|.+||...+..++.++||||+||++|||+||+.||........ ..... ...+++++.+++.+||..||+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 56788999999888999999999999999999999999975322211 11111 123455689999999999999
Q ss_pred HHHH
Q 041491 449 KYFA 452 (467)
Q Consensus 449 ~r~~ 452 (467)
+|++
T Consensus 236 ~R~~ 239 (323)
T cd05571 236 QRLG 239 (323)
T ss_pred HcCC
Confidence 9985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=313.15 Aligned_cols=231 Identities=21% Similarity=0.249 Sum_probs=192.8
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3777899999999999999875 58999999987542 1223457889999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 295 YMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999999988875433 36899999999999999999999 9999999999999999999999999999998764322
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHH-------hhhcccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWV-------NDFLPISVMNVVD 440 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~-------~~~~~~~~~~~i~ 440 (467)
..++..|.+||++.+..++.++|||||||++|||++|+.||........ ...... ...+++.+.+++.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 2456788999999999999999999999999999999999976422110 111111 1224456889999
Q ss_pred cccccchhHHHH
Q 041491 441 TSLLRREDKYFA 452 (467)
Q Consensus 441 ~~l~~~~~~r~~ 452 (467)
+||..||.+|++
T Consensus 238 ~~l~~~P~~R~~ 249 (285)
T cd05631 238 MLLTKNPKERLG 249 (285)
T ss_pred HHhhcCHHHhcC
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=319.38 Aligned_cols=224 Identities=23% Similarity=0.280 Sum_probs=187.8
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.||+|+||.||+++.. +|+.||+|+++... ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999876 58999999997542 223456778999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Ccc
Q 041491 300 SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ESM 374 (467)
Q Consensus 300 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~ 374 (467)
+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence 99988854 346899999999999999999999 999999999999999999999999999998754221 123
Q ss_pred ccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccccccchh
Q 041491 375 RTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLLRRED 448 (467)
Q Consensus 375 ~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~~~ 448 (467)
++..|.+||+..+..++.++|||||||++|||++|+.||........ ..... ...+++.+.+++.+||..||+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 56778999999989999999999999999999999999975432211 11111 123455689999999999999
Q ss_pred HHHH
Q 041491 449 KYFA 452 (467)
Q Consensus 449 ~r~~ 452 (467)
+|+.
T Consensus 236 ~R~~ 239 (323)
T cd05595 236 QRLG 239 (323)
T ss_pred HhCC
Confidence 9973
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=298.96 Aligned_cols=196 Identities=22% Similarity=0.285 Sum_probs=173.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec--CCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 291 (467)
.+.|+...+|++|.||.||+|+++ +++.||+|+++... .+..-...+||.+|.+++|||||.+..+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356888899999999999999986 48899999997653 2334556899999999999999999988754 357999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|||||+. ||...+.....++...++..++.|+++|++||| .+.|+||||||+|+|+++.|.+||+|||+|+.++.+
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999987 999999888889999999999999999999999 999999999999999999999999999999999876
Q ss_pred Cc-----cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 372 ES-----MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 372 ~~-----~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
.. .-|..|.+||.+.+ ..|+++.|+||+|||+.||+++++-|.+.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 43 34667899998765 67899999999999999999999988764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=326.19 Aligned_cols=232 Identities=26% Similarity=0.338 Sum_probs=197.7
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 288 (467)
....++|...+.||+|+||+|+++..+. ++.+|||++++.. ....+....|.+|+... +||.++.++..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 5566789999999999999999999874 8899999998763 45667888999998877 59999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||+.|||+..+ ...+.+++..+.-++..++.||+||| ++|||+||||.+|||+|.+|++||+|||+++.-
T Consensus 444 l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999995443 34467999999999999999999999 999999999999999999999999999999865
Q ss_pred CC-----CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccc
Q 041491 369 NG-----KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMN 437 (467)
Q Consensus 369 ~~-----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~ 437 (467)
-. ....+|+.|.|||.+.+..|+.++|.|||||+||||+.|..||.+...++ .+...+. ..++.+..+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~FdsI~~d~~~yP~~ls~ea~~ 597 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDSIVNDEVRYPRFLSKEAIA 597 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCCCCCCCcccHHHHH
Confidence 32 23356777888888888999999999999999999999999998754443 2222222 223456889
Q ss_pred ccccccccchhHHH
Q 041491 438 VVDTSLLRREDKYF 451 (467)
Q Consensus 438 ~i~~~l~~~~~~r~ 451 (467)
++++.|.++|++|.
T Consensus 598 il~~ll~k~p~kRL 611 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRL 611 (694)
T ss_pred HHHHHhccCccccc
Confidence 99999999999995
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.77 Aligned_cols=236 Identities=22% Similarity=0.320 Sum_probs=194.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999986 48999999997542 233456788999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999998653 46899999999999999999999 9999999999999999999999999999987643211
Q ss_pred ------------------------------------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCC
Q 041491 373 ------------------------------------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKK 410 (467)
Q Consensus 373 ------------------------------------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~ 410 (467)
..++..|.|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 13566789999998889999999999999999999999
Q ss_pred CCCCccccccc--cHHHHHhh-------hcccccccccccccccchhHHHH--HHHHHH
Q 041491 411 KPTCEIFCEEM--NLKNWVND-------FLPISVMNVVDTSLLRREDKYFA--AKKQCV 458 (467)
Q Consensus 411 ~Pf~~~~~~~~--~~~~~~~~-------~~~~~~~~~i~~~l~~~~~~r~~--~~~~~~ 458 (467)
.||......+. ....|... .+++.+.++|.+++. +|.+|+. ++.+++
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 99976432211 11111110 234458889999886 8999986 455544
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=316.52 Aligned_cols=228 Identities=25% Similarity=0.248 Sum_probs=189.9
Q ss_pred cCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
||+|+||.||+|++.+ ++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999864 8899999987532 23446678899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Ccccc
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ESMRT 376 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~ 376 (467)
.+++.. .+.+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++..... ...++
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence 998854 456899999999999999999999 999999999999999999999999999999864322 12356
Q ss_pred ccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccccccchhHH
Q 041491 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLLRREDKY 450 (467)
Q Consensus 377 ~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~~~~~~r 450 (467)
..|.+||...+..++.++||||+||++|||+||+.||.+....+ ....... ..+++.+.+++.+||..||.+|
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-MYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-HHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 77899999998899999999999999999999999997542221 1111111 2344568999999999999999
Q ss_pred HH--HHHHHH
Q 041491 451 FA--AKKQCV 458 (467)
Q Consensus 451 ~~--~~~~~~ 458 (467)
++ ++.+++
T Consensus 236 ~~~~~~~e~l 245 (312)
T cd05585 236 LGYNGAQEIK 245 (312)
T ss_pred CCCCCHHHHH
Confidence 74 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=318.32 Aligned_cols=231 Identities=23% Similarity=0.282 Sum_probs=190.7
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.||+|+||.||++++. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999876 48999999997542 233456788999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Ccc
Q 041491 300 SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ESM 374 (467)
Q Consensus 300 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~ 374 (467)
+|.+++.. ...+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence 99988854 346899999999999999999999 999999999999999999999999999998764321 123
Q ss_pred ccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-----HhhhcccccccccccccccchhH
Q 041491 375 RTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-----VNDFLPISVMNVVDTSLLRREDK 449 (467)
Q Consensus 375 ~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~~~~~ 449 (467)
++..|.+||++.+..++.++|||||||++|||++|+.||......+...... ....+++++.+++.+||..+|.+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHH
Confidence 5677899999988899999999999999999999999997542221110000 11234456899999999999999
Q ss_pred HHH----HHHHHH
Q 041491 450 YFA----AKKQCV 458 (467)
Q Consensus 450 r~~----~~~~~~ 458 (467)
|++ ++.+++
T Consensus 237 R~~~~~~~~~~il 249 (328)
T cd05593 237 RLGGGPDDAKEIM 249 (328)
T ss_pred cCCCCCCCHHHHh
Confidence 973 455554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=304.69 Aligned_cols=239 Identities=25% Similarity=0.317 Sum_probs=200.7
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
...++|++.+.||.|..++||+|++. .+..||||++...... ..+.+.+|+..++.++||||++++..|..+...|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 45678999999999999999999886 4899999999876543 358899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 293 LEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|.||.+|++.+.++..- ..+++..+..+++++++||.||| ++|-||||||+.|||++++|.+||+|||.+..+...
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999986543 36999999999999999999999 999999999999999999999999999987765433
Q ss_pred C---------cccccccccccccc--CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------------
Q 041491 372 E---------SMRTQTLATIEYGR--EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-------------- 426 (467)
Q Consensus 372 ~---------~~~~~~~~~pe~~~--~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-------------- 426 (467)
. ..+++.|+|||++. ...|+.|+||||||++..|+.+|..||.....-++.+...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 2 24566788888843 3468999999999999999999999998754333222211
Q ss_pred -HhhhcccccccccccccccchhHHHHHHHH
Q 041491 427 -VNDFLPISVMNVVDTSLLRREDKYFAAKKQ 456 (467)
Q Consensus 427 -~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~ 456 (467)
....++..++++|..||.+||.+|+++.+-
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskL 290 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKL 290 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHH
Confidence 122334468899999999999999876543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.90 Aligned_cols=236 Identities=22% Similarity=0.309 Sum_probs=196.4
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|++.+ ++.||+|+++... ......+.+|+++++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468999999999999999999874 8999999997542 223456888999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC--C
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG--K 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~--~ 371 (467)
||+++|+|.+++.. .+.+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence 99999999999854 346889999999999999999999 99999999999999999999999999999987654 2
Q ss_pred CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHHh----h-------hcccccccc
Q 041491 372 ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWVN----D-------FLPISVMNV 438 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~~----~-------~~~~~~~~~ 438 (467)
...++..|.+||+..+..++.++|||||||++|||++|+.||......+. ....|.. . .+++++.++
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 33467788999999988999999999999999999999999976432221 1112211 0 224568899
Q ss_pred cccccccchhHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~ 458 (467)
+.+||..+|.+|+ ++.+++
T Consensus 237 i~~~l~~~~~rr~-s~~~ll 255 (333)
T cd05600 237 ITKLINDPSRRFG-SLEDIK 255 (333)
T ss_pred HHHHhhChhhhcC-CHHHHH
Confidence 9999998777775 455544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=330.67 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=208.9
Q ss_pred HHHHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
..+...+.+..+.||+|+||+||+|+... .+.||||.++...+. ..++|++|+++++.++|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34555666778999999999999997642 467999999877665 67899999999999999999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSN-------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD 352 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 352 (467)
++..++|+|||..|||.+++.... ..++..+.+.|+.|||.||.||- ++.+|||||-.+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence 999999999999999999986432 23788999999999999999999 99999999999999999
Q ss_pred CCCcEEEeccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHH
Q 041491 353 DDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLK 424 (467)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~ 424 (467)
++..|||+|||+++.+-..+. .-+..|++||.+..+.||++||||||||+|||++| |+.||.+...++....
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 999999999999997654433 34557899999999999999999999999999998 9999988655543111
Q ss_pred HH------HhhhcccccccccccccccchhHH--HHHHHHHHHHHHh
Q 041491 425 NW------VNDFLPISVMNVVDTSLLRREDKY--FAAKKQCVSSALS 463 (467)
Q Consensus 425 ~~------~~~~~~~~~~~~i~~~l~~~~~~r--~~~~~~~~~~l~~ 463 (467)
-- ..+..|.++.++...|+.+.|.+| |+++..+++.+.+
T Consensus 718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 11 233456679999999999999998 5566666666644
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.00 Aligned_cols=234 Identities=21% Similarity=0.274 Sum_probs=193.5
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeecccccc---hHHHHHHHHHHHcCCCCCceeEEEEeec----CCeeeEEEecc
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA---LKSFDAECEVLKSVRHRNLVKIISSCSN----GNFEALVLEYM 296 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 296 (467)
..||+|++|.||+|.+ +|+.||+|+++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 78999999987553322 4677899999999999999999999876 45789999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCCCC--c
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--S 373 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~ 373 (467)
++|+|.+++... ..+++.....++.|++.|+.||| + .+++||||||+||++++++.+||+|||+++...... .
T Consensus 105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~ 180 (283)
T PHA02988 105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180 (283)
T ss_pred CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccc
Confidence 999999998654 46889999999999999999999 6 489999999999999999999999999998655432 3
Q ss_pred cccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccccccccccccc
Q 041491 374 MRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTSL 443 (467)
Q Consensus 374 ~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l 443 (467)
.++..|.+||+..+ ..++.++|||||||++|||++|+.||.+....+. ...... ...++.+.+++.+||
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 35667899999876 6889999999999999999999999986532221 111111 123456999999999
Q ss_pred ccchhHHHHHHHHHHHHHHhc
Q 041491 444 LRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~~~l~~l 464 (467)
..||++|+ ++.+++..|-++
T Consensus 260 ~~dp~~Rp-s~~ell~~l~~~ 279 (283)
T PHA02988 260 SHDSIKRP-NIKEILYNLSLY 279 (283)
T ss_pred cCCcccCc-CHHHHHHHHHHH
Confidence 99999997 777777776543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=306.57 Aligned_cols=232 Identities=28% Similarity=0.387 Sum_probs=188.2
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---------c-----cchHHHHHHHHHHHcCCCCCceeE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---------D-----GALKSFDAECEVLKSVRHRNLVKI 279 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~-----~~~~~~~~E~~~l~~l~h~niv~~ 279 (467)
..-+.|++.+.||+|.||.|-+|++. +++.||+|++.+.. . ...+...+||.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999986 58999999996431 1 123578899999999999999999
Q ss_pred EEEeecC--CeeeEEEecccCCCHHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 280 ISSCSNG--NFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 280 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
+++..+. +..|||+|||..|.+...- .... +++.+++.++++++.||+||| .+|||||||||+|+|++++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence 9998764 5889999999999886542 2233 899999999999999999999 999999999999999999999
Q ss_pred EEEeccccceecCCC----------CccccccccccccccCCC----CCCcccchhhHHHHHHHhcCCCCCCcccccccc
Q 041491 357 AHLSDFGIAKLLNGK----------ESMRTQTLATIEYGREGQ----VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN 422 (467)
Q Consensus 357 ~kl~Dfg~a~~~~~~----------~~~~~~~~~~pe~~~~~~----~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~ 422 (467)
+||+|||.+...... ...+|+.+.|||...++. .+.+.||||+||+||.|+.|+.||.+.+.-+ .
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-l 327 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-L 327 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-H
Confidence 999999999876321 245788889999877633 2567899999999999999999997643222 1
Q ss_pred HHHHHhh--------hcccccccccccccccchhHHHH
Q 041491 423 LKNWVND--------FLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 423 ~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
+.+.+.. .+.+.++++|.++|.+||++|.+
T Consensus 328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee
Confidence 1222221 12334899999999999999974
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=317.00 Aligned_cols=225 Identities=24% Similarity=0.329 Sum_probs=186.7
Q ss_pred CccCcccceeEEEEEec----CCCeEEEEEeeccc----ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 224 SLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+.||+|+||.||+++.. .++.||+|+++... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999763 47889999987532 12335677899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999998854 346788899999999999999999 9999999999999999999999999999987543221
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLL 444 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~ 444 (467)
..++..|.+||+..+..++.++|||||||++|||++|+.||....... ...... ...+++.+.+++.+||.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDKILKGKLNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 235667899999988889999999999999999999999997643221 111111 12234458899999999
Q ss_pred cchhHHHHH
Q 041491 445 RREDKYFAA 453 (467)
Q Consensus 445 ~~~~~r~~~ 453 (467)
.+|++|+++
T Consensus 237 ~~p~~R~~~ 245 (323)
T cd05584 237 RNPSSRLGA 245 (323)
T ss_pred cCHhHcCCC
Confidence 999999853
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=294.49 Aligned_cols=238 Identities=22% Similarity=0.314 Sum_probs=201.1
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecc--cccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++.|++.+.||+|+|+.||++.+. +|+.+|+|++... .....+.+.+|++|-+.++||||+++.+.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888999999999999999765 5999999988643 234568899999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~ 369 (467)
+|++.|++|..-+-.. ..+++..+-.+++||++||.|+| .+||||||+||+|+++.+ .--+||+|||+|....
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999997665433 46788999999999999999999 999999999999999943 3468999999999988
Q ss_pred CCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc---------ccHHHHHhhhcccccc
Q 041491 370 GKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE---------MNLKNWVNDFLPISVM 436 (467)
Q Consensus 370 ~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~---------~~~~~~~~~~~~~~~~ 436 (467)
+.. ..+++.|.+||.....+|+..+||||.|||+|-++.|.+||.+..+.. .++..-.++.++++.+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 432 357888999999999999999999999999999999999998743222 2222224456677899
Q ss_pred cccccccccchhHHHHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~ 457 (467)
++|.+||..||.+|.++.+.+
T Consensus 245 ~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred HHHHHHhccChhhhccHHHHh
Confidence 999999999999998665543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.66 Aligned_cols=243 Identities=21% Similarity=0.264 Sum_probs=201.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|.+.. ++.||+|++..... ...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 579999999999999999998864 89999999875422 23467889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccc
Q 041491 294 EYMANGSLEKCLYSS----------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 294 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
||++||+|.+++... ....++..+..++.|+++||+||| ++||+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988532 123566788999999999999999 9999999999999999999999999999
Q ss_pred cceecCCC-----------------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc
Q 041491 364 IAKLLNGK-----------------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE 420 (467)
Q Consensus 364 ~a~~~~~~-----------------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~ 420 (467)
+++..... ...++..|.+||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876210 1235677899999999999999999999999999999999997633222
Q ss_pred ccHHHHH--------hhhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 421 MNLKNWV--------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 421 ~~~~~~~--------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
....... ...+|+.+.+++.+|+..||++|++++++++..+.+
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2111111 123556689999999999999999988888776643
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.69 Aligned_cols=237 Identities=25% Similarity=0.342 Sum_probs=199.1
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|++. +++.||+|+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999986 58999999997542 234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++++|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998655 67899999999999999999999 9999999999999999999999999999998665432
Q ss_pred ---------------------------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccc
Q 041491 373 ---------------------------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE 419 (467)
Q Consensus 373 ---------------------------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~ 419 (467)
..++..|.+||...+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 23566789999999999999999999999999999999999764322
Q ss_pred cc--cHHHHHh-------hhcccccccccccccccchhHHHHHHHHHHH
Q 041491 420 EM--NLKNWVN-------DFLPISVMNVVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 420 ~~--~~~~~~~-------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
.. ....|.. ..+++++.++|.+|+. +|.+|++++.+++.
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 11 1111100 1135568899999997 99999976766654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=323.43 Aligned_cols=229 Identities=22% Similarity=0.332 Sum_probs=188.1
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999876 58999999986532 223466788999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999998854 356889999999999999999999 999999999999999999999999999998633110
Q ss_pred --------------------------------------------------CccccccccccccccCCCCCCcccchhhHH
Q 041491 372 --------------------------------------------------ESMRTQTLATIEYGREGQVSPKSDVYGYGI 401 (467)
Q Consensus 372 --------------------------------------------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGv 401 (467)
...++..|.+||++....++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 123566789999998888999999999999
Q ss_pred HHHHHhcCCCCCCccccccc--cHHHHHhh-------hcccccccccccccccchhHHH
Q 041491 402 TLIETFTKKKPTCEIFCEEM--NLKNWVND-------FLPISVMNVVDTSLLRREDKYF 451 (467)
Q Consensus 402 il~el~tg~~Pf~~~~~~~~--~~~~~~~~-------~~~~~~~~~i~~~l~~~~~~r~ 451 (467)
++|||+||+.||......+. ....|... .++.++.+++.++|. +|.+|.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence 99999999999975432221 11111110 133457899999997 777773
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=318.15 Aligned_cols=225 Identities=22% Similarity=0.251 Sum_probs=187.2
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.||+|+||.||+|++. +++.||+|+++... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 58999999997542 223456778999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 300 SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 300 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
+|.+++.. ...+++..+..++.|++.||+||| + +||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence 99988854 346899999999999999999999 7 79999999999999999999999999998754321 12
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-----Hhhhcccccccccccccccchh
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-----VNDFLPISVMNVVDTSLLRRED 448 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~~~~ 448 (467)
.++..|.+||+..+..++.++|||||||++|||+||+.||.....+......+ ....+++++.+++.+||..||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 35677899999988899999999999999999999999997643221111111 1123455689999999999999
Q ss_pred HHHH
Q 041491 449 KYFA 452 (467)
Q Consensus 449 ~r~~ 452 (467)
+|++
T Consensus 237 ~R~~ 240 (325)
T cd05594 237 QRLG 240 (325)
T ss_pred HhCC
Confidence 9973
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=316.27 Aligned_cols=230 Identities=21% Similarity=0.237 Sum_probs=190.5
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCC-CceeEEEEeecCCeeeEEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHR-NLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 293 (467)
+|++.+.||+|+||.||+|++.+ ++.||+|++.... ....+.+..|++++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58889999999999999998864 7899999997542 23446678899999999764 6888999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999999998854 346889999999999999999999 999999999999999999999999999998753221
Q ss_pred ---CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccc
Q 041491 372 ---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTS 442 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~ 442 (467)
...++..|.+||++.+..++.++||||+||++|||+||+.||......+. ..... ...+++++.+++.+|
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQSIMEHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 12356778999999988999999999999999999999999976432221 11111 122344578999999
Q ss_pred cccchhHHHHH
Q 041491 443 LLRREDKYFAA 453 (467)
Q Consensus 443 l~~~~~~r~~~ 453 (467)
|..+|.+|++.
T Consensus 236 l~~~P~~R~~~ 246 (324)
T cd05587 236 LTKHPAKRLGC 246 (324)
T ss_pred hhcCHHHcCCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.60 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=200.0
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEee
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCS 284 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 284 (467)
+....++|++.+.||+|+||.||+|++. ++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4455668999999999999999999742 35689999987442 23346788999999999 8999999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhcCC-------------------------------------------------------
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSSN------------------------------------------------------- 309 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 309 (467)
..+..++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999885432
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 310 -------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 310 -------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
..+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 14678889999999999999999 99999999999999999999999999999987653
Q ss_pred CCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcccc
Q 041491 371 KES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 371 ~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
... ..+..|.+||+.....++.++|||||||++|||++ |..||.....+. ...++... ..+.+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccCCCCCCCCHH
Confidence 321 12345899999999999999999999999999998 899997643222 22222222 23445
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHh
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+.+++..|+..||++|+ ++.++++.+-+
T Consensus 346 l~~li~~cl~~dP~~RP-s~~eil~~l~~ 373 (375)
T cd05104 346 MYDIMKSCWDADPLKRP-TFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHccCChhHCc-CHHHHHHHHHh
Confidence 88999999999999996 67777776643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=310.18 Aligned_cols=233 Identities=24% Similarity=0.302 Sum_probs=190.3
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999986 589999999875432 233467789999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
|++ ++|.+++....+.+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 995 5888888666667899999999999999999999 999999999999999999999999999999765322
Q ss_pred --CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHH------------------------
Q 041491 372 --ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK------------------------ 424 (467)
Q Consensus 372 --~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~------------------------ 424 (467)
...++..|.+||...+ ..++.++||||+||++|||++|+.||.+.......+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 2234567899998754 4578899999999999999999999975321110000
Q ss_pred --------------HHHhhhcccccccccccccccchhHHHHH
Q 041491 425 --------------NWVNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 425 --------------~~~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.|.....++.+.+++++||..||.+|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~ 282 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA 282 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH
Confidence 01111123457799999999999999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=316.33 Aligned_cols=229 Identities=25% Similarity=0.342 Sum_probs=188.5
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHH---HcCCCCCceeEEEEeecCCeeeEE
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVL---KSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
|++.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999876 48999999997542 22345567777665 456899999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
|||+++++|...+.. +.+++..+..++.|++.||+||| ++|++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999988743 46899999999999999999999 999999999999999999999999999998754321
Q ss_pred ----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhccccccccccc
Q 041491 372 ----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDT 441 (467)
Q Consensus 372 ----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~ 441 (467)
...++..|.+||+..+..++.++|||||||++|||++|+.||......+ ...... ...+++.+.+++.+
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIVNDEVRYPRFLSREAISIMRR 234 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1235667899999988899999999999999999999999997643221 111111 12345568899999
Q ss_pred ccccchhHHHHHH
Q 041491 442 SLLRREDKYFAAK 454 (467)
Q Consensus 442 ~l~~~~~~r~~~~ 454 (467)
||..||.+|++..
T Consensus 235 ~L~~dP~~R~~~~ 247 (324)
T cd05589 235 LLRRNPERRLGSG 247 (324)
T ss_pred HhhcCHhHcCCCC
Confidence 9999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.87 Aligned_cols=228 Identities=22% Similarity=0.295 Sum_probs=186.4
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||+||+|++.. ++.||+|+++... ......+.+|+.++.+++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999998764 8999999997542 223456788999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999864 357899999999999999999999 999999999999999999999999999998754321
Q ss_pred --------------------------------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCC
Q 041491 372 --------------------------------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPT 413 (467)
Q Consensus 372 --------------------------------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf 413 (467)
...++..|.|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 123566789999998889999999999999999999999999
Q ss_pred Ccccccccc--HHHHHhh-------hcccccccccccccccchhHH
Q 041491 414 CEIFCEEMN--LKNWVND-------FLPISVMNVVDTSLLRREDKY 450 (467)
Q Consensus 414 ~~~~~~~~~--~~~~~~~-------~~~~~~~~~i~~~l~~~~~~r 450 (467)
.+....+.. ...|... .+++++.+++.+++. +|.+|
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r 281 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHR 281 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Chhhc
Confidence 764322211 1111110 123357778877664 56655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=308.74 Aligned_cols=236 Identities=22% Similarity=0.259 Sum_probs=193.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|+||.||+|+++ +++.||+|+++... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999986 48899999987542 2334667899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|++++.+..+. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99987776554 44457899999999999999999999 9999999999999999999999999999998764321
Q ss_pred ----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc--HHH---------------------
Q 041491 373 ----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--LKN--------------------- 425 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--~~~--------------------- 425 (467)
..++..|.+||+..+..++.++||||+||++|||++|+.||......+.. ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 23566789999998888999999999999999999999999753211100 000
Q ss_pred --------------HHhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 426 --------------WVNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 426 --------------~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
-....+++.+.+++.+||..||++|++. +|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~-~~~l 282 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT-EQCL 282 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH-HHHh
Confidence 0011234458899999999999999864 4443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=307.54 Aligned_cols=235 Identities=22% Similarity=0.329 Sum_probs=191.5
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999876 589999999875432 2345678999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC----
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 371 (467)
+++ +|.+++......+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 975 999988666667899999999999999999999 999999999999999999999999999999765432
Q ss_pred -CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--------------------cHHHHH--
Q 041491 372 -ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--------------------NLKNWV-- 427 (467)
Q Consensus 372 -~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--------------------~~~~~~-- 427 (467)
...++..|.+||...+ ..++.++||||+||++|||+||+.||......+. ....+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 2234667899998765 5688999999999999999999999975322110 000000
Q ss_pred -------------hhhcccccccccccccccchhHHHHHHHHH
Q 041491 428 -------------NDFLPISVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 428 -------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
...++++..+++.+||..||.+|++ ++|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t-~~~~ 282 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS-AEAA 282 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC-HHHH
Confidence 0122345788999999999999975 4444
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.43 Aligned_cols=232 Identities=25% Similarity=0.380 Sum_probs=186.3
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC-----eeeEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-----FEALV 292 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 292 (467)
.|...+.+|+|+||.||+|...+ ++.||||.+-.... --.+|..+|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667999999999999998865 79999998754322 2237999999999999999998885432 34589
Q ss_pred EecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-CcEEEeccccceec
Q 041491 293 LEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAKLL 368 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~ 368 (467)
|||++. +|.+.++.. +..++...++-+.+||.+||+||| +.||+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 999888642 457888889999999999999999 9999999999999999977 89999999999988
Q ss_pred CCCCc----cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--------------cH------
Q 041491 369 NGKES----MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--------------NL------ 423 (467)
Q Consensus 369 ~~~~~----~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--------------~~------ 423 (467)
...+. ..+..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+...-++ ++
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 75543 46778899998876 5789999999999999999999999976321110 00
Q ss_pred -----------HHH---HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 424 -----------KNW---VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 424 -----------~~~---~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..| .....+++..+++.+.|..+|.+|.++.+-|.
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011 22334556889999999999999987666443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=317.60 Aligned_cols=234 Identities=24% Similarity=0.291 Sum_probs=193.0
Q ss_pred CccCcccceeEEEEEec----CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 224 SLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
+.||+|+||.||+++.. +|+.||+|+++.... .....+.+|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 67999999999999762 478999999975432 233456789999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----- 372 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----- 372 (467)
+|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 9999998854 346899999999999999999999 9999999999999999999999999999998654331
Q ss_pred ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccccccc
Q 041491 373 SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLLRR 446 (467)
Q Consensus 373 ~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~ 446 (467)
..++..|.+||......++.++|||||||++|||+||+.||......+. ..... ...+++.+.+++.+||..|
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-MTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 2346678999999888889999999999999999999999976432211 11111 1224456899999999999
Q ss_pred hhHHHHHHHHHHHHHH
Q 041491 447 EDKYFAAKKQCVSSAL 462 (467)
Q Consensus 447 ~~~r~~~~~~~~~~l~ 462 (467)
|.+|+++.++.+.+++
T Consensus 237 P~~R~~a~~~~~~~~~ 252 (318)
T cd05582 237 PANRLGAGPDGVEEIK 252 (318)
T ss_pred HhHcCCCCCCCHHHHh
Confidence 9999987555555554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.59 Aligned_cols=229 Identities=21% Similarity=0.292 Sum_probs=187.9
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999886 48899999987542 2334678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC----
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG---- 370 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~---- 370 (467)
|+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999988554 46889999999999999999999 99999999999999999999999999999753210
Q ss_pred ------------------------------------------------CCccccccccccccccCCCCCCcccchhhHHH
Q 041491 371 ------------------------------------------------KESMRTQTLATIEYGREGQVSPKSDVYGYGIT 402 (467)
Q Consensus 371 ------------------------------------------------~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvi 402 (467)
....++..|.|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 01134667899999988899999999999999
Q ss_pred HHHHhcCCCCCCcccccccc--HHHHHh-------hhcccccccccccccccchhHHHH
Q 041491 403 LIETFTKKKPTCEIFCEEMN--LKNWVN-------DFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 403 l~el~tg~~Pf~~~~~~~~~--~~~~~~-------~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
+|||++|+.||......+.. ...|.. ..++++..++|.+++ .+|.+|.+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999764322211 111111 123455778888864 69999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=309.92 Aligned_cols=235 Identities=28% Similarity=0.379 Sum_probs=201.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
...|+..+.||+|+||.||+|.+. .++.||+|++.... ....+++++|+.++.+++++||.++|+.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 346777899999999999999886 48899999998764 3456789999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC----
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG---- 370 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~---- 370 (467)
||.||++.+.+.. ...+++..+.-++++++.|+.||| .++.+|||||+.||++..+|.+|++|||.+..+..
T Consensus 92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999998843 345588888899999999999999 99999999999999999999999999999987764
Q ss_pred -CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc------cHHHHHhhhccccccccccccc
Q 041491 371 -KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM------NLKNWVNDFLPISVMNVVDTSL 443 (467)
Q Consensus 371 -~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l 443 (467)
....+++.|+|||++....|+.|+||||||++.+||++|.+|+.+..+... +...-....+++.++++|..||
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 334678889999999988999999999999999999999999987543211 0011122255667999999999
Q ss_pred ccchhHHHHHHH
Q 041491 444 LRREDKYFAAKK 455 (467)
Q Consensus 444 ~~~~~~r~~~~~ 455 (467)
.++|+.|+++.+
T Consensus 248 ~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 248 DKNPEFRPSAKE 259 (467)
T ss_pred hcCcccCcCHHH
Confidence 999999986554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=294.54 Aligned_cols=235 Identities=26% Similarity=0.339 Sum_probs=191.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCC-ceeEEEEeecCC-----
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRN-LVKIISSCSNGN----- 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 287 (467)
...|+..++||+|+||+||+|+.+ +|+.||+|.+..... +......+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456777889999999999999886 589999999987644 45677889999999999999 999999998777
Q ss_pred -eeeEEEecccCCCHHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccc
Q 041491 288 -FEALVLEYMANGSLEKCLYSSN---GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 288 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
..++|+||++. +|.+++.... ..++...++.+++||+.|++||| +++|+||||||+||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 88999999965 9999997765 35777899999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCC-----ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc----------------
Q 041491 364 IAKLLNGKE-----SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------------- 421 (467)
Q Consensus 364 ~a~~~~~~~-----~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------------- 421 (467)
+|+...-+. ...+..|.|||.+.+. .|++..||||+|||++||++++.-|.+....+.
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 999776322 2356678999998776 799999999999999999999998876432110
Q ss_pred ----cHHHHH------------hhhcc---cccccccccccccchhHHHHHHH
Q 041491 422 ----NLKNWV------------NDFLP---ISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 422 ----~~~~~~------------~~~~~---~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
.+.+|. ....+ +...+++.++|..+|.+|.++..
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 111111 11112 24777888899999988865443
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=311.25 Aligned_cols=229 Identities=21% Similarity=0.294 Sum_probs=187.0
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++.+ ++.||+|+++... ....+....|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998864 7889999997542 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|.+++... +.+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccc
Confidence 9999988543 46899999999999999999999 999999999999999999999999999999865322 12
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccccccch
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~~ 447 (467)
.++..|.+||+..+..++.++|||||||++|||++|+.||.+....+. ..... ...++.++.+++.+||..+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-FDSILNDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 356788999999888899999999999999999999999976432211 11111 12234458899999999999
Q ss_pred hHHHHHHHHH
Q 041491 448 DKYFAAKKQC 457 (467)
Q Consensus 448 ~~r~~~~~~~ 457 (467)
.+|++...++
T Consensus 236 ~~R~~~~~~l 245 (316)
T cd05592 236 TKRLGVDGDI 245 (316)
T ss_pred HHcCCChHHH
Confidence 9998655444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.07 Aligned_cols=231 Identities=24% Similarity=0.282 Sum_probs=189.1
Q ss_pred cCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc----ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 289 (467)
+|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|+.+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5888999999999999999763 47899999987432 22345678899999999 599999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999988543 46899999999999999999999 9999999999999999999999999999998653
Q ss_pred CCC------ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHHh-------hhccc
Q 041491 370 GKE------SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWVN-------DFLPI 433 (467)
Q Consensus 370 ~~~------~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~~-------~~~~~ 433 (467)
... ..++..|.+||++.+. .++.++|||||||++|||+||+.||........ ....... ..+++
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP 236 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 321 2356778999988765 478899999999999999999999964321111 1111111 12344
Q ss_pred ccccccccccccchhHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~ 453 (467)
.+.+++.+||..||++|+++
T Consensus 237 ~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCC
Confidence 58899999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=297.25 Aligned_cols=235 Identities=24% Similarity=0.283 Sum_probs=191.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecc--cccchHHHHHHHHHHHcCCCCCceeEEEEeec-----CC
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSN-----GN 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 287 (467)
....|...+.||+|+||.|+.|.++ +|+.||+|.+... .....++..+|+++++.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999886 4899999998743 33456788899999999999999999998865 35
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..|+|+|+| +.+|.+.++.. ..++...+..+++|+++||+|+| +.+|+||||||+|++++.+..+||+|||+|+.
T Consensus 100 DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 789999999 55999988543 45899999999999999999999 99999999999999999999999999999998
Q ss_pred cCC-------CCcccccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCccc--------------cccc----
Q 041491 368 LNG-------KESMRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCEIF--------------CEEM---- 421 (467)
Q Consensus 368 ~~~-------~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~--------------~~~~---- 421 (467)
... .+...|..|.|||.+. ...|+.+.||||.|||+.||++|++-|.+.. .++.
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 853 2335677889999764 5689999999999999999999999886531 1111
Q ss_pred ----cHHHHHhh--------------hcccccccccccccccchhHHHHHHH
Q 041491 422 ----NLKNWVND--------------FLPISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 422 ----~~~~~~~~--------------~~~~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
....++.+ ...+.+.+++++||.-||.+|.++.+
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 12223222 12335889999999999999986443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=318.56 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=199.5
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
.+....++|++.+.||+|+||.||+|++. ++..||+|+++... ......+.+|+.+++.+ +||||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34556678999999999999999999753 24579999997543 22345688999999999 899999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCC------------------------------------------------------
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSN------------------------------------------------------ 309 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 309 (467)
...+..++||||+++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999875321
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 310 ---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 310 ---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
..+++.++..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24678889999999999999999 99999999999999999999999999999986543221
Q ss_pred ------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccc
Q 041491 374 ------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNV 438 (467)
Q Consensus 374 ------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~ 438 (467)
..+..|.+||+.....++.++|||||||++|||++ |+.||....... ....... ...++++.++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCCCCCHHHHHH
Confidence 12345899999988899999999999999999997 999997643322 1111111 1235568999
Q ss_pred cccccccchhHHHHHHHHHHHHHHh
Q 041491 439 VDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+.+|+..+|.+|+ ++.++++.+.+
T Consensus 348 i~~cl~~dp~~RP-s~~~l~~~l~~ 371 (374)
T cd05106 348 MKMCWNLEPTERP-TFSQISQLIQR 371 (374)
T ss_pred HHHHcCCChhhCc-CHHHHHHHHHH
Confidence 9999999999996 55566665544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.19 Aligned_cols=230 Identities=20% Similarity=0.237 Sum_probs=190.9
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 293 (467)
+|++.+.||+|+||.||+|++.. ++.||+|++.... ......+..|..++..+ .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58889999999999999998864 7899999987542 22334566788888777 5899999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++|+|.+++... +.+++.++..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999988543 46899999999999999999999 999999999999999999999999999999864321
Q ss_pred ---CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccc
Q 041491 372 ---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTS 442 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~ 442 (467)
...++..|.+||++....++.++|||||||++|||+||+.||......+ ....... ..++.++.+++.+|
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence 2235677899999999999999999999999999999999997643222 1111111 22445688999999
Q ss_pred cccchhHHHHH
Q 041491 443 LLRREDKYFAA 453 (467)
Q Consensus 443 l~~~~~~r~~~ 453 (467)
|..+|.+|++.
T Consensus 236 l~~~p~~R~~~ 246 (323)
T cd05616 236 MTKHPGKRLGC 246 (323)
T ss_pred cccCHHhcCCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=314.15 Aligned_cols=235 Identities=25% Similarity=0.333 Sum_probs=202.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe-eeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF-EALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv 292 (467)
.++|...+.+|+|+||.++.++++ ++..+++|.+.... ....+...+|+.++++++|||||.+.+.|..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367899999999999999999886 48899999987553 3344578899999999999999999999988887 9999
Q ss_pred EecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 293 LEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|+||+||++.+.+...+ ..++++.+..|+.|++.|+.||| +++|+|||||+.|||++.++.+||+|||+|+.+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998776 47999999999999999999999 999999999999999999999999999999999877
Q ss_pred C-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH------Hhhhcccccccccc
Q 041491 372 E-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------VNDFLPISVMNVVD 440 (467)
Q Consensus 372 ~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~i~ 440 (467)
. ..+++.|..||.+.+.+|..|+||||+||++|||++-+++|............. +...+..+++.+|.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence 5 457888999999999999999999999999999999999998753333221111 12223345899999
Q ss_pred cccccchhHHHHHH
Q 041491 441 TSLLRREDKYFAAK 454 (467)
Q Consensus 441 ~~l~~~~~~r~~~~ 454 (467)
.|+.++|..|+++.
T Consensus 240 ~~l~~~P~~RPsa~ 253 (426)
T KOG0589|consen 240 SMLRKNPEHRPSAL 253 (426)
T ss_pred HHhhcCCccCCCHH
Confidence 99999999997543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=302.73 Aligned_cols=241 Identities=22% Similarity=0.304 Sum_probs=198.5
Q ss_pred HhccCccCCccCcccceeEEEEEec----CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3467899999999999999999764 367899999876532 33457889999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++|+|.+++......+++.+++.++.|++.||+||| ++|++||||||+||+++.++.+|++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999766667899999999999999999999 99999999999999999999999999998765432
Q ss_pred CC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccc
Q 041491 371 KE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISV 435 (467)
Q Consensus 371 ~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 435 (467)
.. ...+..|.+||+...+.++.++|||||||++||+++ |+.||......+ ..+... ...|..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVEDGFRLPAPRNCPNLL 237 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCCCCCCCCCCHHH
Confidence 21 122346899999988999999999999999999775 999997643221 122211 2234568
Q ss_pred ccccccccccchhHHHHHHHHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.+++.+|+..+|++|+ ++.+..+.+-
T Consensus 238 ~~li~~c~~~~p~~RP-~~~~i~~~l~ 263 (266)
T cd05064 238 HQLMLDCWQKERGERP-RFSQIHSILS 263 (266)
T ss_pred HHHHHHHcCCCchhCC-CHHHHHHHHH
Confidence 8999999999999997 5566666553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=315.00 Aligned_cols=223 Identities=23% Similarity=0.356 Sum_probs=191.6
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
+.....+-||.|+.|.||+|+. .++.||||.++.. -..+|+-|++|+||||+.|.|+|.....+|||||||.
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 3334467899999999999998 5789999987522 2357889999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----c
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----S 373 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----~ 373 (467)
.|.|...++.. ..+.......|..+||.|+.||| .+.|||||||.-||||..+..+||+|||-++...+.. .
T Consensus 196 ~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 196 QGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred cccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence 99999999654 46778888899999999999999 9999999999999999999999999999998776543 3
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc-------cHHHHHhhhcccccccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-------NLKNWVNDFLPISVMNVVDTSLLRR 446 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~~ 446 (467)
.++..|+|||++..++.+.|+||||||||||||+||..||.+.....+ .+.--+....|+.+.-++..|+..-
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 467889999999999999999999999999999999999987543322 2333366677788999999999999
Q ss_pred hhHHHH
Q 041491 447 EDKYFA 452 (467)
Q Consensus 447 ~~~r~~ 452 (467)
|..|++
T Consensus 352 pRNRPS 357 (904)
T KOG4721|consen 352 PRNRPS 357 (904)
T ss_pred CCCCcc
Confidence 988863
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=300.60 Aligned_cols=238 Identities=24% Similarity=0.343 Sum_probs=198.4
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.++|++.+.||+|+||.||+|+++++..+|+|.+... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 3568889999999999999999988889999987643 233467889999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc---
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES--- 373 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 373 (467)
++|+|.+++....+.+++..+..++.|++.||+||| ++|++||||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999998766567899999999999999999999 99999999999999999999999999999986543221
Q ss_pred ---cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccccccccccc
Q 041491 374 ---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPISVMNVVDT 441 (467)
Q Consensus 374 ---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~i~~ 441 (467)
..+..|.+||+.....++.++||||||+++|||++ |+.||...... ........ ..+..+.+++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 12345889999988889999999999999999999 89999754322 11122211 123348899999
Q ss_pred ccccchhHHHHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l 461 (467)
|+..+|++|+ ++.+++..|
T Consensus 237 c~~~~p~~Rp-s~~~l~~~l 255 (256)
T cd05114 237 CWHEKPEGRP-TFAELLRAI 255 (256)
T ss_pred HccCCcccCc-CHHHHHHhh
Confidence 9999999997 566666554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=310.62 Aligned_cols=229 Identities=20% Similarity=0.282 Sum_probs=188.1
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++. +|+.||+|+++... .........|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 48899999997542 23345567788888754 899999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC-----CCc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG-----KES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~ 373 (467)
|+|.+++.. .+.+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.... ...
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceecc
Confidence 999998854 356899999999999999999999 99999999999999999999999999999875321 122
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhcccccccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDTSLLRR 446 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~~l~~~ 446 (467)
.++..|.+||++.+..++.++||||+||++|||++|+.||......+ ..+... ..++.++.+++.+||..|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 234 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESIRVDTPHYPRWITKESKDILEKLFERD 234 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCCCCCCCHHHHHHHHHHccCC
Confidence 35677899999999999999999999999999999999997543221 111111 113345889999999999
Q ss_pred hhHHHHHHHHHH
Q 041491 447 EDKYFAAKKQCV 458 (467)
Q Consensus 447 ~~~r~~~~~~~~ 458 (467)
|++|++...+++
T Consensus 235 P~~R~~~~~~~~ 246 (316)
T cd05620 235 PTRRLGVVGNIR 246 (316)
T ss_pred HHHcCCChHHHH
Confidence 999987655543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=311.08 Aligned_cols=195 Identities=25% Similarity=0.341 Sum_probs=173.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||++++. ++..||+|++..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 578999999999999999999986 488899999876532 334678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
|+++++|.+++... ..+++..+..++.|++.||.||| ++ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence 99999999998543 46889999999999999999999 65 6999999999999999999999999999765432
Q ss_pred -CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 372 -ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 372 -~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
...++..|.+||+..+..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22456778999999988999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=310.92 Aligned_cols=224 Identities=22% Similarity=0.283 Sum_probs=186.2
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998864 7899999997542 23345677888988866 799999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----c
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-----S 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~ 373 (467)
|+|..++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence 9999888543 46899999999999999999999 9999999999999999999999999999987643221 2
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccccccch
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~~~~ 447 (467)
.++..|.+||+.....++.++||||+||++|||+||+.||......+ .+..... ..++.++.+++.+||..+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESILHDDVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 35677899999988899999999999999999999999997643222 1112111 1234568899999999999
Q ss_pred hHHHH
Q 041491 448 DKYFA 452 (467)
Q Consensus 448 ~~r~~ 452 (467)
++|++
T Consensus 236 ~~R~~ 240 (321)
T cd05591 236 NKRLG 240 (321)
T ss_pred HHcCC
Confidence 99973
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.94 Aligned_cols=230 Identities=22% Similarity=0.287 Sum_probs=188.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.+|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368999999999999999998764 8999999986532 223456789999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC---
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG--- 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~--- 370 (467)
||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999998543 46889999999999999999999 99999999999999999999999999999753210
Q ss_pred ---------------------------------------------CCccccccccccccccCCCCCCcccchhhHHHHHH
Q 041491 371 ---------------------------------------------KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIE 405 (467)
Q Consensus 371 ---------------------------------------------~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~e 405 (467)
....++..|.|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 01135667899999988899999999999999999
Q ss_pred HhcCCCCCCccccccc--cHHHHHh-------hhcccccccccccccccchhHHHH
Q 041491 406 TFTKKKPTCEIFCEEM--NLKNWVN-------DFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 406 l~tg~~Pf~~~~~~~~--~~~~~~~-------~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
|++|+.||......+. ....|.. ..+++.+.+++.+++ .+|.+|+.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 9999999976433221 1111211 123445778888854 69999973
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=296.94 Aligned_cols=234 Identities=26% Similarity=0.320 Sum_probs=195.6
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
...++|+..+.||+|.-|+||+++.++ +..+|+|++.+.. .....+.+.|.+||+.++||.++.+|+.++.+++.|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 345678888999999999999999875 6899999998653 334567788999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 291 LVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+|||||+||+|....+.+.+ .+++..++.++.+++-||+||| -.|||.|||||+||||.++|++.|+||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999998866544 7999999999999999999999 9999999999999999999999999998764321
Q ss_pred C---------------------------------C-C---------------------------ccccccccccccccCC
Q 041491 370 G---------------------------------K-E---------------------------SMRTQTLATIEYGREG 388 (467)
Q Consensus 370 ~---------------------------------~-~---------------------------~~~~~~~~~pe~~~~~ 388 (467)
. . . ..+|..|.|||.+.++
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 0134456678888888
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhh--------cccccccccccccccchhHHHH
Q 041491 389 QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDF--------LPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 389 ~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~--------~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
..+.++|+|+|||++|||+.|+.||.+....+ .+.+.+.+. ++...+++|.+.|.+||.+|.-
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 88999999999999999999999998754443 344443332 2235899999999999999964
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=312.24 Aligned_cols=231 Identities=20% Similarity=0.244 Sum_probs=190.7
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 293 (467)
+|+..+.||+|+||.||+|++. +++.||+|++.... ....+.+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999886 48899999987542 233456778889988886 577888999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++|+|.+++... +.+++.++..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999988543 46899999999999999999999 999999999999999999999999999998764322
Q ss_pred ---CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccc
Q 041491 372 ---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTS 442 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~ 442 (467)
...++..|.+||+.....++.++||||+||++|||+||+.||........ ...... ..++..+.+++.+|
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-FQSIMEHNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCccCCHHHHHHHHHH
Confidence 22356778999999888999999999999999999999999976432211 111111 22344588999999
Q ss_pred cccchhHHHHHH
Q 041491 443 LLRREDKYFAAK 454 (467)
Q Consensus 443 l~~~~~~r~~~~ 454 (467)
|.++|.+|++..
T Consensus 236 l~~~p~~R~~~~ 247 (323)
T cd05615 236 MTKHPSKRLGCG 247 (323)
T ss_pred cccCHhhCCCCC
Confidence 999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=325.10 Aligned_cols=234 Identities=19% Similarity=0.239 Sum_probs=195.3
Q ss_pred ccCccCCccCcccceeEEEEEec-C-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-D-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34899999999999999999764 3 678899987655444556778899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 296 MANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
+++|+|.+++... ...+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999887542 346889999999999999999999 9999999999999999999999999999998765432
Q ss_pred -------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------hhhcccccccc
Q 041491 373 -------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-------NDFLPISVMNV 438 (467)
Q Consensus 373 -------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~ 438 (467)
..++..|.+||+..+..++.++|||||||++|||++|+.||......+. +.... ...+++++.++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~l 302 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-MQQVLYGKYDPFPCPVSSGMKAL 302 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCCccCCHHHHHH
Confidence 2356778999999888999999999999999999999999975432211 11111 11234568999
Q ss_pred cccccccchhHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKK 455 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~ 455 (467)
+.+||..+|++|++..+
T Consensus 303 i~~~L~~dP~~Rps~~~ 319 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQ 319 (478)
T ss_pred HHHHhccChhhCcCHHH
Confidence 99999999999986544
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.42 Aligned_cols=237 Identities=22% Similarity=0.263 Sum_probs=204.0
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.-|...+.||+|.|..|-+|++. +|.+||||++.+.. ......+.+|++.|+-++|||||++|++.......|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45888899999999999999875 69999999997653 2345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec-CCCcEEEeccccceecCCCC-
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~- 372 (467)
.-++|+|.+|+......+.+..+.+++.||+.|+.|+| +..+|||||||+|+.+- .-|-+||.|||++..+.+..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999888888999999999999999999999 99999999999999875 45799999999999887654
Q ss_pred ---ccccccccccccccCCCCC-CcccchhhHHHHHHHhcCCCCCCccccccccHH-----HHHhhhccccccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVS-PKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK-----NWVNDFLPISVMNVVDTSL 443 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~-~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l 443 (467)
.++...|.|||.+.+..|+ +++||||+|||+|.++.|+.||+.....+...+ --+...++.+-+++|..||
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSML 254 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHH
Confidence 4567789999999998885 689999999999999999999987644442211 1145566678999999999
Q ss_pred ccchhHHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQCV 458 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~ 458 (467)
.+||.+| ++++|..
T Consensus 255 vRdPkkR-AslEeI~ 268 (864)
T KOG4717|consen 255 VRDPKKR-ASLEEIV 268 (864)
T ss_pred hcCchhh-ccHHHHh
Confidence 9999999 4555443
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=310.13 Aligned_cols=225 Identities=22% Similarity=0.290 Sum_probs=187.2
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|+++. ++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999864 8899999987542 23445677888888876 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF 156 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence 9999988544 46899999999999999999999 999999999999999999999999999998764321 22
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccccccch
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~~~~ 447 (467)
.++..|.+||+..+..++.++|||||||++|||++|+.||......+ ....... ..++.++.+++.+||..||
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 35677899999988899999999999999999999999997643221 1111111 1234468899999999999
Q ss_pred hHHHHH
Q 041491 448 DKYFAA 453 (467)
Q Consensus 448 ~~r~~~ 453 (467)
.+|+++
T Consensus 236 ~~R~~~ 241 (320)
T cd05590 236 TMRLGS 241 (320)
T ss_pred HHCCCC
Confidence 999876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=317.95 Aligned_cols=229 Identities=21% Similarity=0.283 Sum_probs=185.6
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.|+..+.||+|+||.||+|++. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999876 48899999997542 2334568899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC----
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG---- 370 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~---- 370 (467)
|+++|+|.+++... +.+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998543 46889999999999999999999 99999999999999999999999999999754310
Q ss_pred ------------------------------------------------CCccccccccccccccCCCCCCcccchhhHHH
Q 041491 371 ------------------------------------------------KESMRTQTLATIEYGREGQVSPKSDVYGYGIT 402 (467)
Q Consensus 371 ------------------------------------------------~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvi 402 (467)
....++..|.|||.+....++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 01135667899999888889999999999999
Q ss_pred HHHHhcCCCCCCcccccccc--HHHHHh-------hhcccccccccccccccchh--HHH
Q 041491 403 LIETFTKKKPTCEIFCEEMN--LKNWVN-------DFLPISVMNVVDTSLLRRED--KYF 451 (467)
Q Consensus 403 l~el~tg~~Pf~~~~~~~~~--~~~~~~-------~~~~~~~~~~i~~~l~~~~~--~r~ 451 (467)
+|||+||+.||......+.. ...|.. ..+++++.+++.+++..+++ +|+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence 99999999999764322211 112111 02344578888886554333 364
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=303.68 Aligned_cols=233 Identities=22% Similarity=0.258 Sum_probs=193.4
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999875 589999999865321 223456789999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 295 YMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+++|+|.+++... ...+++..+..++.|++.|+.||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999887553 346899999999999999999999 9999999999999999999999999999998764332
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHHh-------hhcccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWVN-------DFLPISVMNVVD 440 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~~-------~~~~~~~~~~i~ 440 (467)
..++..|.+||+..+..++.++||||+||++|||++|+.||........ .....+. ..+++.+.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 2346678999999888899999999999999999999999976322110 1111111 124456899999
Q ss_pred cccccchhHHHHHH
Q 041491 441 TSLLRREDKYFAAK 454 (467)
Q Consensus 441 ~~l~~~~~~r~~~~ 454 (467)
+|+..||.+|++..
T Consensus 238 ~~l~~~P~~R~~~~ 251 (285)
T cd05605 238 QLLTKDPGFRLGCR 251 (285)
T ss_pred HHccCCHHHhcCCC
Confidence 99999999999633
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.00 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=192.0
Q ss_pred hccCccCCccCcccceeEEEEEecC-----------------CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCcee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-----------------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVK 278 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 278 (467)
.++|.+.+.||+|+||.||+|.+.+ +..||+|++.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997632 3469999987543 223467889999999999999999
Q ss_pred EEEEeecCCeeeEEEecccCCCHHHhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 041491 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSN------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVV 340 (467)
Q Consensus 279 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 340 (467)
+++++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 9999999999999999999999999885421 24677889999999999999999 99999
Q ss_pred ecCCCCCCeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc--CCC
Q 041491 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT--KKK 411 (467)
Q Consensus 341 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t--g~~ 411 (467)
||||||+||++++++.+||+|||+++...... ...+..|.+||+...+.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998664322 122456899999888899999999999999999986 567
Q ss_pred CCCccccccc--cHHHHH-----------hhhcccccccccccccccchhHHHHHHHHHHHH
Q 041491 412 PTCEIFCEEM--NLKNWV-----------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSS 460 (467)
Q Consensus 412 Pf~~~~~~~~--~~~~~~-----------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~ 460 (467)
||......+. ....+. ....|..+.+++.+|+..+|.+|+ ++.++...
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-s~~~i~~~ 301 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP-SFSDIHAF 301 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc-CHHHHHHH
Confidence 8865432211 011111 112344588999999999999997 45555443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=298.32 Aligned_cols=237 Identities=29% Similarity=0.393 Sum_probs=198.3
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
.+|++.+.||+|+||.||+|.+.++..+|+|++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4688889999999999999998777889999986432 234568889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc----
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES---- 373 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---- 373 (467)
+++|.+++......+++..+..++.|++.|++||| +.|++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999999766667899999999999999999999 99999999999999999999999999999986643221
Q ss_pred --cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccccc
Q 041491 374 --MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTS 442 (467)
Q Consensus 374 --~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~ 442 (467)
..+..|.+||+.....++.++||||||+++|||++ |+.||......+ ...... ...+..+.+++.+|
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 11235889999988899999999999999999999 899997542221 111111 12345699999999
Q ss_pred cccchhHHHHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~~~l 461 (467)
+..+|++|+ ++.+.+..+
T Consensus 238 l~~~p~~Rp-t~~~~l~~l 255 (256)
T cd05059 238 WHEKPEDRP-AFKKLLSQL 255 (256)
T ss_pred hcCChhhCc-CHHHHHHHh
Confidence 999999996 566666654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=301.94 Aligned_cols=224 Identities=23% Similarity=0.264 Sum_probs=185.9
Q ss_pred cCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
||+|+||+||++.+. +++.||+|.+..... ...+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999876 588999999865422 2235677899999999999999999999999999999999999999
Q ss_pred HHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----c
Q 041491 302 EKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-----S 373 (467)
Q Consensus 302 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~ 373 (467)
.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++....... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 887743 2346899999999999999999999 9999999999999999999999999999998765432 2
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc--ccHHHHH-------hhhcccccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--MNLKNWV-------NDFLPISVMNVVDTSLL 444 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--~~~~~~~-------~~~~~~~~~~~i~~~l~ 444 (467)
.++..|.+||+..+..++.++|||||||++|||++|+.||....... ....... ...+++.+.+++.+||.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 35667899999999999999999999999999999999997532211 1111111 12245568899999999
Q ss_pred cchhHHHH
Q 041491 445 RREDKYFA 452 (467)
Q Consensus 445 ~~~~~r~~ 452 (467)
.+|++|++
T Consensus 238 ~~P~~R~~ 245 (280)
T cd05608 238 KDPEKRLG 245 (280)
T ss_pred CCHHHhcC
Confidence 99999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=309.45 Aligned_cols=225 Identities=21% Similarity=0.262 Sum_probs=186.0
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++. +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999886 48899999997542 22345678899999988 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccc
Confidence 999988754 357899999999999999999999 999999999999999999999999999998753211 12
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccc---cccHHHHH-----------hhhccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE---EMNLKNWV-----------NDFLPISVMNVV 439 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~---~~~~~~~~-----------~~~~~~~~~~~i 439 (467)
.++..|.+||+..+..++.++|||||||++|||+||+.||+..... .....++. ...++..+.+++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 3566789999999999999999999999999999999999642111 11112221 112334578999
Q ss_pred ccccccchhHHHH
Q 041491 440 DTSLLRREDKYFA 452 (467)
Q Consensus 440 ~~~l~~~~~~r~~ 452 (467)
.+||..||.+|++
T Consensus 237 ~~~L~~dP~~R~~ 249 (329)
T cd05588 237 KGFLNKDPKERLG 249 (329)
T ss_pred HHHhccCHHHcCC
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=307.51 Aligned_cols=228 Identities=22% Similarity=0.292 Sum_probs=187.2
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++.+ ++.||+|+++... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999864 7899999997642 23345566788888764 899999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|.+++... ..+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeee
Confidence 9999988543 46889999999999999999999 999999999999999999999999999998754221 12
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhcccccccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDTSLLRR 446 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~~l~~~ 446 (467)
.++..|.+||++.+..++.++||||+||++|||++|+.||......+ ....+. ..++.++.+++.+||..+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCCCccCCHHHHHHHHHHhccC
Confidence 35677899999988899999999999999999999999997643221 111111 123345889999999999
Q ss_pred hhHHHHHHHHH
Q 041491 447 EDKYFAAKKQC 457 (467)
Q Consensus 447 ~~~r~~~~~~~ 457 (467)
|.+|++...++
T Consensus 235 P~~R~~~~~~l 245 (316)
T cd05619 235 PERRLGVKGDI 245 (316)
T ss_pred HhhcCCChHHH
Confidence 99998654443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=313.46 Aligned_cols=230 Identities=24% Similarity=0.304 Sum_probs=192.8
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999886 489999999975432 24456889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999776678999999999999999999999 9999999999999999999999999999998765432
Q ss_pred -----cccccccccccccc------CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhc
Q 041491 373 -----SMRTQTLATIEYGR------EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFL 431 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~------~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~ 431 (467)
..++..|.+||++. ...++.++|||||||++|||++|+.||....... .+..... ..+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcCCCccCCCCCCCC
Confidence 23566789999876 4567899999999999999999999997543221 1111110 123
Q ss_pred ccccccccccccccchhHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~ 452 (467)
++.+.+++..++. +|.+|++
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t 256 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLG 256 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCC
Confidence 4458899999997 9999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=310.50 Aligned_cols=196 Identities=26% Similarity=0.366 Sum_probs=172.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... .....+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999986 488899998875432 33467889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
||+++++|.+++... +.+++..+..++.|++.|+.||| +. +++||||||+||++++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 83 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999998643 46889999999999999999999 64 7999999999999999999999999998765432
Q ss_pred --CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 372 --ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 372 --~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
...++..|.+||+..+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22456678999999888899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=310.59 Aligned_cols=226 Identities=28% Similarity=0.311 Sum_probs=184.9
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHH-HHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECE-VLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||+||+|++. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999986 58999999997542 122334455554 46789999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccc
Confidence 999998854 456899999999999999999999 999999999999999999999999999998754221 12
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH------Hhhhcccccccccccccccch
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------VNDFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~~ 447 (467)
.++..|.+||++.+..++.++|||||||++|||++|+.||......+. .... ....++..+.+++.+||..||
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-YDNILNKPLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 356678999999988999999999999999999999999975422211 1111 122345568999999999999
Q ss_pred hHHHHHH
Q 041491 448 DKYFAAK 454 (467)
Q Consensus 448 ~~r~~~~ 454 (467)
.+|++..
T Consensus 236 ~~R~~~~ 242 (323)
T cd05575 236 TKRLGAK 242 (323)
T ss_pred HhCCCCC
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=308.68 Aligned_cols=226 Identities=22% Similarity=0.275 Sum_probs=185.5
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999998864 7899999997542 22345677899888876 799999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|..++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccc
Confidence 999988754 356899999999999999999999 999999999999999999999999999998754221 22
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccc---cccHHHHHh-----------hhccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE---EMNLKNWVN-----------DFLPISVMNVV 439 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~---~~~~~~~~~-----------~~~~~~~~~~i 439 (467)
.++..|.+||+..+..++.++|||||||++|||+||+.||...... ......+.. ..++..+.+++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 3567789999999999999999999999999999999999632111 111122211 12233477999
Q ss_pred ccccccchhHHHHH
Q 041491 440 DTSLLRREDKYFAA 453 (467)
Q Consensus 440 ~~~l~~~~~~r~~~ 453 (467)
.+||..||++|++.
T Consensus 237 ~~~L~~dP~~R~~~ 250 (329)
T cd05618 237 KSFLNKDPKERLGC 250 (329)
T ss_pred HHHhcCCHHHcCCC
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.18 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=199.8
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+..++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456799999999999999999998778899999987543 335678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc
Q 041491 295 YMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (467)
|+++++|.+++.... ..+++..+..++.|++.|+.||| ++|++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999986544 46899999999999999999999 99999999999999999999999999999987653321
Q ss_pred c------ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-------hhccccccccc
Q 041491 374 M------RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVV 439 (467)
Q Consensus 374 ~------~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i 439 (467)
. .+..|.+||+.....++.++||||||+++|||+| |+.||.+..... ....... ...+..+.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1 1235889999988899999999999999999999 999997643221 1111111 12345689999
Q ss_pred ccccccchhHHHHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~~~l 461 (467)
.+|+..+|++|+ ++.+.+..|
T Consensus 238 ~~~l~~~P~~Rp-~~~~l~~~l 258 (261)
T cd05068 238 LDCWKEDPDDRP-TFETLQWKL 258 (261)
T ss_pred HHHhhcCcccCC-CHHHHHHHH
Confidence 999999999996 455555554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=309.20 Aligned_cols=225 Identities=23% Similarity=0.296 Sum_probs=187.3
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++.. ++.||+|+++... ......+..|+++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998864 7899999997542 23345677899999887 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|.+++... +.+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccce
Confidence 9999888543 46899999999999999999999 999999999999999999999999999998753221 12
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccccccch
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~~ 447 (467)
.++..|.+||++.+..++.++|||||||++|||++|+.||........ ..... ...++..+.+++.+||..||
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-FQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 356678999999999999999999999999999999999975432211 11111 12244568899999999999
Q ss_pred hHHHHH
Q 041491 448 DKYFAA 453 (467)
Q Consensus 448 ~~r~~~ 453 (467)
.+|++.
T Consensus 236 ~~R~s~ 241 (318)
T cd05570 236 EKRLGC 241 (318)
T ss_pred HHcCCC
Confidence 999876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=309.77 Aligned_cols=227 Identities=27% Similarity=0.274 Sum_probs=184.3
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHH-HHHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAEC-EVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++.. ++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999998864 7889999987542 12223344444 356788999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccc
Confidence 999998854 346788899999999999999999 999999999999999999999999999998754321 22
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH------Hhhhcccccccccccccccch
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------VNDFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~~ 447 (467)
.++..|.+||++.+..++.++||||+||++|||++|+.||......+. +... ....+++.+.+++.+||..+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-YDNILNKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-HHHHHhCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 356788999999999999999999999999999999999975432221 1111 112345568999999999999
Q ss_pred hHHHHHHH
Q 041491 448 DKYFAAKK 455 (467)
Q Consensus 448 ~~r~~~~~ 455 (467)
.+|++..+
T Consensus 236 ~~R~~~~~ 243 (325)
T cd05602 236 TKRLGAKD 243 (325)
T ss_pred HHCCCCCC
Confidence 99986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=315.61 Aligned_cols=230 Identities=22% Similarity=0.303 Sum_probs=189.0
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|+..+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++.+++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999886 48999999997532 233466788999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999854 346899999999999999999999 999999999999999999999999999998754321
Q ss_pred --------------------------------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCC
Q 041491 372 --------------------------------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPT 413 (467)
Q Consensus 372 --------------------------------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf 413 (467)
...++..|.|||++.+..++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 123566789999998889999999999999999999999999
Q ss_pred Cccccccc--cHHHHHhh-------hcccccccccccccccchhHHHH
Q 041491 414 CEIFCEEM--NLKNWVND-------FLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 414 ~~~~~~~~--~~~~~~~~-------~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
......+. ....|... .+++++.+++.+++ .+|.+|..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 283 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIG 283 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCC
Confidence 76433221 11111110 12345778888865 58988864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=299.34 Aligned_cols=238 Identities=25% Similarity=0.346 Sum_probs=197.7
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.++|++.+.||+|+||.||+|++.++..+|+|.+... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3578899999999999999998877778999988744 233467899999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc---
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES--- 373 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 373 (467)
++|+|.+++......+++.+++.++.|++.|++||| +.|++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999998765557899999999999999999999 99999999999999999999999999999886643321
Q ss_pred ---cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 374 ---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 374 ---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
..+..|.+||+.....++.++|||||||++|||+| |+.||......+ ...... ...+..+.+++.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 12345889999988889999999999999999999 999997543221 111111 1223458999999
Q ss_pred ccccchhHHHHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l 461 (467)
|+..+|.+|+ ++.+.+..+
T Consensus 237 cl~~~p~~Rp-~~~~ll~~~ 255 (256)
T cd05113 237 CWHEKAEERP-TFQQLLSSI 255 (256)
T ss_pred HcCCCcccCC-CHHHHHHhh
Confidence 9999999997 445655543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.58 Aligned_cols=240 Identities=22% Similarity=0.371 Sum_probs=199.9
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+..++|++.++||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3457899999999999999999998888899999876542 335678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc
Q 041491 295 YMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (467)
|+++++|.+++... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999998654 346888999999999999999999 99999999999999999999999999999987654321
Q ss_pred ------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccc
Q 041491 374 ------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNV 438 (467)
Q Consensus 374 ------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~ 438 (467)
..+..|.+||+...+.++.++|||||||++|||+| |+.||......+ ...... ...+.++.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCHHHHHH
Confidence 12345899999988889999999999999999998 999997532221 222211 1234568899
Q ss_pred cccccccchhHHHHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+.+|+..+|++|+ +++++...|
T Consensus 237 i~~~l~~~p~~Rp-~~~~i~~~l 258 (261)
T cd05072 237 MKTCWKEKAEERP-TFDYLQSVL 258 (261)
T ss_pred HHHHccCCcccCc-CHHHHHHHH
Confidence 9999999999996 555555544
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=308.76 Aligned_cols=228 Identities=26% Similarity=0.280 Sum_probs=183.8
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHH-HHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECE-VLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 48899999987542 122334555554 57889999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----c
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-----S 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~ 373 (467)
++|...+.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccc
Confidence 999888754 356888999999999999999999 9999999999999999999999999999987542211 2
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh------hcccccccccccccccch
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND------FLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~------~~~~~~~~~i~~~l~~~~ 447 (467)
.++..|.+||......++.++|||||||++|||++|+.||........ ....... ..+..+.+++.+||..+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDNILHKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 356678999999888899999999999999999999999976432211 1111111 122348899999999999
Q ss_pred hHHHHHHHH
Q 041491 448 DKYFAAKKQ 456 (467)
Q Consensus 448 ~~r~~~~~~ 456 (467)
.+|+++..+
T Consensus 236 ~~R~~~~~~ 244 (321)
T cd05603 236 RRRLGAKAD 244 (321)
T ss_pred hhcCCCCCC
Confidence 999865433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=282.47 Aligned_cols=245 Identities=20% Similarity=0.231 Sum_probs=201.8
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecC-----
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG----- 286 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 286 (467)
+-+..++|.+.+.+|+|||+.||.++.. ++..||+|++........+...+|++..++++|||+++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3456789999999999999999999854 5889999999877767778899999999999999999999876433
Q ss_pred CeeeEEEecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeecCCCcEEEec
Q 041491 287 NFEALVLEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~D 361 (467)
...||+++|...|+|.+.+... +..+++.+++.|+.++++||++|| +.. ++||||||.||++.+++.+++.|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEe
Confidence 3589999999999999988653 237899999999999999999999 666 99999999999999999999999
Q ss_pred cccceecCC--------------CCcccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---
Q 041491 362 FGIAKLLNG--------------KESMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--- 421 (467)
Q Consensus 362 fg~a~~~~~--------------~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--- 421 (467)
||.+....- .....+..|.|||... +...++++|||||||++|+|+.|..||+.......
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 999986531 1124577889999864 45668899999999999999999999987644332
Q ss_pred ------cHHHHHhhhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 422 ------NLKNWVNDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 422 ------~~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
.+.-|....+++.+.++|..||+.||.+||+ +.+.+..+
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~-i~~ll~~~ 297 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPT-IPELLSKL 297 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCC-HHHHHHHH
Confidence 2222333446667999999999999999974 44555444
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=314.65 Aligned_cols=237 Identities=20% Similarity=0.242 Sum_probs=192.4
Q ss_pred HHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
....++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678999999999999999999886 48899999986432 22335577899999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++|+|.+++... .+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999988543 5788889999999999999999 9999999999999999999999999999998765
Q ss_pred CCC------ccccccccccccccCC----CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------h
Q 041491 370 GKE------SMRTQTLATIEYGREG----QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------D 429 (467)
Q Consensus 370 ~~~------~~~~~~~~~pe~~~~~----~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~ 429 (467)
... ..++..|.|||++... .++.++|||||||++|||++|+.||....... .+..... .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHcCCCcCCCCCcC
Confidence 322 2356778899987543 47889999999999999999999997643221 1112111 0
Q ss_pred hcccccccccccccccchhH--HHHHHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDK--YFAAKKQC 457 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~--r~~~~~~~ 457 (467)
.++.++.+++.+||..+|.+ |+ ++.++
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~-s~~el 301 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRN-GVDEI 301 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCC-CHHHH
Confidence 23445889999999988876 64 34444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.34 Aligned_cols=241 Identities=25% Similarity=0.406 Sum_probs=203.0
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+..+|++.+.||.|+||.||+|.+.++..+|+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45679999999999999999999988999999999866554567889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 296 MANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
+++++|.+++.... ..+++.++..++.|++.|++||| ++|++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999997643 36899999999999999999999 99999999999999999999999999999986643321
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVD 440 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~ 440 (467)
..+..|.+||......++.++||||||+++|+|++ |+.||......+ ...... ...++.+.+++.
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITAGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence 23345789999888889999999999999999998 899997643222 111111 123345899999
Q ss_pred cccccchhHHHHHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
+|+..+|.+|+ ++.+.+..|-
T Consensus 239 ~~l~~~p~~Rp-t~~~l~~~L~ 259 (261)
T cd05148 239 ECWAAEPEDRP-SFKALREELD 259 (261)
T ss_pred HHcCCCchhCc-CHHHHHHHHh
Confidence 99999999995 6666666654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=310.03 Aligned_cols=232 Identities=25% Similarity=0.321 Sum_probs=186.0
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|+..+.||+|+||.||+|++. +++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999876 589999999865432 3346788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC----
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 371 (467)
+++++|.+.. ..++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.....
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9999986532 3567788899999999999999 999999999999999999999999999999876532
Q ss_pred -CccccccccccccccC-----CCCCCcccchhhHHHHHHHhcCCCCCCccccccc-cHHHHH--------hhhcccccc
Q 041491 372 -ESMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-NLKNWV--------NDFLPISVM 436 (467)
Q Consensus 372 -~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-~~~~~~--------~~~~~~~~~ 436 (467)
...++..|.+||++.. ...+.++|||||||++|||++|+.||......+. ...... ....+.++.
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 2345667889998643 2345689999999999999999999974322211 111111 112344689
Q ss_pred cccccccccchhHHHHHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+++.+||..+|++|++ +.|++
T Consensus 306 ~li~~~l~~~P~~Rpt-~~ell 326 (353)
T PLN00034 306 HFISCCLQREPAKRWS-AMQLL 326 (353)
T ss_pred HHHHHHccCChhhCcC-HHHHh
Confidence 9999999999999985 44443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=312.42 Aligned_cols=247 Identities=22% Similarity=0.312 Sum_probs=197.0
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeecccc-cchHHHHHHHHHHHcCC-CCCceeEEEEe
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVR-HRNLVKIISSC 283 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 283 (467)
.+....++|.+.+.||+|+||.||+|.+.. +..||+|+++.... ...+.+.+|+++++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 344556789999999999999999998632 34699999875432 23467889999999996 99999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCC------------------------------------------------------
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSN------------------------------------------------------ 309 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 309 (467)
...+..++||||+++|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999998875421
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 310 -----------------------------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 310 -----------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
..+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence 13677888999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
|++++++.+||+|||+++...... ...+..|.+||...+..++.++|||||||++|||++ |..||.....+.
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 999999999999999998654322 123456899999988889999999999999999997 999997643222
Q ss_pred ccHHHH-------HhhhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 421 MNLKNW-------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 421 ~~~~~~-------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
...... ....++..+.+++.+|+..+|++|+ ++.++.+.+.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~~l~~~l~ 395 (400)
T cd05105 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP-SFLHLSDIVE 395 (400)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCc-CHHHHHHHHH
Confidence 111111 1123445689999999999999996 4555555443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=295.44 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=201.8
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999876 58999999876432 233456889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||+++++|.+++.. ....+++..+..++.|++.||+||| +++++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988743 2345788999999999999999999 99999999999999999999999999999987654
Q ss_pred CC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh---------hcccccc
Q 041491 371 KE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND---------FLPISVM 436 (467)
Q Consensus 371 ~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~ 436 (467)
.. ..++..|.+||+..+..++.++|+||+|+++|||++|+.||.............+.. ..+..+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 32 234556889999888888999999999999999999999996533222222222211 2334589
Q ss_pred cccccccccchhHHHHHHHHHHHHHHhcc
Q 041491 437 NVVDTSLLRREDKYFAAKKQCVSSALSLA 465 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~~~l~~l~ 465 (467)
+++.+|+..+|++|+ ++.++++.+.++.
T Consensus 239 ~li~~cl~~~p~~Rp-~~~~vl~~~~~~~ 266 (267)
T cd08228 239 ELVSMCIYPDPDQRP-DIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHCCCCcccCc-CHHHHHHHHHHhc
Confidence 999999999999996 6778888777664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=297.49 Aligned_cols=225 Identities=22% Similarity=0.269 Sum_probs=186.5
Q ss_pred cCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
||+|+||.||+++.. +|+.||+|.+.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999876 48999999986432 12234556799999999999999999999999999999999999999
Q ss_pred HHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----cccc
Q 041491 302 EKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----SMRT 376 (467)
Q Consensus 302 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----~~~~ 376 (467)
.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.++|+|||++....... ..++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 88875433 35889999999999999999999 9999999999999999999999999999998765432 2356
Q ss_pred ccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----H-------hhhccccccccccccccc
Q 041491 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----V-------NDFLPISVMNVVDTSLLR 445 (467)
Q Consensus 377 ~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----~-------~~~~~~~~~~~i~~~l~~ 445 (467)
..|.+||+.....++.++||||+||++|||++|+.||....... ..... . ...+++++.+++.+||..
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 67899999988889999999999999999999999997532111 11111 1 123455689999999999
Q ss_pred chhHHHHHH
Q 041491 446 REDKYFAAK 454 (467)
Q Consensus 446 ~~~~r~~~~ 454 (467)
+|++|+++.
T Consensus 237 ~P~~R~~~~ 245 (277)
T cd05607 237 KPEDRLGSR 245 (277)
T ss_pred CHhhCCCCc
Confidence 999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=306.97 Aligned_cols=234 Identities=25% Similarity=0.282 Sum_probs=200.8
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccccc---chHHHHHHHHHHHcCC-CCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG---ALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 290 (467)
..+.|++.+.||+|.||.||+++.+. |+.+|+|++.+.... ....+.+|+.+|+++. ||||+.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45679999999999999999999876 999999999766432 3468899999999998 999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC----CcEEEeccccce
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD----MVAHLSDFGIAK 366 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~ 366 (467)
+|||++.||.|.+.+... .+++..+..++.|++.+++||| +.||+||||||+|+|+... +.+|++|||+|.
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999998666 3899999999999999999999 9999999999999999543 479999999999
Q ss_pred ecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---------cHHHHHhhhccc
Q 041491 367 LLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------NLKNWVNDFLPI 433 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------~~~~~~~~~~~~ 433 (467)
...... ..+++.|.|||......|+..+||||+||++|.|++|.+||.+...... .+..-.+..++.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 988732 3577888899998889999999999999999999999999987543322 111223344455
Q ss_pred ccccccccccccchhHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.+.++|+++|..||.+|+++.
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~ 288 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAA 288 (382)
T ss_pred HHHHHHHHhcccCcccCCCHH
Confidence 699999999999999997544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=311.75 Aligned_cols=239 Identities=26% Similarity=0.352 Sum_probs=200.3
Q ss_pred ccHHHHHHHhccCccCCccCcccceeEEEEEecC--C---CeEEEEEeecc---cccchHHHHHHHHHHHcCCCCCceeE
Q 041491 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLD--G---MEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKI 279 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~ 279 (467)
...+.|++.-++-...++||+|+||+||+|+.+. + ..||+|..+.. ......++.+|+++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3445566666677777999999999999998753 2 23899998752 24456789999999999999999999
Q ss_pred EEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEE
Q 041491 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHL 359 (467)
Q Consensus 280 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 359 (467)
+|++.....+++|||+|.||+|.+++......++..+...++.+.+.||+||| +++++||||-.+|+|++.++.+||
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEe
Confidence 99999999999999999999999999887778999999999999999999999 999999999999999999999999
Q ss_pred eccccceecCCC-----CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-hh---
Q 041491 360 SDFGIAKLLNGK-----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-ND--- 429 (467)
Q Consensus 360 ~Dfg~a~~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-~~--- 429 (467)
+|||+++.-..- ....+..|.|||.+..+.|++++|||||||++||+++ |..||.+.... ....++ ..
T Consensus 304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r 381 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYR 381 (474)
T ss_pred CccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCcc
Confidence 999998765311 1123456889999999999999999999999999999 88899875333 344444 21
Q ss_pred -----hcccccccccccccccchhHHH
Q 041491 430 -----FLPISVMNVVDTSLLRREDKYF 451 (467)
Q Consensus 430 -----~~~~~~~~~i~~~l~~~~~~r~ 451 (467)
.-|..+..+.++|...+|++|+
T Consensus 382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~ 408 (474)
T KOG0194|consen 382 MPIPSKTPKELAKVMKQCWKKDPEDRP 408 (474)
T ss_pred CCCCCCCHHHHHHHHHHhccCChhhcc
Confidence 2233588999999999999994
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=294.04 Aligned_cols=232 Identities=23% Similarity=0.367 Sum_probs=192.0
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999886 58999999876443 23446789999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-------c
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-------M 374 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------~ 374 (467)
.+++......+++.+++.++.|++.||.||| ++|++||||||+||+++.++.+||+|||.+........ .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9998766567899999999999999999999 99999999999999999999999999999876543211 1
Q ss_pred ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------hhhccccccccccccccc
Q 041491 375 RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVDTSLLR 445 (467)
Q Consensus 375 ~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~~l~~ 445 (467)
.+..|.+||+...+.++.++||||||+++|||++ |..||....... ..... ....+..+.+++.+|+..
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVRLPCPELCPDAVYRLMERCWEY 235 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCCCCcccCCHHHHHHHHHHcCC
Confidence 1235789999988889999999999999999998 999986543221 11111 122345688999999999
Q ss_pred chhHHHHHHHHHHHHH
Q 041491 446 REDKYFAAKKQCVSSA 461 (467)
Q Consensus 446 ~~~~r~~~~~~~~~~l 461 (467)
+|++|+ ++.+.++.|
T Consensus 236 ~p~~Rp-s~~~~~~~l 250 (252)
T cd05084 236 DPGQRP-SFSTVHQEL 250 (252)
T ss_pred ChhhCc-CHHHHHHHH
Confidence 999996 566666655
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.29 Aligned_cols=234 Identities=21% Similarity=0.257 Sum_probs=190.6
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
..++....++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44566677899999999999999999999874 8899999986432 2233557789999999999999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
++..++||||+++|+|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999988543 4788899999999999999999 999999999999999999999999999999
Q ss_pred eecCCC------CccccccccccccccCC----CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------
Q 041491 366 KLLNGK------ESMRTQTLATIEYGREG----QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------- 428 (467)
Q Consensus 366 ~~~~~~------~~~~~~~~~~pe~~~~~----~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------- 428 (467)
+..... ...++..|.|||++... .++.++|||||||++|||++|+.||....... .......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~ 268 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKNSLTF 268 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCcccC
Confidence 876532 22356778999987643 37889999999999999999999997532211 1122211
Q ss_pred ---hhcccccccccccccccchhHH
Q 041491 429 ---DFLPISVMNVVDTSLLRREDKY 450 (467)
Q Consensus 429 ---~~~~~~~~~~i~~~l~~~~~~r 450 (467)
..++..+.+++..+|. +|.+|
T Consensus 269 ~~~~~~s~~~~~li~~~L~-~~~~r 292 (371)
T cd05622 269 PDDNDISKEAKNLICAFLT-DREVR 292 (371)
T ss_pred CCcCCCCHHHHHHHHHHcC-Chhhh
Confidence 1234457889999997 55544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=322.40 Aligned_cols=250 Identities=24% Similarity=0.271 Sum_probs=202.6
Q ss_pred HHHHhccCccCCccCcccceeEEEEEecCC-CeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEE-eec----
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFLDG-MEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISS-CSN---- 285 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~---- 285 (467)
+.+...++++.+.|.+|||+.||.|++..+ .+||+|++-..+....+.+.+||++|++|+ |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 455677889999999999999999998775 999999998777777888999999999997 9999999993 321
Q ss_pred --CCeeeEEEecccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecc
Q 041491 286 --GNFEALVLEYMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 286 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
.-.++|.||||+||.|-+++..+ ...+++.++++|+.|+++|+++||. .+..|||||||-+|||++.+|..|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 13567999999999999998643 2369999999999999999999993 2556999999999999999999999999
Q ss_pred ccceecCCCC--------------ccccccccccccc---cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHH
Q 041491 363 GIAKLLNGKE--------------SMRTQTLATIEYG---REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN 425 (467)
Q Consensus 363 g~a~~~~~~~--------------~~~~~~~~~pe~~---~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~ 425 (467)
|.|...-... ...|..|.+||++ .+..+++|+|||||||+||-|+....||++.-.-.+.-..
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~ 270 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN 270 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence 9987432211 2357778999975 4678899999999999999999999999875333333333
Q ss_pred HHhhh---cccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 426 WVNDF---LPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 426 ~~~~~---~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
|..+. ++..+.++|..||..+|++|+ .+-|.+..+.++
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP-nI~Qv~~~~~~l 311 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERP-NIYQVLEEIFEL 311 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCC-CHHHHHHHHHHH
Confidence 43322 334599999999999999996 555666665544
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.13 Aligned_cols=231 Identities=21% Similarity=0.267 Sum_probs=187.3
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
++....++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 344456789999999999999999999864 8899999986432 223455788999999999999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..|+||||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999988543 5789999999999999999999 99999999999999999999999999999987
Q ss_pred cCCC------CccccccccccccccCC----CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh--------
Q 041491 368 LNGK------ESMRTQTLATIEYGREG----QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND-------- 429 (467)
Q Consensus 368 ~~~~------~~~~~~~~~~pe~~~~~----~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~-------- 429 (467)
.... ...++..|.|||.+... .++.++||||+||++|||++|+.||....... .+......
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDHKNSLNFPE 270 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCcccCCCC
Confidence 6532 22367778999987643 37889999999999999999999997543211 12222211
Q ss_pred --hcccccccccccccccchh
Q 041491 430 --FLPISVMNVVDTSLLRRED 448 (467)
Q Consensus 430 --~~~~~~~~~i~~~l~~~~~ 448 (467)
.++..+.+++..+|..++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~ 291 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREV 291 (370)
T ss_pred cccCCHHHHHHHHHHccCchh
Confidence 1233477888888874443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=303.37 Aligned_cols=241 Identities=25% Similarity=0.360 Sum_probs=197.7
Q ss_pred hccCccCCccCcccceeEEEEEecC-CC----eEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..+|+..+.||+|+||.||+|++.. +. .||+|+++... ....+++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 4579999999999999999998743 33 48999986543 23456788999999999999999999998765 467
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+++||+++|+|.+++......+++..++.++.|++.||+||| ++||+||||||+||++++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999876667899999999999999999999 99999999999999999999999999999987653
Q ss_pred CCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcccc
Q 041491 371 KES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 371 ~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
... ..+..|.+||+.....++.++|||||||++|||++ |+.||++....+ +...... ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLPQPPICTID 239 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCCCCCCCCCCCCHH
Confidence 221 12345889999998999999999999999999998 999997643222 2222211 12335
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+.+++.+|+..+|++|+ ++.+++..+.++
T Consensus 240 ~~~li~~cl~~~p~~Rp-s~~~l~~~l~~~ 268 (316)
T cd05108 240 VYMIMVKCWMIDADSRP-KFRELIIEFSKM 268 (316)
T ss_pred HHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 88999999999999996 577777766554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=306.59 Aligned_cols=226 Identities=24% Similarity=0.300 Sum_probs=185.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+++... ++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 478999999999999999999864 8999999987531 223456888999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999765667899999999999999999999 9999999999999999999999999999997764322
Q ss_pred -----ccccccccccccccC-----CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-----------hhc
Q 041491 373 -----SMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-----------DFL 431 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~-----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-----------~~~ 431 (467)
..++..|.+||++.. ..++.++||||+||++|||++|+.||......+. ...... ..+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCcccCCCccCCC
Confidence 235677899998753 4578899999999999999999999975422211 111110 123
Q ss_pred ccccccccccccccch
Q 041491 432 PISVMNVVDTSLLRRE 447 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~ 447 (467)
++.+.+++.++|..++
T Consensus 237 ~~~~~~li~~ll~~~~ 252 (331)
T cd05597 237 SEEAKDLIRRLICSPE 252 (331)
T ss_pred CHHHHHHHHHHccCcc
Confidence 4557888888886533
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=299.05 Aligned_cols=239 Identities=29% Similarity=0.439 Sum_probs=198.3
Q ss_pred hccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|.+.+.||+|+||.||+|.+.+ ++.||+|.++..... ..+.+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4578889999999999999998643 478999998765443 457899999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 290 ALVLEYMANGSLEKCLYSSN-------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
++||||+++++|.+++.... ..+++.++..++.|++.|++||| ++|++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999986432 35788899999999999999999 999999999999999999999
Q ss_pred EEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh
Q 041491 357 AHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN 428 (467)
Q Consensus 357 ~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~ 428 (467)
+||+|||+++...... ...+..|.+||+.....+++++|||||||++|||++ |+.||.....++ ..+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~ 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH
Confidence 9999999998653221 122456899999999999999999999999999998 999997543322 122211
Q ss_pred --------hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 --------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 --------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
...+..+.+++.+|+..+|++|+ ++.|.++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-~~~eil~~l 278 (280)
T cd05049 239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRI-NIKDIHERL 278 (280)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCC-CHHHHHHHh
Confidence 12344689999999999999997 566766655
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=299.23 Aligned_cols=234 Identities=32% Similarity=0.477 Sum_probs=188.7
Q ss_pred cCCccCcccceeEEEEEec-----CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 222 EKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 222 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+.+.||.|+||.||+|.+. .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999887 267899999965432 2467899999999999999999999999988889999999
Q ss_pred ccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 296 MANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
+++|+|.+++... ...+++.++..++.|+++||.||| +++++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999877 567999999999999999999999 9999999999999999999999999999998873221
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------hhhcccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------NDFLPISVMNV 438 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~ 438 (467)
......|.+||......++.++||||||+++||++| |+.||.+....+ ..... ...++..+.++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEKLKQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHHHHTTEETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccceeccchhHHHHHH
Confidence 234456789999988889999999999999999999 789987653222 11221 11234458999
Q ss_pred cccccccchhHHHHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+..|+..+|++|| +++++++.|
T Consensus 238 i~~C~~~~p~~RP-s~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRP-SFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS---HHHHHHHH
T ss_pred HHHHcCCChhhCc-CHHHHHhcC
Confidence 9999999999997 566666654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=299.27 Aligned_cols=241 Identities=27% Similarity=0.396 Sum_probs=197.1
Q ss_pred hccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467899999999999999999752 24568999987655555677999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEE
Q 041491 291 LVLEYMANGSLEKCLYSSN------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 358 (467)
+||||+++++|.+++.... ..+++.++..++.|++.||+||| ++|++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 24899999999999999999999 99999999999999999999999
Q ss_pred EeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--
Q 041491 359 LSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-- 428 (467)
Q Consensus 359 l~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-- 428 (467)
|+|||+++...... ...+..|.+||+.....++.++|||||||++|||+| |+.||......+. ......
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-IECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCC
Confidence 99999998654322 122446899999988899999999999999999998 9999976433221 111111
Q ss_pred -----hhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 429 -----DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 429 -----~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
...+..+.+++.+|+..+|.+|+ ++.+....+-
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~v~~~l~ 277 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRL-NIKEIHSLLQ 277 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCC-CHHHHHHHHH
Confidence 12345699999999999999997 4445444443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=307.18 Aligned_cols=228 Identities=23% Similarity=0.296 Sum_probs=187.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||++++. +++.||+|++.... ......+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999886 47889999986531 223455788999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999765667899999999999999999999 9999999999999999999999999999998765432
Q ss_pred -----ccccccccccccccC-----CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-----------hhc
Q 041491 373 -----SMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-----------DFL 431 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~-----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-----------~~~ 431 (467)
..++..|.+||++.. +.++.++|||||||++|||++|+.||......+ .+..... ..+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHcCCCcccCCCccccC
Confidence 235667889998765 567889999999999999999999997532221 1111111 123
Q ss_pred ccccccccccccccchhH
Q 041491 432 PISVMNVVDTSLLRREDK 449 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~ 449 (467)
++.+.+++.++|..++.+
T Consensus 237 ~~~~~~li~~ll~~~~~~ 254 (331)
T cd05624 237 SEEAKDLIQRLICSRERR 254 (331)
T ss_pred CHHHHHHHHHHccCchhh
Confidence 456888899988765543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=298.72 Aligned_cols=231 Identities=24% Similarity=0.305 Sum_probs=184.9
Q ss_pred ccCccCCccCcccceeEEEEEec--CCCeEEEEEeecccc--cchHHHHHHHHHHHcC---CCCCceeEEEEee-----c
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFD--GALKSFDAECEVLKSV---RHRNLVKIISSCS-----N 285 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~ 285 (467)
++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999874 368899999875432 2334566788777765 6999999999885 3
Q ss_pred CCeeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
....++||||++ ++|.+++.... ..+++.++..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 58988886543 35899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc-----------cHHHH---
Q 041491 365 AKLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-----------NLKNW--- 426 (467)
Q Consensus 365 a~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-----------~~~~~--- 426 (467)
++...... ..++..|.+||......++.++|||||||++|||++|++||.+....+. ...+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 98765332 2356678999999888899999999999999999999999975422110 00011
Q ss_pred ------------------HhhhcccccccccccccccchhHHHH
Q 041491 427 ------------------VNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 427 ------------------~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
....+++.+.+++.+||..+|++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 280 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC
Confidence 11123445789999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=296.36 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=198.7
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..+|++.+.||+|+||.||+|.+.+ ++.||+|.+... ......+.+|++++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 4568888999999999999998764 889999998744 33456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 296 MANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
+++++|.+++.... ..+++..++.++.|+++||+||| ++|++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999999986543 36899999999999999999999 99999999999999999999999999999987654321
Q ss_pred -----cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-------hhhcccccccccc
Q 041491 374 -----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-------NDFLPISVMNVVD 440 (467)
Q Consensus 374 -----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~i~ 440 (467)
..+..|.+||+..+..++.++|||||||++|||++ |..||.....++. ..... ....|.++.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 12345899999988899999999999999999998 9999975432211 11111 1123456899999
Q ss_pred cccccchhHHHHHHHHHHHHHHh
Q 041491 441 TSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+|+..+|++|+ ++.++++.+-+
T Consensus 240 ~cl~~~p~~Rp-~~~~l~~~l~~ 261 (263)
T cd05052 240 ACWQWNPSDRP-SFAEIHQAFET 261 (263)
T ss_pred HHccCCcccCC-CHHHHHHHHHh
Confidence 99999999996 56666666543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=307.53 Aligned_cols=234 Identities=21% Similarity=0.280 Sum_probs=185.9
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC-----Ceee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NFEA 290 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 290 (467)
+|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999876 58999999986432 22345688999999999999999999987543 2479
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||++ ++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 689888854 346899999999999999999999 99999999999999999999999999999986432
Q ss_pred C--------CccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--------------cHH--
Q 041491 371 K--------ESMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--------------NLK-- 424 (467)
Q Consensus 371 ~--------~~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--------------~~~-- 424 (467)
. ...++..|.|||+... ..++.++|||||||++|||+||+.||.+...... ...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 1 1245677899998765 6789999999999999999999999965321100 000
Q ss_pred ------HHH--------------hhhcccccccccccccccchhHHHHHHHHHH
Q 041491 425 ------NWV--------------NDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 425 ------~~~--------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
... ....++.+.+++.+||..+|++|++ +.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-~~e~l 288 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT-AEEAL 288 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC-HHHHh
Confidence 000 0123345789999999999999975 44443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=294.00 Aligned_cols=242 Identities=23% Similarity=0.368 Sum_probs=202.1
Q ss_pred hccCccCCccCcccceeEEEEEecC----CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
.++|++.+.||+|+||.||+|.+.. ...||+|.++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4679999999999999999998753 45799999875432 344678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
+|||+++++|.+++....+.+++.++..++.|++.|++||| +++|+||||||+||++++++.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999776668899999999999999999999 999999999999999999999999999999877521
Q ss_pred C-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccc
Q 041491 372 E-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISV 435 (467)
Q Consensus 372 ~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 435 (467)
. ...+..|.+||+.....++.++||||||+++|||++ |..||......+ ..+... ...++.+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l 237 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVEDGYRLPPPMDCPSAL 237 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCHHH
Confidence 1 112345889999988889999999999999999998 999996543221 222221 1234468
Q ss_pred ccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+++.+|+..+|++|+ ++.+.++.|.++
T Consensus 238 ~~li~~cl~~~p~~Rp-~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERP-TFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCc-CHHHHHHHHHhh
Confidence 9999999999999996 677887777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=297.02 Aligned_cols=241 Identities=24% Similarity=0.397 Sum_probs=198.8
Q ss_pred hccCccCCccCcccceeEEEEEecC------CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|++.+.||+|+||.||+|.... ...||+|.++.... .....+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578899999999999999998753 25799998864432 2346688999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC
Q 041491 290 ALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 354 (467)
+++|||+++++|.+++.... ..+++.++..++.|++.||+||| +++++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 99999999999999986432 35788899999999999999999 9999999999999999999
Q ss_pred CcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHH
Q 041491 355 MVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNW 426 (467)
Q Consensus 355 ~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~ 426 (467)
+.+||+|||+++...... ...+..|.|||+.....++.++|||||||++|||++ |..||.+....+ ....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH
Confidence 999999999998653321 223456899999988889999999999999999998 999997643332 2222
Q ss_pred H--------hhhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 427 V--------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 427 ~--------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+ ....|+++.+++.+|+..+|.+|+ ++.++.+.|.+
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp-~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRP-RFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhhCc-CHHHHHHHHhc
Confidence 2 123455689999999999999996 67777776643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=299.09 Aligned_cols=240 Identities=20% Similarity=0.228 Sum_probs=195.7
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
|+..+.||+|+||+||+|.+. +++.||+|.+.... ......+.+|++++++++|++|+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999886 48899999986542 12234577899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 296 MANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
+++++|.+++.... ..+++..+..++.|++.||.||| ++||+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99999998876533 36899999999999999999999 9999999999999999999999999999997654322
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHH-------HHhhhccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKN-------WVNDFLPISVMNVVDT 441 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~-------~~~~~~~~~~~~~i~~ 441 (467)
..++..|.+||+..+..++.++|+||+||++|||++|+.||........ .... .....+++.+.+++.+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 2456778999999888999999999999999999999999975422111 1111 0112344568899999
Q ss_pred ccccchhHHHHHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l~ 462 (467)
|+..+|++|++..+.+..+++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVK 259 (285)
T ss_pred HccCCHhHcCCCcccChHHHH
Confidence 999999999985444344443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=303.41 Aligned_cols=225 Identities=24% Similarity=0.300 Sum_probs=186.1
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|+... ++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999998864 7899999997542 22345678899999888 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|..++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecc
Confidence 9999887543 46899999999999999999999 999999999999999999999999999999753221 12
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccc-cccHHHHHh-----------hhccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE-EMNLKNWVN-----------DFLPISVMNVVDT 441 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~-~~~~~~~~~-----------~~~~~~~~~~i~~ 441 (467)
.++..|.+||+..+..++.++|||||||++|||++|+.||...... .....++.. ..++..+.+++.+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 3567789999999999999999999999999999999999643211 111122211 1233458899999
Q ss_pred ccccchhHHHH
Q 041491 442 SLLRREDKYFA 452 (467)
Q Consensus 442 ~l~~~~~~r~~ 452 (467)
||..||.+|++
T Consensus 237 ~L~~dP~~R~~ 247 (327)
T cd05617 237 FLNKDPKERLG 247 (327)
T ss_pred HhccCHHHcCC
Confidence 99999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=280.35 Aligned_cols=236 Identities=24% Similarity=0.311 Sum_probs=197.5
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--------cchHHHHHHHHHHHcC-CCCCceeEEEEeec
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--------GALKSFDAECEVLKSV-RHRNLVKIISSCSN 285 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 285 (467)
.-..|...+.+|+|..+.|-++.++ +|+++|+|++..... ...+...+|++||+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456888899999999999999776 589999999864321 1234567899999998 59999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
+...++|+|.|+.|.|.+++.+ .-.+++....++++|+.+|++||| .++||||||||+|||+|++.++||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999954 457899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCc----ccccccccccccc------CCCCCCcccchhhHHHHHHHhcCCCCCCcc---------ccccccHHHH
Q 041491 366 KLLNGKES----MRTQTLATIEYGR------EGQVSPKSDVYGYGITLIETFTKKKPTCEI---------FCEEMNLKNW 426 (467)
Q Consensus 366 ~~~~~~~~----~~~~~~~~pe~~~------~~~~~~~~Dv~slGvil~el~tg~~Pf~~~---------~~~~~~~~~~ 426 (467)
+.+..... ++++.|.|||.+. ...|+..+|+||.|||||.++.|.+||-.. ..+...+..-
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 99987653 5788888888653 346788999999999999999999999642 1222223233
Q ss_pred HhhhcccccccccccccccchhHHHHHHH
Q 041491 427 VNDFLPISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 427 ~~~~~~~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
-|..++...+++|.++|+.||.+|.++.+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake 279 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKE 279 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHH
Confidence 34556677999999999999999986554
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=296.68 Aligned_cols=231 Identities=20% Similarity=0.237 Sum_probs=192.1
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.|+..+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999886 489999999865421 223457789999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 295 YMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+++++|.+++.... ..+++.++..++.|++.||.||| +++|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999999885433 36899999999999999999999 9999999999999999999999999999998654322
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc--ccHH-------HHHhhhcccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--MNLK-------NWVNDFLPISVMNVVD 440 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--~~~~-------~~~~~~~~~~~~~~i~ 440 (467)
..++..|.+||+.....++.++||||+||++|||++|+.||....... .... ......+++++.+++.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 245667899999998899999999999999999999999997532211 0011 1112234556899999
Q ss_pred cccccchhHHHH
Q 041491 441 TSLLRREDKYFA 452 (467)
Q Consensus 441 ~~l~~~~~~r~~ 452 (467)
+||..||.+|++
T Consensus 238 ~~l~~~p~~R~s 249 (285)
T cd05630 238 MLLCKDPKERLG 249 (285)
T ss_pred HHhhcCHHHccC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=297.64 Aligned_cols=242 Identities=27% Similarity=0.418 Sum_probs=197.7
Q ss_pred ccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
.+|.+.+.||+|+||.||+|.+. ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56888899999999999999753 245689998876554555778999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 292 VLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
||||+++++|.+++.... +.+++..++.++.|++.|++||| ++||+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999986432 34789999999999999999999 999999999999999999999
Q ss_pred EEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh
Q 041491 357 AHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN 428 (467)
Q Consensus 357 ~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~ 428 (467)
+||+|||++....... ..++..|.+||+.....++.++|||||||++|||+| |+.||......+. ......
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-IECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhC
Confidence 9999999997654321 223456899999988899999999999999999999 9999865433221 111111
Q ss_pred -------hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 429 -------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 429 -------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
...|..+.+++.+|+..+|++|+ ++.+.++.+.++
T Consensus 241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-t~~~v~~~l~~~ 282 (291)
T cd05094 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRL-NIKEIYKILHAL 282 (291)
T ss_pred CCCCCCCccCCHHHHHHHHHHcccChhhCc-CHHHHHHHHHHH
Confidence 12344588999999999999997 555666655443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.26 Aligned_cols=225 Identities=26% Similarity=0.283 Sum_probs=183.5
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHH-HHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECE-VLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999876 58999999997542 122344555554 46778999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++..... ..
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccc
Confidence 999988854 457899999999999999999999 999999999999999999999999999998753221 12
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccccccch
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~~~~ 447 (467)
.++..|.+||++.+..++.++|||||||++|||++|+.||......+ ....... ...+..+.+++.+||..+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-MYDNILHKPLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-HHHHHHcCCccCCCCCCHHHHHHHHHHhccCH
Confidence 35677899999999999999999999999999999999997643222 1111111 1233457899999999999
Q ss_pred hHHHHH
Q 041491 448 DKYFAA 453 (467)
Q Consensus 448 ~~r~~~ 453 (467)
.+|++.
T Consensus 236 ~~R~~~ 241 (325)
T cd05604 236 QRRLGA 241 (325)
T ss_pred HhcCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=300.90 Aligned_cols=233 Identities=22% Similarity=0.334 Sum_probs=190.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|.+.+.||+|+||.||+|++. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999886 478899999875432 2334677899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++ +|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 975 888888666667899999999999999999999 9999999999999999999999999999997654322
Q ss_pred --ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc-----------HHHH---------H--
Q 041491 373 --SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-----------LKNW---------V-- 427 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-----------~~~~---------~-- 427 (467)
...+..|.+||...+ ..++.++||||+||++|||+||+.||......+.. ...| .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 234567889998754 46789999999999999999999999753221100 0000 0
Q ss_pred -------------hhhcccccccccccccccchhHHHHHH
Q 041491 428 -------------NDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 428 -------------~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
...+++++.+++.+||..||.+|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 281 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAE 281 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHH
Confidence 012344678999999999999998644
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.97 Aligned_cols=235 Identities=24% Similarity=0.336 Sum_probs=202.9
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
+-|.+.++||+|+||.||+|.++. |+.+|+|.+... ...+++..|+.++++++.|++|++||.+......|||||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 347788999999999999998875 999999988654 45688999999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC-----C
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG-----K 371 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~ 371 (467)
..|+..+.++.++..+++.++..+++..+.||+||| ...-+|||||..|||++.+|.+||+|||.|..+.+ .
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 999999999888889999999999999999999999 88889999999999999999999999999987754 3
Q ss_pred CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH--------HHHHhhhccccccccccccc
Q 041491 372 ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL--------KNWVNDFLPISVMNVVDTSL 443 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l 443 (467)
...+++.|++||++..-.|..++||||+|++..||..|++||.+...-...+ .-.....++.++.++|.+||
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 4467888999999988899999999999999999999999998753211100 00123344567899999999
Q ss_pred ccchhHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQC 457 (467)
Q Consensus 444 ~~~~~~r~~~~~~~ 457 (467)
.+.|++|-++.+-|
T Consensus 268 iK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 268 IKKPEERKTALRLC 281 (502)
T ss_pred cCCHHHHHHHHHHh
Confidence 99999997665544
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=297.40 Aligned_cols=241 Identities=22% Similarity=0.345 Sum_probs=195.4
Q ss_pred HHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
+..++|++.+.||+|+||.||+|.+. .+..||+|++..... .....+.+|+.+++.++||||+++++++..++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999763 246799998864322 23456889999999999999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEE
Q 041491 288 FEALVLEYMANGSLEKCLYSSN---------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 358 (467)
..++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.|++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999986532 23577889999999999999999 99999999999999999999999
Q ss_pred EeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHH-H--
Q 041491 359 LSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNW-V-- 427 (467)
Q Consensus 359 l~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~-~-- 427 (467)
|+|||+++...... ...+..|.+||+...+.++.++|||||||++|||++ |..||......+ ..+. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~ 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFVMEG 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcC
Confidence 99999987654322 122456899999988889999999999999999999 788987543221 1111 1
Q ss_pred -----hhhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 428 -----NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 428 -----~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
....++.+.+++.+|+..+|++|+ ++.|++..+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~e~l~~l 275 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRP-SFLEIISSI 275 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHh
Confidence 122344588999999999999997 566666654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.55 Aligned_cols=243 Identities=25% Similarity=0.322 Sum_probs=200.2
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|++|.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999987 68999999886432 223567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||+++++|.+++.. ....+++.++..++.|++.|+.||| +.|++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 2346889999999999999999999 99999999999999999999999999999886643
Q ss_pred CC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh---------hhcccccc
Q 041491 371 KE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN---------DFLPISVM 436 (467)
Q Consensus 371 ~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~ 436 (467)
.. ...+..|.+||+..+..++.++|||||||++|+|++|+.||...........+... ...+..+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 32 23455688999988888999999999999999999999999653221111111111 13344688
Q ss_pred cccccccccchhHHHHHHHHHHHHHHhc
Q 041491 437 NVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+++.+|+..+|++|+ ++.+.++.+-++
T Consensus 239 ~~i~~cl~~~p~~Rp-~~~~il~~~~~~ 265 (267)
T cd08224 239 DLVSRCINPDPEKRP-DISYVLQVAKEM 265 (267)
T ss_pred HHHHHHcCCCcccCC-CHHHHHHHHHHh
Confidence 999999999999997 556666666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=308.01 Aligned_cols=188 Identities=23% Similarity=0.268 Sum_probs=165.2
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
...+|++.+.||+|+||.||+|.+. +++.||+|... ...+.+|++++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 4468999999999999999999886 48899999643 2346789999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
++. ++|..++... ..+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 164 ~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 164 RYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred cCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 995 6888887543 46889999999999999999999 999999999999999999999999999999754321
Q ss_pred ---CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCC
Q 041491 372 ---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTC 414 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~ 414 (467)
...++..|.+||++....++.++||||+||++|||+||+.||.
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 1245677899999988899999999999999999999998874
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=292.64 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=197.1
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+..++|++.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++||||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4567899999999999999999998889999999987543 34567899999999999999999999874 456899999
Q ss_pred cccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc
Q 041491 295 YMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (467)
|+++++|.+++.... ..+++.++..++.|++.||+||| +.|++||||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999886543 36899999999999999999999 99999999999999999999999999999987653221
Q ss_pred ------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------hhhcccccccc
Q 041491 374 ------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------NDFLPISVMNV 438 (467)
Q Consensus 374 ------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~ 438 (467)
..+..|.+||+.....++.++||||||+++||+++ |+.||.+....+ ..... ....+.++.++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCCCCCCCCCCHHHHHH
Confidence 22346899999988889999999999999999999 999997543221 11111 12234469999
Q ss_pred cccccccchhHHHHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+.+|+..+|++|+ +++++...|
T Consensus 236 i~~~l~~~p~~Rp-~~~~l~~~l 257 (260)
T cd05067 236 MRLCWKEKPEERP-TFEYLRSVL 257 (260)
T ss_pred HHHHccCChhhCC-CHHHHHHHh
Confidence 9999999999996 555555444
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=303.37 Aligned_cols=244 Identities=21% Similarity=0.336 Sum_probs=194.8
Q ss_pred HHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEeec-
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSN- 285 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~- 285 (467)
.+.++|++.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34568999999999999999999643 24789999987442 22345678899999999 79999999998864
Q ss_pred CCeeeEEEecccCCCHHHhhhcCC--------------------------------------------------------
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSN-------------------------------------------------------- 309 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 309 (467)
+...+++|||+++++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 457889999999999999885421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-------cccccc
Q 041491 310 ----GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQT 378 (467)
Q Consensus 310 ----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~ 378 (467)
..+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++..+.... ...+..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 25788999999999999999999 9999999999999999999999999999998754221 123446
Q ss_pred ccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccccccccchhH
Q 041491 379 LATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTSLLRREDK 449 (467)
Q Consensus 379 ~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~ 449 (467)
|.+||+.....++.++|||||||++|||++ |+.||......+ .+..... ...++++.+++.+|+..+|++
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 899999999999999999999999999998 999997532221 1211111 122345889999999999999
Q ss_pred HHHHHHHHHHHHHh
Q 041491 450 YFAAKKQCVSSALS 463 (467)
Q Consensus 450 r~~~~~~~~~~l~~ 463 (467)
|+ ++.|+++.|-+
T Consensus 320 RP-s~~ell~~l~~ 332 (337)
T cd05054 320 RP-TFSELVEILGD 332 (337)
T ss_pred Cc-CHHHHHHHHHH
Confidence 96 66677766644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=313.37 Aligned_cols=232 Identities=22% Similarity=0.294 Sum_probs=183.3
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecC--------
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG-------- 286 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------- 286 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999886 48899999885432 2345799999999999999999876432
Q ss_pred CeeeEEEecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEecc
Q 041491 287 NFEALVLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDF 362 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Df 362 (467)
...++||||+++ ++.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 256799999975 67666542 3457899999999999999999999 99999999999999998665 7999999
Q ss_pred ccceecCCCC----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------------
Q 041491 363 GIAKLLNGKE----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------------- 421 (467)
Q Consensus 363 g~a~~~~~~~----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------------- 421 (467)
|+|+.+.... ..++..|.|||++.+ ..++.++||||+||++|||+||++||.+....+.
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 9998764322 245677899998765 4689999999999999999999999975421110
Q ss_pred ------------------cHHHHHhhhcccccccccccccccchhHHHHHHH
Q 041491 422 ------------------NLKNWVNDFLPISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 422 ------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
.+........++++.+++.+||..+|.+|+++.+
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e 347 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0001111123456889999999999999986654
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=289.77 Aligned_cols=230 Identities=26% Similarity=0.307 Sum_probs=194.6
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecc--cccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|++|.||+|.+. +++.|++|.+... .....+.+.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999886 4899999998643 233456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 296 MANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
+++++|.+++... ...+++.+++.++.|++.||.||| ++|++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999998764 357899999999999999999999 99999999999999999999999999999987654332
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh-------hcccccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND-------FLPISVMNVVDTS 442 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~i~~~ 442 (467)
.++..|.+||+..+..++.++|+||||+++|||++|+.||....... ........ .++..+.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-LILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 34556889999998889999999999999999999999997543221 11111111 3344689999999
Q ss_pred cccchhHHHH
Q 041491 443 LLRREDKYFA 452 (467)
Q Consensus 443 l~~~~~~r~~ 452 (467)
+..+|++|++
T Consensus 237 l~~~p~~Rp~ 246 (256)
T cd08529 237 LTKDYRQRPD 246 (256)
T ss_pred ccCCcccCcC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=319.01 Aligned_cols=238 Identities=24% Similarity=0.314 Sum_probs=194.7
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC--
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-- 287 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 287 (467)
.....++|.+.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.++..++|+|++++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445679999999999999999999875 58999999987542 233456788999999999999999988764332
Q ss_pred ------eeeEEEecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEE
Q 041491 288 ------FEALVLEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 288 ------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 358 (467)
..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence 368999999999999988643 236889999999999999999999 99999999999999999999999
Q ss_pred EeccccceecCCC-------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-----
Q 041491 359 LSDFGIAKLLNGK-------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----- 426 (467)
Q Consensus 359 l~Dfg~a~~~~~~-------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----- 426 (467)
|+|||+++.+... ...++..|.+||+..+..++.++|||||||++|||++|+.||......+. +...
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-~~~~~~~~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-MHKTLAGRY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCC
Confidence 9999999875432 12356779999999999999999999999999999999999975432211 1111
Q ss_pred --HhhhcccccccccccccccchhHHHHHH
Q 041491 427 --VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 427 --~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
....+++++.+++.+||..+|.+|++..
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ 292 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSSDPKRRPSSS 292 (496)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence 1223445699999999999999998643
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=296.55 Aligned_cols=241 Identities=24% Similarity=0.380 Sum_probs=193.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-C--CeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-G--MEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 292 (467)
++|++.+.||+|+||.||+|...+ + ..+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998754 3 347888876432 23446788999999999 799999999999999999999
Q ss_pred EecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcE
Q 041491 293 LEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVA 357 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 357 (467)
+||+++++|.+++.... ..+++..+..++.|++.|++||| ++|++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999986432 24788999999999999999999 9999999999999999999999
Q ss_pred EEeccccceecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh----
Q 041491 358 HLSDFGIAKLLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN---- 428 (467)
Q Consensus 358 kl~Dfg~a~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~---- 428 (467)
||+|||++...... ....+..|.+||+.....++.++|||||||++|||+| |..||......+. ......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-~~~~~~~~~~ 237 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQGYRM 237 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhcCCCC
Confidence 99999998643221 1112345889999988889999999999999999997 9999976433221 111111
Q ss_pred ---hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 429 ---DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 429 ---~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..++..+.+++.+|+..+|.+|+ ++.+.++.+..
T Consensus 238 ~~~~~~~~~~~~li~~~l~~~p~~Rp-~~~~i~~~l~~ 274 (297)
T cd05089 238 EKPRNCDDEVYELMRQCWRDRPYERP-PFAQISVQLSR 274 (297)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 12345688999999999999996 56666666543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.54 Aligned_cols=230 Identities=26% Similarity=0.382 Sum_probs=190.5
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..++|++.++||+|+||.||+|++.++..||+|.++... ...+.+.+|++++++++||||+++++.+.. +..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 356799999999999999999998777789999987532 234678999999999999999999998754 557999999
Q ss_pred ccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 296 MANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999996543 35789999999999999999999 99999999999999999999999999999987654321
Q ss_pred -----cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-------hhhcccccccccc
Q 041491 374 -----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-------NDFLPISVMNVVD 440 (467)
Q Consensus 374 -----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~i~ 440 (467)
..+..|.+||+.....++.++||||||+++|||+| |+.||......+. ..... ....+..+.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYRMPCPPECPESLHDLMC 237 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHHhcCCCCCCccccCHHHHHHHH
Confidence 23345899999988889999999999999999999 8889875432221 11110 1224456899999
Q ss_pred cccccchhHHH
Q 041491 441 TSLLRREDKYF 451 (467)
Q Consensus 441 ~~l~~~~~~r~ 451 (467)
+|+..+|++|+
T Consensus 238 ~~l~~~p~~Rp 248 (262)
T cd05071 238 QCWRKEPEERP 248 (262)
T ss_pred HHccCCcccCC
Confidence 99999999995
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.40 Aligned_cols=235 Identities=25% Similarity=0.356 Sum_probs=194.1
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-----cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-----GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
++|++.+.||+|++|.||+|... ++++||+|.+..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999875 489999999864421 123568889999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|+||+++++|.+++... +.+++..+..++.|++.|+.||| +.|++||||+|+||++++++.++|+|||.++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999988543 46888999999999999999999 999999999999999999999999999999865432
Q ss_pred C--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------Hhhhccccc
Q 041491 372 E--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------VNDFLPISV 435 (467)
Q Consensus 372 ~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~ 435 (467)
. ..++..|.+||+..+..++.++||||+|+++|||++|+.||........ .... .....+..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFKIATQPTNPQLPSHVSPDA 236 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHHHhccCCCCCCCccCCHHH
Confidence 1 2234568999999988899999999999999999999999975322211 1111 112334458
Q ss_pred ccccccccccchhHHHHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.+++.+|+..+|++|++ +.+++
T Consensus 237 ~~li~~~l~~~p~~Rpt-~~~ll 258 (263)
T cd06625 237 RNFLRRTFVENAKKRPS-AEELL 258 (263)
T ss_pred HHHHHHHhhcCcccCCC-HHHHh
Confidence 89999999999999974 44444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=294.44 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=197.4
Q ss_pred hccCccCCccCcccceeEEEEEec-----CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeec--CCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 289 (467)
..+|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357889999999999999999753 478999999876655556788999999999999999999998753 3467
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++++|.+++......+++..+..++.|++.||+||| ++|++||||||+||++++++.+||+|||+++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 8999999999999999766667899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccc-------c----c---cHHHHH
Q 041491 370 GKES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE-------E----M---NLKNWV 427 (467)
Q Consensus 370 ~~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~-------~----~---~~~~~~ 427 (467)
.... ..+..|.+||+..+..++.++|||||||++|||++|..|+...... . . .+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 1223478999998888999999999999999999998776432111 0 0 011111
Q ss_pred h--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 428 N--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 428 ~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
. ..++..+.+++.+|+..+|++|+ ++++.+..+-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-t~~ei~~~l~~ 282 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRP-SFSELALQVEA 282 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCC-CHHHHHHHHHh
Confidence 1 12345699999999999999996 67777777644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.99 Aligned_cols=228 Identities=21% Similarity=0.288 Sum_probs=186.4
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||++++.. ++.||+|++.... ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999999865 7889999986431 223345788999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999776667899999999999999999999 9999999999999999999999999999997653322
Q ss_pred -----cccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-----------hhc
Q 041491 373 -----SMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-----------DFL 431 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-----------~~~ 431 (467)
..++..|.+||++. .+.++.++|||||||++|||++|+.||......+. +..... ..+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-HHHHhCCCccccCCCccccC
Confidence 24567789999875 35678999999999999999999999975422111 111111 123
Q ss_pred ccccccccccccccchhH
Q 041491 432 PISVMNVVDTSLLRREDK 449 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~ 449 (467)
++.+.+++.+++..++++
T Consensus 237 s~~~~~li~~ll~~~~~r 254 (332)
T cd05623 237 SEDAKDLIRRLICSREHR 254 (332)
T ss_pred CHHHHHHHHHHccChhhh
Confidence 445888999988765543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.50 Aligned_cols=243 Identities=25% Similarity=0.318 Sum_probs=199.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|++|.||+|++. +++.+|+|.+.... .....++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47888999999999999999875 68999999876432 223457889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||+++++|.+++.. ....+++.+++.++.|++.|+.||| ++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998753 2346899999999999999999999 99999999999999999999999999999886643
Q ss_pred CC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh---------hhcccccc
Q 041491 371 KE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN---------DFLPISVM 436 (467)
Q Consensus 371 ~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~ 436 (467)
.. ..++..|.+||+.....++.++|+||||+++|||++|..||.....+......... ...++.+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 32 23455688999998888999999999999999999999999653322222212211 12334688
Q ss_pred cccccccccchhHHHHHHHHHHHHHHhc
Q 041491 437 NVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+++.+|+..+|++|+ ++.+.++.+.++
T Consensus 239 ~li~~~l~~~p~~Rp-t~~~i~~~~~~~ 265 (267)
T cd08229 239 QLVNMCINPDPEKRP-DITYVYDVAKRM 265 (267)
T ss_pred HHHHHhcCCCcccCC-CHHHHHHHHhhh
Confidence 999999999999997 566666666554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.91 Aligned_cols=235 Identities=27% Similarity=0.316 Sum_probs=196.0
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.+|++.+.||+|++|.||+|.+. +++.||+|.+........+.+.+|+.+++.++|||++++++.+..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57899999999999999999875 58999999987665555677889999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
++++|.+++.. ..+++.++..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+.......
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 99999998854 35789999999999999999999 9999999999999999999999999999987654322
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhccccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVDTSL 443 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~~l 443 (467)
..++..|.+||+.....++.++|||||||++|||++|+.||............+. ...++..+.+++.+|+
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 2345678899999888889999999999999999999999975432221111111 1123345888999999
Q ss_pred ccchhHHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQCV 458 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~ 458 (467)
..+|++|++ +.+.+
T Consensus 255 ~~~p~~Rpt-~~eil 268 (296)
T cd06654 255 DMDVEKRGS-AKELL 268 (296)
T ss_pred cCCcccCcC-HHHHh
Confidence 999999975 44443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.35 Aligned_cols=241 Identities=27% Similarity=0.308 Sum_probs=200.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|++|.||++.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999886 48999999987542 233467889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++++|.+++... ..+++..+..++.|++.||.||| ++|++||||+|+||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence 999999999998554 57899999999999999999999 9999999999999999999999999999998765442
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhccccccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLLR 445 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~ 445 (467)
..++..|.+||.......+.++||||||+++|+|++|+.||....... ...... ...++..+.+++.+||..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEKILEGKVRFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCccCCccCCHHHHHHHHHHccC
Confidence 234566889999888888999999999999999999999997543211 111111 122345688999999999
Q ss_pred chhHHHHHHHHHHHHHHh
Q 041491 446 REDKYFAAKKQCVSSALS 463 (467)
Q Consensus 446 ~~~~r~~~~~~~~~~l~~ 463 (467)
+|.+|++++.+.+.++++
T Consensus 236 ~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CHHHccCcccCCHHHHHc
Confidence 999999766555555543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.88 Aligned_cols=238 Identities=25% Similarity=0.334 Sum_probs=194.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999975 5889999998765444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|.+++.. .+.+++..+..++.|++.|++||| +.||+||||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 88 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 999999998854 346899999999999999999999 9999999999999999999999999999998764322
Q ss_pred --cccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH---------HHH-Hhhhccccccc
Q 041491 373 --SMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL---------KNW-VNDFLPISVMN 437 (467)
Q Consensus 373 --~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~---------~~~-~~~~~~~~~~~ 437 (467)
..++..|.+||.+. ...++.++||||+||++|||++|+.||......+... ..+ ....++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 23445688999874 3457789999999999999999999986432211100 000 01123456889
Q ss_pred ccccccccchhHHHHHHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
++.+||..+|++|++ +.+++.
T Consensus 244 li~~~l~~~P~~Rp~-~~~il~ 264 (267)
T cd06646 244 FVKISLTKNPKKRPT-AERLLT 264 (267)
T ss_pred HHHHHhhCChhhCcC-HHHHhc
Confidence 999999999999974 445443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=292.54 Aligned_cols=238 Identities=25% Similarity=0.336 Sum_probs=190.3
Q ss_pred CccCCccCcccceeEEEEEe-----cCCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecC--CeeeE
Q 041491 220 FSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFEAL 291 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 291 (467)
|+..+.||+|+||+||++.+ .+++.||+|+++.... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988753 2478899999875432 2456788999999999999999999987653 46789
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
+|||+++++|.+++... .+++.++..++.|++.|+.||| +++++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999998543 5899999999999999999999 999999999999999999999999999999876532
Q ss_pred Cc--------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc----------ccHHHHH------
Q 041491 372 ES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE----------MNLKNWV------ 427 (467)
Q Consensus 372 ~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~----------~~~~~~~------ 427 (467)
.. ..+..|.+||+.....++.++||||||+++|||+||+.||....... .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 21 23345789999888889999999999999999999999986432110 0011110
Q ss_pred -----hhhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 428 -----NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 428 -----~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
....+..+.+++.+|+..+|++|+ ++.+.+..+-+
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-s~~~i~~~l~~ 280 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRP-TFRSLIPILKE 280 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCC-CHHHHHHHHHH
Confidence 112345689999999999999996 45555555443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=289.67 Aligned_cols=240 Identities=32% Similarity=0.434 Sum_probs=201.3
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..++|++.+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 356889999999999999999987 478999999876543 457789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 296 MANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
+++++|.+++..... .+++..+..++.|++.|+.||| ++|++||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~ 158 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS 158 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccccc
Confidence 999999999865443 6899999999999999999999 99999999999999999999999999999987643322
Q ss_pred -cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccccccccccc
Q 041491 374 -MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTSL 443 (467)
Q Consensus 374 -~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l 443 (467)
..+..|.+||+...+.++.++||||||+++||+++ |+.||......+ +..... ...++.+.+++.+|+
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGYRMEAPEGCPPEVYKVMKDCW 236 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence 22345789999988889999999999999999997 999997543222 111111 123456899999999
Q ss_pred ccchhHHHHHHHHHHHHHHh
Q 041491 444 LRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~~~l~~ 463 (467)
..+|++|+ ++.+++.++-+
T Consensus 237 ~~~p~~Rp-~~~~l~~~l~~ 255 (256)
T cd05039 237 ELDPAKRP-TFKQLREQLAL 255 (256)
T ss_pred ccChhhCc-CHHHHHHHHhc
Confidence 99999996 56777777643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.97 Aligned_cols=241 Identities=25% Similarity=0.390 Sum_probs=193.1
Q ss_pred hccCccCCccCcccceeEEEEEecC-CC--eEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GM--EVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 291 (467)
.++|++.+.||+|+||.||+|.+.+ +. .+|+|.++... ......+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 4578899999999999999998753 44 45777765432 23446788999999999 89999999999999999999
Q ss_pred EEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 292 VLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
||||+++++|.+++.... ..+++.+++.++.|++.|++||| ++|++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999986432 25789999999999999999999 999999999999999999999
Q ss_pred EEEeccccceecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--
Q 041491 357 AHLSDFGIAKLLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND-- 429 (467)
Q Consensus 357 ~kl~Dfg~a~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~-- 429 (467)
+||+|||++...... ....+..|.+||+.....++.++|||||||++|||+| |..||......+ ..+....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHHhcCC
Confidence 999999998643211 1112345889999888889999999999999999998 999997543221 1111111
Q ss_pred ------hcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 430 ------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 430 ------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..++.+.+++.+|+..+|++|+ ++.+.+..+.+
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp-~~~~il~~l~~ 279 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERP-SFAQILVSLNR 279 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 1345688999999999999996 56666665543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=294.51 Aligned_cols=233 Identities=25% Similarity=0.336 Sum_probs=195.8
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999885 4899999999766555667888999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|.+++......+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999998776667999999999999999999999 9999999999999999999999999999987654322
Q ss_pred --cccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh---------hhcccccc
Q 041491 373 --SMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN---------DFLPISVM 436 (467)
Q Consensus 373 --~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~ 436 (467)
..++..|.+||+.. ...++.++|+||||+++|||++|+.||....... ....+.. ..++.++.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCCCCCcCCcccCCHHHH
Confidence 23455678999864 3456789999999999999999999997643221 1222221 12345688
Q ss_pred cccccccccchhHHHHH
Q 041491 437 NVVDTSLLRREDKYFAA 453 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~ 453 (467)
+++.+|+..+|.+|++.
T Consensus 240 ~li~~~l~~~p~~Rps~ 256 (280)
T cd06611 240 DFLKSCLVKDPDDRPTA 256 (280)
T ss_pred HHHHHHhccChhhCcCH
Confidence 99999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=289.39 Aligned_cols=235 Identities=25% Similarity=0.377 Sum_probs=193.6
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..++|++.+.||+|+||.||+|.+.++..+|+|.+..... ..+.+.+|+.++++++|||++++++++.. +..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 3568999999999999999999988888999999875432 34678999999999999999999998754 557899999
Q ss_pred ccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 296 MANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
+++++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999986543 35899999999999999999999 99999999999999999999999999999987654321
Q ss_pred -----cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccccccccc
Q 041491 374 -----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPISVMNVV 439 (467)
Q Consensus 374 -----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~i 439 (467)
..+..|.+||+.....++.++||||||+++|||++ |+.||.+....+ ..+.... ..+..+.+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 12345899999988889999999999999999999 899997643221 2222211 1234588999
Q ss_pred ccccccchhHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~ 458 (467)
.+|+..+|++|++ +.++.
T Consensus 237 ~~~l~~~p~~Rpt-~~~l~ 254 (260)
T cd05070 237 LQCWKKDPEERPT-FEYLQ 254 (260)
T ss_pred HHHcccCcccCcC-HHHHH
Confidence 9999999999974 33443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.58 Aligned_cols=239 Identities=26% Similarity=0.408 Sum_probs=196.7
Q ss_pred hccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..+|+..++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 357888899999999999999642 35679999887665556678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 291 LVLEYMANGSLEKCLYSSN--------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
++|||+++++|.+++.... ..+++.++..++.|++.|++||| ++|++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 9999999999999986543 24788999999999999999999 999999999999999999999
Q ss_pred EEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-
Q 041491 357 AHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV- 427 (467)
Q Consensus 357 ~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~- 427 (467)
+||+|||++....... ...+..|.+||+.....++.++|||||||++|||++ |+.||......+ .....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHH
Confidence 9999999997654322 122456889999988899999999999999999998 999996543221 11111
Q ss_pred -------hhhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 428 -------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 428 -------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
...+++.+.+++.+|+..+|.+|+ ++.+....+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-~~~~l~~~l 278 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRM-VIKDIHSRL 278 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCC-CHHHHHHHH
Confidence 123455689999999999999996 555555544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=291.35 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=198.1
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCC----eEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGM----EVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
..++|++.+.||+|+||.||+|++. +++ +||+|+++.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3568899999999999999999864 344 489999875432 3456788999999999999999999998754 46
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++++||+++|+|.+++....+.+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999776667999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccc
Q 041491 370 GKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPI 433 (467)
Q Consensus 370 ~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~ 433 (467)
.... ..+..|.+||......++.++|||||||++|||++ |..||+..... ....+... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCcCCCCccCCH
Confidence 3221 12345889999988889999999999999999998 99999754322 12223222 1234
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHhcc
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALSLA 465 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l~ 465 (467)
.+.+++.+|+..||++|+ ++.+++..+.++.
T Consensus 239 ~~~~li~~~l~~dp~~Rp-~~~~l~~~l~~~~ 269 (279)
T cd05109 239 DVYMIMVKCWMIDSECRP-RFRELVDEFSRMA 269 (279)
T ss_pred HHHHHHHHHcCCChhhCc-CHHHHHHHHHHhh
Confidence 577999999999999995 6667777766553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=290.64 Aligned_cols=241 Identities=23% Similarity=0.393 Sum_probs=199.1
Q ss_pred hccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
..+|++.+.||+|+||.||+|++.. +..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678899999999999999998742 3379999886543 2334678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++++|.+++....+.+++.++..++.|++.|++||| +++++||||||+||+++.++.++++|||.+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999776667899999999999999999999 999999999999999999999999999999876543
Q ss_pred Cc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcccc
Q 041491 372 ES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 372 ~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
.. ..+..|.+||+...+.++.++|+||||+++||+++ |+.||.+....+ ....... ..++.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEEGYRLPAPMDCPAA 237 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhCCCcCCCCCCCCHH
Confidence 21 11235789999988889999999999999999886 999997643221 1122111 23446
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHh
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+.+++.+|+..+|.+|+ ++.+++..|.+
T Consensus 238 ~~~li~~~l~~~p~~Rp-~~~~i~~~l~~ 265 (267)
T cd05066 238 LHQLMLDCWQKDRNERP-KFEQIVSILDK 265 (267)
T ss_pred HHHHHHHHcccCchhCC-CHHHHHHHHHh
Confidence 89999999999999996 56677766654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=305.36 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=198.2
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcCC-CCCceeEEEEee
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVR-HRNLVKIISSCS 284 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 284 (467)
+.+..++|.+.+.||+|+||.||+|++. .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 5566778999999999999999999863 246799999975432 23457889999999997 999999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhcCC-------------------------------------------------------
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSSN------------------------------------------------------- 309 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 309 (467)
..+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999886432
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 041491 310 ------------------------------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 347 (467)
Q Consensus 310 ------------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 347 (467)
..+++..+..++.|++.||+||| +++++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 13567778899999999999999 999999999999
Q ss_pred CeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccc
Q 041491 348 NVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCE 419 (467)
Q Consensus 348 NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~ 419 (467)
||++++++.+||+|||+++...... ...+..|.+||+.....++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9999999999999999998653221 123456889999888889999999999999999998 89999754322
Q ss_pred cccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 420 EMNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 420 ~~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+. ....+.. ..+..+.+++.+|+..+|.+|+ ++.+++..|.+
T Consensus 349 ~~-~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-s~~ell~~L~~ 398 (401)
T cd05107 349 EQ-FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP-DFSQLVHLVGD 398 (401)
T ss_pred HH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc-CHHHHHHHHHH
Confidence 21 1111111 2344688999999999999996 56677776644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.04 Aligned_cols=240 Identities=25% Similarity=0.387 Sum_probs=199.6
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+..++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+++.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567899999999999999999998778899999987543 345678999999999999999999999999899999999
Q ss_pred cccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 295 YMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+++++|.+++.... ..+++.++..++.|++.|+.||| +++++|+||||+||++++++.+||+|||.+.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999986654 36899999999999999999999 9999999999999999999999999999998765322
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-------hhccccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVV 439 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i 439 (467)
...+..|.+||...+..++.++||||+|+++||++| |+.||.+..... .+..... ...+..+.+++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELYDLM 237 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 112346889999988889999999999999999998 999997543221 1222211 12244689999
Q ss_pred ccccccchhHHHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCVSS 460 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~~~ 460 (467)
.+|+..+|++|+ ++.+....
T Consensus 238 ~~~l~~~p~~Rp-~~~~l~~~ 257 (261)
T cd05034 238 LQCWDKDPEERP-TFEYLQSF 257 (261)
T ss_pred HHHcccCcccCC-CHHHHHHH
Confidence 999999999996 44454443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=292.35 Aligned_cols=232 Identities=25% Similarity=0.330 Sum_probs=193.3
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
+-|++.+.||+|+||.||+|.+.. +..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 346788999999999999998864 7888999987655555677889999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK----- 371 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----- 371 (467)
++++|..++......+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999999988665667899999999999999999999 999999999999999999999999999998765332
Q ss_pred Ccccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------hhhccccccc
Q 041491 372 ESMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------NDFLPISVMN 437 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~ 437 (467)
...++..|.+||+.. ...++.++|||||||++|||++|+.||......+ ...... ...++..+.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCCCCCCccccCHHHHH
Confidence 123556789999873 4557789999999999999999999997643221 111111 1123456999
Q ss_pred ccccccccchhHHHHH
Q 041491 438 VVDTSLLRREDKYFAA 453 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~ 453 (467)
++.+|+..+|.+|++.
T Consensus 241 li~~~l~~~p~~Rp~~ 256 (282)
T cd06643 241 FLKKCLEKNVDARWTT 256 (282)
T ss_pred HHHHHccCChhhCcCH
Confidence 9999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=296.70 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=201.3
Q ss_pred HHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEeec
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSN 285 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 285 (467)
....++|.+.+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345578999999999999999999752 24579999887543 23346788999999999 79999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
.+..++||||+++|+|.+++..... .+++.++..++.|++.|++||| +++|+|+||||+||+++.++.+|++|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999999865443 4899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh-------
Q 041491 365 AKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND------- 429 (467)
Q Consensus 365 a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~------- 429 (467)
++....... ..+..|.+||+.....++.++||||+||++|||+| |+.||......+ ........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 266 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYRMAQP 266 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCcCCCC
Confidence 986543221 22345889999988889999999999999999998 999997643222 12222221
Q ss_pred -hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 430 -FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 430 -~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..++.+.+++.+|+..+|++|+ ++.+++..+.++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rp-t~~ell~~l~~~ 301 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRP-TFKQIVQLIGKQ 301 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCc-CHHHHHHHHHhh
Confidence 2344588999999999999995 677887777553
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=291.28 Aligned_cols=231 Identities=23% Similarity=0.267 Sum_probs=190.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36888899999999999999875 58899999987542 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---C
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---E 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~ 372 (467)
+++++|..+. .+++..+..++.|++.|+.||| +.||+|+||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 9999997542 4688889999999999999999 999999999999999999999999999999865433 2
Q ss_pred ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHH------------hhhcccccccc
Q 041491 373 SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWV------------NDFLPISVMNV 438 (467)
Q Consensus 373 ~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~------------~~~~~~~~~~~ 438 (467)
..++..|.+||+.....++.++||||||+++|||++|+.||........ ....+. ....++++.++
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 3456678999999888899999999999999999999999975332211 111111 11233458899
Q ss_pred cccccccchhHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~ 457 (467)
+.+|+..+|++|++ +++.
T Consensus 233 i~~~l~~~P~~Rp~-~~ei 250 (279)
T cd06619 233 ITQCMRKQPKERPA-PENL 250 (279)
T ss_pred HHHHhhCChhhCCC-HHHH
Confidence 99999999999984 4443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=289.69 Aligned_cols=239 Identities=23% Similarity=0.391 Sum_probs=193.8
Q ss_pred CccCCccCcccceeEEEEEecC----CCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCe-----
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNF----- 288 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 288 (467)
|++.+.||+|+||.||+|.... +..||+|.++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998753 36799999875432 234678899999999999999999998865543
Q ss_pred -eeEEEecccCCCHHHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecc
Q 041491 289 -EALVLEYMANGSLEKCLYSS-----NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 289 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
.++++||+++|+|..++... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999887442 236889999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh-----
Q 041491 363 GIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND----- 429 (467)
Q Consensus 363 g~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~----- 429 (467)
|+++....... ..+..|.+||+.....++.++|||||||++|||++ |..||.+.... ...++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~ 235 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNRLK 235 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC
Confidence 99987653321 12345789999988889999999999999999999 89999754322 22222221
Q ss_pred ---hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 430 ---FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 430 ---~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..++.+.+++.+|+..+|++|+ ++.+++..|.++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp-~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRP-TFTKLREVLENI 272 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHhh
Confidence 2334688999999999999995 677777777654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.16 Aligned_cols=233 Identities=26% Similarity=0.342 Sum_probs=196.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|.+. +++.+++|++........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468999999999999999999885 4788999999876555667899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|.+++......+++.++..++.|++.|++||| +.+++|+||||+||++++++.+||+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999998766567999999999999999999999 9999999999999999999999999999988655322
Q ss_pred --ccccccccccccccCC---CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------hhhccccccc
Q 041491 373 --SMRTQTLATIEYGREG---QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------NDFLPISVMN 437 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~---~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------~~~~~~~~~~ 437 (467)
...+..|.+||..... .++.++|+||||+++|||+||+.||.............. ...++.++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 2345568899998776 788999999999999999999999976432221111110 1123445889
Q ss_pred ccccccccchhHHHH
Q 041491 438 VVDTSLLRREDKYFA 452 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~ 452 (467)
++.+|+..+|.+|++
T Consensus 239 li~~~l~~~p~~Rpt 253 (262)
T cd06613 239 FIKKCLTKDPKKRPT 253 (262)
T ss_pred HHHHHcCCChhhCCC
Confidence 999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=286.70 Aligned_cols=232 Identities=26% Similarity=0.364 Sum_probs=193.6
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCHH
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLE 302 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 302 (467)
+.||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999987889999999875532 23456889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc------ccc
Q 041491 303 KCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES------MRT 376 (467)
Q Consensus 303 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------~~~ 376 (467)
+++......+++..+..++.|++.||.|+| ++|++||||||+||++++++.+||+|||++........ ..+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 998766667899999999999999999999 99999999999999999999999999999976543211 223
Q ss_pred ccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------hhhcccccccccccccccch
Q 041491 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 377 ~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~~l~~~~ 447 (467)
..|.+||+...+.++.++||||||+++||+++ |..||....... ..... ...++..+.+++.+|+..+|
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 45889999988889999999999999999998 999997542221 11111 12234568999999999999
Q ss_pred hHHHHHHHHHHHHH
Q 041491 448 DKYFAAKKQCVSSA 461 (467)
Q Consensus 448 ~~r~~~~~~~~~~l 461 (467)
++|+ ++.+.++++
T Consensus 236 ~~Rp-~~~~l~~~l 248 (250)
T cd05085 236 ENRP-KFSELQKEL 248 (250)
T ss_pred ccCC-CHHHHHHHh
Confidence 9994 677777665
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=289.98 Aligned_cols=236 Identities=25% Similarity=0.315 Sum_probs=192.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|++. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999875 4889999998766544556688999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC----
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 371 (467)
+++++|.+++.. .+.+++.++..++.|++.|+.||| +.|++|+||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 88 CGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 999999998854 347899999999999999999999 999999999999999999999999999998765432
Q ss_pred -Ccccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhccccccc
Q 041491 372 -ESMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMN 437 (467)
Q Consensus 372 -~~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~ 437 (467)
...++..|.+||+.. ...++.++|+||+||++|||++|+.||............... ..++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 123456788999864 456788999999999999999999998653221111100000 123345788
Q ss_pred ccccccccchhHHHHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~ 457 (467)
++.+|+..+|++|++ +.++
T Consensus 244 li~~~l~~~P~~R~~-~~~l 262 (267)
T cd06645 244 FVKMALTKNPKKRPT-AEKL 262 (267)
T ss_pred HHHHHccCCchhCcC-HHHH
Confidence 999999999999974 4443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=304.30 Aligned_cols=222 Identities=24% Similarity=0.244 Sum_probs=179.8
Q ss_pred cCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcC---CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSV---RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
||+|+||.||+|++. +++.||+|++..... ........|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999886 489999999865321 1223445667777655 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Cc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ES 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 373 (467)
|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCc
Confidence 999988854 457899999999999999999999 999999999999999999999999999998754322 22
Q ss_pred cccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------hhhccccccccccccccc
Q 041491 374 MRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-------NDFLPISVMNVVDTSLLR 445 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~ 445 (467)
.++..|.+||.+.+. .++.++||||+||++|||+||+.||......+. ..... ...+++.+.+++.+||..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-YRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-HHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 356778999987654 478999999999999999999999976432211 11111 112445688999999999
Q ss_pred chhHHHH
Q 041491 446 REDKYFA 452 (467)
Q Consensus 446 ~~~~r~~ 452 (467)
+|.+|++
T Consensus 236 ~P~~R~~ 242 (330)
T cd05586 236 NPQHRLG 242 (330)
T ss_pred CHHHCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.49 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=201.8
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
++.+..++|++.+.||+|+||.||++.+.+ ...+|+|.+.... ......+.+|+++++++ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345666789999999999999999998743 3679999987542 23345688999999999 799999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSS---------------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
..++..+++|||+++|+|.+++... ...+++..++.++.|++.|++||| +++|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceee
Confidence 9999999999999999999998532 246889999999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
|++++++.+||+|||.++....... ..+..|.+||+.....++.++|||||||++||+++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999987653221 12345889999888889999999999999999997 999987543222
Q ss_pred ccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 421 MNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 421 ~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..+... ...+..+.+++.+|+..+|++|+ ++.+++.++..+
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~eil~~l~~~ 291 (293)
T cd05053 243 --LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP-TFKQLVEDLDRM 291 (293)
T ss_pred --HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-CHHHHHHHHHHh
Confidence 111111 11234588999999999999997 788888887553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.82 Aligned_cols=242 Identities=22% Similarity=0.396 Sum_probs=198.5
Q ss_pred HhccCccCCccCcccceeEEEEEecC-C---CeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-G---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..++|+..+.||+|+||.||+|.... + ..+|+|.++... ....+.+.+|++++++++|||++++.+++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 34678889999999999999998753 3 369999886542 234567889999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++++|.+++....+.+++.++..++.|++.|++||| +.|++||||||+||++++++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999776678899999999999999999999 99999999999999999999999999999986643
Q ss_pred CCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccc
Q 041491 371 KES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPI 433 (467)
Q Consensus 371 ~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~ 433 (467)
... ..+..|.+||+.....++.++|||||||++|||++ |+.||......+ ...... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDGFRLPAPMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhcCCCCCCCCCCCH
Confidence 221 11235789999888889999999999999999997 999996543221 111111 12344
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+.+++.+|+..+|++|+ ++.+.+..+.+
T Consensus 238 ~~~~li~~c~~~~p~~Rp-~~~~i~~~l~~ 266 (268)
T cd05063 238 AVYQLMLQCWQQDRARRP-RFVDIVNLLDK 266 (268)
T ss_pred HHHHHHHHHcCCCcccCc-CHHHHHHHHHh
Confidence 588999999999999996 56666666544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=289.18 Aligned_cols=239 Identities=23% Similarity=0.400 Sum_probs=197.3
Q ss_pred ccCccCCccCcccceeEEEEEecC-C---CeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-G---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.+|++.+.||+|+||.||+|.+.. + ..||+|.++... ......+..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468889999999999999998753 3 369999987542 33456789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++++|.+++....+.+++.+++.++.|++.|++||| ++|++||||||+||++++++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999776677899999999999999999999 9999999999999999999999999999987654322
Q ss_pred cc----------ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccc
Q 041491 373 SM----------RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPI 433 (467)
Q Consensus 373 ~~----------~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~ 433 (467)
.. .+..|.+||+.....++.++|||||||++||+++ |..||...... ....++.. ..|.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCcCCCcccCCH
Confidence 11 1235789999988899999999999999999886 99999764322 22233222 2344
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.+.+++.+|+..+|.+|+ ++.+.+..+-
T Consensus 239 ~~~~li~~~l~~~p~~Rp-~~~~i~~~l~ 266 (269)
T cd05065 239 ALHQLMLDCWQKDRNARP-KFGQIVSTLD 266 (269)
T ss_pred HHHHHHHHHcCCChhhCc-CHHHHHHHHH
Confidence 588999999999999996 5566666553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=288.44 Aligned_cols=238 Identities=24% Similarity=0.376 Sum_probs=198.9
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
..+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++|||++++++++......++||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 35788889999999999999998778899999886442 23467889999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
++++|.+++....+.+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999998776667899999999999999999999 9999999999999999999999999999988654321
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------hhhccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVDT 441 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~ 441 (467)
...+..|.+||+..++.++.++||||||+++|||++ |+.||......+ ..+.. ....+..+.+++.+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 122346889999988899999999999999999998 999997532221 11111 11234458899999
Q ss_pred ccccchhHHHHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l 461 (467)
|+..+|++|+ ++.++++.|
T Consensus 237 ~l~~~p~~Rp-~~~~~l~~l 255 (256)
T cd05112 237 CWKERPEDRP-SFSLLLHQL 255 (256)
T ss_pred HcccChhhCC-CHHHHHHhh
Confidence 9999999996 677777654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=287.98 Aligned_cols=236 Identities=28% Similarity=0.337 Sum_probs=199.0
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|+..+.||+|+||.||+|.+.+ ++.+++|.+..... .+.+.+|++++++++||||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4689999999999999999999875 88999999875533 67899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|.+++......+++..+..++.|++.|+.||| +.+++||||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999999766678899999999999999999999 9999999999999999999999999999998765433
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------Hhhhcccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------VNDFLPISVMNVVDTS 442 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~i~~~ 442 (467)
..++..|.+||+..+..++.++||||||+++|||++|+.||............. ....++..+.+++.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 124556889999988889999999999999999999999997543222111000 1122345688999999
Q ss_pred cccchhHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCV 458 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~ 458 (467)
+..+|++|++ +.+.+
T Consensus 237 l~~~P~~Rps-~~~il 251 (256)
T cd06612 237 LVKDPEERPS-AIQLL 251 (256)
T ss_pred HhcChhhCcC-HHHHh
Confidence 9999999974 44443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=288.82 Aligned_cols=235 Identities=21% Similarity=0.295 Sum_probs=194.8
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
+|++.+.||+|+||.||++++. +++.+|+|.++... ....+.+.+|+.++++++||||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788899999999999999886 48999999986532 334567889999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 297 ANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
++++|.+++... ...+++..+..++.|++.||.||| ++|++|+||||+||++++++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999988653 345789999999999999999999 9999999999999999999999999999998765432
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-------Hhhhccccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-------VNDFLPISVMNVVDTSL 443 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~l 443 (467)
..++..|.+||+.....++.++|+||||+++|+|++|+.||........ .... ....++..+.+++.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-ILKVCQGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-HHHHhcCCCCCCCcccCHHHHHHHHHHH
Confidence 2345568899999888899999999999999999999999975422211 1111 11223445889999999
Q ss_pred ccchhHHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQCV 458 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~ 458 (467)
..+|++|++ +.+++
T Consensus 237 ~~~P~~Rp~-~~~il 250 (255)
T cd08219 237 KRNPRSRPS-ATTIL 250 (255)
T ss_pred hCCcccCCC-HHHHh
Confidence 999999974 44443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=290.69 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=193.4
Q ss_pred hccCccCCccCcccceeEEEEEecC-CC----eEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++|++.+.||+|+||.||+|.+.. ++ ++++|.+..... ....++..|+..+++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 3578889999999999999998753 44 477777754322 234567788889999999999999998764 4568
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+++||+++|+|.+++....+.+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||.++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999999776678899999999999999999999 99999999999999999999999999999986543
Q ss_pred CC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcccc
Q 041491 371 KE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 371 ~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
.. ..++..|.+||+...+.++.++|||||||++||++| |+.||.+..... ..++... ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGERLAQPQICTID 239 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCcCCCCCCCCHH
Confidence 22 123346889999988899999999999999999998 999997643221 2222221 12224
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+.+++.+|+..+|.+|+ ++.|.++.+..+
T Consensus 240 ~~~li~~c~~~~p~~Rp-s~~el~~~l~~~ 268 (279)
T cd05111 240 VYMVMVKCWMIDENVRP-TFKELANEFTRM 268 (279)
T ss_pred HHHHHHHHcCCCcccCc-CHHHHHHHHHHH
Confidence 67789999999999996 667777766553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=293.68 Aligned_cols=244 Identities=21% Similarity=0.338 Sum_probs=196.2
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecC
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNG 286 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 286 (467)
.+..++|++.+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3457899999999999999999997542 45799998764432 2334678899999999999999999999999
Q ss_pred CeeeEEEecccCCCHHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcE
Q 041491 287 NFEALVLEYMANGSLEKCLYSSN---------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVA 357 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 357 (467)
+..++||||+++|+|.+++.... ...++..+..++.|++.||.||| +++|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999986422 23466788899999999999999 9999999999999999999999
Q ss_pred EEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-h
Q 041491 358 HLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-N 428 (467)
Q Consensus 358 kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-~ 428 (467)
||+|||+++...... ...+..|.+||+...+.++.++|||||||++|||++ |..||.....++ ..+.. .
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~ 236 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFVMD 236 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc
Confidence 999999988653321 122445889999988889999999999999999998 788997643322 22221 1
Q ss_pred -------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 429 -------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 429 -------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
...++.+.+++.+|+..+|++|+ ++.++++.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~ll~~l~~ 277 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRP-TFLEIVNLLKD 277 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCc-CHHHHHHHHHh
Confidence 12244589999999999999996 56666665543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=324.11 Aligned_cols=240 Identities=27% Similarity=0.421 Sum_probs=201.1
Q ss_pred hccCccCCccCcccceeEEEEEecC--CC----eEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD--GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
....+..+.||+|+||.||.|...+ |. .||+|.++... .....+|.+|..+|++++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566777899999999999998764 43 38999887653 44668899999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccc
Q 041491 290 ALVLEYMANGSLEKCLYSS------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
+|++|||+||||..++++. ...++......++.|||+|++||+ ++++|||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999887 557889999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-------h
Q 041491 364 IAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-------N 428 (467)
Q Consensus 364 ~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-------~ 428 (467)
+|+.+-..+. ..+..|++||.+..+.++.|+|||||||++||++| |..||.+....+ .+..+. .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-v~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-VLLDVLEGGRLDPP 926 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-HHHHHHhCCccCCC
Confidence 9995543322 33456899999999999999999999999999999 788887643332 222232 2
Q ss_pred hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
.+.|+.+.+++..|+..+|++|+ +...+++++
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP-~F~~i~~q~ 958 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRP-SFRTIVEQD 958 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCc-cHHHHHhhh
Confidence 34566788999999999999996 444555443
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=292.08 Aligned_cols=238 Identities=22% Similarity=0.344 Sum_probs=193.2
Q ss_pred ccCccCCccCcccceeEEEEEec-----CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 56888899999999999999852 367899999874332 234678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC
Q 041491 292 VLEYMANGSLEKCLYSSN----------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM 355 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 355 (467)
||||+++++|.+++.... ..+++.++..++.|++.||+||| +++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 999999999999885321 24788889999999999999999 99999999999999999999
Q ss_pred cEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH
Q 041491 356 VAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV 427 (467)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~ 427 (467)
.+||+|||+++...... ...+..|.+||+..+..++.++|||||||++|||++ |..||.+.... ...+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 99999999998654321 122345899999988889999999999999999999 99999653221 112221
Q ss_pred h--------hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 428 N--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 428 ~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
. ...++.+.+++..|+..+|.+|+ ++.+..+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-~~~~i~~~l 280 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP-RFKDIHTRL 280 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-CHHHHHHHh
Confidence 1 22345688999999999999997 455555444
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=294.13 Aligned_cols=241 Identities=27% Similarity=0.314 Sum_probs=198.8
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.+|+..+.||.|++|.||+|.+. +++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999875 58999999987665555677889999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
++++|.+++.. ..+++.++..++.|++.|++||| +.|++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 99999998854 35899999999999999999999 9999999999999999999999999999988654332
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhccccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVDTSL 443 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~~l 443 (467)
..++..|.+||......++.++|||||||++|+|++|+.||.............. ...+++.+.+++.+|+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence 2345568899999888899999999999999999999999976432221111110 1123445889999999
Q ss_pred ccchhHHHHHHHHHHHHHHh
Q 041491 444 LRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~~~l~~ 463 (467)
..+|.+|++..+-.-..+++
T Consensus 254 ~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 254 EMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred hcChhhCCCHHHHhhChHhh
Confidence 99999997644433334433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=295.07 Aligned_cols=242 Identities=22% Similarity=0.353 Sum_probs=193.2
Q ss_pred hccCccCCccCcccceeEEEEEecC---------------CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD---------------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~ 280 (467)
.++|++.+.||+|+||.||+|++.+ ...||+|.++... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999997642 2348999987542 22345788999999999999999999
Q ss_pred EEeecCCeeeEEEecccCCCHHHhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 041491 281 SSCSNGNFEALVLEYMANGSLEKCLYSSN-----------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNV 349 (467)
Q Consensus 281 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI 349 (467)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.|++||| +.+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 99999999999999999999999885432 13678899999999999999999 99999999999999
Q ss_pred eecCCCcEEEeccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc--CCCCCCcccccc
Q 041491 350 LLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT--KKKPTCEIFCEE 420 (467)
Q Consensus 350 ll~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t--g~~Pf~~~~~~~ 420 (467)
++++++.+||+|||++........ ..+..|.+||+...+.++.++|||||||++|||++ |..||.....++
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543221 12346889999888889999999999999999988 677887543221
Q ss_pred c--cHHHHH-----------hhhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 421 M--NLKNWV-----------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 421 ~--~~~~~~-----------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
. ...... ....|+.+.+++.+|+..+|++|+ ++.+.++.|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP-TFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc-CHHHHHHHHh
Confidence 1 000000 112345589999999999999997 5566666553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.04 Aligned_cols=240 Identities=25% Similarity=0.334 Sum_probs=195.0
Q ss_pred HhccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
..++|++.+.||+|++|.||+|.+.+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35679999999999999999998753 5678999876443 2234568899999999999999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC---cEEE
Q 041491 289 EALVLEYMANGSLEKCLYSSN------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---VAHL 359 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl 359 (467)
.++||||+++++|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999986543 25889999999999999999999 99999999999999998755 5999
Q ss_pred eccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh---
Q 041491 360 SDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--- 428 (467)
Q Consensus 360 ~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--- 428 (467)
+|||+++....... ..+..|.+||+..+..++.++|||||||++|||++ |..||.....++ ..+.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence 99999987643221 12345899999988889999999999999999997 999997643322 112211
Q ss_pred -----hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 -----DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 -----~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
..++..+.+++.+|+..+|++|+ ++.+.++.+
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp-s~~~vl~~l 275 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRP-NFATILERI 275 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCc-CHHHHHHHh
Confidence 22345688999999999999996 555666554
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=288.53 Aligned_cols=237 Identities=25% Similarity=0.367 Sum_probs=193.5
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.++|++.+.||+|++|.||+|.+.++..+|+|.+.... ...+.+.+|+.++++++|||++++++++.. +..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 46789999999999999999998777789999876442 334678899999999999999999998754 5678999999
Q ss_pred cCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc--
Q 041491 297 ANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-- 373 (467)
Q Consensus 297 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 373 (467)
++++|.+++.... ..+++..+..++.|++.||.||| +.|++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 9999999986543 35789999999999999999999 99999999999999999999999999999987643321
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVD 440 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~ 440 (467)
..+..|.+||+..+..++.++||||||+++|||+| |+.||.+....+ ...+.. ...+..+.+++.
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 23345889999988889999999999999999999 999997643222 112221 123445899999
Q ss_pred cccccchhHHHHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l 461 (467)
+|+..+|++|+ ++++.++.+
T Consensus 238 ~~l~~~p~~Rp-~~~~i~~~l 257 (260)
T cd05069 238 LCWKKDPDERP-TFEYIQSFL 257 (260)
T ss_pred HHccCCcccCc-CHHHHHHHH
Confidence 99999999996 344444433
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.20 Aligned_cols=231 Identities=23% Similarity=0.275 Sum_probs=185.9
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC-----eee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-----FEA 290 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 290 (467)
+|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999875 58999999986432 223467889999999999999999999998776 789
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+. ++|.+.+.. ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 588887743 456899999999999999999999 99999999999999999999999999999986543
Q ss_pred CC------ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc-----------cHHH-------
Q 041491 371 KE------SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-----------NLKN------- 425 (467)
Q Consensus 371 ~~------~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-----------~~~~------- 425 (467)
.. ...+..|.+||+..+. .++.++||||+||++|||++|+.||......+. ....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 22 2345668999987764 578999999999999999999999975321110 0000
Q ss_pred ---HH----------------hhhcccccccccccccccchhHHHHHH
Q 041491 426 ---WV----------------NDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 426 ---~~----------------~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
+. ....++++.+++.+||..||.+|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 283 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA 283 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHH
Confidence 00 011234577899999999999998643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=291.29 Aligned_cols=237 Identities=24% Similarity=0.299 Sum_probs=195.7
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.+.|++.+.||+|+||.||+|++.. ++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4679999999999999999998865 899999999766555667788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|..++.+....+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 9999999887666667899999999999999999999 9999999999999999999999999999987643321
Q ss_pred --cccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh---------hcccccc
Q 041491 373 --SMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND---------FLPISVM 436 (467)
Q Consensus 373 --~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~ 436 (467)
...+..|.+||++. ...++.++|||||||++|||++|+.||....... ....+... .++.++.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhcCCCccCCCCcccCHHHH
Confidence 23455688999874 3456789999999999999999999997532211 11222111 2233578
Q ss_pred cccccccccchhHHHHHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+++.+|+..+|++|++ +.+.+
T Consensus 247 ~li~~~l~~~p~~Rp~-~~~il 267 (292)
T cd06644 247 DFLKTALDKHPETRPS-AAQLL 267 (292)
T ss_pred HHHHHHhcCCcccCcC-HHHHh
Confidence 8999999999999974 34443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=285.12 Aligned_cols=232 Identities=28% Similarity=0.457 Sum_probs=196.1
Q ss_pred CccCcccceeEEEEEecC----CCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|.+.. +..||+|.++..... ..+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998864 788999998765433 267889999999999999999999999999999999999999
Q ss_pred CCHHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 299 GSLEKCLYSS--------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 299 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
++|.+++... ...+++..++.++.|++.|++||| +++++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765 467899999999999999999999 99999999999999999999999999999987765
Q ss_pred CC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccc
Q 041491 371 KE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPIS 434 (467)
Q Consensus 371 ~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 434 (467)
.. ...+..|.+||......++.++||||+|+++|||++ |..||...... ...+... ...+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRKGYRLPKPEYCPDE 235 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCCCCccCChH
Confidence 32 234556889999888889999999999999999999 69999765222 1222221 223456
Q ss_pred cccccccccccchhHHHHHHHHHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+.+++.+|+..+|++|+ ++.+++..+
T Consensus 236 ~~~li~~~l~~~p~~Rp-s~~~l~~~l 261 (262)
T cd00192 236 LYELMLSCWQLDPEDRP-TFSELVERL 261 (262)
T ss_pred HHHHHHHHccCCcccCc-CHHHHHHhh
Confidence 89999999999999997 566766654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=288.89 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=198.4
Q ss_pred HhccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..++|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcE
Confidence 34578889999999999999998753 2468999887554 33456789999999999999999999988764 568
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999999766567899999999999999999999 99999999999999999999999999999987644
Q ss_pred CCc------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHH-------Hhhhcccccc
Q 041491 371 KES------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNW-------VNDFLPISVM 436 (467)
Q Consensus 371 ~~~------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~ 436 (467)
... ..+..|.+||+.....++.++||||||+++||+++ |..||......+. .... .....+..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHH
Confidence 321 12345889999888889999999999999999986 9999976533221 1111 1123455699
Q ss_pred cccccccccchhHHHHHHHHHHHHHHhc
Q 041491 437 NVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+++.+|+..+|++|+ ++.+++..+.++
T Consensus 239 ~li~~~l~~~P~~Rp-t~~~~~~~l~~~ 265 (270)
T cd05056 239 SLMTKCWAYDPSKRP-RFTELKAQLSDI 265 (270)
T ss_pred HHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 999999999999997 677777776554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=294.28 Aligned_cols=232 Identities=27% Similarity=0.320 Sum_probs=195.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 368999999999999999999875 5899999999766555557788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|.+++.. ..+++.++..++.|++.||.||| +.|++||||||+||+++.++.++|+|||.+.......
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 999999998854 35788999999999999999999 9999999999999999999999999999998764332
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhcccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVDTS 442 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~~ 442 (467)
..++..|.+||+..+..++.++|+|||||++|+|++|+.||............+. ...++..+.+++.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 2345568899999888899999999999999999999999975432211111111 122344578999999
Q ss_pred cccchhHHHHH
Q 041491 443 LLRREDKYFAA 453 (467)
Q Consensus 443 l~~~~~~r~~~ 453 (467)
+..+|++|++.
T Consensus 253 l~~~p~~Rps~ 263 (297)
T cd06656 253 LEMDVDRRGSA 263 (297)
T ss_pred ccCChhhCcCH
Confidence 99999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=286.40 Aligned_cols=231 Identities=18% Similarity=0.263 Sum_probs=185.3
Q ss_pred CccCcccceeEEEEEecC-------------CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 224 SLIGIGSFGTVYKGRFLD-------------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
+.||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358899876654455567888999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc-------EEEeccc
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV-------AHLSDFG 363 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-------~kl~Dfg 363 (467)
+||||+++++|..++......+++..+..++.|+++|++||| +++|+||||||+||+++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988766667899999999999999999999 999999999999999987654 8999999
Q ss_pred cceecCCCC-cccccccccccccc-CCCCCCcccchhhHHHHHHHh-cCCCCCCccccccccHHHHHhhh------cccc
Q 041491 364 IAKLLNGKE-SMRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETF-TKKKPTCEIFCEEMNLKNWVNDF------LPIS 434 (467)
Q Consensus 364 ~a~~~~~~~-~~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~-tg~~Pf~~~~~~~~~~~~~~~~~------~~~~ 434 (467)
.+....... ..++..|.+||+.. ...++.++|||||||++|||+ +|+.||......+ ........ .+++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (262)
T cd05077 158 IPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEGQCMLVTPSCKE 235 (262)
T ss_pred CCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhcCccCCCCChHH
Confidence 987664332 33556789999876 467889999999999999997 6888886532211 11111111 1235
Q ss_pred cccccccccccchhHHHHHHHHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSS 460 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~ 460 (467)
+.+++.+|+..||.+|+ ++.+.++.
T Consensus 236 ~~~li~~cl~~dp~~Rp-~~~~il~~ 260 (262)
T cd05077 236 LADLMTHCMNYDPNQRP-FFRAIMRD 260 (262)
T ss_pred HHHHHHHHcCCChhhCc-CHHHHHHh
Confidence 88999999999999997 44555543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=291.97 Aligned_cols=242 Identities=22% Similarity=0.344 Sum_probs=195.5
Q ss_pred ccCccCCccCcccceeEEEEEec-----CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecC--Cee
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFE 289 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 289 (467)
..|++.+.||+|+||.||+|++. ++..||+|.++... ......+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788999999999999999742 47889999987543 23446789999999999999999999998775 568
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++++|.+++......+++.++..++.|++.||+||| ++|++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999998665557899999999999999999999 9999999999999999999999999999998664
Q ss_pred CCC--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccc----------cccccHHHHH----
Q 041491 370 GKE--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIF----------CEEMNLKNWV---- 427 (467)
Q Consensus 370 ~~~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~----------~~~~~~~~~~---- 427 (467)
... ..++..|.+||+..+..++.++|||||||++|||+|++.|+.... ..+.....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 322 123345789999888889999999999999999999887753211 0111111111
Q ss_pred -------hhhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 428 -------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 428 -------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
...++..+.+++.+|+..+|++|+ ++.+.++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~il~~l~~ 282 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT-TFQNLIEGFEA 282 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCc-CHHHHHHHHHh
Confidence 122344688999999999999996 67777777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=286.37 Aligned_cols=239 Identities=31% Similarity=0.383 Sum_probs=196.3
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEee-cCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS-NGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e 294 (467)
..++|++.+.||+|+||.||+|.. .+..||+|.++.. ...+.+.+|+.++++++|+|++++++++. .++..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 346889999999999999999976 4788999988643 23467889999999999999999999764 5567899999
Q ss_pred cccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 295 YMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+++++|.+++..... .+++..+..++.|++.||+||| ++|++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 9999999999866443 5889999999999999999999 9999999999999999999999999999998654332
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTS 442 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~ 442 (467)
...+..|.+||+.....++.++|||||||++|||++ |+.||...... ....... ...++.+.+++.+|
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 223446899999988889999999999999999997 99998653211 1112221 23455689999999
Q ss_pred cccchhHHHHHHHHHHHHHHh
Q 041491 443 LLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+..+|++|+ ++.+.+..|.+
T Consensus 236 l~~~p~~Rp-t~~~l~~~l~~ 255 (256)
T cd05082 236 WHLDAATRP-SFLQLREQLEH 255 (256)
T ss_pred hcCChhhCc-CHHHHHHHHhc
Confidence 999999996 67777766644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=295.41 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=196.7
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC--------CCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
.+..++|.+.+.||+|+||.||+|++.. ...+|+|.++... ......+.+|+++++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3345789999999999999999997632 3569999987542 23345688899999999 799999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
...+..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.|++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHh
Confidence 99999999999999999999986532 24788999999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
|+++.++.+||+|||.++...... ...+..|.+||+..+..++.++|||||||++|||++ |..||.....++
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999997654321 112346899999988889999999999999999998 889986533221
Q ss_pred ccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 421 MNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 421 ~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
...... ...+..+.+++.+|+..+|++|+ ++.+++..+.+
T Consensus 251 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~evl~~l~~ 298 (307)
T cd05098 251 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 298 (307)
T ss_pred --HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCc-CHHHHHHHHHH
Confidence 111111 12234588999999999999996 66666666544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=288.33 Aligned_cols=242 Identities=26% Similarity=0.347 Sum_probs=194.7
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
++.+++.+.....||+|+||.||+|.+. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445566666789999999999999876 478899999876655556788999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEEEeccccceec
Q 041491 292 VLEYMANGSLEKCLYSSNGIL--DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLSDFGIAKLL 368 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~ 368 (467)
|+||+++++|.+++......+ ++..+..++.|++.|++||| ++||+||||||+||+++. ++.+||+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999987654545 78889999999999999999 999999999999999976 679999999998765
Q ss_pred CCCC-----ccccccccccccccCC--CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHH--------HHhhhccc
Q 041491 369 NGKE-----SMRTQTLATIEYGREG--QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN--------WVNDFLPI 433 (467)
Q Consensus 369 ~~~~-----~~~~~~~~~pe~~~~~--~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~--------~~~~~~~~ 433 (467)
.... ..++..|.+||+.... .++.++||||||+++|+|++|+.||............ ......++
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 4321 2245678899987654 3788999999999999999999999753222111100 01222344
Q ss_pred ccccccccccccchhHHHHHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
++.+++.+|+..+|.+|+ ++.+.+
T Consensus 240 ~~~~li~~~l~~~p~~Rp-t~~~ll 263 (268)
T cd06624 240 EAKNFILRCFEPDPDKRA-SAHDLL 263 (268)
T ss_pred HHHHHHHHHcCCCchhCC-CHHHHH
Confidence 588899999999999997 444443
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=288.39 Aligned_cols=231 Identities=21% Similarity=0.325 Sum_probs=185.9
Q ss_pred ccCcccceeEEEEEecC-------------------------CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeE
Q 041491 225 LIGIGSFGTVYKGRFLD-------------------------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 279 (467)
Q Consensus 225 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 279 (467)
.||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998865544445678889999999999999999
Q ss_pred EEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC----
Q 041491 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---- 355 (467)
Q Consensus 280 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---- 355 (467)
++++...+..++||||+++|+|..++....+.+++..+..++.|+++||+||| +++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766678899999999999999999999 99999999999999997643
Q ss_pred ---cEEEeccccceecCC-CCccccccccccccccC-CCCCCcccchhhHHHHHHH-hcCCCCCCccccccccHHHHHhh
Q 041491 356 ---VAHLSDFGIAKLLNG-KESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIET-FTKKKPTCEIFCEEMNLKNWVND 429 (467)
Q Consensus 356 ---~~kl~Dfg~a~~~~~-~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el-~tg~~Pf~~~~~~~~~~~~~~~~ 429 (467)
.+|++|||.+..... .....+..|.+||+... ..++.++|||||||++||+ ++|+.||......+. ..+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~ 236 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--ERFYEK 236 (274)
T ss_pred ccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--HHHHHh
Confidence 489999998865432 22344567899998765 5689999999999999998 579999976433221 122111
Q ss_pred --hc----ccccccccccccccchhHHHHHHHHHHHHH
Q 041491 430 --FL----PISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 430 --~~----~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
.. .+.+.+++.+|+..+|++|+ ++.++++.|
T Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp-s~~~il~~L 273 (274)
T cd05076 237 KHRLPEPSCKELATLISQCLTYEPTQRP-SFRTILRDL 273 (274)
T ss_pred ccCCCCCCChHHHHHHHHHcccChhhCc-CHHHHHHhh
Confidence 11 23488999999999999996 777777665
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=293.11 Aligned_cols=233 Identities=24% Similarity=0.319 Sum_probs=190.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||.||+|++. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999886 48899999987543 23345677899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
++ ++|.+++......+++..+..++.|++.||+||| +.|++||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 97 5898888766667899999999999999999999 9999999999999999999999999999997654222
Q ss_pred --ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc-----------HHHH------------
Q 041491 373 --SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-----------LKNW------------ 426 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-----------~~~~------------ 426 (467)
...+..|.+||...+ ..++.++|||||||++|||+||+.||......+.. ...|
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 234566889998754 45788999999999999999999999753221100 0000
Q ss_pred ------------HhhhcccccccccccccccchhHHHHHH
Q 041491 427 ------------VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 427 ------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
....+++.+.+++.+||..||.+|++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 281 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 0112344578999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=288.20 Aligned_cols=239 Identities=22% Similarity=0.354 Sum_probs=196.4
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+..++|++.+.||+|+||.||+|.+.++..+|+|.+... ....+.+.+|++++++++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 456789999999999999999998877888999988744 2345678899999999999999999999887 77899999
Q ss_pred cccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc
Q 041491 295 YMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (467)
|+++++|.+++.... ..+++.++..++.|++.||.||| +.|++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999986543 36788999999999999999999 99999999999999999999999999999986643221
Q ss_pred ------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccc
Q 041491 374 ------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNV 438 (467)
Q Consensus 374 ------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~ 438 (467)
..+..|.+||+.....++.++|+|||||++|+++| |+.||...... ....+.. ...+.++.++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCCCCcccCCHHHHHH
Confidence 12345789999988889999999999999999999 99999754322 1222222 1234468899
Q ss_pred cccccccchhHHHHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+.+|+..+|++|+ ++.+++..|
T Consensus 236 i~~~l~~~p~~Rp-~~~~l~~~L 257 (260)
T cd05073 236 MMRCWKNRPEERP-TFEYIQSVL 257 (260)
T ss_pred HHHHcccCcccCc-CHHHHHHHH
Confidence 9999999999996 444555444
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=290.99 Aligned_cols=231 Identities=26% Similarity=0.352 Sum_probs=184.1
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcC---CCCCceeEEEEeec-----CC
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSV---RHRNLVKIISSCSN-----GN 287 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~ 287 (467)
+|++.+.||+|+||.||+|++. +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999886 488999999875422 2234566788777765 69999999998764 34
Q ss_pred eeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 288 FEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||++++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 8888876543 35899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc-----------HHHH-----
Q 041491 367 LLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-----------LKNW----- 426 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-----------~~~~----- 426 (467)
...... ..++..|.+||+..+..++.++||||+||++|||++|++||......+.. ...|
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 765332 23466789999998888999999999999999999999999653221100 0011
Q ss_pred ----------------HhhhcccccccccccccccchhHHHHH
Q 041491 427 ----------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 ----------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
....++..+.+++.+||..||++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 279 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA 279 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH
Confidence 011234457899999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=288.20 Aligned_cols=230 Identities=27% Similarity=0.333 Sum_probs=193.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||.|++|.||+|.+. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999886 48899999987553 33456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|.+++... .+++..+..++.|++.|+.||| +++++||||+|+||++++++.++|+|||.++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 9999999998654 6899999999999999999999 9999999999999999999999999999998776432
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH------Hhh-hccccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------VND-FLPISVMNVVDTSL 443 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~-~~~~~~~~~i~~~l 443 (467)
..++..|.+||+..+..++.++||||||+++|||+||+.||............. ... .++..+.+++.+|+
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 234456899999988889999999999999999999999997543221111000 001 14556899999999
Q ss_pred ccchhHHHH
Q 041491 444 LRREDKYFA 452 (467)
Q Consensus 444 ~~~~~~r~~ 452 (467)
..+|++|++
T Consensus 236 ~~~p~~Rpt 244 (274)
T cd06609 236 NKDPKERPS 244 (274)
T ss_pred hCChhhCcC
Confidence 999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=289.60 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=200.1
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeec-CC
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSN-GN 287 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 287 (467)
+..++|++.+.||+|+||.||+|.+.+ +..|++|++.... ....+.+.+|+.++++++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456789999999999999999998865 6889999886442 2345668899999999999999999998765 56
Q ss_pred eeeEEEecccCCCHHHhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEe
Q 041491 288 FEALVLEYMANGSLEKCLYSSN-------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLS 360 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 360 (467)
..++++||+++++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence 7899999999999999986532 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh---
Q 041491 361 DFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--- 429 (467)
Q Consensus 361 Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--- 429 (467)
|||+++.+.... ...+..|.+||+.....++.++||||||+++||+++ |+.||..... ..+..+...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~ 237 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR 237 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC
Confidence 999998654322 123445899999988889999999999999999999 9999976422 123333222
Q ss_pred -----hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 430 -----FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 430 -----~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..|+.+.+++.+|+..+|++|+ ++.+++..|..+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~~~~l~~~ 276 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALDPEERP-SFSQLVQCLTDF 276 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCC-CHHHHHHHHHHH
Confidence 2345689999999999999995 666777666543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=292.34 Aligned_cols=231 Identities=24% Similarity=0.306 Sum_probs=192.0
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||++.+.. ++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 478899999999999999998864 7899999987553 223456789999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++++|.+++... +.+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999998554 56899999999999999999999 999999999999999999999999999998642100
Q ss_pred ------------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh----
Q 041491 372 ------------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND---- 429 (467)
Q Consensus 372 ------------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~---- 429 (467)
...++..|.+||+.....++.++|+|||||++|||++|+.||.+....+ ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 235 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIEW 235 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCC
Confidence 1123446889999888889999999999999999999999997543222 11222111
Q ss_pred -----hcccccccccccccccchhHHHHH
Q 041491 430 -----FLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 430 -----~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.++.++.+++.+|+..+|++|++.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 264 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGT 264 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCc
Confidence 234568999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=291.54 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=194.5
Q ss_pred cCccCCccCcccceeEEEEEecC------CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
+|++.+.||+|+||.||+|.... ...+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998642 35689998865432 234678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 292 VLEYMANGSLEKCLYSSN-----------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
++||+.+++|.+++.... ..+++.++..++.|++.||+||| +++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999875421 24788999999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
|++++++.+||+|||+++...... ...+..|.+||+..+..++.++||||||+++|||+| |+.||.+...+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999998653221 123446889999888889999999999999999998 99999754322
Q ss_pred ccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 421 MNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 421 ~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+.++... ..+..+.+++.+|+..+|++|+ ++.+.+..+.++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp-~~~~i~~~l~~~ 286 (290)
T cd05045 237 -RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP-TFADISKELEKM 286 (290)
T ss_pred -HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCC-CHHHHHHHHHHH
Confidence 22222221 2334688999999999999995 566666666543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=289.32 Aligned_cols=234 Identities=24% Similarity=0.318 Sum_probs=186.9
Q ss_pred CccCcccceeEEEEEecC--------CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 224 SLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+.||+|+||.||+|.... ..++|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998643 234888887655444556788999999999999999999999998999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc--------EEEecccccee
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV--------AHLSDFGIAKL 367 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~Dfg~a~~ 367 (467)
+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999776667899999999999999999999 999999999999999987765 69999999876
Q ss_pred cCCCC-ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCC-CCCCccccccccHHHHHhhhcc----cccccccc
Q 041491 368 LNGKE-SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKK-KPTCEIFCEEMNLKNWVNDFLP----ISVMNVVD 440 (467)
Q Consensus 368 ~~~~~-~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~-~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~i~ 440 (467)
..... ..++..|.+||+... ..++.++|||||||++|||++|. .||.................+| .++.+++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (258)
T cd05078 158 VLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLIN 237 (258)
T ss_pred cCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHH
Confidence 65433 235567899998876 45789999999999999999995 5655432221110000111222 34889999
Q ss_pred cccccchhHHHHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l 461 (467)
+|+..+|++|+ ++++.+++|
T Consensus 238 ~~l~~~p~~Rp-s~~~il~~l 257 (258)
T cd05078 238 QCMDYEPDFRP-SFRAIIRDL 257 (258)
T ss_pred HHhccChhhCC-CHHHHHHhc
Confidence 99999999996 666777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=291.85 Aligned_cols=238 Identities=23% Similarity=0.341 Sum_probs=193.9
Q ss_pred ccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.+|++.+.||+|+||.||+|.+.+ ++.||+|+++..... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 457788999999999999998642 578999998755332 3456889999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC
Q 041491 291 LVLEYMANGSLEKCLYSS---------------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM 355 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 355 (467)
+++||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 999999999999987422 124788889999999999999999 99999999999999999999
Q ss_pred cEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH
Q 041491 356 VAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV 427 (467)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~ 427 (467)
.+||+|||+++...... ...+..|.+||+...+.++.++|||||||++|||++ |..||.+....+ ..+.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~i 239 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VIEMI 239 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence 99999999988654322 122456899999988889999999999999999998 888987643221 22221
Q ss_pred --------hhhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 428 --------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 428 --------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
....+..+.+++..|+..+|++|+ ++.+.+..|
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-~~~~i~~~l 280 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRP-RFKDIHSRL 280 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCC-CHHHHHHHh
Confidence 122444588999999999999997 566666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.67 Aligned_cols=231 Identities=25% Similarity=0.403 Sum_probs=188.5
Q ss_pred ccCcccceeEEEEEec---CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCC
Q 041491 225 LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGS 300 (467)
Q Consensus 225 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 300 (467)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 355799999875532 234668899999999999999999998864 46799999999999
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-------
Q 041491 301 LEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES------- 373 (467)
Q Consensus 301 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------- 373 (467)
|.+++......+++.++..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++........
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999766668899999999999999999999 99999999999999999999999999999976543221
Q ss_pred -cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccccccccccccc
Q 041491 374 -MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPISVMNVVDTSL 443 (467)
Q Consensus 374 -~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~i~~~l 443 (467)
..+..|.+||+...+.++.++|||||||++||+++ |..||.+....+ ....+.. ..++++.+++.+|+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 11346889999888889999999999999999996 999997643222 2222221 23456889999999
Q ss_pred ccchhHHHHHHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~~~l~ 462 (467)
..+|++|+ ++.+..+.|.
T Consensus 236 ~~~~~~Rp-~~~~i~~~l~ 253 (257)
T cd05115 236 IYKWEDRP-NFAKVEERMR 253 (257)
T ss_pred CCChhhCc-CHHHHHHHHh
Confidence 99999996 5666666554
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.17 Aligned_cols=194 Identities=25% Similarity=0.350 Sum_probs=170.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||.||++.+. ++..+|+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999876 478899998875432 2345688999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
+++++|.+++... +.+++..+..++.|+++||.||| + .+++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 9999999998654 56899999999999999999999 6 58999999999999999999999999998765432
Q ss_pred CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 372 ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
...++..|.+||+..+..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 22345678899998888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=293.80 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=197.9
Q ss_pred HHHhccCccCCccCcccceeEEEEEec--------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
.+..++|.+.+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 355678999999999999999999752 24579999886442 23456788999999999 899999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
...+..++||||+++|+|.+++.... ..+++.++..++.|++.||.||| ++|++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccce
Confidence 99999999999999999999986532 24778889999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
|++++++.+||+|||.++...... ...+..|.+||...+..++.++||||||+++|||++ |..||......+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999999998765322 122346899999888889999999999999999998 788886543222
Q ss_pred ccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 421 MNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 421 ~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..+... ...+..+.+++.+|+..+|++|+ ++.++++.|-+
T Consensus 248 --~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-s~~e~l~~l~~ 295 (304)
T cd05101 248 --LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP-TFKQLVEDLDR 295 (304)
T ss_pred --HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCC-CHHHHHHHHHH
Confidence 111111 12334688999999999999996 66676666544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=287.09 Aligned_cols=238 Identities=21% Similarity=0.354 Sum_probs=189.5
Q ss_pred CccCCccCcccceeEEEEEecC-CC--eEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC------Ce
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-GM--EVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------NF 288 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 288 (467)
|.+.+.||+|+||.||+|++.+ +. .+|+|.++... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998865 32 68999886542 33456788999999999999999999987432 25
Q ss_pred eeEEEecccCCCHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccc
Q 041491 289 EALVLEYMANGSLEKCLYS-----SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
.+++|||+++|+|.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988732 2235789999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-------
Q 041491 364 IAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN------- 428 (467)
Q Consensus 364 ~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~------- 428 (467)
+++....... ..+..|.+||+.....++.++||||||+++|||++ |+.||...... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 235 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGNRLKQ 235 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCCCCC
Confidence 9987643221 23345788998888889999999999999999999 89999753222 1111111
Q ss_pred -hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 429 -DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 429 -~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..++..+.+++.+|+..+|++|+ ++.++++.|-+
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rp-s~~~l~~~l~~ 270 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRP-SFETLRCELEK 270 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCc-CHHHHHHHHHh
Confidence 12334588999999999999995 77788777654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=300.76 Aligned_cols=194 Identities=22% Similarity=0.263 Sum_probs=165.8
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC-----
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----- 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 287 (467)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999876 48999999986542 233466789999999999999999999886443
Q ss_pred -eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 288 -FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 288 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
..|+||||+++ ++.+.+. ..+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46999999976 5666553 24788899999999999999999 9999999999999999999999999999997
Q ss_pred ecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 367 LLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 367 ~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
..... ...++..|.+||...+..++.++||||+||++|||+||+.||...
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 65432 224566789999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=297.69 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=205.6
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.+.+...+.++||+|.||+|..|....+.+||||.++..... ...+|.+|+++|.+++||||++++|+|..++.+++++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 445567788999999999999999877899999999877554 3488999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
||++.|+|.+++.....+ .+.....+++.||+.|++||. +.++||||+.+.|+|+|.++++||+|||+++-+-...
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999766443 355667789999999999999 9999999999999999999999999999999665544
Q ss_pred cc-------ccccccccccccCCCCCCcccchhhHHHHHHHhc--CCCCCCccccccc--cHHHH-----------Hhhh
Q 041491 373 SM-------RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT--KKKPTCEIFCEEM--NLKNW-----------VNDF 430 (467)
Q Consensus 373 ~~-------~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t--g~~Pf~~~~~~~~--~~~~~-----------~~~~ 430 (467)
.. .+..|+|+|.+.-+.++.++|||+||+++||+++ ...||.+...+.. +.... ....
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 43 2456899999999999999999999999999865 7889987543321 11111 1223
Q ss_pred cccccccccccccccchhHHHHHHHHHHHHHHhccc
Q 041491 431 LPISVMNVVDTSLLRREDKYFAAKKQCVSSALSLAM 466 (467)
Q Consensus 431 ~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l~~ 466 (467)
.|.++.+++-+|+.+|-.+|+ +.++.-.-+.+.+.
T Consensus 772 cp~~lyelml~Cw~~es~~RP-sFe~lh~~lq~~~~ 806 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRP-SFEQLHLFLQEDAL 806 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCC-CHHHHHHHHHHhcc
Confidence 455688999999999999995 66676666666554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=309.20 Aligned_cols=244 Identities=22% Similarity=0.403 Sum_probs=204.7
Q ss_pred HHhccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
+......+.+.||.|.||+||+|+.+- ...||||.++... ++...+|..|+.||.+++||||+++.|+.......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 334456788999999999999998863 3569999998764 34567899999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
.||+|||++|+|+.+++..++.+++.+...+++.|+.|++||- +.++|||||...|||++.+..+|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999999999886
Q ss_pred CCCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcc
Q 041491 370 GKES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLP 432 (467)
Q Consensus 370 ~~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~ 432 (467)
++.. .-+..|.|||.++...++.+||||||||||||.++ |.+||=+....+ ..+-+.+ ..|
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--VIkaIe~gyRLPpPmDCP 860 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VIKAIEQGYRLPPPMDCP 860 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--HHHHHHhccCCCCCCCCc
Confidence 5432 12345789999999999999999999999999765 999986654333 2222222 223
Q ss_pred cccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 433 ISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..+.++.-.|+++|=.+|+ ...|.+..|.++
T Consensus 861 ~aL~qLMldCWqkdR~~RP-~F~qiV~~lDkl 891 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRP-KFAQIVSTLDKL 891 (996)
T ss_pred HHHHHHHHHHHHHHhhcCC-CHHHHHHHHHHH
Confidence 3588899999999998885 556666666554
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.75 Aligned_cols=235 Identities=25% Similarity=0.322 Sum_probs=189.3
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|++|.||+|++. +++.||+|.++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788899999999999999886 58999999986542 22346788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 296 MANGSLEKCLYSSN--GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
++ ++|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 58888875433 46899999999999999999999 9999999999999999999999999999998654322
Q ss_pred ----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--------------------cHHHHH
Q 041491 373 ----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--------------------NLKNWV 427 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--------------------~~~~~~ 427 (467)
...+..|.+||+..+ ..++.++|||||||++|||+||+.||......+. ...++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 223556889998765 4568899999999999999999999975321110 011110
Q ss_pred --------------hhhcccccccccccccccchhHHHHHHHHHH
Q 041491 428 --------------NDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 428 --------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
...+++++.+++.+||..||.+|++ +.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt-~~~ll 280 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS-AKKAL 280 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC-HHHHh
Confidence 1123456778999999999999984 34443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.06 Aligned_cols=242 Identities=19% Similarity=0.235 Sum_probs=190.4
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec--CCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 288 (467)
....++|++.+.||+|+||.||+|.+.. +..||+|++.... ......+..|+.++++++||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445789999999999999999999865 7789999987542 2345678899999999999999999998854 457
Q ss_pred eeEEEecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCceecCCCCCCeeecCC-------
Q 041491 289 EALVLEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGY----SNPVVHCDIKPSNVLLDDD------- 354 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~dlkp~NIll~~~------- 354 (467)
+|+||||+++|+|.+++... .+.+++..++.|+.||+.||.|||... .++|+||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999988642 346899999999999999999999211 1459999999999999642
Q ss_pred ----------CcEEEeccccceecCCC----CccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCcccc
Q 041491 355 ----------MVAHLSDFGIAKLLNGK----ESMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEIFC 418 (467)
Q Consensus 355 ----------~~~kl~Dfg~a~~~~~~----~~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~ 418 (467)
+.+||+|||++...... ...++..|.+||++.. ..++.++||||||||+|||+||+.||.....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 35899999999876432 2245778899998754 4588999999999999999999999975322
Q ss_pred ccccHHHHHh------hhcccccccccccccccchhHHHHHHH
Q 041491 419 EEMNLKNWVN------DFLPISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 419 ~~~~~~~~~~------~~~~~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
....+..... ...+.++.++|..||..+|.+|++..+
T Consensus 249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred HHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 1111111111 112345899999999999999986544
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=287.81 Aligned_cols=233 Identities=25% Similarity=0.338 Sum_probs=190.0
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecC------C
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNG------N 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~ 287 (467)
+++.|++.+.||+|+||.||+|.+.+ ++.||+|++.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 46778999999999999999998764 8899999987543 3446788999999998 699999999998653 4
Q ss_pred eeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 288 FEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 6789999999999999987643 46899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCC-----cccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-------Hhh
Q 041491 367 LLNGKE-----SMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-------VND 429 (467)
Q Consensus 367 ~~~~~~-----~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-------~~~ 429 (467)
...... ..++..|.+||++. ...++.++||||+||++|||++|+.||............+ ...
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 654321 23455688999875 3467889999999999999999999997543221111111 111
Q ss_pred hcccccccccccccccchhHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
.++..+.+++.+|+..+|.+|++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt 262 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPT 262 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCC
Confidence 23456899999999999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=285.23 Aligned_cols=232 Identities=25% Similarity=0.330 Sum_probs=191.5
Q ss_pred CccCcccceeEEEEEecC--C--CeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD--G--MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3689999876654 456788999999999999999999999988 889999999999
Q ss_pred CCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----
Q 041491 299 GSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----- 372 (467)
Q Consensus 299 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----- 372 (467)
++|.+++.... ..+++..++.++.|++.||+||| ++|++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999987655 46899999999999999999999 9999999999999999999999999999998765421
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------hhhcccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVD 440 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~ 440 (467)
...+..|.+||+.....++.++|||||||++|||+| |+.||......+. ..... ....|..+.+++.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-LKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 123456889999988889999999999999999999 9999965432221 11111 1123456889999
Q ss_pred cccccchhHHHHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l 461 (467)
+|+..+|.+|+ ++.+.+..+
T Consensus 236 ~~l~~~p~~Rp-s~~~~~~~l 255 (257)
T cd05040 236 QCWAHNPADRP-TFAALREFL 255 (257)
T ss_pred HHCCCCcccCC-CHHHHHHHh
Confidence 99999999997 455555544
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=289.24 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=197.1
Q ss_pred HHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
+..++|++.+.||+|+||.||+|.+.+ +..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 345789999999999999999998753 36899999864432 33456889999999999999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEE
Q 041491 288 FEALVLEYMANGSLEKCLYSSN---------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 358 (467)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence 9999999999999999986432 24678899999999999999999 99999999999999999999999
Q ss_pred EeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--
Q 041491 359 LSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-- 428 (467)
Q Consensus 359 l~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-- 428 (467)
|+|||+++...... ...+..|.+||....+.++.++|||||||++||++| |+.||.+....+ ..++..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~ 237 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVIDG 237 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHhcC
Confidence 99999987654322 123456889999888889999999999999999998 999997543222 122221
Q ss_pred ------hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 ------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 ------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
...+..+.+++.+|+..+|++|+ ++.+++..+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~l~~~l 275 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRP-TFLEIVSSL 275 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCC-CHHHHHHHh
Confidence 12334588999999999999995 676776654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=288.05 Aligned_cols=243 Identities=25% Similarity=0.382 Sum_probs=200.7
Q ss_pred ccCccCCccCcccceeEEEEEec-----CCCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeec--CCee
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFE 289 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 289 (467)
++|+..+.||+|+||.||+|.+. .+..||+|++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56788899999999999999864 3688999999765443 45789999999999999999999999877 5678
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++++|.+++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999776667999999999999999999999 9999999999999999999999999999998776
Q ss_pred CCCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc----------H---HHHHh
Q 041491 370 GKES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN----------L---KNWVN 428 (467)
Q Consensus 370 ~~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~----------~---~~~~~ 428 (467)
.... ..+..|.+||+.....++.++||||||+++|||+||+.||......... . .++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3221 2233478899988888999999999999999999999998754322211 1 11211
Q ss_pred h--------hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 429 D--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 429 ~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
. ..+.++.+++.+|+..+|.+|+ ++.+.+..+.++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-t~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRP-SFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCC-CHHHHHHHHhhc
Confidence 1 2234588999999999999996 677888877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=281.92 Aligned_cols=232 Identities=27% Similarity=0.400 Sum_probs=194.2
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCHH
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLE 302 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 302 (467)
++||+|+||.||+|.+.+++.||+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-------cc
Q 041491 303 KCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-------MR 375 (467)
Q Consensus 303 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------~~ 375 (467)
+++......+++..+..++.+++.|++||| +++++||||||+||+++.++.+||+|||.+........ ..
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999766667889999999999999999999 99999999999999999999999999999986542111 12
Q ss_pred cccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccccccccc
Q 041491 376 TQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTSLLRR 446 (467)
Q Consensus 376 ~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~ 446 (467)
+..|.+||+..++.++.++|+|||||++|||+| |..||....... ...... ...+.++.+++.+|+..+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 235 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIESGYRMPAPQLCPEEIYRLMLQCWAYD 235 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHhcCCCCCCCccCCHHHHHHHHHHhccC
Confidence 345889999888889999999999999999999 889986543221 112211 123456899999999999
Q ss_pred hhHHHHHHHHHHHHH
Q 041491 447 EDKYFAAKKQCVSSA 461 (467)
Q Consensus 447 ~~~r~~~~~~~~~~l 461 (467)
|++|+ ++.|.+..+
T Consensus 236 p~~Rp-~~~ell~~l 249 (251)
T cd05041 236 PENRP-SFSEIYNEL 249 (251)
T ss_pred hhhCc-CHHHHHHHh
Confidence 99996 667777665
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=291.16 Aligned_cols=242 Identities=21% Similarity=0.353 Sum_probs=192.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-----------------CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCcee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-----------------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVK 278 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 278 (467)
.++|++.+.||+|+||.||++.+.+ +..||+|++.... ......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4579999999999999999986432 3468999987543 234567899999999999999999
Q ss_pred EEEEeecCCeeeEEEecccCCCHHHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSN----------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 279 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
+++++...+..++||||+++++|.+++.... ..+++.++..++.|++.|++||| +.|++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 9999999999999999999999999886532 13677889999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc--CCCCCCccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT--KKKPTCEIFCE 419 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t--g~~Pf~~~~~~ 419 (467)
|++++++.++|+|||+++.+..... ..+..|.+||+...+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986543221 12345788998888889999999999999999998 77888653222
Q ss_pred cc--cHHHHHh-----------hhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 420 EM--NLKNWVN-----------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 420 ~~--~~~~~~~-----------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
+. ....+.. ...++.+.+++..|+..+|.+|+ ++.+.++.|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP-SFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC-CHHHHHHHHh
Confidence 21 0111110 12334588999999999999996 5666666553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=283.19 Aligned_cols=239 Identities=21% Similarity=0.216 Sum_probs=193.8
Q ss_pred HHHHHHhccCccCCcc--CcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecC
Q 041491 211 QELLLATDHFSEKSLI--GIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNG 286 (467)
Q Consensus 211 ~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 286 (467)
.+.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +||||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455778887887 99999999999875 48889999986542111 122222222 799999999999999
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccc
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIA 365 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a 365 (467)
+..++||||+++++|.+++... ..+++.++..++.|+++|+.||| +.|++||||||+||+++.++ .++|+|||.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999998654 37899999999999999999999 99999999999999999998 9999999999
Q ss_pred eecCCCC-ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh---------hccccc
Q 041491 366 KLLNGKE-SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND---------FLPISV 435 (467)
Q Consensus 366 ~~~~~~~-~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~---------~~~~~~ 435 (467)
....... ..++..|.+||+.....++.++||||+|+++|||++|+.||.....++.....+... ..++.+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 158 KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred eecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 8765433 235667899999988889999999999999999999999998654444333333211 234568
Q ss_pred ccccccccccchhHHHHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.+++.+||..+|.+|++++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHh
Confidence 89999999999999987777765
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=293.69 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=197.1
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec--------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEE
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISS 282 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 282 (467)
+....++|.+.+.||+|+||.||+|+.. ....+|+|.++... ......+.+|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3445678999999999999999999752 24568999887542 23346688999999999 69999999999
Q ss_pred eecCCeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 041491 283 CSNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 347 (467)
Q Consensus 283 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 347 (467)
+...+..++||||+++|+|.+++.... ..+++.++..++.|++.||.||| ++|++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence 999999999999999999999986532 35788999999999999999999 999999999999
Q ss_pred CeeecCCCcEEEeccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccc
Q 041491 348 NVLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCE 419 (467)
Q Consensus 348 NIll~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~ 419 (467)
||++++++.+||+|||.++....... ..+..|.+||+..+..++.++|||||||++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986643211 12245899999988889999999999999999999 89999754322
Q ss_pred cccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 420 EMNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 420 ~~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+ ...... ...+.++.+++.+|+..+|++|+ ++.+++..+.+
T Consensus 244 ~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~ll~~l~~ 292 (314)
T cd05099 244 E--LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP-TFKQLVEALDK 292 (314)
T ss_pred H--HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc-CHHHHHHHHHH
Confidence 1 111111 12234588999999999999996 56666665544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.51 Aligned_cols=243 Identities=20% Similarity=0.319 Sum_probs=192.9
Q ss_pred HhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEeec-C
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCSN-G 286 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~ 286 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|+++.... .....+.+|+.++.++ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 4578999999999999999999742 368899999975432 2345688999999999 68999999998765 4
Q ss_pred CeeeEEEecccCCCHHHhhhcCC---------------------------------------------------------
Q 041491 287 NFEALVLEYMANGSLEKCLYSSN--------------------------------------------------------- 309 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 309 (467)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999885432
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-------c
Q 041491 310 ---------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-------S 373 (467)
Q Consensus 310 ---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~ 373 (467)
..+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||++....... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 13677888999999999999999 9999999999999999999999999999998653221 1
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTSLL 444 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~ 444 (467)
..+..|.+||+..+..++.++||||||+++|||++ |..||........ ...... ...++++.+++..|+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 22345889999888889999999999999999997 9999975422211 111111 1123458889999999
Q ss_pred cchhHHHHHHHHHHHHHHh
Q 041491 445 RREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 445 ~~~~~r~~~~~~~~~~l~~ 463 (467)
.+|++|+ ++.++++.|.+
T Consensus 321 ~~p~~Rp-s~~eil~~l~~ 338 (343)
T cd05103 321 GEPSQRP-TFSELVEHLGN 338 (343)
T ss_pred CChhhCc-CHHHHHHHHHH
Confidence 9999996 67777776654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=303.46 Aligned_cols=190 Identities=24% Similarity=0.300 Sum_probs=166.7
Q ss_pred HhccCccCCccCcccceeEEEEEec---CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
...+|++.+.||+|+||.||+|... .+..||+|.+... ....+|++++++++||||+++++++...+..++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3468999999999999999999754 2678999987543 3456899999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
||++. ++|.+++ .....+++.++..++.|++.||.||| ++||+||||||+|||++.++.+||+|||++.......
T Consensus 165 ~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 165 MPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred ehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99995 5888888 44457899999999999999999999 9999999999999999999999999999997665322
Q ss_pred -------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 373 -------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 373 -------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
..++..|.+||++....++.++|||||||++|||++|+.||.+
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 2356778899999988999999999999999999999999965
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.68 Aligned_cols=231 Identities=24% Similarity=0.272 Sum_probs=190.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|+..+.||+|++|.||+|++. +++.||+|++..... ...+.+.+|++++++++|||++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999986 489999999865422 233567899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+++++|..+... ...+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 9999888877643 346899999999999999999999 9999999999999999999999999999998775433
Q ss_pred ---ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccH--H----------------------
Q 041491 373 ---SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL--K---------------------- 424 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~--~---------------------- 424 (467)
...+..|.+||+..+ ..++.++||||||+++|||++|+.||.+....+... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 224556789998765 557889999999999999999999997533211100 0
Q ss_pred ------------HHHhhhcccccccccccccccchhHHHH
Q 041491 425 ------------NWVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 425 ------------~~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
......++..+.+++.+|+..+|++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 276 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS 276 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC
Confidence 0011233455889999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=286.68 Aligned_cols=231 Identities=25% Similarity=0.307 Sum_probs=195.4
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+|++.+.||.|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999986 48999999997543 2345788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
|+++++|.+++... ..+++..+..++.|+++||.||| +++++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 99999999998654 57899999999999999999999 999999999999999999999999999998876543
Q ss_pred -CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc-cHHHH-------Hhhhcccccccccccc
Q 041491 372 -ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-NLKNW-------VNDFLPISVMNVVDTS 442 (467)
Q Consensus 372 -~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-~~~~~-------~~~~~~~~~~~~i~~~ 442 (467)
...++..|.+||+.....++.++|+||+|+++|+|++|+.||........ .+... ....++..+.+++.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 22345567899999888899999999999999999999999986432111 11111 1123455699999999
Q ss_pred cccchhHHHHH
Q 041491 443 LLRREDKYFAA 453 (467)
Q Consensus 443 l~~~~~~r~~~ 453 (467)
+..+|++|++.
T Consensus 237 l~~~p~~R~~~ 247 (258)
T cd05578 237 LERDPQKRLGD 247 (258)
T ss_pred ccCChhHcCCc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=289.23 Aligned_cols=239 Identities=22% Similarity=0.316 Sum_probs=195.1
Q ss_pred hccCccCCccCcccceeEEEEEecC-----------------CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCcee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-----------------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVK 278 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 278 (467)
..+|++.+.||+|+||.||+|.+.+ +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999997643 24589999875532 34567889999999999999999
Q ss_pred EEEEeecCCeeeEEEecccCCCHHHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSN----------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 279 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
+++++..++..+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999986543 25889999999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc--CCCCCCccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT--KKKPTCEIFCE 419 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t--g~~Pf~~~~~~ 419 (467)
|++++++.++|+|||+++...... ...+..|.+||+.....++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999998654322 122446889999888889999999999999999998 77888653222
Q ss_pred cccHHHHHh---------------hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 420 EMNLKNWVN---------------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 420 ~~~~~~~~~---------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+ ...... ...+.++.+++.+|+..+|.+|+ ++.|.++.|
T Consensus 241 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-t~~el~~~L 294 (296)
T cd05051 241 Q--VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP-TFREIHLFL 294 (296)
T ss_pred H--HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC-CHHHHHHHh
Confidence 1 111111 12235689999999999999997 566666554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=282.00 Aligned_cols=236 Identities=21% Similarity=0.291 Sum_probs=196.9
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|+..+.||.|+||.||.++.. +++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999875 48899999986542 33456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 296 MANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
+++++|.+++... ...+++.++..++.|++.|+.||| +.|++||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999998665 346899999999999999999999 9999999999999999999999999999998765433
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhcccccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDTS 442 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~~ 442 (467)
..++..|.+||+..+..++.++||||||+++|||++|+.||......+. ...... ...+..+.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-VVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 2356678899998888889999999999999999999999976332211 111111 22344689999999
Q ss_pred cccchhHHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCVS 459 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~~ 459 (467)
+..+|++|+ ++.+.+.
T Consensus 237 l~~~p~~R~-s~~~ll~ 252 (256)
T cd08221 237 LQQDPEKRP-TADEVLD 252 (256)
T ss_pred cccCcccCC-CHHHHhh
Confidence 999999996 5555554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.65 Aligned_cols=230 Identities=24% Similarity=0.383 Sum_probs=190.1
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc---------chHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG---------ALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
+|.+.+.||+|++|.||+|.+. +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999875 4889999988654321 22567889999999999999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++||||+++++|.+++... +.+++..+..++.|++.|++||| +.|++||||+|+||++++++.+||+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999998544 56889999999999999999999 999999999999999999999999999998876
Q ss_pred CCCC-----------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHHh----hhc
Q 041491 369 NGKE-----------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWVN----DFL 431 (467)
Q Consensus 369 ~~~~-----------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~~----~~~ 431 (467)
.... ..++..|.+||+.....++.++|+||+||++|||++|+.||........ ....+.. ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI 236 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCccc
Confidence 5221 1234567899998888889999999999999999999999976422111 0111111 123
Q ss_pred ccccccccccccccchhHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~ 452 (467)
+..+.+++.+|+..+|.+|++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~ 257 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPT 257 (267)
T ss_pred CHHHHHHHHHHccCCchhCcC
Confidence 445889999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.36 Aligned_cols=187 Identities=22% Similarity=0.284 Sum_probs=165.5
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..+|.+.+.||+|+||.||+|.+.. ++.||+|... ...+.+|++++++++||||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999865 7889999632 23467899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+. ++|.+++......+++.++..++.|++.||.||| ++||+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 6888888666567999999999999999999999 9999999999999999999999999999998764321
Q ss_pred ----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCC
Q 041491 373 ----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPT 413 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf 413 (467)
..++..|.+||+..+..++.++|||||||++|||++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 23577889999999999999999999999999999987664
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=282.26 Aligned_cols=231 Identities=28% Similarity=0.398 Sum_probs=188.3
Q ss_pred CccCcccceeEEEEEecC----CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|.+.. +..+|+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997643 26899999875543 24567889999999999999999999876 4457999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCcc----
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM---- 374 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---- 374 (467)
++|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.++........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999996543 6899999999999999999999 999999999999999999999999999999866433221
Q ss_pred ----ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 375 ----RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 375 ----~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
.+..|.+||+.....++.++||||||+++|||++ |+.||...... ....+.. ...+..+.+++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1235889999988899999999999999999998 99999764322 2222221 1233458899999
Q ss_pred ccccchhHHHHHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l~ 462 (467)
|+..+|++|+ ++.++...+-
T Consensus 234 cl~~~p~~Rp-~~~~l~~~l~ 253 (257)
T cd05060 234 CWKYRPEDRP-TFSELESTFR 253 (257)
T ss_pred HhcCChhhCc-CHHHHHHHHH
Confidence 9999999996 5666666554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=283.19 Aligned_cols=231 Identities=22% Similarity=0.354 Sum_probs=186.1
Q ss_pred CccCcccceeEEEEEecCCC-----------eEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 224 SLIGIGSFGTVYKGRFLDGM-----------EVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
+.||+|+||.||+|.+.+.. .+++|++...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999886532 5788877644332 6788899999999999999999999988 778999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-------cEEEeccccc
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-------VAHLSDFGIA 365 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-------~~kl~Dfg~a 365 (467)
|||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999766557899999999999999999999 99999999999999999887 7999999999
Q ss_pred eecCCCC-ccccccccccccccCC--CCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh-hcc----cccc
Q 041491 366 KLLNGKE-SMRTQTLATIEYGREG--QVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND-FLP----ISVM 436 (467)
Q Consensus 366 ~~~~~~~-~~~~~~~~~pe~~~~~--~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~-~~~----~~~~ 436 (467)
....... ......|.+||++... .++.++||||||+++|||++ |..||......+ ....+... ..+ ..+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (259)
T cd05037 156 ITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQDQHRLPMPDCAELA 234 (259)
T ss_pred cccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHhcCCCCCCCCchHHH
Confidence 8765422 2345568999998776 78999999999999999999 578886643221 11111111 111 2588
Q ss_pred cccccccccchhHHHHHHHHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+++.+|+..+|.+|+ ++.+.+++|
T Consensus 235 ~li~~~l~~~p~~Rp-t~~~il~~l 258 (259)
T cd05037 235 NLINQCWTYDPTKRP-SFRAILRDL 258 (259)
T ss_pred HHHHHHhccChhhCC-CHHHHHHhc
Confidence 999999999999997 455666554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=283.40 Aligned_cols=234 Identities=24% Similarity=0.397 Sum_probs=186.5
Q ss_pred CccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEee-cCCeeeEEEeccc
Q 041491 224 SLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCS-NGNFEALVLEYMA 297 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 297 (467)
+.||+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 4579999875432 234567889999999999999999999775 4556899999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----- 372 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----- 372 (467)
+|+|.+++.......++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999766566788888999999999999999 9999999999999999999999999999997653321
Q ss_pred ----ccccccccccccccCCCCCCcccchhhHHHHHHHhcC-CCCCCccccccccHHHHHh--------hhccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTK-KKPTCEIFCEEMNLKNWVN--------DFLPISVMNVV 439 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg-~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i 439 (467)
...+..|.+||+..+..++.++|||||||++|||++| .+||...... .....+. ...|+.+.+++
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li 235 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DITVYLLQGRRLLQPEYCPDPLYEVM 235 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 1224468899998888899999999999999999995 5566543211 2222221 12345688999
Q ss_pred ccccccchhHHHHHHHHHHHHHHh
Q 041491 440 DTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+|+..+|++|+ ++.+++..+-+
T Consensus 236 ~~cl~~~p~~Rp-~~~~il~~l~~ 258 (262)
T cd05058 236 LSCWHPKPEMRP-TFSELVSRIEQ 258 (262)
T ss_pred HHHcCCChhhCC-CHHHHHHHHHH
Confidence 999999999996 56777776644
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=299.82 Aligned_cols=194 Identities=22% Similarity=0.247 Sum_probs=166.4
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC------
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 286 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 286 (467)
..++|++.+.||+|+||.||+|.+. .++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 48899999987542 23346678899999999999999999988643
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
...++||||+++ ++.+.+. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 356999999976 6666653 24788999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 367 LLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
...... ..++..|.+||+..+..++.++|||||||++|||++|+.||.+.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 765432 34567789999998889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=290.56 Aligned_cols=234 Identities=25% Similarity=0.318 Sum_probs=188.8
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|+||.||+|++. +|+.||+|.++... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5788899999999999999986 48999999987542 22335678899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
++ ++|.+++....+.+++..++.++.|+++||.||| +++++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 97 4888877666667999999999999999999999 9999999999999999999999999999998664322
Q ss_pred --ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHH------------HH-----------
Q 041491 373 --SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK------------NW----------- 426 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~------------~~----------- 426 (467)
...+..|.+||+..+. .++.++|||||||++|||+||..||.........+. .|
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 2345668999987664 468999999999999999999999643211110000 00
Q ss_pred ------------HhhhcccccccccccccccchhHHHHHHHHH
Q 041491 427 ------------VNDFLPISVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 427 ------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
....+++.+.+++.+||..||.+|++ +.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t-~~~i 278 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS-AEEA 278 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC-HHHH
Confidence 01123455789999999999999985 3343
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=282.50 Aligned_cols=230 Identities=23% Similarity=0.328 Sum_probs=187.0
Q ss_pred ccCcccceeEEEEEec---CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 225 LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 225 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
.||+|+||.||+|.+. ++..+|+|+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 478899999865432 235678899999999999999999998864 4568999999999
Q ss_pred CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc------
Q 041491 300 SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES------ 373 (467)
Q Consensus 300 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------ 373 (467)
+|.+++... ..+++..+..++.|++.|++||| ++|++||||||+||++++++.+||+|||++........
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998543 46899999999999999999999 99999999999999999999999999999987654321
Q ss_pred --cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccccc
Q 041491 374 --MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTS 442 (467)
Q Consensus 374 --~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~ 442 (467)
..+..|.+||......++.++|||||||++|||+| |+.||...... ...+... ...++++.++|.+|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 11346789998888888999999999999999998 99999764222 1222222 12345689999999
Q ss_pred cccchhHHHHHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~~~l~ 462 (467)
+..+|++|+ ++.+.++.|.
T Consensus 235 ~~~~p~~Rp-~~~~i~~~l~ 253 (257)
T cd05116 235 WTYGVDERP-GFAVVELRLR 253 (257)
T ss_pred hccCchhCc-CHHHHHHHHh
Confidence 999999996 5556665553
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=291.52 Aligned_cols=232 Identities=25% Similarity=0.315 Sum_probs=193.8
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|+..+.||+|++|.||+|...+ ++.||+|.+..... ...+.+..|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 478899999999999999998865 89999999976532 24467889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
||+.+++|.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999886543 46899999999999999999999 9999999999999999999999999999987553211
Q ss_pred ----------------------------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccc
Q 041491 373 ----------------------------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFC 418 (467)
Q Consensus 373 ----------------------------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~ 418 (467)
..++..|.+||+..+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1234557899999888899999999999999999999999975432
Q ss_pred ccccHHHHHhh--------hcccccccccccccccchhHHHHH
Q 041491 419 EEMNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 419 ~~~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.. .+...... ..+..+.+++.+|+..+|++|++.
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 279 (316)
T cd05574 238 DE-TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGS 279 (316)
T ss_pred HH-HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence 22 11111111 134568999999999999999874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.52 Aligned_cols=229 Identities=27% Similarity=0.371 Sum_probs=190.0
Q ss_pred cCccCCccCcccceeEEEEEecCCCeEEEEEeecccc------cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
+|+..+.||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999887899999998864421 1235688999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
+||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999998543 46789999999999999999999 999999999999999999999999999998764311
Q ss_pred ----------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---------Hhhhcc
Q 041491 372 ----------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---------VNDFLP 432 (467)
Q Consensus 372 ----------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---------~~~~~~ 432 (467)
...++..|.+||+.....++.++|||||||++|||++|+.||........ .... ....++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhhccCCCCCCCCCCC
Confidence 12245568899999888899999999999999999999999975322211 1111 111223
Q ss_pred cccccccccccccchhHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~ 452 (467)
..+.+++.+|+..+|++|++
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~ 255 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPS 255 (265)
T ss_pred HHHHHHHHHHhcCCcccCCC
Confidence 45889999999999999974
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.84 Aligned_cols=194 Identities=21% Similarity=0.246 Sum_probs=166.6
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC------
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 286 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 286 (467)
..++|++.+.||+|+||.||+|.+. .++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999876 48899999987542 23346678999999999999999999987543
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 67776632 4788899999999999999999 9999999999999999999999999999998
Q ss_pred ecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 367 LLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 367 ~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
..... ...++..|.+||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 76543 234567789999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.88 Aligned_cols=194 Identities=24% Similarity=0.306 Sum_probs=171.5
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCC-C-----CCceeEEEEeecCCeeeE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-H-----RNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~l 291 (467)
+|++.+.||+|+||.|-+|.+.. ++.||||+++.. .....+...|+++|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 89999999999999999998764 999999999865 334466678999999996 4 489999999999999999
Q ss_pred EEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC--cEEEeccccceec
Q 041491 292 VLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM--VAHLSDFGIAKLL 368 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~a~~~ 368 (467)
|+|.++ .+|.++++.... .++...++.++.||+.||.+|| +.+|||+||||+|||+.+.+ .+||+|||.|...
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999985 499999976543 6899999999999999999999 99999999999999996544 7999999999987
Q ss_pred CCCC--ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccc
Q 041491 369 NGKE--SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIF 417 (467)
Q Consensus 369 ~~~~--~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~ 417 (467)
.... ...+..|.|||++.+.+|+.+.||||||||+.||+||.+.|.+..
T Consensus 342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 6543 456778999999999999999999999999999999988887643
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=288.07 Aligned_cols=229 Identities=29% Similarity=0.391 Sum_probs=189.5
Q ss_pred CccCCccCcccceeEEEEEecC-CCeEEEEEeecccccch--HHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
|++.+.||+|+||.||+++... ++.||+|++........ ....+|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999999875 67899999987643322 23356999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC-----C
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG-----K 371 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~ 371 (467)
++++|.+++. ....+++..+..++.|+++||++|| +.+++|+||||+||++++++.++|+|||.+..... .
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999996 3456899999999999999999999 99999999999999999999999999999986421 1
Q ss_pred Ccccccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCcccc--ccccHHHHH----hhhc------ccccccc
Q 041491 372 ESMRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCEIFC--EEMNLKNWV----NDFL------PISVMNV 438 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~--~~~~~~~~~----~~~~------~~~~~~~ 438 (467)
....+..|.+||... ...++.++||||+|+++|+|++|..||..... .......-. .... +..+.++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 234566789999988 88899999999999999999999999986511 111111111 1111 2469999
Q ss_pred cccccccchhHHHH
Q 041491 439 VDTSLLRREDKYFA 452 (467)
Q Consensus 439 i~~~l~~~~~~r~~ 452 (467)
+.+||..+|++|++
T Consensus 237 i~~~l~~~p~~R~~ 250 (260)
T PF00069_consen 237 IKKMLSKDPEQRPS 250 (260)
T ss_dssp HHHHSSSSGGGSTT
T ss_pred HHHHccCChhHCcC
Confidence 99999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=284.41 Aligned_cols=241 Identities=27% Similarity=0.372 Sum_probs=197.5
Q ss_pred hccCccCCccCcccceeEEEEEecC-CC----eEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..+|++.+.||+|+||.||+|.+.+ |. .+|+|....... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4678899999999999999998753 33 589998765532 234678899999999999999999999987 7789
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++|+|.+++......+++..+..++.|++.|++||| +++++||||||+||++++++.+||+|||.++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999876667999999999999999999999 99999999999999999999999999999987653
Q ss_pred CCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhhh--------cccc
Q 041491 371 KES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVNDF--------LPIS 434 (467)
Q Consensus 371 ~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~--------~~~~ 434 (467)
... ..+..|.+||......++.++|+||||+++||+++ |+.||+.....+ ....+... .+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhCCCCCCCCCCCCHH
Confidence 321 11345789999888889999999999999999999 999997643322 22222211 2234
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+.+++.+|+..+|.+|+ ++.+++..+.++
T Consensus 240 ~~~~~~~~l~~~p~~Rp-~~~~l~~~l~~~ 268 (279)
T cd05057 240 VYMVLVKCWMIDAESRP-TFKELINEFSKM 268 (279)
T ss_pred HHHHHHHHcCCChhhCC-CHHHHHHHHHHH
Confidence 77899999999999996 566666666554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.99 Aligned_cols=240 Identities=25% Similarity=0.375 Sum_probs=196.4
Q ss_pred HhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3568999999999999999999864 367899999875432 234678899999999999999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 041491 289 EALVLEYMANGSLEKCLYSSN---------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 347 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 347 (467)
.++||||+++|+|.+++.... ..+++.+++.++.|++.||.||| +++++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 999999999999999986421 24678889999999999999999 999999999999
Q ss_pred CeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccc
Q 041491 348 NVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCE 419 (467)
Q Consensus 348 NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~ 419 (467)
||++++++.+||+|||++....... ...+..|.+||+.....++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999988653221 122345889999888899999999999999999997 88898654332
Q ss_pred cccHHHHH--------hhhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 420 EMNLKNWV--------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 420 ~~~~~~~~--------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+ ..... ....+.++.+++.+|+..+|++|+ ++.|.++.|
T Consensus 240 ~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~el~~~l 286 (288)
T cd05050 240 E--VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP-SFASINRIL 286 (288)
T ss_pred H--HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCC-CHHHHHHHh
Confidence 2 11111 122345699999999999999996 566666655
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=300.21 Aligned_cols=232 Identities=28% Similarity=0.325 Sum_probs=195.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
..|+..+.||.|+||.||.|++. +.+.||||.+.... ....+++..|++.|++++|||++.+.|+|......|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34667789999999999999886 47889999986443 334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-C
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-E 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 372 (467)
|||-| +-.|.+.-.+.++.+..+..|+.+.++||+||| +.+.||||||..|||+++.|.|||+|||.|....+. .
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 99954 888888777778999999999999999999999 999999999999999999999999999999988764 4
Q ss_pred ccccccccccccc---cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------Hhhhccccccccccc
Q 041491 373 SMRTQTLATIEYG---REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------VNDFLPISVMNVVDT 441 (467)
Q Consensus 373 ~~~~~~~~~pe~~---~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~i~~ 441 (467)
..+++.|+|||++ ..++|+-++||||+|++..|+.-+++|...+..-. .+-.. ....|++.++++||.
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-ALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-HHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 5689999999985 47899999999999999999999999975431110 01111 122344458999999
Q ss_pred ccccchhHHHHHH
Q 041491 442 SLLRREDKYFAAK 454 (467)
Q Consensus 442 ~l~~~~~~r~~~~ 454 (467)
||.+-|.+|+++.
T Consensus 261 CLqKipqeRptse 273 (948)
T KOG0577|consen 261 CLQKIPQERPTSE 273 (948)
T ss_pred HHhhCcccCCcHH
Confidence 9999999998654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=282.99 Aligned_cols=234 Identities=26% Similarity=0.404 Sum_probs=187.1
Q ss_pred CccCcccceeEEEEEecC-CC--eEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD-GM--EVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|++.+ +. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998864 43 46888876432 23456788999999999 799999999999999999999999999
Q ss_pred CCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccc
Q 041491 299 GSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 299 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
|+|.+++.... ..+++.++..++.|++.|++||| ++|++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 24788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------h
Q 041491 364 IAKLLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------F 430 (467)
Q Consensus 364 ~a~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~ 430 (467)
++...... ....+..|.+||+.....++.++|||||||++|||++ |..||.+....+ ....... .
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGYRLEKPLN 235 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHHHhCCCCCCCCCc
Confidence 98633211 1112345889999988889999999999999999997 999997543221 1111111 1
Q ss_pred cccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 431 LPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 431 ~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+.++.+++.+|+..+|.+|+ ++.+.+..|.+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp-s~~~il~~l~~ 267 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERP-SFAQILVSLNR 267 (270)
T ss_pred CCHHHHHHHHHHcccChhhCC-CHHHHHHHHHH
Confidence 234588999999999999996 55566666543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=292.86 Aligned_cols=192 Identities=24% Similarity=0.268 Sum_probs=162.7
Q ss_pred cCCccCcc--cceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 222 EKSLIGIG--SFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 222 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
+.+.||+| +|++||++... +|+.||+|.++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 77899999875 58999999987543 233456788999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC----
Q 041491 297 ANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---- 371 (467)
Q Consensus 297 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 371 (467)
++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+.+......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998653 335899999999999999999999 999999999999999999999999999865433211
Q ss_pred --------CccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 372 --------ESMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 372 --------~~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
....+..|.+||+... ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 1123445789999865 46889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=282.21 Aligned_cols=235 Identities=28% Similarity=0.442 Sum_probs=192.8
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.++|++.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++++++|||++++++++...+ .++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence 35789999999999999999975 67889999986442 3467889999999999999999999987654 69999999
Q ss_pred cCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--Cc
Q 041491 297 ANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--ES 373 (467)
Q Consensus 297 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~ 373 (467)
++++|.+++.... ..+++..+..++.|++.|+.||| +.|++||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence 9999999986543 35889999999999999999999 999999999999999999999999999999865432 22
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTSLL 444 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~ 444 (467)
..+..|.+||+...+.++.++|+|||||++|||++ |+.||......+ ...... ...++.+.+++.+|+.
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKGYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCCCCCCCCCcCCHHHHHHHHHHcC
Confidence 23456889999988899999999999999999997 999997643222 111111 1234458899999999
Q ss_pred cchhHHHHHHHHHHHHH
Q 041491 445 RREDKYFAAKKQCVSSA 461 (467)
Q Consensus 445 ~~~~~r~~~~~~~~~~l 461 (467)
.+|++|+ ++.+.+..+
T Consensus 236 ~~p~~Rp-~~~~l~~~l 251 (254)
T cd05083 236 TEPKKRP-SFHKLREKL 251 (254)
T ss_pred CChhhCc-CHHHHHHHH
Confidence 9999997 455555544
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=280.94 Aligned_cols=235 Identities=26% Similarity=0.447 Sum_probs=194.6
Q ss_pred CccCCccCcccceeEEEEEecC-----CCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
+++.+.||+|+||.||+|.+.+ +..||+|++...... ..+.+.+|++.++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998864 388999998755433 5678899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
||+++++|.+++...... +++.++..++.|++.|++||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998665444 899999999999999999999 9999999999999999999999999999998765432
Q ss_pred c------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------hhhccccccc
Q 041491 373 S------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------NDFLPISVMN 437 (467)
Q Consensus 373 ~------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~ 437 (467)
. ..+..|.+||......++.++||||+|+++|||++ |+.||...... ...... ....+..+.+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCCCCCCcCCHHHHH
Confidence 1 23456789998888889999999999999999998 78888753221 111111 1123456889
Q ss_pred ccccccccchhHHHHHHHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAKKQCVSS 460 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~~~~ 460 (467)
++.+|+..+|++|+ ++.++++.
T Consensus 236 ~i~~~l~~~p~~Rp-t~~~ll~~ 257 (258)
T smart00219 236 LMLQCWAEDPEDRP-TFSELVEI 257 (258)
T ss_pred HHHHHCcCChhhCc-CHHHHHhh
Confidence 99999999999997 55565543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=302.88 Aligned_cols=236 Identities=25% Similarity=0.312 Sum_probs=202.0
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.+.|+++..||.|+||.||+|..++ +-..|.|++........+++.-||+||..++||+||++++.|...+.++|..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3457778889999999999998875 445678999888777889999999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC-----C
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-----G 370 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-----~ 370 (467)
|.||.....+-.-...+.+.++..+++|++.||.||| +++|||||||..|||++-+|.++|+|||.+.... .
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 9999999988888889999999999999999999999 9999999999999999999999999999987553 2
Q ss_pred CCcccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---------Hhhhcccccc
Q 041491 371 KESMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---------VNDFLPISVM 436 (467)
Q Consensus 371 ~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~ 436 (467)
....++++|+|||++. ..+|+.++||||||+++.||.-+.+|..+...-. .+... ....|+..+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-VllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-HHHHHhhcCCCcccCcchhhhHHH
Confidence 4457888999998754 5689999999999999999999999987642221 11112 1234455699
Q ss_pred cccccccccchhHHHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAKKQ 456 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~ 456 (467)
+++.+||.++|..|+++++-
T Consensus 267 DfLk~cL~Knp~~Rp~aaql 286 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQL 286 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHH
Confidence 99999999999999887753
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=284.13 Aligned_cols=232 Identities=24% Similarity=0.314 Sum_probs=195.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|+..+.||+|++|.||+|.+. +++.+|+|.+..... ...+.+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888899999999999999886 489999999876532 3456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
+++++|.+++......+++..+..++.|++.|++||| + .+++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999999766577899999999999999999999 8 99999999999999999999999999998765422
Q ss_pred CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----h--------hccccccccc
Q 041491 372 ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----D--------FLPISVMNVV 439 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----~--------~~~~~~~~~i 439 (467)
....+..|.+||+..+..++.++||||||+++|+|++|+.||...........+... . .++.++.+++
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 134556789999998889999999999999999999999999754222122222211 1 1445688999
Q ss_pred ccccccchhHHHH
Q 041491 440 DTSLLRREDKYFA 452 (467)
Q Consensus 440 ~~~l~~~~~~r~~ 452 (467)
.+|+..+|++|++
T Consensus 238 ~~~l~~~p~~Rpt 250 (265)
T cd06605 238 NLCLIKDPRERPS 250 (265)
T ss_pred HHHcCCCchhCcC
Confidence 9999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=285.83 Aligned_cols=234 Identities=26% Similarity=0.374 Sum_probs=193.9
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..|+..+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46778899999999999999886 48899999987543 33456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc--
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 373 (467)
+++++|.+++.. +.+++.++..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999999998854 45888999999999999999999 99999999999999999999999999999977654321
Q ss_pred ---cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH------HHHHhhhcccccccccccccc
Q 041491 374 ---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL------KNWVNDFLPISVMNVVDTSLL 444 (467)
Q Consensus 374 ---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~ 444 (467)
..+..|.+||+..+..++.++|+|||||++|||+||+.||.......... ........+..+.+++.+|+.
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 23456789999988889999999999999999999999997643221110 001112334568899999999
Q ss_pred cchhHHHHHHHHH
Q 041491 445 RREDKYFAAKKQC 457 (467)
Q Consensus 445 ~~~~~r~~~~~~~ 457 (467)
.+|++|++ +.+.
T Consensus 239 ~~p~~Rp~-~~~i 250 (277)
T cd06640 239 KDPSFRPT-AKEL 250 (277)
T ss_pred cCcccCcC-HHHH
Confidence 99999974 3443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=296.31 Aligned_cols=189 Identities=22% Similarity=0.274 Sum_probs=164.8
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
....+|++.+.||+|+||.||+|.+.. ++.||+|+.... ....|+.++++++||||+++++++...+..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 445689999999999999999998864 788999974322 2356999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
|++. ++|.+++......+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 9995 5888888766678999999999999999999999 999999999999999999999999999999754322
Q ss_pred --CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCC
Q 041491 372 --ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPT 413 (467)
Q Consensus 372 --~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf 413 (467)
...++..|.+||+..+..++.++|||||||++|||+++..|+
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 224567789999999999999999999999999999865554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=281.49 Aligned_cols=235 Identities=28% Similarity=0.355 Sum_probs=195.0
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999875 48899999986543 23457789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc
Q 041491 296 MANGSLEKCLYSSN--GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (467)
+++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999986542 46899999999999999999999 99999999999999999999999999999876654322
Q ss_pred ---------cccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------------hhc
Q 041491 374 ---------MRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------------DFL 431 (467)
Q Consensus 374 ---------~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------------~~~ 431 (467)
.++..|.+||++... .++.++|+|||||++|||++|+.||......+ ...+... ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCCCcCCccccccc
Confidence 244567889987766 78899999999999999999999997643221 1222211 133
Q ss_pred ccccccccccccccchhHHHHHHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
++.+.+++.+|+..+|++|++ +.++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~-~~~l 261 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPT-AEEL 261 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcC-HHHH
Confidence 455789999999999999984 4443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=289.90 Aligned_cols=187 Identities=22% Similarity=0.271 Sum_probs=155.3
Q ss_pred CCccCcccceeEEEEEec---CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeec--CCeeeEEEeccc
Q 041491 223 KSLIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFEALVLEYMA 297 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 297 (467)
.++||+|+||.||+|++. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999875 36789999986432 23557889999999999999999998854 456889999985
Q ss_pred CCCHHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----cCCCcEEEeccccc
Q 041491 298 NGSLEKCLYSS--------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIA 365 (467)
Q Consensus 298 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a 365 (467)
+ +|.+++... ...+++..+..++.|++.||+||| ++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 887776422 125889999999999999999999 9999999999999999 45678999999999
Q ss_pred eecCCC--------CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 366 KLLNGK--------ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 366 ~~~~~~--------~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
+..... ...++..|.|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876432 1234667899998866 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.08 Aligned_cols=199 Identities=21% Similarity=0.247 Sum_probs=164.1
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCC------CCceeEEEEee
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRH------RNLVKIISSCS 284 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~ 284 (467)
++....++|++.+.||+|+||.||+|.+.. ++.||||+++... ........|+.+++.++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 444567899999999999999999998764 7889999986432 223455677877777654 45889999887
Q ss_pred cC-CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCC-------
Q 041491 285 NG-NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDM------- 355 (467)
Q Consensus 285 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~------- 355 (467)
.. +..++|||++ +++|.+++... +.+++..+..++.|++.||+||| + .||+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccc
Confidence 54 5789999988 67888887543 57899999999999999999999 7 5999999999999998765
Q ss_pred ---------cEEEeccccceecCCC--CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 356 ---------VAHLSDFGIAKLLNGK--ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 356 ---------~~kl~Dfg~a~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
.+||+|||.+...... ...++..|.+||++.+..++.++|||||||++|||++|+.||+..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999988654322 234677899999999999999999999999999999999999753
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=280.64 Aligned_cols=235 Identities=23% Similarity=0.322 Sum_probs=192.4
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec-CCeeeEEEe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNFEALVLE 294 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 294 (467)
+|++.+.||+|++|.||++.+.. ++.||+|.+.... ....+.+.+|++++++++|||++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58889999999999999998764 7899999987543 2344668899999999999999999998764 456799999
Q ss_pred cccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 295 YMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+++++|.+++.... ..+++.++..++.|++.|+++|| +.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999886643 36899999999999999999999 9999999999999999999999999999998764322
Q ss_pred ----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhccccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDT 441 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~ 441 (467)
..++..|.+||+.....++.++||||+|+++|||++|+.||........ ...... ...++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCccccCHHHHHHHHH
Confidence 2345668999999888899999999999999999999999975332221 111111 1233458999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
|+..+|++|++ +.+.+
T Consensus 237 ~l~~~p~~Rp~-~~~~l 252 (257)
T cd08223 237 MLSKRPEKRPS-VKSIL 252 (257)
T ss_pred HhccCcccCCC-HHHHh
Confidence 99999999974 44443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=284.74 Aligned_cols=231 Identities=25% Similarity=0.332 Sum_probs=191.0
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|++|.||+|.+. +|+.||+|++.... ......+.+|+.++++++||||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999986 58999999987653 33456789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+ +++|.+++......+++.+++.++.|++.||+||| +.+++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999998766677999999999999999999999 9999999999999999999999999999998765432
Q ss_pred ---ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc--------------------cHHHH--
Q 041491 373 ---SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--------------------NLKNW-- 426 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--------------------~~~~~-- 426 (467)
..++..|.+||+..+. .++.++||||+|+++|||+||++||........ .+.+|
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 2345568899987654 468899999999999999999888854321100 00001
Q ss_pred -------------HhhhcccccccccccccccchhHHHHH
Q 041491 427 -------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 -------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.....+..+.+++.+||..+|.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 001233458899999999999999853
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=283.85 Aligned_cols=232 Identities=25% Similarity=0.282 Sum_probs=184.9
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHH-HHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEV-LKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|+||.||+|.+. +|+.||+|.++.... .....+..|+.+ ++..+||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999986 489999999876532 233455566665 566789999999999999999999999
Q ss_pred cccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 295 YMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 295 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
|++ |+|.+++.. ....+++..++.++.|++.||+||| ++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 588777643 2346899999999999999999999 86 999999999999999999999999999986643
Q ss_pred CC----ccccccccccccccC----CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhcccc
Q 041491 371 KE----SMRTQTLATIEYGRE----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPIS 434 (467)
Q Consensus 371 ~~----~~~~~~~~~pe~~~~----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 434 (467)
.. ..++..|.+||...+ ..++.++|+|||||++|||++|+.||.........+..... ..++.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 22 234556889998754 45688999999999999999999999753222112222221 124456
Q ss_pred cccccccccccchhHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~ 453 (467)
+.+++.+||..+|++|++.
T Consensus 237 l~~li~~~l~~~p~~Rp~~ 255 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNY 255 (283)
T ss_pred HHHHHHHHccCChhhCcCH
Confidence 8899999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=283.37 Aligned_cols=239 Identities=22% Similarity=0.343 Sum_probs=196.5
Q ss_pred hccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|++.+.||+|+||.||+|+.+. .+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 3678999999999999999998642 467999988654433 456789999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEec
Q 041491 290 ALVLEYMANGSLEKCLYSSN--------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 361 (467)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999986543 15899999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-------
Q 041491 362 FGIAKLLNGKE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV------- 427 (467)
Q Consensus 362 fg~a~~~~~~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~------- 427 (467)
||++....... ...+..|.+||+.....++.++||||||+++|+|++ |..||....... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~~~~~~~ 238 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQAGKLEL 238 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHHcCCcCC
Confidence 99987543221 223445899999888888999999999999999999 888996543221 11111
Q ss_pred --hhhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 428 --NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 428 --~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
....|..+.+++.+|+..+|.+|+ ++.+++..+
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp-~~~~~l~~l 273 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRP-SFSELVSAL 273 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCC-CHHHHHHHh
Confidence 122345689999999999999996 677777665
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=292.29 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=199.0
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC--------CCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEE
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIIS 281 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~ 281 (467)
++.+...+|++.+.||+|+||.||+|++.. +..||+|.++... ....+.+.+|+.+++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 344555689999999999999999997532 2368999887543 23456788999999999 7999999999
Q ss_pred EeecCCeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 041491 282 SCSNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKP 346 (467)
Q Consensus 282 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 346 (467)
++...+..++++||+++|+|.+++.... ..+++.++..++.|++.||+||| ++|++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeecccccc
Confidence 9999999999999999999999986432 24788899999999999999999 99999999999
Q ss_pred CCeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccc
Q 041491 347 SNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFC 418 (467)
Q Consensus 347 ~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~ 418 (467)
+||++++++.+||+|||+++...... ...+..|.+||......++.++||||||+++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999998664322 112345899999988889999999999999999998 8899876432
Q ss_pred ccccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 419 EEMNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 419 ~~~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
++ ....... ..+.++.+++.+|+..+|.+|+ ++.+++..+.++
T Consensus 243 ~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~ell~~l~~~ 293 (334)
T cd05100 243 EE--LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP-TFKQLVEDLDRV 293 (334)
T ss_pred HH--HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCc-CHHHHHHHHHHH
Confidence 22 1111111 1233588899999999999996 677777777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=287.16 Aligned_cols=233 Identities=26% Similarity=0.354 Sum_probs=192.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35667788999999999999875 47889999987443 33456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc--
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 373 (467)
+++++|.+++.. ..+++..+..++.|++.|+.||| +++++|+||+|+||++++++.++++|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 999999998853 46889999999999999999999 99999999999999999999999999999987654321
Q ss_pred ---cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhcccccccccccc
Q 041491 374 ---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTS 442 (467)
Q Consensus 374 ---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~ 442 (467)
.++..|.+||+.....++.++|||||||++|||+||+.||....... ...+.. ...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNSPPTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence 24556889999988889999999999999999999999997543221 111111 12334588999999
Q ss_pred cccchhHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCV 458 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~ 458 (467)
+..+|++|++ +.+.+
T Consensus 237 l~~~p~~Rp~-~~~il 251 (277)
T cd06642 237 LNKDPRFRPT-AKELL 251 (277)
T ss_pred ccCCcccCcC-HHHHH
Confidence 9999999974 44444
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=286.92 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=194.7
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEee--
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCS-- 284 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-- 284 (467)
.++.+....++|++.+.||+|+||.||+|.+.. ++.+|+|++... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 345566678899999999999999999998864 889999987643 22346678899999999 6999999999873
Q ss_pred ---cCCeeeEEEecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEE
Q 041491 285 ---NGNFEALVLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 285 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 358 (467)
.++..++||||+++++|.+++.. ....+++..+..++.|++.|+.||| +.+++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence 44678999999999999988753 2346889999999999999999999 99999999999999999999999
Q ss_pred EeccccceecCCCC-----ccccccccccccccC-----CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-
Q 041491 359 LSDFGIAKLLNGKE-----SMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV- 427 (467)
Q Consensus 359 l~Dfg~a~~~~~~~-----~~~~~~~~~pe~~~~-----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~- 427 (467)
|+|||+++...... ..++..|.+||+... ..++.++||||+||++|||++|+.||....... .+....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~ 243 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIPR 243 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhccc
Confidence 99999998764322 234566889998753 447889999999999999999999997542211 111110
Q ss_pred --------hhhcccccccccccccccchhHHHHHHHHHHH
Q 041491 428 --------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 428 --------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
...++..+.+++.+|+..+|++|+ ++.|.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~ell~ 282 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP-TVSDLLQ 282 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCC-CHHHHhh
Confidence 111233588999999999999997 4555554
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=280.05 Aligned_cols=233 Identities=24% Similarity=0.328 Sum_probs=187.2
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-----cchHHHHHHHHHHHcCCCCCceeEEEEeec--CCee
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-----GALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFE 289 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 289 (467)
.+|+..+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.++++++||||+++++++.. .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999876 489999998864321 234568889999999999999999998865 4678
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++++||+++++|.+++... ..+++.....++.|++.||+||| +.+++||||||+||++++++.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 8999999999999988543 35889999999999999999999 9999999999999999999999999999987653
Q ss_pred CC--------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhccc
Q 041491 370 GK--------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPI 433 (467)
Q Consensus 370 ~~--------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~ 433 (467)
.. ...++..|.+||+..+..++.++||||+||++|||++|+.||........ ..... ...+++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IFKIATQPTNPQLPSHISE 236 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HHHHhcCCCCCCCchhcCH
Confidence 21 12245568899999888899999999999999999999999975422211 11111 112233
Q ss_pred ccccccccccccchhHHHHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
.+.+++ +|+..+|++|++ ++|+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~-~~ei 258 (266)
T cd06651 237 HARDFL-GCIFVEARHRPS-AEEL 258 (266)
T ss_pred HHHHHH-HHhcCChhhCcC-HHHH
Confidence 467777 688889999984 4443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.64 Aligned_cols=232 Identities=21% Similarity=0.308 Sum_probs=189.2
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||.||+|.+. +++.||+|.++... ......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999986 58999999887542 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 296 MANGSLEKCLYSS--NGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
+++++|..++... ...+++..+..++.|++.|+.||| . .+++||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999988653 236899999999999999999999 6 599999999999999999999999999997654322
Q ss_pred ---ccccccccccccccCC------CCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHH-------Hhhhcccc
Q 041491 373 ---SMRTQTLATIEYGREG------QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNW-------VNDFLPIS 434 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~------~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~-------~~~~~~~~ 434 (467)
..++..|.+||+.... .++.++|+|||||++|||++|+.||........ .+... +...+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 2344568899987543 357899999999999999999999965322111 01111 11123445
Q ss_pred cccccccccccchhHHHH
Q 041491 435 VMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~ 452 (467)
+.+++.+|+..+|++|++
T Consensus 238 ~~~li~~~l~~~p~~Rp~ 255 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPT 255 (286)
T ss_pred HHHHHHHHcccCcccCCC
Confidence 889999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=281.62 Aligned_cols=224 Identities=22% Similarity=0.269 Sum_probs=178.3
Q ss_pred ccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHH---cCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 225 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLK---SVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 225 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
.||+|+||.||++.+. +++.+|+|.+..... .....+.+|..+++ ..+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999886 489999999865421 11223444544433 3479999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---cc
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---SM 374 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~ 374 (467)
+++|.+++... +.+++..+..++.|++.||+||| +++|+||||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcC
Confidence 99999988543 46899999999999999999999 9999999999999999999999999999987654322 24
Q ss_pred cccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc-HHHH-------Hhhhccccccccccccccc
Q 041491 375 RTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-LKNW-------VNDFLPISVMNVVDTSLLR 445 (467)
Q Consensus 375 ~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-~~~~-------~~~~~~~~~~~~i~~~l~~ 445 (467)
++..|.+||... +..++.++||||+||++|||++|+.||......... .... ....+++++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 566789999876 456789999999999999999999999754322111 1111 1123445688999999999
Q ss_pred chhHHHH
Q 041491 446 REDKYFA 452 (467)
Q Consensus 446 ~~~~r~~ 452 (467)
+|.+|++
T Consensus 237 ~p~~R~~ 243 (279)
T cd05633 237 DVSKRLG 243 (279)
T ss_pred CHHHhcC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=292.90 Aligned_cols=194 Identities=21% Similarity=0.302 Sum_probs=165.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecC------
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 286 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 286 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999875 588999999875422 2345677899999999999999999887543
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+||++++++.+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccce
Confidence 3568999988 7799887743 46899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 367 LLNGKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 367 ~~~~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
...... ..++..|.+||+..+ ..++.++||||+||++|||++|+.||..
T Consensus 167 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 167 QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred ecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 765432 345677899998766 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=284.63 Aligned_cols=233 Identities=24% Similarity=0.322 Sum_probs=186.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999875 589999999875432 233467889999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+. +++.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 996 6777776555556788889999999999999999 9999999999999999999999999999987643221
Q ss_pred ---ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHH-----------------------
Q 041491 373 ---SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN----------------------- 425 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~----------------------- 425 (467)
...+..|.+||+..+ ..++.++|||||||++|||++|+.||+........+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 224566889998765 34788999999999999999999999753221110000
Q ss_pred --H-----------Hhhh--cccccccccccccccchhHHHHH
Q 041491 426 --W-----------VNDF--LPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 426 --~-----------~~~~--~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
+ .... .+..+.+++.+|+..||.+|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~ 282 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence 0 0001 12347789999999999999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.72 Aligned_cols=233 Identities=24% Similarity=0.344 Sum_probs=198.4
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
....|.+.+.||+|.|+.|.+|++. ++..||+|.+++..- ...+.+.+|+++|+.++|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567999999999999999999886 499999999976532 2335588999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
|||+.+|.+.+++... +++.+..+..++.|+.+|++||| +++|+|||||++||+++.+.++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999999999655 45666999999999999999999 999999999999999999999999999999988753
Q ss_pred ---CccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHH-----HHhhhcccccccccccc
Q 041491 372 ---ESMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN-----WVNDFLPISVMNVVDTS 442 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~ 442 (467)
..++++.|.+||...+..| ++++|+||+|+++|-|+.|..||++..-.+..-+. .+...+..+..++++++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence 3467788999999888776 68999999999999999999999975322221111 13334455688999999
Q ss_pred cccchhHHHH
Q 041491 443 LLRREDKYFA 452 (467)
Q Consensus 443 l~~~~~~r~~ 452 (467)
|..+|.+|.+
T Consensus 290 lvl~Pskr~~ 299 (596)
T KOG0586|consen 290 LVLNPSKRGP 299 (596)
T ss_pred hccCccccCC
Confidence 9999999963
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=284.57 Aligned_cols=195 Identities=26% Similarity=0.376 Sum_probs=168.5
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999886 589999999875432 2334567899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++ +|.+++......+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 975 999988766667899999999999999999999 9999999999999999999999999999987543221
Q ss_pred --ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 373 --SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
...+..|.+||+..+ ..++.++||||+|+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 123456789998765 45788999999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=278.18 Aligned_cols=235 Identities=24% Similarity=0.314 Sum_probs=194.4
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999875 48999999987532 23446788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 296 MANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
+++++|.+++.... ..+++.++..++.|++.|+.||| +++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999886543 35789999999999999999999 9999999999999999999999999999998765432
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhcccccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDTS 442 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~~ 442 (467)
..++..|.+||+..+..++.++|+|||||++|+|++|+.||......+ ....+.. ...+.++.+++.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-LVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-HHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 124556889999988889999999999999999999999997532221 1112211 12334588999999
Q ss_pred cccchhHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCV 458 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~ 458 (467)
+..+|++|++ +.+++
T Consensus 237 l~~~p~~Rp~-~~~vl 251 (256)
T cd08218 237 FKRNPRDRPS-VNSIL 251 (256)
T ss_pred hhCChhhCcC-HHHHh
Confidence 9999999974 44443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=281.54 Aligned_cols=232 Identities=26% Similarity=0.345 Sum_probs=189.3
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCC------
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGN------ 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------ 287 (467)
.+++|++.+.||+|++|.||+|.+. +++.+++|++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4689999999999999999999986 478999999875533 346789999999999 6999999999996544
Q ss_pred eeeEEEecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 288 FEALVLEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
..++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 589999999999999987543 357899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC-----ccccccccccccccC-----CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------
Q 041491 365 AKLLNGKE-----SMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------ 428 (467)
Q Consensus 365 a~~~~~~~-----~~~~~~~~~pe~~~~-----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------ 428 (467)
+....... ..++..|.+||++.. ..++.++|||||||++|||++|+.||....... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~ 238 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNPPPTL 238 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccCCCCC
Confidence 87654322 234556888997653 346788999999999999999999997532211 1111111
Q ss_pred ---hhcccccccccccccccchhHHHH
Q 041491 429 ---DFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 429 ---~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
..++..+.+++.+||..||++|++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt 265 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPF 265 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcC
Confidence 113445889999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=285.96 Aligned_cols=243 Identities=26% Similarity=0.296 Sum_probs=193.4
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecC
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNG 286 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 286 (467)
+..++...+++|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455566889999999999999999999885 4889999998643 22346678899999998 799999999998643
Q ss_pred -----CeeeEEEecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEE
Q 041491 287 -----NFEALVLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 287 -----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 358 (467)
+..++||||+++++|.++++. ....+++..++.++.|++.||+||| +.+++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 368999999999999998753 2346899999999999999999999 99999999999999999999999
Q ss_pred EeccccceecCCCC-----ccccccccccccccCCC-----CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh
Q 041491 359 LSDFGIAKLLNGKE-----SMRTQTLATIEYGREGQ-----VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN 428 (467)
Q Consensus 359 l~Dfg~a~~~~~~~-----~~~~~~~~~pe~~~~~~-----~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~ 428 (467)
|+|||++....... ..++..|.+||+...+. ++.++|||||||++|||++|+.||....... ...++..
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~ 247 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKIPR 247 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHHhc
Confidence 99999988654322 23456688999875433 6789999999999999999999997643221 1222211
Q ss_pred h---------hcccccccccccccccchhHHHHHHHHH
Q 041491 429 D---------FLPISVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 429 ~---------~~~~~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
. .++..+.+++.+|+..+|++|++ +.++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~i 284 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS-VTHL 284 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcC-HHHH
Confidence 1 12234778999999999999975 4343
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=281.92 Aligned_cols=235 Identities=24% Similarity=0.362 Sum_probs=190.2
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc----------cchHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD----------GALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
+|...+.||+|++|.||+|... +++.||+|.++.... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999875 589999998864311 11246788999999999999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..++||||+++++|.+++... +.+++..+..++.|++.|+.||| +++++||||+|+||++++++.++++|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998654 57899999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCC-------ccccccccccccccCCC--CCCcccchhhHHHHHHHhcCCCCCCcccccccc-----------HHHHH
Q 041491 368 LNGKE-------SMRTQTLATIEYGREGQ--VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-----------LKNWV 427 (467)
Q Consensus 368 ~~~~~-------~~~~~~~~~pe~~~~~~--~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-----------~~~~~ 427 (467)
..... ..++..|.+||+..... ++.++|+||||+++||+++|+.||......+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 54321 12455678999876654 789999999999999999999999643211100 00111
Q ss_pred hhhcccccccccccccccchhHHHHHHHHHH
Q 041491 428 NDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 428 ~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
...++..+.+++.+|+..+|++|++ +.+++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps-~~~il 267 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPT-ARELL 267 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCC-HHHHh
Confidence 1234556889999999999999985 44443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=283.67 Aligned_cols=240 Identities=24% Similarity=0.327 Sum_probs=193.6
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeec-
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSN- 285 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~- 285 (467)
++.++..+.+.|++.+.||+|+||.||+|.+. +++.+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45555667789999999999999999999885 48899999986543 3345688899999998 69999999999853
Q ss_pred -----CCeeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEE
Q 041491 286 -----GNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHL 359 (467)
Q Consensus 286 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 359 (467)
.+..+++|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 467899999999999999886543 35788889999999999999999 999999999999999999999999
Q ss_pred eccccceecCCC-----Ccccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHH-H---
Q 041491 360 SDFGIAKLLNGK-----ESMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK-N--- 425 (467)
Q Consensus 360 ~Dfg~a~~~~~~-----~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~-~--- 425 (467)
+|||++...... ...++..|.+||.+. ...++.++|||||||++|||++|+.||........... .
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 242 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC
Confidence 999998765422 123456688999875 34678899999999999999999999975432211110 0
Q ss_pred ---HHhhhcccccccccccccccchhHHHH
Q 041491 426 ---WVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 426 ---~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
.....++..+.+++.+|+..+|.+|++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 272 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPS 272 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcC
Confidence 111234556899999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=279.41 Aligned_cols=234 Identities=24% Similarity=0.355 Sum_probs=193.1
Q ss_pred cCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
||.|++|.||+|++.. ++.||+|++.... ....+.+.+|+.++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999864 8999999987542 23446789999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----ccccc
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----SMRTQ 377 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----~~~~~ 377 (467)
.+++... ..+++..+..++.|++.||+||| +++++|+||+|+||+++.++.++|+|||.+....... ..++.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCc
Confidence 9998654 45889999999999999999999 9999999999999999999999999999998775432 23456
Q ss_pred cccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc-HHHHH--------hhhcccccccccccccccchh
Q 041491 378 TLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-LKNWV--------NDFLPISVMNVVDTSLLRRED 448 (467)
Q Consensus 378 ~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-~~~~~--------~~~~~~~~~~~i~~~l~~~~~ 448 (467)
.|.+||+.....++.++|+||+|+++|||++|+.||.....+... ..... ....++++.+++.+|+..+|+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 688999988888899999999999999999999999765421111 11111 112244689999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 041491 449 KYFAAKKQCVSSALS 463 (467)
Q Consensus 449 ~r~~~~~~~~~~l~~ 463 (467)
+|++.++..++++++
T Consensus 237 ~R~~~~~~~~~~l~~ 251 (262)
T cd05572 237 ERLGNLKGGIKDIKK 251 (262)
T ss_pred hCcCCcccCHHHHhc
Confidence 999854444555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.29 Aligned_cols=236 Identities=27% Similarity=0.324 Sum_probs=198.9
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|++|.||+|++.. ++.||+|++..... ...+.+.+|++.+.+++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468889999999999999999875 89999999876543 3457789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999998654 56899999999999999999999 8 9999999999999999999999999999987654332
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccc-ccccHHHHHhh--------h-ccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFC-EEMNLKNWVND--------F-LPISVMNVV 439 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~-~~~~~~~~~~~--------~-~~~~~~~~i 439 (467)
..+..|.+||+.....++.++|+||||+++|||+||+.||..... .......+... . ++..+.+++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 245567899999888899999999999999999999999976531 11122222111 1 455699999
Q ss_pred ccccccchhHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~ 458 (467)
.+|+..+|++|++ +.+.+
T Consensus 237 ~~~l~~~p~~R~~-~~~ll 254 (264)
T cd06623 237 SACLQKDPKKRPS-AAELL 254 (264)
T ss_pred HHHccCChhhCCC-HHHHH
Confidence 9999999999974 44444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=283.83 Aligned_cols=238 Identities=26% Similarity=0.358 Sum_probs=195.8
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 467888999999999999999886 48899999886543 2345678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
|+++++|.+++.. .+.+++..+..++.+++.|+.||| + .+++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 84 FMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred cCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 9999999998854 346899999999999999999999 6 58999999999999999999999999998755322
Q ss_pred -CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc------ccHHHHHhh------------hcc
Q 041491 372 -ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE------MNLKNWVND------------FLP 432 (467)
Q Consensus 372 -~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~------~~~~~~~~~------------~~~ 432 (467)
...++..|.+||++.+..++.++|+|||||++||++||+.||......+ .....+... .++
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 2245667899999888889999999999999999999999997543210 111122111 134
Q ss_pred cccccccccccccchhHHHHHHHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
..+.+++.+|+..+|++|++ +.|++.
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt-~~e~~~ 265 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPT-PQQLCA 265 (284)
T ss_pred HHHHHHHHHHhcCCcccCcC-HHHHhc
Confidence 45889999999999999974 445443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=277.87 Aligned_cols=234 Identities=27% Similarity=0.333 Sum_probs=192.7
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-----ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999886 68999999986543 12446788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
+||+++++|.+++... ..+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998654 45889999999999999999999 9999999999999999999999999999988654332
Q ss_pred ----ccccccccccccccCCC-CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQ-VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVV 439 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~-~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i 439 (467)
..++..|.+||+..... ++.++|+||||+++|+|++|+.||......+ ....+.. ..+++.+.+++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhcccCCCcCCCcCHHHHHHH
Confidence 23455678999887666 8899999999999999999999997643211 1111111 22334588899
Q ss_pred ccccccchhHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~ 458 (467)
.+|+..+|++|+ ++.+++
T Consensus 236 ~~~l~~~p~~Rp-~~~~~l 253 (258)
T cd06632 236 LKCLQRDPSLRP-TAAELL 253 (258)
T ss_pred HHHhhcCcccCc-CHHHHh
Confidence 999999999997 444443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=286.35 Aligned_cols=233 Identities=23% Similarity=0.280 Sum_probs=191.3
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
.|.....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 4444577999999999999875 488999999876555556778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----- 372 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----- 372 (467)
+++|.+++.. +.+++.++..++.|++.|++||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 103 ~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 103 GGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 9999998743 35889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---hh------hccccccccccccc
Q 041491 373 SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---ND------FLPISVMNVVDTSL 443 (467)
Q Consensus 373 ~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---~~------~~~~~~~~~i~~~l 443 (467)
..++..|.+||+.....++.++||||||+++|||++|+.||....... ...... .. ..+..+.+++.+|+
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence 234556889999888889999999999999999999999997532211 111111 11 22345788999999
Q ss_pred ccchhHHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQCV 458 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~ 458 (467)
..+|.+|++. ++.+
T Consensus 257 ~~~P~~Rpt~-~~il 270 (292)
T cd06658 257 VREPSQRATA-QELL 270 (292)
T ss_pred cCChhHCcCH-HHHh
Confidence 9999999754 4444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=276.58 Aligned_cols=230 Identities=24% Similarity=0.341 Sum_probs=192.0
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|+..+.||+|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999875 48899999987542 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceecCCCC-
Q 041491 296 MANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~- 372 (467)
+++++|.+++.... ..+++..+..++.|++.|++||| ++|++||||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997643 35899999999999999999999 99999999999999998654 68999999998765432
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhcccccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDTS 442 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~~ 442 (467)
..++..|.+||+.....++.++||||||+++|+|++|+.||....... ....... ..++.++.+++..|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSGTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-HHHHHHhcCCCCCCCCcCHHHHHHHHHH
Confidence 234557899999988888999999999999999999999997643221 1111111 12345688999999
Q ss_pred cccchhHHHH
Q 041491 443 LLRREDKYFA 452 (467)
Q Consensus 443 l~~~~~~r~~ 452 (467)
+..+|++|++
T Consensus 237 l~~~p~~Rpt 246 (256)
T cd08220 237 LNLDPSKRPQ 246 (256)
T ss_pred ccCChhhCCC
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=273.72 Aligned_cols=241 Identities=23% Similarity=0.259 Sum_probs=199.5
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
+..++|+..+.||+|.||+|.+++-+ .++.+|+|++++.. .........|-++|+..+||.+..+.-.|...++.|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 34568999999999999999999876 48999999998763 233445667999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||..||.|.-++.. ...+++.....+..+|+.||.||| +++||.||+|.+|.|+|.+|++||+|||+++.--.
T Consensus 245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999888843 457899999999999999999999 99999999999999999999999999999985322
Q ss_pred -----CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---cHHHH--Hhhhcccccccccc
Q 041491 371 -----KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---NLKNW--VNDFLPISVMNVVD 440 (467)
Q Consensus 371 -----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---~~~~~--~~~~~~~~~~~~i~ 440 (467)
...++++.|.|||++....|+.++|.|.+|||||||+.|+.||.....+.. .+..- ....++++...++.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 223566677777777778899999999999999999999999986544321 11111 34456678999999
Q ss_pred cccccchhHH----HHHHHHHHH
Q 041491 441 TSLLRREDKY----FAAKKQCVS 459 (467)
Q Consensus 441 ~~l~~~~~~r----~~~~~~~~~ 459 (467)
-.|.+||.+| +..+.|.+.
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHh
Confidence 9999999999 455555543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=299.18 Aligned_cols=227 Identities=27% Similarity=0.374 Sum_probs=193.3
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCHH
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLE 302 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 302 (467)
-.||+|.||+||.|++.+ ...+|||-+........+-+..||.+.++++|.|||+++|.+..+++.-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 368999999999999876 5668999998777777788999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec-CCCcEEEeccccceecCCCC-----cc
Q 041491 303 KCLYSSNGIL--DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKE-----SM 374 (467)
Q Consensus 303 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~-----~~ 374 (467)
.++...-+++ .+.+.-.+.+||++||.||| ...|||||||-+|+|++ -.|.+||+|||-++.+.+-. ..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9999888887 78889999999999999999 99999999999999996 57899999999999876533 34
Q ss_pred ccccccccccccCC--CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHH----HHhhhccc----ccccccccccc
Q 041491 375 RTQTLATIEYGREG--QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN----WVNDFLPI----SVMNVVDTSLL 444 (467)
Q Consensus 375 ~~~~~~~pe~~~~~--~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~----~~~~~~~~----~~~~~i~~~l~ 444 (467)
++..|+|||.+..+ .|+.++|||||||++.||.||++||.+.-.....+-+ .+.+.+|. +.+.+|-+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 67778999998654 5789999999999999999999999764332211111 13334444 48899999999
Q ss_pred cchhHHHHH
Q 041491 445 RREDKYFAA 453 (467)
Q Consensus 445 ~~~~~r~~~ 453 (467)
.||..|+++
T Consensus 818 pd~~~R~sA 826 (1226)
T KOG4279|consen 818 PDPCDRPSA 826 (1226)
T ss_pred CCcccCccH
Confidence 999999743
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=280.06 Aligned_cols=231 Identities=22% Similarity=0.333 Sum_probs=190.0
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc------cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
+|+..+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999874 589999999874321 134678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceecCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNG 370 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 370 (467)
|+||+++++|.+++... +.+++..+..++.|++.||.||| ++|++|+||||+||+++.++ .+||+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999998643 46889999999999999999999 99999999999999998776 699999999987653
Q ss_pred CC---------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc-cHH-HH--------Hhhhc
Q 041491 371 KE---------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-NLK-NW--------VNDFL 431 (467)
Q Consensus 371 ~~---------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-~~~-~~--------~~~~~ 431 (467)
.. ..++..|.+||+..+..++.++||||+|+++|+|++|+.||........ ... .. ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 21 1234568899998888899999999999999999999999964322111 111 11 11123
Q ss_pred ccccccccccccccchhHHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
++++.+++.+|+..+|++|++.
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~ 258 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPS 258 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCH
Confidence 4458889999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=276.19 Aligned_cols=240 Identities=24% Similarity=0.328 Sum_probs=187.7
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHc--CCCCCceeEEEEeecCC----eee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKS--VRHRNLVKIISSCSNGN----FEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~ 290 (467)
.+..+..+.||+|.||.||+|+. +++.||||++..+ ..+.|..|-+|.+. ++|+||++++++-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 44556678999999999999998 4699999998744 45778888888875 58999999999887665 889
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF------GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~------~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
||++|.+.|+|.+++... ..+|....+++..+++||+|||+ +++++|+|||||++|||+.+|+++.|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999999654 58999999999999999999994 4578899999999999999999999999999
Q ss_pred ceecCCCC-------ccccccccccccccCCCC------CCcccchhhHHHHHHHhcCCCC------------CCccccc
Q 041491 365 AKLLNGKE-------SMRTQTLATIEYGREGQV------SPKSDVYGYGITLIETFTKKKP------------TCEIFCE 419 (467)
Q Consensus 365 a~~~~~~~-------~~~~~~~~~pe~~~~~~~------~~~~Dv~slGvil~el~tg~~P------------f~~~~~~ 419 (467)
|..+.... ..+|..|+|||++.+..- -.+.||||+|.|+|||+++-.- |+.....
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99886432 357889999999865422 1368999999999999986432 3211111
Q ss_pred cc---cHHHH-----Hhhhccc---------ccccccccccccchhHHHHH--HHHHHHHHH
Q 041491 420 EM---NLKNW-----VNDFLPI---------SVMNVVDTSLLRREDKYFAA--KKQCVSSAL 462 (467)
Q Consensus 420 ~~---~~~~~-----~~~~~~~---------~~~~~i~~~l~~~~~~r~~~--~~~~~~~l~ 462 (467)
.. .+.+. .++.+|+ .+++.+..|+..|++.|.++ +.|.+.+|.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 11 11111 2223332 38889999999999999764 445555543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=285.42 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=193.9
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CC----eEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
..++|+..+.||+|+||.||+|.+.. +. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 34678889999999999999998753 43 578888765432 2234688999999999999999999998754 46
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++++||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence 7999999999999998776667899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccc
Q 041491 370 GKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPI 433 (467)
Q Consensus 370 ~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~ 433 (467)
.... ..+..|.+||+..+..++.++|||||||++|||++ |+.||.+.... ...++... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLEKGERLPQPPICTI 238 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCCCCCCCCCCH
Confidence 3221 12346889999888889999999999999999997 99999764222 12223221 1223
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+.+++.+|+..+|++|+ ++.+.+..+.++
T Consensus 239 ~~~~li~~c~~~~p~~Rp-~~~~l~~~l~~~ 268 (303)
T cd05110 239 DVYMVMVKCWMIDADSRP-KFKELAAEFSRM 268 (303)
T ss_pred HHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 478899999999999996 456666665543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=282.29 Aligned_cols=233 Identities=22% Similarity=0.254 Sum_probs=188.5
Q ss_pred cCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
||+|+||+||+|.+. +|+.||+|.+.... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999876 48999999986532 22345567899999999999999999999999999999999999999
Q ss_pred HHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----cccc
Q 041491 302 EKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----SMRT 376 (467)
Q Consensus 302 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----~~~~ 376 (467)
.+++.... ..+++..+..++.|++.|+.||| +.|++||||+|+||++++++.+||+|||.+....... ...+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99886544 36899999999999999999999 9999999999999999999999999999987654321 2344
Q ss_pred ccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHH-------HHhhhcccccccccccccccch
Q 041491 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKN-------WVNDFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 377 ~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~-------~~~~~~~~~~~~~i~~~l~~~~ 447 (467)
..|.+||+..+..++.++||||+||++|+|++|+.||........ .+.. .....+++.+.+++.+||..+|
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 568899998888899999999999999999999999975432110 0111 0112345568999999999999
Q ss_pred hHHHHHHHHHHHHH
Q 041491 448 DKYFAAKKQCVSSA 461 (467)
Q Consensus 448 ~~r~~~~~~~~~~l 461 (467)
.+|++..+....++
T Consensus 238 ~~R~~~~~~~~~~l 251 (277)
T cd05577 238 EKRLGCRGGSADEV 251 (277)
T ss_pred hHccCCCcccHHHH
Confidence 99985333233333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=284.61 Aligned_cols=235 Identities=24% Similarity=0.313 Sum_probs=189.0
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc-----chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG-----ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
+|+..+.||+|++|.||+|.+. +++.||+|.++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999876 5899999999754322 335567899999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+ +++|.+++......+++..+..++.|+++||.||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999998665447899999999999999999999 9999999999999999999999999999998775432
Q ss_pred c-----cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc-----------cHHHH---------
Q 041491 373 S-----MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-----------NLKNW--------- 426 (467)
Q Consensus 373 ~-----~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-----------~~~~~--------- 426 (467)
. ..+..|.+||+..+ ..++.++|||||||++|||++|.+||......+. ....|
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 1 23445788997754 4678899999999999999999888764321110 00001
Q ss_pred -------------HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 427 -------------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 427 -------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.....+..+.+++.+||..+|++|++ +.|.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s-~~e~l 280 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT-ARQAL 280 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC-HHHHh
Confidence 00122345778999999999999984 44443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.23 Aligned_cols=232 Identities=22% Similarity=0.266 Sum_probs=179.4
Q ss_pred CccCcccceeEEEEEecC---CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 224 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998653 46789998875532 23356888999999999999999999999999999999999999
Q ss_pred CHHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 300 SLEKCLYSSN----GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 300 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 24567788899999999999999 9999999999999999999999999999997543322
Q ss_pred ----ccccccccccccccCC-------CCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-----------h
Q 041491 373 ----SMRTQTLATIEYGREG-------QVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-----------D 429 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~-------~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-----------~ 429 (467)
..++..|.+||+.... .++.++||||||+++|||++ |+.||......+.....+.. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 1234457899987532 35789999999999999996 99999754333211111111 0
Q ss_pred hcccccccccccccccchhHHHHHHHHHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFAAKKQCVSS 460 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~ 460 (467)
..++.+.+++..|+ .+|++|+ +++++...
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rp-t~~~l~~~ 266 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRP-SAEEVHLL 266 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCC-CHHHHHHH
Confidence 12234667888887 6899996 55565554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=279.52 Aligned_cols=231 Identities=22% Similarity=0.271 Sum_probs=177.2
Q ss_pred CccCcccceeEEEEEecC---CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 224 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997643 45688887654322 23456789999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 300 SLEKCLYSSNG----ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 300 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+|.+++..... ..++.....++.|++.|++||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 3467788999999999999999 9999999999999999999999999999987543221
Q ss_pred ----cccccccccccccc-------CCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH------------h
Q 041491 373 ----SMRTQTLATIEYGR-------EGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV------------N 428 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~-------~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~------------~ 428 (467)
...+..|.+||+.. ...++.++|||||||++|||++ |..||......+ .+.... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccCccCCCCccc
Confidence 12234588999864 3456789999999999999999 788887543221 111111 1
Q ss_pred hhcccccccccccccccchhHHHHHHHHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCVSS 460 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~ 460 (467)
..+++.+.+++..|+ .||++|++ +.+.++.
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt-~~~v~~~ 266 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPT-AEEVHEL 266 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccC-HHHHHHH
Confidence 122334566777776 59999974 5565554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.37 Aligned_cols=229 Identities=29% Similarity=0.381 Sum_probs=191.1
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc--chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG--ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999875 5899999999766443 567889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc--
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 373 (467)
+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998654 45789999999999999999999 99999999999999999999999999999987654322
Q ss_pred -------cccccccccccccCCC---CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhccc
Q 041491 374 -------MRTQTLATIEYGREGQ---VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPI 433 (467)
Q Consensus 374 -------~~~~~~~~pe~~~~~~---~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~ 433 (467)
..+..|.+||+..... ++.++||||||+++||+++|+.||....... ....... ...++
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcCCCCCCCcccccCH
Confidence 2345678999887665 7899999999999999999999997532111 1111111 01234
Q ss_pred ccccccccccccchhHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~ 452 (467)
.+.+++.+|+..+|.+|++
T Consensus 236 ~~~~li~~~l~~~p~~R~~ 254 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPT 254 (264)
T ss_pred HHHHHHHHHccCCcccCCC
Confidence 5789999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=283.29 Aligned_cols=237 Identities=28% Similarity=0.326 Sum_probs=195.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999875 5789999998755445557788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc--
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 373 (467)
+++++|.+++... .+++..+..++.|++.|+.||| ++|++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 9999999998543 4788999999999999999999 99999999999999999999999999999876543322
Q ss_pred ---cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------Hhhhcccccccccccc
Q 041491 374 ---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------VNDFLPISVMNVVDTS 442 (467)
Q Consensus 374 ---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~i~~~ 442 (467)
.++..|.+||+.....++.++|+||||+++||+++|+.||......+.....+ ....++..+.+++.+|
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 23455889999888888999999999999999999999997542221111111 0112344588999999
Q ss_pred cccchhHHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCVS 459 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~~ 459 (467)
+..+|++|+ ++.+++.
T Consensus 253 l~~~p~~Rp-~~~~il~ 268 (293)
T cd06647 253 LEMDVEKRG-SAKELLQ 268 (293)
T ss_pred ccCChhhCc-CHHHHhc
Confidence 999999996 4555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=281.97 Aligned_cols=232 Identities=23% Similarity=0.390 Sum_probs=188.7
Q ss_pred CccCcccceeEEEEEecC-------CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 224 SLIGIGSFGTVYKGRFLD-------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+.||+|+||.||+|++.+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998753 2579999876443 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-----cEEEecccc
Q 041491 296 MANGSLEKCLYSS------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-----VAHLSDFGI 364 (467)
Q Consensus 296 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~Dfg~ 364 (467)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998642 234788999999999999999999 99999999999999999877 899999999
Q ss_pred ceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------h
Q 041491 365 AKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------N 428 (467)
Q Consensus 365 a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~ 428 (467)
+....... ...+..|.+||+...+.++.++|||||||++|||+| |+.||......+ ...+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~~~ 235 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVTAGGRLQKP 235 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHhcCCccCCc
Confidence 97654321 123456889999998999999999999999999998 999996532221 11111 1
Q ss_pred hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
...|+.+.+++.+||..+|.+|+ ++.++.+.+
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp-~~~~i~~~l 267 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERP-TFDRIQEIL 267 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCC-CHHHHHHHH
Confidence 23445689999999999999996 566666554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=279.65 Aligned_cols=237 Identities=27% Similarity=0.328 Sum_probs=198.1
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
..+.|+..+.||+|++|.||+|.+. +++.|++|++..... ..+.+.+|++.++.++|+|++++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999986 589999999976543 45678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+++++|.+++......+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 99999999999765547899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh---------hhcccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN---------DFLPISVMNVVD 440 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~~~i~ 440 (467)
..++..|.+||+..+..++.++|+|||||++|+|++|+.||....... ....+.. ..++..+.+++.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 123456889999888889999999999999999999999997532221 1111111 124556899999
Q ss_pred cccccchhHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~ 458 (467)
+|+..+|.+|++ +.+.+
T Consensus 252 ~~l~~~p~~Rpt-~~~il 268 (286)
T cd06614 252 KCLVKDPEKRPS-AEELL 268 (286)
T ss_pred HHhccChhhCcC-HHHHh
Confidence 999999999975 34443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=284.32 Aligned_cols=232 Identities=28% Similarity=0.314 Sum_probs=189.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.+.|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999876 589999999864322 2335688999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||++ |++.+.+......+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||++.......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 99997 5777777655567899999999999999999999 9999999999999999999999999999998765432
Q ss_pred -cccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHH-------HHHhhhccccccccccc
Q 041491 373 -SMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK-------NWVNDFLPISVMNVVDT 441 (467)
Q Consensus 373 -~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~ 441 (467)
..++..|.+||+.. .+.++.++||||||+++|||+||+.||........... ......++..+.+++.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence 23456688999863 45688999999999999999999999975322111000 00011234468899999
Q ss_pred ccccchhHHHH
Q 041491 442 SLLRREDKYFA 452 (467)
Q Consensus 442 ~l~~~~~~r~~ 452 (467)
|+..+|++|++
T Consensus 250 ~l~~~p~~Rp~ 260 (307)
T cd06607 250 CLQKIPQDRPS 260 (307)
T ss_pred HhcCChhhCcC
Confidence 99999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=280.33 Aligned_cols=232 Identities=27% Similarity=0.414 Sum_probs=190.4
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCC---CCCceeEEEEeecCCeeeEEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVR---HRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 293 (467)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++ |||++++++++...+..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5778899999999999999975 58999999987543 234567889999999986 999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (467)
||+++++|.+++.. +.+++..+..++.|++.|+.||| +.|++||||+|+||++++++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999998854 36899999999999999999999 99999999999999999999999999999987654332
Q ss_pred -----cccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccH-------HHHHhhhcccccccccc
Q 041491 374 -----MRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL-------KNWVNDFLPISVMNVVD 440 (467)
Q Consensus 374 -----~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~i~ 440 (467)
.++..|.+||+...+ .++.++|+|||||++|+|++|+.||.......... ..+.....+.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 244567899987654 46889999999999999999999997642221100 00111124456889999
Q ss_pred cccccchhHHHHHHH
Q 041491 441 TSLLRREDKYFAAKK 455 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~ 455 (467)
+|+..+|++|++..+
T Consensus 237 ~~l~~~p~~R~~~~~ 251 (277)
T cd06917 237 ACLDEEPKERLSAEE 251 (277)
T ss_pred HHcCCCcccCcCHHH
Confidence 999999999986443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=277.88 Aligned_cols=234 Identities=24% Similarity=0.306 Sum_probs=186.9
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc-----ccchHHHHHHHHHHHcCCCCCceeEEEEeecC--Cee
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFE 289 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 289 (467)
.+|++.+.||+|+||.||+|.+.+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578899999999999999998764 8999999886432 12345788899999999999999999988763 567
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+++|||+++++|.+++... ..+++..+..++.|++.||+||| +++++|+||||+||+++.++.+||+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998644 45788899999999999999999 9999999999999999999999999999987653
Q ss_pred CC--------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhccc
Q 041491 370 GK--------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPI 433 (467)
Q Consensus 370 ~~--------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~ 433 (467)
.. ...++..|.+||...+..++.++|||||||++|||++|+.||....... ...... ...++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIATQPTNPVLPPHVSD 236 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHHHhcCCCCCCCchhhCH
Confidence 21 1234556899999888888999999999999999999999997532111 111111 111223
Q ss_pred ccccccccccccchhHHHHHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.+.+++.+|+. +|.+|++ +.+++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~-~~~il 259 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPS-ADELL 259 (265)
T ss_pred HHHHHHHHHhc-ChhhCCC-HHHHh
Confidence 46788888885 8999974 44443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=283.17 Aligned_cols=232 Identities=25% Similarity=0.281 Sum_probs=188.3
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|+||.||+|.+.+ ++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 478899999999999999999864 89999998764422 234568899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
|++++++.++... ...+++.++..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9999999887643 345899999999999999999999 99999999999999999999999999999987644322
Q ss_pred ----cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHH---------------------
Q 041491 374 ----MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKN--------------------- 425 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~--------------------- 425 (467)
.++..|.+||+..+ ..++.++||||||+++|||++|++||......+. ....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 24556789998764 4567899999999999999999999864321100 0000
Q ss_pred -------------HHhhhcccccccccccccccchhHHHHH
Q 041491 426 -------------WVNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 426 -------------~~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
-....++..+.+++.+|+..+|++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 277 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS 277 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH
Confidence 0011234458899999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=283.96 Aligned_cols=232 Identities=23% Similarity=0.287 Sum_probs=191.0
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
|+....||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344567999999999999875 5899999998765445556788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----c
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-----S 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~ 373 (467)
++|..++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....... .
T Consensus 103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 999987744 45899999999999999999999 9999999999999999999999999999987554321 2
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------hhhcccccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------NDFLPISVMNVVDTSLL 444 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~l~ 444 (467)
.++..|.+||+.....++.++|||||||++|||++|+.||......+ ...... ...++..+.+++.+|+.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 34567889999988889999999999999999999999997532211 111110 11234458899999999
Q ss_pred cchhHHHHHHHHHH
Q 041491 445 RREDKYFAAKKQCV 458 (467)
Q Consensus 445 ~~~~~r~~~~~~~~ 458 (467)
.+|.+|++ +.+.+
T Consensus 257 ~~P~~Rps-~~~ll 269 (297)
T cd06659 257 REPQERAT-AQELL 269 (297)
T ss_pred CCcccCcC-HHHHh
Confidence 99999974 44444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=277.24 Aligned_cols=238 Identities=22% Similarity=0.338 Sum_probs=192.1
Q ss_pred cCccCCccCcccceeEEEEEecC--CCeEEEEEeeccc----------ccchHHHHHHHHHHHc-CCCCCceeEEEEeec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD--GMEVAIKVFHLQF----------DGALKSFDAECEVLKS-VRHRNLVKIISSCSN 285 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 285 (467)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999865 6889999875321 2233456778888875 799999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEec
Q 041491 286 GNFEALVLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~D 361 (467)
.+..+++|||+++++|.+++.. ....+++..++.++.|++.|+.||| . .+++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3446899999999999999999999 6 6899999999999999999999999
Q ss_pred cccceecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------h
Q 041491 362 FGIAKLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------D 429 (467)
Q Consensus 362 fg~a~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~ 429 (467)
||.+....... ..++..|.+||+..+..++.++||||||+++|||++|+.||....... ....... .
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-LATKIVEAVYEPLPEG 236 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-HHHHHhhccCCcCCcc
Confidence 99998765442 234556889999988889999999999999999999999996532111 1111111 1
Q ss_pred hcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
..++.+.+++.+|+..+|++|+ ++.|+...+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp-~~~e~~~~~ 267 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARP-DIIQVSAMI 267 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCC-CHHHHHHHh
Confidence 2345688999999999999997 455555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=285.30 Aligned_cols=186 Identities=23% Similarity=0.274 Sum_probs=154.2
Q ss_pred CccCcccceeEEEEEecC---CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEee--cCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS--NGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~ 298 (467)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999998753 5789999886442 2346788999999999999999999885 35678999999865
Q ss_pred CCHHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----cCCCcEEEeccccce
Q 041491 299 GSLEKCLYSS--------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAK 366 (467)
Q Consensus 299 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~ 366 (467)
+|.+++... ...+++..+..++.|++.||.||| +++|+||||||+||++ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777766321 125788999999999999999999 9999999999999999 566799999999998
Q ss_pred ecCCCC--------ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 367 LLNGKE--------SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 367 ~~~~~~--------~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
...... ..++..|.+||+..+ ..++.++|||||||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 765322 234566899998765 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.06 Aligned_cols=231 Identities=24% Similarity=0.292 Sum_probs=190.3
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|++|.||+|.+.+ ++.||+|+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368899999999999999998864 8899999886542 2344678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|++++.+..+.. ....+++.++..++.|++.|+.||| +.+++||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 999877766553 4456899999999999999999999 9999999999999999999999999999998765443
Q ss_pred ----ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc--------------------------
Q 041491 373 ----SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-------------------------- 421 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-------------------------- 421 (467)
...+..|.+||+.... .++.++||||||+++|+|++|+.||......+.
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 1234567899998877 789999999999999999999999964311100
Q ss_pred -----------cHHHHHhhhcccccccccccccccchhHHHH
Q 041491 422 -----------NLKNWVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 422 -----------~~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
.........++.++.+++.+||..+|++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 278 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc
Confidence 0011111223566899999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=270.54 Aligned_cols=231 Identities=23% Similarity=0.386 Sum_probs=187.0
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHc--CCCCCceeEEEEeecCC----eeeE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKS--VRHRNLVKIISSCSNGN----FEAL 291 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l 291 (467)
.+..+.+.||+|.||+||+|+| .|+.||||++... ..+.+.+|.+|.+. ++|+||+.+++.-..++ .++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 4677889999999999999999 5899999999744 44678889998886 59999999998865443 6789
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF-----GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
|++|-+.|+|.||+.. ..++....++++..++.||+|||. ..++.|.|||||+.|||+..++.+.|+|+|+|.
T Consensus 287 vTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999955 568999999999999999999993 236789999999999999999999999999998
Q ss_pred ecCCC---------CccccccccccccccCCC----C--CCcccchhhHHHHHHHhcC----------CCCCCccccccc
Q 041491 367 LLNGK---------ESMRTQTLATIEYGREGQ----V--SPKSDVYGYGITLIETFTK----------KKPTCEIFCEEM 421 (467)
Q Consensus 367 ~~~~~---------~~~~~~~~~~pe~~~~~~----~--~~~~Dv~slGvil~el~tg----------~~Pf~~~~~~~~ 421 (467)
..... ...+|..|+|||++.... + -..+||||||.|+||++-+ +.||.+....+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 76543 345788899999875432 1 1368999999999998763 578988777776
Q ss_pred cHHHHH--------hhhccc---------ccccccccccccchhHHHHHH
Q 041491 422 NLKNWV--------NDFLPI---------SVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 422 ~~~~~~--------~~~~~~---------~~~~~i~~~l~~~~~~r~~~~ 454 (467)
++.+.. ++.+|. .+..+...|+-.+|.-|.++.
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 666552 223332 256677888888998887654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=279.63 Aligned_cols=233 Identities=25% Similarity=0.284 Sum_probs=190.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeec--CCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 293 (467)
++|+..+.||.|++|.||+|.+. +++.+|+|.+..... .....+.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999986 488999999875432 345678999999999999999999998854 34789999
Q ss_pred ecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887643 3346889999999999999999999 99999999999999999999999999999876543
Q ss_pred CC---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccc---ccccHHHHHhh--------------h
Q 041491 371 KE---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFC---EEMNLKNWVND--------------F 430 (467)
Q Consensus 371 ~~---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~---~~~~~~~~~~~--------------~ 430 (467)
.. ...+..|.+||...+..++.++||||+|+++|||++|+.||..... .......+... .
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 22 2345568899999888899999999999999999999999976522 11223333222 0
Q ss_pred cccccccccccccccchhHHHHH
Q 041491 431 LPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 431 ~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
+++.+.+++.+|+..+|.+|++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~ 260 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTP 260 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCH
Confidence 12246799999999999999753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=281.77 Aligned_cols=231 Identities=21% Similarity=0.264 Sum_probs=187.4
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecC--CeeeEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFEALV 292 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 292 (467)
++|++.+.||+|+||.||+|.+. +++.+|+|.++.... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999986 488999999875432 2234567899999999999999999998877 889999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++ +|.+++......+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||.+.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999975 999888665567899999999999999999999 9999999999999999999999999999998765532
Q ss_pred -----ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc-------------------------
Q 041491 373 -----SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM------------------------- 421 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~------------------------- 421 (467)
...+..|.+||...+. .++.++|+||+|+++|||++|+.||......+.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 2245567899987654 468899999999999999999999974321100
Q ss_pred --------cHHHH---Hhhh-cccccccccccccccchhHHHH
Q 041491 422 --------NLKNW---VNDF-LPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 422 --------~~~~~---~~~~-~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
....+ .... +++.+.+++.+||..+|++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t 283 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC
Confidence 00000 0001 2445788999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=276.88 Aligned_cols=239 Identities=22% Similarity=0.353 Sum_probs=190.5
Q ss_pred CccCCccCcccceeEEEEEec----CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC------
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 287 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 287 (467)
|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999764 36889999987542 234567889999999999999999999886432
Q ss_pred eeeEEEecccCCCHHHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecc
Q 041491 288 FEALVLEYMANGSLEKCLYSS-----NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
..++++||+++|+|.+++... ...+++.....++.|++.|++||| +++|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998876432 125788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh------
Q 041491 363 GIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN------ 428 (467)
Q Consensus 363 g~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~------ 428 (467)
|+++...... ...+..|.+||......++.++||||||+++|||++ |+.||...... ....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~ 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIKGNRLK 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHcCCcCC
Confidence 9998664322 112345678888888888999999999999999999 88998754322 2222221
Q ss_pred --hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 429 --DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 429 --~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
...+..+.+++.+|+..+|++|+ ++.+.+..|-++
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rp-s~~~~~~~l~~~ 272 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRP-SFQHLRDQLELI 272 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHhh
Confidence 12334589999999999999995 777888777554
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=281.67 Aligned_cols=235 Identities=21% Similarity=0.236 Sum_probs=199.7
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
....+.|+.-+.||+|+||+||-++.++ |+.||+|.+.+.. ........+|..+|.+++.+.||.+--.|+..+..
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 4456778999999999999999998764 9999999886442 23345677899999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 290 ALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
|+|+..|.||||.-++.+.. +.+++..+..++.+|+-||++|| +.+||.||+||+|||+|+.|+++|+|+|+|..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999887664 37999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccc----cccH-----HHHHhhhccccc
Q 041491 369 NGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE----EMNL-----KNWVNDFLPISV 435 (467)
Q Consensus 369 ~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~----~~~~-----~~~~~~~~~~~~ 435 (467)
.... ..+|..|+|||++..+.|+...|.||+||++|||+.|+.||...... +.+- ..-....++++.
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 7654 35788999999999999999999999999999999999999653111 1110 011224456678
Q ss_pred ccccccccccchhHHH
Q 041491 436 MNVVDTSLLRREDKYF 451 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~ 451 (467)
+++....|.+||.+|.
T Consensus 418 kslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRL 433 (591)
T ss_pred HHHHHHHHccCHHHhc
Confidence 8899999999999984
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=272.09 Aligned_cols=236 Identities=31% Similarity=0.365 Sum_probs=197.9
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
+|+..+.||+|++|.||++.+. +++.+++|++........+.+.+|++.+++++||+++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999986 588999999976654456789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----c
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----S 373 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----~ 373 (467)
+++|.+++......+++..+..++.|++.|+++|| .+|++||||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99999998766567899999999999999999999 9999999999999999999999999999998776542 2
Q ss_pred cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-------H-hhhccccccccccccccc
Q 041491 374 MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-------V-NDFLPISVMNVVDTSLLR 445 (467)
Q Consensus 374 ~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-------~-~~~~~~~~~~~i~~~l~~ 445 (467)
.++..|.+||+.....++.++||||||+++|+|++|+.||............. . ...++..+.+++.+|+..
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 34566789999988889999999999999999999999997542111100000 0 011245589999999999
Q ss_pred chhHHHHHHHHHH
Q 041491 446 REDKYFAAKKQCV 458 (467)
Q Consensus 446 ~~~~r~~~~~~~~ 458 (467)
+|++|++ +.+.+
T Consensus 238 ~p~~R~t-~~~~l 249 (253)
T cd05122 238 NPEKRPT-AEQLL 249 (253)
T ss_pred ChhhCCC-HHHHh
Confidence 9999975 44443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=276.22 Aligned_cols=232 Identities=25% Similarity=0.307 Sum_probs=191.1
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec--CCeeeEEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFEALVL 293 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 293 (467)
+|++.+.||.|+||.||+|.+. +++.||+|.+.... ....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888899999999999999875 48899999986432 2334668889999999999999999997753 45679999
Q ss_pred ecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 294 EYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGY--SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 294 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
||+++++|.+++... ...+++..++.++.|++.||.|||..+ +.+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988653 457899999999999999999999443 578999999999999999999999999999877
Q ss_pred CCCCc-----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccccc
Q 041491 369 NGKES-----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISV 435 (467)
Q Consensus 369 ~~~~~-----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 435 (467)
..... .++..|.+||+.....++.++|+||||+++|+|++|+.||...... ...+... ..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHHHhcCCCCCCccccCHHH
Confidence 54332 3456688999998888999999999999999999999999764321 1212211 2233458
Q ss_pred ccccccccccchhHHHH
Q 041491 436 MNVVDTSLLRREDKYFA 452 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~ 452 (467)
.+++.+|+..+|++|++
T Consensus 239 ~~l~~~~l~~~p~~Rp~ 255 (265)
T cd08217 239 NEVIKSMLNVDPDKRPS 255 (265)
T ss_pred HHHHHHHccCCcccCCC
Confidence 89999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=279.01 Aligned_cols=232 Identities=27% Similarity=0.361 Sum_probs=192.0
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
-|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4777899999999999999875 58899999886442 234467889999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
++++|.+++.. ..+++..+..++.|++.|+.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999998853 45889999999999999999999 9999999999999999999999999999987665432
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhccccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVDTSL 443 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~~l 443 (467)
..++..|.+||+..+..++.++|+|||||++|+|++|..||....... ..... ....+.++.+++.+|+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIPKNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence 134556789999888888999999999999999999999997532211 11111 1123446889999999
Q ss_pred ccchhHHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQCV 458 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~ 458 (467)
..+|.+|++ +.+.+
T Consensus 238 ~~~p~~Rp~-~~~~l 251 (277)
T cd06641 238 NKEPSFRPT-AKELL 251 (277)
T ss_pred cCChhhCcC-HHHHH
Confidence 999999964 44443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=293.43 Aligned_cols=193 Identities=32% Similarity=0.478 Sum_probs=162.4
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC------eeeE
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------FEAL 291 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l 291 (467)
|...+.||+|+||.||+|+++ .|+.||||.++... ....+...+|++++++++|||||++.++-+... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445688999999999999976 59999999997643 234577889999999999999999999765543 5679
Q ss_pred EEecccCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec--CCC--cEEEeccccc
Q 041491 292 VLEYMANGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--DDM--VAHLSDFGIA 365 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~Dfg~a 365 (467)
|||||.||||...+.+... .+++.+.+.++.++..||.||| ++||+||||||.||++- ++| --||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999976543 6999999999999999999999 99999999999999983 334 4699999999
Q ss_pred eecCCCCc----ccccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 366 KLLNGKES----MRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 366 ~~~~~~~~----~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
+.+.+... .+|..|-+||... .+.|+..+|.|||||++||.+||..||..
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99887663 2444555555555 36788899999999999999999999964
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=283.44 Aligned_cols=194 Identities=25% Similarity=0.331 Sum_probs=164.0
Q ss_pred cCccCCccCcccceeEEEEEecC---CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecC--Ceee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFEA 290 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 290 (467)
+|++.+.||+|++|.||+|.+.. ++.||+|.+.... ......+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998854 7899999998633 34446778899999999999999999999888 8899
Q ss_pred EEEecccCCCHHHhhhcC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC----CCcEEEecc
Q 041491 291 LVLEYMANGSLEKCLYSS----NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD----DMVAHLSDF 362 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~Df 362 (467)
+||||+++ ++.+.+... ...+++..++.++.|++.|++||| +++|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666655322 236889999999999999999999 999999999999999999 899999999
Q ss_pred ccceecCCCCc--------cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 363 GIAKLLNGKES--------MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 363 g~a~~~~~~~~--------~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
|++........ ..+..|.+||+..+ ..++.++|||||||++|||++|+.||...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99987643221 33556889997765 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=317.06 Aligned_cols=233 Identities=27% Similarity=0.340 Sum_probs=193.0
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
+-+++...+||.|.||.||.|...+ |.-.|+|-++.+.. ...+.+.+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3467788899999999999998764 88899998875532 34567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|||++|+|.+.+. ..+..++.....+..|++.|++||| +.|||||||||+||+++.+|.+|++|||.|..+.+..
T Consensus 1314 EyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999999884 4445677777889999999999999 9999999999999999999999999999999887543
Q ss_pred --------ccccccccccccccCCC---CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-------Hhhhcccc
Q 041491 373 --------SMRTQTLATIEYGREGQ---VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-------VNDFLPIS 434 (467)
Q Consensus 373 --------~~~~~~~~~pe~~~~~~---~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-------~~~~~~~~ 434 (467)
..+|+.|+|||.+.+.. -.-++||||+|||+.||+||++||.....+-..+-+. ..+.++.+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 35788899999876533 3568999999999999999999998754332111111 11223445
Q ss_pred cccccccccccchhHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~ 453 (467)
-+++++.||..||++|+++
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred HHHHHHHHHhcCchhhhHH
Confidence 7899999999999999854
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=277.76 Aligned_cols=233 Identities=23% Similarity=0.273 Sum_probs=191.9
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
+|...+.||+|++|.||++.+. +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555689999999999999875 588999999875544455678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----- 372 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----- 372 (467)
+++|.+++.. ..+++..+..++.|++.|++||| ++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 9999999865 46899999999999999999999 9999999999999999999999999999887544321
Q ss_pred ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------hhhccccccccccccc
Q 041491 373 SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------NDFLPISVMNVVDTSL 443 (467)
Q Consensus 373 ~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~l 443 (467)
..++..|.+||...+..++.++|||||||++|||++|+.||........ ..... ...++..+.+++.+|+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-MKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 2345668899999888899999999999999999999999965321110 00000 0113446889999999
Q ss_pred ccchhHHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQCV 458 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~ 458 (467)
..+|++|++ +.+.+
T Consensus 254 ~~~p~~Rpt-~~~il 267 (285)
T cd06648 254 VRDPAQRAT-AAELL 267 (285)
T ss_pred ccChhhCcC-HHHHc
Confidence 999999974 34443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=279.12 Aligned_cols=239 Identities=21% Similarity=0.249 Sum_probs=191.1
Q ss_pred cCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc----ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 289 (467)
+|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++++ +|+||+++++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999863 58899999987532 12346678899999999 599999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||++++++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999998654 46889999999999999999999 9999999999999999999999999999998764
Q ss_pred CCC------ccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh----------hc
Q 041491 370 GKE------SMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND----------FL 431 (467)
Q Consensus 370 ~~~------~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~----------~~ 431 (467)
... ..++..|.+||+... ..++.++||||||+++|+|++|+.||..... ......+... .+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEPPYPQEM 235 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccCCCCCccC
Confidence 422 224556789998765 3467899999999999999999999964211 1111222111 12
Q ss_pred ccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
++.+.+++.+|+..+|++|++.....+.+++
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 3347899999999999999854444444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=281.72 Aligned_cols=238 Identities=24% Similarity=0.301 Sum_probs=189.2
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecC--Ceee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 290 (467)
..++|++.+.||+|+||.||+|.+. +|+.||+|+++.... .....+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999999986 489999999875432 2234566899999999999999999998754 5689
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++ +|.+++......+++.++..++.|++.|++||| +.|++||||||+||++++++.+||+|||.+.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999965 888888765667899999999999999999999 99999999999999999999999999999987754
Q ss_pred CCc-----cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHH---------H-------
Q 041491 371 KES-----MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKN---------W------- 426 (467)
Q Consensus 371 ~~~-----~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~---------~------- 426 (467)
... ..+..|.+||...+ ..++.++||||+||++|||++|+.||......+. .... |
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 321 22445889998765 5578999999999999999999999964321110 0000 0
Q ss_pred -----------------HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 427 -----------------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 427 -----------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.....++.+.++|.+||..||.+|++ +.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t-~~~il 288 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT-AEEAL 288 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC-HHHHh
Confidence 00112445778999999999999975 33433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=278.53 Aligned_cols=230 Identities=24% Similarity=0.314 Sum_probs=187.8
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
+|+..+.||.|++|.||+|++. +|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999986 488999999876532 23466778999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 297 ANGSLEKCLYSSN--GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
++ +|.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||++++++.++++|||.+.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 8888875543 46899999999999999999999 9999999999999999999999999999997654321
Q ss_pred ---ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc--------------HH----------
Q 041491 373 ---SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--------------LK---------- 424 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--------------~~---------- 424 (467)
...+..|.+||+..+ ..++.++|||||||++|||++|+.||.+....+.. ..
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 223556889998755 35688999999999999999999999754322100 00
Q ss_pred ----------HHHhhhcccccccccccccccchhHHHH
Q 041491 425 ----------NWVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 425 ----------~~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
.......+..+.+++.+|+..+|.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 274 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS 274 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence 0011233556889999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=267.26 Aligned_cols=227 Identities=19% Similarity=0.279 Sum_probs=186.9
Q ss_pred CccCcccceeEEEEEe-cCCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 224 SLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
+.||+|+|+.|--+.. .+|.+||||++.++......+..+|++++.+.+ |+||++++++|+++..+|+|||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 7899999999998865 469999999999886667788999999999995 99999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC---cEEEeccccceecCCCC------
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---VAHLSDFGIAKLLNGKE------ 372 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~------ 372 (467)
...+.+. ..+++.++.++.++|+.||.||| .+||.|||+||+|||-.+.. -+|||||.++.-+....
T Consensus 164 LshI~~~-~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQKR-KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHh-hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9988544 46899999999999999999999 99999999999999986544 58999998875443211
Q ss_pred ------cccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCcccc-----------------------
Q 041491 373 ------SMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFC----------------------- 418 (467)
Q Consensus 373 ------~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~----------------------- 418 (467)
..++..|+|||+.. .-.|+.++|.||+|||+|-|++|.+||.+.-.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 12334456666532 23578899999999999999999999975311
Q ss_pred -ccccHHHHHhhhcccccccccccccccchhHHHHHH
Q 041491 419 -EEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 419 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
....+.+.-|.+++.+..+++...|.+++.+|..++
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~ 356 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAA 356 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhh
Confidence 112344445667778899999999999999997554
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=276.48 Aligned_cols=224 Identities=21% Similarity=0.272 Sum_probs=177.9
Q ss_pred ccCcccceeEEEEEec-CCCeEEEEEeeccccc---chHHHHHHHH---HHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 225 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG---ALKSFDAECE---VLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 225 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
.||+|+||.||+|.+. +++.||+|.+...... ....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 4889999998654211 1122334433 3444579999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---Ccc
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---ESM 374 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~ 374 (467)
|++|.+++.. .+.+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcC
Confidence 9999998854 457899999999999999999999 999999999999999999999999999998765432 234
Q ss_pred ccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------Hhhhccccccccccccccc
Q 041491 375 RTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------VNDFLPISVMNVVDTSLLR 445 (467)
Q Consensus 375 ~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~ 445 (467)
++..|.+||+...+ .++.++||||+||++|||++|+.||............. .....+.++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 56678899998754 58899999999999999999999997642221111111 1112345688999999999
Q ss_pred chhHHHH
Q 041491 446 REDKYFA 452 (467)
Q Consensus 446 ~~~~r~~ 452 (467)
+|.+|+.
T Consensus 237 ~p~~R~~ 243 (278)
T cd05606 237 DVNRRLG 243 (278)
T ss_pred CHHhccC
Confidence 9999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=271.45 Aligned_cols=229 Identities=31% Similarity=0.395 Sum_probs=193.4
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|++|.||+|.+. +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788899999999999999876 478999999976543 3456789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc--
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 373 (467)
+++++|.+++... ..+++..+..++.|++.|+.+|| +.|++||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 9999999988654 57899999999999999999999 99999999999999999999999999999987765433
Q ss_pred ---cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------hhhccccccccccccc
Q 041491 374 ---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-------NDFLPISVMNVVDTSL 443 (467)
Q Consensus 374 ---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l 443 (467)
..+..|.+||+.....++.++||||+|+++|+|++|+.||....... ...... ...++..+.+++.+||
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 235 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-ALFRIVQDDHPPLPEGISPELKDFLMQCF 235 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence 34556789998877778999999999999999999999997532111 111111 1223456889999999
Q ss_pred ccchhHHHH
Q 041491 444 LRREDKYFA 452 (467)
Q Consensus 444 ~~~~~~r~~ 452 (467)
..+|++|++
T Consensus 236 ~~~p~~R~~ 244 (254)
T cd06627 236 QKDPNLRPT 244 (254)
T ss_pred hCChhhCcC
Confidence 999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=273.55 Aligned_cols=224 Identities=23% Similarity=0.277 Sum_probs=182.0
Q ss_pred CccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHH-HcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVL-KSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|.+. +++.||+|+++.... .....+..|..++ ...+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999885 489999999865422 1223344555444 455899999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-Cccccc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-ESMRTQ 377 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 377 (467)
++|.+++... +.+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||++...... ...++.
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTP 157 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCc
Confidence 9999988543 46889999999999999999999 999999999999999999999999999998865432 234556
Q ss_pred cccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----------Hhhhcccccccccccccccch
Q 041491 378 TLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----------VNDFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 378 ~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~~ 447 (467)
.|.+||+..+..++.++||||+|+++|||+||..||........ .... ....++..+.+++.+||..+|
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence 78899998888889999999999999999999999975432211 1111 111345678999999999999
Q ss_pred hHHHH
Q 041491 448 DKYFA 452 (467)
Q Consensus 448 ~~r~~ 452 (467)
++|++
T Consensus 237 ~~R~~ 241 (260)
T cd05611 237 AKRLG 241 (260)
T ss_pred HHccC
Confidence 99985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=272.28 Aligned_cols=235 Identities=30% Similarity=0.368 Sum_probs=197.3
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecC--CeeeEEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFEALVL 293 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 293 (467)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999987 589999999876542 3467889999999999999999999999988 8899999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999986554 7899999999999999999999 9999999999999999999999999999998776543
Q ss_pred ------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHH--------HHhhhcccccccc
Q 041491 373 ------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN--------WVNDFLPISVMNV 438 (467)
Q Consensus 373 ------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~ 438 (467)
...+..|.+||+.....++.++||||||+++|+|++|+.||............ .....++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 23455678999988888999999999999999999999999764311111111 1122335569999
Q ss_pred cccccccchhHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~ 458 (467)
+.+|+..+|++|+ ++.+++
T Consensus 237 i~~~l~~~p~~Rp-~~~~ll 255 (260)
T cd06606 237 LRKCLRRDPKKRP-TADELL 255 (260)
T ss_pred HHHhCcCChhhCC-CHHHHh
Confidence 9999999999997 444444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=279.89 Aligned_cols=235 Identities=27% Similarity=0.312 Sum_probs=191.2
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.|+..+.||+|+||.||+|++. ++..||+|.+.... ......+.+|++++++++|||++++++++..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999875 48899999986432 2234568889999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-c
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-S 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 373 (467)
|+.+ ++.+.+......+++.++..++.|++.|+.||| +++++||||+|+||+++.++.+||+|||++....... .
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF 181 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccc
Confidence 9975 787777665667899999999999999999999 9999999999999999999999999999987655432 3
Q ss_pred cccccccccccc---cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh--------hcccccccccccc
Q 041491 374 MRTQTLATIEYG---REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND--------FLPISVMNVVDTS 442 (467)
Q Consensus 374 ~~~~~~~~pe~~---~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~i~~~ 442 (467)
.++..|.+||+. ..+.++.++|||||||++|||++|+.||....... ....+... .+++.+.+++.+|
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 355678999986 34678899999999999999999999987532211 12222221 2334588999999
Q ss_pred cccchhHHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCVS 459 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~~ 459 (467)
+..+|.+|+ ++.+.+.
T Consensus 261 l~~~p~~Rp-t~~~il~ 276 (317)
T cd06635 261 LQKIPQDRP-TSEELLK 276 (317)
T ss_pred ccCCcccCc-CHHHHHh
Confidence 999999996 4555554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=279.72 Aligned_cols=231 Identities=25% Similarity=0.311 Sum_probs=186.1
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|+..+.||.|++|.||+|++. +++.||+|.++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999886 48999999886543 22335788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 296 MANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
+. ++|..++... ...+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 5888887554 346899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ---ccccccccccccccCCC-CCCcccchhhHHHHHHHhcCCCCCCcccccccc--------------------HHHH--
Q 041491 373 ---SMRTQTLATIEYGREGQ-VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--------------------LKNW-- 426 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~-~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--------------------~~~~-- 426 (467)
...+..|.+||+..+.. ++.++||||||+++|||+||+.||......+.. ...+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 12345678999876544 588999999999999999999999653211100 0000
Q ss_pred -----H-------hhhcccccccccccccccchhHHHHH
Q 041491 427 -----V-------NDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 -----~-------~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
. ...+++++.++|.+|+..||.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 275 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence 0 01233457789999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=276.03 Aligned_cols=232 Identities=23% Similarity=0.254 Sum_probs=184.7
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCC-CCCceeEEEEeecC--CeeeEEEe
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVR-HRNLVKIISSCSNG--NFEALVLE 294 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 294 (467)
|++.+.||+|+||.||+|... +++.||+|.++.... .......+|+.+++++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 667889999999999999876 589999999875422 22234457888898885 99999999999887 88999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+++ ++.+.+......+++.++..++.|++.||+||| +.|++||||||+||+++. +.+||+|||.++......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 9974 888877665567899999999999999999999 999999999999999999 999999999998764332
Q ss_pred --cccccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------cHH---------------
Q 041491 373 --SMRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----------NLK--------------- 424 (467)
Q Consensus 373 --~~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----------~~~--------------- 424 (467)
...+..|.+||+.. .+.++.++||||+||++|||++|+.||......+. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence 23456688999654 45678899999999999999999999965321110 000
Q ss_pred ---------HHHhhhcccccccccccccccchhHHHHHHHHH
Q 041491 425 ---------NWVNDFLPISVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 425 ---------~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
......++..+.+++.+||..+|++|++ +.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~-~~~~ 276 (282)
T cd07831 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT-AKQA 276 (282)
T ss_pred CcccccccHHHHcccccHHHHHHHHHHhccCcccccC-HHHH
Confidence 0011234566899999999999999975 3443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=273.71 Aligned_cols=232 Identities=19% Similarity=0.269 Sum_probs=175.4
Q ss_pred CccCcccceeEEEEEecCCC---eEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 224 SLIGIGSFGTVYKGRFLDGM---EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 35999999999999765433 45666655432 234567899999999999999999999999999999999999999
Q ss_pred CHHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC------
Q 041491 300 SLEKCLYSSN---GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG------ 370 (467)
Q Consensus 300 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~------ 370 (467)
+|.+++.... ...++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999986532 24567778899999999999999 99999999999999999999999999999864321
Q ss_pred -CCccccccccccccccC-------CCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------h----
Q 041491 371 -KESMRTQTLATIEYGRE-------GQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------D---- 429 (467)
Q Consensus 371 -~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~---- 429 (467)
....++..|.+||+... ..++.++|||||||++|||++ |..||......+ .+..... +
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhhcccccCCCccCC
Confidence 12234556889998642 245789999999999999997 577886532221 1111111 1
Q ss_pred hcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
.+++.+.+++..|+ .+|++|+ ++.++++.|
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp-~~~~i~~~l 266 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRA-TAEEVHRLL 266 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCC-CHHHHHHHh
Confidence 12233667888888 5799996 555665544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=290.67 Aligned_cols=230 Identities=23% Similarity=0.352 Sum_probs=184.6
Q ss_pred ccCCccCcccceeEEEEEecC-CCeEEEEEeec----ccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe--eeEEE
Q 041491 221 SEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL----QFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF--EALVL 293 (467)
Q Consensus 221 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~ 293 (467)
+....||+|+|-+||+|.+.. |.+||--.++. +.....++|..|+++|+.|+||||+++++++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 334789999999999998853 77776432221 223455889999999999999999999999987654 77899
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-CcEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 372 (467)
|.+..|+|..|.++. +.++...++.|++||++||.|||. ...+|||||||.+||||+.+ |.|||+|+|+|.......
T Consensus 123 EL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999999654 468899999999999999999994 47899999999999999764 799999999999876544
Q ss_pred c---cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhc--------cccccccccc
Q 041491 373 S---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFL--------PISVMNVVDT 441 (467)
Q Consensus 373 ~---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~i~~ 441 (467)
. .+|+.++|||+.. +.|+..+||||||+.++||+|+.+||..-......+++.....- .++++++|.+
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek 279 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK 279 (632)
T ss_pred cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence 3 4566666666544 77899999999999999999999999875544444444433222 2359999999
Q ss_pred ccccchhHHHHHH
Q 041491 442 SLLRREDKYFAAK 454 (467)
Q Consensus 442 ~l~~~~~~r~~~~ 454 (467)
||.. ..+|+++.
T Consensus 280 Cl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 280 CLAT-KSERLSAK 291 (632)
T ss_pred HhcC-chhccCHH
Confidence 9999 77887544
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=274.06 Aligned_cols=235 Identities=23% Similarity=0.324 Sum_probs=192.8
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|+||.||+|.... |..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 57888999999999999998864 8899999986542 12345778999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceecCCCCc
Q 041491 296 MANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 373 (467)
+++++|.+++....+ .+++..+..++.|++.|+.||| +.+++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999998865443 5799999999999999999999 99999999999999999886 469999999987654321
Q ss_pred -----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhccccccccccc
Q 041491 374 -----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDT 441 (467)
Q Consensus 374 -----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~ 441 (467)
.++..|.+||+.....++.++|+||||+++|||++|+.||......+. ...... ...+..+.+++.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-VLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 245568899998888899999999999999999999999975322211 111111 1233458999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
|+..+|++|+ ++.+++
T Consensus 237 ~l~~~p~~Rp-t~~~ll 252 (257)
T cd08225 237 LFKVSPRDRP-SITSIL 252 (257)
T ss_pred HhccChhhCc-CHHHHh
Confidence 9999999997 444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=283.69 Aligned_cols=234 Identities=23% Similarity=0.292 Sum_probs=189.1
Q ss_pred HHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecc--cccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeee
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 290 (467)
.+....|++.++||+||.+.||++...+.+.||+|.+... +......|.+|+..|.+++ |.+|+++++|-..+++.|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3445679999999999999999999878788888876432 3445678999999999995 999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||- ..||..++.+....++...++.+..||+.|+.++| ..||||.||||.|+|+-. |.+||+|||.|..+..
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 999965 56999999887776665688899999999999999 999999999999999975 5899999999998775
Q ss_pred CC-------ccccccccccccccCC-----------CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----
Q 041491 371 KE-------SMRTQTLATIEYGREG-----------QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN---- 428 (467)
Q Consensus 371 ~~-------~~~~~~~~~pe~~~~~-----------~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~---- 428 (467)
.. ..+|..|++||.+... ..+.++||||+|||+|+|+.|+.||......-..+.....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 43 3578889999865321 2467899999999999999999999764211111111111
Q ss_pred ---hhccc--ccccccccccccchhHHHH
Q 041491 429 ---DFLPI--SVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 429 ---~~~~~--~~~~~i~~~l~~~~~~r~~ 452 (467)
+.+|+ ++.++...||.+||++|++
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~s 620 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWS 620 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCC
Confidence 12222 2889999999999999984
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=277.33 Aligned_cols=232 Identities=24% Similarity=0.297 Sum_probs=184.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|++|.||+|.+. +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999886 589999998865422 234568899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEEEeccccceecCCCC
Q 041491 295 YMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 372 (467)
|++ +++.+++..... .+++..+..++.|++.||+||| +++++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 478777644333 4678888999999999999999 999999999999999985 5579999999997654321
Q ss_pred -----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc--------------------HHHH
Q 041491 373 -----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--------------------LKNW 426 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--------------------~~~~ 426 (467)
..++..|.+||+..+ ..++.++||||+||++|+|+||+.||......+.. +.++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 223456889998765 45789999999999999999999999653221110 0111
Q ss_pred --------------HhhhcccccccccccccccchhHHHHH
Q 041491 427 --------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 --------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
....+++.+.+++.+||..+|++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 278 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA 278 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence 011234457889999999999999753
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=279.27 Aligned_cols=231 Identities=22% Similarity=0.244 Sum_probs=184.4
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCC-CCCceeEEEEeecCCe-----
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVR-HRNLVKIISSCSNGNF----- 288 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 288 (467)
++|++.+.||+|+||.||+|.+. +++.||+|.++.... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999986 489999998865432 23456888999999995 6999999999876655
Q ss_pred eeEEEecccCCCHHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEEEeccc
Q 041491 289 EALVLEYMANGSLEKCLYSSN----GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLSDFG 363 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg 363 (467)
.|+||||+++ +|.+++.... ..+++..++.++.|++.||.||| +++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 8888775432 35799999999999999999999 999999999999999998 8899999999
Q ss_pred cceecCCCC-----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc---------------
Q 041491 364 IAKLLNGKE-----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--------------- 422 (467)
Q Consensus 364 ~a~~~~~~~-----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--------------- 422 (467)
.++...... ...+..|.+||+..+ ..++.++||||||+++|||++|..||.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 998654321 123456789998754 45789999999999999999999999643211100
Q ss_pred -----HH-------------HHHhhhcccccccccccccccchhHHHH
Q 041491 423 -----LK-------------NWVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 423 -----~~-------------~~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
.. ......++.++.++|.+||..+|.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~ 284 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC
Confidence 00 0011234556889999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=276.40 Aligned_cols=234 Identities=26% Similarity=0.323 Sum_probs=188.0
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
|++.+.||.|++|.||+|.+. +|..||+|++.... ......+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999876 59999999987543 223456888999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 297 ANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+ ++|.+++.... ..+++..+..++.|++.||+||| +++++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 5 68998886544 36899999999999999999999 9999999999999999999999999999997654321
Q ss_pred --ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCcccccccc--------------------HHHH---
Q 041491 373 --SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--------------------LKNW--- 426 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--------------------~~~~--- 426 (467)
...+..|.+||+..+. .++.++||||||+++|||++|+.||......+.. ..++
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 1235567899987654 5688999999999999999999999643211100 0000
Q ss_pred -----------HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 427 -----------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 427 -----------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
....++..+.+++.+|+..+|.+|++ +.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-~~~il 278 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS-AKAAL 278 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC-HHHHh
Confidence 01223345788999999999999984 44443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.11 Aligned_cols=231 Identities=27% Similarity=0.348 Sum_probs=195.2
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|++|.||++.+. +++.||+|++..... ...+.+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999986 489999999876533 4456788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 296 MANGSLEKCLYSSN---GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
+++++|.+++.... ..+++.++..++.+++.|+.||| +.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987653 67899999999999999999999 9999999999999999999999999999998765543
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhcccccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVD 440 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~ 440 (467)
..++..|.+||......++.++|+||+|+++|+|++|+.||......+ ....... ..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-LALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-HHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 234556889999888889999999999999999999999997543221 1111111 134456889999
Q ss_pred cccccchhHHHHH
Q 041491 441 TSLLRREDKYFAA 453 (467)
Q Consensus 441 ~~l~~~~~~r~~~ 453 (467)
.|+..+|++|++.
T Consensus 237 ~~l~~~p~~Rp~~ 249 (258)
T cd08215 237 SLLQKDPEERPSI 249 (258)
T ss_pred HHcCCChhhCcCH
Confidence 9999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=271.71 Aligned_cols=231 Identities=25% Similarity=0.323 Sum_probs=186.4
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-----ccchHHHHHHHHHHHcCCCCCceeEEEEeecC--Cee
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFE 289 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 289 (467)
.+|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999875 48999999875321 22345788999999999999999999998764 467
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++++||+++++|.+++... +.+++..+..++.|++.|+.||| +.|++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999988643 35789999999999999999999 9999999999999999999999999999998653
Q ss_pred CC--------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhccc
Q 041491 370 GK--------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPI 433 (467)
Q Consensus 370 ~~--------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~ 433 (467)
.. ...++..|.+||+..+..++.++|+|||||++||+++|+.||.+..... ...+.. ...+++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHHcCCCCCCCCcccCH
Confidence 21 1224556889999988888999999999999999999999997642222 111211 112233
Q ss_pred ccccccccccccchhHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.+.+++++|+.. |..|++..
T Consensus 237 ~~~~~i~~~l~~-~~~r~~~~ 256 (264)
T cd06653 237 ACRDFLKQIFVE-EKRRPTAE 256 (264)
T ss_pred HHHHHHHHHhcC-cccCccHH
Confidence 588889999984 67776543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.93 Aligned_cols=229 Identities=28% Similarity=0.369 Sum_probs=188.1
Q ss_pred CccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC--CeeeEEEe
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFEALVLE 294 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 294 (467)
|++.+.||+|++|.||+|.+.+ ++.+|+|.+.... ......+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6778899999999999998874 8899999998653 33446788999999999999999999999888 88999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+++ +|.+++......+++..++.++.|++.|++||| +.|++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 898888665567899999999999999999999 9999999999999999999999999999998775442
Q ss_pred ----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc-----------c--------------
Q 041491 373 ----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-----------N-------------- 422 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-----------~-------------- 422 (467)
...+..|.+||...+ ..++.++||||||+++|||+||+.||+....... .
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 223456789997654 4578999999999999999999999965321110 0
Q ss_pred -----------HHHHHhhhcccccccccccccccchhHHHH
Q 041491 423 -----------LKNWVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 423 -----------~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
+........+..+.+++.+|+..+|.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 277 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS 277 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC
Confidence 001111112556788999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.62 Aligned_cols=234 Identities=29% Similarity=0.331 Sum_probs=188.9
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC----
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN---- 287 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 287 (467)
...++|++.+.||+|+||.||+|.+. +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999986 48899999987543 223456778999999999999999999887654
Q ss_pred ------eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEec
Q 041491 288 ------FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 288 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 361 (467)
..++|+||+++ ++...+......+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 777777655557899999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCC------ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHH--------
Q 041491 362 FGIAKLLNGKE------SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLK-------- 424 (467)
Q Consensus 362 fg~a~~~~~~~------~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~-------- 424 (467)
||.+....... ...+..|.+||...+ ..++.++|||||||++|||++|++||......+. .+.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99998765332 123456789997654 4578899999999999999999999974311100 000
Q ss_pred -------------------------HHHhhhcccccccccccccccchhHHHH
Q 041491 425 -------------------------NWVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 425 -------------------------~~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
......+|+.+.+++.+||..+|.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 292 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC
Confidence 0011235667899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=283.01 Aligned_cols=233 Identities=20% Similarity=0.272 Sum_probs=187.3
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeec----CCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 289 (467)
.++|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999876 489999999875432 334667889999999999999999988753 3568
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+. ++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 5898888543 45899999999999999999999 9999999999999999999999999999997654
Q ss_pred CCC---------ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccc-------------------
Q 041491 370 GKE---------SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE------------------- 420 (467)
Q Consensus 370 ~~~---------~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~------------------- 420 (467)
... ..++..|.+||++.. ..++.++|||||||++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 321 134556788998654 467899999999999999999999996532110
Q ss_pred ---ccHHHH--------------HhhhcccccccccccccccchhHHHHHH
Q 041491 421 ---MNLKNW--------------VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 421 ---~~~~~~--------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.....+ .....+.++.++|.+||..+|.+|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 289 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE 289 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 000000 1122455688999999999999998644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=277.96 Aligned_cols=226 Identities=24% Similarity=0.288 Sum_probs=188.0
Q ss_pred CCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 223 KSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
...||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|+|++++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999999885 5899999998655444556788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----cccc
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-----SMRT 376 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~ 376 (467)
.+++.. ..+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||++....... ..++
T Consensus 105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 998743 35789999999999999999999 9999999999999999999999999999987654322 2245
Q ss_pred ccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhcccccccccccccccc
Q 041491 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMNVVDTSLLRR 446 (467)
Q Consensus 377 ~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~ 446 (467)
..|.+||+.....++.++|+||+|+++|||++|+.||....... ...... ..+++.+.+++.+|+..+
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 56889999888888999999999999999999999997532211 111111 123445888999999999
Q ss_pred hhHHHHHHH
Q 041491 447 EDKYFAAKK 455 (467)
Q Consensus 447 ~~~r~~~~~ 455 (467)
|.+|++..+
T Consensus 258 P~~R~~~~~ 266 (292)
T cd06657 258 PAQRATAAE 266 (292)
T ss_pred cccCcCHHH
Confidence 999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=283.30 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=202.8
Q ss_pred HHhccCccCCccCcccceeEEEEEecC---C--CeEEEEEeecc-cccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD---G--MEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
+..+.....+.||.|-||.||+|.+.+ | -.||||..+.+ .....+.|.+|..+|++++||||++++|+|.+..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P- 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP- 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-
Confidence 333445567889999999999998753 2 34889988764 3445788999999999999999999999998765
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|||||.++-|.|..|++.....++......++.||+.||+||| ++++|||||...|||+.+..-+||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 69999999999999999988889999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCcc------ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHH------HHhhhccccc
Q 041491 369 NGKESM------RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKN------WVNDFLPISV 435 (467)
Q Consensus 369 ~~~~~~------~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~------~~~~~~~~~~ 435 (467)
.+.... -+..|++||.+.-.+++.++|||-|||.+||+++ |..||.+....+....- -..+..|+.+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence 765543 2345789999999999999999999999999876 99999876554432211 1344566678
Q ss_pred ccccccccccchhHH--HHHHHHHHHHHHh
Q 041491 436 MNVVDTSLLRREDKY--FAAKKQCVSSALS 463 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r--~~~~~~~~~~l~~ 463 (467)
..+..+|+..+|.+| ++.+...+.++++
T Consensus 622 YslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 899999999999997 4455555555443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.08 Aligned_cols=230 Identities=24% Similarity=0.258 Sum_probs=186.7
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+.+....||.|..|.|++++.+. |...|||.+..... ...+++...+.++..- +.|.||+.+|+|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 44456789999999999999875 88999999976543 3446677777776665 489999999999999999999998
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
|. ..++.++....+++++.-+-++...++.||.||.+ .++|+|||+||+|||+|+.|++|+||||.+..+.+..
T Consensus 173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 84 46777777777789999999999999999999985 7899999999999999999999999999998776543
Q ss_pred -ccccccccccccccCC---CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhh---------ccccccccc
Q 041491 373 -SMRTQTLATIEYGREG---QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDF---------LPISVMNVV 439 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~---~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~---------~~~~~~~~i 439 (467)
..+-..|++||-+.+. .|+.++||||||+.++|++||+.||..-..+-.-+....... +++.+.+++
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFV 329 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHH
Confidence 3455678888887654 578899999999999999999999987433322222222211 445689999
Q ss_pred ccccccchhHHH
Q 041491 440 DTSLLRREDKYF 451 (467)
Q Consensus 440 ~~~l~~~~~~r~ 451 (467)
+.||.+|+.+|+
T Consensus 330 ~~CL~kd~r~RP 341 (391)
T KOG0983|consen 330 KDCLTKDHRKRP 341 (391)
T ss_pred HHHhhcCcccCc
Confidence 999999999996
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=264.00 Aligned_cols=233 Identities=20% Similarity=0.244 Sum_probs=188.3
Q ss_pred hccCccC-CccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeec----CCee
Q 041491 217 TDHFSEK-SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSN----GNFE 289 (467)
Q Consensus 217 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~ 289 (467)
+++|++. +.||-|-.|.|-.+.++ +++++|+|++... ...++|++..-.. .|||||.++++|++ ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556543 67899999999999876 4899999997522 4456788876555 59999999998864 3466
Q ss_pred eEEEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a 365 (467)
.+|||.++||.|...+..... .+++.++..|++||..|+.||| +.+|.||||||+|+|... +..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 799999999999998866543 7999999999999999999999 999999999999999964 447999999999
Q ss_pred eecCCCCc----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc-------------ccHHHHHh
Q 041491 366 KLLNGKES----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE-------------MNLKNWVN 428 (467)
Q Consensus 366 ~~~~~~~~----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~-------------~~~~~~~~ 428 (467)
+.-..... ..++.|.+||++.++.|+..+|+||+||++|-|+.|.+||....... ..+.+--|
T Consensus 212 K~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 212 KETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred cccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 98775443 45677899999999999999999999999999999999997532211 12222234
Q ss_pred hhcccccccccccccccchhHHHHHHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+++..+++|...|..+|.+|. +++++|
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRl-TI~~~m 320 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERL-TIEEVM 320 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhhe-eHHHhh
Confidence 45566789999999999999996 455544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=278.13 Aligned_cols=231 Identities=27% Similarity=0.280 Sum_probs=187.2
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
|...+.||+|+||.||+|++. +++.||+|.+..... .....+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999875 488999999875422 2335678899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-Ccc
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-ESM 374 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~ 374 (467)
+. |++.+++......+++.++..++.|++.|+.||| ++|++||||+|+||++++++.+||+|||++...... ...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~ 178 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV 178 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcc
Confidence 96 5787777666667899999999999999999999 999999999999999999999999999998754332 223
Q ss_pred cccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH-------HHHHhhhcccccccccccccc
Q 041491 375 RTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL-------KNWVNDFLPISVMNVVDTSLL 444 (467)
Q Consensus 375 ~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~ 444 (467)
++..|.+||+.. .+.++.++|||||||++|||++|..||.......... .......++..+.+++.+|+.
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 258 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence 456689999873 4668899999999999999999999986532111000 001112234458899999999
Q ss_pred cchhHHHHHH
Q 041491 445 RREDKYFAAK 454 (467)
Q Consensus 445 ~~~~~r~~~~ 454 (467)
.+|.+|++..
T Consensus 259 ~~P~~Rp~~~ 268 (313)
T cd06633 259 KIPQERPASA 268 (313)
T ss_pred CChhhCcCHH
Confidence 9999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.03 Aligned_cols=193 Identities=22% Similarity=0.262 Sum_probs=165.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC------
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 286 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 286 (467)
..++|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999876 58999999986432 22345677899999999999999999988643
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 356999999965 888877432 788999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 367 LLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
...... ...+..|.+||...+..++.++|||||||++|+|++|+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 765432 2345568999999888999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=304.13 Aligned_cols=203 Identities=26% Similarity=0.325 Sum_probs=179.4
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecc---cccchHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
..++....++|.+.+.||+|+||.|..++++. ++.||+|++.+. ......-|..|-.+|..-+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45667788899999999999999999999875 889999999763 23345678899999999999999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
..+.|+||||++||||-.++.... ++++..+..++..|+-||.-+| +.|+|||||||+|||+|..|++||+|||.|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999997666 8999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCc------ccccccccccccc----C-CCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 366 KLLNGKES------MRTQTLATIEYGR----E-GQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 366 ~~~~~~~~------~~~~~~~~pe~~~----~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
-.+...+. .+|+.|.+||.+. + +.|++.+|.||+||++|||+.|..||...
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 88875443 4566666666543 3 67899999999999999999999999753
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=277.04 Aligned_cols=195 Identities=25% Similarity=0.381 Sum_probs=164.3
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCC------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 287 (467)
.++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999886 489999998865422 22345678999999999999999999886554
Q ss_pred --eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 288 --FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 288 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
..++||||+.+ ++.+++......+++.+++.++.|++.||+||| ++|++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999964 888888666557899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCc---------cccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 366 KLLNGKES---------MRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 366 ~~~~~~~~---------~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
........ ..+..|.+||+..+. .++.++||||||+++|||+||+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 86643221 234557899987654 468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=275.05 Aligned_cols=229 Identities=24% Similarity=0.309 Sum_probs=189.9
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
|++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|++++++++||||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 667889999999999999886 588999999875432 24567888999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
++ ++.+++......+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 75 888888665568899999999999999999999 9999999999999999999999999999998776543
Q ss_pred -ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc-----------------cHH---------
Q 041491 373 -SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-----------------NLK--------- 424 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-----------------~~~--------- 424 (467)
......|.+||..... .++.++|+||+|+++|+|+||+.||......+. ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 2344567899988766 788999999999999999999999965321110 000
Q ss_pred ---------HHHhhhcccccccccccccccchhHHHH
Q 041491 425 ---------NWVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 425 ---------~~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
.-....++.++.+++.+|+..+|.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 273 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC
Confidence 0112234556889999999999999984
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=284.53 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=209.7
Q ss_pred HHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 211 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
++|+....+.....+||-|.||.||.|.|+. .-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 5667767777888999999999999999976 678999998755 45678999999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 290 ALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
|||+|||..|+|.+|++..+. .++.-..+.++.||..|++||. .+++|||||...|+|+.++..+|++|||+++.+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999977654 4566667889999999999999 999999999999999999999999999999998
Q ss_pred CCCCcc------ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccc------cHHHHHhhhccccc
Q 041491 369 NGKESM------RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEM------NLKNWVNDFLPISV 435 (467)
Q Consensus 369 ~~~~~~------~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~------~~~~~~~~~~~~~~ 435 (467)
..+... -+..|.+||-++...++.|+|||+|||++||+.| |..||.+...... .++---.+.+|+.+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkV 495 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKV 495 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHH
Confidence 876532 2345789999999999999999999999999988 8889977533321 11111334567789
Q ss_pred ccccccccccchhHH--HHHHHHHHHHHHh
Q 041491 436 MNVVDTSLLRREDKY--FAAKKQCVSSALS 463 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r--~~~~~~~~~~l~~ 463 (467)
.++...|++-.|..| |.++.+.++.|.+
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 999999999999887 5566666666653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=277.66 Aligned_cols=234 Identities=27% Similarity=0.332 Sum_probs=189.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecc---cccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
+.|+..+.||+|+||.||+|++. ++..+|+|.+... ......++.+|+++++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999986 4788999988643 2233456788999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+. |++.+.+......+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 9996 5888777655567899999999999999999999 9999999999999999999999999999988765432
Q ss_pred cccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 373 SMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 373 ~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
..++..|.+||+.. .+.++.++|||||||++|||++|+.||......+ ....+.. ..++..+.+++.+
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence 23456788999864 4567889999999999999999999986532221 1111211 1234458899999
Q ss_pred ccccchhHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQC 457 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~ 457 (467)
||..+|++|++ +.+.
T Consensus 250 cl~~~P~~Rp~-~~~l 264 (308)
T cd06634 250 CLQKIPQDRPT-SEVL 264 (308)
T ss_pred HhhCCcccCCC-HHHH
Confidence 99999999975 3433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=275.10 Aligned_cols=233 Identities=25% Similarity=0.274 Sum_probs=187.1
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 292 (467)
.-++|++.+.||+|++|.||+|.+.+ ++.||+|.++.... .....+..|+.++.+. .||||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 44678899999999999999999875 89999999875432 2345566777777666 499999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|||+. +++.++.......+++..+..++.|++.|++||| + .||+||||+|+||++++++.+||+|||++..+...
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99985 4787777665567899999999999999999999 7 59999999999999999999999999999866432
Q ss_pred C----ccccccccccccccCCC----CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh---------hcccc
Q 041491 372 E----SMRTQTLATIEYGREGQ----VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND---------FLPIS 434 (467)
Q Consensus 372 ~----~~~~~~~~~pe~~~~~~----~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~---------~~~~~ 434 (467)
. ...+..|.+||+..+.. ++.++||||||+++|||++|+.||.....+...+...... .++.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 2 22345688999876543 7889999999999999999999997532221122222211 13445
Q ss_pred cccccccccccchhHHHH
Q 041491 435 VMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~ 452 (467)
+.+++.+|+..+|++|++
T Consensus 249 l~~li~~~l~~~p~~Rp~ 266 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPK 266 (296)
T ss_pred HHHHHHHHccCChhhCCC
Confidence 889999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=278.70 Aligned_cols=228 Identities=25% Similarity=0.361 Sum_probs=190.3
Q ss_pred CCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 223 KSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
.+.||+|.||+||-|.++ +|+.||||++.+.. ......+++|+.||+++.||.||.+.-.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 378999999999999886 59999999997542 234577899999999999999999999999999999999999776
Q ss_pred CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC---CcEEEeccccceecCCCC----
Q 041491 300 SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD---MVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 300 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~---- 372 (467)
-|+-.+....+++++.....++.||+.||.||| .++|+|+||||+|||+.+. -.+||||||+|+++++..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence 666667777889999999999999999999999 9999999999999999643 389999999999998754
Q ss_pred ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-------Hhhhccccccccccccccc
Q 041491 373 SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-------VNDFLPISVMNVVDTSLLR 445 (467)
Q Consensus 373 ~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~ 445 (467)
..+++.|.+||++....|...-|+||.|||+|--++|..||.+...-...+.+. -|..++++..++|...|+.
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV 805 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV 805 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence 357889999999999999999999999999999999999997532111111111 1233444577788888888
Q ss_pred chhHHHHH
Q 041491 446 REDKYFAA 453 (467)
Q Consensus 446 ~~~~r~~~ 453 (467)
.-.+|++.
T Consensus 806 km~kRysv 813 (888)
T KOG4236|consen 806 KMRKRYSV 813 (888)
T ss_pred HHHHhcch
Confidence 88888753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=280.68 Aligned_cols=231 Identities=22% Similarity=0.287 Sum_probs=184.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecC-----Cee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 289 (467)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999875 58999999986432 23446678899999999999999999887544 357
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++|+||+++ ++.+.+.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999965 88877743 46899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCC--------ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccc--------------ccH---
Q 041491 370 GKE--------SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--------------MNL--- 423 (467)
Q Consensus 370 ~~~--------~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--------------~~~--- 423 (467)
... ..++..|.+||.+.+ ..++.++||||+||++|||++|+.||.+..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 322 134556889997654 568899999999999999999999996431100 000
Q ss_pred -----HHHH--------------hhhcccccccccccccccchhHHHHH
Q 041491 424 -----KNWV--------------NDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 424 -----~~~~--------------~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..+. ....++++.+++.+||..+|++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 286 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV 286 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH
Confidence 0000 11234568899999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=276.26 Aligned_cols=232 Identities=26% Similarity=0.282 Sum_probs=183.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc-ccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|+..+.||+|+||.||++.+.. ++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 456677899999999999998864 8999999987543 234567889999999996 9999999999999999999999
Q ss_pred cccCCCHHHhh---hc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 295 YMANGSLEKCL---YS-SNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 295 ~~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
|+.. ++.++. .. ....+++..+..++.|++.||+||| + .+++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 554432 22 2357899999999999999999999 6 599999999999999999999999999997654
Q ss_pred CC----CccccccccccccccCC---CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-----------hhhc
Q 041491 370 GK----ESMRTQTLATIEYGREG---QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-----------NDFL 431 (467)
Q Consensus 370 ~~----~~~~~~~~~~pe~~~~~---~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-----------~~~~ 431 (467)
.. ...++..|.+||++.+. .++.++||||+||++|||++|+.||...........+.. ...+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence 32 22345668999988765 689999999999999999999999975321111111111 1123
Q ss_pred ccccccccccccccchhHHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
+.++.+++.+|+..+|++|++.
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~ 261 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKY 261 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCH
Confidence 4457899999999999999853
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=268.60 Aligned_cols=225 Identities=16% Similarity=0.098 Sum_probs=179.9
Q ss_pred ccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCHHHhhhc
Q 041491 229 GSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS 307 (467)
Q Consensus 229 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 307 (467)
|.+|.||++++. +++.||+|+++... ...+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999886 48999999987542 233455555666799999999999999999999999999999998854
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--Cccccccccccccc
Q 041491 308 SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--ESMRTQTLATIEYG 385 (467)
Q Consensus 308 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~pe~~ 385 (467)
. ..+++..+..++.|++.||+||| ++|++||||||+||+++.++.++++|||.+...... ....+..|.+||+.
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG 154 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCccc
Confidence 4 45899999999999999999999 999999999999999999999999999988765542 22334568999998
Q ss_pred cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-HhhhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 386 REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-VNDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 386 ~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
....++.++|+||+|+++|||++|+.|+............+ ....+++.+.+++.+||..||++|++..++.+.+++
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 232 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHH
Confidence 88888999999999999999999999876432111100000 122345568899999999999999875433444443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=296.48 Aligned_cols=194 Identities=20% Similarity=0.233 Sum_probs=156.3
Q ss_pred HhccCccCCccCcccceeEEEEEecC--CCeEEEEEe--------------ec---ccccchHHHHHHHHHHHcCCCCCc
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD--GMEVAIKVF--------------HL---QFDGALKSFDAECEVLKSVRHRNL 276 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni 276 (467)
..++|++.+.||+|+||+||+|..+. +...+.|.+ .+ ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999987642 222222211 00 111234567899999999999999
Q ss_pred eeEEEEeecCCeeeEEEecccCCCHHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec
Q 041491 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSN----GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD 352 (467)
Q Consensus 277 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 352 (467)
+++++++...+..|+|+|++. +++.+++.... ......++..++.|++.||+||| ++||+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999985 47777664321 12345677889999999999999 99999999999999999
Q ss_pred CCCcEEEeccccceecCCCC------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCC
Q 041491 353 DDMVAHLSDFGIAKLLNGKE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPT 413 (467)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf 413 (467)
.++.+||+|||+++.+.... ..++..|.+||++.+..++.++|||||||++|||++|..|+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999998765432 24677789999999999999999999999999999988643
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.10 Aligned_cols=231 Identities=23% Similarity=0.286 Sum_probs=190.2
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC-----eee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-----FEA 290 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 290 (467)
+|++.+.||+|++|.||+|+..+ ++.||+|.+.... ....+.+.+|+.+++.++||||+++.+++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999999864 8999999987643 334567889999999999999999999987765 789
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
++|||++ ++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 4898888544 37899999999999999999999 99999999999999999999999999999987654
Q ss_pred CC--------ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCcccccc---------------------
Q 041491 371 KE--------SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--------------------- 420 (467)
Q Consensus 371 ~~--------~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--------------------- 420 (467)
.. ...+..|.+||++.+. .++.++|+||+|+++|+|++|+.||......+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 42 2235567899998877 78999999999999999999999996532110
Q ss_pred -ccHHHHHh--------------hhcccccccccccccccchhHHHHHH
Q 041491 421 -MNLKNWVN--------------DFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 421 -~~~~~~~~--------------~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.....++. ..++..+.+++.+||..+|.+|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 284 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH
Confidence 01111111 22345688999999999999998533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=276.74 Aligned_cols=233 Identities=24% Similarity=0.345 Sum_probs=183.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecC-------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG------- 286 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 286 (467)
.++|++.+.||+|+||.||+|.+. +++.+|+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999886 489999999865432 2234677899999999999999999877543
Q ss_pred -CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 287 -NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 287 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
...++|+||+.+ ++...+......+++.++..++.|+++||+||| ++|++||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999965 777777655567999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCc----------------cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc-------
Q 041491 366 KLLNGKES----------------MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM------- 421 (467)
Q Consensus 366 ~~~~~~~~----------------~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~------- 421 (467)
........ .++..|.+||+..+ ..++.++|||||||++|||++|++||.+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 86543221 12344788997654 4578999999999999999999999964321110
Q ss_pred -------cHHHH---------------------HhhhcccccccccccccccchhHHHHH
Q 041491 422 -------NLKNW---------------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 422 -------~~~~~---------------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
....| ......+.+.+++.+||..+|.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~ 302 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence 00000 001122346799999999999999863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=278.28 Aligned_cols=190 Identities=26% Similarity=0.327 Sum_probs=159.6
Q ss_pred CccCcc--cceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIG--SFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
..||+| +||+||+|++. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999885 58999999987542 23346788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----
Q 041491 299 GSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----- 372 (467)
Q Consensus 299 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----- 372 (467)
+++.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||+++.++.++++||+.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999886543 35889999999999999999999 9999999999999999999999999998654322111
Q ss_pred -------ccccccccccccccCC--CCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 373 -------SMRTQTLATIEYGREG--QVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 373 -------~~~~~~~~~pe~~~~~--~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
...+..|.+||+...+ .++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1123458899998663 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=279.04 Aligned_cols=232 Identities=25% Similarity=0.305 Sum_probs=184.6
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcC-CCCCceeEEEEeecC--Cee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSV-RHRNLVKIISSCSNG--NFE 289 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 289 (467)
..++|++.+.||+|+||.||+|.+. +++.+|+|.+.... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3568999999999999999999886 48899999885432 22345677899999999 999999999988643 468
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||++ ++|..++... .+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||.+....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5998888543 6789999999999999999999 9999999999999999999999999999998664
Q ss_pred CCCc----------cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc-----------------
Q 041491 370 GKES----------MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----------------- 421 (467)
Q Consensus 370 ~~~~----------~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----------------- 421 (467)
.... .++..|.+||++.. ..++.++||||||+++|||+||+.||......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3221 23456788997644 5678899999999999999999999964321110
Q ss_pred --------------------cHHHHHhhhcccccccccccccccchhHHHHHH
Q 041491 422 --------------------NLKNWVNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 422 --------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
..... ...++.++.+++.+|+..+|++|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~ 290 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKRLTAE 290 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhh-ccCCCHHHHHHHHHhccCCcccccCHH
Confidence 00000 011345578999999999999998644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=270.42 Aligned_cols=222 Identities=26% Similarity=0.334 Sum_probs=185.3
Q ss_pred cCcccceeEEEEEecC-CCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
||+|+||.||+|.+.+ ++.+|+|++..... ...+.+.+|++++++++||||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999999875432 3456788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---------
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--------- 372 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--------- 372 (467)
.+++.... .+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99986543 7899999999999999999999 9999999999999999999999999999987543321
Q ss_pred ----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------h--hcccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------D--FLPISVMNVVD 440 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~--~~~~~~~~~i~ 440 (467)
...+..|.+||+......+.++||||||+++||+++|+.||......+. ...... . .++..+.+++.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILNGKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCcCCCccccCCHHHHHHHH
Confidence 1234567889998888889999999999999999999999975432211 111110 0 12556899999
Q ss_pred cccccchhHHHH
Q 041491 441 TSLLRREDKYFA 452 (467)
Q Consensus 441 ~~l~~~~~~r~~ 452 (467)
+|+..+|++|++
T Consensus 236 ~~l~~~p~~Rpt 247 (265)
T cd05579 236 KLLVPDPEKRLG 247 (265)
T ss_pred HHhcCCHhhcCC
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=273.00 Aligned_cols=239 Identities=17% Similarity=0.208 Sum_probs=175.9
Q ss_pred HHhccCccCCccCcccceeEEEEEecC----CCeEEEEEeecccccch-----------HHHHHHHHHHHcCCCCCceeE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFDGAL-----------KSFDAECEVLKSVRHRNLVKI 279 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~ 279 (467)
+..++|++.+.||+|+||.||+|.+.+ +..+|+|+......... .....+...+..++|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345689999999999999999998764 34567775433221110 111223344556789999999
Q ss_pred EEEeecCC----eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC
Q 041491 280 ISSCSNGN----FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM 355 (467)
Q Consensus 280 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 355 (467)
++++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+||| +++|+||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 98765443 44788888744 666665432 34578889999999999999999 99999999999999999999
Q ss_pred cEEEeccccceecCCCC------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH
Q 041491 356 VAHLSDFGIAKLLNGKE------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL 423 (467)
Q Consensus 356 ~~kl~Dfg~a~~~~~~~------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~ 423 (467)
.++|+|||+|+.+.... ..++..|.+||...+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999998653211 235667889999988899999999999999999999999997652221100
Q ss_pred ----HHHH---------hhhcccccccccccccccchhHHHHHHHHHHH
Q 041491 424 ----KNWV---------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 424 ----~~~~---------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
.++. ....+..+.++++.|+..+|++|+ +..+..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp-~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKP-DYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCC-CHHHHHH
Confidence 1111 112344588999999999999997 4444443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=268.08 Aligned_cols=230 Identities=24% Similarity=0.315 Sum_probs=191.8
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|++.+.||+|++|.||++.+. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999876 58899999987542 23345678899999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 296 MANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
+++++|.+++... ...+++..++.++.|++.|++||| +.|++|+||+|+||++++++.+|++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988552 246889999999999999999999 9999999999999999999999999999998765432
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh-------hcccccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND-------FLPISVMNVVDTS 442 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~i~~~ 442 (467)
..++..|.+||+..+..++.++|+||+|+++|||++|+.||......+. ....... ..+.++.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-RYKVQRGKYPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence 2345568899999888899999999999999999999999976432211 1111111 2334588999999
Q ss_pred cccchhHHHH
Q 041491 443 LLRREDKYFA 452 (467)
Q Consensus 443 l~~~~~~r~~ 452 (467)
+..+|++|++
T Consensus 237 l~~~p~~Rp~ 246 (256)
T cd08530 237 LQVKPKLRPN 246 (256)
T ss_pred cCCCcccCCC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=276.07 Aligned_cols=191 Identities=24% Similarity=0.222 Sum_probs=158.9
Q ss_pred cCCccCcccceeEEEEEecCCCeEEEEEeecc--cccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCC
Q 041491 222 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 222 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++...+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344555555555555544 5899999998754 2345578999999999999999999999999999999999999999
Q ss_pred CHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC------
Q 041491 300 SLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE------ 372 (467)
Q Consensus 300 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------ 372 (467)
+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+.......
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999998754 346889999999999999999999 9999999999999999999999999999887553221
Q ss_pred ------ccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 373 ------SMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 373 ------~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
...+..|.+||+... ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 123445788998765 35789999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=273.69 Aligned_cols=231 Identities=29% Similarity=0.398 Sum_probs=192.9
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 292 (467)
++|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999886 58999999987532 233467888999999998 99999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++++|.+++... +.+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999998654 47899999999999999999999 9999999999999999999999999999988665432
Q ss_pred c-------------------------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH
Q 041491 373 S-------------------------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV 427 (467)
Q Consensus 373 ~-------------------------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~ 427 (467)
. .++..|.+||......++.++|+||+|+++|++++|+.||....... .+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~ 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKIL 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH
Confidence 1 13455788998888888999999999999999999999997643111 111111
Q ss_pred ------hhhcccccccccccccccchhHHHHH
Q 041491 428 ------NDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 428 ------~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
...+++.+.+++.+||..+|++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 12234568999999999999999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=277.85 Aligned_cols=236 Identities=21% Similarity=0.258 Sum_probs=188.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC-----Ce
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 288 (467)
.++|.+.+.||+|+||.||+|++. +++.||+|.++... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999875 48999999987532 22345677899999999999999999987644 35
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++|+||+. ++|.+++.. .+.+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999995 689888754 357899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCC-----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccc----------------------c
Q 041491 369 NGKE-----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCE----------------------E 420 (467)
Q Consensus 369 ~~~~-----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~----------------------~ 420 (467)
.... ...+..|.+||.... ..++.++|||||||++|+|++|+.||...... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 5431 234556889997654 56889999999999999999999999643110 0
Q ss_pred ccHHHH--------------HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 421 MNLKNW--------------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 421 ~~~~~~--------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.....+ ....+++.+.+++.+||..+|.+|++ +.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps-~~ell 289 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT-VEEAL 289 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC-HHHHH
Confidence 011111 11234556789999999999999985 44444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=278.43 Aligned_cols=234 Identities=21% Similarity=0.275 Sum_probs=187.8
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC-----
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----- 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 287 (467)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999875 58999999986432 223456789999999999999999999887553
Q ss_pred -eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 288 -FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 288 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
..++||||+ +++|.+++.. ..+++..+..++.|++.|++||| +.||+||||||+||++++++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 458999998 7799888753 46899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------c-----------
Q 041491 367 LLNGKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----------N----------- 422 (467)
Q Consensus 367 ~~~~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----------~----------- 422 (467)
...... ...+..|.+||+..+ ..++.++|+||+|+++|++++|+.||........ .
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 167 QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred ccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 765432 234556789998765 4578899999999999999999999975321100 0
Q ss_pred -HHHH--------------HhhhcccccccccccccccchhHHHHHHH
Q 041491 423 -LKNW--------------VNDFLPISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 423 -~~~~--------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
...+ .....++.+.+++.+||..+|.+|++..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~ 294 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHH
Confidence 0000 11223445789999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=270.83 Aligned_cols=229 Identities=23% Similarity=0.288 Sum_probs=185.9
Q ss_pred cCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc----ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 289 (467)
+|++.+.||+|++|.||+++.. +++.||+|+++... ....+.+.+|+.++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999753 46889999987432 22345678899999999 599999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++++|.+++... ..+++..+..++.|+++||.||| +.+++||||||+||+++.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999988543 46889999999999999999999 9999999999999999999999999999988654
Q ss_pred CCCc------cccccccccccccCCC--CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------hhhc
Q 041491 370 GKES------MRTQTLATIEYGREGQ--VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------NDFL 431 (467)
Q Consensus 370 ~~~~------~~~~~~~~pe~~~~~~--~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------~~~~ 431 (467)
.... .++..|.+||+..+.. .+.++||||||+++|||++|+.||...... ....... ...+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPPFPKTM 235 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHccCCCCCccc
Confidence 3321 2455678899876654 688999999999999999999999532111 1111111 1123
Q ss_pred ccccccccccccccchhHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~ 452 (467)
+..+.+++.+|+..+|++|++
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t 256 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLG 256 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccC
Confidence 446889999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=265.27 Aligned_cols=224 Identities=28% Similarity=0.327 Sum_probs=187.6
Q ss_pred cCcccceeEEEEEecC-CCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
||+|+||.||++.+.+ ++.+|+|++..... .....+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999998864 89999999875432 2345788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----Ccccc
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-----ESMRT 376 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~ 376 (467)
.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+...... ....+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 9998654 36899999999999999999999 999999999999999999999999999999876543 22345
Q ss_pred ccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccccccchhHH
Q 041491 377 QTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTSLLRREDKY 450 (467)
Q Consensus 377 ~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~~~~r 450 (467)
..|.+||...+...+.++|+||||+++||+++|+.||....... ...... ....+..+.+++.+|+..+|++|
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-IYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 66889999888888999999999999999999999997543211 111111 11224458999999999999999
Q ss_pred HHHH
Q 041491 451 FAAK 454 (467)
Q Consensus 451 ~~~~ 454 (467)
++..
T Consensus 236 ~~~~ 239 (250)
T cd05123 236 LGSG 239 (250)
T ss_pred CCcc
Confidence 8754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=276.50 Aligned_cols=231 Identities=20% Similarity=0.262 Sum_probs=183.3
Q ss_pred ccCc-cCCccCcccceeEEEEEec-CCCeEEEEEeecccccc--------------hHHHHHHHHHHHcCCCCCceeEEE
Q 041491 218 DHFS-EKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA--------------LKSFDAECEVLKSVRHRNLVKIIS 281 (467)
Q Consensus 218 ~~y~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~ 281 (467)
++|. +.+.||+|+||.||+|.+. +++.||+|.++...... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999876 58999999986542211 124778999999999999999999
Q ss_pred EeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEec
Q 041491 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 282 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 361 (467)
++...+..++||||++ |+|.+++.. ...+++.....++.|++.||+||| +.|++||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 589988854 446899999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCC-------------------ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc
Q 041491 362 FGIAKLLNGKE-------------------SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM 421 (467)
Q Consensus 362 fg~a~~~~~~~-------------------~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~ 421 (467)
||.+....... ...+..|.+||+..+. .++.++||||+||++|||+||+.||......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99998665111 1124457889987653 468899999999999999999999975322110
Q ss_pred c--H---------HHH----------------------HhhhcccccccccccccccchhHHHHH
Q 041491 422 N--L---------KNW----------------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 422 ~--~---------~~~----------------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
. . ..| .....+..+.+++.+||..+|++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~ 307 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence 0 0 000 001223457899999999999999853
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=299.88 Aligned_cols=234 Identities=25% Similarity=0.337 Sum_probs=181.4
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEee---------
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCS--------- 284 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--------- 284 (467)
-..+|+..+.||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++++|||||+++..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467889999999999999999987 79999999997663 334567889999999999999999982110
Q ss_pred ---------------------------------------------------------------------cC---------
Q 041491 285 ---------------------------------------------------------------------NG--------- 286 (467)
Q Consensus 285 ---------------------------------------------------------------------~~--------- 286 (467)
++
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 00
Q ss_pred --------------------------------CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 041491 287 --------------------------------NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334 (467)
Q Consensus 287 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 334 (467)
...||-||||+..++.+++......-.....++++++|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-- 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-- 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH--
Confidence 1347889999998888877554322246788999999999999999
Q ss_pred CCCCceecCCCCCCeeecCCCcEEEeccccceecC-----------------------CCCccccccccccccccCC---
Q 041491 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN-----------------------GKESMRTQTLATIEYGREG--- 388 (467)
Q Consensus 335 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~~~~~pe~~~~~--- 388 (467)
++|||||||||.||++|+++.|||+|||+|+... .....+|..|.|||.....
T Consensus 715 -~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 715 -DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred -hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 9999999999999999999999999999998721 0112467789999987654
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhcccc----------cccccccccccchhHHHHHHH
Q 041491 389 QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPIS----------VMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 389 ~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----------~~~~i~~~l~~~~~~r~~~~~ 455 (467)
.|+.|+||||+|||++||+ .||.........+.+.....+|.. -..+|..++.+||.+||++.+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred cccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 4999999999999999999 567654333222333323333322 456889999999999986553
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=276.96 Aligned_cols=230 Identities=21% Similarity=0.297 Sum_probs=183.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 287 (467)
.++|...+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999875 58999999986532 223456789999999999999999999886543
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..++|+||+.. ++..+. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46899999964 777654 235789999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------------------c
Q 041491 368 LNGKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----------------------N 422 (467)
Q Consensus 368 ~~~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----------------------~ 422 (467)
..... ...+..|.+||+... ..++.++|||||||++|||++|+.||........ .
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred CCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 54322 234556889998765 4688999999999999999999999975321110 0
Q ss_pred HHHHHh--------------hhcccccccccccccccchhHHHHH
Q 041491 423 LKNWVN--------------DFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 423 ~~~~~~--------------~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
...+.. ...+..+.+++.+||..||.+|++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~ 291 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA 291 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH
Confidence 011110 1233457899999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=276.04 Aligned_cols=241 Identities=20% Similarity=0.272 Sum_probs=190.0
Q ss_pred ccHHHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEee
Q 041491 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCS 284 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 284 (467)
....++....++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 344566667899999999999999999999875 589999999875422 23456778999999999999999999875
Q ss_pred cC------CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEE
Q 041491 285 NG------NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 285 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 358 (467)
.. ...+++++++ +++|.+++.. ..+++..+..++.|++.|++||| +.||+||||||+||++++++.+|
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence 43 3467888876 7899887743 35899999999999999999999 99999999999999999999999
Q ss_pred EeccccceecCCCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--------------
Q 041491 359 LSDFGIAKLLNGKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-------------- 421 (467)
Q Consensus 359 l~Dfg~a~~~~~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-------------- 421 (467)
|+|||++....... ..++..|.+||...+ ..++.++|||||||++|||++|+.||........
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 161 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred EecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99999998654432 234566889998765 5678899999999999999999999964321110
Q ss_pred --------cHHHHHh--------------hhcccccccccccccccchhHHHHHH
Q 041491 422 --------NLKNWVN--------------DFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 422 --------~~~~~~~--------------~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
....+.. ...++.+.+++.+||..+|.+|++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 295 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence 0000100 01234578899999999999998644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=269.39 Aligned_cols=234 Identities=22% Similarity=0.294 Sum_probs=186.8
Q ss_pred CccCCccCcccceeEEEEEecC-CCeEEEEEeeccccc-chHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEecc
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
|++.+.||+|++|.||+|...+ ++.||+|.+...... ......+|+..+++++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6778999999999999999864 788999998654322 2234557899999998 999999999999999999999999
Q ss_pred cCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 297 ANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+|+|.+++.... ..+++.++..++.|++.+|.||| +++++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 779988886654 47899999999999999999999 9999999999999999999999999999998765432
Q ss_pred -cccccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc-----------HHHH-------------
Q 041491 373 -SMRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-----------LKNW------------- 426 (467)
Q Consensus 373 -~~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-----------~~~~------------- 426 (467)
..++..|.+||+.. ...++.++|+||||+++|||++|+.||......+.. -..|
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 23455678999764 455789999999999999999999999643211100 0000
Q ss_pred --------Hh---hhcccccccccccccccchhHHHHHHHHHH
Q 041491 427 --------VN---DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 427 --------~~---~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.. ...+..+.+++.+|+..+|.+|++ +.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt-~~ei~ 278 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT-ASQAL 278 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC-HHHHh
Confidence 00 111345889999999999999985 34443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=273.21 Aligned_cols=235 Identities=23% Similarity=0.279 Sum_probs=188.4
Q ss_pred HHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec-CCee
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNFE 289 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 289 (467)
...+++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++.+++.. .+..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999876 58999999886432 2334678899999999999999999998865 5678
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++++||+ +++|.+++.. ..+++..+..++.|++.||+||| +++++||||+|+||++++++.+||+|||.+....
T Consensus 86 ~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 9999998 5689888753 35788888999999999999999 9999999999999999999999999999998654
Q ss_pred CCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------cHHHHH---------
Q 041491 370 GKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----------NLKNWV--------- 427 (467)
Q Consensus 370 ~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----------~~~~~~--------- 427 (467)
... ...+..|.+||++.+ ..++.++||||||+++|||+||+.||........ ...++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 322 234556889998765 5689999999999999999999999965321100 000000
Q ss_pred -----------------hhhcccccccccccccccchhHHHHHH
Q 041491 428 -----------------NDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 428 -----------------~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
...+++.+.+++.+|+..+|++|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 283 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 012345688999999999999998543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=266.80 Aligned_cols=229 Identities=24% Similarity=0.335 Sum_probs=184.6
Q ss_pred CccCCccCcccceeEEEEEecC-CCeEEEEEeecccc--cchHHHHHHHHHHHcC---CCCCceeEEEEeecCCe-----
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSV---RHRNLVKIISSCSNGNF----- 288 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 288 (467)
|++.+.||+|+||.||+|++.. ++.||+|+++.... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999875 89999999975432 2234566788777665 69999999999987776
Q ss_pred eeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 289 EALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
.+++|||+.+ +|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8888876543 36899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCc----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------------
Q 041491 368 LNGKES----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------------- 427 (467)
Q Consensus 368 ~~~~~~----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------------- 427 (467)
...... ..+..|.+||+..+..++.++|+|||||++|||++|+.||......+ .+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCcc
Confidence 654322 24556789999988889999999999999999999999987532211 111111
Q ss_pred -----------------hhhcccccccccccccccchhHHHHH
Q 041491 428 -----------------NDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 428 -----------------~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
...+++.+.+++.+||..||.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 278 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence 11223456789999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.66 Aligned_cols=229 Identities=21% Similarity=0.250 Sum_probs=190.8
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++.|.....+|.|+|+.|-.+.+. +++..++|++.... .+..+|+.++... +||||+++.+.+.++...|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888999999999999999876 48899999987652 3345677776665 69999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee-cCCCcEEEeccccceecCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL-DDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
.+.|+-+.+.+...+. +. ..+..|+.+|+.|+.||| ++|+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~ 471 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD 471 (612)
T ss_pred hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence 9999988887754432 22 677789999999999999 9999999999999999 68899999999999988766
Q ss_pred CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-----hhcccccccccccccccc
Q 041491 372 ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-----DFLPISVMNVVDTSLLRR 446 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~i~~~l~~~ 446 (467)
...-+..|.|||+.....|++++|+||||++||+|++|+.||.....+ ..+..-+. ..+++.++++|..+|..|
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~d 550 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPKFSECVSDEAKDLLQQLLQVD 550 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCccccccCHHHHHHHHHhccCC
Confidence 344567789999999999999999999999999999999999865444 22222211 345667999999999999
Q ss_pred hhHHHHHHH
Q 041491 447 EDKYFAAKK 455 (467)
Q Consensus 447 ~~~r~~~~~ 455 (467)
|.+|++..+
T Consensus 551 P~~Rl~~~~ 559 (612)
T KOG0603|consen 551 PALRLGADE 559 (612)
T ss_pred hhhCcChhh
Confidence 999986443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=276.09 Aligned_cols=231 Identities=22% Similarity=0.291 Sum_probs=183.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecC---------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG--------- 286 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------- 286 (467)
..+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999886 4899999998766555567788999999999999999999776543
Q ss_pred -----CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEEEe
Q 041491 287 -----NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLS 360 (467)
Q Consensus 287 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~ 360 (467)
...++||||++ ++|.+++.. ..+++..++.++.|++.||.||| +.|++||||||+||+++. ++.+|++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 589887743 35889999999999999999999 999999999999999974 5578999
Q ss_pred ccccceecCCCC--------cccccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------
Q 041491 361 DFGIAKLLNGKE--------SMRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------- 421 (467)
Q Consensus 361 Dfg~a~~~~~~~--------~~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------- 421 (467)
|||.+....... ..++..|.+||+.. +..++.++|||||||++|||++|+.||......+.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998654221 12355688999754 35678899999999999999999999964321000
Q ss_pred -----------cHHHH--------------HhhhcccccccccccccccchhHHHHH
Q 041491 422 -----------NLKNW--------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 422 -----------~~~~~--------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..... ....++.++.+++.+||..+|.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 294 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence 00000 011234457789999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.39 Aligned_cols=233 Identities=23% Similarity=0.358 Sum_probs=193.8
Q ss_pred HHhccCccCCccCcccceeEEEEEecC--C--CeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD--G--MEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
+..+.....++||+|.||.|++|.|+. | ..||||.++..... ...+|.+|+.+|.+|+|||++++||+..+ ...
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 334445566899999999999999964 4 35899999866544 67899999999999999999999999988 667
Q ss_pred eEEEecccCCCHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 290 ALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.+|||.++.|+|.+.++. .+..+-......++.||+.||.||. .+++|||||...|+++-....+||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 899999999999999987 4557888899999999999999999 999999999999999999999999999999988
Q ss_pred CCCCcc--------ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccccc-HHHHHhh------hcc
Q 041491 369 NGKESM--------RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMN-LKNWVND------FLP 432 (467)
Q Consensus 369 ~~~~~~--------~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~-~~~~~~~------~~~ 432 (467)
+..+.. -...|++||.+....++.++|||+|||++|||+| |+.||-+.....+. ..+ ..+ ..+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~cs 341 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCS 341 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCCh
Confidence 765432 2346799999999999999999999999999998 78899764322210 111 222 234
Q ss_pred cccccccccccccchhHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~ 452 (467)
+.+.++...|+...|.+|++
T Consensus 342 edIY~imk~cWah~paDRpt 361 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPT 361 (1039)
T ss_pred HHHHHHHHHhccCCcccccc
Confidence 45999999999999999953
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=267.75 Aligned_cols=229 Identities=27% Similarity=0.321 Sum_probs=188.6
Q ss_pred CccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
|+..+.||+|++|.||+|...+ ++.||+|++.... ....+.+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999998875 8999999997653 334467788999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
+ ++|.+++......+++..+..++.|++.||+||| +.|++||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 7 5999999766557899999999999999999999 9999999999999999999999999999998765432
Q ss_pred -ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc---------------------------cH
Q 041491 373 -SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------------------------NL 423 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------------------------~~ 423 (467)
...+..|.+||+.... .++.++|||||||++||+++|+.||......+. ..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 1234457899987766 789999999999999999999999965321100 00
Q ss_pred HHH-------HhhhcccccccccccccccchhHHHH
Q 041491 424 KNW-------VNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 424 ~~~-------~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
..| ....++..+.+++.+||..+|++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 272 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCC
Confidence 000 01122446899999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=256.03 Aligned_cols=194 Identities=25% Similarity=0.299 Sum_probs=164.1
Q ss_pred hccCccCCccCcccceeEEEEEecC-----CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec-CCe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 288 (467)
...|+....||+|.||.||+|.-.+ ...+|+|.++.+. .+......+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4579999999999999999995432 3478999987553 2344667899999999999999999998876 788
Q ss_pred eeEEEecccCCCHHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC----CcEEEe
Q 041491 289 EALVLEYMANGSLEKCLYSSN----GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD----MVAHLS 360 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~ 360 (467)
.++++||.+. +|.+.++-.+ ..++...+..++.||+.|+.||| ++-|+||||||+|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 8888775432 36888899999999999999999 9999999999999999877 899999
Q ss_pred ccccceecCCCC--------ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCC
Q 041491 361 DFGIAKLLNGKE--------SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTC 414 (467)
Q Consensus 361 Dfg~a~~~~~~~--------~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~ 414 (467)
|||+|+.+..+- ..-|..|.|||.+.+ ..|+++.||||.|||+.||+|-++-|.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999876532 234667899998876 468999999999999999999887664
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=272.48 Aligned_cols=231 Identities=22% Similarity=0.221 Sum_probs=181.5
Q ss_pred cCccCCccCcccceeEEEEEec-C--CCeEEEEEeecccc--cchHHHHHHHHHHHcC-CCCCceeEEEEeec----CCe
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-D--GMEVAIKVFHLQFD--GALKSFDAECEVLKSV-RHRNLVKIISSCSN----GNF 288 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~ 288 (467)
+|++.+.||+|+||.||++++. . +..||+|.+..... ...+.+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999875 3 67899999864322 2345678899999999 59999999987532 245
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++++||+. ++|.+++.. ...+++..+..++.|++.||+||| +.|++||||||+||++++++.+||+|||.++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788999885 689888854 456899999999999999999999 999999999999999999999999999999865
Q ss_pred CCCC---------ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccc--------------ccHH
Q 041491 369 NGKE---------SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--------------MNLK 424 (467)
Q Consensus 369 ~~~~---------~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--------------~~~~ 424 (467)
.... ..++..|.+||+..+ ..++.++||||+||++|+|++|+.||......+ ..+.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4321 134566889997655 568899999999999999999999997532100 0000
Q ss_pred ----------------------HHHhhhcccccccccccccccchhHHHHHH
Q 041491 425 ----------------------NWVNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 425 ----------------------~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.+.....+..+.+++.+||..+|.+|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 287 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE 287 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 011112344588999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=266.03 Aligned_cols=234 Identities=24% Similarity=0.324 Sum_probs=186.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-------ccchHHHHHHHHHHHcCCCCCceeEEEEee-cCC
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-------DGALKSFDAECEVLKSVRHRNLVKIISSCS-NGN 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~ 287 (467)
.++|-...+||+|+|++||+|.+. ..+.||||+-.... ....+...+|.+|.+.++||.||++|+++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 456888899999999999999875 47889999875432 122355678999999999999999999996 556
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec---CCCcEEEecccc
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---DDMVAHLSDFGI 364 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~ 364 (467)
.+|-|+|||+|.+|.-|++.. ..+++.++..|+.||+.||.||.. .+.+|||-||||.|||+. ..|.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 889999999999999999654 468999999999999999999983 367999999999999995 457899999999
Q ss_pred ceecCCCCc------------ccccccccccccc----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH-----
Q 041491 365 AKLLNGKES------------MRTQTLATIEYGR----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL----- 423 (467)
Q Consensus 365 a~~~~~~~~------------~~~~~~~~pe~~~----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~----- 423 (467)
++++++... .++.+|.+||.+- +..++.|+||||.|||+|..+.|+.||.........+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 999876432 3566677888653 4567889999999999999999999997532221111
Q ss_pred HHH------HhhhcccccccccccccccchhHHHH
Q 041491 424 KNW------VNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 424 ~~~------~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
... ..+.++.+..++|.+||....+.|..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh
Confidence 111 12233446889999999999988864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=232.60 Aligned_cols=195 Identities=27% Similarity=0.329 Sum_probs=170.3
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.+|...++||+|.||+||+|+..+ ++.||+|.++... ++......+||-+++.++|.|||++++....++...+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 357778999999999999998765 8889999997653 4456788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
||.. +|..+...-++.++.+.+..++.|+++||.++| ++++.|||+||.|.+++.+|++|++|||+|+.++-+..
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9965 999999888999999999999999999999999 99999999999999999999999999999998875543
Q ss_pred ----cccccccccccccC-CCCCCcccchhhHHHHHHHhc-CCCCCCcc
Q 041491 374 ----MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFT-KKKPTCEI 416 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~t-g~~Pf~~~ 416 (467)
.-+..|.+|.++.+ .-|++..|+||.|||+.|+.. |++.|.+.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 23556778887665 457889999999999999987 55556553
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=282.51 Aligned_cols=228 Identities=28% Similarity=0.364 Sum_probs=188.0
Q ss_pred CccCCccCcccceeEEEEEec-C----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-D----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
....++||+|+||+||+|.|. + .-+||+|++.... ....+++..|+-+|.+++|||+++++++|..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 344588999999999999874 2 4578999986543 345678999999999999999999999998776 78999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (467)
+|++.|+|.++++..+..+.....+.|..||++||.||| .+++|||||-.+|||+.+...+||.|||+|+.......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999889999999999999999999999 99999999999999999999999999999998775443
Q ss_pred c-------ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhhhcc------ccccccc
Q 041491 374 M-------RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVNDFLP------ISVMNVV 439 (467)
Q Consensus 374 ~-------~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~i 439 (467)
. ....+.+-|.+....|+.++|||||||++||++| |..|+++...+++.-.--....++ .++.-++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 2 2233456677788899999999999999999988 999999876554321111111222 2466788
Q ss_pred ccccccchhHHH
Q 041491 440 DTSLLRREDKYF 451 (467)
Q Consensus 440 ~~~l~~~~~~r~ 451 (467)
-+|+..|++.|+
T Consensus 934 vkCwmid~~~rp 945 (1177)
T KOG1025|consen 934 VKCWMIDADSRP 945 (1177)
T ss_pred HHHhccCcccCc
Confidence 899999998774
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=265.99 Aligned_cols=232 Identities=22% Similarity=0.240 Sum_probs=191.6
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 288 (467)
.+...+|.....||+|+||.|.+|..+. .+.+|||++++.. +...+--..|-++|.-. +-|.+++++..|..-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5556689999999999999999998764 6779999998653 22334455677787766 57899999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
+|+||||+.||+|...+++ -+++.++.+..++.+|+-||-+|| ++||+.||||.+|||+|.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999888844 467889999999999999999999 999999999999999999999999999999853
Q ss_pred C-----CCCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh------hccccccc
Q 041491 369 N-----GKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND------FLPISVMN 437 (467)
Q Consensus 369 ~-----~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~------~~~~~~~~ 437 (467)
- .....+++.|.|||.+...+|+..+|.|||||++|||+.|++||++...++ .+...... .++.+..+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF~aI~ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQAIMEHNVSYPKSLSKEAVA 579 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHccCcCcccccHHHHH
Confidence 2 223457888899999999999999999999999999999999999854443 23333222 23345777
Q ss_pred ccccccccchhHH
Q 041491 438 VVDTSLLRREDKY 450 (467)
Q Consensus 438 ~i~~~l~~~~~~r 450 (467)
++...|.+.|.+|
T Consensus 580 ickg~ltK~P~kR 592 (683)
T KOG0696|consen 580 ICKGLLTKHPGKR 592 (683)
T ss_pred HHHHHhhcCCccc
Confidence 8888888888887
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=262.07 Aligned_cols=229 Identities=21% Similarity=0.258 Sum_probs=183.5
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc-----ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
+|.+.+.||+|+||.||++.+.. +..+++|+++... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998764 4556666654321 12334567899999999999999999999999999999
Q ss_pred EecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+||+++++|.+++.. ....+++.+++.++.|++.|+.||| +.|++|+||||+||++++ +.+||+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988753 3346899999999999999999999 999999999999999975 579999999998764
Q ss_pred CCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------hhhccccccc
Q 041491 370 GKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-------NDFLPISVMN 437 (467)
Q Consensus 370 ~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~ 437 (467)
... ..++..|.+||+.....++.++|+||||+++|+|++|..||....... ...... ....+..+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-VVLRIVEGPTPSLPETYSRQLNS 235 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHcCCCCCCcchhcHHHHH
Confidence 332 123456789998887888899999999999999999999996532111 111111 1223446889
Q ss_pred ccccccccchhHHHH
Q 041491 438 VVDTSLLRREDKYFA 452 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~ 452 (467)
++.+|+..+|++|++
T Consensus 236 li~~~l~~~p~~Rp~ 250 (260)
T cd08222 236 IMQSMLNKDPSLRPS 250 (260)
T ss_pred HHHHHhcCChhhCcC
Confidence 999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=272.61 Aligned_cols=231 Identities=21% Similarity=0.281 Sum_probs=185.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe----
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF---- 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 288 (467)
..++|++.+.||+|++|.||+|++. +++.||+|++.... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999986 48899999986532 2234567789999999999999999988766554
Q ss_pred --eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 289 --EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 289 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++||| +.||+||||||+||++++++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999998 6699998854 46899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCC--CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------------------
Q 041491 367 LLNGK--ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------------------- 421 (467)
Q Consensus 367 ~~~~~--~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------------------- 421 (467)
..... ....+..|.+||.... ..++.++||||+||++|||+||+.||......+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 167 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred cccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 76543 2234556889998754 3678899999999999999999999964321110
Q ss_pred cHHHHH--------------hhhcccccccccccccccchhHHHH
Q 041491 422 NLKNWV--------------NDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 422 ~~~~~~--------------~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
....+. ....+..+.+++.+||..+|.+|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt 291 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT 291 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC
Confidence 000000 0123456889999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.35 Aligned_cols=146 Identities=31% Similarity=0.472 Sum_probs=131.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|.+.++||+|+||.||+|.+. +++.||+|+++... ......+..|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999987 48999999987542 22346788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
|||+++++|.+++... +.+++..++.++.||+.||+||| .++|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998543 46889999999999999999999 9999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=268.98 Aligned_cols=216 Identities=22% Similarity=0.317 Sum_probs=181.0
Q ss_pred cccHHHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEE
Q 041491 207 RFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISS 282 (467)
Q Consensus 207 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~ 282 (467)
...+..-.....-|..++.||-|+||+|.+++..| ...||+|.+++.+ .........|-.||...+.+-||++|-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 33444555566678899999999999999997655 6789999987653 2344567889999999999999999999
Q ss_pred eecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecc
Q 041491 283 CSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 283 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
|.+.+.+|+||||++||++..++-+. +.+++..+..++.++..|+++.| ..|+|||||||+|||||.+|++||+||
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeec
Confidence 99999999999999999999988544 57899999999999999999999 999999999999999999999999999
Q ss_pred ccceecC---------CC--------------------------------------CccccccccccccccCCCCCCccc
Q 041491 363 GIAKLLN---------GK--------------------------------------ESMRTQTLATIEYGREGQVSPKSD 395 (467)
Q Consensus 363 g~a~~~~---------~~--------------------------------------~~~~~~~~~~pe~~~~~~~~~~~D 395 (467)
|+|.-+. .. ...++..|.+||++....|+..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9986432 00 002456678889888888999999
Q ss_pred chhhHHHHHHHhcCCCCCCccccccc--cHHHH
Q 041491 396 VYGYGITLIETFTKKKPTCEIFCEEM--NLKNW 426 (467)
Q Consensus 396 v~slGvil~el~tg~~Pf~~~~~~~~--~~~~~ 426 (467)
.||.|||||||+.|+.||.+....+. ...+|
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 99999999999999999987655543 34555
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=250.32 Aligned_cols=234 Identities=22% Similarity=0.276 Sum_probs=197.9
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 288 (467)
...-++|...+.||+|+|.+|-.++++. .+.||+|++++.. +...+-.+.|..+..+. +||.+|-++.+|....+
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 3455689999999999999999998864 7889999998652 33445567888888877 69999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++|.||++||+|.-.+. ..+.++++.+..+..+|.-||.||| ++||+.||||.+|+|+|..|++|++|+|+++.-
T Consensus 326 lffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999999987774 3457999999999999999999999 999999999999999999999999999999864
Q ss_pred CCC-----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc--cccccccHHHHHhhh-------ccc-
Q 041491 369 NGK-----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE--IFCEEMNLKNWVNDF-------LPI- 433 (467)
Q Consensus 369 ~~~-----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~--~~~~~~~~~~~~~~~-------~~~- 433 (467)
-.+ ...+++.|.|||.++++.|+..+|.|++||+|+||+.|+.||+- ....+++..+|..+. +|.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 322 23577888999999999999999999999999999999999973 345566666665443 232
Q ss_pred ---ccccccccccccchhHHH
Q 041491 434 ---SVMNVVDTSLLRREDKYF 451 (467)
Q Consensus 434 ---~~~~~i~~~l~~~~~~r~ 451 (467)
....++..-|.+||.+|.
T Consensus 482 lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhc
Confidence 366788889999999983
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=232.70 Aligned_cols=214 Identities=25% Similarity=0.288 Sum_probs=174.5
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCee
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 289 (467)
+++..++......||+|++|.|-+-++. +|+..|+|.++... ....++..+|+.+..+. ..|.+|+++|.+.+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4455566777789999999999888775 58999999997653 33456777888876654 799999999999999999
Q ss_pred eEEEecccCCCHHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 290 ALVLEYMANGSLEKCLY---SSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
+|.||.|+. +|..+-. ...+.+++.-.-+|+..+.+||.|||. +..++|||+||+|||++.+|++|+||||.+.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999955 7766532 345689999999999999999999995 6789999999999999999999999999998
Q ss_pred ecCCCC----ccccccccccccccC----CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh
Q 041491 367 LLNGKE----SMRTQTLATIEYGRE----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND 429 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~~----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~ 429 (467)
.+.+.- ..+-..|+|||.+.+ ..|+.++||||+|+++.||.+++.||+.-..+-..+.+.+..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 876543 234567899998754 368899999999999999999999998655444445444443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-34 Score=250.28 Aligned_cols=231 Identities=25% Similarity=0.230 Sum_probs=181.1
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+.+....||.|+||+|++-.++. |+..|||.++.... ...+++..|.+...+- +.||||+++|.+..++..|+-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34445789999999999998864 99999999986644 5567888888876655 689999999999999999999999
Q ss_pred ccCCCHHHhhh---c-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 296 MANGSLEKCLY---S-SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 296 ~~~g~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|+- ++..+.. . .+..+++.-.-+|....+.||.||.. ...|||||+||+|||+|..|.+||||||.+..+.+.
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 954 6655432 1 23468888888899999999999985 678999999999999999999999999999876543
Q ss_pred ----CccccccccccccccCC--CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhh------------ccc
Q 041491 372 ----ESMRTQTLATIEYGREG--QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDF------------LPI 433 (467)
Q Consensus 372 ----~~~~~~~~~~pe~~~~~--~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~------------~~~ 433 (467)
...+-..|+|||-+.+. .|+.+|||||+|+++||+.||+.|+.+-..--..+...+... .+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 33456678999988654 378899999999999999999999865322111122222221 233
Q ss_pred ccccccccccccchhHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~ 452 (467)
.+..+|..||.+|-..|+.
T Consensus 302 ~~~~fintCl~Kd~~~Rpk 320 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPK 320 (361)
T ss_pred HHHHHHHHHhhcccccCcc
Confidence 5788999999999998863
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-34 Score=267.05 Aligned_cols=230 Identities=19% Similarity=0.268 Sum_probs=190.0
Q ss_pred ccCccCCccCcccceeEEEEEecCC-CeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDG-MEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.+++.+..||-|+||.|=++..... ..+|+|++++.. ....+.+..|-++|...+.|.||++|..|.++.+.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 3566778899999999999987543 348999887542 344567788999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 373 (467)
|-|-||.+...+. .++.++..++..++..+++|++||| ++|||.|||||+|.++|.+|.+||.|||+|+.+.....
T Consensus 500 EaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 500 EACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9999999999884 5678999999999999999999999 99999999999999999999999999999999876543
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc------cHHHH-Hhhhcccccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM------NLKNW-VNDFLPISVMNVVDTS 442 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~------~~~~~-~~~~~~~~~~~~i~~~ 442 (467)
++++.|.|||.+.....+.++|.||+|+++||++||.+||.+..+-.. .+..| ....++....+++.+.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 456666666666666778899999999999999999999987432211 11112 2345566688888888
Q ss_pred cccchhHHH
Q 041491 443 LLRREDKYF 451 (467)
Q Consensus 443 l~~~~~~r~ 451 (467)
=..+|.+|.
T Consensus 656 Cr~~P~ERL 664 (732)
T KOG0614|consen 656 CRDNPTERL 664 (732)
T ss_pred HhcCcHhhh
Confidence 888888884
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=272.36 Aligned_cols=240 Identities=26% Similarity=0.349 Sum_probs=197.5
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEee--
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCS-- 284 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-- 284 (467)
.++.+...++-|++.+.||.|.+|.||+++.. +++..|+|+..... ...++++.|.++++.. .|||++.++|++.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34555567788999999999999999999876 48899999987653 3456788899999987 6999999999885
Q ss_pred ---cCCeeeEEEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEe
Q 041491 285 ---NGNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLS 360 (467)
Q Consensus 285 ---~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 360 (467)
.++.+|||||||.+|+..|+++...+ ++.|..+..|++.++.|+.+|| ...++|||+|-.|||++.++.+|++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence 35689999999999999999876544 8999999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCC-----CCccccccccccccccC-----CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--------c
Q 041491 361 DFGIAKLLNG-----KESMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--------N 422 (467)
Q Consensus 361 Dfg~a~~~~~-----~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--------~ 422 (467)
|||.+...+. ....+++.|+|||+++- ..|+..+|+||+|++..||.-|.+|+.+...-.. .
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 9999987764 33467888899998753 3467789999999999999999999977532210 0
Q ss_pred HHHHHhhhcccccccccccccccchhHHHH
Q 041491 423 LKNWVNDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 423 ~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
..-..+..+..++.++|+.||.+|.++|++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~ 275 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPS 275 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcc
Confidence 000112334456889999999999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-34 Score=247.40 Aligned_cols=194 Identities=25% Similarity=0.411 Sum_probs=164.4
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecc--cccchHHHHHHHHHHHcCCCCCceeEEEEeec--------C
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSN--------G 286 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 286 (467)
..|+...+||+|.||+||+|+.++ |++||+|++-.. .++......+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 457777899999999999998865 888999866432 34455667899999999999999999887642 3
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
...|+||++|+. +|.-.+.+...+++..++.+++.++..||.|+| +..|+|||+||+|+||+.+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 358999999987 899988777778999999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCCc---------cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 367 LLNGKES---------MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 367 ~~~~~~~---------~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
.+..... .-+..|.+||.+.+ ..|+++.|||+.|||+.||.||.+-+.+
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 6654322 12566788998765 5789999999999999999999988765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=243.29 Aligned_cols=223 Identities=28% Similarity=0.336 Sum_probs=186.4
Q ss_pred cceeEEEEEecC-CCeEEEEEeecccccc-hHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCHHHhhhc
Q 041491 230 SFGTVYKGRFLD-GMEVAIKVFHLQFDGA-LKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYS 307 (467)
Q Consensus 230 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 307 (467)
+||.||+|.+.+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8999999997654443 67899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC----Cccccccccccc
Q 041491 308 SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK----ESMRTQTLATIE 383 (467)
Q Consensus 308 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~~~pe 383 (467)
.. .+++..+..++.+++.++.+|| +.+++|+||+|+||++++++.++++|||.+...... .......|.+||
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 43 3889999999999999999999 999999999999999999999999999999887653 233455678999
Q ss_pred cccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhh----------cccccccccccccccchhHHHHH
Q 041491 384 YGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDF----------LPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 384 ~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~----------~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
......++.++||||+|+++|++++|..||....... ...++.... ++..+.+++.+|+..+|++|+ +
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp-~ 234 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL-T 234 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc-C
Confidence 9888888999999999999999999999997632111 122222111 455688999999999999998 4
Q ss_pred HHHHH
Q 041491 454 KKQCV 458 (467)
Q Consensus 454 ~~~~~ 458 (467)
+.+.+
T Consensus 235 ~~~~~ 239 (244)
T smart00220 235 AEEAL 239 (244)
T ss_pred HHHHh
Confidence 44444
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=272.50 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=199.9
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC--------CCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEE
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIIS 281 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~ 281 (467)
.+++..++..+.+.+|+|+||.|++|.... ...||||..+.... ...+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 566777777888899999999999997531 35699999875533 4567899999999998 6999999999
Q ss_pred EeecCCeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 041491 282 SCSNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKP 346 (467)
Q Consensus 282 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 346 (467)
+|...+..++|+||++.|+|.++++..+ ..++......++.||+.|++||+ +.+++||||-.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 9999999999999999999999998776 34888999999999999999999 99999999999
Q ss_pred CCeeecCCCcEEEeccccceecCCCCcc--------ccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccc
Q 041491 347 SNVLLDDDMVAHLSDFGIAKLLNGKESM--------RTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIF 417 (467)
Q Consensus 347 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~ 417 (467)
+|||+.++..+||+|||+|+........ -+..|+|||.+....|+.++|||||||++||++| |..|+.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999965443221 2344899999999999999999999999999998 788887633
Q ss_pred cccccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 418 CEEMNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 418 ~~~~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
.. .++.++.++ ..++++.++...|+..+|++|+ +..+|.+.+
T Consensus 527 ~~-~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP-~F~~~~~~~ 576 (609)
T KOG0200|consen 527 PT-EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP-TFSECVEFF 576 (609)
T ss_pred cH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC-CHHHHHHHH
Confidence 11 222335443 2234577889999999999995 344444433
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=246.74 Aligned_cols=195 Identities=22% Similarity=0.238 Sum_probs=168.2
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCC-C-C----CceeEEEEeecCCe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-H-R----NLVKIISSCSNGNF 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~ 288 (467)
.+++|.+...+|+|.||.|-.+.+.. +..||+|+++.- ....+...-|+++++++. + | -++++.+||...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 37899999999999999999998764 789999998743 344566778999999993 2 2 37888899999999
Q ss_pred eeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC--------------
Q 041491 289 EALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-------------- 353 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-------------- 353 (467)
.|||+|.+ |-++.+++.... .+++..++..+++|+++++++|| +.+++|-||||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999987 669999996643 47999999999999999999999 999999999999999832
Q ss_pred ------CCcEEEeccccceecCCCC--ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 354 ------DMVAHLSDFGIAKLLNGKE--SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 354 ------~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
+..+|++|||.|+...... ...|..|.|||.+.+-.++..+||||+||||+|+.||...|..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2368999999999876554 3578899999999999999999999999999999999998864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=256.14 Aligned_cols=194 Identities=23% Similarity=0.317 Sum_probs=169.4
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--------ccchHHHHHHHHHHHcCC---CCCceeEEEEeec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--------DGALKSFDAECEVLKSVR---HRNLVKIISSCSN 285 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 285 (467)
.+|...+.+|.|+||.|+.|.++. ...|++|.+.+.. +........||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 368999999999999999999875 6789999987552 112233567999999997 9999999999999
Q ss_pred CCeeeEEEecc-cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 286 GNFEALVLEYM-ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 286 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
++++||+||-- +|.+|.+++. ....+++.++..|++|++.|+++|| +.||||||||-+|+.++.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999974 4668999984 4567999999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC---ccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCc
Q 041491 365 AKLLNGKE---SMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 365 a~~~~~~~---~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
|....... ..++..|+|||++.++.| +..-||||+|+++|.++....||..
T Consensus 717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98776543 457888999999999888 5678999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=229.83 Aligned_cols=190 Identities=21% Similarity=0.395 Sum_probs=161.3
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecC--CeeeE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNG--NFEAL 291 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~l 291 (467)
..++|++.+++|+|.|++||.|... +++++++|+++.- ..+.+.+|+.||+.++ ||||+++++...++ ....+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4578999999999999999999764 5889999998743 4577899999999997 99999999998765 46679
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceecCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNG 370 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 370 (467)
|+||+.+.+..... ..++...+..++.+++.||.|+| +.||+|||+||.|+++|... .++|+|+|+|.++.+
T Consensus 113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999998877654 35778889999999999999999 99999999999999999765 799999999998876
Q ss_pred CCcc----ccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 371 KESM----RTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 371 ~~~~----~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
.... .+..+.-||.+-. ..|+..-|+|||||++..|+..+.||..
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 5432 3444566887654 5678899999999999999999999853
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.67 Aligned_cols=232 Identities=19% Similarity=0.237 Sum_probs=159.5
Q ss_pred HhccCccCCccCcccceeEEEEEecC-----CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEE------ee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISS------CS 284 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~ 284 (467)
..++|++.+.||+|+||.||+|++.+ +..||+|.+..... .+....| .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999998854 68999998754321 1111111 1122222222222211 24
Q ss_pred cCCeeeEEEecccCCCHHHhhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSSNGI-------------------LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIK 345 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 345 (467)
.....++|+||+++++|.+++...... .....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 566789999999999999988643211 123346689999999999999 9999999999
Q ss_pred CCCeeecC-CCcEEEeccccceecCCC------CccccccccccccccCC----------------------CCCCcccc
Q 041491 346 PSNVLLDD-DMVAHLSDFGIAKLLNGK------ESMRTQTLATIEYGREG----------------------QVSPKSDV 396 (467)
Q Consensus 346 p~NIll~~-~~~~kl~Dfg~a~~~~~~------~~~~~~~~~~pe~~~~~----------------------~~~~~~Dv 396 (467)
|+|||+++ ++.+||+|||+|+.+... ....+..|.+||..... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 579999999999865432 22345678888843211 23446799
Q ss_pred hhhHHHHHHHhcCCCCCCccc--------cccccHHHHHhhhccc---c--------------cccccccccccchhHHH
Q 041491 397 YGYGITLIETFTKKKPTCEIF--------CEEMNLKNWVNDFLPI---S--------------VMNVVDTSLLRREDKYF 451 (467)
Q Consensus 397 ~slGvil~el~tg~~Pf~~~~--------~~~~~~~~~~~~~~~~---~--------------~~~~i~~~l~~~~~~r~ 451 (467)
||+||++|||+++..|++... ..+.+...|.....+. + ..++|.+||..||.+|+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 999999999999888876421 1123344553221111 1 22799999999999998
Q ss_pred HHH
Q 041491 452 AAK 454 (467)
Q Consensus 452 ~~~ 454 (467)
+..
T Consensus 443 ta~ 445 (566)
T PLN03225 443 SAK 445 (566)
T ss_pred CHH
Confidence 533
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=260.28 Aligned_cols=236 Identities=21% Similarity=0.250 Sum_probs=169.4
Q ss_pred HhccCccCCccCcccceeEEEEEe-----------------cCCCeEEEEEeecccccchHH--------------HHHH
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRF-----------------LDGMEVAIKVFHLQFDGALKS--------------FDAE 264 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 264 (467)
..++|++.++||+|+||.||+|.+ ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 577999999999999999999964 135679999987543322222 3346
Q ss_pred HHHHHcCCCCC-----ceeEEEEeec--------CCeeeEEEecccCCCHHHhhhcCCC---------------------
Q 041491 265 CEVLKSVRHRN-----LVKIISSCSN--------GNFEALVLEYMANGSLEKCLYSSNG--------------------- 310 (467)
Q Consensus 265 ~~~l~~l~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 310 (467)
+..+.+++|.+ +++++++|.. .+..++||||+++++|.++++...+
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 67777776654 4677777643 3567999999999999998864321
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC------cccccccccc
Q 041491 311 --ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE------SMRTQTLATI 382 (467)
Q Consensus 311 --~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~~p 382 (467)
.+++..+..++.|++.+|.||| +.+|+||||||+||+++.++.+||+|||++....... ...+..|.+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 2356778899999999999999 9999999999999999999999999999997654322 1224568888
Q ss_pred ccccCCC--------------------C--CCcccchhhHHHHHHHhcCCC-CCCccc--c-----ccccHHHHHh----
Q 041491 383 EYGREGQ--------------------V--SPKSDVYGYGITLIETFTKKK-PTCEIF--C-----EEMNLKNWVN---- 428 (467)
Q Consensus 383 e~~~~~~--------------------~--~~~~Dv~slGvil~el~tg~~-Pf~~~~--~-----~~~~~~~~~~---- 428 (467)
|.+.... + ..+.||||+||++|||++|.. ||.... . .+.+...|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 8754321 1 124799999999999999986 775321 1 1122333311
Q ss_pred -------hhcccccccccccccccch---hHHHHHH
Q 041491 429 -------DFLPISVMNVVDTSLLRRE---DKYFAAK 454 (467)
Q Consensus 429 -------~~~~~~~~~~i~~~l~~~~---~~r~~~~ 454 (467)
...++...+++.++|.++| .+|+++.
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ 495 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVG 495 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHH
Confidence 1123347788999998876 5687533
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=230.32 Aligned_cols=228 Identities=19% Similarity=0.313 Sum_probs=180.1
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEE-EeecCCeeeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIIS-SCSNGNFEALVL 293 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~~~~~~lv~ 293 (467)
.+.|.+.+.+|+|.||.+-+++++. .+.+++|.++.+ .....+|.+|...--.+. |.||+.-|+ .|+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999975 788999998765 345678999988766664 899998877 467778889999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec--CCCcEEEeccccceecCCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--DDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~ 371 (467)
||++.|+|..-+.. ..+.+....+++.|+++|+.|+| ++++||||||.+||||- +..++|+||||..+..+..
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999887743 35788888999999999999999 99999999999999993 3348999999999877654
Q ss_pred Ccc--cccccccccccc---CCC--CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---Hhhh---cc------
Q 041491 372 ESM--RTQTLATIEYGR---EGQ--VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---VNDF---LP------ 432 (467)
Q Consensus 372 ~~~--~~~~~~~pe~~~---~~~--~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---~~~~---~~------ 432 (467)
... ....|.+||... .+. ..+.+|+|.||+++|.++||++||......+..+.+| .... .|
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f 256 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF 256 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence 322 344567777643 232 3678999999999999999999998765555555444 3222 22
Q ss_pred -cccccccccccccchhHH
Q 041491 433 -ISVMNVVDTSLLRREDKY 450 (467)
Q Consensus 433 -~~~~~~i~~~l~~~~~~r 450 (467)
+.+..+..+.|..++++|
T Consensus 257 s~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred CHHHHHHHHHhcCCccccc
Confidence 346667777888888888
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=265.62 Aligned_cols=227 Identities=27% Similarity=0.379 Sum_probs=182.3
Q ss_pred CccCCccCccccee-EEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEeccc
Q 041491 220 FSEKSLIGIGSFGT-VYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 220 y~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
|...+.+|.|+.|+ ||+|.+ +|+.||||++-.. ......+|+..|+.- +||||+++++.-.++.+.||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45557789999875 799988 7899999987533 345677999999988 59999999999999999999999995
Q ss_pred CCCHHHhhhcCCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---C--CcEEEeccccceecC
Q 041491 298 NGSLEKCLYSSNG---ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---D--MVAHLSDFGIAKLLN 369 (467)
Q Consensus 298 ~g~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~Dfg~a~~~~ 369 (467)
. +|.+++..... .......+....|+++||++|| +.+||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999976411 1111345788999999999999 999999999999999975 3 479999999999987
Q ss_pred CCC--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcC-CCCCCccccccccHHHHHhhh------cccc
Q 041491 370 GKE--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTK-KKPTCEIFCEEMNLKNWVNDF------LPIS 434 (467)
Q Consensus 370 ~~~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg-~~Pf~~~~~~~~~~~~~~~~~------~~~~ 434 (467)
... ..++..|.|||.+....-+.++||||+|||+|+.++| ..||.+....+.++..-.... -..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~e 742 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCE 742 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHH
Confidence 543 3467788999999998889999999999999999997 999987655544332221111 1115
Q ss_pred cccccccccccchhHHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~ 454 (467)
+.++|.+|+..+|..|+++.
T Consensus 743 A~dLI~~ml~~dP~~RPsa~ 762 (903)
T KOG1027|consen 743 AKDLISRMLNPDPQLRPSAT 762 (903)
T ss_pred HHHHHHHhcCCCcccCCCHH
Confidence 88999999999999997543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=228.58 Aligned_cols=193 Identities=30% Similarity=0.398 Sum_probs=170.4
Q ss_pred CccCCccCcccceeEEEEEecC-CCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
|++.+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999875 899999999866544 56788999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE----- 372 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----- 372 (467)
+++|.+++......+++..+..++.+++.++.+|| +.+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999998655433789999999999999999999 9999999999999999999999999999998876542
Q ss_pred -ccccccccccccc-cCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 373 -SMRTQTLATIEYG-REGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 373 -~~~~~~~~~pe~~-~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
......+.+||.. ....++.++|+||||++++||++|+.||+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2344557889987 666778899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-31 Score=229.64 Aligned_cols=192 Identities=24% Similarity=0.356 Sum_probs=161.7
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCC-----eee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGN-----FEA 290 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 290 (467)
+.+..+.||-|+||.||.+.+. +|+.||+|.+..-.. ...+++-+|++++..++|.|++..++.....+ ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3445589999999999999875 699999998864322 34577889999999999999999988776543 467
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+++|.+. .+|...+- ....++...++-+++||++||+||| +.+|.||||||.|.+++++..+||||||+|+..+.
T Consensus 134 V~TELmQ-SDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-hhhhheec-cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 8999884 48888774 4457888899999999999999999 99999999999999999999999999999998765
Q ss_pred CCc------cccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 371 KES------MRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 371 ~~~------~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
... .-+..|.+||.+.+ ..|+.+.||||.|||+.|++-++..|..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 432 24677899998765 5689999999999999999999988864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=216.91 Aligned_cols=203 Identities=34% Similarity=0.504 Sum_probs=177.0
Q ss_pred cCcccceeEEEEEecC-CCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCHHH
Q 041491 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEK 303 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 303 (467)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999998755332 34678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEEEeccccceecCCCC-----ccccc
Q 041491 304 CLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLSDFGIAKLLNGKE-----SMRTQ 377 (467)
Q Consensus 304 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~-----~~~~~ 377 (467)
++......+++..+..++.++++++++|| +.|++|+||+|.||+++. ++.++|+|||.+....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 98665456899999999999999999999 999999999999999999 8999999999998776542 33455
Q ss_pred cccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhcccccccccccccccchhHHHHHHHH
Q 041491 378 TLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAAKKQ 456 (467)
Q Consensus 378 ~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~ 456 (467)
.|.+||..... .++.++|+|++|++++++ ..+.+++..|+..+|++|++ +.+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------~~~~~~l~~~l~~~p~~R~~-~~~ 210 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------PELKDLIRKMLQKDPEKRPS-AKE 210 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------HHHHHHHHHHhhCCcccCcC-HHH
Confidence 67889988776 788999999999999999 56889999999999999985 344
Q ss_pred HH
Q 041491 457 CV 458 (467)
Q Consensus 457 ~~ 458 (467)
.+
T Consensus 211 l~ 212 (215)
T cd00180 211 IL 212 (215)
T ss_pred Hh
Confidence 44
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-29 Score=226.17 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=199.7
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEE
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISS 282 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~ 282 (467)
.+++.+..++++....+-+|.||.||+|.|.+ .+.|-+|.++... +-....+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 56777888899999999999999999997653 3456777776443 3345678899999999999999999998
Q ss_pred ee-cCCeeeEEEecccCCCHHHhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC
Q 041491 283 CS-NGNFEALVLEYMANGSLEKCLYSSN-------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354 (467)
Q Consensus 283 ~~-~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 354 (467)
+. +....++.+.+..-|+|..++...+ ..++..+...++.|++.|++||| +.|+||.||..+|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence 75 4567788899999999999987221 25667788899999999999999 9999999999999999999
Q ss_pred CcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHH
Q 041491 355 MVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNW 426 (467)
Q Consensus 355 ~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~ 426 (467)
.++||+|=.+++.+.+.+ ..++..|+++|-+....|+.++|||||||++|||+| |+.|+.+..+.++ ..+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~y 510 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHY 510 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHH
Confidence 999999999999876543 345667899999999999999999999999999987 8999987655543 223
Q ss_pred --------HhhhcccccccccccccccchhHHHHHHHHHHH
Q 041491 427 --------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 427 --------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
..-..|+++-.+..-|+...|++|++ .+|...
T Consensus 511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPs-f~Qlv~ 550 (563)
T KOG1024|consen 511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPS-FSQLVI 550 (563)
T ss_pred HhccceecCCCCCcHHHHHHHHHHHhcCcccCCC-HHHHHH
Confidence 23356778999999999999999963 444433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-30 Score=247.78 Aligned_cols=235 Identities=27% Similarity=0.358 Sum_probs=197.1
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
..++|+..+++|.|.||.||+|+++ .++..|+|+++........-+++|+-+++..+||||+.+++.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4578999999999999999999986 489999999998877777888999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC----
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG---- 370 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~---- 370 (467)
||.+|+|++.- ...+.+++.++...++..++|++||| +.|-+|||||-.||++++.|.+|++|||.+..++.
T Consensus 93 ycgggslQdiy-~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred ecCCCccccee-eecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 99999999954 55678999999999999999999999 99999999999999999999999999999877653
Q ss_pred -CCcccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-----------hhhccccc
Q 041491 371 -KESMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-----------NDFLPISV 435 (467)
Q Consensus 371 -~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-----------~~~~~~~~ 435 (467)
....+++.+++||+.. .+.|...+|||+.|+...|+---++|-.+..+-. .+.-.. ...+.+-+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-ALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-HHHHhhccCCCCCcccCCccchHHH
Confidence 4456788889999754 5678899999999999999998888854422111 000000 11123347
Q ss_pred ccccccccccchhHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~ 455 (467)
-+++.-+|.++|++|+++-.
T Consensus 248 h~fvK~altknpKkRptaek 267 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEK 267 (829)
T ss_pred HHHHHHHhcCCCccCCChhh
Confidence 88999999999999976443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=231.87 Aligned_cols=198 Identities=27% Similarity=0.293 Sum_probs=171.5
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCC------CCCceeEEEEeecC
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR------HRNLVKIISSCSNG 286 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~ 286 (467)
+.-..+|.+....|+|-|++|.+|.+.. |+.||||++... ....+.=..|+++|++|+ --|+++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 4456799999999999999999998865 889999999855 333455578999999995 34899999999999
Q ss_pred CeeeEEEecccCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccc
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFG 363 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg 363 (467)
+++|||+|-+ ..+|.+.++..+. .+....+..++.|+.-||..|. ..||+|.||||+|||+++.. .+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999988 4599999876544 5788899999999999999999 99999999999999998765 68999999
Q ss_pred cceecCCCCc---cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 364 IAKLLNGKES---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 364 ~a~~~~~~~~---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
.|........ .-+..|.|||.+.+-+|+...|+||.||+|||+.||+..|.+.
T Consensus 583 SA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 583 SASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 9998876553 2455789999999999999999999999999999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=219.34 Aligned_cols=131 Identities=27% Similarity=0.357 Sum_probs=110.9
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCC-----C---CCceeEEEEeec--
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-----H---RNLVKIISSCSN-- 285 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~-- 285 (467)
..+|.+.++||-|.|++||+|.+.. .+.||+|+.+.. ....+....||++|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4689999999999999999998864 778999998744 344567789999999983 3 369999999964
Q ss_pred --CCeeeEEEecccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 041491 286 --GNFEALVLEYMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL 351 (467)
Q Consensus 286 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll 351 (467)
+.+.|+|+|++ |.+|..+|... .+.++...++.|++|++.||.|||. ..||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 45899999998 66777777543 4579999999999999999999996 6799999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=213.02 Aligned_cols=191 Identities=23% Similarity=0.257 Sum_probs=161.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 287 (467)
..+|.-.+.+|.|+- .|..|.+. .++.||+|.+..+. ....++..+|...+..++|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888899999998 66666553 58999999876543 234567789999999999999999999986443
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..|+|||++.. +|...+. -.++..+...+..|++.|++||| +.||+||||||+||++..++.+||.|||+|+.
T Consensus 95 e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence 56899999954 8888875 24678899999999999999999 99999999999999999999999999999987
Q ss_pred cCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 368 LNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 368 ~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
.+.. ....+..|.+||.+.+-.+.+.+||||.||++.||++|+..|.+
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 6654 23345667999999888899999999999999999999998864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=215.30 Aligned_cols=163 Identities=21% Similarity=0.255 Sum_probs=127.7
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEec--CCCeEEEEEeecc-----cccchHHHHHHHHHHHcCCCCCcee-EEEEe
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQ-----FDGALKSFDAECEVLKSVRHRNLVK-IISSC 283 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~ 283 (467)
+.....++|++.+.||+|+||+||+|++. +++.||+|++... .....+.+.+|++++++++|+|++. ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34456688999999999999999999875 4777899987533 1223466899999999999999985 4432
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeeecCCCcEEEecc
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI-KPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Df 362 (467)
+..++||||++|++|... . .. . ...++.|+++||.||| ++||+|||| ||+|||++.++.+||+||
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~-~~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-R-PH---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-C-cc---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999732 1 11 1 1467899999999999 999999999 999999999999999999
Q ss_pred ccceecCCCCcc-------------ccccccccccccCCC
Q 041491 363 GIAKLLNGKESM-------------RTQTLATIEYGREGQ 389 (467)
Q Consensus 363 g~a~~~~~~~~~-------------~~~~~~~pe~~~~~~ 389 (467)
|+|+.+...... ++..|.+||++.+++
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999977654321 233467888877654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=207.19 Aligned_cols=205 Identities=24% Similarity=0.317 Sum_probs=164.4
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec----CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCC
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGN 287 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 287 (467)
.....+.|...++||.|.|+.||++.+. ..+.||+|.+.... ...++.+|++.|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999764 36789999886543 4577899999999995 899999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-CcEEEeccccce
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAK 366 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~ 366 (467)
...+|+||++..+..++.. .++...+..+++.++.||+++| .+|||||||||+|++.+.. +.-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999888774 3578899999999999999999 9999999999999999754 577899999997
Q ss_pred ecCCC-------------------------------------------------CccccccccccccccC-CCCCCcccc
Q 041491 367 LLNGK-------------------------------------------------ESMRTQTLATIEYGRE-GQVSPKSDV 396 (467)
Q Consensus 367 ~~~~~-------------------------------------------------~~~~~~~~~~pe~~~~-~~~~~~~Dv 396 (467)
..+.. ...+++.+.+||++.. +.-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 22100 0013444556665533 345789999
Q ss_pred hhhHHHHHHHhcCCCCCCccccccccHHHH
Q 041491 397 YGYGITLIETFTKKKPTCEIFCEEMNLKNW 426 (467)
Q Consensus 397 ~slGvil~el~tg~~Pf~~~~~~~~~~~~~ 426 (467)
||.|||+.-+++++.||.....+-..+.+.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHH
Confidence 999999999999999997654444334333
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=193.47 Aligned_cols=151 Identities=21% Similarity=0.175 Sum_probs=123.6
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCcccccc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT 378 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 378 (467)
|+|.+++......+++.+++.++.|++.||+||| +++ ||+||+++.++.+|+ ||.+.........++..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~ 69 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPY 69 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccccCCCccc
Confidence 6899999766667999999999999999999999 776 999999999999999 99999887766677888
Q ss_pred ccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhc-------------cc--cccccccccc
Q 041491 379 LATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFL-------------PI--SVMNVVDTSL 443 (467)
Q Consensus 379 ~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------------~~--~~~~~i~~~l 443 (467)
|.|||++.+..++.++|||||||++|||+||+.||.........+..+..... +. .+.+++.+|+
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 149 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA 149 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence 99999999999999999999999999999999999754332222333322211 12 4889999999
Q ss_pred ccchhHHHHHHHHHHHHH
Q 041491 444 LRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~~~l 461 (467)
..+|.+|++ +.+++..+
T Consensus 150 ~~~p~~Rp~-~~~ll~~~ 166 (176)
T smart00750 150 SRLPQRREA-ANHYLAHC 166 (176)
T ss_pred hcccccccC-HHHHHHHH
Confidence 999999975 44555543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=241.85 Aligned_cols=177 Identities=18% Similarity=0.183 Sum_probs=131.6
Q ss_pred cCCC-CCceeEEEEe-------ecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 041491 270 SVRH-RNLVKIISSC-------SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341 (467)
Q Consensus 270 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 341 (467)
.++| +||.+++++| .....++.++||+ +++|.+++......+++.+++.+++||++||+||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 4455 5777788877 2334567788887 66999999766667999999999999999999999 999999
Q ss_pred cCCCCCCeeecC-------------------CCcEEEeccccceecCCC---------------------Cccccccccc
Q 041491 342 CDIKPSNVLLDD-------------------DMVAHLSDFGIAKLLNGK---------------------ESMRTQTLAT 381 (467)
Q Consensus 342 ~dlkp~NIll~~-------------------~~~~kl~Dfg~a~~~~~~---------------------~~~~~~~~~~ 381 (467)
|||||+|||++. ++.+|++|||+++..... ...++..|++
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 445667777776542210 0123556999
Q ss_pred cccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhcc-------cccccccccccccchhHHHHH
Q 041491 382 IEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLP-------ISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 382 pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~~~i~~~l~~~~~~r~~~ 453 (467)
||++.+..++.++|||||||++|||++|..|+...... ...+.....+ +...+++..||..+|.+|++.
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcCh
Confidence 99999999999999999999999999999987642111 1111111111 235577788999999999753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=189.64 Aligned_cols=198 Identities=24% Similarity=0.290 Sum_probs=164.0
Q ss_pred HHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCC-CCceeEEEEeecCCeeeE
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~l 291 (467)
.+....|.+.++||+|+||.+|.|... +|.+||+|+-.... ....+..|.++.+.+++ ..|+.+..+..+..+-.+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 345578999999999999999999875 59999999865432 33567789999999975 788888888999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEeccccceec
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIAKLL 368 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~ 368 (467)
|||.+ |.+|++.+.-....++..+++-++-|++.-++|+| .++++||||||+|+|+.- ...+.++|||+|+.+
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99988 78999998777778999999999999999999999 999999999999999953 347899999999987
Q ss_pred CCCCc------------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccc
Q 041491 369 NGKES------------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIF 417 (467)
Q Consensus 369 ~~~~~------------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~ 417 (467)
.+... .+|..|++.....+-.-+.+.|+=|+|.++.+.--|..||.+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 65332 23444444444444455678899999999999999999998763
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=202.07 Aligned_cols=195 Identities=26% Similarity=0.291 Sum_probs=161.5
Q ss_pred cCccCCccCcccceeEEEEEecCC--CeEEEEEeecccccchHHHHHHHHHHHcCCC----CCceeEEEEe-ecCCeeeE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLDG--MEVAIKVFHLQFDGALKSFDAECEVLKSVRH----RNLVKIISSC-SNGNFEAL 291 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l 291 (467)
+|.+.+.||+|+||.||.|..... ..+|+|+...........+..|+.++..+.. +++.++++.. ....+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999998653 4789998765533333378889999998863 6899999999 57888999
Q ss_pred EEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-----CcEEEeccccc
Q 041491 292 VLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-----MVAHLSDFGIA 365 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~Dfg~a 365 (467)
||+.+ |.+|.++..... +.++..++..++.|++.+|+++| +.|++||||||+|+.+... ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 789999875554 68999999999999999999999 9999999999999999754 46999999999
Q ss_pred e--ecCCCC-------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccc
Q 041491 366 K--LLNGKE-------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIF 417 (467)
Q Consensus 366 ~--~~~~~~-------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~ 417 (467)
+ .+.... ..++..|.++....+...+.+.|+||++.++.|++.|..||....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 9 321111 114556667777778888999999999999999999999997643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=192.59 Aligned_cols=173 Identities=13% Similarity=0.093 Sum_probs=136.0
Q ss_pred HHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHH---------HHHHHHHHHcCCCCCceeEEEEee
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKS---------FDAECEVLKSVRHRNLVKIISSCS 284 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~ 284 (467)
....++|+..+.+|.|+||.||.+.. ++..+|+|+++......... +.+|+..+.+++||+|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34578999999999999999999766 67799999997554332222 688999999999999999998865
Q ss_pred cC--------CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 285 NG--------NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 285 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
.. +..++||||++|.+|.++.. .++ ....+++.++..+| +.|++|||+||+||+++++|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence 33 35789999999999988631 222 34669999999999 99999999999999999988
Q ss_pred EEEeccccceecCCCCccccccccccccccCCCCCCcccchhhHHHHHHHh
Q 041491 357 AHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETF 407 (467)
Q Consensus 357 ~kl~Dfg~a~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~ 407 (467)
++++|||........... ..+.....+..++|+||||+++....
T Consensus 173 i~liDfg~~~~~~e~~a~-------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999998765332211 11334445667999999999876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=185.17 Aligned_cols=141 Identities=18% Similarity=0.176 Sum_probs=110.3
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeeccccc--c-------h-----------------HHHHHHHHHHHcCCCCCc
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG--A-------L-----------------KSFDAECEVLKSVRHRNL 276 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 276 (467)
.+.||+|++|.||+|...+|+.||+|+++..... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999754211 0 0 122359999999987776
Q ss_pred eeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCCCCCeeecCCC
Q 041491 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDDDM 355 (467)
Q Consensus 277 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlkp~NIll~~~~ 355 (467)
.....+... ..++||||++|+++..... ....++..++..++.|++.+|.++ | +.||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 443332222 2389999999987765432 235688999999999999999999 7 88999999999999998 47
Q ss_pred cEEEeccccceecCC
Q 041491 356 VAHLSDFGIAKLLNG 370 (467)
Q Consensus 356 ~~kl~Dfg~a~~~~~ 370 (467)
.++|+|||+|.....
T Consensus 155 ~v~LiDFG~a~~~~~ 169 (190)
T cd05147 155 KLYIIDVSQSVEHDH 169 (190)
T ss_pred cEEEEEccccccCCC
Confidence 899999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=187.22 Aligned_cols=196 Identities=22% Similarity=0.315 Sum_probs=167.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 293 (467)
..-+|.+.++||+|+||+.+.|... +++.||||.-...+ ...++..|.+..+.|. .++|..++-+...+.+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 3458999999999999999999753 79999999865443 3356788999998885 699999998888888889999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-----CcEEEeccccceec
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-----MVAHLSDFGIAKLL 368 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~Dfg~a~~~ 368 (467)
|.+ |.+|+|++.-..+.++..++.-++.|++.-++|+| ++.+|.|||||+|+||... ..+.++|||+|+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 988 78999999888889999999999999999999999 9999999999999999643 36899999999988
Q ss_pred CCCCc------------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccc
Q 041491 369 NGKES------------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIF 417 (467)
Q Consensus 369 ~~~~~------------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~ 417 (467)
.++.+ .++..|++..-..+..-+.+.|+=|+|-++++.+-|..||.+..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 76543 34556666666667777889999999999999999999998753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=194.20 Aligned_cols=234 Identities=31% Similarity=0.408 Sum_probs=187.9
Q ss_pred CccCCccCcccceeEEEEEecCCCeEEEEEeeccccc---chHHHHHHHHHHHcCCCC-CceeEEEEeecCCeeeEEEec
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG---ALKSFDAECEVLKSVRHR-NLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 295 (467)
|...+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677789999999999999886 88999998765433 367789999999999988 799999999888878999999
Q ss_pred ccCCCHHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceecCCC-
Q 041491 296 MANGSLEKCLYSSN--GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~- 371 (467)
+.++++.+++.... ..++......++.|++.++.|+| +.+++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997765443 26889999999999999999999 99999999999999999988 7999999999865432
Q ss_pred ----------CccccccccccccccC---CCCCCcccchhhHHHHHHHhcCCCCCCccccc--cccHHHHHhhhcc----
Q 041491 372 ----------ESMRTQTLATIEYGRE---GQVSPKSDVYGYGITLIETFTKKKPTCEIFCE--EMNLKNWVNDFLP---- 432 (467)
Q Consensus 372 ----------~~~~~~~~~~pe~~~~---~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~---- 432 (467)
...++..|.+||.... ..++...|+||+|++++++++|..||...... .............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2345667888998877 57888999999999999999999997664321 1122222222111
Q ss_pred ------------cccccccccccccchhHHHHHHHHHH
Q 041491 433 ------------ISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 433 ------------~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+.+++.+++..+|..|.+......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 13678888888889988876655443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=178.26 Aligned_cols=142 Identities=20% Similarity=0.189 Sum_probs=112.7
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeecccccc--------------------------hHHHHHHHHHHHcCCCCCc
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--------------------------LKSFDAECEVLKSVRHRNL 276 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 276 (467)
.+.||+|++|.||+|.+.+|+.||+|+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 47899999999999998789999999997642110 1123578999999999987
Q ss_pred eeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCC
Q 041491 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDM 355 (467)
Q Consensus 277 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~ 355 (467)
.....+.... .++||||++|+++..... ....++..+...++.|++.++.++| . .||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence 5544443332 489999999886543321 2345788899999999999999999 8 9999999999999999 78
Q ss_pred cEEEeccccceecCCC
Q 041491 356 VAHLSDFGIAKLLNGK 371 (467)
Q Consensus 356 ~~kl~Dfg~a~~~~~~ 371 (467)
.++|+|||+|.....+
T Consensus 155 ~~~liDFG~a~~~~~~ 170 (190)
T cd05145 155 KPYIIDVSQAVELDHP 170 (190)
T ss_pred CEEEEEcccceecCCC
Confidence 9999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=169.13 Aligned_cols=179 Identities=16% Similarity=0.092 Sum_probs=135.1
Q ss_pred ccCCccCcccceeEEEEEecCCCeEEEEEeeccccc----chHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEec
Q 041491 221 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG----ALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 221 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999998765 6788887776543211 1225789999999995 5889999886 346899999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeeecCCCcEEEeccccceecCCCCcc
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI-KPSNVLLDDDMVAHLSDFGIAKLLNGKESM 374 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 374 (467)
+.|.+|.+.... ....++.|++++++++| ++||+|||| ||+||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998764311 12357889999999999 999999999 799999999999999999999865543321
Q ss_pred ----c---------cccccccccccCCC------CC-CcccchhhHHHHHHHhcCCCCCCc
Q 041491 375 ----R---------TQTLATIEYGREGQ------VS-PKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 375 ----~---------~~~~~~pe~~~~~~------~~-~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
. --.-.+|+++.+.+ .+ ...+.++-|.-+|.++|+..|+-.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 00114566665432 22 457899999999999999998644
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-23 Score=179.99 Aligned_cols=228 Identities=18% Similarity=0.310 Sum_probs=175.5
Q ss_pred CccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
....-+|.+...|+.|+|+| .|..+++|++.... ....++|..|.-.++-+.||||+.+++.|.......++..|++
T Consensus 192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34456788999999999999 45667778776442 2344678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEe--ccccceecCCCCcc
Q 041491 298 NGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLS--DFGIAKLLNGKESM 374 (467)
Q Consensus 298 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~--Dfg~a~~~~~~~~~ 374 (467)
.|+|...++...+ ..+..++.+++.++++|++|||+- ..-|----|.+..+++|++.+++|. |--++ +......
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs--fqe~gr~ 347 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQEVGRA 347 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee--eeccccc
Confidence 9999999987665 578889999999999999999942 2334445688999999999987764 32222 2333444
Q ss_pred ccccccccccccCCCC---CCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---Hhhhccc----ccccccccccc
Q 041491 375 RTQTLATIEYGREGQV---SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---VNDFLPI----SVMNVVDTSLL 444 (467)
Q Consensus 375 ~~~~~~~pe~~~~~~~---~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---~~~~~~~----~~~~~i~~~l~ 444 (467)
-.+.+.+||.+...+- -.++|+|||++++||+.|+..||.+...-+-.++-. .+..+|+ .+..++.-|+.
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmn 427 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMN 427 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhc
Confidence 4567788887755443 247899999999999999999998765444332222 3444555 47788999999
Q ss_pred cchhHHH
Q 041491 445 RREDKYF 451 (467)
Q Consensus 445 ~~~~~r~ 451 (467)
.||.+|+
T Consensus 428 edpgkrp 434 (448)
T KOG0195|consen 428 EDPGKRP 434 (448)
T ss_pred CCCCcCC
Confidence 9999996
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=170.06 Aligned_cols=137 Identities=17% Similarity=0.253 Sum_probs=107.8
Q ss_pred CccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcC-----CCCCceeEEEEeecCC---eee-
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV-----RHRNLVKIISSCSNGN---FEA- 290 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~- 290 (467)
+...+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ +||||++++|+++++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34468899999999996 443333379988765444567899999999999 5799999999998763 433
Q ss_pred EEEec--ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceecCCCCCCeeecC----CCcEEEeccc
Q 041491 291 LVLEY--MANGSLEKCLYSSNGILDIFQRLSIMIDVALAL-EYLHFGYSNPVVHCDIKPSNVLLDD----DMVAHLSDFG 363 (467)
Q Consensus 291 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~Dfg 363 (467)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +||| +++|+||||||+||+++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5579999999553 35555 35678888888 9999 999999999999999974 3489999954
Q ss_pred cc
Q 041491 364 IA 365 (467)
Q Consensus 364 ~a 365 (467)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-22 Score=206.30 Aligned_cols=232 Identities=19% Similarity=0.215 Sum_probs=176.4
Q ss_pred ccCCccCcccceeEEEEEecC-CCeEEEEEeec---cccc---chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 221 SEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL---QFDG---ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 221 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.....+|.|++|.|+.+.... ...++.|.+.. .... ....+..|.-+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456788999999888776542 44444443321 1111 1112455666677789999988877766666555569
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
|||++ ||...+... +.+....+..++.|++.|++|+| ..||.|||+||+|++++.+|.+||+|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999988543 46888899999999999999999 999999999999999999999999999998765432
Q ss_pred -------CccccccccccccccCCCCCC-cccchhhHHHHHHHhcCCCCCCcccccccc--------------HHHHHhh
Q 041491 372 -------ESMRTQTLATIEYGREGQVSP-KSDVYGYGITLIETFTKKKPTCEIFCEEMN--------------LKNWVND 429 (467)
Q Consensus 372 -------~~~~~~~~~~pe~~~~~~~~~-~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--------------~~~~~~~ 429 (467)
+..+...|.|||...+..|.+ ..||||.|+++..|++|+.||.....++.. -...+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 234677888999999999876 579999999999999999999654333221 1222556
Q ss_pred hcccccccccccccccchhHHHHHHHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.+|...+.++.++|+.+|.+|.+ +++.+
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~t-i~~i~ 583 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRIT-IEQIL 583 (601)
T ss_pred hchhhHHHHHHHHccCChhheec-HHHHh
Confidence 67778999999999999999964 44443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-22 Score=203.44 Aligned_cols=235 Identities=20% Similarity=0.199 Sum_probs=177.2
Q ss_pred cCccCCccCcccceeEEEEEecCCCeEEEEEeecccc-cchHHHHHHHHH--HHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEV--LKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+|...+.||++.|=+|.+|++.+|. |+||++-++.+ -..+.+.++++- ...++|||++.+..+.......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999998777 99999976653 233444443333 4456899999999888888888999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC--C--C
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN--G--K 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~--~--~ 371 (467)
+.. +|.|.+ ..++.+...+.+.|+.|++.|+..+| ..||+|||||.+|||++.-..+.|+||..-+..- . +
T Consensus 103 vkh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 965 999988 34456777888899999999999999 9999999999999999999999999998765321 1 1
Q ss_pred --------CccccccccccccccC----------CC-CCCcccchhhHHHHHHHhc-CCCCCCcc-----ccccccHHHH
Q 041491 372 --------ESMRTQTLATIEYGRE----------GQ-VSPKSDVYGYGITLIETFT-KKKPTCEI-----FCEEMNLKNW 426 (467)
Q Consensus 372 --------~~~~~~~~~~pe~~~~----------~~-~~~~~Dv~slGvil~el~t-g~~Pf~~~-----~~~~~~~~~~ 426 (467)
...+..-|-|||-.-. .. .+++-||||+||+++|+++ |++||.-. ........+.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 1123344678885432 12 5678999999999999987 68888632 1111333344
Q ss_pred Hhhhccc-ccccccccccccchhHHHHHHHHHHHH
Q 041491 427 VNDFLPI-SVMNVVDTSLLRREDKYFAAKKQCVSS 460 (467)
Q Consensus 427 ~~~~~~~-~~~~~i~~~l~~~~~~r~~~~~~~~~~ 460 (467)
+-+.+++ .++++|..|+++||.+|. ++++.++.
T Consensus 258 ~Le~Ied~~~Rnlil~Mi~rdPs~Rl-SAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKIEDVSLRNLILSMIQRDPSKRL-SAEDYLQK 291 (1431)
T ss_pred HHHhCcCccHHHHHHHHHccCchhcc-CHHHHHHh
Confidence 4444555 599999999999999996 45555544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=176.85 Aligned_cols=227 Identities=22% Similarity=0.254 Sum_probs=146.1
Q ss_pred cCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc---cchHHHHHHHHHHHcCCC----------CCceeEEEEe-
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRH----------RNLVKIISSC- 283 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~~~~~~- 283 (467)
.+...+.||.|+++.||.+++.+ |+++|+|++..... ...+++.+|.-....+.+ -.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 44556889999999999999975 89999999865432 234566666644444322 1222222211
Q ss_pred -----------ecCC-----eeeEEEecccCCCHHHhhhc---CCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 041491 284 -----------SNGN-----FEALVLEYMANGSLEKCLYS---SNG---ILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341 (467)
Q Consensus 284 -----------~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 341 (467)
.... ..+++|+-+ .+||.+++.. ... ......+..+..|+++.+++|| ..|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 1111 225677777 5588877532 111 2334455677799999999999 999999
Q ss_pred cCCCCCCeeecCCCcEEEeccccceecCCCCc--cccccccccccccC--------CCCCCcccchhhHHHHHHHhcCCC
Q 041491 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES--MRTQTLATIEYGRE--------GQVSPKSDVYGYGITLIETFTKKK 411 (467)
Q Consensus 342 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~pe~~~~--------~~~~~~~Dv~slGvil~el~tg~~ 411 (467)
+||||+|++++.+|.++|+||+.....+.... ..+..+.+||.... -.++.+.|.|++|+++|.|.+|+.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999999998887765433 23345667776533 246788999999999999999999
Q ss_pred CCCccccccccHHHH--HhhhcccccccccccccccchhHH
Q 041491 412 PTCEIFCEEMNLKNW--VNDFLPISVMNVVDTSLLRREDKY 450 (467)
Q Consensus 412 Pf~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~~~~r 450 (467)
||.....+.....+| .. .+|+.++.+|..+|+.+|.+|
T Consensus 249 Pf~~~~~~~~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 998654333222233 22 556679999999999999876
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-20 Score=167.38 Aligned_cols=144 Identities=18% Similarity=0.147 Sum_probs=113.4
Q ss_pred cCccCCccCcccceeEEEEE--ecCCCeEEEEEeeccccc------------------------chHHHHHHHHHHHcCC
Q 041491 219 HFSEKSLIGIGSFGTVYKGR--FLDGMEVAIKVFHLQFDG------------------------ALKSFDAECEVLKSVR 272 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 272 (467)
.|++.+.||+|++|.||+|. ..+|+.||+|+++..... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 457999999998754210 0123568999999997
Q ss_pred C--CCceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCe
Q 041491 273 H--RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP-VVHCDIKPSNV 349 (467)
Q Consensus 273 h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlkp~NI 349 (467)
+ ..+++++++ ...++||||++|+++...... ....+..+...++.|++.++++|| ..| ++||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 5 334555543 234899999999888765422 234566677899999999999999 999 99999999999
Q ss_pred eecCCCcEEEeccccceecCCC
Q 041491 350 LLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 350 ll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
+++ ++.++|+|||.|...+.+
T Consensus 181 li~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred EEE-CCCEEEEEChhhhccCCc
Confidence 999 789999999998865543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-21 Score=198.75 Aligned_cols=194 Identities=26% Similarity=0.309 Sum_probs=155.0
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC---CCCceeEEEEeecCCe
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR---HRNLVKIISSCSNGNF 288 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~ 288 (467)
+.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+....-. |.-=.+++.+|+ -+.|..+...+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4556777899999999999999999998889999999876543221 111123344444 2455566666666777
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec-------CCCcEEEec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-------DDMVAHLSD 361 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-------~~~~~kl~D 361 (467)
.++|+||.+.|+|.+++. ..+.+++..++.+..|++..+++|| ..+|||+||||+|+|+. +...++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 899999999999999985 5668999999999999999999999 99999999999999993 234689999
Q ss_pred cccceecCC--CC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCC
Q 041491 362 FGIAKLLNG--KE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412 (467)
Q Consensus 362 fg~a~~~~~--~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~P 412 (467)
||.+..+.- .. ...+..+..+|+..+..++.++|.|.++.+++-|+.|+.-
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999986642 11 1234455679999999999999999999999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-21 Score=190.02 Aligned_cols=219 Identities=23% Similarity=0.220 Sum_probs=174.2
Q ss_pred cCcccceeEEEEEe----cCCCeEEEEEeeccccc--chHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEecccC
Q 041491 226 IGIGSFGTVYKGRF----LDGMEVAIKVFHLQFDG--ALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 226 lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+|+|+||.|+.++- ..+.-+|+|+.++.... .......|..++...+ ||.++++.-.++.+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 69999999998743 23778999998765322 1225567888888886 99999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-Cccccc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-ESMRTQ 377 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 377 (467)
|++...+... ..+++.....+...++-+++++| +.+|+|||+|++||+++.+|++++.|||.++..-.. ..+++.
T Consensus 82 g~lft~l~~~-~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~ 157 (612)
T KOG0603|consen 82 GDLFTRLSKE-VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTY 157 (612)
T ss_pred chhhhccccC-CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccch
Confidence 9998877443 45677777888899999999999 999999999999999999999999999999876433 235677
Q ss_pred cccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----HhhhcccccccccccccccchhHHHHH
Q 041491 378 TLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 378 ~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.|++||... .....+|.||||++++||+||..||.. +.....-. +.+.+...+.++++.++.++|..|...
T Consensus 158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 889999877 456899999999999999999999976 11111111 122233357888889999999888654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=162.46 Aligned_cols=134 Identities=22% Similarity=0.321 Sum_probs=113.7
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeeccccc--------chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG--------ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
+.||+|++|.||+|.+ .|..+++|+....... ....+.+|++++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6788999986543211 124577899999999999988777777777788999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
++|++|.+++.... . ....++.+++.++.++| +.+++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885432 2 77889999999999999 99999999999999999 78999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-19 Score=158.69 Aligned_cols=145 Identities=22% Similarity=0.202 Sum_probs=113.8
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccccc----------------------chHHHHHHHHHHH
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG----------------------ALKSFDAECEVLK 269 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 269 (467)
++......|.+.+.||+|+||.||+|...+|+.||||+++..... .......|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444458888999999999999999878999999987643210 1123567888898
Q ss_pred cCCCC--CceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 041491 270 SVRHR--NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 347 (467)
Q Consensus 270 ~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 347 (467)
.+.|+ .+++.++. ...++||||++|++|...... .....++.+++.++.++| +.|++||||||+
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcc
Confidence 88777 45555542 345899999999999775421 345678899999999999 999999999999
Q ss_pred CeeecCCCcEEEeccccceecCC
Q 041491 348 NVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 348 NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||++++++.++|+|||.+.....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=160.90 Aligned_cols=131 Identities=23% Similarity=0.340 Sum_probs=106.6
Q ss_pred ccCcccceeEEEEEecCCCeEEEEEeecccc--------cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 225 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.||+|++|.||+|.+ ++..+++|+...... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998653211 11255778999999999887655555555666778999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
+|++|.+.+..... .++.+++.+|.++| +.|++|||++|+||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988743211 78999999999999 99999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=180.43 Aligned_cols=139 Identities=23% Similarity=0.305 Sum_probs=113.4
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEee-cccc-------cchHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFH-LQFD-------GALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
....|...+.||+|+||.||+|.+.+. .+++|+.. .... ...+++.+|+++++.++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 345567789999999999999987543 44444332 1111 12356789999999999999998888877777
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..++||||++|++|.+++. ....++.++++++.+|| +.|++|||+||+||++ +++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999999874 35679999999999999 9999999999999999 577999999999976
Q ss_pred c
Q 041491 368 L 368 (467)
Q Consensus 368 ~ 368 (467)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-18 Score=158.16 Aligned_cols=175 Identities=23% Similarity=0.281 Sum_probs=131.2
Q ss_pred CCCCceeEEEEeec---------------------------CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHH
Q 041491 272 RHRNLVKIISSCSN---------------------------GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDV 324 (467)
Q Consensus 272 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i 324 (467)
+|||||++.++|.+ +...|+||..++. +|..++.... .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999876632 2356899998865 9999986543 5667778899999
Q ss_pred HHHHHHHhcCCCCCceecCCCCCCeee--cCCC--cEEEeccccceecCCCC-----------cccccccccccccc--C
Q 041491 325 ALALEYLHFGYSNPVVHCDIKPSNVLL--DDDM--VAHLSDFGIAKLLNGKE-----------SMRTQTLATIEYGR--E 387 (467)
Q Consensus 325 ~~~l~~LH~~~~~~ivH~dlkp~NIll--~~~~--~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~pe~~~--~ 387 (467)
++|+.||| ++||.|||+|++|||+ |+|+ .+.++|||++---+... .-+....++||... +
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 9999999999999998 4444 67899999875332211 11233457888753 2
Q ss_pred CCC----CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhc-------ccccccccccccccchhHHHH
Q 041491 388 GQV----SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFL-------PISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 388 ~~~----~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------~~~~~~~i~~~l~~~~~~r~~ 452 (467)
++. -.|+|.|+.|.+.||+++...||...-+-..+...|....+ |+.++++|...|++||.+|.+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCC
Confidence 322 24899999999999999999999874333344555544444 445899999999999999954
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-18 Score=165.90 Aligned_cols=182 Identities=29% Similarity=0.399 Sum_probs=146.0
Q ss_pred HHcCCCCCceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-eecCCCC
Q 041491 268 LKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV-VHCDIKP 346 (467)
Q Consensus 268 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~dlkp 346 (467)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.-...+.++++.||+|+| ...| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 35788999999999999999999999999999999999887778999999999999999999999 4444 9999999
Q ss_pred CCeeecCCCcEEEeccccceecCCC-------CccccccccccccccCC-------CCCCcccchhhHHHHHHHhcCCCC
Q 041491 347 SNVLLDDDMVAHLSDFGIAKLLNGK-------ESMRTQTLATIEYGREG-------QVSPKSDVYGYGITLIETFTKKKP 412 (467)
Q Consensus 347 ~NIll~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~~~pe~~~~~-------~~~~~~Dv~slGvil~el~tg~~P 412 (467)
.|.++|..+.+|++|||+....... .......|.+||.++.. ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876421 11123346889987653 146789999999999999999999
Q ss_pred CCccccccc--cHHHHHhh--------------hcccccccccccccccchhHHHH
Q 041491 413 TCEIFCEEM--NLKNWVND--------------FLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 413 f~~~~~~~~--~~~~~~~~--------------~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
|+....... .+..++.. ..++....++..|+..+|.+|++
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc
Confidence 986422221 12222221 22334777888999999999964
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=146.37 Aligned_cols=137 Identities=23% Similarity=0.223 Sum_probs=99.3
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeecccccc--hHH----------------------HHHHHHHHHcCCCC--Cc
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKS----------------------FDAECEVLKSVRHR--NL 276 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--ni 276 (467)
.+.||+|+||.||+|.+.+++.||+|+++...... ... ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999987532111 011 13455556655433 34
Q ss_pred eeEEEEeecCCeeeEEEecccCCCHHHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCC
Q 041491 277 VKIISSCSNGNFEALVLEYMANGSLEKC-LYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDD 354 (467)
Q Consensus 277 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~ 354 (467)
.+.++. ...++||||++++++... +.... .. ..+..++.+++.++.++| . ++|+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 455543 235899999999543211 11110 11 567889999999999999 8 9999999999999999 8
Q ss_pred CcEEEeccccceecCC
Q 041491 355 MVAHLSDFGIAKLLNG 370 (467)
Q Consensus 355 ~~~kl~Dfg~a~~~~~ 370 (467)
+.++++|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 8999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-18 Score=176.21 Aligned_cols=194 Identities=26% Similarity=0.318 Sum_probs=139.5
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
...+|+.++.|..|+||.||.++++. .+.+|+|+ .++.. +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee-----------------
Confidence 34689999999999999999999875 78899954 22211 1111 34444455544
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC-----
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN----- 369 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~----- 369 (467)
||-...++.. +.++.. ++.+++|+| +.||+|||+||+|.+|+.-|++|+.|||+++..-
T Consensus 136 ----gDc~tllk~~-g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-GPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ----chhhhhcccC-CCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 3444444322 233322 277899999 9999999999999999999999999999987532
Q ss_pred ---------------CCCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc------cHHHHHh
Q 041491 370 ---------------GKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM------NLKNWVN 428 (467)
Q Consensus 370 ---------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~------~~~~~~~ 428 (467)
+....+++.|.+||++.-..|+..+|+|++|+|+||.+.|..||.+...++. +...|-.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 1222456667777777777899999999999999999999999988644432 2233332
Q ss_pred h--hcccccccccccccccchhHH
Q 041491 429 D--FLPISVMNVVDTSLLRREDKY 450 (467)
Q Consensus 429 ~--~~~~~~~~~i~~~l~~~~~~r 450 (467)
. -+++++.++++..|..+|..|
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhh
Confidence 2 234568889999998888887
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.9e-17 Score=136.59 Aligned_cols=135 Identities=20% Similarity=0.240 Sum_probs=114.0
Q ss_pred cCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCC--CCceeEEEEeecCCeeeEEEecccCC
Q 041491 222 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH--RNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 222 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999844 7899999865433 4678899999999976 58999999988888899999999988
Q ss_pred CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 300 SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 300 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77553 5566778899999999999933235899999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.4e-16 Score=143.26 Aligned_cols=136 Identities=19% Similarity=0.192 Sum_probs=105.5
Q ss_pred CccC-cccceeEEEEEecCCCeEEEEEeeccc-------------ccchHHHHHHHHHHHcCCCCCc--eeEEEEeecC-
Q 041491 224 SLIG-IGSFGTVYKGRFLDGMEVAIKVFHLQF-------------DGALKSFDAECEVLKSVRHRNL--VKIISSCSNG- 286 (467)
Q Consensus 224 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~- 286 (467)
..|| .|+.|+||.+.. ++..+++|.+.... ......+.+|++++..++|+++ ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5577 888899999877 47889999885321 1123567889999999998774 6777764332
Q ss_pred C---eeeEEEecccC-CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecc
Q 041491 287 N---FEALVLEYMAN-GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 287 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
. ..++|||+++| .+|.+++.. ..++.. .+.+++.++.+|| ++||+||||||+|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999997 699888754 234443 3678999999999 999999999999999999899999999
Q ss_pred ccceecC
Q 041491 363 GIAKLLN 369 (467)
Q Consensus 363 g~a~~~~ 369 (467)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9988644
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5e-18 Score=139.31 Aligned_cols=126 Identities=29% Similarity=0.501 Sum_probs=106.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|-||+|+++. .|+.+..+.+|+.|++++|+|+ .+|..++++++|+.|+++-|++. .+|..|+.++.|+.|||++|++
T Consensus 38 LtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl 114 (264)
T KOG0617|consen 38 LTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNL 114 (264)
T ss_pred hhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccc
Confidence 5689999994 6778999999999999999998 78989999999999999999997 8899999999999999999888
Q ss_pred cC------------------------CCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QG------------------------PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~------------------------~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
.. .+|..++++++|+.|.+..|.+- .+|.+++.+.+|++|++.+|.++-
T Consensus 115 ~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v 187 (264)
T KOG0617|consen 115 NENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV 187 (264)
T ss_pred ccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee
Confidence 63 35666777888888888888777 567788888888888888888774
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.2e-17 Score=178.31 Aligned_cols=133 Identities=40% Similarity=0.594 Sum_probs=77.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|.+++..|..|+++++|++|+|++|.+.+.+|..|.++++|++|+|++|++++.+|..++++++|+.|+|++|++
T Consensus 145 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred EECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 45555555555555566666666666666666555555566666666666666665555555555555555555555555
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++.+|..++.+++|+.|++++|.+++.+|..+.++++|+.|++++|.+.+.+|
T Consensus 225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 277 (968)
T PLN00113 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277 (968)
T ss_pred CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCc
Confidence 55555555555555555555555555555555555555555555555554443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.5e-17 Score=156.34 Aligned_cols=162 Identities=23% Similarity=0.311 Sum_probs=126.1
Q ss_pred CeeeEEEecccCCCHHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 287 NFEALVLEYMANGSLEKCLYSSN--GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
.+.||.|++|...+|.+++...+ ...++.....++.|++.|+.| ++.+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 36789999999999999995433 256788889999999999998 6899999999999999999999999999
Q ss_pred ceecCCCC-----------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhhhcc
Q 041491 365 AKLLNGKE-----------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVNDFLP 432 (467)
Q Consensus 365 a~~~~~~~-----------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 432 (467)
........ ..++..|++||.+.+..|+.++||||||++++|+++ -..+|+.. ..+.+.-...+|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----HhhhhhhcCCCC
Confidence 88765443 246778999999999999999999999999999997 33344321 122222222333
Q ss_pred c-------ccccccccccccchhHHHHHHHHHH
Q 041491 433 I-------SVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 433 ~-------~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+ .-..++..++...|.+|++.+.--+
T Consensus 479 ~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 479 PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhh
Confidence 2 2447888899999999995554433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=158.46 Aligned_cols=113 Identities=38% Similarity=0.609 Sum_probs=105.0
Q ss_pred CccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEcc
Q 041491 22 SILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS 101 (467)
Q Consensus 22 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~ 101 (467)
.++.|+|++|.+.|.+|..+..+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccCCccccccccc-ccccccccccccccCCCC
Q 041491 102 VNNLSGVIPISLEKL-VYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 102 ~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~ 134 (467)
+|+++|.+|..+..+ .++..+++++|...|..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999988764 467789999998777544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.9e-17 Score=166.46 Aligned_cols=235 Identities=22% Similarity=0.272 Sum_probs=185.1
Q ss_pred HhccCccCCccCcccceeEEEEEecC--CCeEEEEEeeccc--ccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD--GMEVAIKVFHLQF--DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 290 (467)
....|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-+.+. |+|++++++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 34568888889999999998886643 4456666665442 223344556777777776 999999999999999999
Q ss_pred EEEecccCCCHHHhh-hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceec
Q 041491 291 LVLEYMANGSLEKCL-YSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLL 368 (467)
Q Consensus 291 lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~ 368 (467)
++++|..|+++.+-+ .......+......++.|+..++.|+|. ..++.|||+||+|.+++..+ ..++.|||+|..+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999998887 3333256777788899999999999996 67899999999999999999 9999999999877
Q ss_pred CC-CC-------ccc-cccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh---------
Q 041491 369 NG-KE-------SMR-TQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND--------- 429 (467)
Q Consensus 369 ~~-~~-------~~~-~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~--------- 429 (467)
.. .+ ..+ +..|++||...+ ....+..|+||.|+++.-+++|..||+.....+..+..|...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 65 22 234 667778887766 345678999999999999999999998776666665556443
Q ss_pred -hcccccccccccccccchhHHHH
Q 041491 430 -FLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 430 -~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
.+.....+++.+++..+|..|.+
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s 279 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLS 279 (601)
T ss_pred ccCChhhhhcccccccCCchhccc
Confidence 23345788889999888888853
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.9e-15 Score=147.91 Aligned_cols=142 Identities=20% Similarity=0.269 Sum_probs=100.6
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeecccccc----------------------------------------hHHHH
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA----------------------------------------LKSFD 262 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 262 (467)
.+.||+|++|.||+|+..+|+.||||+.+...... .-++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999986432100 00234
Q ss_pred HHHHHHHcC----CCCCceeEEEEe-ecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 041491 263 AECEVLKSV----RHRNLVKIISSC-SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL-ALEYLHFGYS 336 (467)
Q Consensus 263 ~E~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~ 336 (467)
+|++.+.++ +|.+-+.+-..+ ......++||||++|++|.+......... ....++.+++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence 455555544 233223332222 23445689999999999988764322122 23456666666 467889 9
Q ss_pred CCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 337 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
.|++|+|+||.||++++++.++++|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999988764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-16 Score=152.83 Aligned_cols=129 Identities=26% Similarity=0.289 Sum_probs=69.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+||+|.|..+.+..+...++|++|+||+|+|+...++.|..|.+|++|+|++|+++..-...|.++++|+.|||++|.|
T Consensus 298 L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~l 377 (873)
T KOG4194|consen 298 LDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNEL 377 (873)
T ss_pred hccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeE
Confidence 44555555555555555555555555555555544444555555555555555555433334455555555555555555
Q ss_pred cCCCC---ccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 82 QGPIP---ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 82 ~~~~p---~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
++.+- .+|..+++|+.|+|.+|+|..+....|..+..|+.|||.+|.|.
T Consensus 378 s~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 378 SWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred EEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcce
Confidence 54332 23555666666666666665444456666666666666666554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.6e-15 Score=141.83 Aligned_cols=128 Identities=28% Similarity=0.336 Sum_probs=60.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccE------------------------EEccCCcC
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVE------------------------INLSRNYL 57 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~------------------------l~l~~n~l 57 (467)
|-|+.|+|+.+++..|++|++|+.|+|..|+|....--.|.+|++|+. |+|+.|++
T Consensus 202 lkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l 281 (873)
T KOG4194|consen 202 LKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRL 281 (873)
T ss_pred eecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchh
Confidence 445566666555555555666666666555554222233444433333 33333333
Q ss_pred CCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccc
Q 041491 58 TGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 129 (467)
Q Consensus 58 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 129 (467)
+..--..+.+|++|+.||||+|.|....++++..+++|+.|+|++|+|+...+..|..|.+|+.|+|++|.+
T Consensus 282 ~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi 353 (873)
T KOG4194|consen 282 QAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSI 353 (873)
T ss_pred hhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccch
Confidence 322223333444444444444444444444444444455555555555444444444444455555554444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.1e-14 Score=140.50 Aligned_cols=146 Identities=19% Similarity=0.187 Sum_probs=94.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccccc----------------------------------chH---
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG----------------------------------ALK--- 259 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--- 259 (467)
..|+. +.||+|++|.||+|+.++ |+.||||+.++.... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35776 799999999999999987 999999999754110 011
Q ss_pred ---HHHHHHHHHHcC----CCCCceeEEEEee-cCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHH-HHH
Q 041491 260 ---SFDAECEVLKSV----RHRNLVKIISSCS-NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA-LEY 330 (467)
Q Consensus 260 ---~~~~E~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~ 330 (467)
++.+|+.-+.++ .+...+.+-.++. .....++||||++|+.+.+.-.-.....+.. .++...+.. +..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHH
Confidence 133444444443 2444344433333 2456689999999999987421111111211 122222211 223
Q ss_pred HhcCCCCCceecCCCCCCeeecCCC----cEEEeccccceecCC
Q 041491 331 LHFGYSNPVVHCDIKPSNVLLDDDM----VAHLSDFGIAKLLNG 370 (467)
Q Consensus 331 LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 370 (467)
+. ..|++|+|+||.||+++.++ +++++|||++..+..
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 68999999999999999888 999999999988764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.1e-13 Score=118.65 Aligned_cols=128 Identities=23% Similarity=0.213 Sum_probs=96.8
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCC-ceeEEEEeecCCeeeEEEecccCCCH
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-LVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
.+.++.|.++.||+++. .+..|++|+...... ....+..|+.+++.+.+.+ +++++.+.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 36789999999999987 478899998754422 2345678999999886544 445665543 335799999999887
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeeecCCCcEEEecccccee
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP-----VVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
...- .....++.+++++++.|| ..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~---------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED---------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc---------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 112346789999999999 776 49999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-15 Score=146.90 Aligned_cols=127 Identities=31% Similarity=0.488 Sum_probs=113.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+|||+|+++ +.|+.+.++++|+.|+||+|+|+ .+....+...+|+.|+||+|+++ .+|+.++.|++|+.|++.+|++
T Consensus 227 vDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL 303 (1255)
T KOG0444|consen 227 VDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKL 303 (1255)
T ss_pred ccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcc
Confidence 689999999 68999999999999999999998 56666777788999999999999 8899999999999999999987
Q ss_pred cC-CCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 82 QG-PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 82 ~~-~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
+- -+|+.++.+.+|+.+..++|.|. .+|+.++.|..|+.|.|+.|.+...
T Consensus 304 ~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTL 354 (1255)
T KOG0444|consen 304 TFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITL 354 (1255)
T ss_pred cccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeec
Confidence 52 37899999999999999999998 8899999999999999999988643
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.8e-15 Score=144.20 Aligned_cols=55 Identities=35% Similarity=0.536 Sum_probs=32.2
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcC
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYL 57 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l 57 (467)
|+||+|+|.+++-..|.+|+.|-+||||+|+|. .+|..+..|..|+.|.|++|.+
T Consensus 131 LNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 131 LNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred EEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence 556666666554455556666666666666665 4555555555555555555554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-12 Score=113.58 Aligned_cols=138 Identities=20% Similarity=0.200 Sum_probs=101.6
Q ss_pred CCccCcccceeEEEEEecC-------CCeEEEEEeeccc------------c----------cchHHH----HHHHHHHH
Q 041491 223 KSLIGIGSFGTVYKGRFLD-------GMEVAIKVFHLQF------------D----------GALKSF----DAECEVLK 269 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~ 269 (467)
...||.|.-+.||.|...+ +..+|+|+++... + ...+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997643 4799999986321 0 011223 37999999
Q ss_pred cCC--CCCceeEEEEeecCCeeeEEEecccCCCHHH-hhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCC
Q 041491 270 SVR--HRNLVKIISSCSNGNFEALVLEYMANGSLEK-CLYSSNGILDIFQRLSIMIDVALALEYL-HFGYSNPVVHCDIK 345 (467)
Q Consensus 270 ~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlk 345 (467)
++. .-++++.+++ ...++||||+.+..+.. .+. ...++..+...+..+++.++..+ | ..|++|+||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 885 3567777765 45689999997653321 121 12345556777889999999998 8 8999999999
Q ss_pred CCCeeecCCCcEEEeccccceecCC
Q 041491 346 PSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 346 p~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+.||++++ +.+.++|||.|.....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCCC
Confidence 99999974 6899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.2e-15 Score=136.08 Aligned_cols=124 Identities=29% Similarity=0.442 Sum_probs=114.1
Q ss_pred ecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCccc
Q 041491 3 SLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQ 82 (467)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~ 82 (467)
.+++|.++ .+|..++.+++|+.|+|++|.+. .+|..++.+..|+.|+++.|++. .+|..+-.+..|+.+-.++|++.
T Consensus 418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~ 494 (565)
T KOG0472|consen 418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG 494 (565)
T ss_pred HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc
Confidence 45666666 78899999999999999999998 79999999999999999999998 88999988889999999999999
Q ss_pred CCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 83 GPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 83 ~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
...|+.+.+|.+|++|||.+|.+. .+|..+++|.+|+.|.++||+|.
T Consensus 495 ~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 495 SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 877788999999999999999999 67889999999999999999997
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-14 Score=119.64 Aligned_cols=115 Identities=32% Similarity=0.541 Sum_probs=105.0
Q ss_pred ccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCC
Q 041491 17 FWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLE 96 (467)
Q Consensus 17 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~ 96 (467)
+.++++++.|-||.|+++ ..|..+..+.+|+.|++++|++. .+|..++.+++|+.|+++.|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 456899999999999998 78889999999999999999998 88999999999999999999999 7999999999999
Q ss_pred EEEccCCccC-CcccccccccccccccccccccccCCCC
Q 041491 97 SLDLSVNNLS-GVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 97 ~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
.|||++|+++ ..+|..|..+..|..|+|++|.+.--+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~ 144 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPP 144 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcccCCh
Confidence 9999999997 4568889999999999999998864433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.4e-13 Score=140.21 Aligned_cols=91 Identities=43% Similarity=0.630 Sum_probs=87.4
Q ss_pred CccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccc
Q 041491 46 VVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 125 (467)
Q Consensus 46 ~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 125 (467)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC
Q 041491 126 FNRLKGDIPTR 136 (467)
Q Consensus 126 ~N~l~~~~~~~ 136 (467)
+|+++|.+|..
T Consensus 499 ~N~l~g~iP~~ 509 (623)
T PLN03150 499 GNSLSGRVPAA 509 (623)
T ss_pred CCcccccCChH
Confidence 99999988864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-13 Score=124.41 Aligned_cols=191 Identities=17% Similarity=0.188 Sum_probs=135.9
Q ss_pred HHHHcCCCCCceeEEEEeecCC-----eeeEEEecccCCCHHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 041491 266 EVLKSVRHRNLVKIISSCSNGN-----FEALVLEYMANGSLEKCLYSSN---GILDIFQRLSIMIDVALALEYLHFGYSN 337 (467)
Q Consensus 266 ~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 337 (467)
.-+-++.|.|+++++.|+.+.+ +..+++||+..|++..++++.. ..+......+|+.||+.||.||| ++..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCC
Confidence 3355667999999999886543 5678999999999999986543 26777888999999999999999 4589
Q ss_pred CceecCCCCCCeeecCCCcEEEeccccceec---------CCCCccccccccccccccCCCCCCcccchhhHHHHHHHhc
Q 041491 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL---------NGKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408 (467)
Q Consensus 338 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~---------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t 408 (467)
.|+|+++..+-|++..+|-+|+.----.... ......+...+.+||+...-..+.++|||+||+...||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998887532111100 0111123445678888877777889999999999999998
Q ss_pred CCCCCCccccccccHHHH--Hhhhcccc-cccccccccccchhHHHHHHHHH
Q 041491 409 KKKPTCEIFCEEMNLKNW--VNDFLPIS-VMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 409 g~~Pf~~~~~~~~~~~~~--~~~~~~~~-~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
+..--......-..-... +-..+... -++.+.+|+..+|..|+++..+.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred heeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhh
Confidence 876532221111111111 11222333 66899999999999998655443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.8e-12 Score=127.09 Aligned_cols=162 Identities=18% Similarity=0.199 Sum_probs=125.1
Q ss_pred cCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHH
Q 041491 240 LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS 319 (467)
Q Consensus 240 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 319 (467)
.++.+|.|.+++...........+.++.++.++||||+++++.++..+..|||+|-+. .|..++.+. .......
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~~ 108 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVCL 108 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHHH
Confidence 3688999998876655445667788899999999999999999999999999999984 566666443 3556667
Q ss_pred HHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCccc-----cccccccccccCCCCCCcc
Q 041491 320 IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR-----TQTLATIEYGREGQVSPKS 394 (467)
Q Consensus 320 i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~pe~~~~~~~~~~~ 394 (467)
-++||+.||.|||+ ..+++|++|..+.|+++..|+.||++|.++.......... ...+..|+-+.+.. -..
T Consensus 109 Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 109 GLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence 88999999999985 7899999999999999999999999999887654333211 11122333322221 246
Q ss_pred cchhhHHHHHHHhcCCC
Q 041491 395 DVYGYGITLIETFTKKK 411 (467)
Q Consensus 395 Dv~slGvil~el~tg~~ 411 (467)
|.|-||++++|++.|..
T Consensus 185 D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNGSL 201 (690)
T ss_pred hhhhHHHHHHHHhCccc
Confidence 99999999999999943
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-14 Score=134.08 Aligned_cols=129 Identities=26% Similarity=0.358 Sum_probs=95.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++.+|+++..+|..+. ++.|+.||.-.|-++ .+|..++++.+|..|||.+|++. .+| .|.+|+.|.+|+++.|+|
T Consensus 165 l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i 240 (565)
T KOG0472|consen 165 LDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQI 240 (565)
T ss_pred hhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHH
Confidence 45566666654333333 666677777777665 67777777777777777777776 556 677778888888888887
Q ss_pred cCCCCccc-cCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCC
Q 041491 82 QGPIPESF-GELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 82 ~~~~p~~~-~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
+ .+|... .++++|..|||..|+++ ..|+++.-+.+|+.||+|+|.|++-+++-
T Consensus 241 ~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sL 294 (565)
T KOG0472|consen 241 E-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSL 294 (565)
T ss_pred H-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCccc
Confidence 7 455544 48889999999999998 67888888899999999999998765543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.2e-13 Score=114.47 Aligned_cols=122 Identities=25% Similarity=0.387 Sum_probs=43.8
Q ss_pred ecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCcc-CCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 3 SLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE-NMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
.|..+.|..+ ..+.+..++++|+|++|+|+. +. .++ .+.+|+.|+|++|.|+ .++ .+..+++|++|++++|+|
T Consensus 3 ~lt~~~i~~~--~~~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I 76 (175)
T PF14580_consen 3 RLTANMIEQI--AQYNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRI 76 (175)
T ss_dssp -------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS--
T ss_pred cccccccccc--ccccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCC
Confidence 3556666642 345566789999999999984 43 455 5889999999999998 443 688899999999999999
Q ss_pred cCCCCccc-cCCCCCCEEEccCCccCCccc-ccccccccccccccccccccC
Q 041491 82 QGPIPESF-GELTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~-~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+. +++.+ ..+++|+.|+|++|+|...-- ..+..+++|+.|++.+|+++.
T Consensus 77 ~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 77 SS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred Cc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 95 44444 468999999999999985433 567788999999999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=128.63 Aligned_cols=193 Identities=24% Similarity=0.266 Sum_probs=156.7
Q ss_pred ccCccCCccCc--ccceeEEEEEe--c-CCCeEEEEEeecccc--cchHHHHHHHHHHHcC-CCCCceeEEEEeecCCee
Q 041491 218 DHFSEKSLIGI--GSFGTVYKGRF--L-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 218 ~~y~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 289 (467)
..|.+.+.+|. |.+|.||.+.. . ++..+|+|.-+.... ....+=.+|+....++ .|++.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999987 3 488899998544332 2223334666666666 499999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceecCCCCCCeeecCC-CcEEEecccc
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL----ALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGI 364 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~ 364 (467)
++-+|++. .+|..+.+.....++....+....+... |+.++| ..+++|-|+||+||+...+ ..++++|||+
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 99999985 6888887766666888899999999999 999999 9999999999999999999 7899999999
Q ss_pred ceecCCCCc----------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 365 AKLLNGKES----------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 365 a~~~~~~~~----------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
...+.+... .+...|.+||.. .+.++..+|+||+|.++.+..++..++..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccC
Confidence 998876542 234457778764 45678899999999999999998877643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-11 Score=103.80 Aligned_cols=143 Identities=20% Similarity=0.247 Sum_probs=105.9
Q ss_pred cCCccCcccceeEEEEEecCCCeEEEEEeecc-c-------ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 222 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQ-F-------DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 222 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
....+-+|+-+.|+++.+ .|+.+.||.-... . .-..++..+|++++.++.--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467889999999999988 6788777743221 1 112456788999999886544444444555666667999
Q ss_pred ecccC-CCHHHhhhcCCCCCCHHH-HHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC---cEEEeccccceec
Q 041491 294 EYMAN-GSLEKCLYSSNGILDIFQ-RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---VAHLSDFGIAKLL 368 (467)
Q Consensus 294 e~~~~-g~L~~~l~~~~~~~~~~~-~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~ 368 (467)
||++| .++.+++...-..-.... ...+++++-+.+.-|| ..+|+|+||..+||++.+++ .+.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99987 477777755433323333 3788999999999999 99999999999999997665 4689999998654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.1e-14 Score=131.74 Aligned_cols=135 Identities=25% Similarity=0.344 Sum_probs=120.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccC-CcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSR-NYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~-n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
++|..|+|+.++|++|+.+++|++||||+|+|+.+-|++|.++.+|..|-+.+ |+|+...-..|.+|.+|+.|.+.-|+
T Consensus 72 irLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~ 151 (498)
T KOG4237|consen 72 IRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANH 151 (498)
T ss_pred EEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhh
Confidence 67899999999999999999999999999999999999999999988887766 99996656789999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
+.-...++|..+++|.-|.+-.|.+..+....|..+..++.+++..|++.+++.-.
T Consensus 152 i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 152 INCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence 99888889999999999999999999655569999999999999999988776543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-11 Score=103.92 Aligned_cols=132 Identities=23% Similarity=0.317 Sum_probs=100.2
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeecccc--------cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..+++|+-+.+|.+.+. |.++++|.-.++.. -...+..+|++++.+++--.|..-.=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999774 44577775432211 1234567899999998655554444455566667899999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
++|-.|.+.+... ...++..+-.-+.-|| ..||+|+||.++||++.+++ +.++|||++...
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888544 2457778888889999 99999999999999998775 999999998743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-11 Score=111.51 Aligned_cols=142 Identities=20% Similarity=0.178 Sum_probs=111.6
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeecccc-cchHHHHHHHHHHHcCCC--CCceeEEEEeecC---CeeeEEEeccc
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRH--RNLVKIISSCSNG---NFEALVLEYMA 297 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~ 297 (467)
+.++.|..+.||++...+|+.+++|....... .....+.+|.++++.+.+ ..+++++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999886678999999764432 134678899999999975 4567788877654 36689999999
Q ss_pred CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 041491 298 NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG------------------------------------------- 334 (467)
Q Consensus 298 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------- 334 (467)
|.++.+.+.. ..++..+...++.++++++..||..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988775532 3467778888899999999999831
Q ss_pred ----------CCCCceecCCCCCCeeecC--CCcEEEecccccee
Q 041491 335 ----------YSNPVVHCDIKPSNVLLDD--DMVAHLSDFGIAKL 367 (467)
Q Consensus 335 ----------~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~ 367 (467)
....++|+|++|.||++++ ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0245799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.5e-13 Score=113.15 Aligned_cols=118 Identities=27% Similarity=0.384 Sum_probs=53.4
Q ss_pred CeecCCCcccccCCcCcc-CCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCc-CCCCCCCEEeccC
Q 041491 1 NLSLGSNELSSVIPSTFW-NLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTI-GGLTNLQLLSLEN 78 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~-~~l~~L~~l~l~~ 78 (467)
.|+|.+|+|+.+ +.++ .+.+|+.||||+|.|+. ++ .+..+++|+.|++++|+|+ .+++.+ ..+++|++|+|++
T Consensus 23 ~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~ 97 (175)
T PF14580_consen 23 ELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSN 97 (175)
T ss_dssp ---------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TT
T ss_pred cccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcC
Confidence 389999999975 4565 58999999999999984 54 5889999999999999998 555545 4689999999999
Q ss_pred CcccCCCC-ccccCCCCCCEEEccCCccCCccc---ccccccccccccc
Q 041491 79 NRLQGPIP-ESFGELTSLESLDLSVNNLSGVIP---ISLEKLVYLKDLN 123 (467)
Q Consensus 79 N~l~~~~p-~~~~~~~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~ 123 (467)
|+|...-- ..+..+++|+.|+|.+|.++...- ..+..+|+|+.||
T Consensus 98 N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 98 NKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp S---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 99975322 467789999999999999985421 2467889999887
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.4e-13 Score=135.68 Aligned_cols=125 Identities=33% Similarity=0.383 Sum_probs=105.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|.+|.++.--=+.|.++..|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..++.|++|...+|++
T Consensus 364 LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l 442 (1081)
T KOG0618|consen 364 LYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQL 442 (1081)
T ss_pred HHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCce
Confidence 678899998655566888999999999999998444457889999999999999998 8899999999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 129 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 129 (467)
. ..| .+..+++|+.+|++.|+|+...-......++|++||++||..
T Consensus 443 ~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 443 L-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred e-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9 577 788999999999999999844433333338999999999974
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-10 Score=100.93 Aligned_cols=127 Identities=24% Similarity=0.249 Sum_probs=85.6
Q ss_pred eEEEEEecCCCeEEEEEeeccc--------------c------------cchHHHHHHHHHHHcCCCC--CceeEEEEee
Q 041491 233 TVYKGRFLDGMEVAIKVFHLQF--------------D------------GALKSFDAECEVLKSVRHR--NLVKIISSCS 284 (467)
Q Consensus 233 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 284 (467)
.||.|...+|..+|+|+.+... . .......+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999986421 0 0123457899999999755 577777553
Q ss_pred cCCeeeEEEeccc--CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCceecCCCCCCeeecCCCcEEEec
Q 041491 285 NGNFEALVLEYMA--NGSLEKCLYSSNGILDIFQRLSIMIDVALALEY-LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 285 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 361 (467)
..+|||||++ |..+..+.... ++......++.+++..+.. +| ..||+|+|+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 65554433211 1133456677888885555 68 9999999999999999988 999999
Q ss_pred cccceecCC
Q 041491 362 FGIAKLLNG 370 (467)
Q Consensus 362 fg~a~~~~~ 370 (467)
||.+.....
T Consensus 150 f~qav~~~~ 158 (188)
T PF01163_consen 150 FGQAVDSSH 158 (188)
T ss_dssp GTTEEETTS
T ss_pred cCcceecCC
Confidence 999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.4e-12 Score=115.26 Aligned_cols=129 Identities=23% Similarity=0.297 Sum_probs=104.6
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.||||+|.|+. +.+...-++.++.|++|+|.|. ... .+..|++|+.||||+|.++ .+...-..|.+.+.|.|+.|.
T Consensus 288 elDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~ 363 (490)
T KOG1259|consen 288 ELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNK 363 (490)
T ss_pred hccccccchhh-hhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhh
Confidence 37899999995 6777888899999999999987 333 4888899999999999998 555556678899999999998
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCccc-ccccccccccccccccccccCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
|.. -+.++.+-+|..||+.+|+|...-. ..++++|-|+.+.|.+|++.+.+..
T Consensus 364 iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 364 IET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred Hhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 873 2568888899999999999974332 5788889999999999999876553
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-12 Score=120.00 Aligned_cols=72 Identities=29% Similarity=0.286 Sum_probs=59.8
Q ss_pred cCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCC
Q 041491 65 IGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 65 ~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
|.+|++|+.|+|++|+|+++-+.+|.....++.|+|..|+|.......|.++..|+.|+|.+|+|++..|..
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~a 341 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGA 341 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccc
Confidence 678888888999999888888888888888888888888888666678888888888888888888766543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-11 Score=126.26 Aligned_cols=105 Identities=30% Similarity=0.329 Sum_probs=66.0
Q ss_pred CCccEEEcCCCcccCCCCcCccCC-----------------CCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccC
Q 041491 21 NSILSFDFSSNSLNGSLPLDIENM-----------------KVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQG 83 (467)
Q Consensus 21 ~~L~~L~l~~N~l~~~~~~~~~~l-----------------~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 83 (467)
.+|+.|+|++|+|+ .+|....++ .+|+.|+|++|+|+ .+|... ++|+.|++++|+|++
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss 416 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS 416 (788)
T ss_pred cccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC
Confidence 36778888888877 345322211 24555666666665 234322 456666777776664
Q ss_pred CCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 84 PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 84 ~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+|.. +.+|+.|++++|+|+ .+|..+.++++|+.|+|++|+|++..+.
T Consensus 417 -IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 417 -LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred -CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 4532 235677777777777 4577777888888888888888876544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-12 Score=125.69 Aligned_cols=125 Identities=34% Similarity=0.498 Sum_probs=93.0
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|.|++|.|. .+|..++++..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|.+
T Consensus 103 liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei 178 (722)
T KOG0532|consen 103 LILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI 178 (722)
T ss_pred HHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence 457777777 46788888888888888888887 6777777665 677777777776 6677777667777777777766
Q ss_pred cC----------------------CCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 82 QG----------------------PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 82 ~~----------------------~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
.. .+|..+..+ .|..||+++|+++ .+|-.|.+|..|+.|.|.+|+++.+
T Consensus 179 ~slpsql~~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 179 QSLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred hhchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC
Confidence 62 234444433 4778888888888 6788888888888888888888764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.1e-11 Score=119.90 Aligned_cols=195 Identities=24% Similarity=0.204 Sum_probs=147.5
Q ss_pred HHHhccCccCCccCcccceeEEEEEec--CCCeEEEEEeecccccchHH--HHHHHHHHHcC-CCCCceeEEEEeecCCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFDGALKS--FDAECEVLKSV-RHRNLVKIISSCSNGNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 288 (467)
.....+|..+..||.|.|+.|+....+ ++..|++|...........+ -..|+.+...+ .|.+++.....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 445568899999999999999998654 47889999776543322222 23455555555 58888888877777777
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-CcEEEecccccee
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAKL 367 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~ 367 (467)
.|+--|||+++++.... .....+++...+++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.+..
T Consensus 341 ~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence 78999999999887665 22336778889999999999999999 9999999999999999876 7889999999874
Q ss_pred cCCC---Cccccccc-cccccccCCCCCCcccchhhHHHHHHHhcCCCC
Q 041491 368 LNGK---ESMRTQTL-ATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412 (467)
Q Consensus 368 ~~~~---~~~~~~~~-~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~P 412 (467)
+.-. .......+ .++.......+..+.|++|||.-+.|.+++..-
T Consensus 417 ~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 417 LAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cceecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 3211 11222223 355555666778899999999999999998743
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.5e-11 Score=84.43 Aligned_cols=61 Identities=34% Similarity=0.461 Sum_probs=36.2
Q ss_pred CCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 21 NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 21 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
++|++|+|++|+|+...++.|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3556666666666644445566666666666666666655555566666666666666654
|
... |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6e-12 Score=121.87 Aligned_cols=121 Identities=26% Similarity=0.397 Sum_probs=98.0
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|.+++|+++. +|+.++.+..|..||.|.|.+. .+|..++++.+|+.|.+..|++. .+|..++. -.|..||+|.|++
T Consensus 148 li~sNNkl~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKI 223 (722)
T ss_pred EEEecCcccc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCce
Confidence 5677888884 6777778888888888888887 67888888888888888888887 77887874 4589999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCccccccccccc---cccccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY---LKDLNLSFNR 128 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~l~l~~N~ 128 (467)
+ .+|..|.+|+.|++|-|.+|.|. .+|..++..-. .|+|+..-.+
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 9 68999999999999999999998 67777654433 3666666564
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=105.43 Aligned_cols=168 Identities=20% Similarity=0.179 Sum_probs=127.9
Q ss_pred cceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEee----cCCeeeEEEecccC-CCHHH
Q 041491 230 SFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS----NGNFEALVLEYMAN-GSLEK 303 (467)
Q Consensus 230 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~ 303 (467)
-..+.|++... +|..|++|+++............-++.++++.|+|+|++.+++. .+...++|++|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34578888654 79999999995443333333345578899999999999999876 34578999999986 46766
Q ss_pred hhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 304 CLYS--------------SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 304 ~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+... .+...++...|.++.|+..||.++| +.|..-+-|.|.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5322 1124678899999999999999999 9999999999999999999999999888877665
Q ss_pred CCCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCC
Q 041491 370 GKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412 (467)
Q Consensus 370 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~P 412 (467)
.+. ++| + .--.+-|.=.||.+++.+.||..-
T Consensus 445 ~d~-------~~~--l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDP-------TEP--L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC-------Ccc--h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 443 111 0 112467999999999999999543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.2e-11 Score=83.37 Aligned_cols=61 Identities=41% Similarity=0.545 Sum_probs=38.4
Q ss_pred CCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCcc
Q 041491 45 KVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105 (467)
Q Consensus 45 ~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l 105 (467)
++|++|+|++|+++...+..|.++++|++|++++|+++...|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666644445666666666666666666655555666666666666666654
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.1e-09 Score=99.57 Aligned_cols=139 Identities=14% Similarity=0.045 Sum_probs=98.3
Q ss_pred ccCcccceeEEEEEecCCCeEEEEEeecccc-----------cchHHHHHHHHHHHcCCCCC--ceeEEEEeec-----C
Q 041491 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-----------GALKSFDAECEVLKSVRHRN--LVKIISSCSN-----G 286 (467)
Q Consensus 225 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~-----~ 286 (467)
.+-......|++... +|+.|.||....... .....+.+|...+.++...+ .++.+++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344667655 678899997643221 01124778998888874333 3344555432 2
Q ss_pred CeeeEEEecccCC-CHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-------CCcE
Q 041491 287 NFEALVLEYMANG-SLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-------DMVA 357 (467)
Q Consensus 287 ~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-------~~~~ 357 (467)
...++|||++++. +|.+++... ....+......++.+++..+.-|| ..||+|+|++++|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 3568999999886 798887432 234556677889999999999999 999999999999999975 4689
Q ss_pred EEecccccee
Q 041491 358 HLSDFGIAKL 367 (467)
Q Consensus 358 kl~Dfg~a~~ 367 (467)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.1e-10 Score=119.04 Aligned_cols=114 Identities=31% Similarity=0.473 Sum_probs=63.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|++ +|..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|
T Consensus 204 L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L 274 (754)
T PRK15370 204 LILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKI 274 (754)
T ss_pred EEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCcc
Confidence 5666666664 333332 36666666666666 3454432 34666666666665 4455443 3667777777776
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
+. +|..+. ++|+.|+|++|+|++. |..+. ++|+.|++++|+++
T Consensus 275 ~~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 275 SC-LPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLT 317 (754)
T ss_pred Cc-cccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCccc
Confidence 63 454442 4677777777777643 33222 24555555555554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-09 Score=97.20 Aligned_cols=136 Identities=24% Similarity=0.234 Sum_probs=103.0
Q ss_pred CccCCccCcccceeEEEEEecCCCeEEEEEeecccc----------------------cchHHHHHHHHHHHcCCCC--C
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD----------------------GALKSFDAECEVLKSVRHR--N 275 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 275 (467)
+.+...||-|.-+.||.|....|.++|+|.-+.... -.....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455688999999999999998899999997642210 1123457899999998654 6
Q ss_pred ceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC
Q 041491 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM 355 (467)
Q Consensus 276 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 355 (467)
+++.+++ ++..+||||++|-.|...- ++......++..|++-+..+- ..|+||+|+.+-||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 6666653 5568999999997665432 234445566677777777776 78999999999999999999
Q ss_pred cEEEeccccceec
Q 041491 356 VAHLSDFGIAKLL 368 (467)
Q Consensus 356 ~~kl~Dfg~a~~~ 368 (467)
.+.++||--+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999666543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.7e-10 Score=119.54 Aligned_cols=114 Identities=23% Similarity=0.452 Sum_probs=67.0
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|++
T Consensus 246 L~Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~L 316 (754)
T PRK15370 246 MELSINRITE-LPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSL 316 (754)
T ss_pred EECcCCccCc-CChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcc
Confidence 6788888885 455553 47888888888887 5666553 47888888888887 3454432 3555666666666
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
+. +|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+
T Consensus 317 t~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 317 TA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT 359 (754)
T ss_pred cc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC
Confidence 53 33322 1345555555555553 233322 34555555555554
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.8e-12 Score=126.72 Aligned_cols=109 Identities=28% Similarity=0.356 Sum_probs=95.4
Q ss_pred CCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEE
Q 041491 20 LNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLD 99 (467)
Q Consensus 20 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~ 99 (467)
+..|+.|+|-+|.|+...-..+.+.++|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..++.|++|.
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 456777888888888666567889999999999999998555567889999999999999999 6889999999999999
Q ss_pred ccCCccCCcccccccccccccccccccccccC
Q 041491 100 LSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 100 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
..+|+|. ..| .+.++++|+.+|++.|+|+-
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 9999998 556 88999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.7e-11 Score=121.68 Aligned_cols=233 Identities=21% Similarity=0.201 Sum_probs=161.0
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
...+.+.+.+.+-+|+++.++.+.-.. |...+.|+..... ....+....+-.++-...+|.+++..-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 456778888899999999999876543 4444555443221 111222333333333345576766655566677889
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
++++|+.+++|...++... ..+..-.......+..+.++|| ...+.|||++|.|++...++..++.|||......-
T Consensus 881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999886654 4455555667778889999999 88899999999999999999999999984332210
Q ss_pred ------C------------------------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCC
Q 041491 371 ------K------------------------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTC 414 (467)
Q Consensus 371 ------~------------------------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~ 414 (467)
. ...++..|.+||...+......+|+|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0113444566777777788889999999999999999999998
Q ss_pred ccccccccHHHHHhhh---------cccccccccccccccchhHHHH
Q 041491 415 EIFCEEMNLKNWVNDF---------LPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 415 ~~~~~~~~~~~~~~~~---------~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
....+. .+....... .+....+++.+.+..++.+|-.
T Consensus 1037 a~tpq~-~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1037 AETPQQ-IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred Ccchhh-hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccC
Confidence 754332 222222222 2234777888888888888843
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.98 E-value=3e-11 Score=116.33 Aligned_cols=130 Identities=24% Similarity=0.286 Sum_probs=86.3
Q ss_pred eecCCCcccc------cCCcCccCCCCccEEEcCCCcccCCCCcCccCCCC---ccEEEccCCcCCC----CCCCCcCCC
Q 041491 2 LSLGSNELSS------VIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKV---VVEINLSRNYLTG----DIPPTIGGL 68 (467)
Q Consensus 2 L~l~~n~l~~------~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~l~l~~n~l~~----~~~~~~~~l 68 (467)
|+++.|.+.+ ..+..|..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+
T Consensus 56 l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~ 135 (319)
T cd00116 56 LCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL 135 (319)
T ss_pred EeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhC
Confidence 4566666652 23455667788888888888887555555555555 8888888888763 223345566
Q ss_pred -CCCCEEeccCCcccCC----CCccccCCCCCCEEEccCCccCCc----ccccccccccccccccccccccC
Q 041491 69 -TNLQLLSLENNRLQGP----IPESFGELTSLESLDLSVNNLSGV----IPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 69 -~~L~~l~l~~N~l~~~----~p~~~~~~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 136 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred CCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence 7888888888888742 233456667788888888888742 22334445578888888887763
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.5e-09 Score=113.39 Aligned_cols=93 Identities=28% Similarity=0.381 Sum_probs=59.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|++ +|..+. ++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|..+ ++|+.|+|++|.|
T Consensus 206 LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~lp---~sL~~L~Ls~N~L 274 (788)
T PRK15387 206 LNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVLP---PGLLELSIFSNPL 274 (788)
T ss_pred EEcCCCCCCc-CCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCcc---cccceeeccCCch
Confidence 7888899985 566664 47888888888887 4664 2467888888888887 445432 3444444444444
Q ss_pred cC-------------------CCCccccCCCCCCEEEccCCccCCc
Q 041491 82 QG-------------------PIPESFGELTSLESLDLSVNNLSGV 108 (467)
Q Consensus 82 ~~-------------------~~p~~~~~~~~L~~L~l~~N~l~~~ 108 (467)
+. .+|. .+++|+.|+|++|+|+++
T Consensus 275 ~~Lp~lp~~L~~L~Ls~N~Lt~LP~---~p~~L~~LdLS~N~L~~L 317 (788)
T PRK15387 275 THLPALPSGLCKLWIFGNQLTSLPV---LPPGLQELSVSDNQLASL 317 (788)
T ss_pred hhhhhchhhcCEEECcCCccccccc---cccccceeECCCCccccC
Confidence 42 2232 135677777777777753
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.7e-10 Score=103.58 Aligned_cols=109 Identities=24% Similarity=0.314 Sum_probs=91.7
Q ss_pred ccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCC
Q 041491 17 FWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLE 96 (467)
Q Consensus 17 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~ 96 (467)
......|++||||+|.|+ .+.+...-++.++.|++|+|.++ .+. .+..|++|+.||||+|.++. +...-..+.+.+
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHh-hhhhHhhhcCEe
Confidence 344578999999999998 67778888899999999999998 443 49999999999999999984 445455788999
Q ss_pred EEEccCCccCCcccccccccccccccccccccccC
Q 041491 97 SLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 97 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+|.|+.|.+... ..+..+-+|..||+++|+|..
T Consensus 356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ 388 (490)
T KOG1259|consen 356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEE 388 (490)
T ss_pred eeehhhhhHhhh--hhhHhhhhheeccccccchhh
Confidence 999999999743 567788899999999999863
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.90 E-value=6e-09 Score=116.49 Aligned_cols=125 Identities=25% Similarity=0.307 Sum_probs=76.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++.+|.++. +|..| ...+|+.|+|++|+|. .++..+..+++|+.|+|++|.....+|. ++.+++|+.|+|++|..
T Consensus 594 L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~ 669 (1153)
T PLN03210 594 LRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSS 669 (1153)
T ss_pred EEecCCCCCC-CCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCC
Confidence 3444555553 45555 3567777777777765 4666666777777777776553335553 66667777777777654
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
...+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|....
T Consensus 670 L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~ 718 (1153)
T PLN03210 670 LVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLK 718 (1153)
T ss_pred ccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcc
Confidence 45666667777777777777654333455444 56666666666664433
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-10 Score=111.45 Aligned_cols=130 Identities=30% Similarity=0.298 Sum_probs=100.2
Q ss_pred eecCCCccccc----CCcCccCCCCccEEEcCCCcccC------CCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCC-
Q 041491 2 LSLGSNELSSV----IPSTFWNLNSILSFDFSSNSLNG------SLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTN- 70 (467)
Q Consensus 2 L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~------~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~- 70 (467)
|+|++|.++.. ++..+...++|+.|++++|.+.+ .++..+..+++|+.|++++|.+.+..+..+..+.+
T Consensus 28 l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~ 107 (319)
T cd00116 28 LRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRS 107 (319)
T ss_pred EeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhcc
Confidence 67888888532 45667788889999999998862 23446777889999999999998666666666555
Q ss_pred --CCEEeccCCcccC----CCCccccCC-CCCCEEEccCCccCCcc----cccccccccccccccccccccC
Q 041491 71 --LQLLSLENNRLQG----PIPESFGEL-TSLESLDLSVNNLSGVI----PISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 71 --L~~l~l~~N~l~~----~~p~~~~~~-~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
|+.|++++|++++ .+...+..+ ++|+.|++++|.+++.. +..+..+.+|+.|++++|.+++
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 9999999999873 223345666 89999999999998432 3455666789999999999885
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.4e-08 Score=88.51 Aligned_cols=108 Identities=22% Similarity=0.227 Sum_probs=84.1
Q ss_pred hHHHHHHHHHHHcCCC--CCceeEEEEeecC----CeeeEEEecccCC-CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 041491 258 LKSFDAECEVLKSVRH--RNLVKIISSCSNG----NFEALVLEYMANG-SLEKCLYSSNGILDIFQRLSIMIDVALALEY 330 (467)
Q Consensus 258 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 330 (467)
.....+|...+..+.. =.+++.+++.+.. ...++|+|++++. +|.+++..... .+......++.+++..++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3457788888777743 3345556665542 2458999999884 79988854322 5667788999999999999
Q ss_pred HhcCCCCCceecCCCCCCeeecCCC---cEEEeccccceecC
Q 041491 331 LHFGYSNPVVHCDIKPSNVLLDDDM---VAHLSDFGIAKLLN 369 (467)
Q Consensus 331 LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~ 369 (467)
|| ..||+|+|+++.|||++.++ .+.++||+-++...
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99 99999999999999998887 89999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.4e-09 Score=114.92 Aligned_cols=108 Identities=22% Similarity=0.276 Sum_probs=70.6
Q ss_pred cCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCE
Q 041491 18 WNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLES 97 (467)
Q Consensus 18 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~ 97 (467)
...++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|.. .++|+.
T Consensus 775 ~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~ 850 (1153)
T PLN03210 775 MLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISD 850 (1153)
T ss_pred hccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCE
Confidence 334677777777776656677777777777777777765434666655 5677777777776543344432 346777
Q ss_pred EEccCCccCCccccccccccccccccccc-cccc
Q 041491 98 LDLSVNNLSGVIPISLEKLVYLKDLNLSF-NRLK 130 (467)
Q Consensus 98 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~-N~l~ 130 (467)
|+|++|.++ .+|..+..+++|+.|++++ |++.
T Consensus 851 L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~ 883 (1153)
T PLN03210 851 LNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ 883 (1153)
T ss_pred eECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC
Confidence 777777776 4566677777777777776 3444
|
syringae 6; Provisional |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-10 Score=116.09 Aligned_cols=124 Identities=31% Similarity=0.302 Sum_probs=101.9
Q ss_pred ecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCC-CcCCCCCCCEEeccCCcc
Q 041491 3 SLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP-TIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~l~~L~~l~l~~N~l 81 (467)
+.++|.+.. ....+.-++.|+.||||.|++.... .+..+++|++|||++|++. .+|. ...++. |+.|+|+||.+
T Consensus 170 ~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l 244 (1096)
T KOG1859|consen 170 SFSYNRLVL-MDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNAL 244 (1096)
T ss_pred hcchhhHHh-HHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHH
Confidence 567888884 5777888999999999999998433 7899999999999999998 5554 345565 99999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCccc-ccccccccccccccccccccCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
+.. ..+.++++|..|||+.|-|++..- ..+..|..|..|+|.||++.|.+
T Consensus 245 ~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 245 TTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred Hhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 853 358899999999999999986533 33456778999999999998754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.9e-08 Score=99.54 Aligned_cols=142 Identities=22% Similarity=0.245 Sum_probs=94.5
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeecccc----------------------c--------ch----H------HHHH
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD----------------------G--------AL----K------SFDA 263 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~--------~~----~------~~~~ 263 (467)
+.|+.++-|.||+|+.++|+.||||+.+.... . .. + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 78899999999999999999999999864310 0 00 1 1334
Q ss_pred HHHHHHcC----C-CCCceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCC
Q 041491 264 ECEVLKSV----R-HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA-LEYLHFGYSN 337 (467)
Q Consensus 264 E~~~l~~l----~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~~~ 337 (467)
|..-+.++ + .|++.--.=+.+..+...++|||++|..+.+.........+... ++..++++ +..+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence 44444443 2 23322222233445667899999999988887433333455333 33333332 22233 57
Q ss_pred CceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 338 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|+.|.|..|.||+++.+|++.+.|||+...+.+.
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 8999999999999999999999999999877643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.7e-07 Score=82.40 Aligned_cols=138 Identities=17% Similarity=0.083 Sum_probs=100.9
Q ss_pred cCcccceeEEEEEecCCCeEEEEEeeccc------ccchHHHHHHHHHHHcCCC--CCceeEEEEee--cC--CeeeEEE
Q 041491 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQF------DGALKSFDAECEVLKSVRH--RNLVKIISSCS--NG--NFEALVL 293 (467)
Q Consensus 226 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~--~~--~~~~lv~ 293 (467)
-|+||.+.|++... +|+.+-+|.-.... +.....|.+|...+.++.. -.+++...... .+ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46789999999776 45578888654111 2245678999999998853 22455442211 11 2457999
Q ss_pred ecccC-CCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc--EEEecccccee
Q 041491 294 EYMAN-GSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV--AHLSDFGIAKL 367 (467)
Q Consensus 294 e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~ 367 (467)
|-+++ .+|.+++.+.. .+.+......+..+++..++-|| ..|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 58888874432 25577778899999999999999 999999999999999986666 99999987764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.9e-09 Score=107.01 Aligned_cols=125 Identities=34% Similarity=0.528 Sum_probs=86.2
Q ss_pred eecCCCcccccCCcCccCCC-CccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLN-SILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|++.+|.++. +|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+
T Consensus 121 L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~ 197 (394)
T COG4886 121 LDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197 (394)
T ss_pred EecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCc
Confidence 5677777775 455555563 7888888888876 56666777888888888888887 666666677778888888888
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++ .+|.....+..|+.|++++|++. ..+..+..+.++..+.+++|++..
T Consensus 198 i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred cc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence 77 45555555556777777777543 345556666666666666666654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.2e-10 Score=91.17 Aligned_cols=128 Identities=22% Similarity=0.306 Sum_probs=85.9
Q ss_pred eecCCCcccccCCcCcc---CCCCccEEEcCCCcccCCCCcCccCC-CCccEEEccCCcCCCCCCCCcCCCCCCCEEecc
Q 041491 2 LSLGSNELSSVIPSTFW---NLNSILSFDFSSNSLNGSLPLDIENM-KVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLE 77 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~ 77 (467)
|+|+++.|.. ++.... ....|+..+|++|.+. ..|+.|... +.++.|+|++|+|+ .+|..+..++.|+.|+++
T Consensus 32 ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~ 108 (177)
T KOG4579|consen 32 LDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLR 108 (177)
T ss_pred cccccchhhH-HHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccc
Confidence 5677777764 344333 3445555688888887 566656543 47788888888887 677778888888888888
Q ss_pred CCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 78 NNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 78 ~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
.|.|. ..|..+..+.+|..|+..+|.+.. +|-.+-.-...-..++.++++.+..+
T Consensus 109 ~N~l~-~~p~vi~~L~~l~~Lds~~na~~e-id~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 109 FNPLN-AEPRVIAPLIKLDMLDSPENARAE-IDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cCccc-cchHHHHHHHhHHHhcCCCCcccc-CcHHHhccccHHHHHhcCCcccccCc
Confidence 88887 567777778888888888888773 34323332344455566667766544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.9e-09 Score=103.07 Aligned_cols=126 Identities=35% Similarity=0.546 Sum_probs=99.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|++++|++.. +|..++.+++|+.|++++|+++ .+|.....++.|+.|++++|+++ .+|.....+..|++|.+++|+
T Consensus 144 ~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 144 ELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 47889999995 5678889999999999999998 67766668899999999999998 777777667779999999996
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+. ..+..+..++++..|.+++|++. .++..+..+++++.|++++|+++.
T Consensus 221 ~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~ 269 (394)
T COG4886 221 II-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269 (394)
T ss_pred ce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccc
Confidence 44 35566777777777777777776 336667777777778888777764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.69 E-value=3e-07 Score=83.41 Aligned_cols=132 Identities=15% Similarity=0.146 Sum_probs=87.1
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCC--CceeEEEEeecCCeeeEEEecccCCC-
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR--NLVKIISSCSNGNFEALVLEYMANGS- 300 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~- 300 (467)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 35578889876432 335578999999988533 35778888888888889999999964
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------CCCCCce
Q 041491 301 LEKCLYSSNGILDIFQRLSIMIDVALALEYLHF----------------------------------------GYSNPVV 340 (467)
Q Consensus 301 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~----------------------------------------~~~~~iv 340 (467)
+...+. .+......++.++++.+.-+|. .....++
T Consensus 82 ~~~~~~-----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 82 FSRIIS-----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred hhhhhc-----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 211110 0011111112222222222220 1134578
Q ss_pred ecCCCCCCeeecCCCcEEEeccccce
Q 041491 341 HCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 341 H~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
|+|+.|.||++++++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-07 Score=82.89 Aligned_cols=140 Identities=14% Similarity=0.149 Sum_probs=94.0
Q ss_pred HHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHH---------HHHHHHHHcCCC---CCceeEEE
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSF---------DAECEVLKSVRH---RNLVKIIS 281 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~~~~ 281 (467)
.+...+|...+.+.......|.+-.. +|+.+++|..+.......+.+ .+++..+..++. .....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 35667888888888887777777655 689999998765433222222 233343333332 22222222
Q ss_pred Ee-----ecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 282 SC-----SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 282 ~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
+. .-....+++|||++|..|.++.. +++ .+...+.+++.-+| +.|+.|+|..|.|++++++ .
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-c
Confidence 22 22345578999999988866531 222 25566778899999 9999999999999999865 4
Q ss_pred EEEecccccee
Q 041491 357 AHLSDFGIAKL 367 (467)
Q Consensus 357 ~kl~Dfg~a~~ 367 (467)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4e-07 Score=81.13 Aligned_cols=156 Identities=20% Similarity=0.187 Sum_probs=102.7
Q ss_pred cccHHHHHHHhccCccCCcc---CcccceeEEEEEecCCCeEEEEEeecccccc-------------------h-----H
Q 041491 207 RFSYQELLLATDHFSEKSLI---GIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA-------------------L-----K 259 (467)
Q Consensus 207 ~~~~~~~~~~~~~y~~~~~l---g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~-----~ 259 (467)
..++..+.....+..+.... ++|.-+.||+|...++..+|+|+++...... . .
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 44555565555666555554 4677778999988789999999997542110 0 0
Q ss_pred HHHHHHHHHHcCC--CCCceeEEEEeecCCeeeEEEecccCCCH-HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 041491 260 SFDAECEVLKSVR--HRNLVKIISSCSNGNFEALVLEYMANGSL-EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336 (467)
Q Consensus 260 ~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 336 (467)
-..+|..-|+++. +-.+++-+++.. -.|||||+..... .-.+ ..-.++......+..++++.+.-|-. .
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~--~ 185 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYK--E 185 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHH--h
Confidence 1234666666653 334445554432 3699999865311 0111 11123333677788899999988871 3
Q ss_pred CCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 337 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
.++||+||..=|||+. ++.+.|+|||-|.....+
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 8999999999999999 789999999999876643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-08 Score=101.93 Aligned_cols=127 Identities=21% Similarity=0.223 Sum_probs=90.1
Q ss_pred HHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc--------------cccccccccccccCC
Q 041491 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES--------------MRTQTLATIEYGREG 388 (467)
Q Consensus 323 ~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~pe~~~~~ 388 (467)
+.+.|+.|+|. +.++||++|.|++|.++..+..||+.|+++....++.. .....|.+||++.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44599999996 78999999999999999999999999999877655221 123356789999988
Q ss_pred CCCCcccchhhHHHHHHHh-cCCCCCCccccc--------cccHH-HHHhhhcccccccccccccccchhHHH
Q 041491 389 QVSPKSDVYGYGITLIETF-TKKKPTCEIFCE--------EMNLK-NWVNDFLPISVMNVVDTSLLRREDKYF 451 (467)
Q Consensus 389 ~~~~~~Dv~slGvil~el~-tg~~Pf~~~~~~--------~~~~~-~~~~~~~~~~~~~~i~~~l~~~~~~r~ 451 (467)
..++++|+||+||.+|.+. .|+.-+...... ..+.. ......+|.++++-+.+.+..++.-|+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 8899999999999999999 455444321000 00110 112234556666666666666666665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.3e-06 Score=82.83 Aligned_cols=187 Identities=14% Similarity=0.138 Sum_probs=121.4
Q ss_pred cCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHc-CCCCCceeEEEE------eec-CCeeeEEE
Q 041491 222 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKS-VRHRNLVKIISS------CSN-GNFEALVL 293 (467)
Q Consensus 222 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~------~~~-~~~~~lv~ 293 (467)
..+.||+|+-+.+|-.- .-...+.|+++........+. ...|.. -.||-+..-+.+ ..+ +....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45789999999999642 223345688876644322222 222333 356644331111 112 22356778
Q ss_pred ecccCCC-HHHhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 294 EYMANGS-LEKCLY-----SSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 294 e~~~~g~-L~~~l~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..+.+.. ...+.. +.-....|.-..+.++.++.+.+.|| ..|.+-+|+.++|+|+.+++.+.|+|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 8777642 222221 11225789999999999999999999 99999999999999999999999998654333
Q ss_pred cCCCC----cccccccccccccc-----CCCCCCcccchhhHHHHHHHhcC-CCCCCcc
Q 041491 368 LNGKE----SMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTK-KKPTCEI 416 (467)
Q Consensus 368 ~~~~~----~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg-~~Pf~~~ 416 (467)
..... ..+...|.+||... +-.-+...|-|.+||++++++.| +.||.+.
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 22221 12344455666543 22335678999999999999887 9999865
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.4e-08 Score=98.44 Aligned_cols=123 Identities=27% Similarity=0.349 Sum_probs=90.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
++|..|.|.. .-..+..+.+|+.|+|.+|+|.+ +...+..+++|+.|+|++|+|+.. ..+..++.|+.|++++|.|
T Consensus 77 l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i 152 (414)
T KOG0531|consen 77 LNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLI 152 (414)
T ss_pred hccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhheeccCcc
Confidence 3456666664 33457778888888888888874 433377788888888888888744 3466677788888888888
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCccc-ccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+. + ..+..++.|+.+++++|++....+ . +..+.+++.+++++|.+..
T Consensus 153 ~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 153 SD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred hh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence 84 2 356668888888888888885544 2 4677788888888888763
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.3e-07 Score=89.30 Aligned_cols=142 Identities=20% Similarity=0.290 Sum_probs=91.0
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeeccccc-------------------------------chH------HHHHHH
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-------------------------------ALK------SFDAEC 265 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------~~~------~~~~E~ 265 (467)
.+.||.-+.|.||+|+.++|+.||||+-+..-.. ..+ +|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3789999999999999999999999987643110 011 123333
Q ss_pred HHHH----cCCCCC------ceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 041491 266 EVLK----SVRHRN------LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335 (467)
Q Consensus 266 ~~l~----~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 335 (467)
+-.. .+.|-+ |++++- .......|+|||++|..+.+.-.-....++...+..-+.+...-+-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf----- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF----- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-----
Confidence 3222 233444 333332 22345689999999987766543333345555443333332221222
Q ss_pred CCCceecCCCCCCeeecC----CCcEEEeccccceecCCC
Q 041491 336 SNPVVHCDIKPSNVLLDD----DMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 336 ~~~ivH~dlkp~NIll~~----~~~~kl~Dfg~a~~~~~~ 371 (467)
..|++|.|=.|.||+++. ++++.+-|||+...+...
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 568999999999999983 668999999998876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=78.67 Aligned_cols=140 Identities=20% Similarity=0.270 Sum_probs=84.1
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCC--CceeEEEEee---cCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR--NLVKIISSCS---NGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~ 298 (467)
+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+++++.+.. .....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999866 69999997644 3456778898888887422 3567776443 33457899999999
Q ss_pred CCHHH----------------h---hhcC--C-CCCCHHH---------HHHH------------HHHHHH-HHHHHh--
Q 041491 299 GSLEK----------------C---LYSS--N-GILDIFQ---------RLSI------------MIDVAL-ALEYLH-- 332 (467)
Q Consensus 299 g~L~~----------------~---l~~~--~-~~~~~~~---------~~~i------------~~~i~~-~l~~LH-- 332 (467)
..+.. . ++.. . ....... .... ...+.+ .+..++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 1 1111 0 1111100 0000 011122 223332
Q ss_pred --cCCCCCceecCCCCCCeeec-CCCcEEEeccccce
Q 041491 333 --FGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAK 366 (467)
Q Consensus 333 --~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~ 366 (467)
......++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 11357799999999999999 66666899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.5e-06 Score=78.73 Aligned_cols=138 Identities=16% Similarity=0.064 Sum_probs=85.9
Q ss_pred ccCcccc-eeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEecccCCCHH
Q 041491 225 LIGIGSF-GTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLEYMANGSLE 302 (467)
Q Consensus 225 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 302 (467)
.|..|.+ ..||+.... +..+.+|+..... .....+|+++++.+. +--+++++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 789999764 4788888865332 345678999888873 455778888887777789999999998776
Q ss_pred Hhh-------------------hcCCC---CCCHH--HHHHHHH--------------------HHHHHHHHHh----cC
Q 041491 303 KCL-------------------YSSNG---ILDIF--QRLSIMI--------------------DVALALEYLH----FG 334 (467)
Q Consensus 303 ~~l-------------------~~~~~---~~~~~--~~~~i~~--------------------~i~~~l~~LH----~~ 334 (467)
... +.... .+... ....... .....+..|- ..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 11100 00000 0000000 0111111221 01
Q ss_pred CCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 335 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
....++|+|+.|.||++++++...|+||+.|.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 14568999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.3e-06 Score=71.20 Aligned_cols=132 Identities=20% Similarity=0.256 Sum_probs=92.0
Q ss_pred ccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCce-eEEEEeecCCeeeEEEecccCC
Q 041491 221 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV-KIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 221 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g 299 (467)
...+.|++|.+|.||+|.+. |.++|+|+-+.+ .....+..|++++..+.-.++. +++.|..+ ++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 34578999999999999984 568999986644 3457889999999998765544 45554433 3559999998
Q ss_pred CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC-CCCeeecCCCcEEEeccccceecCC
Q 041491 300 SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIK-PSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 300 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk-p~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
.|.+.-... +.. -...++++---|- ..||-|+.|. |..+++.+++.+.|+||..|+.-..
T Consensus 98 ~L~~~~~~~----~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 98 PLGKLEIGG----DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred chhhhhhcc----cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 887754211 222 2334455544456 7888898886 4555555555999999999985443
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.1e-07 Score=76.65 Aligned_cols=104 Identities=22% Similarity=0.168 Sum_probs=50.7
Q ss_pred cEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCC
Q 041491 24 LSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN 103 (467)
Q Consensus 24 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N 103 (467)
++++|.+.++.. +...=..+.+...+||++|.+. . -..|..+++|..|.|++|+|+.+-|.--.-+++|+.|.|.+|
T Consensus 22 ~e~~LR~lkip~-ienlg~~~d~~d~iDLtdNdl~-~-l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnN 98 (233)
T KOG1644|consen 22 RELDLRGLKIPV-IENLGATLDQFDAIDLTDNDLR-K-LDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNN 98 (233)
T ss_pred cccccccccccc-hhhccccccccceecccccchh-h-cccCCCccccceEEecCCcceeeccchhhhccccceEEecCc
Confidence 445555555541 1111111234455555555554 2 234555555566666666555444443334455556666665
Q ss_pred ccCCccc-cccccccccccccccccccc
Q 041491 104 NLSGVIP-ISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 104 ~l~~~~~-~~~~~l~~L~~l~l~~N~l~ 130 (467)
+|..... +-++.|++|++|.+-+|+.+
T Consensus 99 si~~l~dl~pLa~~p~L~~Ltll~Npv~ 126 (233)
T KOG1644|consen 99 SIQELGDLDPLASCPKLEYLTLLGNPVE 126 (233)
T ss_pred chhhhhhcchhccCCccceeeecCCchh
Confidence 5553221 33445555556555555554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.6e-08 Score=80.74 Aligned_cols=111 Identities=18% Similarity=0.223 Sum_probs=87.3
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
.+|++|.+...++..-..++.++.|+|++|.|+ .+|..+..++.|+.|+++.|.+. ..|..+..|.+|-.|+..+|.+
T Consensus 58 i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 58 ISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred EecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 479999999754444445679999999999998 79989999999999999999998 7788888899999999999998
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEK 115 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~ 115 (467)
- .+|-.+--.+.....++.++.+.+.-+..+..
T Consensus 136 ~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa 168 (177)
T KOG4579|consen 136 A-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQA 168 (177)
T ss_pred c-cCcHHHhccccHHHHHhcCCcccccCcccccc
Confidence 8 45544332333444466788887765554443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 467 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-05 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 6e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 8e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 1e-68
Identities = 87/236 (36%), Positives = 130/236 (55%), Gaps = 13/236 (5%)
Query: 205 WRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDA 263
+RFS +EL +A+D+FS K+++G G FG VYKGR DG VA+K + G F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 264 ECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLY---SSNGILDIFQRLSI 320
E E++ HRNL+++ C LV YMANGS+ CL S LD +R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 321 MIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-MRTQTL 379
+ A L YLH ++H D+K +N+LLD++ A + DFG+AKL++ K++ + T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 380 ATI-----EYGREGQVSPKSDVYGYGITLIETFTKKKPT---CEIFCEEMNLKNWV 427
TI EY G+ S K+DV+GYG+ L+E T ++ +++ L +WV
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-67
Identities = 88/293 (30%), Positives = 140/293 (47%), Gaps = 21/293 (7%)
Query: 186 RKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV 245
+ N+ + + R +L AT++F K LIG G FG VYKG DG +V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 246 AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL 305
A+K + ++ F+ E E L RH +LV +I C N L+ +YM NG+L++ L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 306 YSSNG---ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362
Y S+ + QRL I I A L YLH + ++H D+K N+LLD++ V ++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183
Query: 363 GIAKLLNGKES--MRTQTLATI-----EYGREGQVSPKSDVYGYGITLIETFTKKKPT-C 414
GI+K + + T T+ EY +G+++ KSDVY +G+ L E +
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 415 EIFCEEMNLKNWVNDFLPIS-VMNVVDTSLLRREDKYFAAKKQCVSSALSLAM 466
+ E +NL W + + +VD +L DK + + + A+
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNL---ADKI---RPESLRKFGDTAV 290
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-61
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 30/278 (10%)
Query: 206 RRFSYQELLLATDHFSEK------SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA-- 257
FS+ EL T++F E+ + +G G FG VYKG +++ VA+K D
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTE 71
Query: 258 --LKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNG--ILD 313
+ FD E +V+ +H NLV+++ S+G+ LV YM NGSL L +G L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 314 IFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL--NGK 371
R I A + +LH N +H DIK +N+LLD+ A +SDFG+A+ +
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 372 ESMRTQTLATI-----EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW 426
M ++ + T E R G+++PKSD+Y +G+ L+E T E E L +
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDI 246
Query: 427 VNDFL--PISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462
+ ++ + +D + D + + S A
Sbjct: 247 KEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVAS 281
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-52
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 11/213 (5%)
Query: 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKSFDAECE 266
++ + + K IG GSFGTV++ + G +VA+K+ Q A + F E
Sbjct: 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI--LDIFQRLSIMIDV 324
++K +RH N+V + + + ++V EY++ GSL + L+ S LD +RLS+ DV
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
A + YLH + P+VH ++K N+L+D + DFG+++L T E+
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 205
Query: 385 -----GREGQVSPKSDVYGYGITLIETFTKKKP 412
R+ + KSDVY +G+ L E T ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-50
Identities = 54/230 (23%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ-------FDGALKSFDAECEVLK 269
+ + IG G FG V+KGR + D VAIK L + F E ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 270 SVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALE 329
++ H N+VK+ N +V+E++ G L L + +L +M+D+AL +E
Sbjct: 79 NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 330 YLHFGYSNPVVHCDIKPSNVLLD-----DDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
Y+ + P+VH D++ N+ L + A ++DFG+++ + L ++
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQW 192
Query: 385 -------GREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV 427
E + K+D Y + + L T + P E ++ N +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-49
Identities = 58/265 (21%), Positives = 98/265 (36%), Gaps = 33/265 (12%)
Query: 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV 267
+ L + + G FG V+K + VA+K+F +Q +S+ E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ---DKQSWQNEYEV 69
Query: 268 --LKSVRHRNLVKIISSCSNGNFEA----LVLEYMANGSLEKCLYSSNGILDIFQRLSIM 321
L ++H N+++ I + G L+ + GSL L ++ + I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIA 127
Query: 322 IDVALALEYLH------FGYSNP-VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM 374
+A L YLH P + H DIK NVLL +++ A ++DFG+A +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 375 RTQTLA--TIEY----------GREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE-EM 421
T Y + + D+Y G+ L E ++ E +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 422 NLKNWVNDFLPISVM-NVVDTSLLR 445
+ + + M VV R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKR 272
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 18/230 (7%)
Query: 195 IEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF 254
++ R + + + + IG GSFGTVYKG++ +VA+K+ ++
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTA 58
Query: 255 DGA--LKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGIL 312
L++F E VL+ RH N++ + + A+V ++ SL L++S
Sbjct: 59 PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKF 117
Query: 313 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372
++ + + I A ++YLH + ++H D+K +N+ L +D + DFG+A +
Sbjct: 118 EMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 373 SMRTQTLAT----------IEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ I S +SDVY +GI L E T + P
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-49
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
+ ++G G+FG V K ++ +VAIK + + K+F E L V H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI--LDIFQRLSIMIDVALALEYLHFGY 335
K+ +C N LV+EY GSL L+ + + +S + + + YLH
Sbjct: 65 KLYGACLN-PV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 336 SNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGKESMRTQTLATI--EYGREGQVSP 392
++H D+KP N+LL V + DFG A + + + A + E S
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 393 KSDVYGYGITLIETFTKKKP 412
K DV+ +GI L E T++KP
Sbjct: 183 KCDVFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 40/195 (20%), Positives = 85/195 (43%), Gaps = 10/195 (5%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRNLVKIISSC 283
+ G ++KGR+ G ++ +KV ++ + F+ EC L+ H N++ ++ +C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 284 SNGNFE--ALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ L+ +M GSL L+ +D Q + +D+A + +LH +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT-QTLA--TIEYGREGQVSPKSDVY 397
+ +V++D+DM A +S + M +A ++ E +D++
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMW 195
Query: 398 GYGITLIETFTKKKP 412
+ + L E T++ P
Sbjct: 196 SFAVLLWELVTREVP 210
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 28/246 (11%)
Query: 189 NTELSNIEVNMSP-QAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAI 247
LS + P +A QE + + LIG G FG VY GR+ EVAI
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAI 60
Query: 248 KVFHLQFDGA--LKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL 305
++ ++ D LK+F E + RH N+V + +C + A++ +L +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 306 YSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
+ +LD+ + I ++ + YLH + ++H D+K NV D+ V ++DFG+
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLF 176
Query: 366 KLLNGKESMRTQTLATIEYG-------------------REGQVSPKSDVYGYGITLIET 406
+ ++ R + I+ G + S SDV+ G E
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 407 FTKKKP 412
++ P
Sbjct: 237 HAREWP 242
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-46
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 22/204 (10%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFD----GALKSFDAECEVLKSVRHRNLVKIIS 281
IGIG FG VY+ + G EVA+K D +++ E ++ ++H N++ +
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
C LV+E+ G L + L + ++ + +A + YLH P++H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 342 CDIKPSNVLLDDDMVAH--------LSDFGIAKLLNGKESMRTQTLATIEY-----GREG 388
D+K SN+L+ + ++DFG+A+ + M + R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS--AAGAYAWMAPEVIRAS 189
Query: 389 QVSPKSDVYGYGITLIETFTKKKP 412
S SDV+ YG+ L E T + P
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVP 213
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 5e-45
Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 3/135 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSF-DFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
++ N +S IP ++ + + + + S N L G +P N+ + ++LSRN L GD
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGD 212
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
G N Q + L N L + G +L LDL N + G +P L +L +L
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 121 DLNLSFNRLKGDIPT 135
LN+SFN L G+IP
Sbjct: 272 SLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 4/138 (2%)
Query: 1 NLSLGSNELS--SVIPSTFWNLNSILSFDFSS-NSLNGSLPLDIENMKVVVEINLSRNYL 57
NL L L IPS+ NL + N+L G +P I + + + ++ +
Sbjct: 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 58 TGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
+G IP + + L L N L G +P S L +L + N +SG IP S
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
Query: 118 YL-KDLNLSFNRLKGDIP 134
L + +S NRL G IP
Sbjct: 174 KLFTSMTISRNRLTGKIP 191
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 3/137 (2%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGS--LPLDIENMKVVVEINLS-RNYL 57
+ V+ T + + D S +L +P + N+ + + + N L
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 58 TGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
G IPP I LT L L + + + G IP+ ++ +L +LD S N LSG +P S+ L
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149
Query: 118 YLKDLNLSFNRLKGDIP 134
L + NR+ G IP
Sbjct: 150 NLVGITFDGNRISGAIP 166
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 43/127 (33%), Positives = 64/127 (50%), Gaps = 3/127 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+++ N L+ IP TF NLN + D S N L G + + K +I+L++N L D+
Sbjct: 179 MTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+G NL L L NNR+ G +P+ +L L SL++S NNL G IP L
Sbjct: 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDV 295
Query: 122 LNLSFNR 128
+ N+
Sbjct: 296 SAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 7/121 (5%)
Query: 18 WNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG--DIPPTIGGLTNLQLLS 75
W + D + + G L V ++LS L IP ++ L L L
Sbjct: 27 WLPTT----DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82
Query: 76 LEN-NRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
+ N L GPIP + +LT L L ++ N+SG IP L ++ L L+ S+N L G +P
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 135 T 135
Sbjct: 143 P 143
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 22/88 (25%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+ L N L+ + ++ D +N + G+LP + +K + +N+S N L G+
Sbjct: 225 KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 61 IPPTIGGLTNLQLLSLENNRLQ--GPIP 86
I P G L + + NN+ P+P
Sbjct: 284 I-PQGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 284
+G G FG K + G + +K + ++F E +V++ + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
+ EY+ G+L + S + QR+S D+A + YLH S ++H D+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP------------ 392
N L+ ++ ++DFG+A+L+ +++ + + R+ + +
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 393 -------KSDVYGYGITLIETFTKKKP 412
K DV+ +GI L E +
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-44
Identities = 62/238 (26%), Positives = 88/238 (36%), Gaps = 39/238 (16%)
Query: 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV 267
+ E L D+ LIG G +G VYKG LD VA+KVF ++F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSFA---NRQNFINEKNI 58
Query: 268 --LKSVRHRNLVKIISSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSI 320
+ + H N+ + I + LV+EY NGSL K L D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116
Query: 321 MIDVALALEYLH------FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM 374
V L YLH Y + H D+ NVL+ +D +SDFG++ L G +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 375 RTQTLA--------TIEY------------GREGQVSPKSDVYGYGITLIETFTKKKP 412
R TI Y + D+Y G+ E F +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-42
Identities = 41/135 (30%), Positives = 67/135 (49%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+ + E + L++ + +S G +N ++ +++S N L+G
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP IG + L +L+L +N + G IP+ G+L L LDLS N L G IP ++ L L
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707
Query: 121 DLNLSFNRLKGDIPT 135
+++LS N L G IP
Sbjct: 708 EIDLSNNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-37
Identities = 45/133 (33%), Positives = 70/133 (52%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L +N + IP T N + ++S S N L+G++P + ++ + ++ L N L G+I
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + + L+ L L+ N L G IP T+L + LS N L+G IP + +L L
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 122 LNLSFNRLKGDIP 134
L LS N G+IP
Sbjct: 519 LKLSNNSFSGNIP 531
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-37
Identities = 49/136 (36%), Positives = 72/136 (52%), Gaps = 2/136 (1%)
Query: 2 LSLGSNELSSVIPSTFWN--LNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG 59
L L SN S I N++ +N G +P + N +V ++LS NYL+G
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
IP ++G L+ L+ L L N L+G IP+ + +LE+L L N+L+G IP L L
Sbjct: 433 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 120 KDLNLSFNRLKGDIPT 135
++LS NRL G+IP
Sbjct: 493 NWISLSNNRLTGEIPK 508
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 21/215 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L N LS IPS+ +L+ + N L G +P ++ +K + + L N LTG+I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + TNL +SL NNRL G IP+ G L +L L LS N+ SG IP L L
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 542
Query: 122 LNLSFNRLKGDIP---------------TRSPHLQVPLCKSSSHRKSSKNVILLGVVLPL 166
L+L+ N G IP ++ + + N++ +
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602
Query: 167 SVFIIAVLLALGI------GLITRYRKGNTELSNI 195
+ ++ I G + N + +
Sbjct: 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-35
Identities = 47/137 (34%), Positives = 69/137 (50%), Gaps = 4/137 (2%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L + N+LS + + SSN G +P +K + ++L+ N TG+
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGE 284
Query: 61 IPPTIGG-LTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPI-SLEKLVY 118
IP + G L L L N G +P FG + LESL LS NN SG +P+ +L K+
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 119 LKDLNLSFNRLKGDIPT 135
LK L+LSFN G++P
Sbjct: 345 LKVLDLSFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 4/137 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD-IENMKVVVEINLSRNYLTGD 60
L L N +P F + + + S SSN+ +G LP+D + M+ + ++LS N +G+
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 61 IPPTIGGLT-NLQLLSLENNRLQGPIPESFGE--LTSLESLDLSVNNLSGVIPISLEKLV 117
+P ++ L+ +L L L +N GPI + + +L+ L L N +G IP +L
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS 418
Query: 118 YLKDLNLSFNRLKGDIP 134
L L+LSFN L G IP
Sbjct: 419 ELVSLHLSFNYLSGTIP 435
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-32
Identities = 33/136 (24%), Positives = 53/136 (38%), Gaps = 2/136 (1%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSN--SLNGSLPLDIENMKVVVEINLSRNYLTG 59
+ +N ++ N + N G + + N++ G
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
PT ++ L + N L G IP+ G + L L+L N++SG IP + L L
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 120 KDLNLSFNRLKGDIPT 135
L+LS N+L G IP
Sbjct: 683 NILDLSSNKLDGRIPQ 698
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-31
Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIE---NMKVVVEINLSRNYL 57
L++ SN L S LNS+ D S+NS++G+ + + + +S N +
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 58 TGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
+GD+ + NL+ L + +N IP G+ ++L+ LD+S N LSG ++
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 118 YLKDLNLSFNRLKGDIPT-RSPHLQV 142
LK LN+S N+ G IP LQ
Sbjct: 248 ELKLLNISSNQFVGPIPPLPLKSLQY 273
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-31
Identities = 34/136 (25%), Positives = 60/136 (44%), Gaps = 8/136 (5%)
Query: 2 LSLGSNELSSVIPSTFW---NLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT 58
L L +N +S + + S N ++G + + + +++S N +
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
IP +G + LQ L + N+L G + T L+ L++S N G IP L
Sbjct: 214 TGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKS 270
Query: 119 LKDLNLSFNRLKGDIP 134
L+ L+L+ N+ G+IP
Sbjct: 271 LQYLSLAENKFTGEIP 286
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 35/143 (24%), Positives = 63/143 (44%), Gaps = 6/143 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L N+L+ IPS N ++ S+N L G +P I ++ + + LS N +G+
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
IP +G +L L L N G IP + + S ++ N ++G + ++ K
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKK 585
Query: 121 DLNLSFN--RLKGDIPTRSPHLQ 141
+ + + N +G + L
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLS 608
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 2 LSLGSNELSSV---IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT 58
+ L S L+ + S+ +L + S S++ +NGS+ + + ++LSRN L+
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 59 GDIPP--TIGGLTNLQLLSLENNRLQGPIP-ESFGELTSLESLDLSVNNLSGVIPISLE- 114
G + ++G + L+ L++ +N L P +L SLE LDLS N++SG +
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173
Query: 115 --KLVYLKDLNLSFNRLKGDIP 134
LK L +S N++ GD+
Sbjct: 174 SDGCGELKHLAISGNKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 35/140 (25%), Positives = 62/140 (44%), Gaps = 9/140 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE--NMKVVVEINLSRNYLT 58
+L L ++ ++ + F S+ S D S NSL+G + + + +N+S N L
Sbjct: 81 SLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 139
Query: 59 GDIP-PTIGGLTNLQLLSLENNRLQGPIPESF---GELTSLESLDLSVNNLSGVIPISLE 114
L +L++L L N + G + L+ L +S N +SG + +S
Sbjct: 140 FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVS-- 197
Query: 115 KLVYLKDLNLSFNRLKGDIP 134
+ V L+ L++S N IP
Sbjct: 198 RCVNLEFLDVSSNNFSTGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-21
Identities = 32/123 (26%), Positives = 55/123 (44%), Gaps = 7/123 (5%)
Query: 18 WNLNSILSFDFSSNSLN---GSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLL 74
+ + S D SS LN ++ + ++ + + LS +++ G + +L L
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSL 105
Query: 75 SLENNRLQGPIPE--SFGELTSLESLDLSVNNLSGVIPISLE-KLVYLKDLNLSFNRLKG 131
L N L GP+ S G + L+ L++S N L +S KL L+ L+LS N + G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 132 DIP 134
Sbjct: 166 ANV 168
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 22/72 (30%), Positives = 35/72 (48%), Gaps = 1/72 (1%)
Query: 66 GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 125
+T++ L S N + S LT LESL LS ++++G + + L L+LS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 126 FNRLKGDIPTRS 137
N L G + T +
Sbjct: 109 RNSLSGPVTTLT 120
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 47/218 (21%), Positives = 86/218 (39%), Gaps = 32/218 (14%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIISS 282
+G G +G V++G + G VA+K+F + KS+ E E+ +RH N++ I+S
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 283 CSNGNFEA----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-----F 333
+ L+ Y GSL L LD L I++ +A L +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM----RTQTLATIEY----- 384
+ H D+K N+L+ + ++D G+A + + + + T Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 385 ------GREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416
+ D++ +G+ L E + +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 32/238 (13%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIISS 282
IG G +G V+ G++ G +VA+KVF S+ E E+ +RH N++ I++
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 283 CSNGNFE----ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-----F 333
G L+ +Y NGSL L S+ LD L + L +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-----SMRTQT---------- 378
+ H D+K N+L+ + ++D G+A T+
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 379 LATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVM 436
L Q +D+Y +G+ L E + + ++ + V M
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-38
Identities = 48/238 (20%), Positives = 93/238 (39%), Gaps = 32/238 (13%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIISS 282
IG G FG V++G++ G EVA+K+F + +S+ E E+ +RH N++ I++
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 283 CSNGNFEA----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-----F 333
+ N LV +Y +GSL L + + + + + + A L +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA----TIEY----- 384
+ H D+K N+L+ + ++D G+A + T Y
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 385 ------GREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVM 436
+ + ++D+Y G+ E + ++ + V + M
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 222 EKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKII 280
++ ++G G++G VY GR L + +AIK + + E + K ++H+N+V+ +
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL--SIMIDVALALEYLHFGYSNP 338
S S F + +E + GSL L S G L ++ + L+YLH N
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142
Query: 339 VVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGKESMRTQTLAT--------IEYGREGQ 389
+VH DIK NVL++ V +SDFG +K L G T I+ G G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG- 201
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
+D++ G T+IE T K P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 16/237 (6%)
Query: 181 LITRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRF- 239
LI L S + R + +L + IG G+FG V+ GR
Sbjct: 81 LIDHLLSTQQPL----TKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR 136
Query: 240 LDGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298
D VA+K F E +LK H N+V++I C+ +V+E +
Sbjct: 137 ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196
Query: 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358
G L + L + L ++ D A +EYL S +H D+ N L+ + V
Sbjct: 197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLK 253
Query: 359 LSDFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPKSDVYGYGITLIETFT 408
+SDFG+++ + L + E G+ S +SDV+ +GI L ETF+
Sbjct: 254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 62/244 (25%), Positives = 95/244 (38%), Gaps = 34/244 (13%)
Query: 191 ELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKV 249
EL V MS + +F IG GSF TVYKG + +EVA
Sbjct: 13 ELETKAVGMSNDGRFLKF--------------DIEIGRGSFKTVYKGLDTETTVEVAWCE 58
Query: 250 FHL--QFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA----LVLEYMANGSLEK 303
+ F E E+LK ++H N+V+ S + LV E M +G+L K
Sbjct: 59 LQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL-K 117
Query: 304 CLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDF 362
++ I S + L++LH + P++H D+K N+ + + D
Sbjct: 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 363 GIAKLLNGKESMRTQTLATI-----EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIF 417
G+A L S + T E E DVY +G+ ++E T + P E
Sbjct: 177 GLATLKR--ASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSE-- 231
Query: 418 CEEM 421
C+
Sbjct: 232 CQNA 235
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 43/204 (21%), Positives = 80/204 (39%), Gaps = 29/204 (14%)
Query: 224 SLIGIGSFGTVYKGR--FLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKII 280
I G G +Y ++G V +K D A AE + L V H ++V+I
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 281 SSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+ + + +V+EY+ SL++ L + + ++ ++++ AL YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLH--- 199
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT---LATIEYG----REG 388
S +V+ D+KP N++L ++ + L D G + T +
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRI-------NSFGYLYGTPGFQAPEIVRT 251
Query: 389 QVSPKSDVYGYGITLIETFTKKKP 412
+ +D+Y G TL
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 44/208 (21%), Positives = 75/208 (36%), Gaps = 21/208 (10%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+ + +G GSFG V++ + G + A+K L+ E +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPR 111
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+V + + G + + +E + GSL + + G L + L + LEYLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLH--- 167
Query: 336 SNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAKLLNGKESMRTQTLATIEYG--------- 385
+ ++H D+K NVLL D A L DFG A L ++ G
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 386 -REGQVSPKSDVYGYGITLIETFTKKKP 412
K D++ ++ P
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-33
Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 13/203 (6%)
Query: 218 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSV-RH 273
F S +G GS+G V+K R DG A+K F G AE + V +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
V++ + G L E SL++ + L Q + D LAL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH- 174
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY----GREGQ 389
S +VH D+KP+N+ L L DFG+ L + Q Y +G
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGS 231
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
+DV+ G+T++E +
Sbjct: 232 YGTAADVFSLGLTILEVACNMEL 254
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHL--QFDGALKSFDAECEVLKSVRHR 274
+ + IG GSFG + DG + IK ++ + E VL +++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHF 333
N+V+ S +V++Y G L K + + G+ Q L + + LAL+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSP- 392
++H DIK N+ L D L DFGIA++LN + + T Y +SP
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY-----LSPE 195
Query: 393 ---------KSDVYGYGITLIETFTKKKP 412
KSD++ G L E T K
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIK---VFHLQFDGALKSFDAECEVLKSVRH 273
+F + IG G F VY+ L DG+ VA+K +F L A E ++LK + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLE---KCLYSSNGILDIFQRLSIMIDVALALEY 330
N++K +S N +VLE G L K ++ + + ALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQV 390
+H S V+H DIKP+NV + V L D G+ + + K + + T Y +
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY-----M 203
Query: 391 SP----------KSDVYGYGITLIETFTKKKP 412
SP KSD++ G L E + P
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 224 SLIGIGSFGTVYKGR--FLDGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVK 278
+G G TVY L+ ++VAIK + + LK F+ E + H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+I + LV+EY+ +L S+G L + ++ + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT---LATIEY-----GREGQV 390
+VH DIKP N+L+D + + DFGIAK L+ E+ TQT L T++Y +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 391 SPKSDVYGYGITLIETFTKKKP 412
+D+Y GI L E + P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 60/240 (25%), Positives = 116/240 (48%), Gaps = 19/240 (7%)
Query: 181 LITRYRKGN----TELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYK 236
L+ Y+KGN +LS ++ PQ W + +++ + + + +G G FG V+
Sbjct: 150 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWE---IPRESLKLEKKLGAGQFGEVWM 206
Query: 237 GRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296
+ +VA+K ++++F AE V+K+++H LVK+ + + ++ E+M
Sbjct: 207 ATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFM 264
Query: 297 ANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM 355
A GSL L S G + + + +A + ++ +H D++ +N+L+ +
Sbjct: 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 321
Query: 356 VAHLSDFGIAKLLNGKE-SMRTQTLATI-----EYGREGQVSPKSDVYGYGITLIETFTK 409
V ++DFG+A+++ E + R I E G + KSDV+ +GI L+E T
Sbjct: 322 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 220 FSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
F E LIG G FG V+K + +DG IK + A + E + L + H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 279 ----------------IISSCSNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIM 321
SS S + +E+ G+LE+ + G LD L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT 381
+ ++Y+H S +++ D+KPSN+ L D + DFG+ L + RT++ T
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRTRSKGT 184
Query: 382 IEYGREGQVSP----------KSDVYGYGITLIETFTKKKP 412
+ Y +SP + D+Y G+ L E
Sbjct: 185 LRY-----MSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 53/242 (21%), Positives = 105/242 (43%), Gaps = 17/242 (7%)
Query: 181 LITRYRKGN----TELSNIEVNMSPQAMWRR-FSYQELLLATDHFSEKSLIGIGSFGTVY 235
L+ + T L + ++ +Y + + + K +G G +G VY
Sbjct: 178 LVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVY 237
Query: 236 KGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294
+G + + VA+K + ++ F E V+K ++H NLV+++ C+ ++ E
Sbjct: 238 EGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296
Query: 295 YMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD 353
+M G+L L N + L + ++ A+EYL +H ++ N L+ +
Sbjct: 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGE 353
Query: 354 DMVAHLSDFGIAKLLNGKE-SMRTQTLATI-----EYGREGQVSPKSDVYGYGITLIETF 407
+ + ++DFG+++L+ G + I E + S KSDV+ +G+ L E
Sbjct: 354 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413
Query: 408 TK 409
T
Sbjct: 414 TY 415
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 58/191 (30%), Positives = 96/191 (50%), Gaps = 12/191 (6%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285
+G G FG V+ G + VAIK + ++F E +V+K +RH LV++ + S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 286 GNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
+V EYM+ GSL L G L + Q + + +A + Y+ VH D+
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKE-SMRTQTLATI-----EYGREGQVSPKSDVYG 398
+ +N+L+ +++V ++DFG+A+L+ E + R I E G+ + KSDV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 399 YGITLIETFTK 409
+GI L E TK
Sbjct: 450 FGILLTELTTK 460
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 12/191 (6%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285
+G G FG V+ G + VAIK + ++F E +V+K +RH LV++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 286 GNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344
+V EYM+ GSL L G L + Q + + +A + Y+ VH D+
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL------ATIEYGREGQVSPKSDVYG 398
+ +N+L+ +++V ++DFG+A+L+ E Q E G+ + KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 399 YGITLIETFTK 409
+GI L E TK
Sbjct: 367 FGILLTELTTK 377
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 31/228 (13%)
Query: 202 QAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGME-----VAIKVFHLQF-D 255
QA+ R E ++G G+FGTVYKG ++ E VAIK
Sbjct: 6 QALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58
Query: 256 GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF 315
A K E V+ SV + ++ +++ C L+ + M G L + +
Sbjct: 59 KANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 316 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR 375
L+ + +A + YL +VH D+ NVL+ ++DFG+AKLL +E
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 376 TQTLA----------TIEYGREGQVSPKSDVYGYGITLIETFTK-KKP 412
+I + + +SDV+ YG+T+ E T KP
Sbjct: 175 HAEGGKVPIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 224 SLIGIGSFGTVYKGR--FLDGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVK 278
++G G V+ R +VA+KV F E + ++ H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 279 I----ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
+ + G +V+EY+ +L + + + G + + + ++ D AL + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT---LATIEY-----GR 386
N ++H D+KP+N+++ + DFGIA+ + + TQT + T +Y R
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 387 EGQVSPKSDVYGYGITLIETFTKKKP 412
V +SDVY G L E T + P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 26/206 (12%)
Query: 226 IGIGSFGTVYKGRFL----DGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVK 278
+G GSFG V +G + + VA+K L A+ F E + S+ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ +V E GSL L G + + VA + YL S
Sbjct: 86 LYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----------IEYGRE 387
+H D+ N+LL + + DFG+ + L + ++
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT- 200
Query: 388 GQVSPKSDVYGYGITLIETFTK-KKP 412
S SD + +G+TL E FT ++P
Sbjct: 201 --FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 219 HFSEKSL-----IGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKSFDAECEVL 268
F E+ L +G G+FG+V R+ G VA+K + L+ F+ E E+L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 269 KSVRHRNLVKIISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
KS++H N+VK C + L++EY+ GSL L +D + L +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTLATI--- 382
+EYL + +H D+ N+L++++ + DFG+ K+L KE + +
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 383 ----EYGREGQVSPKSDVYGYGITLIETFT 408
E E + S SDV+ +G+ L E FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 16/192 (8%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
IG G FG V+ G +L+ +VAIK +GA+ + F E EV+ + H LV++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
LV E+M +G L L + G+ L + +DV + YL V+H D
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPKSDV 396
+ N L+ ++ V +SDFG+ + + + + T E + S KSDV
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 397 YGYGITLIETFT 408
+ +G+ + E F+
Sbjct: 189 WSFGVLMWEVFS 200
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+ + +G G+FG VYK + + G A KV + + L+ + E E+L + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+VK++ + + +++E+ G+++ + + L Q + + AL +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT----------IEYG 385
S ++H D+K NVL+ + L+DFG++ R + T E
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 386 REGQVSPKSDVYGYGITLIE 405
++ K+D++ GITLIE
Sbjct: 195 KDTPYDYKADIWSLGITLIE 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 222 EKSLIGIGSFGTVYKGRFLDG---MEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLV 277
+G G+FG+V +G + ++VAIKV + A E +++ + + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL---HFG 334
++I C LV+E G L K L + + ++ V++ ++YL +F
Sbjct: 74 RLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----------IE 383
VH D+ NVLL + A +SDFG++K L +S T A I
Sbjct: 132 -----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186
Query: 384 YGREGQVSPKSDVYGYGITLIETFTK-KKP 412
+ + S +SDV+ YG+T+ E + +KP
Sbjct: 187 FRK---FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 219 HFSEKSL-----IGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKSFDAECEVL 268
F E+ L +G G+FG+V R+ G VA+K + L+ F+ E E+L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 269 KSVRHRNLVKIISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
KS++H N+VK C + L++EY+ GSL L +D + L +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTLATI--- 382
+EYL + +H D+ N+L++++ + DFG+ K+L KE + +
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 383 ----EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK 424
E E + S SDV+ +G+ L E FT + + E M +
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 46/203 (22%), Positives = 75/203 (36%), Gaps = 22/203 (10%)
Query: 224 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLV 277
L+G G G VY+ D VA+K+ E ++ ++V
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
I + + + L L G L + ++I+ + AL+ H +
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT---LATIEY-----GREGQ 389
H D+KP N+L+ D A+L DFGIA + TQ + T+ Y E
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
+ ++D+Y L E T P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 43/227 (18%), Positives = 82/227 (36%), Gaps = 28/227 (12%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLK 269
+++ H+ +G G F V DG A+K + E ++ +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 270 SVRHRNLVKIISSC---SNGNFEA-LVLEYMANGSLEKCLY---SSNGILDIFQRLSIMI 322
H N++++++ C EA L+L + G+L + L Q L +++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-----NGKESMRTQ 377
+ LE +H + H D+KP+N+LL D+ L D G ++++ Q
Sbjct: 142 GICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 378 TLAT------------IEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
A + ++DV+ G L + P
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 76/237 (32%), Positives = 106/237 (44%), Gaps = 23/237 (9%)
Query: 180 GLITRYRKGNTELSNIEVNMSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRF 239
GL TR K +V A F L IG G FG V G +
Sbjct: 162 GLCTRLIK-------PKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 240 LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA-LVLEYMAN 298
G +VA+K ++ D ++F AE V+ +RH NLV+++ +V EYMA
Sbjct: 215 -RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 299 GSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVA 357
GSL L S +L L +DV A+EYL N VH D+ NVL+ +D VA
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVA 328
Query: 358 HLSDFGIAKLLNGKESMRTQTLATI-----EYGREGQVSPKSDVYGYGITLIETFTK 409
+SDFG+ K + S + + E RE + S KSDV+ +GI L E ++
Sbjct: 329 KVSDFGLTKEAS---STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 382
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280
IG G G V GR + VAIK + + + F +E ++ H N++++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ G +V EYM NGSL+ L + +G I Q + ++ V + YL V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYV 173
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTLA----------TIEYGREGQ 389
H D+ NVL+D ++V +SDFG++++L + ++ T T I +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT--- 230
Query: 390 VSPKSDVYGYGITLIETFTK-KKP 412
S SDV+ +G+ + E ++P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-30
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 226 IGIGSFGTVYKGRFLDG---MEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLVKIIS 281
+G G+FG+V +G + ++VAIKV + A E +++ + + +V++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL---HFGYSNP 338
C LV+E G L K L + + ++ V++ ++YL +F
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----------IEYGRE 387
VH ++ NVLL + A +SDFG++K L +S T A I + +
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK- 515
Query: 388 GQVSPKSDVYGYGITLIETFTK-KKP 412
S +SDV+ YG+T+ E + +KP
Sbjct: 516 --FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV 271
+G G FG V R+ G +VA+K + + E E+L+++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 272 RHRNLVKIISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALE 329
H N+VK C+ L++E++ +GSL++ L + +++ Q+L + + ++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTLATI------ 382
YL S VH D+ NVL++ + + DFG+ K + KE +
Sbjct: 141 YLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 383 -EYGREGQVSPKSDVYGYGITLIETFT 408
E + + SDV+ +G+TL E T
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDG--ALKSFDAECEVLKS 270
H S +G G+FG+V R+ G VA+K LQ G + F E ++LK+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKA 80
Query: 271 VRHRNLVKIISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
+ +VK ++ LV+EY+ +G L L LD + L + +
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATI----- 382
EYL S VH D+ N+L++ + ++DFG+AKLL + +
Sbjct: 141 EYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 383 --EYGREGQVSPKSDVYGYGITLIETFT 408
E + S +SDV+ +G+ L E FT
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNL--VKII 280
IG G V++ AIK +L+ + L S+ E L ++ + +++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +V+E N L L +D ++R S ++ A+ +H + +V
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 149
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK------------------ESMRTQTLATI 382
H D+KP+N L+ D M+ L DFGIA + E+++ + +
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ ++SPKSDV+ G L K P
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 25/201 (12%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V G++ +VA+K+ +G++ F E + + + H LVK C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
S +V EY++NG L L S L+ Q L + DV + +L S+ +H D
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----------IEYGREGQVSP 392
+ N L+D D+ +SDFG+ + + + ++ T Y + S
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAPEVFHYFK---YSS 184
Query: 393 KSDVYGYGITLIETFTK-KKP 412
KSDV+ +GI + E F+ K P
Sbjct: 185 KSDVWAFGILMWEVFSLGKMP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 23/199 (11%)
Query: 226 IGIGSFGTVYKGRFLDGME-----VAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 279
+G G FGTV+KG ++ E V IKV + + ++ + S+ H ++V++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
+ C + LV +Y+ GSL + G L L+ + +A + YL + +
Sbjct: 81 LGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA----------TIEYGREGQ 389
VH ++ NVLL ++DFG+A LL + + A +I +G+
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK--- 193
Query: 390 VSPKSDVYGYGITLIETFT 408
+ +SDV+ YG+T+ E T
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 25/215 (11%)
Query: 218 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 274
+ + IG GS+G K R DG + K + + +E +L+ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 275 NLVKIISSCSNGNFEAL--VLEYMANGSLE---KCLYSSNGILDIFQRLSIMIDVALALE 329
N+V+ + L V+EY G L LD L +M + LAL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 330 YLH--FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGRE 387
H + V+H D+KP+NV LD L DFG+A++LN S + T Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY--- 182
Query: 388 GQVSP----------KSDVYGYGITLIETFTKKKP 412
+SP KSD++ G L E P
Sbjct: 183 --MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 24/196 (12%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V G++ +VAIK+ +G++ F E +V+ ++ H LV++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+ ++ EYMANG L L Q L + DV A+EYL S +H D
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----------IEYGREGQVSP 392
+ N L++D V +SDFG+++ + + T ++ + + Y + S
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK---FSS 200
Query: 393 KSDVYGYGITLIETFT 408
KSD++ +G+ + E ++
Sbjct: 201 KSDIWAFGVLMWEIYS 216
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNL--VKII 280
IG G V++ AIK +L+ + L S+ E L ++ + +++
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +V+E N L L +D ++R S ++ A+ +H + +V
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 130
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK------------------ESMRTQTLATI 382
H D+KP+N L+ D M+ L DFGIA + E+++ + +
Sbjct: 131 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ ++SPKSDV+ G L K P
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 225 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNL--VKII 280
IG G V++ AIK +L+ + L S+ E L ++ + +++
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +V+E N L L +D ++R S ++ A+ +H + +V
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 177
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK------------------ESMRTQTLATI 382
H D+KP+N L+ D M+ L DFGIA + E+++ + +
Sbjct: 178 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ ++SPKSDV+ G L K P
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 27/230 (11%)
Query: 201 PQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDG-----MEVAIKVFHLQF- 254
P +F+ + + + + +IG G FG VYKG + VAIK +
Sbjct: 30 PNQAVLKFTTE---IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT 86
Query: 255 DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDI 314
+ F E ++ H N++++ S ++ EYM NG+L+K L +G +
Sbjct: 87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV 146
Query: 315 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM 374
Q + ++ +A ++YL + VH D+ N+L++ ++V +SDFG++++L
Sbjct: 147 LQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203
Query: 375 RTQTLAT-----------IEYGREGQVSPKSDVYGYGITLIETFTK-KKP 412
T I Y + + SDV+ +GI + E T ++P
Sbjct: 204 TYTTSGGKIPIRWTAPEAISYRK---FTSASDVWSFGIVMWEVMTYGERP 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 226 IGIGSFGTVYKGRFLDG---MEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKII 280
+G G+FGTV KG + VA+K+ + + AE V++ + + +V++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL---HFGYSN 337
C ++ LV+E G L K L N + + ++ V++ ++YL +F
Sbjct: 85 GICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF---- 138
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----------IEYGR 386
VH D+ NVLL A +SDFG++K L E+ I Y +
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 387 EGQVSPKSDVYGYGITLIETFTK-KKP 412
S KSDV+ +G+ + E F+ +KP
Sbjct: 197 ---FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 202 QAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGME-----VAIKVFHLQF-D 255
QA+ R E ++G G+FGTVYKG ++ E VAIK
Sbjct: 6 QALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58
Query: 256 GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF 315
A K E V+ SV + ++ +++ C L+ + M G L + +
Sbjct: 59 KANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 316 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR 375
L+ + +A + YL +VH D+ NVL+ ++DFG+AKLL +E
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 376 TQTLATI-------EYGREGQVSPKSDVYGYGITLIETFT 408
+ E + +SDV+ YG+T+ E T
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 24/201 (11%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280
IG G FG VY G LD + A+K + G + F E ++K H N++ ++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 281 SSCSNGNFEAL-VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
C L VL YM +G L + + + + + VA ++YL S
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKF 149
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT------------IEYGRE 387
VH D+ N +LD+ ++DFG+A+ + KE ++ +
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK- 208
Query: 388 GQVSPKSDVYGYGITLIETFT 408
+ KSDV+ +G+ L E T
Sbjct: 209 --FTTKSDVWSFGVLLWELMT 227
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
++ IG G+ GTVY + G EVAI+ +LQ + E V++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+V + S G+ +V+EY+A GSL + + +D Q ++ + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-----EYGREGQV 390
SN V+H DIK N+LL D L+DFG + ++S R+ + T E
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 391 SPKSDVYGYGITLIE 405
PK D++ GI IE
Sbjct: 194 GPKVDIWSLGIMAIE 208
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 38/223 (17%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
F E +++G G+FG V K R LD AIK + L + +E +L S+ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63
Query: 276 LVKIISS-CSNGNFEA------------LVLEYMANGSLEKCLYSSNGILDIFQRLSIMI 322
+V+ ++ NF + +EY NG+L ++S N + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI 382
+ AL Y+H S ++H D+KP N+ +D+ + DFG+AK ++ + +
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 383 EYGREGQ---------VSP-----------KSDVYGYGITLIE 405
+ V+ K D+Y GI E
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 36/221 (16%)
Query: 218 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRN 275
F +G G FG V++ + +D AIK L + A + E + L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 276 LVKIISSCSNGNFEA------------LVLEYMANGSLEKCLYSSNGI--LDIFQRLSIM 321
+V+ ++ N + ++ +L+ + I + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLA 380
+ +A A+E+LH S ++H D+KPSN+ D V + DFG+ ++ E T
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 381 TIEYGREGQV------SP----------KSDVYGYGITLIE 405
GQV SP K D++ G+ L E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 226 IGIGSFGTVYKGRFL----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280
+G G FG V GR + VAIK + + + + F E ++ H N++++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +V EYM NGSL+ L + + Q + ++ +A ++YL V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYV 169
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTLA----------TIEYGREGQ 389
H D+ N+L++ ++V +SDFG+ ++L + E+ T I Y +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK--- 226
Query: 390 VSPKSDVYGYGITLIETFTK-KKP 412
+ SDV+ YGI L E + ++P
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP 250
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 23/201 (11%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
IG GS G V R G +VA+K+ L+ + E +++ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+V++ S G +++E++ G+L + S L+ Q ++ V AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH--- 158
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----------IEY 384
+ V+H DIK ++LL D LSDFG ++ R + T Y
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 385 GREGQVSPKSDVYGYGITLIE 405
+ D++ GI +IE
Sbjct: 219 A------TEVDIWSLGIMVIE 233
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 24/197 (12%)
Query: 226 IGIGSFGTVYKGRFLDG-MEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISS 282
+G G +G VY+G + + VA+K + + + F E V+K ++H NLV+++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 283 CSNGNFEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341
C+ ++ E+M G+L L N + L + ++ A+EYL +H
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA----------TIEYGREGQVS 391
D+ N L+ ++ + ++DFG+++L+ G ++ A ++ Y + S
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK---FS 190
Query: 392 PKSDVYGYGITLIETFT 408
KSDV+ +G+ L E T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 2/136 (1%)
Query: 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L + L + S F +L +++ D S + + + + ++ N +
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
P L NL L L +L+ P +F L+SL+ L++S NN + + L L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520
Query: 120 KDLNLSFNRLKGDIPT 135
+ L+ S N +
Sbjct: 521 QVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 30/137 (21%), Positives = 55/137 (40%), Gaps = 2/137 (1%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L + F L+S+ + NS + DI ++ + ++LS+ L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY-L 119
P L++LQ+L++ +N + L SL+ LD S+N++ L+ L
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 545
Query: 120 KDLNLSFNRLKGDIPTR 136
LNL+ N +
Sbjct: 546 AFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 29/136 (21%), Positives = 56/136 (41%), Gaps = 1/136 (0%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
NL L N L + +F++ + D S + +++ + + L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYL 119
GL++LQ L L G L +L+ L+++ N + +P L L
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 120 KDLNLSFNRLKGDIPT 135
+ L+LS N+++ T
Sbjct: 152 EHLDLSSNKIQSIYCT 167
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 31/144 (21%), Positives = 56/144 (38%), Gaps = 5/144 (3%)
Query: 2 LSLGSNELS--SVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG 59
L L N LS + + S+ D S N + + + ++ + ++ + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVI-PISLEKLV 117
++ L NL L + + + F L+SLE L ++ N+ P +L
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 118 YLKDLNLSFNRLKGDIPTRSPHLQ 141
L L+LS +L+ PT L
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 26/126 (20%), Positives = 51/126 (40%), Gaps = 3/126 (2%)
Query: 6 SNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTI 65
+ + ++ ++ D S N L + + ++LSR +
Sbjct: 16 ELNFYKIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 66 GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 125
L++L L L N +Q +F L+SL+ L NL+ + + L LK+LN++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 126 FNRLKG 131
N ++
Sbjct: 133 HNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 28/149 (18%), Positives = 51/149 (34%), Gaps = 8/149 (5%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLN--GSLPLDIENMKVVVEINLSRNYLT 58
L + +L S+ D S N L+ G + ++LS N +
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPISLEKLV 117
+ GL L+ L +++ L+ S F L +L LD+S + L
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 118 YLKDLNLSFNRLKGDIPTRS----PHLQV 142
L+ L ++ N + + +L
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTF 474
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 35/143 (24%), Positives = 48/143 (33%), Gaps = 15/143 (10%)
Query: 1 NLSLGSNELSSV------IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSR 54
NL++ L+ + I F L ++ SF S ++ + L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVN 313
Query: 55 NYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS--GVIPIS 112
L L L +G S +L SLE LDLS N LS G S
Sbjct: 314 CKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 113 LEKLVYLKDLNLSFNRLKGDIPT 135
LK L+LSFN +
Sbjct: 369 DFGTTSLKYLDLSFNGVITMSSN 391
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 11/195 (5%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+ F +G GS+G+VYK + G VAIK ++ D L+ E +++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+VK S +V+EY GS+ + N L + +I+ LEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-----EYGREGQV 390
+H DIK N+LL+ + A L+DFG+A L + R + T E +E
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 391 SPKSDVYGYGITLIE 405
+ +D++ GIT IE
Sbjct: 203 NCVADIWSLGITAIE 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280
+G G FG VY+G + + + VA+K + F +E ++K++ H ++VK+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+++E G L L + L + + + + A+ YL S V
Sbjct: 80 GIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT-------LA--TIEYGREGQVS 391
H DI N+L+ L DFG+++ + ++ + ++ +I + R +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR---FT 192
Query: 392 PKSDVYGYGITLIETFTK-KKP 412
SDV+ + + + E + K+P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQP 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 16/193 (8%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 283
+G G FG V+ G + +VA+K G++ +F AE ++K ++H+ LV++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
+ ++ EYM NGSL L + +GI L I + L + +A + ++ +H
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 343 DIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-SMRTQTLATI-----EYGREGQVSPKSDV 396
D++ +N+L+ D + ++DFG+A+L+ E + R I E G + KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 397 YGYGITLIETFTK 409
+ +GI L E T
Sbjct: 194 WSFGILLTEIVTH 206
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280
IG G FG VY G ++D ++ AIK +++F E +++ + H N++ +I
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 281 SSCSNGN-FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL---HFGYS 336
++L YM +G L + + S + +S + VA +EYL F
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF--- 145
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--SMRTQTLA----------TIEY 384
VH D+ N +LD+ ++DFG+A+ + +E S++ A +++
Sbjct: 146 ---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 385 GREGQVSPKSDVYGYGITLIETFT 408
R + KSDV+ +G+ L E T
Sbjct: 203 YR---FTTKSDVWSFGVLLWELLT 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDG---ALKSFDAECEVLK 269
+ + +G G FG V + G VA+K L+ D + E ++L+
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILR 88
Query: 270 SVRHRNLVKIISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
++ H +++K C + + LV+EY+ GSL L + + + Q L +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEG 146
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTLA------ 380
+ YLH + +H D+ NVLLD+D + + DFG+AK + G E R +
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 381 ----TIEYGREGQVSPKSDVYGYGITLIETFT 408
++ + SDV+ +G+TL E T
Sbjct: 204 YAPECLKEYK---FYYASDVWSFGVTLYELLT 232
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 58/295 (19%), Positives = 111/295 (37%), Gaps = 38/295 (12%)
Query: 143 PLCKSSSHRKSSKNVILLGVVLPLSVFIIAVLLALGIGLITRYRKGNTELSNIEVNMSPQ 202
P+ H + + G+++P + + ++ + Y+K +E + +
Sbjct: 6 PMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVH 65
Query: 203 AMWRRFSYQELLLATDHFSEKS--------LIGIGSFGTVYKGRFLDG----MEVAIKVF 250
+ + + S +IG G FG VY G LD + A+K
Sbjct: 66 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125
Query: 251 HLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL-VLEYMANGSLEKCLYSS 308
+ G + F E ++K H N++ ++ C L VL YM +G L + +
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185
Query: 309 NGILDIFQRLSIMIDVALALEYL---HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
+ + + VA +++L F VH D+ N +LD+ ++DFG+A
Sbjct: 186 THNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLA 239
Query: 366 KLLNGKESMRTQTLAT------------IEYGREGQVSPKSDVYGYGITLIETFT 408
+ + KE ++ + + KSDV+ +G+ L E T
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMT 291
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 58/201 (28%), Positives = 82/201 (40%), Gaps = 20/201 (9%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA---LKSFDAECEVLKSVR 272
FS+ IG GSFG VY R + VAIK + + E L+ +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
H N ++ + LV+EY GS L L + ++ L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT--------IEY 384
S+ ++H D+K N+LL + + L DFG A ++ S + T I
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----VGTPYWMAPEVILA 224
Query: 385 GREGQVSPKSDVYGYGITLIE 405
EGQ K DV+ GIT IE
Sbjct: 225 MDEGQYDGKVDVWSLGITCIE 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHR 274
+ F++ IG GSFG V+KG VAIK+ L + + ++ E VL
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
+ K S +++EY+ GS L G LD Q +I+ ++ L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH-- 136
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-----EYGREGQ 389
S +H DIK +NVLL + L+DFG+A L + R + T E ++
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 390 VSPKSDVYGYGITLIETFTKKKPTCEI 416
K+D++ GIT IE + P E+
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSEL 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 22/202 (10%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280
IG G FG V++G ++ + VAIK D + F E ++ H ++VK+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +++E G L L LD+ + ++ AL YL S V
Sbjct: 83 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT-------LA--TIEYGREGQVS 391
H DI NVL+ + L DFG+++ + + +A +I + R +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR---FT 195
Query: 392 PKSDVYGYGITLIETFTK-KKP 412
SDV+ +G+ + E KP
Sbjct: 196 SASDVWMFGVCMWEILMHGVKP 217
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 50/211 (23%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRNLV 277
+G G FG+V +G ++VA+K ++ D + ++ F +E +K H N++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 278 KIISSCSNGNFEA-----LVLEYMANGSL-----EKCLYSSNGILDIFQRLSIMIDVALA 327
+++ C + + ++L +M G L L + + + L M+D+AL
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA------- 380
+EYL + +H D+ N +L DDM ++DFG++K + + R +A
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 381 ---TIEYGREGQVSPKSDVYGYGITLIETFT 408
++ + KSDV+ +G+T+ E T
Sbjct: 217 AIESLADRV---YTSKSDVWAFGVTMWEIAT 244
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 40/210 (19%), Positives = 85/210 (40%), Gaps = 24/210 (11%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLK-SVRHRNLVK 278
F K ++G G+ GT+ D +VA+K + D E ++L+ S H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ + F+ + +E A +L++ + + + ++++ L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 339 VVHCDIKPSNVLL-----DDDMVAHLSDFGIAKLLNGKESMRTQTLAT-----------I 382
+VH D+KP N+L+ + A +SDFG+ K L ++ +
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ + D++ G ++
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 66/198 (33%), Positives = 93/198 (46%), Gaps = 32/198 (16%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285
IG G FG V G G +VA+K ++ D ++F AE V+ +RH NLV+++
Sbjct: 29 IGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 286 GNFEA-LVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
+V EYMA GSL L S +L L +DV A+EYL N VH D
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 344 IKPSNVLLDDDMVAHLSDFGIAKLL-----NGK--------ESMRTQTLATIEYGREGQV 390
+ NVL+ +D VA +SDFG+ K GK E+ + +
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA--------LREKK---F 191
Query: 391 SPKSDVYGYGITLIETFT 408
S KSDV+ +GI L E ++
Sbjct: 192 STKSDVWSFGILLWEIYS 209
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 38/214 (17%)
Query: 226 IGIGSFGTVYKGRF--------LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
+G G+F ++KG L EV +KV +SF ++ + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL---HFG 334
C G+ LV E++ GSL+ L + ++I +L + +A A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 335 YSNPVVHCDIKPSNVLLD--------DDMVAHLSDFGIAKLLNGKESMR-----TQTLA- 380
+H ++ N+LL + LSD GI+ + K+ ++
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV---PP 186
Query: 381 -TIEYGREGQVSPKSDVYGYGITLIETFTK-KKP 412
IE + ++ +D + +G TL E + KP
Sbjct: 187 ECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 33/235 (14%), Positives = 63/235 (26%), Gaps = 50/235 (21%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVFHLQF---DGALKSFDAECEVLKS---------- 270
++G + G + V + A+K E L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 271 ------------VRHRNLVKIISSCSNGN----FEALVLEYMANGSLEKCL------YSS 308
V+ K+I + L +L+ S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 309 NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368
+ L RL + + V L LH +VH ++P +++LD L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 369 N-GKESMRTQTLATIEY----------GREGQVSPKSDVYGYGITLIETFTKKKP 412
S + A E ++ D + G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 44/210 (20%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKI 279
+G G FG+V + + ++VA+K+ ++ F E +K H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 280 ISSCSNGNFEA------LVLEYMANGSLEKCLYSS-----NGILDIFQRLSIMIDVALAL 328
+ + ++L +M +G L L +S L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-------- 380
EYL S +H D+ N +L +DM ++DFG+++ + + R +
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 381 --TIEYGREGQVSPKSDVYGYGITLIETFT 408
++ + SDV+ +G+T+ E T
Sbjct: 208 LESLADNL---YTVHSDVWAFGVTMWEIMT 234
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 16/199 (8%)
Query: 226 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 280
IG G FG V++G ++ M VAIK D + F E ++ H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +++E G L L LD+ + ++ AL YL S V
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-SMRTQTLATI-----EYGREGQVSPKS 394
H DI NVL+ + L DFG+++ + ++ I E + + S
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 395 DVYGYGITLIETFTK-KKP 412
DV+ +G+ + E KP
Sbjct: 574 DVWMFGVCMWEILMHGVKP 592
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 43/210 (20%), Positives = 73/210 (34%), Gaps = 25/210 (11%)
Query: 217 TDHFSEKSLIGIG--SFGTVYKGRFLD-GMEVAIKVFHL--QFDGALKSFDAECEVLKSV 271
+ ++IG G TV R+ G V ++ +L + + E V K
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL-YSSNGILDIFQRLSIMIDVALALEY 330
H N+V ++ N +V +MA GS + + ++ I+ V AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREG-- 388
+H VH +K S++L+ D +LS + + +
Sbjct: 144 IH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR-VVHDFPKYSVKVL 199
Query: 389 -------------QVSPKSDVYGYGITLIE 405
KSD+Y GIT E
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 36/134 (26%), Positives = 63/134 (47%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L+L N+L + + F + + S D N+++ P + + ++ +NL N L+
Sbjct: 29 VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQL 88
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
T TNL L L +N +Q F + +L +LDLS N LS + +L L+
Sbjct: 89 SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQ 148
Query: 121 DLNLSFNRLKGDIP 134
+L LS N+++
Sbjct: 149 ELLLSNNKIQALKS 162
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-26
Identities = 28/149 (18%), Positives = 53/149 (35%), Gaps = 9/149 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLN--------GSLPLDIENMKVVVEINLS 53
L L +N ++++ L + D N+L G ++ + + +NL
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 54 RNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISL 113
N L L+++ L N L F SL+SL+L N ++ V
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 114 EK-LVYLKDLNLSFNRLKGDIPTRSPHLQ 141
L +L++ FN + + +
Sbjct: 605 GPAFRNLTELDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 39/144 (27%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 2 LSLGSNELSSV--IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT- 58
L L L +V PS F L ++ D S+N++ +E ++ + ++L N L
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
Query: 59 -------GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPI 111
G + GL++L +L+LE+N E F +L L+ +DL +NNL+ +
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 112 SLEKLVYLKDLNLSFNRLKGDIPT 135
V LK LNL N +
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKK 602
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 31/135 (22%), Positives = 52/135 (38%), Gaps = 2/135 (1%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L +G N +S + P L + + N L+ + E++L N +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP--ISLEKLVYL 119
NL L L +N L + +L +L+ L LS N + + + + L
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 120 KDLNLSFNRLKGDIP 134
K L LS N++K P
Sbjct: 174 KKLELSSNQIKEFSP 188
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 26/133 (19%), Positives = 51/133 (38%), Gaps = 3/133 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+L+ V N+ + + + N L + + +++ N ++
Sbjct: 9 ADCSHLKLTQVPDDLPTNITVL---NLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P L L++L+L++N L ++F T+L L L N++ + K L
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 122 LNLSFNRLKGDIP 134
L+LS N L
Sbjct: 126 LDLSHNGLSSTKL 138
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 39/141 (27%), Positives = 58/141 (41%), Gaps = 5/141 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI---ENMKVVVEINLSRNYLT 58
L L SN++ P F + + ++ L SL + + ++LS + L+
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 59 GDIPPTIGGL--TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKL 116
T GL TNL +L L N L +SF L LE L NN+ + SL L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 117 VYLKDLNLSFNRLKGDIPTRS 137
++ LNL + K I S
Sbjct: 296 FNVRYLNLKRSFTKQSISLAS 316
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 11/148 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLN--SILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT 58
NLSL +++LS+ +TF L ++ D S N+LN + + L N +
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 59 GDIPPTIGGLTNLQLLSLENN---------RLQGPIPESFGELTSLESLDLSVNNLSGVI 109
++ GL N++ L+L+ + L SF L LE L++ N++ G+
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 110 PISLEKLVYLKDLNLSFNRLKGDIPTRS 137
L+ LK L+LS + T
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNE 373
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 29/139 (20%), Positives = 60/139 (43%), Gaps = 5/139 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L SN + + + F ++++ D S N L+ + ++ + E+ LS N +
Sbjct: 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161
Query: 62 PPTIG--GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISL---EKL 116
+ ++L+ L L +N+++ P F + L L L+ L + L
Sbjct: 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN 221
Query: 117 VYLKDLNLSFNRLKGDIPT 135
+++L+LS ++L T
Sbjct: 222 TSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-21
Identities = 30/140 (21%), Positives = 56/140 (40%), Gaps = 7/140 (5%)
Query: 2 LSLGSNELS--SVIPSTFWNL--NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYL 57
LSL ++ S ++ TF +L + + + + N ++ + + ++L N +
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 58 TGDIPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV--IPISLE 114
++ GL N+ + L N+ SF + SL+ L L L V P +
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 115 KLVYLKDLNLSFNRLKGDIP 134
L L L+LS N +
Sbjct: 478 PLRNLTILDLSNNNIANIND 497
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 23/146 (15%), Positives = 49/146 (33%), Gaps = 9/146 (6%)
Query: 2 LSLGSNELSSV--------IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLS 53
L L N L+ + L+ + + SN + +++ + I+L
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568
Query: 54 RNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGE-LTSLESLDLSVNNLSGVIPIS 112
N L +L+ L+L+ N + + FG +L LD+ N
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI 628
Query: 113 LEKLVYLKDLNLSFNRLKGDIPTRSP 138
+ ++ + + + L +P
Sbjct: 629 AWFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 12/66 (18%), Positives = 29/66 (43%), Gaps = 3/66 (4%)
Query: 69 TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNR 128
+ ++ + +L +P+ T++ L+L+ N L + + + L L++ FN
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 129 LKGDIP 134
+ P
Sbjct: 61 ISKLEP 66
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 26/241 (10%)
Query: 198 NMSPQAMWRRFSYQELLLATD---HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ 253
+M+ + R +L D F L+G G++G VYKGR + G AIKV +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 254 FDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEA------LVLEYMANGSLEKCL- 305
D + E +LK HRN+ + N LV+E+ GS+ +
Sbjct: 61 GD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 306 YSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
+ L I ++ L +LH + V+H DIK NVLL ++ L DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 366 KLLNGKESMRTQTLAT----------IEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415
L+ R + T + + KSD++ GIT IE P C+
Sbjct: 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
Query: 416 I 416
+
Sbjct: 237 M 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 51/233 (21%), Positives = 91/233 (39%), Gaps = 49/233 (21%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSV-R 272
T F E IG G FG+V+K LDG AIK G++ +A E + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF---QRLSIMIDVALALE 329
H ++V+ S+ + + + EY GSL + + I+ F + +++ V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDD-------------------MVAHLSDFGIAKLLNG 370
Y+H S +VH DIKPSN+ + ++ + D G ++
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185
Query: 371 KESMRTQT-----LA------TIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
S + + LA + PK+D++ +T++ +
Sbjct: 186 --SPQVEEGDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPL 230
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 27/156 (17%), Positives = 52/156 (33%), Gaps = 17/156 (10%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNG-------SLPLDIENMKVVVEINLSR 54
++L +N++S F + + S + N L + +N ++ I+L
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497
Query: 55 NYLTGDIPPTI--GGLTNLQLLSLENNRLQGPIPESFGELTSLESL------DLSVNNLS 106
N LT + L L + L N P ++L+ D N
Sbjct: 498 NKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
Query: 107 GVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQV 142
P + L L + N ++ +P++ V
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISV 591
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 30/146 (20%), Positives = 62/146 (42%), Gaps = 17/146 (11%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP--LDIENMKVVVEINLSRNYLTG 59
L+L N+++ + + + + F+ N L +P D +++ V+ I+ S N +
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGS 416
Query: 60 -------DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV---- 108
+ PT N+ ++L NN++ E F + L S++L N L+ +
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476
Query: 109 ---IPISLEKLVYLKDLNLSFNRLKG 131
+ + L ++L FN+L
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 27/159 (16%), Positives = 51/159 (32%), Gaps = 13/159 (8%)
Query: 2 LSLGSNELSSV--------IPSTFWNLNSILSFDFSSNSL-NGSLPLDIENMKVVVEINL 52
+++ N S + I N+L + ++ MK + +
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 53 SRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPIS 112
N L G P G L L+L N++ G +E+L + N L IP
Sbjct: 338 LYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNI 395
Query: 113 LE--KLVYLKDLNLSFNRLKGDIPTRSPHLQVPLCKSSS 149
+ + + ++ S+N + L K +
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 30/149 (20%), Positives = 49/149 (32%), Gaps = 20/149 (13%)
Query: 2 LSLGSNELSSV-------IPSTFWNLNSILSFDFSSNSLNGSLPLDIE--NMKVVVEINL 52
++L N L+ + F N + S D N L L D + +V I+L
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDL 520
Query: 53 SRNYLTGDIPPTIGGLTNLQLLSLEN------NRLQGPIPESFGELTSLESLDLSVNNLS 106
S N + P + L+ + N NR PE SL L + N++
Sbjct: 521 SYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579
Query: 107 GVIPISLEKLVYLKDLNLSFNRLKGDIPT 135
V + L++ N +
Sbjct: 580 KVNEKITPNISV---LDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 15/144 (10%), Positives = 40/144 (27%), Gaps = 15/144 (10%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+ SN ++ + L + F ++ + + N
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE-----NSEYAQQYKT 240
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL--------SGVIPIS 112
L +L + + N +P L ++ ++++ N
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300
Query: 113 LEKLVYLKDLNLSFNRLK-GDIPT 135
++ + + +N LK + T
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVET 324
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 32/155 (20%), Positives = 50/155 (32%), Gaps = 22/155 (14%)
Query: 2 LSLGSNELSSV-------IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSR 54
+ NE+ SV + T + ++ S + S+N ++ + INL
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466
Query: 55 NYLTG-------DIPPTIGGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSVNNLS 106
N LT D L + L N+L + L L +DLS N+ S
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS 526
Query: 107 GVIPISLEKLVYLKDL------NLSFNRLKGDIPT 135
P LK + NR + P
Sbjct: 527 K-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-20
Identities = 21/135 (15%), Positives = 46/135 (34%), Gaps = 11/135 (8%)
Query: 2 LSLGSNELSSVIPS-TFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEI------NLSR 54
+ L N+L+ + L ++ D S NS + P N + +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 55 NYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE 114
N + P I +L L + +N ++ + E ++ LD+ N + +
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVC 608
Query: 115 KLVYLKDLNLSFNRL 129
+ L +++
Sbjct: 609 PYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 18/147 (12%), Positives = 42/147 (28%), Gaps = 7/147 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNG----SLPLDIENMKVVVEINLSRNY 56
LSL S +P L + S+ P I + R +
Sbjct: 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144
Query: 57 LTGDIPPTIGGL--TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE 114
++L + ++ Q I +S + NN++ + ++
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVM 203
Query: 115 KLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
+L L+ + + + + +
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENE 230
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 18/117 (15%), Positives = 40/117 (34%), Gaps = 6/117 (5%)
Query: 25 SFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGP 84
+F+ + + + + V ++L +G +P IG LT L++L+L ++ +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 85 ----IPESFGELTSLESLDLSVNNLSGVIP--ISLEKLVYLKDLNLSFNRLKGDIPT 135
P+ S E + E L ++ + + I
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 12/140 (8%), Positives = 37/140 (26%), Gaps = 7/140 (5%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
N + + + + + + +G +P I + + + L + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 61 ----IPPTIGGLTNLQLLSLENNRLQGPIPESFG--ELTSLESLDLSVNNLSGVIPISLE 114
P I + + Q + + + L ++ + I S
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 115 KLVYLKDLNLSFNRLKGDIP 134
+ + N + +
Sbjct: 181 ITLKDTQIGQLSNNITF-VS 199
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 16/111 (14%), Positives = 33/111 (29%), Gaps = 10/111 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSF------DFSSNSLNGSLPLDIENMKVVVEINLSRN 55
+ L N S P+ N +++ F D N P I + ++ + N
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576
Query: 56 YLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS 106
+ + I N+ +L +++N L +
Sbjct: 577 DIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 15/82 (18%), Positives = 27/82 (32%), Gaps = 4/82 (4%)
Query: 64 TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSG----VIPISLEKLVYL 119
++ + LSLE G +P++ G+LT LE L L + P + +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 120 KDLNLSFNRLKGDIPTRSPHLQ 141
+ + P
Sbjct: 136 EQKQKMRMHYQKTFVDYDPRED 157
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 26/231 (11%), Positives = 56/231 (24%), Gaps = 50/231 (21%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKII 280
+ +G V+ R ++ + A+KVF + + L+ + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 281 SSCSNGNFEA--------------------------LVLEYMA-----NGSLEKCLYSSN 309
L++ + S +Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 310 GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369
G I + + L S +VH P N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 370 GKESMRTQTLATIEY--------GREGQVSPKSDVYGYGITLIETFTKKKP 412
K R + + + + G+++ + P
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 15/170 (8%)
Query: 218 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRN 275
+ ++G G+ V++GR G AIKVF+ + F + E EVLK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 276 LVK---IISSCSNGNFEALVLEYMANGSLEKCLYS--SNGILDIFQRLSIMIDVALALEY 330
+VK I + + L++E+ GSL L + L + L ++ DV + +
Sbjct: 69 IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 331 LHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLNGKESMRT 376
L N +VH +IKP N++ D V L+DFG A+ L E +
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 44/209 (21%), Positives = 81/209 (38%), Gaps = 32/209 (15%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVK 278
+G GSFG VY+G VAIK + F E V+K ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 279 IISSCSNGNFEALVLEYMANGSL---------EKCLYSSNGILDIFQRLSIMIDVALALE 329
++ S G +++E M G L + + + + ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA--------- 380
YL+ +N VH D+ N ++ +D + DFG+ + + + R
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 381 -TIEYGREGQVSPKSDVYGYGITLIETFT 408
+++ G + SDV+ +G+ L E T
Sbjct: 210 ESLKDGV---FTTYSDVWSFGVVLWEIAT 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRN 275
D + + +IG G+ V +VAIK +L + ++ E + + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 276 LVKIISSCSNGNFEALVLEYMANGSL-------EKCLYSSNGILDIFQRLSIMIDVALAL 328
+V +S + LV++ ++ GS+ +G+LD +I+ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI-AKLLNGKESMRTQTLAT------ 381
EYLH N +H D+K N+LL +D ++DFG+ A L G + R + T
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 382 ------IEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416
+E + K+D++ +GIT IE T P +
Sbjct: 192 WMAPEVME--QVRGYDFKADIWSFGITAIELATGAAPYHKY 230
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 43/180 (23%), Positives = 73/180 (40%), Gaps = 12/180 (6%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLK 269
Q + L + ++ G F VY+ + + G E A+K + ++ E +K
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 270 SVR-HRNLVKIISSCS-------NGNFEALVLEYMANGSLEKCL--YSSNGILDIFQRLS 319
+ H N+V+ S+ S G E L+L + G L + L S G L L
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 320 IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL 379
I A++++H P++H D+K N+LL + L DFG A ++
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 41/185 (22%), Positives = 78/185 (42%), Gaps = 27/185 (14%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVL-KSVRHRNL 276
+ + ++G GS GTV G VA+K + F E ++L +S H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 277 VKIISSCSNGNFEALVLEYMANGSLE------KCLYSSNGILDIFQRLSIMIDVALALEY 330
++ S + F + LE N +L+ + + + +S++ +A + +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 331 LHFGYSNPVVHCDIKPSNVLLD-------------DDMVAHLSDFGIAKLLNGKESMRTQ 377
LH S ++H D+KP N+L+ +++ +SDFG+ K L+ +S
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 378 TLATI 382
L
Sbjct: 188 NLNNP 192
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 15/170 (8%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRN 275
+ ++G G+ V++GR G AIKVF+ + F + E EVLK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 276 LVK---IISSCSNGNFEALVLEYMANGSLEKCLYS--SNGILDIFQRLSIMIDVALALEY 330
+VK I + + L++E+ GSL L + L + L ++ DV + +
Sbjct: 69 IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 331 LHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLNGKESMRT 376
L N +VH +IKP N++ D V L+DFG A+ L E +
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA-LKSFDAECEVLKSVR 272
L D F + S +G G+ G V+K G+ +A K+ HL+ A E +VL
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
+V + + ++ +E+M GSL++ + G + + I V L YL
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY-----GRE 387
+ ++H D+KPSN+L++ L DFG++ L +SM + T Y +
Sbjct: 149 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQG 204
Query: 388 GQVSPKSDVYGYGITLIETFTKKKP 412
S +SD++ G++L+E + P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 279
+G G+FG V+ + M VA+K A K F E E+L +++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 280 ISSCSNGNFEALVLEYMANGSL---------------EKCLYSSNGILDIFQRLSIMIDV 324
C +G+ +V EYM +G L + + G L + Q L I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA---- 380
A + YL S VH D+ N L+ +++ + DFG+++ + + R
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 381 ------TIEYGREGQVSPKSDVYGYGITLIETFT 408
+I Y + + +SDV+ +G+ L E FT
Sbjct: 200 RWMPPESIMYRK---FTTESDVWSFGVILWEIFT 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 27/236 (11%), Positives = 66/236 (27%), Gaps = 51/236 (21%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKS----------------------- 260
++G + G + V + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 261 -----FDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM-ANGSLEKCL------YSS 308
F +++K + + ++++ + + Y +L+ S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 309 NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368
+ L RL + + V L LH +VH ++P +++LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 369 NGK------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ E + + R ++ D + G+ + + P
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 16/173 (9%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHR 274
+ K +G G FG V + G +VAIK + + + E +++K + H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 275 NLVKII------SSCSNGNFEALVLEYMANGSLEKCL--YSSNGILDIFQRLSIMIDVAL 326
N+V + + L +EY G L K L + + L +++ D++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLD---DDMVAHLSDFGIAKLLNGKESMRT 376
AL YLH N ++H D+KP N++L ++ + D G AK L+ E
Sbjct: 133 ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 38/212 (17%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 275
+G G+FG VY+G+ ++VA+K + F E ++ H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSS------NGILDIFQRLSIMIDVALALE 329
+V+ I +++E MA G L+ L + L + L + D+A +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 330 YL---HFGYSNPVVHCDIKPSNVLLD---DDMVAHLSDFGIAKLLNGKESMRTQTLATI- 382
YL HF +H DI N LL VA + DFG+A+ + R A +
Sbjct: 155 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 383 ------EYGREGQVSPKSDVYGYGITLIETFT 408
E EG + K+D + +G+ L E F+
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 36/213 (16%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 279
+G G+FG V+ + M VA+K + A + F E E+L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 280 ISSCSNGNFEALVLEYMANGSL--------------EKCLYSSNGILDIFQRLSIMIDVA 325
C+ G +V EYM +G L + G L + Q L++ VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 326 LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA----- 380
+ YL VH D+ N L+ +V + DFG+++ + + R
Sbjct: 169 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 381 -----TIEYGREGQVSPKSDVYGYGITLIETFT 408
+I Y + + +SDV+ +G+ L E FT
Sbjct: 226 WMPPESILYRK---FTTESDVWSFGVVLWEIFT 255
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 45/266 (16%), Positives = 83/266 (31%), Gaps = 31/266 (11%)
Query: 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGALKSFDAEC 265
E L + L+G G+F VY+ D + +KV
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 266 EVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL----EKCLYSSNGILDIFQRLSIM 321
E LK +K S+ N LV E + G+L + ++ +S
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH-----------LSDFGIAKLLN- 369
+ + +E +H ++H DIKP N +L + + L D G + +
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 370 -GKESMRTQTLATIEYG----REGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL 423
K ++ T T + + + + D +G T+ + E
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295
Query: 424 KNWVNDFLPISVMNVVDTSLLRREDK 449
+ + + N +L D
Sbjct: 296 EGLFRRLPHLDMWNEFFHVMLNIPDC 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 38/212 (17%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 275
+G G+FG VY+G+ ++VA+K + F E ++ H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSS------NGILDIFQRLSIMIDVALALE 329
+V+ I ++LE MA G L+ L + L + L + D+A +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 330 YL---HFGYSNPVVHCDIKPSNVLLD---DDMVAHLSDFGIAKLLNGKESMRTQTLATI- 382
YL HF +H DI N LL VA + DFG+A+ + R A +
Sbjct: 196 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 249
Query: 383 ------EYGREGQVSPKSDVYGYGITLIETFT 408
E EG + K+D + +G+ L E F+
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 50/221 (22%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 275
+G FG VYKG VAIK D A + F E + ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 276 LVKIISSCSNGNFEALVLEYMANGSL---------------EKCLYSSNGILDIFQRLSI 320
+V ++ + +++ Y ++G L + L+ + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 321 MIDVALALEYL---HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
+ +A +EYL H VH D+ NVL+ D + +SD G+ + + + +
Sbjct: 134 VAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 378 TLA----------TIEYGREGQVSPKSDVYGYGITLIETFT 408
+ I YG+ S SD++ YG+ L E F+
Sbjct: 188 GNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFS 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 46/221 (20%), Positives = 92/221 (41%), Gaps = 47/221 (21%)
Query: 226 IGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-R 272
+G G+FG V + + VA+K+ D A L +E E++K + +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSL---------------EKCLYSSNGILDIFQR 317
H+N++ ++ +C+ +++EY + G+L +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
+S +A +EYL S +H D+ NVL+ ++ V ++DFG+A+ +N + +
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 378 TLA----------TIEYGREGQVSPKSDVYGYGITLIETFT 408
T + + +SDV+ +G+ + E FT
Sbjct: 217 TNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIFT 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 6e-23
Identities = 48/189 (25%), Positives = 85/189 (44%), Gaps = 14/189 (7%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 280
L+G GSF VY+ + G+EVAIK+ + G ++ E ++ ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ + N+ LVLE NG + + L + + M + + YLH S+ ++
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY------GREGQVSPKS 394
H D+ SN+LL +M ++DFG+A L T Y R +S
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GLES 193
Query: 395 DVYGYGITL 403
DV+ G
Sbjct: 194 DVWSLGCMF 202
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 29/129 (22%), Positives = 49/129 (37%), Gaps = 1/129 (0%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L + F L S+ + + NS + ++ N + ++LS+ L
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
L LQLL++ +N L + +L SL +LD S N + I L
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548
Query: 121 DLNLSFNRL 129
NL+ N +
Sbjct: 549 FFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 2/136 (1%)
Query: 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L + L V S F +L +L D S + + + + ++ N +
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
TNL L L +L+ F L L+ L++S NNL + +L L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
Query: 120 KDLNLSFNRLKGDIPT 135
L+ SFNR++
Sbjct: 524 STLDCSFNRIETSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-22
Identities = 28/132 (21%), Positives = 56/132 (42%), Gaps = 1/132 (0%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
N+ L N L + +F N + + D S + + + + L+ N +
Sbjct: 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF 95
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYL 119
P + GLT+L+ L +L G+L +L+ L+++ N + +P L L
Sbjct: 96 SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNL 155
Query: 120 KDLNLSFNRLKG 131
++LS+N ++
Sbjct: 156 VHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 35/130 (26%), Positives = 53/130 (40%), Gaps = 3/130 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+LS V + +I D S N L N + ++LSR +
Sbjct: 16 YQCMDQKLSKVPDDIPSSTKNI---DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
GL +L L L N +Q P SF LTSLE+L L+ + + +L+ LK
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132
Query: 122 LNLSFNRLKG 131
LN++ N +
Sbjct: 133 LNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 27/134 (20%), Positives = 53/134 (39%), Gaps = 5/134 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L E+ ++ + L+ + + + N + P + + + L
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 62 PPTIGGLTNLQLLSLENNRLQG-PIPESFGELTSLESLDLSVNNLSGVIPISLEKL---- 116
IG L L+ L++ +N + +P F LT+L +DLS N + + L+ L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 117 VYLKDLNLSFNRLK 130
L++S N +
Sbjct: 181 QVNLSLDMSLNPID 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 32/131 (24%), Positives = 46/131 (35%), Gaps = 9/131 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L S F L ++ + + S+ D+ +++ R L
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-Q 321
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE--KLVY 118
P L L+ L+L N+ I L SL LDLS N LS S
Sbjct: 322 FPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377
Query: 119 LKDLNLSFNRL 129
L+ L+LSFN
Sbjct: 378 LRHLDLSFNGA 388
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 21/106 (19%), Positives = 37/106 (34%), Gaps = 1/106 (0%)
Query: 2 LSLGSNELSSVIPS-TFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L + N S F N ++ D S L + + + +N+S N L
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS 106
L +L L NR++ SL +L+ N+++
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 25/142 (17%), Positives = 52/142 (36%), Gaps = 14/142 (9%)
Query: 2 LSLGSNELSSVIPSTFWNL----NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYL 57
+ L N + ++ + L LS D S N ++ + +K+ E+ L N+
Sbjct: 158 VDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLH-ELTLRGNFN 216
Query: 58 TGDIPPT-IGGLTNLQLLSL------ENNRLQGPIPESFGELTSL--ESLDLSVNNLSGV 108
+ +I T + L L + L + L+ P L + + L+ N
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 109 IPISLEKLVYLKDLNLSFNRLK 130
+ L + ++L+ +K
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIK 298
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 25/141 (17%), Positives = 49/141 (34%), Gaps = 13/141 (9%)
Query: 2 LSLGSNELSSV-IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMK----VVVEINLSRNY 56
L++ N + S +P+ F NL +++ D S N + D++ ++ V + +++S N
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
Query: 57 LTGDIPPTIGGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSVNNLSGVIPIS--- 112
+ I L L+L N I + L L L + +
Sbjct: 193 IDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 113 ---LEKLVYLKDLNLSFNRLK 130
+E L +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTN 272
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 19/150 (12%), Positives = 50/150 (33%), Gaps = 12/150 (8%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD-IENMKVVVEINLSRNYLTGD 60
L + N + + F + + N + ++ ++N+ + L +
Sbjct: 186 LDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244
Query: 61 I------PPTIGGLTNLQL--LSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPIS 112
P + GL ++ + L F L ++ ++ L+ ++ +
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--ED 302
Query: 113 LEKLVYLKDLNLSFNRLKGDIPTRSPHLQV 142
+ K + L++ +LK P L+
Sbjct: 303 VPKHFKWQSLSIIRCQLKQFPTLDLPFLKS 332
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-23
Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 46/223 (20%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 275
+G G FG V K VA+K+ + A L+ +E VLK V H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 276 LVKIISSCSNGNFEALVLEYMANGSL-----------------------EKCLYSSNGIL 312
++K+ +CS L++EY GSL + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 313 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372
+ +S ++ ++YL +VH D+ N+L+ + +SDFG+++ + ++
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 373 SMRTQTLA-------TIEYGREGQVSPKSDVYGYGITLIETFT 408
S ++ IE + + +SDV+ +G+ L E T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 24/130 (18%), Positives = 45/130 (34%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L N L ++ +TF L ++ D + + ++ + + L+ N L
Sbjct: 38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ G L+ L + +LESL L N++S + LK
Sbjct: 98 ETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKV 157
Query: 122 LNLSFNRLKG 131
L+ N +
Sbjct: 158 LDFQNNAIHY 167
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-22
Identities = 27/134 (20%), Positives = 55/134 (41%), Gaps = 4/134 (2%)
Query: 1 NLSLGSNELSSVIPSTFWNL--NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT 58
+ + + P+ F L S+ S + + + E++L+ +L+
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVI-PISLEKLV 117
++P + GL+ L+ L L N+ + S SL L + N + LE L
Sbjct: 292 -ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 118 YLKDLNLSFNRLKG 131
L++L+LS + ++
Sbjct: 351 NLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 3/130 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ + L+ + + + + +FS N L + + ++L+R +
Sbjct: 17 YNCENLGLNEIPGTLPNSTECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
T L L L N L + +L+ L +S + I L L+
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 122 LNLSFNRLKG 131
L L N +
Sbjct: 134 LYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 4/137 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD-IENMKVVVEINLSRNYLT-- 58
L L +N+ ++ + N S+ N+ L +EN++ + E++LS + +
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPIS-LEKLV 117
+ L++LQ L+L N E+F E LE LDL+ L S + L
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 118 YLKDLNLSFNRLKGDIP 134
LK LNLS + L
Sbjct: 426 LLKVLNLSHSLLDISSE 442
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 24/145 (16%), Positives = 49/145 (33%), Gaps = 4/145 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L ++ + TF + + + + ++N L + K + + + ++
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK- 120
+ L+ L L +N + L+ LD N + + + L
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 121 -DLNLSFNRLKGDIPT--RSPHLQV 142
LNL+ N + G P S Q
Sbjct: 182 LSLNLNGNDIAGIEPGAFDSAVFQS 206
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 33/150 (22%), Positives = 54/150 (36%), Gaps = 9/150 (6%)
Query: 1 NLSLGSNELSSVIPS--TFWNLNSILSFDFSSNSLNGSLPLDIENMKV--VVEINLSRNY 56
+L+ G + VI + S+ F P E + V INL ++Y
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 57 LTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKL 116
T + LQ L L L +P L++L+ L LS N + IS
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 117 VYLKDLNLSFNRLKGDIPTRS----PHLQV 142
L L++ N + ++ T +L+
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRE 354
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-20
Identities = 32/138 (23%), Positives = 56/138 (40%), Gaps = 5/138 (3%)
Query: 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L L S F NL+ + + S + L+ S + + + +NL N+
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 61 I---PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
++ L L++L L L +F L + +DLS N L+ +L L
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
Query: 118 YLKDLNLSFNRLKGDIPT 135
+ LNL+ N + +P+
Sbjct: 525 GIY-LNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 27/134 (20%), Positives = 51/134 (38%), Gaps = 4/134 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD---IENMKVVVEINLSRNYLT 58
L+L + L F L ++ + N ++ + + + LS L+
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
L + + L +NRL E+ L + L+L+ N++S ++P L L
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQ 548
Query: 119 LKDLNLSFNRLKGD 132
+ +NL N L
Sbjct: 549 QRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 4/144 (2%)
Query: 2 LSLGSNELSSVIPS-TFWNLNSILSFDFSSNSLNGS--LPLDIENMKVVVEINLSRNYLT 58
LS+ N + + NL ++ D S + + S L + N+ + +NLS N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPISLEKLV 117
L+LL L RL+ +S F L L+ L+LS + L + L
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 118 YLKDLNLSFNRLKGDIPTRSPHLQ 141
L+ LNL N ++ LQ
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQ 473
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 20/133 (15%), Positives = 40/133 (30%), Gaps = 5/133 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L +SS+ N ++ S SN ++ + + ++ N +
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 62 PPTIGGLTNLQL--LSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE--KLV 117
+ L L+L N + G I + +SL+ VI L+ +
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 118 YLKDLNLSFNRLK 130
L +
Sbjct: 229 SLWLGTFEDMDDE 241
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 7e-23
Identities = 25/156 (16%), Positives = 51/156 (32%), Gaps = 17/156 (10%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSL-------NGSLPLDIENMKVVVEINLSR 54
++L NE+ F + I + S+N + + +N ++ I+L
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRF 737
Query: 55 NYLTGDIPPTI--GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDL------SVNNLS 106
N LT + L L + + N P + L++ + N +
Sbjct: 738 NKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRIL 795
Query: 107 GVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQV 142
P + L L + N ++ +P L +
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYI 831
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 2e-21
Identities = 26/146 (17%), Positives = 55/146 (37%), Gaps = 17/146 (11%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP--LDIENMKVVVEINLSRNYLT 58
+L L N++ + + + FS N L +P + +++ V+ ++ S N +
Sbjct: 599 DLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 59 GDIPPTIGG------LTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS------ 106
I N ++L N +Q E F + + ++ LS N ++
Sbjct: 658 S-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716
Query: 107 -GVIPISLEKLVYLKDLNLSFNRLKG 131
+ + L ++L FN+L
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 2e-20
Identities = 27/156 (17%), Positives = 57/156 (36%), Gaps = 21/156 (13%)
Query: 2 LSLGSNELSSV-------IPSTFWNLNSILSFDFSSNSLNGSLPLDIE--NMKVVVEINL 52
+ L +N ++S+ + N + + D N L SL D + + +++
Sbjct: 702 IILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDV 760
Query: 53 SRNYLTGDIPPTIGGLTNLQLLSLE------NNRLQGPIPESFGELTSLESLDLSVNNLS 106
S N + P + L+ + NR+ P SL L + N++
Sbjct: 761 SYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR 819
Query: 107 GVIPISLEKLVYLKDLNLSFNRLK-GDIPTRSPHLQ 141
V +L L+++ N D+ + P+++
Sbjct: 820 KVDEKLTPQLYI---LDIADNPNISIDVTSVCPYIE 852
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 17/140 (12%), Positives = 44/140 (31%), Gaps = 15/140 (10%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+ +N ++ I L + F+++ + N +
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE-----DANSDYAKQYEN 482
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV---------IPI 111
+ L +L + L N +P+ +L L+SL+++ N +
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 112 SLEKLVYLKDLNLSFNRLKG 131
+ ++ + +N L+
Sbjct: 543 DEDTGPKIQIFYMGYNNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 22/157 (14%), Positives = 51/157 (32%), Gaps = 13/157 (8%)
Query: 2 LSLGSNELSSV---------IPSTFWNLNSILSFDFSSNSLNG-SLPLDIENMKVVVEIN 51
L++ N S + I F N+L ++ M + ++
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579
Query: 52 LSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV-IP 110
N + G L L L+ N+++ + +E L S N L +
Sbjct: 580 CVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNI 637
Query: 111 ISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQVPLCKS 147
+ + + + ++ S+N++ + S + +
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 19/143 (13%), Positives = 49/143 (34%), Gaps = 7/143 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+ + E+ + + +L +N + + I+ + + I + + T D
Sbjct: 406 DAINRNPEMKPIKKDSRISLKD-TQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYD 463
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ + + + + S+ L L ++L +P L L L+
Sbjct: 464 NIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518
Query: 121 DLNLSFNRLKGDIPTRSPHLQVP 143
LN++ NR ++ ++
Sbjct: 519 SLNIACNRGISAAQLKADWTRLA 541
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 24/135 (17%), Positives = 48/135 (35%), Gaps = 11/135 (8%)
Query: 2 LSLGSNELSSVIPS-TFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSR------ 54
+ L N+L+S+ L + + D S N + S P N + +
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEG 791
Query: 55 NYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE 114
N + P I +L L + +N ++ + E L LD++ N + S+
Sbjct: 792 NRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVC 848
Query: 115 KLVYLKDLNLSFNRL 129
+ L +++
Sbjct: 849 PYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 9e-14
Identities = 24/132 (18%), Positives = 48/132 (36%), Gaps = 7/132 (5%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
N S +++ I S WN N + +D++N V ++L+ G
Sbjct: 285 NWRYYSGTINNTIHSLNWNFNK------ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVI-PISLEKLVYL 119
+P IG LT L++LS + E + + + + + + L+ L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 120 KDLNLSFNRLKG 131
+L + +
Sbjct: 399 NLSDLLQDAINR 410
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 12/86 (13%), Positives = 31/86 (36%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
N + + + LSL +G +P++ G+LT L+ L ++ +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 109 IPISLEKLVYLKDLNLSFNRLKGDIP 134
+ ++ + +R++
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYK 388
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 15/164 (9%), Positives = 42/164 (25%), Gaps = 29/164 (17%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
N + + N + + G +P I + + ++ + T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGE-LTSLESLDLSVNNLSGV----------- 108
+ +R++ + F + L DL + ++
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 109 -----------------IPISLEKLVYLKDLNLSFNRLKGDIPT 135
I ++++L L+ + + + D
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA 466
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 17/112 (15%), Positives = 36/112 (32%), Gaps = 10/112 (8%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSF------DFSSNSLNGSLPLDIENMKVVVEINLSR 54
N+ + N SS P+ N + + +F D N + P I ++++ +
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 55 NYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS 106
N + + + L +L + +N S L +
Sbjct: 816 NDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA-LKSFDAECEV-LKSV 271
+ D +G G++G V K R + G +A+K + K + ++ +++V
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL---YSSNGILDIFQRLSIMIDVALAL 328
V + + +E M + SL+K + I + + AL
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-TIEY--- 384
E+LH S V+H D+KPSNVL++ + DFGI+ L + + A Y
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAP 178
Query: 385 ------GREGQVSPKSDVYGYGITLIE 405
+ S KSD++ GIT+IE
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 41/218 (18%)
Query: 226 IGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-R 272
+G G+FG V + +VA+K+ A L +E E++K + +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSL---------------EKCLYSSNGILDIFQR 317
H+N++ ++ +C+ +++EY + G+L ++ L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
+S VA +EYL S +H D+ NVL+ +D V ++DFG+A+ ++ + +
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 378 TLA-------TIEYGREGQVSPKSDVYGYGITLIETFT 408
T E + + +SDV+ +G+ L E FT
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 280
+G G FG VY R +A+KV L+ G E E+ +RH N++++
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ L+LEY G++ + L D + + + ++A AL Y H S V+
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRVI 131
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY 384
H DIKP N+LL ++DFG + S R L T++Y
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDY 173
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 46/221 (20%), Positives = 91/221 (41%), Gaps = 47/221 (21%)
Query: 226 IGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-R 272
+G G FG V + + VA+K+ D A L +E E++K + +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSL---------------EKCLYSSNGILDIFQR 317
H+N++ ++ +C+ +++EY + G+L +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
+S +A +EYL S +H D+ NVL+ ++ V ++DFG+A+ +N + +
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 378 TLA----------TIEYGREGQVSPKSDVYGYGITLIETFT 408
T + + +SDV+ +G+ + E FT
Sbjct: 263 TNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 41/218 (18%)
Query: 226 IGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHR 274
+G G+FG V + M VA+K+ A ++ +E +VL + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSL-----------------EKCLYSSNGILDIFQR 317
N+V ++ +C+ G ++ EY G L + LD+
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
LS VA + +L S +H D+ N+LL + + DFG+A+ + + +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 378 TLA-------TIEYGREGQVSPKSDVYGYGITLIETFT 408
A E + +SDV+ YGI L E F+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 44/183 (24%), Positives = 74/183 (40%), Gaps = 39/183 (21%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA---------ECE 266
+++ K ++G G V + E A+K+ + G+ + + E +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 267 VLKSV-RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL------- 318
+L+ V H N++++ + F LV + M G L F L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLS 122
Query: 319 -----SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373
IM + + LH +VH D+KP N+LLDDDM L+DFG + L+ E
Sbjct: 123 EKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 374 MRT 376
+R
Sbjct: 180 LRE 182
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 58/229 (25%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 275
IG G+FG V++ R VA+K+ + A F E ++ + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 276 LVKIISSCSNGNFEALVLEYMANGSL-----------------------EKCLYSSNGIL 312
+VK++ C+ G L+ EYMA G L + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 313 DIFQRLSIMIDVALALEYL---HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369
++L I VA + YL F VH D+ N L+ ++MV ++DFG+++ +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 370 GKESMRTQTLA----------TIEYGREGQVSPKSDVYGYGITLIETFT 408
+ + +I Y R + +SDV+ YG+ L E F+
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFS 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 45/217 (20%), Positives = 86/217 (39%), Gaps = 40/217 (18%)
Query: 226 IGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHR 274
+G G+FG V + VA+K+ +GA ++ +E ++L + H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 275 NLVKIISSCSNGNFEALV-LEYMANGSL---------------EKCLYSSNGILDIFQRL 318
N+V ++ +C+ +V +E+ G+L L + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 319 SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT 378
VA +E+L S +H D+ N+LL + V + DFG+A+ + +
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 379 LA-------TIEYGREGQVSPKSDVYGYGITLIETFT 408
A E + + +SDV+ +G+ L E F+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 22/212 (10%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA-LKSFDAECEV- 267
Q + + IG G++G+V K G +A+K D K + +V
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 268 LKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL----YSSNGILDIFQRLSIMID 323
++S +V+ + + +E M+ S +K + ++ I +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLAT- 381
AL +L ++H DIKPSN+LLD L DFGI+ L +S+ +T+
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCR 189
Query: 382 -------IEYGREGQV-SPKSDVYGYGITLIE 405
I+ Q +SDV+ GITL E
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 46/233 (19%), Positives = 82/233 (35%), Gaps = 44/233 (18%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFH-----------------LQFDGALKSFDAECEVL 268
+ G F + D A+K + + F E +++
Sbjct: 39 LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 269 KSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVA--- 325
+++ + +N + ++ EYM N S+ K +LD I I V
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQVIKCI 156
Query: 326 -----LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA 380
+ Y+H + H D+KPSN+L+D + LSDFG ++ + K + +
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSR 211
Query: 381 -TIEY-------GREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN 425
T E+ K D++ GI L F P F +++L
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-22
Identities = 34/156 (21%), Positives = 63/156 (40%), Gaps = 8/156 (5%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKII 280
+G G F ++ D A K+ L + E + +S+ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +F +VLE SL + L + + + L +YLH N V+
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 137
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT 376
H D+K N+ L++D+ + DFG+A + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 19/209 (9%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA-LKSFDAECEVL 268
Q + +G G+ G V+K RF G +A+K + K + +V+
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 269 -KSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
KS +V+ + + +E M EK G + + + + A
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLAT----- 381
L YL + V+H D+KPSN+LLD+ L DFGI+ L + + ++
Sbjct: 137 LYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMA 192
Query: 382 ---IEYGREGQV--SPKSDVYGYGITLIE 405
I+ + ++DV+ GI+L+E
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 34/156 (21%), Positives = 63/156 (40%), Gaps = 8/156 (5%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 280
+G G F ++ D A K+ L + E + +S+ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVV 340
+ +F +VLE SL + L + + + L +YLH N V+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 163
Query: 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT 376
H D+K N+ L++D+ + DFG+A + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 29/195 (14%), Positives = 56/195 (28%), Gaps = 36/195 (18%)
Query: 224 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLV 277
G ++ D +VA+ Q D L+ + L + +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+++ +V E++ GSL++ + + M +A A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RA 148
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPKSDVY 397
V PS V + D L+ +P+ D+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATM----------------------PDANPQDDIR 186
Query: 398 GYGITLIETFTKKKP 412
G G +L + P
Sbjct: 187 GIGASLYALLVNRWP 201
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 24/171 (14%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKII 280
+G G FG VY R +A+KV L+ +G E E+ +RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS------IMIDVALALEYLHFG 334
+ + L+LE+ G L K L R M ++A AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY 384
V+H DIKP N+L+ ++DFG + S+R +T+ T++Y
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLDY 178
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 43/217 (19%)
Query: 226 IGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHR 274
+G G+FG V + ++VA+K+ A ++ +E +++ + +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSL-------------EKCLYSSNGILDIFQRLSIM 321
N+V ++ +C++G ++ EY G L + +N L
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA- 380
VA + +L S +H D+ NVLL + VA + DFG+A+ + + + A
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 381 ---------TIEYGREGQVSPKSDVYGYGITLIETFT 408
+I + +SDV+ YGI L E F+
Sbjct: 228 LPVKWMAPESIFDCV---YTVQSDVWSYGILLWEIFS 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 50/223 (22%), Positives = 84/223 (37%), Gaps = 46/223 (20%)
Query: 226 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHR 274
+G G+FG V ++VA+K+ + A ++ +E +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSL----------------------EKCLYSSNGIL 312
N+V ++ +C+ L+ EY G L +L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 313 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372
L VA +E+L VH D+ NVL+ V + DFG+A+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 373 SMRTQTLA-------TIEYGREGQVSPKSDVYGYGITLIETFT 408
+ + A E EG + KSDV+ YGI L E F+
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 55/222 (24%)
Query: 225 LIGIGSFGTVYKGRFLDG---MEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHRNL 276
+IG G+FG V K R M+ AIK + A + F E EVL + H N+
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 277 VKIISSCSNGNFEALVLEYMANGSL---------------EKCLYSSNGILDIFQRLSIM 321
+ ++ +C + + L +EY +G+L S+ L Q L
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA-------KLLNGK--- 371
DVA ++YL +H D+ N+L+ ++ VA ++DFG++ K G+
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205
Query: 372 -----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT 408
ES + Y + SDV+ YG+ L E +
Sbjct: 206 RWMAIES--------LNYSV---YTTNSDVWSYGVLLWEIVS 236
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 50/182 (27%), Positives = 77/182 (42%), Gaps = 38/182 (20%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVF--------HLQFDGALKSFDAECEV 267
+ K +IG G V + G E A+K+ Q + ++ E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 268 LKSVR-HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL-------- 318
L+ V H +++ +I S + +F LV + M G L F L
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTEKVALSE 199
Query: 319 ----SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM 374
SIM + A+ +LH +N +VH D+KP N+LLDD+M LSDFG + L E +
Sbjct: 200 KETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 375 RT 376
R
Sbjct: 257 RE 258
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 31/139 (22%), Positives = 50/139 (35%), Gaps = 13/139 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEI---------NL 52
L+L N L + +P++ +LN + + LP + + E L
Sbjct: 132 LTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 53 SRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPIS 112
+ +P +I L NL+ L + N+ L + + L LE LDL P
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 113 LEKLVYLKDLNLS-FNRLK 130
LK L L + L
Sbjct: 249 FGGRAPLKRLILKDCSNLL 267
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 30/130 (23%), Positives = 57/130 (43%), Gaps = 4/130 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L + S +P++ NL ++ S ++ L+ +L I ++ + E++L +
Sbjct: 188 LRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNY 245
Query: 62 PPTIGGLTNLQLLSLEN-NRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
PP GG L+ L L++ + L +P LT LE LDL +P + +L
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 121 DLNLSFNRLK 130
+ + +
Sbjct: 305 IILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 4/123 (3%)
Query: 13 IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQ 72
L ++ S + SLP I N++ + + + + L+ + P I L L+
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLE 232
Query: 73 LLSL-ENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131
L L L+ P FG L+ L L + +P+ + +L L+ L+L
Sbjct: 233 ELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 132 DIP 134
+P
Sbjct: 292 RLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 23/123 (18%), Positives = 49/123 (39%), Gaps = 8/123 (6%)
Query: 13 IPSTFWNLNSI--LSFDFSSNSLNGSLPLDIENMKVV--VEINLSRNYLTGDIPPTIGGL 68
+ W + + + + +E+ V + L L P L
Sbjct: 45 RWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRL 103
Query: 69 TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS-FN 127
++LQ ++++ L +P++ + LE+L L+ N L +P S+ L L++L++
Sbjct: 104 SHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 128 RLK 130
L
Sbjct: 162 ELT 164
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 19/116 (16%), Positives = 41/116 (35%), Gaps = 6/116 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLS-RNYLTGD 60
L + ++ LS+ + +L + D + + P + + L + L
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-T 268
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN---NLSGVIPISL 113
+P I LT L+ L L +P +L + + + + L P++
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 23/135 (17%), Positives = 51/135 (37%), Gaps = 5/135 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNG-SLPLDIENMKVVVEINLSRNYLTG 59
N+ L +N+++ + + + D N ++ + + + +NL N++
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
D+ + L+ L L +N+L + F + + L N L +I +L L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 120 KDLNLSFNRLKGDIP 134
+ +L N
Sbjct: 240 EHFDLRGNGFHCGTL 254
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 29/129 (22%), Positives = 54/129 (41%), Gaps = 10/129 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ + L + S + ++ D S N L+ D+ + +NLS N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ L+ L+ L L NN +Q S+E+L + NN+S +S + K+
Sbjct: 73 TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKN 124
Query: 122 LNLSFNRLK 130
+ L+ N++
Sbjct: 125 IYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 26/147 (17%), Positives = 53/147 (36%), Gaps = 21/147 (14%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPL-----------------DIENM 44
L L N LS + + + + SSN L +L L ++
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVG 98
Query: 45 KVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNN 104
+ ++ + N ++ + + + + L NN++ G + ++ LDL +N
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 105 LSGV-IPISLEKLVYLKDLNLSFNRLK 130
+ V L+ LNL +N +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 28/118 (23%), Positives = 51/118 (43%), Gaps = 7/118 (5%)
Query: 13 IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQ 72
I N N + +SL +L ++ V E++LS N L+ + T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 73 LLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
LL+L +N L + L++L +LDL+ N + L ++ L+ + N +
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 20/95 (21%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 36 SLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSL 95
++ +N ++ + L + N++ L L N L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 96 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
E L+LS N L + + L L+ L+L+ N ++
Sbjct: 61 ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ 93
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 48/181 (26%), Positives = 75/181 (41%), Gaps = 35/181 (19%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH--------LQFDGALKSFDAECEV 267
D + +G G+ G V +VAIK+ + + + E E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 268 LKSVRHRNLVKIISSCSNGNFEA----LVLEYMANGSL-----EKCLYSSNGILDIFQRL 318
LK + H ++KI F+A +VLE M G L F
Sbjct: 69 LKKLNHPCIIKIK-----NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY-- 121
Query: 319 SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMR 375
+ LA++YLH N ++H D+KP NVLL ++D + ++DFG +K+L MR
Sbjct: 122 ----QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 376 T 376
T
Sbjct: 175 T 175
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 22/179 (12%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFD---AECEVLKSVRH 273
+ F ++G GSF TV R L E AIK+ + E +V+ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSI------MIDVALA 327
VK+ + + L Y NG L K + ++ A
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSA 142
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL-NGKESMRTQTL-ATIEY 384
LEYLH ++H D+KP N+LL++DM ++DFG AK+L + R + T +Y
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 49/227 (21%), Positives = 84/227 (37%), Gaps = 64/227 (28%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVF--------------------HLQFDGALKSFDA 263
IG GS+G V D A+KV G ++
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 264 ------ECEVLKSVRHRNLVK---IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILD- 313
E +LK + H N+VK ++ + + +V E + G + + + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVME--VPTLKPLSE 136
Query: 314 -----IFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368
FQ D+ +EYLH ++H DIKPSN+L+ +D ++DFG++
Sbjct: 137 DQARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 369 NGKESMRTQTLAT------------IEYGREGQVSPKSDVYGYGITL 403
G +++ L+ + R+ DV+ G+TL
Sbjct: 188 KGSDAL----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 27/177 (15%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFH--------LQFDGALKSFDAECEV 267
D + +G G+ G V +VAI++ + + + E E+
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 268 LKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL-----EKCLYSSNGILDIFQRLSIMI 322
LK + H ++KI + ++ +VLE M G L F
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------ 246
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
+ LA++YLH N ++H D+KP NVLL ++D + ++DFG +K+L MRT
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 33/176 (18%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
F ++G G+F V+ + G A+K S + E VLK ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL------------SIMID 323
+V + + LV++ ++ G L F R+ ++
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQ 114
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
V A++YLH N +VH D+KP N+L +++ ++DFG++K+ M T
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMST 166
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 42/212 (19%), Positives = 87/212 (41%), Gaps = 31/212 (14%)
Query: 204 MWRRFSYQELLLATDHFSEK----SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL 258
+W+++ Q + + + +G G+FG V++ G K + +
Sbjct: 33 IWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK 92
Query: 259 KSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL------EKCLYSSNGIL 312
+ E ++ + H L+ + + + L+LE+++ G L E S ++
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152
Query: 313 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHL--SDFGIAKLLNG 370
+ M L+++H + +VH DIKP N++ + + + DFG+A LN
Sbjct: 153 N------YMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 371 KESMRTQTLATIEYGREGQVSP---KSDVYGY 399
E ++ T AT E+ +P + G+
Sbjct: 204 DEIVKV-TTATAEF-----AAPEIVDREPVGF 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 28/175 (16%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRH 273
+D++ K +G G+F V + G+E A K+ + + A + + E + + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSL-----EKCLYS----SNGILDIFQRLSIMIDV 324
N+V++ S +F LV + + G L + YS S+ I I +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 116
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
++ Y H SN +VH ++KP N+LL L+DFG+A +N E+
Sbjct: 117 --SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 52/166 (31%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVK 278
IG GS+G V+K R D G VAIK F D AL+ E +LK ++H NLV
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
++ LV EY + ++ L + SI A+ + H +
Sbjct: 67 LLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
+H D+KP N+L+ V L DFG A+LL G +AT Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 30/135 (22%), Positives = 55/135 (40%), Gaps = 2/135 (1%)
Query: 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L + L + S F +L +++ D S + + + + ++ N +
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
P I L NL L L +L+ P +F L+SL+ L+++ N L V ++L L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520
Query: 120 KDLNLSFNRLKGDIP 134
+ + L N P
Sbjct: 521 QKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 28/131 (21%), Positives = 55/131 (41%), Gaps = 1/131 (0%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
NL L N L + +F++ + D S + +++ + + L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYL 119
GL++LQ L L G L +L+ L+++ N + +P L L
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 120 KDLNLSFNRLK 130
+ L+LS N+++
Sbjct: 152 EHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 6/138 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT-GD 60
L L N + S+ F L+S+ +L I ++K + E+N++ N +
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLE----SLDLSVNNLSGVIPISLEKL 116
+P LTNL+ L L +N++Q L + SLDLS+N ++ + P + +++
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 117 VYLKDLNLSFNRLKGDIP 134
L L L N ++
Sbjct: 201 -RLHKLTLRNNFDSLNVM 217
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 26/127 (20%), Positives = 51/127 (40%), Gaps = 3/127 (2%)
Query: 4 LGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP 63
+ + ++ ++ D S N L + + ++LSR +
Sbjct: 14 CMELNFYKIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 64 TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLN 123
L++L L L N +Q +F L+SL+ L NL+ + + L LK+LN
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 124 LSFNRLK 130
++ N ++
Sbjct: 131 VAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 29/142 (20%), Positives = 54/142 (38%), Gaps = 6/142 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLN--GSLPLDIENMKVVVEINLSRNYLT 58
L+ SN+ + + +L S+ D S N L+ G + ++LS N +
Sbjct: 329 RLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPISLEKLV 117
+ GL L+ L +++ L+ S F L +L LD+S + L
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 118 YLKDLNLSFNRLKGDIPTRSPH 139
L+ L ++ N + +
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFT 467
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 33/141 (23%), Positives = 52/141 (36%), Gaps = 13/141 (9%)
Query: 2 LSLGSNELSSV-IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMK----VVVEINLSRNY 56
L++ N + S +P F NL ++ D SSN + D+ + + + ++LS N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 57 LTGDIPPTIGGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSV------NNLSGVI 109
+ I P L L+L NN + + L LE L + NL
Sbjct: 189 MNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 110 PISLEKLVYLKDLNLSFNRLK 130
+LE L L L
Sbjct: 248 KSALEGLCNLTIEEFRLAYLD 268
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 34/145 (23%), Positives = 53/145 (36%), Gaps = 13/145 (8%)
Query: 1 NLSLGSNELS-SVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE-NMKVVVEINLSRNYLT 58
L + I F L ++ SF S ++ + + +N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP 320
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS--GVIPISLEKL 116
L +L+ L+ +N+ S +L SLE LDLS N LS G S
Sbjct: 321 T------LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 117 VYLKDLNLSFNRLKGDIPTRSPHLQ 141
LK L+LSFN + + + L+
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLE 396
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 26/151 (17%), Positives = 50/151 (33%), Gaps = 12/151 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-------ENMKVVVEINLS 53
+L L N ++ + P F + + +N + ++ E ++V+ +
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 54 RNYLTGDIPPTIGGLTNLQLLSLENNRLQG---PIPESFGELTSLESLDLSVNNLSGVIP 110
L + GL NL + L I + F LT++ S L + V
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 111 IS-LEKLVYLKDLNLSFNRLKGDIPTRSPHL 140
S +L+ +N F + L
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRL 330
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-19
Identities = 46/195 (23%), Positives = 80/195 (41%), Gaps = 27/195 (13%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
DH+ +G G+FG V++ G A K + ++ E + + +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 276 LVKIISSCSNGNFEALVLEYMANGSL------EKCLYSSNGILDIFQRLSIMIDVALALE 329
LV + + + N ++ E+M+ G L E S + ++ M V L
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE------YMRQVCKGLC 269
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHL--SDFGIAKLLNGKESMRTQTLATIEYGRE 387
++H N VH D+KP N++ L DFG+ L+ K+S++ T T E+
Sbjct: 270 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEF--- 322
Query: 388 GQVSP---KSDVYGY 399
+P + GY
Sbjct: 323 --AAPEVAEGKPVGY 335
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DG----ALKSFDAECEVLKSVRHRNLVKI 279
+G G++G VYK + G VA+K L +G A++ E +LK + H N+V +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
I + LV E+M L+K L + L Q + + + + H + +
Sbjct: 85 IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+H D+KP N+L++ D L+DFG+A+
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 52/202 (25%), Positives = 84/202 (41%), Gaps = 37/202 (18%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVF---HLQFDGALKSFDA-----ECEVLKSVRHRNL 276
+G G+FG V+ EV +K + D ++ E +L V H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLY---SSNGILD------IFQRLSIMIDVALA 327
+K++ N F LV+E +G L+ L+ + LD IF++L A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQL------VSA 142
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY--- 384
+ YL ++H DIK N+++ +D L DFG A L + T TIEY
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAP 198
Query: 385 ---GREGQVSPKSDVYGYGITL 403
P+ +++ G+TL
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTL 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 43/207 (20%), Positives = 78/207 (37%), Gaps = 43/207 (20%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKV-----FHLQFDGALKSFDAECEVLKS 270
D + +IG G F V + + G + A+K+ F + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILD-IFQRLS---------- 319
++H ++V+++ + S+ +V E+M L I +R
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----------CFEIVKRADAGFVYSEAVA 132
Query: 320 --IMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESM 374
M + AL Y H N ++H D+KP VLL ++ L FG+A L +
Sbjct: 133 SHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 375 RTQTLATIEYGREGQVSP---KSDVYG 398
+ T + ++P K + YG
Sbjct: 190 AGGRVGTPHF-----MAPEVVKREPYG 211
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 32/131 (24%), Positives = 56/131 (42%), Gaps = 2/131 (1%)
Query: 2 LSLGSNELSSVIPSTFWNL--NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG 59
G + + +TF L +S+ D S + E +K + +NL+ N +
Sbjct: 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK 304
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
GL NLQ+L+L N L +F L + +DL N+++ + + + L L
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364
Query: 120 KDLNLSFNRLK 130
+ L+L N L
Sbjct: 365 QTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 32/134 (23%), Positives = 57/134 (42%), Gaps = 6/134 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N + +V S+F L + + S ++ + N+ + ++L + +
Sbjct: 29 LLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-F 87
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPI--PESFGELTSLESLDLSVNNLSGV-IPISLEKL 116
+ P GL +L L L L + F L +L LDLS N + + + S KL
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 117 VYLKDLNLSFNRLK 130
LK ++ S N++
Sbjct: 148 NSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 29/130 (22%), Positives = 54/130 (41%), Gaps = 5/130 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L L + S+ F L + + + N +N + + +NLS N L
Sbjct: 270 HLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
GL + + L+ N + ++F L L++LDL N L+ ++ + +
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIP 384
Query: 121 DLNLSFNRLK 130
D+ LS N+L
Sbjct: 385 DIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 28/128 (21%), Positives = 48/128 (37%), Gaps = 7/128 (5%)
Query: 6 SNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP-T 64
L+ V LN+ S N + ++ + + L Y I
Sbjct: 13 FCNLTQV----PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 65 IGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVI--PISLEKLVYLKDL 122
L NL++L L ++++ P++F L L L L LS + L L L
Sbjct: 69 FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128
Query: 123 NLSFNRLK 130
+LS N+++
Sbjct: 129 DLSKNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 38/149 (25%), Positives = 59/149 (39%), Gaps = 6/149 (4%)
Query: 2 LSLGSNELSSVI-PSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L LGS I F NL ++ D S+ + P + + + E+ L L+
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 61 IPP--TIGGLTNLQLLSLENNRLQG-PIPESFGELTSLESLDLSVNNLSGVIPISLEKL- 116
+ L L L L N+++ + SFG+L SL+S+D S N + V LE L
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 117 -VYLKDLNLSFNRLKGDIPTRSPHLQVPL 144
L +L+ N L + P
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 34/150 (22%), Positives = 57/150 (38%), Gaps = 9/150 (6%)
Query: 2 LSLGSNELSSV-IPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
+ L N L ++ I + + + N + + ++ L N L
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 60 DIPPTI-----GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE 114
+ GL++LQ+L L +N L P F LT+L L L+ N L+ + L
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525
Query: 115 KLVYLKDLNLSFNRLKGDIPTRSPHLQVPL 144
L+ L++S N+L P L V
Sbjct: 526 AN--LEILDISRNQLLAPNPDVFVSLSVLD 553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 5/108 (4%)
Query: 27 DFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPI- 85
+ +L +P + + + LS NY+ + L LQLL L + I
Sbjct: 10 FYRFCNLT-QVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 86 PESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133
E+F L +L LDL + + + P + + L +L +L L F L +
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 31/140 (22%), Positives = 50/140 (35%), Gaps = 11/140 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ L N ++ + TF L + + D N+L I + + +I LS N L
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLP 397
Query: 62 PPTIGGLTNLQLLSLENNRLQG-PIPESFGELTSLESLDLSVNNLSGVIPISL-EKLVYL 119
+ L+ L NRL+ I + L+ L L+ N S + L
Sbjct: 398 KINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
Query: 120 KDLNLSFNRLKGDIPTRSPH 139
+ L L N L+ T
Sbjct: 454 EQLFLGENMLQLAWETELCW 473
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 32/152 (21%), Positives = 50/152 (32%), Gaps = 23/152 (15%)
Query: 2 LSLGSNELSSVI--PSTFWNLNSILSFDFSSNSLNG-SLPLDIENMKVVVEINLSRNYLT 58
L L LS + F NL ++ D S N + L + + I+ S N +
Sbjct: 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
Query: 59 GDIPPTIGGLT--NLQLLSLENNRLQGPIPESFGEL------TSLESLDLSVNNLSGVIP 110
+ L L SL N L + +G+ LE LD+S N + I
Sbjct: 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT 221
Query: 111 ------------ISLEKLVYLKDLNLSFNRLK 130
SL ++ F+ +K
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 42/190 (22%), Positives = 74/190 (38%), Gaps = 20/190 (10%)
Query: 2 LSLGSNEL-----SSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNY 56
L LG N L + + F L+ + + N LN P ++ + ++L+ N
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515
Query: 57 LTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKL 116
LT + NL++L + N+L P P+ F SL LD++ N +S +
Sbjct: 516 LT-VLSHND-LPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELS-TFI 569
Query: 117 VYLKDLNLSFNRLKGDIPTRSP---------HLQVPLCKSSSHRKSSKNVILLGVVLPLS 167
+L N++ DI P L C KS K + + + L+
Sbjct: 570 NWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLT 629
Query: 168 VFIIAVLLAL 177
+F++ +L
Sbjct: 630 LFLMTILTVT 639
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 4/58 (6%)
Query: 89 FGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRS----PHLQV 142
L + E L LS N + V S L L+ L L I + P+L++
Sbjct: 20 PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRI 77
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 40/171 (23%), Positives = 74/171 (43%), Gaps = 20/171 (11%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH--LQFDGALKSFDAECEVLKSVRH 273
+ ++ ++G GSFG V K + E A+KV + + + E E+LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSL-----EKCLYSSNGILDIFQRLSIMIDVALAL 328
N++K+ + + +V E G L ++ +S + I + V +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGI 134
Query: 329 EYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
Y+H + +VH D+KP N+LL + D + DFG++ M+
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 18/169 (10%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+++ ++ IG GS+G V + A K F + F E E++KS+ H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 276 LVKIISSCSNGNFEALVLEYMANGSL-----EKCLYSSNGILDIFQRLSIMIDVALALEY 330
++++ + + LV+E G L K ++ + I + DV A+ Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAY 121
Query: 331 LHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
H V H D+KP N L D L DFG+A + MRT
Sbjct: 122 CH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 23/135 (17%), Positives = 51/135 (37%), Gaps = 5/135 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNG-SLPLDIENMKVVVEINLSRNYLTG 59
N+ L +N+++ + + + D N ++ + + + +NL N++
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
D+ + L+ L L +N+L + F + + L N L +I +L L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 120 KDLNLSFNRLKGDIP 134
+ +L N
Sbjct: 240 EHFDLRGNGFHCGTL 254
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 29/129 (22%), Positives = 54/129 (41%), Gaps = 10/129 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ + L + S + ++ D S N L+ D+ + +NLS N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ L+ L+ L L NN +Q S+E+L + NN+S +S + K+
Sbjct: 73 TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKN 124
Query: 122 LNLSFNRLK 130
+ L+ N++
Sbjct: 125 IYLANNKIT 133
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 28/161 (17%), Positives = 58/161 (36%), Gaps = 24/161 (14%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPL-----------------DIENM 44
L L N LS + + + + SSN L +L L ++
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVG 98
Query: 45 KVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNN 104
+ ++ + N ++ + + + + L NN++ G + ++ LDL +N
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 105 LSGV-IPISLEKLVYLKDLNLSFNRLKGDIPTRS--PHLQV 142
+ V L+ LNL +N + D+ + L+
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKT 195
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 28/118 (23%), Positives = 51/118 (43%), Gaps = 7/118 (5%)
Query: 13 IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQ 72
I N N + +SL +L ++ V E++LS N L+ + T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 73 LLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
LL+L +N L + L++L +LDL+ N + L ++ L+ + N +
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 8e-14
Identities = 20/95 (21%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 36 SLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSL 95
++ +N ++ + L + N++ L L N L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 96 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
E L+LS N L + + L L+ L+L+ N ++
Sbjct: 61 ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 17/71 (23%), Positives = 29/71 (40%)
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I ++ + ++ L+ + +++ LDLS N LS + L L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 121 DLNLSFNRLKG 131
LNLS N L
Sbjct: 62 LLNLSSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 14/157 (8%), Positives = 42/157 (26%), Gaps = 31/157 (19%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L SN+L+ + F + + +N L + + + + +L N
Sbjct: 196 LDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN------------------ 103
N ++ ++ ++ ++ E T
Sbjct: 254 LRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR 312
Query: 104 ----------NLSGVIPISLEKLVYLKDLNLSFNRLK 130
+ + + E ++++ + +
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 18/132 (13%), Positives = 34/132 (25%), Gaps = 5/132 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGS----LPLDIENMKVVVEINLSRNYL 57
G+ + L ++ + + S GS L + EN EI+ +
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 58 TGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
I L + L + L+ + + E+
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQS 407
Query: 118 YLKDLNLSFNRL 129
L+ L R
Sbjct: 408 PLQLLRAIVKRY 419
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 5/130 (3%), Positives = 25/130 (19%), Gaps = 4/130 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD- 60
++ + + + + + + + + G
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 61 ---IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
+ + + + + I + + +L+ L +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
Query: 118 YLKDLNLSFN 127
L
Sbjct: 385 ELDGTLQQAV 394
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 30/129 (23%), Positives = 67/129 (51%), Gaps = 8/129 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L +G+N+++ + P NL+ + + +N ++ + ++++ + +N+ N ++ DI
Sbjct: 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQIS-DI 280
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ L+ L L L NN+L E G LT+L +L LS N+++ + P++ L +
Sbjct: 281 SV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDS 337
Query: 122 LNLSFNRLK 130
+ + +K
Sbjct: 338 ADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 33/134 (24%), Positives = 58/134 (43%), Gaps = 10/134 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L ++ V+ L SI + + S+ IE + + +NL+ N +T D
Sbjct: 26 RAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQIT-D 80
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I P + L L L + N++ + LT+L L L+ +N+S + P++ L +
Sbjct: 81 ISP-LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISPLA--NLTKMY 135
Query: 121 DLNLSFNRLKGDIP 134
LNL N D+
Sbjct: 136 SLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 27/130 (20%), Positives = 54/130 (41%), Gaps = 8/130 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ N+++ + P N+ + S +N + PL N+ + + + N ++
Sbjct: 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD-- 257
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ LT L++L++ +N++ L+ L SL L+ N L + L L
Sbjct: 258 INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 122 LNLSFNRLKG 131
L LS N +
Sbjct: 316 LFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 31/134 (23%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
NL +G+N+++ + S NL ++ + ++++ PL N+ + +NL N+ D
Sbjct: 92 NLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSD 147
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ P + +T L L++ ++++ P LT L SL L+ N + + P++ L L
Sbjct: 148 LSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLA--SLTSLH 202
Query: 121 DLNLSFNRLKGDIP 134
N++ P
Sbjct: 203 YFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 32/130 (24%), Positives = 59/130 (45%), Gaps = 9/130 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L + +S + P NL + S + +N S + NM + + ++ + + D+
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVK-DV 170
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P I LT+L LSL N+++ P LTSL VN ++ + P++ + L
Sbjct: 171 TP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMTRLNS 225
Query: 122 LNLSFNRLKG 131
L + N++
Sbjct: 226 LKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 30/134 (22%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L+L N+++ + P NL + + +N + + ++N+ + E+ L+ + ++ D
Sbjct: 70 YLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNIS-D 124
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I P + LT + L+L N +T L L ++ + + V PI+ L L
Sbjct: 125 ISP-LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLY 180
Query: 121 DLNLSFNRLKGDIP 134
L+L++N+++ P
Sbjct: 181 SLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 17/86 (19%), Positives = 32/86 (37%), Gaps = 6/86 (6%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
+ + I P L L+ + + EL S+ L ++ ++ +
Sbjct: 4 TLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI 59
Query: 109 IPISLEKLVYLKDLNLSFNRLKGDIP 134
I E L L+ LNL+ N++ P
Sbjct: 60 QGI--EYLTNLEYLNLNGNQITDISP 83
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 37/204 (18%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVFH----LQFDGALKSFDAECEVLKSVRHRNLVK- 278
L+G GS+G V + A+K+ + + E ++L+ +RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 279 --IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILD------IFQRLSIMIDVALALEY 330
++ + +V+EY G E F +L ID LEY
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL---ID---GLEY 124
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT--------- 381
LH S +VH DIKP N+LL +S G+A+ L T T
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL--HPFAADDTCRTSQGSPAFQP 179
Query: 382 --IEYGREGQVSPKSDVYGYGITL 403
I G + K D++ G+TL
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTL 203
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVK 278
+G GS+G V K R D G VAIK F D A++ E ++LK +RH NLV
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENLVN 88
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
++ C LV E++ + ++ L LD + + + + H S+
Sbjct: 89 LLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHN 144
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
++H DIKP N+L+ V L DFG A+ L + +AT Y
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWY 190
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 34/178 (19%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
+D++ K +G G+F V + G+E A K+ + + L + D E + +
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRK 84
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSL-----EKCLYS----SNGILDIFQRLSIM 321
++H N+V++ S +F LV + + G L + YS S+ I I +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE----- 139
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
++ Y H SN +VH ++KP N+LL L+DFG+A +N E+
Sbjct: 140 -----SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 42/188 (22%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEV---LKSVR 272
TD + K IG+GS+ + ME A+K+ D E+ L+ +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQ 74
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL------------SI 320
H N++ + +G + +V E M G L ++ ++
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAV 121
Query: 321 MIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLNGKESMRT 376
+ + +EYLH + VVH D+KPSN+L + + DFG AK L + +
Sbjct: 122 LFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 377 QTLATIEY 384
T +
Sbjct: 179 TPCYTANF 186
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 34/142 (23%), Positives = 63/142 (44%), Gaps = 10/142 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L LG+N++S++ P L ++ + + + N L P I N+K + + L N ++
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS 325
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + LT LQ L NN++ S LT++ L N +S + P++ L +
Sbjct: 326 P--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLA--NLTRITQ 379
Query: 122 LNLSFNRLKGDIPTRSPHLQVP 143
L L+ ++ +P
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIP 401
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 38/131 (29%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
LSL N+L + T +L ++ D ++N ++ PL + + E+ L N ++ +
Sbjct: 225 ELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQIS-N 279
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I P + GLT L L L N+L+ P L +L L L NN+S + P+S L L+
Sbjct: 280 ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQ 334
Query: 121 DLNLSFNRLKG 131
L N++
Sbjct: 335 RLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 33/131 (25%), Positives = 57/131 (43%), Gaps = 10/131 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
LG ++ + +L+ + + + S+ +E + + +IN S N LT D
Sbjct: 28 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLT-D 82
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I P + LT L + + NN++ P LT+L L L N ++ + P+ L L
Sbjct: 83 ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLK--NLTNLN 137
Query: 121 DLNLSFNRLKG 131
L LS N +
Sbjct: 138 RLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 37/126 (29%), Positives = 64/126 (50%), Gaps = 10/126 (7%)
Query: 6 SNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTI 65
N+++ + P NL ++ D SSN ++ + + + + + N ++ DI P +
Sbjct: 164 GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS-DITP-L 217
Query: 66 GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 125
G LTNL LSL N+L+ + LT+L LDL+ N +S + P+S L L +L L
Sbjct: 218 GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLG 273
Query: 126 FNRLKG 131
N++
Sbjct: 274 ANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 34/133 (25%), Positives = 64/133 (48%), Gaps = 11/133 (8%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ + +N+++ + P NL ++ +N + PL +N+ + + LS N ++
Sbjct: 95 ILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISD-- 148
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ GLT+LQ LS N + LT+LE LD+S N +S + ++ KL L+
Sbjct: 149 ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDISVLA--KLTNLES 203
Query: 122 LNLSFNRLKGDIP 134
L + N++ P
Sbjct: 204 LIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 21/131 (16%), Positives = 47/131 (35%), Gaps = 10/131 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
++ + T L + ++ ++ ++ V + R +
Sbjct: 6 ATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-- 59
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ L NL ++ NN+L P LT L + ++ N ++ + P++ L L
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLT 115
Query: 121 DLNLSFNRLKG 131
L L N++
Sbjct: 116 GLTLFNNQITD 126
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 27/150 (18%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L + S LN++ +FS+N L PL +N+ +V+I ++ N + D
Sbjct: 50 TLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIA-D 104
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPIS-------- 112
I P + LTNL L+L NN++ P LT+L L+LS N +S + +S
Sbjct: 105 ITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQL 161
Query: 113 -----------LEKLVYLKDLNLSFNRLKG 131
L L L+ L++S N++
Sbjct: 162 SFGNQVTDLKPLANLTTLERLDISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 15/94 (15%), Positives = 37/94 (39%), Gaps = 6/94 (6%)
Query: 41 IENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDL 100
+ ++ L + +T + L + L + ++ + L +L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75
Query: 101 SVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
S N L+ + P+ L L D+ ++ N++ P
Sbjct: 76 SNNQLTDITPLK--NLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 20/130 (15%), Positives = 50/130 (38%), Gaps = 8/130 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L+L N +S + P +L + F +N ++ L N+ + ++ N ++ D
Sbjct: 313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSL--ANLTNINWLSAGHNQIS-D 367
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ P + LT + L L + ++ ++ L + P ++
Sbjct: 368 LTP-LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYT 424
Query: 121 DLNLSFNRLK 130
+ ++++N
Sbjct: 425 EPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 21/129 (16%), Positives = 46/129 (35%), Gaps = 8/129 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L +N++S S+ NL +I N ++ P + N+ + ++ L+ T
Sbjct: 335 RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPIS--LEKLVY 118
++ + L P + + S D++ N S +S + V
Sbjct: 391 PVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVT 448
Query: 119 LKDLNLSFN 127
+ +F+
Sbjct: 449 IGKGTTTFS 457
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 37/167 (22%), Positives = 73/167 (43%), Gaps = 20/167 (11%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
S+ ++G G FG V+K G+++A K+ + + E V+ + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 279 IISSCSNGNFEALVLEYMANGSL------EKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
+ + + N LV+EY+ G L E + + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL------FMKQICEGIRHMH 204
Query: 333 FGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
++H D+KP N+L D + + DFG+A+ +E ++
Sbjct: 205 ---QMYILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKV 247
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 44/245 (17%), Positives = 71/245 (28%), Gaps = 61/245 (24%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
+ K IG GS+G V AIK+ + + D E ++K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSL----------------------------- 301
+ H N+ ++ + + LV+E G L
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 302 ----EKCLYSSNGILDIFQRLS------IMIDVALALEYLHFGYSNPVVHCDIKPSNVLL 351
+ IM + AL YLH + + H DIKP N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLF 201
Query: 352 DDDMVAHL--SDFGIAKLLNGKESMRTQTLATI----EY-------GREGQVSPKSDVYG 398
+ + DFG++K + + T + PK D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 399 YGITL 403
G+ L
Sbjct: 262 AGVLL 266
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 4e-18
Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 226 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVKI 279
IG G++G VYK + G A+K L+ + ++ E +LK ++H N+VK+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
LV E++ + L+K L G L+ S ++ + + Y H V
Sbjct: 66 YDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+H D+KP N+L++ + ++DFG+A+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKS---FDA--ECEVLKSVRHRNLVKI 279
+G G F TVYK R VAIK L K A E ++L+ + H N++ +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339
+ + + + +LV ++M LE + ++ +L + M+ LEYLH + +
Sbjct: 78 LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133
Query: 340 VHCDIKPSNVLLDDDMVAHLSDFGIAK 366
+H D+KP+N+LLD++ V L+DFG+AK
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVR 272
+D + + ++G GSFG V + + G E A+KV ++ +S E ++LK +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSL-----EKCLYSSNGILDIFQRLSIMIDVALA 327
H N++K+ + + LV E G L + +S I ++ V
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSG 138
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
+ Y+H N +VH D+KP N+LL D + DFG++ + M+ + T Y
Sbjct: 139 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KIGTAYY 194
Query: 385 GR----EGQVSPKSDVYGYGITL 403
G K DV+ G+ L
Sbjct: 195 IAPEVLHGTYDEKCDVWSTGVIL 217
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 5/132 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L SN L+ + + F L + D S N+ S+ + + ++L R L +
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-E 119
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+ P + GL LQ L L++N LQ +P+ +F +L +L L L N +S V + L
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 119 LKDLNLSFNRLK 130
L L L NR+
Sbjct: 179 LDRLLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 34/130 (26%), Positives = 53/130 (40%), Gaps = 1/130 (0%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+ L N +S V ++F ++ SN L + ++ +++LS N
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+ P T GL L L L+ LQ P F L +L+ L L N L + + L L
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL 155
Query: 120 KDLNLSFNRL 129
L L NR+
Sbjct: 156 THLFLHGNRI 165
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 38/132 (28%), Positives = 52/132 (39%), Gaps = 5/132 (3%)
Query: 2 LSLGSNE-LSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L N L SV P+TF L + + L L + + + + L N L
Sbjct: 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ- 142
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+P L NL L L NR+ +F L SL+ L L N ++ V P + L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 119 LKDLNLSFNRLK 130
L L L N L
Sbjct: 203 LMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 37/128 (28%), Positives = 58/128 (45%), Gaps = 4/128 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L L + P F L ++ N+L +LP D ++ + + L N ++
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-S 167
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+P GL +L L L NR+ P +F +L L +L L NNLS + +L L L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227
Query: 120 KDLNLSFN 127
+ L L+ N
Sbjct: 228 QYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 25/106 (23%), Positives = 43/106 (40%), Gaps = 4/106 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N L ++ TF +L ++ N ++ S+P + + + L +N +
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-H 191
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
+ P L L L L N L E+ L +L+ L L+ N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 20/86 (23%), Positives = 32/86 (37%), Gaps = 3/86 (3%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
+ + L +P I Q + L NR+ SF +L L L N L+ +
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 109 IPISLEKLVYLKDLNLSFNRLKGDIP 134
+ L L+ L+LS N +
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVD 97
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 15/148 (10%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DG----ALKSFDAECEVLKSVRHRNLVK 278
IG G++GTV+K + + VA+K L +G AL+ E +LK ++H+N+V+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ + LV E+ + L+K S NG LD S + + L + H S
Sbjct: 66 LHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
V+H D+KP N+L++ + L++FG+A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 45/200 (22%), Positives = 79/200 (39%), Gaps = 36/200 (18%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVF--HLQFDGALKSFDAECEVLKSVRH 273
T+ + +G G+F V + + G E A + + + E + + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSL-----EKCLYS----SNGILDIFQRLSIMIDV 324
N+V++ S S L+ + + G L + YS S+ I I +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------- 121
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRTQTLAT 381
A+ + H VVH ++KP N+LL L+DFG+A + G++ T
Sbjct: 122 --AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 382 IEYGREGQVSP---KSDVYG 398
Y +SP + D YG
Sbjct: 177 PGY-----LSPEVLRKDPYG 191
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 28/133 (21%), Positives = 54/133 (40%), Gaps = 4/133 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD--IENMKVVVEINLSRNYLTG 59
L L N LSS+ S F L+S+ + N +L + N+ + + +
Sbjct: 79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 60 DIPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+I GLT+L L ++ L+ +S + + L L ++ + ++ I + L
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 119 LKDLNLSFNRLKG 131
++ L L L
Sbjct: 198 VRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 28/135 (20%), Positives = 54/135 (40%), Gaps = 6/135 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L + L + + + L + ++ + +++K + ++LS N + +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 61 IPPT---IGGLTNLQLLSLENNRLQ--GPIPESFGELTSLESLDLSVNNLSGVIPISLEK 115
G +LQ L L N L+ E L +L SLD+S N +P S +
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 116 LVYLKDLNLSFNRLK 130
++ LNLS ++
Sbjct: 409 PEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 31/146 (21%), Positives = 56/146 (38%), Gaps = 10/146 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSN---SLNGSLPLDIENMKVVVEINLSRNYLT 58
+++ ++++ V S +L S+ D S N + + LS+N+L
Sbjct: 315 ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
Query: 59 --GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKL 116
+ L NL L + N P+P+S + L+LS + V+ +
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--P 430
Query: 117 VYLKDLNLSFNRLKGDIPTRSPHLQV 142
L+ L++S N L P LQ
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLPRLQE 455
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 34/104 (32%), Positives = 51/104 (49%), Gaps = 3/104 (2%)
Query: 27 DFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIP 86
D S S S+P + + ++LS N +T + NLQ+L L+++R+
Sbjct: 11 DGRSRSFT-SIPSGLTAA--MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67
Query: 87 ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
++F L SLE LDLS N+LS + L LK LNL N +
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 28/132 (21%), Positives = 50/132 (37%), Gaps = 14/132 (10%)
Query: 13 IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEI-----------NLSRNYLTGDI 61
+ + + +F +LNG + VV E+ ++ + YL D+
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVI---PISLEKLVY 118
L ++ +++EN+++ L SLE LDLS N +
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 119 LKDLNLSFNRLK 130
L+ L LS N L+
Sbjct: 363 LQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 20/130 (15%), Positives = 47/130 (36%), Gaps = 2/130 (1%)
Query: 2 LSLGSNELSSV-IPSTFWNLNSILSFDFSSNSLNGSLP-LDIENMKVVVEINLSRNYLTG 59
L+L N ++ + S F NL ++ + + + +D + + E+ + L
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
++ + ++ L+L + + L+S+ L+L NL+ L
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 120 KDLNLSFNRL 129
+ R
Sbjct: 223 SPMKKLAFRG 232
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 33/150 (22%), Positives = 54/150 (36%), Gaps = 22/150 (14%)
Query: 2 LSLGSNELSSV--IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT- 58
L L N L S+ L ++ S D S N+ + +P + + + +NLS +
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV 424
Query: 59 --GDIPPTI--------------GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSV 102
IP T+ L LQ L + N+L+ S L + +S
Sbjct: 425 VKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISR 482
Query: 103 NNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132
N L V ++L L+ + L N
Sbjct: 483 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 26/134 (19%), Positives = 41/134 (30%), Gaps = 5/134 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+E V +I L L ++ V I + + +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326
Query: 62 PPTIGGLTNLQLLSLENNRLQ---GPIPESFGELTSLESLDLSVNNLS--GVIPISLEKL 116
L +L+ L L N + G SL++L LS N+L L L
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 117 VYLKDLNLSFNRLK 130
L L++S N
Sbjct: 387 KNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 28/147 (19%), Positives = 49/147 (33%), Gaps = 10/147 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
S +S+ + S+ D S N + D+ + + L + + I
Sbjct: 10 CDGRSRSFTSIPSGLTAAMKSL---DLSFNKITYIGHGDLRACANLQVLILKSSRIN-TI 65
Query: 62 PPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYL 119
L +L+ L L +N L FG L+SL+ L+L N + + L L
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 120 KDLNLSFNRLKGDIPTRS----PHLQV 142
+ L + +I L
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNE 152
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 20/130 (15%), Positives = 46/130 (35%), Gaps = 1/130 (0%)
Query: 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L +G+ E S I F L S+ + + SL +++++ + + L +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ L++++ L L + L + S + S +L+ L
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 121 DLNLSFNRLK 130
L + ++
Sbjct: 248 RYILELSEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 15/148 (10%), Positives = 41/148 (27%), Gaps = 18/148 (12%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L+L +E + ++ L+S+ + +L + +V + +
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 61 IPPTIGGLTNL------------------QLLSLENNRLQGPIPESFGELTSLESLDLSV 102
+ L L L + E ++ L +
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 103 NNLSGVIPISLEKLVYLKDLNLSFNRLK 130
L + L +K + + +++
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVF 323
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 9e-18
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQF-DG----ALKSFDAECEVLKSV 271
+ + + +G G++ TVYKG+ L VA+K L+ +G A++ E +LK +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYL 331
+H N+V + LV EY+ + L++ L I+++ + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
H V+H D+KP N+L+++ L+DFG+A+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 50/175 (28%), Positives = 75/175 (42%), Gaps = 25/175 (14%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHR 274
D F K +G G+FG V+ G+E IK + + ++ +AE EVLKS+ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSL-EKCLYSSNGILDIFQRL---------SIMIDV 324
N++KI + + +V+E G L E+ I+ R +M +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLER-------IVSAQARGKALSEGYVAELMKQM 133
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
AL Y H S VVH D+KP N+L + DFG+A+L E
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 44/209 (21%), Positives = 72/209 (34%), Gaps = 48/209 (22%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH------LQFDGALKSFDAECEVLK 269
D + +G G F V K R G+E A K + + + E +L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 270 SVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL----------- 318
V H N++ + N L+LE ++ G L F L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117
Query: 319 -SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLNGKES 373
S + + + YLH + + H D+KP N++L L DFG+A +
Sbjct: 118 TSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 374 MRTQTLATIEYGREGQVSP---KSDVYGY 399
+ T E+ V+P + G
Sbjct: 175 FKN-IFGTPEF-----VAPEIVNYEPLGL 197
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 41/183 (22%), Positives = 66/183 (36%), Gaps = 39/183 (21%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH------LQFDGALKSFDAECEVLK 269
DH+ +G G F V K R G E A K + + + + E +L+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 270 SVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL----------- 318
+RH N++ + N L+LE ++ G L F L
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEA 110
Query: 319 -SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLNGKES 373
+ + + YLH S + H D+KP N++L + L DFGIA +
Sbjct: 111 TQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
Query: 374 MRT 376
+
Sbjct: 168 FKN 170
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 40/179 (22%), Positives = 72/179 (40%), Gaps = 34/179 (18%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRH 273
+ ++ ++G GSFG V K + E A+KV + + + E E+LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL------------SIM 321
N++K+ + + +V E G L F + I+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARII 127
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRTQ 377
V + Y+H + +VH D+KP N+LL + D + DFG++ M+ +
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 4/132 (3%)
Query: 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L + L + S F +L +++ D S I + + + ++ N
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQE 164
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+ P I L NL L L +L+ P +F L+SL+ L++S NN + + L
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224
Query: 119 LKDLNLSFNRLK 130
L+ L+ S N +
Sbjct: 225 LQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 4/136 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLN--GSLPLDIENMKVVVEINLSRNYLTG 59
L L SN+L S+ F L + SSN L+ G + ++LS N +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 91
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+ GL L+ L +++ L+ S F L +L LD+S + L
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151
Query: 119 LKDLNLSFNRLKGDIP 134
L+ L ++ N + +
Sbjct: 152 LEVLKMAGNSFQENFL 167
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 30/131 (22%), Positives = 55/131 (41%), Gaps = 4/131 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L + F L+S+ + NS + DI ++ + ++LS+ L
Sbjct: 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-Q 189
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY- 118
+ P L++LQ+L++ +N + L SL+ LD S+N++ L+
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 119 LKDLNLSFNRL 129
L LNL+ N
Sbjct: 250 LAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 31/84 (36%), Positives = 40/84 (47%), Gaps = 5/84 (5%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS-- 106
EI + LT +P I ++ L LE+N+LQ F +LT L L LS N LS
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 107 GVIPISLEKLVYLKDLNLSFNRLK 130
G S LK L+LSFN +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI 91
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 22/108 (20%), Positives = 41/108 (37%), Gaps = 4/108 (3%)
Query: 2 LSLGSN-ELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L + N + +P F L ++ D S L L ++ + +N+S N
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS 213
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGEL-TSLESLDLSVNNLS 106
L +LQ+L N + + +SL L+L+ N+ +
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 41/176 (23%), Positives = 64/176 (36%), Gaps = 36/176 (20%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSC 283
+G GSF K A+K+ + E LK H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL------------SIMIDVALALEYL 331
+ LV+E + G L F+R+ IM + A+ ++
Sbjct: 76 HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 332 HFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY 384
H VVH D+KP N+L +D++ + DFG A+L T+ Y
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 34/176 (19%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+D F +S +G G+ VY+ + A+KV D K E VL + H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN 109
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL------------SIMID 323
++K+ +LVLE + G L F R+ +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQ 156
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
+ A+ YLH N +VH D+KP N+L D ++DFG++K++ + M+T
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 20/152 (13%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKIISS 282
+G G++G V VA+K+ + + ++ E + K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 283 CSNGNFEALVLEYMANGSL-EKCLYSSNGILD------IFQRLSIMIDVALALEYLHFGY 335
GN + L LEY + G L ++ + + F +L + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQL---MA---GVVYLH--- 122
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367
+ H DIKP N+LLD+ +SDFG+A +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 44/209 (21%), Positives = 73/209 (34%), Gaps = 48/209 (22%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH------LQFDGALKSFDAECEVLK 269
D + +G G F V K R G+E A K + + + + E +L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 270 SVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL----------- 318
V H N++ + N L+LE ++ G L F L
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117
Query: 319 -SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLNGKES 373
S + + + YLH + + H D+KP N++L L DFG+A +
Sbjct: 118 TSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 374 MRTQTLATIEYGREGQVSP---KSDVYGY 399
+ T E+ V+P + G
Sbjct: 175 FKN-IFGTPEF-----VAPEIVNYEPLGL 197
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 28/133 (21%), Positives = 59/133 (44%), Gaps = 7/133 (5%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
N LG + +++ + +NS+ ++ ++ + E + ++ ++ + T +
Sbjct: 27 NGLLGQSSTANITEA---QMNSLTYITLANINVTDLTGI--EYAHNIKDLTINNIHAT-N 80
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
P I GL+NL+ L + + + LTSL LD+S + I + L +
Sbjct: 81 YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
Query: 121 DLNLSFNRLKGDI 133
++LS+N DI
Sbjct: 140 SIDLSYNGAITDI 152
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 16/129 (12%), Positives = 44/129 (34%), Gaps = 5/129 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L++ + ++ + L+++ + ++ + + +++S +
Sbjct: 70 DLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I I L + + L N I L L+SL++ + + +E L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLN 184
Query: 121 DLNLSFNRL 129
L +
Sbjct: 185 QLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-12
Identities = 22/108 (20%), Positives = 42/108 (38%), Gaps = 3/108 (2%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L + +++S L S+ D S ++ + S+ I + V I+LS N D
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
I P + L L+ L+++ + + + L L + G
Sbjct: 152 IMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 20/106 (18%), Positives = 41/106 (38%), Gaps = 4/106 (3%)
Query: 30 SNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESF 89
+ + + M + I L+ +T D+ I N++ L++ N
Sbjct: 29 LLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNY--NPI 84
Query: 90 GELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135
L++LE L + +++ +L L L L++S + I T
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 25/202 (12%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRH 273
++ + +G G++G V R +E AIK+ + E VLK + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSL-----EKCLYSSNGILDIFQRLSIMIDVALAL 328
N++K+ + LV+E G L + ++ I + V +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGV 149
Query: 329 EYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG 385
YLH + +VH D+KP N+LL + D + + DFG++ + ++ M+ + L T Y
Sbjct: 150 TYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER-LGTAYYI 205
Query: 386 R----EGQVSPKSDVYGYGITL 403
+ K DV+ G+ L
Sbjct: 206 APEVLRKKYDEKCDVWSIGVIL 227
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 5/131 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSL-NGSLPLDI-ENMKVVVEINLSRNYLTG 59
L + NE++ V S F LN ++ + +N L + + + MK + I ++ +T
Sbjct: 126 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
IP G +L L L+ N++ S L +L L LS N++S V SL +L
Sbjct: 185 TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 242
Query: 120 KDLNLSFNRLK 130
++L+L+ N+L
Sbjct: 243 RELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 20/136 (14%), Positives = 54/136 (39%), Gaps = 12/136 (8%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ + ++++ +L + N + ++ + + ++ LS N ++ +
Sbjct: 176 IRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AV 231
Query: 62 PP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV------IPISLE 114
++ +L+ L L NN+L +P + ++ + L NN+S + P
Sbjct: 232 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290
Query: 115 KLVYLKDLNLSFNRLK 130
K ++L N ++
Sbjct: 291 KKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 11/111 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L N +S+V + N + ++N L +P + + K + + L N ++ I
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AI 278
Query: 62 PPT-------IGGLTNLQLLSLENNRLQGPI--PESFGELTSLESLDLSVN 103
+ +SL +N +Q P +F + ++ L
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 30/133 (22%), Positives = 51/133 (38%), Gaps = 14/133 (10%)
Query: 2 LSLGSNELSSV---IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT 58
+ L V +P L D +N + D +N+K + + L N ++
Sbjct: 36 VQCSDLGLEKVPKDLPPDTALL------DLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 59 GDIPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
I P L L+ L L N+L+ +PE +L+ L + N ++ V L
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLKE-LPE--KMPKTLQELRVHENEITKVRKSVFNGLN 145
Query: 118 YLKDLNLSFNRLK 130
+ + L N LK
Sbjct: 146 QMIVVELGTNPLK 158
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 50 INLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVI 109
+ S L +P + + LL L+NN++ F L +L +L L N +S +
Sbjct: 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92
Query: 110 PISLEKLVYLKDLNLSFNRLKGDIPTRSP 138
P + LV L+ L LS N+LK ++P + P
Sbjct: 93 PGAFAPLVKLERLYLSKNQLK-ELPEKMP 120
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 15/87 (17%), Positives = 30/87 (34%), Gaps = 9/87 (10%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNG------SLPLDIENMKVVVEINLSRN 55
L L +N+L +P + I +N+++ P ++L N
Sbjct: 245 LHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 56 YLT-GDIPP-TIGGLTNLQLLSLENNR 80
+ +I P T + + L N +
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 36/195 (18%), Positives = 72/195 (36%), Gaps = 28/195 (14%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+ + +G G FG V++ K ++ E +L RHRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRN 62
Query: 276 LVKIISSCSNGNFEALVLEYMANGSL------EKCLYSSNGILDIFQRLSIMIDVALALE 329
++ + S + ++ E+++ + + I+ + V AL+
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVS------YVHQVCEALQ 116
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHL--SDFGIAKLLNGKESMRTQTLATIEYGRE 387
+LH S+ + H DI+P N++ + + +FG A+ L ++ R EY
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEY--- 169
Query: 388 GQVSP---KSDVYGY 399
+P + DV
Sbjct: 170 --YAPEVHQHDVVST 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 45/189 (23%), Positives = 81/189 (42%), Gaps = 30/189 (15%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKV---FHLQFDGALKSFDAECE 266
++L + + + +IG G+FG V R +V A+K+ F + F E +
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVA- 325
++ +V++ + + + +V+EYM G L +++ + A
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWAR 171
Query: 326 -------LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESMRT 376
LAL+ +H S +H D+KP N+LLD H L+DFG +N + +R
Sbjct: 172 FYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRC 226
Query: 377 QTL-ATIEY 384
T T +Y
Sbjct: 227 DTAVGTPDY 235
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 23/131 (17%), Positives = 52/131 (39%), Gaps = 4/131 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
++ ++ + + + + + + + + + + ++ + N +
Sbjct: 50 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-Y 107
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+PP + + L +L LE N L F L +L +S NNL + + + L
Sbjct: 108 LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSL 167
Query: 120 KDLNLSFNRLK 130
++L LS NRL
Sbjct: 168 QNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 30/132 (22%), Positives = 53/132 (40%), Gaps = 9/132 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N L+ + N ++ D S N L + M+ + + +S N L
Sbjct: 231 LKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-A 286
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ + L++L L +N L + + + LE+L L N++ + L LK
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLK 342
Query: 121 DLNLSFNRLKGD 132
+L LS N +
Sbjct: 343 NLTLSHNDWDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L+L ++ + F ++I N++ LP + +N+ ++ + L RN L+
Sbjct: 74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-S 131
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+P I L LS+ NN L+ ++F TSL++L LS N L+ + L + L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSL 188
Query: 120 KDLNLSFNRLK 130
N+S+N L
Sbjct: 189 FHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 25/132 (18%), Positives = 51/132 (38%), Gaps = 4/132 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
++ + LN+ F ++++ LP + ++ + V +NL+ +
Sbjct: 25 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 82
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+I +Q L + N ++ P F + L L L N+LS +
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142
Query: 119 LKDLNLSFNRLK 130
L L++S N L+
Sbjct: 143 LTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 38/157 (24%), Positives = 60/157 (38%), Gaps = 23/157 (14%)
Query: 1 NLSLGSNELSSVIPSTFWNL-------NSILSF---------DFSSNSLNGSLPLDIENM 44
NL L SN L+ V S +L N + + D S NS+N + +
Sbjct: 169 NLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--N 225
Query: 45 KVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNN 104
+ + L N LT + L + L N L+ + F ++ LE L +S N
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 105 LSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
L + + + + LK L+LS N L + P
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 318
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 32/149 (21%), Positives = 55/149 (36%), Gaps = 29/149 (19%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
LS+ +N L + TF S+ + SSN L +D+ + + N+S N L+
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS--- 199
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPE--------------------SFGELTSLESLDLS 101
T+ ++ L +N + + L +DLS
Sbjct: 200 --TLAIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 256
Query: 102 VNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
N L ++ K+ L+ L +S NRL
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 15/119 (12%), Positives = 40/119 (33%), Gaps = 2/119 (1%)
Query: 13 IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTI-GGLTNL 71
I S + + + + + + + +P + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 72 QLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
+LL+L + +++ +F +++ L + N + + P + + L L L N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 10/95 (10%), Positives = 37/95 (38%)
Query: 36 SLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSL 95
+ +++ V ++++ L N ++++ +N+ ++ +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 96 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
E L+L+ + + + ++ L + FN ++
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 42/254 (16%), Positives = 83/254 (32%), Gaps = 27/254 (10%)
Query: 196 EVNMSPQAMWRRFSYQE--LLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFH-- 251
+ + + + R +E L +H K +
Sbjct: 38 RIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDW 97
Query: 252 -LQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNG 310
L + + + + +N V + S + + ++ +L+ +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 311 I--LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368
+ + L I I +A A+E+LH S ++H D+KPSN+ D V + DFG+ +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 369 NGKESMRTQTLATIEYGREGQ-------VSP----------KSDVYGYGITLIETFTKKK 411
+ E +T Y +SP K D++ G+ L E
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 412 PTCEIFCEEMNLKN 425
E +++N
Sbjct: 275 TQMERVRIITDVRN 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 2/93 (2%)
Query: 218 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIK-VFHLQFDGALKSFDAECEVLKSVRHRN 275
F +G G FG V++ + +D AIK + + A + E + L + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSS 308
+V+ ++ E E ++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
++ +IG GSFG V++ + ++ EVAIK + E ++++ V+H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 277 VK----IISSCSNGNFEA--LVLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALA 327
V S+ + LVLEY+ ++ + + + M + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGKESM 374
L Y+H S + H DIKP N+LLD V L DFG AK+L E
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 36/179 (20%)
Query: 223 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKII 280
+ ++G G+ V L E A+K+ Q E E+L + HRN++++I
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL------------SIMIDVALAL 328
+ LV E M GS+ + ++ DVA AL
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASAL 124
Query: 329 EYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMR---TQTLAT 381
++LH + + H D+KP N+L + + DF + + T L T
Sbjct: 125 DFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 20/152 (13%)
Query: 225 LIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKIISS 282
+G G++G V VA+K+ + + ++ E + K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 283 CSNGNFEALVLEYMANGSL-EKCLYSSNGILD------IFQRLSIMIDVALALEYLHFGY 335
GN + L LEY + G L ++ + + F +L + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQL---MA---GVVYLH--- 122
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367
+ H DIKP N+LLD+ +SDFG+A +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 40/181 (22%), Positives = 68/181 (37%), Gaps = 42/181 (23%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEV---LKSVRH 273
D+ ++G+G G V + + A+K+ A EV ++ +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQC 114
Query: 274 RNLVKIISSCSNGNFEA----LVLEYMANGSLEKCLYSSNGILD-IFQRLS--------- 319
++V+I+ N +V+E + G L I R
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREAS 164
Query: 320 -IMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMR 375
IM + A++YLH S + H D+KP N+L + + L+DFG AK S+
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 376 T 376
T
Sbjct: 222 T 222
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 34/202 (16%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH------LQFDGALKSFDAECEVLK 269
D++ +G G F V K R G++ A K + + + + E +LK
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 270 SVRHRNLVKIISSCSNGNFEALVLEYMANGSL-----EKCLYSSNGILDIFQRLSIMIDV 324
++H N++ + N L+LE +A G L EK + + + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQI 123
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAKLLNGKESMRTQTLA 380
+ YLH S + H D+KP N++L + DFG+A ++ +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-IFG 179
Query: 381 TIEYGREGQVSP---KSDVYGY 399
T E+ V+P + G
Sbjct: 180 TPEF-----VAPEIVNYEPLGL 196
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 28/130 (21%), Positives = 55/130 (42%), Gaps = 2/130 (1%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L ++++ +F L + + S ++ + + ++++ LT +
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AV 239
Query: 62 PP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
P + L L+ L+L N + EL L+ + L L+ V P + L YL+
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299
Query: 121 DLNLSFNRLK 130
LN+S N+L
Sbjct: 300 VLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 25/131 (19%), Positives = 53/131 (40%), Gaps = 4/131 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L + N++ ++ F +L ++ S + N L + + + ++ L + LT
Sbjct: 109 LDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-S 166
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
IP + L L +L L + + SF L L+ L++S + + + L
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226
Query: 120 KDLNLSFNRLK 130
L+++ L
Sbjct: 227 TSLSITHCNLT 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 33/138 (23%), Positives = 61/138 (44%), Gaps = 5/138 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L LG N + ++ F + + + + N + ++ N+ + + L N L
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRLK-L 94
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
IP GL+NL L + N++ + F +L +L+SL++ N+L + + L L
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSL 154
Query: 120 KDLNLSFNRLKGDIPTRS 137
+ L L L IPT +
Sbjct: 155 EQLTLEKCNLT-SIPTEA 171
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 28/130 (21%), Positives = 58/130 (44%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L +G N+L + F LNS+ +L + ++ ++ + L +
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ L L++L + + + + +L SL ++ NL+ V +++ LVYL+
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251
Query: 121 DLNLSFNRLK 130
LNLS+N +
Sbjct: 252 FLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 28/129 (21%), Positives = 51/129 (39%), Gaps = 5/129 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ +V + D N + + + + E+ L+ N ++ +
Sbjct: 16 VLCHRKRFVAVPEGIPTETRLL---DLGKNRIKTLNQDEFASFPHLEELELNENIVS-AV 71
Query: 62 PP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
P L NL+ L L +NRL+ F L++L LD+S N + ++ + L LK
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131
Query: 121 DLNLSFNRL 129
L + N L
Sbjct: 132 SLEVGDNDL 140
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 27/130 (20%), Positives = 53/130 (40%), Gaps = 4/130 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD-IENMKVVVEINLSRNYLTGD 60
L + + ++ S + +L ++P + ++ + +NLS N ++
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
I ++ L LQ + L +L P +F L L L++S N L+ + + L
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322
Query: 120 KDLNLSFNRL 129
+ L L N L
Sbjct: 323 ETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 25/107 (23%), Positives = 48/107 (44%), Gaps = 4/107 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
LS+ L++V +L + + S N ++ ++ + + + EI L L
Sbjct: 229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-V 286
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS 106
+ P GL L++L++ N+L F + +LE+L L N L+
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 26/82 (31%), Positives = 37/82 (45%), Gaps = 3/82 (3%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
+ R +P I T +LL L NR++ + F LE L+L+ N +S V
Sbjct: 15 AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 109 IPISLEKLVYLKDLNLSFNRLK 130
P + L L+ L L NRLK
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLK 93
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 42/181 (23%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKV---FHLQFDGALKSFDAECE 266
+++ L + F +IG G+FG V + + +V A+K+ + + F E +
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
VL + + + + + + N LV++Y G L L L + ++ +
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESMRTQTL-ATIE 383
A++ +H VH DIKP N+L+D + H L+DFG L ++++ T +
Sbjct: 187 AIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 384 Y 384
Y
Sbjct: 242 Y 242
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 44/184 (23%), Positives = 79/184 (42%), Gaps = 35/184 (19%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRH 273
DHF IG GSFG V + D ++ A+K +++ E ++++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI----------- 322
LV + S + +V++ + G D+ L +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGG-------------DLRYHLQQNVHFKEETVKLFI 121
Query: 323 -DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA- 380
++ +AL+YL + ++H D+KP N+LLD+ H++DF IA +L + T+A
Sbjct: 122 CELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML--PRETQITTMAG 176
Query: 381 TIEY 384
T Y
Sbjct: 177 TKPY 180
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 40/189 (21%), Positives = 74/189 (39%), Gaps = 45/189 (23%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKV-------------FHLQFDGALKSFD 262
+ + + +G G++G V + E AIKV + + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 263 AECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL---- 318
E +LKS+ H N++K+ + + LV E+ G L F+++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRH 141
Query: 319 --------SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKL 367
+IM + + YLH + +VH DIKP N+LL + + + DFG++
Sbjct: 142 KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 368 LNGKESMRT 376
+ +R
Sbjct: 199 FSKDYKLRD 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKV---FHLQFDGALKSFDAECE 266
+E+ L D F +IG G+F V + +V A+K+ + + G + F E +
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
VL + R + ++ + + N+ LV+EY G L L + + ++ +
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESMRTQTL-ATIE 383
A++ +H VH DIKP N+LLD H L+DFG L ++R+ T +
Sbjct: 174 AIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 384 Y 384
Y
Sbjct: 229 Y 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 48/162 (29%), Positives = 86/162 (53%), Gaps = 20/162 (12%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKII 280
+G+G+FG V G L G +VA+K+ ++ + E + LK RH +++K+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILD------IFQRLSIMIDVALALEYLHFG 334
S +V+EY++ G L + +G ++ +FQ++ + A++Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQI---LS---AVDYCH-- 128
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT 376
+ VVH D+KP NVLLD M A ++DFG++ +++ E +RT
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 42/191 (21%), Positives = 74/191 (38%), Gaps = 32/191 (16%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHR-NLVKIIS 281
+G G F V + G E A K + G E VL+ + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 282 SCSNGNFEALVLEYMANGSL-EKCLYSSNGILDIFQRLS------IMIDVALALEYLHFG 334
N + L+LEY A G + C + ++ + +S ++ + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLH-- 148
Query: 335 YSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVS 391
N +VH D+KP N+LL + DFG+++ + +R + T EY ++
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE-IMGTPEY-----LA 201
Query: 392 P---KSDVYGY 399
P D
Sbjct: 202 PEILNYDPITT 212
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 30/130 (23%), Positives = 54/130 (41%), Gaps = 3/130 (2%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L +N + S+ F + S++ D + E + + +NL +
Sbjct: 151 ELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
P + L L+ L + N P SF L+SL+ L + + +S + + + L L
Sbjct: 211 M--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268
Query: 120 KDLNLSFNRL 129
+LNL+ N L
Sbjct: 269 VELNLAHNNL 278
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L LG N + + F L S+ + + N L +P E + + E+ L N +
Sbjct: 104 LQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-S 161
Query: 61 IPPTI-GGLTNLQLLSL-ENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
IP + +L L L E +L+ +F L +L+ L+L + N+ +P +L LV
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVG 219
Query: 119 LKDLNLSFNRL 129
L++L +S N
Sbjct: 220 LEELEMSGNHF 230
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 6/137 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L+L N + + TF +L+ + NS+ + + + + + L N+LT
Sbjct: 80 LNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-V 137
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS-VNNLSGVIPISLEKLVY 118
IP L+ L+ L L NN ++ +F + SL LDL + L + + E L
Sbjct: 138 IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN 197
Query: 119 LKDLNLSFNRLKGDIPT 135
LK LNL +K D+P
Sbjct: 198 LKYLNLGMCNIK-DMPN 213
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 7/132 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSR-NYLTG 59
L L N L+ + F L+ + +N + S+P + ++ ++L L
Sbjct: 128 LELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE- 185
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
I GL NL+ L+L ++ +P + L LE L++S N+ + P S L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 119 LKDLNLSFNRLK 130
LK L + +++
Sbjct: 244 LKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 32/127 (25%), Positives = 61/127 (48%), Gaps = 3/127 (2%)
Query: 2 LSLGS-NELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L LG +L + F L ++ + ++ +P ++ + + E+ +S N+
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEI 233
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
P + GL++L+ L + N+++ +F L SL L+L+ NNLS + L YL
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293
Query: 121 DLNLSFN 127
+L+L N
Sbjct: 294 ELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 5/111 (4%)
Query: 21 NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP-TIGGLTNLQLLSLENN 79
N + L+ +P I +NL N + I T L +L++L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
++ +F L SL +L+L N L+ + + E L L++L L N ++
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE 160
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 21/105 (20%), Positives = 38/105 (36%), Gaps = 4/105 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L+LG + + L + + S N P + + ++ + + ++ I
Sbjct: 201 LNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LI 257
Query: 62 PP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
GL +L L+L +N L + F L L L L N
Sbjct: 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 18/82 (21%), Positives = 35/82 (42%), Gaps = 2/82 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L + N + P +F L+S+ ++ ++ + + +VE+NL+ N L+ +
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-L 281
Query: 62 PP-TIGGLTNLQLLSLENNRLQ 82
P L L L L +N
Sbjct: 282 PHDLFTPLRYLVELHLHHNPWN 303
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 23/131 (17%), Positives = 52/131 (39%), Gaps = 4/131 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
++ ++ + + + + + + + + + + ++ + N +
Sbjct: 56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-Y 113
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+PP + + L +L LE N L F L +L +S NNL + + + L
Sbjct: 114 LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSL 173
Query: 120 KDLNLSFNRLK 130
++L LS NRL
Sbjct: 174 QNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 8e-16
Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L+L ++ + F ++I N++ LP + +N+ ++ + L RN L+
Sbjct: 80 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-S 137
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+P I L LS+ NN L+ ++F TSL++L LS N L+ + L + L
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSL 194
Query: 120 KDLNLSFNRLK 130
N+S+N L
Sbjct: 195 FHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 30/132 (22%), Positives = 53/132 (40%), Gaps = 9/132 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N L+ + N ++ D S N L + M+ + + +S N L
Sbjct: 237 LKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ + L++L L +N L + + + LE+L L N++ + L LK
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLK 348
Query: 121 DLNLSFNRLKGD 132
+L LS N +
Sbjct: 349 NLTLSHNDWDCN 360
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 39/158 (24%), Positives = 60/158 (37%), Gaps = 25/158 (15%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP-------LDIENMKVVV----- 48
NL L SN L+ V S +L + S N L+ +L LD + + V
Sbjct: 175 NLQLSSNRLTHVDLSLIPSLFHA---NVSYNLLS-TLAIPIAVEELDASHNSINVVRGPV 230
Query: 49 -----EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN 103
+ L N LT + L + L N L+ + F ++ LE L +S N
Sbjct: 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 288
Query: 104 NLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
L + + + + LK L+LS N L + P
Sbjct: 289 RLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 324
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 25/132 (18%), Positives = 51/132 (38%), Gaps = 4/132 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
++ + LN+ F ++++ LP + ++ + V +NL+ +
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 88
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+I +Q L + N ++ P F + L L L N+LS +
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148
Query: 119 LKDLNLSFNRLK 130
L L++S N L+
Sbjct: 149 LTTLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 15/119 (12%), Positives = 40/119 (33%), Gaps = 2/119 (1%)
Query: 13 IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTI-GGLTNL 71
I S + + + + + + + +P + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 72 QLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
+LL+L + +++ +F +++ L + N + + P + + L L L N L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 43/190 (22%), Positives = 87/190 (45%), Gaps = 19/190 (10%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
D + + LIG GS+G V + L+ VAIK F+ D E +L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILNR 108
Query: 271 VRHRNLVK---IISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVA 325
+ H ++VK I+ F+ +VLE + +K + + ++ + +++ ++
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIK-TLLYNLL 166
Query: 326 LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG 385
+ ++Y+H S ++H D+KP+N L++ D + DFG+A+ ++ E+ +Q +
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 386 REGQVSPKSD 395
V+
Sbjct: 224 DMNLVTFPHT 233
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 16/149 (10%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DG----ALKSFDAECEVLKSVRHRNLVK 278
IG G++G VYK R G VA+K L +G A++ E +LK + H N+VK
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNIVK 66
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSN 337
++ N LV E++ + L+K + +S + + S + + L + H S+
Sbjct: 67 LLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SH 122
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
V+H D+KP N+L++ + L+DFG+A+
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 6/135 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
+ L N ++ + ++F L + + + + + ++ + L N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPI--PESFGELTSLESLDLSVNNLSGVIPISL-EK 115
+ GL NL++L+L L G + F LTSLE L L NN+ + P S
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 116 LVYLKDLNLSFNRLK 130
+ L+L+FN++K
Sbjct: 153 MRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 37/132 (28%), Positives = 58/132 (43%), Gaps = 6/132 (4%)
Query: 3 SLGSNELSSVIPSTFWNL--NSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
S G TF L + + + D S + + +L + + + ++ L++N +
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN- 312
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
I GLT+L L+L N L F L LE LDLS N++ + S L
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN 372
Query: 119 LKDLNLSFNRLK 130
LK+L L N+LK
Sbjct: 373 LKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 29/128 (22%), Positives = 60/128 (46%), Gaps = 4/128 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L +++ +++ S F + + + N +N + + + ++++NLS+N+L
Sbjct: 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-S 337
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
I + L L++L L N ++ +SF L +L+ L L N L V ++L L
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSL 397
Query: 120 KDLNLSFN 127
+ + L N
Sbjct: 398 QKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 25/114 (21%), Positives = 42/114 (36%), Gaps = 11/114 (9%)
Query: 21 NSILSFDFSSNSLNG--SLPLDIENMKVVVEINLSRNYLTGDIPPT-IGGLTNLQLLSLE 77
+ + L+ LP + ++LS N + ++ T L +LQ L +E
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNY------VDLSLNSIA-ELNETSFSRLQDLQFLKVE 62
Query: 78 NNRLQGPIPE-SFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
I +F L+SL L L N + + L L+ L L+ L
Sbjct: 63 QQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L+L NE++ + + FW L +L + S N L GS+ + EN+ + ++LS N++
Sbjct: 303 QLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRA 361
Query: 60 DIPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
+ + GL NL+ L+L+ N+L+ F LTSL+ + L N
Sbjct: 362 -LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 29/170 (17%), Positives = 55/170 (32%), Gaps = 13/170 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGS-LPLDI-ENMKVVVEINLSRNYLTG 59
L L N+ + F L ++ + +L+G+ L + + + + + L N +
Sbjct: 84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK 143
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTS--LESLDLSVNNL--------SGV 108
P + + +L L N+++ E L LS L
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWE 203
Query: 109 IPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQVPLCKSSSHRKSSKNVI 158
+ K + L+LS N K + R S +S N+
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 20/170 (11%), Positives = 53/170 (31%), Gaps = 29/170 (17%)
Query: 2 LSLGSNELSSVIPST-FWNLNSILSFDFSSNSLN----------GSLPLDIENMKVVVEI 50
L L N + + P++ F N+ D + N + + + +
Sbjct: 134 LVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ 193
Query: 51 NLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESL------------ 98
+++ +L + T++ L L N + + + F + + +
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 99 -DLSVNNLSGVIPISLEKLVY--LKDLNLSFNRLK---GDIPTRSPHLQV 142
N + + L +K +LS +++ + + L+
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQ 303
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 45/181 (24%), Positives = 69/181 (38%), Gaps = 21/181 (11%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIK-VFHLQFDGAL-----KSFDA-----EC 265
++ + I GS+G V G +G+ VAIK VF+ DG SF E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 266 EVLKSVRHRNLVK---IISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSI 320
+L H N++ I LV E M L + ++ ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139
Query: 321 MIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA 380
M + L L LH VVH D+ P N+LL D+ + DF +A+ + T +
Sbjct: 140 MYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVT 195
Query: 381 T 381
Sbjct: 196 H 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 33/130 (25%), Positives = 51/130 (39%), Gaps = 3/130 (2%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L N L + +T + + L L +D + V+ ++LS N L
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-S 91
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+P L L +L + NRL + L L+ L L N L + P L L+
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151
Query: 121 DLNLSFNRLK 130
L+L+ N L
Sbjct: 152 KLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-16
Identities = 41/130 (31%), Positives = 58/130 (44%), Gaps = 5/130 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L+L EL+ + L + + D S N L SLPL + + + +++S N LT +
Sbjct: 60 LNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 62 PPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
P GL LQ L L+ N L+ P LE L L+ NNL+ + L L L
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 121 DLNLSFNRLK 130
L L N L
Sbjct: 176 TLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 39/128 (30%), Positives = 53/128 (41%), Gaps = 6/128 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N+L S +P L ++ D S N L SLPL + + E+ L N L
Sbjct: 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-T 138
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+PP + L+ LSL NN L L +L++L L N+L IP L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLL 197
Query: 120 KDLNLSFN 127
L N
Sbjct: 198 PFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 24/92 (26%), Positives = 39/92 (42%), Gaps = 6/92 (6%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
E+N + LT +PP + + +L L N L + T L L+L L+
Sbjct: 14 EVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-K 69
Query: 109 IPISLEKLVYLKDLNLSFNRLKGDIPTRSPHL 140
+ + L L L+LS N+L+ +P L
Sbjct: 70 LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTL 99
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 50/162 (30%), Positives = 88/162 (54%), Gaps = 20/162 (12%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 280
+G+G+FG V G+ L G +VA+K+ + ++ + E + LK RH +++K+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILD------IFQRLSIMIDVALALEYLHFG 334
S + +V+EY++ G L + NG LD +FQ++ + ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQI---LS---GVDYCH-- 133
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT 376
+ VVH D+KP NVLLD M A ++DFG++ +++ E +RT
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 43/176 (24%)
Query: 223 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEV---LKSVRHRNLVK 278
K ++G+G G V + G + A+K+ + S A EV ++ ++V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVC 86
Query: 279 IISSCSNGNFEA----LVLEYMANGSLEKCLYSSNGILD-IFQRLS----------IMID 323
I+ N + +++E M G L I +R IM D
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRD 136
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKESMRT 376
+ A+++LH S+ + H D+KP N+L + D V L+DFG AK +++T
Sbjct: 137 IGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQT 188
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 5/142 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSL-NGSLPLDIENMKVVVEINLSRNYLTG 59
L + N + V F L ++ + N L N + + + +S LT
Sbjct: 127 ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT- 185
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
IP L L L++N++Q E + L L L N + + SL L L
Sbjct: 186 GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTL 243
Query: 120 KDLNLSFNRLKGDIPTRSPHLQ 141
++L+L N+L +P P L+
Sbjct: 244 RELHLDNNKLS-RVPAGLPDLK 264
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 27/136 (19%), Positives = 51/136 (37%), Gaps = 12/136 (8%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L + +L+ + LN + N + D+ + + L N + I
Sbjct: 177 LRISEAKLTGIPKDLPETLNEL---HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MI 232
Query: 62 PP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP------ISLE 114
++ L L+ L L+NN+L +P +L L+ + L NN++ V
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV 291
Query: 115 KLVYLKDLNLSFNRLK 130
K Y ++L N +
Sbjct: 292 KRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 19/135 (14%), Positives = 44/135 (32%), Gaps = 9/135 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L N++ ++ + + N + + + + E++L N L+ +
Sbjct: 198 LHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RV 256
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESF------GELTSLESLDLSVNNLS--GVIPISL 113
P + L LQ++ L N + F + + L N + V P +
Sbjct: 257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316
Query: 114 EKLVYLKDLNLSFNR 128
+ + +
Sbjct: 317 RCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 26/133 (19%), Positives = 46/133 (34%), Gaps = 14/133 (10%)
Query: 2 LSLGSNELSSV---IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT 58
+ L +V I L D +N ++ D + ++ + + L N ++
Sbjct: 38 VQCSDLGLKAVPKEISPDTTLL------DLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 59 GDIPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
I L LQ L + N L IP +SL L + N + V L
Sbjct: 92 -KIHEKAFSPLRKLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 118 YLKDLNLSFNRLK 130
+ + + N L+
Sbjct: 148 NMNCIEMGGNPLE 160
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 25/90 (27%), Positives = 38/90 (42%), Gaps = 4/90 (4%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
+ S L +P I + LL L+NN + + F L L +L L N +S +
Sbjct: 37 VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKI 93
Query: 109 IPISLEKLVYLKDLNLSFNRLKGDIPTRSP 138
+ L L+ L +S N L +IP P
Sbjct: 94 HEKAFSPLRKLQKLYISKNHLV-EIPPNLP 122
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 38/174 (21%), Positives = 66/174 (37%), Gaps = 48/174 (27%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEV---LKSVRH 273
D+ ++G+G G V + + A+K+ A EV ++ +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQC 70
Query: 274 RNLVKIISSCSNGNFEA----LVLEYMANGSLEKCLYSSNGILDIFQRL----------- 318
++V+I+ N +V+E + G L F R+
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTER 117
Query: 319 ---SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAK 366
IM + A++YLH S + H D+KP N+L + + L+DFG AK
Sbjct: 118 EASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 36/163 (22%), Positives = 67/163 (41%), Gaps = 23/163 (14%)
Query: 222 EKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
E +G G++G VYK + D + A+K G S E +L+ ++H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVIS 82
Query: 279 ---IISSCSNGNFEALVLEYMA-------NGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
+ S ++ L+ +Y L S++ + +
Sbjct: 83 LQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAH----LSDFGIAKL 367
YLH +N V+H D+KP+N+L+ + ++D G A+L
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DG----ALKSFDAECEVLKSVRHRNLVKI 279
+G G++ TVYKG G+ VA+K L +G A++ E ++K ++H N+V++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRL 68
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSN-----GILDIFQRLSIMIDVALALEYLHFG 334
N LV E+M + L+K + S L++ + L + H
Sbjct: 69 YDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH-- 125
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
N ++H D+KP N+L++ L DFG+A
Sbjct: 126 -ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 30/130 (23%), Positives = 51/130 (39%), Gaps = 3/130 (2%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L +N + S+ F + S+ D + E + + +NL+ L
Sbjct: 140 ELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
P + L L L L N L P SF L L+ L + + + + + + L L
Sbjct: 200 I--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257
Query: 120 KDLNLSFNRL 129
++NL+ N L
Sbjct: 258 VEINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 6/137 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L+L N++ + ++F +L + S N + ++ + + + + L N LT
Sbjct: 69 LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-T 126
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS-VNNLSGVIPISLEKLVY 118
IP L+ L+ L L NN ++ +F + SL LDL + LS + + E L
Sbjct: 127 IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN 186
Query: 119 LKDLNLSFNRLKGDIPT 135
L+ LNL+ L+ +IP
Sbjct: 187 LRYLNLAMCNLR-EIPN 202
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 7/132 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSR-NYLTG 59
L L N L+++ F L+ + +N + S+P + + ++L L+
Sbjct: 117 LELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS- 174
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
I GL+NL+ L+L L+ IP + L L+ LDLS N+LS + P S + L++
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 119 LKDLNLSFNRLK 130
L+ L + ++++
Sbjct: 233 LQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 5/128 (3%)
Query: 2 LSLGS-NELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L LG LS + F L+++ + + +L +P ++ + + E++LS N+L+
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA- 221
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
I P + GL +LQ L + +++Q +F L SL ++L+ NNL+ + L +L
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281
Query: 120 KDLNLSFN 127
+ ++L N
Sbjct: 282 ERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 30/127 (23%), Positives = 55/127 (43%), Gaps = 6/127 (4%)
Query: 14 PSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGDIPPTIGGLTNLQ 72
PS N +L +P I N ++ +NL N + + L +L+
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGISTNTRL---LNLHENQIQIIKVNSFKHLRHLE 91
Query: 73 LLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132
+L L N ++ +F L +L +L+L N L+ + + L LK+L L N ++
Sbjct: 92 ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-S 150
Query: 133 IPTRSPH 139
IP+ + +
Sbjct: 151 IPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 21/105 (20%), Positives = 40/105 (38%), Gaps = 4/105 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L+L L + L + D S N L+ P + + + ++ + ++ + I
Sbjct: 190 LNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VI 246
Query: 62 PP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
L +L ++L +N L + F L LE + L N
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 21/81 (25%), Positives = 36/81 (44%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L N LS++ P +F L + + + +N++ +VEINL+ N LT
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271
Query: 62 PPTIGGLTNLQLLSLENNRLQ 82
L +L+ + L +N
Sbjct: 272 HDLFTPLHHLERIHLHHNPWN 292
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 24/193 (12%)
Query: 205 WRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKS 260
W+ Q + D F + ++G G FG V+ + ++ A K L+ +
Sbjct: 174 WKWLEAQPMGE--DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 261 FDAECEVLKSVRHRNLVKIISSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGILDIF 315
E ++L V R +V + + FE LV+ M G + +Y+ + F
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 316 --QRLSIMI-DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372
R + LE+LH +++ D+KP NVLLDDD +SD G+A
Sbjct: 287 QEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAG 342
Query: 373 SMRTQTLA-TIEY 384
+T+ A T +
Sbjct: 343 QTKTKGYAGTPGF 355
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 26/141 (18%), Positives = 53/141 (37%), Gaps = 2/141 (1%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N LS++ S F L+S+ + N + ++ + + +
Sbjct: 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
I GLT L+ L ++ + LQ P+S + ++ L L + ++ I ++ +
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224
Query: 120 KDLNLSFNRLKGDIPTRSPHL 140
+ L L L +
Sbjct: 225 ECLELRDTDLDTFHFSELSTG 245
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 35/133 (26%), Positives = 58/133 (43%), Gaps = 6/133 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L SN ++++ +F +L S+ D S N L +L + + + +NL N
Sbjct: 81 LVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-T 138
Query: 61 IPPTI--GGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSVNNLSGVIPISLEKLV 117
+ T LT LQ+L + N I F LT LE L++ ++L P SL+ +
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198
Query: 118 YLKDLNLSFNRLK 130
+ L L +
Sbjct: 199 NVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 21/138 (15%), Positives = 49/138 (35%), Gaps = 10/138 (7%)
Query: 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L+L N ++ S F +L + + + + + E+ + + L
Sbjct: 129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV----IPI---- 111
P ++ + N+ L L + + +S+E L+L +L +
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 112 SLEKLVYLKDLNLSFNRL 129
SL K +++ ++ L
Sbjct: 249 SLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 29/133 (21%), Positives = 62/133 (46%), Gaps = 6/133 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L +N ++ + S ++ + +SN +N ++ D ++ + ++LS NYL+ +
Sbjct: 57 LDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-N 114
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPI-SLEKLV 117
+ + L++L L+L N + S F LT L+ L + + I L
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 118 YLKDLNLSFNRLK 130
+L++L + + L+
Sbjct: 175 FLEELEIDASDLQ 187
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 19/134 (14%), Positives = 50/134 (37%), Gaps = 9/134 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG-- 59
L + +++L S P + ++ ++ L + ++ V + L L
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238
Query: 60 --DIPP----TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISL 113
++ ++ + + + + L + + +++ L L+ S N L V
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIF 297
Query: 114 EKLVYLKDLNLSFN 127
++L L+ + L N
Sbjct: 298 DRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 17/113 (15%), Positives = 39/113 (34%), Gaps = 11/113 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE--------NMKVVVEINLS 53
L L + ++ +S+ + L+ ++ + ++
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262
Query: 54 RNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNL 105
L + + ++ L L N+L+ +P+ F LTSL+ + L N
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 40/104 (38%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 29 SSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGDIPPTI-GGLTNLQLLSLENNRLQGPIP 86
SS SLN S+P + E +K ++LS N +T I + NLQ L L +N +
Sbjct: 39 SSGSLN-SIPSGLTEAVKS---LDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 87 ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
+SF L SLE LDLS N LS + + L L LNL N K
Sbjct: 94 DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK 137
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 20/141 (14%), Positives = 53/141 (37%), Gaps = 12/141 (8%)
Query: 1 NLSLGSNE-LSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG 59
L +G+ + + + F L + + ++ L P +++++ V + L
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI- 211
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGP--------IPESFGELTSLESLDLSVNNLSGVIP 110
+ ++++ L L + L S + + ++ ++ +L +
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 111 ISLEKLVYLKDLNLSFNRLKG 131
L ++ L +L S N+LK
Sbjct: 271 KLLNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 21/80 (26%), Positives = 35/80 (43%), Gaps = 3/80 (3%)
Query: 51 NLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP 110
S L IP + ++ L L NNR+ +L++L L+ N ++ +
Sbjct: 37 KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 111 ISLEKLVYLKDLNLSFNRLK 130
S L L+ L+LS+N L
Sbjct: 94 DSFSSLGSLEHLDLSYNYLS 113
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVK 278
+G G++G VYK VAIK L+ + A++ E +LK ++HRN+++
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
+ S + + L+ EY N L+K + N + + S + + + + H S
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRR 152
Query: 339 VVHCDIKPSNVLLDDDMVAH-----LSDFGIAK 366
+H D+KP N+LL + + DFG+A+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 23/155 (14%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIK--VFHLQFDG----ALKSFDAECEVLKSVRHRNLVK 278
IG G+FG V+K R G +VA+K + + +G AL+ E ++L+ ++H N+V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80
Query: 279 ---IISSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEY 330
I + ++ LV ++ + L L + + + +M + L Y
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
+H N ++H D+K +NVL+ D V L+DFG+A
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 25/163 (15%)
Query: 226 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVRHRNLVKI 279
IG G+F V R L G EVAIK+ L E ++K + H N+VK+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 280 ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILD------IFQRLSIMIDVALALEYLHF 333
L++EY + G + L ++G + F+++ A++Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQI------VSAVQYCH- 131
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT 376
+VH D+K N+LLD DM ++DFG + +
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+++ +IG GSFG VY+ + D G VAIK + E ++++ + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 276 LVK----IISSCSNGNFEAL--VLEYMANGSLEKCLY-------SSNGILDIFQRLSIMI 322
+V+ SS + L VL+Y+ + +Y + L + M
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 323 DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGKESM 374
+ +L Y+H S + H DIKP N+LLD D V L DFG AK L E
Sbjct: 164 QLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 4/129 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
+ L N + + P F + D S+N ++ L D + ++ + + L N +T
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
++P ++ GL +LQLL L N++ ++F +L +L L L N L + + L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 119 LKDLNLSFN 127
++ ++L+ N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-11
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 2/85 (2%)
Query: 47 VVEINLSRNYLTGDIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
+ EI L +N + IPP L+ + L NN++ P++F L SL SL L N +
Sbjct: 34 ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 106 SGVIPISLEKLVYLKDLNLSFNRLK 130
+ + E L L+ L L+ N++
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKIN 117
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 41/163 (25%), Positives = 64/163 (39%), Gaps = 24/163 (14%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVF--HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 281
IG G+FG R L VA+K D ++ E +S+RH N+V+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIINHRSLRHPNIVRFKE 83
Query: 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILD------IFQRLSIMIDVALALEYLHFGY 335
A+++EY + G L + + + G FQ+L + + Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQL---LS---GVSYCH--- 133
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHL--SDFGIAKLLNGKESMRT 376
S + H D+K N LLD L DFG +K ++
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 46/132 (34%), Positives = 69/132 (52%), Gaps = 6/132 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N+L ++ F L ++ + + N L +LP+ + + + + E+ L RN L
Sbjct: 66 LYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-S 123
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+PP + LT L LSL N LQ +P+ F +LTSL+ L L N L V + +KL
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182
Query: 119 LKDLNLSFNRLK 130
LK L L N+LK
Sbjct: 183 LKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 43/133 (32%), Positives = 64/133 (48%), Gaps = 6/133 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L SN+LSS+ F L + + N L +LP I + +K + + ++ N L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPISLEKLV 117
+P + L NL L L+ N+L+ +P F LT L L L N L + +KL
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157
Query: 118 YLKDLNLSFNRLK 130
LK+L L N+LK
Sbjct: 158 SLKELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 4/128 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L + N+L ++ F L ++ N L SLP + +++ + ++L N L
Sbjct: 90 LWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-S 147
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+P + LT+L+ L L NN+L+ +F +LT L++L L N L V + + L L
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL 207
Query: 120 KDLNLSFN 127
K L L N
Sbjct: 208 KMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 3/82 (3%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
++ S LT IP I + + L L++N+L ++F LT L L L+ N L +
Sbjct: 20 SVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76
Query: 109 IPISLEKLVYLKDLNLSFNRLK 130
++L L+ L ++ N+L+
Sbjct: 77 PAGIFKELKNLETLWVTDNKLQ 98
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 46/176 (26%), Positives = 69/176 (39%), Gaps = 27/176 (15%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIK-VF-HLQFDGALKSFDAECEVLKSVRH 273
D F + + G G+FGTV G+ GM VAIK V +F + + L + H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNREL-QIMQDLAVLHH 78
Query: 274 RNLVK---IISSCSNGNFE----ALVLEYMANGSLEKCLY-------SSNGILDIFQRLS 319
N+V+ + + +V+EY+ L+
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 320 IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKESM 374
+ + ++ LH N V H DIKP NVL++ D L DFG AK L+ E
Sbjct: 134 FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 41/159 (25%), Positives = 63/159 (39%), Gaps = 19/159 (11%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIK------VFHLQFDGALKSFDAECEVLKSVRHR--N 275
L+G G FG+VY G D + VAIK + E +LK V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLY---SSNGILDIFQRLSIMIDVALALEYLH 332
+++++ + L+LE + L+ + G L S V A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 333 FGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNG 370
+ V+H DIK N+L+D + L DFG LL
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 280
+G GSFG V + +VA+K L+ + E LK +RH +++K+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILD------IFQRLSIMIDVALALEYLHFG 334
+ +V+EY A G L + + FQ++ I A+EY H
Sbjct: 76 DVITTPTDIVMVIEY-AGGELFDYI-VEKKRMTEDEGRRFFQQI---IC---AIEYCH-- 125
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT 376
+ +VH D+KP N+LLDD++ ++DFG++ ++ ++T
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 8/136 (5%)
Query: 1 NLSLGSNELSSVIPST-FWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLT 58
L L N LS + L ++ S S N LN + + + + ++LS N+L
Sbjct: 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 59 GDIPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP---ISLE 114
+ L L++L L NN + +F ++ L+ L LS N +S
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGN 160
Query: 115 KLVYLKDLNLSFNRLK 130
KL L L+LS N+LK
Sbjct: 161 KLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 31/131 (23%), Positives = 54/131 (41%), Gaps = 7/131 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N L+ + F + ++ D SSN L+ +L + +++ + + L N++
Sbjct: 69 LLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-V 126
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFG---ELTSLESLDLSVNNLSGVIPISLEKL 116
+ + LQ L L N++ E +L L LDLS N L + L+KL
Sbjct: 127 VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186
Query: 117 VYLKDLNLSFN 127
L +
Sbjct: 187 PAWVKNGLYLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 37/135 (27%), Positives = 58/135 (42%), Gaps = 14/135 (10%)
Query: 2 LSLGSNELSSV---IPSTFWNLNSILSFDFSSNSLNGSLPLDI--ENMKVVVEINLSRNY 56
LS +L +V +PS L D S N+L L + + + + LS N+
Sbjct: 23 LSCSKQQLPNVPQSLPSYTALL------DLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 57 LTGDIPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEK 115
L I + NL+ L L +N L F +L +LE L L N++ V + E
Sbjct: 76 LN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134
Query: 116 LVYLKDLNLSFNRLK 130
+ L+ L LS N++
Sbjct: 135 MAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 24/108 (22%), Positives = 47/108 (43%), Gaps = 7/108 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L SN L ++ F +L ++ +N + + + E+M + ++ LS+N ++
Sbjct: 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-R 150
Query: 61 IPP----TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNN 104
P L L LL L +N+L+ +L + L ++N
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 45/188 (23%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSV 271
F +G GSFG V+ R A+KV L+ + ++ E +L V
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI--------- 322
H ++++ + + ++++Y+ G L F L
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGEL-------------FSLLRKSQRFPNPVAKF 110
Query: 323 ---DVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESMRTQ 377
+V LALEYLH S +++ D+KP N+LLD + H ++DFG AK + T
Sbjct: 111 YAAEVCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPD----VTY 161
Query: 378 TL-ATIEY 384
TL T +Y
Sbjct: 162 TLCGTPDY 169
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 21/142 (14%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
LS+ N+L+S +P+ L + +N L SLP+ ++ E+++S N L
Sbjct: 145 ELSVSDNQLAS-LPALPSELCKL---WAYNNQLT-SLPMLPSGLQ---ELSVSDNQLA-S 195
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+P L L NNRL +P + L+ L +S N L+ +P+ + LK
Sbjct: 196 LPTLPSELYKLWAY---NNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVLPSE---LK 244
Query: 121 DLNLSFNRLKGDIPTRSPHLQV 142
+L +S NRL +P L
Sbjct: 245 ELMVSGNRLT-SLPMLPSGLLS 265
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 38/130 (29%), Positives = 57/130 (43%), Gaps = 17/130 (13%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
LS+ N+L+S +P+ L + +N L SLP +K E+ +S N LT
Sbjct: 185 ELSVSDNQLAS-LPTLPSELYKL---WAYNNRLT-SLPALPSGLK---ELIVSGNRLT-S 235
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+P L+ L + NRL +P + L SL + N L+ +P SL L
Sbjct: 236 LPVLPS---ELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSET 287
Query: 121 DLNLSFNRLK 130
+NL N L
Sbjct: 288 TVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 35/154 (22%), Positives = 58/154 (37%), Gaps = 28/154 (18%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L++G + L++ +P I + N+L SLP ++ + +S N LT +
Sbjct: 45 LNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLT-SL 96
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGEL--------------TSLESLDLSVNNLSG 107
P GL L + S L +P +L L+ L +S N L+
Sbjct: 97 PVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA- 154
Query: 108 VIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
+P + L L N+L +P LQ
Sbjct: 155 SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQ 184
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 13/128 (10%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L +N L+S +P+ L + S N L SLP+ +K E+ +S N LT
Sbjct: 205 KLWAYNNRLTS-LPALPSGLKEL---IVSGNRLT-SLPVLPSELK---ELMVSGNRLT-S 255
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+P L LS+ N+L +PES L+S +++L N LS +L ++
Sbjct: 256 LPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311
Query: 121 DLNLSFNR 128
+ R
Sbjct: 312 GYSGPIIR 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 27/124 (21%), Positives = 50/124 (40%), Gaps = 10/124 (8%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L + N L+S +P L + S N L SLP+ + +++ RN LT +
Sbjct: 226 LIVSGNRLTS-LPVLPSELKEL---MVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RL 276
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P ++ L++ ++LE N L ++ E+TS + + S +
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD-MAGASAPRETRALH 335
Query: 122 LNLS 125
L +
Sbjct: 336 LAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 12/80 (15%), Positives = 26/80 (32%), Gaps = 20/80 (25%)
Query: 68 LTNLQLLSLENNRLQGPIPESFG------------------ELTSLESLDLSVNNLSGVI 109
+L++ + L +P+ L +L++S N L+ +
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-SL 96
Query: 110 PISLEKLVYLKDLNLSFNRL 129
P+ L+ L + L
Sbjct: 97 PVLPPGLLELSIFSNPLTHL 116
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 216 ATDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL-QFDGALKSFDAEC--EV---- 267
AT + + IG+G++GTVYK R G VA+K + G EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 268 -LKSVRHRNLVKIISSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGI-LDIFQRLSI 320
L++ H N+V+++ C+ + LV E++ L L + L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 321 MIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
M L++LH +N +VH D+KP N+L+ L+DFG+A+
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 25/178 (14%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFD---AECEVLKSVRH 273
D F +G GSFG V + + A+K+ Q LK + E +L++V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMI------DVALA 327
LVK+ S + + +V+EY+A G + L R S + L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLT 153
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-ATIEY 384
EYLH S +++ D+KP N+L+D ++DFG AK + G RT TL T E
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEA 204
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 41/190 (21%), Positives = 79/190 (41%), Gaps = 19/190 (10%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
D++ K LIG GS+G VY VAIK + F+ D E +L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE---DLIDCKRILREITILNR 81
Query: 271 VRHRNLVK---IISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVA 325
++ +++ +I F+ +VLE + L+K + + + + +I+ ++
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIK-TILYNLL 139
Query: 326 LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG 385
L ++H + ++H D+KP+N LL+ D + DFG+A+ +N ++
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 386 REGQVSPKSD 395
Sbjct: 197 PGPHNKNLKK 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 44/160 (27%), Positives = 63/160 (39%), Gaps = 19/160 (11%)
Query: 225 LIGIGSFGTVYKGR-FLDGMEVAIK------VFHLQFDGALKSFDAECEVLKSVR----H 273
L+G G FGTV+ G D ++VAIK V + E +L V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGS--LEKCLYSSNGILDIFQRLSIMIDVALALEYL 331
+++++ LVLE + + G L V A+++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 332 HFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNG 370
H S VVH DIK N+L+D A L DFG LL+
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 15/175 (8%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRH 273
+ F + ++G G FG V + ++ A K ++ E ++L+ V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF--QRLSIMI-DVALALEY 330
R +V + + + LVL M G L+ +Y F R ++ LE
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLED 301
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-TIEY 384
LH +V+ D+KP N+LLDD +SD G+A + E + T+ Y
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVGY 351
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 32/133 (24%), Positives = 59/133 (44%), Gaps = 8/133 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE---NMKVVVEINLSRNYLT 58
L +N L+ + +L + + N L L E MK + ++++S+N ++
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 59 GDIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
D +L L++ +N L I ++ LDL N + IP + KL
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLE 444
Query: 118 YLKDLNLSFNRLK 130
L++LN++ N+LK
Sbjct: 445 ALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 32/129 (24%), Positives = 61/129 (47%), Gaps = 6/129 (4%)
Query: 2 LSLGSNELSSV--IPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLT 58
L L N+L + I + S+ D S NS++ K ++ +N+S N LT
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
I + +++L L +N+++ IP+ +L +L+ L+++ N L V ++L
Sbjct: 413 DTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTS 469
Query: 119 LKDLNLSFN 127
L+ + L N
Sbjct: 470 LQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 6/104 (5%)
Query: 27 DFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIP 86
D S N L +P D+ + +N+S+NY++ I L+ L++L + +NR+Q
Sbjct: 6 DRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDI 62
Query: 87 ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
F LE LDLS N L IS V LK L+LSFN
Sbjct: 63 SVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFD 103
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 32/142 (22%), Positives = 57/142 (40%), Gaps = 3/142 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ S+ + +++ +F+ + L + + ++ S N LT +
Sbjct: 281 HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTV 340
Query: 62 PPTIGGLTNLQLLSLENNRLQ--GPIPESFGELTSLESLDLSVNNLSGVIP-ISLEKLVY 118
G LT L+ L L+ N+L+ I E ++ SL+ LD+S N++S
Sbjct: 341 FENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400
Query: 119 LKDLNLSFNRLKGDIPTRSPHL 140
L LN+S N L I P
Sbjct: 401 LLSLNMSSNILTDTIFRCLPPR 422
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 30/139 (21%), Positives = 54/139 (38%), Gaps = 6/139 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L++ N +S + S +L+ + S N + L + + + + + ++LS N L
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK 83
Query: 60 DIPPTIGGLTNLQLLSLENNRLQG-PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
I NL+ L L N PI + FG ++ L+ L LS +L + + L
Sbjct: 84 -IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 119 LKDLNLSFNRLKGDIPTRS 137
K L +
Sbjct: 141 SKVLLVLGETYGEKEDPEG 159
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 21/135 (15%), Positives = 46/135 (34%), Gaps = 7/135 (5%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-----ENMKVVVEINLSRN 55
N+ N ++ ++ F S+ L G L ++K + + +
Sbjct: 229 NIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286
Query: 56 YLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEK 115
+N+ + + + + +++ LD S N L+ + +
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346
Query: 116 LVYLKDLNLSFNRLK 130
L L+ L L N+LK
Sbjct: 347 LTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 27/171 (15%), Positives = 47/171 (27%), Gaps = 10/171 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD-IENMKVVVEINLSRNYLTGD 60
L + N + + S F + D S N L + N+K ++LS N
Sbjct: 50 LIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLK---HLDLSFNAFD-A 104
Query: 61 IPPT--IGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+P G ++ L+ L L L+ L + L + E L
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQD 162
Query: 119 LKDLNLSFNRLKGDIPTRSPHLQVPLCKSSSHRKSSKNVILLGVVLPLSVF 169
+L + V + + LS+
Sbjct: 163 FNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 27/143 (18%), Positives = 53/143 (37%), Gaps = 14/143 (9%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
++ +N+L+ +P +L + +N L LP E+++ +++S N L
Sbjct: 144 YINADNNQLTM-LPELPTSLEVL---SVRNNQLT-FLPELPESLE---ALDVSTNLLE-S 194
Query: 61 IPPTIGGLTNLQ----LLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKL 116
+P + + NR+ IPE+ L ++ L N LS I SL +
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
Query: 117 VYLKDLNLSFNRLKGDIPTRSPH 139
D + ++
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 32/161 (19%), Positives = 50/161 (31%), Gaps = 32/161 (19%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L N LS+ +P +L + D +N L LP ++ IN N LT
Sbjct: 104 YLDACDNRLST-LPELPASLKHL---DVDNNQLT-MLPELPALLE---YINADNNQLT-M 154
Query: 61 IPPTIGGLT-----------------NLQLLSLENNRLQGPIPESFGELTSLES----LD 99
+P L +L+ L + N L+ +P E
Sbjct: 155 LPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 100 LSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHL 140
N ++ IP ++ L + L N L I
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 17/147 (11%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILS----FDFSSNSLNGSLP-LDIENMKVVVEINLSRN 55
N SL N + I T+ + S + N ++ L + E+ L+R
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRL 69
Query: 56 YLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEK 115
L+ +P + + +L + N L +PE SLE LD N LS +P E
Sbjct: 70 NLS-SLPDNLP--PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLP---EL 118
Query: 116 LVYLKDLNLSFNRLKGDIPTRSPHLQV 142
LK L++ N+L +P L+
Sbjct: 119 PASLKHLDVDNNQLT-MLPELPALLEY 144
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 10/109 (9%)
Query: 36 SLPLDIENMKVVVEINLSRNYLTG---DIPPTIGGLTNLQLLSLENNRLQGPIPESFGEL 92
S+ L I N + N N ++G D L N + E +
Sbjct: 2 SIMLPI-NNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 93 TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
L L+ NLS +P +L + L ++ N L +P L+
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPASLE 103
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 31/161 (19%)
Query: 226 IGIGSFGTVYKGR--FLDGMEVAIKVFHLQF--DGA----------LKSFDAECEVLKSV 271
IG G++G V+K R G VA+K +Q +G L+ L++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-------LETF 71
Query: 272 RHRNLVKIISSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVA 325
H N+V++ C+ + LV E++ + L L + +M +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 326 LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366
L++LH S+ VVH D+KP N+L+ L+DFG+A+
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 45/184 (24%), Positives = 72/184 (39%), Gaps = 33/184 (17%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRH 273
+ F L+G G+FG V + A+K+ + + E VL++ RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSI------------M 321
L + S + V+EY G ++F LS
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGG-------------ELFFHLSRERVFSEDRARFYG 254
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL-A 380
++ AL+YLH VV+ D+K N++LD D ++DFG+ K K+ +T
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCG 311
Query: 381 TIEY 384
T EY
Sbjct: 312 TPEY 315
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 28/133 (21%), Positives = 57/133 (42%), Gaps = 5/133 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
NL L N L + +F++ + D S + ++ +++ + + L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVI-PISLEKLV 117
+ GL++LQ L L G L +L+ L+++ N + P L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 118 YLKDLNLSFNRLK 130
L+ L+LS N+++
Sbjct: 150 NLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 39/135 (28%), Positives = 62/135 (45%), Gaps = 8/135 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L L N + S+ F L+S+ +L SL ++K + E+N++ N +
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLE----SLDLSVNNLSGVIPISLEK 115
P LTNL+ L L +N++Q L + SLDLS+N ++ I K
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 116 LVYLKDLNLSFNRLK 130
+ LK+L L N+LK
Sbjct: 199 EIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 30/133 (22%), Positives = 53/133 (39%), Gaps = 10/133 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD--IENMKVVVEINLSRNYLTG 59
L L+S+ +L ++ + + N + S L N+ + ++LS N +
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ- 162
Query: 60 DIPP-TIGGLTNLQL----LSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE 114
I + L + L L L N + P +F E+ L+ L L N L V +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFD 221
Query: 115 KLVYLKDLNLSFN 127
+L L+ + L N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 8/109 (7%)
Query: 1 NLSLGSNELSSVI-PSTFWNLNSILSFDFSSNSLNGSLPLDI----ENMKVV-VEINLSR 54
L++ N + S P F NL ++ D SSN + S+ M ++ + ++LS
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 55 NYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN 103
N + I P L+ L+L+ N+L+ F LTSL+ + L N
Sbjct: 187 NPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 42/182 (23%), Positives = 70/182 (38%), Gaps = 29/182 (15%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC--------EVL 268
+ FS +IG G FG VY R D ++ A+K L ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLV 246
Query: 269 KSVRHRNLVKIISSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMID 323
+ +V + + F +L+ M G L L G+ +
Sbjct: 247 STGDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAE 300
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-TI 382
+ L LE++H + VV+ D+KP+N+LLD+ +SD G+A + K + T
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTH 354
Query: 383 EY 384
Y
Sbjct: 355 GY 356
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 31/150 (20%), Positives = 49/150 (32%), Gaps = 9/150 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
N+S + + + W + + + + ++LS N G+
Sbjct: 130 NVSW-ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 61 IPPTI----GGLTNLQLLSLENNRLQ---GPIPESFGELTSLESLDLSVNNLSGVIP-IS 112
LQ+L+L N ++ G L+ LDLS N+L S
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 113 LEKLVYLKDLNLSFNRLKGDIPTRSPHLQV 142
+ L LNLSF LK L V
Sbjct: 249 CDWPSQLNSLNLSFTGLKQVPKGLPAKLSV 278
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 30/133 (22%), Positives = 45/133 (33%), Gaps = 7/133 (5%)
Query: 1 NLSLGSNEL-SSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG 59
N LG L S++ P F L + + + +G + ++LS N L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+ L L+L L+ L LDLS N L P E L
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLDR-NPSPDE-LPQ 297
Query: 119 LKDLNLSFNRLKG 131
+ +L+L N
Sbjct: 298 VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 22/143 (15%), Positives = 45/143 (31%), Gaps = 13/143 (9%)
Query: 1 NLSLGSNELSSVIPST---FWNLNSILSFDFSSNSLNGSLPLDIENMKV--VVEINLSRN 55
L++ + + S I ++ + + + G+ P + + +NL
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 56 YLTG--DIPPTIGGL--TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPI 111
+ L++LS+ E +L +LDLS N G +
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 112 S----LEKLVYLKDLNLSFNRLK 130
K L+ L L ++
Sbjct: 192 ISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 19/103 (18%), Positives = 30/103 (29%), Gaps = 20/103 (19%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP-LDIENMKVVVEINLSRNYLT-- 58
+ G S V + + D S NSL + + + +NLS L
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV 268
Query: 59 -GDIP----------------PTIGGLTNLQLLSLENNRLQGP 84
+P P+ L + LSL+ N
Sbjct: 269 PKGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEV 267
S L++ +F IG G+FG + G+ L VAIK+ + E
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRF 57
Query: 268 LKSVRH-RNLVKIISSCSNGNFEALVLEYMANG-SLEKCLYSSNGILDIFQRLSIMIDVA 325
K + + ++ G + A+VLE + G SLE + + L I I +
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLI 115
Query: 326 LALEYLHFGYSNPVVHCDIKPSNVLL-----DDDMVAHLSDFGIAK 366
+EY+H S +++ D+KP N L+ V H+ DF +AK
Sbjct: 116 SRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 47/187 (25%), Positives = 74/187 (39%), Gaps = 40/187 (21%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSV 271
+ F L+G G+FG V R A+K+ L+ + + + VL++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 272 RHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIFQRL 318
RH L + + + V+EY G L E+ Y +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA---------- 112
Query: 319 SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT 378
++ ALEYLH S VV+ DIK N++LD D ++DFG+ K + +T
Sbjct: 113 ----EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT 164
Query: 379 L-ATIEY 384
T EY
Sbjct: 165 FCGTPEY 171
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 6e-13
Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L ++ + LNSI +++ + S+ I+ + V ++ L+ N LT D
Sbjct: 25 KDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-D 79
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I P + L NL L L+ N+++ S +L L+SL L N +S + L L L+
Sbjct: 80 IKP-LTNLKNLGWLFLDENKIK--DLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLE 134
Query: 121 DLNLSFNRLK 130
L L N++
Sbjct: 135 SLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 36/142 (25%), Positives = 61/142 (42%), Gaps = 10/142 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L N++ + S+ +L + S N ++ + + ++ + + L N +T DI
Sbjct: 92 LFLDENKIKDL--SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DI 146
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ LT L LSLE+N++ LT L++L LS N++S + L L L
Sbjct: 147 TV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDV 201
Query: 122 LNLSFNRLKGDIPTRSPHLQVP 143
L L +L VP
Sbjct: 202 LELFSQECLNKPINHQSNLVVP 223
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 10/130 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+ ++++ SV L ++ + N L PL N+K + + L N + D
Sbjct: 47 QIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKPL--TNLKNLGWLFLDENKIK-D 101
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ + L L+ LSLE+N + L LESL L N ++ + L +L L
Sbjct: 102 LSS-LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLD 156
Query: 121 DLNLSFNRLK 130
L+L N++
Sbjct: 157 TLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 21/126 (16%), Positives = 52/126 (41%), Gaps = 8/126 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L LG+N+++ + + L + + N ++ + + + + + LS+N+++ D+
Sbjct: 136 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL 190
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ GL NL +L L + L ++ + +L IS +
Sbjct: 191 RA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEK 247
Query: 122 LNLSFN 127
N+ ++
Sbjct: 248 PNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 13/82 (15%), Positives = 30/82 (36%), Gaps = 6/82 (7%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
E + I P +L+ + + EL S++ + + +++ V
Sbjct: 3 ETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV 58
Query: 109 IPISLEKLVYLKDLNLSFNRLK 130
++ L + L L+ N+L
Sbjct: 59 QG--IQYLPNVTKLFLNGNKLT 78
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 6/133 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L S L+++ +TF L + + N L +L + +++ + + L+ N L
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPISLEKLV 117
+P + LT L L L N+L+ +P F LT L+ L L+ N L + + +KL
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155
Query: 118 YLKDLNLSFNRLK 130
L+ L+LS N+L+
Sbjct: 156 NLQTLSLSTNQLQ 168
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 40/129 (31%), Positives = 69/129 (53%), Gaps = 6/129 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGD 60
L+L N+L ++ F +L + + ++N L SLPL + +++ + ++ L N L
Sbjct: 64 LNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS- 121
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+P + LT L+ L L N+LQ IP F +LT+L++L LS N L V + ++L
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGK 180
Query: 119 LKDLNLSFN 127
L+ + L N
Sbjct: 181 LQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 4/105 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L +N+L+S+ F +L + N L SLP + + + + E+ L+ N L
Sbjct: 87 TLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ- 144
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN 103
IP LTNLQ LSL N+LQ +F L L+++ L N
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 31/168 (18%), Positives = 59/168 (35%), Gaps = 35/168 (20%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKV-------------VV 48
S+ L+ +P N+ S + + + + P +
Sbjct: 16 PLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAH 74
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
E+ L+ L+ +P +L+ L N L +PE L SL + ++ LS +
Sbjct: 75 ELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL 129
Query: 109 IPI---------------SLEKLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
P+ L+ +LK +++ N LK +P P L+
Sbjct: 130 PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLE 176
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 32/134 (23%), Positives = 57/134 (42%), Gaps = 13/134 (9%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
++ G+N+L + NL + + +NSL LP +++ I N L
Sbjct: 177 FIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNILE-- 228
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
P + L L + +NN L+ +P+ SLE+L++ N L+ +P + L +L
Sbjct: 229 ELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPELPQSLTFLD 283
Query: 121 DLNLSFNRLKGDIP 134
F+ L P
Sbjct: 284 VSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 33/141 (23%), Positives = 63/141 (44%), Gaps = 17/141 (12%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L N L+ +P +L S+L + + +L+ PL + + +S N L
Sbjct: 95 SLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-K 145
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+P + + L+++ ++NN L+ +P+ SLE + N L +P L+ L +L
Sbjct: 146 LPE-LQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLE-ELP-ELQNLPFLT 198
Query: 121 DLNLSFNRLKGDIPTRSPHLQ 141
+ N LK +P L+
Sbjct: 199 AIYADNNSLK-KLPDLPLSLE 218
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 25/155 (16%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
++ G+N L NL + + +N L +LP +++ +N+ NYLT D
Sbjct: 219 SIVAGNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDLPPSLE---ALNVRDNYLT-D 271
Query: 61 IPPTIGGLTNLQLLSLENNRLQG-------------PIPESFGELTSLESLDLSVNNLSG 107
+P LT L + + L I SLE L++S N L
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI- 330
Query: 108 VIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQV 142
+P + L+ L SFN L ++P +L+
Sbjct: 331 ELPALPPR---LERLIASFNHLA-EVPELPQNLKQ 361
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 30/157 (19%), Positives = 55/157 (35%), Gaps = 30/157 (19%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L+ SNE+ S+ S+ + S+N L LP ++ + S N+L +
Sbjct: 301 YLNASSNEIRSLCDL----PPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-E 351
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELT----------------SLESLDLSVNN 104
+P NL+ L +E N L+ P+ + +L+ L + N
Sbjct: 352 VPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNP 407
Query: 105 LSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
L P E + L+ + + L+
Sbjct: 408 LR-EFPDIPESVEDLRMNSERVVDPYEFAHETTDKLE 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 29/129 (22%), Positives = 46/129 (35%), Gaps = 19/129 (14%)
Query: 19 NLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGL---------- 68
+ + S++L +P++ EN+K E + + + PP G
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 69 ---TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 125
L L N L +PE LESL S N+L+ +P + L L N +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 126 FNRLKGDIP 134
L P
Sbjct: 123 LKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 16/94 (17%), Positives = 27/94 (28%), Gaps = 15/94 (15%)
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY-- 118
I P T LQ ++ L +P + S + + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 119 -----------LKDLNLSFNRLKGDIPTRSPHLQ 141
+L L+ L +P PHL+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLE 94
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 16/105 (15%), Positives = 39/105 (37%), Gaps = 13/105 (12%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L + N L P ++ + ++ L +P +N+K ++++ N L +
Sbjct: 362 LHVEYNPLRE-FPDIPESVEDLRM----NSHLA-EVPELPQNLK---QLHVETNPLR-EF 411
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS 106
P + +L++ + R+ P + LE ++
Sbjct: 412 PDIPESVEDLRM---NSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-13
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 5/130 (3%)
Query: 1 NLSLGSNELSSVIPS-TFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLT 58
L L +NE + + + F L + +FS+N + + E V EI L+ N L
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE 94
Query: 59 GDIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
++ + GL +L+ L L +NR+ +SF L+S+ L L N ++ V P + + L
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 118 YLKDLNLSFN 127
L LNL N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 31/130 (23%), Positives = 57/130 (43%), Gaps = 12/130 (9%)
Query: 6 SNELSSV---IPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGDI 61
+ +L+ + IP L ++N I + + + +IN S N +T DI
Sbjct: 20 NQKLNKIPEHIPQYTAEL------RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DI 72
Query: 62 PPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
G + + + L +NRL+ + F L SL++L L N ++ V S L ++
Sbjct: 73 EEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132
Query: 121 DLNLSFNRLK 130
L+L N++
Sbjct: 133 LLSLYDNQIT 142
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 29/136 (21%), Positives = 49/136 (36%), Gaps = 12/136 (8%)
Query: 14 PSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQL 73
+ + L ++ +E + +V ++LS N L +PP + L L++
Sbjct: 434 SVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490
Query: 74 LSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPI-SLEKLVYLKDLNLSFNRLKGD 132
L +N L+ + L L+ L L N L I L L LNL N L +
Sbjct: 491 LQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548
Query: 133 IPTRS------PHLQV 142
+ P +
Sbjct: 549 EGIQERLAEMLPSVSS 564
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 28/130 (21%), Positives = 60/130 (46%), Gaps = 10/130 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
++ G + ++ T +L+ I + + ++ ++ + ++ + L N +T D
Sbjct: 23 KIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-D 77
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ P + LT + L L N L+ + L S+++LDL+ ++ V P L L L+
Sbjct: 78 LAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQ 132
Query: 121 DLNLSFNRLK 130
L L N++
Sbjct: 133 VLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 28/144 (19%), Positives = 57/144 (39%), Gaps = 10/144 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L S +++ V P L+++ N + PL + + +++ ++ D
Sbjct: 111 TLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPL--AGLTNLQYLSIGNAQVS-D 165
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ P + L+ L L ++N++ L +L + L N +S V P L L
Sbjct: 166 LTP-LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLF 220
Query: 121 DLNLSFNRLKGDIPTRSPHLQVPL 144
+ L+ + + +L VP
Sbjct: 221 IVTLTNQTITNQPVFYNNNLVVPN 244
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 29/130 (22%), Positives = 62/130 (47%), Gaps = 10/130 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
LS ++++ LN+++ + N + PL +N+ + E+ LS N L +
Sbjct: 45 TLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPL--KNLTKITELELSGNPLK-N 99
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ I GL +++ L L + ++ P L++L+ L L +N ++ + P L L L+
Sbjct: 100 VSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQ 154
Query: 121 DLNLSFNRLK 130
L++ ++
Sbjct: 155 YLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 22/129 (17%), Positives = 49/129 (37%), Gaps = 8/129 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L N+++++ P L ++ + ++ PL N+ + + N ++ D
Sbjct: 133 VLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPL--ANLSKLTTLKADDNKIS-D 187
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I P + L NL + L+NN++ ++L + L+ ++ LV
Sbjct: 188 ISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPN 244
Query: 121 DLNLSFNRL 129
+
Sbjct: 245 VVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 24/126 (19%), Positives = 57/126 (45%), Gaps = 8/126 (6%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
LS+G+ ++S + P NL+ + + N ++ PL ++ ++E++L N ++ D+
Sbjct: 156 LSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQIS-DV 210
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
P + +NL +++L N + L + + + + P ++
Sbjct: 211 SP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYAS 267
Query: 122 LNLSFN 127
NL++N
Sbjct: 268 PNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 9/64 (14%), Positives = 24/64 (37%), Gaps = 4/64 (6%)
Query: 67 GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 126
L N ++ + + + +L + +L ++ + ++ L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKD 72
Query: 127 NRLK 130
N++
Sbjct: 73 NQIT 76
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 41/197 (20%), Positives = 70/197 (35%), Gaps = 43/197 (21%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
+ +S +G GSFG V + ++ G A+K + E +++K + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 276 LVKIIS---SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEY-- 330
++K++ + + + N K +N + S + + +EY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 331 --LH--------------------FGY----------SNPVVHCDIKPSNVLLD-DDMVA 357
LH + Y S + H DIKP N+L++ D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 358 HLSDFGIAKLLNGKESM 374
L DFG AK L E
Sbjct: 182 KLCDFGSAKKLIPSEPS 198
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
+ + S +G G++G+V G+ VA+K F A E +LK
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKH 84
Query: 271 VRHRNLVKI----ISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLS----- 319
++H N++ + + S F LV M L + Q+L+
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQ 135
Query: 320 -IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT 378
++ + L+Y+H S ++H D+KPSN+ +++D + DFG+A+ T
Sbjct: 136 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGY 189
Query: 379 LAT 381
+AT
Sbjct: 190 VAT 192
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 48/193 (24%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV----AIKVFHLQFDGALKSFD------AECEV 267
+ F ++G G +G V++ R + G A+KV L+ +++ AE +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNI 74
Query: 268 LKSVRHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDI 314
L+ V+H +V +I + G L+LEY++ G L E C Y +
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA------ 128
Query: 315 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKE 372
++++AL +LH +++ D+KP N++L+ H L+DFG+ K + +
Sbjct: 129 --------EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCK-ESIHD 174
Query: 373 SMRTQTLA-TIEY 384
T T TIEY
Sbjct: 175 GTVTHTFCGTIEY 187
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 27/200 (13%)
Query: 198 NMSPQAMWRRFSYQELL----LATDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL 252
NMS + +F E+ + IG G+ G V + VAIK
Sbjct: 38 NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97
Query: 253 QFDGALKSFDA-----ECEVLKSVRHRNLVKII----SSCSNGNFEA--LVLEYMANGSL 301
F A E ++K V H+N++ ++ + F+ LV+E M + +L
Sbjct: 98 PFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 153
Query: 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361
+ + LD + ++ + +++LH S ++H D+KPSN+++ D + D
Sbjct: 154 CQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 207
Query: 362 FGIAKLLNGKESMRTQTLAT 381
FG+A+ M T + T
Sbjct: 208 FGLARTAGTSFMM-TPYVVT 226
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSC 283
IG GSFG +Y G + G EVAIK+ ++ E ++ K ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 284 SNGNFEALVLEYMANG-SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
+ G++ +V+E + G SLE + + L + + +EY+H S +H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 343 DIKPSNVLL---DDDMVAHLSDFGIAK 366
D+KP N L+ + ++ DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 5e-12
Identities = 46/191 (24%), Positives = 83/191 (43%), Gaps = 46/191 (24%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV----AIKVFHLQFDGALKSFDAEC----EVLK 269
F ++G GSFG V+ + + G + A+KV L+ ++L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILV 81
Query: 270 SVRHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIFQ 316
V H +VK+ + L+L+++ G L E+ Y +
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-------- 133
Query: 317 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESM 374
++ALAL++LH S +++ D+KP N+LLD++ H L+DFG++K +
Sbjct: 134 ------ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK-ESIDHEK 181
Query: 375 RTQTL-ATIEY 384
+ + T+EY
Sbjct: 182 KAYSFCGTVEY 192
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIK---VFHLQFDGALKSFDAECEVLKSVR 272
+ F KSL+G G++G V G VAIK F AL++ E ++LK +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTL-REIKILKHFK 67
Query: 273 HRNLVK---IISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
H N++ I S NF ++ E M L + + S +L + A
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI--STQMLSDDHIQYFIYQTLRA 124
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
++ LH + V+H D+KPSN+L++ + + DFG+A
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 44/192 (22%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV----AIKVFH----LQFDGALKSFDAECEVLK 269
++F ++G G++G V+ R + G + A+KV +Q + E +VL+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 270 SVRHRN-LVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIF 315
+R LV + + L+L+Y+ G L E +Y
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG------- 166
Query: 316 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKES 373
++ LALE+LH +++ DIK N+LLD + H L+DFG++K E+
Sbjct: 167 -------EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADET 214
Query: 374 MRTQTLA-TIEY 384
R TIEY
Sbjct: 215 ERAYDFCGTIEY 226
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 59/335 (17%), Positives = 115/335 (34%), Gaps = 30/335 (8%)
Query: 27 DFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPI 85
D+S+ +L +P D+ K ++LS+N ++ P I L+ L++L L +NR++
Sbjct: 37 DYSNRNLT-HVPKDLPPRTKA---LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLD 92
Query: 86 PESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQVPLC 145
F LE LD+S N L IS + L+ L+LSFN +P+C
Sbjct: 93 FHVFLFNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFD----------VLPVC 139
Query: 146 KSSSHRKSSKNVILLGVVL---PLSVFIIAVLLALGIGLITRYRKGNTELSNIEVNMS-- 200
K + + L L L + + L++ + KG S N +
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL 199
Query: 201 --PQAMWRRFSYQELL-LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA 257
FS Q + + + S I + FL + + ++
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 258 LKSFDAECEVLKSVRHRNLVKI-ISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQ 316
++ ++ + R + + I + + + +L+ +
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319
Query: 317 RLSIMIDVALALEYLHFGYSN---PVVHCDIKPSN 348
+ V + S+ + C PS+
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 31/138 (22%), Positives = 57/138 (41%), Gaps = 11/138 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE---NMKVVVEINLSRNYLT 58
L+ N + + L + + N L + NM + +++S N L
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLN 416
Query: 59 GDIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELT-SLESLDLSVNNLSGVIPISLEKL 116
++ +L+L +N L G + F L ++ LDL N + IP + L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHL 472
Query: 117 VYLKDLNLSFNRLKGDIP 134
L++LN++ N+LK +P
Sbjct: 473 QALQELNVASNQLK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 37/170 (21%), Positives = 62/170 (36%), Gaps = 7/170 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
LSL N +S + L+ + S N + SL + + + +++S N L
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN 114
Query: 60 DIPPTIGGLTNLQLLSLENNRLQG-PIPESFGELTSLESLDLSVNNLSGVIPISLEKL-V 117
I + +L+ L L N P+ + FG LT L L LS + + + L +
Sbjct: 115 -ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHL 171
Query: 118 YLKDLNLSFNRLKGDIPTRSPHLQVPLCKSSSHRKSSKNVILLGVVLPLS 167
L+L +KG + H S +V + V L
Sbjct: 172 SCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 34/131 (25%), Positives = 58/131 (44%), Gaps = 10/131 (7%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKV-----VVEINLSRNY 56
L L N L + ++ S + SLN SL + ++ +NLS N
Sbjct: 382 LILQRNGLKN-FFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNM 439
Query: 57 LTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKL 116
LTG + + +++L L NNR+ IP+ L +L+ L+++ N L V ++L
Sbjct: 440 LTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRL 496
Query: 117 VYLKDLNLSFN 127
L+ + L N
Sbjct: 497 TSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 23/146 (15%), Positives = 51/146 (34%), Gaps = 6/146 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ + + + + S + + + +N ++N T +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY--- 118
L LQ L L+ N L+ + ++ SL+ +L+ + + ++
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 119 -LKDLNLSFNRLKGDIPTR-SPHLQV 142
+ LNLS N L G + P ++V
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPPKVKV 454
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 15/151 (9%), Positives = 41/151 (27%), Gaps = 12/151 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIEN-----MKVVVEINLSRN 55
++ + FW + + + ++ + + +K ++ ++
Sbjct: 258 HIETTWKCSVK-LFQFFWP-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315
Query: 56 YLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEK 115
+ + L + +S L+ + N + +
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375
Query: 116 LVYLKDLNLSFNRLK-----GDIPTRSPHLQ 141
L L+ L L N LK + L+
Sbjct: 376 LKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 15/112 (13%)
Query: 1 NLSLGSNELSSVIPSTFWNL----NSILSFDFSSNSLNG----SLPLDIENMKVVVEINL 52
+L L+S+ + SIL + SSN L G LP ++ ++L
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVK------VLDL 457
Query: 53 SRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNN 104
N + IP + L LQ L++ +N+L+ F LTSL+ + L N
Sbjct: 458 HNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 44/203 (21%), Positives = 81/203 (39%), Gaps = 28/203 (13%)
Query: 199 MSPQAMWRRFSYQELLLAT-----DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL 252
M ++ Y + + + IG G+ G V + VAIK
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 253 QFDGALKSFDA-----ECEVLKSVRHRNLVKI----ISSCSNGNFEA--LVLEYMANGSL 301
F A E ++K V H+N++ + S F+ +V+E M + +L
Sbjct: 61 PFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 116
Query: 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361
+ + LD + ++ + +++LH S ++H D+KPSN+++ D + D
Sbjct: 117 CQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 170
Query: 362 FGIAKLLNGKESMRTQTLATIEY 384
FG+A+ M T + T Y
Sbjct: 171 FGLARTAGTSFMM-TPYVVTRYY 192
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 35/149 (23%), Positives = 59/149 (39%), Gaps = 15/149 (10%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSC 283
IG GSFG +++G L + +VAIK + D E K + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 284 SNGNFEALVLEYMANG-SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHC 342
G LV++ + G SLE L + + ++ +H +V+
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130
Query: 343 DIKPSNVLLDDDM-----VAHLSDFGIAK 366
DIKP N L+ + ++ DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 44/192 (22%), Positives = 82/192 (42%), Gaps = 18/192 (9%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
+ +G G++G V+K G VA+K F S DA E +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---NSTDAQRTFREIMILTE 64
Query: 271 VR-HRNLVKIISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
+ H N+V +++ N LV +YM L + ++ IL+ + ++ +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKV 121
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGRE 387
++YLH S ++H D+KPSN+LL+ + ++DFG+++ + +I E
Sbjct: 122 IKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 388 GQVSPKSDVYGY 399
+ + Y
Sbjct: 179 NFDDDQPILTDY 190
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 58/190 (30%), Positives = 80/190 (42%), Gaps = 45/190 (23%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 270
F +IG GSFG V R A+KV LQ LK + + VL K+
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKN 95
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIFQR 317
V+H LV + S + VL+Y+ G L E Y++
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------- 146
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESMR 375
++A AL YLH S +V+ D+KP N+LLD H L+DFG+ K N + +
Sbjct: 147 -----EIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK-ENIEHNST 195
Query: 376 TQTL-ATIEY 384
T T T EY
Sbjct: 196 TSTFCGTPEY 205
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
+ + +G G++G+V G +VAIK F A E +LK
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKH 79
Query: 271 VRHRNLVKI----ISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDV 324
++H N++ + + S NF LV+ +M L+K + + ++ +
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK---FSEEKIQYLVYQM 135
Query: 325 ALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369
L+Y+H S VVH D+KP N+ +++D + DFG+A+ +
Sbjct: 136 LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 34/157 (21%), Positives = 58/157 (36%), Gaps = 12/157 (7%)
Query: 259 KSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRL 318
K + V R ++ SS S+G E E L + +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK--SLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 319 SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT 378
VA +E+L S +H D+ N+LL + V + DFG+A+ + +
Sbjct: 197 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 379 LA-------TIEYGREGQVSPKSDVYGYGITLIETFT 408
A E + + +SDV+ +G+ L E F+
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 63/478 (13%), Positives = 130/478 (27%), Gaps = 184/478 (38%)
Query: 18 WNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLE 77
N + +F+ S K+++ +R D + T +SL+
Sbjct: 254 QNAKAWNAFNLSC--------------KILL---TTRFKQVTDF---LSAATTTH-ISLD 292
Query: 78 NNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRS 137
++ LT E L L + + L
Sbjct: 293 HHS---------MTLTPDEVKSL----LLKYLDCRPQDL--------------------- 318
Query: 138 PHLQVPLCKSSSHRKSSKNVILLGVVLPLSVFIIAVLLALGIGLITRYRKGNTE-LSNI- 195
P +V ++ P + IIA + G+ ++ N + L+ I
Sbjct: 319 PR-EV--LTTN----------------PRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 196 ------------------------EVNMSPQAM---WRRFSYQELLLATDHFSEKSLIGI 228
++ + W ++++ + + SL+
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV-- 417
Query: 229 GSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288
E I + + + + E ++ HR++V
Sbjct: 418 ----------EKQPKESTISIPSIYLE-----LKVKLENEYAL-HRSIVD---------- 451
Query: 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348
Y ++ K + S+ ++ + Y H G+ H +K
Sbjct: 452 -----HY----NIPKT-FDSDDLIPPYLDQYF---------YSHIGH-----H--LKNIE 485
Query: 349 VLLDDDMVAHL-SDFGI--AKL------LNGKESMRTQTLATIE-YGREGQVSPKSDVYG 398
+ + DF K+ N S+ TL ++ Y + + Y
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI-LNTLQQLKFY--KPYICDNDPKYE 542
Query: 399 YGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRREDKYFAAKKQ 456
+ I F K EE + + D L I++M + + + A KQ
Sbjct: 543 RLVNAILDFLPK-------IEENLICSKYTDLLRIALMA--EDEAI-----FEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 4e-08
Identities = 59/400 (14%), Positives = 127/400 (31%), Gaps = 120/400 (30%)
Query: 112 SLEKLVYLKDLNLSFNR----LKGDIPTRSPHLQVPLCKSSSHRKSSKNVILLGV----- 162
S+ +Y++ + +N K ++ P+L+ L ++ + +KNV++ GV
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK--LRQALLELRPAKNVLIDGVLGSGK 163
Query: 163 -VL--------------PLSVFIIAV--------LLALGIGLITRYRKGNTELSNIEVNM 199
+ +F + + +L + L+ + T S+ N+
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 200 SPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALK 259
+ + + LL + + E L+ + L ++Q A
Sbjct: 224 KLRIHSIQAELRRLLKSKPY--ENCLL-V-----------LL---------NVQNAKAWN 260
Query: 260 SFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS 319
+F+ C++L + R + + + S + L++ + L +
Sbjct: 261 AFNLSCKILLTTRFKQVTDFL---SAATTTHISLDHHSMT-----LTPDEV-KSLL---- 307
Query: 320 IMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT 378
L+YL + P P LS ES+R
Sbjct: 308 --------LKYLDCRPQDLPREVLTTNP----------RRLSIIA--------ESIR-DG 340
Query: 379 LATIEYGREGQVSPKSDVYGYGITLIETFTKKK--PTCEIFCEEMNLKN------WVNDF 430
LAT + + + + + ++E +K +F ++ W D
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW-FDV 399
Query: 431 LPISVMNVVDT----SLLRREDK---------YFAAKKQC 457
+ VM VV+ SL+ ++ K Y K +
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL 439
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 29/164 (17%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIK---VFHLQFDGALKSFDAECEVLKSVR 272
++ S IG G++G V L+ + VAIK F Q ++ E ++L R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTL-REIKILLRFR 83
Query: 273 HRNLVK---IISSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLS------IM 321
H N++ II + + + +V + M L K L + Q LS +
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT--------QHLSNDHICYFL 134
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365
+ L+Y+H S V+H D+KPSN+LL+ + DFG+A
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L ++ + LNSI +++ + S+ I+ + V ++ L+ N LT D
Sbjct: 28 KDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-D 82
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I P + L NL L L+ N+++ S +L L+SL L N +S + L L L+
Sbjct: 83 IKP-LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLE 137
Query: 121 DLNLSFNRLK 130
L L N++
Sbjct: 138 SLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 20/132 (15%), Positives = 52/132 (39%), Gaps = 6/132 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L LG+N+++ + + L + + N ++ + + + + + LS+N+++ D+
Sbjct: 139 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL 193
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ GL NL +L L + L ++ + +L IS + +
Sbjct: 194 RA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 252
Query: 122 LNLSFNRLKGDI 133
+ ++
Sbjct: 253 VKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 11/71 (15%), Positives = 27/71 (38%), Gaps = 5/71 (7%)
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
I +L+ + + EL S++ + + +++ V ++ L +
Sbjct: 16 QIFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNV 70
Query: 120 KDLNLSFNRLK 130
L L+ N+L
Sbjct: 71 TKLFLNGNKLT 81
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 29/165 (17%), Positives = 56/165 (33%), Gaps = 29/165 (17%)
Query: 226 IGIGSFGTVYKGR---------FLDGMEVAIKV----------FHLQFDGALKSFDAECE 266
+ G +Y+ + ++K+ + A + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 267 VLKSVRHRNLVKIISSCSN-GNFEALVLEYMANG-SLEKCL-YSSNGILDIFQRLSIMID 323
L S + + + + LVL + G SL+ L S +L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLL--DDDMVAHLSDFGIAK 366
+ ALE+LH N VH ++ N+ + +D L+ +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 22/114 (19%), Positives = 45/114 (39%), Gaps = 8/114 (7%)
Query: 29 SSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPES 88
++ + + + E + + ++ + +T D+ I LT L L +N +
Sbjct: 26 AAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTL---D 80
Query: 89 FGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQV 142
+ T+L L N L+ + + L L LN N+L +++P L
Sbjct: 81 LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKLDVSQNPLLTY 131
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 23/130 (17%), Positives = 50/130 (38%), Gaps = 14/130 (10%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L+ +N+L+ + S + + + N+L +D+ + + E++ N
Sbjct: 110 YLNCDTNKLTKLDVS---QNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT- 162
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ T L L N++ + L L+ NN++ + L + + L
Sbjct: 163 -KLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLT 215
Query: 121 DLNLSFNRLK 130
L+ S N+L
Sbjct: 216 FLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 29/130 (22%), Positives = 54/130 (41%), Gaps = 14/130 (10%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L+ SN+L+++ + L + + +N L LD+ ++ +N +RN LT +
Sbjct: 89 YLACDSNKLTNLDVT---PLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-E 141
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I + T L L N+ + T L +LD S N ++ + + + L
Sbjct: 142 ID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLN 194
Query: 121 DLNLSFNRLK 130
LN N +
Sbjct: 195 RLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 27/130 (20%), Positives = 45/130 (34%), Gaps = 14/130 (10%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L SN+L+ + L + FD S N L LD+ + + ++ + L +
Sbjct: 216 FLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-E 268
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I + T L E R + T L LD ++ + L + L
Sbjct: 269 ID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLV 321
Query: 121 DLNLSFNRLK 130
L L+ L
Sbjct: 322 YLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 18/138 (13%), Positives = 44/138 (31%), Gaps = 8/138 (5%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
+ + + + + D + + LD+ +V + L+ LT ++
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL 333
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ T L+ LS N +Q G++ +L + + + +L
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389
Query: 122 LNLSFNRLKGDIPTRSPH 139
++ G+ P
Sbjct: 390 VSPDLLDQFGNPMNIEPG 407
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 16/141 (11%), Positives = 43/141 (30%), Gaps = 15/141 (10%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L + ++ + ++ ++ L LD+ + + ++ ++ D
Sbjct: 302 LDCQAAGITEL---DLSQNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQ-DF 354
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGEL-----TSLESLDLSVNNLSGVIPISLEKL 116
+G + L + E+ S + LD N ++ I +
Sbjct: 355 SS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGV 411
Query: 117 VYLKDLNLSFNRLKGDIPTRS 137
+++ L D P +
Sbjct: 412 YDQATNTITWENLSTDNPAVT 432
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 2/61 (3%)
Query: 70 NLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 129
N +Q S +L +L SLD ++++ + I EKL L L + N +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGI--EKLTGLTKLICTSNNI 76
Query: 130 K 130
Sbjct: 77 T 77
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 11/146 (7%)
Query: 226 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV-KIISSC 283
IG GSFG +Y G + EVAIK+ ++ E ++ + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343
G++ LV++ + SLE + L + L + + +E++H S +H D
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 344 IKPSNVLLDDDMVAH---LSDFGIAK 366
IKP N L+ A+ + DFG+AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 35/170 (20%), Positives = 67/170 (39%), Gaps = 28/170 (16%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA---------LKSFDAECEVL 268
+ IG G FG +Y + A V +++ + + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 269 KSVRHRNLVKI---------ISSCSNGNFEALVLEYMANG-SLEKCLYSSNGILDIFQRL 318
K + + L + ++ ++ +V+E + G L+K + NG L
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVL 154
Query: 319 SIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--DDMVAHLSDFGIAK 366
+ I + LEY+H N VH DIK +N+LL + +L+D+G++
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 41/188 (21%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 270
D+F ++G GSFG V R + ++ A+KV L+ D L+ D EC +L +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIFQR 317
H L ++ + V+E++ G L E Y++
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------- 131
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
++ AL +LH +++ D+K NVLLD + L+DFG+ K + T
Sbjct: 132 -----EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTA 182
Query: 378 TL-ATIEY 384
T T +Y
Sbjct: 183 TFCGTPDY 190
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 37/171 (21%), Positives = 73/171 (42%), Gaps = 33/171 (19%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
+ + +G G++G V G +VAIK + F A E +LK
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKH 80
Query: 271 VRHRNLVKII----SSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQRLS----- 319
+RH N++ ++ + +F LV+ +M L K + ++L
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQ 131
Query: 320 -IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369
++ + L Y+H + ++H D+KP N+ +++D + DFG+A+ +
Sbjct: 132 FLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 19/126 (15%), Positives = 42/126 (33%), Gaps = 2/126 (1%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI--ENMKVVVEINLSRNYLTG 59
L + + + + + + D N ++ + V + L++N +
Sbjct: 109 LLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
G +L +NN L+ + F + LD+S + + LE L L
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 228
Query: 120 KDLNLS 125
+ +
Sbjct: 229 RARSTY 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 2/128 (1%)
Query: 4 LGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP 63
+N L + P F NL ++ S+ + + + V +++ N I
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 64 -TIGGLT-NLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ GL+ +L L N +Q +F E NNL +
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206
Query: 122 LNLSFNRL 129
L++S R+
Sbjct: 207 LDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 25/138 (18%), Positives = 48/138 (34%), Gaps = 5/138 (3%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
++++ IPS + + F L + +I +S+N + I
Sbjct: 14 FLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 62 PP-TIGGLTNLQLLSLEN-NRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
L L + +E N L PE+F L +L+ L +S + + + +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130
Query: 120 KDLNLSFNRLKGDIPTRS 137
L++ N I S
Sbjct: 131 VLLDIQDNINIHTIERNS 148
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 22/135 (16%), Positives = 49/135 (36%), Gaps = 8/135 (5%)
Query: 2 LSLGSNELSSVIPS-TFWNLNSILSFDFS-SNSLNGSLPLDI-ENMKVVVEINLSRNYLT 58
+ + N++ VI + F NL + +N+L + + +N+ + + +S +
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK 117
Query: 59 GDIPP-TIGGLTNLQLLSL-ENNRLQGPIPESFGELTS-LESLDLSVNNLSGVIPISLEK 115
+P LL + +N + SF L+ L L+ N + + +
Sbjct: 118 -HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNG 176
Query: 116 LVYLKDLNLSFNRLK 130
+ N L+
Sbjct: 177 TQLDELNLSDNNNLE 191
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 2e-10
Identities = 34/201 (16%), Positives = 56/201 (27%), Gaps = 54/201 (26%)
Query: 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------GALKSFDAEC 265
L T+ IG G FG V++ D VAIK+ ++ + E
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 266 EVLKSV---------RHRNLVKIISSC------------------------------SNG 286
+ K + R + + S
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 287 NFEALVLEYMANG-SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIK 345
+ +VLE+ G LE+ + + SI+ + +L H D+
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 346 PSNVLLDDDMVAHLSDFGIAK 366
NVLL + L K
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 41/188 (21%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSV 271
F+ ++G GSFG V E+ A+K+ L+ D ++ D EC VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALP 398
Query: 272 -RHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIFQR 317
+ L ++ S + V+EY+ G L E Y++
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------- 449
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
++A+ L +L S +++ D+K NV+LD + ++DFG+ K N + + T+
Sbjct: 450 -----EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTK 500
Query: 378 TLA-TIEY 384
T T +Y
Sbjct: 501 TFCGTPDY 508
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 11/130 (8%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+LG ++ + + L+ + +F+ ++++ SL ++ + E++LS N ++ D
Sbjct: 23 KQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-D 77
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ P + LT L+ LS+ NRL+ + L L L N L L L L+
Sbjct: 78 LSP-LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRDTDS--LIHLKNLE 131
Query: 121 DLNLSFNRLK 130
L++ N+LK
Sbjct: 132 ILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 11/143 (7%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L N++S + S +L + + N L + + + L N L D
Sbjct: 67 ELHLSHNQISDL--SPLKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNELR-D 120
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ L NL++LS+ NN+L+ G L+ LE LDL N ++ L +L +
Sbjct: 121 TDS-LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVN 175
Query: 121 DLNLSFNRLKGDIPTRSPHLQVP 143
++L+ + + P L +
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYIT 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 25/127 (19%), Positives = 47/127 (37%), Gaps = 11/127 (8%)
Query: 4 LGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP 63
++ V P L + + + S+ + + + V N + + +
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVSQ--KELSGVQNFNGDNSNIQ-SLAG 58
Query: 64 TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLN 123
+ TNL+ L L +N++ +LT LE L ++ N L + I L L
Sbjct: 59 -MQFFTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLF 112
Query: 124 LSFNRLK 130
L N L+
Sbjct: 113 LDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 23/129 (17%), Positives = 46/129 (35%), Gaps = 9/129 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
LS+ N L ++ L+ + +N L + L ++K + +++ N L
Sbjct: 89 ELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDTDSL--IHLKNLEILSIRNNKLK-S 142
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
I +G L+ L++L L N + L + +DL+ +L
Sbjct: 143 IVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITN 199
Query: 121 DLNLSFNRL 129
+ R
Sbjct: 200 TVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 18/127 (14%), Positives = 43/127 (33%), Gaps = 8/127 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L +NEL + +L ++ +N L S+ + + + ++L N +T +
Sbjct: 110 RLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-N 164
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ L + + L + + EL ++ + P +
Sbjct: 165 TGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYV 221
Query: 121 DLNLSFN 127
D + +
Sbjct: 222 DGCVLWE 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 19/177 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 270
+ F ++G GSFG V+ F + AIK L+ D L D EC VL +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEY 330
H L + + V+EY+ G L + S D+ + ++ L L++
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQF 133
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESMRTQTL-ATIEY 384
LH S +V+ D+K N+LLD D H ++DFG+ K N +T T T +Y
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK-ENMLGDAKTNTFCGTPDY 184
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 36/179 (20%), Positives = 66/179 (36%), Gaps = 55/179 (30%)
Query: 225 LIGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
IG G FG +Y +KV +G L + E + + ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEP-SDNGPLFT---ELKFYQRAAKPEQIQ 97
Query: 279 IISS-------------------CSNGNFEALVLEYMANG-SLEKCLYSSNGILDIFQRL 318
+ ++ ++++ G L+K +Y +N +R
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANA-----KRF 149
Query: 319 SI---------MIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--DDMVAHLSDFGIAK 366
S ++D+ LEY+H + VH DIK SN+LL+ + +L D+G+A
Sbjct: 150 SRKTVLQLSLRILDI---LEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 45/188 (23%), Positives = 73/188 (38%), Gaps = 41/188 (21%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 270
F +IG GS+ V R + A+KV ++ + D + V ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIFQR 317
H LV + S + V+EY+ G L E+ YS+
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------- 117
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
+++LAL YLH +++ D+K NVLLD + L+D+G+ K + T
Sbjct: 118 -----EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS 168
Query: 378 TL-ATIEY 384
T T Y
Sbjct: 169 TFCGTPNY 176
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 45/190 (23%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 270
F+ ++G GSFG V E+ A+K+ L+ D ++ D EC VL
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALP 77
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIFQR 317
+ L ++ S + V+EY+ G L E Y++
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------- 128
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESMR 375
++A+ L +L S +++ D+K NV+LD + H ++DFG+ K N + +
Sbjct: 129 -----EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-ENIWDGVT 177
Query: 376 TQTL-ATIEY 384
T+T T +Y
Sbjct: 178 TKTFCGTPDY 187
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 35/189 (18%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
+ + +G G G V+ VAIK + E ++++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLT---DPQSVKHALREIKIIRR 64
Query: 271 VRHRNLVKII------------SSCSNGNFEA--LVLEYMANGSLEKCLYSSNGILDIFQ 316
+ H N+VK+ S + +V EYM L L G L
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ--GPLLEEH 121
Query: 317 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKESMR 375
M + L+Y+H S V+H D+KP+N+ ++ +D+V + DFG+A++++ S +
Sbjct: 122 ARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 376 ---TQTLAT 381
++ L T
Sbjct: 179 GHLSEGLVT 187
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 44/188 (23%), Positives = 73/188 (38%), Gaps = 41/188 (21%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 270
F +IG GS+ V R + A++V ++ + D + V ++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSL-----------EK--CLYSSNGILDIFQR 317
H LV + S + V+EY+ G L E+ YS+
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------- 160
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
+++LAL YLH +++ D+K NVLLD + L+D+G+ K + T
Sbjct: 161 -----EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS 211
Query: 378 TL-ATIEY 384
T T Y
Sbjct: 212 TFCGTPNY 219
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 33/129 (25%), Positives = 60/129 (46%), Gaps = 5/129 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L N+++ + P F +L ++ SN L +LP+ + +++ + ++L N LT
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+P + L +L+ L + N+L +P LT L L L N L + + ++L
Sbjct: 103 -LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 119 LKDLNLSFN 127
L L N
Sbjct: 161 LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 27/80 (33%), Positives = 39/80 (48%)
Query: 51 NLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP 110
L N +T P L NL+ L L +N+L F LT L LDL N L+ +
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPS 105
Query: 111 ISLEKLVYLKDLNLSFNRLK 130
++LV+LK+L + N+L
Sbjct: 106 AVFDRLVHLKELFMCCNKLT 125
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 22/70 (31%), Positives = 33/70 (47%), Gaps = 2/70 (2%)
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+P I TN Q+L L +N++ P F L +L+ L L N L + + L L
Sbjct: 34 VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 121 DLNLSFNRLK 130
L+L N+L
Sbjct: 92 VLDLGTNQLT 101
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 2/84 (2%)
Query: 48 VEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIP-ESFGELTSLESLDLSVNNLS 106
+ +R+ D + G NL L +EN + + L L +L + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 107 GVIPISLEKLVYLKDLNLSFNRLK 130
V P + L LNLSFN L+
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 21/101 (20%), Positives = 43/101 (42%), Gaps = 2/101 (1%)
Query: 30 SNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP-TIGGLTNLQLLSLENNRLQGPIPES 88
+ + + + E+ + + + GL L+ L++ + L+ P++
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 89 FGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 129
F L L+LS N L + +++ L L++L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-10
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
E+ L N T +P + +L L+ L NNR+ +SF +T L +L LS N L +
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 109 IPISLEKLVYLKDLNLSFNRLK 130
P + + L L+ L+L N +
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 12/107 (11%)
Query: 6 SNELSSV---IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIP 62
+ L + IP L N +P ++ N K + I+LS N ++ +
Sbjct: 19 NKGLKVLPKGIPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLS 70
Query: 63 P-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
+ +T L L L NRL+ P +F L SL L L N++S V
Sbjct: 71 NQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVV 117
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 46/132 (34%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L+LG N+L + S L ++ + N L SLP + + + + E+ L N L
Sbjct: 67 YLALGGNKLHDI--SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
+P + LTNL L+L +N+LQ F +LT+L LDLS N L + +KL
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQ 182
Query: 119 LKDLNLSFNRLK 130
LKDL L N+LK
Sbjct: 183 LKDLRLYQNQLK 194
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 37/133 (27%), Positives = 58/133 (43%), Gaps = 12/133 (9%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+L ++ + LNSI +++ + S+ I+ + V + L N L
Sbjct: 23 KANLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLH-- 76
Query: 61 IPPTIG---GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV 117
I LTNL L L N+LQ F +LT+L+ L L N L + +KL
Sbjct: 77 ---DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT 133
Query: 118 YLKDLNLSFNRLK 130
L LNL+ N+L+
Sbjct: 134 NLTYLNLAHNQLQ 146
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 6/111 (5%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L N+L S+ F L ++ N L SLP + + + + +NL+ N L
Sbjct: 89 YLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ- 146
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGV 108
+P + LTNL L L N+LQ +PE F +LT L+ L L N L V
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKSV 196
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 37/166 (22%), Positives = 73/166 (43%), Gaps = 39/166 (23%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 270
D + +G G + V++ + +V +K+ LK E ++L++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--------LKPVKKKKIKREIKILEN 86
Query: 271 VR-HRNLVK---IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS------I 320
+R N++ I+ + ALV E++ N ++ ++Q L+
Sbjct: 87 LRGGPNIITLADIVKDPVSRT-PALVFEHVNNTDFKQ----------LYQTLTDYDIRFY 135
Query: 321 MIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIA 365
M ++ AL+Y H S ++H D+KP NV++D + L D+G+A
Sbjct: 136 MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 41/130 (31%), Positives = 61/130 (46%), Gaps = 6/130 (4%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L +N L S+ F L S+ N L SLP + + + +NLS N L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSVNNLSGVIPISLEKLV 117
+P + LT L+ L+L N+LQ +P+ F +LT L+ L L N L V ++L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 148
Query: 118 YLKDLNLSFN 127
L+ + L N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 27/82 (32%), Positives = 33/82 (40%), Gaps = 3/82 (3%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
+ T +P I L LE N L+ F ELTSL L L N L +
Sbjct: 11 TVECYSQGRTS-VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL 67
Query: 109 IPISLEKLVYLKDLNLSFNRLK 130
KL L LNLS N+L+
Sbjct: 68 PNGVFNKLTSLTYLNLSTNQLQ 89
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 25/128 (19%), Positives = 49/128 (38%), Gaps = 6/128 (4%)
Query: 2 LSLGSNELSSVIPSTFW-NLNSILSFDFSSNSLNGSLPLDI-ENM-KVVVEINLSRNYLT 58
L + + L T + + + + N S+P++ + + + + L N T
Sbjct: 110 LGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
Query: 59 GDIPPTIGGLTNLQLLSL-ENNRLQGPIPESFGELTS-LESLDLSVNNLSGVIPISLEKL 116
+ T L + L +N L ++FG + S LD+S +++ + LE L
Sbjct: 170 -SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228
Query: 117 VYLKDLNL 124
L N
Sbjct: 229 KELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 22/135 (16%), Positives = 47/135 (34%), Gaps = 9/135 (6%)
Query: 2 LSLGSN-ELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD--IENMKVVVEINLSRNYLT 58
+ + + L+ + P L + + L P + + + + ++ N
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143
Query: 59 GDIPP-TIGGLTN-LQLLSLENNRLQGPIPESFGELTSLESLDLSVNN-LSGVIPISLEK 115
IP GL N L L NN + T L+++ L+ N L+ + +
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGG 202
Query: 116 LV-YLKDLNLSFNRL 129
+ L++S +
Sbjct: 203 VYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 23/140 (16%), Positives = 43/140 (30%), Gaps = 29/140 (20%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L L ++ F NL + + I +S + +
Sbjct: 36 LKLIETHLRTIPSHAFSNLPN------------------------ISRIYVSIDVTLQQL 71
Query: 62 PPTI-GGLTNLQLLSLENNR-LQGPIPESFGELTSLESLDLSVNNLSGVIP--ISLEKLV 117
L+ + + + N R L P++ EL L+ L + L + P +
Sbjct: 72 ESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTD 130
Query: 118 YLKDLNLSFNRLKGDIPTRS 137
L ++ N IP +
Sbjct: 131 IFFILEITDNPYMTSIPVNA 150
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 13/81 (16%), Positives = 30/81 (37%), Gaps = 5/81 (6%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNN-LSG 107
+ ++ + IP + Q L L L+ +F L ++ + +S++ L
Sbjct: 15 DFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 108 VIPISLEKLVYLKDLNLSFNR 128
+ S L + + + R
Sbjct: 71 LESHSFYNLSKVTHIEIRNTR 91
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 3/84 (3%)
Query: 49 EINLSRNYLTGDIPPT--IGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS 106
E+ L+ N L I G L +L L L+ N+L G P +F + ++ L L N +
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 107 GVIPISLEKLVYLKDLNLSFNRLK 130
+ L LK LNL N++
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 38/129 (29%), Positives = 57/129 (44%), Gaps = 16/129 (12%)
Query: 6 SNELSSV---IPSTFWNLNSILSFDFSSNSLNGSLPLD--IENMKVVVEINLSRNYLTGD 60
L + IP L + N L + D + +V++ L RN LT
Sbjct: 17 GRGLKEIPRDIPLHTTEL------LLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-G 68
Query: 61 IPPTI-GGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSVNNLSGVIPISLEKLVY 118
I P G +++Q L L N+++ I F L L++L+L N +S V+P S E L
Sbjct: 69 IEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 119 LKDLNLSFN 127
L LNL+ N
Sbjct: 128 LTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-07
Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 7/107 (6%)
Query: 1 NLSLGSNELSSVIPS-TFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLT 58
L L NEL + F L ++ + N L + + E + E+ L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 59 GDIPPTI-GGLTNLQLLSLENNRLQGPIPE-SFGELTSLESLDLSVN 103
+I + GL L+ L+L +N++ + SF L SL SL+L+ N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 43/225 (19%), Positives = 82/225 (36%), Gaps = 59/225 (26%)
Query: 224 SLIGIGSFGTVYKGR-FLDGMEVAIKV------FHLQFDGALKSFDAECEVLKSVR---- 272
+G G F TV+ + ++ VA+K+ + A E ++L+ V
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AED----EIKLLQRVNDADN 77
Query: 273 -------HRNLVKIISS----CSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLS-- 319
+++K++ NG +V E + +L + + +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-----HRGIPLI 131
Query: 320 ----IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH------LSDFGIAKLLN 369
I + L L+Y+H ++H DIKP NVL++ ++D G A +
Sbjct: 132 YVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 370 GKESMRTQTLATIEYGREGQV------SPKSDVYGYGITLIETFT 408
T ++ T EY R +V +D++ + E T
Sbjct: 190 EH---YTNSIQTREY-RSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 45/174 (25%), Positives = 70/174 (40%), Gaps = 47/174 (27%)
Query: 218 DHFSEK----SLIGIGSFGTVYKGR-FLDGMEVAIKV------FHLQFDGALKSFDAECE 266
DH + + +IG GSFG V K VA+K+ FH Q A + E
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---AAE----EIR 145
Query: 267 VLKSVRHR------NLVKIISSCSNGNFEALVLEYMANGSLEKCLYS---SNGILDIFQR 317
+L+ +R + N++ ++ + + N + E L LY N FQ
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNK----FQG 196
Query: 318 LS------IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFG 363
S + L+ LH N ++HCD+KP N+LL + + DFG
Sbjct: 197 FSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 28/80 (35%), Positives = 35/80 (43%)
Query: 51 NLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP 110
L N L LT L LSL N++Q F +LT L L L N L +
Sbjct: 34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPN 93
Query: 111 ISLEKLVYLKDLNLSFNRLK 130
+KL LK+L L N+LK
Sbjct: 94 GVFDKLTQLKELALDTNQLK 113
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 40/128 (31%), Positives = 63/128 (49%), Gaps = 15/128 (11%)
Query: 6 SNELSSV---IPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGDI 61
S L+SV IPS+ L + SN L SLP + + + + +++LS+N + +
Sbjct: 16 SKGLTSVPTGIPSSATRL------ELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SL 67
Query: 62 PPTI-GGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
P + LT L +L L N+LQ +P F +LT L+ L L N L V ++L L
Sbjct: 68 PDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSL 126
Query: 120 KDLNLSFN 127
+ + L N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 21/62 (33%), Positives = 31/62 (50%)
Query: 69 TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNR 128
++ L LE+N+LQ F +LT L L LS N + + +KL L L L N+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 129 LK 130
L+
Sbjct: 88 LQ 89
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 4/105 (3%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTG 59
L L SN+L S+ F L + S N + SLP + + + + + L N L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQS 90
Query: 60 DIPPTI-GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN 103
+P + LT L+ L+L+ N+L+ F LTSL+ + L N
Sbjct: 91 -LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 37/190 (19%), Positives = 59/190 (31%), Gaps = 44/190 (23%)
Query: 218 DHFSEK----SLIGIGSFGTVYKGR-FLDGMEVAIKV------FHLQFDGALKSFDAECE 266
+ +G G+FG V + + A+KV + A E +
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS---AKI----EAD 83
Query: 267 VLKSVRHR-----NLVKIISSCSNGNFEALVLEYMANGSLEKCLYS---SNGILDIFQRL 318
+LK +++ N+VK + L+ E L LY N +
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNN----YNGF 134
Query: 319 S------IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372
I++ AL YL + H D+KP N+LLDD K
Sbjct: 135 HIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 373 SMRTQTLATI 382
+ I
Sbjct: 192 QIYRTKSTGI 201
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 17/89 (19%), Positives = 35/89 (39%), Gaps = 3/89 (3%)
Query: 42 ENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS 101
N E++L + I L + +N ++ + + F L L++L ++
Sbjct: 16 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVN 72
Query: 102 VNNLSGVIPISLEKLVYLKDLNLSFNRLK 130
N + + + L L +L L+ N L
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 8e-04
Identities = 22/105 (20%), Positives = 40/105 (38%), Gaps = 8/105 (7%)
Query: 2 LSLGSNELSSV--IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG 59
L L ++ + + +T ++I DFS N + L ++ + + ++ N +
Sbjct: 24 LDLRGYKIPVIENLGATLDQFDAI---DFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR 78
Query: 60 DIPPTIGGLTNLQLLSLENNRLQGP-IPESFGELTSLESLDLSVN 103
L +L L L NN L + L SL L + N
Sbjct: 79 IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-07
Identities = 29/141 (20%), Positives = 54/141 (38%), Gaps = 13/141 (9%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIEN---MKVVVEINLSRNYLT 58
L + + +T L + S+N++ I + M+ + ++L RN +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK 83
Query: 59 GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPIS-LEKLV 117
I L+ L + N++ +L +L L +S N ++ I L L
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 118 YLKDLNLSFNRLKGDIPTRSP 138
L+DL L+ N L D +
Sbjct: 141 KLEDLLLAGNPLYNDYKENNA 161
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 68 LTNLQLLSLEN--NRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 125
T + + L ++ + + L + + L LS NN+ + L + L+ L+L
Sbjct: 22 ATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLG 78
Query: 126 FNRLK 130
N +K
Sbjct: 79 RNLIK 83
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 41/173 (23%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKV------FHLQFDGALKSFDAECEVLK 269
D + SLIG GSFG V K + VAIK+ F Q A E +L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ---AQI----EVRLLE 105
Query: 270 SVRHR------NLVKIISSCSNGNFEALVLEYMANGSLEKCLYS---SNGILDIFQRLS- 319
+ +V + N LV E L LY + F+ +S
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTN----FRGVSL 156
Query: 320 -----IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH--LSDFGIA 365
+ AL +L + ++HCD+KP N+LL + + + DFG +
Sbjct: 157 NLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 30/85 (35%), Positives = 40/85 (47%), Gaps = 3/85 (3%)
Query: 47 VVEINLSRNYLT-GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
V E+ L G I NL+ LSL N L + +L L+ L+LS N +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRI 83
Query: 106 SGVIPISLEKLVYLKDLNLSFNRLK 130
G + + EKL L LNLS N+LK
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 7e-04
Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 1/65 (1%)
Query: 40 DIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGP-IPESFGELTSLESL 98
++ + + ++ LS N + G + L NL L+L N+L+ E +L L+SL
Sbjct: 66 NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125
Query: 99 DLSVN 103
DL
Sbjct: 126 DLFNC 130
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
++ S L +P I T Q+L L +N++ P F LT L LDL N L+ +
Sbjct: 13 TVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVL 69
Query: 109 IPISLEKLVYLKDLNLSFNRLK 130
+KL L L+L+ N+LK
Sbjct: 70 PAGVFDKLTQLTQLSLNDNQLK 91
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 21/60 (35%), Positives = 30/60 (50%), Gaps = 4/60 (6%)
Query: 51 NLSRNYLTGDIPPTI-GGLTNLQLLSLENNRLQGPIPES-FGELTSLESLDLSVNNLSGV 108
L N +T + P + LT L L L+NN+L +P F +LT L L L+ N L +
Sbjct: 36 YLYDNQITK-LEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQLKSI 93
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108
+N L +P I T+ Q L L NN++ P F L +L+ L + N L+ +
Sbjct: 16 LVNCQNIRLAS-VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAI 72
Query: 109 IPISLEKLVYLKDLNLSFNRLK 130
+KL L L+L+ N LK
Sbjct: 73 PTGVFDKLTQLTQLDLNDNHLK 94
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 33/164 (20%), Positives = 56/164 (34%), Gaps = 46/164 (28%)
Query: 218 DHFSEK----SLIGIGSFGTVYKGRFL--DGMEVAIKV------FHLQFDGALKSFDAEC 265
D S + +G G+FG V + G VA+K+ + A E
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---ARS----EI 62
Query: 266 EVLKSVRHR------NLVKIISSCSNGNFEALVLEYMANGSLEKCLYS---SNGILDIFQ 316
+VL+ + V+++ + +V E L Y NG F
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENG----FL 113
Query: 317 RLS------IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354
+ + ++ +LH SN + H D+KP N+L
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 42/144 (29%), Positives = 62/144 (43%), Gaps = 22/144 (15%)
Query: 224 SLIGIGSFGTVYKGRFLDGME-VAIKVFHLQFDGALKSFDAECEVLKSVR-----HRNLV 277
+G G F TV+ + G + VA+KV + D E +LKSVR N
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNRE 101
Query: 278 KIIS-------SCSNGNFEALVLEYMANGSLEKCLYSSNGI---LDIFQRLSIMIDVALA 327
++ S NG +V E + + L K + SN L ++ I+ V
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQG 158
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLL 351
L+YLH ++H DIKP N+LL
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILL 180
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 34/171 (19%), Positives = 55/171 (32%), Gaps = 60/171 (35%)
Query: 218 DHFSEK----SLIGIGSFGTVYKG--RFLDGMEVAIKV------FHLQFDGALKSFDAEC 265
D E+ +G G+FG V + +VA+K+ + A E
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---ARL----EI 67
Query: 266 EVLKSVRHR------NLVKIISS-------CSNGNFEALVLEYMANGSLEKCLYS---SN 309
VLK ++ + V + C + E L K + N
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKEN 115
Query: 310 GILDIFQRLS------IMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354
FQ + + AL +LH N + H D+KP N+L +
Sbjct: 116 N----FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS 159
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-06
Identities = 22/63 (34%), Positives = 32/63 (50%), Gaps = 2/63 (3%)
Query: 68 LTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 127
L+ LS N L + +L L+ L+LS N +SG + + EK L LNLS N
Sbjct: 41 FEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 128 RLK 130
++K
Sbjct: 99 KIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 16/65 (24%), Positives = 32/65 (49%), Gaps = 1/65 (1%)
Query: 40 DIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGP-IPESFGELTSLESL 98
++ + + ++ LS N ++G + NL L+L N+++ E +L +L+SL
Sbjct: 59 NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118
Query: 99 DLSVN 103
DL
Sbjct: 119 DLFNC 123
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 1e-05
Identities = 20/71 (28%), Positives = 36/71 (50%), Gaps = 7/71 (9%)
Query: 66 GGLTNLQLLSLENNRLQGPIPESFGE---LTSLESLDLSVNNLS--GVIPI--SLEKLVY 118
NL+ L + + Q + E F E L LE++D+S L+ G + ++K+ +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 119 LKDLNLSFNRL 129
LK +N+ +N L
Sbjct: 309 LKFINMKYNYL 319
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 24/101 (23%), Positives = 42/101 (41%), Gaps = 7/101 (6%)
Query: 9 LSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG--DIPPTIG 66
L + +I + + +L + EN+ ++ +NLS N L D+ +
Sbjct: 134 LKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQ 193
Query: 67 GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSG 107
NL++L+L N L+ S EL ++ L L L G
Sbjct: 194 KAPNLKILNLSGNELK-----SERELDKIKGLKLEELWLDG 229
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 25/154 (16%), Positives = 53/154 (34%), Gaps = 22/154 (14%)
Query: 1 NLSLGSNELS----SVIPSTFWNLNSILSFDFSSNSLNGS-----LPLDIENMKVVVEIN 51
LSL + L+ V+ ST L ++ S N L + ++ + ++
Sbjct: 89 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ 148
Query: 52 LSRNYLT----GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGEL-----TSLESLDLSV 102
L L+ + + + + L++ NN + + LE+L L
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLES 208
Query: 103 NNLS--GVIPIS--LEKLVYLKDLNLSFNRLKGD 132
++ + + L++L L N+L
Sbjct: 209 CGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 25/107 (23%), Positives = 40/107 (37%), Gaps = 18/107 (16%)
Query: 41 IENMKVVVEINLSRNYLTGD----IPPTIGGLTNLQLLSLENN---RLQGPIPESFGEL- 92
+ V EI LS N + + + I +L++ + R++ IPE+ L
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87
Query: 93 ------TSLESLDLSVNNLS--GVIPIS--LEKLVYLKDLNLSFNRL 129
L ++ LS N P+ L K L+ L L N L
Sbjct: 88 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 134
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 19/97 (19%), Positives = 32/97 (32%), Gaps = 13/97 (13%)
Query: 49 EINLSRNYLTGD----IPPTIGGLTNLQLLSLENNRL-----QGPIPESFGELTSLESLD 99
I RN L T L + + N + + + E L+ LD
Sbjct: 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 222
Query: 100 LSVNNLS--GVIPIS--LEKLVYLKDLNLSFNRLKGD 132
L N + G ++ L+ L++L L+ L
Sbjct: 223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 467 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.87 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.86 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.83 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.83 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.83 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.81 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.8 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.8 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.79 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.79 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.79 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.79 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.78 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.78 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.77 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.77 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.76 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.76 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.75 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.75 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.74 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.74 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.74 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.73 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.73 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.72 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.72 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.71 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.71 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.71 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.71 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.71 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.71 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.7 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.7 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.7 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.7 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.69 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.69 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.69 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.69 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.69 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.69 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.69 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.69 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.68 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.68 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.67 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.67 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.67 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.66 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.66 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.66 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.66 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.66 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.66 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.66 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.66 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.65 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.65 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.64 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.63 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.63 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.63 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.63 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.63 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.63 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.63 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.63 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.63 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.62 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.62 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.62 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.62 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.62 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.62 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.61 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.61 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.61 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.61 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.6 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.6 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.59 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.58 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.56 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.54 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.53 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.53 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.48 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.48 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.45 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.44 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.42 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.42 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.4 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.4 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.39 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.39 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.39 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.37 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.35 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.23 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.21 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.11 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.09 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.09 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.8 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.79 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.78 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.72 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.47 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.47 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.39 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.23 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.18 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.06 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.02 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.96 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.86 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.84 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.8 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.75 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.75 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.58 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.53 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.22 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.76 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.39 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.61 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.25 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.13 | |
| 2lz0_A | 100 | Uncharacterized protein; hypothetical leucine rich | 80.56 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-54 Score=410.33 Aligned_cols=236 Identities=23% Similarity=0.324 Sum_probs=197.2
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999986 49999999997653 2345678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 295 YMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+||+|.+++...+ ..+++.+++.++.||+.||+||| ++||+||||||+|||++++|.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999999997554 46799999999999999999999 9999999999999999999999999999999876432
Q ss_pred ----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh-------hccccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND-------FLPISVMNVVDT 441 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~i~~ 441 (467)
..+|..|+|||.+.+..|+.++||||+||++|||+||+.||.+....+. +...... .+++++.++|.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL-VLKIISGSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 2478899999999999999999999999999999999999986433221 2222222 234568999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
||.+||.+|++ +.|++
T Consensus 260 ~L~~dP~~R~s-~~e~l 275 (350)
T 4b9d_A 260 LFKRNPRDRPS-VNSIL 275 (350)
T ss_dssp HTCSSGGGSCC-HHHHH
T ss_pred HccCChhHCcC-HHHHh
Confidence 99999999974 44544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=406.21 Aligned_cols=233 Identities=23% Similarity=0.282 Sum_probs=202.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
+.|++.++||+|+||+||+|+++ +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999986 59999999998766666678899999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK----- 371 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----- 371 (467)
+||+|.+++.. +.+++.++..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 99999999865 45899999999999999999999 999999999999999999999999999999987543
Q ss_pred CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh---------hhcccccccccccc
Q 041491 372 ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN---------DFLPISVMNVVDTS 442 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~~ 442 (467)
...+|..|+|||.+.+..|+.++||||+||++|||++|+.||.+....+ .+..... ..+++++.++|.+|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 2357888999999999999999999999999999999999997643221 1111111 23455688999999
Q ss_pred cccchhHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQC 457 (467)
Q Consensus 443 l~~~~~~r~~~~~~~ 457 (467)
|.+||++|++ +.|+
T Consensus 308 L~~dP~~R~t-a~e~ 321 (346)
T 4fih_A 308 LVRDPAQRAT-AAEL 321 (346)
T ss_dssp SCSSTTTSCC-HHHH
T ss_pred cCCChhHCcC-HHHH
Confidence 9999999985 4444
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=404.43 Aligned_cols=239 Identities=26% Similarity=0.385 Sum_probs=201.2
Q ss_pred hccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467889999999999999999874 36789999998766666788999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEE
Q 041491 291 LVLEYMANGSLEKCLYSS------------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 358 (467)
||||||++|+|.++++.. ...+++.++..++.|+++||+||| +++|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence 999999999999999653 236899999999999999999999 99999999999999999999999
Q ss_pred EeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--
Q 041491 359 LSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-- 428 (467)
Q Consensus 359 l~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-- 428 (467)
|+|||+|+...... ..++..|+|||++.++.|+.++|||||||++|||+| |+.||.+....+ +...+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~~ 246 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQG 246 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHHT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcC
Confidence 99999998664322 235677999999999999999999999999999999 899998754332 222221
Q ss_pred ------hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 ------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 ------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
..+|+++.+++.+|+..||++|+ ++.+....|
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RP-s~~~i~~~L 284 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRK-NIKGIHTLL 284 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCc-CHHHHHHHH
Confidence 23445689999999999999996 444544443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=402.00 Aligned_cols=231 Identities=25% Similarity=0.337 Sum_probs=200.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||+||+|++. +|+.||+|++.+.. ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 48999999997542 344577999999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
|||+||+|.+++... +.+++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999653 57999999999999999999999 999999999999999999999999999999987532
Q ss_pred -----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccc
Q 041491 372 -----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVD 440 (467)
Q Consensus 372 -----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~ 440 (467)
...+|..|+|||.+.+..|+.++||||+||++|||+||+.||.+....+ .+..... ..+++++.++|.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEYDFPEKFFPKARDLVE 266 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTTCCHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCcccCHHHHHHHH
Confidence 2357889999999999999999999999999999999999997643222 1222222 234556899999
Q ss_pred cccccchhHHHHH
Q 041491 441 TSLLRREDKYFAA 453 (467)
Q Consensus 441 ~~l~~~~~~r~~~ 453 (467)
+||.+||.+|+++
T Consensus 267 ~lL~~dp~~R~t~ 279 (311)
T 4aw0_A 267 KLLVLDATKRLGC 279 (311)
T ss_dssp HHSCSSGGGSTTS
T ss_pred HHccCCHhHCcCh
Confidence 9999999999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=404.25 Aligned_cols=241 Identities=26% Similarity=0.400 Sum_probs=199.0
Q ss_pred hccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357888899999999999999874 37889999998766666788999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 291 LVLEYMANGSLEKCLYSSN--------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
||||||++|+|.++++... +.+++.++..++.|++.||+||| +++|+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence 9999999999999986532 36899999999999999999999 999999999999999999999
Q ss_pred EEEeccccceecCCC-------CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh
Q 041491 357 AHLSDFGIAKLLNGK-------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN 428 (467)
Q Consensus 357 ~kl~Dfg~a~~~~~~-------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~ 428 (467)
+||+|||+|+..... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+....+ ....+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~ 274 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCIT 274 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHH
Confidence 999999999876432 2345678999999999999999999999999999999 899998653322 222221
Q ss_pred --------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 429 --------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 429 --------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..+|+++.+++.+|+..||++|+ ++.|.+..|-+
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RP-s~~ei~~~L~~ 316 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRH-SIKDVHARLQA 316 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSC-CHHHHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCc-CHHHHHHHHHH
Confidence 23455689999999999999996 55555555433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=403.21 Aligned_cols=234 Identities=21% Similarity=0.244 Sum_probs=198.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.+.|++.++||+|+||.||+|+++ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 457888999999999999999986 489999999975422 24799999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceecCCCC--
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~-- 372 (467)
|+||+|.+++... +.+++.++..++.|++.||+||| ++||+||||||+|||++.+| ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999654 57999999999999999999999 99999999999999999987 69999999999765321
Q ss_pred --------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------hhhccccc
Q 041491 373 --------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------NDFLPISV 435 (467)
Q Consensus 373 --------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~ 435 (467)
..+|..|+|||.+.+..|+.++||||+||++|||+||+.||.+....+. +.... ...+++.+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCCCchhcCccCCHHH
Confidence 2478899999999999999999999999999999999999987543332 22221 22345568
Q ss_pred ccccccccccchhHHHHHHHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
.++|.+||.+||.+|+ ++.|+++.+
T Consensus 287 ~~li~~~L~~dP~~R~-sa~el~~~l 311 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRA-SAMELRRKV 311 (336)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHHHH
T ss_pred HHHHHHHccCCHhHCc-CHHHHHHHH
Confidence 9999999999999997 556665554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-54 Score=403.94 Aligned_cols=239 Identities=22% Similarity=0.272 Sum_probs=195.6
Q ss_pred ccCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
++|++.+.||+|+||+||+|++. .++.||+|+++... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 68999999999999999999873 37889999997543 2234568899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|||||+||+|.+++... +.+++.++..++.|++.||+||| ++||+||||||+|||++++|.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999654 57999999999999999999999 999999999999999999999999999999865432
Q ss_pred -----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccc
Q 041491 372 -----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVD 440 (467)
Q Consensus 372 -----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~ 440 (467)
...+|..|+|||.+.+..|+.++||||+||++|||+||+.||.+....+. +.... ...+++++.++|.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-MTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-HHHHHcCCCCCCCcCCHHHHHHHH
Confidence 23578899999999999999999999999999999999999986433221 11111 1234556999999
Q ss_pred cccccchhHHHHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l 461 (467)
+||.+||++|+++..+.++++
T Consensus 259 ~~L~~dP~~R~ta~~~~~~ei 279 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEI 279 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHH
T ss_pred HHcccCHHHCCCCCcCCHHHH
Confidence 999999999998643333333
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=397.87 Aligned_cols=241 Identities=27% Similarity=0.402 Sum_probs=198.2
Q ss_pred HHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
|++..+++++.++||+|+||+||+|++. ..||||+++... ....+.|.+|++++++++|||||++++++.+ +..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 3455678889999999999999999874 469999987543 2345789999999999999999999998865 4579
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||||||++|+|.++++.....+++.++..++.|++.||+||| +++||||||||+|||+++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999999877778999999999999999999999 99999999999999999999999999999987543
Q ss_pred C-------CccccccccccccccC---CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------------
Q 041491 371 K-------ESMRTQTLATIEYGRE---GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------------ 428 (467)
Q Consensus 371 ~-------~~~~~~~~~~pe~~~~---~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------------ 428 (467)
. ...+|..|+|||++.. +.|+.++|||||||++|||+||+.||.+...... +...+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTTCCCCCSTTSC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCCCCccccc
Confidence 2 2356788999998753 4689999999999999999999999976432221 111111
Q ss_pred hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
..+|+.+.+++.+|+..||++|+ ++.|++..+
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RP-s~~ei~~~L 295 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERP-LFPQILSSI 295 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSC-CHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCc-CHHHHHHHH
Confidence 12344588999999999999996 566666554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=388.51 Aligned_cols=240 Identities=21% Similarity=0.344 Sum_probs=190.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||+||+|++. +|+.||+|++++.. ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999986 59999999997542 234567899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+ +|+|.+++... +.+++.++..++.|++.||+||| ++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 999 67999988654 57999999999999999999999 999999999999999999999999999999876543
Q ss_pred --CccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccc
Q 041491 372 --ESMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTS 442 (467)
Q Consensus 372 --~~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~ 442 (467)
...+|..|+|||.+.+..+ +.++||||+||++|||+||+.||.+..... .+..... ..+++++.++|.+|
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 2457889999999988776 579999999999999999999997643221 1111111 23455689999999
Q ss_pred cccchhHHHHHHHHHH-HHHHhc
Q 041491 443 LLRREDKYFAAKKQCV-SSALSL 464 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~-~~l~~l 464 (467)
|..||++|++ ++|++ ..+++.
T Consensus 247 L~~dP~~R~s-~~eil~hpw~k~ 268 (275)
T 3hyh_A 247 LIVNPLNRIS-IHEIMQDDWFKV 268 (275)
T ss_dssp SCSSGGGSCC-HHHHHHCHHHHT
T ss_pred ccCChhHCcC-HHHHHcCccccc
Confidence 9999999985 44444 345543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=407.22 Aligned_cols=234 Identities=23% Similarity=0.281 Sum_probs=203.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.+.|++.+.||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999986 4999999999877666667899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC----
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 371 (467)
|+||+|.+++.. +.+++.++..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 999999999865 35899999999999999999999 999999999999999999999999999999987543
Q ss_pred -CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhcccccccccc
Q 041491 372 -ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMNVVD 440 (467)
Q Consensus 372 -~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~i~ 440 (467)
...+|..|+|||.+.+..|+.++|||||||++|||++|+.||.+....+ ....+. ..+++++.++|.
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 2357888999999999999999999999999999999999997643221 112221 123456889999
Q ss_pred cccccchhHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~ 458 (467)
+||..||++|++ +.|++
T Consensus 383 ~~L~~dP~~R~t-a~ell 399 (423)
T 4fie_A 383 RLLVRDPAQRAT-AAELL 399 (423)
T ss_dssp HHSCSSTTTSCC-HHHHT
T ss_pred HHcCCChhHCcC-HHHHh
Confidence 999999999985 44443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=394.56 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=200.7
Q ss_pred ccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++++.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 367899999975433 34578999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC
Q 041491 291 LVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM 355 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 355 (467)
+|||||++|+|.+++.... ..+++.++..++.|++.||+||| +++||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 9999999999999996432 35899999999999999999999 99999999999999999999
Q ss_pred cEEEeccccceecCCC-------CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH
Q 041491 356 VAHLSDFGIAKLLNGK-------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV 427 (467)
Q Consensus 356 ~~kl~Dfg~a~~~~~~-------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~ 427 (467)
.+||+|||+|+..... ...++..|+|||++..+.|+.++|||||||++|||+| |+.||.+.... .+...+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMI 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH
Confidence 9999999999865432 2346678999999999999999999999999999999 89999875332 223332
Q ss_pred h--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 428 N--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 428 ~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
. ..+|+++.+++.+|+..||++|+ ++.|.+..|-+
T Consensus 261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP-s~~ei~~~L~a 303 (308)
T 4gt4_A 261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRP-RFKDIHSRLRA 303 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHT
T ss_pred HcCCCCCCcccchHHHHHHHHHHcCCChhHCc-CHHHHHHHHHh
Confidence 2 22344588999999999999996 56666666544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=387.74 Aligned_cols=233 Identities=24% Similarity=0.349 Sum_probs=191.3
Q ss_pred CccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec----CCeeeEE
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFEALV 292 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 292 (467)
|+..+.||+|+||+||+|.+.. ++.||+|++.... ....+.+.+|++++++++|||||++++++.+ .+..|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3666789999999999999864 8999999997542 2345679999999999999999999999865 3568999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeecC-CCcEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDD-DMVAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 369 (467)
||||+||+|.+++... +.+++..+..++.||+.||+||| +++ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999653 57899999999999999999999 888 999999999999984 7899999999998655
Q ss_pred CCC---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------Hhhhcccccccc
Q 041491 370 GKE---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------VNDFLPISVMNV 438 (467)
Q Consensus 370 ~~~---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~ 438 (467)
... ..+|+.|+|||.+.+ .|+.++|||||||++|||+||+.||.+........... .....++++.++
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 432 357889999998764 69999999999999999999999997533222111111 112233458899
Q ss_pred cccccccchhHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~ 458 (467)
|.+||..||++|++ +.|++
T Consensus 263 i~~~L~~dP~~R~s-~~e~l 281 (290)
T 3fpq_A 263 IEGCIRQNKDERYS-IKDLL 281 (290)
T ss_dssp HHHHSCSSGGGSCC-HHHHH
T ss_pred HHHHccCChhHCcC-HHHHh
Confidence 99999999999984 44544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=391.85 Aligned_cols=249 Identities=20% Similarity=0.315 Sum_probs=205.7
Q ss_pred ccHHHHHHHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeecccc-cchHHHHHHHHHHHcCCC-CCceeE
Q 041491 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRH-RNLVKI 279 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~ 279 (467)
+..++|++..++|++.+.||+|+||+||+|++.. ++.||||+++.... ...+.+.+|++++++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4456788889999999999999999999998753 35799999976533 345679999999999976 899999
Q ss_pred EEEeec-CCeeeEEEecccCCCHHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 041491 280 ISSCSN-GNFEALVLEYMANGSLEKCLYSS---------------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343 (467)
Q Consensus 280 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 343 (467)
+|+|.. ++..+||||||++|+|.++++.. ...+++.++..++.||+.||+||| +++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 999866 45789999999999999999653 235899999999999999999999 99999999
Q ss_pred CCCCCeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCc
Q 041491 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCE 415 (467)
Q Consensus 344 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~ 415 (467)
|||+|||+++++.+||+|||+|+...... ..++..|+|||++.++.|+.++|||||||++|||+| |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999765432 235667999999999999999999999999999998 9999987
Q ss_pred cccccccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 416 IFCEEMNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 416 ~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
....+. +...+. ...++++.+++.+|+..||.+|+ ++.|+++.|
T Consensus 291 ~~~~~~-~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP-t~~eil~~L 342 (353)
T 4ase_A 291 VKIDEE-FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-TFSELVEHL 342 (353)
T ss_dssp CCCSHH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHH
T ss_pred CCHHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc-CHHHHHHHH
Confidence 543322 222222 22344689999999999999996 455555543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=377.24 Aligned_cols=234 Identities=22% Similarity=0.289 Sum_probs=184.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCC--------
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGN-------- 287 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 287 (467)
++|++.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999986 589999999976543 34567899999999999999999999986543
Q ss_pred ----eeeEEEecccCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEec
Q 041491 288 ----FEALVLEYMANGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 288 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 361 (467)
..|+|||||++|+|.+++..... ..++..++.++.|++.||+||| ++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 46899999999999999965433 3566778899999999999999 99999999999999999999999999
Q ss_pred cccceecCCCC-----------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHH
Q 041491 362 FGIAKLLNGKE-----------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK 424 (467)
Q Consensus 362 fg~a~~~~~~~-----------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~ 424 (467)
||+|+...... ..+|..|+|||.+.+..|+.++|||||||++|||++ ||.........+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 99998765421 247888999999999999999999999999999996 8865322211122
Q ss_pred HHHhhhc-------ccccccccccccccchhHHHHHHHHHH
Q 041491 425 NWVNDFL-------PISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 425 ~~~~~~~-------~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
....... ++...++|.+||..||.+|++ +.|++
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps-~~eil 278 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE-AINII 278 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC-HHHHH
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcC-HHHHh
Confidence 2222222 234678999999999999985 44444
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=373.62 Aligned_cols=242 Identities=19% Similarity=0.268 Sum_probs=187.1
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC----eeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----FEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 293 (467)
++|.+.+.||+|+||+||+|++ +|+.||||+++.... .....+.|+..+.+++||||+++++++.+++ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5688889999999999999998 689999999875422 1222345566667889999999999997654 579999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG-----YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
|||++|+|.++++.. .+++..+.+++.|++.||+|||.. +.++|+||||||+|||+++++++||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999654 589999999999999999999921 1239999999999999999999999999999876
Q ss_pred CCCC---------ccccccccccccccCC------CCCCcccchhhHHHHHHHhcCCCCCCccc----------cccccH
Q 041491 369 NGKE---------SMRTQTLATIEYGREG------QVSPKSDVYGYGITLIETFTKKKPTCEIF----------CEEMNL 423 (467)
Q Consensus 369 ~~~~---------~~~~~~~~~pe~~~~~------~~~~~~Dv~slGvil~el~tg~~Pf~~~~----------~~~~~~ 423 (467)
.... ..+|..|+|||++.+. .++.++|||||||++|||+||+.||.... ......
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 4322 2467889999988654 46789999999999999999987764321 111122
Q ss_pred HHHHh--------hhcc---------cccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 424 KNWVN--------DFLP---------ISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 424 ~~~~~--------~~~~---------~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..... ..+| +.+.+++.+|+..||++|+ ++.|.++.|-++
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ei~~~L~~l 295 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-TALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc-CHHHHHHHHHHH
Confidence 22211 1112 1356899999999999997 566666666544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=375.15 Aligned_cols=192 Identities=20% Similarity=0.287 Sum_probs=169.1
Q ss_pred HHhccCccCCccCcccceeEEEEEec----CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 289 (467)
...++|++.+.||+|+||+||+|+++ .++.||+|.+.... ...++.+|+++++.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999864 36789999986543 346688999999998 699999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-CcEEEeccccceec
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAKLL 368 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~ 368 (467)
|+||||+++|+|.+++. .+++.++..+++|++.||+||| ++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999883 4899999999999999999999 9999999999999999877 79999999999865
Q ss_pred CCCC---------------------------------ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCC
Q 041491 369 NGKE---------------------------------SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTC 414 (467)
Q Consensus 369 ~~~~---------------------------------~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~ 414 (467)
.... ..+|..|+|||.+.+. .|+.++||||+||++|||+||+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 4321 2467889999988765 58999999999999999999999995
Q ss_pred c
Q 041491 415 E 415 (467)
Q Consensus 415 ~ 415 (467)
.
T Consensus 249 ~ 249 (361)
T 4f9c_A 249 K 249 (361)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=375.70 Aligned_cols=232 Identities=23% Similarity=0.288 Sum_probs=190.5
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeec------CCe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSN------GNF 288 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 288 (467)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999986 599999999975432 334678899999999999999999998754 367
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|||||||+ |+|.+++.. .+.+++..+..+++||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 689998854 457999999999999999999999 999999999999999999999999999999876
Q ss_pred CCC---------CccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc-----------------
Q 041491 369 NGK---------ESMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----------------- 421 (467)
Q Consensus 369 ~~~---------~~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----------------- 421 (467)
... ...+|..|+|||.+.+. .++.++||||+||++|||++|++||.+....+.
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 421 23578889999987764 569999999999999999999999975422110
Q ss_pred -----cHHHH--------------HhhhcccccccccccccccchhHHHHHH
Q 041491 422 -----NLKNW--------------VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 422 -----~~~~~--------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
....+ ....+++++.++|.+||..||.+|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 340 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 00000 1122345678999999999999998543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=389.27 Aligned_cols=233 Identities=21% Similarity=0.276 Sum_probs=195.3
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHH---HHHHHHcCCCCCceeEEEEeecCCe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDA---ECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
..++|++.+.||+|+||+||+|+++. |+.||+|++++.. ........+ ++.+++.++|||||++++++.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 34689999999999999999999874 9999999997542 122233334 4566778899999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+|||||+||+|.+++... +.+++..+..++.||+.||+||| ++|||||||||+|||++.+|++||+|||+|+.+
T Consensus 267 lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999654 57999999999999999999999 999999999999999999999999999999987
Q ss_pred CCC---CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc-cHHHHH-------hhhcccccc
Q 041491 369 NGK---ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-NLKNWV-------NDFLPISVM 436 (467)
Q Consensus 369 ~~~---~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-~~~~~~-------~~~~~~~~~ 436 (467)
... ...+|+.|+|||.+.. ..|+.++||||+||++|||++|+.||.+....+. .+.... +..+++++.
T Consensus 343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~ 422 (689)
T 3v5w_A 343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422 (689)
T ss_dssp SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHH
Confidence 643 3468899999999864 5799999999999999999999999976433221 111111 123455699
Q ss_pred cccccccccchhHHHH
Q 041491 437 NVVDTSLLRREDKYFA 452 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~ 452 (467)
++|.+||.+||.+|++
T Consensus 423 dLI~~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRLG 438 (689)
T ss_dssp HHHHHHTCSCGGGCTT
T ss_pred HHHHHHccCCHhHCCC
Confidence 9999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=391.34 Aligned_cols=237 Identities=22% Similarity=0.293 Sum_probs=205.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|+++ +|+.||+|++........+.+.+|+++|+.++||||+++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999986 4999999999876555667889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC--CcEEEeccccceecCCCCc
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD--MVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~ 373 (467)
|+||+|.+++....+.+++.++..++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999999777778999999999999999999999 9999999999999999854 8999999999998876543
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----------Hhhhccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----------VNDFLPISVMNVV 439 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----------~~~~~~~~~~~~i 439 (467)
.++..|+|||.+.+..|+.++||||+||++|||++|+.||.+....+. +... ....+++++.++|
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 467889999999999999999999999999999999999976432221 1111 1223455688999
Q ss_pred ccccccchhHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~ 458 (467)
.+||..||.+|++ +.|++
T Consensus 392 ~~~L~~dp~~R~t-~~e~l 409 (573)
T 3uto_A 392 RKLLLADPNTRMT-IHQAL 409 (573)
T ss_dssp HTTSCSSGGGSCC-HHHHH
T ss_pred HHHccCChhHCcC-HHHHh
Confidence 9999999999984 44544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.35 Aligned_cols=242 Identities=20% Similarity=0.296 Sum_probs=206.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999986 4899999998766556678899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++++|.+++......+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999877778999999999999999999999 9999999999999999999999999999998764322
Q ss_pred ----------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc----ccHHHHH----h
Q 041491 373 ----------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE----MNLKNWV----N 428 (467)
Q Consensus 373 ----------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~----~~~~~~~----~ 428 (467)
..++..|.+||...+..++.++||||||+++|||++|..||....... ....... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence 235667899999999999999999999999999999999987543322 2233333 3
Q ss_pred hhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
..+++.+.+++.+|+..||.+|+ ++.++++.|.
T Consensus 246 ~~~~~~l~~li~~~l~~dP~~Rp-s~~~l~~~L~ 278 (310)
T 3s95_A 246 PNCPPSFFPITVRCCDLDPEKRP-SFVKLEHWLE 278 (310)
T ss_dssp TTCCTTHHHHHHHHTCSSGGGSC-CHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCc-CHHHHHHHHH
Confidence 44566799999999999999995 3444444443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=341.36 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=207.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999976 48999999986543 23346788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++++|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999998654 46899999999999999999999 9999999999999999999999999999998765332
Q ss_pred ------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------cHHHHHhhhcccccc
Q 041491 373 ------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----------NLKNWVNDFLPISVM 436 (467)
Q Consensus 373 ------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~ 436 (467)
..++..|.+||...+..++.++||||+|+++|||+||+.||.+...... .........+|+.+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 2357788999999999999999999999999999999999976432221 122223345667799
Q ss_pred cccccccccchhHHHHHHHHHHHHHHhc
Q 041491 437 NVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+++.+||..||.+|+++++++...|.++
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 9999999999999999999888887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=338.17 Aligned_cols=232 Identities=27% Similarity=0.322 Sum_probs=200.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999875 5899999999877666677889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+++|+|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 9999999998654 5899999999999999999999 9999999999999999999999999999998765432
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhcccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVVDTS 442 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~~ 442 (467)
..++..|.+||...+..++.++||||+||++|||+||+.||.............. ...+++.+.+++.+|
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 2467778999999999999999999999999999999999976432221111111 123444588999999
Q ss_pred cccchhHHHHH
Q 041491 443 LLRREDKYFAA 453 (467)
Q Consensus 443 l~~~~~~r~~~ 453 (467)
|..||.+|++.
T Consensus 254 l~~dp~~Rps~ 264 (297)
T 3fxz_A 254 LEMDVEKRGSA 264 (297)
T ss_dssp SCSSTTTSCCH
T ss_pred ccCChhHCcCH
Confidence 99999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.25 Aligned_cols=230 Identities=23% Similarity=0.277 Sum_probs=197.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999986 48999999997542 33456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
|||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999988543 46899999999999999999999 999999999999999999999999999999864322
Q ss_pred ----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhccccccccccc
Q 041491 372 ----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDT 441 (467)
Q Consensus 372 ----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~ 441 (467)
...++..|.|||.+.+..++.++|||||||++|||++|+.||........ ..... ...+++++.++|.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23467789999999999999999999999999999999999976432211 11111 12345568999999
Q ss_pred ccccchhHHH
Q 041491 442 SLLRREDKYF 451 (467)
Q Consensus 442 ~l~~~~~~r~ 451 (467)
||..||.+|+
T Consensus 239 lL~~dP~~R~ 248 (337)
T 1o6l_A 239 LLKKDPKQRL 248 (337)
T ss_dssp HTCSSTTTST
T ss_pred HhhcCHHHhc
Confidence 9999999997
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=340.34 Aligned_cols=258 Identities=34% Similarity=0.527 Sum_probs=217.5
Q ss_pred cccccHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEe
Q 041491 205 WRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 283 (467)
Q Consensus 205 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 283 (467)
...+++.++....++|++.+.||+|+||.||+|++.+++.||+|++..... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456889999999999999999999999999999987899999999875532 2334689999999999999999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCCC---CCCHHHHHHHHHHHHHHHHHHhcCCCC---CceecCCCCCCeeecCCCcE
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSNG---ILDIFQRLSIMIDVALALEYLHFGYSN---PVVHCDIKPSNVLLDDDMVA 357 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~---~ivH~dlkp~NIll~~~~~~ 357 (467)
...+..++||||+++|+|.+++..... .+++..+..++.|++.||+||| ++ ||+||||||+||++++++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCE
Confidence 999999999999999999999976432 5899999999999999999999 77 99999999999999999999
Q ss_pred EEeccccceecCCCCc------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc---ccccccHHHHHh
Q 041491 358 HLSDFGIAKLLNGKES------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI---FCEEMNLKNWVN 428 (467)
Q Consensus 358 kl~Dfg~a~~~~~~~~------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~---~~~~~~~~~~~~ 428 (467)
||+|||+++....... .++..|.+||...+..++.++|||||||++|||+||+.||+.. ........+|+.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999987653322 2567789999988888999999999999999999999999642 223334555544
Q ss_pred hhcc---------------------cccccccccccccchhHHHHHHHHHHHHHHhccc
Q 041491 429 DFLP---------------------ISVMNVVDTSLLRREDKYFAAKKQCVSSALSLAM 466 (467)
Q Consensus 429 ~~~~---------------------~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l~~ 466 (467)
.... ..+.+++.+||..||.+|+ ++.|+++.|-..++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~~~~ 311 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP-KMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC-CHHHHHHHHHTSSC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC-CHHHHHHHhcCcch
Confidence 3222 2477888999999999997 67788888765543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=342.70 Aligned_cols=251 Identities=32% Similarity=0.480 Sum_probs=208.4
Q ss_pred ccHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
+++.++...+++|++.+.||+|+||.||+|++.+++.||+|++........+.+.+|++++++++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33444555778999999999999999999998889999999987765566778999999999999999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 288 FEALVLEYMANGSLEKCLYSSN---GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999986543 25899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc-ccHHHHHh--------
Q 041491 365 AKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE-MNLKNWVN-------- 428 (467)
Q Consensus 365 a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~-~~~~~~~~-------- 428 (467)
++...... ..++..|.+||...++.++.++||||||+++|||+||+.||......+ .....|..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98754321 235677899999888899999999999999999999999997643322 23333321
Q ss_pred -------------hhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 429 -------------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 429 -------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
...+..+.+++.+||..||++|+ ++.|+++.+-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~ 311 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP-SMGDVLWKLE 311 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC-CHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc-CHHHHHHHHH
Confidence 11122467888899999999996 4555555543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=337.07 Aligned_cols=234 Identities=19% Similarity=0.279 Sum_probs=200.9
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|.+.. ++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4689999999999999999999864 889999998754 23456688999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC--CCcEEEeccccceecCCCCc
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD--DMVAHLSDFGIAKLLNGKES 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~ 373 (467)
+++|+|.+++......+++.++..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999776667999999999999999999999 999999999999999987 78999999999998765432
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----------Hhhhccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----------VNDFLPISVMNVV 439 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----------~~~~~~~~~~~~i 439 (467)
.++..|.+||...+..++.++||||+||++|||++|+.||......+ ..... ....+++++.+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 35667899999888888999999999999999999999997643221 11111 2234566799999
Q ss_pred ccccccchhHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKK 455 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~ 455 (467)
.+||..||.+|++..+
T Consensus 239 ~~~L~~dp~~Rpt~~e 254 (321)
T 1tki_A 239 DRLLVKERKSRMTASE 254 (321)
T ss_dssp HTTSCSSGGGSCCHHH
T ss_pred HHHcCCChhHCcCHHH
Confidence 9999999999986443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=338.04 Aligned_cols=246 Identities=27% Similarity=0.381 Sum_probs=196.6
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG 286 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 286 (467)
...++.+..++|++.+.||+|+||.||+|++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3445556678999999999999999999987 68899999987553 23346788999999999999999999999999
Q ss_pred CeeeEEEecccCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeecCCCcEEEecc
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+||| ++| |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999965432 3899999999999999999999 999 999999999999999999999999
Q ss_pred ccceecCCC-----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------h
Q 041491 363 GIAKLLNGK-----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------N 428 (467)
Q Consensus 363 g~a~~~~~~-----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------~ 428 (467)
|+++..... ...++..|.+||...+..++.++|||||||++|||+||+.||......+. ...+ .
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~ 261 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKCKRLEIP 261 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHHSCCCCCCC
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCCCCCC
Confidence 999865433 23467789999999999999999999999999999999999986433221 1111 1
Q ss_pred hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
..+++.+.+++.+||..+|.+|+ ++.++++.|
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rp-s~~~ll~~L 293 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRP-SFATIMDLL 293 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSC-CHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCc-CHHHHHHHH
Confidence 23455689999999999999995 344444433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=341.53 Aligned_cols=238 Identities=22% Similarity=0.290 Sum_probs=199.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4689999999999999999999864 8899999997542 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||++||+|.+++.. .+.+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999864 457999999999999999999999 9999999999999999999999999999999775432
Q ss_pred ----ccccccccccccccC---CCCCCcccchhhHHHHHHHhcCCCCCCccccccc-cHHHHH-------hhhccccccc
Q 041491 373 ----SMRTQTLATIEYGRE---GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM-NLKNWV-------NDFLPISVMN 437 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~---~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~-~~~~~~-------~~~~~~~~~~ 437 (467)
..++..|.|||.+.. ..++.++|||||||++|||++|+.||........ ...... ...+++.+.+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~ 249 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHH
Confidence 346778999998863 4589999999999999999999999975322211 111111 1234456899
Q ss_pred ccccccccchhHHHHHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~~ 458 (467)
++.+||..+|.+|+++++++.
T Consensus 250 li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 250 LLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp HHHHHSCSSGGGSCCSHHHHH
T ss_pred HHHHHhcCCHhHhcccHHHHH
Confidence 999999999999987655543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=353.88 Aligned_cols=237 Identities=21% Similarity=0.287 Sum_probs=199.9
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEee
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCS 284 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 284 (467)
.+.++....++|++.+.||+|+||+||+|++.. ++.||+|+++... ......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 355666778899999999999999999999875 7899999997532 223345889999999999999999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
+.+..|+||||+++|+|.+++....+.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 999999999999999999999776678999999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC------cccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-----
Q 041491 365 AKLLNGKE------SMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----- 428 (467)
Q Consensus 365 a~~~~~~~------~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----- 428 (467)
|+...... ..++..|.|||++. .+.++.++|||||||++|||++|+.||......+. +.....
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~ 300 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKERF 300 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHC
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhccccc
Confidence 98765432 34677889999876 56789999999999999999999999976433221 111111
Q ss_pred ------hhcccccccccccccccchhH
Q 041491 429 ------DFLPISVMNVVDTSLLRREDK 449 (467)
Q Consensus 429 ------~~~~~~~~~~i~~~l~~~~~~ 449 (467)
..+++++.++|.++|..+|++
T Consensus 301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r 327 (437)
T 4aw2_A 301 QFPTQVTDVSENAKDLIRRLICSREHR 327 (437)
T ss_dssp CCCSSCCCSCHHHHHHHHTTSSCGGGC
T ss_pred cCCcccccCCHHHHHHHHHHhcccccc
Confidence 114456889999999888776
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.92 Aligned_cols=231 Identities=24% Similarity=0.338 Sum_probs=196.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
..++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3468999999999999999999985 69999999997653 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999998554 46899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ----ccccccccccccccCCCCC-CcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-h------hhcccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQVS-PKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-N------DFLPISVMNVVD 440 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~-~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-~------~~~~~~~~~~i~ 440 (467)
..++..|.|||.+.+..++ +++||||+||++|||++|+.||.+....+ +...+ . ...++++.+++.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LRERVLRGKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 3467788999998887765 79999999999999999999997643222 11111 1 123456889999
Q ss_pred cccccchhHHHH
Q 041491 441 TSLLRREDKYFA 452 (467)
Q Consensus 441 ~~l~~~~~~r~~ 452 (467)
+||..||.+|++
T Consensus 247 ~~L~~dP~~R~t 258 (328)
T 3fe3_A 247 RFLVLNPIKRGT 258 (328)
T ss_dssp HHCCSSTTTSCC
T ss_pred HHCCCChhHCcC
Confidence 999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=348.69 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=204.2
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEee
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCS 284 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 284 (467)
.+.+.....++|++.+.||+|+||.||+|+++ +|+.||+|++++.. ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45566677899999999999999999999986 58999999997532 233456889999999999999999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
+.+..|+||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999766567999999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC------cccccccccccccc-------CCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHH--
Q 041491 365 AKLLNGKE------SMRTQTLATIEYGR-------EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWV-- 427 (467)
Q Consensus 365 a~~~~~~~------~~~~~~~~~pe~~~-------~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~-- 427 (467)
++...... ..++..|.|||++. .+.++.++|||||||++|||++|+.||......+. ....+.
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 98875432 24677889999876 45689999999999999999999999976433221 111111
Q ss_pred ------hhhcccccccccccccccchhHHH--HHHHHH
Q 041491 428 ------NDFLPISVMNVVDTSLLRREDKYF--AAKKQC 457 (467)
Q Consensus 428 ------~~~~~~~~~~~i~~~l~~~~~~r~--~~~~~~ 457 (467)
...+++++.++|.+||. +|.+|. .+++|+
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei 325 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 12355679999999998 999984 244444
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=335.93 Aligned_cols=231 Identities=23% Similarity=0.314 Sum_probs=198.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999986 58999999997542 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 9999999999998653 46899999999999999999999 9999999999999999999999999999998775432
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLL 444 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~ 444 (467)
..++..|.|||...+..++.++||||+||++|||++|+.||.+....+ ....... ..+++++.+++.+||.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAELRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 356778999999999999999999999999999999999997643221 1122222 2344568999999999
Q ss_pred cchhHHHH
Q 041491 445 RREDKYFA 452 (467)
Q Consensus 445 ~~~~~r~~ 452 (467)
.||.+|+.
T Consensus 240 ~dp~~R~~ 247 (318)
T 1fot_A 240 RDLSQRLG 247 (318)
T ss_dssp SCTTTCTT
T ss_pred cCHHHcCC
Confidence 99999984
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.76 Aligned_cols=233 Identities=21% Similarity=0.288 Sum_probs=199.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc------chHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 468999999999999999999986 4899999999765321 346789999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC----cEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM----VAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a 365 (467)
++||||+++|+|.+++.. .+.+++..+..++.|++.||.||| ++||+||||||+||++++++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999854 457899999999999999999999 99999999999999998877 7999999999
Q ss_pred eecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---------cHHHHHhhhcc
Q 041491 366 KLLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------NLKNWVNDFLP 432 (467)
Q Consensus 366 ~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------~~~~~~~~~~~ 432 (467)
+..... ...++..|.+||...+..++.++||||+||++|||++|..||.+....+. .+..-.+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 887643 23467789999999988999999999999999999999999976432211 11112234456
Q ss_pred cccccccccccccchhHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~ 453 (467)
+.+.++|.+||..||.+|++.
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~ 267 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTI 267 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHHHHCCCChhHCcCH
Confidence 679999999999999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.20 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=205.7
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
+..++|++.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3457899999999999999999999888999999997553 344678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
|+++++|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999877778999999999999999999999 999999999999999999999999999999866432
Q ss_pred ---CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-------hhcccccccccc
Q 041491 372 ---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVD 440 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~ 440 (467)
....+..|.+||......++.++||||+|+++|||++ |+.||......+ ....... ...++.+.+++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 2234456899999988899999999999999999999 999997643322 1111111 123445889999
Q ss_pred cccccchhHHHHHHHHHHHHHHhc
Q 041491 441 TSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+||..+|.+|+ ++.++++.+.++
T Consensus 242 ~~l~~~p~~Rp-s~~~ll~~l~~l 264 (269)
T 4hcu_A 242 HCWRERPEDRP-AFSRLLRQLAEI 264 (269)
T ss_dssp HHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHccCCcccCc-CHHHHHHHHHHH
Confidence 99999999996 455566555443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=337.42 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=200.2
Q ss_pred HhccCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..++|++.+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3568999999999999999999985 24569999997653 334567899999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++|+|.+++....+.+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999777778999999999999999999999 99999999999999999999999999999997754
Q ss_pred CCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccc
Q 041491 371 KES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPI 433 (467)
Q Consensus 371 ~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~ 433 (467)
... ..+..|.+||...+..++.++|||||||++|||++ |+.||......+ ....+. ..+++
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCCCCCCTTCCH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCCCCCCCCcCH
Confidence 321 12345899999988889999999999999999999 999997643322 112211 12445
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.+.+++.+||..||.+|+ ++.+++..|.
T Consensus 282 ~l~~li~~~l~~dp~~Rp-s~~eil~~L~ 309 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRP-RFSQIVSVLD 309 (325)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCc-CHHHHHHHHH
Confidence 689999999999999995 4445554443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=327.35 Aligned_cols=243 Identities=25% Similarity=0.323 Sum_probs=207.1
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..++|++.+.||+|+||.||+|++.++..||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 457899999999999999999999888899999997553 3456789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc--
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-- 373 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 373 (467)
+++++|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999776667999999999999999999999 99999999999999999999999999999987654432
Q ss_pred ----cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-------hhccccccccccc
Q 041491 374 ----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDT 441 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~ 441 (467)
..+..|.+||...+..++.++||||+|+++|||+| |+.||......+. ...... ...++.+.+++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLKVSQGHRLYRPHLASDTIYQIMYS 240 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHHHHcCCCCCCCCcChHHHHHHHHH
Confidence 23445899999988889999999999999999999 9999976433321 111111 1234458899999
Q ss_pred ccccchhHHHHHHHHHHHHHHhc
Q 041491 442 SLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
||..+|.+|+ ++.++++.|.++
T Consensus 241 ~l~~~p~~Rp-s~~~ll~~L~~l 262 (268)
T 3sxs_A 241 CWHELPEKRP-TFQQLLSSIEPL 262 (268)
T ss_dssp TTCSSGGGSC-CHHHHHHHHGGG
T ss_pred HcCCChhhCc-CHHHHHHHHHHh
Confidence 9999999995 677888877654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.53 Aligned_cols=244 Identities=21% Similarity=0.350 Sum_probs=201.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCe----
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNF---- 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 288 (467)
.++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999985 589999999976532 234578899999999999999999999876543
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++||||+++++|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999998644 46899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCC--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH---------HHHHhhhc
Q 041491 369 NGKE--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL---------KNWVNDFL 431 (467)
Q Consensus 369 ~~~~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~---------~~~~~~~~ 431 (467)
.... ..++..|.+||...+..++.++||||||+++|||+||+.||......+... .......+
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 5322 235778899999998999999999999999999999999997643322211 11122345
Q ss_pred ccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
++++.+++.+||..||.+|+++++++...+.++
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 667999999999999999999888888888764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.47 Aligned_cols=235 Identities=22% Similarity=0.283 Sum_probs=196.0
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 288 (467)
....++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 3456799999999999999999999864 8999999997542 23456678999999988 79999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|+..
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999998654 46899999999999999999999 999999999999999999999999999999864
Q ss_pred CCC-----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccc
Q 041491 369 NGK-----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMN 437 (467)
Q Consensus 369 ~~~-----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~ 437 (467)
... ...++..|.|||.+.+..++.++||||+||++|||++|+.||......+ ....... ..+++.+.+
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~ 253 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEVVYPTWLHEDATG 253 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHH
Confidence 322 2346778899999888889999999999999999999999997643322 1122222 124456899
Q ss_pred ccccccccchhHHHHH
Q 041491 438 VVDTSLLRREDKYFAA 453 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~ 453 (467)
++.+||..+|.+|+++
T Consensus 254 li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGS 269 (353)
T ss_dssp HHHHHTCSSGGGSTTS
T ss_pred HHHHHhhhCHHHccCC
Confidence 9999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.35 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=201.4
Q ss_pred HhccCccCCccCcccceeEEEEEec--------CCCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEeec
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCSN 285 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 285 (467)
..++|++.+.||+|+||.||+|++. ++..||+|+++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999863 245799999975532 3456789999999999 89999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVL 350 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 350 (467)
.+..|+||||+++|+|.+++.... ..+++.++..++.|++.||+||| ++||+||||||+||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence 999999999999999999987643 24789999999999999999999 999999999999999
Q ss_pred ecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccccc
Q 041491 351 LDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMN 422 (467)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~ 422 (467)
++.++.+||+|||+++...... ...+..|.+||.+.+..++.++|||||||++|||+| |+.||.+....+
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 9999999999999998765432 223456899999999999999999999999999999 999997643322
Q ss_pred HHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 423 LKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 423 ~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
....+.. .+++++.+++.+||..+|.+|+ ++.|+++.|.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~L~~ 361 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 361 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 2222221 2344688999999999999995 56666655544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=331.40 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=205.3
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
.+.+..++|++.+.||+|+||.||+|.+.++..||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 3445678999999999999999999999888899999997553 345778999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++++|.+++......+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999999776667999999999999999999999 999999999999999999999999999999866432
Q ss_pred ------CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-------hhccccccc
Q 041491 372 ------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-------DFLPISVMN 437 (467)
Q Consensus 372 ------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~ 437 (467)
....+..|.+||......++.++||||+|+++|||+| |+.||......+. ...... ...++.+.+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-HHHHhcccCCCCCCcCCHHHHH
Confidence 2233456899999988889999999999999999998 9999976432221 111111 123445889
Q ss_pred ccccccccchhHHHHHHHHHHHHHHhc
Q 041491 438 VVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
++.+||..+|.+|+ ++.+++..|.++
T Consensus 253 li~~~l~~~p~~Rp-s~~~ll~~L~~~ 278 (283)
T 3gen_A 253 IMYSCWHEKADERP-TFKILLSNILDV 278 (283)
T ss_dssp HHHHTTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHccCChhHCc-CHHHHHHHHHHH
Confidence 99999999999996 566777766553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=340.21 Aligned_cols=233 Identities=23% Similarity=0.276 Sum_probs=200.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999986 58999999997542 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 9999999999998654 46899999999999999999999 9999999999999999999999999999999876543
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLL 444 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~ 444 (467)
..++..|.+||.+.+..++.++|||||||++|||++|+.||......+ ....... ..+++.+.++|.+||.
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 356788999999999999999999999999999999999997643221 1222221 2345569999999999
Q ss_pred cchhHHHHHH
Q 041491 445 RREDKYFAAK 454 (467)
Q Consensus 445 ~~~~~r~~~~ 454 (467)
.||.+|++++
T Consensus 275 ~dp~~R~~~~ 284 (350)
T 1rdq_E 275 VDLTKRFGNL 284 (350)
T ss_dssp SCTTTCTTSS
T ss_pred cCHHhccCCc
Confidence 9999998743
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=330.82 Aligned_cols=245 Identities=22% Similarity=0.259 Sum_probs=206.4
Q ss_pred ccccHHHHHHHhcc----------CccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCC
Q 041491 206 RRFSYQELLLATDH----------FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR 274 (467)
Q Consensus 206 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 274 (467)
..++++++..+++. |+..+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777766653 777889999999999999987 5999999999876666667899999999999999
Q ss_pred CceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC
Q 041491 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354 (467)
Q Consensus 275 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 354 (467)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999998854 46899999999999999999999 9999999999999999999
Q ss_pred CcEEEeccccceecCCCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-
Q 041491 355 MVAHLSDFGIAKLLNGKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN- 428 (467)
Q Consensus 355 ~~~kl~Dfg~a~~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~- 428 (467)
+.+||+|||++....... ..++..|.+||+..+..++.++||||||+++|||++|+.||......+ ......
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~~~ 255 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRD 255 (321)
T ss_dssp CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH
T ss_pred CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhc
Confidence 999999999998765432 346777899999999999999999999999999999999997542221 111111
Q ss_pred ---------hhcccccccccccccccchhHHHHHHHHHH
Q 041491 429 ---------DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 429 ---------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+++.+.+++.+||..||.+|++ +.+++
T Consensus 256 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell 293 (321)
T 2c30_A 256 SPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT-AQELL 293 (321)
T ss_dssp SSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC-HHHHH
T ss_pred CCCCCcCccccCCHHHHHHHHHHccCChhhCcC-HHHHh
Confidence 123455889999999999999974 44443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=331.01 Aligned_cols=237 Identities=20% Similarity=0.272 Sum_probs=200.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc------chHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999986 4899999999754321 356789999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC----cEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM----VAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a 365 (467)
++||||+++++|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+||+++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999854 457899999999999999999999 99999999999999999887 8999999999
Q ss_pred eecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---------cHHHHHhhhcc
Q 041491 366 KLLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------NLKNWVNDFLP 432 (467)
Q Consensus 366 ~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------~~~~~~~~~~~ 432 (467)
+..... ...++..|.+||......++.++|||||||++|||++|+.||......+. ..........+
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 887533 23467789999999989999999999999999999999999975432211 11111223455
Q ss_pred cccccccccccccchhHHHHHHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+.+.+++.+||..||.+|++ +.|++
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt-~~e~l 270 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMT-IQDSL 270 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCC-HHHHH
T ss_pred HHHHHHHHHHccCChhhCCC-HHHHh
Confidence 66899999999999999985 33443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.52 Aligned_cols=235 Identities=22% Similarity=0.271 Sum_probs=195.5
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 289 (467)
...++|++.+.||+|+||.||+|+++. ++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 345789999999999999999999874 8899999998653 22345688999999887 899999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|+...
T Consensus 129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999988653 56899999999999999999999 9999999999999999999999999999998633
Q ss_pred C-----CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc---cc----HHHH-Hh------hh
Q 041491 370 G-----KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE---MN----LKNW-VN------DF 430 (467)
Q Consensus 370 ~-----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~---~~----~~~~-~~------~~ 430 (467)
. ....++..|.|||.+.+..++.++|||||||++|||++|+.||......+ .. +... .. ..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 2 22346778999999999999999999999999999999999996431111 11 1111 11 12
Q ss_pred cccccccccccccccchhHHHHH
Q 041491 431 LPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 431 ~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
+++++.++|.+||..||.+|+++
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCHHHHHHHHHHhcCCHhHcCCC
Confidence 34468999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.51 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=195.7
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|++.+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 468999999999999999999998899999999875432 234678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+++ +|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9975 888888777677999999999999999999999 9999999999999999999999999999998765322
Q ss_pred ---ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc--------------------HHHHH-
Q 041491 373 ---SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--------------------LKNWV- 427 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--------------------~~~~~- 427 (467)
..++..|.+||...+ ..++.++||||+||++|||++|+.||......+.. +..|.
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 245677899998765 56899999999999999999999999764322210 11111
Q ss_pred --------------hhhcccccccccccccccchhHHHHHHHHHH
Q 041491 428 --------------NDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 428 --------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
...+++++.+++.+||..||.+|++ +.|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell 299 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS-ARDAM 299 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC-HHHHH
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC-HHHHh
Confidence 1123345778999999999999985 33433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.22 Aligned_cols=235 Identities=21% Similarity=0.331 Sum_probs=198.8
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3578999999999999999999886 48999999997543 23446788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC---cEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---VAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~ 369 (467)
|||+++|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999998854 356899999999999999999999 99999999999999998654 59999999998776
Q ss_pred CCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----------Hhhhccccc
Q 041491 370 GKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----------VNDFLPISV 435 (467)
Q Consensus 370 ~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----------~~~~~~~~~ 435 (467)
... ..++..|.+||...+..++.++|||||||++|||++|+.||.+....+. .... .+..+++++
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCTTGGGGSCHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCCcccccCCCHHH
Confidence 433 3467789999999988999999999999999999999999976432211 1111 113445678
Q ss_pred ccccccccccchhHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~ 455 (467)
.++|.+||..||.+|+++.+
T Consensus 262 ~~li~~~L~~dP~~R~t~~e 281 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQ 281 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHcCCChhhCcCHHH
Confidence 99999999999999986543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=338.94 Aligned_cols=237 Identities=19% Similarity=0.266 Sum_probs=202.3
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999886 4899999999866555556789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC--CCcEEEeccccceecCCCC-
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD--DMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~- 372 (467)
+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999766668999999999999999999999 999999999999999974 4689999999999876543
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMNVV 439 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~i 439 (467)
..++..|.|||...+..++.++|||||||++|||+||+.||.+....+ .+..... ..+++++.++|
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 246778999999999999999999999999999999999997642211 1111111 23455689999
Q ss_pred ccccccchhHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~ 458 (467)
.+||..||.+|++ +.|++
T Consensus 286 ~~~L~~dP~~Rpt-~~ell 303 (387)
T 1kob_A 286 KNLLQKEPRKRLT-VHDAL 303 (387)
T ss_dssp HTTSCSSGGGSCC-HHHHH
T ss_pred HHHcCCChhHCcC-HHHHh
Confidence 9999999999985 33443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.70 Aligned_cols=236 Identities=23% Similarity=0.314 Sum_probs=197.5
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCC
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGN 287 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 287 (467)
.....++|++.+.||+|+||.||+|+++ +++.||+|+++... ....+.+..|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 4556789999999999999999999986 48999999997642 23456678899999876 8999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..|+||||++||+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999998653 46899999999999999999999 99999999999999999999999999999986
Q ss_pred cCC-----CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccc
Q 041491 368 LNG-----KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVM 436 (467)
Q Consensus 368 ~~~-----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~ 436 (467)
... ....++..|.|||...+..++.++||||+||++|||++|+.||......+. ..... ...+++++.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~ 246 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMDNPFYPRWLEKEAK 246 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHhCCCCCCcccCHHHH
Confidence 432 223467789999999999999999999999999999999999976432221 11111 122445689
Q ss_pred cccccccccchhHHHHH
Q 041491 437 NVVDTSLLRREDKYFAA 453 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~ 453 (467)
+++.+||..||.+|++.
T Consensus 247 ~li~~lL~~dp~~R~~~ 263 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGV 263 (345)
T ss_dssp HHHHHHSCSSGGGSBTT
T ss_pred HHHHHHhcCCHhHcCCC
Confidence 99999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=333.46 Aligned_cols=232 Identities=21% Similarity=0.298 Sum_probs=196.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999987 589999999875432 234678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
|+++|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999998853 456999999999999999999999 999999999999999999999999999999865422
Q ss_pred ----CccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhcccccccc
Q 041491 372 ----ESMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNV 438 (467)
Q Consensus 372 ----~~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~ 438 (467)
...++..|.+||...+..+ +.++|||||||++|||++|+.||............|.. ..+++.+.++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 2346777899999877665 77899999999999999999999875444444444432 2345568899
Q ss_pred cccccccchhHHHH
Q 041491 439 VDTSLLRREDKYFA 452 (467)
Q Consensus 439 i~~~l~~~~~~r~~ 452 (467)
+.+||..||.+|++
T Consensus 242 i~~~L~~dP~~R~t 255 (323)
T 3tki_A 242 LHKILVENPSARIT 255 (323)
T ss_dssp HHHHSCSSTTTSCC
T ss_pred HHHHccCChhhCcC
Confidence 99999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.57 Aligned_cols=233 Identities=20% Similarity=0.268 Sum_probs=197.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-----ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468999999999999999999886 58999999986432 123577899999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc---EEEecccc
Q 041491 291 LVLEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV---AHLSDFGI 364 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~ 364 (467)
+||||+++++|.+.+... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877542 235899999999999999999999 999999999999999986654 99999999
Q ss_pred ceecCCCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----------Hhh
Q 041491 365 AKLLNGKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----------VND 429 (467)
Q Consensus 365 a~~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----------~~~ 429 (467)
+....... ..++..|.+||.+.+..++.++||||+||++|||++|+.||.+.... ..... .+.
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--LFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--HHHHHHHTCCCCCHHHHT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--HHHHHHcCCCCCCccccc
Confidence 98876533 34677899999999899999999999999999999999999764221 11111 223
Q ss_pred hcccccccccccccccchhHHHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.+++.+.+++.+||..||.+|++..
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~ 282 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVY 282 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHH
Confidence 4566799999999999999998544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=338.36 Aligned_cols=234 Identities=19% Similarity=0.226 Sum_probs=197.7
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 288 (467)
....++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 3456789999999999999999999875 8899999997642 23456788999999988 79999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||++||+|.+++... +.+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999998643 46899999999999999999999 999999999999999999999999999999864
Q ss_pred CC-----CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccc
Q 041491 369 NG-----KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMN 437 (467)
Q Consensus 369 ~~-----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~ 437 (467)
.. ....++..|.|||.+.+..++.++|||||||++|||++|+.||......+ ....... ..+++++.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~ 250 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNVAYPKSMSKEAVA 250 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCHHHHH
Confidence 32 22346778999999998999999999999999999999999997643222 1122221 234556899
Q ss_pred ccccccccchhHHHH
Q 041491 438 VVDTSLLRREDKYFA 452 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~ 452 (467)
++.+||..||.+|+.
T Consensus 251 li~~lL~~dP~~R~~ 265 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLG 265 (353)
T ss_dssp HHHHHTCSCTTSCTT
T ss_pred HHHHHhhcCHHHcCC
Confidence 999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=342.45 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=206.3
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
+.+..++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3455678999999999999999999987 589999999875432 23457889999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999766667999999999999999999999 99999999999999999999999999999987554
Q ss_pred CCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccc
Q 041491 371 KES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPIS 434 (467)
Q Consensus 371 ~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 434 (467)
... ..+..|.|||.+..+.++.++|||||||++|||+| |+.||......+ ....+. ...|+.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKGGRLPCPELCPDA 343 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTTCCCCCCTTCCHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCHH
Confidence 321 23456899999988889999999999999999998 999997643222 222222 224456
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+.+++.+|+..||++|+ ++.++++.|.++
T Consensus 344 l~~li~~cl~~dP~~Rp-s~~~i~~~L~~i 372 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRP-SFSTIYQELQSI 372 (377)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCc-CHHHHHHHHHHH
Confidence 88999999999999996 566666666543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=339.46 Aligned_cols=242 Identities=23% Similarity=0.406 Sum_probs=193.8
Q ss_pred HhccCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..++|++.+.||+|+||.||+|++. ++..||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999875 47789999997653 234567899999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++|+|.+++......+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999877678999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccc
Q 041491 371 KES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPI 433 (467)
Q Consensus 371 ~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~ 433 (467)
... ..+..|.+||+..+..++.++|||||||++|||++ |+.||......+ ....+.. ..+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHHTTEECCCCTTCBH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCccccH
Confidence 321 12346899999998999999999999999999998 999997643222 2222221 2344
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+.+++.+|+..+|.+|+ ++.+++..|.+
T Consensus 278 ~l~~li~~cl~~dp~~RP-s~~~i~~~L~~ 306 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRP-KFEQIVSILDK 306 (373)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHHHhCcChhhCc-CHHHHHHHHHH
Confidence 588999999999999996 55566655543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=331.71 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=200.7
Q ss_pred HhccCccCCccCcccceeEEEEEec-----CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecC--Ce
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NF 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 288 (467)
..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 4578999999999999999999842 4889999999876656667899999999999999999999998643 56
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 89999999999999999877667999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCC--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--------------cHHHH
Q 041491 369 NGKE--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--------------NLKNW 426 (467)
Q Consensus 369 ~~~~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--------------~~~~~ 426 (467)
.... ..++..|.+||...+..++.++||||||+++|||+||..||.....+.. .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 5332 1234458999999989999999999999999999999999875321100 01111
Q ss_pred H--------hhhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 427 V--------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 427 ~--------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
. ...+++++.+++.+|+..+|.+|+ ++.|++..|.++
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~el~~~L~~l 289 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-SFRDLALRVDQI 289 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-CHHHHHHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCC-CHHHHHHHHHHH
Confidence 1 123455689999999999999996 566776666554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=327.28 Aligned_cols=231 Identities=22% Similarity=0.304 Sum_probs=193.1
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||.||+|++.+++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999997799999999965432 2346788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC----
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 371 (467)
+++ +|.+++....+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 976 999988776678999999999999999999999 999999999999999999999999999999876532
Q ss_pred -CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh---------------------
Q 041491 372 -ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------------------- 428 (467)
Q Consensus 372 -~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------------------- 428 (467)
...++..|.|||...+ ..++.++||||+||++|||+||+.||......+. +.....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhccccccc
Confidence 2245677899998865 4589999999999999999999999976432221 111110
Q ss_pred --------------hhcccccccccccccccchhHHHHH
Q 041491 429 --------------DFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 429 --------------~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..+++.+.+++.+||..||.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 275 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH
Confidence 1133446789999999999999854
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=324.22 Aligned_cols=236 Identities=23% Similarity=0.287 Sum_probs=193.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999986 489999999975532 234678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+++ ++.+.+....+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9976 666666666678999999999999999999999 9999999999999999999999999999998765332
Q ss_pred ---ccccccccccccccCCC-CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------------------
Q 041491 373 ---SMRTQTLATIEYGREGQ-VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------------------- 428 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~-~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------------------- 428 (467)
..++..|.+||...+.. ++.++||||+||++|||++|..||.........+.....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 24567789999887655 799999999999999999998886433222212222211
Q ss_pred ---------------hhcccccccccccccccchhHHHHHHHHHH
Q 041491 429 ---------------DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 429 ---------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+++.+.+++.+||..||.+|++ +.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~e~l 281 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-AEEAL 281 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC-HHHHH
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC-HHHHh
Confidence 113344679999999999999985 34433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=332.81 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=195.0
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC----eee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----FEA 290 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 290 (467)
...++|++.+.||+|+||.||+|++. ++.||+|++.... .......+|+.++++++||||+++++++.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 45678999999999999999999875 7999999997553 23345667899999999999999999998744 469
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CceecCCCCCCeeecCCCcEEEe
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN----------PVVHCDIKPSNVLLDDDMVAHLS 360 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~dlkp~NIll~~~~~~kl~ 360 (467)
+||||+++|+|.+++... .+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999999653 4899999999999999999999 88 99999999999999999999999
Q ss_pred ccccceecCCCC-------ccccccccccccccC-----CCCCCcccchhhHHHHHHHhcCCCCCCcccccc--------
Q 041491 361 DFGIAKLLNGKE-------SMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE-------- 420 (467)
Q Consensus 361 Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~-----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~-------- 420 (467)
|||+++...... ..++..|.+||...+ ..++.++|||||||++|||+||+.||.......
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 999998765432 245777899998876 345678899999999999999999997542221
Q ss_pred ---ccHHHHHhhh-----------------cccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 421 ---MNLKNWVNDF-----------------LPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 421 ---~~~~~~~~~~-----------------~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.....+.... .++.+.+++.+||..||.+|+ ++.|+++.|.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL-SAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 1122221111 011277899999999999997 566666666544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=340.22 Aligned_cols=253 Identities=19% Similarity=0.291 Sum_probs=207.2
Q ss_pred cccHHHHHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCcee
Q 041491 207 RFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVK 278 (467)
Q Consensus 207 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~ 278 (467)
.+...++.+..++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3456777888999999999999999999999842 367899999976432 3446789999999999 7899999
Q ss_pred EEEEeecCC-eeeEEEecccCCCHHHhhhcCCC-----------------------------------------------
Q 041491 279 IISSCSNGN-FEALVLEYMANGSLEKCLYSSNG----------------------------------------------- 310 (467)
Q Consensus 279 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 310 (467)
+++++.+.+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999988755 48999999999999999876432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 311 ------------------ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 311 ------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
.+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1889999999999999999999 9999999999999999999999999999998764322
Q ss_pred -------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-------hhccccccc
Q 041491 373 -------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-------DFLPISVMN 437 (467)
Q Consensus 373 -------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~ 437 (467)
..++..|.+||...+..++.++|||||||++|||+| |+.||......+........ ..+++++.+
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 327 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 234556899999988999999999999999999998 99999764433222222211 123456899
Q ss_pred ccccccccchhHHHHHHHHHHHHHHh
Q 041491 438 VVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
++.+||..||.+|+ ++.|+++.|.+
T Consensus 328 li~~~l~~dP~~Rp-s~~ell~~L~~ 352 (359)
T 3vhe_A 328 TMLDCWHGEPSQRP-TFSELVEHLGN 352 (359)
T ss_dssp HHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHccCChhhCC-CHHHHHHHHHH
Confidence 99999999999997 56666666544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=343.16 Aligned_cols=234 Identities=19% Similarity=0.248 Sum_probs=197.3
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999876 58999999997553 22346788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec---CCCcEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---DDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~ 369 (467)
|||+++|+|.+.+... +.+++..+..++.|++.||+||| ++||+||||||+||+++ .++.+||+|||++....
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999988654 56899999999999999999999 99999999999999998 46789999999998776
Q ss_pred CCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------hhhcccc
Q 041491 370 GKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------NDFLPIS 434 (467)
Q Consensus 370 ~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------~~~~~~~ 434 (467)
... ..++..|.|||.+.+..++.++||||+||++|+|++|+.||.+....+ ...... +..++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCCCCccccccCCHH
Confidence 432 346778999999998899999999999999999999999997643221 111111 1234566
Q ss_pred cccccccccccchhHHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~ 454 (467)
+.+++.+||..||.+|+++.
T Consensus 244 ~~~li~~~L~~dP~~Rpta~ 263 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAA 263 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHHHHHcCCChhHCCCHH
Confidence 99999999999999998644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=333.89 Aligned_cols=233 Identities=23% Similarity=0.321 Sum_probs=185.5
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
..++|++.+.||+|+||.||+|++.. ++.||+|+++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 35689999999999999999999874 8899999997543 34668899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEeccccceecCCC
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~ 371 (467)
|+++++|.+++.. .+.+++.++..++.|++.||.||| ++||+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999998854 456899999999999999999999 999999999999999975 889999999999876543
Q ss_pred C----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhccccccc
Q 041491 372 E----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMN 437 (467)
Q Consensus 372 ~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~ 437 (467)
. ..++..|.+||+..+..++.++|||||||++|||++|+.||.........+..... ..++..+.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 284 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence 2 34677899999999999999999999999999999999999764433322223222 234456889
Q ss_pred ccccccccchhHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAK 454 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~ 454 (467)
++.+||..||++|++..
T Consensus 285 li~~~L~~dP~~Rpt~~ 301 (349)
T 2w4o_A 285 LVRKLIVLDPKKRLTTF 301 (349)
T ss_dssp HHHTTSCSSGGGSCCHH
T ss_pred HHHHHccCChhhCcCHH
Confidence 99999999999998644
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=340.74 Aligned_cols=242 Identities=16% Similarity=0.146 Sum_probs=197.4
Q ss_pred HHHhccCccCCccCcccceeEEEEE------ecCCCeEEEEEeecccccchHHHHHHHHHHHcCC---CCCceeEEEEee
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGR------FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR---HRNLVKIISSCS 284 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 284 (467)
....++|.+.+.||+|+||.||+|. ..+++.||+|+++.. ....+..|+++++.++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456789999999999999999994 335899999998744 3456788888888886 999999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-------
Q 041491 285 NGNFEALVLEYMANGSLEKCLYS----SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD------- 353 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~------- 353 (467)
..+..++||||+++|+|.+++.. ....+++..++.++.|++.||+||| ++||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999864 3457999999999999999999999 999999999999999998
Q ss_pred ----CCcEEEeccccceecCC-------CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc
Q 041491 354 ----DMVAHLSDFGIAKLLNG-------KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN 422 (467)
Q Consensus 354 ----~~~~kl~Dfg~a~~~~~-------~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~ 422 (467)
++.+||+|||+|+.+.. ....++..|.|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 89999999999976531 1234677899999999999999999999999999999999999654332221
Q ss_pred HHHHHhhh-cccccccccccccccchhHHHHHHHHHHHHH
Q 041491 423 LKNWVNDF-LPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 423 ~~~~~~~~-~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
........ .++.+.++++.+|..+|.+|+++++++.+.|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 295 PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 11111111 1234888999999999999966655544433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=333.15 Aligned_cols=233 Identities=22% Similarity=0.261 Sum_probs=195.3
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 291 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 4689999999999999999999864 8899999997653 22345678999999988 89999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++|+|.+++... +.+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999988643 46899999999999999999999 999999999999999999999999999999864322
Q ss_pred -----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc----c---cH-HHHHh------hhcc
Q 041491 372 -----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE----M---NL-KNWVN------DFLP 432 (467)
Q Consensus 372 -----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~----~---~~-~~~~~------~~~~ 432 (467)
...++..|.|||.+.+..++.++||||+||++|||++|+.||......+ . .+ ..... ..++
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 243 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence 2346778999999999999999999999999999999999996421110 0 01 11111 2234
Q ss_pred cccccccccccccchhHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..+.+++.+||..||.+|+++
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHHHhcCCHhHCCCC
Confidence 568899999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.26 Aligned_cols=241 Identities=21% Similarity=0.255 Sum_probs=199.6
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
..++....++|++.+.||+|+||.||+|++.. ++.||+|+++... ......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 44566677899999999999999999999874 8899999997532 2234568899999999999999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
.+..|+||||++||+|.+++... .+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999998653 5899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCC------CccccccccccccccCCC----CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------
Q 041491 366 KLLNGK------ESMRTQTLATIEYGREGQ----VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------- 428 (467)
Q Consensus 366 ~~~~~~------~~~~~~~~~~pe~~~~~~----~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------- 428 (467)
+..... ...++..|.|||++.... ++.++|||||||++|||+||+.||......+. +.....
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~~~ 294 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMNHKNSLTF 294 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHCCC
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HHHHHhccccccC
Confidence 877643 234677889999876654 78999999999999999999999976432221 112211
Q ss_pred ---hhcccccccccccccccchhH--HHHHHHHH
Q 041491 429 ---DFLPISVMNVVDTSLLRREDK--YFAAKKQC 457 (467)
Q Consensus 429 ---~~~~~~~~~~i~~~l~~~~~~--r~~~~~~~ 457 (467)
..+++++.++|.+||..+|.+ |+ +++|+
T Consensus 295 p~~~~~s~~~~~li~~lL~~~~~rlgR~-~~~ei 327 (410)
T 3v8s_A 295 PDDNDISKEAKNLICAFLTDREVRLGRN-GVEEI 327 (410)
T ss_dssp CTTCCCCHHHHHHHHHHSSCGGGCTTSS-CHHHH
T ss_pred CCcccccHHHHHHHHHHccChhhhCCCC-CHHHH
Confidence 124456899999999977766 64 44443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.73 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=201.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc-------chHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG-------ALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
..++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3578999999999999999999985 5899999998654322 1267889999999999999999999997765
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeecCCCc-----EEEe
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDDDMV-----AHLS 360 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~-----~kl~ 360 (467)
++||||+++|+|.+++......+++..+..++.|++.||+||| ++| |+||||||+||+++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6999999999999998777778999999999999999999999 999 999999999999988776 9999
Q ss_pred ccccceecCCCC--ccccccccccccc--cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------
Q 041491 361 DFGIAKLLNGKE--SMRTQTLATIEYG--REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------- 428 (467)
Q Consensus 361 Dfg~a~~~~~~~--~~~~~~~~~pe~~--~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------- 428 (467)
|||+++...... ..++..|.+||.. ....++.++||||+||++|||++|+.||...............
T Consensus 172 Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 172 DFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251 (287)
T ss_dssp CCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred CCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence 999998655432 3456778999988 3456788999999999999999999999865443332222221
Q ss_pred -hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 429 -DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 429 -~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..+++.+.+++.+||..||.+|+ ++.++++.|.++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~l 287 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSGDPKKRP-HFSYIVKELSEL 287 (287)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHTC
T ss_pred CcccCHHHHHHHHHHhcCChhhCc-CHHHHHHHHHhC
Confidence 23445689999999999999997 677788777553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=331.23 Aligned_cols=232 Identities=22% Similarity=0.311 Sum_probs=188.7
Q ss_pred HhccCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc----ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
..++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 4578999999999999999999873 68999999997542 223456788999999999999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..++||||+++++|.+++... +.+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999998643 46899999999999999999999 99999999999999999999999999999986
Q ss_pred cCCC-----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccc
Q 041491 368 LNGK-----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVM 436 (467)
Q Consensus 368 ~~~~-----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~ 436 (467)
.... ...++..|.+||...+..++.++|||||||++|||++|+.||......+ ....... ..+++.+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCCTTSCHHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCHHHH
Confidence 4322 2346778999999988899999999999999999999999997643222 1111211 23445689
Q ss_pred cccccccccchhHHHH
Q 041491 437 NVVDTSLLRREDKYFA 452 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~ 452 (467)
+++.+||..+|.+|++
T Consensus 250 ~li~~~L~~dp~~R~~ 265 (327)
T 3a62_A 250 DLLKKLLKRNAASRLG 265 (327)
T ss_dssp HHHHHHSCSCGGGSTT
T ss_pred HHHHHHHhcCHhhccC
Confidence 9999999999999984
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=321.50 Aligned_cols=243 Identities=18% Similarity=0.315 Sum_probs=205.0
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC--CeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++ +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46899999999999999999998 48899999997653 23456789999999999999999999999877 788999
Q ss_pred EecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +++ ++||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999976544 5899999999999999999999 889 9999999999999999999999999988777
Q ss_pred CCCccccccccccccccCCCCCC---cccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------hhhccccccccc
Q 041491 370 GKESMRTQTLATIEYGREGQVSP---KSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-------NDFLPISVMNVV 439 (467)
Q Consensus 370 ~~~~~~~~~~~~pe~~~~~~~~~---~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~i 439 (467)
.....++..|.+||...+..++. ++||||||+++|||+||+.||......+....... ...+++.+.+++
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (271)
T 3kmu_A 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLM 244 (271)
T ss_dssp CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHH
T ss_pred ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 77777888999999987665544 79999999999999999999976433322111111 123455689999
Q ss_pred ccccccchhHHHHHHHHHHHHHHhc
Q 041491 440 DTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+||..||.+|+ ++.++++.|.++
T Consensus 245 ~~~l~~~p~~Rp-s~~~il~~L~~l 268 (271)
T 3kmu_A 245 KICMNEDPAKRP-KFDMIVPILEKM 268 (271)
T ss_dssp HHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHcCCChhhCc-CHHHHHHHHHHh
Confidence 999999999997 567777776654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=335.55 Aligned_cols=232 Identities=21% Similarity=0.302 Sum_probs=193.0
Q ss_pred cCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccCCC
Q 041491 222 EKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGS 300 (467)
Q Consensus 222 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 300 (467)
..+.||+|+||.||+|.+. +|+.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999885 589999999987655566789999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee--cCCCcEEEeccccceecCCCC----cc
Q 041491 301 LEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL--DDDMVAHLSDFGIAKLLNGKE----SM 374 (467)
Q Consensus 301 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~----~~ 374 (467)
|.+++......+++..+..++.|++.||+||| ++||+||||||+||++ ++++.+||+|||+++...... ..
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 249 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence 99988766667999999999999999999999 9999999999999999 567899999999999876433 23
Q ss_pred ccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhcccccccccccccc
Q 041491 375 RTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMNVVDTSLL 444 (467)
Q Consensus 375 ~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~ 444 (467)
++..|.+||+...+.++.++|||||||++|||++|+.||......+ .+..... ..+++++.+++.+||.
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 328 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWDLEDEEFQDISEEAKEFISKLLI 328 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence 6778999999988899999999999999999999999997643221 1222222 2345668999999999
Q ss_pred cchhHHHHHHHHHH
Q 041491 445 RREDKYFAAKKQCV 458 (467)
Q Consensus 445 ~~~~~r~~~~~~~~ 458 (467)
.||.+|++. .|++
T Consensus 329 ~dp~~Rps~-~e~l 341 (373)
T 2x4f_A 329 KEKSWRISA-SEAL 341 (373)
T ss_dssp SSGGGSCCH-HHHH
T ss_pred CChhhCCCH-HHHh
Confidence 999999853 4443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=326.53 Aligned_cols=244 Identities=21% Similarity=0.306 Sum_probs=202.7
Q ss_pred hccCccCCccCcccceeEEEEEecC-C-------CeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-G-------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
.++|++.+.||+|+||.||+|.+.. + ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 5689999999999999999998764 3 4699999977666667889999999999999999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc--------EEEe
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV--------AHLS 360 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~ 360 (467)
.++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999876666999999999999999999999 999999999999999998886 9999
Q ss_pred ccccceecCCCC-ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-----hhhccc
Q 041491 361 DFGIAKLLNGKE-SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-----NDFLPI 433 (467)
Q Consensus 361 Dfg~a~~~~~~~-~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-----~~~~~~ 433 (467)
|||++....... ..++..|.+||...+ ..++.++||||||+++|||++|..|+............+. ....++
T Consensus 164 Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (289)
T 4fvq_A 164 DPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA 243 (289)
T ss_dssp CCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSC
T ss_pred cCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCCH
Confidence 999997664432 235667899998877 7789999999999999999996555443222211111111 122345
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
++.+++.+||..||.+|+ ++.++++.|.++
T Consensus 244 ~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~l 273 (289)
T 4fvq_A 244 ELANLINNCMDYEPDHRP-SFRAIIRDLNSL 273 (289)
T ss_dssp TTHHHHHHHSCSSGGGSC-CHHHHHHHHHTC
T ss_pred HHHHHHHHHcCCChhHCc-CHHHHHHHHHHh
Confidence 699999999999999995 677888777654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=321.89 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=205.6
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
..++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 4578999999999999999999998889999999976532 346789999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC----
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK---- 371 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 371 (467)
+++++|.+++......+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999877778999999999999999999999 999999999999999999999999999999876432
Q ss_pred --CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccccccccc
Q 041491 372 --ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVD 440 (467)
Q Consensus 372 --~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~ 440 (467)
....+..|.+||...+..++.++||||+|+++|||++ |+.||......+ ....+. ...++.+.+++.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 2234456899999988889999999999999999999 899997643221 111111 123445889999
Q ss_pred cccccchhHHHHHHHHHHHHHHhc
Q 041491 441 TSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+|+..+|.+|+ ++.++++.|.++
T Consensus 240 ~~l~~~p~~Rp-s~~~ll~~L~~l 262 (267)
T 3t9t_A 240 HCWRERPEDRP-AFSRLLRQLAEI 262 (267)
T ss_dssp HHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHccCChhhCc-CHHHHHHHHHHH
Confidence 99999999996 566666666554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.96 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=196.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC--eeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--FEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 292 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4689999999999999999999875 8999999997543 234567889999999999999999999987655 77999
Q ss_pred EecccCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----cCCCcEEEeccccce
Q 041491 293 LEYMANGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAK 366 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~ 366 (467)
|||+++++|.+++..... .+++.+++.++.|++.||+||| ++||+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999965433 3899999999999999999999 9999999999999999 778889999999999
Q ss_pred ecCCCC----cccccccccccccc--------CCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc---HHHHHh---
Q 041491 367 LLNGKE----SMRTQTLATIEYGR--------EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN---LKNWVN--- 428 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~--------~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~---~~~~~~--- 428 (467)
...... ..++..|.+||... +..++.++|||||||++|||+||+.||......... +.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 876543 24567889999875 577899999999999999999999999643222111 111111
Q ss_pred ----------------------------hhcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 429 ----------------------------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 429 ----------------------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
..++..+.+++.+||..||.+|++ ++|+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s-~~ell~h~ 304 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG-FDQFFAET 304 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC-HHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc-HHHhhhcc
Confidence 112235778999999999999974 55655543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.20 Aligned_cols=233 Identities=22% Similarity=0.354 Sum_probs=195.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999985 58999999997542 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+ +|+|.+++... +.+++.++..++.|++.||+||| ++||+||||||+||++++++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 67898888543 46899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ----ccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCcccccccc-----HHHHHhhhcccccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-----LKNWVNDFLPISVMNVVDTS 442 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~ 442 (467)
..++..|.|||...+..+ ++++||||+||++|||++|+.||.+....... ........+++.+.+++.+|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHH
Confidence 346778899999887776 78999999999999999999999764322110 00011234566789999999
Q ss_pred cccchhHHHHHH
Q 041491 443 LLRREDKYFAAK 454 (467)
Q Consensus 443 l~~~~~~r~~~~ 454 (467)
|..||.+|++..
T Consensus 243 L~~dP~~Rpt~~ 254 (336)
T 3h4j_B 243 IVADPMQRITIQ 254 (336)
T ss_dssp SCSSGGGSCCHH
T ss_pred cCCChhHCcCHH
Confidence 999999998543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=329.80 Aligned_cols=228 Identities=20% Similarity=0.248 Sum_probs=194.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 468999999999999999999975 58999999987543 235688999999999 99999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc-----EEEeccccceecC
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV-----AHLSDFGIAKLLN 369 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfg~a~~~~ 369 (467)
|+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 99999999876678999999999999999999999 999999999999999998887 9999999998764
Q ss_pred CC------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHH---------
Q 041491 370 GK------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNW--------- 426 (467)
Q Consensus 370 ~~------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~--------- 426 (467)
.. ...++..|.+||...+..++.++|||||||++|||++|+.||.+...... .+...
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 32 23467788999999999999999999999999999999999986432221 11111
Q ss_pred --HhhhcccccccccccccccchhHHH
Q 041491 427 --VNDFLPISVMNVVDTSLLRREDKYF 451 (467)
Q Consensus 427 --~~~~~~~~~~~~i~~~l~~~~~~r~ 451 (467)
.....| ++.+++..|+..+|.+|+
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP 267 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKP 267 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCC
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCC
Confidence 111234 799999999999999995
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=329.14 Aligned_cols=238 Identities=21% Similarity=0.269 Sum_probs=192.3
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC-------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------- 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 287 (467)
.++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 468999999999999999999987 69999999997543 334577899999999999999999999885543
Q ss_pred --------------------------------------------------eeeEEEecccCCCHHHhhhcCCC--CCCHH
Q 041491 288 --------------------------------------------------FEALVLEYMANGSLEKCLYSSNG--ILDIF 315 (467)
Q Consensus 288 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~ 315 (467)
..++||||+++++|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999976443 45667
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-----------------cccccc
Q 041491 316 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-----------------SMRTQT 378 (467)
Q Consensus 316 ~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~ 378 (467)
.++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++...... ..++..
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999 9999999999999999999999999999998876432 236778
Q ss_pred ccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHH----HHHhhhcccccccccccccccchhHHHHHH
Q 041491 379 LATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK----NWVNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 379 ~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
|.+||...+..++.++|||||||++|||++|..|+........... .......++.+.+++.+||..||.+|++ +
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~ 320 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE-A 320 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC-H
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCC-H
Confidence 8999999988999999999999999999999888643211100000 0011223455789999999999999985 4
Q ss_pred HHHH
Q 041491 455 KQCV 458 (467)
Q Consensus 455 ~~~~ 458 (467)
.|++
T Consensus 321 ~~~l 324 (332)
T 3qd2_B 321 TDII 324 (332)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 4443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=325.68 Aligned_cols=243 Identities=19% Similarity=0.245 Sum_probs=198.2
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc---chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG---ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
..++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999986 5889999998754322 34678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++++|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998653 46899999999999999999999 999999999999999999999999999999876543
Q ss_pred C------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------hhhccccc
Q 041491 372 E------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------NDFLPISV 435 (467)
Q Consensus 372 ~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------~~~~~~~~ 435 (467)
. ..++..|.+||...+..++.++||||||+++|||++|+.||...... ...... ...+|+.+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCCccccCCCCCHHH
Confidence 2 24567789999999999999999999999999999999999764322 111111 22355668
Q ss_pred ccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+++.+||..||++|++++++++..+.+.
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred HHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 99999999999999998888888887653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=336.31 Aligned_cols=233 Identities=27% Similarity=0.266 Sum_probs=189.1
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc---cchHHHHHHHHH-HHcCCCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEV-LKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
.++|++.+.||+|+||.||+|+++. ++.||+|+++.... .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4689999999999999999999874 88999999976532 233456667776 467899999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC-
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG- 370 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 370 (467)
||||++||+|.+++... +.+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999988653 46899999999999999999999 99999999999999999999999999999986422
Q ss_pred ----CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccc
Q 041491 371 ----KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVD 440 (467)
Q Consensus 371 ----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~ 440 (467)
....++..|.|||.+.+..++.++|||||||++|||++|+.||......+ ....... ..++..+.+++.
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~ 271 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNKPLQLKPNITNSARHLLE 271 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHSCCCCCSSSCHHHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcccCCCCCCCHHHHHHHH
Confidence 22346778999999999999999999999999999999999997643322 1222222 234456899999
Q ss_pred cccccchhHHHHHH
Q 041491 441 TSLLRREDKYFAAK 454 (467)
Q Consensus 441 ~~l~~~~~~r~~~~ 454 (467)
+||..||.+|++..
T Consensus 272 ~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 272 GLLQKDRTKRLGAK 285 (373)
T ss_dssp HHTCSSGGGSTTTT
T ss_pred HHcccCHHhCCCCC
Confidence 99999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.60 Aligned_cols=234 Identities=25% Similarity=0.329 Sum_probs=179.6
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|+++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3568999999999999999999886 489999999975532 34467889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 294 EYMANGSLEKCLYSSN-----GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
||++ |+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59988875432 35899999999999999999999 999999999999999999999999999999876
Q ss_pred CCC-----CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc---------------------
Q 041491 369 NGK-----ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--------------------- 421 (467)
Q Consensus 369 ~~~-----~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--------------------- 421 (467)
... ...++..|.+||...+ ..++.++|||||||++|||+||+.||......+.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 532 2345777899998875 4689999999999999999999999975432211
Q ss_pred --------------cHHHHHhh----hcccccccccccccccchhHHHHH
Q 041491 422 --------------NLKNWVND----FLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 422 --------------~~~~~~~~----~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.+...... .+++.+.+++.+||..||.+|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 288 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence 00111111 234458899999999999999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=319.89 Aligned_cols=235 Identities=20% Similarity=0.257 Sum_probs=200.4
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
..++|++.+.||+|+||.||+|.+.. +..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35689999999999999999999865 78999999987666667889999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---cCCCcEEEeccccceecCCC
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|+++++|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999988553 46899999999999999999999 9999999999999999 78889999999999876543
Q ss_pred C----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----------Hhhhccccccc
Q 041491 372 E----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----------VNDFLPISVMN 437 (467)
Q Consensus 372 ~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----------~~~~~~~~~~~ 437 (467)
. ..++..|.+||...+ .++.++||||||+++|||++|+.||......+. .... ....+++.+.+
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCCchhhhcCCHHHHH
Confidence 3 345677899998765 489999999999999999999999976432221 1111 12245667999
Q ss_pred ccccccccchhHHHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAKKQ 456 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~ 456 (467)
++.+||..||.+|++..+.
T Consensus 241 li~~~l~~dp~~R~s~~~~ 259 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQA 259 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHccCChhhCcCHHHH
Confidence 9999999999999875543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.11 Aligned_cols=235 Identities=23% Similarity=0.244 Sum_probs=195.8
Q ss_pred HhccCccCCccCcc--cceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIG--SFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..++|++.+.||+| +||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35789999999999 99999999987 59999999997653 234467888999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 291 LVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999986642 46899999999999999999999 9999999999999999999999999999986542
Q ss_pred CC------------CccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHH----------
Q 041491 370 GK------------ESMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN---------- 425 (467)
Q Consensus 370 ~~------------~~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~---------- 425 (467)
.. ...++..|.+||.+.+ ..++.++|||||||++|||++|+.||.+....+.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 1245666899999877 67899999999999999999999999764222111000
Q ss_pred -----------------------------------------HHhhhcccccccccccccccchhHHHHH
Q 041491 426 -----------------------------------------WVNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 426 -----------------------------------------~~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
-....+++.+.+++.+||..||.+|++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 0122345568899999999999999853
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.21 Aligned_cols=241 Identities=21% Similarity=0.339 Sum_probs=195.3
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHc--CCCCCceeEEEEeec----CCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKS--VRHRNLVKIISSCSN----GNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~ 290 (467)
.++|++.+.||+|+||.||+|++ +++.||+|++... ....+.+|.+++.. ++||||+++++++.. .+..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57899999999999999999988 6899999998644 33556667777766 799999999998643 35689
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG-----YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||.. .+++|+||||||+||+++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999999943 4689999999999999999999932 2679999999999999999999999999999
Q ss_pred eecCCCC---------ccccccccccccccCC------CCCCcccchhhHHHHHHHhcC----------CCCCCcccccc
Q 041491 366 KLLNGKE---------SMRTQTLATIEYGREG------QVSPKSDVYGYGITLIETFTK----------KKPTCEIFCEE 420 (467)
Q Consensus 366 ~~~~~~~---------~~~~~~~~~pe~~~~~------~~~~~~Dv~slGvil~el~tg----------~~Pf~~~~~~~ 420 (467)
+...... ..++..|.|||...+. .++.++|||||||++|||+|| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 7654322 2467788999988776 455799999999999999999 88987654444
Q ss_pred ccHHHHHhh-----------------hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 421 MNLKNWVND-----------------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 421 ~~~~~~~~~-----------------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
......... ..++.+.+++.+||..||.+|+ ++.++++.|.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL-TALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC-CHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC-CHHHHHHHHhcc
Confidence 333333221 1223478999999999999997 577888887665
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=333.39 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=206.2
Q ss_pred HHHHHHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEe
Q 041491 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 283 (467)
Q Consensus 211 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 283 (467)
..+....++|++.+.||+|+||.||+|++.+ ++.||+|+++.... ...+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445567899999999999999999998853 47899999976532 3456789999999999999999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSN-----------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVV 340 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 340 (467)
.+.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||.||| ++||+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 99999999999999999999987642 46899999999999999999999 99999
Q ss_pred ecCCCCCCeeecCCCcEEEeccccceecCCC-------CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCC
Q 041491 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKP 412 (467)
Q Consensus 341 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~P 412 (467)
||||||+||+++.++.+||+|||+++..... ...++..|.+||...+..++.++||||||+++|||+| |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999999999999999999999765422 2234566899999888899999999999999999999 9999
Q ss_pred CCccccccccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 413 TCEIFCEEMNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 413 f~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
|.+....+ ....+. ..+++.+.+++.+||..||.+|+ ++.++++.|.++
T Consensus 277 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~~~~L~~~ 333 (343)
T 1luf_A 277 YYGMAHEE--VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-SFCSIHRILQRM 333 (343)
T ss_dssp TTTSCHHH--HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHT
T ss_pred CCCCChHH--HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCC-CHHHHHHHHHHH
Confidence 97643222 111111 23445689999999999999996 566676666554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=321.27 Aligned_cols=239 Identities=18% Similarity=0.171 Sum_probs=200.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 468999999999999999999974 58999999986542 335688999999999 79999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc-----EEEeccccceecC
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV-----AHLSDFGIAKLLN 369 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfg~a~~~~ 369 (467)
|+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999877667999999999999999999999 999999999999999987775 9999999998765
Q ss_pred CCC------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHH---------
Q 041491 370 GKE------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNW--------- 426 (467)
Q Consensus 370 ~~~------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~--------- 426 (467)
... ..++..|.+||...+..++.++||||||+++|||++|+.||........ .+...
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 432 2356778999999999999999999999999999999999986422111 11111
Q ss_pred --HhhhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 427 --VNDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 427 --~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
....+++.+.+++.+|+..+|.+|+ ++.++++.+.
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP-~~~~l~~~l~ 279 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATP-DYDYLQGLFS 279 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCC-CHHHHHHHHH
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCC-CHHHHHHHHH
Confidence 1124566799999999999999996 3445554443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=345.61 Aligned_cols=246 Identities=21% Similarity=0.328 Sum_probs=206.1
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.+++.+..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345566778999999999999999999999888999999997653 45678999999999999999999999987 5678
Q ss_pred eEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 290 ALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999996543 26889999999999999999999 999999999999999999999999999999876
Q ss_pred CCC------CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccc
Q 041491 369 NGK------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPI 433 (467)
Q Consensus 369 ~~~------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~ 433 (467)
... ....+..|.|||.+..+.++.++|||||||++|||+| |+.||.+....+ ....+. ..+|+
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~~~~~~~~~~ 412 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPENCPE 412 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHTCCCCCCTTSCH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCH
Confidence 532 2223456899999988899999999999999999999 999997643322 112221 23445
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+.+++.+|+..||++|+ ++.+++..|.+
T Consensus 413 ~l~~li~~cl~~dp~~RP-t~~~i~~~L~~ 441 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERP-TFEYIQSVLDD 441 (454)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHT
T ss_pred HHHHHHHHHccCChhHCc-CHHHHHHHHHH
Confidence 689999999999999996 56666666544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.24 Aligned_cols=240 Identities=18% Similarity=0.190 Sum_probs=192.9
Q ss_pred HhccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccccc-----------chHHHHHHHHHHHcCCCCCcee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDG-----------ALKSFDAECEVLKSVRHRNLVK 278 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~ 278 (467)
..++|++.+.||+|+||.||+|.+.. ++.||+|++...... .......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998864 478999998754321 1122345666777889999999
Q ss_pred EEEEeecC----CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec--
Q 041491 279 IISSCSNG----NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-- 352 (467)
Q Consensus 279 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-- 352 (467)
+++++... ...++||||+ +++|.+++......+++.++..++.|++.||+||| ++||+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99998764 5689999999 99999999877678999999999999999999999 99999999999999999
Q ss_pred CCCcEEEeccccceecCCCC------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc
Q 041491 353 DDMVAHLSDFGIAKLLNGKE------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE 420 (467)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~ 420 (467)
.++.+||+|||+++.+.... ..++..|.+||...+..++.++|||||||++|||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998764321 126778899999999999999999999999999999999998642221
Q ss_pred c-----------cHHHHHh-----hhcccccccccccccccchhHHHHHHHHHHHH
Q 041491 421 M-----------NLKNWVN-----DFLPISVMNVVDTSLLRREDKYFAAKKQCVSS 460 (467)
Q Consensus 421 ~-----------~~~~~~~-----~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~ 460 (467)
. .+..+.. ...|+++.+++..|+..+|.+|++ +.++++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~-~~~l~~~ 323 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPL-YENLRDI 323 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCC-HHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCC-HHHHHHH
Confidence 1 1222222 234667999999999999999963 4444433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=332.55 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=202.7
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC--------CCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
.+..++|.+.+.||+|+||.||+|++.. +..||+|+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 3456799999999999999999998632 35799999976532 3446788999999999 899999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
...+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| ++||+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence 99999999999999999999997653 35899999999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
|+++.++.+||+|||+++...... ...+..|.+||...+..++.++|||||||++|||+| |+.||......+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998765322 223456899999999999999999999999999999 999997643222
Q ss_pred ccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 421 MNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 421 ~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
....+.. .+++++.+++.+||..+|.+|+ ++.|+++.|.+
T Consensus 302 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~ 349 (382)
T 3tt0_A 302 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 349 (382)
T ss_dssp --HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred --HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 2222222 2345689999999999999995 55566665544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=322.11 Aligned_cols=230 Identities=23% Similarity=0.315 Sum_probs=188.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--------------------------cchHHHHHHHHHHH
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--------------------------GALKSFDAECEVLK 269 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 269 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999886 488999999865421 12356889999999
Q ss_pred cCCCCCceeEEEEeec--CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 041491 270 SVRHRNLVKIISSCSN--GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 347 (467)
Q Consensus 270 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 347 (467)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||+||| ++||+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999986 568899999999999988653 346899999999999999999999 999999999999
Q ss_pred CeeecCCCcEEEeccccceecCCCC-----ccccccccccccccCCC---CCCcccchhhHHHHHHHhcCCCCCCccccc
Q 041491 348 NVLLDDDMVAHLSDFGIAKLLNGKE-----SMRTQTLATIEYGREGQ---VSPKSDVYGYGITLIETFTKKKPTCEIFCE 419 (467)
Q Consensus 348 NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~~pe~~~~~~---~~~~~Dv~slGvil~el~tg~~Pf~~~~~~ 419 (467)
||+++.++.+||+|||+++...... ..++..|.+||...+.. ++.++|||||||++|||++|+.||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999999998776432 34677889999887655 377899999999999999999999764221
Q ss_pred cccHHHHH-h--------hhcccccccccccccccchhHHHHH
Q 041491 420 EMNLKNWV-N--------DFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 420 ~~~~~~~~-~--------~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
. ..... . ..+++.+.+++.+||..||.+|++.
T Consensus 247 ~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~ 287 (298)
T 2zv2_A 247 C--LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV 287 (298)
T ss_dssp H--HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred H--HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCH
Confidence 1 11111 1 1244568999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=343.48 Aligned_cols=241 Identities=20% Similarity=0.251 Sum_probs=202.9
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
...++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34578999999999999999999986 59999999997542 234566889999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 291 LVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+||||++||+|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999886543 35899999999999999999999 9999999999999999999999999999999876
Q ss_pred CCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc--ccHHHHHh-------hhcccccc
Q 041491 370 GKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--MNLKNWVN-------DFLPISVM 436 (467)
Q Consensus 370 ~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--~~~~~~~~-------~~~~~~~~ 436 (467)
... ..++..|.|||.+.+..++.++|||||||++|||++|+.||....... ..+..... ..+++++.
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence 432 346778999999988889999999999999999999999998643211 11112211 22455689
Q ss_pred cccccccccchhHHHH----HHHHHH
Q 041491 437 NVVDTSLLRREDKYFA----AKKQCV 458 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~----~~~~~~ 458 (467)
++|.+||..||.+|+. ++.|++
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil 443 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVK 443 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHH
Confidence 9999999999999983 445543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.07 Aligned_cols=240 Identities=22% Similarity=0.342 Sum_probs=191.6
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccc----cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD----GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|.+ .++.||+|+++.... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 488999999875432 2346788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---ceecCCCCCCeeecC--------CCcEEEec
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP---VVHCDIKPSNVLLDD--------DMVAHLSD 361 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~dlkp~NIll~~--------~~~~kl~D 361 (467)
|||+++++|.+++. ...+++..++.++.|++.||+||| ++| |+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999884 346899999999999999999999 888 999999999999986 67899999
Q ss_pred cccceecCCCC---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-------Hhhhc
Q 041491 362 FGIAKLLNGKE---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-------VNDFL 431 (467)
Q Consensus 362 fg~a~~~~~~~---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-------~~~~~ 431 (467)
||++....... ..++..|.+||...+..++.++||||||+++|||++|+.||............. ....+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 99998765432 346677899999988889999999999999999999999997643222111111 11234
Q ss_pred ccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
++.+.+++.+|+..+|.+|+ ++.|+++.|.+
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp-s~~e~l~~L~~ 270 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRP-SFTNILDQLTT 270 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCCcccCc-CHHHHHHHHhc
Confidence 45689999999999999996 67788887754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=324.46 Aligned_cols=233 Identities=21% Similarity=0.289 Sum_probs=198.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc------chHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 468999999999999999999986 4899999999754321 356789999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC----cEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM----VAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a 365 (467)
++||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999864 456899999999999999999999 99999999999999999888 7999999999
Q ss_pred eecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---------cHHHHHhhhcc
Q 041491 366 KLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------NLKNWVNDFLP 432 (467)
Q Consensus 366 ~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------~~~~~~~~~~~ 432 (467)
....... ..++..|.+||...+..++.++||||||+++|||++|+.||......+. ..........+
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 8776432 3467789999999989999999999999999999999999976432211 01111223455
Q ss_pred cccccccccccccchhHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~ 453 (467)
+.+.+++.+||..||.+|++.
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~ 267 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTI 267 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCH
T ss_pred HHHHHHHHHHcCCChhhCcCH
Confidence 668999999999999999853
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.23 Aligned_cols=245 Identities=23% Similarity=0.329 Sum_probs=204.2
Q ss_pred HHHhccCccCCccCcccceeEEEEEe------cCCCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEeec
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRF------LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCSN 285 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 285 (467)
....++|++.+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 44567899999999999999999985 2367899999975533 3457789999999999 89999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNG-----------------ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
.+..++||||+++|+|.+++..... .+++..++.++.|++.||+||| ++||+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccce
Confidence 9999999999999999999876543 4899999999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
|+++.++.+||+|||++........ .++..|.+||...+..++.++||||||+++|||+| |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999987764432 23456899999888899999999999999999999 999997643322
Q ss_pred ccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 421 MNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 421 ~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
. ...... ...++.+.+++.+||..||.+|+ ++.++++.|.+
T Consensus 256 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~ 304 (313)
T 1t46_A 256 K-FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-TFKQIVQLIEK 304 (313)
T ss_dssp H-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred H-HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc-CHHHHHHHHHH
Confidence 1 222222 23445689999999999999997 56666665543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=345.60 Aligned_cols=231 Identities=22% Similarity=0.264 Sum_probs=188.5
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
..++|++.+.||+|+||.||+|++. +|+.||+|+++... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4578999999999999999999986 48999999997542 2334567889999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||||+++|+|.+++... +.+++..+..++.|++.||+||| + +||+||||||+|||++.++.+||+|||+|+....
T Consensus 226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999988553 46899999999999999999999 8 8999999999999999999999999999986432
Q ss_pred C-----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhccccccccc
Q 041491 371 K-----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVV 439 (467)
Q Consensus 371 ~-----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i 439 (467)
. ...++..|.|||++.+..++.++|||||||++|||++|+.||........ ..... ...+++.+.++|
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCCCCccCCHHHHHHH
Confidence 2 23467789999999999999999999999999999999999976432211 11111 123455689999
Q ss_pred ccccccchhHHH
Q 041491 440 DTSLLRREDKYF 451 (467)
Q Consensus 440 ~~~l~~~~~~r~ 451 (467)
.+||..||.+|+
T Consensus 381 ~~~L~~dP~~R~ 392 (446)
T 4ejn_A 381 SGLLKKDPKQRL 392 (446)
T ss_dssp HHHTCSSTTTST
T ss_pred HHHcccCHHHhC
Confidence 999999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=318.69 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=210.7
Q ss_pred cccccHHHHHHHhccCccC------CccCcccceeEEEEEecCCCeEEEEEeeccc----ccchHHHHHHHHHHHcCCCC
Q 041491 205 WRRFSYQELLLATDHFSEK------SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRHR 274 (467)
Q Consensus 205 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~ 274 (467)
...+++.++...+++|... +.||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568899999999999887 8999999999999987 68899999986532 23456789999999999999
Q ss_pred CceeEEEEeecCCeeeEEEecccCCCHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec
Q 041491 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSS--NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD 352 (467)
Q Consensus 275 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~ 352 (467)
||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999988643 346899999999999999999999 99999999999999999
Q ss_pred CCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc----
Q 041491 353 DDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---- 421 (467)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---- 421 (467)
+++.+||+|||++....... ..++..|.+||...+ .++.++||||||+++|||++|+.||........
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 99999999999998765422 245677899998765 478999999999999999999999976433221
Q ss_pred ---------cHHHHHhhh-------cccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 422 ---------NLKNWVNDF-------LPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 422 ---------~~~~~~~~~-------~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+..+.... .+..+.+++.+||..+|.+|+ ++.++++.|.++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~l~~~L~~l 304 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP-DIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC-CHHHHHHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCc-CHHHHHHHHHHH
Confidence 112222111 123477899999999999997 566777777655
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=324.54 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=204.3
Q ss_pred HHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecC
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG 286 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 286 (467)
....++|.+.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 345678999999999999999999873 35789999997543 23456788999999999999999999999999
Q ss_pred CeeeEEEecccCCCHHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 041491 287 NFEALVLEYMANGSLEKCLYSSN-----------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 343 (467)
+..++||||+++++|.+++.... ..+++.+++.++.|++.||+||| ++||+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccc
Confidence 99999999999999999987543 24889999999999999999999 99999999
Q ss_pred CCCCCeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCc
Q 041491 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCE 415 (467)
Q Consensus 344 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~ 415 (467)
|||+||++++++.+||+|||+++...... ...+..|.+||...+..++.++||||||+++|||+| |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765432 223456899999888889999999999999999999 9999976
Q ss_pred cccccccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 416 IFCEEMNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 416 ~~~~~~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..... ....+.. .+++.+.+++.+||..||.+|+ ++.++++.|.++
T Consensus 256 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IPPER--LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP-VFADISKDLEKM 309 (314)
T ss_dssp CCGGG--HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CCHHH--HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 44332 2222222 3455689999999999999996 566776666544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=323.42 Aligned_cols=246 Identities=19% Similarity=0.216 Sum_probs=202.5
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEee----cCCee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS----NGNFE 289 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~ 289 (467)
+..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++. ..+..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 45678999999999999999999984 58999999987665556678999999999999999999999986 34578
Q ss_pred eEEEecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 290 ALVLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
++||||+++|+|.+++.. ....+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999998865 3457999999999999999999999 9999999999999999999999999999988
Q ss_pred ecCCCC--------------ccccccccccccccCCC---CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-
Q 041491 367 LLNGKE--------------SMRTQTLATIEYGREGQ---VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN- 428 (467)
Q Consensus 367 ~~~~~~--------------~~~~~~~~~pe~~~~~~---~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~- 428 (467)
...... ..++..|.+||...... ++.++||||||+++|||++|+.||...............
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 654321 12366789999876543 688999999999999999999999764333333322222
Q ss_pred -------hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 429 -------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 429 -------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..+++.+.+++.+||..||.+|+ ++.++++.+.++
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~ 304 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRP-HIPLLLSQLEAL 304 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHT
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCC-CHHHHHHHhhhc
Confidence 12345689999999999999997 677777777654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.55 Aligned_cols=240 Identities=23% Similarity=0.301 Sum_probs=195.8
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecc-----cccchHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ-----FDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
++....++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556789999999999999999999885 4889999998754 23445778999999999999999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 041491 286 GNFEALVLEYMANGSLEKCLYSS---------------------------------------NGILDIFQRLSIMIDVAL 326 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~ 326 (467)
.+..++||||+++|+|.+++... ...+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988421 113467788899999999
Q ss_pred HHHHHhcCCCCCceecCCCCCCeeecCCC--cEEEeccccceecCC---------CCccccccccccccccC--CCCCCc
Q 041491 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDM--VAHLSDFGIAKLLNG---------KESMRTQTLATIEYGRE--GQVSPK 393 (467)
Q Consensus 327 ~l~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~a~~~~~---------~~~~~~~~~~~pe~~~~--~~~~~~ 393 (467)
||+||| ++||+||||||+||+++.++ .+||+|||+++.+.. ....++..|.+||.+.. ..++.+
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999 99999999999999998776 899999999986532 12345677899998764 678999
Q ss_pred ccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhcccccccccccccccchhHHHHHHH
Q 041491 394 SDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 394 ~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
+|||||||++|||++|+.||......+. ...... ..+++.+.+++.+||..+|.+|++..+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999999999999999976433221 111111 124566899999999999999986543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=330.51 Aligned_cols=246 Identities=21% Similarity=0.353 Sum_probs=187.3
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC-C---CeEEEEEeecc--cccchHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD-G---MEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
++.+..++|++.+.||+|+||.||+|++.. + ..||+|+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344566789999999999999999998764 3 27999998754 23446789999999999999999999999987
Q ss_pred CCee------eEEEecccCCCHHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC
Q 041491 286 GNFE------ALVLEYMANGSLEKCLYSSN-----GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354 (467)
Q Consensus 286 ~~~~------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 354 (467)
.+.. ++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| ++||+||||||+||+++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCC
Confidence 7655 99999999999999885432 25899999999999999999999 9999999999999999999
Q ss_pred CcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHH
Q 041491 355 MVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNW 426 (467)
Q Consensus 355 ~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~ 426 (467)
+.+||+|||+++...... ...+..|.+||...+..++.++|||||||++|||++ |+.||......+. ....
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~ 252 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYL 252 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHH
Confidence 999999999998764432 223456899999988899999999999999999999 9999986433321 1111
Q ss_pred Hh-------hhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 427 VN-------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 427 ~~-------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.. ..+++.+.+++.+||..||.+|+ ++.++++.+.
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~l~~~l~ 294 (323)
T 3qup_A 253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRP-SFTCLRMELE 294 (323)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-CHHHHHHHHH
T ss_pred hcCCCCCCCCccCHHHHHHHHHHccCChhhCc-CHHHHHHHHH
Confidence 11 22345688999999999999995 4445544443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.21 Aligned_cols=242 Identities=21% Similarity=0.291 Sum_probs=192.0
Q ss_pred HHhccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
+..++|++.+.||+|+||.||+|.+.. +..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 446789999999999999999998753 4569999987543 234567889999999999999999999985 4567
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999999877667999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccc
Q 041491 370 GKE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPIS 434 (467)
Q Consensus 370 ~~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 434 (467)
... ...+..|.+||......++.++||||||+++|||++ |+.||......+ ....+. ..+++.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCCCCCCCCCCCHH
Confidence 432 123456899999988899999999999999999997 999998643332 222221 234556
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHh
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+.+++.+||..||.+|+ ++.+++..+.+
T Consensus 246 l~~li~~~l~~~p~~Rp-s~~~l~~~l~~ 273 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRP-RFTELKAQLST 273 (281)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCc-CHHHHHHHHHH
Confidence 89999999999999996 45566655544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.08 Aligned_cols=241 Identities=23% Similarity=0.321 Sum_probs=198.3
Q ss_pred HhccCccCCccCcccceeEEEEEec------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ......+.+|+.++++++||||+++++++...+.
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3468999999999999999999853 36789999986542 3344578899999999999999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC---cEEE
Q 041491 289 EALVLEYMANGSLEKCLYSSN------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---VAHL 359 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl 359 (467)
.++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| ++||+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999986543 35899999999999999999999 99999999999999999555 5999
Q ss_pred eccccceecCC-------CCccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--
Q 041491 360 SDFGIAKLLNG-------KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND-- 429 (467)
Q Consensus 360 ~Dfg~a~~~~~-------~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~-- 429 (467)
+|||+++.... ....++..|.+||.+.+..++.++|||||||++|||+| |+.||...... .....+..
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC
Confidence 99999975421 12234567899999988899999999999999999998 99999764322 22222221
Q ss_pred ------hcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 430 ------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 430 ------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.+++.+.+++.+||..+|.+|+ ++.++++.+-
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~eil~~l~ 341 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRP-NFAIILERIE 341 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCc-CHHHHHHHHH
Confidence 2344588999999999999996 5666666553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.33 Aligned_cols=241 Identities=25% Similarity=0.365 Sum_probs=197.4
Q ss_pred hccCccCCccCcccceeEEEEEecC-CC----eEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++|++.+.||+|+||.||+|++.. ++ +||+|.+.... ....+.+.+|+.++++++||||+++++++..++ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 4689999999999999999998753 44 35788775432 245578999999999999999999999998765 67
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+|+||+++|+|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 899999999999999887788999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcccc
Q 041491 371 KES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 371 ~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
... ..+..|.+||+..+..++.++|||||||++|||+| |+.||......+ ....+.. ..+..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCCCCCTTBCHH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCCCCCCCccCCHH
Confidence 321 23457899999999999999999999999999999 999998643332 2333222 23345
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+.+++.+|+..+|.+|+ ++.+++..+.++
T Consensus 248 ~~~li~~~l~~~p~~Rp-s~~ell~~l~~~ 276 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRP-KFRELIIEFSKM 276 (327)
T ss_dssp HHHHHHHHTCSCGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCC-CHHHHHHHHHHH
Confidence 88999999999999996 566777766544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.79 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=205.9
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
++.+..++|++.+.||+|+||.||+|.+.. +..||+|++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 444567899999999999999999999875 889999999754 334577899999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 291 LVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+||||+++++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999997643 46899999999999999999999 9999999999999999999999999999998766
Q ss_pred CCCc------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccc
Q 041491 370 GKES------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPIS 434 (467)
Q Consensus 370 ~~~~------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 434 (467)
.... ..+..|.+||...+..++.++||||||+++|+|++ |..||...... ....... ..+++.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRMERPEGCPEK 240 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCCCCCTTCCHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCCCCCCCCCCHH
Confidence 4332 23446899999988899999999999999999999 99999764322 2222222 223456
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHh
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+.+++.+||..||.+|+ ++.++++.+.+
T Consensus 241 l~~li~~~l~~dp~~Rp-s~~~~~~~l~~ 268 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRP-SFAEIHQAFET 268 (288)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHHhCCChhhCc-CHHHHHHHHHH
Confidence 88999999999999995 55566555543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.06 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=201.3
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
++.+..++|++.+.||+|+||.||+|++. ++..||+|+++... ....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34556789999999999999999999862 35689999997543 33457789999999999 899999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSNG----------------------ILDIFQRLSIMIDVALALEYLHFGYSNPVVH 341 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 341 (467)
...+..++||||+++|+|.+++..... .+++..++.++.|++.||+||| ++||+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 999999999999999999999976543 3789999999999999999999 999999
Q ss_pred cCCCCCCeeecCCCcEEEeccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCC
Q 041491 342 CDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPT 413 (467)
Q Consensus 342 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf 413 (467)
|||||+||+++.++.+||+|||++........ .++..|.+||...++.++.++|||||||++|||+| |+.||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986643321 23446899999888899999999999999999998 99999
Q ss_pred CccccccccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 414 CEIFCEEMNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 414 ~~~~~~~~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
....... ........ ..++.+.+++.+||..||.+|+ ++.+++..+-
T Consensus 276 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~l~~~l~ 330 (344)
T 1rjb_A 276 PGIPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-SFPNLTSFLG 330 (344)
T ss_dssp TTCCCSH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHH
T ss_pred ccCCcHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCc-CHHHHHHHHH
Confidence 7653322 22223222 2345689999999999999997 4555555543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.11 Aligned_cols=244 Identities=18% Similarity=0.141 Sum_probs=194.7
Q ss_pred hccCccCCccCcccceeEEEEEec----CCCeEEEEEeeccccc-----------chHHHHHHHHHHHcCCCCCceeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDG-----------ALKSFDAECEVLKSVRHRNLVKIIS 281 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 281 (467)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999986 4788999998754321 1234667888999999999999999
Q ss_pred Eeec----CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC--
Q 041491 282 SCSN----GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-- 355 (467)
Q Consensus 282 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-- 355 (467)
++.. .+..++||||+ +++|.+++.... .+++.+++.++.|++.||+||| ++||+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence 9887 77899999999 999999986543 7899999999999999999999 99999999999999998877
Q ss_pred cEEEeccccceecCCC------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccH
Q 041491 356 VAHLSDFGIAKLLNGK------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL 423 (467)
Q Consensus 356 ~~kl~Dfg~a~~~~~~------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~ 423 (467)
.+||+|||+++.+... ...++..|.|||...+..++.++|||||||++|||+||+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999876421 1245677899999998899999999999999999999999996532222111
Q ss_pred HHH-----------Hhh-----hcccccccccccccccchhHHHHHHHHHHHHHHhccc
Q 041491 424 KNW-----------VND-----FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSLAM 466 (467)
Q Consensus 424 ~~~-----------~~~-----~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l~~ 466 (467)
... ... .+++++.+++.+||..||++|+ ++.++++.|.++.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP-NYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC-CHHHHHHHHCTTCC
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC-CHHHHHHHHhccCC
Confidence 111 111 4555799999999999999996 67788887766543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=337.81 Aligned_cols=241 Identities=31% Similarity=0.380 Sum_probs=200.7
Q ss_pred HHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC-eeeE
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-FEAL 291 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~l 291 (467)
+.+..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++...+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3456678999999999999999999884 7899999997543 4578999999999999999999999987655 7899
Q ss_pred EEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 292 VLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||||+++|+|.+++..... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999976544 4799999999999999999999 99999999999999999999999999999986653
Q ss_pred CC--ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccccccc
Q 041491 371 KE--SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVV 439 (467)
Q Consensus 371 ~~--~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i 439 (467)
.. ...+..|.|||.+....++.++|||||||++|||+| |+.||......+ ....+. ..+|+.+.+++
T Consensus 342 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 32 234567899999999999999999999999999998 999998643322 222222 23455689999
Q ss_pred ccccccchhHHHHHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.+|+..||.+|+ ++.+++..|.
T Consensus 420 ~~cl~~dp~~Rp-t~~~l~~~L~ 441 (450)
T 1k9a_A 420 KNCWHLDAATRP-TFLQLREQLE 441 (450)
T ss_dssp HHHTCSSGGGSC-CHHHHHHHHH
T ss_pred HHHcCCChhHCc-CHHHHHHHHH
Confidence 999999999996 4555555443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=340.38 Aligned_cols=234 Identities=23% Similarity=0.291 Sum_probs=199.4
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
..++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999986 49999999997542 2344678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 292 VLEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
||||++||+|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999988654 246899999999999999999999 999999999999999999999999999999877
Q ss_pred CCCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc--ccHHHHH-------hhhcccc
Q 041491 369 NGKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--MNLKNWV-------NDFLPIS 434 (467)
Q Consensus 369 ~~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--~~~~~~~-------~~~~~~~ 434 (467)
.... ..++..|.|||.+.+..++.++|||||||++|||+||+.||....... ..+...+ ...+++.
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~ 419 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPA 419 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHH
Confidence 5432 256778999999999999999999999999999999999997642211 1111111 1234556
Q ss_pred cccccccccccchhHHHH
Q 041491 435 VMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~ 452 (467)
+.+++.+||..||.+|++
T Consensus 420 ~~~li~~lL~~dP~~R~~ 437 (543)
T 3c4z_A 420 SKDFCEALLQKDPEKRLG 437 (543)
T ss_dssp HHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHhccCCHhHCCC
Confidence 899999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.59 Aligned_cols=237 Identities=23% Similarity=0.303 Sum_probs=197.7
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--------cchHHHHHHHHHHHcCCCCCceeEEEEeecC
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--------GALKSFDAECEVLKSVRHRNLVKIISSCSNG 286 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 286 (467)
..++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999875 589999999976531 1334677899999999999999999999999
Q ss_pred CeeeEEEecccCC-CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 287 NFEALVLEYMANG-SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 287 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
+..++||||+.+| +|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 99998854 446899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCc----cccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhcccccccccc
Q 041491 366 KLLNGKES----MRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVD 440 (467)
Q Consensus 366 ~~~~~~~~----~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~i~ 440 (467)
+....... .++..|.+||...+..+ +.++|||||||++|||++|+.||........ ........+++.+.+++.
T Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~l~~li~ 256 (335)
T 3dls_A 178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-AAIHPPYLVSKELMSLVS 256 (335)
T ss_dssp EECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-TCCCCSSCCCHHHHHHHH
T ss_pred eECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-hccCCCcccCHHHHHHHH
Confidence 98765432 35778999999888776 7899999999999999999999976322111 000112234567999999
Q ss_pred cccccchhHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~ 458 (467)
+||..||.+|++ +.+++
T Consensus 257 ~~L~~dP~~Rps-~~ell 273 (335)
T 3dls_A 257 GLLQPVPERRTT-LEKLV 273 (335)
T ss_dssp HHTCSSGGGSCC-HHHHH
T ss_pred HHccCChhhCcC-HHHHh
Confidence 999999999975 44444
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.89 Aligned_cols=232 Identities=28% Similarity=0.331 Sum_probs=195.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.+.|+..+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 356999999999999999999975 589999999975432 2346788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
|||++ |++.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 208 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 208 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC
Confidence 99997 5888888666678999999999999999999999 999999999999999999999999999999876543
Q ss_pred Ccccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhcccccccccc
Q 041491 372 ESMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVD 440 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~ 440 (467)
...++..|.+||... .+.++.++|||||||++|||+||+.||........ +..... ..+++.+.+++.
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 335677899999873 57789999999999999999999999976432211 111211 123445889999
Q ss_pred cccccchhHHHHH
Q 041491 441 TSLLRREDKYFAA 453 (467)
Q Consensus 441 ~~l~~~~~~r~~~ 453 (467)
+||..+|.+|++.
T Consensus 288 ~~l~~dP~~Rps~ 300 (348)
T 1u5q_A 288 SCLQKIPQDRPTS 300 (348)
T ss_dssp HHTCSSGGGSCCH
T ss_pred HHcccChhhCcCH
Confidence 9999999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=320.42 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=192.8
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.++|++.+.||+|+||.||+|++ .++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 46899999999999999999988 4789999998643 345778999999999999999999998874 478999999
Q ss_pred cCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc-EEEeccccceecCCC--
Q 041491 297 ANGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV-AHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 297 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~-- 371 (467)
++|+|.+++..... .+++..++.++.|+++||+|||..+.+||+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~ 161 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT 161 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccc
Confidence 99999999976543 4788999999999999999999221189999999999999998886 799999999866542
Q ss_pred CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccccccccccccc
Q 041491 372 ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDTSL 443 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l 443 (467)
...++..|.+||...+..++.++||||||+++|||+||+.||............... ..+++.+.+++.+||
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 241 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCW 241 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHT
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHh
Confidence 234677899999999999999999999999999999999999754322211111111 234456889999999
Q ss_pred ccchhHHHHHHHHHHHHHHhc
Q 041491 444 LRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 444 ~~~~~~r~~~~~~~~~~l~~l 464 (467)
..||.+|+ ++.++++.|.++
T Consensus 242 ~~dp~~Rp-s~~ell~~L~~~ 261 (307)
T 2eva_A 242 SKDPSQRP-SMEEIVKIMTHL 261 (307)
T ss_dssp CSSGGGSC-CHHHHHHHHHHH
T ss_pred cCChhhCc-CHHHHHHHHHHH
Confidence 99999996 566777666543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=323.12 Aligned_cols=237 Identities=19% Similarity=0.268 Sum_probs=192.8
Q ss_pred hccCccC-CccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEE
Q 041491 217 TDHFSEK-SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 217 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.++|++. +.||+|+||.||+|.+. +++.||+|++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578884 78999999999999875 5899999999876555667899999999985 7999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc---EEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV---AHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~~ 370 (467)
||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999998654 46899999999999999999999 999999999999999988775 99999999876542
Q ss_pred C------------CccccccccccccccC-----CCCCCcccchhhHHHHHHHhcCCCCCCccccccc------------
Q 041491 371 K------------ESMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM------------ 421 (467)
Q Consensus 371 ~------------~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~------------ 421 (467)
. ...++..|.+||.... ..++.++|||||||++|||++|+.||......+.
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 1 1225677899998764 5678999999999999999999999976432210
Q ss_pred --cHHHH----------HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 422 --NLKNW----------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 422 --~~~~~----------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..... ....+++.+.+++.+||..||.+|++ +.|++
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-~~e~l 294 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS-AAQVL 294 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC-HHHHH
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC-HHHHh
Confidence 01111 11235566899999999999999985 33443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=326.29 Aligned_cols=241 Identities=24% Similarity=0.371 Sum_probs=198.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCe----EEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GME----VAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++|++.+.||+|+||.||+|.+.. ++. ||+|.+.... ......+.+|+.++++++||||+++++++.. +..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 4689999999999999999998754 444 7777775432 2334667889999999999999999999864 5578
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++|+|.+++....+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999776678999999999999999999999 99999999999999999999999999999987654
Q ss_pred CC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcccc
Q 041491 371 KE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 371 ~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
.. ..++..|.+||....+.++.++|||||||++|||+| |+.||......+ ....... ..+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTCBCCCCTTBCTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCCCCCCcCcHH
Confidence 32 123446899999988899999999999999999999 999998643222 2222222 23456
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+.+++.+||..||.+|+ ++.++++.+.++
T Consensus 246 ~~~li~~~l~~dp~~Rp-s~~el~~~l~~~ 274 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRP-TFKELANEFTRM 274 (325)
T ss_dssp TTHHHHHHTCSCTTTSC-CHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 99999999999999995 667777776554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=317.14 Aligned_cols=233 Identities=21% Similarity=0.329 Sum_probs=197.6
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.++|++.+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4789999999999999999998864 8999999997553 233467889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc---EEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV---AHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~~ 370 (467)
||+++++|.+.+... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999998888544 46899999999999999999999 999999999999999986655 99999999987765
Q ss_pred CC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhcccccc
Q 041491 371 KE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVM 436 (467)
Q Consensus 371 ~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~ 436 (467)
.. ..++..|.+||...+..++.++||||+|+++|+|++|+.||....... ....... ..+++.+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhccccCCchhhcccCHHHH
Confidence 43 246778899999999999999999999999999999999997643222 1111111 23455689
Q ss_pred cccccccccchhHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~ 454 (467)
+++.+||..||++|++..
T Consensus 240 ~li~~~l~~dp~~Rps~~ 257 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITAD 257 (284)
T ss_dssp HHHHHHSCSSTTTSCCHH
T ss_pred HHHHHHcccChhhCCCHH
Confidence 999999999999998644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=318.72 Aligned_cols=245 Identities=25% Similarity=0.379 Sum_probs=193.6
Q ss_pred HHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
++..++|++.+.||+|+||.||+|++. ..||+|+++... ....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 445678999999999999999999864 469999987543 23456789999999999999999999965 4556799
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++++|.+++......+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999999777778999999999999999999999 999999999999999999999999999999865431
Q ss_pred -------Ccccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-----------hh
Q 041491 372 -------ESMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-----------DF 430 (467)
Q Consensus 372 -------~~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-----------~~ 430 (467)
...++..|.+||... ...++.++||||||+++|||++|+.||......+........ ..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 123567789999876 667888999999999999999999999764332221111111 13
Q ss_pred cccccccccccccccchhHHHHHHHHHHHHHHhcc
Q 041491 431 LPISVMNVVDTSLLRREDKYFAAKKQCVSSALSLA 465 (467)
Q Consensus 431 ~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l~ 465 (467)
+++.+.+++.+||..+|.+|+ ++.+++..|.++.
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rp-s~~ell~~L~~l~ 287 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERP-SFPRILAEIEELA 287 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHccCChhhCC-CHHHHHHHHHHHh
Confidence 445688999999999999997 6778888776653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=328.19 Aligned_cols=232 Identities=20% Similarity=0.231 Sum_probs=187.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999987 58999999997543 334678899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc--EEEeccccceecCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV--AHLSDFGIAKLLNG-- 370 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~~~~-- 370 (467)
|+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 97 YASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999988543 46899999999999999999999 999999999999999987765 99999999975432
Q ss_pred --CCccccccccccccccCCCCCCc-ccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh------------hccccc
Q 041491 371 --KESMRTQTLATIEYGREGQVSPK-SDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND------------FLPISV 435 (467)
Q Consensus 371 --~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~------------~~~~~~ 435 (467)
....++..|.+||.+.+..++.+ +||||+||++|||++|+.||....... ........ .+++.+
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence 22346778999999887777655 899999999999999999998643322 22222111 234568
Q ss_pred ccccccccccchhHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~ 453 (467)
.+++.+||..||.+|++.
T Consensus 252 ~~li~~~L~~dP~~Rps~ 269 (361)
T 3uc3_A 252 CHLISRIFVADPATRISI 269 (361)
T ss_dssp HHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHccCChhHCcCH
Confidence 899999999999999854
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=338.07 Aligned_cols=236 Identities=26% Similarity=0.391 Sum_probs=199.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|.+.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999986 59999999997542 22346788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999854 457999999999999999999999 9999999999999999999999999999999876432
Q ss_pred ----ccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDT 441 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~ 441 (467)
..++..|.|||...+..+ +.++||||+||++|||++|+.||.+..... ....... ..+++.+.+++.+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDGIFYTPQYLNPSVISLLKH 249 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHHTTCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCCcCCCccCCHHHHHHHHH
Confidence 346778899999888766 689999999999999999999997643221 1111111 2245568999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
||..||.+|++ +.+++
T Consensus 250 ~L~~dP~~Rpt-~~eil 265 (476)
T 2y94_A 250 MLQVDPMKRAT-IKDIR 265 (476)
T ss_dssp HTCSSTTTSCC-HHHHH
T ss_pred HcCCCchhCcC-HHHHH
Confidence 99999999975 33433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=314.21 Aligned_cols=232 Identities=21% Similarity=0.295 Sum_probs=198.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999986 58999999997543 2345778999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
|+++++|.+++.. ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999998853 457899999999999999999999 999999999999999999999999999999865422
Q ss_pred ----CccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhcccccccc
Q 041491 372 ----ESMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNV 438 (467)
Q Consensus 372 ----~~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~ 438 (467)
...++..|.+||...+..+ +.++||||||+++|||++|+.||............|.. ..+++.+.++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 2345677899999877665 77899999999999999999999875444334444432 2345568999
Q ss_pred cccccccchhHHHH
Q 041491 439 VDTSLLRREDKYFA 452 (467)
Q Consensus 439 i~~~l~~~~~~r~~ 452 (467)
+.+||..||.+|++
T Consensus 242 i~~~l~~~p~~Rps 255 (276)
T 2yex_A 242 LHKILVENPSARIT 255 (276)
T ss_dssp HHHHSCSSTTTSCC
T ss_pred HHHHCCCCchhCCC
Confidence 99999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=316.49 Aligned_cols=232 Identities=24% Similarity=0.387 Sum_probs=180.8
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999985 58999999997542 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++++|.+++......+++..++.++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999776678999999999999999999999 9999999999999999999999999999998765322
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH------Hhhhccccccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------VNDFLPISVMNVVDT 441 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~i~~ 441 (467)
..++..|.+||...+..++.++||||||+++|||++|+.||......+. .... ....++.++.+++.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhcccCCccccCHHHHHHHHH
Confidence 2356678999999888899999999999999999999999975422211 1110 112345568999999
Q ss_pred ccccchhHHHH
Q 041491 442 SLLRREDKYFA 452 (467)
Q Consensus 442 ~l~~~~~~r~~ 452 (467)
||..||.+|++
T Consensus 246 ~l~~dp~~Rps 256 (278)
T 3cok_A 246 LLRRNPADRLS 256 (278)
T ss_dssp HSCSSGGGSCC
T ss_pred HcccCHhhCCC
Confidence 99999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.26 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=200.5
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
++.+..++|++.+.||+|+||.||+|.+.+++.||+|+++... ...+.+.+|++++++++||||+++++++.. +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 4455668999999999999999999998888899999987543 345788999999999999999999999874 45799
Q ss_pred EEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 292 VLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||||+++++|.+++....+ .+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999999865322 6899999999999999999999 99999999999999999999999999999987754
Q ss_pred CC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccc
Q 041491 371 KE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISV 435 (467)
Q Consensus 371 ~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 435 (467)
.. ...+..|.+||...++.++.++||||||+++|||++ |+.||.+....+ ...... ..+++.+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l 239 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEEL 239 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhcccCCCCcccccHHH
Confidence 32 223456899999988889999999999999999999 999997643222 112211 2345568
Q ss_pred ccccccccccchhHHHHHHHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
.+++.+|+..+|.+|+ ++.+++..+
T Consensus 240 ~~li~~~l~~~p~~Rp-s~~~l~~~l 264 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRP-TFDYLRSVL 264 (279)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHHHH
T ss_pred HHHHHHHhccChhhCC-CHHHHHHHH
Confidence 9999999999999996 444544444
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=319.22 Aligned_cols=235 Identities=26% Similarity=0.331 Sum_probs=190.4
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-----cchHHHHHHHHHHHcCC---CCCceeEEEEeec
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-----GALKSFDAECEVLKSVR---HRNLVKIISSCSN 285 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 285 (467)
...++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34679999999999999999999975 589999999875421 22356778888887764 9999999999976
Q ss_pred CC-----eeeEEEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEE
Q 041491 286 GN-----FEALVLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHL 359 (467)
Q Consensus 286 ~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 359 (467)
.. ..++||||++ ++|.+++..... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 55 5799999997 599998866543 4899999999999999999999 999999999999999999999999
Q ss_pred eccccceecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---------
Q 041491 360 SDFGIAKLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------- 426 (467)
Q Consensus 360 ~Dfg~a~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------- 426 (467)
+|||+++...... ..++..|.+||...+..++.++|||||||++|||++|+.||......+. +...
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCCCCT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 9999998765433 2456778999999889999999999999999999999999976432221 1111
Q ss_pred ------------------------HhhhcccccccccccccccchhHHHHHH
Q 041491 427 ------------------------VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 427 ------------------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
....+++.+.+++.+||..||.+|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 292 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence 1123344578899999999999998644
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.91 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=203.8
Q ss_pred hccCccCCccCcccceeEEEEEe-----cCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEee--cCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS--NGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 289 (467)
.++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 248899999998766566677999999999999999999999886 45678
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++++|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999999776667999999999999999999999 9999999999999999999999999999998775
Q ss_pred CCC--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc----------c---cHHHHHh
Q 041491 370 GKE--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE----------M---NLKNWVN 428 (467)
Q Consensus 370 ~~~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~----------~---~~~~~~~ 428 (467)
... ..++..|.+||...+..++.++||||||+++|||++|+.||.....+. . .......
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 432 124445899999888889999999999999999999999996543211 0 1111111
Q ss_pred --------hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 429 --------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 429 --------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..+++.+.+++.+||..||.+|+ ++.++++.|.++
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~~ 301 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRP-SFSALGPQLDML 301 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHC
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 13345689999999999999995 677777766554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.07 Aligned_cols=244 Identities=25% Similarity=0.315 Sum_probs=193.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457999999999999999999875 58999999997532 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
|||+++++|.+++.. ....+++..++.++.|++.||.||| ++|++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999998854 3456899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh---------hhccccc
Q 041491 370 GKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN---------DFLPISV 435 (467)
Q Consensus 370 ~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~ 435 (467)
... ..++..|.+||...+..++.++||||||+++|||++|+.||.+............. ..+++++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 432 23566789999998889999999999999999999999999764322222222221 2345568
Q ss_pred ccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+++.+||..||.+|+ ++.++++.+.++
T Consensus 268 ~~li~~~l~~dp~~Rp-s~~~il~~l~~l 295 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRP-DVTYVYDVAKRM 295 (310)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCC-CHHHHHHHHHHH
Confidence 9999999999999996 566666665544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=340.40 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=207.8
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
++.+..++|++.+.||+|+||.||+|.+.. +..||+|+++... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345566789999999999999999999875 8899999997553 34678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 291 LVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999997643 46899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcccc
Q 041491 370 GKE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 370 ~~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
... ...+..|.|||.+..+.++.++|||||||++|||+| |+.||...... ...+.+.. .+++.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 447 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRMERPEGCPEK 447 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCCCCCTTCCHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHH
Confidence 432 123456899999988889999999999999999999 99999764332 22233322 23456
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+.+++.+|+..+|.+|+ ++.++++.|-++
T Consensus 448 l~~li~~cl~~dP~~RP-s~~el~~~L~~~ 476 (495)
T 1opk_A 448 VYELMRACWQWNPSDRP-SFAEIHQAFETM 476 (495)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHHHHHHTS
T ss_pred HHHHHHHHcCcChhHCc-CHHHHHHHHHHH
Confidence 88999999999999996 566777666543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=323.13 Aligned_cols=227 Identities=21% Similarity=0.250 Sum_probs=175.9
Q ss_pred cCccC---CccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEE
Q 041491 219 HFSEK---SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 219 ~y~~~---~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 293 (467)
+|++. +.||+|+||.||+|.+. +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+.+..++||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 45443 78999999999999986 4899999998743 3466789999999997 999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC---cEEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---VAHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~ 370 (467)
||+++|+|.+++... +.+++.++..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 86 ELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp CCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999999999999654 57899999999999999999999 99999999999999997765 899999999987654
Q ss_pred CC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc-----ccHHHH-----------Hhh
Q 041491 371 KE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE-----MNLKNW-----------VND 429 (467)
Q Consensus 371 ~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~-----~~~~~~-----------~~~ 429 (467)
.. ..++..|.+||...+..++.++||||+||++|||++|+.||....... ...... .+.
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence 32 234677899999999999999999999999999999999997642211 011111 123
Q ss_pred hcccccccccccccccchhHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
.+++++.+++.+||..||.+|++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt 264 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLK 264 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCC
T ss_pred CCCHHHHHHHHHHCCCChhHCCC
Confidence 45667999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=327.77 Aligned_cols=207 Identities=25% Similarity=0.310 Sum_probs=181.1
Q ss_pred cccccHHHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-----CCCcee
Q 041491 205 WRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-----HRNLVK 278 (467)
Q Consensus 205 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 278 (467)
...+++.+.....++|++.+.||+|+||.||+|++. +++.||+|+++.. ....+.+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344556666667889999999999999999999985 5899999998743 234466788999999986 999999
Q ss_pred EEEEeecCCeeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC----
Q 041491 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---- 353 (467)
Q Consensus 279 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---- 353 (467)
+++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999 889999987654 36899999999999999999999 999999999999999975
Q ss_pred ---------------------CCcEEEeccccceecCCC--CccccccccccccccCCCCCCcccchhhHHHHHHHhcCC
Q 041491 354 ---------------------DMVAHLSDFGIAKLLNGK--ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKK 410 (467)
Q Consensus 354 ---------------------~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~ 410 (467)
++.+||+|||+++..... ...++..|.|||.+.+..++.++|||||||++|||+||+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 789999999999876543 335677899999999999999999999999999999999
Q ss_pred CCCCcc
Q 041491 411 KPTCEI 416 (467)
Q Consensus 411 ~Pf~~~ 416 (467)
.||...
T Consensus 257 ~pf~~~ 262 (360)
T 3llt_A 257 LLFRTH 262 (360)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=320.33 Aligned_cols=231 Identities=24% Similarity=0.221 Sum_probs=189.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc--chHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG--ALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.++||+|+||+||+|++. +++.||||++...... .......|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999987 5999999998654322 233445566555554 899999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+ +++|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 66999988777778999999999999999999999 9999999999999999999999999999998775432
Q ss_pred ----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc----ccHHHHHhhhcccccccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE----MNLKNWVNDFLPISVMNVVDTSLL 444 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~ 444 (467)
..++..|.+||+..+ .++.++|||||||++|||++|..|+....... .....-....+++++.+++.+||.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHcC
Confidence 235778999998875 78999999999999999999977765421110 011112334566779999999999
Q ss_pred cchhHHHH
Q 041491 445 RREDKYFA 452 (467)
Q Consensus 445 ~~~~~r~~ 452 (467)
.||++|++
T Consensus 291 ~dP~~Rpt 298 (311)
T 3p1a_A 291 PDPKLRAT 298 (311)
T ss_dssp SSTTTSCC
T ss_pred CChhhCcC
Confidence 99999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=316.27 Aligned_cols=240 Identities=23% Similarity=0.365 Sum_probs=199.8
Q ss_pred hccCccCC-ccCcccceeEEEEEec---CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKS-LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
.++|.+.+ .||+|+||.||+|.+. ++..||+|+++... ....+.+.+|++++++++||||+++++++. .+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence 45677776 9999999999999864 47789999997643 234577899999999999999999999994 556899
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++++|.+++......+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999999776678999999999999999999999 999999999999999999999999999999877543
Q ss_pred Cc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccc
Q 041491 372 ES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPIS 434 (467)
Q Consensus 372 ~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 434 (467)
.. .++..|.+||...+..++.++||||||+++|||+| |+.||......+ ....+. ..+++.
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCCCCCCTTCCHH
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcCCcCCCCCCcCHH
Confidence 21 23456899999888889999999999999999999 999997643222 222222 234556
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHh
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+.+++.+|+..+|.+|+ ++.++++.+.+
T Consensus 242 l~~li~~~l~~~p~~Rp-s~~~l~~~l~~ 269 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRP-DFLTVEQRMRA 269 (287)
T ss_dssp HHHHHHHTTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 89999999999999996 56666665544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=319.26 Aligned_cols=236 Identities=25% Similarity=0.283 Sum_probs=192.8
Q ss_pred ccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|+||.||+|++.. |+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 689999999999999999999864 89999999865432 234668899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+++++|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999988754 456899999999999999999999 9999999999999999999999999999998776432
Q ss_pred ---ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccH--H----------------------
Q 041491 373 ---SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL--K---------------------- 424 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~--~---------------------- 424 (467)
..++..|.+||...+ ..++.++||||+|+++|||+||+.||.+....+... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 245667899998865 678999999999999999999999997643221100 0
Q ss_pred ------------HHHhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 425 ------------NWVNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 425 ------------~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
......+++.+.+++.+||..||.+|++ +.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell 283 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT-CEQLL 283 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC-HHHHH
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC-HHHHh
Confidence 0011234445788999999999999985 44443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=314.65 Aligned_cols=237 Identities=24% Similarity=0.317 Sum_probs=196.7
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
..++|++.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 35789999999999999999998864 7899999986542 2235678899999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999988654 46899999999999999999999 999999999999999999999999999998765433
Q ss_pred ---CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccccc
Q 041491 372 ---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDTS 442 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~ 442 (467)
...++..|.+||...+..++.++||||+|+++|||++|+.||......+. ..... ...+++.+.+++.+|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRISRVEFTFPDFVTEGARDLISRL 241 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence 23456778999999999999999999999999999999999976432211 11111 122345588999999
Q ss_pred cccchhHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCV 458 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~ 458 (467)
|..+|.+|++ +.|++
T Consensus 242 l~~~p~~Rps-~~e~l 256 (279)
T 3fdn_A 242 LKHNPSQRPM-LREVL 256 (279)
T ss_dssp CCSSGGGSCC-HHHHH
T ss_pred hccChhhCCC-HHHHh
Confidence 9999999975 33433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=327.24 Aligned_cols=232 Identities=19% Similarity=0.256 Sum_probs=187.5
Q ss_pred ccCccC-CccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHH-cCCCCCceeEEEEeec----CCeee
Q 041491 218 DHFSEK-SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLK-SVRHRNLVKIISSCSN----GNFEA 290 (467)
Q Consensus 218 ~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~----~~~~~ 290 (467)
++|.+. +.||+|+||.||+|.+. +++.||+|+++.. ..+.+|+.++. ..+||||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 466665 68999999999999986 4899999998632 45678888874 4589999999998865 56789
Q ss_pred EEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEeccccce
Q 041491 291 LVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIAK 366 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~ 366 (467)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999997653 36899999999999999999999 999999999999999987 7899999999998
Q ss_pred ecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHHh-----------h
Q 041491 367 LLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWVN-----------D 429 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~~-----------~ 429 (467)
...... ..++..|.+||++.++.++.++|||||||++|||++|+.||........ .....+. .
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 292 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292 (400)
T ss_dssp ECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred ccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence 765432 3457779999999999999999999999999999999999976432221 1212211 2
Q ss_pred hcccccccccccccccchhHHHHHHHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.+++++.++|.+||..||.+|++ +.|++
T Consensus 293 ~~s~~~~~li~~~L~~dP~~Rpt-~~eil 320 (400)
T 1nxk_A 293 EVSEEVKMLIRNLLKTEPTQRMT-ITEFM 320 (400)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCC-HHHHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcC-HHHHh
Confidence 34556999999999999999985 44443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=312.62 Aligned_cols=233 Identities=22% Similarity=0.292 Sum_probs=197.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc------cchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999987 589999999875432 1357789999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC----cEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM----VAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a 365 (467)
++||||+++++|.+++... ..+++..+..++.|++.||.||| ++|++||||||+||+++.++ .+||+|||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999998543 46899999999999999999999 99999999999999998877 8999999999
Q ss_pred eecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHH----------HHhhhc
Q 041491 366 KLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN----------WVNDFL 431 (467)
Q Consensus 366 ~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~----------~~~~~~ 431 (467)
....... ..++..|.+||...+..++.++||||||+++|||++|+.||......+ .... -.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCCCHHHHTTC
T ss_pred eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHhcccCCcchhcccC
Confidence 8775432 245677899999998999999999999999999999999997643221 1111 122345
Q ss_pred ccccccccccccccchhHHHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
++.+.+++.+||..||.+|++..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~ 261 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIA 261 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHH
Confidence 56689999999999999998644
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=322.66 Aligned_cols=244 Identities=22% Similarity=0.340 Sum_probs=201.6
Q ss_pred HHHhccCccCCccCcccceeEEEEEec--------CCCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
....++|++.+.||+|+||.||+|++. ++..||+|+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345689999999999999999999873 367899999975432 3456788999999999 899999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSNG---------------ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
...+..++||||+++|+|.+++..... .+++..++.++.|++.||+||| ++||+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccce
Confidence 999999999999999999999875432 4889999999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
|+++.++.+||+|||+++...... ...+..|.+||...+..++.++||||||+++|||+| |+.||.+....+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 999999999999999998765432 223456899999888889999999999999999999 999997643222
Q ss_pred ccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 421 MNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 421 ~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
....+. ..++..+.+++.+|+..+|.+|+ ++.++++.|.+
T Consensus 268 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~ 315 (334)
T 2pvf_A 268 --LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 315 (334)
T ss_dssp --HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred --HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCc-CHHHHHHHHHH
Confidence 122221 22345689999999999999996 56666665544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=314.95 Aligned_cols=241 Identities=20% Similarity=0.310 Sum_probs=197.7
Q ss_pred HhccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
..++|++.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 45789999999999999999998753 3359999987653 23457789999999999999999999998754 468
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999776677999999999999999999999 99999999999999999999999999999987654
Q ss_pred CC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccc
Q 041491 371 KE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISV 435 (467)
Q Consensus 371 ~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 435 (467)
.. ...+..|.+||...+..++.++||||||+++|||+| |+.||......+ ...... ..+++.+
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l 243 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDRLPKPDLCPPVL 243 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCCCCCCTTCCHHH
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCCCCCCCCCCHHH
Confidence 32 223456899999988899999999999999999998 999997543322 222221 1234458
Q ss_pred ccccccccccchhHHHHHHHHHHHHHHh
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+++.+||..+|.+|+ ++.+++..|.+
T Consensus 244 ~~li~~~l~~~p~~Rp-s~~ell~~L~~ 270 (281)
T 3cc6_A 244 YTLMTRCWDYDPSDRP-RFTELVCSLSD 270 (281)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHccCCchhCc-CHHHHHHHHHH
Confidence 9999999999999996 55566555543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=323.57 Aligned_cols=231 Identities=23% Similarity=0.297 Sum_probs=188.5
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc-chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||.||+|++. +++.||+|++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999986 5899999998754322 223456799999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
++ |+|.+++......+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 97 5999988777778999999999999999999999 9999999999999999999999999999998665322
Q ss_pred --ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-----------------------
Q 041491 373 --SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----------------------- 426 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----------------------- 426 (467)
..++..|.+||...+ ..++.++||||+||++|||++|+.||.+....+. +...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHhchhhhcchhhcc
Confidence 235777899998765 5689999999999999999999999976432211 1000
Q ss_pred -------------HhhhcccccccccccccccchhHHHHH
Q 041491 427 -------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 -------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
....+++.+.+++.+||..||.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 276 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA 276 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH
Confidence 011234457899999999999999853
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=326.78 Aligned_cols=195 Identities=23% Similarity=0.343 Sum_probs=160.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCC-CCCceeEEEEeecCC--ee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGN--FE 289 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~ 289 (467)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.+++.+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999886 58999999986432 234567789999999997 999999999997544 78
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
|+||||++ ++|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 589998865 36899999999999999999999 9999999999999999999999999999998753
Q ss_pred C--------------------------CCccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 370 G--------------------------KESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 370 ~--------------------------~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
. ....++..|.|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 11246677899998876 67899999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.36 Aligned_cols=247 Identities=20% Similarity=0.235 Sum_probs=188.3
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEee------
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCS------ 284 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~------ 284 (467)
+.+...+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3445678999999999999999999986 58999999987665556678899999999996 999999999983
Q ss_pred --cCCeeeEEEecccCCCHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeecCCCcEE
Q 041491 285 --NGNFEALVLEYMANGSLEKCLYS--SNGILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 285 --~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~k 358 (467)
.....++||||+. |+|.+++.. ..+.+++..++.++.|++.||+||| ++| |+||||||+||+++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEE
Confidence 3446799999996 689888754 3457999999999999999999999 888 99999999999999999999
Q ss_pred EeccccceecCCCC-----------------ccccccccccccc---cCCCCCCcccchhhHHHHHHHhcCCCCCCcccc
Q 041491 359 LSDFGIAKLLNGKE-----------------SMRTQTLATIEYG---REGQVSPKSDVYGYGITLIETFTKKKPTCEIFC 418 (467)
Q Consensus 359 l~Dfg~a~~~~~~~-----------------~~~~~~~~~pe~~---~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~ 418 (467)
|+|||+++...... ..++..|.+||.. .+..++.++|||||||++|||+||+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765422 2256678999987 567788999999999999999999999976432
Q ss_pred ccccHHHH---HhhhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 419 EEMNLKNW---VNDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 419 ~~~~~~~~---~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.......+ .....+..+.+++.+||..||.+|+ ++.|+++.+.++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~e~l~~l~~~ 306 (337)
T 3ll6_A 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL-SIAEVVHQLQEI 306 (337)
T ss_dssp -------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHhhcCcccCCcccccchHHHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 21111111 1122334588999999999999997 677777776554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.70 Aligned_cols=243 Identities=21% Similarity=0.345 Sum_probs=198.0
Q ss_pred hccCccCCccCcccceeEEEEEe-----cCCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecC--Ce
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 288 (467)
.++|++.+.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|++++++++||||+++++++... +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45789999999999999999984 258899999997543 23457789999999999999999999999876 66
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++||||+++++|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999777678999999999999999999999 999999999999999999999999999999877
Q ss_pred CCCC--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccc----------ccccHHHH---H
Q 041491 369 NGKE--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFC----------EEMNLKNW---V 427 (467)
Q Consensus 369 ~~~~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~----------~~~~~~~~---~ 427 (467)
.... ..++..|.+||...+..++.++||||+|+++|||+||+.|+..... ........ .
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 6432 2344558999998888899999999999999999999998753211 11111111 1
Q ss_pred h--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 428 N--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 428 ~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
. ..+++.+.+++.+||..||.+|+ ++.++++.|.+
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~ 299 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT-SFQNLIEGFEA 299 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-CHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHH
Confidence 1 23445689999999999999995 55566655543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=333.36 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=195.7
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC--eeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--FEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 292 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4689999999999999999999875 8999999997543 234567889999999999999999999998655 77999
Q ss_pred EecccCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----cCCCcEEEeccccce
Q 041491 293 LEYMANGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHLSDFGIAK 366 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~ 366 (467)
|||+++|+|.+++..... .+++..++.++.|++.||+||| ++||+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999865432 3899999999999999999999 9999999999999999 777889999999998
Q ss_pred ecCCCC----ccccccccccccccC--------CCCCCcccchhhHHHHHHHhcCCCCCCccccccccH---HHHHh---
Q 041491 367 LLNGKE----SMRTQTLATIEYGRE--------GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL---KNWVN--- 428 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~~--------~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~---~~~~~--- 428 (467)
...... ..++..|.+||.... ..++.++|||||||++|||+||+.||.......... .....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 876533 235677889998754 567789999999999999999999996532222111 11111
Q ss_pred ----------------------------hhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 429 ----------------------------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 429 ----------------------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
..++..+.+++.+||..||++|+ ++.+++..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~-s~~e~l~~l~ 305 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW-GFDQFFAETS 305 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-CHHHHHHHHH
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc-cHHHHHHHHH
Confidence 12223477899999999999996 4455555543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=340.49 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=200.7
Q ss_pred HHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 211 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
+.+.+..++|++.+.||+|+||.||+|.+.++..||+|+++... ...+.+.+|++++++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34456678899999999999999999999888889999997653 345789999999999999999999999876 6689
Q ss_pred EEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 291 LVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
+||||+++|+|.+++.... ..+++.++..++.|++.||+||| ++||+||||||+|||+++++.+||+|||+++...
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999996532 35899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccc
Q 041491 370 GKE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPIS 434 (467)
Q Consensus 370 ~~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 434 (467)
... ...+..|.|||....+.++.++|||||||++|||+| |+.||.+....+ ....+. ..+|+.
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRMPCPPECPES 409 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCCTTSCHH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCHH
Confidence 322 123456899999988899999999999999999999 999997643322 122221 234456
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHh
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+.+++.+|+..+|++|+ ++.+++..|-+
T Consensus 410 l~~li~~cl~~dP~~Rp-t~~~l~~~L~~ 437 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERP-TFEYLQAFLED 437 (452)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHHHHHHT
T ss_pred HHHHHHHHccCChhhCc-CHHHHHHHHHH
Confidence 89999999999999996 45566655543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=315.69 Aligned_cols=233 Identities=27% Similarity=0.332 Sum_probs=191.8
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|.+.+.||+|+||.||+|++. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 368999999999999999999986 48999999997654 2345788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---cCCCcEEEeccccceec
Q 041491 295 YMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 295 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~ 368 (467)
|+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988543 357899999999999999999999 9999999999999999 45678999999999876
Q ss_pred CCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhcccccc
Q 041491 369 NGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVM 436 (467)
Q Consensus 369 ~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~ 436 (467)
... ...++..|.+||... +.++.++||||||+++|||++|+.||.+....+........ ..+++++.
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 543 234567789999875 56889999999999999999999999764332221111110 11345688
Q ss_pred cccccccccchhHHHHH
Q 041491 437 NVVDTSLLRREDKYFAA 453 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~ 453 (467)
+++.+||..||.+|++.
T Consensus 257 ~li~~~L~~dP~~Rps~ 273 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSA 273 (285)
T ss_dssp HHHHHHTCSCTTTSCCH
T ss_pred HHHHHHccCChhhCcCH
Confidence 99999999999999853
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=322.92 Aligned_cols=241 Identities=25% Similarity=0.370 Sum_probs=195.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCe----EEEEEeecc-cccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GME----VAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.++|++.+.||+|+||.||+|++.. ++. ||+|.+... .....+.+.+|+.++++++||||+++++++..++ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4689999999999999999998753 554 466666433 2345678999999999999999999999998765 68
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+|+||+++|+|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999887778999999999999999999999 99999999999999999999999999999987643
Q ss_pred CC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcccc
Q 041491 371 KE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 371 ~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
.. ...+..|.+||...+..++.++|||||||++|||++ |+.||......+ ....... ..+..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLPQPPICTID 247 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCCCCCTTBCHH
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCCCCccCCHH
Confidence 22 123456899999999999999999999999999999 999998653332 2233222 23445
Q ss_pred cccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+.+++.+||..||.+|+ ++.|+++.+.++
T Consensus 248 l~~li~~~l~~dp~~Rp-s~~ell~~L~~~ 276 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRP-KFRELIIEFSKM 276 (327)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCc-CHHHHHHHHHHH
Confidence 88999999999999995 566777766554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=321.29 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=205.2
Q ss_pred ccHHHHHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeE
Q 041491 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKI 279 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~ 279 (467)
+...++....++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 455667777899999999999999999999852 368899999976533 2346788999999999 69999999
Q ss_pred EEEeecCC-eeeEEEecccCCCHHHhhhcCCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 041491 280 ISSCSNGN-FEALVLEYMANGSLEKCLYSSNGI---------------LDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343 (467)
Q Consensus 280 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 343 (467)
++++...+ ..++||||+++++|.+++...... +++..+..++.|++.||.||| ++||+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99987654 589999999999999999765432 889999999999999999999 99999999
Q ss_pred CCCCCeeecCCCcEEEeccccceecCCCCc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCc
Q 041491 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCE 415 (467)
Q Consensus 344 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~ 415 (467)
|||+||+++.++.+||+|||+++....... .++..|.+||...+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654321 23456899999988899999999999999999998 9999976
Q ss_pred cccccccHHHHHh-------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 416 IFCEEMNLKNWVN-------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 416 ~~~~~~~~~~~~~-------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
....+........ ...++.+.+++.+||..+|.+|+ ++.+++..+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~ 307 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-TFSELVEHLGN 307 (316)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred cchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 4333222222211 22345689999999999999996 55555555543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.05 Aligned_cols=237 Identities=15% Similarity=0.149 Sum_probs=195.7
Q ss_pred hccCccCCccCcccceeEEEEEecC---------CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCcee---------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD---------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK--------- 278 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 278 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998864 789999998744 46889999999999999887
Q ss_pred ------EEEEeec-CCeeeEEEecccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 041491 279 ------IISSCSN-GNFEALVLEYMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVL 350 (467)
Q Consensus 279 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 350 (467)
+++++.. .+..++||||+ +++|.+++... ...+++.++..++.|++.||+||| ++||+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 6777765 77889999999 99999999765 357999999999999999999999 999999999999999
Q ss_pred ecCCC--cEEEeccccceecCCCC------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 351 LDDDM--VAHLSDFGIAKLLNGKE------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 351 l~~~~--~~kl~Dfg~a~~~~~~~------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
++.++ .+||+|||+++.+.... ..++..|.+||...+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 99999999998764321 24566789999998889999999999999999999999999875
Q ss_pred ccccccHHHHHh---h-------------hcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 417 FCEEMNLKNWVN---D-------------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 417 ~~~~~~~~~~~~---~-------------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
............ . .+++.+.+++.+||..||.+|++ +.++++.|.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~l~~~L~~ 333 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP-YAMLRNNLEA 333 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC-HHHHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC-HHHHHHHHHH
Confidence 423222222221 1 23566999999999999999964 6666665544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=317.51 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=195.0
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcC--CCCCceeEEEEeecC---
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV--RHRNLVKIISSCSNG--- 286 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~--- 286 (467)
.-....++|++.+.||+|+||.||+|++. ++.||+|++... ....+.+|.+++... +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445679999999999999999999885 899999998643 234455666666654 899999999999877
Q ss_pred -CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CceecCCCCCCeeecCCCcE
Q 041491 287 -NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN--------PVVHCDIKPSNVLLDDDMVA 357 (467)
Q Consensus 287 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~dlkp~NIll~~~~~~ 357 (467)
+..++||||+++|+|.+++... .+++..++.++.|++.||+||| ++ ||+||||||+||+++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7889999999999999999654 5899999999999999999999 77 99999999999999999999
Q ss_pred EEeccccceecCCCC---------ccccccccccccccCCCCCCc------ccchhhHHHHHHHhcC----------CCC
Q 041491 358 HLSDFGIAKLLNGKE---------SMRTQTLATIEYGREGQVSPK------SDVYGYGITLIETFTK----------KKP 412 (467)
Q Consensus 358 kl~Dfg~a~~~~~~~---------~~~~~~~~~pe~~~~~~~~~~------~Dv~slGvil~el~tg----------~~P 412 (467)
||+|||+++...... ..++..|.+||...+...+.+ +|||||||++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999998764322 246778899999887766665 9999999999999999 777
Q ss_pred CCccccccccHHHHHh-----------------hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 413 TCEIFCEEMNLKNWVN-----------------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 413 f~~~~~~~~~~~~~~~-----------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
|............... ...++.+.+++.+||..||.+|+ ++.++++.|.++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~l 329 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL-TALRVKKTLAKM 329 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC-CHHHHHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC-CHHHHHHHHHHH
Confidence 7654333333322211 12233478899999999999997 566777666554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=322.91 Aligned_cols=238 Identities=22% Similarity=0.285 Sum_probs=189.3
Q ss_pred HHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
....++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999876 589999999975432 23456779999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec-----CCCcEEEeccccc
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-----DDMVAHLSDFGIA 365 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-----~~~~~kl~Dfg~a 365 (467)
+||||+++ +|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++ .++.+||+|||++
T Consensus 110 lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999975 999988654 46899999999999999999999 99999999999999994 4556999999999
Q ss_pred eecCCCC-----ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccc------------------
Q 041491 366 KLLNGKE-----SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM------------------ 421 (467)
Q Consensus 366 ~~~~~~~-----~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~------------------ 421 (467)
+...... ..++..|.+||.+.+. .++.++|||||||++|||++|+.||......+.
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 8765322 2346778999988764 589999999999999999999999975422111
Q ss_pred -----------------cHHHHHhhhcccccccccccccccchhHHHHHHHHH
Q 041491 422 -----------------NLKNWVNDFLPISVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 422 -----------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
.+.......+++++.+++.+||..||.+|++ +.|+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~e~ 316 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS-AKNA 316 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC-HHHH
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC-HHHH
Confidence 1122233335566889999999999999985 3343
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.93 Aligned_cols=241 Identities=24% Similarity=0.403 Sum_probs=194.9
Q ss_pred HhccCccCCccCcccceeEEEEEecC-----CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
..++|++.+.||+|+||.||+|.+.. +..||+|+++.... .....+.+|+.++++++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34678888999999999999998753 23599999975532 3445788999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++++|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999877778999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcc
Q 041491 370 GKES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLP 432 (467)
Q Consensus 370 ~~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~ 432 (467)
.... ..+..|.+||......++.++||||||+++|||++ |+.||......+ ....+.. .++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCCCCCTTCB
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHCCCcCCCcccCC
Confidence 4321 22446899999988899999999999999999999 999997643221 2222211 234
Q ss_pred cccccccccccccchhHHHHHHHHHHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
+.+.+++.+||..+|.+|+ ++.+++..|.
T Consensus 277 ~~l~~li~~~l~~~p~~Rp-s~~~l~~~L~ 305 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRP-KFADIVSILD 305 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSC-CHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCc-CHHHHHHHHH
Confidence 5689999999999999996 3445544443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=325.70 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=206.6
Q ss_pred ccHHHHHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEE
Q 041491 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKII 280 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~ 280 (467)
+..+++.+..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344556677889999999999999999999865 267899999875432 3345688999999999999999999
Q ss_pred EEeecCCeeeEEEecccCCCHHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 041491 281 SSCSNGNFEALVLEYMANGSLEKCLYSSN---------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL 351 (467)
Q Consensus 281 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll 351 (467)
+++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence 99999999999999999999999986532 35689999999999999999999 9999999999999999
Q ss_pred cCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccH
Q 041491 352 DDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNL 423 (467)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~ 423 (467)
+.++.+||+|||+++...... ..++..|.+||...++.++.++||||||+++|||+| |+.||......+ .
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~ 249 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--V 249 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--H
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--H
Confidence 999999999999998654322 123456899999988889999999999999999999 899997643221 1
Q ss_pred HHHH-h-------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 424 KNWV-N-------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 424 ~~~~-~-------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
...+ . ..+++.+.+++.+||..+|.+|+ ++.+++..|.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~e~l~~L~~ 296 (322)
T 1p4o_A 250 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP-SFLEIISSIKE 296 (322)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHGG
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCc-CHHHHHHHHHH
Confidence 1221 1 23345688999999999999996 67777777654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=351.41 Aligned_cols=235 Identities=19% Similarity=0.222 Sum_probs=198.7
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 288 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 288 (467)
....++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 3456789999999999999999999864 8889999997542 33456788899999988 69999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||+++|+|.+++... +.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+..
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999998654 46899999999999999999999 999999999999999999999999999999864
Q ss_pred CCC-----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccc
Q 041491 369 NGK-----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMN 437 (467)
Q Consensus 369 ~~~-----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~ 437 (467)
... ...++..|.|||++....++.++|||||||++|||++|+.||.+....+ .+..... ..+++++.+
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~ 571 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNVAYPKSMSKEAVA 571 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHSSCCCCCTTSCHHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCCCCCCccCCHHHHH
Confidence 322 2346778999999999999999999999999999999999998643222 1222221 234556999
Q ss_pred ccccccccchhHHHHH
Q 041491 438 VVDTSLLRREDKYFAA 453 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~ 453 (467)
+|.++|.+||.+|++.
T Consensus 572 li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHHHSCSSSTTCTTC
T ss_pred HHHHHccCCHHHCCCC
Confidence 9999999999999865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.96 Aligned_cols=241 Identities=22% Similarity=0.373 Sum_probs=196.0
Q ss_pred cCccCCccCcccceeEEEEEecC-C---CeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCee-eEE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLD-G---MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE-ALV 292 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv 292 (467)
.|+..+.||+|+||.||+|.+.+ + ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667999999999999998753 2 3699999875433 3457788999999999999999999999866654 999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
|||+.+|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999876778999999999999999999999 999999999999999999999999999999865432
Q ss_pred --------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh--------hccccc
Q 041491 372 --------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND--------FLPISV 435 (467)
Q Consensus 372 --------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~--------~~~~~~ 435 (467)
....+..|.+||...+..++.++||||||+++|||+||..|+...... ......... .+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCCCCCCccchHHH
Confidence 123456788999999999999999999999999999966665432222 223333222 234468
Q ss_pred ccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+++.+||..+|.+|+ ++.+++..+.++
T Consensus 258 ~~li~~~l~~~p~~Rp-s~~~ll~~l~~~ 285 (298)
T 3pls_A 258 YQVMQQCWEADPAVRP-TFRVLVGEVEQI 285 (298)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 9999999999999996 566666666543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.92 Aligned_cols=233 Identities=21% Similarity=0.285 Sum_probs=195.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|.+.+.||+|+||.||+|++. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 468999999999999999999986 5899999999865444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---cCCCcEEEeccccceecCCCC
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
+++++|.+++... +.+++..+..++.|++.||.||| ++||+||||||+||++ ++++.+||+|||++.......
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999999988543 46899999999999999999999 9999999999999999 788899999999998655432
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMNVV 439 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~i 439 (467)
..++..|.+||...+..++.++||||+|+++|||++|+.||......+ ....... ..+++.+.+++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 235677899999999999999999999999999999999997643221 1111111 23455689999
Q ss_pred ccccccchhHHHHHH
Q 041491 440 DTSLLRREDKYFAAK 454 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~ 454 (467)
.+||..||.+|++..
T Consensus 243 ~~~l~~dp~~Rps~~ 257 (304)
T 2jam_A 243 CHLLEKDPNERYTCE 257 (304)
T ss_dssp HHHHCSSTTTSCCHH
T ss_pred HHHcCCChhHCcCHH
Confidence 999999999998643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=315.09 Aligned_cols=240 Identities=21% Similarity=0.264 Sum_probs=193.3
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEe-ecCCeeeEEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC-SNGNFEALVL 293 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 293 (467)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+|+++++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3578999999999999999999974 58999999876543 235688999999999987766665554 6778889999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---cCCCcEEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 370 (467)
||+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||++ ++++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 99999999766678999999999999999999999 9999999999999999 7889999999999987654
Q ss_pred C------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHH----------
Q 041491 371 K------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNW---------- 426 (467)
Q Consensus 371 ~------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~---------- 426 (467)
. ...++..|.+||...+..++.++|||||||++|||++|+.||........ .....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 3 22457778999999998999999999999999999999999986432211 11111
Q ss_pred -HhhhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 427 -VNDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 427 -~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
....+|+.+.+++.+|+..+|++|+ ++.++++.+.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~l~~~l~ 276 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKP-DYSYLRQLFR 276 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCC-CHHHHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCC-CHHHHHHHHH
Confidence 1134466799999999999999996 3444444443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=337.22 Aligned_cols=193 Identities=22% Similarity=0.252 Sum_probs=164.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC------C
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------N 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 287 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999886 48999999997542 33456788999999999999999999999654 3
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|+.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 56999999976 46665532 4899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 368 LNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 368 ~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
..... ..++..|.|||.+.+..++.++||||+||++|||++|+.||.+.
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 76432 34677899999999999999999999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=312.79 Aligned_cols=232 Identities=25% Similarity=0.309 Sum_probs=197.5
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 4689999999999999999999864 7889999986542 22346788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
|||+++++|.+++... +.+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999998654 46899999999999999999999 999999999999999999999999999999766542
Q ss_pred --CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccccccccc
Q 041491 372 --ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSL 443 (467)
Q Consensus 372 --~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l 443 (467)
...++..|.+||...+..++.++||||||+++|||++|+.||......+ ....... ..+++.+.+++.+||
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNVDLKFPPFLSDGSKDLISKLL 247 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCCCTTSCHHHHHHHHHHS
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHhccccCCCCcCCHHHHHHHHHHh
Confidence 2345778899999999999999999999999999999999997643222 1111111 234556899999999
Q ss_pred ccchhHHHHH
Q 041491 444 LRREDKYFAA 453 (467)
Q Consensus 444 ~~~~~~r~~~ 453 (467)
..||.+|++.
T Consensus 248 ~~~p~~Rps~ 257 (284)
T 2vgo_A 248 RYHPPQRLPL 257 (284)
T ss_dssp CSSGGGSCCH
T ss_pred hcCHhhCCCH
Confidence 9999999853
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=324.89 Aligned_cols=233 Identities=23% Similarity=0.301 Sum_probs=190.7
Q ss_pred HhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccc--cchHHHHHHHHHHHcCCC--CCceeEEEEeecCCeeeE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRH--RNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~l 291 (467)
..++|++.+.||+|+||.||+|.+.+++.||+|++..... ...+.+.+|+.++++++| |||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3568999999999999999999998899999999975432 334678899999999986 999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||| +.+++|.+++... ..+++.++..++.|++.||+||| ++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 87 v~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999 5688999999654 56899999999999999999999 99999999999999997 578999999999876533
Q ss_pred C-------ccccccccccccccC-----------CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhh---
Q 041491 372 E-------SMRTQTLATIEYGRE-----------GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDF--- 430 (467)
Q Consensus 372 ~-------~~~~~~~~~pe~~~~-----------~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~--- 430 (467)
. ..++..|.+||+..+ ..++.++|||||||++|||++|+.||.........+.......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 2 246778899998754 6788999999999999999999999976433222222322211
Q ss_pred -----cccccccccccccccchhHHHHHH
Q 041491 431 -----LPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 431 -----~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.+..+.+++.+||..||.+|++..
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 269 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIP 269 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 123488999999999999998543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=314.12 Aligned_cols=239 Identities=21% Similarity=0.246 Sum_probs=196.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEE-eecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISS-CSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+.+++.++|++++..+.+ ....+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 468999999999999999999974 58999999987543 23568899999999998876655554 467788899999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---cCCCcEEEeccccceecCCC
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||++ ++++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 89999999766678999999999999999999999 9999999999999999 48889999999999876543
Q ss_pred C------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc--ccHHHH-----------
Q 041491 372 E------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE--MNLKNW----------- 426 (467)
Q Consensus 372 ~------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~--~~~~~~----------- 426 (467)
. ..++..|.+||...+..++.++|||||||++|||++|+.||....... ..+...
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 2 245677899999999999999999999999999999999998643221 111111
Q ss_pred HhhhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 427 VNDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 427 ~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
....+|+.+.+++.+||..||.+|+ ++.++++.+.
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~l~~~l~ 276 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKP-DYSYLRQLFR 276 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCC-CHHHHHHHHH
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCC-CHHHHHHHHH
Confidence 1134566799999999999999996 4455555443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=315.17 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=196.1
Q ss_pred hccCccCCccCcccceeEEEEEecC----CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEe-ecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC-SNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~ 290 (467)
..+|++.+.||+|+||.||+|.+.+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578899999999999999998753 23589998875432 3456789999999999999999999985 4566889
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999877778899999999999999999999 99999999999999999999999999999986643
Q ss_pred CC---------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-------hhhccc
Q 041491 371 KE---------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-------NDFLPI 433 (467)
Q Consensus 371 ~~---------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-------~~~~~~ 433 (467)
.. ..++..|.+||...+..++.++||||+|+++|||++ |.+||......+ ...... ...+++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHHTTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHhcCCCCCCCccCCH
Confidence 22 223456889999988899999999999999999999 555665432222 111121 122345
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+.+++.+||..+|.+|+ ++.++++.|.+
T Consensus 260 ~l~~li~~~l~~~p~~Rp-s~~ell~~L~~ 288 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRP-SFSELVSRISA 288 (298)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 689999999999999995 56666666554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.67 Aligned_cols=187 Identities=24% Similarity=0.351 Sum_probs=153.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec-----CCe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-----GNF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 288 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+++.+|+++++.++||||+++++++.. .+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999886 58999999986543 2345678899999999999999999999843 357
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||+ +++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 5699998854 457999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCC--------------------------------ccccccccccccc-cCCCCCCcccchhhHHHHHHHhc
Q 041491 369 NGKE--------------------------------SMRTQTLATIEYG-REGQVSPKSDVYGYGITLIETFT 408 (467)
Q Consensus 369 ~~~~--------------------------------~~~~~~~~~pe~~-~~~~~~~~~Dv~slGvil~el~t 408 (467)
.... ..++..|.|||++ ....++.++|||||||++|||+|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 4221 1346678999975 56779999999999999999999
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=325.07 Aligned_cols=231 Identities=23% Similarity=0.333 Sum_probs=191.0
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 293 (467)
..++|++.+.||+|+||.||+|.++ +++.||+|+++.... ...+|++++.++ +||||+++++++.+.+..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3578999999999999999999986 489999999975532 345788888887 7999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC----CcEEEeccccceecC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD----MVAHLSDFGIAKLLN 369 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~~~ 369 (467)
||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||++.++ +.+||+|||+++...
T Consensus 96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999998854 456899999999999999999999 9999999999999998443 359999999998765
Q ss_pred CCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc-ccHHHHH-----------hhhcc
Q 041491 370 GKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE-MNLKNWV-----------NDFLP 432 (467)
Q Consensus 370 ~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~-~~~~~~~-----------~~~~~ 432 (467)
... ..++..|.|||...+..++.++|||||||++|||++|+.||.....+. ..+.... +..++
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 432 235677889998887778999999999999999999999997532111 1111111 12355
Q ss_pred cccccccccccccchhHHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
+.+.+++.+||..||.+|++..
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~ 273 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAA 273 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHHHHHHCCCChhHCcCHH
Confidence 6689999999999999998644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=328.19 Aligned_cols=241 Identities=23% Similarity=0.377 Sum_probs=190.6
Q ss_pred ccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEee-cCCeeeE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCS-NGNFEAL 291 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l 291 (467)
..|++.+.||+|+||.||+|.+.+ +..||+|.++... ....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 357778999999999999998743 2468999986543 234578899999999999999999999865 4567899
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999877777899999999999999999999 999999999999999999999999999999866432
Q ss_pred C---------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccc
Q 041491 372 E---------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPI 433 (467)
Q Consensus 372 ~---------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~ 433 (467)
. ...+..|.+||...+..++.++|||||||++|||+| |.+||...... ....... ..+++
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~~~~~p~~~~~ 323 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRLLQPEYCPD 323 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCH
Confidence 1 223456899999988999999999999999999999 67778654322 2222222 22455
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+.+++.+|+..+|++|+ ++.++++.|.++
T Consensus 324 ~l~~li~~cl~~dp~~RP-s~~ell~~L~~i 353 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRP-SFSELVSRISAI 353 (373)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 689999999999999996 566666666543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=325.51 Aligned_cols=238 Identities=21% Similarity=0.265 Sum_probs=193.9
Q ss_pred hccCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc----ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCC
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGN 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 287 (467)
.++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999883 58999999986532 23345677899999999 6999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..++||||+++++|.+++... ..+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999998654 46899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCC------ccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHHHHh-------hh
Q 041491 368 LNGKE------SMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKNWVN-------DF 430 (467)
Q Consensus 368 ~~~~~------~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~~~~-------~~ 430 (467)
..... ..++..|.+||+..+ ..++.++|||||||++|||+||+.||........ .+..... ..
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence 64322 245777899998875 4478999999999999999999999975322211 1111111 12
Q ss_pred cccccccccccccccchhHHHH----HHHHHH
Q 041491 431 LPISVMNVVDTSLLRREDKYFA----AKKQCV 458 (467)
Q Consensus 431 ~~~~~~~~i~~~l~~~~~~r~~----~~~~~~ 458 (467)
++..+.+++.+||..||.+|++ +++|++
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell 320 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 320 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH
Confidence 3345789999999999999983 455554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.41 Aligned_cols=233 Identities=22% Similarity=0.304 Sum_probs=193.7
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
..++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 35789999999999999999999864 89999999987666667889999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC-----
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN----- 369 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~----- 369 (467)
|+++++|.+++......+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 99999999998776677999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCccccccccccccc-----cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------hhhccccc
Q 041491 370 GKESMRTQTLATIEYG-----REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------NDFLPISV 435 (467)
Q Consensus 370 ~~~~~~~~~~~~pe~~-----~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~ 435 (467)
.....++..|.+||.. ....++.++||||||+++|||++|+.||....... ...... ...++..+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCcccCCccccCHHH
Confidence 2233467788999987 46778999999999999999999999997643222 111221 12334458
Q ss_pred ccccccccccchhHHHH
Q 041491 436 MNVVDTSLLRREDKYFA 452 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~ 452 (467)
.+++.+||..||.+|++
T Consensus 253 ~~li~~~l~~dp~~Rps 269 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPS 269 (302)
T ss_dssp HHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHcccChhhCCC
Confidence 89999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=314.85 Aligned_cols=233 Identities=26% Similarity=0.309 Sum_probs=193.4
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
...++|++.+.||+|+||.||+|.+.. |+.||+|++.... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 356789999999999999999999864 8999999987543 3467899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++++|.+++......+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999998766668999999999999999999999 999999999999999999999999999999876543
Q ss_pred ---CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------hhhccccccccc
Q 041491 372 ---ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------NDFLPISVMNVV 439 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~i 439 (467)
...++..|.+||...+..++.++||||||+++|||++|+.||......... .... ...+++.+.+++
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-FMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcCCCcccCCcccCCHHHHHHH
Confidence 224566789999999889999999999999999999999999764322111 0110 123455689999
Q ss_pred ccccccchhHHHHH
Q 041491 440 DTSLLRREDKYFAA 453 (467)
Q Consensus 440 ~~~l~~~~~~r~~~ 453 (467)
.+||..||.+|++.
T Consensus 260 ~~~l~~dp~~Rpt~ 273 (314)
T 3com_A 260 KQCLVKSPEQRATA 273 (314)
T ss_dssp HHHTCSCTTTSCCH
T ss_pred HHHccCChhhCcCH
Confidence 99999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.60 Aligned_cols=234 Identities=24% Similarity=0.303 Sum_probs=198.1
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3568999999999999999999986 58999999996542 2345778999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---cCCCcEEEeccccceec
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~ 368 (467)
||||+.+|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||+++..
T Consensus 104 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999998854 356899999999999999999999 9999999999999999 56789999999999877
Q ss_pred CCCCc----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------hhhcccc
Q 041491 369 NGKES----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------NDFLPIS 434 (467)
Q Consensus 369 ~~~~~----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------~~~~~~~ 434 (467)
..... .++..|.|||.+.+ .++.++||||+||++|+|++|+.||.+....+ .+.... +..+++.
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCSGGGGGSCHH
T ss_pred ccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCCCcccccCCHH
Confidence 65432 46778899998765 68999999999999999999999997643221 111111 1234566
Q ss_pred cccccccccccchhHHHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~ 455 (467)
+.+++.+||..+|.+|+++.+
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e 278 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARD 278 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHCCCChhHCcCHHH
Confidence 899999999999999986543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=323.32 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=202.8
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC-C-----CeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD-G-----MEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
++....++|++.+.||+|+||.||+|.+.. + ..||+|++..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455667899999999999999999998753 2 4799999975532 3456788999999999 899999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSS-------------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVL 350 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 350 (467)
...+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence 9999999999999999999998643 235789999999999999999999 999999999999999
Q ss_pred ecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccccc
Q 041491 351 LDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMN 422 (467)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~ 422 (467)
++.++.+||+|||+++...... ..++..|.+||...+..++.++|||||||++|||+| |..||.+..... .
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~ 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-K 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-H
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-H
Confidence 9999999999999998664322 223456899999888899999999999999999999 999997643322 1
Q ss_pred HHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 423 LKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 423 ~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
....... ..++.+.+++.+||..+|.+|+ ++.+++..|.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~l~~~L~~ 323 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP-TFQQICSFLQE 323 (333)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCc-CHHHHHHHHHH
Confidence 2222222 2344588999999999999996 55566655544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=330.08 Aligned_cols=193 Identities=23% Similarity=0.333 Sum_probs=165.5
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC-----Ce
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 288 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+++.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999864 8899999997543 23456788999999999999999999999766 57
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||++ ++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|+..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999986 599998854 456899999999999999999999 999999999999999999999999999999876
Q ss_pred CCC---------------------------Cccccccccccccc-cCCCCCCcccchhhHHHHHHHhcCCCCCC
Q 041491 369 NGK---------------------------ESMRTQTLATIEYG-REGQVSPKSDVYGYGITLIETFTKKKPTC 414 (467)
Q Consensus 369 ~~~---------------------------~~~~~~~~~~pe~~-~~~~~~~~~Dv~slGvil~el~tg~~Pf~ 414 (467)
... ...++..|.|||.+ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 532 22356778999975 56779999999999999999998655543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.43 Aligned_cols=234 Identities=23% Similarity=0.299 Sum_probs=188.5
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-----cchHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-----GALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
...++|++.+.||+|+||.||+|++. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999986 489999999875322 123568899999999999999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++||||+++ +|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999986 899888776667899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCC-----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----------------
Q 041491 369 NGKE-----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---------------- 426 (467)
Q Consensus 369 ~~~~-----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---------------- 426 (467)
.... ..++..|.+||...+ ..++.++|||||||++|||++|.+||.+....+. +...
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTT
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhhhc
Confidence 5332 345677899998865 4588999999999999999999999976432211 1111
Q ss_pred ------------------HhhhcccccccccccccccchhHHHHH
Q 041491 427 ------------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 ------------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.....++.+.+++.+||..||.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 286 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 286 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH
Confidence 112334568889999999999999853
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.74 Aligned_cols=247 Identities=21% Similarity=0.361 Sum_probs=193.2
Q ss_pred HHHHHHhccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEee
Q 041491 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCS 284 (467)
Q Consensus 211 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 284 (467)
.++.+..++|.+.+.||+|+||.||+|.+.. ++.||+|+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3445567899999999999999999998753 4579999987543 234467889999999999999999999997
Q ss_pred cCC-----eeeEEEecccCCCHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC
Q 041491 285 NGN-----FEALVLEYMANGSLEKCLYS-----SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354 (467)
Q Consensus 285 ~~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 354 (467)
..+ ..++||||+++++|.+++.. ....+++..++.++.|++.||.||| ++||+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence 655 34999999999999998843 3346899999999999999999999 9999999999999999999
Q ss_pred CcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHH
Q 041491 355 MVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNW 426 (467)
Q Consensus 355 ~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~ 426 (467)
+.+||+|||+++...... ...+..|.+||...+..++.++||||||+++|||++ |..||......+ ....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~ 261 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDY 261 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHH
Confidence 999999999998764332 223456889999988999999999999999999999 899997643322 2222
Q ss_pred Hh--------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 427 VN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 427 ~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.. ..+++.+.+++.+||..+|.+|+ ++.+++..|.+
T Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~l~~~L~~ 305 (313)
T 3brb_A 262 LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRP-TFSVLRLQLEK 305 (313)
T ss_dssp HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHcCCCCCCCccccHHHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 21 22345689999999999999996 55666665544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.33 Aligned_cols=242 Identities=25% Similarity=0.385 Sum_probs=197.2
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCe--EEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GME--VAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 291 (467)
.++|++.+.||+|+||.||+|++.. +.. +|+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 3689999999999999999998764 554 4999887532 33456789999999999 89999999999999999999
Q ss_pred EEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc
Q 041491 292 VLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV 356 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 356 (467)
||||+++++|.+++.... ..+++..++.++.|++.||+||| ++||+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 999999999999986543 36899999999999999999999 999999999999999999999
Q ss_pred EEEeccccceecCC----CCccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh---
Q 041491 357 AHLSDFGIAKLLNG----KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--- 428 (467)
Q Consensus 357 ~kl~Dfg~a~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--- 428 (467)
+||+|||+++.... .....+..|.+||...+..++.++||||||+++|||+| |+.||......+ ......
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGY 258 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGGTC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHhhcCC
Confidence 99999999975432 12234556899999888889999999999999999998 999997643221 111111
Q ss_pred -----hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 429 -----DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 429 -----~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
..+++.+.+++.+||..+|.+|+ ++.+++..|.++
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~ 298 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERP-SFAQILVSLNRM 298 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 12345689999999999999996 566777666543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=330.60 Aligned_cols=234 Identities=24% Similarity=0.297 Sum_probs=188.3
Q ss_pred HHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--------ccchHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--------DGALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
...++|.+.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 346799999999999999999998864 8999999997542 1122458899999999999999999999865
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC---cEEEecc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---VAHLSDF 362 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Df 362 (467)
. ..++||||+++|+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+||
T Consensus 212 ~-~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 E-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp S-EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred C-ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 4 57899999999999998854 457899999999999999999999 99999999999999997544 5999999
Q ss_pred ccceecCCCC----cccccccccccccc---CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---------
Q 041491 363 GIAKLLNGKE----SMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------- 426 (467)
Q Consensus 363 g~a~~~~~~~----~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------- 426 (467)
|+++...... ..++..|.|||++. ...++.++|||||||++|||+||+.||....... .+...
T Consensus 287 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNFI 365 (419)
T ss_dssp STTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTCCCCC
T ss_pred ccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCCCCCC
Confidence 9998776432 24577889999875 3667889999999999999999999997643222 22222
Q ss_pred --HhhhcccccccccccccccchhHHHHHH
Q 041491 427 --VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 427 --~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
....+++.+.+++.+||..||.+|++..
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 395 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTE 395 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHH
Confidence 2234566799999999999999998643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=319.48 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=202.6
Q ss_pred HhccCccCCccCcccceeEEEEEe-----cCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC--e
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--F 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~ 288 (467)
..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 356799999999999999999984 258899999998766666678999999999999999999999987654 7
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++||||+++++|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 89999999999999999877778999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccc-------cc-------cHHHH
Q 041491 369 NGKES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE-------EM-------NLKNW 426 (467)
Q Consensus 369 ~~~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~-------~~-------~~~~~ 426 (467)
..... ..+..|.+||...+..++.++||||||+++|||+||..||.....+ .. .+.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 54321 2344589999988888899999999999999999999998643111 00 11112
Q ss_pred Hh--------hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 427 VN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 427 ~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+. ..+++++.+++.+||..+|.+|+ ++.+++..+-++
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~el~~~L~~l 320 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-SFRDLALRVDQI 320 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-CHHHHHHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 11 22445689999999999999997 566666666543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=315.82 Aligned_cols=231 Identities=19% Similarity=0.331 Sum_probs=191.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeec--CCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSN--GNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++. +++.||+|+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 468999999999999999999875 5899999998743 3467899999999997 9999999999987 6678999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceecCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGK 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 371 (467)
|||+++++|.+++. .+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999874 3789999999999999999999 99999999999999999777 8999999999876543
Q ss_pred C----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccH------------HHHHh------
Q 041491 372 E----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL------------KNWVN------ 428 (467)
Q Consensus 372 ~----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~------------~~~~~------ 428 (467)
. ..++..|.+||...+ ..++.++|||||||++|||++|+.||.........+ .++..
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2 345667899998876 678999999999999999999999995432211111 11111
Q ss_pred -------------------------hhcccccccccccccccchhHHHHHHHHHH
Q 041491 429 -------------------------DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 429 -------------------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+++.+.+++.+||..||.+|++ +.|++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~e~l 318 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-AREAM 318 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC-HHHHH
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC-HHHHh
Confidence 114566889999999999999985 33443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.62 Aligned_cols=242 Identities=20% Similarity=0.237 Sum_probs=193.8
Q ss_pred ccHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccccc-----------chHHHHHHHHHHHcCCCCCc
Q 041491 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-----------ALKSFDAECEVLKSVRHRNL 276 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni 276 (467)
....++....++|++.+.||+|+||.||+|.+.+|+.||+|++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4467788889999999999999999999999888999999998643221 13678999999999999999
Q ss_pred eeEEEEeec-----CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 041491 277 VKIISSCSN-----GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL 351 (467)
Q Consensus 277 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll 351 (467)
+++++++.. ....++||||++ |+|.+++......+++..+..++.|++.||.||| ++||+||||||+||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 999999843 346899999997 5888888777678999999999999999999999 9999999999999999
Q ss_pred cCCCcEEEeccccceecCCCC----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc-----
Q 041491 352 DDDMVAHLSDFGIAKLLNGKE----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----- 421 (467)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----- 421 (467)
+.++.+||+|||+++...... ..++..|.+||...+ ..++.++||||+||++|||++|+.||......+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999998654322 245667899998776 6789999999999999999999999976421110
Q ss_pred ------cHH-----------HH---------------HhhhcccccccccccccccchhHHHHH
Q 041491 422 ------NLK-----------NW---------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 422 ------~~~-----------~~---------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
... ++ .....++.+.+++.+||..||.+|++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 000 00 111234458899999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=325.86 Aligned_cols=231 Identities=23% Similarity=0.304 Sum_probs=189.6
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCC--CCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVR--HRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ....+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45699999999999999999998889999999997543 234577899999999996 59999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK- 371 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 371 (467)
|| +.+++|.+++... ..+++.++..++.|++.||.||| ++||+||||||+|||++ ++.+||+|||+++.+...
T Consensus 135 ~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99 5688999998654 47899999999999999999999 99999999999999996 579999999999876532
Q ss_pred ------CccccccccccccccC-----------CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhh----
Q 041491 372 ------ESMRTQTLATIEYGRE-----------GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDF---- 430 (467)
Q Consensus 372 ------~~~~~~~~~~pe~~~~-----------~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~---- 430 (467)
...++..|.|||++.+ ..++.++|||||||++|||++|+.||.........+.......
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 2346778999998754 4688999999999999999999999976432222222222211
Q ss_pred ----cccccccccccccccchhHHHHH
Q 041491 431 ----LPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 431 ----~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.+..+.+++.+||..||.+|++.
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~ 315 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISI 315 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCccchHHHHHHHHHHcccChhhCCCH
Confidence 12348899999999999999853
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=317.17 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=198.0
Q ss_pred HHHHHhccCccCC-ccCcccceeEEEEEec---CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeec
Q 041491 212 ELLLATDHFSEKS-LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSN 285 (467)
Q Consensus 212 ~~~~~~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 285 (467)
++....++|.+.+ .||+|+||.||+|.+. .++.||+|+++.... ...+.+.+|++++++++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3444567888888 9999999999999653 368899999975532 2356789999999999999999999999 5
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
.+..++||||+++++|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 56779999999999999999654 46899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------
Q 041491 366 KLLNGKES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-------- 428 (467)
Q Consensus 366 ~~~~~~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-------- 428 (467)
........ ..+..|.+||......++.++||||||+++|||+| |+.||......+ ....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~ 242 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCP 242 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCCCCC
Confidence 87754332 12356899999888888999999999999999999 999997643322 222222
Q ss_pred hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..+++.+.+++.+||..||.+|+ ++.++++.|-+
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rp-s~~~l~~~L~~ 276 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRP-GFAAVELRLRN 276 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSC-CHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 23455699999999999999996 45555555543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=318.52 Aligned_cols=232 Identities=26% Similarity=0.314 Sum_probs=190.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccccc--chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG--ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4689999999999999999999865 899999998654322 3456789999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||+++++|.++.. ....+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999988764 3456899999999999999999999 999999999999999999999999999999876532
Q ss_pred ---CccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---------------------
Q 041491 372 ---ESMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------------------- 426 (467)
Q Consensus 372 ---~~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------------------- 426 (467)
...++..|.+||...+. .++.++||||+||++|||++|+.||......+. +...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcccc
Confidence 23456778999988765 789999999999999999999999976432211 1000
Q ss_pred ----------------HhhhcccccccccccccccchhHHHHH
Q 041491 427 ----------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 ----------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
....+++.+.+++.+||..||.+|++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 301 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC 301 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH
Confidence 112345568899999999999999753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=318.17 Aligned_cols=239 Identities=23% Similarity=0.321 Sum_probs=196.2
Q ss_pred cCccCCccCcccceeEEEEEec-----CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeec--CCeee
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFEA 290 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 290 (467)
.|++.+.||+|+||.||++.+. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+ ....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3499999999999999998653 478899999976532 345678999999999999999999999987 46789
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+++++|.+++... .+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999998654 4899999999999999999999 99999999999999999999999999999998764
Q ss_pred CC--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc----------c---cHHHHHh-
Q 041491 371 KE--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE----------M---NLKNWVN- 428 (467)
Q Consensus 371 ~~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~----------~---~~~~~~~- 428 (467)
.. ..++..|.+||...+..++.++||||||+++|||+||+.||....... . .......
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 32 124455899999988889999999999999999999999997532211 0 1111111
Q ss_pred -------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 429 -------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 429 -------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..+++.+.+++.+||..||.+|+ ++.++++.|.+
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~ 307 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRP-TFENLIPILKT 307 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCc-CHHHHHHHHHH
Confidence 12445689999999999999996 55566655544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=334.53 Aligned_cols=233 Identities=22% Similarity=0.281 Sum_probs=195.9
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3468999999999999999999986 58999999996542 23457789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec---CCCcEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---DDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~ 369 (467)
|||+++|+|.+.+... +.+++..+..++.|++.||.||| ++||+||||||+||+++ .++.+||+|||+++...
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999988554 46899999999999999999999 99999999999999995 45679999999998765
Q ss_pred CCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------hhhccccc
Q 041491 370 GKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------NDFLPISV 435 (467)
Q Consensus 370 ~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------~~~~~~~~ 435 (467)
... ..++..|.|||.+.+ .++.++||||+||++|+|++|+.||.+....+ .+.... +..+++.+
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCcccCCCCHHH
Confidence 432 346778999998865 58999999999999999999999997643222 111111 12345568
Q ss_pred ccccccccccchhHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~ 454 (467)
.++|.+||..+|.+|+++.
T Consensus 254 ~~li~~~L~~dp~~R~t~~ 272 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITAT 272 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHHHcCCChhhCcCHH
Confidence 9999999999999998644
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=323.49 Aligned_cols=233 Identities=21% Similarity=0.296 Sum_probs=185.8
Q ss_pred HHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeec-------
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN------- 285 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------- 285 (467)
....++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 456789999999999999999999885 58999999986442 223479999999999999999999843
Q ss_pred -------------------------------CCeeeEEEecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHH
Q 041491 286 -------------------------------GNFEALVLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYL 331 (467)
Q Consensus 286 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L 331 (467)
....++||||+++ +|.+.+.. ....+++..+..++.|++.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999985 77776642 445799999999999999999999
Q ss_pred hcCCCCCceecCCCCCCeeec-CCCcEEEeccccceecCCCC----ccccccccccccccCC-CCCCcccchhhHHHHHH
Q 041491 332 HFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKE----SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIE 405 (467)
Q Consensus 332 H~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~e 405 (467)
| ++||+||||||+||+++ .++.+||+|||+|+...... ..++..|.|||.+.+. .++.++||||+||++||
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 9 99999999999999998 68899999999999765432 3456678999987764 48999999999999999
Q ss_pred HhcCCCCCCccccccc----------------------------------cHHHHHhhhcccccccccccccccchhHHH
Q 041491 406 TFTKKKPTCEIFCEEM----------------------------------NLKNWVNDFLPISVMNVVDTSLLRREDKYF 451 (467)
Q Consensus 406 l~tg~~Pf~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~r~ 451 (467)
|++|+.||.+....+. ..........++.+.+++.+||..||.+|+
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999999976432211 011111222455688999999999999997
Q ss_pred HHH
Q 041491 452 AAK 454 (467)
Q Consensus 452 ~~~ 454 (467)
++.
T Consensus 315 t~~ 317 (383)
T 3eb0_A 315 NPY 317 (383)
T ss_dssp CHH
T ss_pred CHH
Confidence 544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=323.11 Aligned_cols=232 Identities=21% Similarity=0.267 Sum_probs=186.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCC------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 287 (467)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999985 589999999865432 23467889999999999999999999997653
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 459999999 8899999865 46899999999999999999999 99999999999999999999999999999998
Q ss_pred cCCC--CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc----------------------
Q 041491 368 LNGK--ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN---------------------- 422 (467)
Q Consensus 368 ~~~~--~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~---------------------- 422 (467)
.... ...++..|.|||.+.+ ..++.++||||+||++|||++|+.||.+....+..
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 6543 2346778899998876 67899999999999999999999999754221100
Q ss_pred HHHHHh--------------hhcccccccccccccccchhHHHHHH
Q 041491 423 LKNWVN--------------DFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 423 ~~~~~~--------------~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
...+.. ...++.+.+++.+||..||.+|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~ 303 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH
Confidence 001111 12244588999999999999998543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.73 Aligned_cols=233 Identities=14% Similarity=0.137 Sum_probs=183.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecc---cccchHHHHHHHH---HHHcCCCCCceeEE-------EE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ---FDGALKSFDAECE---VLKSVRHRNLVKII-------SS 282 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~ 282 (467)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999975 5999999999743 2334577889995 45556899999998 66
Q ss_pred eecCCe-----------------eeEEEecccCCCHHHhhhcCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 041491 283 CSNGNF-----------------EALVLEYMANGSLEKCLYSSNG------ILDIFQRLSIMIDVALALEYLHFGYSNPV 339 (467)
Q Consensus 283 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 339 (467)
+...+. .++||||+ +|+|.+++..... .+++..++.++.|++.||+||| ++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 665542 78999999 6799999865321 2335888899999999999999 9999
Q ss_pred eecCCCCCCeeecCCCcEEEeccccceecCCC--CccccccccccccccCC-----------CCCCcccchhhHHHHHHH
Q 041491 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--ESMRTQTLATIEYGREG-----------QVSPKSDVYGYGITLIET 406 (467)
Q Consensus 340 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~pe~~~~~-----------~~~~~~Dv~slGvil~el 406 (467)
+||||||+|||++.++.+||+|||+|+..... ...+ ..|.|||+..+. .++.++|||||||++|||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999999999999999999999975542 1234 778999998877 899999999999999999
Q ss_pred hcCCCCCCccccccccH-HHHHhhhcccccccccccccccchhHHHHHH
Q 041491 407 FTKKKPTCEIFCEEMNL-KNWVNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 407 ~tg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
+||+.||.......... .......+++.+.+++.+||..||.+|++..
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp HHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred HHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence 99999997643222110 0001135567799999999999999997543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=335.42 Aligned_cols=233 Identities=21% Similarity=0.310 Sum_probs=191.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.++|++.+.||+|+||.||+|++. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999986 58899999997543 234577899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC---CcEEEeccccceecCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD---MVAHLSDFGIAKLLNG 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~ 370 (467)
||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.. +.+||+|||++.....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999888544 46899999999999999999999 9999999999999999764 4599999999987754
Q ss_pred CC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------hhhcccccc
Q 041491 371 KE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------NDFLPISVM 436 (467)
Q Consensus 371 ~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------~~~~~~~~~ 436 (467)
.. ..++..|.|||.+. +.++.++||||+||++|+|++|+.||.+....+. +.... +..+++.+.
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCchhcccCCHHHH
Confidence 33 34677889999876 5689999999999999999999999976433221 11111 123455688
Q ss_pred cccccccccchhHHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~ 455 (467)
++|.+||..+|.+|+++.+
T Consensus 270 ~li~~~L~~dp~~R~s~~e 288 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQ 288 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHCCCChhhCccHHH
Confidence 9999999999999985443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=343.34 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=204.6
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.+.+++..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344556778899999999999999999999888889999997653 345789999999999999999999999876 678
Q ss_pred eEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 290 ALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999996532 35899999999999999999999 999999999999999999999999999999876
Q ss_pred CCC------CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccc
Q 041491 369 NGK------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPI 433 (467)
Q Consensus 369 ~~~------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~ 433 (467)
... ....+..|.+||.+..+.++.++|||||||++|||+| |+.||.+....+ ....+. ..+++
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRMPCPPECPE 491 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTCCCCCCTTCCH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCH
Confidence 532 2233456899999988899999999999999999999 999997643322 222221 23345
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+.+++.+||..||++|+ ++.+++..|.+
T Consensus 492 ~l~~li~~cl~~dP~~RP-t~~~l~~~L~~ 520 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERP-TFEYLQAFLED 520 (535)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCc-CHHHHHHHHHH
Confidence 689999999999999996 45566555543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.97 Aligned_cols=238 Identities=21% Similarity=0.328 Sum_probs=199.7
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeec---------
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN--------- 285 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 285 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3468999999999999999999986 69999999987543 456789999999999999999998854
Q ss_pred -------CCeeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcE
Q 041491 286 -------GNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVA 357 (467)
Q Consensus 286 -------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 357 (467)
....++||||+++++|.+++.... ..+++..++.++.|++.||.||| ++||+||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence 445799999999999999996543 46899999999999999999999 9999999999999999999999
Q ss_pred EEeccccceecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----h
Q 041491 358 HLSDFGIAKLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----D 429 (467)
Q Consensus 358 kl~Dfg~a~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----~ 429 (467)
||+|||++....... ..++..|.+||...+..++.++||||||+++|||++|..||..... ....... .
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~~ 238 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIISD 238 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---HHHHHHTTCCCT
T ss_pred EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---HHHHhhcccccc
Confidence 999999998775432 3456778999999888999999999999999999999999854211 1111111 2
Q ss_pred hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 430 FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+++.+.+++.+||..||.+|+ ++.|++..+..+
T Consensus 239 ~~~~~~~~li~~~l~~dp~~Rp-s~~e~l~~l~~~ 272 (284)
T 2a19_B 239 IFDKKEKTLLQKLLSKKPEDRP-NTSEILRTLTVW 272 (284)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 3455688999999999999997 677777776543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=312.31 Aligned_cols=231 Identities=19% Similarity=0.226 Sum_probs=196.2
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|.+.+.||+|+||.||+|.+.+ ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4689999999999999999999874 8899999987543 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++++|.+++... ..+++.++..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999988543 46899999999999999999999 9999999999999999999999999999998765322
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDT 441 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~ 441 (467)
..++..|.+||...+..++.++||||+|+++|||++|+.||......+ ....... ..+++.+.+++.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhccCCCccccCHHHHHHHHH
Confidence 235667899999988889999999999999999999999997643222 1112211 2234458899999
Q ss_pred ccccchhHHHH
Q 041491 442 SLLRREDKYFA 452 (467)
Q Consensus 442 ~l~~~~~~r~~ 452 (467)
||..||.+|++
T Consensus 249 ~l~~~p~~Rps 259 (294)
T 2rku_A 249 MLQTDPTARPT 259 (294)
T ss_dssp HTCSSGGGSCC
T ss_pred HcccChhhCcC
Confidence 99999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=334.80 Aligned_cols=235 Identities=21% Similarity=0.277 Sum_probs=195.0
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc-------------cchHHHHHHHHHHHcCCCCCceeEEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------------GALKSFDAECEVLKSVRHRNLVKIIS 281 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 281 (467)
..++|++.+.||+|+||.||+|++.. ++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999864 88999999975421 23467889999999999999999999
Q ss_pred EeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC---cEE
Q 041491 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM---VAH 358 (467)
Q Consensus 282 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~k 358 (467)
++.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999988554 46899999999999999999999 99999999999999998776 699
Q ss_pred EeccccceecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc---------HHH
Q 041491 359 LSDFGIAKLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN---------LKN 425 (467)
Q Consensus 359 l~Dfg~a~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~---------~~~ 425 (467)
|+|||++....... ..++..|.|||.+. +.++.++||||+||++|+|++|+.||.+....+.. ...
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 99999998876532 34677889999876 56899999999999999999999999764322210 001
Q ss_pred HHhhhcccccccccccccccchhHHHHHHH
Q 041491 426 WVNDFLPISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 426 ~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
-.+..+++++.+++.+||..||.+|++..+
T Consensus 269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 298 (504)
T 3q5i_A 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEE 298 (504)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cccCCCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 122446677999999999999999986443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.07 Aligned_cols=241 Identities=31% Similarity=0.384 Sum_probs=193.4
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecC-CeeeEEE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG-NFEALVL 293 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ 293 (467)
+..++|++.+.||+|+||.||+|++ +|+.||+|+++... ..+.+.+|++++++++||||+++++++... +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3467899999999999999999987 58899999987542 457789999999999999999999987544 5789999
Q ss_pred ecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
||+++++|.+++..... .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999865432 3789999999999999999999 9999999999999999999999999999998665432
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
...+..|.+||...+..++.++||||||+++|||+| |+.||...... .....+. ..+++.+.+++.+
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence 234566899999988899999999999999999998 99999764322 2222221 2345568999999
Q ss_pred ccccchhHHHHHHHHHHHHHHhc
Q 041491 442 SLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
|+..||.+|+ ++.++++.|-++
T Consensus 250 ~l~~~p~~Rp-s~~~l~~~L~~i 271 (278)
T 1byg_A 250 CWHLDAAMRP-SFLQLREQLEHI 271 (278)
T ss_dssp HTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HhcCChhhCC-CHHHHHHHHHHH
Confidence 9999999996 566666655443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=311.37 Aligned_cols=233 Identities=27% Similarity=0.342 Sum_probs=191.4
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEeccc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMA 297 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 297 (467)
+|.....||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555569999999999999985 488999999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEEEeccccceecCCC---
Q 041491 298 NGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 298 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~--- 371 (467)
+++|.+++....+ .+++..+..++.|++.||.||| ++|++||||||+||+++. ++.+||+|||++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999876543 4678899999999999999999 999999999999999987 889999999999876542
Q ss_pred --CccccccccccccccCCC--CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhccccccccc
Q 041491 372 --ESMRTQTLATIEYGREGQ--VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPISVMNVV 439 (467)
Q Consensus 372 --~~~~~~~~~~pe~~~~~~--~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~i 439 (467)
...++..|.+||...... ++.++||||||+++|||++|+.||.............. ...+++.+.+++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 234567789999876543 78999999999999999999999975432221111111 122345688999
Q ss_pred ccccccchhHHHHHH
Q 041491 440 DTSLLRREDKYFAAK 454 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~ 454 (467)
.+||..||++|++..
T Consensus 260 ~~~l~~dp~~Rps~~ 274 (295)
T 2clq_A 260 LKCFEPDPDKRACAN 274 (295)
T ss_dssp HHTTCSSTTTSCCHH
T ss_pred HHHccCChhhCCCHH
Confidence 999999999998543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=318.54 Aligned_cols=231 Identities=19% Similarity=0.226 Sum_probs=196.5
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|.+.+.||+|+||.||+|++.+ ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4689999999999999999999865 8899999987543 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++++|.+++... ..+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999988543 46899999999999999999999 9999999999999999999999999999998765322
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDT 441 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~ 441 (467)
..++..|.+||...+..++.++||||||+++|||++|+.||......+ ....... ..+++.+.+++.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 235667899999988889999999999999999999999997643222 1111111 2234458899999
Q ss_pred ccccchhHHHH
Q 041491 442 SLLRREDKYFA 452 (467)
Q Consensus 442 ~l~~~~~~r~~ 452 (467)
||..||.+|++
T Consensus 275 ~l~~dp~~Rps 285 (335)
T 2owb_A 275 MLQTDPTARPT 285 (335)
T ss_dssp HTCSSGGGSCC
T ss_pred HccCChhHCcC
Confidence 99999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=320.20 Aligned_cols=238 Identities=25% Similarity=0.309 Sum_probs=197.6
Q ss_pred HHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--------cchHHHHHHHHHHHcC-CCCCceeEE
Q 041491 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--------GALKSFDAECEVLKSV-RHRNLVKII 280 (467)
Q Consensus 211 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~ 280 (467)
.......++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999986 599999999975432 1245678999999999 799999999
Q ss_pred EEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEe
Q 041491 281 SSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLS 360 (467)
Q Consensus 281 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 360 (467)
+++...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999998643 46899999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCC----ccccccccccccccC------CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----
Q 041491 361 DFGIAKLLNGKE----SMRTQTLATIEYGRE------GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---- 426 (467)
Q Consensus 361 Dfg~a~~~~~~~----~~~~~~~~~pe~~~~------~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---- 426 (467)
|||++....... ..++..|.+||+..+ ..++.++|||||||++|||+||+.||....... .+...
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i~~~~ 321 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-MLRMIMEGQ 321 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC
Confidence 999998776432 346777899998753 358899999999999999999999997532211 11111
Q ss_pred ------HhhhcccccccccccccccchhHHHHH
Q 041491 427 ------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 ------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
.+...+..+.+++.+||..||.+|++.
T Consensus 322 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 354 (365)
T 2y7j_A 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTA 354 (365)
T ss_dssp CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCcccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 112345568999999999999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.63 Aligned_cols=234 Identities=27% Similarity=0.358 Sum_probs=198.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.+.|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 457999999999999999999875 58999999997553 3345788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+++++|.+++.. +.+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 9999999999854 46899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
..++..|.+||...+..++.++||||||+++|||++|+.||....... ...... ..++..+.+++.+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 245677899999999999999999999999999999999997643221 111111 1234458999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
||..+|.+|++ +.+++
T Consensus 254 ~l~~dp~~Rps-~~~ll 269 (303)
T 3a7i_A 254 CLNKEPSFRPT-AKELL 269 (303)
T ss_dssp HCCSSGGGSCC-HHHHT
T ss_pred HcCCChhhCcC-HHHHh
Confidence 99999999974 44443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.95 Aligned_cols=233 Identities=23% Similarity=0.318 Sum_probs=190.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeec--------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSN-------- 285 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 285 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|++..... .....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999985 589999999865432 234578899999999999999999999876
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
.+..++||||+++ +|.+.+......+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999975 787877776678999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCC---------CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---------
Q 041491 366 KLLNGK---------ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------- 426 (467)
Q Consensus 366 ~~~~~~---------~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------- 426 (467)
+..... ...++..|.|||...+ ..++.++|||||||++|||+||+.||.+....+. ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCh
Confidence 876522 1234667899998765 4579999999999999999999999976432211 0000
Q ss_pred -----------------------------HhhhcccccccccccccccchhHHHHHH
Q 041491 427 -----------------------------VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 427 -----------------------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.....++.+.+++.+||..||.+|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 307 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 307 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHH
Confidence 0001133477999999999999998543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=316.03 Aligned_cols=239 Identities=19% Similarity=0.245 Sum_probs=198.0
Q ss_pred HHHHHHHhccCccC-CccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCC-CCCceeEEEEee
Q 041491 210 YQELLLATDHFSEK-SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVR-HRNLVKIISSCS 284 (467)
Q Consensus 210 ~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 284 (467)
++......++|.+. +.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445567788887 89999999999999986 48999999997543 234577899999999995 699999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEe
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLS 360 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~ 360 (467)
+.+..++||||+++|+|.+++... ...+++.+++.++.|++.||+||| ++||+||||||+||+++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999988543 357899999999999999999999 999999999999999988 7899999
Q ss_pred ccccceecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------
Q 041491 361 DFGIAKLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------- 427 (467)
Q Consensus 361 Dfg~a~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------- 427 (467)
|||+++...... ..++..|.+||......++.++||||||+++|||++|+.||......+. .....
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVNVDYSEE 255 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCTT
T ss_pred eCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhcccccCch
Confidence 999998876432 3467789999999999999999999999999999999999976432221 11111
Q ss_pred -hhhcccccccccccccccchhHHHH
Q 041491 428 -NDFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 428 -~~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
...+++.+.+++.+||..||.+|++
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt 281 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPT 281 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcC
Confidence 1234455889999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.62 Aligned_cols=239 Identities=23% Similarity=0.305 Sum_probs=179.2
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.+.+..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 34566789999999999999999999875 58999999986543 23456788999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecc
Q 041491 290 ALVLEYMANGSLEKCLYS-------SNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
++||||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999998864 3456899999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCC----------CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-----
Q 041491 363 GIAKLLNGK----------ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----- 426 (467)
Q Consensus 363 g~a~~~~~~----------~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----- 426 (467)
|++...... ...++..|.+||.... ..++.++||||||+++|||++|+.||.............
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 998765432 1235667889998765 568999999999999999999999997643222111110
Q ss_pred ----------HhhhcccccccccccccccchhHHHHH
Q 041491 427 ----------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 ----------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
....+++.+.+++.+||..||.+|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 282 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA 282 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCH
Confidence 011234457889999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.63 Aligned_cols=242 Identities=23% Similarity=0.306 Sum_probs=192.4
Q ss_pred HhccCccCCccCcccceeEEEEEecC--CC--eEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD--GM--EVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
..++|++.+.||+|+||.||+|++.. ++ .||+|+++... ....+.+.+|++++++++||||+++++++...+
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 35689999999999999999998642 33 68999987542 234577899999999999999999999998765
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.++||||+++++|.+++......+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 78999999999999999776667999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhc
Q 041491 369 NGKES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFL 431 (467)
Q Consensus 369 ~~~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~ 431 (467)
..... ..+..|.+||...+..++.++||||||+++|||++ |+.||......+ ....... ..+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTSCCCCCCCTTC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-HHHHHHccCCCCCCCcCc
Confidence 54322 23446899999888888999999999999999999 999997643221 1111111 234
Q ss_pred ccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
++.+.+++.+||..+|.+|+ ++.++++.|.+
T Consensus 251 ~~~l~~li~~~l~~~p~~Rp-s~~~l~~~l~~ 281 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRP-TFVALRDFLLE 281 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCc-CHHHHHHHHHH
Confidence 55689999999999999996 56666665544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=311.24 Aligned_cols=234 Identities=23% Similarity=0.238 Sum_probs=181.3
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc--chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG--ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
..++|++.+.||+|+||.||+|++. +++.||+|+++..... ..+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999985 5899999999754322 223344555557888999999999999999999999
Q ss_pred EecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 293 LEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
|||+++ +|.+++.. ....+++..+..++.|++.||+||| ++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999975 88776643 4567999999999999999999999 87 9999999999999999999999999999876
Q ss_pred CCCC----ccccccccccccc----cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh--------hcc
Q 041491 369 NGKE----SMRTQTLATIEYG----REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND--------FLP 432 (467)
Q Consensus 369 ~~~~----~~~~~~~~~pe~~----~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~--------~~~ 432 (467)
.... ..++..|.+||.. ....++.++||||+|+++|||+||+.||................ .++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 5432 2466778999985 56678899999999999999999999997533333233333222 344
Q ss_pred cccccccccccccchhHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~ 453 (467)
+.+.+++.+||..||.+|++.
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~ 261 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTY 261 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHhhcChhhCcCH
Confidence 568899999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=311.66 Aligned_cols=230 Identities=20% Similarity=0.289 Sum_probs=192.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999986 59999999997643 23456788999999999 899999999999999999999
Q ss_pred EecccCCCHHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC---------------
Q 041491 293 LEYMANGSLEKCLYSSN---GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD--------------- 354 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--------------- 354 (467)
|||+++++|.+++.... ..+++..++.++.|++.||+||| ++||+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999986532 46899999999999999999999 9999999999999999844
Q ss_pred ----CcEEEeccccceecCCCC-ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh
Q 041491 355 ----MVAHLSDFGIAKLLNGKE-SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN 428 (467)
Q Consensus 355 ----~~~kl~Dfg~a~~~~~~~-~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~ 428 (467)
..+||+|||.+....... ..++..|.+||...+. .+++++|||||||++|||++|.+|+.... .......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~ 242 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHEIRQ 242 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHHHHHT
T ss_pred cCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHHHHHc
Confidence 479999999999876543 3467789999988765 56689999999999999999998775421 1122221
Q ss_pred -------hhcccccccccccccccchhHHHHH
Q 041491 429 -------DFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 429 -------~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..+++.+.+++.+||..||.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 274 (289)
T 1x8b_A 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSA 274 (289)
T ss_dssp TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCcccCHHHHHHHHHHhCCCcccCCCH
Confidence 2344569999999999999999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=307.89 Aligned_cols=234 Identities=24% Similarity=0.333 Sum_probs=191.5
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec----CCeee
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFEA 290 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 290 (467)
+.|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788899999999999999886 48899999987543 2345678899999999999999999998865 45689
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeec-CCCcEEEecccccee
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLD-DDMVAHLSDFGIAKL 367 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~ 367 (467)
+||||+++++|.+++... ..+++..+..++.|++.||.||| +++ |+||||||+||+++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999998653 46899999999999999999999 888 99999999999997 788999999999976
Q ss_pred cCCCC---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH--------hhhcccccc
Q 041491 368 LNGKE---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV--------NDFLPISVM 436 (467)
Q Consensus 368 ~~~~~---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~ 436 (467)
..... ..++..|.+||... +.++.++||||+|+++|||++|+.||.............. ....++.+.
T Consensus 182 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 182 KRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred ccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence 55433 23567789999876 4589999999999999999999999976432222222111 112234588
Q ss_pred cccccccccchhHHHHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~ 457 (467)
+++.+||..||.+|++ +.++
T Consensus 261 ~li~~~l~~dp~~Rps-~~el 280 (290)
T 1t4h_A 261 EIIEGCIRQNKDERYS-IKDL 280 (290)
T ss_dssp HHHHHHSCSSGGGSCC-HHHH
T ss_pred HHHHHHccCChhhCCC-HHHH
Confidence 9999999999999985 3343
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.82 Aligned_cols=233 Identities=24% Similarity=0.307 Sum_probs=191.1
Q ss_pred HhccCccCCccCcccceeEEEEEecC-CCeEEEEEeeccc--------ccchHHHHHHHHHHHcCCCCCceeEEEEeecC
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--------DGALKSFDAECEVLKSVRHRNLVKIISSCSNG 286 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 286 (467)
..++|++.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34689999999999999999999864 8899999986432 12234688999999999999999999998776
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc---EEEeccc
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV---AHLSDFG 363 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg 363 (467)
+ .++||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 7999999999999998854 457899999999999999999999 999999999999999987654 9999999
Q ss_pred cceecCCCC----ccccccccccccc---cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH----------
Q 041491 364 IAKLLNGKE----SMRTQTLATIEYG---REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---------- 426 (467)
Q Consensus 364 ~a~~~~~~~----~~~~~~~~~pe~~---~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---------- 426 (467)
+++...... ..++..|.+||.. ....++.++|||||||++|||++|+.||....... .+...
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNFIP 241 (322)
T ss_dssp TCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCCCCCH
T ss_pred cceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCccccCc
Confidence 999876543 2356778999986 35678999999999999999999999997643222 22222
Q ss_pred -HhhhcccccccccccccccchhHHHHHH
Q 041491 427 -VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 427 -~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
....+++.+.+++.+||..||.+|++..
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~ 270 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTE 270 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHH
Confidence 2234566789999999999999998543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=342.09 Aligned_cols=238 Identities=22% Similarity=0.362 Sum_probs=195.2
Q ss_pred ccCccCC-ccCcccceeEEEEEec---CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 218 DHFSEKS-LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 218 ~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999875 35679999997653 2356789999999999999999999999976 558999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999777678999999999999999999999 9999999999999999999999999999998765322
Q ss_pred c--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccc
Q 041491 373 S--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISV 435 (467)
Q Consensus 373 ~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 435 (467)
. ..+..|.|||++..+.++.++|||||||++|||+| |+.||.+....+ ....+. ..+++++
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~~~~p~~~~~~l 568 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRMECPPECPPEL 568 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTCCCCCCTTCCHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCCCCCcCCHHH
Confidence 1 12356899999988999999999999999999998 999998643322 222322 2345569
Q ss_pred ccccccccccchhHHHHHHHHHHHHHH
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
.+++.+|+..+|++|+ ++.++++.|-
T Consensus 569 ~~li~~cl~~dP~~RP-s~~~l~~~L~ 594 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRP-DFLTVEQRMR 594 (613)
T ss_dssp HHHHHHTTCSSTTTSC-CHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCc-CHHHHHHHHH
Confidence 9999999999999996 4555555443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.27 Aligned_cols=196 Identities=26% Similarity=0.363 Sum_probs=174.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999986 58999999997653 2345678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCCcEEEeccccceecCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG--- 370 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~--- 370 (467)
|+++++|.+++... +.+++..+..++.|++.||.||| ++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 187 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187 (360)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999998654 46899999999999999999999 75 999999999999999999999999999875432
Q ss_pred CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 371 KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 371 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
....++..|.+||...+..++.++|||||||++|||+||+.||...
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2335677899999999999999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.33 Aligned_cols=238 Identities=24% Similarity=0.314 Sum_probs=194.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEee--cCCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCS--NGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l 291 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999986 58999999997543 234567889999999999999999999874 4678899
Q ss_pred EEecccCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeeecCCCcEEEeccc
Q 041491 292 VLEYMANGSLEKCLYSS---NGILDIFQRLSIMIDVALALEYLHFGYSNP-----VVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
||||+++++|.+++... ...+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998643 235899999999999999999999 888 9999999999999999999999999
Q ss_pred cceecCCCCc-----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhc
Q 041491 364 IAKLLNGKES-----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFL 431 (467)
Q Consensus 364 ~a~~~~~~~~-----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~ 431 (467)
+++....... .++..|.+||...+..++.++||||||+++|||+||+.||......+. ...... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRRIPYRY 240 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCCTTS
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-HHHHhhcccccCCccc
Confidence 9987654432 356678999999888899999999999999999999999976432211 111111 123
Q ss_pred ccccccccccccccchhHHHHHHHHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
++++.+++.+||..+|.+|+ ++.|+++
T Consensus 241 ~~~l~~li~~~l~~~p~~Rp-s~~~ll~ 267 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRP-SVEEILE 267 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSC-CHHHHHT
T ss_pred CHHHHHHHHHHcCCCcccCC-CHHHHHh
Confidence 45689999999999999997 4555554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=307.60 Aligned_cols=235 Identities=26% Similarity=0.382 Sum_probs=192.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999986 58999999997542 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++++|.+++... +.+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999998654 46899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ----ccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhcccccccccc
Q 041491 373 ----SMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVD 440 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~ 440 (467)
..++..|.+||...+..+ +.++||||||+++|||++|+.||....... ..+... ..++..+.+++.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRGGVFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhcCcccCchhcCHHHHHHHH
Confidence 235667899999887765 689999999999999999999997643221 111111 223456899999
Q ss_pred cccccchhHHHHHHHHHH
Q 041491 441 TSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~ 458 (467)
+||..||.+|++. .+++
T Consensus 244 ~~l~~~p~~Rps~-~~~l 260 (276)
T 2h6d_A 244 HMLQVDPLKRATI-KDIR 260 (276)
T ss_dssp HHTCSSGGGSCCH-HHHH
T ss_pred HHccCChhhCCCH-HHHH
Confidence 9999999999754 3443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=326.45 Aligned_cols=236 Identities=20% Similarity=0.242 Sum_probs=196.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCC-CCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999975 589999998875432 3568899999999986 666677777788889999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---cCCCcEEEeccccceecCCC
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|+ +++|.+++......+++.+++.++.||+.||+||| ++||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 99999999876778999999999999999999999 9999999999999999 68889999999999876543
Q ss_pred ------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHH-----------HH
Q 041491 372 ------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLK-----------NW 426 (467)
Q Consensus 372 ------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~-----------~~ 426 (467)
...++..|.+||...+..++.++|||||||++|||++|+.||.+...... .+. ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 23456778999999999999999999999999999999999986432211 111 11
Q ss_pred HhhhcccccccccccccccchhHHHHHHHHHHH
Q 041491 427 VNDFLPISVMNVVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 427 ~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
....+++++.+++..|+..+|++|+ ++.++++
T Consensus 240 l~~~~p~~l~~li~~cl~~dP~~RP-s~~el~~ 271 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRFDDKP-DYSYLKR 271 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCTTCCC-CHHHHHH
T ss_pred HhcCCcHHHHHHHHHHhcCChhhCc-CHHHHHH
Confidence 2245677899999999999999995 3333333
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=318.11 Aligned_cols=240 Identities=25% Similarity=0.341 Sum_probs=193.1
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeec-
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSN- 285 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~- 285 (467)
++.++....++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33444456789999999999999999999985 58999999987543 3457789999999998 79999999999976
Q ss_pred -----CCeeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEE
Q 041491 286 -----GNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHL 359 (467)
Q Consensus 286 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 359 (467)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEE
Confidence 568899999999999999987643 46899999999999999999999 999999999999999999999999
Q ss_pred eccccceecCCC-----Ccccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-
Q 041491 360 SDFGIAKLLNGK-----ESMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN- 428 (467)
Q Consensus 360 ~Dfg~a~~~~~~-----~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~- 428 (467)
+|||++...... ...++..|.+||... +..++.++|||||||++|||+||+.||.+...... ......
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~ 249 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRN 249 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcC
Confidence 999999876532 224567789999876 56789999999999999999999999976432211 111111
Q ss_pred -------hhcccccccccccccccchhHHHHH
Q 041491 429 -------DFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 429 -------~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..+++.+.+++.+||..||.+|++.
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 281 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT 281 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCH
Confidence 2234568999999999999999853
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=314.61 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=197.0
Q ss_pred HHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 287 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 287 (467)
+..++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++...+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34678999999999999999999842 47789999986442 334567889999999999999999999999999
Q ss_pred eeeEEEecccCCCHHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEE
Q 041491 288 FEALVLEYMANGSLEKCLYSSN------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAH 358 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k 358 (467)
..++||||+++++|.+++.... ..+++..++.++.|++.||.||| ++||+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999997654 35889999999999999999999 999999999999999984 44699
Q ss_pred EeccccceecCCC-------CccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh-
Q 041491 359 LSDFGIAKLLNGK-------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND- 429 (467)
Q Consensus 359 l~Dfg~a~~~~~~-------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~- 429 (467)
|+|||++...... ...++..|.+||...+..++.++||||||+++|||+| |+.||...... .....+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~ 261 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSG 261 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTT
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhcC
Confidence 9999999754322 1234567899999988899999999999999999998 99999764322 22222221
Q ss_pred -------hcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 430 -------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 430 -------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+++.+.+++.+||..||.+|+ ++.++++.+-.
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~ 301 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRP-NFAIILERIEY 301 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCc-CHHHHHHHHHH
Confidence 3445688999999999999996 56666666543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=318.98 Aligned_cols=240 Identities=25% Similarity=0.365 Sum_probs=185.2
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHH--HHcCCCCCceeEEEEee-----cCC
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIISSCS-----NGN 287 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~-----~~~ 287 (467)
+..++|++.+.||+|+||.||+|++ +++.||+|++.... ...+..|.++ +..++||||+++++.+. ...
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3457899999999999999999987 68999999987542 2344445555 44589999999998543 233
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CceecCCCCCCeeecCCCcEE
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN---------PVVHCDIKPSNVLLDDDMVAH 358 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~dlkp~NIll~~~~~~k 358 (467)
..++||||+++|+|.+++.... .++..+..++.|++.||+||| +. ||+||||||+||+++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence 6789999999999999996543 588999999999999999999 88 999999999999999999999
Q ss_pred EeccccceecCCC-------------CccccccccccccccC-------CCCCCcccchhhHHHHHHHhcCCCCCCcccc
Q 041491 359 LSDFGIAKLLNGK-------------ESMRTQTLATIEYGRE-------GQVSPKSDVYGYGITLIETFTKKKPTCEIFC 418 (467)
Q Consensus 359 l~Dfg~a~~~~~~-------------~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~ 418 (467)
|+|||+++.+... ...++..|.|||...+ ..++.++|||||||++|||+||..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 9999999876532 1236678899998876 4566789999999999999999877643211
Q ss_pred cc-------------ccHHHH---Hh-----hhcc----------cccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 419 EE-------------MNLKNW---VN-----DFLP----------ISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 419 ~~-------------~~~~~~---~~-----~~~~----------~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.. .....+ +. ..++ +.+.+++.+||..||.+|+ ++.|+++.|.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL-TAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC-CHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc-chHHHHHHHHHH
Confidence 10 011111 10 1111 2488999999999999997 566666665543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=328.17 Aligned_cols=234 Identities=13% Similarity=0.083 Sum_probs=177.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcC--CCCCceeEE-------EEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSV--RHRNLVKII-------SSC 283 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~ 283 (467)
..+|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999986 589999999987532 2345677785444444 799988865 444
Q ss_pred ecC-----------------CeeeEEEecccCCCHHHhhhcCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCce
Q 041491 284 SNG-----------------NFEALVLEYMANGSLEKCLYSSNGILDIFQR------LSIMIDVALALEYLHFGYSNPVV 340 (467)
Q Consensus 284 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~iv 340 (467)
... ...++||||++ |+|.+++......+++..+ ..++.|++.||+||| ++||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 332 33799999998 8999999765444555556 778899999999999 99999
Q ss_pred ecCCCCCCeeecCCCcEEEeccccceecCCCC--ccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 341 HCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--SMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 341 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
||||||+|||++.++.+||+|||+|+...... ..++..|.|||...+ ..++.++|||||||++|||+||+.||...
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999999999876543 345678899999987 77899999999999999999999999865
Q ss_pred cccccc-H----------HHH---HhhhcccccccccccccccchhHHHHHH
Q 041491 417 FCEEMN-L----------KNW---VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 417 ~~~~~~-~----------~~~---~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
...... . ..+ ....+++.+.+++.+||..||++|++..
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 348 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 222110 0 000 1124566799999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=318.99 Aligned_cols=231 Identities=21% Similarity=0.296 Sum_probs=195.3
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccc-----------------hHHHHHHHHHHHcCCCCCceeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA-----------------LKSFDAECEVLKSVRHRNLVKI 279 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~~ 279 (467)
.++|++.+.||+|+||.||+|.+ +++.||+|++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999997542211 1789999999999999999999
Q ss_pred EEEeecCCeeeEEEecccCCCHHHh------hhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeee
Q 041491 280 ISSCSNGNFEALVLEYMANGSLEKC------LYSS-NGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLL 351 (467)
Q Consensus 280 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll 351 (467)
++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||.||| + +||+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999998 5432 457999999999999999999999 8 999999999999999
Q ss_pred cCCCcEEEeccccceecCCC---CccccccccccccccCC-CCCC-cccchhhHHHHHHHhcCCCCCCccccccccHHHH
Q 041491 352 DDDMVAHLSDFGIAKLLNGK---ESMRTQTLATIEYGREG-QVSP-KSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW 426 (467)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~pe~~~~~-~~~~-~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~ 426 (467)
+.++.+||+|||.+...... ...++..|.+||...+. .++. ++||||||+++|||++|+.||....... .....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~ 264 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-ELFNN 264 (348)
T ss_dssp CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-HHHHH
T ss_pred cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHH
Confidence 99999999999999876443 23466778999998877 6666 9999999999999999999997643311 11111
Q ss_pred Hh--------------------------hhcccccccccccccccchhHHHH
Q 041491 427 VN--------------------------DFLPISVMNVVDTSLLRREDKYFA 452 (467)
Q Consensus 427 ~~--------------------------~~~~~~~~~~i~~~l~~~~~~r~~ 452 (467)
+. ..+++.+.+++.+||..||.+|++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps 316 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC
Confidence 11 334556889999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=311.52 Aligned_cols=233 Identities=22% Similarity=0.297 Sum_probs=185.8
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEee-----------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS----------- 284 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------- 284 (467)
.++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3689999999999999999999875 8999999998665556678899999999999999999999874
Q ss_pred ---cCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec-CCCcEEEe
Q 041491 285 ---NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLS 360 (467)
Q Consensus 285 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~ 360 (467)
..+..++||||++ |+|.+++.. +.+++..++.++.|++.||+||| ++||+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 599998853 46899999999999999999999 99999999999999997 56799999
Q ss_pred ccccceecCCC--------CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-----
Q 041491 361 DFGIAKLLNGK--------ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW----- 426 (467)
Q Consensus 361 Dfg~a~~~~~~--------~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~----- 426 (467)
|||+++..... ....+..|.+||.... ..++.++||||||+++|||+||+.||......+. ....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 99999876432 1233566889997654 6789999999999999999999999976432110 0000
Q ss_pred -------------------------------HhhhcccccccccccccccchhHHHHHHHHH
Q 041491 427 -------------------------------VNDFLPISVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 427 -------------------------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
....+++.+.+++.+||..||.+|++ +.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~el 303 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT-AEEA 303 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC-HHHH
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC-HHHH
Confidence 11235667999999999999999985 3344
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.84 Aligned_cols=233 Identities=23% Similarity=0.294 Sum_probs=195.2
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---------ccchHHHHHHHHHHHcCC-CCCceeEEEEee
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---------DGALKSFDAECEVLKSVR-HRNLVKIISSCS 284 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 284 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999986 48999999997543 122456789999999995 999999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999998653 46899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC----cccccccccccccc------CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------
Q 041491 365 AKLLNGKE----SMRTQTLATIEYGR------EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------ 428 (467)
Q Consensus 365 a~~~~~~~----~~~~~~~~~pe~~~------~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------ 428 (467)
+....... ..++..|.+||... ...++.++||||||+++|||++|+.||....... .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~ 249 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQFG 249 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCC
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHHHhcCCcccC
Confidence 98775432 23566789999874 4568899999999999999999999997542221 1111111
Q ss_pred ----hhcccccccccccccccchhHHHHH
Q 041491 429 ----DFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 429 ----~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..+++.+.+++.+||..||.+|++.
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 278 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTA 278 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCH
Confidence 2345568999999999999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=317.56 Aligned_cols=193 Identities=21% Similarity=0.244 Sum_probs=162.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 287 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999886 48899999997542 234467889999999999999999999997665
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999975 7888774 34889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 368 LNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 368 ~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
.... ...++..|.|||...+..++.++||||+||++|||++|+.||.+.
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 6543 234577799999999999999999999999999999999999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=306.21 Aligned_cols=218 Identities=15% Similarity=0.092 Sum_probs=185.4
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|++.. ++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999999865 89999999976532 2346789999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||++|++|.+++... ....++..++.|++.||+||| ++||+||||||+||+++.++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~------- 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATM------- 176 (286)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCC-------
T ss_pred EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecccc-------
Confidence 9999999999998432 356678899999999999999 999999999999999999999999866542
Q ss_pred ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc------------ccHHHHHhhhcccccccccc
Q 041491 373 SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE------------MNLKNWVNDFLPISVMNVVD 440 (467)
Q Consensus 373 ~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~------------~~~~~~~~~~~~~~~~~~i~ 440 (467)
..++.++|||||||++|||+||+.||.+....+ .....-....+++.+.+++.
T Consensus 177 ---------------~~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (286)
T 3uqc_A 177 ---------------PDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241 (286)
T ss_dssp ---------------TTCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred ---------------CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHH
Confidence 136889999999999999999999997643221 11122344567778999999
Q ss_pred cccccchhHHHHHHHHHHHHHHhc
Q 041491 441 TSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 441 ~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+||..||.+| ++.|+++.|.++
T Consensus 242 ~~l~~dP~~R--s~~el~~~L~~~ 263 (286)
T 3uqc_A 242 RSVQGDGGIR--SASTLLNLMQQA 263 (286)
T ss_dssp HHHCTTSSCC--CHHHHHHHHHHH
T ss_pred HHcccCCccC--CHHHHHHHHHHH
Confidence 9999999999 888888888664
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=319.35 Aligned_cols=232 Identities=21% Similarity=0.278 Sum_probs=175.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC------C
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------N 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 287 (467)
.++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999875 58999999986542 23456788999999999999999999998654 5
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..++|+|++ +++|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 7899998854 46899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCC--CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccc----------------------c
Q 041491 368 LNGK--ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM----------------------N 422 (467)
Q Consensus 368 ~~~~--~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~----------------------~ 422 (467)
.... ...++..|.+||.+.+ ..++.++||||+||++|||++|+.||.+....+. .
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 6543 2346778899998876 6789999999999999999999999976422110 0
Q ss_pred HHHHH--------------hhhcccccccccccccccchhHHHHHH
Q 041491 423 LKNWV--------------NDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 423 ~~~~~--------------~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
...+. ....++.+.+++.+||..||.+|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~ 307 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHH
Confidence 01111 112344588999999999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=320.17 Aligned_cols=231 Identities=23% Similarity=0.288 Sum_probs=184.5
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC------eee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------FEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 290 (467)
..+|++.+.||+|+||.||+|++..+..||+|++..... ...+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999998777799998864322 2237999999999999999999985433 478
Q ss_pred EEEecccCCCHHHhh--hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec-CCCcEEEecccccee
Q 041491 291 LVLEYMANGSLEKCL--YSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKL 367 (467)
Q Consensus 291 lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~ 367 (467)
+||||++++.+.... ......+++..+..++.|++.||+||| ++||+||||||+||+++ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999875443332 123457899999999999999999999 99999999999999999 789999999999987
Q ss_pred cCCC----CccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCcccccccc--------------------
Q 041491 368 LNGK----ESMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-------------------- 422 (467)
Q Consensus 368 ~~~~----~~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-------------------- 422 (467)
.... ...++..|.|||.+.+. .++.++||||+||++|||++|+.||.+....+..
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 6433 23457779999988654 5899999999999999999999999764322110
Q ss_pred --------------HHHHHhhhcccccccccccccccchhHHHHHH
Q 041491 423 --------------LKNWVNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 423 --------------~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
+........++++.+++.+||..||.+|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHH
Confidence 01111122455789999999999999998644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=321.12 Aligned_cols=195 Identities=24% Similarity=0.310 Sum_probs=167.8
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC--------CCCceeEEEEee---
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR--------HRNLVKIISSCS--- 284 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~--- 284 (467)
.++|++.+.||+|+||.||+|++. +++.||+|+++.. ....+.+.+|+++++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999876 4889999999744 334567889999999885 788999999987
Q ss_pred -cCCeeeEEEecccCCCHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCC------
Q 041491 285 -NGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDM------ 355 (467)
Q Consensus 285 -~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~------ 355 (467)
.....++||||+.+ ++.+.+.. ....+++..++.++.|++.||+||| ++ ||+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence 56688999999954 55555544 3357999999999999999999999 88 999999999999998775
Q ss_pred -------------------------------------------cEEEeccccceecCCC--CccccccccccccccCCCC
Q 041491 356 -------------------------------------------VAHLSDFGIAKLLNGK--ESMRTQTLATIEYGREGQV 390 (467)
Q Consensus 356 -------------------------------------------~~kl~Dfg~a~~~~~~--~~~~~~~~~~pe~~~~~~~ 390 (467)
.+||+|||++...... ...++..|.+||.+.+..+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCC
Confidence 7999999999876543 2346788999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 391 SPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 391 ~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
+.++|||||||++|||+||+.||...
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=309.53 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=199.7
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHc--CCCCCceeEEEEeecC
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKS--VRHRNLVKIISSCSNG 286 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~ 286 (467)
+...-....++|++.+.||+|+||.||+|++ +++.||+|++... ....+.+|++++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3333455678999999999999999999998 5899999998643 34567789998887 7899999999999877
Q ss_pred C----eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeeecCCCcE
Q 041491 287 N----FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG-----YSNPVVHCDIKPSNVLLDDDMVA 357 (467)
Q Consensus 287 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~ 357 (467)
+ ..++||||+++|+|.+++... .+++.+++.++.|++.||+|||.. .+++|+||||||+||+++.++.+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 6 789999999999999999653 589999999999999999999932 14789999999999999999999
Q ss_pred EEeccccceecCCCC---------ccccccccccccccCCC------CCCcccchhhHHHHHHHhcC----------CCC
Q 041491 358 HLSDFGIAKLLNGKE---------SMRTQTLATIEYGREGQ------VSPKSDVYGYGITLIETFTK----------KKP 412 (467)
Q Consensus 358 kl~Dfg~a~~~~~~~---------~~~~~~~~~pe~~~~~~------~~~~~Dv~slGvil~el~tg----------~~P 412 (467)
||+|||++....... ..++..|.+||...+.. ++.++|||||||++|||+|| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765432 24567789999887652 34689999999999999999 789
Q ss_pred CCccccccccHHHHHhhh--------cc---------cccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 413 TCEIFCEEMNLKNWVNDF--------LP---------ISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 413 f~~~~~~~~~~~~~~~~~--------~~---------~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
|......+.....+.... ++ +.+.+++.+||..||.+|+ ++.++++.|.++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-TALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC-CHHHHHHHHHHH
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC-CHHHHHHHHHHH
Confidence 876544333333332211 11 2467899999999999997 566777666554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=321.89 Aligned_cols=195 Identities=19% Similarity=0.263 Sum_probs=171.1
Q ss_pred hccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcC------CCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV------RHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 289 (467)
..+|++.+.||+|+||.||+|.+.. ++.||+|+++.. ......+.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4579999999999999999998864 899999999754 23346677888888876 577999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc--EEEeccccce
Q 041491 290 ALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV--AHLSDFGIAK 366 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~ 366 (467)
++||||+. ++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 58988886654 35899999999999999999999 999999999999999999887 9999999998
Q ss_pred ecCCCC--ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 367 LLNGKE--SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 367 ~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
...... ..++..|.|||++.+..++.++|||||||++|||+||+.||...
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 765432 34677899999999999999999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=315.68 Aligned_cols=230 Identities=22% Similarity=0.245 Sum_probs=189.8
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecC-----Cee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 289 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999886 58899999997543 23346788999999999999999999998654 368
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||++ |+|.+++.. +.+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99999997 499998865 35899999999999999999999 9999999999999999999999999999998765
Q ss_pred CC--------CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------------
Q 041491 370 GK--------ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-------------- 426 (467)
Q Consensus 370 ~~--------~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-------------- 426 (467)
.. ...++..|.+||.+.+ ..++.++||||+||++|||++|+.||.+....+. +...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHH
Confidence 32 2245777899997654 4589999999999999999999999976432211 1000
Q ss_pred -----------------------HhhhcccccccccccccccchhHHHHH
Q 041491 427 -----------------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 427 -----------------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
....+++++.+++.+||..||.+|++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 308 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence 012344568899999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=320.47 Aligned_cols=230 Identities=23% Similarity=0.306 Sum_probs=184.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecC------Cee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG------NFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 289 (467)
..+|++.+.||+|+||.||+|++. +|+.||||++.... ....+|+++++.++||||+++++++... .+.
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 347999999999999999999986 48999999986442 2234799999999999999999988432 246
Q ss_pred eEEEecccCCCHHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-CcEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLY---SSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a 365 (467)
++||||+++ ++.+.+. .....+++..+..++.|++.||+||| ++||+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999976 5655543 34557999999999999999999999 9999999999999999965 57899999999
Q ss_pred eecCCC----CccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------------
Q 041491 366 KLLNGK----ESMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------------- 427 (467)
Q Consensus 366 ~~~~~~----~~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------------- 427 (467)
+..... ...++..|.+||++.+. .++.++|||||||++|||++|+.||.+....+ .+.+..
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHh
Confidence 876433 23457779999988664 78999999999999999999999997643211 111111
Q ss_pred ----------------------hhhcccccccccccccccchhHHHHHHH
Q 041491 428 ----------------------NDFLPISVMNVVDTSLLRREDKYFAAKK 455 (467)
Q Consensus 428 ----------------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~ 455 (467)
....++++.+++.+||..||.+|++..+
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e 333 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 333 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHH
Confidence 1223556899999999999999986543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=305.97 Aligned_cols=234 Identities=24% Similarity=0.315 Sum_probs=187.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeec----------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN---------- 285 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------- 285 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 468999999999999999999985 5899999998653 3345778899999999999999999998754
Q ss_pred ---CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecc
Q 041491 286 ---GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 286 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
.+..++||||+++++|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 45779999999999999999876667889999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCC-------------------CccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCcccccccc
Q 041491 363 GIAKLLNGK-------------------ESMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN 422 (467)
Q Consensus 363 g~a~~~~~~-------------------~~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~ 422 (467)
|++...... ...++..|.+||...+. .++.++|||||||++|||++ ||.........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999876421 12356678999988754 78999999999999999998 66432211111
Q ss_pred HHHHHh----------hhcccccccccccccccchhHHHHHHHHHH
Q 041491 423 LKNWVN----------DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 423 ~~~~~~----------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
...... ...++.+.+++.+||..||.+|++ +.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll 282 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG-ARTLL 282 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC-HHHHH
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC-HHHHh
Confidence 111111 111223789999999999999975 44443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=316.63 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=199.6
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecC
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG 286 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 286 (467)
..+++.+..++|++.+.||+|+||.||+|.+. ..||+|+++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34556667789999999999999999999874 359999987543 23345678899999999999999999999999
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
+..++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++ ++.+||+|||+++
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999999776667999999999999999999999 99999999999999998 6799999999987
Q ss_pred ecCCC----------CccccccccccccccC---------CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH
Q 041491 367 LLNGK----------ESMRTQTLATIEYGRE---------GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV 427 (467)
Q Consensus 367 ~~~~~----------~~~~~~~~~~pe~~~~---------~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~ 427 (467)
..... ...++..|.+||.... ..++.++||||||+++|||++|+.||........ .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~ 256 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMG 256 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHHHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhc
Confidence 65321 1235667889998764 4578899999999999999999999976433221 11111
Q ss_pred h--------hhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 428 N--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 428 ~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
. ..++..+.+++.+|+..+|.+|+ ++.++++.+.++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~l~~~l~~l 300 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERP-TFTKLMDMLEKL 300 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSC-CHHHHHHHHTTC
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCc-CHHHHHHHHHHH
Confidence 1 12455789999999999999996 677777776543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=309.27 Aligned_cols=234 Identities=24% Similarity=0.294 Sum_probs=191.4
Q ss_pred HhccCccCCccCcccceeEEEEEec--CCCeEEEEEeecccc--cchHHHHHHHHHHHcC---CCCCceeEEEEee----
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFD--GALKSFDAECEVLKSV---RHRNLVKIISSCS---- 284 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---- 284 (467)
..++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999984 588999999875432 2234677888887766 8999999999987
Q ss_pred -cCCeeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecc
Q 041491 285 -NGNFEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDF 362 (467)
Q Consensus 285 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 362 (467)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5667899999997 59999886654 35899999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-----------
Q 041491 363 GIAKLLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------- 427 (467)
Q Consensus 363 g~a~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------- 427 (467)
|+++..... ...++..|.+||...+..++.++|||||||++|||++|+.||......+ .+....
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGS
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCcccC
Confidence 999876532 2345677899999998899999999999999999999999997643221 111111
Q ss_pred ----------------------hhhcccccccccccccccchhHHHHHH
Q 041491 428 ----------------------NDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 428 ----------------------~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
...+++.+.+++.+||..||.+|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 292 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence 112344577899999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=305.15 Aligned_cols=236 Identities=22% Similarity=0.270 Sum_probs=189.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc----ccchHHHHHHHHHHHcCCCCCceeEEEEe--ecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRHRNLVKIISSC--SNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~ 289 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|+++... ......+.+|++++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999986 48899999997542 23457789999999999999999999998 445688
Q ss_pred eEEEecccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 290 ALVLEYMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
++||||++++ +.+++... ...+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999886 66666543 457899999999999999999999 999999999999999999999999999999876
Q ss_pred CCC-------CccccccccccccccCCC--CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccc
Q 041491 369 NGK-------ESMRTQTLATIEYGREGQ--VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPI 433 (467)
Q Consensus 369 ~~~-------~~~~~~~~~~pe~~~~~~--~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~ 433 (467)
... ...++..|.+||...+.. ++.++||||||+++|||++|+.||......+ ....... ...++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~ 238 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-LFENIGKGSYAIPGDCGP 238 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCCCCCSSSCH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHHHhcCCCCCCCccCH
Confidence 532 123567789999876543 3779999999999999999999997642221 1111111 12344
Q ss_pred ccccccccccccchhHHHHHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.+.+++.+||..||.+|++ +.|++
T Consensus 239 ~l~~li~~~l~~dp~~Rps-~~~ll 262 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFS-IRQIR 262 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCC-HHHHH
T ss_pred HHHHHHHHHccCChhhCCC-HHHHh
Confidence 5899999999999999985 44444
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.13 Aligned_cols=231 Identities=24% Similarity=0.330 Sum_probs=189.5
Q ss_pred CccCcccceeEEEEEec---CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
+.||+|+||.||+|.+. .++.||||+++.... ...+.+.+|++++++++||||+++++++..+ ..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence 47999999999999764 367899999976432 3357899999999999999999999999754 57899999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-----
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES----- 373 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 373 (467)
|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999964 456899999999999999999999 99999999999999999999999999999987654321
Q ss_pred ---cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 374 ---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 374 ---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
..+..|.|||++....++.++|||||||++|||+| |+.||.+....+ ....+. ..+++++.+++..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~~~~p~~~~~~l~~li~~ 607 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCPAGCPREMYDLMNL 607 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 23456899999998899999999999999999998 999997643332 222221 2345568999999
Q ss_pred ccccchhHHHHHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l~ 462 (467)
|+..||++|+ ++.+++..|.
T Consensus 608 cl~~dP~~RP-s~~~l~~~L~ 627 (635)
T 4fl3_A 608 CWTYDVENRP-GFAAVELRLR 627 (635)
T ss_dssp HTCSSTTTSC-CHHHHHHHHH
T ss_pred HcCCCHhHCc-CHHHHHHHHH
Confidence 9999999996 4445554443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=301.85 Aligned_cols=237 Identities=22% Similarity=0.293 Sum_probs=195.9
Q ss_pred HHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 58999999997543 2345778999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC---CcEEEeccccceec
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD---MVAHLSDFGIAKLL 368 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~~ 368 (467)
||||+++++|.+++... ..+++..++.++.|++.||.||| ++|++||||||+||+++.+ +.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999888543 46899999999999999999999 9999999999999999764 47999999999876
Q ss_pred CCCCc----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhcccc
Q 041491 369 NGKES----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPIS 434 (467)
Q Consensus 369 ~~~~~----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~ 434 (467)
..... .++..|.+||...+ .++.++||||||+++|+|++|+.||......+ ....... ..+++.
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp CCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCSGGGTTSCHH
T ss_pred cCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCchhhhhcCHH
Confidence 54332 35667899998765 48999999999999999999999997643221 1111111 234556
Q ss_pred cccccccccccchhHHHHHHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+.+++.+||..+|.+|++ +.|++
T Consensus 253 ~~~li~~~l~~dp~~Rps-~~ell 275 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRIT-ATQCL 275 (287)
T ss_dssp HHHHHHHHTCSSGGGSCC-HHHHH
T ss_pred HHHHHHHHcccChhhCcC-HHHHh
Confidence 899999999999999985 33443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=315.24 Aligned_cols=231 Identities=21% Similarity=0.257 Sum_probs=187.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCee----
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE---- 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 289 (467)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999886 489999999975432 2356788999999999999999999999877654
Q ss_pred --eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 290 --ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 290 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
++||||++ ++|.+.+. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 58888763 34899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc----------------------
Q 041491 368 LNGKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN---------------------- 422 (467)
Q Consensus 368 ~~~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~---------------------- 422 (467)
..... ..++..|.+||...+ ..++.++|||||||++|||++|+.||.+....+..
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 65432 345778899998876 78899999999999999999999999764211100
Q ss_pred HHHH--------------HhhhcccccccccccccccchhHHHHHH
Q 041491 423 LKNW--------------VNDFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 423 ~~~~--------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
...+ .....++.+.+++.+||..||.+|++..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 319 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHH
Confidence 0001 0123355689999999999999998543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=334.76 Aligned_cols=245 Identities=21% Similarity=0.287 Sum_probs=200.8
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecC
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG 286 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 286 (467)
+..+..++|++.+.||+|+||.||+|.+.. +..||+|.++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 444556789999999999999999998753 4579999986543 2344678999999999999999999999854
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
+..++||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 5689999999999999999876667999999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH--------hhhc
Q 041491 367 LLNGKE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV--------NDFL 431 (467)
Q Consensus 367 ~~~~~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~ 431 (467)
...... ...+..|.|||......++.++|||||||++|||++ |..||.+....+ ....+ ...+
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~ 617 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERLPMPPNC 617 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHHTCCCCCCTTC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCCCCCCccc
Confidence 765432 123456899999988899999999999999999997 999997643322 11111 1234
Q ss_pred ccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
++.+.+++.+||..||.+|+ ++.+++..|.+
T Consensus 618 ~~~l~~li~~~l~~dP~~RP-s~~el~~~L~~ 648 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRP-RFTELKAQLST 648 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCc-CHHHHHHHHHH
Confidence 45689999999999999996 56666665544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.97 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=195.4
Q ss_pred ccHHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCC--CCCceeEEEEe
Q 041491 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVR--HRNLVKIISSC 283 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~ 283 (467)
+.++.+.+..++|++.+.||+|+||.||+|.+.+++.||+|++.... ....+.+.+|++++++++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 44444556678899999999999999999999889999999997543 234577899999999997 59999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccc
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
...+..++||| +.+++|.+++... ..+++..+..++.|++.||.||| ++||+||||||+||++++ +.+||+|||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecc
Confidence 99999999999 5688999998654 47899999999999999999999 999999999999999975 799999999
Q ss_pred cceecCCCC-------ccccccccccccccC-----------CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHH
Q 041491 364 IAKLLNGKE-------SMRTQTLATIEYGRE-----------GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN 425 (467)
Q Consensus 364 ~a~~~~~~~-------~~~~~~~~~pe~~~~-----------~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~ 425 (467)
+++...... ..++..|.+||.... ..++.++||||||+++|||++|+.||............
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 998765432 245778899998765 47888999999999999999999999764333222233
Q ss_pred HHhh--------hcccccccccccccccchhHHHHHHHHHH
Q 041491 426 WVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 426 ~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.... ..+..+.+++.+||..||.+|++ +.|++
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell 291 (313)
T 3cek_A 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS-IPELL 291 (313)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC-HHHHH
T ss_pred HHhcccccCCcccchHHHHHHHHHHccCCcccCcC-HHHHh
Confidence 3222 12335889999999999999985 33443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.60 Aligned_cols=231 Identities=22% Similarity=0.275 Sum_probs=189.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecC-----Cee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 289 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999986 48999999996443 23346678999999999999999999988654 678
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||++ ++|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 589998865 46899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCC---------------cccccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCccccccc------------
Q 041491 370 GKE---------------SMRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM------------ 421 (467)
Q Consensus 370 ~~~---------------~~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~------------ 421 (467)
... ..++..|.+||... ...++.++|||||||++|||++|+.||.+....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 321 13466789999765 47789999999999999999999999975421110
Q ss_pred -----------cHHHH--------------HhhhcccccccccccccccchhHHHHH
Q 041491 422 -----------NLKNW--------------VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 422 -----------~~~~~--------------~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
...++ ....+++.+.+++.+||..||.+|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH
Confidence 01111 112455668899999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=319.25 Aligned_cols=192 Identities=23% Similarity=0.295 Sum_probs=153.2
Q ss_pred ccCcc-CCccCcccceeEEEEEec---CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEee--cCCeeeE
Q 041491 218 DHFSE-KSLIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS--NGNFEAL 291 (467)
Q Consensus 218 ~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l 291 (467)
+.|++ .++||+|+||.||+|++. +++.||+|++... .....+.+|+.++++++||||+++++++. .....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999975 4789999998644 23357889999999999999999999994 4678999
Q ss_pred EEecccCCCHHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----cCCCcEEE
Q 041491 292 VLEYMANGSLEKCLYSS--------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DDDMVAHL 359 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl 359 (467)
||||+++ +|.+++... ...+++..++.++.|++.||+||| ++||+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999965 787776421 124899999999999999999999 9999999999999999 67789999
Q ss_pred eccccceecCCC--------CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 360 SDFGIAKLLNGK--------ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 360 ~Dfg~a~~~~~~--------~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
+|||+|+..... ...++..|.|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999876532 1245777899998876 4589999999999999999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=308.12 Aligned_cols=239 Identities=22% Similarity=0.252 Sum_probs=179.5
Q ss_pred HHHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCC--
Q 041491 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-- 287 (467)
Q Consensus 211 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 287 (467)
.+.....++|++.+.||+|+||.||+|++. +++.||+|++... ........+|++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455677789999999999999999999986 4899999998654 233456678888889999999999999986533
Q ss_pred -----eeeEEEecccCCCHHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEE
Q 041491 288 -----FEALVLEYMANGSLEKCLY---SSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAH 358 (467)
Q Consensus 288 -----~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~k 358 (467)
..++||||+++ +|.+.+. .....+++..+..++.|++.||.|||. +++||+||||||+||+++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence 37899999987 5444332 244578999999999999999999993 3789999999999999997 89999
Q ss_pred EeccccceecCCCC----ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh----
Q 041491 359 LSDFGIAKLLNGKE----SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND---- 429 (467)
Q Consensus 359 l~Dfg~a~~~~~~~----~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~---- 429 (467)
|+|||+++...... ..++..|.+||...+. .++.++|||||||++|||+||+.||......+ .+......
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~ 251 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLGCP 251 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcCCC
Confidence 99999998775433 2456778999987654 48999999999999999999999997643221 11111110
Q ss_pred ---------------------------h-------cccccccccccccccchhHHHHH
Q 041491 430 ---------------------------F-------LPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 430 ---------------------------~-------~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
. .++.+.+++.+||..||.+|++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 309 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH
Confidence 0 23358899999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=311.63 Aligned_cols=198 Identities=24% Similarity=0.297 Sum_probs=170.5
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CC-----CceeEEEEeecCCe
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HR-----NLVKIISSCSNGNF 288 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~ 288 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|+++.. ......+..|+.+++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999886 4889999999744 233466778999988875 44 49999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec--CCCcEEEeccccc
Q 041491 289 EALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--DDMVAHLSDFGIA 365 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a 365 (467)
.++||||+++ +|.+++.... ..+++..+..++.|++.||.|||. ++.||+||||||+|||++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999964 9999887654 468999999999999999999992 147999999999999994 4778999999999
Q ss_pred eecCCC--CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 366 KLLNGK--ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 366 ~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
+..... ...++..|.|||...+..++.++|||||||++|||+||+.||.+.
T Consensus 209 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 887643 345677899999999999999999999999999999999999764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=339.68 Aligned_cols=238 Identities=21% Similarity=0.240 Sum_probs=196.2
Q ss_pred hccCccCCccCcccceeEEEEEec--CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe-----
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF----- 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 288 (467)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999986 58999999986443 2344678899999999999999999999987655
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||++|++|.+++.. .+++.+++.++.|++.||.||| ++||+||||||+||+++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999987643 6899999999999999999999 9999999999999999986 8999999999987
Q ss_pred CCCC-ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhcccccccccccccccch
Q 041491 369 NGKE-SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLRRE 447 (467)
Q Consensus 369 ~~~~-~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~ 447 (467)
.... ..++..|.+||++.++. +.++|||||||++|||++|..||.......... .......++.+.++|.+||..||
T Consensus 232 ~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP 309 (681)
T 2pzi_A 232 NSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE-DDPVLKTYDSYGRLLRRAIDPDP 309 (681)
T ss_dssp TCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT-TCHHHHHCHHHHHHHHHHTCSSG
T ss_pred ccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccc-cccccccCHHHHHHHhhhccCCh
Confidence 6543 34678899999876654 889999999999999999999987643332210 01111234568999999999999
Q ss_pred hHHHHHHHHHHHHHHh
Q 041491 448 DKYFAAKKQCVSSALS 463 (467)
Q Consensus 448 ~~r~~~~~~~~~~l~~ 463 (467)
.+|+++++++...+..
T Consensus 310 ~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 310 RQRFTTAEEMSAQLTG 325 (681)
T ss_dssp GGSCSSHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHH
Confidence 9999888888777654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=306.16 Aligned_cols=195 Identities=21% Similarity=0.247 Sum_probs=171.1
Q ss_pred hccCccCCccCcccceeEEEEEe-c-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCC------CceeEEEEeecCCe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRF-L-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR------NLVKIISSCSNGNF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~ 288 (467)
.++|++.+.||+|+||.||+|.+ . +++.||+|+++.. ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 3 5889999998744 33456788999999988655 59999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC--------------
Q 041491 289 EALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-------------- 353 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-------------- 353 (467)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999886654 36899999999999999999999 999999999999999987
Q ss_pred -----CCcEEEeccccceecCCCC--ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 354 -----DMVAHLSDFGIAKLLNGKE--SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 354 -----~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
++.+||+|||+++...... ..++..|.+||...+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 6689999999998765432 34677899999999989999999999999999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.82 Aligned_cols=231 Identities=21% Similarity=0.263 Sum_probs=187.1
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecCCe-----
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNF----- 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 288 (467)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999986 489999999975432 234678899999999999999999999987654
Q ss_pred -eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 289 -EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 289 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
.++||||++ ++|.+++. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 58888763 34899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc----------------------
Q 041491 368 LNGKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN---------------------- 422 (467)
Q Consensus 368 ~~~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~---------------------- 422 (467)
..... ..++..|.+||...+ ..++.++|||||||++|||++|+.||.+....+..
T Consensus 176 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred CCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 65432 345777899998776 67899999999999999999999999764321100
Q ss_pred HHHHHh--------------hhcccccccccccccccchhHHHHHH
Q 041491 423 LKNWVN--------------DFLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 423 ~~~~~~--------------~~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
...+.. ...++.+.+++.+||..||.+|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 301 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHH
Confidence 000100 12345688999999999999998643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.75 Aligned_cols=232 Identities=19% Similarity=0.252 Sum_probs=168.3
Q ss_pred HhccCccCC-ccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeec----CCee
Q 041491 216 ATDHFSEKS-LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFE 289 (467)
Q Consensus 216 ~~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 289 (467)
..++|.+.+ .||+|+||.||+|.+. +++.||+|++.... .........++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356888855 6999999999999987 58999999986431 222223334567799999999999876 4568
Q ss_pred eEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a 365 (467)
++||||+++|+|.+++.... ..+++.+++.++.|++.||.||| ++||+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999997654 36999999999999999999999 999999999999999976 456999999999
Q ss_pred eecCCCC---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc--HHHH-----------Hhh
Q 041491 366 KLLNGKE---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--LKNW-----------VND 429 (467)
Q Consensus 366 ~~~~~~~---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--~~~~-----------~~~ 429 (467)
+...... ..++..|.+||...+..++.++||||||+++|||++|+.||......... .... ...
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3fhr_A 179 KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258 (336)
T ss_dssp EEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTST
T ss_pred eeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhc
Confidence 8765432 34567789999998888899999999999999999999999764332211 0000 012
Q ss_pred hcccccccccccccccchhHHHHHH
Q 041491 430 FLPISVMNVVDTSLLRREDKYFAAK 454 (467)
Q Consensus 430 ~~~~~~~~~i~~~l~~~~~~r~~~~ 454 (467)
.+++.+.+++.+||..||.+|++..
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ 283 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTIT 283 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHH
Confidence 3456689999999999999998543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.12 Aligned_cols=234 Identities=24% Similarity=0.253 Sum_probs=172.8
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc-cchHHHHHHHH-HHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECE-VLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
..++|++.+.||+|+||.||+|.+. +++.||+|+++.... .....+..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4578999999999999999999986 589999999976532 23345556665 67778999999999999999999999
Q ss_pred EecccCCCHHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCCcEEEecccccee
Q 041491 293 LEYMANGSLEKCLYS----SNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
|||+++ +|.+++.. ....+++..+..++.|++.||.||| +. ||+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999976 77776642 2457899999999999999999999 88 999999999999999999999999999987
Q ss_pred cCCCC----ccccccccccccc----cCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH-----------Hh
Q 041491 368 LNGKE----SMRTQTLATIEYG----REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW-----------VN 428 (467)
Q Consensus 368 ~~~~~----~~~~~~~~~pe~~----~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~-----------~~ 428 (467)
..... ..++..|.+||.. ....++.++||||||+++|||++|+.||.........+... ..
T Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3aln_A 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSS
T ss_pred cccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccc
Confidence 65432 2456778999998 45678999999999999999999999997532111100000 01
Q ss_pred hhcccccccccccccccchhHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
..+++.+.+++.+||..||.+|++.
T Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~ 280 (327)
T 3aln_A 256 REFSPSFINFVNLCLTKDESKRPKY 280 (327)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCH
Confidence 2245568899999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=302.90 Aligned_cols=233 Identities=23% Similarity=0.246 Sum_probs=176.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc--chHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG--ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|++...... ..+.+..+..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999986 5899999999765322 2233445556788889999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
||+ ++.+..+.......+++..+..++.|++.||.||| ++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 56676666555567999999999999999999999 85 99999999999999999999999999997664432
Q ss_pred ----cccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh---------hcccc
Q 041491 373 ----SMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND---------FLPIS 434 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~---------~~~~~ 434 (467)
..++..|.+||... ...++.++||||||+++|||++|+.||................ .+++.
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHH
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHH
Confidence 24567789999984 5668899999999999999999999997633222222222221 23456
Q ss_pred cccccccccccchhHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~ 453 (467)
+.+++.+||..||.+|++.
T Consensus 260 l~~li~~~l~~dp~~Rps~ 278 (318)
T 2dyl_A 260 FQSFVKDCLTKDHRKRPKY 278 (318)
T ss_dssp HHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHHHHccCChhHCcCH
Confidence 8999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=306.39 Aligned_cols=195 Identities=21% Similarity=0.257 Sum_probs=168.5
Q ss_pred hccCccCCccCcccceeEEEEEecC-C-CeEEEEEeecccccchHHHHHHHHHHHcCCCCC------ceeEEEEeecCCe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-G-MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN------LVKIISSCSNGNF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 288 (467)
.++|++.+.||+|+||.||+|.+.. + +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4689999999999999999998853 4 68999999754 234567888999999987655 9999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----------------
Q 041491 289 EALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL---------------- 351 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---------------- 351 (467)
.++||||+ ++++.+++.... ..+++.++..++.|++.||+||| ++||+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 556666665443 47899999999999999999999 9999999999999999
Q ss_pred ---cCCCcEEEeccccceecCCCC--ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 352 ---DDDMVAHLSDFGIAKLLNGKE--SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 352 ---~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
+.++.+||+|||+++...... ..++..|.+||.+.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 567899999999998765432 35677899999999999999999999999999999999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=310.11 Aligned_cols=241 Identities=22% Similarity=0.216 Sum_probs=195.5
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc------chHHHHHHHHHHHcCC--CCCceeEEEE
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG------ALKSFDAECEVLKSVR--HRNLVKIISS 282 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~ 282 (467)
+.....++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999875 5899999999765321 2355778999999996 5999999999
Q ss_pred eecCCeeeEEEecccC-CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec-CCCcEEEe
Q 041491 283 CSNGNFEALVLEYMAN-GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLS 360 (467)
Q Consensus 283 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~ 360 (467)
+...+..++|||++.+ ++|.+++.. .+.+++..++.++.|++.||+||| ++||+||||||+||+++ +++.+||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999999976 899999865 356899999999999999999999 99999999999999999 78899999
Q ss_pred ccccceecCCCC---ccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhcccccc
Q 041491 361 DFGIAKLLNGKE---SMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVM 436 (467)
Q Consensus 361 Dfg~a~~~~~~~---~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 436 (467)
|||+++...... ..++..|.+||......+ +.++||||||+++|||+||+.||......... .......+++.+.
T Consensus 193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 271 (320)
T 3a99_A 193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-QVFFRQRVSSECQ 271 (320)
T ss_dssp CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC-CCCCSSCCCHHHH
T ss_pred eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc-cccccccCCHHHH
Confidence 999998876432 245677899998876665 67899999999999999999999753211000 0011234566799
Q ss_pred cccccccccchhHHHHHHHHHH
Q 041491 437 NVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 437 ~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+++.+||..||.+|++ +.+++
T Consensus 272 ~li~~~l~~dp~~Rps-~~~ll 292 (320)
T 3a99_A 272 HLIRWCLALRPSDRPT-FEEIQ 292 (320)
T ss_dssp HHHHHHTCSSGGGSCC-HHHHH
T ss_pred HHHHHHccCChhhCcC-HHHHh
Confidence 9999999999999975 43443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=308.65 Aligned_cols=241 Identities=23% Similarity=0.237 Sum_probs=185.7
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc------cchHHHHHHHHHHHcC----CCCCceeEE
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSV----RHRNLVKII 280 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~ 280 (467)
+.....++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44556789999999999999999999875 588999999965432 1234456799999988 899999999
Q ss_pred EEeecCCeeeEEEec-ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec-CCCcEE
Q 041491 281 SSCSNGNFEALVLEY-MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAH 358 (467)
Q Consensus 281 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~k 358 (467)
+++...+..++|||| +.+++|.+++... +.+++..++.++.|++.||+||| ++||+||||||+||+++ .++.+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence 999999999999999 7899999998653 46899999999999999999999 99999999999999999 889999
Q ss_pred EeccccceecCCCC---ccccccccccccccCCCCC-CcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhcccc
Q 041491 359 LSDFGIAKLLNGKE---SMRTQTLATIEYGREGQVS-PKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPIS 434 (467)
Q Consensus 359 l~Dfg~a~~~~~~~---~~~~~~~~~pe~~~~~~~~-~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 434 (467)
|+|||++....... ..++..|.+||+..+..+. .++||||||+++|||++|+.||......... .......+++.
T Consensus 181 l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 259 (312)
T 2iwi_A 181 LIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA-ELHFPAHVSPD 259 (312)
T ss_dssp ECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT-CCCCCTTSCHH
T ss_pred EEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh-ccCCcccCCHH
Confidence 99999998776432 2456678999988776664 5899999999999999999999753210000 00011334556
Q ss_pred cccccccccccchhHHHHHHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+.+++.+||..+|++|++ +.|++
T Consensus 260 ~~~li~~~l~~~p~~Rps-~~e~l 282 (312)
T 2iwi_A 260 CCALIRRCLAPKPSSRPS-LEEIL 282 (312)
T ss_dssp HHHHHHHHTCSSTTTSCC-HHHHH
T ss_pred HHHHHHHHccCChhhCcC-HHHHh
Confidence 899999999999999974 44443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=296.94 Aligned_cols=215 Identities=20% Similarity=0.280 Sum_probs=176.9
Q ss_pred ccCccC-CccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHH-HcCCCCCceeEEEEeec----CCeee
Q 041491 218 DHFSEK-SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVL-KSVRHRNLVKIISSCSN----GNFEA 290 (467)
Q Consensus 218 ~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~ 290 (467)
++|.+. +.||+|+||.||+|.+. +++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. .+..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567776 78999999999999985 5899999998632 4577888888 56689999999999876 67889
Q ss_pred EEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEeccccce
Q 041491 291 LVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIAK 366 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~ 366 (467)
+||||+++|+|.+++.... ..+++..++.++.|++.||+||| ++||+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999997654 36899999999999999999999 999999999999999998 7899999999997
Q ss_pred ecCCCCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc-------------ccHHHHHhhhccc
Q 041491 367 LLNGKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE-------------MNLKNWVNDFLPI 433 (467)
Q Consensus 367 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~-------------~~~~~~~~~~~~~ 433 (467)
.... ..++.++||||+||++|||+||+.||....... .....-....+++
T Consensus 169 ~~~~-----------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (299)
T 3m2w_A 169 ETTG-----------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231 (299)
T ss_dssp ECTT-----------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred cccc-----------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCH
Confidence 5442 446789999999999999999999996532111 1112222345677
Q ss_pred ccccccccccccchhHHHHHHHHHH
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
++.+++.+||..||.+|++ +.|++
T Consensus 232 ~~~~li~~~l~~dP~~Rps-~~e~l 255 (299)
T 3m2w_A 232 EVKMLIRNLLKTEPTQRMT-ITEFM 255 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCC-HHHHH
T ss_pred HHHHHHHHHcccChhhCCC-HHHHh
Confidence 8999999999999999985 34443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=310.61 Aligned_cols=195 Identities=19% Similarity=0.285 Sum_probs=167.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-----------CCCceeEEEEee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-----------HRNLVKIISSCS 284 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 284 (467)
.++|++.+.||+|+||.||+|++. +++.||+|++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999985 5899999998744 234567889999998876 899999999987
Q ss_pred cCC----eeeEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeec------
Q 041491 285 NGN----FEALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLD------ 352 (467)
Q Consensus 285 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~------ 352 (467)
..+ ..++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++ ||+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence 654 789999999 889999987643 46899999999999999999999 87 999999999999994
Q ss_pred CCCcEEEeccccceecCCC--CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 353 DDMVAHLSDFGIAKLLNGK--ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 353 ~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
..+.+||+|||++...... ...++..|.+||...+..++.++|||||||++|||+||+.||...
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4458999999999877643 335677899999999999999999999999999999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.48 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=193.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeec------CCe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSN------GNF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 288 (467)
.++|++.+.||+|+||.||+|.+. +|+.||+|+++... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999885 48999999987542 3345678999999999999999999998765 677
Q ss_pred eeEEEecccCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCc---EEEeccc
Q 041491 289 EALVLEYMANGSLEKCLYSSNG--ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMV---AHLSDFG 363 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg 363 (467)
.++||||+++|+|.+++..... .+++..++.++.|++.||+||| +.||+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976443 6889999999999999999999 999999999999999997764 9999999
Q ss_pred cceecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc-------------------
Q 041491 364 IAKLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE------------------- 420 (467)
Q Consensus 364 ~a~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~------------------- 420 (467)
++....... ..++..|.+||...+..++.++|||||||++|||++|+.||.......
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 998875433 345778899999999999999999999999999999999996421000
Q ss_pred ----cc------HHHHHhhhcccccccccccccccchhHHHHHH-------HHHHHHHHhc
Q 041491 421 ----MN------LKNWVNDFLPISVMNVVDTSLLRREDKYFAAK-------KQCVSSALSL 464 (467)
Q Consensus 421 ----~~------~~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~-------~~~~~~l~~l 464 (467)
.. ........+++.+.+++.+||..||.+|+++. -+.+..+++.
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00 00001122345588999999999999998763 2445555543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=315.00 Aligned_cols=229 Identities=22% Similarity=0.301 Sum_probs=178.7
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998776667999999998754 235678999999876 8999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC-------------CcE
Q 041491 297 ANGSLEKCLYSSNGI------LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD-------------MVA 357 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-------------~~~ 357 (467)
+ |+|.+++...... .++..++.++.|++.||+||| ++||+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 5999998654321 123345789999999999999 9999999999999999754 489
Q ss_pred EEeccccceecCCCC---------ccccccccccccccC-------CCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 358 HLSDFGIAKLLNGKE---------SMRTQTLATIEYGRE-------GQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 358 kl~Dfg~a~~~~~~~---------~~~~~~~~~pe~~~~-------~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
||+|||+++...... ..++..|.|||.+.+ ..++.++|||||||++|||+| |+.||.+.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999876432 246778899998865 678999999999999999999 999997643222
Q ss_pred ccHHHHH----------hhhcccccccccccccccchhHHHHH
Q 041491 421 MNLKNWV----------NDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 421 ~~~~~~~----------~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
....... ...+++++.+++.+||..||.+|++.
T Consensus 248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 290 (434)
T 2rio_A 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290 (434)
T ss_dssp HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH
Confidence 1111110 11223458899999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=314.06 Aligned_cols=234 Identities=19% Similarity=0.288 Sum_probs=183.3
Q ss_pred HHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEE
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 292 (467)
.+...+|++.+.||+|+||+||.....+++.||||++.... ...+.+|+++++++ +||||+++++++.+.+..|+|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 34556799999999999999766555679999999986542 23456899999999 799999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-----CCcEEEecccccee
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-----DMVAHLSDFGIAKL 367 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~a~~ 367 (467)
|||++ |+|.+++........+..+..++.|++.||+||| ++||+||||||+||+++. ...+||+|||+|+.
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99996 5999999776666666677899999999999999 999999999999999953 23688999999987
Q ss_pred cCCC--------Ccccccccccccccc---CCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh------
Q 041491 368 LNGK--------ESMRTQTLATIEYGR---EGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND------ 429 (467)
Q Consensus 368 ~~~~--------~~~~~~~~~~pe~~~---~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~------ 429 (467)
.... ...++..|.|||.+. ...++.++|||||||++|||+| |..||........ .....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~---~~~~~~~~~~~ 249 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA---NILLGACSLDC 249 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH---HHHTTCCCCTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH---HHHhccCCccc
Confidence 6532 134677889999987 4567889999999999999999 9999965322211 11111
Q ss_pred -----hcccccccccccccccchhHHHHHHHHHH
Q 041491 430 -----FLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 430 -----~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+..+.+++.+||..||.+|++ +.+++
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps-~~evl 282 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPS-AKHVL 282 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCC-HHHHH
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCC-HHHHH
Confidence 11123678999999999999975 33433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=306.41 Aligned_cols=226 Identities=16% Similarity=0.153 Sum_probs=181.1
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--------ccchHHHHHHHHHHHcCC---------CCCce
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--------DGALKSFDAECEVLKSVR---------HRNLV 277 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv 277 (467)
+..++|++.+.||+|+||.||+|++ +|+.||+|+++... ....+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3457899999999999999999998 78999999997653 223477889999998885 88888
Q ss_pred eEEEEee------------------------------cCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 041491 278 KIISSCS------------------------------NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327 (467)
Q Consensus 278 ~~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~ 327 (467)
++.+.+. ..+..|+||||+++|++.+.+.. ..+++..++.++.|++.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 8877642 26789999999999976666633 568999999999999999
Q ss_pred HHHHhcCCCCCceecCCCCCCeeecCCC--------------------cEEEeccccceecCCCCccccccccccccccC
Q 041491 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDM--------------------VAHLSDFGIAKLLNGKESMRTQTLATIEYGRE 387 (467)
Q Consensus 328 l~~LH~~~~~~ivH~dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~pe~~~~ 387 (467)
|+|||. ++||+||||||+|||++.++ .+||+|||+|+........++..|.|||.+.+
T Consensus 174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCC
T ss_pred HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcC
Confidence 999993 47899999999999999887 89999999999888777778889999999886
Q ss_pred CCCCCcccchhhHHH-HHHHhcCCCCCCccccccccH-------------HHHHhhhcccccccccccccccc
Q 041491 388 GQVSPKSDVYGYGIT-LIETFTKKKPTCEIFCEEMNL-------------KNWVNDFLPISVMNVVDTSLLRR 446 (467)
Q Consensus 388 ~~~~~~~Dv~slGvi-l~el~tg~~Pf~~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~~ 446 (467)
.. +.++||||+|++ .+++++|..||.......... ..-....+++++.++|.+||..|
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 66 889999998777 788999999996421000000 00122345566888888888877
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=302.71 Aligned_cols=232 Identities=16% Similarity=0.142 Sum_probs=176.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCC-CCc---------------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRH-RNL--------------- 276 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni--------------- 276 (467)
...|...+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 456788899999999999999975 599999999874322 235778999999999977 221
Q ss_pred ------eeEEEEeec-----CCeeeEEEecccCCCHHHhhh------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 041491 277 ------VKIISSCSN-----GNFEALVLEYMANGSLEKCLY------SSNGILDIFQRLSIMIDVALALEYLHFGYSNPV 339 (467)
Q Consensus 277 ------v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 339 (467)
..+..++.. ....+++|+++ +++|.+++. .....+++..+..++.|++.||+||| ++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 111111111 12356777765 679998883 22446788899999999999999999 9999
Q ss_pred eecCCCCCCeeecCCCcEEEeccccceecCCC--Cccccccccccccc----------cCCCCCCcccchhhHHHHHHHh
Q 041491 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--ESMRTQTLATIEYG----------REGQVSPKSDVYGYGITLIETF 407 (467)
Q Consensus 340 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~pe~~----------~~~~~~~~~Dv~slGvil~el~ 407 (467)
+||||||+|||++.++.+||+|||+++..... ...+ ..|.+||++ ....++.++|||||||++|||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999876543 2234 778999988 5566888999999999999999
Q ss_pred cCCCCCCccccccccHHHH-HhhhcccccccccccccccchhHHHHH
Q 041491 408 TKKKPTCEIFCEEMNLKNW-VNDFLPISVMNVVDTSLLRREDKYFAA 453 (467)
Q Consensus 408 tg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~~~~r~~~ 453 (467)
||+.||......+.....+ ....+|+.+.+++.+||..||++|++.
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence 9999998653332211111 113466779999999999999999654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=272.15 Aligned_cols=181 Identities=18% Similarity=0.078 Sum_probs=127.6
Q ss_pred ccCcccceeEEEEEec-CCCeEEEEEeeccc----------ccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEE
Q 041491 225 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF----------DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 225 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 292 (467)
..+.|+.|.+..++.. -|+.||+|++.... ....+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777766665432 48999999997542 12346789999999999 699999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||++|++|.+++... +.++.. .|+.||+.||+|+| ++|||||||||+|||++++|.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999654 556654 48899999999999 9999999999999999999999999999998776543
Q ss_pred c-----cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCC
Q 041491 373 S-----MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPT 413 (467)
Q Consensus 373 ~-----~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf 413 (467)
. .++..|++||.+.+ .+..++|+||+|++++++.++..|+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 35677888888764 4677899999999988887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=241.93 Aligned_cols=180 Identities=18% Similarity=0.180 Sum_probs=142.0
Q ss_pred CccCCccCcccceeEEEEEecCCCeEEEEEeecccc--------cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
+...+.||+|+||.||+|.. .++.+++|....... ...+++.+|++++++++||||+++..++...+..++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567999999999999954 578899998643321 123457899999999999999965555556777799
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++++|.+++.. +..++.|+++||+||| ++||+||||||+|||+++ .+||+|||+|+.....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999999854 5689999999999999 999999999999999998 9999999999988763
Q ss_pred C------------ccccccccccccccC--CCCCCcccchhhHHHHHHHhcCCCCCC
Q 041491 372 E------------SMRTQTLATIEYGRE--GQVSPKSDVYGYGITLIETFTKKKPTC 414 (467)
Q Consensus 372 ~------------~~~~~~~~~pe~~~~--~~~~~~~Dv~slGvil~el~tg~~Pf~ 414 (467)
. ..++..|.+||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2 235667888998876 567888999999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=208.93 Aligned_cols=165 Identities=15% Similarity=0.113 Sum_probs=125.6
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccc------------------cchHHHHHHHHHHHcC
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD------------------GALKSFDAECEVLKSV 271 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 271 (467)
...+......|++.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344455566778899999999999999996799999999964321 1245688999999999
Q ss_pred CCCCceeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 041491 272 RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLL 351 (467)
Q Consensus 272 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll 351 (467)
+|+++.. ++.. +..++||||++|++|.+ +.. .....++.|++.||.||| ++||+||||||+|||+
T Consensus 162 ~~~~v~~---~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl 226 (282)
T 1zar_A 162 QGLAVPK---VYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV 226 (282)
T ss_dssp TTSSSCC---EEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred cCCCcCe---EEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence 8544444 4333 55699999999999988 421 234579999999999999 9999999999999999
Q ss_pred cCCCcEEEeccccceecCCCCccccccccccccccC----------CCCCCcccchh
Q 041491 352 DDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGRE----------GQVSPKSDVYG 398 (467)
Q Consensus 352 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~pe~~~~----------~~~~~~~Dv~s 398 (467)
+ ++.+||+|||+|+.... +.+||++.. ..++.++|+|.
T Consensus 227 ~-~~~vkl~DFG~a~~~~~--------~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEVGE--------EGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp E-TTEEEECCCTTCEETTS--------TTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred E-CCcEEEEECCCCeECCC--------CCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9 99999999999985432 456666532 33455566654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.5e-22 Score=177.60 Aligned_cols=133 Identities=23% Similarity=0.311 Sum_probs=116.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+++.+..|..+++|++|+|++|+|++..|+.|.++++|++|+|++|+|+...+..|.++++|+.|+|++|+|
T Consensus 37 L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 116 (220)
T 2v9t_B 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI 116 (220)
T ss_dssp EECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCC
Confidence 78889999988888899999999999999999887788899999999999999999866666788899999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++..|..|..+++|+.|+|++|.|++..+..|..+++|+.|++++|++.|++.
T Consensus 117 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 117 NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 98888889999999999999999998877888888999999999999887643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=177.43 Aligned_cols=133 Identities=29% Similarity=0.314 Sum_probs=108.9
Q ss_pred eecCCCcccccCC-cCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+|+++.| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 37 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 116 (220)
T 2v70_A 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR 116 (220)
T ss_dssp EECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSC
T ss_pred EEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCc
Confidence 6788888887754 457888888888888888887777788888888888888888887777778888888888888888
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|++++|+++|+++
T Consensus 117 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 117 ITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 888778888888888888888888887778888888888888888888887654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=7e-21 Score=173.04 Aligned_cols=132 Identities=23% Similarity=0.254 Sum_probs=106.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+++.|..|.++++|++|+|++|+|+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus 45 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l 124 (229)
T 3e6j_A 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL 124 (229)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcc
Confidence 67888888887788888888888888888888765556678888888888888888866667778888888888888888
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+ .+|..+..+++|+.|+|++|+|++.++..+..+++|+.|++++|++.|+++
T Consensus 125 ~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 125 T-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp C-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred c-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8 567778888888888888888887766778888888888888888887654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-21 Score=181.70 Aligned_cols=140 Identities=19% Similarity=0.238 Sum_probs=109.0
Q ss_pred cCccCCccCcccceeEEEEEe-cCCCe--EEEEEeeccccc------------------------chHHHHHHHHHHHcC
Q 041491 219 HFSEKSLIGIGSFGTVYKGRF-LDGME--VAIKVFHLQFDG------------------------ALKSFDAECEVLKSV 271 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 271 (467)
-|++.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999998 57888 999997543111 013578899999999
Q ss_pred CCCC--ceeEEEEeecCCeeeEEEecccC-C----CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 041491 272 RHRN--LVKIISSCSNGNFEALVLEYMAN-G----SLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344 (467)
Q Consensus 272 ~h~n--iv~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 344 (467)
.|++ ++..++. +..++||||+.+ | +|.+.... .++..+..++.|++.||.|||. +.||+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 8875 4455543 356899999942 3 67665432 2344677899999999999994 579999999
Q ss_pred CCCCeeecCCCcEEEeccccceecCC
Q 041491 345 KPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 345 kp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||+|||+++ .++|+|||+|.....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETTS
T ss_pred CHHHEEEcC--cEEEEECcccccCCC
Confidence 999999998 999999999987643
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-20 Score=172.65 Aligned_cols=135 Identities=26% Similarity=0.306 Sum_probs=123.0
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.|..|.++++|++|+|++|.|++..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|+
T Consensus 39 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 118 (251)
T 3m19_A 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQ 118 (251)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCc
Confidence 37899999999888999999999999999999998888889999999999999999998878889999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
|++..+..|..+++|+.|+|++|+|++.++..+..+++|+.|++++|++++.++.
T Consensus 119 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 173 (251)
T 3m19_A 119 LKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG 173 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence 9987777789999999999999999988777899999999999999999876553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.8e-20 Score=166.52 Aligned_cols=135 Identities=27% Similarity=0.275 Sum_probs=119.1
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 32 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 111 (208)
T 2o6s_A 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQ 111 (208)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCc
Confidence 37899999998888889999999999999999987666778899999999999999997777778999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+++..+..|..+++|+.|++++|.+++.++..+..+++|+.|++++|++.+.++.
T Consensus 112 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 112 LQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred CcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence 9987777789999999999999999987777788899999999999999887653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-20 Score=170.73 Aligned_cols=130 Identities=25% Similarity=0.310 Sum_probs=64.0
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|
T Consensus 64 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 143 (251)
T 3m19_A 64 LNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143 (251)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcC
Confidence 44455555544444455555555555555555444444444555555555555555444444444455555555555555
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++..+..|..+++|+.|+|++|++++.++..+..+++|+.|++++|+++|
T Consensus 144 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 144 QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 54443344455555555555555554444444445555555555555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-20 Score=164.62 Aligned_cols=131 Identities=27% Similarity=0.318 Sum_probs=119.7
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCc-CccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPL-DIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
+|++++|+++. +|..+.. +|++|+|++|.|++..+. .|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 37899999986 5665543 999999999999966654 4999999999999999999998999999999999999999
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+|++..|..|..+++|+.|+|++|+|++.+|..+..+++|+.|++++|+++|+++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 9999888889999999999999999999999999999999999999999998765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.3e-20 Score=171.85 Aligned_cols=131 Identities=32% Similarity=0.365 Sum_probs=91.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+++++ ..+.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus 68 L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 145 (272)
T 3rfs_A 68 LALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQL 145 (272)
T ss_dssp EECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCcc
Confidence 56777777753 3666777777777777777765566667777777777777777766666677777777777777777
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++..+..|..+++|+.|++++|++++.++..+..+++|+.|++++|++++.++
T Consensus 146 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 146 QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 76666666777777777777777776666666777777777777777766444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=8.8e-20 Score=161.06 Aligned_cols=129 Identities=26% Similarity=0.317 Sum_probs=118.6
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+++++|+++. +|..+. ++|++|+|++|.|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 6899999996 455553 68999999999998 7889999999999999999999988888999999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++..|..|..+++|+.|+|++|.|++.++..|..+++|+.|++++|++.|++.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99888899999999999999999998877889999999999999999998654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=3e-19 Score=166.53 Aligned_cols=134 Identities=31% Similarity=0.326 Sum_probs=120.8
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
+|+|++|+|+.+.+..|.++++|++|+|++|.+++..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|+
T Consensus 65 ~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 65 LLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp EEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 37899999998888888999999999999999997777788999999999999999998888889999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+++..+..|..+++|+.|+|++|.+++.++..|..+++|+.|++++|++++..+
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCH
Confidence 998777778999999999999999998877889999999999999999986544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.8e-20 Score=196.41 Aligned_cols=91 Identities=40% Similarity=0.679 Sum_probs=54.2
Q ss_pred CCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCccccccccccccccccc
Q 041491 45 KVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNL 124 (467)
Q Consensus 45 ~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 124 (467)
++|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..+..+++|+.|++
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 44555555555555555555556666666666666666566666666666666666666666666666666666666666
Q ss_pred ccccccCCCCC
Q 041491 125 SFNRLKGDIPT 135 (467)
Q Consensus 125 ~~N~l~~~~~~ 135 (467)
++|+++|.+|.
T Consensus 712 s~N~l~g~iP~ 722 (768)
T 3rgz_A 712 SNNNLSGPIPE 722 (768)
T ss_dssp CSSEEEEECCS
T ss_pred cCCcccccCCC
Confidence 66666655554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.6e-19 Score=153.28 Aligned_cols=130 Identities=26% Similarity=0.328 Sum_probs=117.0
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+++++|+++.+ |..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|
T Consensus 12 l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 88 (177)
T 2o6r_A 12 IRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL 88 (177)
T ss_dssp EECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCc
Confidence 68899999975 5444 37999999999999977777889999999999999999977777889999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++..+..|..+++|+.|++++|.+++.++..+..+++|+.|++++|++.|+++
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 89 QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 98877789999999999999999998877778999999999999999998765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.5e-19 Score=168.49 Aligned_cols=134 Identities=28% Similarity=0.291 Sum_probs=119.4
Q ss_pred CeecCCCc-ccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNE-LSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
+|+|++|+ ++.+.|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 163 (285)
T 1ozn_A 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (285)
T ss_dssp EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence 37899997 88877899999999999999999999877888999999999999999999777777999999999999999
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++++..+..|..+++|+.|++++|.+++..|..+..+++|+.|++++|++++.++
T Consensus 164 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 218 (285)
T 1ozn_A 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (285)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred cccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCH
Confidence 9997766779999999999999999998888999999999999999999987443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.5e-19 Score=179.94 Aligned_cols=134 Identities=22% Similarity=0.299 Sum_probs=127.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|++|+|++|++
T Consensus 280 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 359 (455)
T 3v47_A 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCC
T ss_pred EEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcc
Confidence 78999999999999999999999999999999988899999999999999999999988889999999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
++..|..|..+++|+.|+|++|++++.++..+..+++|+.|++++|+++|++|.
T Consensus 360 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 360 RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred cccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 988899999999999999999999988788889999999999999999998874
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-18 Score=162.76 Aligned_cols=135 Identities=29% Similarity=0.304 Sum_probs=124.2
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+..|.++++|++|+|++|.++...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 41 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 120 (270)
T 2o6q_A 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQ 120 (270)
T ss_dssp EEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSC
T ss_pred EEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCc
Confidence 37999999999888899999999999999999997666778999999999999999997777889999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+++..|..|..+++|+.|+|++|.+++.++..+..+++|+.|++++|.+++..+.
T Consensus 121 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 175 (270)
T 2o6q_A 121 LKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChh
Confidence 9988888899999999999999999988778899999999999999999875553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.78 E-value=6.9e-20 Score=174.66 Aligned_cols=135 Identities=28% Similarity=0.468 Sum_probs=126.1
Q ss_pred eecCCCcccc--cCCcCccCCCCccEEEcCC-CcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccC
Q 041491 2 LSLGSNELSS--VIPSTFWNLNSILSFDFSS-NSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLEN 78 (467)
Q Consensus 2 L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~ 78 (467)
|+|++|++++ ..|..|.++++|++|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++
T Consensus 55 L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~ 134 (313)
T 1ogq_A 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134 (313)
T ss_dssp EEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCS
T ss_pred EECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCC
Confidence 7899999998 8899999999999999995 999999999999999999999999999989999999999999999999
Q ss_pred CcccCCCCccccCCCCCCEEEccCCccCCcccccccccc-cccccccccccccCCCCCC
Q 041491 79 NRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV-YLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 79 N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~~~~~~~ 136 (467)
|++++.+|..+..+++|+.|+|++|.+++.+|..+..++ +|+.|++++|.+++.+|..
T Consensus 135 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~ 193 (313)
T 1ogq_A 135 NALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193 (313)
T ss_dssp SEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG
T ss_pred CccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChH
Confidence 999999999999999999999999999988999999998 9999999999998766643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3e-19 Score=186.73 Aligned_cols=135 Identities=21% Similarity=0.275 Sum_probs=124.8
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|||++|+|+++.|..|.++++|++|||++|+|++..|++|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 56 ~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~ 135 (635)
T 4g8a_A 56 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 135 (635)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSC
T ss_pred EEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCc
Confidence 48999999999999999999999999999999998888899999999999999999997777889999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCc-ccccccccccccccccccccccCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
|++..+..|+++++|+.|+|++|.+++. .|..+..+++|+.|++++|++++..+.
T Consensus 136 l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 136 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 9988778899999999999999999864 578889999999999999999876543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.1e-19 Score=171.61 Aligned_cols=130 Identities=28% Similarity=0.217 Sum_probs=105.3
Q ss_pred eecCCCcccccCCcCcc-CCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFW-NLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+|+++.+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 44 L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 123 (361)
T 2xot_A 44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH 123 (361)
T ss_dssp EECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCc
Confidence 68888888887777787 88888888888888887777778888888888888888887767778888888888888888
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccc---cccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISL---EKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~l~l~~N~l~~ 131 (467)
|++..|..|..+++|+.|+|++|+|++.++..+ ..+++|+.|+|++|+|+.
T Consensus 124 i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 124 IVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred ccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 887777888888888888888888886655555 567888888888888875
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-19 Score=173.45 Aligned_cols=133 Identities=32% Similarity=0.590 Sum_probs=106.0
Q ss_pred eecCC-CcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGS-NELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++ |++++..|..|.++++|++|+|++|.+++.+|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|+
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 67774 88887778888888888888888888877788888888888888888888887788888888888888888888
Q ss_pred ccCCCCccccCCC-CCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 81 LQGPIPESFGELT-SLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 81 l~~~~p~~~~~~~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+++.+|..+..++ +|+.|++++|.+++.+|..+..+. |+.|++++|.+++.+|.
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~ 215 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGG
T ss_pred ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCH
Confidence 8877788888777 788888888888877777777776 78888888877765543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-18 Score=156.78 Aligned_cols=131 Identities=24% Similarity=0.265 Sum_probs=119.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+++++|+++. +|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|.++++|++|+|++|+|
T Consensus 16 v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 6789999997 465554 7999999999999987778999999999999999999988899999999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
++..+..|..+++|+.|+|++|.|++..|..|..+++|+.|+|++|+|++..+.
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 987777789999999999999999999999999999999999999999976554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-18 Score=163.22 Aligned_cols=128 Identities=31% Similarity=0.314 Sum_probs=113.2
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+++.+. ..+++|++|+|++|+|+ .+|..+.++++|++|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 59 ~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 59 QLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp EEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred EEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 378999999986553 78899999999999998 688888999999999999999997777889999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
|++..+..|..+++|+.|+|++|+|++.++..+..+++|+.|++++|+++.
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 186 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT 186 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc
Confidence 998777788899999999999999997777778889999999999999984
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-18 Score=161.35 Aligned_cols=133 Identities=27% Similarity=0.269 Sum_probs=74.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|++
T Consensus 90 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 169 (272)
T 3rfs_A 90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCc
Confidence 45555555555555555555555555555555544444455555555555555555544444455555555555555555
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++..+..|..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.|.+|
T Consensus 170 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 170 QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 55444455555555555555555555555555555555555555555555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-18 Score=162.17 Aligned_cols=133 Identities=26% Similarity=0.267 Sum_probs=109.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCc-CCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNY-LTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~-l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+++++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+ ++...|..|..+++|++|+|++|+
T Consensus 37 L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~ 116 (285)
T 1ozn_A 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116 (285)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCc
Confidence 6788888888777888888888888888888887778888888888888888887 776667788888888888888888
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+++..|..|..+++|+.|++++|.+++.++..+..+++|+.|++++|.+++..+
T Consensus 117 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 887777788888888888888888887766778888888888888888875443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=166.06 Aligned_cols=136 Identities=21% Similarity=0.314 Sum_probs=120.7
Q ss_pred CeecCCCcccccCC-cCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCC-CCCCCcCCCCCCCEEeccC
Q 041491 1 NLSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG-DIPPTIGGLTNLQLLSLEN 78 (467)
Q Consensus 1 ~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~-~~~~~~~~l~~L~~l~l~~ 78 (467)
.|+|++|+++++.+ ..|.++++|++|+|++|.+.+..+..|.++++|++|+|++|.+++ .+|..+..+++|+.|+|++
T Consensus 105 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 184 (306)
T 2z66_A 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184 (306)
T ss_dssp EEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred EEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCC
Confidence 37899999998765 689999999999999999998888889999999999999999986 5788899999999999999
Q ss_pred CcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCC
Q 041491 79 NRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 79 N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
|++++..|..|..+++|+.|+|++|.+++..+..+..+++|+.|++++|++++..+..
T Consensus 185 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 242 (306)
T 2z66_A 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242 (306)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSS
T ss_pred CCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHH
Confidence 9999888888999999999999999999887778889999999999999998876643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-20 Score=176.58 Aligned_cols=139 Identities=16% Similarity=0.181 Sum_probs=103.4
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeeccccc--------------chHH--------HHHHHHHHHcCCCCC
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG--------------ALKS--------FDAECEVLKSVRHRN 275 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~E~~~l~~l~h~n 275 (467)
.-|++.+.||+|++|.||+|...+|+.||||+++..... .... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 349999999999999999999988999999998642100 0011 234666666664443
Q ss_pred c--eeEEEEeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC
Q 041491 276 L--VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD 353 (467)
Q Consensus 276 i--v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 353 (467)
+ .+.++. ...+|||||++|++|.++... .....++.|++.+|.+|| +.|||||||||.|||+++
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeC
Confidence 3 233332 123799999999998765421 234568899999999999 999999999999999987
Q ss_pred CC----------cEEEeccccceecCC
Q 041491 354 DM----------VAHLSDFGIAKLLNG 370 (467)
Q Consensus 354 ~~----------~~kl~Dfg~a~~~~~ 370 (467)
++ .+.|+||+-+.....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCCcccccccccceEEEEeCCcccCCC
Confidence 76 389999998876553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=7.3e-19 Score=171.02 Aligned_cols=134 Identities=25% Similarity=0.238 Sum_probs=120.7
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 68 ~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 147 (361)
T 2xot_A 68 SLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147 (361)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCc
Confidence 37999999999999999999999999999999998777889999999999999999998889999999999999999999
Q ss_pred ccCCCCccc---cCCCCCCEEEccCCccCCccccccccccc--ccccccccccccCCCC
Q 041491 81 LQGPIPESF---GELTSLESLDLSVNNLSGVIPISLEKLVY--LKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~---~~~~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~l~l~~N~l~~~~~ 134 (467)
|++..+..| ..+++|+.|+|++|+|++.++..+..++. ++.|+|++|++.|++.
T Consensus 148 l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 997555555 67999999999999999887788888887 4899999999998753
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=161.56 Aligned_cols=133 Identities=21% Similarity=0.281 Sum_probs=120.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|+
T Consensus 32 ~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 111 (276)
T 2z62_A 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111 (276)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCC
Confidence 37899999999888899999999999999999997777889999999999999999998888899999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCc-ccccccccccccccccccccccCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
+++..+..+..+++|+.|++++|.+++. +|..+..+++|+.|++++|++++..
T Consensus 112 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~ 165 (276)
T 2z62_A 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (276)
T ss_dssp CCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred ccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCC
Confidence 9987777899999999999999999874 5889999999999999999988643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.4e-18 Score=153.48 Aligned_cols=133 Identities=21% Similarity=0.214 Sum_probs=119.6
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCC-cCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP-LDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
.+++++|+++. +|..+. ..+++|+|++|+|++..| ..|..+++|+.|+|++|++++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 37899999997 466553 467899999999997655 46899999999999999999888889999999999999999
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCC
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 148 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGA 148 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTT
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHH
Confidence 999988888999999999999999999998999999999999999999999866643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.5e-18 Score=160.15 Aligned_cols=131 Identities=24% Similarity=0.217 Sum_probs=119.7
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+++.|..|.++++|++|+|++|.|++..+ ...+++|+.|+|++|+++ .+|..+.++++|+.|+|++|+
T Consensus 35 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~ 111 (290)
T 1p9a_G 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR 111 (290)
T ss_dssp EEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSC
T ss_pred EEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCc
Confidence 37999999999989999999999999999999985433 378999999999999998 788899999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
|++..|..|..+++|+.|+|++|+|++.++..|..+++|+.|++++|+|+..++
T Consensus 112 l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 165 (290)
T 1p9a_G 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (290)
T ss_dssp CCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred CcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCH
Confidence 998888899999999999999999998888889999999999999999986544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=186.25 Aligned_cols=134 Identities=34% Similarity=0.516 Sum_probs=91.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|++++..|..|.++++|++|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+..+++|++|+|++|++
T Consensus 399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 56667777766677777777777777777777666666666666777777777766666666666666666666666666
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|.
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 532 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCH
Confidence 666666666666666666666666666666666666666666666666665553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=150.46 Aligned_cols=129 Identities=19% Similarity=0.184 Sum_probs=111.0
Q ss_pred CeecCCCccc-ccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELS-SVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
.|+|++|+++ +.+|..|..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|+.|+|++|
T Consensus 28 ~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 105 (168)
T 2ell_A 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105 (168)
T ss_dssp EEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSS
T ss_pred EEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCC
Confidence 3789999998 56788889999999999999999865 78899999999999999999778888888999999999999
Q ss_pred cccCCCC-ccccCCCCCCEEEccCCccCCccc---ccccccccccccccccccccC
Q 041491 80 RLQGPIP-ESFGELTSLESLDLSVNNLSGVIP---ISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 80 ~l~~~~p-~~~~~~~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++++..+ ..+..+++|+.|++++|.+++.++ ..+..+++|+.|++++|.+..
T Consensus 106 ~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 106 KLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp SCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 9986422 688899999999999999997655 478889999999999998764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=8.8e-18 Score=152.50 Aligned_cols=129 Identities=24% Similarity=0.272 Sum_probs=116.6
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+++++++++. +|..+. ++|++|+|++|.|++..|..|.++++|+.|+|++|+++...+..|.++++|+.|+|++|+|
T Consensus 24 v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l 100 (229)
T 3e6j_A 24 VDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQL 100 (229)
T ss_dssp EECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred eEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcC
Confidence 6788999996 455553 8999999999999988899999999999999999999877677889999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|++..+
T Consensus 101 ~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred CccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence 9887788999999999999999999 668888999999999999999986544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=166.54 Aligned_cols=133 Identities=23% Similarity=0.282 Sum_probs=102.4
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccC---------CCCccEEEccCCcCCCCCCCCcCCCCCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIEN---------MKVVVEINLSRNYLTGDIPPTIGGLTNL 71 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~---------l~~L~~l~l~~n~l~~~~~~~~~~l~~L 71 (467)
+|+|++|+++ .+|..|.++++|++|+|++|.+.+.+|..+.. +++|++|+|++|+++ .+|..++.+++|
T Consensus 131 ~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L 208 (328)
T 4fcg_A 131 TLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208 (328)
T ss_dssp EEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTC
T ss_pred EEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCC
Confidence 3678888888 46777888888888888887777777776554 788888888888887 677777778888
Q ss_pred CEEeccCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCC
Q 041491 72 QLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 72 ~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
++|+|++|++++ +|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|++++|++.+.+|..
T Consensus 209 ~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~ 272 (328)
T 4fcg_A 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272 (328)
T ss_dssp CEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT
T ss_pred CEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchh
Confidence 888888888875 5556777788888888887777777777777778888888887777766643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.1e-18 Score=151.20 Aligned_cols=131 Identities=25% Similarity=0.253 Sum_probs=118.7
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+..|..+++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 56 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 135 (208)
T 2o6s_A 56 QLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ 135 (208)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCc
Confidence 37999999999888889999999999999999997777778999999999999999998777789999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSP 138 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~ 138 (467)
+++..+..|..+++|+.|++++|.+.+ .+++|+.|+++.|+++|.+|....
T Consensus 136 l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 136 LKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred cceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCc
Confidence 998777779999999999999998875 356899999999999999987644
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.1e-18 Score=161.85 Aligned_cols=133 Identities=25% Similarity=0.355 Sum_probs=113.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCC-cCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP-LDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
.|+|++|++++ .|..|..+++|++|+|++|.+++..+ ..+..+++|+.|+|++|++++..|..+.++++|++|+|++|
T Consensus 82 ~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 82 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp EEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred EEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 37889999986 56668889999999999999986554 57888999999999999998888888889999999999999
Q ss_pred cccC-CCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 80 RLQG-PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 80 ~l~~-~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++++ ..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++..+
T Consensus 161 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCS
T ss_pred ccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccCh
Confidence 9886 578888899999999999999988878888889999999999999886544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-18 Score=146.46 Aligned_cols=122 Identities=18% Similarity=0.203 Sum_probs=73.5
Q ss_pred eecCCCccc-ccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELS-SVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+++ +..|..+..+++|++|+|++|.+++. ..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|+
T Consensus 22 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~ 99 (149)
T 2je0_A 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99 (149)
T ss_dssp EECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSC
T ss_pred EEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCc
Confidence 556666666 44555666666666666666666543 456666666666666666665455555556666666666666
Q ss_pred ccCC-CCccccCCCCCCEEEccCCccCCccc---ccccccccccccccc
Q 041491 81 LQGP-IPESFGELTSLESLDLSVNNLSGVIP---ISLEKLVYLKDLNLS 125 (467)
Q Consensus 81 l~~~-~p~~~~~~~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~ 125 (467)
+++. .|..+..+++|+.|++++|.+++.++ ..+..+++|+.|+++
T Consensus 100 i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 100 IKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 6642 22556666666666666666665444 355666666666654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.8e-18 Score=175.35 Aligned_cols=135 Identities=21% Similarity=0.287 Sum_probs=125.7
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 36 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 115 (606)
T 3vq2_A 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSC
T ss_pred EEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCc
Confidence 37999999999999999999999999999999998889999999999999999999998889999999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCC-cccccccccccccccccccccccCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSG-VIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+++..|..++++++|+.|++++|.+++ .+|..+.++++|+.|++++|.+++..+.
T Consensus 116 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred cccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 998877899999999999999999986 4699999999999999999999876554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7.1e-18 Score=176.31 Aligned_cols=133 Identities=23% Similarity=0.280 Sum_probs=121.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcc-cCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSL-NGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l-~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
+++++|++++..|..+..+++|+.|+|++|.+ .+..|+.|..+++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 450 l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~ 529 (635)
T 4g8a_A 450 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 529 (635)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred ccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCc
Confidence 67889999998899999999999999999984 45678899999999999999999998889999999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCccccccccc-ccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKL-VYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~ 134 (467)
|++..|..|..+++|+.|+|++|+|++.+|..+..+ ++|+.|++++|++.|++.
T Consensus 530 l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 530 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 998888899999999999999999999999999888 589999999999999865
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=7.6e-18 Score=148.54 Aligned_cols=134 Identities=25% Similarity=0.358 Sum_probs=113.2
Q ss_pred CeecCCCcccccCCc-CccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPS-TFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
.|+|++|+|+++.+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 33 ~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 112 (192)
T 1w8a_A 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp EEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS
T ss_pred EEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence 379999999988775 5999999999999999999888999999999999999999999888888999999999999999
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+|++..|..|..+++|+.|+|++|.+++..+.... ...++...+.++...|..|.
T Consensus 113 ~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~-~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 113 QISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHHHHHCCSGGGCBBCSST
T ss_pred cCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHH-HHHHHHcCCCCCCCCCCCCh
Confidence 99999999999999999999999999977652210 11233444555655554444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-17 Score=156.65 Aligned_cols=134 Identities=24% Similarity=0.320 Sum_probs=122.1
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+..|.++++|++|+|++|.+++..+..|.++++|+.|++++|++++..+..+..+++|++|+|++|+
T Consensus 56 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 135 (276)
T 2z62_A 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135 (276)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCc
Confidence 37999999999988999999999999999999998888899999999999999999998777789999999999999999
Q ss_pred ccCC-CCccccCCCCCCEEEccCCccCCccccccccccccc----ccccccccccCCCC
Q 041491 81 LQGP-IPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK----DLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~-~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~l~l~~N~l~~~~~ 134 (467)
+++. +|..+..+++|+.|++++|++++..+..+..+.+|+ .|++++|.+++..+
T Consensus 136 l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~ 194 (276)
T 2z62_A 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194 (276)
T ss_dssp CCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECT
T ss_pred cceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCc
Confidence 9874 589999999999999999999988888888888887 78899999886544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.5e-18 Score=169.86 Aligned_cols=133 Identities=22% Similarity=0.256 Sum_probs=120.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+++.|..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..|.++++|++|+|++|+
T Consensus 36 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 115 (477)
T 2id5_A 36 LLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENK 115 (477)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSC
T ss_pred EEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCc
Confidence 37899999999889999999999999999999998889999999999999999999997666778999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
+++..|..|..+++|+.|++++|.+++..|..|..+++|+.|++++|.+++..
T Consensus 116 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 116 IVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp CCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred cccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence 99888889999999999999999999888888999999999999999887643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.72 E-value=5.9e-18 Score=154.74 Aligned_cols=131 Identities=21% Similarity=0.253 Sum_probs=118.9
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCc-ccCCCCcCccCCCCccEEEccC-CcCCCCCCCCcCCCCCCCEEeccC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNS-LNGSLPLDIENMKVVVEINLSR-NYLTGDIPPTIGGLTNLQLLSLEN 78 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~l~l~~-n~l~~~~~~~~~~l~~L~~l~l~~ 78 (467)
.|+|++|+|+++.+..|.++++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|+.|++++
T Consensus 35 ~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~ 114 (239)
T 2xwt_C 35 TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114 (239)
T ss_dssp EEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEE
T ss_pred EEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCC
Confidence 37899999999888899999999999999997 9876777899999999999999 999977778899999999999999
Q ss_pred CcccCCCCccccCCCCCC---EEEccCC-ccCCccccccccccccc-ccccccccccCCCC
Q 041491 79 NRLQGPIPESFGELTSLE---SLDLSVN-NLSGVIPISLEKLVYLK-DLNLSFNRLKGDIP 134 (467)
Q Consensus 79 N~l~~~~p~~~~~~~~L~---~L~l~~N-~l~~~~~~~~~~l~~L~-~l~l~~N~l~~~~~ 134 (467)
|++++ +|. |..+++|+ .|++++| .+++.++..|..+++|+ .|++++|+++ .+|
T Consensus 115 n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~ 172 (239)
T 2xwt_C 115 TGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQ 172 (239)
T ss_dssp ECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EEC
T ss_pred CCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccC
Confidence 99996 666 88999998 9999999 99988778899999999 9999999998 444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-17 Score=166.92 Aligned_cols=136 Identities=23% Similarity=0.332 Sum_probs=123.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCC-CcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSL-PLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
.|+|++|+|+++.|..|.++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 34 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 113 (455)
T 3v47_A 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQC 113 (455)
T ss_dssp EEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTS
T ss_pred EEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCC
Confidence 3899999999999999999999999999999997555 678999999999999999999888999999999999999999
Q ss_pred cccCCCCcc--ccCCCCCCEEEccCCccCCccccc-ccccccccccccccccccCCCCCC
Q 041491 80 RLQGPIPES--FGELTSLESLDLSVNNLSGVIPIS-LEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 80 ~l~~~~p~~--~~~~~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
++++..|.. |..+++|+.|+|++|.+++..|.. +..+++|+.|++++|.+++..+..
T Consensus 114 ~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 173 (455)
T 3v47_A 114 NLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEED 173 (455)
T ss_dssp CCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTT
T ss_pred CCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhh
Confidence 999855554 999999999999999999887876 899999999999999998876653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=158.74 Aligned_cols=135 Identities=21% Similarity=0.299 Sum_probs=124.7
Q ss_pred CeecCCCcccccCCcCccC---------CCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCC
Q 041491 1 NLSLGSNELSSVIPSTFWN---------LNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNL 71 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L 71 (467)
.|+|++|++.+..|..+.. +++|++|+|++|+++ .+|..+.++++|++|+|++|+++ .+|..+..+++|
T Consensus 154 ~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L 231 (328)
T 4fcg_A 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231 (328)
T ss_dssp EEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTC
T ss_pred EEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCC
Confidence 3789999988888988765 999999999999998 78989999999999999999999 467789999999
Q ss_pred CEEeccCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCCC
Q 041491 72 QLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRS 137 (467)
Q Consensus 72 ~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~ 137 (467)
++|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|++++|++.+.+|...
T Consensus 232 ~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l 297 (328)
T 4fcg_A 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297 (328)
T ss_dssp CEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGG
T ss_pred CEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHH
Confidence 999999999999999999999999999999999999999999999999999999999999888653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=173.03 Aligned_cols=130 Identities=24% Similarity=0.298 Sum_probs=104.0
Q ss_pred eecCCCcccccCC-cCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCC-CCCCCcCCCCCCCEEeccCC
Q 041491 2 LSLGSNELSSVIP-STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG-DIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 2 L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~-~~~~~~~~l~~L~~l~l~~N 79 (467)
|+|++|++++..| ..|.++++|++|++++|.+.+..|..|.++++|+.|+|++|++++ .+|..+..+++|+.|+|++|
T Consensus 404 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n 483 (606)
T 3vq2_A 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483 (606)
T ss_dssp EECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred eECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCC
Confidence 6788888887766 677888888888888888887777778888888888888888876 36777888888888888888
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++++..|..|..+++|+.|++++|++++.+|..+..+++|+.|++++|+++.
T Consensus 484 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 535 (606)
T 3vq2_A 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535 (606)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC
T ss_pred cCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc
Confidence 8887777778888888888888888887777888888888888888888773
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.2e-17 Score=165.64 Aligned_cols=132 Identities=25% Similarity=0.270 Sum_probs=116.9
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+++.|..|.++++|+.|+|++|.|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 79 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 158 (452)
T 3zyi_A 79 YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP 158 (452)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCC
T ss_pred EEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCC
Confidence 37899999999999999999999999999999998888999999999999999999997777789999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccC-CccCCcccccccccccccccccccccccCC
Q 041491 81 LQGPIPESFGELTSLESLDLSV-NNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
+++..+..|..+++|+.|++++ |.+....+..|..+++|+.|++++|.+++.
T Consensus 159 l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 159 IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp CCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred cceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9977777899999999999998 555555456788899999999999998753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=164.15 Aligned_cols=131 Identities=24% Similarity=0.281 Sum_probs=91.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCC-CcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSS-NSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+|+.+.+..|.++++|+.|+|++ |.+....+..|.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|+
T Consensus 141 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~ 218 (440)
T 3zyj_A 141 LWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNH 218 (440)
T ss_dssp EECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSC
T ss_pred eeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCc
Confidence 67888888887777777778888888877 3454334446777777777777777776 444 36667777777777777
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus 219 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 272 (440)
T 3zyj_A 219 LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH 272 (440)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCT
T ss_pred cCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccCh
Confidence 776666677777777777777777776666666677777777777777665433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=161.12 Aligned_cols=134 Identities=20% Similarity=0.277 Sum_probs=107.2
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+++++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++
T Consensus 57 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 136 (353)
T 2z80_A 57 LDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136 (353)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCC
T ss_pred EECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCC
Confidence 78888888887777888888888888888888877777888888888888888888855445588888888888888888
Q ss_pred cCCCC-ccccCCCCCCEEEccCC-ccCCcccccccccccccccccccccccCCCCC
Q 041491 82 QGPIP-ESFGELTSLESLDLSVN-NLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 82 ~~~~p-~~~~~~~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
++..+ ..+..+++|+.|++++| .+.+..+..+..+++|+.|++++|.+++..|.
T Consensus 137 ~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 192 (353)
T 2z80_A 137 KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192 (353)
T ss_dssp SSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred cccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHH
Confidence 85444 47888888888888888 46666677888888888888888888765443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-17 Score=172.18 Aligned_cols=134 Identities=18% Similarity=0.087 Sum_probs=119.8
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+++.|..|.++++|++|+|++|++.+..|+.|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 37 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 116 (606)
T 3t6q_A 37 CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116 (606)
T ss_dssp EEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSC
T ss_pred EEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccC
Confidence 37999999999989999999999999999999998889999999999999999999998889999999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+
T Consensus 117 i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp CSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred cccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence 998778889999999999999999997554555568999999999999886543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=170.60 Aligned_cols=130 Identities=25% Similarity=0.385 Sum_probs=63.3
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCC-cCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP-LDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+++++.+. |..+++|++|+|++|.+.+..| ..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|+
T Consensus 378 L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 456 (570)
T 2z63_A 378 LDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456 (570)
T ss_dssp EECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCE
T ss_pred EECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCc
Confidence 44555555543333 4455555555555555544333 234445555555555555544444445555555555555555
Q ss_pred cc-CCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 81 LQ-GPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 81 l~-~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
++ +.+|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++.
T Consensus 457 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 509 (570)
T 2z63_A 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509 (570)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCC
Confidence 44 33444445555555555555555544444444455555555555554443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.70 E-value=6.5e-17 Score=139.55 Aligned_cols=107 Identities=29% Similarity=0.298 Sum_probs=61.0
Q ss_pred cEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCC
Q 041491 24 LSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN 103 (467)
Q Consensus 24 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N 103 (467)
+.+++++|.|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45566666655 3444332 55556666666665555555556666666666666665554445555666666666666
Q ss_pred ccCCcccccccccccccccccccccccCCC
Q 041491 104 NLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 104 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
+|++.++..|..+++|+.|+|++|+++|++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 665554555555566666666666655543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4e-17 Score=168.63 Aligned_cols=134 Identities=21% Similarity=0.271 Sum_probs=122.7
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+..|.++++|++|+|++|++++..|+.|.++++|++|+|++|++++..|..|.++++|++|++++|+
T Consensus 32 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 111 (570)
T 2z63_A 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111 (570)
T ss_dssp EEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccc
Confidence 37999999999989999999999999999999998778899999999999999999998888999999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCc-ccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+++..+..++.+++|+.|++++|.+++. +|..+.++++|+.|++++|++++..+
T Consensus 112 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~ 166 (570)
T 2z63_A 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (570)
T ss_dssp CCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred cccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH
Confidence 9977666799999999999999999873 68999999999999999999986544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.6e-17 Score=169.85 Aligned_cols=132 Identities=17% Similarity=0.189 Sum_probs=116.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|.++.+++..|.++++|++|+|++|.|++..|..|.++++|+.|+|++|.+++..|..|+++++|++|+|++|.|
T Consensus 56 l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 135 (597)
T 3oja_B 56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135 (597)
T ss_dssp EEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCC
Confidence 67888899888777888899999999999999887778899999999999999999988888889999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
++..+..|+.+++|+.|+|++|.+++.+|..|..+++|+.|++++|.+++..
T Consensus 136 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 187 (597)
T 3oja_B 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD 187 (597)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred CCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC
Confidence 9766666789999999999999999888888999999999999999988643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=172.98 Aligned_cols=134 Identities=27% Similarity=0.253 Sum_probs=118.0
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+..|.++++|++|+|++|.+++..|+.|.++++|++|+|++|++++..+..|+++++|++|+|++|+
T Consensus 29 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~ 108 (680)
T 1ziw_A 29 VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108 (680)
T ss_dssp EEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSC
T ss_pred EEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCc
Confidence 37899999998888889999999999999999998888889999999999999999986666679999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+++..|..|+.+++|+.|++++|.+++.+|..+.++++|+.|++++|.+++..+
T Consensus 109 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp CCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred cCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 988777889999999999999999998888888889999999999998876544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-17 Score=145.88 Aligned_cols=125 Identities=22% Similarity=0.326 Sum_probs=109.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++. +| .+..+++|++|+|++|.++ .+..+..+++|++|+|++|++++..|..++.+++|++|+|++|+
T Consensus 48 ~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 123 (197)
T 4ezg_A 48 YITLANINVTD-LT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123 (197)
T ss_dssp EEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSB
T ss_pred EEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCc
Confidence 37899999995 45 6889999999999999775 33478999999999999999997788899999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCc-cCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNN-LSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+++..|..+..+++|+.|++++|. ++ .+| .+..+++|+.|++++|++++
T Consensus 124 i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 124 HDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp CBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC
T ss_pred cCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC
Confidence 998788889999999999999998 66 445 68899999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.1e-17 Score=165.72 Aligned_cols=134 Identities=25% Similarity=0.241 Sum_probs=124.2
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|.|+++.|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 60 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~ 139 (477)
T 2id5_A 60 ELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND 139 (477)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTT
T ss_pred EEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCc
Confidence 37999999999999999999999999999999997666778999999999999999998889999999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+++..|..|..+++|+.|+|++|.+++.++..+..+++|+.|++++|.+.+..+
T Consensus 140 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~ 193 (477)
T 2id5_A 140 LVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193 (477)
T ss_dssp CCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECT
T ss_pred cceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeCh
Confidence 998888899999999999999999998877889999999999999999986544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.6e-17 Score=162.11 Aligned_cols=130 Identities=25% Similarity=0.259 Sum_probs=113.3
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+++.+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++
T Consensus 69 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i 148 (440)
T 3zyj_A 69 LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI 148 (440)
T ss_dssp EECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCC
T ss_pred EEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcc
Confidence 78999999998889999999999999999999987788999999999999999999977777899999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccC-CccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSV-NNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++..+..|..+++|+.|+|++ |.+....+..|..+++|+.|++++|.++.
T Consensus 149 ~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 199 (440)
T 3zyj_A 149 ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199 (440)
T ss_dssp CEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred cccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence 977777888899999999988 45554445578888888888888888874
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.8e-17 Score=163.18 Aligned_cols=132 Identities=23% Similarity=0.279 Sum_probs=95.7
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCC-CcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSS-NSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
.|+|++|+|+++.+..|.++++|+.|+|++ |.+....+..|.++++|+.|+|++|++++ +| .+..+++|+.|+|++|
T Consensus 151 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N 228 (452)
T 3zyi_A 151 ELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGN 228 (452)
T ss_dssp EEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTS
T ss_pred EEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCC
Confidence 378888988887777888888888888887 44554444567777777777777777773 33 4667777777777777
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.++
T Consensus 229 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 283 (452)
T 3zyi_A 229 HFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH 283 (452)
T ss_dssp CCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccCh
Confidence 7777667777777777777777777777667777777777777777777765433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.2e-17 Score=170.71 Aligned_cols=132 Identities=23% Similarity=0.253 Sum_probs=96.6
Q ss_pred eecCCCcccccCCc-CccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCC---CCCCcCCCCCCCEEecc
Q 041491 2 LSLGSNELSSVIPS-TFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD---IPPTIGGLTNLQLLSLE 77 (467)
Q Consensus 2 L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~---~~~~~~~l~~L~~l~l~ 77 (467)
|+|++|++++..|. .|.++++|+.|+|++|.+.+..|..|..+++|++|+|++|++++. .+..+..+++|+.|+|+
T Consensus 405 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls 484 (606)
T 3t6q_A 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484 (606)
T ss_dssp EECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECT
T ss_pred EECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECC
Confidence 67777777766544 377777777777777777776777777777777777777777652 23457777777777777
Q ss_pred CCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 78 NNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 78 ~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+|++++..|..|..+++|+.|+|++|++++..|..+..+++| .|++++|++++.+|
T Consensus 485 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~ 540 (606)
T 3t6q_A 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCG
T ss_pred CCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCH
Confidence 777777777777777777777777777777777777777777 77777777776544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.6e-17 Score=160.06 Aligned_cols=131 Identities=17% Similarity=0.200 Sum_probs=116.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|.++.+++..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 50 l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 129 (390)
T 3o6n_A 50 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129 (390)
T ss_dssp EEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCcc
Confidence 67889999987777789999999999999999877778999999999999999999988888899999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
+...+..|..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++.
T Consensus 130 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 965555678999999999999999988888899999999999999998864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-17 Score=174.28 Aligned_cols=98 Identities=13% Similarity=0.269 Sum_probs=75.5
Q ss_pred CCcCccCCCCccEEEccCCcCCCC-----------------CCCCcC--CCCCCCEEeccCCcccCCCCccccCCCCCCE
Q 041491 37 LPLDIENMKVVVEINLSRNYLTGD-----------------IPPTIG--GLTNLQLLSLENNRLQGPIPESFGELTSLES 97 (467)
Q Consensus 37 ~~~~~~~l~~L~~l~l~~n~l~~~-----------------~~~~~~--~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~ 97 (467)
+|..|+++++|++|+|++|++++. +|..++ ++++|++|+|++|++.+.+|..|+++++|+.
T Consensus 198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 277 (636)
T 4eco_A 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277 (636)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCE
T ss_pred CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCE
Confidence 677777888888888888888764 777777 8888888888888887778888888888888
Q ss_pred EEccCCc-cCC-ccccccccc------ccccccccccccccCCCCC
Q 041491 98 LDLSVNN-LSG-VIPISLEKL------VYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 98 L~l~~N~-l~~-~~~~~~~~l------~~L~~l~l~~N~l~~~~~~ 135 (467)
|++++|+ +++ .+|..+..+ ++|+.|++++|+++ .+|.
T Consensus 278 L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~ 322 (636)
T 4eco_A 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV 322 (636)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred EECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence 8888887 776 677777665 77777888877777 4544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.9e-17 Score=168.94 Aligned_cols=136 Identities=20% Similarity=0.223 Sum_probs=114.9
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.|..|.++++|++|+|++|++++..|+.|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 30 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 109 (549)
T 2z81_A 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP 109 (549)
T ss_dssp EEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred EEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCc
Confidence 37889999998888889999999999999999988778889999999999999999987777778999999999999999
Q ss_pred ccCC-CCccccCCCCCCEEEccCCccCCcc-cccccccccccccccccccccCCCCCC
Q 041491 81 LQGP-IPESFGELTSLESLDLSVNNLSGVI-PISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 81 l~~~-~p~~~~~~~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
+++. .|..++.+++|+.|++++|.+.+.+ +..+..+++|+.|++++|.+++..|..
T Consensus 110 l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 167 (549)
T 2z81_A 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167 (549)
T ss_dssp CSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred ccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhh
Confidence 8863 5678889999999999999844444 468888999999999999988765543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.69 E-value=9.2e-18 Score=159.89 Aligned_cols=132 Identities=15% Similarity=0.149 Sum_probs=105.6
Q ss_pred eecCCCcccccCCcCc--cCCCCccEEEcCCCcccCCCCcCccCC-----CCccEEEccCCcCCCCCCCCcCCCCCCCEE
Q 041491 2 LSLGSNELSSVIPSTF--WNLNSILSFDFSSNSLNGSLPLDIENM-----KVVVEINLSRNYLTGDIPPTIGGLTNLQLL 74 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~--~~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l 74 (467)
|+|++|++++..|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+++++|++|
T Consensus 100 L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 178 (312)
T 1wwl_A 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178 (312)
T ss_dssp EEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEE
T ss_pred EEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEE
Confidence 7888899988778776 8889999999999999866 7777777 889999999999987777888899999999
Q ss_pred eccCCcccCC--CCccc--cCCCCCCEEEccCCccCCc---ccccccccccccccccccccccCCCC
Q 041491 75 SLENNRLQGP--IPESF--GELTSLESLDLSVNNLSGV---IPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 75 ~l~~N~l~~~--~p~~~--~~~~~L~~L~l~~N~l~~~---~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+|++|++.+. .|..+ ..+++|+.|+|++|.+++. ....+..+++|+.|++++|++++..|
T Consensus 179 ~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp ECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred ECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 9999987754 23334 7888899999999988832 22344567888999999998887653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-16 Score=137.35 Aligned_cols=107 Identities=26% Similarity=0.280 Sum_probs=71.6
Q ss_pred cEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCC
Q 041491 24 LSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN 103 (467)
Q Consensus 24 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N 103 (467)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56677777765 5555443 66777777777777666666777777777777777777655555666777777777777
Q ss_pred ccCCcccccccccccccccccccccccCCC
Q 041491 104 NLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 104 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
+|++.++..|..+++|+.|+|++|+|.+++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 777655555666777777777777766543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.4e-17 Score=173.73 Aligned_cols=134 Identities=24% Similarity=0.231 Sum_probs=113.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCC-CcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSL-PLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
.|+|++|+|+++.|..|.++++|++|+|++|.+.+.+ |..|.++++|+.|+|++|++++..|..|+++++|++|+|++|
T Consensus 28 ~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n 107 (844)
T 3j0a_A 28 RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107 (844)
T ss_dssp EEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTC
T ss_pred EEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCC
Confidence 3789999999988899999999999999999655455 778999999999999999998888889999999999999999
Q ss_pred cccCCCCcc--ccCCCCCCEEEccCCccCCccc-ccccccccccccccccccccCCCC
Q 041491 80 RLQGPIPES--FGELTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 80 ~l~~~~p~~--~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++++..|.. |.++++|+.|+|++|.+++..+ ..|.++++|+.|++++|.+++..+
T Consensus 108 ~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~ 165 (844)
T 3j0a_A 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165 (844)
T ss_dssp CCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCS
T ss_pred CCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCH
Confidence 998766654 8889999999999999987655 578888999999999998876544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=168.73 Aligned_cols=133 Identities=20% Similarity=0.257 Sum_probs=63.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCC--------cCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCE
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP--------LDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQL 73 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--------~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~ 73 (467)
|+|++|+|+++.|..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+++...+..|.++++|+.
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 564 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce
Confidence 3444455554444444455555555555555443211 11444455555555555554333334455555555
Q ss_pred EeccCCcccCCCCccccCCCCCCEEEccCCccCCccccccc-ccccccccccccccccCCCC
Q 041491 74 LSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE-KLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 74 l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~l~l~~N~l~~~~~ 134 (467)
|+|++|++++..+..|..+++|+.|+|++|+|++.+|..+. .+++|+.|++++|++.|+++
T Consensus 565 L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred eECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 55555555544444445555555555555555544444444 44555555555555555443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.2e-16 Score=137.16 Aligned_cols=110 Identities=25% Similarity=0.286 Sum_probs=100.9
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|+
T Consensus 32 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 111 (177)
T 2o6r_A 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQ 111 (177)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCc
Confidence 37899999999888889999999999999999997777778999999999999999998877789999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCccc
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIP 110 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~ 110 (467)
+++..+..+..+++|+.|++++|.+++..|
T Consensus 112 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 112 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 998777778999999999999999997654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.3e-17 Score=142.52 Aligned_cols=123 Identities=13% Similarity=0.220 Sum_probs=74.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc-
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR- 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~- 80 (467)
|+|++|.++. +..+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..++.+++|+.|+|++|+
T Consensus 71 L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~ 148 (197)
T 4ezg_A 71 LTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148 (197)
T ss_dssp EEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTB
T ss_pred EEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCC
Confidence 5566665543 2356666666666666666665556666666666666666666665555666666666666666666
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
++ .+| .+..+++|+.|++++|.+++. + .+..+++|+.|++++|++.
T Consensus 149 i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 149 IT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC---
T ss_pred cc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcccC
Confidence 44 344 466666666666666666643 2 5566666666666666654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=4e-17 Score=158.27 Aligned_cols=130 Identities=25% Similarity=0.271 Sum_probs=117.8
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCC-CCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIP-PTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~-~~~~~l~~L~~l~l~~N 79 (467)
.|+|++|+++++.|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..+.++++|++|++++|
T Consensus 80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n 159 (353)
T 2z80_A 80 ALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159 (353)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEES
T ss_pred EEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCC
Confidence 37999999999999999999999999999999996555569999999999999999995444 47999999999999999
Q ss_pred -cccCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 80 -RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 80 -~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
.+.+..|..|..+++|+.|++++|.+++..|..+..+++|+.|++++|.++
T Consensus 160 ~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp SSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred ccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 577777789999999999999999999988999999999999999999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-17 Score=176.55 Aligned_cols=133 Identities=18% Similarity=0.296 Sum_probs=108.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEc-CCCcccCC--------------------------------------------
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDF-SSNSLNGS-------------------------------------------- 36 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l-~~N~l~~~-------------------------------------------- 36 (467)
|+|++|+++|.+|+.|++|++|+.|+| ++|.++|.
T Consensus 328 L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~ 407 (876)
T 4ecn_A 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407 (876)
T ss_dssp EECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred EECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHH
Confidence 788888888888888888888888888 77755443
Q ss_pred --------------------------------CCcCccCCCCccEEEccCCcCCC-----------------CCCCCcC-
Q 041491 37 --------------------------------LPLDIENMKVVVEINLSRNYLTG-----------------DIPPTIG- 66 (467)
Q Consensus 37 --------------------------------~~~~~~~l~~L~~l~l~~n~l~~-----------------~~~~~~~- 66 (467)
+|..|.++++|+.|+|++|++++ .+|..++
T Consensus 408 l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f 487 (876)
T 4ecn_A 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487 (876)
T ss_dssp HHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCG
T ss_pred hhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhh
Confidence 67778888888888888888887 3788877
Q ss_pred -CCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCc-cCC-cccccccccc-------cccccccccccccCCCCC
Q 041491 67 -GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNN-LSG-VIPISLEKLV-------YLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 67 -~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~-l~~-~~~~~~~~l~-------~L~~l~l~~N~l~~~~~~ 135 (467)
++++|+.|+|++|++.+.+|..|+++++|+.|+|++|+ +++ .+|..+..++ +|+.|++++|.++ .+|.
T Consensus 488 ~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~ 565 (876)
T 4ecn_A 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565 (876)
T ss_dssp GGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred ccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence 88888888888888888888888888888888888887 887 6777766665 8888888888887 5554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-17 Score=172.06 Aligned_cols=127 Identities=22% Similarity=0.440 Sum_probs=115.7
Q ss_pred CCcccccCCcCccCCCCccEEEcCCCcccCC-----------------CCcCcc--CCCCccEEEccCCcCCCCCCCCcC
Q 041491 6 SNELSSVIPSTFWNLNSILSFDFSSNSLNGS-----------------LPLDIE--NMKVVVEINLSRNYLTGDIPPTIG 66 (467)
Q Consensus 6 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-----------------~~~~~~--~l~~L~~l~l~~n~l~~~~~~~~~ 66 (467)
+|++++ +|..|+++++|++|+|++|.+++. +|..+. ++++|++|+|++|++++.+|..|+
T Consensus 192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 789998 788999999999999999999975 899988 999999999999999999999999
Q ss_pred CCCCCCEEeccCCc-ccC-CCCccccCC------CCCCEEEccCCccCCcccc--cccccccccccccccccccCCCC
Q 041491 67 GLTNLQLLSLENNR-LQG-PIPESFGEL------TSLESLDLSVNNLSGVIPI--SLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 67 ~l~~L~~l~l~~N~-l~~-~~p~~~~~~------~~L~~L~l~~N~l~~~~~~--~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++++|++|+|++|+ ++| .+|..++.+ ++|+.|++++|.++ .+|. .+..+++|+.|++++|.++|.+|
T Consensus 271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip 347 (636)
T 4eco_A 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP 347 (636)
T ss_dssp TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC
T ss_pred cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh
Confidence 99999999999998 888 788888776 89999999999999 6777 89999999999999999998777
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.66 E-value=6.7e-17 Score=140.38 Aligned_cols=122 Identities=18% Similarity=0.173 Sum_probs=58.9
Q ss_pred eecCCCcccccCCcCccCCC-CccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLN-SILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+++.+ |. +..+. +|++|+|++|.|++. ..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+
T Consensus 24 L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 99 (176)
T 1a9n_A 24 LDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99 (176)
T ss_dssp EECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred EEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCc
Confidence 44555555543 32 22222 555555555555532 345555555555555555553322333555555555555555
Q ss_pred ccCCCCc--cccCCCCCCEEEccCCccCCcccc----cccccccccccccccccc
Q 041491 81 LQGPIPE--SFGELTSLESLDLSVNNLSGVIPI----SLEKLVYLKDLNLSFNRL 129 (467)
Q Consensus 81 l~~~~p~--~~~~~~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~l~l~~N~l 129 (467)
|+. +|. .+..+++|+.|++++|.++. .|. .+..+++|+.|++++|.+
T Consensus 100 i~~-~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 100 LVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCc-chhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence 542 333 45555555555555555542 233 245555555555555544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.66 E-value=6e-16 Score=133.46 Aligned_cols=107 Identities=21% Similarity=0.248 Sum_probs=96.8
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|++++|+++. +|..+ .++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 37899999997 56555 3899999999999998889999999999999999999998877888999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCccc
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIP 110 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~ 110 (467)
|++..+..|..+++|+.|+|++|.++...+
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 998777789999999999999999986643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.4e-16 Score=162.48 Aligned_cols=128 Identities=26% Similarity=0.273 Sum_probs=116.6
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|.|+++.|..|..+++|++|+|++|.|++..|..|+++++|+.|+|++|.+++..+..|+++++|++|+|++|.
T Consensus 79 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~ 158 (597)
T 3oja_B 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158 (597)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCc
Confidence 37999999999999999999999999999999998888889999999999999999997766778999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+++..|..|..+++|+.|+|++|.+++.. +..+++|+.|++++|.+++
T Consensus 159 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 159 LERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred CCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 99988889999999999999999999763 4556778888888888775
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=4.2e-16 Score=149.57 Aligned_cols=127 Identities=18% Similarity=0.293 Sum_probs=96.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++ .+|..+. ++|+.|++++|++
T Consensus 57 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l 133 (330)
T 1xku_A 57 LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEI 133 (330)
T ss_dssp EECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCC
T ss_pred EECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcc
Confidence 677788888777777888888888888888887666777888888888888888877 5565554 6788888888888
Q ss_pred cCCCCccccCCCCCCEEEccCCccCC--cccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSG--VIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++..+..|..+++|+.|++++|.++. ..+..+..+++|+.|++++|.++.
T Consensus 134 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 134 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp CBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred cccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 77666677778888888888888753 556777777888888888887764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-16 Score=150.64 Aligned_cols=129 Identities=23% Similarity=0.308 Sum_probs=75.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCccc--CCCCcCccCC--------------------CCccEEEccCCcCCC
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLN--GSLPLDIENM--------------------KVVVEINLSRNYLTG 59 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l--------------------~~L~~l~l~~n~l~~ 59 (467)
|+|++|+++++.+..|.++++|+.|+|++|.++ +..|..|..+ ++|++|+|++|++++
T Consensus 128 L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~ 207 (332)
T 2ft3_A 128 LRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQA 207 (332)
T ss_dssp EECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCC
T ss_pred EECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCc
Confidence 667777777766667777888888888888775 2455555554 234444444444444
Q ss_pred CCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 60 DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 60 ~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
..+..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++
T Consensus 208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCc
Confidence 44445555555555555555555544445555555555555555555 344445555555555555555554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.4e-17 Score=170.50 Aligned_cols=119 Identities=23% Similarity=0.349 Sum_probs=83.6
Q ss_pred cCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccC
Q 041491 12 VIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGE 91 (467)
Q Consensus 12 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~ 91 (467)
++|..|..+++|+.|+|++|.+. .+|..+.++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|+.
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 34667777777777777777776 56666667777777777777777 66777777777777777777777 56777777
Q ss_pred CCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 92 LTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 92 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+++|+.|+|++|.|+ .+|..|..+++|+.|+|++|+|++.+|
T Consensus 292 l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p 333 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFL 333 (727)
T ss_dssp GTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHH
T ss_pred CCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCCh
Confidence 777777777777776 456667777777777777777776544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.66 E-value=6.3e-16 Score=148.51 Aligned_cols=126 Identities=23% Similarity=0.410 Sum_probs=76.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+++++.|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..+. ++|++|++++|++
T Consensus 59 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i 135 (332)
T 2ft3_A 59 LDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRI 135 (332)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCC
T ss_pred EECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCcc
Confidence 556666666655666666666666666666666555666666666666666666665 4444443 5666666666666
Q ss_pred cCCCCccccCCCCCCEEEccCCccC--CcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLS--GVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++..+..|..+++|+.|++++|.++ +..|..+..+ +|+.|++++|.+++
T Consensus 136 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 136 RKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp CCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 6554455666666666666666664 2445555555 56666666666654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.1e-16 Score=152.62 Aligned_cols=128 Identities=26% Similarity=0.273 Sum_probs=116.2
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+++...+..|.++++|++|+|++|+
T Consensus 73 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~ 152 (390)
T 3o6n_A 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 152 (390)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCc
Confidence 37999999999989999999999999999999998888889999999999999999996555667999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+++..|..|..+++|+.|++++|.+++.. +..+++|+.|++++|.+++
T Consensus 153 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 153 LERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred cCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccc
Confidence 99888889999999999999999999653 5567888999999998875
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.7e-16 Score=137.72 Aligned_cols=107 Identities=28% Similarity=0.376 Sum_probs=99.6
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+. +|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 35 ~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~ 113 (193)
T 2wfh_A 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND 113 (193)
T ss_dssp EEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCC
Confidence 37999999995 67899999999999999999998888899999999999999999998888899999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCc
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGV 108 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~ 108 (467)
|++..+..|..+++|+.|+|++|.+...
T Consensus 114 l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 114 ISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCeeChhhhhcCccccEEEeCCCCeecC
Confidence 9977777899999999999999999854
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=133.16 Aligned_cols=114 Identities=21% Similarity=0.201 Sum_probs=103.4
Q ss_pred CCCCccEEEcCCCccc-CCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCE
Q 041491 19 NLNSILSFDFSSNSLN-GSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLES 97 (467)
Q Consensus 19 ~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~ 97 (467)
..++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++. ..++.+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999998 78899999999999999999999965 78999999999999999999878888888999999
Q ss_pred EEccCCccCCc-ccccccccccccccccccccccCCCC
Q 041491 98 LDLSVNNLSGV-IPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 98 L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
|++++|.+++. .+..+..+++|+.|++++|++++..+
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 99999999975 34889999999999999999986543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.65 E-value=9e-17 Score=146.85 Aligned_cols=129 Identities=16% Similarity=0.235 Sum_probs=111.5
Q ss_pred CeecCCCc-ccccCCcCccCCCCccEEEcCC-CcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCC---EEe
Q 041491 1 NLSLGSNE-LSSVIPSTFWNLNSILSFDFSS-NSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQ---LLS 75 (467)
Q Consensus 1 ~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~---~l~ 75 (467)
.|+|++|+ ++++.+..|.++++|++|+|++ |+|++..+..|.++++|+.|+|++|++++ +|. |..+++|+ .|+
T Consensus 59 ~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~ 136 (239)
T 2xwt_C 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILE 136 (239)
T ss_dssp EEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEE
T ss_pred EEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEE
Confidence 37899997 9988888999999999999998 99997777889999999999999999985 666 88889998 999
Q ss_pred ccCC-cccCCCCccccCCCCCC-EEEccCCccCCccccccccccccccccccccc-ccCC
Q 041491 76 LENN-RLQGPIPESFGELTSLE-SLDLSVNNLSGVIPISLEKLVYLKDLNLSFNR-LKGD 132 (467)
Q Consensus 76 l~~N-~l~~~~p~~~~~~~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~-l~~~ 132 (467)
+++| ++++..+..|..+++|+ .|++++|.++..++..+.. ++|+.|++++|+ ++..
T Consensus 137 l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i 195 (239)
T 2xwt_C 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVI 195 (239)
T ss_dssp EESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEE
T ss_pred CCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccC
Confidence 9999 99877777899999999 9999999998554555555 889999999995 7753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.4e-17 Score=155.97 Aligned_cols=132 Identities=23% Similarity=0.266 Sum_probs=97.2
Q ss_pred eecCCCcccccCCcCccCC-----CCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCC--CCCCc--CCCCCCC
Q 041491 2 LSLGSNELSSVIPSTFWNL-----NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD--IPPTI--GGLTNLQ 72 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~--~~~~~--~~l~~L~ 72 (467)
|+|++|++++. |..|..+ ++|++|+|++|++.+..|..|..+++|++|+|++|++++. .|..+ ..+++|+
T Consensus 126 L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~ 204 (312)
T 1wwl_A 126 LNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204 (312)
T ss_dssp EEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCC
T ss_pred EEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCC
Confidence 67888888876 7777766 8888888888888877778888888888888888887654 23333 7788888
Q ss_pred EEeccCCcccCC--CC-ccccCCCCCCEEEccCCccCCccc-ccccccccccccccccccccCCCCC
Q 041491 73 LLSLENNRLQGP--IP-ESFGELTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 73 ~l~l~~N~l~~~--~p-~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+|+|++|++++. ++ ..+..+++|+.|+|++|++++.+| ..+..+++|+.|++++|.|+ .+|.
T Consensus 205 ~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~ 270 (312)
T 1wwl_A 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK 270 (312)
T ss_dssp EEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCS
T ss_pred EEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhh
Confidence 888888888732 11 334567788888888888887664 45566778888888888887 4443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-15 Score=132.18 Aligned_cols=105 Identities=20% Similarity=0.205 Sum_probs=94.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+++++|+++. +|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|
T Consensus 17 l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l 93 (174)
T 2r9u_A 17 VNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL 93 (174)
T ss_dssp EECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence 7899999986 566564 8999999999999988899999999999999999999977777789999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVI 109 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~ 109 (467)
++..+..|..+++|+.|+|++|.+....
T Consensus 94 ~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 94 KSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9877777999999999999999998653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.2e-16 Score=133.59 Aligned_cols=114 Identities=22% Similarity=0.200 Sum_probs=103.5
Q ss_pred CCCCccEEEcCCCccc-CCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCE
Q 041491 19 NLNSILSFDFSSNSLN-GSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLES 97 (467)
Q Consensus 19 ~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~ 97 (467)
..++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3589999999999998 77898899999999999999999965 88999999999999999999878888888999999
Q ss_pred EEccCCccCCccc-ccccccccccccccccccccCCCC
Q 041491 98 LDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 98 L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
|+|++|.+++..+ ..+..+++|+.|++++|++++.++
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 9999999997543 789999999999999999987544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=161.64 Aligned_cols=124 Identities=21% Similarity=0.141 Sum_probs=105.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcC-CCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIG-GLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~-~l~~L~~l~l~~N~ 80 (467)
|+|++|+|+++.+.. +++|+.|+|++|.|++..|..|.++++|+.|+|++|++++.+|..+. .+++|+.|+|++|.
T Consensus 104 L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 677888888766543 57899999999999988888999999999999999999988888876 78999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
|++. | .+..+++|+.|+|++|.|++.+| .+..+++|+.|++++|.+++
T Consensus 181 l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~ 228 (487)
T 3oja_A 181 IYDV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL 228 (487)
T ss_dssp CCEE-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE
T ss_pred cccc-c-ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc
Confidence 9875 3 24468999999999999997654 48889999999999999986
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-16 Score=168.69 Aligned_cols=133 Identities=24% Similarity=0.343 Sum_probs=119.1
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|.. +|..+.++++|++|+|++|.|+ .+|..|.++++|+.|+|++|+|+ .+|..|++|++|++|+|++|.
T Consensus 228 ~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 304 (727)
T 4b8c_D 228 ALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM 304 (727)
T ss_dssp EEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred EEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence 38999999995 6666779999999999999999 89999999999999999999999 889999999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCccccccccccc-ccccccccccccCCCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVY-LKDLNLSFNRLKGDIPTRS 137 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~l~l~~N~l~~~~~~~~ 137 (467)
|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..+++++|.+++.+|...
T Consensus 305 l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l 361 (727)
T 4b8c_D 305 VT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER 361 (727)
T ss_dssp CC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred CC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc
Confidence 98 67888999999999999999999999988876543 3458899999999888654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.7e-16 Score=160.63 Aligned_cols=128 Identities=23% Similarity=0.310 Sum_probs=113.4
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccC--CCCcCccCCCCccEEEccCCcCCCCCCC-CcCCCCCCCEEecc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNG--SLPLDIENMKVVVEINLSRNYLTGDIPP-TIGGLTNLQLLSLE 77 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~l~~L~~l~l~ 77 (467)
.|+|++|++++..|..|.++++|++|+|++|++++ .+|..+..+++|+.|+|++|++++.+|. .+..+++|+.|+++
T Consensus 328 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls 407 (520)
T 2z7x_B 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407 (520)
T ss_dssp EEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECC
T ss_pred EEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECc
Confidence 37999999999899999999999999999999986 4567899999999999999999975665 58889999999999
Q ss_pred CCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 78 NNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 78 ~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+|++++..|..+. ++|+.|++++|+++ .+|..+..+++|+.|++++|+++.
T Consensus 408 ~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 458 (520)
T 2z7x_B 408 SNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS 458 (520)
T ss_dssp SSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc
Confidence 9999887776664 78999999999999 567777799999999999999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.3e-16 Score=160.66 Aligned_cols=128 Identities=23% Similarity=0.312 Sum_probs=110.0
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCC--CCcCccCCCCccEEEccCCcCCCCCCC-CcCCCCCCCEEecc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGS--LPLDIENMKVVVEINLSRNYLTGDIPP-TIGGLTNLQLLSLE 77 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~l~~L~~l~l~ 77 (467)
.|+|++|++++..|..|.++++|++|+|++|++++. .|..|.++++|+.|+|++|++++.+|. .+..+++|+.|+|+
T Consensus 357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~ 436 (562)
T 3a79_B 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436 (562)
T ss_dssp EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECC
T ss_pred EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECC
Confidence 378999999998999999999999999999999863 346789999999999999999974554 58889999999999
Q ss_pred CCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 78 NNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 78 ~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++.
T Consensus 437 ~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 437 SNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp SSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC
T ss_pred CCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC
Confidence 9999877666554 68999999999998 456666689999999999999985
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=8.1e-16 Score=147.60 Aligned_cols=126 Identities=29% Similarity=0.375 Sum_probs=95.6
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccC--CCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNG--SLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
|+|++|+++++.+..|.++++|+.|+|++|.+.. ..+..|.++++|+.|++++|+++ .+|..+. ++|+.|++++|
T Consensus 126 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n 202 (330)
T 1xku_A 126 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGN 202 (330)
T ss_dssp EECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTS
T ss_pred EECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCC
Confidence 6788888888777788888888888888888853 56777888888888888888877 4555443 67777777777
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
++++..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|+++
T Consensus 203 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp CCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence 777666677777777777777777777666667777777777777777776
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.63 E-value=7.6e-16 Score=144.98 Aligned_cols=122 Identities=25% Similarity=0.350 Sum_probs=79.0
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|.++.+ | .+..+++|++|+|++|++++..+ +.++++|+.|+|++|++++ +| .+..+++|+.|+|++|++
T Consensus 51 L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i 124 (291)
T 1h6t_A 51 IIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGI 124 (291)
T ss_dssp EECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCC
T ss_pred EEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcC
Confidence 56677777654 2 36667777777777777764333 6677777777777777763 23 366677777777777777
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..
T Consensus 125 ~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 125 SDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 172 (291)
T ss_dssp CCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence 643 3466667777777777776654 45666666777777777666543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-16 Score=150.93 Aligned_cols=124 Identities=20% Similarity=0.122 Sum_probs=91.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcC-CCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIG-GLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~-~l~~L~~l~l~~N~ 80 (467)
|+|++|+++++.+.. +++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..+. .+++|++|+|++|+
T Consensus 104 L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 180 (317)
T 3o53_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (317)
T ss_dssp EECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCc
Confidence 567777777665543 46788888888888876677788888888888888888766666653 67888888888888
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+++. | ....+++|+.|+|++|++++. |..+..+++|+.|++++|++++
T Consensus 181 l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~ 228 (317)
T 3o53_A 181 IYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL 228 (317)
T ss_dssp CCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE
T ss_pred Cccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccc
Confidence 8754 3 233477888888888888754 4447778888888888888874
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-16 Score=150.51 Aligned_cols=128 Identities=20% Similarity=0.195 Sum_probs=62.1
Q ss_pred eecCCCcccccCC----cCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCC--C--CCCcCCCCCCCE
Q 041491 2 LSLGSNELSSVIP----STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD--I--PPTIGGLTNLQL 73 (467)
Q Consensus 2 L~l~~n~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~--~--~~~~~~l~~L~~ 73 (467)
|+|++|++++..| ..+..+++|++|+|++|++.+..|..|.++++|++|+|++|++++. + +..+..+++|++
T Consensus 122 L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~ 201 (310)
T 4glp_A 122 LRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQN 201 (310)
T ss_dssp CEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCS
T ss_pred EEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCE
Confidence 4555555554333 2233455555555555555554455555555555555555554421 1 122244555555
Q ss_pred EeccCCcccCCCCc----cccCCCCCCEEEccCCccCCccccccccc---cccccccccccccc
Q 041491 74 LSLENNRLQGPIPE----SFGELTSLESLDLSVNNLSGVIPISLEKL---VYLKDLNLSFNRLK 130 (467)
Q Consensus 74 l~l~~N~l~~~~p~----~~~~~~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~l~l~~N~l~ 130 (467)
|+|++|+++. +|. .+..+++|+.|+|++|++++..|..+..+ ++|+.|++++|+|+
T Consensus 202 L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~ 264 (310)
T 4glp_A 202 LALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE 264 (310)
T ss_dssp CBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC
T ss_pred EECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC
Confidence 5555555542 222 13444555555555555554444444443 35555555555554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.63 E-value=7.2e-16 Score=158.96 Aligned_cols=124 Identities=23% Similarity=0.260 Sum_probs=84.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+++++|++++ +|..+. ++|+.|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|
T Consensus 36 l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 112 (562)
T 3a79_B 36 VDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112 (562)
T ss_dssp EECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcC
Confidence 5677777775 344442 6777777777777766666777777777777777777766667777777777777777777
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCc-ccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+ .+|.. .+++|+.|+|++|.+++. +|..+.++++|+.|++++|++++
T Consensus 113 ~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 113 Q-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp C-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred C-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 6 34444 677777777777777653 24667777777777777777654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5.9e-16 Score=158.77 Aligned_cols=122 Identities=25% Similarity=0.284 Sum_probs=101.8
Q ss_pred ecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCccc
Q 041491 3 SLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQ 82 (467)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~ 82 (467)
++++|.|+++.+. .|+.|+|++|.|++ +|. |.++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|+
T Consensus 429 ~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 499 (567)
T 1dce_A 429 FLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499 (567)
T ss_dssp HHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred hhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCC
Confidence 3455666654332 48889999999985 676 899999999999999998 77888999999999999999999
Q ss_pred CCCCccccCCCCCCEEEccCCccCCcc-cccccccccccccccccccccCCCCC
Q 041491 83 GPIPESFGELTSLESLDLSVNNLSGVI-PISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 83 ~~~p~~~~~~~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+ +| .++.+++|+.|+|++|+|++.. |..+..+++|+.|++++|++++.++.
T Consensus 500 ~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 500 N-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp C-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred C-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 6 66 7889999999999999999876 88899999999999999999876654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-16 Score=150.28 Aligned_cols=135 Identities=14% Similarity=0.104 Sum_probs=115.1
Q ss_pred CeecCCCcccccCCcCc--cCCCCccEEEcCCCcccCCCC----cCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEE
Q 041491 1 NLSLGSNELSSVIPSTF--WNLNSILSFDFSSNSLNGSLP----LDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLL 74 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~--~~l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l 74 (467)
.|+|++|++++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|+++++|++|
T Consensus 95 ~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 174 (310)
T 4glp_A 95 ELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSL 174 (310)
T ss_dssp EEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEE
T ss_pred EEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEE
Confidence 37899999999999988 999999999999999997655 345679999999999999998888999999999999
Q ss_pred eccCCcccCC--C--CccccCCCCCCEEEccCCccCCcccc----cccccccccccccccccccCCCCCC
Q 041491 75 SLENNRLQGP--I--PESFGELTSLESLDLSVNNLSGVIPI----SLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 75 ~l~~N~l~~~--~--p~~~~~~~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
+|++|++.+. + +..+..+++|+.|+|++|+++.. +. .+..+++|+.|++++|.+++..|..
T Consensus 175 ~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~ 243 (310)
T 4glp_A 175 DLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALAAAGVQPHSLDLSHNSLRATVNPS 243 (310)
T ss_dssp ECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHHHHTCCCSSEECTTSCCCCCCCSC
T ss_pred ECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHHhcCCCCCEEECCCCCCCccchhh
Confidence 9999998652 2 23347899999999999999843 33 3578899999999999999875543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.4e-16 Score=161.72 Aligned_cols=118 Identities=26% Similarity=0.299 Sum_probs=106.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|++ +|. |+++++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|++ +| .++++++|+.|+|++|+|
T Consensus 446 L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l 520 (567)
T 1dce_A 446 LHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL 520 (567)
T ss_dssp EECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCC
T ss_pred EEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCC
Confidence 8999999998 465 999999999999999999 789999999999999999999996 67 899999999999999999
Q ss_pred cCCC-CccccCCCCCCEEEccCCccCCccccc---cccccccccccc
Q 041491 82 QGPI-PESFGELTSLESLDLSVNNLSGVIPIS---LEKLVYLKDLNL 124 (467)
Q Consensus 82 ~~~~-p~~~~~~~~L~~L~l~~N~l~~~~~~~---~~~l~~L~~l~l 124 (467)
++.. |..++.+++|+.|+|++|.|++.+|.. +..+++|+.|++
T Consensus 521 ~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 521 QQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9876 999999999999999999999876532 334778888764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=144.84 Aligned_cols=120 Identities=23% Similarity=0.429 Sum_probs=59.5
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|+++.+ | .+..+++|++|+|++|.+++ ++. +..+++|++|+|++|++++ ++ .+..+++|+.|+|++|++
T Consensus 46 L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l 119 (308)
T 1h6u_A 46 LSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQI 119 (308)
T ss_dssp EECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCC
T ss_pred EEeeCCCccCc-h-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCC
Confidence 44555555542 2 35555555555555555553 222 5555555555555555542 22 355555555555555555
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++. | .+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++
T Consensus 120 ~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 120 TDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 532 2 14555555555555555554322 4445555555555555443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-16 Score=158.82 Aligned_cols=124 Identities=23% Similarity=0.216 Sum_probs=76.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|+++. +|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+|
T Consensus 5 l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 81 (520)
T 2z7x_B 5 VDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81 (520)
T ss_dssp EECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCC
T ss_pred EecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCce
Confidence 5666666664 344443 5666666666666655555666666666666666666655566666666666666666666
Q ss_pred cCCCCccccCCCCCCEEEccCCccCC-cccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSG-VIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++ +|.. .+++|++|+|++|.+++ .+|..+..+++|+.|++++|.+++
T Consensus 82 ~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~ 129 (520)
T 2z7x_B 82 VK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129 (520)
T ss_dssp CE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG
T ss_pred ee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch
Confidence 63 4443 56666666666666665 245666666666666666666553
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.62 E-value=8.1e-16 Score=146.03 Aligned_cols=123 Identities=28% Similarity=0.421 Sum_probs=99.3
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++ +.|..+++|++|+|++|.+++ ++. +..+++|++|+|++|++++..+ +..+++|+.|+|++|+
T Consensus 89 ~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 162 (308)
T 1h6u_A 89 ELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQ 162 (308)
T ss_dssp EEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred EEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCc
Confidence 378889998874 368889999999999999885 443 8888999999999999885433 8888889999999998
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
+++. +. +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..
T Consensus 163 l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 163 VSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp CCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG
T ss_pred CCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc
Confidence 8864 33 8888889999999998886544 778888888888888887654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=164.88 Aligned_cols=135 Identities=27% Similarity=0.305 Sum_probs=119.6
Q ss_pred CeecCCCccc-ccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCC--cCCCCCCCEEecc
Q 041491 1 NLSLGSNELS-SVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPT--IGGLTNLQLLSLE 77 (467)
Q Consensus 1 ~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~--~~~l~~L~~l~l~ 77 (467)
+|+|++|.+. .+.|..|.++++|++|+|++|.|.+..|+.|.++++|++|+|++|.+++.+|.. |.++++|++|+|+
T Consensus 52 ~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls 131 (844)
T 3j0a_A 52 LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131 (844)
T ss_dssp EEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEE
T ss_pred EEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECC
Confidence 3789999555 455899999999999999999999888999999999999999999999866665 9999999999999
Q ss_pred CCcccCCCC-ccccCCCCCCEEEccCCccCCccccccccc--ccccccccccccccCCCCC
Q 041491 78 NNRLQGPIP-ESFGELTSLESLDLSVNNLSGVIPISLEKL--VYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 78 ~N~l~~~~p-~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l--~~L~~l~l~~N~l~~~~~~ 135 (467)
+|.+++..| ..|+++++|+.|+|++|.+++..|..+..+ ++|+.|++++|.+.+..+.
T Consensus 132 ~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~ 192 (844)
T 3j0a_A 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192 (844)
T ss_dssp SCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCC
T ss_pred CCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCcccccccc
Confidence 999987655 579999999999999999999889888887 7899999999988876554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=141.20 Aligned_cols=120 Identities=23% Similarity=0.316 Sum_probs=97.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+.+ | .+..+++|++|+|++|+|++..+ +..+++|+.|+|++|++++ +|.... ++|+.|+|++|++
T Consensus 46 L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l 118 (263)
T 1xeu_A 46 FNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNEL 118 (263)
T ss_dssp EECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCC
T ss_pred EECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCcc
Confidence 78899999864 4 68889999999999999985444 8899999999999999985 444333 8899999999988
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
++. + .+..+++|+.|+|++|++++. + .+..+++|+.|++++|++++.
T Consensus 119 ~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 119 RDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp SBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 863 3 588888899999999998865 3 678888888889998888765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-16 Score=169.57 Aligned_cols=131 Identities=18% Similarity=0.317 Sum_probs=109.8
Q ss_pred CeecCCCcccc-----------------cCCcCcc--CCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCc-CCC-
Q 041491 1 NLSLGSNELSS-----------------VIPSTFW--NLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNY-LTG- 59 (467)
Q Consensus 1 ~L~l~~n~l~~-----------------~~p~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~-l~~- 59 (467)
.|+|++|+|++ .+|..++ ++++|++|+|++|.+.+.+|..|.++++|+.|+|++|+ ++|
T Consensus 452 ~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~ 531 (876)
T 4ecn_A 452 IIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531 (876)
T ss_dssp EEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHH
T ss_pred EEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccc
Confidence 37889999998 3788877 99999999999999888999999999999999999998 887
Q ss_pred CCCCCcCCC-------CCCCEEeccCCcccCCCCc--cccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 60 DIPPTIGGL-------TNLQLLSLENNRLQGPIPE--SFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 60 ~~~~~~~~l-------~~L~~l~l~~N~l~~~~p~--~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
.+|..++.+ ++|+.|+|++|+++ .+|. .++++++|+.|+|++|.++ .+| .+..+++|+.|++++|+++
T Consensus 532 ~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE 608 (876)
T ss_dssp HHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS
T ss_pred cchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc
Confidence 677655444 48999999999988 6787 8888889999999999888 666 8888888888899888888
Q ss_pred CCCCC
Q 041491 131 GDIPT 135 (467)
Q Consensus 131 ~~~~~ 135 (467)
.+|.
T Consensus 609 -~lp~ 612 (876)
T 4ecn_A 609 -EIPE 612 (876)
T ss_dssp -CCCT
T ss_pred -cchH
Confidence 5553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.8e-16 Score=157.85 Aligned_cols=125 Identities=17% Similarity=0.151 Sum_probs=62.3
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCcc-CCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE-NMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+|+++.|..|.++++|+.|+|++|.|++..|..+. .+++|+.|+|++|.+++. |. +..+++|+.|+|++|+
T Consensus 125 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~ 202 (487)
T 3oja_A 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNK 202 (487)
T ss_dssp EECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSC
T ss_pred EECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCC
Confidence 44555555555455555555555555555555544444443 455555555555555533 11 2235555555555555
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
|++.+ ..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|++.
T Consensus 203 l~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 203 LAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred CCCCC-HhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 55422 235555555555555555553 3444445555555555555554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=4.4e-16 Score=160.12 Aligned_cols=130 Identities=25% Similarity=0.284 Sum_probs=113.6
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCC-CCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD-IPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~-~~~~~~~l~~L~~l~l~~N 79 (467)
+|+|++|+++++.|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++. .|..++++++|++|++++|
T Consensus 54 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n 133 (549)
T 2z81_A 54 VLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133 (549)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEES
T ss_pred EEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCC
Confidence 479999999999999999999999999999999987777799999999999999999863 5778999999999999999
Q ss_pred cccCCCC-ccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 80 RLQGPIP-ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 80 ~l~~~~p-~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
++.+.+| ..|..+++|+.|++++|.+++..|..+..+++|+.|++++|.+.
T Consensus 134 ~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp SSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred ccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 9544444 68999999999999999999988888887777777766666543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.2e-15 Score=138.49 Aligned_cols=118 Identities=27% Similarity=0.401 Sum_probs=56.5
Q ss_pred ecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCccc
Q 041491 3 SLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQ 82 (467)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~ 82 (467)
+|++|.++.+. .+..+++|+.|++++|.++ .+| .+..+++|+.|+|++|++++..+ +.++++|+.|+|++|+++
T Consensus 25 ~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~ 98 (263)
T 1xeu_A 25 NLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK 98 (263)
T ss_dssp HHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCS
T ss_pred HhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccC
Confidence 34455555432 3444555555555555554 233 34555555555555555553322 555555555555555555
Q ss_pred CCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 83 GPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 83 ~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+ +|. +.. ++|+.|+|++|.+++. + .+..+++|+.|++++|++++
T Consensus 99 ~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 99 N-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp C-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCB
T ss_pred C-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCC
Confidence 3 222 111 4555555555555532 1 34455555555555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.8e-15 Score=142.43 Aligned_cols=121 Identities=27% Similarity=0.421 Sum_probs=102.9
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+++++.+ +.++++|++|+|++|.+++ +| .+..+++|+.|+|++|++++. ..+..+++|+.|++++|+
T Consensus 72 ~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~ 145 (291)
T 1h6t_A 72 KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNK 145 (291)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSC
T ss_pred EEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCc
Confidence 37899999998655 8899999999999999984 44 488999999999999999853 468889999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+++. ..+..+++|+.|++++|.+++..| +..+++|+.|++++|.+++
T Consensus 146 l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 146 ITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 9864 578889999999999999987655 8888999999999998876
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.59 E-value=4e-15 Score=143.78 Aligned_cols=131 Identities=16% Similarity=0.076 Sum_probs=101.2
Q ss_pred eecCCC-cccccCCcCccCCCCccEEEcCC-CcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 2 LSLGSN-ELSSVIPSTFWNLNSILSFDFSS-NSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 2 L~l~~n-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
++++++ +|++ +|. |..+++|+.|+|++ |.|++..+..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 577777 8887 556 88899999999996 9998777788999999999999999999888888999999999999999
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCccc-ccccccccccccccccccccCCCCC
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+|++..+..|..++ |+.|+|++|.+..... ..|..+.......+..+.++|..|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 99977666776666 9999999999885433 2333333333444555666665554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.3e-15 Score=153.36 Aligned_cols=120 Identities=25% Similarity=0.360 Sum_probs=52.2
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|.|+.+ | .|..+++|+.|+|++|+|++..| +..+++|+.|+|++|++++ +| .+..+++|+.|+|++|+|
T Consensus 48 L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l 121 (605)
T 1m9s_A 48 IIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGI 121 (605)
T ss_dssp CBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCC
T ss_pred EECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCC
Confidence 34445554432 2 24445555555555555443222 4444444444444444442 22 344444444444444444
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++. +.+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.|++
T Consensus 122 ~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 122 SDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 431 2244444444444444444432 233444444444444444443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.3e-15 Score=145.36 Aligned_cols=125 Identities=22% Similarity=0.316 Sum_probs=107.5
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|++++..+ +..+++|+.|+|++|.+++ .+. +..+++|++|++++|++++. ..+..+++|+.|++++|++
T Consensus 204 L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l 277 (347)
T 4fmz_A 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI 277 (347)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred eecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCcc
Confidence 6888999997655 8889999999999999985 443 88999999999999999853 4688899999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++. +.+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++..|
T Consensus 278 ~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 278 SDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 864 458889999999999999998888889999999999999999987655
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=6.8e-18 Score=149.66 Aligned_cols=129 Identities=23% Similarity=0.279 Sum_probs=115.1
Q ss_pred eecCCCcccccCCc------CccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEe
Q 041491 2 LSLGSNELSSVIPS------TFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLS 75 (467)
Q Consensus 2 L~l~~n~l~~~~p~------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~ 75 (467)
++|+.|.+++..|. .|..+++|++|+|++|.+++ +| .+.++++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 23 l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~ 99 (198)
T 1ds9_A 23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEE
T ss_pred cchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEE
Confidence 57888899888777 89999999999999999986 77 8999999999999999998 7788888889999999
Q ss_pred ccCCcccCCCCccccCCCCCCEEEccCCccCCccc-ccccccccccccccccccccCCCCC
Q 041491 76 LENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 76 l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
|++|++++ +| .+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|++++.+|.
T Consensus 100 L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 100 ISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 99999996 45 68899999999999999996544 5788999999999999999887554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.57 E-value=9.1e-15 Score=150.88 Aligned_cols=120 Identities=28% Similarity=0.447 Sum_probs=86.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+++.| |..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|++++ + ..+..|++|+.|+|++|+|
T Consensus 70 L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l 143 (605)
T 1m9s_A 70 LFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKI 143 (605)
T ss_dssp EECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCC
T ss_pred EEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCcc
Confidence 6778888887554 7777888888888887764 33 57777777777777777774 2 3477777777777777777
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++. ..+..+++|+.|+|++|.|++.+| +..+++|+.|+|++|+|++
T Consensus 144 ~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 144 TDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence 754 457777777777777777776655 6677777777777777765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=5.3e-15 Score=128.30 Aligned_cols=113 Identities=19% Similarity=0.108 Sum_probs=98.1
Q ss_pred CcCccCCCCccEEEcCCCcccCCCCcCccCCC-CccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCC
Q 041491 14 PSTFWNLNSILSFDFSSNSLNGSLPLDIENMK-VVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGEL 92 (467)
Q Consensus 14 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~ 92 (467)
...+.++.+|++|+|++|+++. +|. +..+. +|+.|+|++|++++. ..+..+++|+.|+|++|+|++..|..|..+
T Consensus 12 ~~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 87 (176)
T 1a9n_A 12 AAQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQAL 87 (176)
T ss_dssp SCEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHC
T ss_pred HHhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcC
Confidence 3557789999999999999984 564 55555 999999999999965 689999999999999999997655666999
Q ss_pred CCCCEEEccCCccCCcccc--cccccccccccccccccccC
Q 041491 93 TSLESLDLSVNNLSGVIPI--SLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 93 ~~L~~L~l~~N~l~~~~~~--~~~~l~~L~~l~l~~N~l~~ 131 (467)
++|+.|++++|.++. +|. .+..+++|+.|++++|+++.
T Consensus 88 ~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~ 127 (176)
T 1a9n_A 88 PDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN 127 (176)
T ss_dssp TTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred CCCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCC
Confidence 999999999999975 455 88999999999999999974
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.2e-15 Score=143.64 Aligned_cols=126 Identities=17% Similarity=0.165 Sum_probs=97.3
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCc-cCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDI-ENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
|+|++|+++++.|..|..+++|++|+|++|.+++..+..+ ..+++|++|+|++|++++. |. ...+++|++|+|++|+
T Consensus 125 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~ 202 (317)
T 3o53_A 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNK 202 (317)
T ss_dssp EECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSC
T ss_pred EECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCc
Confidence 6788888888777788888888888888888887666666 3678888888888888744 32 3347888888888888
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+++ +|..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++.|
T Consensus 203 l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 203 LAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBH
T ss_pred CCc-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccC
Confidence 885 44457788888888888888884 56677788888888888888874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.55 E-value=7.7e-15 Score=141.79 Aligned_cols=108 Identities=23% Similarity=0.271 Sum_probs=98.7
Q ss_pred cEEEcCCC-cccCCCCcCccCCCCccEEEccC-CcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEcc
Q 041491 24 LSFDFSSN-SLNGSLPLDIENMKVVVEINLSR-NYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS 101 (467)
Q Consensus 24 ~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~-n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~ 101 (467)
..+++++| .|+ .+|. +..+++|+.|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45799998 898 5888 99999999999996 99998878899999999999999999999999999999999999999
Q ss_pred CCccCCcccccccccccccccccccccccCCCC
Q 041491 102 VNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 102 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
+|+|++.++..+..++ |+.|+|++|+|.|++.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 9999988777777766 9999999999998765
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=140.47 Aligned_cols=123 Identities=26% Similarity=0.401 Sum_probs=101.2
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+++++.+ +..+++|+.|++++|.+.+..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|++
T Consensus 182 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l 255 (347)
T 4fmz_A 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255 (347)
T ss_dssp EECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCcc
Confidence 7888999887544 8889999999999999885444 8888999999999999985433 88899999999999998
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++. +.+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..+
T Consensus 256 ~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~ 304 (347)
T 4fmz_A 256 SDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDM 304 (347)
T ss_dssp CCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGH
T ss_pred CCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcCh
Confidence 863 4688889999999999999865 457888899999999998876544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-14 Score=145.09 Aligned_cols=123 Identities=27% Similarity=0.418 Sum_probs=88.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|++++..| +..+++|++|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++
T Consensus 248 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l 321 (466)
T 1o6v_A 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI 321 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCC
T ss_pred EECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcC
Confidence 6778888887544 7778888888888888775433 7777778888888887775433 67777777777777777
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++..| +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..|
T Consensus 322 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 322 SDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp SCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred CCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 76544 66777777777777777754 356677777777777777776554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.1e-14 Score=144.48 Aligned_cols=121 Identities=29% Similarity=0.481 Sum_probs=103.2
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+++++ +.+..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++
T Consensus 226 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l 299 (466)
T 1o6v_A 226 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 299 (466)
T ss_dssp EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCC
T ss_pred EECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcc
Confidence 78899999874 468889999999999999986544 8889999999999999986544 88899999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
++..| +..+++|+.|++++|++++..| +..+++|+.|++++|++++.
T Consensus 300 ~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 300 EDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp SCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred cCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 87544 8889999999999999998766 77889999999999998875
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.5e-14 Score=147.68 Aligned_cols=89 Identities=38% Similarity=0.468 Sum_probs=46.2
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|++ +|. |.+ +|+.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCC
Confidence 5566666665 333 443 56666666666654 443 34555555555555553 333 344555555555555
Q ss_pred cCCCCccccCCCCCCEEEccCCccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLS 106 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~ 106 (467)
++ +|. |. ++|+.|+|++|.|+
T Consensus 173 ~~-lp~-l~--~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 173 TF-LPE-LP--ESLEALDVSTNLLE 193 (571)
T ss_dssp SC-CCC-CC--TTCCEEECCSSCCS
T ss_pred CC-cch-hh--CCCCEEECcCCCCC
Confidence 54 333 33 45555555555555
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1e-13 Score=128.26 Aligned_cols=145 Identities=14% Similarity=0.101 Sum_probs=115.1
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 293 (467)
..-++|++....+.|+.+.||++.. +++.+++|+...........+.+|+.+++.+. +..++++++++...+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446788888899999999999975 47899999987543233456889999999884 678889999999889999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG--------------------------------------- 334 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------- 334 (467)
||++|.++.+... +......++.+++++++.||.-
T Consensus 90 e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999987631 1122346889999999999940
Q ss_pred -----------------CCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 335 -----------------YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 335 -----------------~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876566799999875
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-13 Score=140.75 Aligned_cols=111 Identities=29% Similarity=0.379 Sum_probs=66.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|++ +|..+ +++|+.|+|++|.|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|+.|+|++|+|
T Consensus 64 L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l 132 (571)
T 3cvr_A 64 LQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQL 132 (571)
T ss_dssp EECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCC
T ss_pred EEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcC
Confidence 5677777776 44434 256777777777766 455 345666667777766664 454 443 666666666666
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|++++|+|++
T Consensus 133 ~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 133 TM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp SC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred CC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence 65 443 45566666666666664 333 34556666666666554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.48 E-value=4.2e-14 Score=136.71 Aligned_cols=121 Identities=17% Similarity=0.152 Sum_probs=64.7
Q ss_pred ecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCC-CCcCCCCCCCE-EeccCCc
Q 041491 3 SLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIP-PTIGGLTNLQL-LSLENNR 80 (467)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~-~~~~~l~~L~~-l~l~~N~ 80 (467)
+.++|+++. +|..+ .+++++|+|++|+|+...+++|.++++|++|+|++|++.+.+| ..|.++++|.. +.+++|+
T Consensus 15 ~C~~~~Lt~-iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~ 91 (350)
T 4ay9_X 15 LCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91 (350)
T ss_dssp EEESTTCCS-CCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETT
T ss_pred EecCCCCCc-cCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCc
Confidence 445555554 33333 2455666666666654333455666666666666666544333 34555555543 3444556
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccc
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 126 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 126 (467)
|++..|..|..+++|+.|++++|.+++.++..+....++..+++.+
T Consensus 92 l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~ 137 (350)
T 4ay9_X 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137 (350)
T ss_dssp CCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred ccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc
Confidence 6555555566666666666666666555444444444555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=3.5e-16 Score=138.59 Aligned_cols=124 Identities=21% Similarity=0.263 Sum_probs=107.9
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|++++ +| .|.++++|++|+|++|.++ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|+
T Consensus 52 ~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~ 126 (198)
T 1ds9_A 52 HLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNK 126 (198)
T ss_dssp EEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEE
T ss_pred EEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCc
Confidence 37899999998 56 8999999999999999998 688888888999999999999995 45 68899999999999999
Q ss_pred ccCCCC-ccccCCCCCCEEEccCCccCCccccc----------ccccccccccccccccccC
Q 041491 81 LQGPIP-ESFGELTSLESLDLSVNNLSGVIPIS----------LEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 81 l~~~~p-~~~~~~~~L~~L~l~~N~l~~~~~~~----------~~~l~~L~~l~l~~N~l~~ 131 (467)
+++..+ ..+..+++|+.|++++|.+++.+|.. +..+++|+.|| +|+++.
T Consensus 127 i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 127 ITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp CCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 996433 47899999999999999998776653 78889999886 777753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=136.87 Aligned_cols=122 Identities=24% Similarity=0.252 Sum_probs=95.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+..+.. .+..+++|+.|+|++|++++ +| +..+++|+.|++++|++++. .++.+++|+.|++++|++
T Consensus 153 L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l 224 (457)
T 3bz5_A 153 LDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKL 224 (457)
T ss_dssp EECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCC
T ss_pred EECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcc
Confidence 678888555444 47888999999999999885 55 78888899999999998854 388888999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccc-------cccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLV-------YLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~-------~L~~l~l~~N~l~~~~~ 134 (467)
++ +| +..+++|+.|++++|++++.++..+..+. +|+.|++++|++.+.+|
T Consensus 225 ~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 225 TE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp SC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred cc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 87 55 78888999999999999887666655554 45667777776666555
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.44 E-value=6.4e-13 Score=132.98 Aligned_cols=119 Identities=19% Similarity=0.212 Sum_probs=65.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+++++ | +..+++|++|+|++|++++. + +..+++|++|++++|+..+.+ .+..+++|+.|++++|++
T Consensus 111 L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l 182 (457)
T 3bz5_A 111 LNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKI 182 (457)
T ss_dssp EECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcc
Confidence 67777877764 3 77777777777777777753 2 555555555555555333333 244445555555555555
Q ss_pred cCCCC-------------------ccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 82 QGPIP-------------------ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 82 ~~~~p-------------------~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
++ +| ..++.+++|+.|++++|++++ +| +..+++|+.|++++|++++.
T Consensus 183 ~~-l~l~~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 183 TE-LDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CC-CCCTTCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC
T ss_pred ce-eccccCCCCCEEECcCCcCCeeccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCc
Confidence 43 22 024445555555555555554 23 44455555555555555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.42 E-value=9.2e-15 Score=142.08 Aligned_cols=130 Identities=22% Similarity=0.185 Sum_probs=103.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCC----cCccCCC-CccEEEccCCcCCCCCCCCcCCC-----CCC
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLP----LDIENMK-VVVEINLSRNYLTGDIPPTIGGL-----TNL 71 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~l~-~L~~l~l~~n~l~~~~~~~~~~l-----~~L 71 (467)
+.|++|++++..|..+...++|++|+|++|.|++..+ ..|..++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5788999998888877777779999999999986655 6778888 89999999999987767666664 889
Q ss_pred CEEeccCCcccCCCCcc----ccCC-CCCCEEEccCCccCCcccccccc-----cccccccccccccccC
Q 041491 72 QLLSLENNRLQGPIPES----FGEL-TSLESLDLSVNNLSGVIPISLEK-----LVYLKDLNLSFNRLKG 131 (467)
Q Consensus 72 ~~l~l~~N~l~~~~p~~----~~~~-~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~ 131 (467)
++|+|++|++++..+.. +..+ ++|+.|+|++|.+++..+..+.. .++|+.|++++|.+++
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 99999999998766654 3444 78999999999998776655443 2588999999998874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.42 E-value=4.5e-15 Score=145.65 Aligned_cols=130 Identities=21% Similarity=0.298 Sum_probs=77.4
Q ss_pred eecCCCcccc----cCCcCccCC---------CCccEEEcCCCccc-CCCC---cCccCCCCccEEEccCCcCC--C---
Q 041491 2 LSLGSNELSS----VIPSTFWNL---------NSILSFDFSSNSLN-GSLP---LDIENMKVVVEINLSRNYLT--G--- 59 (467)
Q Consensus 2 L~l~~n~l~~----~~p~~~~~l---------~~L~~L~l~~N~l~-~~~~---~~~~~l~~L~~l~l~~n~l~--~--- 59 (467)
|+|++|.|+. .++..+..+ ++|++|+|++|+++ +..| ..+..+++|+.|+|++|+++ |
T Consensus 127 L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~ 206 (386)
T 2ca6_A 127 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206 (386)
T ss_dssp EECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHH
T ss_pred EECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHH
Confidence 5666666652 234445555 66667777776665 2333 34556666666777666665 2
Q ss_pred CCCCCcCCCCCCCEEeccCCccc----CCCCccccCCCCCCEEEccCCccCCc----ccccccc--cccccccccccccc
Q 041491 60 DIPPTIGGLTNLQLLSLENNRLQ----GPIPESFGELTSLESLDLSVNNLSGV----IPISLEK--LVYLKDLNLSFNRL 129 (467)
Q Consensus 60 ~~~~~~~~l~~L~~l~l~~N~l~----~~~p~~~~~~~~L~~L~l~~N~l~~~----~~~~~~~--l~~L~~l~l~~N~l 129 (467)
..|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.+++. ++..+.. +++|+.|+|++|.+
T Consensus 207 l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i 286 (386)
T 2ca6_A 207 LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286 (386)
T ss_dssp HHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCC
T ss_pred HHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcC
Confidence 23335666666666677666664 34555666666666666666666644 3444422 56666666666666
Q ss_pred cC
Q 041491 130 KG 131 (467)
Q Consensus 130 ~~ 131 (467)
++
T Consensus 287 ~~ 288 (386)
T 2ca6_A 287 EL 288 (386)
T ss_dssp BH
T ss_pred CH
Confidence 65
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.4e-14 Score=140.89 Aligned_cols=133 Identities=26% Similarity=0.303 Sum_probs=107.7
Q ss_pred CeecCCCcccccCC----cCccCCC-CccEEEcCCCcccCCCCcCccCC-----CCccEEEccCCcCCCCCCCCc----C
Q 041491 1 NLSLGSNELSSVIP----STFWNLN-SILSFDFSSNSLNGSLPLDIENM-----KVVVEINLSRNYLTGDIPPTI----G 66 (467)
Q Consensus 1 ~L~l~~n~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~l~l~~n~l~~~~~~~~----~ 66 (467)
.|+|++|+|+...+ ..|..++ +|++|+|++|.|++..+..+..+ ++|++|+|++|++++..+..+ .
T Consensus 26 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 105 (362)
T 3goz_A 26 SLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLA 105 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHH
T ss_pred EEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHH
Confidence 37999999998777 7888898 99999999999997777777765 999999999999987666644 4
Q ss_pred CC-CCCCEEeccCCcccCCCCccc----cC-CCCCCEEEccCCccCCcccc----cccccc-cccccccccccccCCC
Q 041491 67 GL-TNLQLLSLENNRLQGPIPESF----GE-LTSLESLDLSVNNLSGVIPI----SLEKLV-YLKDLNLSFNRLKGDI 133 (467)
Q Consensus 67 ~l-~~L~~l~l~~N~l~~~~p~~~----~~-~~~L~~L~l~~N~l~~~~~~----~~~~l~-~L~~l~l~~N~l~~~~ 133 (467)
.+ ++|+.|+|++|++++..+..+ .. .++|+.|+|++|.+++..+. .+..++ +|+.|++++|++++..
T Consensus 106 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 106 AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp TSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred hCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence 44 899999999999997666544 33 46999999999999854433 344555 8999999999998644
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=130.63 Aligned_cols=78 Identities=24% Similarity=0.411 Sum_probs=37.2
Q ss_pred CCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEc
Q 041491 21 NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDL 100 (467)
Q Consensus 21 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l 100 (467)
++|++|+|++|++++ +| .|.++++|++|++++|++++ +|..+ ++|++|++++|++++ +| .++.+++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 345555555555553 44 35555555555555555542 33322 244555555555543 33 3444444444444
Q ss_pred cCCccC
Q 041491 101 SVNNLS 106 (467)
Q Consensus 101 ~~N~l~ 106 (467)
++|.++
T Consensus 203 ~~N~l~ 208 (454)
T 1jl5_A 203 DNNSLK 208 (454)
T ss_dssp CSSCCS
T ss_pred CCCcCC
Confidence 444444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.39 E-value=8.7e-13 Score=136.34 Aligned_cols=81 Identities=31% Similarity=0.300 Sum_probs=49.3
Q ss_pred CCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCccccccccccccccccc
Q 041491 45 KVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNL 124 (467)
Q Consensus 45 ~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 124 (467)
++|+.|+|++|++++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 445555666665553 33 334566666666666663 443 4566777777777776 44666667777777777
Q ss_pred ccccccCCCC
Q 041491 125 SFNRLKGDIP 134 (467)
Q Consensus 125 ~~N~l~~~~~ 134 (467)
++|++++..+
T Consensus 292 ~~N~l~~~~~ 301 (622)
T 3g06_A 292 EGNPLSERTL 301 (622)
T ss_dssp CSCCCCHHHH
T ss_pred cCCCCCCcCH
Confidence 7777665443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-14 Score=137.54 Aligned_cols=125 Identities=16% Similarity=0.205 Sum_probs=63.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCC-CCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC-
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGS-LPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN- 79 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N- 79 (467)
|+|++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|++++..+..++.+++|++|+|++|
T Consensus 75 L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~ 153 (336)
T 2ast_B 75 FRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153 (336)
T ss_dssp EECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred EEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence 44555555544333 33455555555555555433 4444555555555555555555444555555555555555555
Q ss_pred cccC-CCCccccCCCCCCEEEccCC-ccCCc-ccccccccc-cccccccccc
Q 041491 80 RLQG-PIPESFGELTSLESLDLSVN-NLSGV-IPISLEKLV-YLKDLNLSFN 127 (467)
Q Consensus 80 ~l~~-~~p~~~~~~~~L~~L~l~~N-~l~~~-~~~~~~~l~-~L~~l~l~~N 127 (467)
.+++ .++..+..+++|+.|++++| .+++. ++..+..++ +|+.|++++|
T Consensus 154 ~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp SCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred CCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 3443 13344455555555555555 55432 344445555 5555555555
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.39 E-value=6.8e-15 Score=141.40 Aligned_cols=131 Identities=16% Similarity=0.214 Sum_probs=102.7
Q ss_pred eecCCCccccc-CCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCC-cCCCC-CCCCcCCCCCCCEEeccC
Q 041491 2 LSLGSNELSSV-IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRN-YLTGD-IPPTIGGLTNLQLLSLEN 78 (467)
Q Consensus 2 L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n-~l~~~-~~~~~~~l~~L~~l~l~~ 78 (467)
|+|++|.++.. .|..+..+++|++|+|++|.+++..+..+..+++|++|+|++| .+++. ++..+.++++|++|++++
T Consensus 98 L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~ 177 (336)
T 2ast_B 98 MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 177 (336)
T ss_dssp EECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCC
T ss_pred EEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCC
Confidence 78888888865 6777888889999999999888777778888888999999888 57642 566677888888888888
Q ss_pred C-cccCC-CCccccCCC-CCCEEEccCC--ccC-Cccccccccccccccccccccc-ccCC
Q 041491 79 N-RLQGP-IPESFGELT-SLESLDLSVN--NLS-GVIPISLEKLVYLKDLNLSFNR-LKGD 132 (467)
Q Consensus 79 N-~l~~~-~p~~~~~~~-~L~~L~l~~N--~l~-~~~~~~~~~l~~L~~l~l~~N~-l~~~ 132 (467)
| .+++. ++..+..++ +|+.|++++| .++ +.+|..+..+++|+.|++++|. +++.
T Consensus 178 ~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~ 238 (336)
T 2ast_B 178 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 238 (336)
T ss_dssp CTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGG
T ss_pred CCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHH
Confidence 8 88753 466677888 8888888888 454 4456677788888888888888 5543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.37 E-value=8.7e-15 Score=143.55 Aligned_cols=129 Identities=19% Similarity=0.245 Sum_probs=88.0
Q ss_pred eecCCC---cccccCCcCc-------cCCCCccEEEcCCCcccC----CCCcCccCCCCccEEEccCCcCCCCCCCCc--
Q 041491 2 LSLGSN---ELSSVIPSTF-------WNLNSILSFDFSSNSLNG----SLPLDIENMKVVVEINLSRNYLTGDIPPTI-- 65 (467)
Q Consensus 2 L~l~~n---~l~~~~p~~~-------~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~-- 65 (467)
|+|++| ++++..|..+ ..+++|++|+|++|.++. .+|..+..+++|+.|+|++|.+++..+..+
T Consensus 65 L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~ 144 (386)
T 2ca6_A 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144 (386)
T ss_dssp EECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred EeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH
Confidence 677774 4444445444 677888888888888875 366677778888888888888763333333
Q ss_pred --CCC---------CCCCEEeccCCccc-CCCC---ccccCCCCCCEEEccCCccC--C---cccccccccccccccccc
Q 041491 66 --GGL---------TNLQLLSLENNRLQ-GPIP---ESFGELTSLESLDLSVNNLS--G---VIPISLEKLVYLKDLNLS 125 (467)
Q Consensus 66 --~~l---------~~L~~l~l~~N~l~-~~~p---~~~~~~~~L~~L~l~~N~l~--~---~~~~~~~~l~~L~~l~l~ 125 (467)
..+ ++|++|+|++|+++ +..| ..+..+++|+.|+|++|.++ | ..|..+..+++|+.|+|+
T Consensus 145 ~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls 224 (386)
T 2ca6_A 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224 (386)
T ss_dssp HHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECC
T ss_pred HHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECc
Confidence 333 77888888888876 3344 35667777888888888776 2 334466777778888888
Q ss_pred ccccc
Q 041491 126 FNRLK 130 (467)
Q Consensus 126 ~N~l~ 130 (467)
+|.++
T Consensus 225 ~n~l~ 229 (386)
T 2ca6_A 225 DNTFT 229 (386)
T ss_dssp SSCCH
T ss_pred CCCCC
Confidence 88775
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=130.01 Aligned_cols=54 Identities=33% Similarity=0.471 Sum_probs=28.8
Q ss_pred CCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 70 NLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 70 ~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+|+.|++++|++++ +|.. +++|+.|++++|++++ +|. .+++|+.|++++|++++
T Consensus 318 ~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 318 SLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS
T ss_pred cCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCc
Confidence 55556666665554 3332 3555666666666553 233 24555556666665555
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=120.28 Aligned_cols=136 Identities=15% Similarity=0.061 Sum_probs=101.4
Q ss_pred cCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCC--ceeEEEEeecCCeeeEEEecc
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN--LVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~ 296 (467)
+|.+....+.|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +++++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44443333466679999998767888999997543 2356789999999885433 667999888888889999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY----------------------------------------- 335 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 335 (467)
+|.++. ... .+ ...++.++++.+..||...
T Consensus 98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 998884 211 12 2357788888888888311
Q ss_pred --------------CCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 336 --------------SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 336 --------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999976
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.35 E-value=7.1e-13 Score=128.07 Aligned_cols=132 Identities=21% Similarity=0.133 Sum_probs=87.2
Q ss_pred eecCCCccccc-CCcCccCCCCccE-EEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCC----------------
Q 041491 2 LSLGSNELSSV-IPSTFWNLNSILS-FDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP---------------- 63 (467)
Q Consensus 2 L~l~~n~l~~~-~p~~~~~l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~---------------- 63 (467)
|+|++|++.+. .+..|.++++|++ +++++|+|+...|+.|.++++|+.|++++|++++..+.
T Consensus 59 L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~ 138 (350)
T 4ay9_X 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138 (350)
T ss_dssp EEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC
T ss_pred EECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc
Confidence 67777776543 3456777776654 55566777766667777777777777777776643332
Q ss_pred ---------CcCCCC-CCCEEeccCCcccCCCCccccCCCCCCEEEcc-CCccCCcccccccccccccccccccccccCC
Q 041491 64 ---------TIGGLT-NLQLLSLENNRLQGPIPESFGELTSLESLDLS-VNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 64 ---------~~~~l~-~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~-~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
.|..+. .++.|+|++|+|+.. |.......+|+.|+++ +|.++.++++.|..+++|+.|++++|+|+.-
T Consensus 139 ~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 139 INIHTIERNSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp TTCCEECTTSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred cccccccccchhhcchhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 233333 467778888888754 4333355678888886 4666655556778888888888888888754
Q ss_pred CC
Q 041491 133 IP 134 (467)
Q Consensus 133 ~~ 134 (467)
++
T Consensus 218 p~ 219 (350)
T 4ay9_X 218 PS 219 (350)
T ss_dssp CS
T ss_pred Ch
Confidence 33
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.30 E-value=9.1e-12 Score=128.71 Aligned_cols=14 Identities=36% Similarity=0.515 Sum_probs=6.7
Q ss_pred CCCCEEEccCCccC
Q 041491 93 TSLESLDLSVNNLS 106 (467)
Q Consensus 93 ~~L~~L~l~~N~l~ 106 (467)
++|+.|+|++|.++
T Consensus 141 ~~L~~L~Ls~N~l~ 154 (622)
T 3g06_A 141 PGLQELSVSDNQLA 154 (622)
T ss_dssp TTCCEEECCSSCCS
T ss_pred CCCCEEECcCCcCC
Confidence 44444444444444
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=3e-11 Score=117.09 Aligned_cols=141 Identities=13% Similarity=0.146 Sum_probs=107.0
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEee--ccc-ccchHHHHHHHHHHHcCC--CCCceeEEEEeecC---CeeeEEEe
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFH--LQF-DGALKSFDAECEVLKSVR--HRNLVKIISSCSNG---NFEALVLE 294 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e 294 (467)
.+.++.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 567899999999999874 4688888765 321 122457889999999886 45688999988776 45899999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY--------------------------------------- 335 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 335 (467)
|++|..+.+.. ...++..+...++.++++.|+.||...
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99998875421 124678888899999999999999410
Q ss_pred ----------------CCCceecCCCCCCeeecCCCc--EEEecccccee
Q 041491 336 ----------------SNPVVHCDIKPSNVLLDDDMV--AHLSDFGIAKL 367 (467)
Q Consensus 336 ----------------~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~ 367 (467)
...++|+|++|.||++++++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999875
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.23 E-value=7.2e-14 Score=140.25 Aligned_cols=130 Identities=18% Similarity=0.140 Sum_probs=86.3
Q ss_pred eecCCCcccccC-----CcCccCCCCccEEEcCCCcccCC----CCcCccCCCCccEEEccCCcCCCCCCCCcC-----C
Q 041491 2 LSLGSNELSSVI-----PSTFWNLNSILSFDFSSNSLNGS----LPLDIENMKVVVEINLSRNYLTGDIPPTIG-----G 67 (467)
Q Consensus 2 L~l~~n~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~-----~ 67 (467)
|+|++|+++... +..+..+++|++|+|++|.++.. ++..+..+++|++|+|++|.+++..+..+. .
T Consensus 232 L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~ 311 (461)
T 1z7x_W 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 311 (461)
T ss_dssp EECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTST
T ss_pred EeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccC
Confidence 678888877532 33344578888888888888743 566677778888888888877643222222 2
Q ss_pred CCCCCEEeccCCcccCC----CCccccCCCCCCEEEccCCccCCcccccccc-----cccccccccccccccC
Q 041491 68 LTNLQLLSLENNRLQGP----IPESFGELTSLESLDLSVNNLSGVIPISLEK-----LVYLKDLNLSFNRLKG 131 (467)
Q Consensus 68 l~~L~~l~l~~N~l~~~----~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~ 131 (467)
.++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++..+..+.. .++|+.|++++|.+++
T Consensus 312 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred CccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 35777888888777754 3455666777777777777776554444433 4577777777777764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.8e-11 Score=114.83 Aligned_cols=127 Identities=14% Similarity=0.155 Sum_probs=95.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCcc---------------------------------------
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE--------------------------------------- 42 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--------------------------------------- 42 (467)
|+|.+ +++.+.+.+|.++++|+.|+|++|.+....+.+|.
T Consensus 106 l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~ 184 (329)
T 3sb4_A 106 VILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQV 184 (329)
T ss_dssp -CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEE
T ss_pred EECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEe
Confidence 56777 88888888899999999999998876422222221
Q ss_pred ---------------------------------------CCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccC
Q 041491 43 ---------------------------------------NMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQG 83 (467)
Q Consensus 43 ---------------------------------------~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 83 (467)
.+++|+.|+|++|+++...+..|.+|++|+.|+|.+| ++.
T Consensus 185 ~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~ 263 (329)
T 3sb4_A 185 GAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKT 263 (329)
T ss_dssp CTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCE
T ss_pred cCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cce
Confidence 1567888888888888666667888888888888887 665
Q ss_pred CCCccccCCCCCC-EEEccCCccCCcccccccccccccccccccccccC
Q 041491 84 PIPESFGELTSLE-SLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 84 ~~p~~~~~~~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
..+.+|.+|++|+ .+++.+ .++.+.+..|.+|++|+.+++++|+++.
T Consensus 264 I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~ 311 (329)
T 3sb4_A 264 IGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITT 311 (329)
T ss_dssp ECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCE
T ss_pred ehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCc
Confidence 6667888888888 888887 6766667888888888888888887764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.13 E-value=9.7e-13 Score=131.97 Aligned_cols=130 Identities=22% Similarity=0.231 Sum_probs=88.8
Q ss_pred eecCCCcccccCCcCc-cCCC----CccEEEcCCCcccC----CCCcCccCCCCccEEEccCCcCCCCCCCCc-----CC
Q 041491 2 LSLGSNELSSVIPSTF-WNLN----SILSFDFSSNSLNG----SLPLDIENMKVVVEINLSRNYLTGDIPPTI-----GG 67 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~-~~l~----~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~-----~~ 67 (467)
|+|++|+++...+..+ ..++ +|++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+ ..
T Consensus 61 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~ 140 (461)
T 1z7x_W 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140 (461)
T ss_dssp EECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTST
T ss_pred EeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcC
Confidence 6788888876444333 2344 68888888888873 457778888888888888888764333222 23
Q ss_pred CCCCCEEeccCCcccCCC----CccccCCCCCCEEEccCCccCCcccccccc-----cccccccccccccccC
Q 041491 68 LTNLQLLSLENNRLQGPI----PESFGELTSLESLDLSVNNLSGVIPISLEK-----LVYLKDLNLSFNRLKG 131 (467)
Q Consensus 68 l~~L~~l~l~~N~l~~~~----p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~ 131 (467)
+++|++|+|++|++++.. +..+..+++|+.|++++|.+++..+..+.. .++|+.|++++|.+++
T Consensus 141 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 213 (461)
T 1z7x_W 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTS 213 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBT
T ss_pred CCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcH
Confidence 567888888888887532 455666788888888888876554444432 4478888888887765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.11 E-value=4.6e-11 Score=112.95 Aligned_cols=184 Identities=15% Similarity=0.134 Sum_probs=124.2
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC-CC--CceeEEEEeecCC---eeeEEEecc
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HR--NLVKIISSCSNGN---FEALVLEYM 296 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~--niv~~~~~~~~~~---~~~lv~e~~ 296 (467)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++++.+. +. .+++++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 57899985432 33567889999998873 32 2556666654443 458999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG------------------------------------------ 334 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 334 (467)
+|.++.+... ..++..++..++.++++.++.||..
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988865332 2357777888888888888888831
Q ss_pred -------------CCCCceecCCCCCCeeecC--CCcEEEeccccceecCCCCccccccc----ccccccc-----CCCC
Q 041491 335 -------------YSNPVVHCDIKPSNVLLDD--DMVAHLSDFGIAKLLNGKESMRTQTL----ATIEYGR-----EGQV 390 (467)
Q Consensus 335 -------------~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~----~~pe~~~-----~~~~ 390 (467)
....++|+|++|.||++++ +..+.++||+.+..-........... ..++... .+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 0135799999999999998 45678999999876433211100000 1111100 0111
Q ss_pred ---------CCcccchhhHHHHHHHhcCCCCCCc
Q 041491 391 ---------SPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 391 ---------~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
....+.|++|.++|.+.+|..||..
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 1125899999999999999988743
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.4e-12 Score=126.75 Aligned_cols=129 Identities=19% Similarity=0.200 Sum_probs=69.5
Q ss_pred eecCCCcccccCCcCccCC-----CCccEEEcCCCcccCCCCcC-ccCCCCccEEEccCCcCCCCCCCCc-----CCCCC
Q 041491 2 LSLGSNELSSVIPSTFWNL-----NSILSFDFSSNSLNGSLPLD-IENMKVVVEINLSRNYLTGDIPPTI-----GGLTN 70 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~l~l~~n~l~~~~~~~~-----~~l~~ 70 (467)
|+|++|+|+......|..+ ++|++|+|++|.|+..-... ...+++|+.|+|++|+++......+ ...++
T Consensus 77 L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~ 156 (372)
T 3un9_A 77 LNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQ 156 (372)
T ss_dssp EECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCC
T ss_pred EEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCc
Confidence 5677777765433333222 56777777777765322211 2234566666677666653322222 23456
Q ss_pred CCEEeccCCcccC----CCCccccCCCCCCEEEccCCccCCcc----ccccccccccccccccccccc
Q 041491 71 LQLLSLENNRLQG----PIPESFGELTSLESLDLSVNNLSGVI----PISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 71 L~~l~l~~N~l~~----~~p~~~~~~~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~l~l~~N~l~ 130 (467)
|+.|+|++|.|+. .++..+..+++|+.|+|++|.|++.. +..+...++|+.|+|++|.|+
T Consensus 157 L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred cceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 6666666666643 12333455666666666666665322 334445556666666666664
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.8e-10 Score=110.07 Aligned_cols=103 Identities=15% Similarity=0.084 Sum_probs=93.6
Q ss_pred CCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCC-EEeccCCcccCCCCccccCCCCCCEE
Q 041491 20 LNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQ-LLSLENNRLQGPIPESFGELTSLESL 98 (467)
Q Consensus 20 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~-~l~l~~N~l~~~~p~~~~~~~~L~~L 98 (467)
+++|+.|+|++|+++.+.+.+|.++++|+.|+|++| ++...+..|.+|++|+ .+++.+ .++...+.+|.+|++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 678999999999999777789999999999999998 8867778899999999 999999 7776777899999999999
Q ss_pred EccCCccCCccccccccccccccccc
Q 041491 99 DLSVNNLSGVIPISLEKLVYLKDLNL 124 (467)
Q Consensus 99 ~l~~N~l~~~~~~~~~~l~~L~~l~l 124 (467)
++++|.++.+.+..|.++++|+.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 99999999888889999999998864
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=2.8e-12 Score=124.56 Aligned_cols=130 Identities=22% Similarity=0.219 Sum_probs=93.7
Q ss_pred eecCCCcccccCCcCc-cCCCCccEEEcCCCcccCCCCcCc-----cCCCCccEEEccCCcCCC----CCCCCcCCCCCC
Q 041491 2 LSLGSNELSSVIPSTF-WNLNSILSFDFSSNSLNGSLPLDI-----ENMKVVVEINLSRNYLTG----DIPPTIGGLTNL 71 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~l~l~~n~l~~----~~~~~~~~l~~L 71 (467)
|+|++|.|+......+ ..+++|+.|+|++|.|+..-...+ ...++|++|+|++|.++. .++..+..+++|
T Consensus 106 L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L 185 (372)
T 3un9_A 106 VNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSV 185 (372)
T ss_dssp EECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSC
T ss_pred EEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCc
Confidence 7889998875433333 346788999999998874333333 346789999999998863 244455778889
Q ss_pred CEEeccCCcccCC----CCccccCCCCCCEEEccCCccCCcc----cccccccccccccccccccccC
Q 041491 72 QLLSLENNRLQGP----IPESFGELTSLESLDLSVNNLSGVI----PISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 72 ~~l~l~~N~l~~~----~p~~~~~~~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++|+|++|+|+.. ++..+..+++|+.|+|++|.|++.. ...+...++|+.|+|++|+|+.
T Consensus 186 ~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 186 THLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp CEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 9999999998742 2456677788999999999987532 3344456889999999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.5e-10 Score=106.05 Aligned_cols=105 Identities=25% Similarity=0.328 Sum_probs=68.1
Q ss_pred ccCCCCccE--EEcCCCccc---CCCCcCccCCCCccEEEccCCcCCC--CCCCCcCCCCCCCEEeccCCcccCCCCccc
Q 041491 17 FWNLNSILS--FDFSSNSLN---GSLPLDIENMKVVVEINLSRNYLTG--DIPPTIGGLTNLQLLSLENNRLQGPIPESF 89 (467)
Q Consensus 17 ~~~l~~L~~--L~l~~N~l~---~~~~~~~~~l~~L~~l~l~~n~l~~--~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~ 89 (467)
|...+.|.. ++++.|+.. ..++-...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444455554 666777433 1122222557788888888888886 3445666788888888888888864 334
Q ss_pred cCCC--CCCEEEccCCccCCcccc-------cccccccccccc
Q 041491 90 GELT--SLESLDLSVNNLSGVIPI-------SLEKLVYLKDLN 123 (467)
Q Consensus 90 ~~~~--~L~~L~l~~N~l~~~~~~-------~~~~l~~L~~l~ 123 (467)
..+. +|+.|+|++|.+.+..|. .+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 788888888888765552 356677777665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.79 E-value=7.3e-10 Score=101.38 Aligned_cols=96 Identities=22% Similarity=0.255 Sum_probs=73.3
Q ss_pred eecCCCccc---ccCCcCccCCCCccEEEcCCCcccC--CCCcCccCCCCccEEEccCCcCCCCCCCCcCCCC--CCCEE
Q 041491 2 LSLGSNELS---SVIPSTFWNLNSILSFDFSSNSLNG--SLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLT--NLQLL 74 (467)
Q Consensus 2 L~l~~n~l~---~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~--~L~~l 74 (467)
++++.|+.. ...+-...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 456666433 2222233568999999999999997 3456778999999999999999965 3344444 99999
Q ss_pred eccCCcccCCCCc-------cccCCCCCCEEE
Q 041491 75 SLENNRLQGPIPE-------SFGELTSLESLD 99 (467)
Q Consensus 75 ~l~~N~l~~~~p~-------~~~~~~~L~~L~ 99 (467)
+|++|.+.+..|. .+..+++|+.||
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 9999999986663 477899999887
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.78 E-value=8.8e-11 Score=121.55 Aligned_cols=129 Identities=15% Similarity=0.070 Sum_probs=65.8
Q ss_pred ecCCCcccccCCcCccC-CCCccEEEcC----CCcccCC-----CCcCccCCCCccEEEccCCc--CCCCCCCCcC-CCC
Q 041491 3 SLGSNELSSVIPSTFWN-LNSILSFDFS----SNSLNGS-----LPLDIENMKVVVEINLSRNY--LTGDIPPTIG-GLT 69 (467)
Q Consensus 3 ~l~~n~l~~~~p~~~~~-l~~L~~L~l~----~N~l~~~-----~~~~~~~l~~L~~l~l~~n~--l~~~~~~~~~-~l~ 69 (467)
+|+.|++++..+..+.. +++|+.|+|+ .|.+++. ++..+.++++|+.|+|++|. +++..+..+. .++
T Consensus 384 ~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~ 463 (592)
T 3ogk_B 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463 (592)
T ss_dssp EEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCT
T ss_pred EeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCc
Confidence 33444444433333333 4555555553 4444431 11223445555555554322 3332222222 356
Q ss_pred CCCEEeccCCcccC-CCCccccCCCCCCEEEccCCccCCc-ccccccccccccccccccccccC
Q 041491 70 NLQLLSLENNRLQG-PIPESFGELTSLESLDLSVNNLSGV-IPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 70 ~L~~l~l~~N~l~~-~~p~~~~~~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+|+.|+|++|++++ .++..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|+++.
T Consensus 464 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp TCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred cceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 67777777776654 2333445667777777777776533 23344556677777777777654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.72 E-value=5.6e-10 Score=97.14 Aligned_cols=116 Identities=16% Similarity=0.155 Sum_probs=90.7
Q ss_pred cCccCCCCccEEEcCCC-cccC----CCCcCccCCCCccEEEccCCcCCCC----CCCCcCCCCCCCEEeccCCcccCC-
Q 041491 15 STFWNLNSILSFDFSSN-SLNG----SLPLDIENMKVVVEINLSRNYLTGD----IPPTIGGLTNLQLLSLENNRLQGP- 84 (467)
Q Consensus 15 ~~~~~l~~L~~L~l~~N-~l~~----~~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~- 84 (467)
..+...++|++|+|++| .|.. .+...+...++|++|+|++|+++.. +...+...++|++|+|++|.|+..
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34667899999999999 8863 2345667788999999999999732 344566678999999999999842
Q ss_pred ---CCccccCCCCCCEEEc--cCCccCCcc----ccccccccccccccccccccc
Q 041491 85 ---IPESFGELTSLESLDL--SVNNLSGVI----PISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 85 ---~p~~~~~~~~L~~L~l--~~N~l~~~~----~~~~~~l~~L~~l~l~~N~l~ 130 (467)
+..++...++|+.|+| ++|.+.... ...+...++|+.|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3556788889999999 889998543 344555588999999999875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.8e-09 Score=111.71 Aligned_cols=112 Identities=13% Similarity=0.099 Sum_probs=57.9
Q ss_pred CCCCccEEEcCCCcccCC----CCcCccCCCCccEEEccCCcCCC----CCCCCcCCCCCCCEEeccCCcccC-------
Q 041491 19 NLNSILSFDFSSNSLNGS----LPLDIENMKVVVEINLSRNYLTG----DIPPTIGGLTNLQLLSLENNRLQG------- 83 (467)
Q Consensus 19 ~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~~----~~~~~~~~l~~L~~l~l~~N~l~~------- 83 (467)
++++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++ .++..+.++++|+.|+|++|.+.+
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~ 241 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKA 241 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhh
Confidence 445555555555554432 12223344555555555555541 122223344555555555554442
Q ss_pred -------------------CCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 84 -------------------PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 84 -------------------~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
..+..+..+++|+.|+++++... .+|..+..+++|+.|++++|.+++
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~ 307 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLET 307 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCH
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCH
Confidence 22234445555555555554333 456677778888888888887654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.8e-07 Score=86.45 Aligned_cols=134 Identities=18% Similarity=0.084 Sum_probs=97.9
Q ss_pred ccCcccce-eEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 225 LIGIGSFG-TVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 225 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34556555 68988765 467899998653 24466888999998774 33478899999999999999999999888
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHFG----------------------------------------------- 334 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------------- 334 (467)
.+..... ......+..+++..|..||..
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7754321 123345667777777777721
Q ss_pred --------CCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 335 --------YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 335 --------~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
....++|+|+.+.||++++++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01126999999999999988777899999886
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.3e-07 Score=89.10 Aligned_cols=136 Identities=13% Similarity=0.104 Sum_probs=97.0
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCC---CceeEEEEee-cCCeeeEEEecccC
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR---NLVKIISSCS-NGNFEALVLEYMAN 298 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 298 (467)
.+.++.|....||+. +..+++|+-.. ......+.+|.++++.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 57889998432 23446788999999998642 3667777764 45667899999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG-------------------------------------------- 334 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------- 334 (467)
.++.+... ..++..+...++.++.+.|+.||..
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876321 1234555556666666666666621
Q ss_pred -------------CCCCceecCCCCCCeeecC---CCc-EEEecccccee
Q 041491 335 -------------YSNPVVHCDIKPSNVLLDD---DMV-AHLSDFGIAKL 367 (467)
Q Consensus 335 -------------~~~~ivH~dlkp~NIll~~---~~~-~kl~Dfg~a~~ 367 (467)
....++|+|++|.||++++ ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335699999999999987 455 48999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.66 E-value=4.6e-08 Score=95.74 Aligned_cols=124 Identities=10% Similarity=0.121 Sum_probs=102.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCC-----CCCCCCcCCCCCCCEEec
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLT-----GDIPPTIGGLTNLQLLSL 76 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~-----~~~~~~~~~l~~L~~l~l 76 (467)
++|.+ +++.+...+|.+ .+|+.+.|. |.++.+-+.+|.++++|+.+++.+|.+. ...+..|.+|++|+.++|
T Consensus 231 l~l~~-~l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l 307 (401)
T 4fdw_A 231 IEIPE-NVSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEI 307 (401)
T ss_dssp EECCT-TCCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECC
T ss_pred EecCC-CccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEe
Confidence 45554 477788889998 899999995 5566566789999999999999998875 356678999999999999
Q ss_pred cCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 77 ENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 77 ~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
.+ .++.....+|.+|++|+.++|.+| ++.+.+..|.++ +|+.+++++|.+..
T Consensus 308 ~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 308 PE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp CT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred CC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence 94 577666789999999999999665 776777899999 99999999997653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.64 E-value=1.1e-07 Score=93.17 Aligned_cols=121 Identities=11% Similarity=0.071 Sum_probs=101.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+.|. ++++.+...+|.++++|+.++|.+| ++.+-..+|.+ .+|+.+.| .|.++...+..|.+|++|+.+++.+|.+
T Consensus 208 l~lp-~~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~ 283 (401)
T 4fdw_A 208 VLLP-VTLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTF 283 (401)
T ss_dssp EECC-TTCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred EEeC-CchheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccc
Confidence 4555 4588888999999999999999986 56566778888 79999999 4557756678999999999999999887
Q ss_pred c-----CCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccc
Q 041491 82 Q-----GPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 127 (467)
Q Consensus 82 ~-----~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 127 (467)
. ...+.+|..|++|+.++|. |.++.+....|.+|.+|+.++|..|
T Consensus 284 ~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 284 NDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp CCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred cCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 5 3556789999999999999 4588777789999999999999765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=1.5e-07 Score=90.83 Aligned_cols=81 Identities=11% Similarity=0.010 Sum_probs=58.1
Q ss_pred CCcc-CcccceeEEEEEec-------CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCC-C--CCceeEEEEeecC--
Q 041491 223 KSLI-GIGSFGTVYKGRFL-------DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR-H--RNLVKIISSCSNG-- 286 (467)
Q Consensus 223 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~-- 286 (467)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|..+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 26788999865432 111356788999998874 2 3578888887665
Q ss_pred -CeeeEEEecccCCCHHH
Q 041491 287 -NFEALVLEYMANGSLEK 303 (467)
Q Consensus 287 -~~~~lv~e~~~~g~L~~ 303 (467)
+..++||||++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 45689999999877653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.47 E-value=3.1e-09 Score=109.88 Aligned_cols=124 Identities=16% Similarity=0.132 Sum_probs=74.2
Q ss_pred CCcccccCCcCcc-CCCCccEEEcCCCcccCCCCcCcc-CCCCccEEEcc--C----CcCCCCCC-----CCcCCCCCCC
Q 041491 6 SNELSSVIPSTFW-NLNSILSFDFSSNSLNGSLPLDIE-NMKVVVEINLS--R----NYLTGDIP-----PTIGGLTNLQ 72 (467)
Q Consensus 6 ~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~l~l~--~----n~l~~~~~-----~~~~~l~~L~ 72 (467)
.|.++......+. .+++|+.|+++.|.+++.....+. .+++|+.|+|+ + |++++... ..+..+++|+
T Consensus 356 ~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~ 435 (594)
T 2p1m_B 356 NVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLR 435 (594)
T ss_dssp SSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCC
T ss_pred CCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCcc
Confidence 3455433222232 367788887777777654444443 46778888887 3 45552211 1245667777
Q ss_pred EEeccCCcccCCCCccccC-CCCCCEEEccCCccCCcccccc-ccccccccccccccccc
Q 041491 73 LLSLENNRLQGPIPESFGE-LTSLESLDLSVNNLSGVIPISL-EKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 73 ~l~l~~N~l~~~~p~~~~~-~~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~l~l~~N~l~ 130 (467)
.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|+++
T Consensus 436 ~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 436 RLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp EEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred EEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 777766 554433334443 6777777777777765444443 55677777777777774
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=6.1e-09 Score=90.52 Aligned_cols=106 Identities=13% Similarity=0.211 Sum_probs=84.2
Q ss_pred CeecCCC-ccccc----CCcCccCCCCccEEEcCCCcccCC----CCcCccCCCCccEEEccCCcCCCC----CCCCcCC
Q 041491 1 NLSLGSN-ELSSV----IPSTFWNLNSILSFDFSSNSLNGS----LPLDIENMKVVVEINLSRNYLTGD----IPPTIGG 67 (467)
Q Consensus 1 ~L~l~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~~ 67 (467)
.|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|+|+.. +...+..
T Consensus 40 ~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~ 119 (185)
T 1io0_A 40 EVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQS 119 (185)
T ss_dssp EEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGG
T ss_pred EEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHh
Confidence 3789999 88742 456677789999999999999732 344566678899999999999843 4667888
Q ss_pred CCCCCEEec--cCCcccCC----CCccccCCCCCCEEEccCCccC
Q 041491 68 LTNLQLLSL--ENNRLQGP----IPESFGELTSLESLDLSVNNLS 106 (467)
Q Consensus 68 l~~L~~l~l--~~N~l~~~----~p~~~~~~~~L~~L~l~~N~l~ 106 (467)
.++|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 120 n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 120 NTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 899999999 88999743 3345667789999999999986
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.39 E-value=5.7e-08 Score=93.49 Aligned_cols=115 Identities=14% Similarity=0.089 Sum_probs=76.9
Q ss_pred CcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcC--CCCCCCEEeccC--CcccCC-----
Q 041491 14 PSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIG--GLTNLQLLSLEN--NRLQGP----- 84 (467)
Q Consensus 14 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~--~l~~L~~l~l~~--N~l~~~----- 84 (467)
+..+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++......++ .+++|+.|+|+. |...+.
T Consensus 165 ~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~ 241 (362)
T 2ra8_A 165 SPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241 (362)
T ss_dssp HHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred HHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence 345667899999999988411 2333 43 78899999998887633223333 688999998863 332211
Q ss_pred CCccc--cCCCCCCEEEccCCccCCccccccc---ccccccccccccccccC
Q 041491 85 IPESF--GELTSLESLDLSVNNLSGVIPISLE---KLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 85 ~p~~~--~~~~~L~~L~l~~N~l~~~~~~~~~---~l~~L~~l~l~~N~l~~ 131 (467)
+...+ ..+++|+.|+|.+|.+.+..+..+. .+++|+.|+|+.|.+++
T Consensus 242 l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 11122 3578999999999988754433333 47789999999998875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.1e-08 Score=103.67 Aligned_cols=110 Identities=18% Similarity=0.121 Sum_probs=64.2
Q ss_pred cCCCCccEEEcCCCcccCCCCcCcc-CCCCccEEEccCC-cCCCC-CCCCcCCCCCCCEEeccCCcccCCCCccc----c
Q 041491 18 WNLNSILSFDFSSNSLNGSLPLDIE-NMKVVVEINLSRN-YLTGD-IPPTIGGLTNLQLLSLENNRLQGPIPESF----G 90 (467)
Q Consensus 18 ~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~l~l~~n-~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~p~~~----~ 90 (467)
..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ .
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 3466777777777776655444443 5677777777777 44321 33334467777777777777665443333 2
Q ss_pred CCCCCCEEEccCCc--cCC-cccccccccccccccccccc
Q 041491 91 ELTSLESLDLSVNN--LSG-VIPISLEKLVYLKDLNLSFN 127 (467)
Q Consensus 91 ~~~~L~~L~l~~N~--l~~-~~~~~~~~l~~L~~l~l~~N 127 (467)
.+++|+.|++++|. ++. .++..+..+++|+.|++++|
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 55677777777775 210 01112234467777777766
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.5e-06 Score=82.35 Aligned_cols=75 Identities=15% Similarity=0.042 Sum_probs=50.6
Q ss_pred CCccCcccceeEEEEEec-CCCeEEEEEeecccc-------cchHHHHHHHHHHHcCCC--C-CceeEEEEeecCCeeeE
Q 041491 223 KSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRH--R-NLVKIISSCSNGNFEAL 291 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l 291 (467)
.+.+|.|..+.||++... +++.+++|....... ....++..|.++++.+.. | .+++++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 467899999999999764 468899998653211 123566789999887732 3 455676543 344689
Q ss_pred EEecccCC
Q 041491 292 VLEYMANG 299 (467)
Q Consensus 292 v~e~~~~g 299 (467)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=3.7e-06 Score=80.26 Aligned_cols=139 Identities=17% Similarity=0.130 Sum_probs=79.1
Q ss_pred CccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC--CCCceeEEE------EeecCCeeeEEEec
Q 041491 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR--HRNLVKIIS------SCSNGNFEALVLEY 295 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~------~~~~~~~~~lv~e~ 295 (467)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.+. .-.+++++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999987544 5899988642 233445555555442 112333332 11245678899999
Q ss_pred ccCCCHH-----H---------hhhc----C--CC-------CCCHHHH-------------------------------
Q 041491 296 MANGSLE-----K---------CLYS----S--NG-------ILDIFQR------------------------------- 317 (467)
Q Consensus 296 ~~~g~L~-----~---------~l~~----~--~~-------~~~~~~~------------------------------- 317 (467)
++|.++. . .++. . .. ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 0111 0 00 0112110
Q ss_pred HHHHHHHHHHHHHHhc----------CCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 318 LSIMIDVALALEYLHF----------GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 318 ~~i~~~i~~~l~~LH~----------~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..+..++..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345555541 0257899999999999998888999999998763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.18 E-value=5.3e-06 Score=80.98 Aligned_cols=120 Identities=13% Similarity=0.193 Sum_probs=98.6
Q ss_pred CcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCC
Q 041491 7 NELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIP 86 (467)
Q Consensus 7 n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p 86 (467)
+.++.+...+|.++.+|+.+.+.++... .-..+|.++++|+.+.+. +.++......|.+|.+|+.++|..| ++....
T Consensus 251 ~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~ 327 (394)
T 4gt6_A 251 NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILD 327 (394)
T ss_dssp TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECT
T ss_pred CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehH
Confidence 3455566778999999999999887764 667789999999999997 4566566678999999999999865 654556
Q ss_pred ccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 87 ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 87 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
.+|.+|.+|+.+.+..+ ++.+....|.+|.+|+.+++.+|...
T Consensus 328 ~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 328 DAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred hHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 78999999999999765 66666789999999999999987643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.1e-05 Score=78.11 Aligned_cols=116 Identities=13% Similarity=0.212 Sum_probs=75.6
Q ss_pred ccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCcc
Q 041491 9 LSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPES 88 (467)
Q Consensus 9 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~ 88 (467)
++.+...+|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++......|.+|++|+.+.+.+|.++.....+
T Consensus 228 ~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~a 305 (379)
T 4h09_A 228 VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRV 305 (379)
T ss_dssp CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTT
T ss_pred eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhh
Confidence 44445556666777777777665 44345566777777777777544 44344456777777777777777776555567
Q ss_pred ccCCCCCCEEEccCCccCCcccccccccccccccccccc
Q 041491 89 FGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 127 (467)
Q Consensus 89 ~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 127 (467)
|.+|.+|+.+.|.++ ++.+....|.+|.+|+.+.+..+
T Consensus 306 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 306 FMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred hcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 777777777777654 55455567777777777776543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.1e-06 Score=84.40 Aligned_cols=114 Identities=15% Similarity=0.106 Sum_probs=64.4
Q ss_pred cCccCCCCccEEEcCCCccc---------CCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCC
Q 041491 15 STFWNLNSILSFDFSSNSLN---------GSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPI 85 (467)
Q Consensus 15 ~~~~~l~~L~~L~l~~N~l~---------~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 85 (467)
.+...+++|+.|.+.++... +.++..+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.+....
T Consensus 133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHH
T ss_pred HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHH
Confidence 34555677777777665432 112334456678888888777311 2333 33 678888888877765322
Q ss_pred Ccccc--CCCCCCEEEccC--CccCCcc-----cccc--cccccccccccccccccC
Q 041491 86 PESFG--ELTSLESLDLSV--NNLSGVI-----PISL--EKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 86 p~~~~--~~~~L~~L~l~~--N~l~~~~-----~~~~--~~l~~L~~l~l~~N~l~~ 131 (467)
...+. .+++|+.|+|+. |...+.. ...+ ..+++|+.|+|.+|.++.
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~ 266 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQN 266 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHH
T ss_pred HHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCch
Confidence 22332 677888887752 2211110 1112 235778888888777764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.7e-05 Score=72.17 Aligned_cols=136 Identities=15% Similarity=0.110 Sum_probs=92.1
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC---CCCceeEEEEeecCCeeeEEEecccCC
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR---HRNLVKIISSCSNGNFEALVLEYMANG 299 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 299 (467)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+++++++....+..++||||++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999976 5778999986533 3567889999888873 367889999888888899999999987
Q ss_pred CHHH-----------hhhcCCC---------------------CCCHHHHH---HHH----------------HHHHHHH
Q 041491 300 SLEK-----------CLYSSNG---------------------ILDIFQRL---SIM----------------IDVALAL 328 (467)
Q Consensus 300 ~L~~-----------~l~~~~~---------------------~~~~~~~~---~i~----------------~~i~~~l 328 (467)
.+.. .++.... .-+|.... ++. .+++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6421 1222111 01343221 111 1122222
Q ss_pred -HHHh-cCCCCCceecCCCCCCeeecCCCcEEEeccc
Q 041491 329 -EYLH-FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 329 -~~LH-~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
..|. ......++|+|+.+.|++++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2332 12256899999999999999887 8899974
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.4e-05 Score=77.89 Aligned_cols=116 Identities=13% Similarity=0.188 Sum_probs=86.5
Q ss_pred cccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCc
Q 041491 8 ELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPE 87 (467)
Q Consensus 8 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 87 (467)
.+..+...+|.++++|+.+.+. +.+..+-..+|.++.+|+.+.|..+ ++..-..+|.+|.+|+.+.|..+ ++..-..
T Consensus 275 ~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~ 351 (394)
T 4gt6_A 275 SVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPES 351 (394)
T ss_dssp TCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGG
T ss_pred ccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHh
Confidence 3444667889999999999997 4566566789999999999999875 66556778999999999999765 6656667
Q ss_pred cccCCCCCCEEEccCCccCCcccccccccccccccccccccc
Q 041491 88 SFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 129 (467)
Q Consensus 88 ~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 129 (467)
+|.+|++|+.+++.+|... -..+..+.+|+.+.+..|.+
T Consensus 352 aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 352 AFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp GGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred HhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence 9999999999999998754 24677778899998877754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.92 E-value=1.4e-06 Score=73.94 Aligned_cols=82 Identities=13% Similarity=0.091 Sum_probs=35.4
Q ss_pred CccEEEcCCCcccCCCCcCccCCCCccEEEccCCc-CCCCCCCCcCCC----CCCCEEeccCCc-ccCCCCccccCCCCC
Q 041491 22 SILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNY-LTGDIPPTIGGL----TNLQLLSLENNR-LQGPIPESFGELTSL 95 (467)
Q Consensus 22 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~-l~~~~~~~~~~l----~~L~~l~l~~N~-l~~~~p~~~~~~~~L 95 (467)
+|++|||+++.++..--..+.++++|+.|+|++|. ++..--..++.+ ++|++|+|++|. |+..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555442222334455555555555553 331111122222 245555555542 432211233445555
Q ss_pred CEEEccCC
Q 041491 96 ESLDLSVN 103 (467)
Q Consensus 96 ~~L~l~~N 103 (467)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.86 E-value=6.6e-05 Score=69.76 Aligned_cols=79 Identities=14% Similarity=0.095 Sum_probs=58.5
Q ss_pred cCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC-C--CCceeEEEEeecCCeeeEEEec
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-H--RNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e~ 295 (467)
...-.+.+|.|..+.||+.+..+|+.|++|+...........+..|...|+.+. . -.+++++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 344467789999999999999899999999876444444467889999998874 2 2456666653 24789999
Q ss_pred ccCCCH
Q 041491 296 MANGSL 301 (467)
Q Consensus 296 ~~~g~L 301 (467)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.84 E-value=2.7e-06 Score=72.16 Aligned_cols=92 Identities=17% Similarity=0.144 Sum_probs=68.9
Q ss_pred CCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc-ccCCCCccccCC----CCCCEEEccCCc-cCCccc
Q 041491 37 LPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR-LQGPIPESFGEL----TSLESLDLSVNN-LSGVIP 110 (467)
Q Consensus 37 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~-l~~~~p~~~~~~----~~L~~L~l~~N~-l~~~~~ 110 (467)
+|.....-.+|++|||+++.++..--..+.+|++|+.|+|++|. |+..--..+..+ ++|+.|+|+++. ++..--
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 35444444579999999999885544567899999999999995 664222345543 479999999975 775444
Q ss_pred cccccccccccccccccc
Q 041491 111 ISLEKLVYLKDLNLSFNR 128 (467)
Q Consensus 111 ~~~~~l~~L~~l~l~~N~ 128 (467)
..+.++++|+.|++++++
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 567889999999999875
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.80 E-value=5.4e-05 Score=73.81 Aligned_cols=113 Identities=17% Similarity=0.147 Sum_probs=58.4
Q ss_pred cccCCcCccCCCCccEEEcCCCcccCCCCcCcc---------------------CCCCccEEEccCCcCCCCCCCCcCCC
Q 041491 10 SSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIE---------------------NMKVVVEINLSRNYLTGDIPPTIGGL 68 (467)
Q Consensus 10 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~---------------------~l~~L~~l~l~~n~l~~~~~~~~~~l 68 (467)
+.+....|..+.+|+.+.+..|... .....|. ++.+|+.+.+..+ ++..-..+|.+|
T Consensus 242 ~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c 319 (394)
T 4fs7_A 242 TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESC 319 (394)
T ss_dssp CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC
T ss_pred eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccc-cceechhhhcCC
Confidence 3344556666677777776665543 3333444 4445555555433 332334445555
Q ss_pred CCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccc
Q 041491 69 TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 126 (467)
Q Consensus 69 ~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 126 (467)
++|+.++|.++ ++.....+|.+|++|+.+++..| ++.+....|.+|.+|+.+++..
T Consensus 320 ~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 320 TSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp TTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred CCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 55555555433 43333445555555555555544 4434445555555555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.76 E-value=4.5e-05 Score=74.38 Aligned_cols=117 Identities=18% Similarity=0.073 Sum_probs=85.4
Q ss_pred cccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCccc-----
Q 041491 8 ELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQ----- 82 (467)
Q Consensus 8 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~----- 82 (467)
.++.+...+|.++.+|+.+.|.++ ++.+-..+|.++++|+.++|.+| ++..-...|.++++|+.+.+..+--.
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~a 135 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEA 135 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeeccee
Confidence 456677788999999999999855 76566778999999999999866 65455667888888888776544111
Q ss_pred ----------------CCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccc
Q 041491 83 ----------------GPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 127 (467)
Q Consensus 83 ----------------~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 127 (467)
.....+|.+|++|+.+.+.++.. ......|..+.+|+.+++..|
T Consensus 136 F~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~ 195 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN 195 (394)
T ss_dssp TTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT
T ss_pred eecccccccccCccccccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC
Confidence 11234677788888888876543 355677788888888887665
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=8.9e-05 Score=69.33 Aligned_cols=129 Identities=12% Similarity=0.100 Sum_probs=77.3
Q ss_pred CCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEecc-cCCC
Q 041491 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLEYM-ANGS 300 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~-~~g~ 300 (467)
.+.|+.|....+|+. ..+++|+....... .....+|..+++.+. +.-..++++...+ .-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 678889999999998 67889987643221 223456888877764 2222566665433 347899999 6654
Q ss_pred HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 041491 301 LEKCLYSSNGILDIFQRLSIMIDVALALEYLHF----------------------------------------------- 333 (467)
Q Consensus 301 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~----------------------------------------------- 333 (467)
+....... ...+..++++.|+-||.
T Consensus 95 l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 95 MSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp CCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred CCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 42100000 00112222222222221
Q ss_pred ---CCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 334 ---GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 334 ---~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.....++|+|+.|.||+ ..++.+.++||..+..-
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 12345899999999999 56678899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.75 E-value=8.9e-05 Score=69.99 Aligned_cols=157 Identities=13% Similarity=0.128 Sum_probs=86.7
Q ss_pred ccHHHHHHHhccCcc-----CCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCC--ceeEE
Q 041491 208 FSYQELLLATDHFSE-----KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN--LVKII 280 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~ 280 (467)
++.+++......|.+ .+.|+.|....+|+....+| .+++|+.... .....+..|..+++.+.... +++++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555544455654 24566788889999987555 7889988652 12345667887777663211 33333
Q ss_pred EE------eecCCeeeEEEecccCCCHHH-----h---------hhcC----CCC----C---CHHHHHH----------
Q 041491 281 SS------CSNGNFEALVLEYMANGSLEK-----C---------LYSS----NGI----L---DIFQRLS---------- 319 (467)
Q Consensus 281 ~~------~~~~~~~~lv~e~~~~g~L~~-----~---------l~~~----~~~----~---~~~~~~~---------- 319 (467)
.. ....+..+++++|++|..+.. + ++.. ... . .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122356789999999865321 0 1110 000 0 1111000
Q ss_pred --HHHHHHHHHHHHhc----CCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 320 --IMIDVALALEYLHF----GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 320 --i~~~i~~~l~~LH~----~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
+...+...+++++. ....+++|+|+.+.||++++++.+.++||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 00113334444441 1246799999999999999876668999998763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00011 Score=72.33 Aligned_cols=74 Identities=11% Similarity=0.062 Sum_probs=47.2
Q ss_pred CCCceecCCCCCCeeecCCCcEEEeccccceecCCCCcccc------ccccccccccCC---CCCCcccchhhHHHHHHH
Q 041491 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT------QTLATIEYGREG---QVSPKSDVYGYGITLIET 406 (467)
Q Consensus 336 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~pe~~~~~---~~~~~~Dv~slGvil~el 406 (467)
...++|+|++|.||++++++ ++++||+.+..-........ ..|.+|++.... ......++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 78899999999999998876 99999999875432211111 123334333211 111234556788888888
Q ss_pred hcCC
Q 041491 407 FTKK 410 (467)
Q Consensus 407 ~tg~ 410 (467)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.75 E-value=6.9e-05 Score=72.56 Aligned_cols=107 Identities=10% Similarity=0.107 Sum_probs=87.4
Q ss_pred cccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCc
Q 041491 8 ELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPE 87 (467)
Q Consensus 8 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 87 (467)
.++.+...+|.++.+|+.+.+..+ +......+|.++++|+.+.+.++.++..-+..|.+|.+|+.+.|..+ ++.....
T Consensus 250 ~v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~ 327 (379)
T 4h09_A 250 NVTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVY 327 (379)
T ss_dssp TCCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred CccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHH
Confidence 366677889999999999999766 55456678999999999999999998666788999999999999765 6655567
Q ss_pred cccCCCCCCEEEccCCccCCcccccccccc
Q 041491 88 SFGELTSLESLDLSVNNLSGVIPISLEKLV 117 (467)
Q Consensus 88 ~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~ 117 (467)
+|.+|++|+.+.+..+ ++.+-...|.++.
T Consensus 328 aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 328 AFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred HhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 9999999999999765 5545556776654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=4.8e-05 Score=61.42 Aligned_cols=39 Identities=31% Similarity=0.336 Sum_probs=19.9
Q ss_pred CCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 94 SLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 94 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
+|+.|+|++|+|+.+.+..|..+++|+.|+|++|++.++
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd 70 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD 70 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence 345555555555544444455555555555555555543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00019 Score=69.17 Aligned_cols=139 Identities=12% Similarity=0.105 Sum_probs=84.1
Q ss_pred CccCcccceeEEEEEec--------CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEe
Q 041491 224 SLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 294 (467)
+.+..|-...+|++... +++.+++|+.... ........+|.++++.+. +.-.+++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777888999999864 2478999986332 123456678999988774 3334677777654 28999
Q ss_pred cccCCCHHHh-----------------hhcCC----CCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 041491 295 YMANGSLEKC-----------------LYSSN----GILD--IFQRLSIMIDVAL-------------------ALEYLH 332 (467)
Q Consensus 295 ~~~~g~L~~~-----------------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~~LH 332 (467)
|++|.++..- ++... .... +.++.++..++.. .+.+|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 11111 1112 3444445444321 122322
Q ss_pred -----cCCCCCceecCCCCCCeeecCC----CcEEEecccccee
Q 041491 333 -----FGYSNPVVHCDIKPSNVLLDDD----MVAHLSDFGIAKL 367 (467)
Q Consensus 333 -----~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~ 367 (467)
......++|+|+.+.||+++++ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1124578999999999999876 7899999998863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00044 Score=65.51 Aligned_cols=141 Identities=13% Similarity=0.064 Sum_probs=75.3
Q ss_pred CccCccccee-EEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC-C-CCceeEEEEeecCCeeeEEEecccCCC
Q 041491 224 SLIGIGSFGT-VYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-H-RNLVKIISSCSNGNFEALVLEYMANGS 300 (467)
Q Consensus 224 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~~g~ 300 (467)
+.|+.|.... +|+....++..+++|...... ...+..|+.+++.+. + -.+++++.+....+ +++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565565554 667765446778887644321 134456777777663 2 34667777654444 68999997766
Q ss_pred HHHhhhcC---------------------C----CCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 041491 301 LEKCLYSS---------------------N----GILDIFQRL-------S-I------------MIDVALALEYLH--- 332 (467)
Q Consensus 301 L~~~l~~~---------------------~----~~~~~~~~~-------~-i------------~~~i~~~l~~LH--- 332 (467)
+.+.+... . ..++..... . + ...+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64433110 0 111111100 0 0 001111222221
Q ss_pred cCCCCCceecCCCCCCeeecCC----CcEEEeccccceecC
Q 041491 333 FGYSNPVVHCDIKPSNVLLDDD----MVAHLSDFGIAKLLN 369 (467)
Q Consensus 333 ~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~~~ 369 (467)
......++|||+.+.||+++.+ +.+.|+||+.+..-.
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1125689999999999999874 689999999887543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.60 E-value=5.8e-06 Score=71.48 Aligned_cols=112 Identities=15% Similarity=0.137 Sum_probs=71.2
Q ss_pred ccCCCCccEEEcCCC-cccC----CCCcCccCCCCccEEEccCCcCCCC----CCCCcCCCCCCCEEeccCCcccCC---
Q 041491 17 FWNLNSILSFDFSSN-SLNG----SLPLDIENMKVVVEINLSRNYLTGD----IPPTIGGLTNLQLLSLENNRLQGP--- 84 (467)
Q Consensus 17 ~~~l~~L~~L~l~~N-~l~~----~~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~--- 84 (467)
+.+-+.|++|+|++| .|.. .+.+++..-+.|+.|+|++|+|... +.+.+..-+.|+.|+|+.|+|+..
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 345578888888885 7652 2344556667888888888888632 334455667888888888888742
Q ss_pred -CCccccCCCCCCEEEccCCcc---CCc----cccccccccccccccccccc
Q 041491 85 -IPESFGELTSLESLDLSVNNL---SGV----IPISLEKLVYLKDLNLSFNR 128 (467)
Q Consensus 85 -~p~~~~~~~~L~~L~l~~N~l---~~~----~~~~~~~l~~L~~l~l~~N~ 128 (467)
+-.++..-+.|+.|+|++|.. ... +-..+..=++|+.|+++.|.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 223455666788888886533 211 12233333567777776554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00021 Score=70.39 Aligned_cols=73 Identities=18% Similarity=0.172 Sum_probs=50.5
Q ss_pred CCccCcccceeEEEEEecC--------CCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEE
Q 041491 223 KSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 293 (467)
.+.|+.|....+|++...+ ++.+++|+.... .....+.+|..+++.+. +.-.+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888899999998753 578999987432 12245567998888874 3334677776543 3899
Q ss_pred ecccCCCH
Q 041491 294 EYMANGSL 301 (467)
Q Consensus 294 e~~~~g~L 301 (467)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00017 Score=58.12 Aligned_cols=56 Identities=23% Similarity=0.318 Sum_probs=34.1
Q ss_pred EEEccCCcCC-CCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccC
Q 041491 49 EINLSRNYLT-GDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLS 106 (467)
Q Consensus 49 ~l~l~~n~l~-~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~ 106 (467)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666664 23444332 35666777777776555556666777777777777664
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00032 Score=69.42 Aligned_cols=74 Identities=18% Similarity=0.175 Sum_probs=48.8
Q ss_pred CCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCC-ceeEEEEeecCCeeeEEEecccCCC
Q 041491 223 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-LVKIISSCSNGNFEALVLEYMANGS 300 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g~ 300 (467)
.+.|+.|-...+|++...+ +..+++|+....... .-...+|..+++.+...+ .+++++.+. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568889899999998754 478999987543221 122368899898885433 467777763 2 35999998854
Q ss_pred H
Q 041491 301 L 301 (467)
Q Consensus 301 L 301 (467)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0005 Score=64.94 Aligned_cols=156 Identities=12% Similarity=0.075 Sum_probs=88.0
Q ss_pred ccHHHHHHHhccCcc-----CCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCC--CCceeEE
Q 041491 208 FSYQELLLATDHFSE-----KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH--RNLVKII 280 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~ 280 (467)
.+.+++...-..|.+ .+.++ |....||+....+|+.+++|+..... .....+..|..+++.+.. -.+++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 444444443344432 23466 78889999877667789999986331 234567778888777632 1234443
Q ss_pred EE-----eecCCeeeEEEecccCCCHH-----Hh---------hhc----C----CCCCCHHHH----------------
Q 041491 281 SS-----CSNGNFEALVLEYMANGSLE-----KC---------LYS----S----NGILDIFQR---------------- 317 (467)
Q Consensus 281 ~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~----~----~~~~~~~~~---------------- 317 (467)
.. ....+..+++|+|++|.++. .. ++. . ....++...
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 12245667899999885432 10 111 0 011222111
Q ss_pred ------HHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 318 ------LSIMIDVALALEYLHF-GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 318 ------~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
...+.+++..+...-. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 0111122222222210 1256789999999999999 4 899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00041 Score=66.81 Aligned_cols=73 Identities=15% Similarity=0.236 Sum_probs=45.2
Q ss_pred CccCcccceeEEEEEecC---------CCeEEEEEeecccccchHHHHHHHHHHHcCCCCC-ceeEEEEeecCCeeeEEE
Q 041491 224 SLIGIGSFGTVYKGRFLD---------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-LVKIISSCSNGNFEALVL 293 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 293 (467)
+.++.|....+|+....+ ++.+++|+...... .......|..+++.+...+ ++++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567888889999998643 26889998754322 1223467888888774223 45777654 2 26899
Q ss_pred ecccCCCH
Q 041491 294 EYMANGSL 301 (467)
Q Consensus 294 e~~~~g~L 301 (467)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0016 Score=61.81 Aligned_cols=33 Identities=24% Similarity=0.357 Sum_probs=28.7
Q ss_pred CCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 336 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
...++|+|+.+.||++++++.+.++||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 457999999999999998888999999887643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.22 E-value=2.5e-05 Score=67.47 Aligned_cols=105 Identities=16% Similarity=0.204 Sum_probs=76.8
Q ss_pred eecCCC-cccc----cCCcCccCCCCccEEEcCCCcccC----CCCcCccCCCCccEEEccCCcCCCC----CCCCcCCC
Q 041491 2 LSLGSN-ELSS----VIPSTFWNLNSILSFDFSSNSLNG----SLPLDIENMKVVVEINLSRNYLTGD----IPPTIGGL 68 (467)
Q Consensus 2 L~l~~n-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~~l 68 (467)
|+|++| +|.. .+.+++..-+.|+.|+|++|+|.. .+.+.+..-+.|++|+|++|+|+.. +.+.+..-
T Consensus 46 L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N 125 (197)
T 1pgv_A 46 VNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVT 125 (197)
T ss_dssp EECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTT
T ss_pred EECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhC
Confidence 788875 6653 245667778999999999999972 2334455668899999999999733 34456677
Q ss_pred CCCCEEeccCCcc---cC----CCCccccCCCCCCEEEccCCccC
Q 041491 69 TNLQLLSLENNRL---QG----PIPESFGELTSLESLDLSVNNLS 106 (467)
Q Consensus 69 ~~L~~l~l~~N~l---~~----~~p~~~~~~~~L~~L~l~~N~l~ 106 (467)
+.|+.|+|++|.. .. .+...+..-+.|+.|+++.|.+-
T Consensus 126 ~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 126 QSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp CCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred CceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 7899999997643 31 13345666789999999887753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0038 Score=60.93 Aligned_cols=73 Identities=12% Similarity=0.198 Sum_probs=49.4
Q ss_pred CccCcccceeEEEEEecC--------CCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEe
Q 041491 224 SLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 294 (467)
+.+..|-...+|+....+ ++.+++|+...... ......+|..+++.+. +.-.+++++.+. -+.|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 567778889999998753 57899998654322 2233467888888774 333566666442 268999
Q ss_pred cccCCCH
Q 041491 295 YMANGSL 301 (467)
Q Consensus 295 ~~~~g~L 301 (467)
|++|.++
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0029 Score=54.92 Aligned_cols=106 Identities=14% Similarity=0.034 Sum_probs=70.2
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCcccccc
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT 378 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 378 (467)
-+|.+.+...+.++++.++|.++.|.+.+|.-+-. ++.-..+=+.|..|++..+|.+...+ ..+. .....
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------~~~~~ 102 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------AGEPP 102 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------ccccC
Confidence 37899998888999999999999999999888720 11111333456889999999887664 1111 12334
Q ss_pred ccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 379 LATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 379 ~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
+.+||... ...+.+.=|||+|+++|..+-=..|-+.
T Consensus 103 ~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e 138 (229)
T 2yle_A 103 PVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE 138 (229)
T ss_dssp ----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE
T ss_pred CCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc
Confidence 56677653 3446778899999999999886666543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.39 E-value=0.048 Score=52.85 Aligned_cols=30 Identities=27% Similarity=0.385 Sum_probs=25.3
Q ss_pred CceecCCCCCCeee------cCCCcEEEecccccee
Q 041491 338 PVVHCDIKPSNVLL------DDDMVAHLSDFGIAKL 367 (467)
Q Consensus 338 ~ivH~dlkp~NIll------~~~~~~kl~Dfg~a~~ 367 (467)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4456799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.61 E-value=0.23 Score=42.97 Aligned_cols=120 Identities=9% Similarity=0.105 Sum_probs=81.2
Q ss_pred CCCCceeEEEEeecCCeeeEEEeccc-CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 041491 272 RHRNLVKIISSCSNGNFEALVLEYMA-NGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVL 350 (467)
Q Consensus 272 ~h~niv~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl 350 (467)
.||+++.. .+-...+.+.+.++.-+ +-++.. + ...+...+++++.+++....+++ . -+|--+.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~---~--r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR---T--RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG---S--SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc---C--ceEEEEecceEE
Confidence 58888866 45566666555555433 223322 2 24688899999999988886655 2 378889999999
Q ss_pred ecCCCcEEEeccccceecCCCCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccc
Q 041491 351 LDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCE 419 (467)
Q Consensus 351 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~ 419 (467)
++.++.+++.-.|+-..+ .+...+...=.-.+=+++..+++++..|++...+
T Consensus 112 f~~~~~p~i~~RGik~~l-----------------~P~~~~ee~fL~qyKAliiall~~K~~Fe~l~~G 163 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-----------------DPLPVSEAEFLTRYKALVICAFNEKQSFDALVEG 163 (215)
T ss_dssp ECTTSCEEESCCEETTTB-----------------SCCCCCHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred EcCCCCEEEEEccCccCC-----------------CCCCCCHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence 999999999877764322 1222222333446778888999999999765443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.25 E-value=0.81 Score=39.71 Aligned_cols=116 Identities=8% Similarity=0.058 Sum_probs=77.0
Q ss_pred CCCCceeEEEEeecCCeeeEEEecccCC-CHHHhhhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCceecCCCCCCe
Q 041491 272 RHRNLVKIISSCSNGNFEALVLEYMANG-SLEKCLYSSNGILDIFQRLSIMIDVALALE-YLHFGYSNPVVHCDIKPSNV 349 (467)
Q Consensus 272 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~dlkp~NI 349 (467)
.||++ -...-.+.+...+.++.-+++ ++.. + ..++...+++++.+++.... +++ .-+|--+.|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 57887 334446667766666654332 3332 3 24678889999888877666 444 457888999999
Q ss_pred eecCCCcEEEeccccceecCCCCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 350 LLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 350 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
++|.++.+++.-.|+-..+ .|...+..-=.-.+=+++..++.++..|++.
T Consensus 116 ~f~~~~~p~i~hRGi~~~l-----------------pP~e~~ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL-----------------PPDEWDDERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp EECTTCCEEESCCEETTTB-----------------SSCSCCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred EEeCCCcEEEEEcCCcccC-----------------CCCCCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999999888774322 2222222222346678888889999888754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.13 E-value=0.15 Score=50.35 Aligned_cols=61 Identities=13% Similarity=0.031 Sum_probs=18.0
Q ss_pred ccCCccCcccceeEEEEEecC-CCeEEE------EEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEee
Q 041491 221 SEKSLIGIGSFGTVYKGRFLD-GMEVAI------KVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCS 284 (467)
Q Consensus 221 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 284 (467)
.+.+.+| ||.||+|.+.. ..+||+ |..+... ......+.+|..+++..+|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999998864 468888 6654321 122346778899999999999999877653
|
| >2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} | Back alignment and structure |
|---|
Probab=80.56 E-value=3.7 Score=30.63 Aligned_cols=46 Identities=11% Similarity=-0.018 Sum_probs=21.0
Q ss_pred cccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccC
Q 041491 8 ELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSR 54 (467)
Q Consensus 8 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 54 (467)
.++.+-..+|.++++|+.+.|..+- +.+-..+|.++.+|+.+.+..
T Consensus 7 ~vt~I~~~aF~~c~~L~~i~iP~~v-~~Ig~~aF~~C~~L~~i~~~~ 52 (100)
T 2lz0_A 7 PVVGMDKSLFAGNTVIREITVQPNI-GLLYDGMFSGCTALEKLILTG 52 (100)
T ss_dssp CCCSSCSCTTTTCTTCCCEEECTTS-SCCCTTSSTTCTTCCCEEECC
T ss_pred ccCEecHHHhcCCCCCcEEEcCCch-heEcHHHHhccCCccEEEEcC
Confidence 3444444455555555555554432 223334445555555444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 467 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.003 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-52
Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 18/235 (7%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRN 275
+ IG GSFGTVYKG++ +VA+K+ ++ L++F E VL+ RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
++ + + A+V ++ SL L+ ++ + + I A ++YLH
Sbjct: 66 ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN--GKESMRTQTLATIEY--------G 385
++H D+K +N+ L +D+ + DFG+A + + Q +I +
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 386 REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVD 440
+ S +SDVY +GI L E T + P I + + +L + V
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-51
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVR 272
L D F + S +G G+ G V+K G+ +A K+ HL+ E +VL
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
+V + + ++ +E+M GSL++ L G + + I V L YL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLR 121
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI-----EYGRE 387
+ ++H D+KPSN+L++ L DFG++ L +SM + T E +
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQG 177
Query: 388 GQVSPKSDVYGYGITLIETFTKKKP 412
S +SD++ G++L+E + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-50
Identities = 56/238 (23%), Positives = 104/238 (43%), Gaps = 14/238 (5%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
D + +G G+FG VYK + + + A KV + + L+ + E ++L S H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+VK++ + N +++E+ A G+++ + L Q + AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY----------G 385
N ++H D+K N+L D L+DFG++ R + T +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 386 REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSL 443
++ K+DV+ GITLIE + P E+ + LK ++ ++ + ++
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-49
Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 12/223 (5%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
+ +G G FG V+ G + +VA+K +F AE ++K ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI-LDIFQRLSIMIDVALALEYLHFGYS 336
++ + + ++ EYM NGSL L + +GI L I + L + +A + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI------EYGREGQV 390
+H D++ +N+L+ D + ++DFG+A+L+ E + E G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 391 SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPI 433
+ KSDV+ +GI L E T + ++N + +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 5e-49
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 211 QELLLATDHFSEKSL-IGIGSFGTVYKGRFL---DGMEVAIKVFHLQFD-GALKSFDAEC 265
++L L D+ + +G G+FG+V +G + ++VAIKV + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 266 EVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVA 325
+++ + + +V++I C LV+E G L K L + + ++ V+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 326 LALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI--- 382
+ ++YL VH D+ NVLL + A +SDFG++K L +S T A
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 383 -----EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
E + S +SDV+ YG+T+ E + +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (419), Expect = 3e-48
Identities = 52/229 (22%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 208 FSYQELLLATDHFSEK---------SLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF 254
F++++ A F+++ +IG G FG V G + VAIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 255 -DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILD 313
+ + F +E ++ H N++ + + ++ E+M NGSL+ L ++G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 314 IFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373
+ Q + ++ +A ++YL VH D+ N+L++ ++V +SDFG+++ L S
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 374 MRTQT-----LATIEYG-----REGQVSPKSDVYGYGITLIETFTKKKP 412
T T I + + + + SDV+ YGI + E + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 6e-47
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 10/221 (4%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
+ IG G FG V+ G +L+ +VAIK + F E EV+ + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
++ C LV E+M +G L L + G+ L + +DV + YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT------IEYGREGQVS 391
V+H D+ N L+ ++ V +SDFG+ + + + + E + S
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 392 PKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLP 432
KSDV+ +G+ + E F++ K E +++ F
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 9e-47
Identities = 59/231 (25%), Positives = 91/231 (39%), Gaps = 15/231 (6%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 274
+ + IG GS+G K R DG + K + + +E +L+ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 275 NLVKIISSCSNGNFEAL--VLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALE 329
N+V+ + L V+EY G L + LD L +M + LAL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 330 YLH--FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI----- 382
H + V+H D+KP+NV LD L DFG+A++LN S + T
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPI 433
E + KSD++ G L E P +E+ K F I
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 10/221 (4%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
+ +G G FG V G++ +VAIK+ F E +V+ ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 278 KIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN 337
++ C+ ++ EYMANG L L Q L + DV A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 338 PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT------IEYGREGQVS 391
+H D+ N L++D V +SDFG+++ + E + E + S
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 392 PKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLP 432
KSD++ +G+ + E ++ K E F ++
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 7e-46
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 10/219 (4%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 277
IG G FG V G G +VA+K ++ D ++F AE V+ +RH NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 278 KIISSCSNGNFE-ALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHFGY 335
+++ +V EYMA GSL L S +L L +DV A+EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI--EYGREGQVSPK 393
N VH D+ NVL+ +D VA +SDFG+ K + + + E RE + S K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 394 SDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLP 432
SDV+ +GI L E ++ + + + +
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 8e-46
Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 14/226 (6%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR 272
FS+ IG GSFG VY R + + VAIK + + E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
H N ++ + LV+EY + + L + ++ L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-----TIEYGRE 387
S+ ++H D+K N+LL + + L DFG A ++ + T I E
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-PANSFVGTPYWMAPEVILAMDE 188
Query: 388 GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPI 433
GQ K DV+ GIT IE +K P + N+ +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-45
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 12/232 (5%)
Query: 208 FSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV 267
+ + + + +G G FG V+ G + VAIK ++F E +V
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQV 65
Query: 268 LKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIF-QRLSIMIDVAL 326
+K +RH LV++ + S +V EYM+ GSL L G Q + + +A
Sbjct: 66 MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-TIEY- 384
+ Y+ VH D++ +N+L+ +++V ++DFG+A+L+ E Q I++
Sbjct: 125 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 385 ----GREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLP 432
G+ + KSDV+ +GI L E TK + L +
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (402), Expect = 4e-45
Identities = 45/202 (22%), Positives = 84/202 (41%), Gaps = 10/202 (4%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
DH+ +G G+FG V++ G A K + ++ E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
V + + + N ++ E+M+ G L + + + + + + M V L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142
Query: 337 NPVVHCDIKPSNVLL--DDDMVAHLSDFGIAKLLNGKESMRTQTL----ATIEYGREGQV 390
N VH D+KP N++ L DFG+ L+ K+S++ T A E V
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 391 SPKSDVYGYGITLIETFTKKKP 412
+D++ G+ + P
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSP 224
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 4e-45
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 16/222 (7%)
Query: 199 MSPQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA 257
M P +Y + + + K +G G +G VY+G + + VA+K
Sbjct: 2 MDPS----SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TME 56
Query: 258 LKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSN-GILDIFQ 316
++ F E V+K ++H NLV+++ C+ ++ E+M G+L L N +
Sbjct: 57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 116
Query: 317 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRT 376
L + ++ A+EYL +H D+ N L+ ++ + ++DFG+++L+ G
Sbjct: 117 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173
Query: 377 QTLATI------EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
E + S KSDV+ +G+ L E T
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-45
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 275
++ IG G+ GTVY + G EVAI+ +LQ + E V++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+V + S G+ +V+EY+A GSL + +D Q ++ + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG-----REGQV 390
SN V+H DIK N+LL D L+DFG + ++S R+ + T +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 391 SPKSDVYGYGITLIETFTKKKP 412
PK D++ GI IE + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-45
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 16/230 (6%)
Query: 226 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISS 282
IG GSF TVYKG + +EVA + + F E E+LK ++H N+V+ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 283 C----SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
LV E M +G+L+ L ++ I S + L++LH + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT-RTPP 134
Query: 339 VVHCDIKPSNVLLDD-DMVAHLSDFGIAKLLNGKESMRTQTLATIEYG----REGQVSPK 393
++H D+K N+ + + D G+A L S + T E+ E +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEEKYDES 192
Query: 394 SDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSL 443
DVY +G+ ++E T + P E + + P S V +
Sbjct: 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 3e-44
Identities = 51/202 (25%), Positives = 80/202 (39%), Gaps = 11/202 (5%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFH---LQFDGALKSFDAECEVLKSVRH 273
+ F +G G FG VY R +A+KV L+ G E E+ +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
N++++ + L+LEY G++ + L D + + + ++A AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCH- 123
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR---TQTLATIEYGREGQV 390
S V+H DIKP N+LL ++DFG + T E
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 391 SPKSDVYGYGITLIETFTKKKP 412
K D++ G+ E K P
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPP 203
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-43
Identities = 52/238 (21%), Positives = 93/238 (39%), Gaps = 14/238 (5%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRN 275
+ + +G G++G V VA+K+ ++ ++ E + K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+VK GN + L LEY + G L + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL--NGKESMRTQTLATIEY------GRE 387
+ H DIKP N+LLD+ +SDFG+A + N +E + + T+ Y R
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 388 GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSLLR 445
+ DV+ GI L + P + +W ++ +D++ L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-43
Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 17/240 (7%)
Query: 215 LATDHFSEKSLIGIGSFGTVYKGRFLDG-----MEVAIKVFHLQF-DGALKSFDAECEVL 268
+ + + +IG G FG VYKG + VAIK + + F E ++
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 269 KSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
H N++++ S ++ EYM NG+L+K L +G + Q + ++ +A +
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI------ 382
+YL + VH D+ N+L++ ++V +SDFG++++L T
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 383 --EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVD 440
E + + SDV+ +GI + E T + +K + F + M+
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 9e-43
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 24/225 (10%)
Query: 219 HFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRH 273
HF+E +IG G FG VY G LD + A+K + D G + F E ++K H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 274 RNLVKIISSCSNGNFEA-LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
N++ ++ C +VL YM +G L + + + + + VA +++L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI---------E 383
VH D+ N +LD+ ++DFG+A+ + KE E
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 384 YGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN 428
+ + + KSDV+ +G+ L E T+ P ++N +
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITV 245
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (381), Expect = 3e-42
Identities = 42/222 (18%), Positives = 92/222 (41%), Gaps = 14/222 (6%)
Query: 202 QAMWRRFSYQELLLAT----DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG 256
+ +W+++ Q + + D++ +G G+FG V++ G K + +
Sbjct: 9 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL 68
Query: 257 ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQ 316
+ E ++ + H L+ + + + L+LE+++ G L + + + + +
Sbjct: 69 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE 128
Query: 317 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--DDMVAHLSDFGIAKLLNGKESM 374
++ M L+++H + +VH DIKP N++ + + DFG+A LN E +
Sbjct: 129 VINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185
Query: 375 ----RTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
T A E V +D++ G+ + P
Sbjct: 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-42
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 222 EKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNL 276
E +G G+FGTV KG + VA+K+ + + AE V++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
V++I C ++ LV+E G L K L N + + ++ V++ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 337 NPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI--------EYGREG 388
+ VH D+ NVLL A +SDFG++K L E+ E
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 389 QVSPKSDVYGYGITLIETFTKKKP 412
+ S KSDV+ +G+ + E F+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK 209
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-42
Identities = 47/226 (20%), Positives = 82/226 (36%), Gaps = 15/226 (6%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVR 272
+ IG G FG V++G ++ + VAIK D + F E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
H ++VK+I + +++E G L L LD+ + ++ AL YL
Sbjct: 67 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT------IEYGR 386
S VH DI NVL+ + L DFG+++ + + E
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 387 EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLP 432
+ + SDV+ +G+ + E + + N
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-42
Identities = 53/249 (21%), Positives = 94/249 (37%), Gaps = 40/249 (16%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKS 270
++ ++G G+FG V ++VA+K+ + D ++ +E +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 271 V-RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSN-------------------- 309
+ H N+V ++ +C+ L+ EY G L L S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 310 --GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367
+L L VA +E+L VH D+ NVL+ V + DFG+A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 368 LNGKESMRTQTLATI-------EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE 420
+ + + A + E EG + KSDV+ YGI L E F+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 421 MNLKNWVND 429
N + +
Sbjct: 274 ANFYKLIQN 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-41
Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 15/206 (7%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRH 273
+ F ++G GSF TV R L E AIK+ H+ + + E +V+ + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
VK+ + + L Y NG L K + G D ++ ALEYLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLH- 125
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESM-RTQTLATI------EYGR 386
++H D+KP N+LL++DM ++DFG AK+L+ + R + E
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 387 EGQVSPKSDVYGYGITLIETFTKKKP 412
E SD++ G + + P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 7e-41
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 40/241 (16%)
Query: 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSF 261
L ++ IG G+FG V++ R VA+K+ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 262 DAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNG----------- 310
E ++ + N+VK++ C+ G L+ EYMA G L + L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 311 ------------ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAH 358
L ++L I VA + YL VH D+ N L+ ++MV
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 359 LSDFGIAKLLNGKESMRTQTLATI-------EYGREGQVSPKSDVYGYGITLIETFTKKK 411
++DFG+++ + + + I E + + +SDV+ YG+ L E F+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 412 P 412
Sbjct: 241 Q 241
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-40
Identities = 51/269 (18%), Positives = 100/269 (37%), Gaps = 29/269 (10%)
Query: 223 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISS 282
+ IG G FG V++G+ G EVA+K+F + + + +AE +RH N++ I++
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65
Query: 283 CSNGNFEA----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH-----F 333
+ N LV +Y +GSL L + + + + + + A L +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES----MRTQTLATIEYG---- 385
+ H D+K N+L+ + ++D G+A + + T Y
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 386 -------REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVM-N 437
+ + ++D+Y G+ E + ++ + V + M
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 438 VVDTSLLRREDKYFAAKKQCVSSALSLAM 466
VV LR + + +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-40
Identities = 50/248 (20%), Positives = 92/248 (37%), Gaps = 35/248 (14%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKS 270
+ S +G G+FG V + M VA+K+ ++ +E +VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 271 V-RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSS-----------------NGIL 312
+ H N+V ++ +C+ G ++ EY G L L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 313 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372
D+ LS VA + +L S +H D+ N+LL + + DFG+A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 373 SMRTQTLA--TIEYG-----REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKN 425
+ + A +++ + +SDV+ YGI L E F+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 426 WVNDFLPI 433
+ + +
Sbjct: 260 MIKEGFRM 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-40
Identities = 50/214 (23%), Positives = 82/214 (38%), Gaps = 19/214 (8%)
Query: 214 LLATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF---DGALKSFDAECE 266
L+ +G GSFG V +G + + VA+K A+ F E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 267 VLKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
+ S+ HRNL+++ + +V E GSL L G + + VA
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES---MRTQTLATIE 383
+ YL S +H D+ N+LL + + DFG+ + L + M+
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 384 YG-----REGQVSPKSDVYGYGITLIETFTKKKP 412
+ + S SD + +G+TL E FT +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (355), Expect = 4e-39
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 25/216 (11%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGAL---------KSFDAECEV 267
+++ K ++G G V + E A+K+ + G+ ++ E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 268 LKSVR-HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
L+ V H N++++ + F LV + M G L L + L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT-------- 378
+ LH +VH D+KP N+LLDDDM L+DFG + L+ E +R
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 379 --LATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ + D++ G+ + P
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-39
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDG-ALKSFDAECEV 267
+L F + ++G G+FGTVYKG ++ + VAIK A K E V
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 268 LKSVRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALA 327
+ SV + ++ +++ C + L+ + M G L + + L+ + +A
Sbjct: 65 MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 328 LEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI----- 382
+ YL +VH D+ NVL+ ++DFG+AKLL +E +
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 383 --EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
E + +SDV+ YG+T+ E T
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-39
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 27/219 (12%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDG---MEVAIKVFHLQFD-GALKSFDAECEVLKSV-R 272
+ + +IG G+FG V K R M+ AIK + F E EVL +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLY---------------SSNGILDIFQR 317
H N++ ++ +C + + L +EY +G+L L S+ L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 318 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQ 377
L DVA ++YL +H D+ N+L+ ++ VA ++DFG+++
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 378 TL----ATIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
L IE + SDV+ YG+ L E +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 1e-38
Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 20/234 (8%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR 272
+D + ++G G V+ R L +VA+KV F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 273 HRNLVKIISSC----SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
H +V + + G +V+EY+ +L +++ G + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 124
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI------ 382
+ H N ++H D+KP+N+++ + DFGIA+ + + TQT A I
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 383 --EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPIS 434
E R V +SDVY G L E T + P + ++ D +P S
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-38
Identities = 40/202 (19%), Positives = 84/202 (41%), Gaps = 11/202 (5%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
+ + +G G FG V++ K ++ E +L RHRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNI 63
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
+ + S + ++ E+++ + + + +S L+ + +S + V AL++LH S
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---S 120
Query: 337 NPVVHCDIKPSNVLLDDDMVAH--LSDFGIAKLLNGKESMRTQTLAT----IEYGREGQV 390
+ + H DI+P N++ + + +FG A+ L ++ R A E + V
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 391 SPKSDVYGYGITLIETFTKKKP 412
S +D++ G + + P
Sbjct: 181 STATDMWSLGTLVYVLLSGINP 202
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 140 bits (353), Expect = 4e-38
Identities = 47/237 (19%), Positives = 94/237 (39%), Gaps = 15/237 (6%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL------QFDGALKSFDAECEVLKS 270
+ FS +IG G FG VY R D G A+K Q + + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEY 330
+V + + + + +L+ M G L L S +G+ ++ L LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT----LATIEYGR 386
+H + VV+ D+KP+N+LLD+ +SD G+A + K+ + +A +
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 179
Query: 387 EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDTSL 443
+D + G L + P + ++ + + + + + + + L
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (346), Expect = 1e-37
Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 10/201 (4%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH 273
F +G GSFG V+ R +G A+KV + ++ + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
++++ + + ++++Y+ G L L S +V LALEYLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH- 121
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA--TIEYGREGQVS 391
S +++ D+KP N+LLD + ++DFG AK + T E +
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 392 PKSDVYGYGITLIETFTKKKP 412
D + +GI + E P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 4e-37
Identities = 42/203 (20%), Positives = 75/203 (36%), Gaps = 9/203 (4%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHR 274
D + + ++G G+F V VAIK + +G S + E VL ++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
N+V + +G L+++ ++ G L + G ++ V A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG-----REGQ 389
LD+D +SDFG++K+ + + T T Y +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-GTPGYVAPEVLAQKP 185
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
S D + G+ P
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 4e-36
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 12/203 (5%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRN 275
+ + IG G++G VYK + G A+K L+ +G + E +LK ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 276 LVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+VK+ LV E++ + L+K L G L+ S ++ + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 336 SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG------REGQ 389
V+H D+KP N+L++ + ++DFG+A+ T + T+ Y +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 390 VSPKSDVYGYGITLIETFTKKKP 412
S D++ G E
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-36
Identities = 52/246 (21%), Positives = 96/246 (39%), Gaps = 26/246 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRF------LDGMEVAIKVFHLQFD-GALKSFDAECEVLKS 270
+ + +G GSFG VY+G VAIK + F E V+K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGI---------LDIFQRLSIM 321
++V+++ S G +++E M G L+ L S + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 322 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLAT 381
++A + YL+ +N VH D+ N ++ +D + DFG+ + + + R
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 382 I-------EYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPIS 434
+ E ++G + SDV+ +G+ L E T + + E L+ + L
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 435 VMNVVD 440
N D
Sbjct: 257 PDNCPD 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 5e-36
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 14/205 (6%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFH---LQFDGALKSFDAECEVL-KSVR 272
+ F ++G GSFG V+ F AIK + D ++ E VL +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 273 HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLH 332
H L + + V+EY+ G L + S D+ + ++ L L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG-----RE 387
S +V+ D+K N+LLD D ++DFG+ K ++ T +Y
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 388 GQVSPKSDVYGYGITLIETFTKKKP 412
+ + D + +G+ L E + P
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 8e-36
Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 12/204 (5%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 274
++F + IG G++G VYK R G VA+K L +G + E +LK + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
N+VK++ N LV E++ + S+ + + S + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY------GREG 388
S+ V+H D+KP N+L++ + L+DFG+A+ T + T+ Y
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 389 QVSPKSDVYGYGITLIETFTKKKP 412
S D++ G E T++
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-35
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 22/208 (10%)
Query: 220 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 278
+++ +IG GSFG VY+ + D G VAIK + + E ++++ + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 279 IISSC------SNGNFEALVLEYMANGSLEKCLY--SSNGILDIFQRLSIMIDVALALEY 330
+ + + LVL+Y+ + + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDD-MVAHLSDFGIAKLLNGKESMRTQT-----LATIEY 384
+H S + H DIKP N+LLD D V L DFG AK L E + A
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 385 GREGQVSPKSDVYGYGITLIETFTKKKP 412
+ DV+ G L E +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-35
Identities = 50/227 (22%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVL 268
D +G G+FG V + +VA+K+ + L +E E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 269 KSV-RHRNLVKIISSCSNGNFEALVLEYMANGSLEKCL---------------YSSNGIL 312
K + +H+N++ ++ +C+ +++EY + G+L + L ++ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 313 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372
+S VA +EYL S +H D+ NVL+ +D V ++DFG+A+ ++ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 373 SMRTQTLAT-------IEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ T E + + +SDV+ +G+ L E FT
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-35
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 225 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVK 278
+G G F TVYK R VAIK L DG ++ E ++L+ + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 279 IISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP 338
++ + + + +LV ++M LE + ++ +L + M+ LEYLH +
Sbjct: 65 LLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 120
Query: 339 VVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY------GREGQVSP 392
++H D+KP+N+LLD++ V L+DFG+AK T + T Y
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 393 KSDVYGYGITLIETFTKKKP 412
D++ G L E +
Sbjct: 181 GVDMWAVGCILAELLLRVPF 200
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-34
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 13/204 (6%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHR 274
+ + IG G++GTV+K + VA+K L D G S E +LK ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG 334
N+V++ + LV E+ + S NG LD S + + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHS- 119
Query: 335 YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY------GREG 388
V+H D+KP N+L++ + L++FG+A+ + + T+ Y
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 389 QVSPKSDVYGYGITLIETFTKKKP 412
S D++ G E +P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-33
Identities = 43/209 (20%), Positives = 76/209 (36%), Gaps = 16/209 (7%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHR 274
++ S IG G++G V + + VAIK + + E ++L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 275 NLVKIISSCSNGNFEALVLEYMANGSLEKCLYS--SNGILDIFQRLSIMIDVALALEYLH 332
N++ I E + Y+ + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 333 FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQT---------LATIE 383
S V+H D+KPSN+LL+ + DFG+A++ + A
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 384 YGREGQVSPKSDVYGYGITLIETFTKKKP 412
+ D++ G L E + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-33
Identities = 49/211 (23%), Positives = 76/211 (36%), Gaps = 21/211 (9%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ------FDGALKSFDAECEVLKS 270
+ L+G G FG+VY G + D + VAIK E +LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 271 VR--HRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
V +++++ + L+LE + G L S V A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKESMRTQTLATIEYG-- 385
+ H + V+H DIK N+L+D + L DFG LL K+++ T T Y
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPP 178
Query: 386 ----REGQVSPKSDVYGYGITLIETFTKKKP 412
+ V+ GI L + P
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-33
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 216 ATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQF--DGALKSFDAECEVLK-- 269
A + + IG G++G V+K R L G VA+K +Q +G S E VL+
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 270 -SVRHRNLVKIISSCSNGNFEA-----LVLEYMANGSLEKCLYSSNGILDIFQRLSIMID 323
+ H N+V++ C+ + LV E++ + +M
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 324 VALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIE 383
+ L++LH S+ VVH D+KP N+L+ L+DFG+A++ + + ++ + + T+
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTLW 180
Query: 384 Y-----GREGQVSPKSDVYGYGITLIETFTKKKP 412
Y + + D++ G E F +K
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (314), Expect = 9e-33
Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 10/201 (4%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH 273
D F +G GSFG V + G A+K+ Q ++ E +L++V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
LVK+ S + + +V+EY+A G + L G + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLH- 158
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATI--EYGREGQVS 391
S +++ D+KP N+L+D ++DFG AK + G+ T + E +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 392 PKSDVYGYGITLIETFTKKKP 412
D + G+ + E P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 13/204 (6%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH 273
+ F L+G G+FG V R G A+K+ + + E VL++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 274 RNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHF 333
L + + + V+EY G L L S + + ++ ALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 334 GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLATIEY-----GREG 388
S VV+ DIK N++LD D ++DFG+ K + T EY +
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 389 QVSPKSDVYGYGITLIETFTKKKP 412
D +G G+ + E + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-32
Identities = 44/210 (20%), Positives = 82/210 (39%), Gaps = 19/210 (9%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF------DGALKSFDAECEVLKS 270
D++ +G G F V K R G++ A K + + + + E +LK
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 271 VRHRNLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEY 330
++H N++ + N L+LE +A G L + L + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128
Query: 331 LHFGYSNPVVHCDIKPSNVLLDDDMVA----HLSDFGIAKLLNGKESMR----TQTLATI 382
LH S + H D+KP N++L D V + DFG+A ++ + T
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 383 EYGREGQVSPKSDVYGYGITLIETFTKKKP 412
E + ++D++ G+ + P
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 7e-32
Identities = 42/259 (16%), Positives = 90/259 (34%), Gaps = 34/259 (13%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKS 270
D +G G+FG V + VA+K+ ++ +E ++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 271 VRHRNLVKII--SSCSNGNFEALVLEYMANGSLEKCLYSSNG---------------ILD 313
+ H V + + G +++E+ G+L L S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 314 IFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES 373
+ + VA +E+L S +H D+ N+LL + V + DFG+A+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 374 --MRTQTLATIEYG-----REGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW 426
+ +++ + + +SDV+ +G+ L E F+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 427 VNDFLPISVMNVVDTSLLR 445
+ + + + + +
Sbjct: 250 LKEGTRMRAPDYTTPEMYQ 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 2e-31
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 23/224 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
+ + IG GSFG +Y G + G EVAIK+ ++ E ++ K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 64
Query: 277 VKIISSC-SNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY 335
+ I C + G++ +V+E + SLE + + L + + +EY+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--- 120
Query: 336 SNPVVHCDIKPSNVL---LDDDMVAHLSDFGIAKLLNGKESMR------------TQTLA 380
S +H D+KP N L + ++ DFG+AK + + T A
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 381 TIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK 424
+I + S + D+ G L+ P + K
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-31
Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 274
+ + + IG G+FG V+K R G +VA+K ++ +G + E ++L+ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 275 NLVKIISSCSNGNFEA--------LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVAL 326
N+V +I C LV ++ + + + +M +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQML-- 126
Query: 327 ALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES----MRTQTLATI 382
L L++ + N ++H D+K +NVL+ D V L+DFG+A+ + ++ T + T+
Sbjct: 127 -LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 383 EYG------REGQVSPKSDVYGYGITLIETFTKKKP 412
Y E P D++G G + E +T+
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 39/202 (19%), Positives = 76/202 (37%), Gaps = 22/202 (10%)
Query: 225 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVL-KSVRHRNLVKIISS 282
++G+G G V + + A+K+ E E+ ++ + ++V+I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 283 C----SNGNFEALVLEYMANGSLEKCLYS-SNGILDIFQRLSIMIDVALALEYLHFGYSN 337
+ +V+E + G L + + + IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 338 PVVHCDIKPSNVLLD---DDMVAHLSDFGIAKLLNGKESMRTQTLATI----EYGREGQV 390
+ H D+KP N+L + + L+DFG AK S+ T E +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 391 SPKSDVYGYGITLIETFTKKKP 412
D++ G+ + P
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPP 212
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 44/241 (18%), Positives = 91/241 (37%), Gaps = 22/241 (9%)
Query: 208 FSYQELLLAT----DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKS 260
F QE+ + + +G G++G V G +VAIK + F + K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 261 FDAECEVLKSVRHRNLVKIISSCSNGNFEA------LVLEYMANGSLEKCLYSSNGILDI 314
E +LK +RH N++ ++ + LV+ +M + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120
Query: 315 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373
+ ++ + L Y+H + ++H D+KP N+ +++D + DFG+A+ + + +
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 177
Query: 374 --MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFL 431
+ A + + D++ G + E T K + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 432 P 432
P
Sbjct: 238 P 238
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-29
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 21/212 (9%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFH----LQFDGALKSFDAECEVLK 269
++F ++G G++G V+ R + G A+KV +Q + E +VL+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 270 SVRHR-NLVKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
+R LV + + L+L+Y+ G L L F + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTLA-------- 380
L + +++ DIK N+LLD + L+DFG++K E+ R
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 381 TIEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
I G + D + G+ + E T P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (283), Expect = 1e-28
Identities = 46/228 (20%), Positives = 93/228 (40%), Gaps = 21/228 (9%)
Query: 196 EVNMS-PQAMWRRFSYQELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ 253
+VN P+ W S+ D + +G G + V++ + + +V +K+
Sbjct: 12 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 71
Query: 254 FDGALKSFDAECEVLKSVR-HRNLVKIISSCSN--GNFEALVLEYMANGSLEKCLYSSNG 310
K E ++L+++R N++ + + ALV E++ N ++
Sbjct: 72 K---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----Q 124
Query: 311 ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLN 369
L + M ++ AL+Y H S ++H D+KP NV++D + L D+G+A+ +
Sbjct: 125 TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 370 GKESMRTQTLATIEYGRE-----GQVSPKSDVYGYGITLIETFTKKKP 412
+ + + G E D++ G L +K+P
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (281), Expect = 1e-28
Identities = 38/225 (16%), Positives = 70/225 (31%), Gaps = 23/225 (10%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 276
H+ IG GSFG +++G L + +VAIK + D E K +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 277 VKIISSCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS 336
+ + +++ + SLE L + + ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119
Query: 337 NPVVHCDIKPSNVLLDDDMVAH-----LSDFGIAKLLNGKESMRTQTLAT---------- 381
+V+ DIKP N L+ + + DFG+ K + +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 382 --IEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK 424
I + S + D+ G + P + K
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 39/207 (18%), Positives = 83/207 (40%), Gaps = 16/207 (7%)
Query: 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRH 273
+ + S +G G++G+V G+ VA+K F K E +LK ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 274 RNLVKIISSCSNGNF-----EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
N++ ++ + + ++ ++ L L ++ + L
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGL 134
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMRTQTL---ATIEYG 385
+Y+H S ++H D+KPSN+ +++D + DFG+A+ + + + T A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML 191
Query: 386 REGQVSPKSDVYGYGITLIETFTKKKP 412
+ D++ G + E T +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-24
Identities = 42/208 (20%), Positives = 75/208 (36%), Gaps = 20/208 (9%)
Query: 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 274
+ IG G+ G V VAIK F K E ++K V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 275 NLVKIISSCS------NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
N++ +++ + LV+E M + D + ++ + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGI 132
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKESMR----TQTLATIEY 384
++LH S ++H D+KPSN+++ D + DFG+A+ M T+ E
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 385 GREGQVSPKSDVYGYGITLIETFTKKKP 412
D++ G + E K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.7 bits (247), Expect = 1e-23
Identities = 42/212 (19%), Positives = 75/212 (35%), Gaps = 27/212 (12%)
Query: 225 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC 283
+G G F TV+ + + + VA+K+ ++ + E ++L+ V + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 284 S---------------NGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALAL 328
+ NG +V E + L + + + I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 329 EYLHFGYSNPVVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLNGKESMRTQTLAT------ 381
+Y+H ++H DIKP NVL++ D +L IA L N T +
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 382 -IEYGREGQVSPKSDVYGYGITLIETFTKKKP 412
E +D++ + E T
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 1e-20
Identities = 25/200 (12%), Positives = 59/200 (29%), Gaps = 32/200 (16%)
Query: 224 SLIGIGSFGTVYKGRFLDGMEVAIKVFHL----------QFDGALKSFDAECEVLKSVRH 273
L+G G V+ E +K + + D F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 274 RNLVKIISSCSNGNFE----ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALE 329
R L K+ + A+++E + L + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 330 YLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES----MRTQTLATIEYG 385
+ +VH D+ NVL+ ++ + + DF + + + R +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 386 REGQVSPKSDVYGYGITLIE 405
R + D+ +++
Sbjct: 174 RTY--RTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.1 bits (178), Expect = 1e-14
Identities = 32/147 (21%), Positives = 58/147 (39%), Gaps = 28/147 (19%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLD-------------------- 40
+L L +N++S++ P L + +N ++ PL
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 41 IENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDL 100
I N+K + + L N ++ P + LT LQ L NN++ S LT++ L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSA 358
Query: 101 SVNNLSGVIPISLEKLVYLKDLNLSFN 127
N +S + P++ L + L L+
Sbjct: 359 GHNQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 8e-13
Identities = 35/153 (22%), Positives = 57/153 (37%), Gaps = 28/153 (18%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
LSL N+L T +L ++ D ++N ++ PL + + E+ L N ++
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNIS 279
Query: 62 P--------------------PTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS 101
P I L NL L+L N + P LT L+ L +
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337
Query: 102 VNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
N +S SL L + L+ N++ P
Sbjct: 338 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 5e-07
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 43 NMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSV 102
+ + + + N ++ P I TNL LSL N+L+ + LT+L LDL+
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 250
Query: 103 NNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
N +S + P+S L L +L L N++ P
Sbjct: 251 NQISNLAPLS--GLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 5e-07
Identities = 14/79 (17%), Positives = 33/79 (41%), Gaps = 5/79 (6%)
Query: 42 ENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS 101
+ ++ L + +T + + L + L + ++ + L +L ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 74
Query: 102 VNNLSGVIPIS-LEKLVYL 119
N L+ + P+ L KLV +
Sbjct: 75 NNQLTDITPLKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 12/68 (17%), Positives = 24/68 (35%), Gaps = 4/68 (5%)
Query: 67 GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 126
L L + + ++ +L + +L + + + E L L +N S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGV--EYLNNLTQINFSN 75
Query: 127 NRLKGDIP 134
N+L P
Sbjct: 76 NQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 15/74 (20%), Positives = 31/74 (41%), Gaps = 6/74 (8%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
LG ++ + + +L+ + + + S+ +E + + +IN S N LT
Sbjct: 26 KTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI 81
Query: 61 IPPTIGGLTNLQLL 74
P + LT L +
Sbjct: 82 TP--LKNLTKLVDI 93
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 64.4 bits (155), Expect = 5e-12
Identities = 17/70 (24%), Positives = 29/70 (41%), Gaps = 1/70 (1%)
Query: 43 NMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSV 102
K + ++L N + G +P + L L L++ N L G IP+ G L + +
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYAN 300
Query: 103 NNLSGVIPIS 112
N P+
Sbjct: 301 NKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 3e-11
Identities = 23/66 (34%), Positives = 31/66 (46%), Gaps = 1/66 (1%)
Query: 69 TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNR 128
NL L L NNR+ G +P+ +L L SL++S NNL G IP L + N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 129 LKGDIP 134
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 3e-10
Identities = 19/72 (26%), Positives = 34/72 (47%), Gaps = 3/72 (4%)
Query: 17 FWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSL 76
++ D +N + G+LP + +K + +N+S N L G+I P G L + +
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAY 298
Query: 77 ENNRLQ--GPIP 86
NN+ P+P
Sbjct: 299 ANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.8 bits (112), Expect = 1e-06
Identities = 17/37 (45%), Positives = 23/37 (62%)
Query: 99 DLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135
DL N + G +P L +L +L LN+SFN L G+IP
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 37.4 bits (85), Expect = 0.003
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 47 VVEINLSRNYLTGD--IPPTIGGLTNLQLLSLENN-RLQGPIPESFGELTSLESLDLSVN 103
V ++LS L IP ++ L L L + L GPIP + +LT L L ++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 104 NLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
N+SG IP L ++ L L+ S+N L G +P
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.4 bits (137), Expect = 1e-09
Identities = 28/128 (21%), Positives = 47/128 (36%), Gaps = 3/128 (2%)
Query: 27 DFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIP 86
S L +P D+ ++L N +T L NL L L NN++ P
Sbjct: 16 QCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72
Query: 87 ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQVPLCK 146
+F L LE L LS N L + + L L+ +++ + + V
Sbjct: 73 GAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132
Query: 147 SSSHRKSS 154
++ + S
Sbjct: 133 TNPLKSSG 140
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 2e-08
Identities = 27/164 (16%), Positives = 60/164 (36%), Gaps = 28/164 (17%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L +N+++ + F NL ++ + +N ++ P + + + LS+N L ++
Sbjct: 36 LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-EL 94
Query: 62 PPTI----------------------GGLTNLQLLSLENNRLQ--GPIPESFGELTSLES 97
P + GL + ++ L N L+ G +F + L
Sbjct: 95 PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154
Query: 98 LDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
+ ++ N++ + L L+L N++ L
Sbjct: 155 IRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLN 195
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.0 bits (123), Expect = 5e-08
Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 4/151 (2%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L N+L + L + + + S+ + N +VVE+ + +G
Sbjct: 84 LYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSGIE 142
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
G+ L + + + + IP+ SL L L N ++ V SL+ L L
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 122 LNLSFNRLKGDIPTRSPHLQVPLCKSSSHRK 152
L LSFN + + ++ K
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.1 bits (113), Expect = 8e-07
Identities = 25/132 (18%), Positives = 52/132 (39%), Gaps = 9/132 (6%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L N+++ V ++ LN++ S NS++ + N + E++L+ N L
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 233
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESF------GELTSLESLDLSVNNLS--GVIPIS 112
+P + +Q++ L NN + F + S + L N + + P +
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293
Query: 113 LEKLVYLKDLNL 124
+ + L
Sbjct: 294 FRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 23/159 (14%), Positives = 48/159 (30%), Gaps = 26/159 (16%)
Query: 6 SNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTI 65
L V + + D +N + D +N+K + + L N ++ P
Sbjct: 19 DLGLEKVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
Query: 66 GGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL-------------------- 105
L L+ L L N+L+ + L L + + +
Sbjct: 76 APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP 135
Query: 106 ---SGVIPISLEKLVYLKDLNLSFNRLKGDIPTRSPHLQ 141
SG+ + + + L + ++ + P L
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT 174
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 4e-08
Identities = 24/94 (25%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 51 NLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP 110
N + +I +L+ L++ NN+L +P LE L S N+L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAE-VP 320
Query: 111 ISLEKLVYLKDLNLSFNRLKG--DIPTRSPHLQV 142
+ L K L++ +N L+ DIP L++
Sbjct: 321 ELPQNL---KQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 1e-07
Identities = 22/105 (20%), Positives = 41/105 (39%), Gaps = 9/105 (8%)
Query: 16 TFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLS 75
F L+ + + N+ + + + + E+N+S N L ++P L+ L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLI 310
Query: 76 LENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
N L +PE +L+ L + N L P E + L+
Sbjct: 311 ASFNHLAE-VPEL---PQNLKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.7 bits (122), Expect = 6e-08
Identities = 35/137 (25%), Positives = 54/137 (39%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
L L L + P F L ++ N+L ++ + + L N ++
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
GL +L L L NR+ P +F +L L +L L NNLS + +L L L+
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 121 DLNLSFNRLKGDIPTRS 137
L L+ N D R
Sbjct: 229 YLRLNDNPWVCDCRARP 245
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (116), Expect = 3e-07
Identities = 19/104 (18%), Positives = 42/104 (40%), Gaps = 4/104 (3%)
Query: 4 LGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPP 63
L N ++ V P F +L +++ +N+L+ + ++ + + L+ N D
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243
Query: 64 TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSG 107
LQ ++ + +P+ L + L+ N+L G
Sbjct: 244 -RPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (114), Expect = 5e-07
Identities = 35/142 (24%), Positives = 54/142 (38%), Gaps = 1/142 (0%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD 60
+ L N +S V ++F ++ SN L + ++ +++LS N
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 61 IPP-TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL 119
+ P T GL L L L+ LQ P F L +L+ L L N L + + L L
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL 155
Query: 120 KDLNLSFNRLKGDIPTRSPHLQ 141
L L NR+ L
Sbjct: 156 THLFLHGNRISSVPERAFRGLH 177
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 11/49 (22%), Positives = 17/49 (34%), Gaps = 3/49 (6%)
Query: 48 VEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLE 96
V + + L +P I Q + L NR+ SF +L
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLT 59
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 8e-08
Identities = 18/115 (15%), Positives = 36/115 (31%), Gaps = 10/115 (8%)
Query: 49 EINLSRNYLT-GDIPPTIGGLTNLQLLSLENNRLQG----PIPESFGELTSLESLDLSVN 103
+++ L+ + L Q++ L++ L I + +L L+L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 104 NLSGVIPISLEKLV-----YLKDLNLSFNRLKGDIPTRSPHLQVPLCKSSSHRKS 153
L V + + + ++ L+L L G L S
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 2e-06
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 42 ENMKVVVEINLSRNYLTGD----IPPTIGGLTNLQLLSLENNRLQGPIPESFGE-----L 92
+ V+ + L+ ++ + T+ +L+ L L NN L E
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 93 TSLESLDLSVNNLSGVIPISLEKL 116
LE L L S + L+ L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 5e-06
Identities = 19/90 (21%), Positives = 32/90 (35%), Gaps = 16/90 (17%)
Query: 69 TNLQLLSLENNRLQG----PIPESFGELTSLESLDLSVNNLSGVIPISLEKLV-----YL 119
+ L++L L + + + + SL LDLS N L + L + V L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 120 KDLNLSFNRLKGDIPT-------RSPHLQV 142
+ L L ++ P L+V
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 2e-07
Identities = 14/62 (22%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 40 DIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLD 99
++ + +E+N + LT +PP + + +L L N L + T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 100 LS 101
L
Sbjct: 62 LD 63
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 4e-05
Identities = 24/97 (24%), Positives = 36/97 (37%), Gaps = 1/97 (1%)
Query: 9 LSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGL 68
L+S+ L + N L P + + +++L+ N LT + GL
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 69 TNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNL 105
NL L L+ N L IP+ F L L N
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 4e-05
Identities = 12/65 (18%), Positives = 20/65 (30%), Gaps = 3/65 (4%)
Query: 64 TIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLN 123
+ + + ++ + L +P L LS N L +L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 124 LSFNR 128
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 28/176 (15%), Positives = 42/176 (23%), Gaps = 46/176 (26%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNS----------------------------- 32
L L N L + +T + +
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLL 95
Query: 33 ----------------LNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSL 76
L + + + E+ L N L P + L+ LSL
Sbjct: 96 GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155
Query: 77 ENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132
NN L L +L++L L N IP L L N +
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQ-ENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 5e-04
Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 19 NLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLEN 78
+ S L + +L +LP D+ K ++LS N L T+ T L L+L+
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 79 NR 80
Sbjct: 65 AE 66
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 2e-06
Identities = 28/123 (22%), Positives = 43/123 (34%), Gaps = 6/123 (4%)
Query: 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI 61
L L +L+ L + D S N L P + ++ + + S N +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57
Query: 62 PPTIGGLTNLQLLSLENNRLQG-PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLK 120
+ L LQ L L NNRLQ + L L+L N+L I L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 121 DLN 123
++
Sbjct: 118 SVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 4e-06
Identities = 24/111 (21%), Positives = 36/111 (32%), Gaps = 26/111 (23%)
Query: 50 INLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSL-------------- 95
++L+ LT + + L + L L +NRL+ P + L L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 96 --------ESLDLSVNNLSGVIPI-SLEKLVYLKDLNLSFNRLKGDIPTRS 137
+ L L N L I L L LNL N L + +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 2e-06
Identities = 15/64 (23%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKD 121
+ L+ L L ++N++ P L +L + L N +S V P L L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 122 LNLS 125
+ L+
Sbjct: 222 VTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 5e-04
Identities = 9/63 (14%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 67 GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 126
L N ++ + + + ++ +L + +L ++ + + + L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGV--QYLNNLIGLELKD 72
Query: 127 NRL 129
N++
Sbjct: 73 NQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 13/65 (20%), Positives = 32/65 (49%), Gaps = 4/65 (6%)
Query: 14 PSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQL 73
+ NL+ + + N ++ PL ++ ++E++L N ++ P + +NL +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 74 LSLEN 78
++L N
Sbjct: 222 VTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 12/64 (18%), Positives = 24/64 (37%), Gaps = 4/64 (6%)
Query: 42 ENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS 101
+ ++I ++ +T + T L + LS + E L +L L+L
Sbjct: 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELK 71
Query: 102 VNNL 105
N +
Sbjct: 72 DNQI 75
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 5e-06
Identities = 18/100 (18%), Positives = 40/100 (40%), Gaps = 3/100 (3%)
Query: 25 SFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQG- 83
+ D + +L+ + + + V+ R+++ +Q + L N+ ++
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 84 PIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLN 123
+ + + L++L L LS I +L K L LN
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 9e-06
Identities = 22/97 (22%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 40 DIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQG--PIPESFGELTSLES 97
D+ + V +N + + + L L+L NNRL + + +L+
Sbjct: 37 DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95
Query: 98 LDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134
L+LS N L + K + L++L L N L
Sbjct: 96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 9e-05
Identities = 26/112 (23%), Positives = 47/112 (41%), Gaps = 2/112 (1%)
Query: 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTG- 59
+ S + +L + +I +S+ +L + EN+ ++ +NLS N L
Sbjct: 21 DGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRL 80
Query: 60 -DIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIP 110
D+ + NL++L+L N L+ + LE L L N+LS
Sbjct: 81 DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 3e-05
Identities = 11/65 (16%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 67 GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 126
+L+ + + ++ EL S++ + + +++ V I + L + L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGI--QYLPNVTKLFLNG 77
Query: 127 NRLKG 131
N+L
Sbjct: 78 NKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 7e-04
Identities = 12/40 (30%), Positives = 18/40 (45%), Gaps = 2/40 (5%)
Query: 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS 101
+ GLT LQ L L N + + L +L+ L+L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 3e-05
Identities = 10/54 (18%), Positives = 17/54 (31%), Gaps = 4/54 (7%)
Query: 61 IPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLE 114
G + +L + R+ L L + NL +P +LE
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 3e-05
Identities = 12/51 (23%), Positives = 20/51 (39%), Gaps = 3/51 (5%)
Query: 85 IPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135
+ F + LD+S + + LE L L+ + LK +PT
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 9/52 (17%), Positives = 19/52 (36%), Gaps = 3/52 (5%)
Query: 49 EINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDL 100
+ +T +IP + N L +L+ +F LE +++
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 60
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 9e-05
Identities = 16/101 (15%), Positives = 31/101 (30%), Gaps = 6/101 (5%)
Query: 57 LTGDI---PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISL 113
LT ++ + L L ++ I L +++D S N + +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP- 60
Query: 114 EKLVYLKDLNLSFNRLKGDIPTRSPHLQVPLCKSSSHRKSS 154
L LK L ++ NR+ L ++
Sbjct: 61 -LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 16/90 (17%), Positives = 32/90 (35%), Gaps = 8/90 (8%)
Query: 70 NLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSG----VIPISLEKLVYLKDLNLS 125
+L+L ++ + + E S++ + LS N + + ++ L+ S
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 126 FN---RLKGDIPTRSPHLQVPLCKSSSHRK 152
R+K +IP L L K
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.001
Identities = 14/68 (20%), Positives = 24/68 (35%), Gaps = 11/68 (16%)
Query: 76 LENNRLQGPIPESFGE------LTSLESLDLSVNNLSGVIPISL-----EKLVYLKDLNL 124
L + L + + L++L L N + +L EK+ L L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 125 SFNRLKGD 132
+ NR +
Sbjct: 310 NGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 36.8 bits (83), Expect = 0.004
Identities = 12/85 (14%), Positives = 28/85 (32%), Gaps = 12/85 (14%)
Query: 50 INLSRNYLTGDIPPTIG------GLTNLQLLSLENNRLQGPIPESFGE-----LTSLESL 98
+ L+ L+ + LQ L L+ N ++ + + L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 99 DLSVNNLSGVIPISLEKLVYLKDLN 123
+L+ N S ++++ +
Sbjct: 308 ELNGNRFSE-EDDVVDEIREVFSTR 331
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.001
Identities = 17/64 (26%), Positives = 25/64 (39%), Gaps = 8/64 (12%)
Query: 41 IENMKVVVEINLSRNYLTGDIPP------TIGGLTNLQLLSLENNRLQGPIPESFGELTS 94
E K VV + L G IPP T+ L + L+L N ++ S + +
Sbjct: 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK--ISSLSGMEN 71
Query: 95 LESL 98
L L
Sbjct: 72 LRIL 75
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.6 bits (83), Expect = 0.003
Identities = 11/65 (16%), Positives = 23/65 (35%), Gaps = 4/65 (6%)
Query: 67 GLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 126
L L + + ++ +L + +L + + + E L L +N S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGV--EYLNNLTQINFSN 71
Query: 127 NRLKG 131
N+L
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.6 bits (83), Expect = 0.003
Identities = 10/71 (14%), Positives = 27/71 (38%), Gaps = 4/71 (5%)
Query: 42 ENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLS 101
+ ++ L + +T + L + L + ++ + L +L ++ S
Sbjct: 15 TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 70
Query: 102 VNNLSGVIPIS 112
N L+ + P+
Sbjct: 71 NNQLTDITPLK 81
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 467 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.81 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.74 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.72 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.7 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.69 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.68 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.68 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.66 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.64 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.63 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.63 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.57 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.57 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.56 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.53 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.49 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.48 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.45 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.39 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.34 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.32 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.2 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.03 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.8 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.76 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.66 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.61 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.57 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.49 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.38 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.3 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.06 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.88 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.67 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.07 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.78 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=388.05 Aligned_cols=237 Identities=20% Similarity=0.282 Sum_probs=199.2
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||+||+|+++ +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 368999999999999999999986 58999999997653 2345678999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC---
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK--- 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 371 (467)
||++|+|.+++. ..+.+++.++..++.|++.||+||| ++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999985 4457999999999999999999999 999999999999999999999999999999876422
Q ss_pred ----CccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhcccccccc
Q 041491 372 ----ESMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNV 438 (467)
Q Consensus 372 ----~~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~ 438 (467)
...+|..|+|||.+.+..+ +.++||||+||++|||+||+.||............+.. ..+++++.++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 2346788999999887776 57899999999999999999999765443333333322 2345568899
Q ss_pred cccccccchhHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~ 458 (467)
+.+||..||++|+ +++|++
T Consensus 240 i~~~L~~dP~~R~-t~~eil 258 (271)
T d1nvra_ 240 LHKILVENPSARI-TIPDIK 258 (271)
T ss_dssp HHHHSCSSTTTSC-CHHHHT
T ss_pred HHHHcCCChhHCc-CHHHHh
Confidence 9999999999998 455543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=386.86 Aligned_cols=234 Identities=27% Similarity=0.329 Sum_probs=202.4
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
++|++.+.||+|+||+||+|++. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999985 59999999998766566678999999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
+||+|.+++.. +.+++.++..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 99999998754 35899999999999999999999 9999999999999999999999999999999875432
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH---------hhhcccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------NDFLPISVMNVVDTS 442 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~~ 442 (467)
..++..|.|||.+.++.++.++||||+||++|||+||+.||.+....+. +.... ...+++++.++|.+|
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 2467889999999999999999999999999999999999976432221 11111 123455689999999
Q ss_pred cccchhHHHHHHHHHH
Q 041491 443 LLRREDKYFAAKKQCV 458 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~ 458 (467)
|..||.+|++ +.|++
T Consensus 254 L~~dP~~R~s-~~eil 268 (293)
T d1yhwa1 254 LDMDVEKRGS-AKELL 268 (293)
T ss_dssp TCSSTTTSCC-HHHHT
T ss_pred ccCChhHCcC-HHHHh
Confidence 9999999984 44543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=384.80 Aligned_cols=235 Identities=23% Similarity=0.317 Sum_probs=202.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 48999999987532 334567899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|||++|+|.+++... +.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 999999999998643 46899999999999999999999 9999999999999999999999999999998776543
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhcccccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLL 444 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~ 444 (467)
..++..|.|||.+.+..++.++|||||||++|||+||+.||.+....+ .+..... ..+++++.+++.+||.
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 240 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLISRLLK 240 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence 346788999999999999999999999999999999999997643222 1222222 2345569999999999
Q ss_pred cchhHHHHHHHHHH
Q 041491 445 RREDKYFAAKKQCV 458 (467)
Q Consensus 445 ~~~~~r~~~~~~~~ 458 (467)
.||++|+ +++|++
T Consensus 241 ~dp~~R~-t~~eil 253 (263)
T d2j4za1 241 HNPSQRP-MLREVL 253 (263)
T ss_dssp SSGGGSC-CHHHHH
T ss_pred CCHhHCc-CHHHHH
Confidence 9999998 555554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=388.23 Aligned_cols=236 Identities=25% Similarity=0.329 Sum_probs=203.4
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
+.|++.+.||+|+||+||+|++. +++.||+|+++.......+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999986 48999999998776667788999999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC-----C
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG-----K 371 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~ 371 (467)
++|+|.+++.+..+.+++.++..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|+.... .
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 999999998766677999999999999999999999 99999999999999999999999999999986543 2
Q ss_pred Ccccccccccccccc-----CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh---------hhccccccc
Q 041491 372 ESMRTQTLATIEYGR-----EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN---------DFLPISVMN 437 (467)
Q Consensus 372 ~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~~ 437 (467)
...++..|.|||++. ...|+.++|||||||++|||+||+.||.+....+. +..... ..+++++.+
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCCCCCccccCCHHHHH
Confidence 345678899999873 45688999999999999999999999986533322 222222 234556899
Q ss_pred ccccccccchhHHHHHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~~ 458 (467)
++.+||..||.+|++ +.|++
T Consensus 248 li~~~L~~dp~~R~t-~~ell 267 (288)
T d2jfla1 248 FLKKCLEKNVDARWT-TSQLL 267 (288)
T ss_dssp HHHHHSCSSTTTSCC-HHHHT
T ss_pred HHHHHccCChhHCcC-HHHHh
Confidence 999999999999984 44443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=384.73 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=200.0
Q ss_pred HHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
++..++|++.+.||+|+||+||+|++. ..||||+++... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678999999999999999999864 469999987542 3455789999999999999999999998765 45799
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++|+|.+++...+..+++.++..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999999877778999999999999999999999 999999999999999999999999999999876432
Q ss_pred -------CccccccccccccccC---CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-----------hhh
Q 041491 372 -------ESMRTQTLATIEYGRE---GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-----------NDF 430 (467)
Q Consensus 372 -------~~~~~~~~~~pe~~~~---~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-----------~~~ 430 (467)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||.+............ ...
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2246778999998754 4588999999999999999999999986433222111111 122
Q ss_pred cccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 431 LPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 431 ~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+|+.+.+++.+||..||++|+ ++.|++..|-++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RP-t~~~il~~Le~l 270 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERP-LFPQILASIELL 270 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCc-CHHHHHHHHHHH
Confidence 345689999999999999997 667777766544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-52 Score=387.26 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=208.2
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEecC-CCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCe
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 288 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 288 (467)
++++++..++|++.+.||+|+||+||+|++.+ ++.||||+++... ...+++.+|++++++++||||+++++++.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 34566677899999999999999999999864 8899999987553 345789999999999999999999999999999
Q ss_pred eeEEEecccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 289 EALVLEYMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
.++||||+++|+|.+++... ...+++..+..++.|+++||+||| ++||+||||||+|||+++++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999998654 457899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCc------cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccc
Q 041491 368 LNGKES------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPI 433 (467)
Q Consensus 368 ~~~~~~------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~ 433 (467)
...... .++..|.|||++.++.++.++|||||||++|||++|..||....... ...+.+. ..+++
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCH
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhcCCCCCCCccchH
Confidence 754332 24556889999999999999999999999999999877765432221 2222222 23455
Q ss_pred ccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 434 SVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 434 ~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+.+++.+||..||++|+ ++.|+++.+-+
T Consensus 244 ~l~~li~~cl~~dP~~Rp-s~~ei~~~L~~ 272 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRP-SFAEIHQAFET 272 (287)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCc-CHHHHHHHHHH
Confidence 699999999999999997 56677665544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=378.76 Aligned_cols=241 Identities=24% Similarity=0.365 Sum_probs=197.7
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.++|++.+.||+|+||.||+|++.+++.||||+++.. ....+++.+|++++++++||||++++|++..++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 4679999999999999999999988889999998754 334578999999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+|+......
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999999877778999999999999999999999 9999999999999999999999999999998765432
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhcC-CCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTK-KKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg-~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
..++..|.|||.+.++.++.++|||||||++|||+|+ ++||...... .....+. ...++++.+++.+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 2346678999999999999999999999999999995 5555432211 1222221 1234458999999
Q ss_pred ccccchhHHHHHHHHHHHHHHhc
Q 041491 442 SLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
|+..||++|+ ++.|+++.|-++
T Consensus 238 cl~~~p~~Rp-s~~~il~~L~~i 259 (263)
T d1sm2a_ 238 CWKERPEDRP-AFSRLLRQLAEI 259 (263)
T ss_dssp HTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HccCCHhHCc-CHHHHHHHHHHH
Confidence 9999999997 677777766554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=373.23 Aligned_cols=242 Identities=25% Similarity=0.360 Sum_probs=209.1
Q ss_pred hccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+++.+|++++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 46899999999999999999999888899999998653 34578999999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
++|+|.+++......+++..+.+++.|+++||+||| ++||+||||||+||++++++.+||+|||+|+......
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999998777778999999999999999999999 9999999999999999999999999999998765432
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh-------hhcccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN-------DFLPISVMNVVDTS 442 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~~ 442 (467)
..++..|.|||......++.++|||||||++|||+| |+.||.+....+. ...... ...++++.+++.+|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-~~~i~~~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-HHHHHhCCCCCCcccccHHHHHHHHHH
Confidence 234567899999999999999999999999999998 8999987544332 111211 12234589999999
Q ss_pred cccchhHHHHHHHHHHHHHHhc
Q 041491 443 LLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 443 l~~~~~~r~~~~~~~~~~l~~l 464 (467)
+..||++|+ ++++++..|+.+
T Consensus 238 l~~dP~~RP-t~~eil~~L~di 258 (258)
T d1k2pa_ 238 WHEKADERP-TFKILLSNILDV 258 (258)
T ss_dssp TCSSGGGSC-CHHHHHHHHHCC
T ss_pred ccCCHhHCc-CHHHHHHHhhCC
Confidence 999999998 688888887643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=380.36 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=200.6
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
++++..++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|++++++++||||+++++++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3455668899999999999999999999888999999997543 345789999999999999999999998865 45689
Q ss_pred EEecccCCCHHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 292 VLEYMANGSLEKCLYSSNG-ILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
||||+++|+|.+++....+ .+++..+..++.|+++||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999997754433 5899999999999999999999 99999999999999999999999999999998754
Q ss_pred CC------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhccccccc
Q 041491 371 KE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFLPISVMN 437 (467)
Q Consensus 371 ~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~ 437 (467)
.. ..++..|.|||.+..+.++.++|||||||++|||+||..|+............... ..+++++.+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 241 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence 32 23556789999998889999999999999999999976665433222211222211 234556899
Q ss_pred ccccccccchhHHHHHHHHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
++.+||..||++|+ ++.++++.|
T Consensus 242 li~~cl~~~P~~Rp-t~~ei~~~L 264 (272)
T d1qpca_ 242 LMRLCWKERPEDRP-TFDYLRSVL 264 (272)
T ss_dssp HHHHHTCSSGGGSC-CHHHHHHHH
T ss_pred HHHHHcCCCHhHCc-CHHHHHHHh
Confidence 99999999999996 566665544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=379.92 Aligned_cols=237 Identities=23% Similarity=0.310 Sum_probs=190.0
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec--CCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 291 (467)
.++|++.+.||+|+||+||+|+++ +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+ .+..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999986 58999999997653 2345678899999999999999999999864 456899
Q ss_pred EEecccCCCHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeeecCCCcEEEeccc
Q 041491 292 VLEYMANGSLEKCLYS---SNGILDIFQRLSIMIDVALALEYLHFGYSNP-----VVHCDIKPSNVLLDDDMVAHLSDFG 363 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg 363 (467)
|||||++|+|.+++.. ....+++..++.++.|++.||+||| +++ |+||||||+|||+++++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 9999999999998854 3457999999999999999999999 654 9999999999999999999999999
Q ss_pred cceecCCCC-----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh-------hhc
Q 041491 364 IAKLLNGKE-----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------DFL 431 (467)
Q Consensus 364 ~a~~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~ 431 (467)
+|+...... ..++..|.|||.+.+..++.++|||||||++|||+||+.||.+....+. ...... ..+
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCCCCCTTS
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCCCCCccc
Confidence 998765432 3467789999999999999999999999999999999999986433221 111111 234
Q ss_pred ccccccccccccccchhHHHHHHHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
++++.+++.+||..||.+|+ ++.|++
T Consensus 239 s~~l~~li~~~L~~dp~~Rp-s~~ell 264 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRP-SVEEIL 264 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSC-CHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCc-CHHHHH
Confidence 45689999999999999998 455554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-50 Score=387.51 Aligned_cols=237 Identities=19% Similarity=0.267 Sum_probs=204.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999986 5999999999876555567788999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec--CCCcEEEeccccceecCCCC-
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--DDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+||+|.+++......+++.+++.++.||+.||+||| ++||+||||||+|||++ .++.+||+|||+|+......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999999988776668999999999999999999999 99999999999999997 57899999999999887544
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMNVV 439 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~i 439 (467)
..++..|.|||++.++.++.++||||+||++|||+||+.||.+....+ .+..... ..+++++.++|
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 246778899999999999999999999999999999999997643222 1111111 23455689999
Q ss_pred ccccccchhHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~ 458 (467)
.+||..||.+|++ +.|++
T Consensus 264 ~~~L~~dp~~R~s-~~eil 281 (352)
T d1koba_ 264 KNLLQKEPRKRLT-VHDAL 281 (352)
T ss_dssp HTTSCSSGGGSCC-HHHHH
T ss_pred HHHccCChhHCcC-HHHHh
Confidence 9999999999984 44544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=380.11 Aligned_cols=230 Identities=25% Similarity=0.336 Sum_probs=198.2
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999986 58999999997542 334567899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-- 371 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 371 (467)
||++||+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999988543 57999999999999999999999 999999999999999999999999999999977532
Q ss_pred -----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhcccccccccc
Q 041491 372 -----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVD 440 (467)
Q Consensus 372 -----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~ 440 (467)
...++..|.|||.+.+..++.++||||+||++|||+||+.||.+....+ .+.... ...+++++.++|.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDLVE 242 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCCCCCCccCCHHHHHHHH
Confidence 2246788999999999999999999999999999999999997643222 111211 1234556899999
Q ss_pred cccccchhHHHH
Q 041491 441 TSLLRREDKYFA 452 (467)
Q Consensus 441 ~~l~~~~~~r~~ 452 (467)
+||..||.+|++
T Consensus 243 ~~L~~dP~~R~t 254 (288)
T d1uu3a_ 243 KLLVLDATKRLG 254 (288)
T ss_dssp TTSCSSGGGSTT
T ss_pred HHccCCHhHCcC
Confidence 999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-50 Score=386.23 Aligned_cols=237 Identities=21% Similarity=0.296 Sum_probs=204.7
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
-++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999986 5899999999876655667889999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec--CCCcEEEeccccceecCCCC-
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--DDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~- 372 (467)
|+||+|.+++....+.+++..+..++.||+.||+||| ++||+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999999777778999999999999999999999 99999999999999995 45789999999999876544
Q ss_pred ---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh----------hhccccccccc
Q 041491 373 ---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN----------DFLPISVMNVV 439 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~~~i 439 (467)
..++..|+|||.+.+..++.++||||+||++|||+||+.||.+....+ .+..... ..+++++.++|
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 346788999999999999999999999999999999999997643222 1222111 23455688999
Q ss_pred ccccccchhHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~ 458 (467)
.+||..||.+|++ +.|++
T Consensus 261 ~~~L~~dP~~R~t-~~eil 278 (350)
T d1koaa2 261 RKLLLADPNTRMT-IHQAL 278 (350)
T ss_dssp HHHCCSSGGGSCC-HHHHH
T ss_pred HHHccCChhHCcC-HHHHh
Confidence 9999999999984 44544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=391.36 Aligned_cols=197 Identities=25% Similarity=0.361 Sum_probs=176.8
Q ss_pred HhccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 216 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 216 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
..++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|+.++++++||||++++++|.+.+..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4689999999999999999999986 58999999997653 334567899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeecCCCcEEEeccccceecCC--
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG-- 370 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-- 370 (467)
||++||+|.+++.+. +.+++..+..++.|++.||.||| ++ ||+||||||+|||+++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp ECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 999999999998654 46899999999999999999999 74 899999999999999999999999999986542
Q ss_pred -CCccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 371 -KESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 371 -~~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
....++..|.|||++.+..|+.++||||+||++|||+||+.||...
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2346788899999999999999999999999999999999999653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-50 Score=380.56 Aligned_cols=237 Identities=22% Similarity=0.308 Sum_probs=187.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
.+.|++.+.||+|+||+||+|+++ +++.||||++.... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999986 48999999997553 2334567899999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec---CCCcEEEeccccceecCCC
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---DDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~ 371 (467)
||+||+|.+++.. .+.+++..+..++.|++.||+||| ++||+||||||+||++. +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999954 457999999999999999999999 99999999999999994 5789999999999876543
Q ss_pred C----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------hhhccccccc
Q 041491 372 E----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV----------NDFLPISVMN 437 (467)
Q Consensus 372 ~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~----------~~~~~~~~~~ 437 (467)
. ..++..|.|||.+.++.++.++||||+||++|||+||+.||.+....+. ..... ...+++++.+
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHhccCCCCCCccccCCCHHHHH
Confidence 2 3467889999999999999999999999999999999999976432221 11111 1234556899
Q ss_pred ccccccccchhHHHHHHHHHHH
Q 041491 438 VVDTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~~~~~~~ 459 (467)
++.+||..||++|++ +.|+++
T Consensus 243 li~~~L~~dP~~R~s-~~eil~ 263 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFT-CEQALQ 263 (307)
T ss_dssp HHHHHSCSSGGGSCC-HHHHHH
T ss_pred HHHHHccCCHhHCcC-HHHHhc
Confidence 999999999999984 455543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-50 Score=380.30 Aligned_cols=241 Identities=22% Similarity=0.391 Sum_probs=194.4
Q ss_pred hccCccCCccCcccceeEEEEEecC-C---CeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD-G---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
.++|++.+.||+|+||+||+|+++. + ..||||.+.... ....+.+.+|++++++++||||++++|++..++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3567888999999999999998853 3 258889876543 3345679999999999999999999999999999999
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
|||||++|+|.+++....+.+++.++..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999998877778999999999999999999999 999999999999999999999999999999876543
Q ss_pred Cc----------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hcc
Q 041491 372 ES----------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLP 432 (467)
Q Consensus 372 ~~----------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~ 432 (467)
.. .++..|.|||....+.++.++|||||||++|||+| |+.||.+.... .....+.. .+|
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCCCCTTCC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCccch
Confidence 21 23567899999999999999999999999999998 89999764332 22233322 234
Q ss_pred cccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 433 ISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
+.+.+++.+||..||++|+ ++.|+++.|-+
T Consensus 260 ~~l~~li~~cl~~~P~~RP-s~~ei~~~L~~ 289 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRP-KFGQIVNTLDK 289 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSC-CHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCc-CHHHHHHHHHH
Confidence 4589999999999999997 56666665543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=370.29 Aligned_cols=233 Identities=24% Similarity=0.344 Sum_probs=191.3
Q ss_pred CccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec----CCeeeEE
Q 041491 220 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFEALV 292 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 292 (467)
|+..+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366678999999999999986 48899999987543 2345678999999999999999999999864 4567999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeec-CCCcEEEeccccceecC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNVLLD-DDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 369 (467)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +++ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998653 46899999999999999999999 888 99999999999996 57899999999998765
Q ss_pred CCC---ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH--------Hhhhcccccccc
Q 041491 370 GKE---SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW--------VNDFLPISVMNV 438 (467)
Q Consensus 370 ~~~---~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~ 438 (467)
... ..++..|.|||.+.+ .++.++|||||||++|||+||+.||.+........... .....++++.++
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence 433 346888999998765 69999999999999999999999997543222111111 112234468899
Q ss_pred cccccccchhHHHHHHHHHH
Q 041491 439 VDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 439 i~~~l~~~~~~r~~~~~~~~ 458 (467)
+.+||..||++|+ ++.|++
T Consensus 246 i~~~l~~dp~~R~-s~~ell 264 (270)
T d1t4ha_ 246 IEGCIRQNKDERY-SIKDLL 264 (270)
T ss_dssp HHHHSCSSGGGSC-CHHHHH
T ss_pred HHHHccCCHhHCc-CHHHHh
Confidence 9999999999998 455554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=381.89 Aligned_cols=231 Identities=23% Similarity=0.274 Sum_probs=200.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEE
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 292 (467)
.++|++.+.||+|+||.||+|+++ +|+.||+|++++.. ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999985 59999999997542 33457788999999999999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||++||+|.+++... +.+++..++.++.|++.||+||| ++||+||||||+|||++++|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999988654 56899999999999999999999 9999999999999999999999999999998764422
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDT 441 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~ 441 (467)
..++..|.|||.+.+..|+.++||||+||++|||++|++||.+....+. ...... ..+++++.++|.+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-HHHHhcCCCCCCccCCHHHHHHHHh
Confidence 3467889999999999999999999999999999999999987543321 122211 2355568999999
Q ss_pred ccccchhHHHH
Q 041491 442 SLLRREDKYFA 452 (467)
Q Consensus 442 ~l~~~~~~r~~ 452 (467)
||.+||.+|++
T Consensus 239 ~L~~dP~~R~~ 249 (337)
T d1o6la_ 239 LLKKDPKQRLG 249 (337)
T ss_dssp HTCSSTTTSTT
T ss_pred hccCCchhhcc
Confidence 99999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-50 Score=380.74 Aligned_cols=230 Identities=23% Similarity=0.314 Sum_probs=199.4
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999986 58999999997542 334577899999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||++||+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 99999999998854 446789999999999999999999 9999999999999999999999999999999876543
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLLR 445 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~~ 445 (467)
..++..|.|||.+.+..++.++||||+||++|||+||+.||.+....+. ...... ..+++++.+++.+||..
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAELRFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Confidence 4578889999999999999999999999999999999999976432221 122211 23455699999999999
Q ss_pred chhHHHH
Q 041491 446 REDKYFA 452 (467)
Q Consensus 446 ~~~~r~~ 452 (467)
||.+|++
T Consensus 239 dp~~R~~ 245 (316)
T d1fota_ 239 DLSQRLG 245 (316)
T ss_dssp CTTTCTT
T ss_pred CHHhccc
Confidence 9999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=372.39 Aligned_cols=237 Identities=20% Similarity=0.268 Sum_probs=201.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc------cchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|++.+.||+|+||+||+|+++ +|+.||||++++... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999986 589999999975421 2356789999999999999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC----cEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM----VAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a 365 (467)
|+|||||++|+|.+++... +.+++..++.++.|++.||+||| +++|+||||||+||+++.++ .+|++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999998654 47999999999999999999999 99999999999999998776 5999999999
Q ss_pred eecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---------cHHHHHhhhcc
Q 041491 366 KLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------NLKNWVNDFLP 432 (467)
Q Consensus 366 ~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------~~~~~~~~~~~ 432 (467)
+...... ..++..|.|||.+.++.++.++||||+||++|||+||+.||.+....+. ....-....++
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 9876432 3466789999999999999999999999999999999999976432221 11112233456
Q ss_pred cccccccccccccchhHHHHHHHHHH
Q 041491 433 ISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 433 ~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
+++.++|.+||..||++|++ ++|++
T Consensus 245 ~~~~~li~~~L~~dP~~R~s-~~eil 269 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMT-IQDSL 269 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCC-HHHHH
T ss_pred HHHHHHHHHHccCChhHCcC-HHHHh
Confidence 67899999999999999984 44544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-50 Score=377.94 Aligned_cols=235 Identities=26% Similarity=0.304 Sum_probs=197.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
+.|+..+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 46999999999999999999986 588999999975532 23467889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC-C
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK-E 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 372 (467)
|||++|++..++.. .+.+++.++..++.|++.||.||| ++||+||||||+|||+++++.+||+|||+|+..... .
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 99999999776643 457999999999999999999999 999999999999999999999999999999876543 3
Q ss_pred ccccccccccccccC---CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 373 SMRTQTLATIEYGRE---GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 373 ~~~~~~~~~pe~~~~---~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
..++..|+|||.+.+ +.|+.++|||||||++|||++|+.||.+....+. +..... ..+++++.+++.+
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 457888999998753 5689999999999999999999999976432221 111111 2244568999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
||..||.+|++ +.|++
T Consensus 250 ~L~~dP~~Rpt-~~ell 265 (309)
T d1u5ra_ 250 CLQKIPQDRPT-SEVLL 265 (309)
T ss_dssp HTCSSGGGSCC-HHHHT
T ss_pred HCcCChhHCcC-HHHHH
Confidence 99999999974 44443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.1e-50 Score=372.86 Aligned_cols=244 Identities=21% Similarity=0.352 Sum_probs=203.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc---cchHHHHHHHHHHHcCCCCCceeEEEEeecCC----e
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGN----F 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 288 (467)
.++|++.+.||+|+||.||+|++. +|+.||+|+++.... ...+.+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999985 589999999975432 33467899999999999999999999987543 4
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||++|++|.+++... +.+++.++..++.|++.||+||| ++||+||||||+||+++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 78999999999999988544 57899999999999999999999 999999999999999999999999999998765
Q ss_pred CCC--------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH---------Hhhhc
Q 041491 369 NGK--------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW---------VNDFL 431 (467)
Q Consensus 369 ~~~--------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~---------~~~~~ 431 (467)
... ...++..|.|||...++.+++++||||+||++|||+||+.||.+....+...... ....+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 432 2246778999999999999999999999999999999999998643322211111 12335
Q ss_pred ccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
|+++.++|.+||..||.+|++++++++.+|.++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 567999999999999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=368.76 Aligned_cols=229 Identities=23% Similarity=0.396 Sum_probs=193.3
Q ss_pred hccCccCCc-cCcccceeEEEEEecC---CCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 217 TDHFSEKSL-IGIGSFGTVYKGRFLD---GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 217 ~~~y~~~~~-lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
.++|.+.+. ||+|+||.||+|.++. +..||||+++.... ...+++.+|++++++++||||+++++++.++ ..|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 456777774 9999999999998752 55799999975533 3457899999999999999999999998754 5789
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
||||+++|+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998777778999999999999999999999 999999999999999999999999999999977543
Q ss_pred C--------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhcccc
Q 041491 372 E--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPIS 434 (467)
Q Consensus 372 ~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 434 (467)
. ..++..|.|||++..+.++.++|||||||++|||+| |+.||.+....+ ....+. ..+|++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRMECPPECPPE 240 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCCCCCCTTCCHH
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCCcCCHH
Confidence 2 234567899999998999999999999999999998 999998653322 222222 234456
Q ss_pred cccccccccccchhHHH
Q 041491 435 VMNVVDTSLLRREDKYF 451 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~ 451 (467)
+.+++.+||..+|++||
T Consensus 241 l~~li~~cl~~~p~~RP 257 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRP 257 (285)
T ss_dssp HHHHHHHTTCSSGGGSC
T ss_pred HHHHHHHHcCCCHhHCc
Confidence 89999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=381.62 Aligned_cols=230 Identities=23% Similarity=0.285 Sum_probs=199.8
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++|++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999986 59999999997542 234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC-
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE- 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 372 (467)
||+.+|+|.+++... +.+++..+..++.||+.||.||| ++|||||||||+|||++.++.+||+|||+|+......
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999999988554 46899999999999999999999 9999999999999999999999999999999876543
Q ss_pred -ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh------hhccccccccccccccc
Q 041491 373 -SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN------DFLPISVMNVVDTSLLR 445 (467)
Q Consensus 373 -~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~i~~~l~~ 445 (467)
..++..|+|||.+.+..++.++|||||||++|||+||+.||.+..... .+..... ..+++++.++|.+||..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHhcCCCCCCccCCHHHHHHHHHHhhh
Confidence 457888999999999999999999999999999999999997643221 1111111 23455699999999999
Q ss_pred chhHHHH
Q 041491 446 REDKYFA 452 (467)
Q Consensus 446 ~~~~r~~ 452 (467)
||.+|+.
T Consensus 276 dP~kR~~ 282 (350)
T d1rdqe_ 276 DLTKRFG 282 (350)
T ss_dssp CTTTCTT
T ss_pred CHHhccc
Confidence 9999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=373.33 Aligned_cols=236 Identities=18% Similarity=0.269 Sum_probs=200.9
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecc
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYM 296 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 296 (467)
++|++.+.||+|+||+||+|.+. +++.||+|+++... .....+.+|+++|++++||||+++++++.+++..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 68999999999999999999986 48899999997653 33456889999999999999999999999999999999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC--CcEEEeccccceecCCCCc-
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD--MVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~- 373 (467)
+||+|.+++......+++.++..++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 999999999776668999999999999999999999 9999999999999999854 4899999999998765432
Q ss_pred ---cccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc---------cHHHHHhhhccccccccccc
Q 041491 374 ---MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM---------NLKNWVNDFLPISVMNVVDT 441 (467)
Q Consensus 374 ---~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~---------~~~~~~~~~~~~~~~~~i~~ 441 (467)
.++..|.+||...+..++.++||||+||++|||++|+.||......+. .+..-....+++++.++|.+
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 240 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHH
Confidence 356677888888888899999999999999999999999976433221 11112223456678999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
||..||.+|++ +.|++
T Consensus 241 ~L~~dp~~R~s-~~eil 256 (321)
T d1tkia_ 241 LLVKERKSRMT-ASEAL 256 (321)
T ss_dssp TSCSSGGGSCC-HHHHH
T ss_pred HccCChhHCcC-HHHHh
Confidence 99999999984 55554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=368.46 Aligned_cols=240 Identities=23% Similarity=0.386 Sum_probs=194.7
Q ss_pred hccCccCCccCcccceeEEEEEecCC-----CeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLDG-----MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 290 (467)
.+.|+..+.||+|+||.||+|.++.. ..||||+++.... ....++.+|++++++++||||++++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45688899999999999999987642 4699999875433 34457899999999999999999999999999999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
+||||+.++++.+++......+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999988877788999999999999999999999 99999999999999999999999999999987643
Q ss_pred CC--------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhh--------hcccc
Q 041491 371 KE--------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVND--------FLPIS 434 (467)
Q Consensus 371 ~~--------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 434 (467)
.. ..++..|.|||++..+.++.++|||||||++|||+||..|+....... .....+.. .+|..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCCCCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhccCCCCCchhhHHH
Confidence 22 234567999999999999999999999999999999766665432222 22222222 23445
Q ss_pred cccccccccccchhHHHHHHHHHHHHH
Q 041491 435 VMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 435 ~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
+.+++.+|+..+|++|+ ++.|+++.|
T Consensus 242 l~~li~~cl~~~p~~RP-t~~eil~~L 267 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRP-KFADIVSIL 267 (283)
T ss_dssp HHHHHHHHTCSSTTTSC-CHHHHHHHH
T ss_pred HHHHHHHHCcCCHhHCc-CHHHHHHHH
Confidence 89999999999999997 455555544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=376.18 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=200.6
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC-C-----CeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEEEEeec
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD-G-----MEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSN 285 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 285 (467)
++..++|++.+.||+|+||+||+|++.. + ..||+|.+.... ......+.+|+.+++++ +||||+++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3456789999999999999999998753 2 369999986543 33456789999999998 89999999999999
Q ss_pred CCeeeEEEecccCCCHHHhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSN----------------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 343 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 343 (467)
.+..++|||||++|+|.+++.... ..+++..++.++.|++.||+||| +++|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecc
Confidence 999999999999999999996543 24789999999999999999999 99999999
Q ss_pred CCCCCeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCc
Q 041491 344 IKPSNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCE 415 (467)
Q Consensus 344 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~ 415 (467)
|||+||+++.++.+||+|||+|+...... ..++..|+|||.+.++.++.++|||||||++|||+| |+.||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765432 234667999999999999999999999999999998 8999976
Q ss_pred cccccccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHH
Q 041491 416 IFCEEMNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSA 461 (467)
Q Consensus 416 ~~~~~~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l 461 (467)
..... .+...+.. .+++++.+++.+||..||++|+ +++|.++.|
T Consensus 270 ~~~~~-~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-t~~ei~~~L 321 (325)
T d1rjba_ 270 IPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-SFPNLTSFL 321 (325)
T ss_dssp CCCSH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHH
T ss_pred CCHHH-HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc-CHHHHHHHH
Confidence 43332 23333322 3345689999999999999996 667777665
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.1e-49 Score=379.83 Aligned_cols=233 Identities=21% Similarity=0.272 Sum_probs=194.3
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHH---HHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDA---ECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
-++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+ |+++++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999986 48999999986432 122233334 46777788999999999999999999
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
|+||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999998654 56899999999999999999999 9999999999999999999999999999999776
Q ss_pred CC---CccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc-HHHH-------Hhhhccccccc
Q 041491 370 GK---ESMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-LKNW-------VNDFLPISVMN 437 (467)
Q Consensus 370 ~~---~~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-~~~~-------~~~~~~~~~~~ 437 (467)
.. ...++..|.|||++.. ..++.++|||||||++|||+||+.||......+.. .... ....+++++.+
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 43 3457889999998864 56899999999999999999999999764332211 1111 11234556999
Q ss_pred ccccccccchhHHHHH
Q 041491 438 VVDTSLLRREDKYFAA 453 (467)
Q Consensus 438 ~i~~~l~~~~~~r~~~ 453 (467)
+|.+||..||.+|++.
T Consensus 239 li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGC 254 (364)
T ss_dssp HHHHHTCSSTTTSTTT
T ss_pred HHHHHcccCHHHhCCC
Confidence 9999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=368.88 Aligned_cols=240 Identities=24% Similarity=0.351 Sum_probs=195.2
Q ss_pred HHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEE
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVL 293 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 293 (467)
++..++|++.+.||+|+||+||+|++++++.||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 34567899999999999999999999888899999997543 345789999999999999999999999865 5578999
Q ss_pred ecccCCCHHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSS-NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
||+++|+|..++... ...+++.++..++.|++.||+||| ++||+||||||+|||+++++.+||+|||+|+......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999887643 346899999999999999999999 9999999999999999999999999999998764332
Q ss_pred ------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------hhhccccccccc
Q 041491 373 ------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV-------NDFLPISVMNVV 439 (467)
Q Consensus 373 ------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~i 439 (467)
..++..|.|||+...+.++.++|||||||++|||+||..||.........+.... ...+++++.+++
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHH
Confidence 2356778999999999999999999999999999997766654332222222221 122344589999
Q ss_pred ccccccchhHHHHHHHHHHH
Q 041491 440 DTSLLRREDKYFAAKKQCVS 459 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~~ 459 (467)
.+||..||++|+ ++++.+.
T Consensus 248 ~~cl~~dP~~Rp-s~~~i~~ 266 (285)
T d1fmka3 248 CQCWRKEPEERP-TFEYLQA 266 (285)
T ss_dssp HHHTCSSGGGSC-CHHHHHH
T ss_pred HHHcccCHhHCc-CHHHHHH
Confidence 999999999996 5555544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=365.38 Aligned_cols=227 Identities=24% Similarity=0.334 Sum_probs=187.4
Q ss_pred CccCcccceeEEEEEecC---CCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEecccC
Q 041491 224 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEYMAN 298 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 298 (467)
++||+|+||+||+|.+.+ ++.||||+++... ....+++.+|++++++++||||+++++++..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998753 4679999996542 23456799999999999999999999999765 46899999999
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC------
Q 041491 299 GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE------ 372 (467)
Q Consensus 299 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------ 372 (467)
|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999998654 56899999999999999999999 9999999999999999999999999999998765432
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHh--------hhccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVVDT 441 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~ 441 (467)
..++..|.|||.+.++.++.++|||||||++|||+| |+.||.+....+ ....+. ..+|+++.+++.+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i~~~~~~~~p~~~~~~~~~li~~ 245 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCPAGCPREMYDLMNL 245 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 234567899999988999999999999999999998 899998643322 222222 2344568999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
|+..||++|+ ++.++.
T Consensus 246 cl~~dp~~RP-s~~~i~ 261 (277)
T d1xbba_ 246 CWTYDVENRP-GFAAVE 261 (277)
T ss_dssp HTCSSTTTSC-CHHHHH
T ss_pred HcCCCHhHCc-CHHHHH
Confidence 9999999996 444443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=366.05 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=193.7
Q ss_pred HHhccCccCCccCcccceeEEEEEecC----CCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
+..++|++.+.||+|+||.||+|++.. +..||+|.++... ....+.+.+|++++++++||||+++++++.+ +..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 345789999999999999999998753 3568888886543 3345679999999999999999999999864 568
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++|++.+++......+++..+..++.|+++||+||| +++|+||||||+||++++++.+||+|||+|+...
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999999988777778999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCC------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-------hhhccccc
Q 041491 370 GKE------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-------NDFLPISV 435 (467)
Q Consensus 370 ~~~------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~ 435 (467)
... ..++..|.|||.+..+.++.++|||||||++|||+| |++||.+....+. ..... ...+|+++
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTL 238 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTTCCHHH
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHH
Confidence 322 234567899999999999999999999999999998 8999976543321 11111 12344569
Q ss_pred ccccccccccchhHHHHHHHHHHHHHHh
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+++.+||..||++|+ ++.|++..|-+
T Consensus 239 ~~li~~cl~~dp~~Rp-s~~ei~~~L~~ 265 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRP-RFTELKAQLST 265 (273)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCc-CHHHHHHHHHH
Confidence 9999999999999997 56666665543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.9e-48 Score=361.09 Aligned_cols=234 Identities=23% Similarity=0.305 Sum_probs=197.1
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccccc---------chHHHHHHHHHHHcCC-CCCceeEEEEeecC
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG---------ALKSFDAECEVLKSVR-HRNLVKIISSCSNG 286 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 286 (467)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999985 5899999999765321 2346889999999997 99999999999999
Q ss_pred CeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 287 NFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 287 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
+..|+||||+++|+|.+++.. .+.+++.+++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999965 457999999999999999999999 9999999999999999999999999999999
Q ss_pred ecCCCC----ccccccccccccccC------CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------
Q 041491 367 LLNGKE----SMRTQTLATIEYGRE------GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------- 428 (467)
Q Consensus 367 ~~~~~~----~~~~~~~~~pe~~~~------~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------- 428 (467)
...... ..++..|.+||+..+ ..++.++||||+||++|||+||+.||.+....+ .......
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCCCCCc
Confidence 876432 335677889998753 346889999999999999999999998754332 1111211
Q ss_pred --hhcccccccccccccccchhHHHHHHHHH
Q 041491 429 --DFLPISVMNVVDTSLLRREDKYFAAKKQC 457 (467)
Q Consensus 429 --~~~~~~~~~~i~~~l~~~~~~r~~~~~~~ 457 (467)
..+++++.+++.+||..+|++|++ ++|.
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s-~~ei 267 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYT-AEEA 267 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCC-HHHH
T ss_pred ccccCCHHHHHHHHHHccCChhHCcC-HHHH
Confidence 235566899999999999999984 4444
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=366.95 Aligned_cols=231 Identities=23% Similarity=0.318 Sum_probs=196.2
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc---ccchHHHHHHHHHHH-cCCCCCceeEEEEeecCCeeeEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLK-SVRHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 292 (467)
++|++.+.||+|+||+||+|++. +|+.||||++++.. ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999986 48999999997542 334456777777765 68999999999999999999999
Q ss_pred EecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 293 LEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
|||+++|+|.+++... +.+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999998643 46899999999999999999999 9999999999999999999999999999998665322
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH------hhhccccccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------NDFLPISVMNVVDT 441 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~i~~ 441 (467)
..++..|.|||.+.+..++.++||||+||++|||+||+.||.+....+. ..... ...+++++.++|.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCccCCHHHHHHHHH
Confidence 3467788999999999999999999999999999999999986433221 11111 12345679999999
Q ss_pred ccccchhHHHHH
Q 041491 442 SLLRREDKYFAA 453 (467)
Q Consensus 442 ~l~~~~~~r~~~ 453 (467)
||..||.+|++.
T Consensus 237 ~L~~dP~~R~s~ 248 (320)
T d1xjda_ 237 LFVREPEKRLGV 248 (320)
T ss_dssp HSCSSGGGSBTT
T ss_pred hcccCCCCCcCH
Confidence 999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=360.00 Aligned_cols=241 Identities=30% Similarity=0.384 Sum_probs=195.0
Q ss_pred HHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeec-CCeeeEEE
Q 041491 215 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNFEALVL 293 (467)
Q Consensus 215 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 293 (467)
+..++|++.+.||+|+||.||+|++ .|++||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3457899999999999999999998 5789999999654 345789999999999999999999999854 46689999
Q ss_pred ecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 372 (467)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+|++|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999999986543 35899999999999999999999 9999999999999999999999999999999765433
Q ss_pred --ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccccccccccc
Q 041491 373 --SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPISVMNVVDT 441 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~i~~ 441 (467)
...+..|.|||+..++.+++++|||||||++|||+| |+.||...... ....++.. .+++.+.+++.+
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 345667899999999999999999999999999998 68888764322 33344332 234569999999
Q ss_pred ccccchhHHHHHHHHHHHHHHhc
Q 041491 442 SLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
|+..||.+|+ ++.++++.|.++
T Consensus 236 cl~~dP~~Rp-s~~~l~~~L~~i 257 (262)
T d1byga_ 236 CWHLDAAMRP-SFLQLREQLEHI 257 (262)
T ss_dssp HTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HcccCHhHCc-CHHHHHHHHHHH
Confidence 9999999996 566777766543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=359.92 Aligned_cols=240 Identities=23% Similarity=0.312 Sum_probs=192.8
Q ss_pred hccCccCCccCcccceeEEEEEecC--C--CeEEEEEeeccc---ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFLD--G--MEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFE 289 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 289 (467)
.++|++.+.||+|+||.||+|++.. + ..||||+++... ....+++.+|++++++++||||++++|++.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 4689999999999999999998743 2 368999986542 33456899999999999999999999999764 56
Q ss_pred eEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecC
Q 041491 290 ALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLN 369 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 369 (467)
++||||+++|++.+++....+.+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999988777778999999999999999999999 9999999999999999999999999999999875
Q ss_pred CCCc--------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHH-h--------hhc
Q 041491 370 GKES--------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWV-N--------DFL 431 (467)
Q Consensus 370 ~~~~--------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~-~--------~~~ 431 (467)
.... .++..|.|||....+.++.++|||||||++|||+| |+.||.+....+ ...++ . ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTSCCCCCCCTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHHHhCCCCCCCcccc
Confidence 4322 23456789999999999999999999999999998 899997643332 22222 1 234
Q ss_pred ccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 432 PISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
|+.+.+++.+||..||++|+ ++.|+++.|.+
T Consensus 241 ~~~l~~li~~cl~~dp~~RP-t~~ei~~~L~~ 271 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRP-TFVALRDFLLE 271 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCc-CHHHHHHHHHh
Confidence 55689999999999999997 56666665544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-48 Score=364.53 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=206.0
Q ss_pred HHHHHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEE
Q 041491 210 YQELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISS 282 (467)
Q Consensus 210 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 282 (467)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||+++.... ...+++.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4456667789999999999999999999874 257899999875433 345679999999999999999999999
Q ss_pred eecCCeeeEEEecccCCCHHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 041491 283 CSNGNFEALVLEYMANGSLEKCLYSSN-----------------------GILDIFQRLSIMIDVALALEYLHFGYSNPV 339 (467)
Q Consensus 283 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 339 (467)
+...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence 999999999999999999999986432 14788999999999999999999 9999
Q ss_pred eecCCCCCCeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCC-C
Q 041491 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKK-K 411 (467)
Q Consensus 340 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~-~ 411 (467)
+||||||+|||+|.++.+||+|||+|+...... ..++..|.|||+.....++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998654321 23456789999999999999999999999999999996 5
Q ss_pred CCCccccccccHHHHH-------hhhcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 412 PTCEIFCEEMNLKNWV-------NDFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 412 Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
||.+....+ ...... ...+|+++.+++.+|+..+|++|+ ++.|+++.|-++
T Consensus 242 p~~~~~~~e-~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RP-t~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHEE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-SFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHT
T ss_pred CCCCCCHHH-HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCc-CHHHHHHHHHHh
Confidence 676543222 111211 123445689999999999999997 677776666543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=367.18 Aligned_cols=233 Identities=19% Similarity=0.233 Sum_probs=193.6
Q ss_pred hccCccCC-ccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHc-CCCCCceeEEEEeec----CCee
Q 041491 217 TDHFSEKS-LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKS-VRHRNLVKIISSCSN----GNFE 289 (467)
Q Consensus 217 ~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~ 289 (467)
.++|++.+ .||+|+||.||+|++. +++.||||+++.. ..+.+|++++.+ .+||||+++++++.+ .+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788875 5999999999999985 5899999998643 567789998765 489999999999865 4678
Q ss_pred eEEEecccCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC---CCcEEEeccccc
Q 041491 290 ALVLEYMANGSLEKCLYSSN-GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD---DMVAHLSDFGIA 365 (467)
Q Consensus 290 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a 365 (467)
|+|||||+||+|.+++.... ..+++.+++.++.|++.||+||| ++||+||||||+|||+++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 99999999999999997643 47999999999999999999999 999999999999999975 457999999999
Q ss_pred eecCCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc-------------ccHHHHHh
Q 041491 366 KLLNGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE-------------MNLKNWVN 428 (467)
Q Consensus 366 ~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~-------------~~~~~~~~ 428 (467)
+...... ..++..|.|||.+.+..|+.++||||+||++|||+||+.||.+..... ..+.....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence 8775433 356788999999999999999999999999999999999997542211 11111233
Q ss_pred hhcccccccccccccccchhHHHHHHHHHH
Q 041491 429 DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 429 ~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+++++.++|.+||..||++|++ +.|++
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s-~~eil 270 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMT-ITEFM 270 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCC-HHHHH
T ss_pred ccCCHHHHHHHHHHccCChhHCcC-HHHHH
Confidence 456778999999999999999984 55554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=362.25 Aligned_cols=240 Identities=25% Similarity=0.367 Sum_probs=198.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-CC----eEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEAL 291 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 291 (467)
.+|++.+.||+|+||+||+|.+.. |+ +||+|.++... ....+++.+|++++++++||||+++++++.+++ .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence 469999999999999999998753 43 58888886442 345678999999999999999999999998754 578
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCC
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGK 371 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 371 (467)
++||+.+|+|.+.+......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 88999999999998888788999999999999999999999 999999999999999999999999999999876543
Q ss_pred Cc-------cccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCccccccccHHHHHhh--------hccccc
Q 041491 372 ES-------MRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEEMNLKNWVND--------FLPISV 435 (467)
Q Consensus 372 ~~-------~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~ 435 (467)
.. .++..|.|||++.++.++.++|||||||++|||+| |+.||.+....+ +...+.. .+++++
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLPQPPICTIDV 242 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTCCCCCCTTBCHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCCCCcccCHHH
Confidence 22 34678999999999999999999999999999999 788987654332 2222221 234458
Q ss_pred ccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 436 MNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 436 ~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
.+++.+|+..||.+|+ ++.|++..+.++
T Consensus 243 ~~li~~cl~~dP~~RP-s~~eil~~l~~~ 270 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRP-KFRELIIEFSKM 270 (317)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCc-CHHHHHHHHHHH
Confidence 9999999999999997 566777665543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=359.79 Aligned_cols=237 Identities=23% Similarity=0.273 Sum_probs=191.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999985 58999999996543 2345788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC--
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE-- 372 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 372 (467)
|+.++.+..........+++..+..++.|++.||+||| ++|||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 99776555444455567999999999999999999999 9999999999999999999999999999998765432
Q ss_pred ---ccccccccccccccCCC-CCCcccchhhHHHHHHHhcCCCCCCccccccccHH------------------------
Q 041491 373 ---SMRTQTLATIEYGREGQ-VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK------------------------ 424 (467)
Q Consensus 373 ---~~~~~~~~~pe~~~~~~-~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~------------------------ 424 (467)
..++..|.+||...... ++.++||||+||++|||++|+.||.+....+....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 24667788898765554 57899999999999999999999975422211000
Q ss_pred ----------HHHhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 425 ----------NWVNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 425 ----------~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
......+++++.+++.+||..||.+|++ ++|++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t-~~ell 281 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS-AKAAL 281 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC-HHHHH
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC-HHHHh
Confidence 0011123345788999999999999984 44443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=359.01 Aligned_cols=232 Identities=22% Similarity=0.261 Sum_probs=187.1
Q ss_pred cCCccCcccceeEEEEEec-CCCeEEEEEeecccc-----cchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 222 EKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-----GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 222 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
.++.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999986 489999999865432 1235688999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
++++++..+. .....+++..+..+++||+.||+||| ++||+||||||+|||+++++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 9988776655 45567899999999999999999999 9999999999999999999999999999998765432
Q ss_pred --ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccH--------------------------
Q 041491 373 --SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNL-------------------------- 423 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~-------------------------- 423 (467)
..++..|.|||.+.. ..++.++||||+||++|||+||+.||.+....+...
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 246778999998764 467999999999999999999999997532211100
Q ss_pred -------HHHHhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 424 -------KNWVNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 424 -------~~~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
........++++.+++.+||..||++|++ ++|++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s-a~e~L 278 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT-ATQAL 278 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC-HHHHH
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC-HHHHh
Confidence 01111234456888999999999999985 44444
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=357.27 Aligned_cols=249 Identities=19% Similarity=0.295 Sum_probs=192.4
Q ss_pred cHHHHHHHhccCccCCccCcccceeEEEEEecC------CCeEEEEEeeccc-ccchHHHHHHHHHHHcC-CCCCceeEE
Q 041491 209 SYQELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKII 280 (467)
Q Consensus 209 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~ 280 (467)
...++++..++|++.+.||+|+||.||+|++.. ++.||||+++... ....+.+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 345566677899999999999999999998742 4689999987543 23456678888888877 689999999
Q ss_pred EEeecC-CeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 041491 281 SSCSNG-NFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 344 (467)
Q Consensus 281 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 344 (467)
+++... +..++|||||++|+|.+++.... ..+++.++..++.|+++||+||| +++|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcC
Confidence 987654 56899999999999999986532 25889999999999999999999 999999999
Q ss_pred CCCCeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCC-CCCCcc
Q 041491 345 KPSNVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKK-KPTCEI 416 (467)
Q Consensus 345 kp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~-~Pf~~~ 416 (467)
||+|||+++++.+||+|||+|+...... ..++..|.|||.+.++.++.++|||||||++|||+||. +||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654322 24567899999999999999999999999999999975 577654
Q ss_pred ccccccHHHHHh--------hhcccccccccccccccchhHHHHHHHHHHHHHH
Q 041491 417 FCEEMNLKNWVN--------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSAL 462 (467)
Q Consensus 417 ~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~ 462 (467)
...+ .+...+. ..+++++.+++.+||..||++|+ ++.|+++.|-
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~eil~~L~ 292 (299)
T d1ywna1 241 KIDE-EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-TFSELVEHLG 292 (299)
T ss_dssp CCSH-HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHH
T ss_pred CHHH-HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCc-CHHHHHHHHH
Confidence 3222 2222222 22445689999999999999996 5666665553
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-46 Score=353.26 Aligned_cols=236 Identities=20% Similarity=0.271 Sum_probs=193.1
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||+||+|++++|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999997543 23457899999999999999999999999999999999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC---
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE--- 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 372 (467)
+.++.+..+. ...+.+++..+..++.|++.||+||| +.||+||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9877666654 55578999999999999999999999 9999999999999999999999999999998765432
Q ss_pred --ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH----------------------
Q 041491 373 --SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV---------------------- 427 (467)
Q Consensus 373 --~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~---------------------- 427 (467)
..++..|.+||.... ..++.++||||+||++|||++|+.||.+....+.....+.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 235666888888765 4568999999999999999999999975432211110000
Q ss_pred ------------hhhcccccccccccccccchhHHHHHHHHHH
Q 041491 428 ------------NDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 428 ------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
...+++.+.+++.+||..||++|++ +.|++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s-~~ell 279 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT-AKQAL 279 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC-HHHHH
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC-HHHHh
Confidence 0112334678999999999999985 45554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=355.86 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=196.7
Q ss_pred ccCccCCccCcccceeEEEEEecC-CC--eEEEEEeecc-cccchHHHHHHHHHHHcC-CCCCceeEEEEeecCCeeeEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLD-GM--EVAIKVFHLQ-FDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 292 (467)
++|++.+.||+|+||+||+|++++ |. .||||.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 689999999999999999998864 44 4778887543 233556799999999998 799999999999999999999
Q ss_pred EecccCCCHHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcE
Q 041491 293 LEYMANGSLEKCLYSS---------------NGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVA 357 (467)
Q Consensus 293 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 357 (467)
|||+++|+|.++++.. ...+++..+..++.|++.||.|+| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999998643 357899999999999999999999 9999999999999999999999
Q ss_pred EEeccccceecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCC-CCCccccccccHHHHHh----
Q 041491 358 HLSDFGIAKLLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKK-PTCEIFCEEMNLKNWVN---- 428 (467)
Q Consensus 358 kl~Dfg~a~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~-Pf~~~~~~~~~~~~~~~---- 428 (467)
||+|||+|+..... ...++..|.+||.+..+.++.++|||||||++|||++|.. ||.+.... .+...+.
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i~~~~~ 244 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQGYR 244 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGGGTCC
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhcCC
Confidence 99999999865432 2345677899999999999999999999999999999764 67553222 2222222
Q ss_pred ----hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 429 ----DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 429 ----~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..+++++.+++.+||..||++|+ ++.|+++.|-+
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~eil~~L~~ 282 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERP-SFAQILVSLNR 282 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCc-CHHHHHHHHHH
Confidence 23455699999999999999997 67777776544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=351.74 Aligned_cols=236 Identities=23% Similarity=0.393 Sum_probs=194.1
Q ss_pred CCccCcccceeEEEEEecCC----CeEEEEEeecc-cccchHHHHHHHHHHHcCCCCCceeEEEEeec-CCeeeEEEecc
Q 041491 223 KSLIGIGSFGTVYKGRFLDG----MEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNFEALVLEYM 296 (467)
Q Consensus 223 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 296 (467)
.++||+|+||+||+|++.++ ..||||+++.. .....+++.+|++++++++||||++++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999987542 25899998743 33455789999999999999999999999865 56889999999
Q ss_pred cCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCC----
Q 041491 297 ANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKE---- 372 (467)
Q Consensus 297 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 372 (467)
++|+|.+++.......++..+..++.|++.||.|+| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877778889999999999999999999 9999999999999999999999999999998765332
Q ss_pred -----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------hhccccccccc
Q 041491 373 -----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN--------DFLPISVMNVV 439 (467)
Q Consensus 373 -----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~i 439 (467)
..++..|.+||++..+.++.++||||||+++|||+||..||....... ....++. ..+++++.+++
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCCCCcccCcHHHHHHH
Confidence 234567899999999999999999999999999999888886533222 2233322 23345699999
Q ss_pred ccccccchhHHHHHHHHHHHHHHh
Q 041491 440 DTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 440 ~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.+|+..||++|+ ++.|+++.|-+
T Consensus 268 ~~cl~~dP~~RP-s~~ei~~~L~~ 290 (311)
T d1r0pa_ 268 LKCWHPKAEMRP-SFSELVSRISA 290 (311)
T ss_dssp HHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHcCCCHhHCc-CHHHHHHHHHH
Confidence 999999999996 56666666543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=356.16 Aligned_cols=236 Identities=22% Similarity=0.212 Sum_probs=193.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc------cchHHHHHHHHHHHcCC--CCCceeEEEEeecCC
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSVR--HRNLVKIISSCSNGN 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 287 (467)
.++|++.+.||+|+||.||+|++. +|+.||||+++.... ....++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999986 589999999975421 12244678999999986 899999999999999
Q ss_pred eeeEEEecccC-CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-CCcEEEeccccc
Q 041491 288 FEALVLEYMAN-GSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-DMVAHLSDFGIA 365 (467)
Q Consensus 288 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a 365 (467)
..++||||+.+ +++.+++.. ...+++.+++.++.|++.||+||| ++||+||||||+|||++. ++.+||+|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence 99999999976 577777754 357899999999999999999999 999999999999999985 479999999999
Q ss_pred eecCCCC---ccccccccccccccCCCC-CCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHhhhccccccccccc
Q 041491 366 KLLNGKE---SMRTQTLATIEYGREGQV-SPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVNDFLPISVMNVVDT 441 (467)
Q Consensus 366 ~~~~~~~---~~~~~~~~~pe~~~~~~~-~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 441 (467)
+...... ..++..|.|||++.++.+ +.++||||+||++|||+||+.||.....-. ......+..+++++.++|.+
T Consensus 159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~-~~~~~~~~~~s~~~~~li~~ 237 (273)
T d1xwsa_ 159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-RGQVFFRQRVSSECQHLIRW 237 (273)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-HCCCCCSSCCCHHHHHHHHH
T ss_pred eecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh-hcccCCCCCCCHHHHHHHHH
Confidence 8765432 346788999999887766 567899999999999999999997632100 00001234466779999999
Q ss_pred ccccchhHHHHHHHHHH
Q 041491 442 SLLRREDKYFAAKKQCV 458 (467)
Q Consensus 442 ~l~~~~~~r~~~~~~~~ 458 (467)
||..||.+|+ +++|++
T Consensus 238 ~L~~dp~~R~-s~~eil 253 (273)
T d1xwsa_ 238 CLALRPSDRP-TFEEIQ 253 (273)
T ss_dssp HTCSSGGGSC-CHHHHH
T ss_pred HccCCHhHCc-CHHHHh
Confidence 9999999997 455544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=353.09 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=198.5
Q ss_pred HHHhccCccCCccCcccceeEEEEEecC--------CCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEe
Q 041491 214 LLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSC 283 (467)
Q Consensus 214 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 283 (467)
.+..++|++.+.||+|+||.||+|++.. +..||||+++.... .....+.+|...+.++ +||||+++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3556799999999999999999998643 24799999976543 3456788899999888 799999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSN---------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 348 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 348 (467)
.+++..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccc
Confidence 99999999999999999999996543 35899999999999999999999 9999999999999
Q ss_pred eeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhc-CCCCCCcccccc
Q 041491 349 VLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFT-KKKPTCEIFCEE 420 (467)
Q Consensus 349 Ill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~t-g~~Pf~~~~~~~ 420 (467)
||++.++.+||+|||+++...... ..++..|.|||++.++.|+.++|||||||++|||+| |.+||.+.....
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 999999999999999998765332 235667899999999999999999999999999998 688887643332
Q ss_pred ccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 421 MNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 421 ~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
....+.. .+++.+.+++.+|+..||.+|+ ++.|+++.|-++
T Consensus 246 --~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp-s~~eil~~L~~i 294 (299)
T d1fgka_ 246 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDRI 294 (299)
T ss_dssp --HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCc-CHHHHHHHHHHH
Confidence 2222222 2344589999999999999997 666777666443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=354.37 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=203.3
Q ss_pred HHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcC-CCCCceeEEEEee
Q 041491 213 LLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCS 284 (467)
Q Consensus 213 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 284 (467)
+++..++|++.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 4456689999999999999999999863 357899999976433 3456788999999998 6999999999999
Q ss_pred cCCeeeEEEecccCCCHHHhhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 041491 285 NGNFEALVLEYMANGSLEKCLYSSN-----------------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 347 (467)
Q Consensus 285 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 347 (467)
+.+..++|||||++|+|.+++.... ..+++..+..++.||++||+||| +++++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccc
Confidence 9999999999999999999986543 25889999999999999999999 999999999999
Q ss_pred CeeecCCCcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccc
Q 041491 348 NVLLDDDMVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEE 420 (467)
Q Consensus 348 NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~ 420 (467)
||+++.++.+|++|||.++...... ..++..|.|||+...+.++.++|||||||++|||+|+..|+.......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999999776432 234567888998888899999999999999999999544443322232
Q ss_pred ccHHHHHhh--------hcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 421 MNLKNWVND--------FLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 421 ~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
..+.+.+.. .+++.+.+++.+|+..||++|+ ++.|+++.|.+
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~~il~~L~~ 304 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-TFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCc-CHHHHHHHHHH
Confidence 233344332 3445689999999999999997 67777776643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=350.16 Aligned_cols=237 Identities=22% Similarity=0.263 Sum_probs=192.3
Q ss_pred hccCccCCccCcccceeEEEEEec-C-CCeEEEEEeecccc--cchHHHHHHHHHHHcC---CCCCceeEEEEeec----
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-D-GMEVAIKVFHLQFD--GALKSFDAECEVLKSV---RHRNLVKIISSCSN---- 285 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 285 (467)
.++|++.+.||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 578999999999999999999984 3 56799999975432 2344577888887765 79999999999853
Q ss_pred -CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccc
Q 041491 286 -GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGI 364 (467)
Q Consensus 286 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 364 (467)
....+++|||++++++..........+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 35789999999998887666666678999999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCC----CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHH-------------
Q 041491 365 AKLLNGK----ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWV------------- 427 (467)
Q Consensus 365 a~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~------------- 427 (467)
++..... ...+|..|.|||.+.+..|+.++||||+||++|||+||+.||.+....+. +....
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSCT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchhcccc
Confidence 9865432 34567889999999999999999999999999999999999976432211 11110
Q ss_pred --------------------hhhcccccccccccccccchhHHHHHHHHHH
Q 041491 428 --------------------NDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 428 --------------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
...+++.+.+++.+||..||++|++ +.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s-a~e~L 291 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS-AYSAL 291 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC-HHHHH
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC-HHHHh
Confidence 1122334678999999999999985 44443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=352.31 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=202.7
Q ss_pred HHHHHHhccCccCCccCcccceeEEEEEec------CCCeEEEEEeecccc-cchHHHHHHHHHHHcCCCCCceeEEEEe
Q 041491 211 QELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 283 (467)
Q Consensus 211 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 283 (467)
++|++..++|++.+.||+|+||.||+|.+. +++.||||+++.... .....+.+|++++++++||||+++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 345666789999999999999999999874 257899999975432 3345689999999999999999999999
Q ss_pred ecCCeeeEEEecccCCCHHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCC
Q 041491 284 SNGNFEALVLEYMANGSLEKCLYSSN---------GILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDD 354 (467)
Q Consensus 284 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 354 (467)
...+..++||||+++|+|.+++.... ..+++..+..++.|+++||.||| +++|+||||||+|||++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCC
Confidence 99999999999999999999875422 24688999999999999999999 9999999999999999999
Q ss_pred CcEEEeccccceecCCCC-------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCC-CCCCccccccccHHHH
Q 041491 355 MVAHLSDFGIAKLLNGKE-------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKK-KPTCEIFCEEMNLKNW 426 (467)
Q Consensus 355 ~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~-~Pf~~~~~~~~~~~~~ 426 (467)
+++||+|||+|+...... ..++..|.+||...++.++.++|||||||++|||+||. .||.+....+ .+...
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-HHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-HHHHH
Confidence 999999999998765332 23456678888888889999999999999999999985 6676532222 12221
Q ss_pred Hh-------hhcccccccccccccccchhHHHHHHHHHHHHHHh
Q 041491 427 VN-------DFLPISVMNVVDTSLLRREDKYFAAKKQCVSSALS 463 (467)
Q Consensus 427 ~~-------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~ 463 (467)
.. ..+++.+.+++.+|+..+|++|+ ++.++++.|.+
T Consensus 249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-s~~~il~~L~~ 291 (308)
T d1p4oa_ 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP-SFLEIISSIKE 291 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHGG
T ss_pred HhCCCCCCcccchHHHHHHHHHHcCCChhHCc-CHHHHHHHHHH
Confidence 12 22344699999999999999997 67777776643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=346.07 Aligned_cols=240 Identities=20% Similarity=0.265 Sum_probs=186.1
Q ss_pred ccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHH--HHHHHHcCCCCCceeEEEEeecCC----eeeE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKIISSCSNGN----FEAL 291 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~~~~~~~~~~----~~~l 291 (467)
++|.+.+.||+|+||.||+|++ +|+.||||+++... .+.+.+ |+..+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5678889999999999999987 68999999986442 233444 445556789999999999997543 6799
Q ss_pred EEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 292 VLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFG-----YSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 292 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
||||+++|+|.+++++. .+++.++..++.|++.||+|+|.. +++||+||||||+|||+++++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999754 589999999999999999999932 23699999999999999999999999999998
Q ss_pred ecCCC---------CccccccccccccccCCC------CCCcccchhhHHHHHHHhcCCCCCCccccc----------cc
Q 041491 367 LLNGK---------ESMRTQTLATIEYGREGQ------VSPKSDVYGYGITLIETFTKKKPTCEIFCE----------EM 421 (467)
Q Consensus 367 ~~~~~---------~~~~~~~~~~pe~~~~~~------~~~~~Dv~slGvil~el~tg~~Pf~~~~~~----------~~ 421 (467)
..... ...++..|.|||++.+.. ++.++|||||||++|||+||..||...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76432 234678889999876543 567899999999999999999887532111 11
Q ss_pred cHHHHHhh--------hcc---------cccccccccccccchhHHHHHHHHHHHHHHhc
Q 041491 422 NLKNWVND--------FLP---------ISVMNVVDTSLLRREDKYFAAKKQCVSSALSL 464 (467)
Q Consensus 422 ~~~~~~~~--------~~~---------~~~~~~i~~~l~~~~~~r~~~~~~~~~~l~~l 464 (467)
........ .++ ..+.+++.+|+..||.+|+ ++.|.++.|-++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-TALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC-CHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc-CHHHHHHHHHHH
Confidence 11111110 111 1267899999999999997 566776666544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=347.31 Aligned_cols=238 Identities=21% Similarity=0.280 Sum_probs=194.8
Q ss_pred ccCccCCccCcccceeEEEEEec----CCCeEEEEEeeccc----ccchHHHHHHHHHHHcCCC-CCceeEEEEeecCCe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRH-RNLVKIISSCSNGNF 288 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 288 (467)
++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 37899999986542 2345678899999999977 899999999999999
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.+++|||+.+|+|.+++... +.+++..+..++.|++.|++|+| +++|+||||||+||+++.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999998654 45788999999999999999999 999999999999999999999999999999876
Q ss_pred CCCC------ccccccccccccccCC--CCCCcccchhhHHHHHHHhcCCCCCCccccccccHH---HHHh------hhc
Q 041491 369 NGKE------SMRTQTLATIEYGREG--QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK---NWVN------DFL 431 (467)
Q Consensus 369 ~~~~------~~~~~~~~~pe~~~~~--~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~---~~~~------~~~ 431 (467)
.... ..++..+.+||...+. .++.++||||+||++|||+||+.||......+.... .... ..+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 5422 2345667788877543 468899999999999999999999976543332111 1111 234
Q ss_pred ccccccccccccccchhHHHH----HHHHHHH
Q 041491 432 PISVMNVVDTSLLRREDKYFA----AKKQCVS 459 (467)
Q Consensus 432 ~~~~~~~i~~~l~~~~~~r~~----~~~~~~~ 459 (467)
++++.+++.+||..||++|++ +++|+++
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 456999999999999999986 4666553
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=345.48 Aligned_cols=232 Identities=23% Similarity=0.274 Sum_probs=183.6
Q ss_pred cCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCceeEEEEeec------CCeeeE
Q 041491 219 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN------GNFEAL 291 (467)
Q Consensus 219 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~l 291 (467)
+|+..+.||+|+||+||+|++. +|+.||||+++.... ...+|++++++++||||+++++++.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999986 499999999975432 23479999999999999999999853 335789
Q ss_pred EEecccCCCHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceec
Q 041491 292 VLEYMANGSLEKCLY--SSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLL 368 (467)
Q Consensus 292 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~ 368 (467)
||||++++.+..... .....+++.+++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444322 34457999999999999999999999 99999999999999999775 8999999999887
Q ss_pred CCCC----ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc-----------HHHHH-----
Q 041491 369 NGKE----SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN-----------LKNWV----- 427 (467)
Q Consensus 369 ~~~~----~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~-----------~~~~~----- 427 (467)
.... ..++..|.+||.... ..++.++||||+||++|||++|+.||......+.. ...|.
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 5433 345677888887654 57899999999999999999999999754322110 00010
Q ss_pred ------------------hhhcccccccccccccccchhHHHHHHHHHH
Q 041491 428 ------------------NDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 428 ------------------~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
....++++.+++.+||..||++|++ +.|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t-a~e~L 301 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT-PLEAC 301 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC-HHHHH
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC-HHHHh
Confidence 1123445778999999999999985 44554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-43 Score=332.43 Aligned_cols=240 Identities=18% Similarity=0.206 Sum_probs=200.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCC-CCceeEEEEeecCCeeeEEEe
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 294 (467)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|+++++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999986 48999999986543 23567889999999975 899999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecC-----CCcEEEeccccceecC
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDD-----DMVAHLSDFGIAKLLN 369 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~~ 369 (467)
|+ +++|.+++......+++.++..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 68999998777778999999999999999999999 999999999999999964 5689999999998764
Q ss_pred CC------------CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCccccccc--cHHH----------
Q 041491 370 GK------------ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEM--NLKN---------- 425 (467)
Q Consensus 370 ~~------------~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~--~~~~---------- 425 (467)
.. ...+|..|+|||.+.+..++.++|||||||++|||+||+.||.+...... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 32 12467889999999999999999999999999999999999975432211 1111
Q ss_pred -HHhhhcccccccccccccccchhHH--HHHHHHHHHHHH
Q 041491 426 -WVNDFLPISVMNVVDTSLLRREDKY--FAAKKQCVSSAL 462 (467)
Q Consensus 426 -~~~~~~~~~~~~~i~~~l~~~~~~r--~~~~~~~~~~l~ 462 (467)
-....+|+++.+++..|+..+|++| ++.+.+.+.+++
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1123466779999999999999988 466777766654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-43 Score=335.09 Aligned_cols=238 Identities=21% Similarity=0.269 Sum_probs=192.6
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCCCCC-ceeEEEEeecCCeeeEEEec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-LVKIISSCSNGNFEALVLEY 295 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~ 295 (467)
++|++.+.||+|+||.||+|++. +|+.||||++.... ...++.+|+++++.++|++ |+.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999985 48999999987543 2356889999999998766 55556666788899999999
Q ss_pred ccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeec---CCCcEEEeccccceecCCCC
Q 041491 296 MANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---DDMVAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 296 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~ 372 (467)
+ ++++.+.+......+++..+..++.|++.||+||| ++||+||||||+||+++ .+..+||+|||+|+.+....
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 55777777666778999999999999999999999 99999999999999975 35579999999999875322
Q ss_pred ------------ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCcccccccc--HHHH-----------H
Q 041491 373 ------------SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN--LKNW-----------V 427 (467)
Q Consensus 373 ------------~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~--~~~~-----------~ 427 (467)
..++..|+|||...+..++.++|||||||++|||+||+.||......... ...+ .
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 24677889999999999999999999999999999999999764333211 1111 2
Q ss_pred hhhcccccccccccccccchhHHH--HHHHHHHHHH
Q 041491 428 NDFLPISVMNVVDTSLLRREDKYF--AAKKQCVSSA 461 (467)
Q Consensus 428 ~~~~~~~~~~~i~~~l~~~~~~r~--~~~~~~~~~l 461 (467)
...+|+++.+++..|+..+|++|+ +.+.++++.+
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 234667799999999999999994 4555666654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=343.71 Aligned_cols=236 Identities=20% Similarity=0.232 Sum_probs=186.4
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc-ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC----eee
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----FEA 290 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 290 (467)
+++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357999999999999999999875 69999999997543 334567889999999999999999999987543 234
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCC
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNG 370 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 370 (467)
++++|+.+|+|.+++... .+++..++.++.|++.||+||| ++||+||||||+|||+++++.+||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 555667799999998653 5899999999999999999999 99999999999999999999999999999987643
Q ss_pred C--------Ccccccccccccccc-CCCCCCcccchhhHHHHHHHhcCCCCCCccccccccHH-----------------
Q 041491 371 K--------ESMRTQTLATIEYGR-EGQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLK----------------- 424 (467)
Q Consensus 371 ~--------~~~~~~~~~~pe~~~-~~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~----------------- 424 (467)
. ...++..|.+||.+. ...++.++||||+||++|||++|+.||......+....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 2 223567789999874 45678899999999999999999999975422111000
Q ss_pred ---H----------------HHhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 425 ---N----------------WVNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 425 ---~----------------~~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
. -....+++++.+++.+||..||.+|+ ++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-ta~e~L 293 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-EVEQAL 293 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC-CHHHHH
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc-CHHHHh
Confidence 0 01112334588999999999999998 455554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=333.54 Aligned_cols=236 Identities=22% Similarity=0.253 Sum_probs=192.7
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCCeeeEEEe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 294 (467)
++|++.+.||+|+||+||+|++. +++.||||+++... .....++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999986 58899999997553 2345788999999999999999999999999999999999
Q ss_pred cccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceecCCCCc-
Q 041491 295 YMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLLNGKES- 373 (467)
Q Consensus 295 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 373 (467)
++.++++..++. ..+.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999998888764 4567899999999999999999999 99999999999999999999999999999998764432
Q ss_pred ----cccccccccccccCCC-CCCcccchhhHHHHHHHhcCCCCCCccccccccHHHHHh--------------------
Q 041491 374 ----MRTQTLATIEYGREGQ-VSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNWVN-------------------- 428 (467)
Q Consensus 374 ----~~~~~~~~pe~~~~~~-~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~~~-------------------- 428 (467)
..+..+.+||...... ++.++||||+||++|||++|+.||.........+.....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 2445567888776554 689999999999999999999997543221111111100
Q ss_pred ---------------hhcccccccccccccccchhHHHHHHHHHH
Q 041491 429 ---------------DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 429 ---------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+++.+.+++.+||..||.+|++ ++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s-a~e~L 281 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-AEEAL 281 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC-HHHHT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC-HHHHh
Confidence 111234668999999999999985 44443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=337.39 Aligned_cols=237 Identities=22% Similarity=0.303 Sum_probs=186.9
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec--------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-------- 285 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 285 (467)
.++|++.+.||+|+||+||+|++. +|+.||||++.... .....++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999985 59999999986542 3345778899999999999999999998855
Q ss_pred CCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccc
Q 041491 286 GNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIA 365 (467)
Q Consensus 286 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 365 (467)
.+..++||||++++++.... .....+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 34679999999887665543 55567899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCC---------ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCcccccccc-------------
Q 041491 366 KLLNGKE---------SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN------------- 422 (467)
Q Consensus 366 ~~~~~~~---------~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~------------- 422 (467)
+...... ..++..|.+||.+.+. .+++++||||+||++|||++|+.||.+....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 8765321 2467788999987654 6899999999999999999999999753211100
Q ss_pred -----------------------HHHH-HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 423 -----------------------LKNW-VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 423 -----------------------~~~~-~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.... .....++.+.+++.+||..||++|++ ++|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s-a~elL 303 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID-SDDAL 303 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC-HHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC-HHHHH
Confidence 0000 01112334668999999999999984 44444
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-44 Score=342.71 Aligned_cols=234 Identities=20% Similarity=0.266 Sum_probs=185.6
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeecCC------
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 287 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 287 (467)
.++|++.+.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|++++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999986 49999999997543 233567889999999999999999999997654
Q ss_pred eeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEecccccee
Q 041491 288 FEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 288 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
..|+||||+ +.+|..+... +.+++..++.++.|++.||+||| ++||+||||||+|||++.++.+|++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 569999999 6688887644 46999999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCccccccccHHHH------------------
Q 041491 368 LNGKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMNLKNW------------------ 426 (467)
Q Consensus 368 ~~~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~~~~~------------------ 426 (467)
..... ..++..|.|||.+.+ ..++.++||||+||++|||++|+.||.+....+. +...
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHTCSCH
T ss_pred cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHhhhcch
Confidence 76533 346778899998765 4568999999999999999999999976422110 0000
Q ss_pred -----Hh--------------hhcccccccccccccccchhHHHHHHHHHH
Q 041491 427 -----VN--------------DFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 427 -----~~--------------~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
.. ...++.+.++|.+||..||.+|++ +.|++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-a~eiL 299 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT-AGEAL 299 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC-HHHHH
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC-HHHHh
Confidence 00 112344678999999999999985 44544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-43 Score=337.54 Aligned_cols=189 Identities=21% Similarity=0.354 Sum_probs=165.0
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeec--CCeeeEEE
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSN--GNFEALVL 293 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 293 (467)
++|++.+.||+|+||+||+|++. +|+.||+|+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999985 5899999998743 3467889999999995 9999999999874 45689999
Q ss_pred ecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCC-cEEEeccccceecCCCC
Q 041491 294 EYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDM-VAHLSDFGIAKLLNGKE 372 (467)
Q Consensus 294 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 372 (467)
||+++++|..+. +.+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999997754 45899999999999999999999 99999999999999998655 69999999998876432
Q ss_pred ----ccccccccccccccCC-CCCCcccchhhHHHHHHHhcCCCCCCcc
Q 041491 373 ----SMRTQTLATIEYGREG-QVSPKSDVYGYGITLIETFTKKKPTCEI 416 (467)
Q Consensus 373 ----~~~~~~~~~pe~~~~~-~~~~~~Dv~slGvil~el~tg~~Pf~~~ 416 (467)
..++..|.|||...+. .++.++||||+||++|||++|+.||...
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 3456778999987654 5799999999999999999999999653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=334.02 Aligned_cols=236 Identities=19% Similarity=0.272 Sum_probs=186.5
Q ss_pred hccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccc--cchHHHHHHHHHHHcCCCCCceeEEEEeecC-----Ce
Q 041491 217 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NF 288 (467)
Q Consensus 217 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 288 (467)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... ...+++.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999985 599999999975532 2346788999999999999999999998643 34
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.+++++|+.+|+|.+++.. +.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+|++|||.|...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 4667778889999999844 46999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCC--ccccccccccccccC-CCCCCcccchhhHHHHHHHhcCCCCCCcccccccc----------------------H
Q 041491 369 NGKE--SMRTQTLATIEYGRE-GQVSPKSDVYGYGITLIETFTKKKPTCEIFCEEMN----------------------L 423 (467)
Q Consensus 369 ~~~~--~~~~~~~~~pe~~~~-~~~~~~~Dv~slGvil~el~tg~~Pf~~~~~~~~~----------------------~ 423 (467)
.... ..++..|.+||.... ..++.++||||+||++|||++|+.||.+....... .
T Consensus 172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 5432 345677889997655 45689999999999999999999999653211100 0
Q ss_pred HHH--------------HhhhcccccccccccccccchhHHHHHHHHHH
Q 041491 424 KNW--------------VNDFLPISVMNVVDTSLLRREDKYFAAKKQCV 458 (467)
Q Consensus 424 ~~~--------------~~~~~~~~~~~~i~~~l~~~~~~r~~~~~~~~ 458 (467)
..+ .....++.+.++|.+||..||.+|++ +.|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-a~elL 299 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT-AAQAL 299 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC-HHHHH
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC-HHHHh
Confidence 000 11234456789999999999999985 44443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=333.60 Aligned_cols=191 Identities=22% Similarity=0.238 Sum_probs=159.3
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeeccc--ccchHHHHHHHHHHHcCCCCCceeEEEEeec------CCe
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN------GNF 288 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 288 (467)
++|++.+.||+|+||+||+|++. +|+.||||+++... ....+++.+|+.++++++||||+++++++.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999986 59999999997553 2334578899999999999999999999853 467
Q ss_pred eeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEeccccceec
Q 041491 289 EALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAKLL 368 (467)
Q Consensus 289 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 368 (467)
.|+||||+.++.+.. +. ..+++..++.++.|++.||+||| ++||+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 899999997765544 32 35899999999999999999999 999999999999999999999999999998876
Q ss_pred CCCC----ccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 369 NGKE----SMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 369 ~~~~----~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
.... ..++..|.|||.+.+..+++++||||+||++|||++|+.||.+
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 5432 3467788999999999999999999999999999999999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-37 Score=298.43 Aligned_cols=194 Identities=19% Similarity=0.241 Sum_probs=157.5
Q ss_pred ccCccCCccCcccceeEEEEEec-CCCeEEEEEeecccccchHHHHHHHHHHHcCC-----------CCCceeEEEEeec
Q 041491 218 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-----------HRNLVKIISSCSN 285 (467)
Q Consensus 218 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 285 (467)
++|++.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999985 59999999997542 33467788999888774 5789999988754
Q ss_pred --CCeeeEEEecccCCCH--HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeeecCCC-----
Q 041491 286 --GNFEALVLEYMANGSL--EKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDDDM----- 355 (467)
Q Consensus 286 --~~~~~lv~e~~~~g~L--~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~----- 355 (467)
....+++++++..+.. ..........+++..+..++.|++.||+||| + .||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence 3456666666554432 2223334457899999999999999999999 6 8999999999999997655
Q ss_pred -cEEEeccccceecCCC--CccccccccccccccCCCCCCcccchhhHHHHHHHhcCCCCCCc
Q 041491 356 -VAHLSDFGIAKLLNGK--ESMRTQTLATIEYGREGQVSPKSDVYGYGITLIETFTKKKPTCE 415 (467)
Q Consensus 356 -~~kl~Dfg~a~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Dv~slGvil~el~tg~~Pf~~ 415 (467)
.+|++|||.|...... ...++..|.|||......++.++||||+||+++||++|+.||..
T Consensus 169 ~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 4999999999876543 33467789999999999999999999999999999999999964
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3.7e-26 Score=199.79 Aligned_cols=167 Identities=15% Similarity=0.141 Sum_probs=122.7
Q ss_pred CccCCccCcccceeEEEEEecCCCeEEEEEeecccc------------------cchHHHHHHHHHHHcCCCCCceeEEE
Q 041491 220 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD------------------GALKSFDAECEVLKSVRHRNLVKIIS 281 (467)
Q Consensus 220 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~ 281 (467)
+.+.++||+|+||+||+|++.+|+.||||+++.... ........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999988899999998753210 01123456888999999999999887
Q ss_pred EeecCCeeeEEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeecCCCcEEEec
Q 041491 282 SCSNGNFEALVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNVLLDDDMVAHLSD 361 (467)
Q Consensus 282 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 361 (467)
+.. .+++|||+++..+.+ ++......++.|++.+++||| ++||+||||||+|||++++ .++|+|
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence 642 379999998866543 233445679999999999999 9999999999999999975 589999
Q ss_pred cccceecCCCCccccc--cc-cccccccCCCCCCcccchhhHHHH
Q 041491 362 FGIAKLLNGKESMRTQ--TL-ATIEYGREGQVSPKSDVYGYGITL 403 (467)
Q Consensus 362 fg~a~~~~~~~~~~~~--~~-~~pe~~~~~~~~~~~Dv~slGvil 403 (467)
||.|+....+....-. .. ...++. ...|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999876543321100 00 001221 35678899999986443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.81 E-value=3.5e-20 Score=161.45 Aligned_cols=130 Identities=26% Similarity=0.314 Sum_probs=118.5
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCC-CcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSL-PLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
+++++|+++.+ |..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..|..+++|++|+|++|+
T Consensus 13 v~Cs~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCSSC-CSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCcCcc-CCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 68899999975 55553 78999999999998644 6778999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
|++..|.+|.++++|+.|+|++|+|+++.|..|..+++|+.|+|++|++.+++.
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 998888899999999999999999999989999999999999999999987654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.5e-18 Score=150.93 Aligned_cols=135 Identities=25% Similarity=0.351 Sum_probs=117.3
Q ss_pred CeecCCCcccc-cCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC
Q 041491 1 NLSLGSNELSS-VIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN 79 (467)
Q Consensus 1 ~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N 79 (467)
+|+|++|+|++ +.+..|.++++|+.|+|++|.+.+..++.|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 33 ~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N 112 (192)
T d1w8aa_ 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp EEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS
T ss_pred EEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCc
Confidence 48999999986 45778899999999999999999888999999999999999999999888889999999999999999
Q ss_pred cccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCCC
Q 041491 80 RLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 80 ~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
+|++..|.+|..+++|+.|+|++|.+....+... -...++.+.+..|.+.|..|..
T Consensus 113 ~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~~ 168 (192)
T d1w8aa_ 113 QISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTT
T ss_pred cccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCChh
Confidence 9999888999999999999999999986543221 1234677788888888766653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=3e-18 Score=158.75 Aligned_cols=128 Identities=27% Similarity=0.281 Sum_probs=72.5
Q ss_pred CCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCC
Q 041491 5 GSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGP 84 (467)
Q Consensus 5 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 84 (467)
..|.++.+.|..|.++++|++|+|++|.+....+..+..+++|+.+++++|++++..+..|..+++|+.|+|++|++++.
T Consensus 89 ~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l 168 (284)
T d1ozna_ 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (284)
T ss_dssp SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence 34455555555555566666666666655544445555555555555655555544445555555555555555555555
Q ss_pred CCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 85 IPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 85 ~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
.+..|..+++|+.+++++|++++..|..|..+++|+.|++++|.+.+.
T Consensus 169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~ 216 (284)
T d1ozna_ 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccc
Confidence 555555555555555555555555555555555555555555555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.7e-17 Score=152.03 Aligned_cols=126 Identities=32% Similarity=0.311 Sum_probs=95.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+.+. .+..+++|++|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.+
T Consensus 60 L~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l 136 (266)
T d1p9ag_ 60 LNLDRAELTKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136 (266)
T ss_dssp EECTTSCCCEEE--CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred cccccccccccc--ccccccccccccccccccc-ccccccccccccccccccccccceeecccccccccccccccccccc
Confidence 678888888653 3567888888888888887 4566778888888888888887766667777777777777777777
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
++..+..+..+++|+.|++++|+|++.++..|..+++|+.|+|++|+|+
T Consensus 137 ~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~ 185 (266)
T d1p9ag_ 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185 (266)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ceeccccccccccchhcccccccccccCccccccccccceeecccCCCc
Confidence 7666666777777777777777777776677777777777777777777
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.70 E-value=2.8e-18 Score=161.33 Aligned_cols=47 Identities=43% Similarity=0.722 Sum_probs=35.8
Q ss_pred ccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 89 FGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 89 ~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+..+++|+.|+|++|+|+|.+|..+.++++|+.|+|++|+|+|.+|.
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 34566777788888888777787788888888888888888877764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.69 E-value=7e-18 Score=158.53 Aligned_cols=134 Identities=29% Similarity=0.472 Sum_probs=109.7
Q ss_pred eecCCCcccc--cCCcCccCCCCccEEEcCC-CcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccC
Q 041491 2 LSLGSNELSS--VIPSTFWNLNSILSFDFSS-NSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLEN 78 (467)
Q Consensus 2 L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~ 78 (467)
|+|++|++++ .+|..+++|++|++|+|++ |.++|.+|..|+++++|++|+|++|++++..+..+..+.+|+.+++++
T Consensus 55 L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~ 134 (313)
T d1ogqa_ 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134 (313)
T ss_dssp EEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCS
T ss_pred EECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccc
Confidence 6788888887 3678888888888888876 788888888888888888888888888877788888888888888888
Q ss_pred CcccCCCCccccCCCCCCEEEccCCccCCcccccccccccc-cccccccccccCCCCC
Q 041491 79 NRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYL-KDLNLSFNRLKGDIPT 135 (467)
Q Consensus 79 N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~l~l~~N~l~~~~~~ 135 (467)
|++.+.+|..+..++.|+.+++++|.+++.+|..+..+.++ +.+++++|++++..+.
T Consensus 135 N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~ 192 (313)
T d1ogqa_ 135 NALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192 (313)
T ss_dssp SEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCG
T ss_pred ccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccc
Confidence 88888888888888888888888888888888877777765 7788888888876554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.68 E-value=5e-17 Score=130.04 Aligned_cols=101 Identities=28% Similarity=0.354 Sum_probs=70.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+.+ | .+..+++|++|+|++|+|+ .+|+.|..+++|+.|++++|++++ +| .++.+++|+.|++++|+|
T Consensus 3 L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 3 LHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCC
T ss_pred EEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCcc
Confidence 67777777743 3 3677777777777777776 466667777777777777777773 33 377777777777777777
Q ss_pred cCCCC-ccccCCCCCCEEEccCCccCC
Q 041491 82 QGPIP-ESFGELTSLESLDLSVNNLSG 107 (467)
Q Consensus 82 ~~~~p-~~~~~~~~L~~L~l~~N~l~~ 107 (467)
+.... ..+..+++|+.|++++|.++.
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 64322 456777777777777777763
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1e-16 Score=146.66 Aligned_cols=132 Identities=24% Similarity=0.232 Sum_probs=109.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+++.+..|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|+++ ..+..+.++++|+.|++++|.
T Consensus 35 ~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~ 111 (266)
T d1p9ag_ 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR 111 (266)
T ss_dssp EEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSC
T ss_pred EEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccc
Confidence 3788888888877788888888999999888887 344 3577888888999888887 557778888889999999888
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIPT 135 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 135 (467)
+.+..+..+..+.+++.|++++|.+++.++..+..+++|+.+++++|++++..+.
T Consensus 112 ~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~ 166 (266)
T d1p9ag_ 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166 (266)
T ss_dssp CCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred cceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence 8877777888888899999999998877778888888899999999988875543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=1.9e-16 Score=126.58 Aligned_cols=104 Identities=27% Similarity=0.368 Sum_probs=92.8
Q ss_pred cEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCC
Q 041491 24 LSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVN 103 (467)
Q Consensus 24 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N 103 (467)
+.|||++|.|+ .++ .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+|+. +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57999999998 555 5899999999999999998 678889999999999999999995 45 5999999999999999
Q ss_pred ccCCccc-ccccccccccccccccccccCC
Q 041491 104 NLSGVIP-ISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 104 ~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
+++.... ..+..+++|+.|++++|++++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 9996643 5788999999999999999854
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=8e-17 Score=135.37 Aligned_cols=115 Identities=19% Similarity=0.113 Sum_probs=94.5
Q ss_pred cCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCC
Q 041491 15 STFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTS 94 (467)
Q Consensus 15 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~ 94 (467)
..|.+..+|++|||++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34678888999999999998 45767788899999999999998 443 5888999999999999998766666778999
Q ss_pred CCEEEccCCccCCccc-ccccccccccccccccccccCC
Q 041491 95 LESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 95 L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
|+.|++++|+++.... ..+..+++|+.|++++|+++..
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred cccceeccccccccccccccccccccchhhcCCCccccc
Confidence 9999999999985432 4678889999999999988754
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=5.6e-16 Score=143.19 Aligned_cols=133 Identities=26% Similarity=0.278 Sum_probs=102.7
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|.+..+.+..+..+.+|+.+++++|.|++..+..|..+++|+.|+|++|++++..+..|.++++|+.+++++|++
T Consensus 110 L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l 189 (284)
T d1ozna_ 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189 (284)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccc
Confidence 57777777777777777777888888888888766666777777788888888888766677777788888888888888
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++..|..|..+++|+.|++++|.+++.+|..|..+++|+.|++++|++.|+++
T Consensus 190 ~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 77777777778888888888888877777777777788888888888777544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=2.1e-16 Score=132.76 Aligned_cols=119 Identities=19% Similarity=0.173 Sum_probs=101.2
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+.+ |..+..+++|+.||||+|+|+. ++ .|..+++|++|+|++|+++...+..+..+++|+.|++++|+|
T Consensus 23 L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i 99 (162)
T d1a9na_ 23 LDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99 (162)
T ss_dssp EECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC
T ss_pred EECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceeccccc
Confidence 89999999975 6777889999999999999984 54 589999999999999999965555667899999999999999
Q ss_pred cCCCC-ccccCCCCCCEEEccCCccCCcc---cccccccccccccc
Q 041491 82 QGPIP-ESFGELTSLESLDLSVNNLSGVI---PISLEKLVYLKDLN 123 (467)
Q Consensus 82 ~~~~p-~~~~~~~~L~~L~l~~N~l~~~~---~~~~~~l~~L~~l~ 123 (467)
+.... ..+..+++|+.|++++|.++... +..+..+++|+.||
T Consensus 100 ~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 100 VELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 85322 46889999999999999998543 13578889999887
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.57 E-value=3.9e-15 Score=138.90 Aligned_cols=131 Identities=25% Similarity=0.308 Sum_probs=96.1
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCC--------------------
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGD-------------------- 60 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~-------------------- 60 (467)
+|+|++|+|+.+.+..|.++++|++|++++|.+....|..|.++++|+.|++++|+++..
T Consensus 35 ~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~ 114 (305)
T d1xkua_ 35 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114 (305)
T ss_dssp EEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCB
T ss_pred EEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccchhh
Confidence 378999999987777899999999999999999877788899998888888888876511
Q ss_pred ---------------------------CCCCcCCCC---------------------CCCEEeccCCcccCCCCccccCC
Q 041491 61 ---------------------------IPPTIGGLT---------------------NLQLLSLENNRLQGPIPESFGEL 92 (467)
Q Consensus 61 ---------------------------~~~~~~~l~---------------------~L~~l~l~~N~l~~~~p~~~~~~ 92 (467)
.+..+..++ +|+.|++++|.+++..+..|..+
T Consensus 115 l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~ 194 (305)
T d1xkua_ 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGL 194 (305)
T ss_dssp BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTC
T ss_pred hhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHhhcc
Confidence 011112223 33444444444444555667777
Q ss_pred CCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 93 TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 93 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
+.++.|++++|.+++..+..+..+++|+.|+|++|+|+.
T Consensus 195 ~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~ 233 (305)
T d1xkua_ 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233 (305)
T ss_dssp TTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS
T ss_pred ccccccccccccccccccccccccccceeeecccccccc
Confidence 788888888888887777778888888888888888774
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=8.9e-15 Score=121.79 Aligned_cols=111 Identities=19% Similarity=0.194 Sum_probs=63.1
Q ss_pred CCccEEEcCCCcccCCCCcCccCCCCccEEEccCC-cCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEE
Q 041491 21 NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRN-YLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLD 99 (467)
Q Consensus 21 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n-~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~ 99 (467)
...+.++.+++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|.+|..+++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34445566666655 34555566666666666544 35544445566666666666666666655555666666666666
Q ss_pred ccCCccCCcccccccccccccccccccccccCCC
Q 041491 100 LSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 100 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
|++|+|+...+..+.. .+|+.|+|++|+|.|++
T Consensus 87 Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 87 LSFNALESLSWKTVQG-LSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CCSSCCSCCCSTTTCS-CCCCEEECCSSCCCCCG
T ss_pred ccCCCCcccChhhhcc-ccccccccCCCcccCCc
Confidence 6666666444444433 24666666666665543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=5.8e-15 Score=122.96 Aligned_cols=133 Identities=15% Similarity=0.027 Sum_probs=101.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCC-cccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSN-SLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
++++++++.. .|..+..+++|++|++++| .|+...+++|.++++|+.|+|++|+|+...|..|.++++|++|+|++|+
T Consensus 13 l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 5778888885 5788999999999999866 5887667889999999999999999998878899999999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCccCCcc-cccccccccccccccccccccCCCCCC
Q 041491 81 LQGPIPESFGELTSLESLDLSVNNLSGVI-PISLEKLVYLKDLNLSFNRLKGDIPTR 136 (467)
Q Consensus 81 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~~ 136 (467)
|+...+..|..+ +|+.|+|++|.+.-.- -.++..+.......+..++++|.-|..
T Consensus 92 l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~ 147 (156)
T d2ifga3 92 LESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGP 147 (156)
T ss_dssp CSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSC
T ss_pred CcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChH
Confidence 996555566554 7999999999996321 112222222333444456666554443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.53 E-value=2.1e-14 Score=124.99 Aligned_cols=120 Identities=32% Similarity=0.484 Sum_probs=71.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|+|+.+ +.+..+++|++|+|++|++++..| +.++++|+.|++++|.+. .++ .+.++++|+.|++++|.+
T Consensus 45 L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~ 118 (199)
T d2omxa2 45 LQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQI 118 (199)
T ss_dssp EECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCC
T ss_pred EECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccc
Confidence 56677777653 236667777777777777764332 667777777777777665 333 355666666666666665
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
... ..+..+++|+.|++++|++... + .+..+++|+.|++++|++++
T Consensus 119 ~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 119 TDI--DPLKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CCC--GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCC
T ss_pred ccc--cccchhhhhHHhhhhhhhhccc-c-cccccccccccccccccccC
Confidence 532 2355566666666666666532 2 34555566666666665554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.49 E-value=4.9e-14 Score=131.26 Aligned_cols=125 Identities=16% Similarity=0.289 Sum_probs=67.8
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
+++++|+++.+ |..+ +++|+.|++++|.+.+..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|
T Consensus 155 l~l~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L 231 (305)
T d1xkua_ 155 IRIADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231 (305)
T ss_dssp EECCSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred cccccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccc
Confidence 34555555532 3222 34555666666655555555555566666666666666555555555566666666666665
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccc------ccccccccccccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISL------EKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~------~~l~~L~~l~l~~N~l~ 130 (467)
+ .+|.+|.++++|+.|+|++|+|+.+....| ..+.+|+.|+|++|+++
T Consensus 232 ~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 232 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp S-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred c-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 5 345555556666666666666554322222 23345555666666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.48 E-value=6.1e-14 Score=123.09 Aligned_cols=120 Identities=25% Similarity=0.365 Sum_probs=78.1
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|.++.+. .+..+++|++|+|++|+|++ ++ .+..+++|+.|++++|++++ +| .+.++++|+.|++++|.+
T Consensus 51 L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~ 124 (210)
T d1h6ta2 51 IIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGI 124 (210)
T ss_dssp EECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCC
T ss_pred EECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccccccccc
Confidence 677888887643 36778888888888888875 33 36778888888888888873 44 477778888888888777
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
.. + ..+..++.|+.+++++|.+++. ..+..+++|+.+++++|++++
T Consensus 125 ~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 125 SD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred cc-c-cccccccccccccccccccccc--ccccccccccccccccccccc
Confidence 63 2 2355555555555555555432 234445555555555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.45 E-value=1.6e-13 Score=119.22 Aligned_cols=119 Identities=26% Similarity=0.463 Sum_probs=68.6
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+++.| |+++++|++|++++|.+. .++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++
T Consensus 67 L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l 140 (199)
T d2omxa2 67 INFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTI 140 (199)
T ss_dssp EECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCC
T ss_pred CccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhh
Confidence 5666666665432 566666666666666655 233 255666666666666665522 2355566666666666666
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
.. + +.+..+++|+.|++++|++++.. .+.++++|+.|++++|+++
T Consensus 141 ~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 141 SD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 53 2 24556666666666666665432 2556666666666666655
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.41 E-value=2.3e-13 Score=130.58 Aligned_cols=125 Identities=26% Similarity=0.391 Sum_probs=93.9
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCC--------------------
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDI-------------------- 61 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~-------------------- 61 (467)
|++++|+++.+ +.+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..
T Consensus 224 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~ 299 (384)
T d2omza2 224 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED 299 (384)
T ss_dssp EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSC
T ss_pred EECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccccccc
Confidence 56777777753 356677777777777777764332 666777777777777665332
Q ss_pred CCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCCCC
Q 041491 62 PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 62 ~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
...+..+++++.|++++|++++.. .+..+++|+.|++++|+|++. + .+..+++|+.|++++|++++-+|
T Consensus 300 ~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 300 ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh
Confidence 123667789999999999999753 388899999999999999853 4 58899999999999999986543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=8.7e-16 Score=133.49 Aligned_cols=117 Identities=22% Similarity=0.273 Sum_probs=99.5
Q ss_pred CCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCC
Q 041491 13 IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGEL 92 (467)
Q Consensus 13 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~ 92 (467)
.|..|..+++|++|+|++|+|+ .++ .+.++++|+.|+|++|+++ .+|..+..+++|+.|++++|+++. + +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 3456888999999999999998 455 5999999999999999998 667666667899999999999995 3 358889
Q ss_pred CCCCEEEccCCccCCccc-ccccccccccccccccccccCCCC
Q 041491 93 TSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 93 ~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++|+.|++++|+++.... ..+..+++|+.|++++|++....+
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 999999999999986533 568899999999999999876443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.39 E-value=7.6e-13 Score=115.91 Aligned_cols=119 Identities=29% Similarity=0.439 Sum_probs=75.6
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+|++|+|+++. .++++++|++|++++|+|++ +| .+.++++|+.|++++|.++ .+ ..+..+++|+.+++++|.+
T Consensus 73 L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l 146 (210)
T d1h6ta2 73 LFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI 146 (210)
T ss_dssp EECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCC
T ss_pred EeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccccccc
Confidence 566777776543 25566777777777777663 33 4666677777777777665 22 3466666777777777776
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
++ +..+..+++|+.+++++|++++..+ +.++++|+.|++++|+++
T Consensus 147 ~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 147 TD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp CC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred cc--ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCCC
Confidence 63 2345566677777777777765322 566667777777777665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.37 E-value=1.1e-12 Score=116.52 Aligned_cols=121 Identities=22% Similarity=0.399 Sum_probs=70.5
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++.+|+|+.+ +.+..+++|++|+|++|++.+..| +..+++|+.+++++|.++ .++ .+.++++|+.+++++|..
T Consensus 46 L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~ 119 (227)
T d1h6ua2 46 LSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQI 119 (227)
T ss_dssp EECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCC
T ss_pred EECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccc
Confidence 67778888764 347778888888888888774433 677777777777777766 232 355666666666666554
Q ss_pred cCCC--------------------CccccCCCCCCEEEccCCccCCccccccccccccccccccccccc
Q 041491 82 QGPI--------------------PESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 82 ~~~~--------------------p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
.+.. ...+..+++|+.|++++|.+++.. .+.++++|+.|++++|+++
T Consensus 120 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 120 TDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp CCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccchhccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccC
Confidence 4211 012334444555555555554322 2444555555555555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=2.4e-15 Score=130.66 Aligned_cols=123 Identities=20% Similarity=0.271 Sum_probs=100.5
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCc
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNR 80 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~ 80 (467)
.|+|++|+|+.+ + .|.++++|+.|+|++|.|+ .+|..+..+++|++|++++|+++. + +.+..+++|+.|+|++|+
T Consensus 52 ~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~ 126 (198)
T d1m9la_ 52 HLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNK 126 (198)
T ss_dssp EEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEE
T ss_pred eeECcccCCCCc-c-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccccccccccch
Confidence 379999999975 3 5999999999999999998 567666667889999999999984 4 348889999999999999
Q ss_pred ccCCCC-ccccCCCCCCEEEccCCccCCccccc----------cccccccccccccccccc
Q 041491 81 LQGPIP-ESFGELTSLESLDLSVNNLSGVIPIS----------LEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 81 l~~~~p-~~~~~~~~L~~L~l~~N~l~~~~~~~----------~~~l~~L~~l~l~~N~l~ 130 (467)
|+.... ..+..+++|+.|+|++|.+....+.. +..+++|+.|| +.+++
T Consensus 127 i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 127 ITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp CCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred hccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 985322 46899999999999999997655433 56788888876 44444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.34 E-value=1.3e-12 Score=125.18 Aligned_cols=122 Identities=24% Similarity=0.410 Sum_probs=95.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|.++++.| +...++|+.|++++|+++. + +.+..+++|+.|++++|++++.. .+..+++|+.|++++|++
T Consensus 202 l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l 275 (384)
T d2omza2 202 LIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQI 275 (384)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred eeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCccc
Confidence 5788888887654 4557889999999999873 3 36788899999999999988543 377888899999888887
Q ss_pred cCCCC--------------------ccccCCCCCCEEEccCCccCCcccccccccccccccccccccccC
Q 041491 82 QGPIP--------------------ESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 82 ~~~~p--------------------~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
++..+ ..+..+++++.|++++|++++..+ +..+++|+.|++++|++++
T Consensus 276 ~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 276 SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp CCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC
Confidence 75322 235667888999999999987643 7788899999999998875
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1e-12 Score=117.75 Aligned_cols=83 Identities=20% Similarity=0.255 Sum_probs=68.2
Q ss_pred CeecCCCcccccCCcCccCCCCccEEEcCCCcccCCC-CcCccCCCCccEEEcc-CCcCCCCCCCCcCCCCCCCEEeccC
Q 041491 1 NLSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSL-PLDIENMKVVVEINLS-RNYLTGDIPPTIGGLTNLQLLSLEN 78 (467)
Q Consensus 1 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~-~n~l~~~~~~~~~~l~~L~~l~l~~ 78 (467)
+|+|++|+|+++.+..|.++++|++|+|++|.+...+ +..|.++++++++.+. .|+++...+..|.++++|+.|++++
T Consensus 33 ~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~ 112 (242)
T d1xwdc1 33 ELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112 (242)
T ss_dssp EEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEES
T ss_pred EEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccch
Confidence 3899999999888889999999999999999987544 4578888888888875 4677767777788888888888888
Q ss_pred CcccC
Q 041491 79 NRLQG 83 (467)
Q Consensus 79 N~l~~ 83 (467)
|++..
T Consensus 113 ~~l~~ 117 (242)
T d1xwdc1 113 TGIKH 117 (242)
T ss_dssp CCCCS
T ss_pred hhhcc
Confidence 87763
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.20 E-value=1.9e-11 Score=108.20 Aligned_cols=121 Identities=27% Similarity=0.397 Sum_probs=97.4
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|++++|.++.+ +.|.++++|+.|++++|...+.. .+...+.+..+.++++.+... ..+.++++|+.|++++|.+
T Consensus 90 l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~ 163 (227)
T d1h6ua2 90 LELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV 163 (227)
T ss_dssp EECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccc--ccccccccccccccccccccccc--hhccccchhhhhchhhhhchh--hhhcccccccccccccccc
Confidence 67888988864 35889999999999999987433 467788889999999988733 3477888999999999988
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCcccccccccccccccccccccccCC
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGD 132 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 132 (467)
+.. ..++++++|+.|+|++|++++. + .+.++++|+.|++++|++++-
T Consensus 164 ~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 164 SDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred ccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC
Confidence 753 3488899999999999999864 3 378889999999999998753
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=2.9e-10 Score=101.32 Aligned_cols=126 Identities=19% Similarity=0.129 Sum_probs=93.7
Q ss_pred CCCcccccCCcCccCCCCccEEEcCCCcccCCCCc-CccCCCCccEEEccCCcCCCCCCCCcCCCC-CCCEEeccCCccc
Q 041491 5 GSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPL-DIENMKVVVEINLSRNYLTGDIPPTIGGLT-NLQLLSLENNRLQ 82 (467)
Q Consensus 5 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~-~L~~l~l~~N~l~ 82 (467)
..|++....+..|.++++|+.|++++|.+....+. .+..+..+..+..++++++...+..|.+++ .++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 46788888899999999999999999999743332 345566677777788888766666777765 7888888888888
Q ss_pred CCCCccccCCCCCCE-EEccCCccCCcccccccccccccccccccccccC
Q 041491 83 GPIPESFGELTSLES-LDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 83 ~~~p~~~~~~~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 131 (467)
...+..+ +.+++.. +++++|+++..++..|.++++|+.|++++|+|+.
T Consensus 167 ~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~ 215 (242)
T d1xwdc1 167 EIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215 (242)
T ss_dssp EECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC
T ss_pred ccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCc
Confidence 5444444 3444444 4567888886666778888888888888888874
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.93 E-value=3.6e-09 Score=99.17 Aligned_cols=93 Identities=28% Similarity=0.353 Sum_probs=63.3
Q ss_pred eecCCCcccccCCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcc
Q 041491 2 LSLGSNELSSVIPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 2 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|||++|++++ +|+. .++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++... +.|++|++++|.+
T Consensus 43 LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~~n~l 110 (353)
T d1jl5a_ 43 LELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVSNNQL 110 (353)
T ss_dssp EECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECCSSCC
T ss_pred EEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---ccccccccccccc
Confidence 6778888875 4543 467778888888887 566543 46777778888776 444321 3577888888887
Q ss_pred cCCCCccccCCCCCCEEEccCCccCCc
Q 041491 82 QGPIPESFGELTSLESLDLSVNNLSGV 108 (467)
Q Consensus 82 ~~~~p~~~~~~~~L~~L~l~~N~l~~~ 108 (467)
.. +|. ++.+++|+.|++++|.++..
T Consensus 111 ~~-lp~-~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 111 EK-LPE-LQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp SS-CCC-CTTCTTCCEEECCSSCCSCC
T ss_pred cc-ccc-hhhhccceeecccccccccc
Confidence 74 453 56777888888887777643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=2.3e-08 Score=89.84 Aligned_cols=148 Identities=15% Similarity=0.108 Sum_probs=104.6
Q ss_pred HHHHHhccCccCCccCcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeee
Q 041491 212 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEA 290 (467)
Q Consensus 212 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 290 (467)
++...-..|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444456677666655555678999864 56778899887665555566788988887764 444678888888889999
Q ss_pred EEEecccCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 041491 291 LVLEYMANGSLEKCLYSSNGILDIFQRLSIMIDVALALEYLHFGY----------------------------------- 335 (467)
Q Consensus 291 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 335 (467)
+||++++|.++.+..... .....++.++++.++.||...
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998886644211 112334556666666666210
Q ss_pred ---------------------CCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 336 ---------------------SNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 336 ---------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1126899999999999987667799999876
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.80 E-value=9.8e-09 Score=96.14 Aligned_cols=100 Identities=27% Similarity=0.335 Sum_probs=81.9
Q ss_pred CCccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEc
Q 041491 21 NSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDL 100 (467)
Q Consensus 21 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l 100 (467)
.+|++|||++|.|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++. ++. + .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSD-L--PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCS-C--CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhh-h--ccccccccc
Confidence 47899999999998 68853 578999999999999 778764 589999999999984 443 1 246999999
Q ss_pred cCCccCCcccccccccccccccccccccccCCCC
Q 041491 101 SVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDIP 134 (467)
Q Consensus 101 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 134 (467)
++|.++.. |. +..+++|+.|++++|.+...+.
T Consensus 106 ~~n~l~~l-p~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 106 SNNQLEKL-PE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp CSSCCSSC-CC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred cccccccc-cc-hhhhccceeecccccccccccc
Confidence 99999854 54 5788999999999999876543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=8.2e-11 Score=98.01 Aligned_cols=67 Identities=30% Similarity=0.262 Sum_probs=31.9
Q ss_pred cCCCCccEEEccCCcCCCCC--CCCcCCCCCCCEEeccCCcccCCCCccccCCCCCCEEEccCCccCCc
Q 041491 42 ENMKVVVEINLSRNYLTGDI--PPTIGGLTNLQLLSLENNRLQGPIPESFGELTSLESLDLSVNNLSGV 108 (467)
Q Consensus 42 ~~l~~L~~l~l~~n~l~~~~--~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~ 108 (467)
..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+...+-.+.....|+.|++++|.++..
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence 34555555555555555321 12234455555555555555532221222233455555555555543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=1.1e-09 Score=99.90 Aligned_cols=130 Identities=16% Similarity=0.167 Sum_probs=83.9
Q ss_pred eecCCCccccc-CCcCccCCCCccEEEcCCCcccCCCCcCccCCCCccEEEccCC-cCCCC-CCCCcCCCCCCCEEeccC
Q 041491 2 LSLGSNELSSV-IPSTFWNLNSILSFDFSSNSLNGSLPLDIENMKVVVEINLSRN-YLTGD-IPPTIGGLTNLQLLSLEN 78 (467)
Q Consensus 2 L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n-~l~~~-~~~~~~~l~~L~~l~l~~ 78 (467)
|||++|.++.. ++..+..+++|++|+|++|.++...+..+..+++|+.|+|++| .++.. +...+.++++|++|++++
T Consensus 51 LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~ 130 (284)
T d2astb2 51 MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 130 (284)
T ss_dssp EECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCC
T ss_pred EECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccccc
Confidence 67777777643 3445667777888888877776555666677777777777774 34411 111233456666666665
Q ss_pred C-cccC-----------------------------CCCccccCCCCCCEEEccCC-ccCCcccccccccccccccccccc
Q 041491 79 N-RLQG-----------------------------PIPESFGELTSLESLDLSVN-NLSGVIPISLEKLVYLKDLNLSFN 127 (467)
Q Consensus 79 N-~l~~-----------------------------~~p~~~~~~~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~N 127 (467)
+ .++. .+...+..+++|+.|++++| .+++.....+.++++|+.|+++++
T Consensus 131 c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 131 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp CTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred ccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence 3 2220 01112345789999999885 577677788889999999999984
Q ss_pred -cccC
Q 041491 128 -RLKG 131 (467)
Q Consensus 128 -~l~~ 131 (467)
.+++
T Consensus 211 ~~i~~ 215 (284)
T d2astb2 211 YDIIP 215 (284)
T ss_dssp TTCCG
T ss_pred CCCCh
Confidence 5654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=8.3e-10 Score=100.85 Aligned_cols=85 Identities=19% Similarity=0.200 Sum_probs=57.8
Q ss_pred cCCCCccEEEcCCCcccCC-CCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCC-cccCC-CCccccCCCC
Q 041491 18 WNLNSILSFDFSSNSLNGS-LPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENN-RLQGP-IPESFGELTS 94 (467)
Q Consensus 18 ~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N-~l~~~-~p~~~~~~~~ 94 (467)
....+|++|||++|.++.. ++..+..+++|++|+|++|.+++..+..++.+++|+.|+|+++ .++.. +...+..+++
T Consensus 43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~ 122 (284)
T d2astb2 43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122 (284)
T ss_dssp CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence 3456888888888887633 3445677888888888888887666677788888888888885 45421 1112344566
Q ss_pred CCEEEccC
Q 041491 95 LESLDLSV 102 (467)
Q Consensus 95 L~~L~l~~ 102 (467)
|+.|++++
T Consensus 123 L~~L~ls~ 130 (284)
T d2astb2 123 LDELNLSW 130 (284)
T ss_dssp CCEEECCC
T ss_pred cccccccc
Confidence 66666655
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.57 E-value=1.2e-09 Score=102.81 Aligned_cols=130 Identities=21% Similarity=0.227 Sum_probs=75.3
Q ss_pred eecCCCccccc----CCcCccCCCCccEEEcCCCcccCC-----CCcCccCCCCccEEEccCCcCCCC----CCCCcCCC
Q 041491 2 LSLGSNELSSV----IPSTFWNLNSILSFDFSSNSLNGS-----LPLDIENMKVVVEINLSRNYLTGD----IPPTIGGL 68 (467)
Q Consensus 2 L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~~l 68 (467)
|++++|+++.. +...+...+.|+.|+|++|++... +...+..+++|+.|+|++|.++.. +...+..+
T Consensus 163 l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~ 242 (344)
T d2ca6a1 163 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242 (344)
T ss_dssp EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred eecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccc
Confidence 34555555421 233345567777777777776521 234456677777777777776522 33445667
Q ss_pred CCCCEEeccCCcccCCCC----ccccC--CCCCCEEEccCCccCCcc----cccc-cccccccccccccccccC
Q 041491 69 TNLQLLSLENNRLQGPIP----ESFGE--LTSLESLDLSVNNLSGVI----PISL-EKLVYLKDLNLSFNRLKG 131 (467)
Q Consensus 69 ~~L~~l~l~~N~l~~~~p----~~~~~--~~~L~~L~l~~N~l~~~~----~~~~-~~l~~L~~l~l~~N~l~~ 131 (467)
++|++|+|++|.|++... .++.. .+.|+.|++++|.++..- ...+ .++++|+.|++++|.+..
T Consensus 243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 777777777777764211 12222 355777777777775321 1222 145567777777777753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=1.8e-09 Score=89.60 Aligned_cols=107 Identities=23% Similarity=0.220 Sum_probs=76.7
Q ss_pred CccEEEcCCCcccCCCCcCccCCCCccEEEccCCcCCCCCCCCcCCCCCCCEEeccCCcccCCC--CccccCCCCCCEEE
Q 041491 22 SILSFDFSSNSLNGSLPLDIENMKVVVEINLSRNYLTGDIPPTIGGLTNLQLLSLENNRLQGPI--PESFGELTSLESLD 99 (467)
Q Consensus 22 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~--p~~~~~~~~L~~L~ 99 (467)
..+.|+++++... + .+..+..+..++..+|..+ .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4566777776532 2 3444555555556665554 44555567999999999999999643 34577899999999
Q ss_pred ccCCccCCcccccccccccccccccccccccCCC
Q 041491 100 LSVNNLSGVIPISLEKLVYLKDLNLSFNRLKGDI 133 (467)
Q Consensus 100 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 133 (467)
|++|.++...+-.+....+|+.|++++|++++..
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 9999999665534444567999999999997643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=3.9e-09 Score=102.60 Aligned_cols=59 Identities=24% Similarity=0.240 Sum_probs=24.8
Q ss_pred ccEEEcCCCcccCCC-CcCccCCCCccEEEccCCcCCC----CCCCCcCCCCCCCEEeccCCcc
Q 041491 23 ILSFDFSSNSLNGSL-PLDIENMKVVVEINLSRNYLTG----DIPPTIGGLTNLQLLSLENNRL 81 (467)
Q Consensus 23 L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~n~l~~----~~~~~~~~l~~L~~l~l~~N~l 81 (467)
|+.||+++|+++... .+-+..+++++.|+|++|.++. .++..+..+++|+.|||++|+|
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i 67 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 67 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC
T ss_pred CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcC
Confidence 444555555544211 1123334444455555554431 1222334444555555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.39 E-value=4.2e-09 Score=98.89 Aligned_cols=114 Identities=17% Similarity=0.146 Sum_probs=65.6
Q ss_pred ccCCCCccEEEcCCCcccCC----CCcCccCCCCccEEEccCCcCCCCCC----C---------CcCCCCCCCEEeccCC
Q 041491 17 FWNLNSILSFDFSSNSLNGS----LPLDIENMKVVVEINLSRNYLTGDIP----P---------TIGGLTNLQLLSLENN 79 (467)
Q Consensus 17 ~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~~~~~----~---------~~~~l~~L~~l~l~~N 79 (467)
+...++|+.|+|++|.+... +...+...++|++|++++|.++..-. . .....+.|+.|++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 55667788888888877643 22334556778888888877641100 0 0124456667777776
Q ss_pred cccCC----CCccccCCCCCCEEEccCCccCCc-----cccccccccccccccccccccc
Q 041491 80 RLQGP----IPESFGELTSLESLDLSVNNLSGV-----IPISLEKLVYLKDLNLSFNRLK 130 (467)
Q Consensus 80 ~l~~~----~p~~~~~~~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~l~l~~N~l~ 130 (467)
+++.. +...+..++.|+.|+|++|.+... +...+..+++|+.|++++|+++
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 66421 122344556677777777666521 2233455566666777766654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.38 E-value=5.9e-07 Score=79.83 Aligned_cols=130 Identities=18% Similarity=0.130 Sum_probs=87.6
Q ss_pred ccCcccc-eeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCC--CCCceeEEEEeecCCeeeEEEecccCCCH
Q 041491 225 LIGIGSF-GTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR--HRNLVKIISSCSNGNFEALVLEYMANGSL 301 (467)
Q Consensus 225 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L 301 (467)
.+..|.. +.||+....++..+++|..... ....+..|...++.+. .-.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 6789998877888999976533 2345778888887763 33477888888888889999999998765
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 041491 302 EKCLYSSNGILDIFQRLSIMIDVALALEYLHF------------------------------------------------ 333 (467)
Q Consensus 302 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------------------ 333 (467)
.+.. .... ..+.++.+.++-||.
T Consensus 94 ~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3311 1111 122233333334431
Q ss_pred -------CCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 334 -------GYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 334 -------~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
.....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 001237999999999999987667899999876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=1.2e-08 Score=99.01 Aligned_cols=108 Identities=23% Similarity=0.269 Sum_probs=83.8
Q ss_pred CeecCCCcccccC-CcCccCCCCccEEEcCCCcccC----CCCcCccCCCCccEEEccCCcCCCC----CCCCcC-CCCC
Q 041491 1 NLSLGSNELSSVI-PSTFWNLNSILSFDFSSNSLNG----SLPLDIENMKVVVEINLSRNYLTGD----IPPTIG-GLTN 70 (467)
Q Consensus 1 ~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~-~l~~ 70 (467)
.||+++|+++... .+.+..+++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+.. +...+. ...+
T Consensus 6 ~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~ 85 (460)
T d1z7xw1 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 85 (460)
T ss_dssp EEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCC
T ss_pred EEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCC
Confidence 4899999998642 4556678999999999999872 3455678899999999999998621 233333 3458
Q ss_pred CCEEeccCCcccCC----CCccccCCCCCCEEEccCCccCCc
Q 041491 71 LQLLSLENNRLQGP----IPESFGELTSLESLDLSVNNLSGV 108 (467)
Q Consensus 71 L~~l~l~~N~l~~~----~p~~~~~~~~L~~L~l~~N~l~~~ 108 (467)
|++|+|++|+++.. ++..+..+++|+.|+|++|.++..
T Consensus 86 L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~ 127 (460)
T d1z7xw1 86 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 127 (460)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred CCEEECCCCCccccccccccchhhccccccccccccccchhh
Confidence 99999999999743 455678899999999999998743
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.06 E-value=2.6e-07 Score=76.57 Aligned_cols=111 Identities=15% Similarity=0.123 Sum_probs=77.7
Q ss_pred cCCCCccEEEcCCC-cccCC----CCcCccCCCCccEEEccCCcCCC----CCCCCcCCCCCCCEEeccCCcccCC----
Q 041491 18 WNLNSILSFDFSSN-SLNGS----LPLDIENMKVVVEINLSRNYLTG----DIPPTIGGLTNLQLLSLENNRLQGP---- 84 (467)
Q Consensus 18 ~~l~~L~~L~l~~N-~l~~~----~~~~~~~l~~L~~l~l~~n~l~~----~~~~~~~~l~~L~~l~l~~N~l~~~---- 84 (467)
.+.++|++|+|+++ .++.. +-..+...++|+.|+|++|.++. .+...+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 35688999999974 46521 23356677889999999999863 2334456678999999999998742
Q ss_pred CCccccCCCCCCEEEccCCccCCcc-------ccccccccccccccccccc
Q 041491 85 IPESFGELTSLESLDLSVNNLSGVI-------PISLEKLVYLKDLNLSFNR 128 (467)
Q Consensus 85 ~p~~~~~~~~L~~L~l~~N~l~~~~-------~~~~~~l~~L~~l~l~~N~ 128 (467)
+-.++...++|+.|++++|.+...- ...+..-++|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 2235777888999999999776431 2333445677777776553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.88 E-value=1.9e-05 Score=74.61 Aligned_cols=75 Identities=16% Similarity=0.091 Sum_probs=49.6
Q ss_pred CccCcccceeEEEEEecC-CCeEEEEEeeccc-------ccchHHHHHHHHHHHcCC-C--CCceeEEEEeecCCeeeEE
Q 041491 224 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-------DGALKSFDAECEVLKSVR-H--RNLVKIISSCSNGNFEALV 292 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 292 (467)
+.||.|....||++...+ ++.+++|.-.... .....+...|.+.++.+. + ..+++++.+. .+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 568999999999998754 6789999754211 113345667888887662 2 4567777654 3445799
Q ss_pred EecccCCC
Q 041491 293 LEYMANGS 300 (467)
Q Consensus 293 ~e~~~~g~ 300 (467)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.67 E-value=2.7e-06 Score=70.26 Aligned_cols=104 Identities=16% Similarity=0.189 Sum_probs=76.6
Q ss_pred eecCCC-ccccc----CCcCccCCCCccEEEcCCCcccC----CCCcCccCCCCccEEEccCCcCCCC----CCCCcCCC
Q 041491 2 LSLGSN-ELSSV----IPSTFWNLNSILSFDFSSNSLNG----SLPLDIENMKVVVEINLSRNYLTGD----IPPTIGGL 68 (467)
Q Consensus 2 L~l~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~~l 68 (467)
|+|+++ .++.. +-..+...++|+.|+|++|.+.. .+...+...+.|++|+|++|.++.. +...+...
T Consensus 20 L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n 99 (167)
T d1pgva_ 20 VNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVT 99 (167)
T ss_dssp EECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTT
T ss_pred EEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhC
Confidence 678764 46532 33457778999999999999973 2334456678899999999999742 33457788
Q ss_pred CCCCEEeccCCcccCC-------CCccccCCCCCCEEEccCCcc
Q 041491 69 TNLQLLSLENNRLQGP-------IPESFGELTSLESLDLSVNNL 105 (467)
Q Consensus 69 ~~L~~l~l~~N~l~~~-------~p~~~~~~~~L~~L~l~~N~l 105 (467)
++|++|+|++|++... +...+...++|+.|+++.+..
T Consensus 100 ~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 100 QSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp CCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 9999999999987642 234456678999999977654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.44 E-value=1.4e-06 Score=71.90 Aligned_cols=115 Identities=17% Similarity=0.164 Sum_probs=79.8
Q ss_pred cCccCCCCccEEEcCC-CcccC----CCCcCccCCCCccEEEccCCcCCCC----CCCCcCCCCCCCEEeccCCcccCC-
Q 041491 15 STFWNLNSILSFDFSS-NSLNG----SLPLDIENMKVVVEINLSRNYLTGD----IPPTIGGLTNLQLLSLENNRLQGP- 84 (467)
Q Consensus 15 ~~~~~l~~L~~L~l~~-N~l~~----~~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~- 84 (467)
....+.++|++|+|++ |.++. .+-.++...++|++|+|++|.++.. +...+...++++.+++++|.+...
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g 90 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 90 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence 3445678999999998 45641 1334556788999999999998733 233456778999999999988632
Q ss_pred ---CCccccCCCCCCEEEc--cCCccCCc----ccccccccccccccccccccc
Q 041491 85 ---IPESFGELTSLESLDL--SVNNLSGV----IPISLEKLVYLKDLNLSFNRL 129 (467)
Q Consensus 85 ---~p~~~~~~~~L~~L~l--~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l 129 (467)
+...+...++|+.++| ++|.+... +...+...++|+.|+++.|..
T Consensus 91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 91 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2245677888987655 56677532 234455677888888876653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.33 E-value=0.00039 Score=65.34 Aligned_cols=72 Identities=18% Similarity=0.185 Sum_probs=50.6
Q ss_pred CccCcccceeEEEEEecC--------CCeEEEEEeecccccchHHHHHHHHHHHcCC-CCCceeEEEEeecCCeeeEEEe
Q 041491 224 SLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFEALVLE 294 (467)
Q Consensus 224 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 294 (467)
+.|+.|-.-.+|++...+ .+.|.+++.- .. .......+|..+++.+. +.-.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 578888999999998653 3557777764 22 22345668999988874 4445688887753 58999
Q ss_pred cccCCCH
Q 041491 295 YMANGSL 301 (467)
Q Consensus 295 ~~~~g~L 301 (467)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9988544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.18 E-value=0.00065 Score=61.89 Aligned_cols=133 Identities=13% Similarity=0.114 Sum_probs=77.5
Q ss_pred eeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCCc--eeEE-----EEeecCCeeeEEEecccCCCHH--
Q 041491 232 GTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL--VKII-----SSCSNGNFEALVLEYMANGSLE-- 302 (467)
Q Consensus 232 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~g~L~-- 302 (467)
-.||+++..+|+.|++|+.+.. ....+++..|...+..+....+ +... ..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999989999999998754 2345667888888877632111 1111 1223456778899999874321
Q ss_pred ---Hh-------------hhcC----CCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCCc
Q 041491 303 ---KC-------------LYSS----NGILDIF----------------------QRLSIMIDVALALEYL-HFGYSNPV 339 (467)
Q Consensus 303 ---~~-------------l~~~----~~~~~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~i 339 (467)
.+ .... +...+.. .....+.++...+.-. ......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 10 0000 0111111 1112222333332222 12224679
Q ss_pred eecCCCCCCeeecCCCcEEEecccccee
Q 041491 340 VHCDIKPSNVLLDDDMVAHLSDFGIAKL 367 (467)
Q Consensus 340 vH~dlkp~NIll~~~~~~kl~Dfg~a~~ 367 (467)
||+|+.|.|||++++ ..++||+.+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.07 E-value=0.0013 Score=59.40 Aligned_cols=156 Identities=13% Similarity=0.064 Sum_probs=84.0
Q ss_pred ccHHHHHHHhccCccCCcc-----CcccceeEEEEEecCCCeEEEEEeecccccchHHHHHHHHHHHcCCCCC--ceeEE
Q 041491 208 FSYQELLLATDHFSEKSLI-----GIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN--LVKII 280 (467)
Q Consensus 208 ~~~~~~~~~~~~y~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~ 280 (467)
.+.+++.....+|.+.+.. ..|---+.|+.+..+| .+++|++.... ..+.+..|++++..+...+ ++...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4566777777788775544 3565677899887554 59999986432 2345566777777663211 11111
Q ss_pred E------EeecCCeeeEEEecccCCCHHHh--------------hhc----CC--C--CCCH------------------
Q 041491 281 S------SCSNGNFEALVLEYMANGSLEKC--------------LYS----SN--G--ILDI------------------ 314 (467)
Q Consensus 281 ~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~~----~~--~--~~~~------------------ 314 (467)
. +....+....++.+..+...... ++. .. . ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 11223445566666665432110 000 00 0 0000
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCCceecCCCCCCeeecCCCcEEEeccccce
Q 041491 315 FQRLSIMIDVALALEYLH-FGYSNPVVHCDIKPSNVLLDDDMVAHLSDFGIAK 366 (467)
Q Consensus 315 ~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 366 (467)
......+......+...+ .....|+||+|+.++||+++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011122222333333333 1235789999999999999988777899999986
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.78 E-value=3.1e-05 Score=63.52 Aligned_cols=105 Identities=13% Similarity=0.213 Sum_probs=75.3
Q ss_pred eecCC-Cccccc----CCcCccCCCCccEEEcCCCcccCC----CCcCccCCCCccEEEccCCcCCCC----CCCCcCCC
Q 041491 2 LSLGS-NELSSV----IPSTFWNLNSILSFDFSSNSLNGS----LPLDIENMKVVVEINLSRNYLTGD----IPPTIGGL 68 (467)
Q Consensus 2 L~l~~-n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~~~----~~~~~~~l 68 (467)
|+|++ +.|+.. +-.++...++|++|+|++|.++.. +...+...++++.+++++|.++.. +...+...
T Consensus 22 L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~ 101 (166)
T d1io0a_ 22 VNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSN 101 (166)
T ss_dssp EECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGC
T ss_pred EEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhC
Confidence 56776 445431 344566889999999999998732 234556778999999999998732 33557788
Q ss_pred CCCCEEec--cCCcccC----CCCccccCCCCCCEEEccCCccC
Q 041491 69 TNLQLLSL--ENNRLQG----PIPESFGELTSLESLDLSVNNLS 106 (467)
Q Consensus 69 ~~L~~l~l--~~N~l~~----~~p~~~~~~~~L~~L~l~~N~l~ 106 (467)
++|+.++| ++|.+.. .+...+...++|+.|+++.|...
T Consensus 102 ~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 102 TSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp SSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred ccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 99987655 5667753 24455678899999999877653
|